PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, X; Britto, MD; Kear-Scott, JL; Boone, CD; Rocca, JR; Simmerling, C; Mckenna, R; Bieri, M; Gooley, PR; Dunn, BM; Fanucci, GE				Huang, Xi; Britto, Manuel D.; Kear-Scott, Jamie L.; Boone, Christopher D.; Rocca, James R.; Simmerling, Carlos; Mckenna, Robert; Bieri, Michael; Gooley, Paul R.; Dunn, Ben M.; Fanucci, Gail E.			The Role of Select Subtype Polymorphisms on HIV-1 Protease Conformational Sampling and Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; DRUG-RESISTANCE MUTATIONS; VIRUS TYPE-1 PROTEASE; MOLECULAR-DYNAMICS; STRUCTURAL-CHARACTERIZATION; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; EPR SPECTROSCOPY; LARGER PROTEINS	HIV-1 protease is an essential enzyme for viral particle maturation and is a target in the fight against HIV-1 infection world-wide. Several natural polymorphisms are also associated with drug resistance. Here, we utilized both pulsed electron double resonance, also called double electron-electron resonance, and NMR 15N relaxation measurements to characterize equilibrium conformational sampling and backbone dynamics of an HIV-1 protease construct containing four specific natural polymorphisms commonly found in subtypes A, F, and CRF_01 A/E. Results show enhanced backbone dynamics, particularly in the flap region, and the persistence of a novel conformational ensemble that we hypothesize is an alternative flap orientation of a curled open state or an asymmetric configuration when interacting with inhibitors.	[Huang, Xi; Britto, Manuel D.; Kear-Scott, Jamie L.; Fanucci, Gail E.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Boone, Christopher D.; Mckenna, Robert; Dunn, Ben M.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Rocca, James R.] Univ Florida, McKnight Brain Inst, Adv Magnet Resonance Imaging & Spect Facil, Gainesville, FL 32610 USA; [Simmerling, Carlos] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Bieri, Michael; Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Melbourne	Fanucci, GE (corresponding author), Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA.	fanucci@chem.ufl.edu		Gooley, Paul/0000-0002-0323-449X	National Institutes of Health [S10 RR031603, R01 GM105409, R37 AI28571]; National Science Foundation from the University of Florida Center for AIDS Research [MBC-0746533]; National High Magnetic Field Laboratory user program; National High Magnetic Field Laboratory-In-House Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028571, R37AI028571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105409] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329467] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation from the University of Florida Center for AIDS Research; National High Magnetic Field Laboratory user program; National High Magnetic Field Laboratory-In-House Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants S10 RR031603, R01 GM105409 (to G. E. F.), and R37 AI28571 (to B. M. D.). This work was also supported by National Science Foundation Grant MBC-0746533 from the University of Florida Center for AIDS Research, National High Magnetic Field Laboratory user program, and National High Magnetic Field Laboratory-In-House Research Program.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Alteri C, 2013, J ANTIMICROB CHEMOTH, V68, P2205, DOI 10.1093/jac/dkt173; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Blackburn M. E, 2010, THESIS U FLORIDA GAI; Blackburn ME, 2009, BIOCHEMISTRY-US, V48, P8765, DOI 10.1021/bi901201q; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Cai YF, 2012, J CHEM THEORY COMPUT, V8, P3452, DOI 10.1021/ct300076y; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Clemente JC, 2003, BIOCHEMISTRY-US, V42, P15029, DOI 10.1021/bi035701y; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Coman RM, 2008, BIOCHEMISTRY-US, V47, P731, DOI 10.1021/bi7018332; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; de Vera I. M. S., 2013, CURR PROTOC PROTEIN, P74; de Vera IMS, 2013, BIOCHEMISTRY-US, V52, P3278, DOI 10.1021/bi400109d; de Vera IMS, 2012, BIOCHEMISTRY-US, V51, P7813, DOI 10.1021/bi301010z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Galiano L, 2009, J PHYS CHEM B, V113, P1673, DOI 10.1021/jp8057788; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Hoffmann C, 2009, EUR BIOPHYS J BIOPHY, V38, P557, DOI 10.1007/s00249-009-0404-6; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang X, 2013, BIOMOL NMR ASSIGN, V7, P199, DOI 10.1007/s12104-012-9409-7; Huang X, 2012, J PHYS CHEM B, V116, P14235, DOI 10.1021/jp308207h; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; Ishima R, 1998, J AM CHEM SOC, V120, P10534, DOI 10.1021/ja981546c; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2006, PHYS CHEM CHEM PHYS, V8, P4095, DOI 10.1039/b607826e; Kantor R, 2002, ANTIMICROB AGENTS CH, V46, P1086, DOI 10.1128/AAC.46.4.1086-1092.2002; Sadiq SK, 2010, PROTEINS, V78, P2873, DOI 10.1002/prot.22806; Kear J. L., 2011, J BIOPHYS CHEM, V2, P137; Kear J. L., 2010, THESIS U FLORIDA GAI; Kear JL, 2009, J AM CHEM SOC, V131, P14650, DOI 10.1021/ja907088a; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mahalingam B, 2002, PROTEINS, V48, P107, DOI 10.1002/prot.10140; Mcgee D., 2010, THESIS U FLORIDA GAI; Meiselbach H, 2007, J MOL MODEL, V13, P297, DOI 10.1007/s00894-006-0121-3; MILDNER AM, 1994, BIOCHEMISTRY-US, V33, P9405, DOI 10.1021/bi00198a005; Miller JF, 2006, BIOORG MED CHEM LETT, V16, P1788, DOI 10.1016/j.bmcl.2006.01.035; Mo HM, 2007, ANTIMICROB AGENTS CH, V51, P732, DOI 10.1128/AAC.00690-06; Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4; Muzammil S, 2007, J VIROL, V81, P5144, DOI 10.1128/JVI.02706-06; Naicker P, 2013, J BIOMOL STRUCT DYN, V31, P1370, DOI 10.1080/07391102.2012.736774; Oelrichs RB, 2003, CURR HIV RES, V1, P239, DOI 10.2174/1570162033485302; Sanches M, 2007, J MOL BIOL, V369, P1029, DOI 10.1016/j.jmb.2007.03.049; Sayer JM, 2008, J BIOL CHEM, V283, P13459, DOI 10.1074/jbc.M708506200; Sayer JM, 2009, PROTEINS, V75, P556, DOI 10.1002/prot.22271; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Swanson MA, 2009, J AM CHEM SOC, V131, P15978, DOI 10.1021/ja9059816; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Torbeev VY, 2009, J AM CHEM SOC, V131, P884, DOI 10.1021/ja806526z; Tsvetkov YD, 2009, INSTRUM EXP TECH+, V52, P615, DOI 10.1134/S0020441209050017; Velaquez-Campoy Adrian, 2003, AIDS Reviews, V5, P165; Velazquez-Campoy A, 2002, BIOCHEMISTRY-US, V41, P8613, DOI 10.1021/bi020160i; Velazquez-Campoy A, 2001, P NATL ACAD SCI USA, V98, P6062, DOI 10.1073/pnas.111152698; Weber IT, 2012, ADV PROTEIN CHEM STR, V87, P57, DOI 10.1016/B978-0-12-398312-1.00003-2; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; WENIGER BG, 1994, AIDS, V8, pS13; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	71	36	36	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17203	17214		10.1074/jbc.M114.571836	http://dx.doi.org/10.1074/jbc.M114.571836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24742668	Green Published, hybrid			2022-12-28	WOS:000338016200053
J	Krueger, AB; Drasin, DJ; Lea, WA; Patrick, AN; Patnaik, S; Backos, DS; Matheson, CJ; Hu, X; Barnaeva, E; Holliday, MJ; Blevins, MA; Robin, TP; Eisenmesser, EZ; Ferrer, M; Simeonov, A; Southall, N; Reigan, P; Marugan, J; Ford, HL; Zhao, R				Krueger, Aaron B.; Drasin, David J.; Lea, Wendy A.; Patrick, Aaron N.; Patnaik, Samarjit; Backos, Donald S.; Matheson, Christopher J.; Hu, Xin; Barnaeva, Elena; Holliday, Michael J.; Blevins, Melanie A.; Robin, Tyler P.; Eisenmesser, Elan Z.; Ferrer, Marc; Simeonov, Anton; Southall, Noel; Reigan, Philip; Marugan, Juan; Ford, Heide L.; Zhao, Rui			Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES ABSENT; BRANCHIOOTORENAL SYNDROME; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BREAST-CANCER; BOR SYNDROME; SIX1; IDENTIFICATION; APOPTOSIS	Eya proteins are essential co-activators of the Six family of transcription factors and contain a unique tyrosine phosphatase domain belonging to the haloacid dehalogenase family of phosphatases. The phosphatase activity of Eya is important for the transcription of a subset of Six1-target genes, and also directs cells to the repair rather than apoptosis pathway upon DNA damage. Furthermore, Eya phosphatase activity has been shown to mediate transformation, invasion, migration, and metastasis of breast cancer cells, making it a potential new drug target for breast cancer. We have previously identified a class of N-arylidenebenzohydrazide compounds that specifically inhibit the Eya2 phosphatase. Herein, we demonstrate that these compounds are reversible inhibitors that selectively inhibit the phosphatase activity of Eya2, but not Eya3. Our mutagenesis results suggest that this class of compounds does not bind to the active site and the binding does not require the coordination with Mg2+. Moreover, these compounds likely bind within a site on the opposite face of the active site, and function as allosteric inhibitors. We also demonstrate that this class of compounds inhibits Eya2 phosphatase-mediated cell migration, setting the foundation for these molecules to be developed into chemical probes for understanding the specific function of the Eya2 phosphatase and to serve as a prototype for the development of Eya2 phosphatase specific anti-cancer drugs.	[Krueger, Aaron B.; Holliday, Michael J.; Blevins, Melanie A.; Eisenmesser, Elan Z.; Zhao, Rui] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Drasin, David J.; Patrick, Aaron N.; Robin, Tyler P.; Ford, Heide L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Lea, Wendy A.; Patnaik, Samarjit; Hu, Xin; Barnaeva, Elena; Ferrer, Marc; Simeonov, Anton; Southall, Noel; Marugan, Juan] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Backos, Donald S.; Matheson, Christopher J.; Reigan, Philip] Univ Colorado, Sch Pharm, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Colorado System; University of Colorado Anschutz Medical Campus	Marugan, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	maruganj@mail.nih.gov; heide.ford@ucdenver.edu; rui.zhao@ucdenver.edu	Backos, Donald/N-5265-2019; Backos, Donald/Q-4791-2018; Southall, Noel T/H-8991-2012	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Southall, Noel T/0000-0003-4500-880X; Robin, Tyler/0000-0002-0211-5552	Structural Biology Shared Resource of the University of Colorado Cancer Center [P30CA046934]; NATIONAL CANCER INSTITUTE [R41CA180347, T32CA082086, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497, T32GM008730, R01GM107262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA030559] Funding Source: NIH RePORTER	Structural Biology Shared Resource of the University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The x-ray and NMR facilities were supported in part by the Structural Biology Shared Resource of the University of Colorado Cancer Center (Grant P30CA046934). We thank Drs. David Jones, Geoffrey Armstrong, Natalie Ahn, and the Ahn laboratory for advice and technical help.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Auvergne RM, 2013, CELL REP, V3, P2127, DOI 10.1016/j.celrep.2013.04.035; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; De Munter S, 2013, ACS CHEM BIOL, V8, P36, DOI 10.1021/cb300597g; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Hojo M, 2002, B CHEM SOC JPN, V75, P2629, DOI 10.1246/bcsj.75.2629; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Kanaya S, 1996, J BIOL CHEM, V271, P32729, DOI 10.1074/jbc.271.51.32729; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Krueger AB, 2013, J BIOMOL SCREEN, V18, P85, DOI 10.1177/1087057112453936; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mattila E, 2011, ANTI-CANCER AGENT ME, V11, P141, DOI 10.2174/187152011794941235; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Park H, 2011, CHEM BIOL DRUG DES, V78, P642, DOI 10.1111/j.1747-0285.2011.01192.x; Patrick AN, 2013, NAT STRUCT MOL BIOL, V20, P447, DOI 10.1038/nsmb.2505; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Schneider R, 2013, J AM CHEM SOC, V135, P6838, DOI 10.1021/ja4030484; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Tadjuidje E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034806; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wang QF, 2011, BLOOD, V117, P6895, DOI 10.1182/blood-2010-12-324699; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 2002, DEVELOPMENT, V129, P3033; Zhang L, 2005, CANCER RES, V65, P925; Zhang MM, 2011, ACS CHEM BIOL, V6, P511, DOI 10.1021/cb100357t; Zhang YZ, 2004, JARO-J ASSOC RES OTO, V5, P295, DOI 10.1007/s10162-004-4044-3; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128	43	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16349	16361		10.1074/jbc.M114.566729	http://dx.doi.org/10.1074/jbc.M114.566729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755226	Green Published, hybrid			2022-12-28	WOS:000337965700038
J	Meyer, MB; Benkusky, NA; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley			The RUNX2 Cistrome in Osteoblasts CHARACTERIZATION, DOWN-REGULATION FOLLOWING DIFFERENTIATION, AND RELATIONSHIP TO GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION-FACTOR; BONE-FORMATION; DISTAL ENHANCERS; CLEIDOCRANIAL DYSPLASIA; RECEPTOR ACTIVATOR; EPIGENETIC CONTROL; CANCER CELLS; GENOME; CBFA1	RUNX2 is a transcription factor that is first expressed in early osteoblast-lineage cells and represents a primary determinant of osteoblastogenesis. While numerous target genes are regulated by RUNX2, little is known of sites on the genome occupied by RUNX2 or of the gene networks that are controlled by these sites. To explore this, we conducted a genome-wide analysis of the RUNX2 cistrome in both pre-osteoblastic MC3T3-E1 cells (POB) and their mature osteoblast progeny (OB), characterized the two cistromes and assessed their relationship to changes in gene expression. We found that although RUNX2 was widely bound to the genome in POB cells, this binding profile was reduced upon differentiation to OBs. Numerous sites were lost upon differentiation, new sites were also gained; many sites remained common to both cell states. Additional features were identified as well including location relative to potential target genes, abundance with respect to single genes, the frequent presence of a consensus TGTGGT RUNX2 binding motif, co-occupancy by C/EBP beta and the presence of a typical epigenetic histone enhancer signature. This signature was changed quantitatively following differentiation. While RUNX2 binding sites were associated extensively with adjacent genes, the distal nature of the majority of these sites prevented assessment of whether they represented direct targets of RUNX2 action. Changes in gene expression, however, revealed an abundance of genes that contained RUNX2 binding sites and were regulated in concert. These studies establish a basis for further analysis of the role of RUNX2 activity and its function during osteoblast lineage maturation.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Room 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-072281 (to J. W. P.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Delgado-Calle J, 2012, CURR GENOMICS, V13, P252, DOI 10.2174/138920212800543129; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gordon JAR, 2011, CELLS TISSUES ORGANS, V194, P146, DOI 10.1159/000324790; Hassan MQ, 2009, CELLS TISSUES ORGANS, V189, P122, DOI 10.1159/000151453; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ivkosic A, 2006, COLLEGIUM ANTROPOL, V30, P401; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lian JB, 2013, J BONE MINER RES, V28, P2060, DOI 10.1002/jbmr.2076; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Martowicz ML, 2011, J CELL BIOCHEM, V112, P2030, DOI 10.1002/jcb.23123; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saltman LH, 2005, J CELL PHYSIOL, V204, P871, DOI 10.1002/jcp.20329; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; Stein GS, 2009, BIOCHEM CELL BIOL, V87, P1, DOI 10.1139/O08-094; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Taher L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r117; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wamstad JA, 2014, TRENDS CELL BIOL, V24, P294, DOI 10.1016/j.tcb.2013.10.008; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Zaidi SK, 2006, J CELL PHYSIOL, V209, P935, DOI 10.1002/jcp.20791; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	76	85	88	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16016	16031		10.1074/jbc.M114.552216	http://dx.doi.org/10.1074/jbc.M114.552216			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764292	hybrid, Green Published			2022-12-28	WOS:000337965700012
J	Miyamoto, T; Mochizuki, T; Nakagomi, H; Kira, S; Watanabe, M; Takayama, Y; Suzuki, Y; Koizumi, S; Takeda, M; Tominaga, M				Miyamoto, Tatsuya; Mochizuki, Tsutomu; Nakagomi, Hiroshi; Kira, Satoru; Watanabe, Masaki; Takayama, Yasunori; Suzuki, Yoshiro; Koizumi, Schuichi; Takeda, Masayuki; Tominaga, Makoto			Functional Role for Piezo1 in Stretch-evoked Ca2+ Influx and ATP Release in Urothelial Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; K+ CHANNELS; ION CHANNELS; OVERACTIVE BLADDER; CATION CHANNELS; SENSORY TRANSDUCTION; ACTIVATED CHANNELS; TRP CHANNELS; FATTY-ACIDS; TRAAK	The urothelium is a sensory structure that contributes to mechanosensation in the urinary bladder. Here, we provide evidence for a critical role for the Piezo1 channel, a newly identified mechanosensory molecule, in the mouse bladder urothelium. We performed a systematic analysis of the molecular and functional expression of Piezo1 channels in the urothelium. Immunofluorescence examination demonstrated abundant expression of Piezo1 in the mouse and human urothelium. Urothelial cells isolated from mice exhibited a Piezo1-dependent increase in cytosolic Ca2+ concentrations in response to mechanical stretch stimuli, leading to potent ATP release; this response was suppressed in Piezo1-knockdown cells. In addition, Piezo1 and TRPV4 distinguished different intensities of mechanical stimulus. Moreover, GsMTx4, an inhibitor of stretch-activated channels, attenuated the Ca2+ influx into urothelial cells and decreased ATP release from them upon stretch stimulation. These results suggest that Piezo1 senses extension of the bladder urothelium, leading to production of an ATP signal. Thus, inhibition of Piezo1 might provide a promising means of treating bladder dysfunction.	[Miyamoto, Tatsuya; Mochizuki, Tsutomu; Nakagomi, Hiroshi; Kira, Satoru; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo, Yamanashi 4093898, Japan; [Watanabe, Masaki; Takayama, Yasunori; Suzuki, Yoshiro; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Suzuki, Yoshiro; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropharmacol, Chuo, Yamanashi 4093898, Japan	University of Yamanashi; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; University of Yamanashi	Mochizuki, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	tsutomu@yamanashi.ac.jp; tominaga@nips.ac.jp	Takayama, Yasunori/AAG-1133-2021; Koizumi, Schuichi/E-8568-2010	Koizumi, Schuichi/0000-0001-6184-3106; SUZUKI, YOSHIRO/0000-0003-0010-1867	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24791640, 23592361, 23390381, 23249012]; Grants-in-Aid for Scientific Research [24791640] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 24791640 (to T. Miyamoto), 23592361 (to T. Mochizuki), 23390381 (to M. Takeda), and 23249012 (to M. Tominaga) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Araki I, 2008, INT J UROL, V15, P681, DOI 10.1111/j.1442-2042.2008.02052.x; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Chai TC, 2004, NAT CLIN PRACT UROL, V1, P85, DOI 10.1038/ncpuro0057; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; de Groat WC, 2004, UROLOGY, V64, P7, DOI 10.1016/j.urology.2004.08.063; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Du SQ, 2008, UROLOGY, V72, P450, DOI 10.1016/j.urology.2007.11.127; Dunning-Davies BM, 2013, BJU INT, V111, P505, DOI 10.1111/j.1464-410X.2012.11421.x; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Everaerts W, 2008, NEUROUROL URODYNAM, V27, P264, DOI 10.1002/nau.20511; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Graham Emmanuel, 2006, Curr Urol Rep, V7, P440, DOI 10.1007/s11934-006-0051-8; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Miyaji T, 2011, J BIOL CHEM, V286, P42881, DOI 10.1074/jbc.M111.277269; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Sharif-Naeini R, 2008, PFLUG ARCH EUR J PHY, V456, P529, DOI 10.1007/s00424-007-0432-y; Shibata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023510; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sugaya K, 2009, BIOMED RES-TOKYO, V30, P287, DOI 10.2220/biomedres.30.287; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086	60	174	183	5	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16565	16575		10.1074/jbc.M113.528638	http://dx.doi.org/10.1074/jbc.M113.528638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759099	hybrid, Green Published			2022-12-28	WOS:000337965700057
J	Agarwal, V; Sroka, M; Fulde, M; Bergmann, S; Riesbeck, K; Blom, AM				Agarwal, Vaibhav; Sroka, Magdalena; Fulde, Marcus; Bergmann, Simone; Riesbeck, Kristian; Blom, Anna M.			Binding of Streptococcus pneumoniae Endopeptidase O (PepO) to Complement Component C1q Modulates the Complement Attack and Promotes Host Cell Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Complement System; Host-Pathogen Interaction; Innate Immunity; Streptococcus; c1q; Complement Activation; Host Cell Adherence; Pneumococci	PNEUMOCOCCAL SURFACE PROTEIN; FACTOR-H; C4B-BINDING PROTEIN; INNATE IMMUNITY; EVASION; PSPC; COLONIZATION; PATHOGENS; INVASION; PHAGOCYTOSIS	The Gram-positive species Streptococcus pneumoniae is a human pathogen causing severe local and life-threatening invasive diseases associated with high mortality rates and death. We demonstrated recently that pneumococcal endopeptidase O (PepO) is a ubiquitously expressed, multifunctional plasminogen and fibronectin-binding protein facilitating host cell invasion and evasion of innate immunity. In this study, we found that PepO interacts directly with the complement C1q protein, thereby attenuating the classical complement pathway and facilitating pneumococcal complement escape. PepO binds both free C1q and C1 complex in a dose-dependent manner based on ionic interactions. Our results indicate that recombinant PepO specifically inhibits the classical pathway of complement activation in both hemolytic and complement deposition assays. This inhibition is due to direct interaction of PepO with C1q, leading to a strong activation of the classical complement pathway, and results in consumption of complement components. In addition, PepO binds the classical complement pathway inhibitor C4BP, thereby regulating downstream complement activation. Importantly, pneumococcal surface-exposed PepO-C1q interaction mediates bacterial adherence to host epithelial cells. Taken together, PepO facilitates C1q-mediated bacterial adherence, whereas its localized release consumes complement as a result of its activation following binding of C1q, thus representing an additional mechanism of human complement escape by this versatile pathogen.	[Agarwal, Vaibhav; Sroka, Magdalena; Blom, Anna M.] Lund Univ, Dept Lab Med Malmo, Div Med Prot Chem, S-20502 Malmo, Sweden; [Riesbeck, Kristian] Lund Univ, Dept Lab Med Malmo, Div Med Microbiol, S-20502 Malmo, Sweden; [Fulde, Marcus] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Bergmann, Simone] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	Lund University; Lund University; Hannover Medical School; Braunschweig University of Technology	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Wallenberg Lab, Floor 4,Inga Marie Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965; Sroka, Magdalena/0000-0003-0962-6707	Swedish Research Council [K2012-66X-14928-09-5]; Foundations of Torsten Soderberg, Osterlund; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Torsten Soderberg, Osterlund; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported by Swedish Research Council Grants K2012-66X-14928-09-5), the Foundations of Torsten Soderberg, Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg, the Royal Physiographic Society in Lund, and a grant from the Skane University Hospital.; The recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2013, J IMMUNOL, V191, P4235, DOI 10.4049/jimmunol.1300279; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Forsgren A, 2001, J IMMUNOL, V167, P2112, DOI 10.4049/jimmunol.167.4.2112; Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; TENNER AJ, 1981, J IMMUNOL, V127, P648; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	35	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15833	15844		10.1074/jbc.M113.530212	http://dx.doi.org/10.1074/jbc.M113.530212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739385	Green Published, hybrid			2022-12-28	WOS:000337465400062
J	Reithinger, JH; Yim, C; Kim, S; Lee, H; Kim, H				Reithinger, Johannes H.; Yim, Chewon; Kim, Sungmin; Lee, Hunsang; Kim, Hyun			Structural and Functional Profiling of the Lateral Gate of the Sec61 Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Membrane; Membrane Protein; Protein Translocation; Yeast	SIGNAL SEQUENCE RECOGNITION; POSTTRANSLATIONAL PROTEIN-TRANSPORT; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE SEGMENTS; MEMBRANE-PROTEIN; MOLECULAR CODE; PLUG DOMAIN; CHANNEL; COMPLEX; INTEGRATION	The evolutionarily conserved Sec61 translocon mediates the translocation and membrane insertion of proteins. For the integration of proteins into the membrane, the Sec61 translocon opens laterally to the lipid bilayer. Previous studies suggest that the lateral opening of the channel is mediated by the helices TM2b and TM7 of a pore-forming subunit of the Sec61 translocon. To map key residues in TM2b and TM7 in yeast Sec61 that modulate lateral gating activity, we performed alanine scanning and in vivo site-directed photocross-linking experiments. Alanine scanning identified two groups of critical residues in the lateral gate, one group that leads to defects in the translocation and membrane insertion of proteins and the other group that causes faster translocation and facilitates membrane insertion. Photocross-linking data show that the former group of residues is located at the interface of the lateral gate. Furthermore, different degrees of defects for the membrane insertion of single- and double-spanning membrane proteins were observed depending on whether the mutations were located in TM2b or TM7. These results demonstrate subtle differences in the molecular mechanism of the signal sequence binding/opening of the lateral gate and membrane insertion of a succeeding transmembrane segment in a polytopic membrane protein.	[Yim, Chewon; Kim, Sungmin; Lee, Hunsang; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Reithinger, Johannes H.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr	Lee, Hunsang/ABC-5697-2020		National Research Foundation of Korea [2013R1A1A2A10010894, 202-2001-1-C00031]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Basic Research Grant 2013R1A1A2A10010894 and Global Research Network Grant 202-2001-1-C00031 from the National Research Foundation of Korea (to H.K.).	Bondar AN, 2010, STRUCTURE, V18, P847, DOI 10.1016/j.str.2010.04.010; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Demirci E, 2013, P NATL ACAD SCI USA, V110, P18856, DOI 10.1073/pnas.1318432110; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	48	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15845	15855		10.1074/jbc.M113.533794	http://dx.doi.org/10.1074/jbc.M113.533794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753257	Green Published, hybrid			2022-12-28	WOS:000337465400063
J	Suckow, AT; Polidori, D; Yan, W; Chon, S; Ma, JY; Leonard, J; Briscoe, CP				Suckow, Arthur T.; Polidori, David; Yan, Wen; Chon, Suhyoun; Ma, Jing Ying; Leonard, James; Briscoe, Celia P.			Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice A ROLE FOR GPR120 IN GLUCAGON SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; G Protein-coupled Receptor (GPCR); Lipid; Pancreatic Islet; Polyunsaturated Fatty Acid (PUFA); GPR120; GPR40; Long Chain Fatty Acids; Alpha Cell; Glucagon	ACID RECEPTOR GPR40; SECRETION IN-VIVO; FATTY-ACID; INSULIN-SECRETION; HUMAN ISLETS; ALPHA-CELLS; BETA-CELLS; STIMULATION; MOUSE; INVOLVEMENT	GPR40 (FFAR1) and GPR120 (FFAR4) are G-protein-coupled receptors (GPCRs) that are activated by long chain fatty acids (LCFAs). GPR40 is expressed at high levels in islets and mediates the ability of LCFAs to potentiate glucose-stimulated insulin secretion (GSIS). GPR120 is expressed at high levels in colon, adipose, and pituitary, and at more modest levels in pancreatic islets. The role of GPR120 in islets has not been explored extensively. Here, we confirm that saturated (e.g. palmitic acid) and unsaturated (e.g. docosahexaenoic acid (DHA)) LCFAs engage GPR120 and demonstrate that palmitate- and DHA-potentiated glucagon secretion are greatly reduced in isolated GPR120 KO islets. Remarkably, LCFA potentiated glucagon secretion is similarly reduced in GPR40 KO islets. Compensatory changes in mRNA expression of GPR120 in GPR40 KO islets, and vice versa, do not explain that LCFA potentiated glucagon secretion seemingly involves both receptors. LCFA-potentiated GSIS remains intact in GPR120 KO islets. Consistent with previous reports, GPR120 KO mice are hyperglycemic and glucose intolerant; however, our KO mice display evidence of a hyperactive counter-regulatory response rather than insulin resistance during insulin tolerance tests. An arginine stimulation test and a glucagon challenge confirmed both increases in glucagon secretion and liver glucagon sensitivity in GPR120 KO mice relative to WT mice. Our findings demonstrate that GPR120 is a nutrient sensor that is activated endogenously by both saturated and unsaturated long chain fatty acids and that an altered glucagon axis likely contributes to the impaired glucose homeostasis observed in GPR120 KO mice.	[Suckow, Arthur T.; Polidori, David; Yan, Wen; Chon, Suhyoun; Ma, Jing Ying; Leonard, James; Briscoe, Celia P.] Janssen Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Suckow, AT (corresponding author), MedImmune, One Med Immune Way, Gaithersburg, MD 20878 USA.	suckowa@medimmune.com						Alcazar O, 1997, DIABETES, V46, P1153, DOI 10.2337/diabetes.46.7.1153; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; De Marinis YZ, 2010, CELL METAB, V11, P543, DOI 10.1016/j.cmet.2010.04.007; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hong J, 2005, METABOLISM, V54, P1329, DOI 10.1016/j.metabol.2005.04.022; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olofsson CS, 2004, DIABETES, V53, P2836, DOI 10.2337/diabetes.53.11.2836; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Raptis DA, 2014, J HEPATOL, V60, P625, DOI 10.1016/j.jhep.2013.11.006; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Wang L, 2011, J ENDOCRINOL, V210, P173, DOI 10.1530/JOE-11-0132; WARNOTTE C, 1994, DIABETES, V43, P703, DOI 10.2337/diabetes.43.5.703; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708; Zhang C., PLOS ONE, V8	34	59	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15751	15763		10.1074/jbc.M114.568683	http://dx.doi.org/10.1074/jbc.M114.568683			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742677	hybrid, Green Published			2022-12-28	WOS:000337465400055
J	Hofherr, A; Wagner, C; Fedeles, S; Somlo, S; Kottgen, M				Hofherr, Alexis; Wagner, Claudius; Fedeles, Sorin; Somlo, Stefan; Koettgen, Michael			N-Glycosylation Determines the Abundance of the Transient Receptor Potential Channel TRPP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC LIVER-DISEASE; INTEGRAL MEMBRANE-PROTEIN; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; VANILLOID RECEPTOR-1; PLASMA-MEMBRANE; CATION CHANNEL; KIDNEY-DISEASE; GLUCOSIDASE-II; ION CHANNELS	Glycosylation plays a critical role in the biogenesis and function of membrane proteins. Transient receptor potential channel TRPP2 is a nonselective cation channel that is mutated in autosomal dominant polycystic kidney disease. TRPP2 has been shown to be heavily N-glycosylated, but the glycosylation sites and the biological role of N-linked glycosylation have not been investigated. Here we show, using a combination of mass spectrometry and biochemical approaches, that native TRPP2 is glycosylated at five asparagines in the first extracellular loop. Glycosylation is required for the efficient biogenesis of TRPP2 because mutations of the glycosylated asparagines result in strongly decreased protein expression of the ion channel. Wildtype and N-glycosylation-deficient TRPP2 is degraded in lysosomes, as shown by increased TRPP2 protein levels upon chemical inhibition of lysosomal degradation. In addition, using pharmacological and genetic approaches, we demonstrate that glucosidase II (GII) mediates glycan trimming of TRPP2. The non-catalytic beta subunit of glucosidase II (GII beta) is encoded by PRKCSH, one of the genes causing autosomal dominant polycystic liver disease (ADPLD). The impaired GII beta-dependent glucose trimming of TRPP2 glycosylation in ADPLD may explain the decreased TRPP2 protein expression in Prkcsh(-/-) mice and the genetic interaction observed between TRPP2 and PRKCSH in ADPLD. These results highlight the biological importance of N-linked glycosylation and GII-mediated glycan trimming in the control of biogenesis and stability of TRPP2.	[Hofherr, Alexis; Wagner, Claudius; Koettgen, Michael] Univ Med Ctr Freiburg, Div Renal, Dept Med, D-79106 Freiburg, Germany; [Hofherr, Alexis] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Hofherr, Alexis] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Fedeles, Sorin; Somlo, Stefan] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Fedeles, Sorin; Somlo, Stefan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Freiburg; University of Freiburg; University of Freiburg; Yale University; Yale University	Hofherr, A (corresponding author), Univ Med Ctr Freiburg, Div Renal, Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	alexis.hofherr@uniklinik-freiburg.de; michael.koettgen@uniklinik-freiburg.de	Fedeles, Sorin/AAI-7395-2020	Kottgen, Michael/0000-0003-2406-5039; , Alexis/0000-0003-2842-6161	NIDDK [P30 DK090868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051041, R01DK054053, P30DK090868] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies utilized reagents provided by the NIDDK sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center, P30 DK090868. We thank Feng Qian for providing plasmids, Gerd Walz for TRPP2 antibodies, and Simone Diederichsen and Julia Merkel for technical assistance.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoffmeister H, 2011, J CELL BIOL, V192, P631, DOI 10.1083/jcb.201007050; Hoffmeister H, 2011, BIOCHEM J, V433, P285, DOI 10.1042/BJ20101141; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Qian F, 2005, PFLUG ARCH EUR J PHY, V451, P277, DOI 10.1007/s00424-005-1469-4; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Streets AJ, 2010, MOL BIOL CELL, V21, P3853, DOI 10.1091/mbc.E10-04-0377; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; United States Renal Data System, 2012, USRDS 2012 ANN DAT R, P362; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	60	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14854	14867		10.1074/jbc.M114.562264	http://dx.doi.org/10.1074/jbc.M114.562264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719335	Green Published, hybrid			2022-12-28	WOS:000337248100038
J	Ray, MS; Moskovich, O; Iosefson, O; Fishelson, Z				Ray, Moran Saar; Moskovich, Oren; Iosefson, Ohad; Fishelson, Zvi			Mortalin/GRP75 Binds to Complement C9 and Plays a Role in Resistance to Complement-dependent Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; HUMAN-NEUTROPHILS; NUCLEATED CELLS; PLASMA-MEMBRANE; REMOVAL; RECOVERY; ANTIBODY; LEVEL	Mortalin/GRP75, the mitochondrial heat shock protein 70, plays a role in cell protection from complement-dependent cytotoxicity (CDC). As shown here, interference with mortalin synthesis enhances sensitivity of K562 erythroleukemia cells to CDC, whereas overexpression of mortalin leads to their resistance to CDC. Quantification of the binding of the C5b-9 membrane attack complex to cells during complement activation shows an inverse correlation between C5b-9 deposition and the level of mortalin in the cell. Following transfection, mortalin-enhanced GFP (EGFP) is located primarily in mitochondria, whereas mortalin Delta 51-EGFP lacking the mitochondrial targeting sequence is distributed throughout the cytoplasm. Over-expressed cytosolic mortalin Delta 51-EGFP has a reduced protective capacity against CDC relative to mitochondrial mortalin-EGFP. Mortalin was previously shown by us to bind to components of the C5b-9 complex. Two functional domains of mortalin, the N-terminal ATPase domain and the C-terminal substrate-binding domain, were purified after expression in bacteria. Similar to intact mortalin, the ATPase domain, but not the substrate-binding domain, was found to bind to complement proteins C8 and C9 and to inhibit zinc-induced polymerization of C9. Binding of mortalin to complement C9 and C8 occurs through an ionic interaction that is nucleotide-sensitive. We suggest that to express its full protective effect from CDC, mortalin must first reach the mitochondria. In addition, mortalin can potentially target the C8 and C9 complement components through its ATPase domain and inhibit C5b-9 assembly and stability.	[Ray, Moran Saar; Moskovich, Oren; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Iosefson, Ohad] Tel Aviv Univ, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Fishelson, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	lifish@post.tau.ac.il			Israel Science Foundation; German-Israel Science Foundation; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); German-Israel Science Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Cancer Association	This work was supported in part by grants from the Israel Science Foundation, the German-Israel Science Foundation, and the Israel Cancer Association.	BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; CARNEY DF, 1985, J IMMUNOL, V134, P1804; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Gancz D, 2009, MOL IMMUNOL, V46, P2794, DOI 10.1016/j.molimm.2009.05.009; Iosefson O, 2010, FEBS LETT, V584, P1080, DOI 10.1016/j.febslet.2010.02.019; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; MORGAN BP, 1987, J IMMUNOL, V138, P246; MORGAN BP, 1989, BIOCHEM J, V264, P1; Morris JC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001215; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Moskovich O, 2012, J BIOL CHEM, V287, P19904, DOI 10.1074/jbc.M111.333039; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; REITER Y, 1992, EUR J IMMUNOL, V22, P1207, DOI 10.1002/eji.1830220515; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Taurin S, 2002, CIRC RES, V91, P915, DOI 10.1161/01.RES.0000043020.45534.3E; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; TSCHOPP J, 1984, J BIOL CHEM, V259, P569; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Ziporen L, 2009, J IMMUNOL, V182, P515, DOI 10.4049/jimmunol.182.1.515	29	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15014	15022		10.1074/jbc.M114.552406	http://dx.doi.org/10.1074/jbc.M114.552406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719326	Green Published, hybrid			2022-12-28	WOS:000337248100053
J	Wang, TY; Bruggeman, KAF; Sheean, RK; Turner, BJ; Nisbet, DR; Parish, CL				Wang, Ting-Yi; Bruggeman, Kiara A. F.; Sheean, Rebecca K.; Turner, Bradley J.; Nisbet, David R.; Parish, Clare L.			Characterization of the Stability and Bio-functionality of Tethered Proteins on Bioengineered Scaffolds IMPLICATIONS FOR STEM CELL BIOLOGY AND TISSUE REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; GROWTH-FACTOR; GDNF; SURVIVAL; NEURONS; DIFFERENTIATION; PROLIFERATION; PARKINSONS; STRIATUM; SURFACE	Various engineering applications have been utilized to deliver molecules and compounds in both innate and biological settings. In the context of biological applications, the timely delivery of molecules can be critical for cellular and organ function. As such, previous studies have demonstrated the superiority of long-term protein delivery, by way of protein tethering onto bio-engineered scaffolds, compared with conventional delivery of soluble protein in vitro and in vivo. Despite such benefits little knowledge exists regarding the stability, release kinetics, longevity, activation of intracellular pathway, and functionality of these proteins over time. By way of example, here we examined the stability, degradation and functionality of a protein, glial-derived neurotrophic factor (GDNF), which is known to influence neuronal survival, differentiation, and neurite morphogenesis. Enzyme-linked immunosorbent assays (ELISA) revealed that GDNF, covalently tethered onto polycaprolactone (PCL) electrospun nanofibrous scaffolds, remained present on the scaffold surface for 120 days, with no evidence of protein leaching or degradation. The tethered GDNF protein remained functional and capable of activating downstream signaling cascades, as revealed by its capacity to phosphorylate intracellular Erk in a neural cell line. Furthermore, immobilization of GDNF protein promoted cell survival and differentiation in culture at both 3 and 7 days, further validating prolonged functionality of the protein, well beyond the minutes to hours timeframe observed for soluble proteins under the same culture conditions. This study provides important evidence of the stability and functionality kinetics of tethered molecules.	[Parish, Clare L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Bruggeman, Kiara A. F.; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT 0200, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Australian National University	Nisbet, DR (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	david.nisbet@anu.edu.au; cparish@unimelb.edu.au		Turner, Bradley/0000-0001-6580-7655; Nisbet, David/0000-0002-1343-0769; Parish, Clare/0000-0001-8212-9884; Wang, Ting-Yi/0000-0001-7722-8087	Australian Microscopy and Microanalysis Research Facility (AMMRF)	Australian Microscopy and Microanalysis Research Facility (AMMRF)	We thank Francesca Maclean for electrospinning and Dr. Francesca Ercole for assistance with the determination of attached amines. Access to the facilities of the Centre for Advanced Microscopy (CAM) with funding through the Australian Microscopy and Microanalysis Research Facility (AMMRF) is gratefully acknowledged.	Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Enomoto Hideki, 2005, Anatomical Science International, V80, P42; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Haniu M, 1996, BIOCHEMISTRY-US, V35, P16799, DOI 10.1021/bi9605550; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883; Kauhausen J, 2013, J PHYSIOL-LONDON, V591, P77, DOI 10.1113/jphysiol.2012.243063; Lee CS, 2005, EXP NEUROL, V191, P65, DOI 10.1016/j.expneurol.2004.08.025; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573; Nakajima K, 2001, BRAIN RES, V916, P76, DOI 10.1016/S0006-8993(01)02866-9; Nisbet DR, 2006, J COLLOID INTERF SCI, V299, P647, DOI 10.1016/j.jcis.2006.02.057; Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086; Nisbet DR, 2009, COLLOID SURFACE B, V71, pCP1, DOI 10.1016/j.colsurfb.2009.01.022; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Ortiz-Ortiz MA, 2011, ENVIRON TOXICOL PHAR, V31, P129, DOI 10.1016/j.etap.2010.09.013; Redmond DE, 2009, J COMP NEUROL, V515, P31, DOI 10.1002/cne.22028; Rosenblad C, 1996, NEUROSCIENCE, V75, P979; Sandhu JK, 2009, NEUROBIOL DIS, V33, P405, DOI 10.1016/j.nbd.2008.11.016; SHARPLES.NE, 1966, BIOCHEMISTRY-US, V5, P2963, DOI 10.1021/bi00873a028; Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020; Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013	26	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15044	15051		10.1074/jbc.M113.537381	http://dx.doi.org/10.1074/jbc.M113.537381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24700461	hybrid, Green Published			2022-12-28	WOS:000337248100056
J	Silacci, M; Baenziger-Tobler, N; Lembke, W; Zha, WJ; Batey, S; Bertschinger, J; Grabulovski, D				Silacci, Michela; Baenziger-Tobler, Nadja; Lembke, Wibke; Zha, Wenjuan; Batey, Sarah; Bertschinger, Julian; Grabulovski, Dragan			Linker Length Matters, Fynomer-Fc Fusion with an Optimized Linker Displaying Picomolar IL-17A Inhibition Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Discovery; Inflammation; Interleukin; Protein Engineering; SH3 Domains; Fynomer	ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; BINDING-PROTEINS; INTERLEUKIN-17; FRAGMENTS; SELECTION; DOMAINS; ALPHA; CELLS	Background: IL-17A is a proinflammatory cytokine involved in various inflammatory diseases. Results: Potent IL-17A inhibitors were generated by fusing human Fyn SH3 domain derivatives (Fynomers) to the Fc part of an antibody. Conclusion: The linker length between the Fc part and the binding domain influences significantly the potency of Fc fusion proteins. Significance: Fynomers represent a promising class of therapeutic proteins. Fynomers are small binding proteins derived from the human Fyn SH3 domain. Using phage display technology, Fynomers were generated inhibiting the activity of the proinflammatory cytokine interleukin-17A (IL-17A). One specific Fynomer called 2C1 inhibited human IL-17A in vitro with an IC50 value of 2.2 nm. Interestingly, when 2C1 was genetically fused to the Fc part of a human antibody via four different amino acid linkers to yield bivalent IL-17A binding proteins (each linker differed in length), the 2C1-Fc fusion protein with the longest linker displayed the most potent inhibitory activity. It blocked homodimeric IL-17A with an IC50 value of 21 pm, which corresponds to a hundredfold improved IC50 value as compared to the value obtained with monovalent Fynomer 2C1. In contrast, the 2C1-Fc fusion with the shortest linker showed only an approximate to 8-fold improved IC50 value of 260 pm. Furthermore, in a mouse model of acute inflammation, we have shown that the most potent 2C1-Fc fusion protein is able to efficiently inhibit IL-17A in vivo. With their suitable biophysical properties, Fynomer-Fc fusion proteins represent new drug candidates for the treatment of IL-17A mediated inflammatory conditions such as psoriasis, psoriatic arthritis, or rheumatoid arthritis.	[Silacci, Michela; Baenziger-Tobler, Nadja; Lembke, Wibke; Zha, Wenjuan; Batey, Sarah; Bertschinger, Julian; Grabulovski, Dragan] Covagen AG, CH-8952 Schlieren, Switzerland		Grabulovski, D (corresponding author), Covagen AG, Wagistr 25, CH-8952 Schlieren, Switzerland.	dragan.grabulovski@covagen.com						Allan B., 2007, Patent Number, Patent No. [WO2007/070750, 2007070750]; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Banner DW, 2013, ACTA CRYSTALLOGR D, V69, P1124, DOI 10.1107/S0907444913006574; Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bertschinger J, 2007, PROTEIN ENG DES SEL, V20, P57, DOI 10.1093/protein/gzl055; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Mourlane F, 2012, J CLIN ONCOL, V30; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Schlatter D, 2012, MABS-AUSTIN, V4, P497, DOI 10.4161/mabs.20452; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Viti F, 2000, METHOD ENZYMOL, V326, P480; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	31	37	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14392	14398		10.1074/jbc.M113.534578	http://dx.doi.org/10.1074/jbc.M113.534578			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692552	Green Published, hybrid			2022-12-28	WOS:000335984600064
J	Denoncin, K; Vertommen, D; Arts, IS; Goemans, CV; Rahuel-Clermont, S; Messens, J; Collet, JF				Denoncin, Katleen; Vertommen, Didier; Arts, Isabelle S.; Goemans, Camille V.; Rahuel-Clermont, Sophie; Messens, Joris; Collet, Jean-Francois			A New Role for Escherichia coli DsbC Protein in Protection against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Escherichia coli; Oxidative Stress; Protein Folding; Redox Regulation; Thioredoxin; DsbC; Sulfenic Acid	ARABINOSE-BINDING PROTEIN; DISULFIDE-ISOMERASE; IN-VIVO; SUGAR-BINDING; SUBSTRATE-SPECIFICITY; PERIPLASMIC PROTEIN; BOND; THIOREDOXIN; DIVERSITY; ELECTRONS	Background: DsbC is a protein-disulfide isomerase present in the periplasm of Gram-negative bacteria. Results: We discovered that DsbC also regulates the redox state of the single cysteine residue of the l-arabinose-binding protein AraF. Conclusion: DsbC is involved in the protection of single cysteine residues against oxidative stress. Significance: This finding reveals a new link between oxidative stress protection and oxidative protein folding. We report a new function for Escherichia coli DsbC, a protein best known for disulfide bond isomerization in the periplasm. We found that DsbC regulates the redox state of the single cysteine of the l-arabinose-binding protein AraF. This cysteine, which can be oxidized to a sulfenic acid, mediates the formation of a disulfide-linked homodimer under oxidative stress conditions, preventing l-arabinose binding. DsbC, unlike the homologous protein DsbG, reduces the intermolecular disulfide, restoring AraF binding properties. Thus, our results reveal a new link between oxidative protein folding and the defense mechanisms against oxidative stress.	[Denoncin, Katleen; Vertommen, Didier; Arts, Isabelle S.; Goemans, Camille V.; Collet, Jean-Francois] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Denoncin, Katleen; Arts, Isabelle S.; Goemans, Camille V.; Collet, Jean-Francois] WELBIO, B-1200 Brussels, Belgium; [Denoncin, Katleen; Arts, Isabelle S.; Goemans, Camille V.; Messens, Joris; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Messens, Joris] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Rahuel-Clermont, Sophie] Univ Lorraine, CNRS, F-54505 Vandoeuvre Les Nancy, France	Universite Catholique Louvain; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Collet, JF (corresponding author), Catholic Univ Louvain, Duve Inst, 75 Ave Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Rahuel-Clermont, Sophie/AAB-3451-2020; Messens, Joris/AAH-3008-2020	Rahuel-Clermont, Sophie/0000-0001-5143-0105; Messens, Joris/0000-0002-2128-8264; Vertommen, Didier/0000-0001-7648-8282; Collet, Jean-Francois/0000-0001-8069-7036; Goemans, Camille/0000-0002-5564-1644	European Research Council ERC [282335-Sulfenic]	European Research Council ERC(European Research Council (ERC))	This work was supported by the European Research Council (FP7/2007-2013) ERC Independent Researcher Starting Grant 282335-Sulfenic (to J.-F.C.).	Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Brot N, 2006, J BIOL CHEM, V281, P32668, DOI 10.1074/jbc.M604971200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; DECLERCK N, 1994, PROTEIN ENG, V7, P997, DOI 10.1093/protein/7.8.997; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; HORAZDOVSKY BF, 1989, J BACTERIOL, V171, P3053, DOI 10.1128/jb.171.6.3053-3059.1989; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kawazu SI, 2010, PARASITOL INT, V59, P298, DOI 10.1016/j.parint.2010.03.005; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; MAO B, 1983, J BIOL CHEM, V258, P2543; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; MILLER DM, 1979, J BIOL CHEM, V254, P7521; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NEWCOMER ME, 1979, J BIOL CHEM, V254, P7529; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3213; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; VERMERSCH PS, 1990, J BIOL CHEM, V265, P16592; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x	35	20	21	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12356	12364		10.1074/jbc.M114.554055	http://dx.doi.org/10.1074/jbc.M114.554055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634211	hybrid, Green Published			2022-12-28	WOS:000335581400014
J	Liu, SL; Premont, RT; Rockey, DC				Liu, Songling; Premont, Richard T.; Rockey, Don C.			Endothelial Nitric-oxide Synthase (eNOS) Is Activated through G-protein-coupled Receptor Kinase-interacting Protein 1 (GIT1) Tyrosine Phosphorylation and Src Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAVEOLIN BINDING; ANGIOTENSIN-II; RAT-LIVER; EXPRESSION; COMPLEX; CELLS; TRANSACTIVATION; IDENTIFICATION; CLONING; DOMAIN	Nitric oxide (NO) is a critical regulator of vascular tone and plays an especially prominent role in liver by controlling portal blood flow and pressure within liver sinusoids. Synthesis of NO in sinusoidal endothelial cells by endothelial nitric-oxide synthase (eNOS) is regulated in response to activation of endothelial cells by vasoactive signals such as endothelins. The endothelin B (ETB) receptor is a G-protein-coupled receptor, but the mechanisms by which it regulates eNOS activity in sinusoidal endothelial cells are not well understood. In this study, we built on two previous strands of work, the first showing that G-protein beta gamma subunits mediated activation of phosphatidylinositol 3-kinase and Akt to regulate eNOS and the second showing that eNOS directly bound to the G-protein-coupled receptor kinase-interacting protein 1 (GIT1) scaffold protein, and this association stimulated NO production. Here we investigated the mechanisms by which the GIT1-eNOS complex is formed and regulated. GIT1 was phosphorylated on tyrosine by Src, and Y293F and Y554F mutations reduced GIT1 phosphorylation as well as the ability of GIT1 to bind to and activate eNOS. Akt phosphorylation activated eNOS (at Ser(1177)), and Akt also regulated the ability of Src to phosphorylate GIT1 as well as GIT1-eNOS association. These pathways were activated by endothelin-1 through the ETB receptor; inhibiting receptor-activated G-protein beta gamma subunits blocked activation of Akt, GIT1 tyrosine phosphorylation, and ET-1-stimulated GIT1-eNOS association but did not affect Src activation. These data suggest a model in which Src and Akt cooperate to regulate association of eNOS with the GIT1 scaffold to facilitate NO production.	[Liu, Songling; Rockey, Don C.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Premont, Richard T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Medical University of South Carolina; Duke University	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Med, 96 Jonathan Lucas St,Suite 803,MSC 623, Charleston, SC 29425 USA.	rockey@musc.edu		Premont, Richard/0000-0002-8053-5026	National Institutes of Health [R01 DK 57830]; Burroughs Wellcome Fund Translational Scientist Award; American Liver Fund Liver Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Translational Scientist Award(Burroughs Wellcome Fund); American Liver Fund Liver Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 57830 (to D. C. R.). This work was also supported by a Burroughs Wellcome Fund Translational Scientist Award (to D. C. R.) and an American Liver Fund Liver Scholar Award (to S. L.).	Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; HOUSSET C, 1993, P NATL ACAD SCI USA, V90, P9266, DOI 10.1073/pnas.90.20.9266; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; Liu SL, 2012, J BIOL CHEM, V287, P12309, DOI 10.1074/jbc.M111.320465; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Manabe R, 2002, J CELL SCI, V115, P1497; McGarrigle Deirdre, 2007, Sci STKE, V2007, ppe35, DOI 10.1126/stke.3922007pe35; Menon P, 2010, J CELL PHYSIOL, V225, P777, DOI 10.1002/jcp.22282; Natarajan Kanchana, 2006, V332, P51; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ribas C, 2002, J BIOL CHEM, V277, P50223, DOI 10.1074/jbc.C200567200; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Ruan L, 2013, VASC PHARMACOL, V59, P27, DOI 10.1016/j.vph.2013.05.004; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Schmalzigaug R, 2007, J HISTOCHEM CYTOCHEM, V55, P1039, DOI 10.1369/jhc.7A7207.2007; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Spinella F, 2013, J MOL MED, V91, P395, DOI 10.1007/s00109-012-0956-2; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Su KH, 2009, CARDIOVASC RES, V82, P468, DOI 10.1093/cvr/cvp091; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Yu Q, 2002, AM J PHYSIOL-GASTR L, V282, pG565, DOI 10.1152/ajpgi.00512.2000; Zhan SX, 2009, GASTROENTEROLOGY, V136, P2345, DOI 10.1053/j.gastro.2009.01.062; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	53	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2014	289	26					18163	18174		10.1074/jbc.M113.521203	http://dx.doi.org/10.1074/jbc.M113.521203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9OM	24764294	Green Published, hybrid			2022-12-28	WOS:000338042000019
J	Johswich, A; Longuet, C; Pawling, J; Rahman, AA; Ryczko, M; Drucker, DJ; Dennis, JW				Johswich, Anita; Longuet, Christine; Pawling, Judy; Rahman, Anas Abdel; Ryczko, Michael; Drucker, Daniel J.; Dennis, James W.			N-Glycan Remodeling on Glucagon Receptor Is an Effector of Nutrient Sensing by the Hexosamine Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCKOUT MICE; ACETYLGLUCOSAMINYLTRANSFERASE V; TRANSCRIPTIONAL REGULATION; PLASMA-MEMBRANE; QUALITY-CONTROL; O-GLCNAC; GLUCOSE; GLYCOSYLATION; OBESITY; METABOLISM	Glucose homeostasis in mammals is dependent on the opposing actions of insulin and glucagon. The Golgi N-acetylglucos-aminyltransferases encoded by Mgat1, Mgat2, Mgat4a/b/c, and Mgat5 modify the N-glycans on receptors and solute transporter, possibly adapting activities in response to the metabolic environment. Herein we report that Mgat5(-/-) mice display diminished glycemic response to exogenous glucagon, together with increased insulin sensitivity. Glucagon receptor signaling and gluconeogenesis in Mgat5(-/-) cultured hepatocytes was impaired. In HEK293 cells, signaling by ectopically expressed glucagon receptor was increased by Mgat5 expression and GlcNAc supplementation to UDP-GlcNAc, the donor substrate shared by Mgat branching enzymes. The mobility of glucagon receptor in primary hepatocytes was reduced by galectin-9 binding, and the strength of the interaction was dependent on Mgat5 and UDP-GlcNAc levels. Finally, oral GlcNAc supplementation rescued the glucagon response in Mgat5(-/-) hepatocytes and mice, as well as glycolytic metabolites and UDP-GlcNAc levels in liver. Our results reveal that the hexosamine biosynthesis pathway and GlcNAc salvage contribute to glucose homeostasis through N-glycan branching on glucagon receptor.	[Johswich, Anita; Longuet, Christine; Pawling, Judy; Rahman, Anas Abdel; Ryczko, Michael; Drucker, Daniel J.; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Ryczko, Michael; Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5R 0A3, Canada; [Dennis, James W.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5R 0A3, Canada; [Drucker, Daniel J.; Dennis, James W.] Univ Toronto, Dept Med, Toronto, ON M5R 0A3, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave,R988, Toronto, ON M5G 1X5, Canada.	dennis@lunenfeld.ca	Drucker, Daniel J/A-4092-2010; Dennis, James/E-7268-2013; Longuet, Christine/ABC-2556-2020; Abdel Rahman, Anas/AEC-1515-2022	Abdel Rahman, Anas/0000-0002-9527-9424	Ontario Research Fund Grant [GL-2]; Canadian Institutes for Health Research [MOP-79405, MOP-62975, MOP-93749, MOP-123391]; Canada Research Chairs Program; Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology; Canadian Liver Foundation	Ontario Research Fund Grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology; Canadian Liver Foundation	This work was supported by Ontario Research Fund Grant GL-2, Canadian Institutes for Health Research Grants MOP-79405 and MOP-62975, Grant s from the Canada Research Chairs Program (to J. W. D. and D. J. D.), Canadian Institutes for Health Research Grants MOP-93749 and MOP-123391 (to D. J. D.), the Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology (to D. J. D.), and Canadian Liver Foundation Graduate Studentship (to M. R.).	Abbott KL, 2008, J PROTEOME RES, V7, P1470, DOI 10.1021/pr700792g; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bishop JR, 2010, J BIOL CHEM, V285, P14658, DOI 10.1074/jbc.M110.112391; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; CAMPBELL RM, 1995, GLYCOBIOLOGY, V5, P535, DOI 10.1093/glycob/5.5.535; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; KITAGAWA T, 1995, J CELL SCI, V108, P3735; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee Y, 2012, P NATL ACAD SCI USA, V109, P14972, DOI 10.1073/pnas.1205983109; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shang J, 2007, J CELL BIOL, V176, P605, DOI 10.1083/jcb.200607007; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Sorensen H, 2006, DIABETES, V55, P3463, DOI 10.2337/db06-0307; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; Unson CG, 1996, P NATL ACAD SCI USA, V93, P310, DOI 10.1073/pnas.93.1.310; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Williams R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086088; Wu GC, 2001, J BIOL CHEM, V276, P35450, DOI 10.1074/jbc.M009704200; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Yu CE, 2004, GENOMICS, V84, P600, DOI 10.1016/j.ygeno.2004.06.003	66	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15927	15941		10.1074/jbc.M114.563734	http://dx.doi.org/10.1074/jbc.M114.563734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742675	Green Published, hybrid			2022-12-28	WOS:000337965700004
J	Nadanaka, S; Purunomo, E; Takeda, N; Tamura, J; Kitagawa, H				Nadanaka, Satomi; Purunomo, Eko; Takeda, Naoko; Tamura, Jun-ichi; Kitagawa, Hiroshi			Heparan Sulfate Containing Unsubstituted Glucosamine Residues BIOSYNTHESIS AND HEPARANASE-INHIBITORY ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycobiology; Glycosaminoglycan; Glycosidase; Heparan Sulfate; Heparanase; Proteoglycan; Proteoglycan Synthesis	N-DEACETYLASE/N-SULFOTRANSFERASE; GENE FAMILY; EXPRESSION; GLYPICAN-1; NDST-1; CELLS; ROLES; MICE; GLYCOSAMINOGLYCANS; ACETYLGLUCOSAMINE	Background: The function and biosynthetic mechanism of GlcNH<sub arrange="stack">3<sup arrange="stack">+ in heparan sulfate remain unclear. Results: GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing tetrasaccharides inhibited heparanase activity. Exostosin-like 3 regulated the expression of GlcNH<sub arrange="stack">3<sup arrange="stack">+ structures. Conclusion: GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing tetrasaccharides suppressed cancer cell invasion in vitro. Production of GlcNH<sub arrange="stack">3<sup arrange="stack">+ was controlled by EXTL3 (exostosin-like 3) and NDST-1 (N-deacetylase/N-sulfotransferase-1). Significance: Tumor metastasis might be suppressed by utilizing GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing oligosaccharides. Additionally, a biosynthetic mechanism of GlcNH<sub arrange="stack">3<sup arrange="stack">+-containing heparan sulfates was proposed. Degradation of heparan sulfate (HS) in the extracellular matrix by heparanase is linked to the processes of tumor invasion and metastasis. Thus, a heparanase inhibitor can be a potential anticancer drug. Because HS with unsubstituted glucosamine residues accumulates in heparanase-expressing breast cancer cells, we assumed that these HS structures are resistant to heparanase and can therefore be utilized as a heparanase inhibitor. As expected, chemically synthetic HS-tetrasaccharides containing unsubstituted glucosamine residues, GlcA1-4GlcNH<sub arrange="stack">3<sup arrange="stack">+(6-O-sulfate)1-4GlcA1-4GlcNH<sub arrange="stack">3<sup arrange="stack">+(6-O-sulfate), inhibited heparanase activity and suppressed invasion of breast cancer cells in vitro. Bifunctional NDST-1 (N-deacetylase/N-sulfotransferase-1) catalyzes the modification of N-acetylglucosamine residues within HS chains, and the balance of N-deacetylase and N-sulfotransferase activities of NDST-1 is thought to be a determinant of the generation of unsubstituted glucosamine. We also report here that EXTL3 (exostosin-like 3) controls N-sulfotransferase activity of NDST-1 by forming a complex with NDST-1 and contributes to generation of unsubstituted glucosamine residues.	[Nadanaka, Satomi; Purunomo, Eko; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Takeda, Naoko; Tamura, Jun-ichi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Tamura, Jun-ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079; Purnomo, Eko/0000-0003-2686-4504	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23110003, 25293014, 25460080]; Grants-in-Aid for Scientific Research [13J08319] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 23110003 (to H. K.) and for Scientific Research (B) 25293014 (to H. K.) and (C) 25460080 (to S. N.) and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Desai UR, 1998, BIOCHEMISTRY-US, V37, P13033, DOI 10.1021/bi981426h; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fujii M, 2010, GLYCOCONJUGATE J, V27, P661, DOI 10.1007/s10719-010-9311-4; Gesteira TF, 2011, J BIOL CHEM, V286, P5338, DOI 10.1074/jbc.M110.100719; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Mani K, 2004, GLYCOBIOLOGY, V14, P599, DOI 10.1093/glycob/cwh067; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Murali S, 2011, J BIOL CHEM, V286, P17755, DOI 10.1074/jbc.M110.148874; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Takeda N, 2012, CARBOHYD RES, V353, P13, DOI 10.1016/j.carres.2012.03.014; Tang P, 2009, DIAGN MOL PATHOL, V18, P125, DOI 10.1097/PDM.0b013e31818d107b; Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; VLODAVSKY I, 1994, INVAS METAST, V14, P290; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	46	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15231	15243		10.1074/jbc.M113.545343	http://dx.doi.org/10.1074/jbc.M113.545343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753252	hybrid, Green Published			2022-12-28	WOS:000337465400009
J	Hirata, Y; Funato, Y; Takano, Y; Miki, H				Hirata, Yusuke; Funato, Yosuke; Takano, Yu; Miki, Hiroaki			Mg2+ -dependent Interactions of ATP with the Cystathionine-beta-Synthase (CBS) Domains of a Magnesium Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CONE-ROD DYSTROPHY; CRYSTAL-STRUCTURE; BINDING; MUTATIONS; ANCIENT; AMPK	Ancient conserved domain protein/cyclin M (CNNM) family proteins are evolutionarily conserved Mg2+ transporters. However, their biochemical mechanism of action remains unknown. Here, we show the functional importance of the commonly conserved cystathionine-beta-synthase (CBS) domains and reveal their unique binding ability to ATP. Deletion mutants of CNNM2 and CNNM4, lacking the CBS domains, are unable to promote Mg2+ efflux. Furthermore, the substitution of one amino acid residue in the CBS domains of CNNM2, which is associated with human hereditary hypomagnesemia, abrogates Mg2+ efflux. Binding analyses reveal that the CBS domains of CNNM2 bind directly to ATP and not AMP in a manner dependent on the presence of Mg2+, which is inhibited in a similar pattern by the disease-associated amino acid substitution. The requirement of Mg2+ for these interactions is a unique feature among CBS domains, which can be explained by the presence of highly electronegative surface potentials around the ATP binding site on CNNM2. These results demonstrate that the CBS domains play essential roles in Mg2+ efflux, probably through interactions with ATP. Interactions with ATP, which mostly forms complexes with Mg2+ in cells, may account for the rapid Mg2+ transport by CNNM family proteins.	[Hirata, Yusuke; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Takano, Yu] Osaka Univ, Lab Prot Informat, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Miki, H (corresponding author), Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp	Hirata, Yusuke/T-9580-2019; Takano, Yu/H-1785-2014	Hirata, Yusuke/0000-0002-1428-2075; Takano, Yu/0000-0002-4165-8672	Japan Society for the Promotion of Science (JSPS); Osaka University; JSPS; Ministry of Education, Culture, Sports, Science, and Technology-Japan; Taniguchi Memorial Fellowship project - Research Foundation for Microbial Diseases of Osaka University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Taniguchi Memorial Fellowship project - Research Foundation for Microbial Diseases of Osaka University	This work was supported by Funding Program for Next Generation World-Leading Researchers from Japan Society for the Promotion of Science (JSPS) (to H. M.), Exciting Leading-Edge Research Projects from Osaka University (to H. M.), and Grants-in-aid for Scientific Research from JSPS and Ministry of Education, Culture, Sports, Science, and Technology-Japan (to H. M. and Y.F.).; Supported by the Taniguchi Memorial Fellowship project funded by the Research Foundation for Microbial Diseases of Osaka University.	Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lis M., 2011, IMMUNOME RES, V7, P1, DOI DOI 10.4172/1745-7580.1000041; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983	33	66	66	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14731	14739		10.1074/jbc.M114.551176	http://dx.doi.org/10.1074/jbc.M114.551176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706765	Green Published, hybrid			2022-12-28	WOS:000337248100029
J	Touat-Hamici, Z; Legrain, Y; Bulteau, AL; Chavatte, L				Touat-Hamici, Zahia; Legrain, Yona; Bulteau, Anne-Laure; Chavatte, Laurent			Selective Up-regulation of Human Selenoproteins in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; MESSENGER-RNA STABILITY; NONSENSE-MEDIATED DECAY; SELENOCYSTEINE INCORPORATION; SELENIUM-DEFICIENCY; BINDING PROTEIN; GENE-EXPRESSION; HUMAN HEALTH; MUTATIONS; MACHINERY	Selenocysteine is inserted into selenoproteins via the translational recoding of a UGA codon, normally used as a stop signal. This process depends on the nature of the selenocysteine insertion sequence element located in the 3' UTR of selenoprotein mRNAs, selenium bioavailability, and, possibly, exogenous stimuli. To further understand the function and regulation of selenoproteins in antioxidant defense and redox homeostasis, we investigated how oxidative stress influences selenoprotein expression as a function of different selenium concentrations. We found that selenium supplementation of the culture media, which resulted in a hierarchical up-regulation of selenoproteins, protected HEK293 cells from reactive oxygen species formation. Furthermore, in response to oxidative stress, we identified a selective up-regulation of several selenoproteins involved in antioxidant defense (Gpx1, Gpx4, TR1, SelS, SelK, and Sps2). Interestingly, the response was more efficient when selenium was limiting. Although a modest change in mRNA levels was noted, we identified a novel translational control mechanism stimulated by oxidative stress that is characterized by up-regulation of UGA-selenocysteine recoding efficiency and relocalization of SBP2, selenocysteine-specific elongation factor, and L30 recoding factors from the cytoplasm to the nucleus.	[Touat-Hamici, Zahia; Legrain, Yona; Chavatte, Laurent] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Bulteau, Anne-Laure] CNRS UMR 8104, Ctr Rech Inst Cochin, INSERM U567, F-75005 Paris, France; [Bulteau, Anne-Laure; Chavatte, Laurent] CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Chavatte, L (corresponding author), CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France.	laurent.chavatte@univ-pau.fr	bulteau, anne-laure/AAN-4004-2020	Chavatte, Laurent/0000-0001-7696-2431	CNRS (ATIP program); Fondation pour la Recherche Medicale; Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer [4849]; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche [ANR-09-BLAN-0048]; Ministere de l'Enseignement Superieur et de la Recherche	CNRS (ATIP program); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by the CNRS (ATIP program) (to L. C.), by the Fondation pour la Recherche Medicale (to L. C.), by the Ligue Contre le Cancer (Comite de l'Essonne) (to L. C.), by Association pour la Recherche sur le Cancer grant 4849 (to L. C.), by the Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement (to L. C.), and by Agence Nationale de la Recherche grant ANR-09-BLAN-0048 (to L. C.).; Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; Azevedo MF, 2010, J CLIN ENDOCR METAB, V95, P4066, DOI 10.1210/jc.2009-2611; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; Bermano G, 1996, FEBS LETT, V387, P157, DOI 10.1016/0014-5793(96)00493-0; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Ding F, 1999, RNA, V5, P1561, DOI 10.1017/S1355838299991598; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Karlenius TC, 2011, BIOTECHNIQUES, V50, P295, DOI 10.2144/000113666; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Latreche L, 2012, RNA BIOL, V9, P681, DOI 10.4161/rna.20147; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Legrain Y, 2014, J BIOL CHEM, V289, P6299, DOI 10.1074/jbc.M113.526863; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Muller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P797, DOI 10.1089/ars.2009.2913; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Sachdev SW, 2001, BIOCHEM J, V357, P851; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wingler K, 1999, EUR J BIOCHEM, V259, P149, DOI 10.1046/j.1432-1327.1999.00012.x; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200	53	72	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14750	14761		10.1074/jbc.M114.551994	http://dx.doi.org/10.1074/jbc.M114.551994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706762	Green Published, hybrid			2022-12-28	WOS:000337248100031
J	Chen, Z; Jolley, B; Caldwell, C; Gallie, DR				Chen, Zhong; Jolley, Blair; Caldwell, Christian; Gallie, Daniel R.			Eukaryotic Translation Initiation Factor eIFiso4G Is Required to Regulate Violaxanthin De-epoxidase Expression in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photosynthesis; Protein Synthesis; RNA; Translation; Translation Initiation Factors; VDE; eIFiso4G	CAP-INDEPENDENT TRANSLATION; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; PLANTS; LIGHT; RNA; EIF4A; PHOTOINHIBITION; PHOTOSYNTHESIS; FLUORESCENCE	Background: The initiation factor eIFiso4G organizes the assembly of those factors needed to initiate translation of plant mRNAs. Results: Loss of eIFiso4G results in increased violaxanthin de-epoxidase expression and increased xanthophyll cycle activity. Conclusion: eIFiso4G is required to maintain VDE expression at an optimal level. Significance: Of the two isoforms of eIF4G, eIFiso4G is required specifically to support photosynthetic activity. The eukaryotic translation initiation factor (eIF) 4G is a scaffold protein that organizes the assembly of those initiation factors needed to recruit the 40 S ribosomal subunit to an mRNA. Plants, like many eukaryotes, express two eIF4G isoforms. eIFiso4G, one of the isoforms specific to plants, is unique among eukaryotic eIF4G proteins in that it is highly divergent and unusually small in size, raising the possibility of functional specialization. In this study, the role of eIFiso4G in plant growth was investigated using null mutants for the eIF4G isoforms in Arabidopsis. eIFiso4G loss of function mutants exhibited smaller cell, leaf, plant size, and biomass accumulation that correlated with its reduced photosynthetic activity, phenotypes not observed with the eIF4G loss of function mutant. Although no change in photorespiration or dark respiration was observed in the eIFiso4G loss of function mutant, a reduction in chlorophyll levels and an increase in the level of nonphotochemical quenching were observed. An increase in xanthophyll cycle activity and the generation of reactive oxygen species contributed to the qE and qI components of nonphotochemical quenching, respectively. An increase in the transcript and protein levels of violaxanthin de-epoxidase in the eIFiso4G loss of function mutant and an increase in its xanthophyll de-epoxidation state correlated with the higher qE associated with loss of eIFiso4G expression. These observations indicate that eIFiso4G expression is required to regulate violaxanthin de-epoxidase expression and to support photosynthetic activity.	[Chen, Zhong; Jolley, Blair; Caldwell, Christian; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			National Science Foundation [DBI-0820047]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This work was supported by National Science Foundation Grant DBI-0820047 and grants from the University of California Agricultural Experiment Station (to D.R.G.).	ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K., 1987, PHOTOINHIBITION, P227; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; Cheng SJ, 2010, BIOCHEMISTRY-US, V49, P8251, DOI 10.1021/bi1008529; DEMMIGADAMS B, 1992, PLANT CELL ENVIRON, V15, P411, DOI 10.1111/j.1365-3040.1992.tb00991.x; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; HAVAUX M, 1991, J PHOTOCH PHOTOBIO B, V8, P361, DOI 10.1016/1011-1344(91)80112-U; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Saul H, 2009, PLANT J, V60, P1031, DOI 10.1111/j.1365-313X.2009.04021.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	39	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13926	13936		10.1074/jbc.M114.555151	http://dx.doi.org/10.1074/jbc.M114.555151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706761	Green Published, hybrid			2022-12-28	WOS:000335984600024
J	Mahalingam, B; Van Agthoven, JF; Xiong, JP; Alonso, JL; Adair, BD; Rui, XL; Anand, S; Mehrbod, M; Mofrad, MRK; Burger, C; Goodman, SL; Arnaout, MA				Mahalingam, Bhuvaneshwari; Van Agthoven, Johannes F.; Xiong, Jian-Ping; Alonso, Jose Luis; Adair, Brian D.; Rui, Xianliang; Anand, Saurabh; Mehrbod, Mehrdad; Mofrad, Mohammad R. K.; Burger, Christa; Goodman, Simon L.; Arnaout, M. Amin			Atomic Basis for the Species-specific Inhibition of alpha V Integrins by Monoclonal Antibody 17E6 Is Revealed by the Crystal Structure of alpha V beta 3 Ectodomain-17E6 Fab Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Adhesion; Cell Surface Receptor; Crystal Structure; Extracellular Matrix Proteins; Fibronectin; Integrins	LIGAND-BINDING; EXTRACELLULAR SEGMENT; MOLECULAR-DYNAMICS; METASTATIC GROWTH; RGD PEPTIDES; ACTIVATION; ALPHA(5)BETA(1); ALPHA-V-BETA-3; MELANOMA; SYSTEM	Background: 17E6, a primate-specific mouse mAb that inhibits V integrins, is in phase II trials for treating cancer. Results: We determined crystal structure of the V3-17E6 Fab complex, revealing the molecular basis of 17E6 specificity and function. Conclusion: 17E6 is an allosteric inhibitor of fibronectin-integrin interaction. Significance: The defined 17E6 epitope may help in developing novel therapeutics targeting related regions in other integrins. The function-blocking, non-RGD-containing, and primate-specific mouse monoclonal antibody 17E6 binds the V subfamily of integrins. 17E6 is currently in phase II clinical trials for treating cancer. To elucidate the structural basis of recognition and the molecular mechanism of inhibition, we crystallized V3 ectodomain in complex with the Fab fragment of 17E6. Protein crystals grew in presence of the activating cation Mn2+. The integrin in the complex and in solution assumed the genuflected conformation. 17E6 Fab bound exclusively to the Propeller domain of the V subunit. At the core of V-Fab interface were interactions involving Propeller residues Lys-203 and Gln-145, with the latter accounting for primate specificity. The Propeller residue Asp-150, which normally coordinates Arg of the ligand Arg-Gly-Asp motif, formed contacts with Arg-54 of the Fab that were expected to reduce soluble FN10 binding to cellular V3 complexed with 17E6. This was confirmed in direct binding studies, suggesting that 17E6 is an allosteric inhibitor of V integrins.	[Mahalingam, Bhuvaneshwari; Van Agthoven, Johannes F.; Xiong, Jian-Ping; Adair, Brian D.; Arnaout, M. Amin] Massachusetts Gen Hosp, Struct Biol Program, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Dept Dev & Regenerat Biol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Burger, Christa; Goodman, Simon L.] Merck KGaA, D-64271 Darmstadt, Germany; [Burger, Christa] Discovery Technol, Mol Pharmacol, D-64271 Darmstadt, Germany; [Goodman, Simon L.] Therapeut Innovat Platform, Oncol, D-64271 Darmstadt, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Merck KGaA	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, 149 13th St, Charlestown, MA 02129 USA.	aarnaout1@mgh.harvard.edu	Alonso, José Luis/ABF-5483-2021	Goodman, Simon L./0000-0002-3480-1346	National Institutes of Health [DK088327, DK096334, DK007540]; National Science Foundation [CBET-0955291]; Directorate For Engineering [0955291] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088327, T32DK007540, R21DK096334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK088327, DK096334, and DK007540 (to M. A. A.). This work was also supported by National Science Foundation CAREER Award CBET-0955291 (to M.R.K.M.).	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057951; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBELDA SM, 1990, CANCER RES, V50, P6757; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; BARON M, 1992, BIOCHEMISTRY-US, V31, P2068, DOI 10.1021/bi00122a025; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castel S, 2001, LAB INVEST, V81, P1615, DOI 10.1038/labinvest.3780375; Castel S, 2000, EUR J CELL BIOL, V79, P502, DOI 10.1078/0171-9335-00067; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Copie V, 1998, J MOL BIOL, V277, P663; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Honda S, 2004, THROMB HAEMOSTASIS, V92, P1092, DOI 10.1160/TH04-04-0257; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kraft S, 1999, J BIOL CHEM, V274, P1979, DOI 10.1074/jbc.274.4.1979; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARSHALL JF, 1995, J CELL SCI, V108, P1227; Max R, 1997, INT J CANCER, V71, P320, DOI 10.1002/(SICI)1097-0215(19970502)71:3<320::AID-IJC2>3.3.CO;2-3; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; MITJANS F, 1995, J CELL SCI, V108, P2825; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014	46	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13801	13809		10.1074/jbc.M113.546929	http://dx.doi.org/10.1074/jbc.M113.546929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692540	hybrid, Green Published			2022-12-28	WOS:000335984600014
J	Schworer, SA; Smirnova, II; Kurbatova, I; Bagina, U; Churova, M; Fowler, T; Roy, AL; Degterev, A; Poltorak, A				Schworer, Stephen A.; Smirnova, Irina I.; Kurbatova, Irina; Bagina, Uliana; Churova, Maria; Fowler, Trent; Roy, Ananda L.; Degterev, Alexei; Poltorak, Alexander			Toll-like Receptor-mediated Down-regulation of the Deubiquitinase Cylindromatosis ( CYLD) Protects Macrophages from Necroptosis in Wild-derived Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Gene Regulation; Mouse Genetics; Necrosis (Necrotic Death); Toll-like Receptor (TLR); Forward Genetic Mapping; Wild-derived Mice	NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; PROGRAMMED NECROSIS; CELL-DEATH; NEGATIVE REGULATOR; RIP1 KINASE; ENZYME CYLD; ACTIVATION; INFLAMMATION; PHOSPHORYLATION	Background: Necroptosis is a regulated signaling pathway leading to necrotic cell death. Results: Genetic mapping identified that down-regulation of the deubiquitinase CYLD confers resistance to necroptosis in a wild-derived mouse strain. Conclusion: Different strains of inbred mice regulate cell death pathways using distinct mechanisms. Significance: Genetic diversity of wild-derived mice underlies phenotypic diversity, which can identify novel mechanisms of regulation in cell death signaling. Pathogen recognition by the innate immune system initiates the production of proinflammatory cytokines but can also lead to programmed host cell death. Necroptosis, a caspase-independent cell death pathway, can contribute to the host defense against pathogens or cause damage to host tissues. Receptor-interacting protein (RIP1) is a serine/threonine kinase that integrates inflammatory and necroptotic responses. To investigate the mechanisms of RIP1-mediated activation of immune cells, we established a genetic screen on the basis of RIP1-mediated necroptosis in wild-derived MOLF/EiJ mice, which diverged from classical laboratory mice over a million years ago. When compared with C57BL/6, MOLF/EiJ macrophages were resistant to RIP1-mediated necroptosis induced by Toll-like receptors. Using a forward genetic approach in a backcross panel of mice, we identified cylindromatosis (CYLD), a deubiquitinase known to act directly on RIP1 and promote necroptosis in TNF receptor signaling, as the gene conferring the trait. We demonstrate that CYLD is required for Toll-like receptor-induced necroptosis and describe a novel mechanism by which CYLD is down-regulated at the transcriptional level in MOLF/EiJ macrophages to confer protection from necroptosis.	[Schworer, Stephen A.; Roy, Ananda L.; Poltorak, Alexander] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Schworer, Stephen A.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Med Scientist Training Program, Boston, MA 02111 USA; [Smirnova, Irina I.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Fowler, Trent; Roy, Ananda L.; Degterev, Alexei] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Roy, Ananda L.; Poltorak, Alexander] Tufts Univ, Sch Med, Grad Program Genet, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Kurbatova, Irina; Churova, Maria; Poltorak, Alexander] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk 185910, Russia; [Bagina, Uliana] Petrozavodsk State Univ, Petrozavodsk 185910, Russia	Tufts University; Tufts University; Tufts University; Tufts University; Tufts University; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Petrozavodsk State University	Poltorak, A (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA.	alexander.poltorak@tufts.edu	Churova, Maria/A-5912-2014; Kurbatova, Irina/A-5535-2014	Churova, Maria/0000-0002-8895-0806; Kurbatova, Irina/0000-0001-7620-7065; Schworer, Stephen/0000-0001-7741-8972	National Institutes of Health [AI056234, AI090419]; Government of the Russian Federation (Article 220) [GK 11.G34.31.0052, RFFI 13-04-40267-H13]; Eshe Fund; Keck Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056234, R56AI056234, R21AI090419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of the Russian Federation (Article 220); Eshe Fund; Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056234 and AI090419 (to A. P.). This work was also supported by Government of the Russian Federation (Article 220) Grants GK 11.G34.31.0052, and RFFI 13-04-40267-H13 (to A. P.), by the Eshe Fund, and by the Keck Foundation.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Liang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019613; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu P, 2012, LEUKEMIA, V26, P1293, DOI 10.1038/leu.2011.357; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moseman AP, 2013, J IMMUNOL, V191, P5615, DOI 10.4049/jimmunol.1301438; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Urbanik T, 2011, INT J ONCOL, V38, P121, DOI 10.3892/ijo_00000831; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	60	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14422	14433		10.1074/jbc.M114.547547	http://dx.doi.org/10.1074/jbc.M114.547547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706750	hybrid, Green Published			2022-12-28	WOS:000335984600067
J	Tillman, TS; Seyoum, E; Mowrey, DD; Xu, Y; Tang, P				Tillman, Tommy S.; Seyoum, Edom; Mowrey, David D.; Xu, Yan; Tang, Pei			ELIC- alpha 7 Nicotinic Acetylcholine Receptor ( alpha 7nAChR) Chimeras Reveal a Prominent Role of the ExtracellularTransmembrane Domain Interface in Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Ion Channels; Neurotransmitter Receptors; Nicotinic Acetylcholine Receptors; Protein Chimeras; ELIC; 7nAChR; pLGICs; Pentameric Ligand-gated Ion Channels	GATED ION-CHANNEL; X-RAY-STRUCTURE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; OPEN STATE; IN-VITRO; LOOP; ACTIVATION; DESENSITIZATION	Background: Allosteric modulators bound to the transmembrane domain (TMD) of the 7 nicotinic acetylcholine receptor (7nAChR) can potentiate channel function. Results: ELIC-7nAChR showed potentiation only when the extracellular-transmembrane domain (ECD-TMD) interface matched that of 7nAChR. Conclusion: PAM modulation through the TMD requires a more specific ECD-TMD interface than agonist activation. Significance: The study provides insight into the basis for positive allosteric modulation of 7nAChR. The native 7 nicotinic acetylcholine receptor (7nAChR) is a homopentameric ligand-gated ion channel mediating fast synaptic transmission and is of pharmaceutical interest for treatment of numerous disorders. The transmembrane domain (TMD) of 7nAChR has been identified as a target for positive allosteric modulators (PAMs), but it is unclear whether modulation occurs through changes entirely within the TMD or changes involving both the TMD and the extracellular domain (ECD)-TMD interface. In this study, we constructed multiple chimeras using the TMD of human 7nAChR and the ECD of a prokaryotic homolog, ELIC, which is not sensitive to these modulators, and for which a high resolution structure has been solved. Functional ELIC-7nAChR (EA) chimeras were obtained when their ECD-TMD interfaces were modified to resemble either the ELIC interface (EA(ELIC)) or 7nAChR interface (EA(7)). Both EA(7) and EA(ELIC) show similar activation response and desensitization characteristics, but only EA(7) retained the unique pharmacology of 7nAChR evoked by PAMs, including potentiation by ivermectin, PNU-120596, and TQS, as well as activation by 4BP-TQS. This study suggests that PAM modulation through the TMD has a more stringent requirement at the ECD-TMD interface than agonist activation.	[Tillman, Tommy S.; Seyoum, Edom; Mowrey, David D.; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Mowrey, David D.; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, P (corresponding author), Univ Pittsburgh, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	tangp@upmc.edu		Tang, Pei/0000-0002-2869-2737	National Institutes of Health [R01GM66358, R01GM56257, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066358, R37GM049202, R01GM056257, R01GM049202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM66358 and R01GM56257 (to P. T.) and R37GM049202 (to Y.X.).	AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Barron SC, 2009, MOL PHARMACOL, V76, P253, DOI 10.1124/mol.109.056226; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Chang YC, 2010, PHARMACEUTICALS, V3, P2592, DOI 10.3390/ph3082592; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dascal N., 2001, CURR PROTOC NEUROSCI; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Gronlien JH, 2010, EUR J PHARMACOL, V647, P37, DOI 10.1016/j.ejphar.2010.08.027; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Keramidas A, 2013, CELL MOL LIFE SCI, V70, P1241, DOI 10.1007/s00018-012-1133-z; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Poorthuis RB, 2013, BIOCHEM PHARMACOL, V86, P1089, DOI 10.1016/j.bcp.2013.07.003; Sattelle DB, 2009, BIOCHEM PHARMACOL, V78, P836, DOI 10.1016/j.bcp.2009.06.020; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; Smucny J, 2013, BIOCHEM PHARMACOL, V86, P1163, DOI 10.1016/j.bcp.2013.06.011; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Q, 2011, J BIOL CHEM, V286, P38814, DOI 10.1074/jbc.M111.273631; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang JL, 2011, J BIOL CHEM, V286, P25331, DOI 10.1074/jbc.M111.221754; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	60	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13851	13857		10.1074/jbc.M113.524611	http://dx.doi.org/10.1074/jbc.M113.524611			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695730	hybrid, Green Published			2022-12-28	WOS:000335984600018
J	Abrams, JL; Verghese, J; Gibney, PA; Morano, KA				Abrams, Jennifer L.; Verghese, Jacob; Gibney, Patrick A.; Morano, Kevin A.			Hierarchical Functional Specificity of Cytosolic Heat Shock Protein 70 ( Hsp70) Nucleotide Exchange Factors in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Chaperone; Protein Degradation; Protein Folding; Protein Misfolding; Protein Stability; Yeast; Hsp70; Nucleotide Exchange Factor; Protein Homeostasis; Saccharomyces cerevisiae	HEAT-SHOCK RESPONSE; RIBOSOME-ASSOCIATED HSP70; PROTEIN-QUALITY CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; HSP110 CHAPERONES; TRANSCRIPTION FACTOR; PRION PROPAGATION; STRUCTURAL BASIS; PEPTIDE-BINDING	Background: Several conserved families of nucleotide exchange factor interact with heat shock protein 70 (Hsp70) with unknown functional preferences. Results: Multiple assays for Hsp70-dependent cellular activities reveal major functional defects primarily in cells lacking heat shock protein 110 (Hsp110). Conclusion: The Hsp110 NEF plays a dominant role in Hsp70-mediated processes. Significance: Hsp110 may be a high value target for therapies to treat protein misfolding diseases. Heat shock protein 70 (Hsp70) molecular chaperones play critical roles in protein homeostasis. In the budding yeast Saccharomyces cerevisiae, cytosolic Hsp70 interacts with up to three types of nucleotide exchange factors (NEFs) homologous to human counterparts: Sse1/Sse2 (Heat shock protein 110 (Hsp110)), Fes1 (HspBP1), and Snl1 (Bag-1). All three NEFs stimulate ADP release; however, it is unclear why multiple distinct families have been maintained throughout eukaryotic evolution. In this study we investigate NEF roles in Hsp70 cell biology using an isogenic combinatorial collection of NEF deletion mutants. Utilizing well characterized model substrates, we find that Sse1 participates in most Hsp70-mediated processes and is of particular importance in protein biogenesis and degradation, whereas Fes1 contributes to a minimal extent. Surprisingly, disaggregation and resolubilization of thermally denatured firefly luciferase occurred independently of NEF activity. Simultaneous deletion of SSE1 and FES1 resulted in constitutive activation of heat shock protein expression mediated by the transcription factor Hsf1, suggesting that these two factors are important for modulating stress response. Fes1 was found to interact in vivo preferentially with the Ssa family of cytosolic Hsp70 and not the co-translational Ssb homolog, consistent with the lack of cold sensitivity and protein biogenesis phenotypes for fes1 cells. No significant consequence could be attributed to deletion of the minor Hsp110 SSE2 or the Bag homolog SNL1. Together, these lines of investigation provide a comparative analysis of NEF function in yeast that implies Hsp110 is the principal NEF for cytosolic Hsp70, making it an ideal candidate for therapeutic intervention in human protein folding disorders.	[Abrams, Jennifer L.; Verghese, Jacob; Gibney, Patrick A.; Morano, Kevin A.] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Morano, KA (corresponding author), Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Morano, Kevin/0000-0002-5992-0253	National Institutes of Health [GM074696]; American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074696 (to K. A. M.).; Supported by a Robert D. Watkins Graduate Research Fellowship from the American Society of Microbiology.	Abrams JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50432; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; Cyr DM, 2008, CELL, V133, P945, DOI 10.1016/j.cell.2008.05.036; Dragovic Z, 2006, BIOL CHEM, V387, P1593, DOI 10.1515/BC.2006.198; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Morano KA, 1998, CURR OPIN MICROBIOL, V1, P197, DOI 10.1016/S1369-5274(98)80011-8; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; MUKAI H, 1993, GENE, V132, P57; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Verghese J, 2012, EUKARYOT CELL, V11, P1003, DOI 10.1128/EC.00146-12; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xiao J, 2006, MOL BIOL CELL, V17, P3281, DOI 10.1091/mbc.E06-02-0106; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	78	39	39	0	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13155	13167		10.1074/jbc.M113.530014	http://dx.doi.org/10.1074/jbc.M113.530014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671421	hybrid, Green Published			2022-12-28	WOS:000335522800017
J	Mayes, J; Tinker-Mill, C; Kolosov, O; Zhang, H; Tabner, BJ; Allsop, D				Mayes, Jennifer; Tinker-Mill, Claire; Kolosov, Oleg; Zhang, Hao; Tabner, Brian J.; Allsop, David			beta-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Free Radicals; Hydrogen Peroxide; Oxidative Stress; Reactive Oxygen Species (ROS); -Amyloid; Copper Ions; Peptide Aggregation; Zinc Ions	A-BETA; HYDROXYL RADICALS; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; PROTEIN; AGGREGATION; PEPTIDE; OLIGOMERS; MECHANISM; BINDING	Background: Metal-associated -amyloid (A) aggregates are implicated in the pathogenesis of Alzheimer disease. Results: Copper bound A(1-42) aggregates, including fibrils, degrade hydrogen peroxide, forming hydroxyl radicals and carbonyls. Conclusion: Copper-bound A fibrils can retain redox activity. Significance: A fibrils bound to copper are not inert end points and may be a source of oxidative stress in the Alzheimer brain. According to the amyloid cascade hypothesis of Alzheimer disease, the formation of A fibrils and senile plaques in the brain initiates a cascade of events leading to the formation of neurofibrillary tangles, neurodegeneration, and the symptom of dementia. Recently, however, emphasis has shifted away from amyloid fibrils as the predominant toxic form of A toward smaller aggregates, referred to as soluble oligomers. These oligomers have become one of the prime suspects for involvement in the early oxidative damage that is evident in this disease. This raises the question whether or not A fibrils are actually inert tombstones present at the end of the aggregation process. Here we show that, when A(1-42) aggregates, including fibrils, are bound to Cu(II) ions, they retain their redox activity and are able to degrade hydrogen peroxide (H2O2) with the formation of hydroxyl radicals and the consequent oxidation of the peptide (detected by formation of carbonyl groups). We find that this ability increases as the Cu(II):peptide ratio increases and is accompanied by changes in aggregate morphology, as determined by atomic force microscopy. When aggregates are prepared in the copresence of Cu(II) and Zn(II) ions, the ratio of Cu(II):Zn(II) becomes an important factor in the degeneration of H2O2, the formation of carbonyl groups in the peptide, and in aggregate morphology. We believe, therefore, that A fibrils can destroy H2O2 and generate damaging hydroxyl radicals and, so, are not necessarily inert end points.	[Mayes, Jennifer; Tabner, Brian J.; Allsop, David] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Tinker-Mill, Claire; Kolosov, Oleg] Univ Lancaster, Dept Phys, Fac Sci & Technol, Lancaster LA1 4YQ, England; [Zhang, Hao] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England	Lancaster University; Lancaster University; Lancaster University	Allsop, D (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YQ, England.	d.allsop@lancaster.ac.uk	Kolosov, Oleg V/D-3815-2013; Allsop, David/B-9725-2008; Zhang, Hao/HHM-1940-2022; Zhang, Hao/E-5375-2010	Kolosov, Oleg V/0000-0003-3278-9643; Allsop, David/0000-0002-0513-5575; Tinker-Mill, Claire/0000-0002-1981-3111	Sir John Fisher Foundation; Engineering and Physical Sciences Research Council [1064552, EP/K023373/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish; EPSRC [EP/K023373/1] Funding Source: UKRI	Sir John Fisher Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Sir John Fisher Foundation.	Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dasgupta A, 2012, ASN NEURO, V4, DOI 10.1042/AN20110064; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hewitt N, 2009, J PHYS CHEM B, V113, P1202, DOI 10.1021/jp807327a; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kiselyova O., 2004, METH MOL B, V242, P217; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nunomura A, 2009, ACTA NEUROPATHOL, V118, P151, DOI 10.1007/s00401-009-0508-1; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Riederer BM, 2013, EXP BIOL MED, V238, P519, DOI 10.1177/1535370213488484; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tabner B. J., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/546380; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Tabner Brian J., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P299, DOI 10.2174/1568013033483249; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Turnbull S, 2001, FREE RADICAL BIO MED, V30, P1163, DOI 10.1016/S0891-5849(01)00513-5; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	61	76	80	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12052	12062		10.1074/jbc.M113.525212	http://dx.doi.org/10.1074/jbc.M113.525212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619420	Green Published, hybrid			2022-12-28	WOS:000335010600043
J	Cho, Y; Di Liberto, V; Carlin, D; Abe, N; Li, KH; Burlingame, AL; Guan, S; Michaelevski, I; Cavalli, V				Cho, Yongcheol; Di Liberto, Valentina; Carlin, Dan; Abe, Namiko; Li, Kathy H.; Burlingame, Alma L.; Guan, Shenheng; Michaelevski, Izhak; Cavalli, Valeria			Syntaxin13 Expression Is Regulated by Mammalian Target of Rapamycin (mTOR) in Injured Neurons to Promote Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; mTOR; Proteomics; Regeneration; SNARE Proteins	LOCAL PROTEIN-SYNTHESIS; NEURITE OUTGROWTH; MESSENGER-RNA; GROWTH; TRANSPORT; MEMBRANE; TRANSLATION; TRAFFICKING; ENDOSOMES; NERVE	Injured peripheral neurons successfully activate intrinsic signaling pathways to enable axon regeneration. We have previously shown that dorsal root ganglia (DRG) neurons activate the mammalian target of rapamycin (mTOR) pathway following injury and that this activity enhances their axon growth capacity. mTOR plays a critical role in protein synthesis, but the mTOR-dependent proteins enhancing the regenerative capacity of DRG neurons remain unknown. To identify proteins whose expression is regulated by injury in an mTOR-dependent manner, we analyzed the protein composition of DRGs from mice in which we genetically activated mTOR and from mice with or without a prior nerve injury. Quantitative label-free mass spectrometry analyses revealed that the injury effects were correlated with mTOR activation. We identified a member of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family of proteins, syntaxin13, whose expression was increased by injury in an mTOR-dependent manner. Increased syntaxin13 levels in injured nerves resulted from local protein synthesis and not axonal transport. Finally, knockdown of syntaxin13 in cultured DRG neurons prevented axon growth and regeneration. Together, these data suggest that syntaxin13 translation is regulated by mTOR in injured neurons to promote axon regeneration.	[Cho, Yongcheol; Di Liberto, Valentina; Carlin, Dan; Abe, Namiko; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Li, Kathy H.; Burlingame, Alma L.; Guan, Shenheng] Univ Calif San Francisco, Dept Pharmaceut Chem, Mass Spectrometry Facil, San Francisco, CA 94158 USA; [Michaelevski, Izhak] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Washington University (WUSTL); University of California System; University of California San Francisco; Tel Aviv University	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Di+Liberto, Valentina/ACL-0264-2022; Michaelevski, Izhak/G-8940-2018	Di Liberto, Valentina/0000-0002-8574-0061; Michaelevski, Izhak/0000-0002-0783-1443	National Institutes of Health from NIGMS Biomedical Technology Research Centers Program [8P41GM103481]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS Biomedical Technology Research Centers Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Karen O'Malley and Vitaly Klyachko for critical reading of the manuscript. The mass spectrometry instrumentation access was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California at San Francisco (A. L. Burlingame, Director) and is supported by National Institutes of Health Grant 8P41GM103481 from NIGMS Biomedical Technology Research Centers Program.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; CRAGG BG, 1970, BRAIN RES, V23, P1, DOI 10.1016/0006-8993(70)90345-8; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Hirling H, 2000, EUR J NEUROSCI, V12, P1913, DOI 10.1046/j.1460-9568.2000.00076.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jimenez-Diaz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001961; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Mackay D. J., 2003, INFORM THEORY INFERE, P284, DOI [10.2277/0521642981, DOI 10.2277/0521642981]; Merianda TT, 2013, J CELL SCI, V126, P90, DOI 10.1242/jcs.107268; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Prager-Khoutorsky M, 2009, BRAIN RES, V1251, P65, DOI 10.1016/j.brainres.2008.10.049; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Prekeris R, 1999, J NEUROSCI, V19, P10324; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Salvador S, 2004, PROC INT C TOOLS ART, P576; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Spencer GE, 2000, J NEUROBIOL, V44, P72, DOI 10.1002/1097-4695(200007)44:1<72::AID-NEU7>3.0.CO;2-#; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tuck Elizabeth, 2010, Commun Integr Biol, V3, P209; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; WATSON WE, 1969, J PHYSIOL-LONDON, V201, pP80; WATSON WE, 1968, J PHYSIOL-LONDON, V196, P655, DOI 10.1113/jphysiol.1968.sp008528; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yoo S, 2013, J NEUROCHEM, V126, P792, DOI 10.1111/jnc.12266	59	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15820	15832		10.1074/jbc.M113.536607	http://dx.doi.org/10.1074/jbc.M113.536607			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737317	Green Published, hybrid			2022-12-28	WOS:000337465400061
J	Douillard, FP; Rasinkangas, P; von Ossowski, I; Reunanen, J; Palva, A; de Vos, WM				Douillard, Francois P.; Rasinkangas, Pia; von Ossowski, Ingemar; Reunanen, Justus; Palva, Airi; de Vos, Willem M.			Functional Identification of Conserved Residues Involved in Lactobacillus rhamnosus Strain GG Sortase Specificity and Pilus Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Electron Microscopy (EM); Protein Motif; Signaling; Site-directed Mutagenesis	COMPLETE GENOME SEQUENCE; GRAM-POSITIVE BACTERIA; ENTEROCOCCUS-FAECIUM ISOLATE; GROUP-B STREPTOCOCCUS; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; CORYNEBACTERIUM-DIPHTHERIAE; BACILLUS-ANTHRACIS; PILIN SUBUNIT; REVEALS PILI	In Gram-positive bacteria, sortase-dependent pili mediate the adhesion of bacteria to host epithelial cells and play a pivotal role in colonization, host signaling, and biofilm formation. Lactobacillus rhamnosus strain GG, a well known probiotic bacterium, also displays on its cell surface mucus-binding pilus structures, along with other LPXTG surface proteins, which are processed by sortases upon specific recognition of a highly conserved LPXTG motif. Bioinformatic analysis of all predicted LPXTG proteins encoded by the L. rhamnosus GG genome revealed a remarkable conservation of glycine residues juxtaposed to the canonical LPXTG motif. Here, we investigated and defined the role of this so-called triple glycine (TG) motif in determining sortase specificity during the pilus assembly and anchoring. Mutagenesis of the TG motif resulted in a lack or an alteration of the L. rhamnosus GG pilus structures, indicating that the TG motif is critical in pilus assembly and that they govern the pilin-specific and housekeeping sortase specificity. This allowed us to propose a regulatory model of the L. rhamnosus GG pilus biogenesis. Remarkably, the TG motif was identified in multiple pilus gene clusters of other Gram-positive bacteria, suggesting that similar signaling mechanisms occur in other, mainly pathogenic, species.	[Douillard, Francois P.; Rasinkangas, Pia; von Ossowski, Ingemar; Reunanen, Justus; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki 00790, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6708 PB Wageningen, Netherlands	University of Helsinki; Wageningen University & Research	Douillard, FP (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki 00790, Finland.	francois.douillard@helsinki.fi		von Ossowski, Ingemar Eric/0000-0002-9899-671X	Microbes Inside Program of the European Research Council [ERC 250172]; Center of Excellence in Microbial Food Safety Research of the Academy of Finland [141140]; University of Helsinki; Academy of Finland [252123]	Microbes Inside Program of the European Research Council; Center of Excellence in Microbial Food Safety Research of the Academy of Finland; University of Helsinki; Academy of Finland(Academy of Finland)	This work was supported by Grant ERC 250172 from the Microbes Inside Program of the European Research Council, Grant 141140 from the Center of Excellence in Microbial Food Safety Research of the Academy of Finland, and funds from the University of Helsinki.; Supported by Postdoctoral Research Fellowship Grant 252123 from the Academy of Finland.	Avall-Jaaskelainen S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-165; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; de Vos WM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S2; Dieye Y, 2010, APPL ENVIRON MICROB, V76, P7332, DOI 10.1128/AEM.00928-10; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hendrickx APA, 2010, MICROBIOL-SGM, V156, P2649, DOI 10.1099/mic.0.041392-0; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; McGrath S, 2001, APPL ENVIRON MICROB, V67, P608, DOI 10.1128/AEM.67.2.608-616.2001; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2911, DOI 10.1128/IAI.00039-11; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Singh D, 2013, ACTA CRYSTALLOGR F, V69, P1182, DOI 10.1107/S1744309113024676; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Swierczynski A, 2006, J BACTERIOL, V188, P6318, DOI 10.1128/JB.00606-06; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; YANAGAWA R, 1968, JPN J VET RES, V16, P31; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	58	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15764	15775		10.1074/jbc.M113.542332	http://dx.doi.org/10.1074/jbc.M113.542332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753244	Green Published, hybrid			2022-12-28	WOS:000337465400056
J	Sullivan, SE; Dillon, GM; Sullivan, JM; Ho, A				Sullivan, Sarah E.; Dillon, Gregory M.; Sullivan, Josefa M.; Ho, Angela			Mint Proteins Are Required for Synaptic Activity-dependent Amyloid Precursor Protein (APP) Trafficking and Amyloid beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Trafficking; Mint; X11; Synaptic Activity	ALZHEIMERS-DISEASE; IN-VIVO; RELEASE; PATHWAY; SECRETASE; AUTOINHIBITION; ENDOCYTOSIS; BINDING; OCCURS; ALPHA	Background: Activity-dependent amyloid (A) generation requires endosomal proteolytic cleavage of the amyloid precursor protein (APP). Results: Mints are adaptor proteins that regulate APP endocytosis and insertion at the plasma membrane upon activity induction or inhibition. Conclusion: Mints are necessary for activity-induced APP trafficking and A generation. Significance: Insight into the cell biology and molecules controlling APP trafficking is essential in understanding A pathogenesis. Aberrant amyloid (A) production plays a causal role in Alzheimer disease pathogenesis. A major cellular pathway for A generation is the activity-dependent endocytosis and proteolytic cleavage of the amyloid precursor protein (APP). However, the molecules controlling activity-dependent APP trafficking in neurons are less defined. Mints are adaptor proteins that directly interact with the endocytic sorting motif of APP and are functionally important in regulating APP endocytosis and A production. We analyzed neuronal cultures from control and Mint knockout neurons that were treated with either glutamate or tetrodotoxin to stimulate an increase or decrease in neuronal activity, respectively. We found that neuronal activation by glutamate increased APP endocytosis, followed by elevated APP insertion into the cell surface, stabilizing APP at the plasma membrane. Conversely, suppression of neuronal activity by tetrodotoxin decreased APP endocytosis and insertion. Interestingly, we found that activity-dependent APP trafficking and A generation were blocked in Mint knockout neurons. We showed that wild-type Mint1 can rescue APP internalization and insertion in Mint knockout neurons. In addition, we found that Mint overexpression increased excitatory synaptic activity and that APP was internalized predominantly to endosomes associated with APP processing. We demonstrated that presenilin 1 (PS1) endocytosis requires interaction with the PDZ domains of Mint1 and that this interaction facilitates activity-dependent colocalization of APP and PS1. These findings demonstrate that Mints are necessary for activity-induced APP and PS1 trafficking and provide insight into the cellular fate of APP in endocytic pathways essential for A production.	[Sullivan, Sarah E.; Dillon, Gregory M.; Sullivan, Josefa M.; Ho, Angela] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Ho, A (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	aho1@bu.edu			National Institute of Health [K01 AG027311, R01 AG044499]; Alzheimer's Association [IIRG-09-130591]; NATIONAL INSTITUTE ON AGING [R01AG044499, K01AG027311] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institute of Health Grants K01 AG027311 and R01 AG044499 (to A. H.). This work was also supported by Alzheimer's Association Grant IIRG-09-130591 (to A. H.).	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Beffert U, 2012, J NEUROSCI, V32, P13906, DOI 10.1523/JNEUROSCI.2108-12.2012; Biederer T, 2002, J NEUROSCI, V22, P7340; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Good RL, 2011, NEUROTOXICOLOGY, V32, P751, DOI 10.1016/j.neuro.2011.07.005; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gross GG, 2013, J NEUROSCI, V33, P8575, DOI 10.1523/JNEUROSCI.5749-12.2013; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1994, J BIOL CHEM, V269, P17741; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Matos MF, 2012, P NATL ACAD SCI USA, V109, P3802, DOI 10.1073/pnas.1119075109; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Scorza CA, 2003, EPILEPSY RES, V57, P49, DOI 10.1016/j.eplepsyres.2003.10.010; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xie H, 2013, P NATL ACAD SCI USA, V110, P7904, DOI 10.1073/pnas.1217938110	38	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15374	15383		10.1074/jbc.M113.541003	http://dx.doi.org/10.1074/jbc.M113.541003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742670	Green Published, hybrid			2022-12-28	WOS:000337465400021
J	Paik, J; Haenisch, M; Muller, CH; Goldstein, AS; Arnold, S; Isoherranen, N; Brabb, T; Treuting, PM; Amory, JK				Paik, Jisun; Haenisch, Michael; Muller, Charles H.; Goldstein, Alex S.; Arnold, Samuel; Isoherranen, Nina; Brabb, Thea; Treuting, Piper M.; Amory, John K.			Inhibition of Retinoic Acid Biosynthesis by the Bisdichloroacetyldiamine WIN 18,446 Markedly Suppresses Spermatogenesis and Alters Retinoid Metabolism in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; HUMAN CYTOCHROME-P450; BINDING-PROTEIN; DEHYDROGENASE; EXPRESSION; TESTIS; RAT; DEFICIENT; ANIMALS; ALCOHOL	Knowledge of the regulation of testicular retinoic acid synthesis is crucial for understanding its role in spermatogenesis. Bisdichloroacetyldiamines strongly inhibit spermatogenesis. We reported previously that one of these compounds, WIN 18,446, potently inhibited spermatogenesis in rabbits by inhibiting retinoic acid synthesis. To understand how WIN 18,446 inhibits retinoic acid synthesis, we characterized its effects on human retinal dehydrogenase ALDH1A2 in vitro as well as its effects on retinoid metabolism in vivo using mice. WIN 18,446 strongly and irreversibly inhibited ALDH1A2 in vitro. In vivo, WIN 18,446 treatment completely abolished spermatogenesis after 4 weeks of treatment and modestly reduced adiposity in mice fed a chow diet. Effects of WIN 18,446 on retinoid concentrations were tissue-dependent. Although lung and liver retinyl ester concentrations were lower in WIN 18,446-treated animals, adipose retinyl ester levels were increased following the treatment. Interestingly, animals treated with WIN 18,446 had significantly higher circulating retinol concentrations compared with control mice. The effect on spermatogenesis by WIN18,446 was not prevented by simultaneous treatment with retinoic acid, whereas effects on other tissues were partially or completely reversed. Cessation of WIN 18,446 treatment for 4 weeks reversed most retinoid-related phenotypes except for inhibition of spermatogenesis. Our data suggest that WIN 18,446 may be a useful model of systemic acquired retinoic acid deficiency. Given the effects observed in our study, inhibition of retinoic acid biosynthesis may have relevance for the treatment of obesity and in the development of novel male contraceptives.	[Paik, Jisun; Haenisch, Michael; Brabb, Thea; Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Muller, Charles H.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Arnold, Samuel; Isoherranen, Nina] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Amory, John K.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Goldstein, Alex S.] Focused Sci, Newcastle, WA 98059 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paik, J (corresponding author), Univ Washington, Dept Comparat Med, 1959 NE Pacific St HSB T140Q, Seattle, WA 98195 USA.	jpaik@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Amory, John/0000-0002-7419-435X	National Institutes of Health from the Eunice Kennedy Shriver NICHD [U01 HD060488, U54 HD42454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060488, U54HD042454] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 HD060488 and U54 HD42454 from the Eunice Kennedy Shriver NICHD (to J. K. A.).	AMANN RP, 1986, ENVIRON HEALTH PERSP, V70, P149; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Arnold SLM, 2012, J LIPID RES, V53, P587, DOI 10.1194/jlr.D019745; Asaoka Y, 2013, EXP TOXICOL PATHOL, V65, P817, DOI 10.1016/j.etp.2012.11.008; Blaner William S., 1994, P229; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Clugston RD, 2013, BBA-MOL CELL BIOL L, V1831, P1276, DOI 10.1016/j.bbalip.2013.04.006; DROBECK HANS P., 1962, EXPTL AND MOLECULAR PATHOL, V1, P251, DOI 10.1016/0014-4800(62)90023-0; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; GERLACH TH, 1991, FASEB J, V5, P86, DOI 10.1096/fasebj.5.1.1991596; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Hartmann S, 2001, J CHROMATOGR B, V751, P265, DOI 10.1016/S0378-4347(00)00481-3; HELLER CG, 1961, TOXICOL APPL PHARM, V3, P1, DOI 10.1016/0041-008X(61)90002-3; HOWELL JMG, 1963, J REPROD FERTIL, V5, P159, DOI 10.1530/jrf.0.0050159; HUANG HFS, 1979, BIOL REPROD, V21, P891, DOI 10.1095/biolreprod21.4.891; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; KEILSON B, 1979, J NUTR, V109, P787, DOI 10.1093/jn/109.5.787; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Munson L, 2004, THERIOGENOLOGY, V62, P81, DOI 10.1016/j.theriogenology.2003.07.026; Packer A. I., 1999, RETINOIDS BIOCH MOL, P347; Paik J, 2000, BIOCHEMISTRY-US, V39, P8073, DOI 10.1021/bi992152g; Paik J, 2005, EXP CELL RES, V303, P183, DOI 10.1016/j.yexcr.2004.09.019; Paik J, 2010, COMPARATIVE MED, V60, P189; Petersen PM, 1999, SCAND J WORK ENV HEA, V25, P31; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Soprano Dianne Robert, 1994, P257; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; VOGEL S, 1999, RETINOIDS BIOCH MOL, P31; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wu JW, 2008, ASIAN J ANDROL, V10, P569, DOI 10.1111/j.1745-7262.2008.00408.x	39	49	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15104	15117		10.1074/jbc.M113.540211	http://dx.doi.org/10.1074/jbc.M113.540211			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711451	Green Published, hybrid			2022-12-28	WOS:000337248100061
J	Plaza, JGR; Morales-Nava, R; Diener, C; Schreiber, G; Gonzalez, ZD; Ortiz, MTL; Blake, IO; Pantoja, O; Volkmer, R; Klipp, E; Herrmann, A; Del Rio, G				Rodriguez Plaza, Jonathan G.; Morales-Nava, Rosmarbel; Diener, Christian; Schreiber, Gabriele; Gonzalez, Zyanya D.; Lara Ortiz, Maria Teresa; Ortega Blake, Ivan; Pantoja, Omar; Volkmer, Rudolf; Klipp, Edda; Herrmann, Andreas; Del Rio, Gabriel			Cell Penetrating Peptides and Cationic Antibacterial Peptides TWO SIDES OF THE SAME COIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTOR; FACTOR PHEROMONE RECEPTOR; SACCHAROMYCES-CEREVISIAE; AMPHOTERICIN-B; ANTIMICROBIAL PEPTIDES; ASPERGILLUS-NIDULANS; CARGO DELIVERY; MEMBRANE; BINDING	Cell penetrating peptides (CPP) and cationic antibacterial peptides (CAP) have similar physicochemical properties and yet it is not understood how such similar peptides display different activities. To address this question, we used Iztli peptide 1 (IP-1) because it has both CPP and CAP activities. Combining experimental and computational modeling of the internalization of IP-1, we show it is not internalized by receptor-mediated endocytosis, yet it permeates into many different cell types, including fungi and human cells. We also show that IP-1 makes pores in the presence of high electrical potential at the membrane, such as those found in bacteria and mitochondria. These results provide the basis to understand the functional redundancy of CPPs and CAPs.	[Rodriguez Plaza, Jonathan G.; Diener, Christian; Gonzalez, Zyanya D.; Lara Ortiz, Maria Teresa; Del Rio, Gabriel] Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Morales-Nava, Rosmarbel; Ortega Blake, Ivan] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Mat Sci & Biophys Dept, Cuernavaca 62210, Morelos, Mexico; [Schreiber, Gabriele; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Volkmer, Rudolf] Charite, Inst Med Immunol, D-10117 Berlin, Germany; [Volkmer, Rudolf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Klipp, Edda; Herrmann, Andreas] Humboldt Univ, D-10115 Berlin, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin	Del Rio, G (corresponding author), Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx	Diener, Christian/X-9574-2019	Diener, Christian/0000-0002-7476-0868; Pantoja, Omar/0000-0002-6538-9059; Volkmer, Rudolf/0000-0003-4710-1143	Alexander von Humboldt Foundation; Consejo Nacional de Ciencia y Tecnologia [82308, 128575]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN205911, IG100513]; German Research Council [CRC740]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); German Research Council(German Research Foundation (DFG))	This work was supported in part by the Alexander von Humboldt Foundation, Consejo Nacional de Ciencia y Tecnologia (82308 and 128575), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grants IN205911 and IG100513 (to G. D. R. and I. O. B.), and German Research Council Grant CRC740 (to E. K. and A. H.).	Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; BLUMER KJ, 1988, J BIOL CHEM, V263, P10836; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen QJ, 1996, MOL CELL BIOL, V16, P247; Cohen BE, 2010, J MEMBRANE BIOL, V238, P1, DOI 10.1007/s00232-010-9313-y; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dube P, 1998, MOL CELL BIOL, V18, P7205, DOI 10.1128/MCB.18.12.7205; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Ellerby HM, 2008, J MED CHEM, V51, P5887, DOI 10.1021/jm800495u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gonzalez-Damian J, 2010, J MEMBRANE BIOL, V237, P41, DOI 10.1007/s00232-010-9301-2; Harriss LM, 2011, J AM CHEM SOC, V133, P14507, DOI 10.1021/ja204275t; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang WM, 2002, BIOPHYS J, V83, P3245, DOI 10.1016/S0006-3495(02)75326-5; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kilk K, 2009, TOXICOLOGY, V265, P87, DOI 10.1016/j.tox.2009.09.016; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lee BK, 2001, J BIOL CHEM, V276, P37950; Li LR, 2012, INT J ANTIMICROB AG, V40, P337, DOI 10.1016/j.ijantimicag.2012.05.026; Mak DOD, 1995, BIOPHYS J, V69, P2323, DOI 10.1016/S0006-3495(95)80102-5; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; McBride SM, 2011, MICROBIOL-SGM, V157, P1457, DOI 10.1099/mic.0.045997-0; Morgera F, 2009, BIOCHEM J, V417, P727, DOI 10.1042/BJ20081726; Nan YH, 2011, J PEPT SCI, V17, P812, DOI 10.1002/psc.1408; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Paternostre M., 1996, MANUAL MEMBRANE LIPI, P202, DOI [10.1016/j.ejps.2009.02.021, 10.1007/978-3-642-79837-5, DOI 10.1016/J.EJPS.2009.02.021]; Pooga Margus, 2005, V298, P77; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Recamier KS, 2010, J MEMBRANE BIOL, V237, P31, DOI 10.1007/s00232-010-9304-z; Plaza JGR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040125; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; SUAREZISLA BA, 1983, BIOCHEMISTRY-US, V22, P2319, DOI 10.1021/bi00279a003; Thomson K. B., 2012, YEAST PHEROMONE MODE; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Venegas B, 2003, BIOPHYS J, V85, P2323, DOI 10.1016/S0006-3495(03)74656-6; Vives E, 2005, J CONTROL RELEASE, V109, P77, DOI 10.1016/j.jconrel.2005.09.032; WEINER JL, 1993, J BIOL CHEM, V268, P8070; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	53	36	36	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14448	14457		10.1074/jbc.M113.515023	http://dx.doi.org/10.1074/jbc.M113.515023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706763	Green Published, hybrid			2022-12-28	WOS:000337248100002
J	Hino, K; Saito, A; Kido, M; Kanemoto, S; Asada, R; Takai, T; Cui, M; Cui, X; Imaizumi, K				Hino, Kenta; Saito, Atsushi; Kido, Miori; Kanemoto, Soshi; Asada, Rie; Takai, Tomoko; Cui, Min; Cui, Xiang; Imaizumi, Kazunori			Master Regulator for Chondrogenesis, Sox9, Regulates Transcriptional Activation of the Endoplasmic Reticulum Stress Transducer BBF2H7/CREB3L2 in Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Cell Biology; Chondrogenesis; Protein Secretion; Transcription Factors; BBF2H7; ER Stress Transducer; Sox9	UNFOLDED PROTEIN RESPONSE; CREB/ATF-FAMILY; INDIAN HEDGEHOG; OASIS FAMILY; CARTILAGE FORMATION; BONE-FORMATION; RETINOIC ACID; COLLAGEN GENE; II COLLAGEN; MOUSE MODEL	Background: BBF2H7 promotes cartilage matrix protein secretion through activation of Sec23a expression during chondrogenesis. Results: Sox9 induces BBF2H7 expression, followed by accelerating secretion of cartilage matrix proteins in chondrocytes. Conclusion: Sox9 simultaneously induces Bbf2h7 and Col2, followed by promoting secretion of Col2 through activation of BBF2H7-Sec23a signaling. Significance: This might be the first to define mechanisms for cartilage matrix protein secretion regulated by Sox9. The endoplasmic reticulum (ER) stress transducer, box B-binding factor 2 human homolog on chromosome 7 (BBF2H7), is a basic leucine zipper (bZIP) transmembrane transcription factor. This molecule is activated in response to ER stress during chondrogenesis. The activated BBF2H7 accelerates cartilage matrix protein secretion through the up-regulation of Sec23a, which is responsible for protein transport from the ER to the Golgi apparatus and is a target of BBF2H7. In the present study, we elucidated the mechanisms of the transcriptional activation of Bbf2h7 in chondrocytes. The transcription of Bbf2h7 is regulated by Sex determining region Y-related high-mobility group box 9 (Sox9), a critical factor for chondrocyte differentiation that facilitates the expression of one of the major cartilage matrix proteins Type II collagen (Col2), through binding to the Sox DNA-binding motif in the Bbf2h7 promoter. BBF2H7 is activated as a transcription factor in response to physiological ER stress caused by abundant synthesis of cartilage matrix proteins, and consequently regulates the secretion of cartilage matrix proteins. Taken together, our findings demonstrate novel regulatory mechanisms of Sox9 for controlling the secretion of cartilage matrix proteins through the activation of BBF2H7-Sec23a signaling during chondrogenesis.	[Hino, Kenta; Saito, Atsushi; Kido, Miori; Kanemoto, Soshi; Asada, Rie; Takai, Tomoko; Cui, Min; Cui, Xiang; Imaizumi, Kazunori] Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Saito, A (corresponding author), Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, I-2-3 Kasumi, Hiroshima 7348553, Japan.	asaito@hiroshima-u.ac.jp; imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science KAKENHI [25251014, 25650069, 24689058, 24659678]; Takeda Science Foundation; SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Japan Society for the Promotion of Science KAKENHI (25251014, 25650069, 24689058, and 24659678), Takeda Science Foundation, SEI Group CSR Foundation, INAMORI FOUNDATION, and The Uehara Memorial Foundation, and by a Research Grant of the Princess Takamatsu Cancer Research Fund and The Cell Science Research Foundation.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao GT, 2002, J HUM GENET, V47, P373, DOI 10.1007/s100380200053; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Lui WO, 2008, CANCER RES, V68, P7156, DOI 10.1158/0008-5472.CAN-08-1085; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	47	55	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13810	13820		10.1074/jbc.M113.543322	http://dx.doi.org/10.1074/jbc.M113.543322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711445	Green Published, hybrid			2022-12-28	WOS:000335984600015
J	Sassa, A; Caglayan, M; Dyrkheeva, NS; Beard, WA; Wilson, SH				Sassa, Akira; Caglayan, Melike; Dyrkheeva, Nadezhda S.; Beard, William A.; Wilson, Samuel H.			Base Excision Repair of Tandem Modifications in a Methylated CpG Dinucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; DNA Damage; DNA Methylation; DNA Polymerase; Oxidative Stress; 8-Oxoguanine; DNA Demethylation; DNA Glycosylase	THYMINE-DNA GLYCOSYLASE; POLYMERASE-BETA; SUBSTRATE-SPECIFICITY; AP-ENDONUCLEASE; INITIAL STEPS; MAMMALIAN DNA; ACTIVE-SITE; LIGASE-I; MISMATCH; BINDING	Background: Base excision repair is an important pathway for cytosine demethylation at the CpG dinucleotide for epigenetic control. Results: A deaminated 5-methylcytosine (thymine) and an adjacent oxidized guanine (7,8-dihydro-8-oxoguanine) retard base excision repair of each lesion. Conclusion: Altered in-tandem CpG dinucleotide is a poor substrate for base excision repair. Significance: Oxidized guanine in a CpG dinucleotide interferes with active DNA demethylation. Cytosine methylation and demethylation in tracks of CpG dinucleotides is an epigenetic mechanism for control of gene expression. The initial step in the demethylation process can be deamination of 5-methylcytosine producing the TpG alteration and T:G mispair, and this step is followed by thymine DNA glycosylase (TDG) initiated base excision repair (BER). A further consideration is that guanine in the CpG dinucleotide may become oxidized to 7,8-dihydro-8-oxoguanine (8-oxoG), and this could affect the demethylation process involving TDG-initiated BER. However, little is known about the enzymology of BER of altered in-tandem CpG dinucleotides; e.g. Tp8-oxoG. Here, we investigated interactions between this altered dinucleotide and purified BER enzymes, the DNA glycosylases TDG and 8-oxoG DNA glycosylase 1 (OGG1), apurinic/apyrimidinic (AP) endonuclease 1, DNA polymerase , and DNA ligases. The overall TDG-initiated BER of the Tp8-oxoG dinucleotide is significantly reduced. Specifically, TDG and DNA ligase activities are reduced by a 3-flanking 8-oxoG. In contrast, the OGG1-initiated BER pathway is blocked due to the 5-flanking T:G mispair; this reduces OGG1, AP endonuclease 1, and DNA polymerase activities. Furthermore, in TDG-initiated BER, TDG remains bound to its product AP site blocking OGG1 access to the adjacent 8-oxoG. These results reveal BER enzyme specificities enabling suppression of OGG1-initiated BER and coordination of TDG-initiated BER at this tandem alteration in the CpG dinucleotide.	[Sassa, Akira; Caglayan, Melike; Dyrkheeva, Nadezhda S.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Dyrkheeva, Nadezhda S.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Dyrkheeva, Nadezhda/0000-0002-8360-1041; Sassa, Akira/0000-0003-2454-0223; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health [Z01-ES050158, Z01-ES050159]; Eli Lilly and Co.; United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program; NATIONAL CANCER INSTITUTE [U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, ZIAES050158, Z01ES050159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly and Co.(Eli Lilly); United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01-ES050158 and Z01-ES050159 (NIEHS).; Supported in part by Eli Lilly and Co. and the United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program.	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Boland MJ, 2008, J MOL BIOL, V379, P492, DOI 10.1016/j.jmb.2008.02.049; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Deterding LJ, 2000, J BIOL CHEM, V275, P10463, DOI 10.1074/jbc.275.14.10463; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hashimoto K, 2004, NUCLEIC ACIDS RES, V32, P5928, DOI 10.1093/nar/gkh909; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kasymov RD, 2013, FEBS LETT, V587, P3129, DOI 10.1016/j.febslet.2013.08.008; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lavin MF, 2008, DNA REPAIR, V7, P1061, DOI 10.1016/j.dnarep.2008.03.008; Lee DH, 2002, NUCLEIC ACIDS RES, V30, P3566, DOI 10.1093/nar/gkf478; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Maltseva DV, 2009, BIOCHEMISTRY-US, V48, P1361, DOI 10.1021/bi801947f; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Pfeifer GP, 2000, CURR TOP MICROBIOL, V249, P1; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sakumi K, 2003, CANCER RES, V63, P902; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Schermerhorn KM, 2013, BIOCHEMISTRY-US, V52, P7669, DOI 10.1021/bi401218r; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Sunaga N, 2001, CARCINOGENESIS, V22, P1355, DOI 10.1093/carcin/22.9.1355; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; UESUGI S, 1977, J AM CHEM SOC, V99, P3250, DOI 10.1021/ja00452a008; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Vasovcak P, 2012, DNA REPAIR, V11, P616, DOI 10.1016/j.dnarep.2012.04.004; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Yamane A, 2003, CARCINOGENESIS, V24, P1031, DOI 10.1093/carcin/bgg056; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3734, DOI 10.1021/bi062214k; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	80	21	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13996	14008		10.1074/jbc.M114.557769	http://dx.doi.org/10.1074/jbc.M114.557769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695738	hybrid, Green Published			2022-12-28	WOS:000335984600030
J	Bohovych, I; Donaldson, G; Christianson, S; Zahayko, N; Khalimonchuk, O				Bohovych, Iryna; Donaldson, Garrett; Christianson, Sara; Zahayko, Nataliya; Khalimonchuk, Oleh			Stress-triggered Activation of the Metalloprotease Oma1 Involves Its C-terminal Region and Is Important for Mitochondrial Stress Protection in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetics; Metalloprotease; Mitochondria; Oxidative Stress; Yeast; Mitochondrial Stress; Oma1; Proteases	M-AAA PROTEASE; SACCHAROMYCES-CEREVISIAE; CYTOCHROME-OXIDASE; QUALITY-CONTROL; STRUCTURAL INSIGHT; RHOMBOID PROTEASE; ESCHERICHIA-COLI; STATIONARY-PHASE; OXIDATIVE STRESS; MAMMALIAN-CELLS	Background: Oma1 is a conserved membrane-bound protease that forms a high molecular mass complex. Results: Oma1 activity is induced by stress stimuli and required for survival. The activation is linked to changes in Oma1 oligomer stability and involves its C-terminal region. Conclusion: Oma1 function is activated by mitochondrial stress and is important for stress tolerance. Significance: Novel insights into Oma1 function and a potential stress activation mechanism are provided. Functional integrity of mitochondria is critical for optimal cellular physiology. A suite of conserved mitochondrial proteases known as intramitochondrial quality control represents one of the mechanisms assuring normal mitochondrial function. We previously demonstrated that ATP-independent metalloprotease Oma1 mediates degradation of hypohemylated Cox1 subunit of cytochrome c oxidase and is active in cytochrome c oxidase-deficient mitochondria. Here we show that Oma1 is important for adaptive responses to various homeostatic insults and preservation of normal mitochondrial function under damage-eliciting conditions. Changes in membrane potential, oxidative stress, or chronic hyperpolarization lead to increased Oma1-mediated proteolysis. The stress-triggered induction of Oma1 proteolytic activity appears to be associated with conformational changes within the Oma1 homo-oligomeric complex, and these alterations likely involve C-terminal residues of the protease. Substitutions in the conserved C-terminal region of Oma1 impair its ability to form a labile proteolytically active complex in response to stress stimuli. We demonstrate that Oma1 genetically interacts with other inner membrane-bound quality control proteases. These findings indicate that yeast Oma1 is an important player in IM protein homeostasis and integrity by acting in concert with other intramitochondrial quality control components.	[Khalimonchuk, Oleh] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Nebraska Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Khalimonchuk, O (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.	okhalimonchuk2@unl.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health [P20 RR-017675, P30GM103335, ES03817]; University of Nebraska-Lincoln Lyman Award; University of Nebraska UCARE program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES003817, R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108975, P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska-Lincoln Lyman Award; University of Nebraska UCARE program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR-017675 and P30GM103335 (to the Nebraska Redox Biology Center) and ES03817. This work was also supported by a University of Nebraska-Lincoln Lyman Award (to O.K.) and funds from the University of Nebraska UCARE program (to G. D. and S.C.).	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Baker M.J., 2011, COLD SPRING HARB PER, V3; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P587, DOI 10.1001/archneurol.2010.351; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Leroy I, 2010, FEBS LETT, V584, P3153, DOI 10.1016/j.febslet.2010.05.060; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Lopez-Pelegrin M, 2013, J BIOL CHEM, V288, P21279, DOI 10.1074/jbc.M113.476580; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Ocampo A, 2010, FASEB J, V24, P1431, DOI 10.1096/fj.09-148601; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b	63	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13259	13272		10.1074/jbc.M113.542910	http://dx.doi.org/10.1074/jbc.M113.542910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648523	Green Published, hybrid			2022-12-28	WOS:000335522800026
J	Planque, SA; Nishiyama, Y; Hara, M; Sonoda, S; Murphy, SK; Watanabe, K; Mitsuda, Y; Brown, EL; Massey, RJ; Primmer, SR; O'Nuallain, B; Paul, S				Planque, Stephanie A.; Nishiyama, Yasuhiro; Hara, Mariko; Sonoda, Sari; Murphy, Sarah K.; Watanabe, Kenji; Mitsuda, Yukie; Brown, Eric L.; Massey, Richard J.; Primmer, Stanley R.; O'Nuallain, Brian; Paul, Sudhir			Physiological IgM Class Catalytic Antibodies Selective for Transthyretin Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Amyloid; Antibodies; Innate Immunity; Protein Evolution; Amyloidosis; Catalytic Antibody; Superantigen; Transthyretin	VASOACTIVE-INTESTINAL-PEPTIDE; MYELIN BASIC-PROTEIN; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; ALPHA-SYNUCLEIN; HYDROLYSIS; IMMUNOGLOBULIN; OLIGOMERS; SITE; ALZHEIMERS	Background: Some antibodies express serine protease activity. Transthyretin misfolding causes accumulation of pathogenic amyloid. Results: Constitutively produced IgM but not IgG class antibodies selectively hydrolyzed and dissolved misfolded transthyretin without hydrolyzing physiologically folded transthyretin. Some IgMs were oligoreactive with amyloids and superantigens. Conclusion: Catalytic IgMs may clear misfolded TTR and delay amyloidosis. Significance: The innate antibody repertoire is a source of selective catabodies to toxic proteins. Peptide bond-hydrolyzing catalytic antibodies (catabodies) could degrade toxic proteins, but acquired immunity principles have not provided evidence for beneficial catabodies. Transthyretin (TTR) forms misfolded -sheet aggregates responsible for age-associated amyloidosis. We describe nucleophilic catabodies from healthy humans without amyloidosis that degraded misfolded TTR (misTTR) without reactivity to the physiological tetrameric TTR (phyTTR). IgM class B cell receptors specifically recognized the electrophilic analog of misTTR but not phyTTR. IgM but not IgG class antibodies hydrolyzed the particulate and soluble misTTR species. No misTTR-IgM binding was detected. The IgMs accounted for essentially all of the misTTR hydrolytic activity of unfractionated human serum. The IgMs did not degrade non-amyloidogenic, non-superantigenic proteins. Individual monoclonal IgMs (mIgMs) expressed variable misTTR hydrolytic rates and differing oligoreactivity directed to amyloid peptide and microbial superantigen proteins. A subset of the mIgMs was monoreactive for misTTR. Excess misTTR was dissolved by a hydrolytic mIgM. The studies reveal a novel antibody property, the innate ability of IgMs to selectively degrade and dissolve toxic misTTR species as a first line immune function.	[Planque, Stephanie A.; Nishiyama, Yasuhiro; Hara, Mariko; Sonoda, Sari; Murphy, Sarah K.; Watanabe, Kenji; Mitsuda, Yukie; Paul, Sudhir] Univ Texas Houston Med Sch, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Brown, Eric L.] Univ Texas Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA; [Massey, Richard J.] Covalent Biosci Inc, Houston, TX 77054 USA; [Primmer, Stanley R.] Supercentenarian Res Fdn, Lauderhill, FL 33319 USA; [O'Nuallain, Brian] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [O'Nuallain, Brian] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Paul, S (corresponding author), Univ Texas Houston Med Sch, Dept Pathol & Lab Med, Chem Immunol Res Ctr, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu		Gunter, Sarah/0000-0002-0648-6828	National Institutes of Health [U01AG033183, S10RR024574, AI036211, P30CA125123]; SENS Research Foundation; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R21AI072439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG033183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SENS Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant U01AG033183. This work was also supported by the SENS Research Foundation. The Flow Cytometry Core at the Baylor College of Medicine is funded by National Institutes of Health Grants S10RR024574, AI036211, and P30CA125123. Stephanie Planque, Yasuhiro Nishiyama, Eric Brown, Richard Massey, and Sudhir Paul have a financial interest in Covalent Bioscience, Inc. and patents concerning catalytic antibodies.	Abdallah Emad, 2013, Saudi J Kidney Dis Transpl, V24, P950; Andrievskaya O A, 2000, Med Sci Monit, V6, P460; Baranova SV, 2010, INT IMMUNOL, V22, P671, DOI 10.1093/intimm/dxq051; Bayry Jagadeesh, 2005, Expert Rev Clin Immunol, V1, P213, DOI 10.1586/1744666X.1.2.213; Beynon R.J., 2001, PROTEOLYTIC ENZYMES, P317; Brown EL, 2012, J BIOL CHEM, V287, P9940, DOI 10.1074/jbc.M111.330043; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; CHEN TY, 1993, AM J HEMATOL, V44, P276, DOI 10.1002/ajh.2830440411; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; Graille M, 2002, J BIOL CHEM, V277, P47500, DOI 10.1074/jbc.M206105200; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; KALAGA R, 1995, J IMMUNOL, V155, P2695; Kalinin S, 2013, NEUROBIOL AGING, V34, P2361, DOI 10.1016/j.neurobiolaging.2013.03.023; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kingsbury JS, 2012, ANAL BIOCHEM, V425, P151, DOI 10.1016/j.ab.2012.03.016; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kohler H, 1998, IMMUNOL TODAY, V19, P221, DOI 10.1016/S0167-5699(97)01234-6; Kreyrnann KG, 2007, CRIT CARE MED, V35, P2677, DOI 10.1097/01.CCM.0000295263.12774.97; Lane T, 2013, ARTHRITIS RHEUM-US, V65, P1116, DOI 10.1002/art.37827; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Liu L, 2008, J MOL BIOL, V377, P1236, DOI 10.1016/j.jmb.2008.01.057; Liu YH, 2012, NAT REV NEUROL, V8, P465, DOI 10.1038/nrneurol.2012.118; Lundberg E, 2009, FEBS J, V276, P1999, DOI 10.1111/j.1742-4658.2009.06936.x; Maas A, 1999, J IMMUNOL, V162, P6526; Maftei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044516; Millucci L, 2012, SCI WORLD J, DOI 10.1100/2012/293863; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; MODY R, 1994, INT J PEPT PROT RES, V44, P441; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; Nishiyama Y, 2009, J BIOL CHEM, V284, P30627, DOI 10.1074/jbc.M109.032185; Nissim A., 2008, V181, P3; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; PAUL S, 1990, J BIOL CHEM, V265, P11910; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PILATI CF, 1990, AM J PHYSIOL, V258, pH748, DOI 10.1152/ajpheart.1990.258.3.H748; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Planque SA, 2012, J IMMUNOL, V189, P5367, DOI 10.4049/jimmunol.1200981; POLLACK SJ, 1989, J AM CHEM SOC, V111, P5961, DOI 10.1021/ja00197a078; Polosukhina DI, 2006, IMMUNOL LETT, V103, P75, DOI 10.1016/j.imlet.2005.10.018; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; ROSSING N, 1978, LYMPHOLOGY, V11, P138; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sapparapu G, 2012, J BIOL CHEM, V287, P36096, DOI 10.1074/jbc.M112.401075; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; SCHURR JM, 1966, SCIENCE, V152, P1064, DOI 10.1126/science.152.3725.1064; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Sousa MM, 2004, FASEB J, V18, P124, DOI 10.1096/fj.04-2022fje; SPENCER J, 1984, IMMUNOLOGY, V52, P7; Su Y, 2012, AMYLOID, V19, P45, DOI 10.3109/13506129.2012.674075; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Takeshita S, 2001, CLIN EXP IMMUNOL, V125, P340, DOI 10.1046/j.1365-2249.2001.01608.x; Takeuchi M, 2007, PROTEINS, V66, P716, DOI 10.1002/prot.21252; Teixeira PF, 2006, J BIOL CHEM, V281, P21998, DOI 10.1074/jbc.M602302200; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; Wang XW, 1999, CLIN IMMUNOL, V93, P132, DOI 10.1006/clim.1999.4781; Westermark P, 2003, AMYLOID, V10, P48; Wootla B, 2008, J IMMUNOL, V180, P7714, DOI 10.4049/jimmunol.180.11.7714; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Xia K, 2012, BIOCHEMISTRY-US, V51, P100, DOI 10.1021/bi201362z; XU HJ, 1992, J IMMUNOL METHODS, V146, P241, DOI 10.1016/0022-1759(92)90233-J; Yang DT, 2013, BIOCHEMISTRY-US, V52, P2849, DOI 10.1021/bi4001613	100	39	44	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13243	13258		10.1074/jbc.M114.557231	http://dx.doi.org/10.1074/jbc.M114.557231			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648510	Green Published, hybrid			2022-12-28	WOS:000335522800025
J	Hale, AT; Tian, HM; Anih, E; Recio, FO; Shatat, MA; Johnson, T; Liao, XD; Ramirez-Bergeron, DL; Proweller, A; Ishikawa, M; Hamik, A				Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne			Endothelial Kruppel-like Factor 4 Regulates Angiogenesis and the Notch Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; ATPases; Kinetics; Molecular Motors; Myosin	INHIBITS TUMOR-GROWTH; VASCULAR MORPHOGENESIS; CELL-DIFFERENTIATION; UP-REGULATION; EXPRESSION; KLF4; BLOCKADE; GENE; ACTS; VEGF	Background: The transcription factor Kruppel-like factor 4 (KLF4) is a critical regulator of endothelial cell biology. Results: Sustained expression of endothelial KLF4 limits tumor growth by creating ineffective angiogenesis. Conclusion: KLF4 is an upstream regulator of angiogenesis in part by mediating Notch expression and activity. Significance: KLF4 regulates sprouting angiogenesis and may be a therapeutic target in regulation of tumor angiogenesis. Regulation of endothelial cell biology by the Notch signaling pathway (Notch) is essential to vascular development, homeostasis, and sprouting angiogenesis. Although Notch determines cell fate and differentiation in a wide variety of cells, the molecular basis of upstream regulation of Notch remains poorly understood. Our group and others have implicated the Kruppel-like factor family of transcription factors as critical regulators of endothelial function. Here, we show that Kruppel-like factor 4 (KLF4) is a central regulator of sprouting angiogenesis via regulating Notch. Using a murine model in which KLF4 is overexpressed exclusively in the endothelium, we found that sustained expression of KLF4 promotes ineffective angiogenesis leading to diminished tumor growth independent of endothelial cell proliferation or cell cycling effects. These tumors feature increased vessel density yet are hypoperfused, leading to tumor hypoxia. Mechanistically, we show that KLF4 differentially regulates expression of Notch receptors, ligands, and target genes. We also demonstrate that KLF4 limits cleavage-mediated activation of Notch1. Finally, we rescue Notch target gene expression and the KLF4 sprouting angiogenesis phenotype by supplementation of DLL4 recombinant protein. Identification of this hitherto undiscovered role of KLF4 implicates this transcription factor as a critical regulator of Notch, tumor angiogenesis, and sprouting angiogenesis.	[Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Shatat, Mohammad A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Hamik, Anne] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Cardiovasc Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hamik, A (corresponding author), 2103 Cornell Rd, Cleveland, OH 44106 USA.	anne.hamik@case.edu		Hale, Andrew/0000-0003-3182-2966; Shatat, Mohammad/0000-0002-8715-6889	National Institutes of Health [HL083090, HL113570]; Dominic Visconsi Research Scholars' Fund;  [HL091171];  [HL096603]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091171, R01HL096597, R01HL096603, K08HL083090, R01HL113570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominic Visconsi Research Scholars' Fund; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083090 and HL113570, the Dominic Visconsi Research Scholars' Fund (to A. Hamik) and Grants HL091171 (to D. R-B.) and HL096603 (to A. P.).	Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Crampton Steve P, 2007, J Vis Exp, P183, DOI 10.3791/183; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Hongmei D., 2011, 16 WORLD C HEART DIS; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Klaewsongkram J, 2007, J IMMUNOL, V179, P4679, DOI 10.4049/jimmunol.179.7.4679; Krebs LT, 2000, GENE DEV, V14, P1343; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039663; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Overwijk W. W., 2009, CURR PROT IMMUNOL, V39; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shatat MA, 2014, AM J RESP CELL MOL, V50, P647, DOI 10.1165/rcmb.2013-0135OC; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	40	48	50	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12016	12028		10.1074/jbc.M113.530956	http://dx.doi.org/10.1074/jbc.M113.530956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599951	hybrid, Green Published			2022-12-28	WOS:000335010600040
J	Moschner, K; Sundermann, F; Meyer, H; da Graca, AP; Appel, N; Paululat, A; Bakota, L; Brandt, R				Moschner, Katharina; Suendermann, Frederik; Meyer, Heiko; da Graca, Abel Pereira; Appel, Neele; Paululat, Achim; Bakota, Lidia; Brandt, Roland			RNA Protein Granules Modulate tau Isoform Expression and Induce Neuronal Sprouting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA; CORTICAL-NEURONS; STRESS GRANULES; KH DOMAINS; GENE; LOCALIZATION; ASSOCIATION; MEMBRANE; REVEALS	The neuronal microtubule-associated protein Tau is expressed in different variants, and changes in Tau isoform composition occur during development and disease. Here, we investigate a potential role of the multivalent tau mRNA-binding proteins G3BP1 and IMP1 in regulating neuronal tau expression. We demonstrate that G3BP1 and IMP1 expression induces the formation of structures, which qualify as neuronal ribonucleoprotein (RNP) granules and concentrate multivalent proteins and mRNA. We show that RNP granule formation leads to a >30-fold increase in the ratio of high molecular weight to low molecular weight tau mRNA and an similar to 12-fold increase in high molecular weight to low molecular weight Tau protein. We report that RNP granule formation is associated with increased neurite formation and enhanced process growth. G3BP1 deletion constructs that do not induce granule formation are also deficient in inducing neuronal sprouting or changing the expression pattern of tau. The data indicate that granule formation driven by multivalent proteins modulates tau isoform expression and suggest a morphoregulatory function of RNP granules during health and disease.	[Moschner, Katharina; Suendermann, Frederik; da Graca, Abel Pereira; Appel, Neele; Bakota, Lidia; Brandt, Roland] Univ Osnabruck, Dept Neurobiol, D-49076 Osnabruck, Germany; [Meyer, Heiko; Paululat, Achim] Univ Osnabruck, Dept Zool, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Brandt, R (corresponding author), Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	brandt@biologie.uni-osnabrueck.de		Paululat, Achim/0000-0002-8845-6859; Brandt, Roland/0000-0003-0101-1257; Harten, Heiko/0000-0002-3304-4523; Bakota, Lidia/0000-0002-8777-5006	Deutsche Forschungsgemeinschaft [SFB 944]; Lichtenberg fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lichtenberg fellowship	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 944, Project P1 (to R. B.), and a Lichtenberg fellowship (to F. S.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bakota L, 2012, MOL GENET GENOMICS, V287, P313, DOI 10.1007/s00438-012-0680-1; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; BOYNE LJ, 1995, J COMP NEUROL, V358, P279, DOI 10.1002/cne.903580209; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; Dickson JR, 2013, J NEUROCHEM, V127, P739, DOI 10.1111/jnc.12437; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Fath T, 2002, J NEUROSCI, V22, P9733; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hebert S. S., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/406561; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Martin S, 2013, J NEUROCHEM, V125, P175, DOI 10.1111/jnc.12189; Mellone M, 2013, J NEUROSCI, V33, P18175, DOI 10.1523/JNEUROSCI.4933-12.2013; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; SADOT E, 1994, J MOL BIOL, V241, P325, DOI 10.1006/jmbi.1994.1508; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sica R E, 1998, Electromyogr Clin Neurophysiol, V38, P475; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smith PY, 2011, HUM MOL GENET, V20, P4016, DOI 10.1093/hmg/ddr330; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sohn YK, 1999, J NEUROL SCI, V162, P133, DOI 10.1016/S0022-510X(98)00297-4; Swanger SA, 2011, METHODS MOL BIOL, V714, P103, DOI 10.1007/978-1-61779-005-8_7; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; TENG KK, 1993, J CELL SCI, V106, P611; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	47	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16814	16825		10.1074/jbc.M113.541425	http://dx.doi.org/10.1074/jbc.M113.541425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755223	Green Published, hybrid			2022-12-28	WOS:000338016200019
J	Takeshita, S; Fumoto, T; Naoe, Y; Ikeda, K				Takeshita, Sunao; Fumoto, Toshio; Naoe, Yoshinori; Ikeda, Kyoji			Age-related Marrow Adipogenesis Is Linked to Increased Expression of RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST-LIKE CELLS; MURINE BONE-MARROW; SUPPORT DIFFERENTIATION; TRABECULAR BONE; STROMAL CELLS; IN-VITRO; ADIPOCYTES; LIGAND; OSTEOPOROSIS; MOUSE	With advancing age bone marrow is progressively replaced with adipose tissue, accompanied by a concomitant decline in bone mass and strength. The mechanism underlying the increase in marrow fat and bone destruction remains elusive. We found that on the way of adipogenic differentiation of marrow stromal cells, receptor activator for NF-kappa B ligand (Rankl) expression was induced, concomitantly with a down-regulation of osteoprotegerin, which prompted us to hypothesize that cells at a preadipocyte stage express RANKL. This concept was supported by the findings that the early adipogenic transcription factors C/EBP beta and C/EBP delta, but not the late factor peroxisome proliferator-activated receptor gamma, bind to the Rankl promoter and stimulate Rankl gene transcription. In fact, when cells isolated from the bone marrow of aging mice were analyzed by flow cytometry, we found that cells expressing the pre-adipocyte marker Pref-1 were RANKL-positive, and the number of these cells was increased with aging, with concomitant down-regulation of osteoprotegerin, and most importantly, that these RANKL(+)/Pref-1(+) marrow cells were capable of generating osteoclasts from bone marrow macrophages. Thus, the capacity of cells at a pre-adipocyte stage to express RANKL via C/EBP beta and C/EBP delta and to support osteoclastogenesis may account partly for the co-progression of fatty marrow and bone destruction with aging.	[Takeshita, Sunao; Fumoto, Toshio; Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan; [Naoe, Yoshinori] Natl Ctr Geriatr & Gerontol, Dept Mech Aging, Obu, Aichi 4748511, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Ikeda, K (corresponding author), 35 Gengo, Obu, Aichi 4748511, Japan.	sunao@ncgg.go.jp	fumoto, toshio/F-6345-2015	fumoto, toshio/0000-0002-9273-8939	Ministry of Education, Science of Japan [18590359, 22118007]; program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan [06-31]; Ono Foundation; Daiko Foundation; Tokyo Biochemistry Research Foundation; Grants-in-Aid for Scientific Research [22118007] Funding Source: KAKEN	Ministry of Education, Science of Japan; program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ono Foundation; Daiko Foundation(Daiko Foundation); Tokyo Biochemistry Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research C mice, to support osteoclastogenesis. 18590359 (to S. T.) and a Grant-in-aid for Scientific Research on Innovative Areas 22118007 (to K. I.) from the Ministry of Education, Science of Japan, a grant from the program Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (06-31) (to K. I.), and grants from Ono Foundation (to S. T.), Daiko Foundation (to K. I.), and Tokyo Biochemistry Research Foundation (to K. I.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BENAYAHU D, 1994, J CELL BIOCHEM, V56, P374, DOI 10.1002/jcb.240560314; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Chiang BT, 2006, J BIOMED SCI, V13, P621, DOI 10.1007/s11373-006-9101-y; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1977, BIOMED EXPRESS, V27, P344; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Holloway WR, 2002, J BONE MINER RES, V17, P200, DOI 10.1359/jbmr.2002.17.2.200; JEE WSS, 1983, AM J PHYSIOL, V244, pR310, DOI 10.1152/ajpregu.1983.244.3.R310; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Justesen J, 2004, TISSUE ENG, V10, P381, DOI 10.1089/107632704323061744; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; KAWAI K, 1985, J BONE JOINT SURG AM, V67A, P755, DOI 10.2106/00004623-198567050-00010; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; MARTIN RB, 1991, BONE, V12, P123, DOI 10.1016/8756-3282(91)90011-7; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; MOORE SG, 1990, RADIOLOGY, V175, P219, DOI 10.1148/radiology.175.1.2315484; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; ROZMAN C, 1989, EXP HEMATOL, V17, P34; Sakaguchi K, 2000, PROSTAG LEUKOTR ESS, V62, P319, DOI 10.1054/plef.2000.0161; Shahnazari M, 2012, BONE, V50, P628, DOI 10.1016/j.bone.2011.11.010; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeshita S, 2001, BONE, V29, P236, DOI 10.1016/S8756-3282(01)00505-1; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304	42	82	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16699	16710		10.1074/jbc.M114.547919	http://dx.doi.org/10.1074/jbc.M114.547919			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753250	Green Published, hybrid			2022-12-28	WOS:000338016200010
J	Neumann, S; Hasenauer, J; Pollak, N; Scheurich, P				Neumann, Simon; Hasenauer, Jan; Pollak, Nadine; Scheurich, Peter			Dominant Negative Effects of Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL) Receptor 4 on TRAIL Receptor 1 Signaling by Formation of Heteromeric Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEATH RECEPTOR; DECOY RECEPTOR; COLON-CANCER; CELL-DEATH; DOMAIN; APO2L/TRAIL; INHIBITION; ACTIVATION; PATHWAYS	The cytokine TNF-related apoptosis-inducing ligand (TRAIL) and its cell membrane receptors constitute an elaborate signaling system fulfilling important functions in immune regulation and tumor surveillance. Activation of the death receptors TRAILR1 and TRAILR2 can lead to apoptosis, whereas TRAILR3 and TRAILR4 are generally referred to as decoy receptors, which have been shown to inhibit TRAIL-induced apoptosis. The underlying molecular mechanisms, however, remain unclear. Alike other members of the TNF receptor superfamily, TRAIL receptors contain a pre-ligand binding assembly domain (PLAD) mediating receptor oligomerization. Still, the stoichiometry of TRAIL receptor oligomers as well as the issue of whether the PLAD mediates only homotypic or also heterotypic interactions remained inconclusive until now. Performing acceptor-photobleaching FRET studies with receptors 1, 2, and 4, we demonstrate interactions in all possible combinations. Formation of dimers was shown by chemical cross-linking experiments for interactions of TRAILR2 and heterophilic interactions between the two death receptors or between either of the death receptors and TRAILR4. Implications of the demonstrated receptor-receptor interactions on signaling were investigated in suitable cellular models. Both apoptosis induction and activation of the transcription factor NF kappa B were significantly reduced in the presence of TRAILR4. Our experimental data combined with mathematical modeling show that the inhibitory capacity of TRAILR4 is attributable to signaling-independent mechanisms, strongly suggesting a reduction of signaling competent death receptors through formation heteromeric receptor complexes. In summary, we propose a model of TRAIL receptor interference driven by PLAD-mediated formation of receptor heterodimers on the cell membrane.	[Neumann, Simon; Pollak, Nadine; Scheurich, Peter] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Hasenauer, Jan] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Hasenauer, Jan] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	University of Stuttgart; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Scheurich, P (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	peter.scheurich@izi.uni-stuttgart.de	Hasenauer, Jan/B-8853-2013	Hasenauer, Jan/0000-0002-4935-3312	German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [EXC 310/1]; German Federal Ministry of Education and Research (BMBF) [PREDICT 0316186A]; BMBF [0315766, 0316042G]	German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Research Foundation (DFG) within the Cluster of Excellence in Simulation Technology (EXC 310/1) at the University of Stuttgart, German Federal Ministry of Education and Research (BMBF) Grant PREDICT 0316186A (to S. N. and P. S.), and by the BMBF within Virtual Liver Project Grant 0315766 and LungSys II Grant 0316042G (to J. H.).	Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Gerken M, 2010, BBA-BIOMEMBRANES, V1798, P1081, DOI 10.1016/j.bbamem.2010.02.021; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Lee HW, 2005, BIOCHEM BIOPH RES CO, V330, P1205, DOI 10.1016/j.bbrc.2005.03.101; Lewis AK, 2012, BIOCHEMISTRY-US, V51, P6545, DOI 10.1021/bi3006626; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Winkel C, 2012, MATH BIOSCI ENG, V9, P663, DOI 10.3934/mbe.2012.9.663; Zinonos I, 2011, J BONE MINER RES, V26, P630, DOI 10.1002/jbmr.244	36	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16576	16587		10.1074/jbc.M114.559468	http://dx.doi.org/10.1074/jbc.M114.559468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764293	Green Published, hybrid			2022-12-28	WOS:000337965700058
J	de Assuncao, TM; Lomberk, G; Cao, S; Yaqoob, U; Mathison, A; Simonetto, DA; Huebert, RC; Urrutia, RA; Shah, VH				de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.			New Role for Kruppel-like Factor 14 as a Transcriptional Activator Involved in the Generation of Signaling Lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Epigenetics; Fibroblast Growth Factor (FGF); Kruppel-like Factor (KLF); Sphingosine-1-phosphate (S1P)	PROTEIN-KINASE-C; EXTRACELLULAR EXPORT; GENE-EXPRESSION; CELL-LINE; GROWTH; SPHINGOSINE-1-PHOSPHATE; ACETYLATION; SPECIFICITY; MECHANISMS; REGULATOR	Sphingosine kinase 1 (SK1) is an FGF-inducible gene responsible for generation of sphingosine-1-phosphate, a critical lipid signaling molecule implicated in diverse endothelial cell functions. In this study, we identified SK1 as a target of the canonical FGF2/FGF receptor 1 activation pathway in endothelial cells and sought to identify novel transcriptional pathways that mediate lipid signaling. Studies using the 1.9-kb SK1 promoter and deletion mutants revealed that basal and FGF2-stimulated promoter activity occurred through two GC-rich regions located within 633 bp of the transcription start site. Screening for GC-rich binding transcription factors that could activate this site demonstrated that KLF14, a gene implicated in obesity and the metabolic syndrome, binds to this region. Congruently, overexpression of KLF14 increased basal and FGF2-stimulated SK1 promoter activity by 3-fold, and this effect was abrogated after mutation of the GC-rich sites. In addition, KLF14 siRNA transfection decreased SK1 mRNA and protein levels by 3-fold. Congruently, SK1 mRNA and protein levels were decreased in livers from KLF14 knock-out mice. Combined, luciferase, gel shift, and chromatin immunoprecipitation assays showed that KLF14 couples to p300 to increase the levels of histone marks associated with transcriptional activation (H4K8ac and H3K14ac), while decreasing repressive marks (H3K9me3 and H3K27me3). Collectively, the results demonstrate a novel mechanism whereby SK1 lipid signaling is regulated by epigenetic modifications conferred by KLF14 and p300. Thus, this is the first description of the activity and mechanisms underlying the function of KLF14 as an activator protein and novel regulator of lipid signaling.	[de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Physiol & Biophys, Rochester, MN 55905 USA; [de Assuncao, Thiago M.; Lomberk, Gwen; Cao, Sheng; Yaqoob, Usman; Mathison, Angela; Simonetto, Douglas A.; Huebert, Robert C.; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Dept Med, Rochester, MN 55905 USA; [Lomberk, Gwen; Urrutia, Raul A.] Mayo Clin, Epigen Translat Program, Mayo Clin Ctr Individualized Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, RA (corresponding author), Mayo Clin, Gastroenterol Res Unit, Guggenheim 10-21,200 First St SW, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu; shah.vijay@mayo.edu		Mathison, Angela/0000-0002-6763-2710; Huebert, Robert/0000-0002-9812-7573	National Institutes of Health [DK59015, AA021171, P30 DL 084567, DK52913, DK100575-01]; Mayo Center for Regenerative Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100575, R01DK059615, R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA021171, R01AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Center for Regenerative Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59015, AA021171, and P30 DL 084567 (to V. H. S.); DK52913 (to R. U.); and DK100575-01 (to R. C. H.). This work was also supported by funds from the Mayo Center for Regenerative Medicine (to R.C.H.).	Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belacortu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032004; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Civelek M, 2011, NAT GENET, V43, P506, DOI 10.1038/ng.842; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonzalez CR, 2013, CYTOKINE, V61, P670, DOI 10.1016/j.cyto.2012.12.009; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Huang KP, 2014, CELL SIGNAL, V26, P629, DOI 10.1016/j.cellsig.2013.12.002; Huebert RC, 2011, AM J PATHOL, V179, P1851, DOI 10.1016/j.ajpath.2011.06.045; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2013, J BIOL CHEM, V288, P17745, DOI 10.1074/jbc.M112.434670; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Schwalm S, 2013, BBA-MOL CELL BIOL L, V1831, P239, DOI 10.1016/j.bbalip.2012.07.022; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	35	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15798	15809		10.1074/jbc.M113.544346	http://dx.doi.org/10.1074/jbc.M113.544346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759103	Green Published, hybrid			2022-12-28	WOS:000337465400059
J	Lipscomb, JD				Lipscomb, John D.			Life in a Sea of Oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Heme; Metalloenzymes; Dioxygenase; Spectroscopy	METHYLOSINUS-TRICHOSPORIUM OB3B; MONOOXYGENASE COMPONENT-B; SINGLE-TURNOVER KINETICS; ACTIVE-SITE FE-2+; METHANE MONOOXYGENASE; PROTOCATECHUATE 3,4-DIOXYGENASE; HOMOPROTOCATECHUATE 2,3-DIOXYGENASE; HYDROXYLASE COMPONENT; CRYSTAL-STRUCTURE; PSEUDOMONAS-PUTIDA		[Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Lipscomb, John D.] Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lipscomb, JD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	lipsc001@umn.edu		Lipscomb, John/0000-0002-8158-5594	National Institutes of Health [GM24689, GM40466, GM100943]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040466, R37GM024689, R01GM024689, R01GM100943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am greatly indebted to the many students and postdoctoral fellows who have worked in my laboratory as well as the scientific collaborators who have amplified my studies so greatly over my career. I have attempted to name as many of these individuals as possible, but there are many others who have contributed greatly. I thank my wife, Susan, for forty-two years of support and encouragement beginning on the Champaign-Urbana plain. I also thank the National Institutes of Health for funding these studies for the past four decades through Grants GM24689, GM40466, and GM100943.	ANDERSSON KK, 1991, NEW J CHEM, V15, P411; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARCIERO DM, 1986, J BIOL CHEM, V261, P2170; Banerjee R, 2013, BIOCHEMISTRY-US, V52, P4331, DOI 10.1021/bi400182y; Brazeau BJ, 2003, BIOCHEM BIOPH RES CO, V312, P143, DOI 10.1016/j.bbrc.2003.09.242; Brazeau BJ, 2003, BIOCHEMISTRY-US, V42, P5618, DOI 10.1021/bi027429i; Brazeau BJ, 2001, J AM CHEM SOC, V123, P10421, DOI 10.1021/ja016632i; Brazeau BJ, 2000, BIOCHEMISTRY-US, V39, P13503, DOI 10.1021/bi001473l; Chakrabarty S, 2007, J AM CHEM SOC, V129, P3514, DOI 10.1021/ja068188v; Chang SL, 1999, BIOCHEMISTRY-US, V38, P5799, DOI 10.1021/bi982992f; Chang SL, 2001, BIOCHEMISTRY-US, V40, P9539, DOI 10.1021/bi0103462; Elango N, 1997, PROTEIN SCI, V6, P556; Fielding AJ, 2014, J BIOL INORG CHEM, V19, P491, DOI 10.1007/s00775-014-1122-9; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FOX BG, 1988, J BIOL CHEM, V263, P10553; FOX BG, 1989, J BIOL CHEM, V264, P10023; FOX BG, 1991, J BIOL CHEM, V266, P540; FRAZEE RW, 1993, J BACTERIOL, V175, P6194, DOI 10.1128/JB.175.19.6194-6202.1993; Frazee RW, 1998, BIOCHEMISTRY-US, V37, P2131, DOI 10.1021/bi972047b; FROLAND WA, 1992, J BIOL CHEM, V267, P17588; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Groce SL, 2004, BIOCHEMISTRY-US, V43, P15141, DOI 10.1021/bi048690x; Gunsalus I. C., 1974, MOL MECHANISMS OXYGE, P561; Gunsalus I. C., 1973, OXIDASES RELATED RED, P583; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HARPEL MR, 1990, J BIOL CHEM, V265, P6301; HENDRICH MP, 1990, J AM CHEM SOC, V112, P5861, DOI 10.1021/ja00171a029; Jeoung JH, 2013, P NATL ACAD SCI USA, V110, P12625, DOI 10.1073/pnas.1302144110; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, BIOCHEMISTRY-US, V47, P11168, DOI 10.1021/bi801459q; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Kovaleva EG, 2012, BIOCHEMISTRY-US, V51, P8755, DOI 10.1021/bi301115c; LEE SK, 1993, J BIOL CHEM, V268, P21569; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; Lipscomb J. D., 1982, OXIDASES RELATED RED, P483; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; LIPSCOMB JD, 1978, BIOCHEM BIOPH RES CO, V83, P771, DOI 10.1016/0006-291X(78)91461-4; LIPSCOMB JD, 1992, MET IONS BIOL SYST, V28, P243; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; Liu PH, 2003, BIOCHEMISTRY-US, V42, P11577, DOI 10.1021/bi030140w; LIU Y, 1995, J BIOL CHEM, V270, P24662, DOI 10.1074/jbc.270.42.24662; Makris TM, 2013, BIOCHEMISTRY-US, V52, P6662, DOI 10.1021/bi400845b; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; Mbughuni MM, 2012, BIOCHEMISTRY-US, V51, P8743, DOI 10.1021/bi301114x; Mbughuni MM, 2011, BIOCHEMISTRY-US, V50, P10262, DOI 10.1021/bi201436n; Mbughuni MM, 2010, P NATL ACAD SCI USA, V107, P16788, DOI 10.1073/pnas.1010015107; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; Nesheim JC, 1996, BIOCHEMISTRY-US, V35, P10240, DOI 10.1021/bi960596w; OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0; OHLENDORF DH, 1994, J MOL BIOL, V244, P586, DOI 10.1006/jmbi.1994.1754; ORVILLE AM, 1992, BIOCHEMISTRY-US, V31, P4602, DOI 10.1021/bi00134a010; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10039, DOI 10.1021/bi970468n; ORVILLE AM, 1989, J BIOL CHEM, V264, P8791; ORVILLE AM, 1993, J BIOL CHEM, V268, P8596; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10052, DOI 10.1021/bi970469f; Pau MYM, 2007, P NATL ACAD SCI USA, V104, P18355, DOI 10.1073/pnas.0704191104; POULOS TL, 1985, J BIOL CHEM, V260, P6122; PRIESTLEY ND, 1992, J AM CHEM SOC, V114, P7561, DOI 10.1021/ja00045a037; QUE L, 1977, BIOCHIM BIOPHYS ACTA, V485, P60; QUE L, 1976, BIOCHIM BIOPHYS ACTA, V452, P320; Rocklin AM, 2004, J BIOL INORG CHEM, V9, P171, DOI 10.1007/s00775-003-0510-3; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; SHARROCK M, 1976, BIOCHIM BIOPHYS ACTA, V420, P8, DOI 10.1016/0005-2795(76)90340-8; SHARROCK M, 1973, BIOCHEMISTRY-US, V12, P258, DOI 10.1021/bi00726a013; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; SLIGAR SG, 1974, P NATL ACAD SCI USA, V71, P3906, DOI 10.1073/pnas.71.10.3906; SUGIYAMA K, 1995, P JPN ACAD B-PHYS, V71, P32, DOI 10.2183/pjab.71.32; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wallar BJ, 2001, BIOCHEMISTRY-US, V40, P2220, DOI 10.1021/bi002298b; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4487; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4466; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4476; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200; WOLGEL SA, 1993, J BACTERIOL, V175, P4414, DOI 10.1128/JB.175.14.4414-4426.1993; Zhang JY, 2006, BIOCHEMISTRY-US, V45, P1459, DOI 10.1021/bi051721j; Zheng H, 2006, BIOCHEMISTRY-US, V45, P1685, DOI 10.1021/bi051605g	82	3	3	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15141	15153		10.1074/jbc.X114.574376	http://dx.doi.org/10.1074/jbc.X114.574376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737314	Green Published, hybrid			2022-12-28	WOS:000337465400001
J	Ugarte-Berzal, E; Bailon, E; Amigo-Jimenez, I; Albar, JP; Garcia-Marco, JA; Garcia-Pardo, A				Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Pablo Albar, Juan; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; Cell Adhesion; Cell Migration; Leukemia; Metalloprotease	ALPHA-4-BETA-1 INTEGRIN; MATRIX-METALLOPROTEINASE-9 MMP-9; B-CELLS; PROMOTES; SURVIVAL; DISEASE; CD44; HYALURONAN; ACTIVATION; MECHANISMS	Background: proMMP-9 binds to CLL cells through the hemopexin domain (PEX9), contributing to disease progression. Results: A 20-residue sequence (P6) within PEX9 inhibits CD44-mediated CLL-proMMP-9 interaction and cell migration. P6 cooperates with the previously identified sequence P3, also located in PEX9. Conclusion: P6 is a CD44-binding site and impairs proMMP-9 effects on CLL. Significance: P6 may be a novel therapeutic target in CLL. (pro)MMP-9 binds to CLL cells through the PEX9 domain and contributes to CLL progression. To biochemically characterize this interaction and identify potential therapeutic targets, we prepared GST-PEX9 forms containing structural blades B1B2 or B3B4. We recently described a sequence in blade B4 (P3 sequence) that bound 41 integrin and partially impaired cell adhesion and migration. We have now studied the possible contribution of the B1B2 region to cell interaction with PEX9. CLL cells bound to GST-B1B2 and CD44 was the primary receptor. GST-B1B2 inhibited CLL cell migration as effectively as GST-B3B4. Overlapping synthetic peptides spanning the B1B2 region identified the sequence FDAIAEIGNQLYLFKDGKYW, present in B1 and contained in peptide P6, as the most effective site. P6 inhibited cell adhesion to PEX9 in a dose-dependent manner and with an IC50 value of 90 m. P6 also inhibited cell adhesion to hyaluronan but had no effect on adhesion to VCAM-1 (41 integrin ligand), confirming its specific interaction with CD44. Spatial localization analyses mapped P6 to the central cavity of PEX9, in close proximity to the previously identified P3 sequence. Both P6 and P3 equally impaired cell adhesion to (pro)MMP-9. Moreover, P6 synergistically cooperated with P3, resulting in complete inhibition of CLL cell binding to PEX9, chemotaxis, and transendothelial migration. Thus, P6 is a novel sequence in PEX9 involved in cell-PEX9/(pro)MMP-9 binding by interacting with CD44. Targeting both sites, P6 and P3, should efficiently prevent (pro)MMP-9 binding to CLL cells and its pathological consequences.	[Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain; [Pablo Albar, Juan] CSIC, Ctr Nacl Biotecnol, Prote Facil, Madrid 28040, Spain; [Garcia-Marco, Jose A.] Hosp Univ Puerta de Hierro, Serv Hematol, Madrid 28222, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	agarciapardo@cib.csic.es	Garcia Marco, Jose/H-2554-2015; Bailón, Elvira/G-5057-2015; Garcia Pardo, Angeles/G-5987-2015	Garcia Marco, Jose/0000-0002-8993-5982; Garcia Pardo, Angeles/0000-0001-5577-2954	Red Tematica de Investigacion Cooperativa en Cancer from Ministry of Economy and Competitivity (Madrid, Spain) [RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314]; Fundacion Puerta de Hierro (Madrid, Spain); Ministry of Economy and Competitivity; Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain;  [SAF2012-31613]	Red Tematica de Investigacion Cooperativa en Cancer from Ministry of Economy and Competitivity (Madrid, Spain); Comunidad de Madrid/European Union; Fundacion Puerta de Hierro (Madrid, Spain); Ministry of Economy and Competitivity; Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain; 	This work was supported by Grant SAF2012-31613 and by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0061) (to A. G. P.) from the Ministry of Economy and Competitivity (Madrid, Spain); S2010/BMD-2314 (to A. G. P.) from the Comunidad de Madrid/European Union; and by a grant from the Fundacion Puerta de Hierro (Madrid, Spain) (to J. A. G.-M.).; Supported by a fellowship from the Ministry of Economy and Competitivity.; Supported by the Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain.	Bailon E., 2014, J LEUKOC BI IN PRESS, DOI [10.1189/jlb.0913521, DOI 10.1189/JLB.0913521]; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Davids Matthew S, 2012, Open J Hematol, V3; de la Fuente MT, 1999, LEUKEMIA, V13, P266, DOI 10.1038/sj.leu.2401275; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Dufour A, 2011, CANCER RES, V71, P4977, DOI 10.1158/0008-5472.CAN-10-4552; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Girbl T, 2013, CANCER RES, V73, P561, DOI 10.1158/0008-5472.CAN-12-2749; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Kamiguti AS, 2004, BRIT J HAEMATOL, V125, P128, DOI 10.1111/j.1365-2141.2004.04877.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Shanafelt TD, 2008, BRIT J HAEMATOL, V140, P537, DOI 10.1111/j.1365-2141.2007.06965.x; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Till KJ, 1999, CANCER RES, V59, P4419; Ugarte-Berzal E, 2012, J BIOL CHEM, V287, P27601, DOI 10.1074/jbc.M112.354670; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang SP, 2013, P NATL ACAD SCI USA, V110, P6127, DOI 10.1073/pnas.1221841110	32	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15340	15349		10.1074/jbc.M114.559187	http://dx.doi.org/10.1074/jbc.M114.559187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739387	Green Published, hybrid			2022-12-28	WOS:000337465400018
J	Birsa, N; Norkett, R; Wauer, T; Mevissen, TET; Wu, HC; Foltynie, T; Bhatia, K; Hirst, WD; Komander, D; Plun-Favreau, H; Kittler, JT				Birsa, Nicol; Norkett, Rosalind; Wauer, Tobias; Mevissen, Tycho E. T.; Wu, Hsiu-Chuan; Foltynie, Thomas; Bhatia, Kailash; Hirst, Warren D.; Komander, David; Plun-Favreau, Helene; Kittler, Josef T.			Lysine 27 Ubiquitination of the Mitochondrial Transport Protein Miro Is Dependent on Serine 65 of the Parkin Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED MITOCHONDRIA; MITOPHAGY; PINK1; DEGRADATION; MITOFUSIN; DOMAIN; TRANSLOCATION; PROTEASOME; MEMBRANE; RECEPTOR	Mitochondrial transport plays an important role in matching mitochondrial distribution to localized energy production and calcium buffering requirements. Here, we demonstrate that Miro1, an outer mitochondrial membrane (OMM) protein crucial for the regulation of mitochondrial trafficking and distribution, is a substrate of the PINK1/Parkin mitochondrial quality control system in human dopaminergic neuroblastoma cells. Moreover, Miro1 turnover on damaged mitochondria is altered in Parkinson disease (PD) patient-derived fibroblasts containing a pathogenic mutation in the PARK2 gene (encoding Parkin). By analyzing the kinetics of Miro1 ubiquitination, we further demonstrate that mitochondrial damage triggers rapid (within minutes) and persistent Lys-27-type ubiquitination of Miro1 on the OMM, dependent on PINK1 and Parkin. Proteasomal degradation of Miro1 is then seen on a slower time scale, within 2-3 h of the onset of ubiquitination. We find Miro ubiquitination in dopaminergic neuroblastoma cells is independent of Miro1 phosphorylation at Ser-156 but is dependent on the recently identified Ser-65 residue within Parkin that is phosphorylated by PINK1. Interestingly, we find that Miro1 can stabilize phospho-mutant versions of Parkin on the OMM, suggesting that Miro is also part of a Parkin receptor complex. Moreover, we demonstrate that Ser-65 in Parkin is critical for regulating Miro levels upon mitochondrial damage in rodent cortical neurons. Our results provide new insights into the ubiquitination-dependent regulation of the Miro-mediated mitochondrial transport machinery by PINK1/Parkin and also suggest that disruption of this regulation may be implicated in Parkinson disease pathogenesis.	[Birsa, Nicol; Norkett, Rosalind; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Wauer, Tobias; Mevissen, Tycho E. T.; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Wu, Hsiu-Chuan; Foltynie, Thomas; Bhatia, Kailash; Plun-Favreau, Helene] UCL, Inst Neurol, London WC1N 3BG, England; [Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02139 USA	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Pfizer	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Kittler, Josef/N-7589-2019; Mevissen, Tycho E.T./AAX-4366-2020; Plun-Favreau, Helene/Q-4111-2016; Kittler, Josef T/E-9113-2010	Kittler, Josef/0000-0002-3437-9456; Mevissen, Tycho E.T./0000-0002-2324-5292; Plun-Favreau, Helene/0000-0002-1401-9656; Kittler, Josef T/0000-0002-3437-9456; Bhatia, Kailash/0000-0001-8185-286X; Birsa, Nicol/0000-0002-8271-540X; Hirst, Warren/0000-0003-0389-8891; Norkett, Rosalind/0000-0001-9460-9973	European Research Council (ERC) [282430]; Lister Institute for Preventive Medicine; University College London; Medical Research Council; Marie Curie Initial Training Network (UPStream); National Institute for Health Research University College London Hospitals Biomedical Research Centre; Medical Research Council [U105192732]; European Research Council [309756]; Wellcome/Medical Research Council Parkinson's Disease Consortium Grant; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; Medical Research Council Career Development Award [G0700183]; MRC [MC_U105192732, G0802377, G0700183, MC_G1000735] Funding Source: UKRI; Medical Research Council [MC_U105192732, G0700183, G0802377, 1069309, MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [H-1006] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Initial Training Network (UPStream); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome/Medical Research Council Parkinson's Disease Consortium Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by European Research Council (ERC) Starting Grant (282430) and the Lister Institute for Preventive Medicine.; Recipient of a University College London Impact Ph.D. award.; Recipient of a Medical Research Council Case award.; Supported by the Marie Curie Initial Training Network (UPStream).; Supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.; Supported by the Medical Research Council (U105192732), the European Research Council (309756), and the Lister Institute for Preventive Medicine.; Supported by a Wellcome/Medical Research Council Parkinson's Disease Consortium Grant (to University College London/Institute of Neurology), the University of Sheffield, and MRC Protein Phosphorylation Unit at the University of Dundee Grant WT089698, and Medical Research Council Career Development Award G0700183.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	49	122	125	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14569	14582		10.1074/jbc.M114.563031	http://dx.doi.org/10.1074/jbc.M114.563031			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24671417	Green Published, hybrid			2022-12-28	WOS:000337248100015
J	Colinas, M; Shaw, HV; Loubery, S; Kaufmann, M; Moulin, M; Fitzpatrick, TB				Colinas, Maite; Shaw, Holly V.; Loubery, Sylvain; Kaufmann, Markus; Moulin, Michael; Fitzpatrick, Teresa B.			A Pathway for Repair of NAD(P) H in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXINE 5'-PHOSPHATE OXIDASE; L-2-HYDROXYGLUTARIC ACIDURIA; CRYSTAL-STRUCTURE; ARABIDOPSIS; PROTEIN; IDENTIFICATION; EXPRESSION; NADH; LOCALIZATION; MECHANISM	Unwanted enzyme side reactions and spontaneous decomposition of metabolites can lead to a build-up of compounds that compete with natural enzyme substrates and must be dealt with for efficient metabolism. It has recently been realized that there are enzymes that process such compounds, formulating the concept of metabolite repair. NADH and NADPH are vital cellular redox cofactors but can form non-functional hydrates (named NAD(P) HX) spontaneously or enzymatically that compete with enzymes dependent on NAD(P) H, impairing normal enzyme function. Here we report on the functional characterization of components of a potential NAD(P) H repair pathway in plants comprising a stereospecific dehydratase (NNRD) and an epimerase (NNRE), the latter being fused to a vitamin B-6 salvage enzyme. Through the use of the recombinant proteins, we show that the ATP-dependent NNRD and NNRE act concomitantly to restore NAD(P) HX to NAD(P) H. NNRD behaves as a tetramer and NNRE as a dimer, but the proteins do not physically interact. In vivo fluorescence analysis demonstrates that the proteins are localized to mitochondria and/or plastids, implicating these as the key organelles where this repair is required. Expression analysis indicates that whereas NNRE is present ubiquitously, NNRD is restricted to seeds but appears to be dispensable during the normal Arabidopsis life cycle.	[Colinas, Maite; Shaw, Holly V.; Loubery, Sylvain; Kaufmann, Markus; Moulin, Michael; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland	University of Geneva	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	theresa.fitzpatrick@unige.ch	Frikha, Fakher/AFM-9007-2022	Frikha, Fakher/0000-0003-3261-7884; Colinas, Maite/0000-0001-7053-2983; Loubery, Sylvain/0000-0001-7061-9456	Swiss National Science Foundation [PPOOA_1191186, 31003A-141117/1]; University of Geneva; Ernest Boninchi Foundation; Ernst and Lucie Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva; Ernest Boninchi Foundation; Ernst and Lucie Schmidheiny Foundation	This work was supported by Swiss National Science Foundation Grants PPOOA_1191186 and 31003A-141117/1 (to T. B. F.) as well as the University of Geneva. This work was also supported by the Ernest Boninchi Foundation and the Ernst and Lucie Schmidheiny Foundation.	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Biswal BK, 2005, ACTA CRYSTALLOGR D, V61, P1492, DOI 10.1107/S0907444905026673; Bocobza SE, 2008, TRENDS PLANT SCI, V13, P526, DOI 10.1016/j.tplants.2008.07.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Cheng G, 2002, STRUCTURE, V10, P225, DOI 10.1016/S0969-2126(02)00708-6; CHURCHICH JE, 1984, EUR J BIOCHEM, V138, P327, DOI 10.1111/j.1432-1033.1984.tb07918.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Di Salvo M, 1998, PROTEIN EXPRES PURIF, V13, P349, DOI 10.1006/prep.1998.0904; di Salvo M. L., 2010, BIOCHIM BIOPHYS ACTA, V1814, P1597; di Salvo ML, 2003, BBA-PROTEINS PROTEOM, V1647, P76, DOI 10.1016/S1570-9639(03)00060-8; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gonzalez E, 2007, PLANT PHYSIOL, V145, P985, DOI 10.1104/pp.107.105189; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Ling SHM, 2008, MOL CELL BIOL, V28, P5965, DOI 10.1128/MCB.00761-08; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MEINHART JO, 1956, J BIOL CHEM, V220, P821; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Niehaus T. D., 2014, PLANT PHYSL IN PRESS; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Sang YY, 2007, FEBS LETT, V581, P344, DOI 10.1016/j.febslet.2006.12.028; Sang YY, 2011, PLANT PHYSIOL BIOCH, V49, P88, DOI 10.1016/j.plaphy.2010.10.003; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Szydlowski N, 2013, PLANT J, V75, P40, DOI 10.1111/tpj.12195; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6; Zhang RG, 2002, J STRUCT BIOL, V139, P161, DOI 10.1016/S1047-8477(02)00532-4	47	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14692	14706		10.1074/jbc.M114.556092	http://dx.doi.org/10.1074/jbc.M114.556092			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706747	Green Published, hybrid			2022-12-28	WOS:000337248100026
J	Kanan, Y; Brobst, D; Han, ZC; Naash, MI; Al-Ubaidi, MR				Kanan, Yogita; Brobst, Daniel; Han, Zongchao; Naash, Muna I.; Al-Ubaidi, Muayyad R.			Fibulin 2, a Tyrosine O-Sulfated Protein, Is Up-regulated Following Retinal Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Fibronectin; Post-translational Modification; Retinal Degeneration; Tyrosine Sulfation; Retinal Detachment; Retinal Pigment Epithelium	EPITHELIAL-MESENCHYMAL TRANSITION; MACULAR DEGENERATION; BASEMENT-MEMBRANE; CELL MIGRATION; PROLIFERATIVE VITREORETINOPATHY; TRANSGENIC MICE; PLASMID DNA; P-SELECTIN; CUTIS LAXA; T-ANTIGEN	Background: Fibulin 2 is an ECM protein of basement membranes and elastic tissues. Results: Fibulin 2 is up-regulated during retinal detachment. Conclusion: Up-regulation of fibulin 2 following detachment points to its role in the adhesion of the RPE to the Bruch membrane and prevention of RPE migration. Significance: This is the first study addressing the role of fibulin 2 in retinal detachment. Retinal detachment is the physical separation of the retina from the retinal pigment epithelium. It occurs during aging, trauma, or during a variety of retinal disorders such as age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity, or as a complication following cataract surgery. This report investigates the role of fibulin 2, an extracellular component, in retinal detachment. A major mechanism for detachment resolution is enhancement of cellular adhesion between the retina and the retinal pigment epithelium and prevention of its cellular migration. This report shows that fibulin 2 is mainly present in the retinal pigment epithelium, Bruch membrane, choriocapillary, and to a lesser degree in the retina. In vitro studies revealed the presence of two isoforms for fibulin 2. The small isoform is located inside the cell, and the large isoform is present inside and outside the cells. Furthermore, fibulin 2 is post-translationally modified by tyrosine sulfation, and the sulfated isoform is present outside the cell, whereas the unsulfated pool is internally located. Interestingly, sulfated fibulin 2 significantly reduced the rate of cellular growth and migration. Finally, levels of fibulin 2 dramatically increased in the retinal pigment epithelium following retinal detachment, suggesting a direct role for fibulin 2 in the re-attachment of the retina to the retinal pigment epithelium. Understanding the role of fibulin 2 in enhancing retinal attachment is likely to help improve the current therapies or allow the development of new strategies for the treatment of this sight-threatening condition.	[Kanan, Yogita; Brobst, Daniel; Han, Zongchao; Naash, Muna I.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Kanan, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, BMSB 781,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ykanan@ouhsc.edu; muayyad-al-ubaidi@ouhsc.edu		Han, Zongchao/0000-0002-2019-395X	National Institutes of Health [R01EY10609, R01EY018137]; NEI [P30EY12190]; Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018656, R01EY018137, R01EY010609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY10609 (to M. I. N.) and R01EY018137 (to M. R. A.) and Grant P30EY12190 from NEI. This work was also supported by the Oklahoma Center for the Advancement of Science and Technology (to Y. K.) and the Foundation Fighting Blindness (to M. R. A.).	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; AlUbaidi MR, 1997, EXP EYE RES, V64, P573, DOI 10.1006/exer.1996.0240; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Debeer P, 2002, J MED GENET, V39, P98, DOI 10.1136/jmg.39.2.98; Dietrich-Ntoukas T, 2012, CORNEA, V31, P564, DOI 10.1097/ICO.0b013e3182254b78; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Farjo R, 2008, INVEST OPHTH VIS SCI, V49, P511, DOI 10.1167/iovs.07-1013; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; Garcia S, 2008, J CELL BIOCHEM, V104, P377, DOI 10.1002/jcb.21633; Go SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1237, DOI 10.1001/archopht.123.9.1237; HACKETT SF, 1989, ARCH OPHTHALMOL-CHIC, V107, P391, DOI 10.1001/archopht.1989.01070010401033; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hunzelmann N, 2001, BRIT J DERMATOL, V145, P217, DOI 10.1046/j.1365-2133.2001.04337.x; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; IMMEL J, 1986, INVEST OPHTH VIS SCI, V27, P1770; Ivert L, 2002, GRAEF ARCH CLIN EXP, V240, P232, DOI 10.1007/s00417-001-0392-4; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kanan Y, 2009, EXP EYE RES, V89, P559, DOI 10.1016/j.exer.2009.05.010; Kang HK, 2008, BMJ-BRIT MED J, V336, P1235, DOI 10.1136/bmj.39581.525532.47; Kim TH, 2010, MOL CELLS, V29, P413, DOI 10.1007/s10059-010-0049-4; Kusubata M, 1999, J INVEST DERMATOL, V113, P906, DOI 10.1046/j.1523-1747.1999.00802.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; LEE KP, 1990, ARCH TOXICOL, V64, P135, DOI 10.1007/BF01974399; LEYTE A, 1991, J BIOL CHEM, V266, P740; Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Loveland K, 1998, BIOL REPROD, V58, P1123, DOI 10.1095/biolreprod58.5.1123; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Martin F, 2003, OPHTHALMIC RES, V35, P232, DOI 10.1159/000071175; Miosge N, 1996, HISTOCHEM J, V28, P109, DOI 10.1007/BF02331415; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; Perkumas KM, 2012, EXP EYE RES, V96, P82, DOI 10.1016/j.exer.2011.12.017; PFAFF M, 1995, EXP CELL RES, V219, P87, DOI 10.1006/excr.1995.1208; Piscaglia F, 2009, CELL TISSUE RES, V337, P449, DOI 10.1007/s00441-009-0823-9; Polkinghorne PJ, 2004, CLIN EXP OPHTHALMOL, V32, P159, DOI 10.1111/j.1442-9071.2004.00003.x; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rodgers SD, 2001, BIOPHYS J, V81, P2001, DOI 10.1016/S0006-3495(01)75850-X; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Sasaki T, 1996, J CELL SCI, V109, P2895; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P153, DOI 10.1080/03008200802148702; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	79	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13419	13433		10.1074/jbc.M114.562157	http://dx.doi.org/10.1074/jbc.M114.562157			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692557	hybrid, Green Published			2022-12-28	WOS:000335522800040
J	Gross, TJ; Powers, LS; Boudreau, RL; Brink, B; Reisetter, A; Goel, K; Gerke, AK; Hassan, IH; Monick, MM				Gross, Thomas J.; Powers, Linda S.; Boudreau, Ryan L.; Brink, Brandi; Reisetter, Anna; Goel, Khushboo; Gerke, Alicia K.; Hassan, Ihab H.; Monick, Martha M.			A MicroRNA Processing Defect in Smokers' Macrophages Is Linked to SUMOylation of the Endonuclease DICER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chronic Obstructive Pulmonary Disease (COPD); Cigarette Smoke; DICER; Epigenetics; Macrophage; MicroRNA (miRNA); Small Ubiquitin-like Modifier (SUMO); SUMOylation	GENE-EXPRESSION CHANGES; CIGARETTE-SMOKE; PATHOGENESIS; IMPACT; RELEASE; SUMO; RNA; IDENTIFICATION; EMPHYSEMA; MEDIATORS	Background: Smoking causes a global down-regulation in alveolar macrophage miRNA expression. Results: Cigarette smoke exposure modifies the RNA endonuclease DICER, resulting in a microRNA processing defect. Conclusion: Cigarette smoke alters alveolar macrophage microRNA expression, in part, by SUMOylation of DICER. Significance: This is the first description of an environmental exposure causing changes in microRNA expression via post-translational modification of DICER. Despite the fact that alveolar macrophages play an important role in smoking-related disease, little is known about what regulates their pathophysiologic phenotype. Evaluating smoker macrophages, we found significant down-regulation of multiple microRNAs (miRNAs). This work investigates the hypothesis that cigarette smoke alters mature miRNA expression in lung macrophages by inhibiting processing of primary miRNA transcripts. Studies on smoker alveolar macrophages showed a defect in miRNA maturation. Studies on the miRNA biogenesis machinery led us to focus on the cytosolic RNA endonuclease, DICER. DICER cleaves the stem-loop structure from pre-miRNAs, allowing them to dissociate into their mature 20-22-nucleotide single-stranded form. DICER activity assays confirmed impaired DICER activity following cigarette smoke exposure. Further protein studies demonstrated a decreased expression of the native 217-kDa form of DICER and an accumulation of high molecular weight forms with cigarette smoke exposure. This molecular mass shift was shown to contain SUMO moieties and could be blocked by silencing RNA directed at the primary SUMOylating ligase, Ubc9. In determining the cigarette smoke components responsible for changes in DICER, we found that N-acetylcysteine, an antioxidant and anti-aldehyde, protected DICER protein and activity from cigarette smoke extract. This massive down-regulation of miRNAs (driven in part by alterations in DICER) may be an important regulator of the disease-promoting macrophage phenotype found in the lungs of smokers.	[Gross, Thomas J.; Powers, Linda S.; Boudreau, Ryan L.; Brink, Brandi; Reisetter, Anna; Goel, Khushboo; Gerke, Alicia K.; Hassan, Ihab H.; Monick, Martha M.] Univ Iowa, Carver Coll Med, Dept Med, Iowa City, IA 52242 USA	University of Iowa	Gross, TJ (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Iowa City, IA 52242 USA.	thomas-gross@uiowa.edu	Gross, Thomas/AAO-9404-2021	Gross, Thomas/0000-0001-9617-6606; Boudreau, Ryan/0000-0002-9800-5349	National Institutes of Health [R01 HL079901, RO1 HL096625, R21 HL109589]; NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center; NIEHS/National Institutes of Health [P30 ES005605]; NCRR/National Institutes of Health [UL1RR024979]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, T32HL007121, R01HL079901, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center; NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, RO1 HL096625, and R21 HL109589 ( to M. M.). This research was also supported in part by the NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center, NIEHS/National Institutes of Health Grant P30 ES005605, and NCRR/National Institutes of Health Grant UL1RR024979.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; EISERICH JP, 1995, AM J CLIN NUTR, V62, P1490, DOI 10.1093/ajcn/62.6.1490S; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Graff JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044066; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; JANOFF A, 1968, J EXP MED, V128, P1137, DOI 10.1084/jem.128.5.1137; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Manzel LJ, 2009, AM J RESP CELL MOL, V40, P200, DOI 10.1165/rcmb.2008-0104OC; MARTIN TR, 1985, AM REV RESPIR DIS, V132, P254; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Panayiotidis MI, 2004, CHEM-BIOL INTERACT, V147, P87, DOI 10.1016/j.cbi.2003.10.009; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Philibert RA, 2012, J LEUKOCYTE BIOL, V92, P621, DOI 10.1189/jlb.1211632; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Spira A, 2004, CHEST, V125, p115S, DOI 10.1378/chest.125.5_suppl.115S; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Talbot P, 1998, BIOL REPROD, V58, P1047, DOI 10.1095/biolreprod58.4.1047; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH	53	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12823	12834		10.1074/jbc.M114.565473	http://dx.doi.org/10.1074/jbc.M114.565473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668803	Green Published, hybrid			2022-12-28	WOS:000335581400051
J	Lenzen, S				Lenzen, Sigurd			A Fresh View of Glycolysis and Glucokinase Regulation: History and Current Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Beta Cell; Glucokinase; Glycolysis; Liver; Metabolic Regulation; Phosphofructokinase	PANCREATIC BETA-CELLS; INSULIN-SECRETION; B-CELLS; GENE-EXPRESSION; GLUCOSE SENSOR; FRUCTOSE 2,6-BISPHOSPHATE; METABOLIC OSCILLATIONS; INTERACTION PARTNER; HEXOSE METABOLISM; K+ CHANNELS	This minireview looks back at a century of glycolysis research with a focus on the mechanisms of flux regulation. Traditionally, glycolysis is regarded as a feeder pathway that prepares glucose for further catabolism and energy production. However, glycolysis is much more than that, in particular in those tissues that express the low affinity glucose-phosphorylating enzyme glucokinase. This enzyme equips the glycolytic pathway with a special steering function for the regulation of intermediary metabolism. In beta cells, glycolysis acts as a transducer for triggering and amplifying physiological glucose-induced insulin secretion. On the basis of these considerations, I have defined a glycolytic flux regulatory unit composed of the two fructose ester steps of this pathway with various enzymes and metabolites that regulate glycolysis.	Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Hannover Medical School	Lenzen, S (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	lenzen.sigurd@mh-hannover.de			Innovative Medicines Initiative Joint Undertaking Grant [55005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA)	Innovative Medicines Initiative Joint Undertaking Grant; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA)	The work leading to this publication was supported by Innovative Medicines Initiative Joint Undertaking Grant 55005 (Project IMIDIA), the resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Arden C, 2008, BIOCHEM J, V411, P41, DOI 10.1042/BJ20070962; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT SJ, 1970, BIOCHEM J, V119, P5, DOI 10.1042/bj1190005; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2012, BIOCHEM PHARMACOL, V83, P1300, DOI 10.1016/j.bcp.2012.01.020; Barnett JA, 2003, YEAST, V20, P1015, DOI 10.1002/yea.1021; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORI CF, 1983, TRENDS BIOCHEM SCI, V8, P257, DOI 10.1016/0968-0004(83)90353-5; CORKEY BE, 1988, J BIOL CHEM, V263, P4254; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; EMBDEN G, 1933, KLIN WOCHENSCHR, V12, P213; FERRER J, 1995, DIABETES, V44, P1369, DOI 10.2337/diabetes.44.12.1369; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; GIROIX MH, 1987, MOL CELL ENDOCRINOL, V49, P219, DOI 10.1016/0303-7207(87)90216-4; GIROIX MH, 1984, BIOCHEM J, V223, P447, DOI 10.1042/bj2230447; Grimsby J, 2008, CURR TOP MED CHEM, V8, P1524, DOI 10.2174/156802608786413483; Heimberg H, 1996, P NATL ACAD SCI USA, V93, P7036, DOI 10.1073/pnas.93.14.7036; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HERS HG, 1982, BIOCHEM J, V206, P1; Hofmeister-Brix A, 2013, J BIOL CHEM, V288, P35824, DOI 10.1074/jbc.M113.526632; Hofmeister-Brix A, 2013, BIOCHEM J, V456, P173, DOI 10.1042/BJ20130262; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jaenicke L., 2007, PROFILE BIOCH; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; Lenzen S, 2000, BBA-GEN SUBJECTS, V1523, P65, DOI 10.1016/S0304-4165(00)00100-8; LENZEN S, 1988, BIOCHEM PHARMACOL, V37, P371, DOI 10.1016/0006-2952(88)90201-8; LENZEN S, 1987, ACTA ENDOCRINOL-COP, V115, P514, DOI 10.1530/acta.0.1150514; LENZEN S, 1987, ACTA ENDOCRINOL-COP, V115, P21, DOI 10.1530/acta.0.1150021; Lenzen S., 1992, NUT REGULATION INSUL, P101; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; Lynch RM, 2000, DIABETES, V49, P693, DOI 10.2337/diabetes.49.5.693; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MacDonald MJ, 1997, DIABETES, V46, P1996, DOI 10.2337/diabetes.46.12.1996; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; Nachmansohn D., 1988, GROBETAE ARA WISSENS; NACHMANSOHN D, 1979, GERMAN JEWISH PIONEE; PANTEN U, 1988, N-S ARCH PHARMACOL, V338, P459; Panten U, 2013, METABOLISM, V62, P1375, DOI 10.1016/j.metabol.2013.05.006; Pilkis S J, 1975, Methods Enzymol, V42, P31; Sarabu R, 2011, EXPERT OPIN THER PAT, V21, P13, DOI 10.1517/13543776.2011.542413; Schuit F, 1999, J BIOL CHEM, V274, P32803, DOI 10.1074/jbc.274.46.32803; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; Seino S, 2012, DIABETOLOGIA, V55, P2096, DOI 10.1007/s00125-012-2562-9; TIEDGE M, 1995, BIOCHEM J, V308, P139, DOI 10.1042/bj3080139; Tiedge M, 1999, DIABETES, V48, P514, DOI 10.2337/diabetes.48.3.514; TIEDGE M, 1991, BIOCHEM J, V279, P899, DOI 10.1042/bj2790899; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; Velho G., 2004, GLUCOKINASE GLYCEMIC, P42; WALKER D. G., 1966, ESSAYS BIOCHEM, V2, P33; Watford M, 2002, NUTR REV, V60, P253, DOI 10.1301/002966402320289377; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Zelent D, 2006, DIABETES, V55, P1923, DOI 10.2337/db06-0151	70	93	97	4	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12189	12194		10.1074/jbc.R114.557314	http://dx.doi.org/10.1074/jbc.R114.557314			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24637025	Green Published, hybrid			2022-12-28	WOS:000335581400001
J	Dixon, AM; Drake, L; Hughes, KT; Sargent, E; Hunt, D; Harton, JA; Drake, JR				Dixon, Ann M.; Drake, Lisa; Hughes, Kelly T.; Sargent, Elizabeth; Hunt, Danielle; Harton, Jonathan A.; Drake, James R.			Differential Transmembrane Domain GXXXG Motif Pairing Impacts Major Histocompatibility Complex ( MHC) Class II Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Lipid Raft; Major Histocompatibility Complex (MHC); Molecular Modeling; Protein Conformation	MYASTHENIA-GRAVIS; ANTIGEN PRESENTATION; PEPTIDE COMPLEXES; B-CELLS; HLA-DQ; MOLECULES; ASSOCIATION; BINDING; SEGMENT	Background: Major histocompatibility complex class II molecules are structurally and functionally heterogeneous. Results: Combined mutagenesis and structural studies establish a role for pairing between conserved transmembrane (TM) GXXXG dimerization motifs in determining class II conformation. Conclusion: Differential pairing of highly conserved TM domain dimerization motifs contributes to class II structure and function. Significance: Global conformation contributes to the function of peptide-class II complexes. Major histocompatibility complex (MHC) class II molecules exhibit conformational heterogeneity, which influences their ability to stimulate CD4 T cells and drive immune responses. Previous studies suggest a role for the transmembrane domain of the class II heterodimer in determining molecular structure and function. Our previous studies identified an MHC class II conformer that is marked by the Ia.2 epitope. These Ia.2(+) class II conformers are lipid raft-associated and able to drive both tyrosine kinase signaling and efficient antigen presentation to CD4 T cells. Here, we establish that the Ia.2(+) I-A(k) conformer is formed early in the class II biosynthetic pathway and that differential pairing of highly conserved transmembrane domain GXXXG dimerization motifs is responsible for formation of Ia.2(+)versus Ia.2(-) I-A(k) class II conformers and controlling lipid raft partitioning. These findings provide a molecular explanation for the formation of two distinct MHC class II conformers that differ in their inherent ability to signal and drive robust T cell activation, providing new insight into the role of MHC class II in regulating antigen-presenting cell-T cell interactions critical to the initiation and control of multiple aspects of the immune response.	[Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Drake, Lisa; Hughes, Kelly T.; Sargent, Elizabeth; Hunt, Danielle; Harton, Jonathan A.; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	University of Warwick; Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA.	drakej@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Dixon, Ann M/I-3696-2012	Harton, Jonathan A/0000-0002-0350-1877; Dixon, Ann M/0000-0002-5261-304X; Hughes, Kelly T/0000-0003-1546-6746	National Institutes of Health [AI-083922, AI-065773, PO1 AI-056321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI056321, R21AI083922, P01AI056320, R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-083922 (to J. R. D. and J. A. H.), AI-065773 (to J. R. D.), and PO1 AI-056321 to the Center for Immunology and Microbial Disease.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Brosig B, 1998, PROTEIN SCI, V7, P1052; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Castellino F, 2001, EUR J IMMUNOL, V31, P841, DOI 10.1002/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Deitiker PR, 2011, INT J IMMUNOGENET, V38, P55, DOI 10.1111/j.1744-313X.2010.00979.x; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Gondre-Lewis TA, 2001, J IMMUNOL, V166, P6657, DOI 10.4049/jimmunol.166.11.6657; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Khalil H, 2003, INT IMMUNOL, V15, P1249, DOI 10.1093/intimm/dxg124; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Lee KW, 2006, TISSUE ANTIGENS, V68, P167, DOI 10.1111/j.1399-0039.2006.00645.x; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; Morkowski S, 1999, J BIOMED SCI, V6, P53; Nashar TO, 2006, J IMMUNOL, V176, P827, DOI 10.4049/jimmunol.176.2.827; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Porter KA, 2010, J IMMUNOL, V185, P6480, DOI 10.4049/jimmunol.1000830; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; Saruhan-Direskeneli G, 2006, HUM IMMUNOL, V67, P352, DOI 10.1016/j.humimm.2006.02.039; Zhu WH, 2012, J NEUROIMMUNOL, V247, P81, DOI 10.1016/j.jneuroim.2012.03.018	25	25	25	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11695	11703		10.1074/jbc.M113.516997	http://dx.doi.org/10.1074/jbc.M113.516997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619409	Green Published, hybrid			2022-12-28	WOS:000335010600012
J	Wang, XW; Xu, JD; Zhao, XF; Vasta, GR; Wang, JX				Wang, Xian-Wei; Xu, Ji-Dong; Zhao, Xiao-Fan; Vasta, Gerardo Raul; Wang, Jin-Xing			A Shrimp C-type Lectin Inhibits Proliferation of the Hemolymph Microbiota by Maintaining the Expression of Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Invertebrates; Lectin; Pattern Recognition Receptor; RNA Interference (RNAi); C-type Lectin; Hemolymph Microbiota; Shrimp	ANTILIPOPOLYSACCHARIDE FACTOR ALF; LITOPENAEUS-VANNAMEI; CALLINECTES-SAPIDUS; BACTERIAL-FLORA; MANDUCA-SEXTA; BLUE-CRAB; PROTEIN; HEPATOPANCREAS; DIVERSITY; BINDING	Background: The hemolymph of healthy shrimp contains low albeit stable numbers of bacteria. Results: Knockdown of C-type lectin MjHeCL led to suppressed expression of antimicrobial peptides, bacterial proliferation, and shrimp death. Conclusion: MjHeCL protects shrimp by inhibiting the proliferation of hemolymph microbiota. Significance: This study demonstrated a novel role for soluble C-type lectins in antibacterial response. Some aquatic invertebrates such as shrimp contain low albeit stable numbers of bacteria in the circulating hemolymph. The proliferation of this hemolymph microbiota in such a nutrient-rich environment is tightly controlled in healthy animals, but the mechanisms responsible had remained elusive. In the present study, we report a C-type lectin (MjHeCL) from the kuruma shrimp (Marsupenaeus japonicus) that participates in restraining the hemolymph microbiota. Although the expression of MjHeCL did not seem to be modulated by bacterial challenge, the down-regulation of its expression by RNA interference led to proliferation of the hemolymph microbiota, ultimately resulting in shrimp death. This phenotype was rescued by the injection of recombinant MjHeCL, which restored the healthy status of the knockdown shrimp. A mechanistic analysis revealed that MjHeCL inhibited bacterial proliferation by modulating the expression of antimicrobial peptides. The key function of MjHeCL in the shrimp immune homeostasis might be related to its broader recognition spectrum of the hemolymph microbiota components than other lectins. Our study demonstrates the role of MjHeCL in maintaining the healthy status of shrimp and provides new insight into the biological significance of C-type lectins, a diversified and abundant lectin family in invertebrate species.	[Wang, Xian-Wei; Xu, Ji-Dong; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Vasta, Gerardo Raul] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21202 USA; [Vasta, Gerardo Raul] Inst Marine & Environm Technol, Baltimore, MD 21202 USA	Shandong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wang, JX (corresponding author), Shandong Univ, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056, 31302217]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; Ph.D. Program Foundation of the Ministry of Education of China [20110131130003]; China Postdoctoral Science Foundation [2013M540553]; National Science Foundation [IOS-1050518, IOB-0618409, IOS-0822257]; National Institutes of Health [5R01GM070589-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong, China; Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (Grants 31130056 and 31302217), the Provincial Natural Science Foundation of Shandong, China (Grant ZR2011CM014), the Ph.D. Program Foundation of the Ministry of Education of China (Grant 20110131130003), and the China Postdoctoral Science Foundation (Grant 2013M540553) (to J.-X. W. and X.-W. W.) and by National Science Foundation Grants IOS-1050518, IOB-0618409, and IOS-0822257 (to G. R. V.). This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM070589-06 (to G. R. V.).	Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cuthbertson BJ, 2005, J BIOL CHEM, V280, P16009, DOI 10.1074/jbc.M412420200; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; Dean MM, 2005, J CLIN IMMUNOL, V25, P346, DOI 10.1007/s10875-005-4702-1; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; GEWURZ H, 1982, ADV INTERNAL MED, V27, P345; Gomez-Gil B, 1998, AQUACULTURE, V163, P1, DOI 10.1016/S0044-8486(98)00162-8; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Kaizu A, 2011, J BIOL CHEM, V286, P44344, DOI 10.1074/jbc.M111.292672; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rosa RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067937; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; SIZEMORE RK, 1975, APPL MICROBIOL, V29, P393, DOI 10.1177/0146167202250221; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; TUBIASH HS, 1975, APPL MICROBIOL, V29, P388, DOI 10.1128/AEM.29.3.388-392.1975; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Wang XW, 2014, J BIOL CHEM, V289, P2405, DOI 10.1074/jbc.M113.528885; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Wu CL, 2013, IMMUNOBIOLOGY, V218, P159, DOI 10.1016/j.imbio.2012.02.011; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	49	108	111	8	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11779	11790		10.1074/jbc.M114.552307	http://dx.doi.org/10.1074/jbc.M114.552307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619414	Green Published, hybrid			2022-12-28	WOS:000335010600019
J	Manandhar, SP; Calle, EN; Gharakhanian, E				Manandhar, Surya P.; Calle, Erika N.; Gharakhanian, Editte			Distinct Palmitoylation Events at the Amino-terminal Conserved Cysteines of Env7 Direct Its Stability, Localization, and Vacuolar Fusion Regulation in S. cerevisiae*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lysosomes; Membrane Fusion; Membrane Proteins; Protein Kinases; Protein Palmitoylation; Protein Sorting; Protein Stability; Env7; Yeast Lysosomal Vacuole; Yeast Vacuolar Fusion	PROTEIN PALMITOYLATION; SNARE YKT6; SERINE/THREONINE KINASE; YEAST VACUOLES; EARLY-STAGE; MEMBRANE; COMPLEX; VAC8; RAB; PHOSPHORYLATION	Background: Env7 is a conserved palmitoylated kinase that regulates vacuolar fusion. Results: Specific Env7 palmitoylated cysteines direct its membrane localization, stability, and function. Conclusion: Distinct palmitoylation events direct Env7 membrane localization as well as its stability and function at the membrane. Significance: This may represent the largest set of functions attributed to palmitoylated cysteines in a single protein. Palmitoylation at cysteine residues is the only known reversible form of lipidation and has been implicated in protein membrane association as well as function. Many palmitoylated proteins have regulatory roles in dynamic cellular processes, including membrane fusion. Recently, we identified Env7 as a conserved and palmitoylated protein kinase involved in negative regulation of membrane fusion at the lysosomal vacuole. Env7 contains a palmitoylation consensus sequence, and substitution of its three consecutive cysteines (Cys(13)-Cys(15)) results in a non-palmitoylated and cytoplasmic Env7. In this study, we further dissect and define the role(s) of individual cysteines of the consensus sequence in various properties of Env7 in vivo. Our results indicate that more than one of the cysteines serve as palmitoylation substrates, and any pairwise combination is essential and sufficient for near wild type levels of Env7 palmitoylation, membrane localization, and phosphorylation. Furthermore, individually, each cysteine can serve as a minimum requirement for distinct aspects of Env7 behavior and function in cells. Cys(13) is sufficient for membrane association, Cys(15) is essential for the fusion regulatory function of membrane-bound Env7, and Cys(14) and Cys(15) are redundantly essential for protection of membrane-bound Env7 from proteasomal degradation. A role for Cys(14) and Cys(15) in correct sorting at the membrane is also discussed. Thus, palmitoylation at the N-terminal cysteines of Env7 directs not only its membrane association but also its stability, phosphorylation, and cellular function.	[Manandhar, Surya P.; Calle, Erika N.; Gharakhanian, Editte] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Gharakhanian, E (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	e.ghara@csulb.edu			National Science Foundation (NSF)-RUI Grant [0843569]; NSF-Major Research Instrumentation Grant [DBI0722757]; NSF-RUI Grant [0843569]; NSF-LSAMP undergraduate training grant [HRD-1302873]; Direct For Education and Human Resources [1302873] Funding Source: National Science Foundation	National Science Foundation (NSF)-RUI Grant(National Science Foundation (NSF)); NSF-Major Research Instrumentation Grant; NSF-RUI Grant; NSF-LSAMP undergraduate training grant; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This project was supported by National Science Foundation (NSF)-RUI Grant 0843569 (to E. G.) and NSF-Major Research Instrumentation Grant DBI0722757 for confocal microscopy.; Supported by NSF-RUI Grant 0843569.; Supported in part by an NSF-LSAMP undergraduate training grant (HRD-1302873).	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Armstrong J, 2010, TRENDS CELL BIOL, V20, P580, DOI 10.1016/j.tcb.2010.06.010; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Berson AE, 1999, BIOCHEM BIOPH RES CO, V259, P533, DOI 10.1006/bbrc.1999.0811; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chen Y, 2005, J MOL BIOL, V350, P92, DOI 10.1016/j.jmb.2005.04.061; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dietrich LEP, 2005, J BIOL CHEM, V280, P15348, DOI 10.1074/jbc.M410582200; Dietrich LEP, 2005, EMBO REP, V6, P245, DOI 10.1038/sj.embor.7400350; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Eswaran J, 2008, STRUCTURE, V16, P115, DOI 10.1016/j.str.2007.10.026; Flaumenhaft R, 2005, HEMATOLOGY, V10, P511, DOI 10.1080/10245330500141507; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Guinea B, 2005, EXP CELL RES, V312, P135, DOI 10.1016/j.yexcr.2005.10.010; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; He B, 2011, BIOCHEM J, V437, P399, DOI 10.1042/BJ20101381; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Ligos JM, 2002, J BIOL CHEM, V277, P6333, DOI 10.1074/jbc.M105766200; Manandhar S. P., 2013, FEMS YEAST RES, DOI [10.1111/1567-1364.12128, DOI 10.1111/1567-1364. 12128]; Manandhar SP, 2013, MOL CELL BIOL, V33, P526, DOI 10.1128/MCB.01303-12; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Richards Andrea, 2010, Fungal Biology Reviews, V24, P93, DOI 10.1016/j.fbr.2010.04.002; Rohde J, 2003, J BIOL CHEM, V278, P1656, DOI 10.1074/jbc.M209522200; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Roth AF, 2011, MOL BIOL CELL, V22, P2702, DOI 10.1091/mbc.E11-02-0115; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Song SP, 2013, BIOCHEM J, V454, P323, DOI 10.1042/BJ20121799; Stairs DB, 2005, TRANSGENIC RES, V14, P919, DOI 10.1007/s11248-005-1806-6; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; SUDO Y, 1992, EMBO J, V11, P2095, DOI 10.1002/j.1460-2075.1992.tb05268.x; Tanimura N, 2006, BIOCHEM BIOPH RES CO, V341, P1177, DOI 10.1016/j.bbrc.2006.01.076; Thayanidhi N, 2012, BIOL CELL, V104, P397, DOI 10.1111/boc.201100048; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wen WY, 2010, MOL CELL, V37, P383, DOI 10.1016/j.molcel.2010.01.024; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	60	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11431	11442		10.1074/jbc.M113.524082	http://dx.doi.org/10.1074/jbc.M113.524082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610781	Green Published, hybrid			2022-12-28	WOS:000334638500044
J	Sjogren, LLE; Tanabe, N; Lymperopoulos, P; Khan, NZ; Rodermel, SR; Aronsson, H; Clarke, AK				Sjogren, Lars L. E.; Tanabe, Noriaki; Lymperopoulos, Panagiotis; Khan, Nadir Z.; Rodermel, Steven R.; Aronsson, Henrik; Clarke, Adrian K.			Quantitative Analysis of the Chloroplast Molecular Chaperone ClpC/Hsp93 in Arabidopsis Reveals New Insights into Its Localization, Interaction with the Clp Proteolytic Core, and Functional Importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloroplast; Molecular Chaperone; Protease; Protein Degradation; Protein Translocation	ATP-DEPENDENT PROTEASE; IN-VIVO; ENVELOPE MEMBRANES; TRANSIT-PEPTIDE; PROTEINS; IDENTIFICATION; COMPLEXES; THALIANA; SUBUNIT; SYSTEM	Background: ClpC/Hsp93 is a chloroplast molecular chaperone whose function is essential for plant viability. Results: Chloroplast ClpC localized in both the stromal and envelope-membrane fractions associates with the Clp proteolytic core. Conclusion: ClpC functions primarily as the chaperone component of the chloroplast Clp protease. Significance: Learning how ClpC contributes to key functions of the Clp protease is crucial to understanding the importance of this essential enzyme for chloroplast biology. The molecular chaperone ClpC/Hsp93 is essential for chloroplast function in vascular plants. ClpC has long been held to act both independently and as the regulatory partner for the ATP-dependent Clp protease, and yet this and many other important characteristics remain unclear. In this study, we reveal that of the two near-identical ClpC paralogs (ClpC1 and ClpC2) in Arabidopsis chloroplasts, along with the closely related ClpD, it is ClpC1 that is the most abundant throughout leaf maturation. An unexpectedly large proportion of both chloroplast ClpC proteins (30% of total ClpC content) associates to envelope membranes in addition to their stromal localization. The Clp proteolytic core is also bound to envelope membranes, the amount of which is sufficient to bind to all the similarly localized ClpC. The role of such an envelope membrane Clp protease remains unclear although it appears uninvolved in preprotein processing or Tic subunit protein turnover. Within the stroma, the amount of oligomeric ClpC protein is less than that of the Clp proteolytic core, suggesting most if not all stromal ClpC functions as part of the Clp protease; a proposal supported by the near abolition of Clp degradation activity in the clpC1 knock-out mutant. Overall, ClpC appears to function primarily within the Clp protease, as the principle stromal protease responsible for maintaining homeostasis, and also on the envelope membrane where it possibly confers a novel protein quality control mechanism for chloroplast preprotein import.	[Sjogren, Lars L. E.; Tanabe, Noriaki; Lymperopoulos, Panagiotis; Khan, Nadir Z.; Aronsson, Henrik; Clarke, Adrian K.] Gothenburg Univ, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	University of Gothenburg; Iowa State University	Clarke, AK (corresponding author), Gothenburg Univ, Dept Biol & Environm Sci, Box 461, S-40530 Gothenburg, Sweden.	adrian.clarke@bioenv.gu.se	Zaman, Nadir/ABE-6560-2020	Zaman, Nadir/0000-0003-0405-2724; Lymperopoulos, Panagiotis/0000-0003-2706-3717	Swedish Research Council (VR); Stiftelsen Olle Engkvist Byggmastare	Swedish Research Council (VR)(Swedish Research Council); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	This work was supported by grants from The Swedish Research Council (VR) and Stiftelsen Olle Engkvist Byggmastare (to A. K. C.).	Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Aronsson H, 2011, METHODS MOL BIOL, V774, P281, DOI 10.1007/978-1-61779-234-2_17; Balsera M, 2009, J BIOL CHEM, V284, P2603, DOI 10.1074/jbc.M807134200; Block MA, 2002, EUR J BIOCHEM, V269, P240, DOI 10.1046/j.0014-2956.2001.02643.x; Bruch EM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-57; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chu CC, 2012, PLANT PHYSIOL, V158, P1656, DOI 10.1104/pp.112.193300; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Desimone M, 1997, BOT ACTA, V110, P234, DOI 10.1111/j.1438-8677.1997.tb00634.x; Ellis R. John, 2005, P3, DOI 10.1017/CBO9780511546310.002; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Halperin T, 2001, PLANTA, V213, P614, DOI 10.1007/s004250100527; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Koussevitzky S, 2007, PLANT MOL BIOL, V63, P85, DOI 10.1007/s11103-006-9074-2; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; McClellan A., 2012, ELS, DOI [10.1002/9780470015902.a0020886.pub2, DOI 10.1002/9780470015902.A0020886.PUB2]; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504, DOI 10.1093/oxfordjournals.pcp.a029571; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nishimura K, 2013, PLANT CELL, V25, P2276, DOI 10.1105/tpc.113.112557; Olinares PDB, 2011, PLANT CELL, V23, P2348, DOI 10.1105/tpc.111.086454; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Randelj Olga, 2007, V390, P417; Richter S, 1999, J CELL BIOL, V147, P33, DOI 10.1083/jcb.147.1.33; Rosano GL, 2011, J BIOL CHEM, V286, P29671, DOI 10.1074/jbc.M110.211946; Rudella A, 2006, PLANT CELL, V18, P1704, DOI 10.1105/tpc.106.042861; Schwenkert S, 2011, BBA-BIOMEMBRANES, V1808, P901, DOI 10.1016/j.bbamem.2010.07.021; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Sjogren LLE, 2011, PLANT CELL, V23, P322, DOI 10.1105/tpc.110.082321; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Sokolenko A, 1998, PLANTA, V207, P286, DOI 10.1007/s004250050485; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Stanne TM, 2009, BIOCHEM J, V417, P257, DOI 10.1042/BJ20081146; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Tryggvesson A, 2012, BIOCHEM J, V446, P311, DOI 10.1042/BJ20120649; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x; Zheng B, 2006, PLANTA, V224, P1103, DOI 10.1007/s00425-006-0292-2	64	43	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11318	11330		10.1074/jbc.M113.534552	http://dx.doi.org/10.1074/jbc.M113.534552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599948	Green Published, hybrid			2022-12-28	WOS:000334638500034
J	Halpert, G; Eitan, T; Voronov, E; Apte, RN; Rath-Wolfson, L; Albeck, M; Kalechman, Y; Sredni, B				Halpert, Gilad; Eitan, Tom; Voronov, Elena; Apte, Ron N.; Rath-Wolfson, Lea; Albeck, Michael; Kalechman, Yona; Sredni, Benjamin			Multifunctional Activity of a Small Tellurium Redox Immunomodulator Compound, AS101, on Dextran Sodium Sulfate-induced Murine Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPRIA MONONUCLEAR-CELLS; GROWTH-FACTOR-BETA; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; ADHESION MOLECULE-1; EPITHELIAL-CELLS; UP-REGULATION; T-CELLS; INDUCTION	Inflammatory bowel diseases (IBDs) are a group of idiopathic, chronic immune-mediated diseases characterized by an aberrant immune response, including imbalances of inflammatory cytokine production and activated innate and adaptive immunity. Selective blockade of leukocyte migration into the gut is a promising strategy for the treatment of IBD. This study explored the effect of the immunomodulating tellurium compound ammonium trichloro (dioxoethylene-o,o') tellurate (AS101) on dextran sodium sulfate (DSS)-induced murine colitis. Both oral and intraperitoneal administration of AS101 significantly reduced clinical manifestations of IBD. Colonic inflammatory cytokine levels (IL-17 and IL-1 beta) were significantly down-regulated by AS101 treatment, whereas IFN-gamma was not affected. Neutrophil and alpha 4 beta 7(+) macrophage migration into the tissue was inhibited by AS101 treatment. Adhesion of mesenteric lymph node cells to mucosal addressin cell adhesion molecule (MAdCAM-1), the ligand for alpha 4 beta 7 integrin, was blocked by AS101 treatment both in vitro and in vivo. DSS-induced destruction of colonic epithelial barrier/integrity was prevented by AS101, via up-regulation of colonic glial-derived neurotrophic factor, which was found previously to regulate the intestinal epithelial barrier through activation of the PI3K/AKT pathway. Indeed, the up-regulation of glial-derived neurotrophic factor by AS101 was associated with increased levels of colonic pAKT and BCL-2 and decreased levels of BAX. Furthermore, AS101 treatment reduced colonic permeability to Evans blue and decreased colonic TUNEL+ cells. Our data revealed multifunctional activities of AS101 in the DSS-induced colitis model via anti-inflammatory and anti-apoptotic properties. We suggest that treatment with the small, nontoxic molecule AS101 may be an effective early therapeutic approach for controlling human IBD.	[Halpert, Gilad; Eitan, Tom; Kalechman, Yona; Sredni, Benjamin] Bar Ilan Univ, CAIR Inst, Mina & Everard Goodman Fac Life Sci, Safdie AIDS & Immunol Res Ctr, IL-52900 Ramat Gan, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; [Rath-Wolfson, Lea] Rabin Med Ctr, Dept Pathol, IL-49372 Petah Tiqwa, Israel; [Rath-Wolfson, Lea] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [Albeck, Michael] Bar Ilan Univ, Dept Chem, Fac Exact Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University	Sredni, B (corresponding author), Bar Ilan Univ, CAIR Inst, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	srednib@gmail.com			Dr. Tovi Comet-Walerstein Cancer Research Chair; Dave and Florence Muskovitz Chair in Cancer Research; Jaime Lusinchi Research Institute in Applied Sciences	Dr. Tovi Comet-Walerstein Cancer Research Chair; Dave and Florence Muskovitz Chair in Cancer Research; Jaime Lusinchi Research Institute in Applied Sciences	This work was supported in part by the Dr. Tovi Comet-Walerstein Cancer Research Chair, by the Dave and Florence Muskovitz Chair in Cancer Research, and the Jaime Lusinchi Research Institute in Applied Sciences.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Albeck A, 1998, INORG CHEM, V37, P1704, DOI 10.1021/ic971456t; Ando Tomoaki, 2007, BMC Physiology, V7, P10, DOI 10.1186/1472-6793-7-10; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Briskin M, 1997, AM J PATHOL, V151, P97; Brodsky M, 2007, J INTERF CYTOK RES, V27, P453, DOI 10.1089/jir.2007.0168; Brodsky M, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-3; Brodsky M, 2009, J HEPATOL, V51, P491, DOI 10.1016/j.jhep.2009.04.024; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; D'Haens GR, 2010, NAT REV GASTRO HEPAT, V7, P86, DOI 10.1038/nrgastro.2009.222; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Grimm MC, 2009, J GASTROEN HEPATOL, V24, pS69, DOI 10.1111/j.1440-1746.2009.06074.x; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto M, 1996, J PATHOL, V180, P152; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NYSKA A, 1989, ARCH TOXICOL, V63, P386, DOI 10.1007/BF00303128; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Okun E, 2006, DEV COMP IMMUNOL, V30, P441, DOI 10.1016/j.dci.2005.07.002; Peyrin-Biroulet L, 2008, LANCET, V372, P67, DOI 10.1016/S0140-6736(08)60995-2; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SATSANGI J, 1987, CLIN EXP IMMUNOL, V67, P594; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sredni B, 2003, FASEB J, V17, P400, DOI 10.1096/fj.03-0552fje; SREDNI B, 1987, NATURE, V330, P173, DOI 10.1038/330173a0; SREDNI B, 1995, J CLIN ONCOL, V13, P2342, DOI 10.1200/JCO.1995.13.9.2342; Sredni B, 1996, INT J CANCER, V65, P97, DOI 10.1002/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F; Sredni B, 2007, FASEB J, V21, P1870, DOI 10.1096/fj.06-7500com; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sund M, 2005, IMMUNOLOGY, V114, P554, DOI 10.1111/j.1365-2567.2005.02123.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang Y, 1996, IMMUNOL CELL BIOL, V74, P383, DOI 10.1038/icb.1996.67; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749	71	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17215	17227		10.1074/jbc.M113.536664	http://dx.doi.org/10.1074/jbc.M113.536664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764299	Green Published, hybrid			2022-12-28	WOS:000338016200054
J	Faure, E; Thompson, C; Blunck, R				Faure, Elise; Thompson, Christine; Blunck, Rikard			Do Lipids Show State-dependent Affinity to the Voltage-gated Potassium Channel KvAP?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; K+ CHANNEL; S4-S5 LINKER; WILD-TYPE; ACTIVATION; MECHANISM; INTERFACE; BILAYER; WATER; S4	As all integral membrane proteins, voltage-gated ion channels are embedded in a lipid matrix that regulates their channel behavior either by physicochemical properties or by direct binding. Because manipulation of the lipid composition in cells is difficult, we investigated the influence of different lipids on purified KvAP channels reconstituted in planar lipid bilayers of known composition. Lipids developed two distinct and independent effects on the KvAP channels; lipids interacting with the pore lowered the energy barriers for the final transitions, whereas voltage sensor-bound lipids shifted the midpoint of activation dependent on their electrostatic charge. Above all, the midpoint of activation was determined only by those lipids the channels came in contact with first after purification and can seemingly only be exchanged if the channel resides in the open state. The high affinity of the bound lipids to the binding site has implications not only on our understanding of the gating mechanism but also on the general experimental design of any lipid dependence study.	[Thompson, Christine; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ CH3C 3J7, Canada; [Faure, Elise; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ CH3C 3J7, Canada; [Faure, Elise; Thompson, Christine; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ CH3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Thompson, Christine/GWV-6539-2022; Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research [MOP-102689]; Natural Sciences and Engineering Research Council [327201-2012]; Canadian Foundation for Innovation [950-225005]; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche du Quebec-Nature et technologie (FRQNT)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche du Quebec-Nature et technologie (FRQNT)	This work was supported in part by Canadian Institutes for Health Research Grant MOP-102689, Natural Sciences and Engineering Research Council Grant 327201-2012, and Canadian Foundation for Innovation Grant 950-225005. GEPROMis a research group supported by the Fonds de recherche du Quebec-Sante (FRQS).; Supported by a fellowship of the Fonds de recherche du Quebec-Nature et technologie (FRQNT).	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Combs DJ, 2013, J GEN PHYSIOL, V142, P367, DOI 10.1085/jgp.201310986; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Faure E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415497; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Gaede HC, 2003, BIOPHYS J, V85, P1734, DOI 10.1016/S0006-3495(03)74603-7; Groulx N, 2010, J GEN PHYSIOL, V136, P497, DOI 10.1085/jgp.200910347; Heberle FA, 2013, J AM CHEM SOC, V135, P6853, DOI 10.1021/ja3113615; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kalstrup T, 2013, P NATL ACAD SCI USA, V110, P8272, DOI 10.1073/pnas.1220398110; Krepkiy D, 2012, J MOL BIOL, V423, P632, DOI 10.1016/j.jmb.2012.07.015; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salvati A, 2007, J PHYS CHEM B, V111, P10357, DOI 10.1021/jp0731710; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; van der Cruijsen EAW, 2013, P NATL ACAD SCI USA, V110, P13008, DOI 10.1073/pnas.1305563110; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	40	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16452	16461		10.1074/jbc.M113.537134	http://dx.doi.org/10.1074/jbc.M113.537134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742679	Green Published, hybrid			2022-12-28	WOS:000337965700047
J	Hislop, JN; Islam, TA; Eleftheriadou, I; Carpentier, DCJ; Trabalza, A; Parkinson, M; Schiavo, G; Mazarakis, ND				Hislop, James N.; Islam, Tarin A.; Eleftheriadou, Ioanna; Carpentier, David C. J.; Trabalza, Antonio; Parkinson, Michael; Schiavo, Giampietro; Mazarakis, Nicholas D.			Rabies Virus Envelope Glycoprotein Targets Lentiviral Vectors to the Axonal Retrograde Pathway in Motor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NEUROTROPHIN RECEPTOR P75(NTR); CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; TETANUS TOXIN; OVERLAP EXTENSION; ENDOCYTIC PATHWAY; MEMBRANE-FUSION; EARLY ENDOSOMES; LIVE CELLS	Rabies pseudotyped lentiviral vectors have great potential in gene therapy, not least because of their ability to transduce neurons following their distal axonal application. However, very little is known about the molecular processes that underlie their retrograde transport and cell transduction. Using multiple labeling techniques and confocal microscopy, we demonstrated that pseudotyping with rabies virus envelope glycoprotein (RV-G) enabled the axonal retrograde transport of two distinct subtypes of lentiviral vector in motor neuron cultures. Analysis of this process revealed that these vectors trafficked through Rab5-positive endosomes and accumulated within a non-acidic Rab7 compartment. RV-G pseudotyped vectors were co-transported with both the tetanus neurotoxin-binding fragment and the membrane proteins thought to mediate rabies virus endocytosis (neural cell adhesion molecule, nicotinic acetylcholine receptor, and p75 neurotrophin receptor), thus demonstrating that pseudotyping with RV-G targets lentiviral vectors for transport along the same pathway exploited by several toxins and viruses. Using motor neurons cultured in compartmentalized chambers, we demonstrated that axonal retrograde transport of these vectors was rapid and efficient; however, it was not able to transduce the targeted neurons efficiently, suggesting that impairment in processes occurring after arrival of the viral vector in the soma is responsible for the low transduction efficiency seen in vivo, which suggests a novel area for improvement of gene therapy vectors.	[Hislop, James N.; Islam, Tarin A.; Eleftheriadou, Ioanna; Carpentier, David C. J.; Trabalza, Antonio; Mazarakis, Nicholas D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London W12 0NN, England; [Parkinson, Michael; Schiavo, Giampietro] Canc Res UK London Res Inst, Mol NeuroPathoBiol Lab, Lincolns Inn Fields Labs, London WC2A 3LY, England; [Schiavo, Giampietro] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England	Imperial College London; Cancer Research UK; University of London; University College London	Mazarakis, ND (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, Du Cane Rd, London W12 0NN, England.	n.mazarakis@imperial.ac.uk		Schiavo, Giampietro/0000-0002-4319-8745; Trabalza, Antonio/0000-0003-3018-9820; Islam, Tarin/0000-0002-7602-3175; Carpentier, David/0000-0002-8172-9121	European Research Council [23314]; Imperial College funds; Cancer Research UK	European Research Council(European Research Council (ERC)European Commission); Imperial College funds; Cancer Research UK(Cancer Research UK)	This work was supported by Seventh Framework Programme European Research Council Advanced Investigators Grant 23314 (to N. D. M. supporting J. N. H., T. A. I., I. E., A. T., and D. C. J. C.), Imperial College funds (to N. D. M.), and Cancer Research UK (to M. P., K. B., and G. S.).	Adams S, 2002, FORBES, V169, P124; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bercsenyi K, 2013, CURR TOP MICROBIOL, V364, P91, DOI 10.1007/978-3-642-33570-9_5; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Butowt R, 2003, EUR J NEUROSCI, V17, P673, DOI 10.1046/j.1460-9568.2003.02497.x; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Carpentier DCJ, 2012, GENE THER, V19, P761, DOI 10.1038/gt.2011.124; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Colpitts TM, 2007, VIROLOGY, V369, P78, DOI 10.1016/j.virol.2007.07.012; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Eleftheriadou I, 2014, MOL THER, V22, P1285, DOI 10.1038/mt.2014.49; Gaudin Y, 1999, MOL MEMBR BIOL, V16, P21, DOI 10.1080/096876899294724; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Kovalevich J, 2012, FUTURE VIROL, V7, P687, DOI 10.2217/FVL.12.57; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Lei Yuning, 2009, J Biol Eng, V3, P8, DOI 10.1186/1754-1611-3-8; LENTZ TL, 1983, YALE J BIOL MED, V56, P315; Liu YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067400; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mentis GZ, 2006, J NEUROSCI METH, V157, P208, DOI 10.1016/j.jneumeth.2006.04.011; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rasalingam P, 2005, VIRUS RES, V111, P55, DOI 10.1016/j.virusres.2005.03.010; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Schenkwein D, 2010, HUM GENE THER, V21, P589, DOI 10.1089/hum.2009.051; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; St Pierre CA, 2011, EXP MOL PATHOL, V91, P723, DOI 10.1016/j.yexmp.2011.05.011; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Trabalza A, 2013, GENE THER, V20, P723, DOI 10.1038/gt.2012.85; Trabalza A, 2014, J VIROL, V88, P2877, DOI 10.1128/JVI.03376-13; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; Verhoeyen E, 2004, J GENE MED, V6, pS83, DOI 10.1002/jgm.494; Wade A, 2012, J NEUROCHEM, V121, P575, DOI 10.1111/j.1471-4159.2012.07658.x; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	61	25	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16148	16163		10.1074/jbc.M114.549980	http://dx.doi.org/10.1074/jbc.M114.549980			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753246	Green Published, hybrid			2022-12-28	WOS:000337965700021
J	Baek, JH; Rubinstein, M; Scheuer, T; Trimmer, JS				Baek, Je-Hyun; Rubinstein, Moran; Scheuer, Todd; Trimmer, James S.			Reciprocal Changes in Phosphorylation and Methylation of Mammalian Brain Sodium Channels in Response to Seizures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Epilepsy; Ion Channels; Mass Spectrometry (MS); Proteomics	PROTEIN-KINASE-C; STATUS EPILEPTICUS MODEL; TEMPORAL-LOBE EPILEPSY; RAT CA1 NEURONS; ALPHA-SUBUNITS; NA+ CHANNELS; KINDLING EPILEPTOGENESIS; ANTIEPILEPTIC DRUGS; CURRENTS; MECHANISMS	Background: Sodium channels underlie neuronal excitability and are regulated by seizures. Results: Mass spectrometric analysis of brain sodium channels revealed novel phosphorylation and methylation sites that decreased and increased, respectively, after seizures. Inducing methylation increased sodium channel activity. Conclusion: Reciprocal phosphorylation and methylation after seizures will alter sodium channel function. Significance: Such regulation would impact neuronal excitability. Voltage-gated sodium (Nav) channels initiate action potentials in brain neurons and are primary therapeutic targets for anti-epileptic drugs controlling neuronal hyperexcitability in epilepsy. The molecular mechanisms underlying abnormal Nav channel expression, localization, and function during development of epilepsy are poorly understood but can potentially result from altered posttranslational modifications (PTMs). For example, phosphorylation regulates Nav channel gating, and has been proposed to contribute to acquired insensitivity to anti-epileptic drugs exhibited by Nav channels in epileptic neurons. However, whether changes in specific brain Nav channel PTMs occur acutely in response to seizures has not been established. Here, we show changes in PTMs of the major brain Nav channel, Nav1.2, after acute kainate-induced seizures. Mass spectrometry-based proteomic analyses of Nav1.2 purified from the brains of control and seizure animals revealed a significant down-regulation of phosphorylation at nine sites, primarily located in the interdomain I-II linker, the region of Nav1.2 crucial for phosphorylation-dependent regulation of activity. Interestingly, Nav1.2 in the seizure samples contained methylated arginine (MeArg) at three sites. These MeArgs were adjacent to down-regulated sites of phosphorylation, and Nav1.2 methylation increased after seizure. Phosphorylation and MeArg were not found together on the same tryptic peptide, suggesting reciprocal regulation of these two PTMs. Coexpression of Nav1.2 with the primary brain arginine methyltransferase PRMT8 led to a surprising 3-fold increase in Nav1.2 current. Reciprocal regulation of phosphorylation and MeArg of Nav1.2 may underlie changes in neuronal Nav channel function in response to seizures and also contribute to physiological modulation of neuronal excitability.	[Baek, Je-Hyun; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Rubinstein, Moran; Scheuer, Todd] Univ Washington, Dept Pharmacol, Sch Med, Seattle, WA 98195 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu		Baek, Je-Hyun/0000-0003-4974-8397; Rubinstein, Moran/0000-0003-2617-2276	National Institutes of Health [R21 NS64428, R01 NS25704]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064428, R01NS025704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS64428 (to J. S. T. and T. S.) and R01 NS25704 (to William A. Catterall).	Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bartolomei F, 1997, J NEUROCYTOL, V26, P667, DOI 10.1023/A:1018549928277; Beacham D, 2007, J NEUROSCI, V27, P11543, DOI 10.1523/JNEUROSCI.1743-07.2007; Beck H, 2007, EPILEPSIA, V48, P14, DOI 10.1111/j.1528-1167.2007.00994.x; Beltran-Alvarez P, 2013, FEBS LETT, V587, P3159, DOI 10.1016/j.febslet.2013.07.043; Beltran-Alvarez P, 2011, J PROTEOME RES, V10, P3712, DOI 10.1021/pr200339n; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Curia G, 2007, BRIT J PHARMACOL, V150, P792, DOI 10.1038/sj.bjp.0707144; Curia G, 2004, NEUROSCIENCE, V127, P63, DOI 10.1016/j.neuroscience.2004.04.040; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Guo F, 2013, NEUROCHEM INT, V62, P287, DOI 10.1016/j.neuint.2013.01.005; Hargus NJ, 2011, NEUROBIOL DIS, V41, P361, DOI 10.1016/j.nbd.2010.10.004; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Jeub M, 2002, NEUROPHARMACOLOGY, V42, P107, DOI 10.1016/S0028-3908(01)00148-4; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Minge D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026664; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Qiao X, 2013, EPILEPSY RES, V106, P17, DOI 10.1016/j.eplepsyres.2013.06.006; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Remy S, 2003, EUR J NEUROSCI, V17, P2648, DOI 10.1046/j.1460-9568.2003.02710.x; Schaub C, 2007, EPILEPSIA, V48, P1339, DOI 10.1111/j.1528-1167.2007.01103.x; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Trimmer J.S., 2014, HDB ION CHANNELS; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Velisek L, 2006, MODELS OF SEIZURES AND EPILEPSY, P127, DOI 10.1016/B978-012088554-1/50013-X; Vreugdenhil M, 2004, EUR J NEUROSCI, V19, P2769, DOI 10.1111/j.1460-9568.2004.03400.x; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Vreugdenhil M, 1999, EPILEPSIA, V40, P1512, DOI 10.1111/j.1528-1157.1999.tb02034.x; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Williams CA, 2013, EXP NEUROL, V244, P51, DOI 10.1016/j.expneurol.2011.12.001	54	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15363	15373		10.1074/jbc.M114.562785	http://dx.doi.org/10.1074/jbc.M114.562785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737319	hybrid, Green Published			2022-12-28	WOS:000337465400020
J	Barroso, M; Florindo, C; Kalwa, H; Silva, Z; Turanov, AA; Carlson, BA; de Almeida, IT; Blom, HJ; Gladyshev, VN; Hatfield, DL; Michel, T; Castro, R; Loscalzo, J; Handy, DE				Barroso, Madalena; Florindo, Cristina; Kalwa, Hermann; Silva, Zelia; Turanov, Anton A.; Carlson, Bradley A.; de Almeida, Isabel Tavares; Blom, Henk J.; Gladyshev, Vadim N.; Hatfield, Dolph L.; Michel, Thomas; Castro, Rita; Loscalzo, Joseph; Handy, Diane E.			Inhibition of Cellular Methyltransferases Promotes Endothelial Cell Activation by Suppressing Glutathione Peroxidase 1 Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Endothelial Cell; Glutathione Peroxidase; Oxidative Stress; Selenoprotein; S-Adenosylhomocysteine; tRNA Methylation	S-ADENOSYLHOMOCYSTEINE CONCENTRATIONS; INTERCELLULAR-ADHESION MOLECULE-1; TRANSFER-RNA; CARDIOVASCULAR EVENTS; ARGININE METHYLATION; DNA HYPOMETHYLATION; OXIDATIVE STRESS; SELENOCYSTEINE; THIOREDOXIN; HOMOCYSTEINE	Background: Methylation of tRNA(Sec) facilitates the incorporation of selenocysteine at a UGA codon during translation. Results: Accumulation of the homocysteine precursor S-adenosylhomocysteine decreases tRNA(Sec) methylation, reducing glutathione peroxidase 1 expression and increasing oxidative stress-induced inflammatory activation of endothelial cells. Conclusion: Methylation modulates the expression of selenoproteins to regulate redox-dependent inflammatory pathways. Significance: Hypomethylation stress promotes a proatherogenic endothelial cell phenotype. S-Adenosylhomocysteine (SAH) is a negative regulator of most methyltransferases and the precursor for the cardiovascular risk factor homocysteine. We have previously identified a link between the homocysteine-induced suppression of the selenoprotein glutathione peroxidase 1 (GPx-1) and endothelial dysfunction. Here we demonstrate a specific mechanism by which hypomethylation, promoted by the accumulation of the homocysteine precursor SAH, suppresses GPx-1 expression and leads to inflammatory activation of endothelial cells. The expression of GPx-1 and a subset of other selenoproteins is dependent on the methylation of the tRNA(Sec) to the Um34 form. The formation of methylated tRNA(Sec) facilitates translational incorporation of selenocysteine at a UGA codon. Our findings demonstrate that SAH accumulation in endothelial cells suppresses the expression of GPx-1 to promote oxidative stress. Hypomethylation stress, caused by SAH accumulation, inhibits the formation of the methylated isoform of the tRNA(Sec) and reduces GPx-1 expression. In contrast, under these conditions, the expression and activity of thioredoxin reductase 1, another selenoprotein, is increased. Furthermore, SAH-induced oxidative stress creates a proinflammatory activation of endothelial cells characterized by up-regulation of adhesion molecules and an augmented capacity to bind leukocytes. Taken together, these data suggest that SAH accumulation in endothelial cells can induce tRNA(Sec) hypomethylation, which alters the expression of selenoproteins such as GPx-1 to contribute to a proatherogenic endothelial phenotype.	[Barroso, Madalena; Kalwa, Hermann; Michel, Thomas; Loscalzo, Joseph; Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Barroso, Madalena; Florindo, Cristina; de Almeida, Isabel Tavares; Castro, Rita] Univ Lisbon, Res Inst Med & Pharmaceut Sci iMed UL, Fac Pharm, P-1649004 Lisbon, Portugal; [de Almeida, Isabel Tavares; Castro, Rita] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1649004 Lisbon, Portugal; [Silva, Zelia] Univ Nova Lisboa, Fac Ciencias Med, Dept Imunol, Chron Dis Res Ctr, P-1099085 Lisbon, Portugal; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Blom, Henk J.] Univ Hosp, Ctr Pediat & Adolescent Med, Dept Gen Pediat, D-79106 Freiburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Freiburg	Handy, DE (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Castro, Rita/J-7672-2019; de Almeida, Isabel Tavares/F-8319-2014; Kalwa, Hermann/ABG-2323-2021; Loscalzo, Joseph/ABD-8980-2021; iMed.ULisboa, MetGen/B-5293-2014; silva, zélia mc/O-7243-2015; Barroso, Madalena/AAT-9916-2020	Castro, Rita/0000-0002-4585-0741; silva, zélia mc/0000-0001-6660-426X; Barroso, Madalena/0000-0002-1600-890X; Blom, Henk/0000-0001-5202-9241; Florindo, Cristina/0000-0002-0664-5411; Handy, Diane/0000-0002-4310-8527; Gladyshev, Vadim/0000-0002-0372-7016; Tavares de Almeida, Isabel/0000-0002-4024-8305	National Institutes of Health [HL067195, HL070819, HL048743, HL107192, HL108630, HL46457, HL48743, GM061603]; American Heart Association; Portuguese Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-ORG/112683/2009, SFRH/BD/73021/2010]; NATIONAL CANCER INSTITUTE [ZIABC011620, ZIABC010767] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R37HL061795, R01HL067195, P50HL107192, R01HL061795, U01HL108630, R01HL046457, U54HL070819, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067195, HL070819, HL048743, HL107192, and HL108630 (to J. L.); HL46457 and HL48743 (to T. M.); and GM061603 (to V. N. G.). This work was also supported by an American Heart Association postdoctoral fellowship grant (to H. K.) and by Portuguese Fundacao para a Ciencia e a Tecnologia Grants PTDC/SAU-ORG/112683/2009 (to R. C.) and SFRH/BD/73021/2010 (M. B.).	Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Barroso M, 2012, AMINO ACIDS, V42, P1903, DOI 10.1007/s00726-011-0916-0; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Donovan J, 2010, ANTIOXID REDOX SIGN, V12, P881, DOI 10.1089/ars.2009.2878; Esse R, 2014, FASEB J, V28, P2686, DOI 10.1096/fj.13-246579; Esse R, 2013, BBA-MOL BASIS DIS, V1832, P1708, DOI 10.1016/j.bbadis.2013.05.013; Esse R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055483; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Frazier-Wood AC, 2012, PHARMACOGENET GENOM, V22, P750, DOI 10.1097/FPC.0b013e328357f6af; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hellebrekers DMEI, 2006, CANCER RES, V66, P10770, DOI 10.1158/0008-5472.CAN-06-1609; Howard MT, 2013, J BIOL CHEM, V288, P19401, DOI 10.1074/jbc.M113.481051; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Jeong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049204; Kalwa H, 2012, J BIOL CHEM, V287, P29147, DOI 10.1074/jbc.M112.381517; Kim GH, 2013, ANTIOXID REDOX SIGN, V18, P1920, DOI 10.1089/ars.2012.4926; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; King WD, 2012, MOL BIOL REP, V39, P7805, DOI 10.1007/s11033-012-1623-y; Kloor D, 2000, J HISTOCHEM CYTOCHEM, V48, P211, DOI 10.1177/002215540004800206; Kloor D, 2007, CELL PHYSIOL BIOCHEM, V19, P57, DOI 10.1159/000099192; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Le NT, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/678190; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Lubos E, 2011, J BIOL CHEM, V286, P35407, DOI 10.1074/jbc.M110.205708; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lubos E, 2010, FASEB J, V24, P2525, DOI 10.1096/fj.09-147421; Miller S, 2001, CLIN SCI, V100, P543, DOI 10.1042/CS20000299; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Pastori D, 2014, INTERN EMERG MED, V9, P123, DOI 10.1007/s11739-013-0999-6; Polotskaia A, 2007, CELL CYCLE, V6, P2524, DOI 10.4161/cc.6.20.4799; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schnabel R, 2005, J AM COLL CARDIOL, V45, P1631, DOI 10.1016/j.jacc.2005.02.053; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Smith AD, 2002, METHOD ENZYMOL, V347, P113; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Struys EA, 2000, CLIN CHEM, V46, P1650; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Xiao YJ, 2013, AM J CLIN NUTR, V98, P1162, DOI 10.3945/ajcn.113.058727; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P23, DOI 10.1007/978-1-4614-1025-6_2; Yan MSC, 2010, J APPL PHYSIOL, V109, P916, DOI 10.1152/japplphysiol.00131.2010; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007	65	35	35	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15350	15362		10.1074/jbc.M114.549782	http://dx.doi.org/10.1074/jbc.M114.549782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719327	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000337465400019
J	Bollmann, F; Wu, ZX; Oelze, M; Siuda, D; Xia, N; Henke, J; Daiber, A; Li, HG; Stumpo, DJ; Blackshear, PJ; Kleinert, H; Pautz, A				Bollmann, Franziska; Wu, Zhixiong; Oelze, Matthias; Siuda, Daniel; Xia, Ning; Henke, Jenny; Daiber, Andreas; Li, Huige; Stumpo, Deborah J.; Blackshear, Perry J.; Kleinert, Hartmut; Pautz, Andrea			Endothelial Dysfunction in Tristetraprolin-deficient Mice Is Not Caused by Enhanced Tumor Necrosis Factor-alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endothelial Dysfunction; NADPH Oxidase; Reactive Nitrogen Species; Reactive Oxygen Species (ROS); Tumor Necrosis Factor (TNF)	FINGER PROTEIN TRISTETRAPROLIN; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; TNF-ALPHA; CARDIOVASCULAR MORTALITY; REDUCES ATHEROSCLEROSIS; CHRONIC INFLAMMATION; OXIDATIVE STRESS	Cardiovascular events are important co-morbidities in patients with chronic inflammatory diseases like rheumatoid arthritis. Tristetraprolin (TTP) regulates pro-inflammatory processes through mRNA destabilization and therefore TTP-deficient mice (TTP-/- mice) develop a chronic inflammation resembling human rheumatoid arthritis. We used this mouse model to evaluate molecular signaling pathways contributing to the enhanced atherosclerotic risk in chronic inflammatory diseases. In the aorta of TTP-/- mice we observed elevated mRNA expression of known TTP targets like tumor necrosis factor- (TNF-) and macrophage inflammatory protein-1, as well as of other pro-atherosclerotic mediators, like Calgranulin A, Cathepsin S, and Osteopontin. Independent of cholesterol levels TTP-/- mice showed a significant reduction of acetylcholine-induced, nitric oxide-mediated vasorelaxation. The endothelial dysfunction in TTP-/- mice was associated with increased levels of reactive oxygen and nitrogen species (RONS), indicating an enhanced nitric oxide inactivation by RONS in the TTP-/- animals. The altered RONS generation correlates with increased expression of NADPH oxidase 2 (Nox2) resulting from enhanced Nox2 mRNA stability. Although TNF- is believed to be a central mediator of inflammation-driven atherosclerosis, genetic inactivation of TNF- neither improved endothelial function nor normalized Nox2 expression or RONS production in TTP-/- animals. Systemic inflammation caused by TTP deficiency leads to endothelial dysfunction. This process is independent of cholesterol and not mediated by TNF- solely. Thus, other mediators, which need to be identified, contribute to enhanced cardiovascular risk in chronic inflammatory diseases.	[Bollmann, Franziska; Wu, Zhixiong; Siuda, Daniel; Xia, Ning; Henke, Jenny; Li, Huige; Kleinert, Hartmut; Pautz, Andrea] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany; [Bollmann, Franziska; Siuda, Daniel] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Oelze, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin 2, D-55131 Mainz, Germany; [Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kleinert, H (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany.	kleinert@mail.uni-mainz.de; pautz@uni-mainz.de	Blackshear, Perry J./C-6206-2019; Xia, Ning/P-3535-2015; Kleinert, Hartmut/M-2988-2018; Li, Huige/M-2662-2013; Siuda, Daniel/K-2597-2012; Xia, Ning/AFT-8078-2022	Blackshear, Perry J./0000-0002-9561-8529; Xia, Ning/0000-0002-5553-1752; Kleinert, Hartmut/0000-0003-2202-3548; Li, Huige/0000-0003-3458-7391; Siuda, Daniel/0000-0001-5120-7931; Xia, Ning/0000-0002-5553-1752	Federal Ministry of Education and Research [BMBF 01EO1003]; Innovation Foundation of the State of Rhineland-Palatinate [961-386261/917K]; Deutsche Forschungsgemeinschaft [LI 1759/1-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Innovation Foundation of the State of Rhineland-Palatinate; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Federal Ministry of Education and Research Grant BMBF 01EO1003, Innovation Foundation of the State of Rhineland-Palatinate Grant 961-386261/917K, and Deutsche Forschungsgemeinschaft Grant LI 1759/1-1 (to H. K.).	Al-Aly Z, 2011, TRANSL RES, V157, P10, DOI 10.1016/j.trsl.2010.09.005; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Badimon L, 2010, CARDIOVASC THER, V28, P202, DOI 10.1111/j.1755-5922.2010.00189.x; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bobryshev YV, 2002, J VASC SURG, V35, P368, DOI 10.1067/mva.2002.121067; Bosello S, 2008, CLIN RHEUMATOL, V27, P833, DOI 10.1007/s10067-007-0803-y; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crook MF, 2002, J VASC RES, V39, P221, DOI 10.1159/000063687; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ghosh S, 2010, AM J PATHOL, V176, P1484, DOI 10.2353/ajpath.2010.090498; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; JAYAKODY L, 1988, BRIT J PHARMACOL, V94, P335, DOI 10.1111/j.1476-5381.1988.tb11535.x; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Kerekes G, 2008, J RHEUMATOL, V35, P398; Knorr M, 2011, ARTERIOSCL THROM VAS, V31, P2223, DOI 10.1161/ATVBAHA.111.232058; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lee HH, 2013, MOL CELLS, V36, P571, DOI 10.1007/s10059-013-0268-6; Li H, 2005, NITRIC OXIDE-BIOL CH, V12, P231, DOI 10.1016/j.niox.2005.04.001; Lim H, 2013, J BIOL CHEM, V288, P7572, DOI 10.1074/jbc.M112.414904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangan SH, 2007, CARDIOVASC RES, V76, P494, DOI 10.1016/j.cardiores.2007.07.017; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Moe KT, 2011, J CELL MOL MED, V15, P2601, DOI 10.1111/j.1582-4934.2011.01261.x; MORI L, 1992, J EXP MED, V176, P381, DOI 10.1084/jem.176.2.381; Munzel T, 2005, ARTERIOSCL THROM VAS, V25, P1551, DOI 10.1161/01.ATV.0000168896.64927.bb; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt N, 2012, J PHARMACOL EXP THER, V343, P106, DOI 10.1124/jpet.112.192047; Schmidt N, 2010, BIOCHEM PHARMACOL, V79, P722, DOI 10.1016/j.bcp.2009.10.012; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schuhmacher S, 2010, HYPERTENSION, V55, P897, DOI 10.1161/HYPERTENSIONAHA.109.149542; Siuda D, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0283-3; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Uddin MJ, 2013, FREE RADICAL BIO MED, V65, P1331, DOI 10.1016/j.freeradbiomed.2013.09.027; Yoshida LS, 2008, INT IMMUNOPHARMACOL, V8, P1377, DOI 10.1016/j.intimp.2008.05.004; Zhang HC, 2013, ARTERIOSCL THROM VAS, V33, P1212, DOI 10.1161/ATVBAHA.113.301496; Zhang JP, 2009, EXP CELL RES, V315, P304, DOI 10.1016/j.yexcr.2008.10.042	70	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15653	15665		10.1074/jbc.M114.566984	http://dx.doi.org/10.1074/jbc.M114.566984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727475	Green Published, hybrid			2022-12-28	WOS:000337465400047
J	Kinoshita, T; Nagamatsu, G; Saito, S; Takubo, K; Horimoto, K; Suda, T				Kinoshita, Taisuke; Nagamatsu, Go; Saito, Shigeru; Takubo, Keiyo; Horimoto, Katsuhisa; Suda, Toshio			Telomerase Reverse Transcriptase Has an Extratelomeric Function in Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Induced Pluripotent Stem (iPS) Cell; Microarray; Reprogramming; Telomeres	PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; TARGET GENE; MOUSE; PROMOTES; ESRRB; TERT; DIFFERENTIATION; PROLIFERATION	Reactivation of the endogenous telomerase reverse transcriptase (TERT) catalytic subunit and telomere elongation occur during the reprogramming of somatic cells to induced pluripotent stem (iPS) cells. However, the role of TERT in the reprogramming process is unclear. To clarify its function, the reprogramming process was examined in TERT-KO somatic cells. To exclude the effect of telomere elongation, tail-tip fibroblasts (TTFs) from first generation TERT-KO mice were used. Although iPS cells were successfully generated from TERT-KO TTFs, the efficiency of reprogramming these cells was markedly lower than that of WT TTFs. The gene expression profiles of iPS cells induced from TERT-KO TTFs were similar to those of WT iPS cells and ES cells, and TERT-KO iPS cells formed teratomas that differentiated into all three germ layers. These data indicate that TERT plays an extratelomeric role in the reprogramming process, but its function is dispensable. However, TERT-KO iPS cells showed transient defects in growth and teratoma formation during continuous growth. In addition, TERT-KO iPS cells developed chromosome fusions that accumulated with increasing passage numbers, consistent with the fact that TERT is essential for the maintenance of genome structure and stability in iPS cells. In a rescue experiment, an enzymatically inactive mutant of TERT (D702A) had a positive effect on somatic cell reprogramming of TERT-KO TTFs, which confirmed the extratelomeric role of TERT in this process.	[Kinoshita, Taisuke; Nagamatsu, Go; Takubo, Keiyo; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab, Tokyo 1608582, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Nagamatsu, Go] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka 8128582, Japan; [Saito, Shigeru] OPT Inc, Data Sci Lab, Tokyo 1020081, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST)	Nagamatsu, G (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	gonag@hgs.med.kyushu-u.ac.jp	Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592	PRESTO of the Japan Science and Technology Agency; funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research; Japan Society for the Promotion of Science [247121]; Project for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [12J07121] Funding Source: KAKEN	PRESTO of the Japan Science and Technology Agency; funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project for the Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO of the Japan Science and Technology Agency, funds for the Development of Human Resources in Science and Technology of the Program to Disseminate Tenure Tracking System for Tenure Track Program at the Sakaguchi Laboratory and Scientific Research (C), Grant-in-aid 247121 for JSPS Fellows from the Japan Society for the Promotion of Science, and in part by a grant from the Project for the Realization of Regenerative Medicine.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Kinoshita T, 2011, BIOCHEM BIOPH RES CO, V407, P321, DOI 10.1016/j.bbrc.2011.03.013; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagamatsu G, 2012, J BIOL CHEM, V287, P36273, DOI 10.1074/jbc.M112.380683; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	43	13	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15776	15787		10.1074/jbc.M113.536037	http://dx.doi.org/10.1074/jbc.M113.536037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733392	Green Published, hybrid			2022-12-28	WOS:000337465400057
J	He, HZ; Singh, I; Wek, SA; Dey, S; Baird, TD; Wek, RC; Georgiadis, MM				He, Hongzhen; Singh, Isha; Wek, Sheree A.; Dey, Souvik; Baird, Thomas D.; Wek, Ronald C.; Georgiadis, Millie M.			Crystal Structures of GCN2 Protein Kinase C-terminal Domains Suggest Regulatory Differences in Yeast and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSLATION INITIATION; TRANSFER-RNA; PHOSPHORYLATION; ACTIVATION; BINDING; MICE; DIMERIZATION; EXPRESSION; MECHANISM	In response to amino acid starvation, GCN2 phosphorylation of eIF2 leads to repression of general translation and initiation of gene reprogramming that facilitates adaptation to nutrient stress. GCN2 is a multidomain protein with key regulatory domains that directly monitor uncharged tRNAs which accumulate during nutrient limitation, leading to activation of this eIF2 kinase and translational control. A critical feature of regulation of this stress response kinase is its C-terminal domain (CTD). Here, we present high resolution crystal structures of murine and yeast CTDs, which guide a functional analysis of the mammalian GCN2. Despite low sequence identity, both yeast and mammalian CTDs share a core subunit structure and an unusual interdigitated dimeric form, albeit with significant differences. Disruption of the dimeric form of murine CTD led to loss of translational control by GCN2, suggesting that dimerization is critical for function as is true for yeast GCN2. However, although both CTDs bind single-and double-stranded RNA, murine GCN2 does not appear to stably associate with the ribosome, whereas yeast GCN2 does. This finding suggests that there are key regulatory differences between yeast and mammalian CTDs, which is consistent with structural differences.	[He, Hongzhen; Singh, Isha; Wek, Sheree A.; Dey, Souvik; Baird, Thomas D.; Wek, Ronald C.; Georgiadis, Millie M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Georgiadis, Millie M.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu; mgeorgia@iu.edu	Singh, Isha/GWV-6216-2022; Singh, Isha/AHA-8448-2022	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM049164]; Showalter Research Trust;  [T32DK064466]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research Trust; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049164 (to R. C. W. and M. M. G.) and Predoctoral Fellowship T32DK064466 (T. D. B.). This work was also supported by the Showalter Research Trust (R. C. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sood R, 2000, GENETICS, V154, P787; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15023	15034		10.1074/jbc.M114.560789	http://dx.doi.org/10.1074/jbc.M114.560789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719324	hybrid, Green Published			2022-12-28	WOS:000337248100054
J	Jiang, XL; Fischer, D; Chen, XY; McKenna, SD; Liu, HL; Sriraman, V; Yu, HN; Goutopoulos, A; Arkinstall, S; He, XL				Jiang, Xuliang; Fischer, David; Chen, Xiaoyan; McKenna, Sean D.; Liu, Heli; Sriraman, Venkataraman; Yu, Henry N.; Goutopoulos, Andreas; Arkinstall, Steve; He, Xiaolin			Evidence for Follicle- stimulating Hormone Receptor as a Functional Trimer*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Arrestin; G Protein-coupled Receptors (GPCR); Glycoprotein Hormones; Receptor Structure-function; Reproduction; Cysteine-knot Growth Factor; Cysteine-knot Growth Factor	PROTEIN-COUPLED RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; BETA-ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; TSH RECEPTOR; COMPLEX; ACTIVATION; AGONIST; BINDING; RHODOPSIN	Background: A carbohydrate of follicle-stimulating hormone (FSH) has been proposed to sterically block other FSH molecules from binding to the putative receptor (FSHR) trimer. Results: FSH increases its receptor binding by 3-fold when the steric hindrance is removed. Conclusion: FSHR forms a functional trimer. Significance: This knowledge may improve designs of therapeutic drugs targeting FSHR. Follicle-stimulating hormone receptor (FSHR), a G-protein coupled receptor, is an important drug target in the development of novel therapeutics for reproductive indications. The FSHR extracellular domains were observed in the crystal structure as a trimer, which enabled us to propose a novel model for the receptor activation mechanism. The model predicts that FSHR binds Asn(52)-deglycosylated FSH at a 3-fold higher capacity than fully glycosylated FSH. It also predicts that, upon dissociation of the FSHR trimer into monomers, the binding of glycosylated FSH, but not deglycosylated FSH, would increase 3-fold, and that the dissociated monomers would in turn enhance FSHR binding and signaling activities by 3-fold. This study presents evidence confirming these predictions and provides crystallographic and mutagenesis data supporting the proposed model. The model also provides a mechanistic explanation to the agonist and antagonist activities of thyroid-stimulating hormone receptor autoantibodies. We conclude that FSHR exists as a functional trimer.	[Jiang, Xuliang; Fischer, David; McKenna, Sean D.; Sriraman, Venkataraman; Yu, Henry N.; Goutopoulos, Andreas; Arkinstall, Steve] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA; [Chen, Xiaoyan; Liu, Heli; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jiang, XL (corresponding author), 45A Middlesex Turnpike, Billerica, MA 01821 USA.	xuliang.jiang@emdserono.com			NCI NIH HHS [P30 CA060553] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson RJ, 2005, PROTEINS, V60, P679, DOI 10.1002/prot.20530; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Blanc E., 2011, BUSTER VERSION 2 11; Bousfield GR, 2014, MOL CELL ENDOCRINOL, V382, P989, DOI 10.1016/j.mce.2013.11.008; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; DATTATREYAMURTY B, 1992, J MOL ENDOCRINOL, V9, P115, DOI 10.1677/jme.0.0090115; Dias JA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.109397; Dias JA, 2011, MOL CELL ENDOCRINOL, V333, P143, DOI 10.1016/j.mce.2010.12.023; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Harvey R. A., 2012, LIPPINCOTTS ILLUSTRA; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Janovick JA, 2009, MOL CELL ENDOCRINOL, V298, P84, DOI 10.1016/j.mce.2008.09.015; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Landomiel F, 2014, MOL CELL ENDOCRINOL, V382, P452, DOI 10.1016/j.mce.2013.09.035; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Nickolls SA, 2011, J BIOMOL SCREEN, V16, P706, DOI 10.1177/1087057111406548; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Tegoni M, 1999, J MOL BIOL, V289, P1375, DOI 10.1006/jmbi.1999.2845; Thomas RM, 2007, ENDOCRINOLOGY, V148, P1987, DOI 10.1210/en.2006-1672; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; van Koppen CJ, 2013, BIOCHEM PHARMACOL, V85, P1162, DOI 10.1016/j.bcp.2013.02.001; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yanofsky SD, 2006, J BIOL CHEM, V281, P13226, DOI 10.1074/jbc.M600601200; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	49	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14273	14282		10.1074/jbc.M114.549592	http://dx.doi.org/10.1074/jbc.M114.549592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692546	hybrid, Green Published			2022-12-28	WOS:000335984600052
J	Delgoshaie, N; Tang, XJ; Kanshin, ED; Williams, EC; Rudner, AD; Thibault, P; Tyers, M; Verreault, A				Delgoshaie, Neda; Tang, Xiaojing; Kanshin, Evgeny D.; Williams, Elizabeth C.; Rudner, Adam D.; Thibault, Pierre; Tyers, Mike; Verreault, Alain			Regulation of the Histone Deacetylase Hst3 by Cyclindependent Kinases and the Ubiquitin Ligase SCFCdc4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Chromatin Histone Modification; E3 Ubiquitin Ligase; Histone Deacetylase; Histones; Ubiquitination	SISTER-CHROMATID COHESION; H3 LYSINE-56 ACETYLATION; DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; MULTISITE PHOSPHORYLATION; GENOME INTEGRITY; YEAST; REPLICATION	Background: A genome-wide wave of histone H3 acetylation and deacetylation occurs during the fungal cell cycle. Results: Cyclin-dependent kinases and the ubiquitin ligase SCFCdc4 promote timely degradation of Hst3, a sirtuin involved in genome-wide histone H3 deacetylation. Conclusion: Mutations that interfere with cell cycle-regulated degradation of the Hst3 histone deacetylase reduce cell fitness. Significance: Similar regulatory mechanisms may exist in pathogenic fungi. In Saccharomyces cerevisiae, histone H3 lysine 56 acetylation (H3K56ac) is a modification of new H3 molecules deposited throughout the genome during S-phase. H3K56ac is removed by the sirtuins Hst3 and Hst4 at later stages of the cell cycle. Previous studies indicated that regulated degradation of Hst3 plays an important role in the genome-wide waves of H3K56 acetylation and deacetylation that occur during each cell cycle. However, little is known regarding the mechanism of cell cycle-regulated Hst3 degradation. Here, we demonstrate that Hst3 instability in vivo is dependent upon the ubiquitin ligase SCFCdc4 and that Hst3 is phosphorylated at two Cdk1 sites, threonine 380 and threonine 384. This creates a diphosphorylated degron that is necessary for Hst3 polyubiquitylation by SCFCdc4. Mutation of the Hst3 diphospho-degron does not completely stabilize Hst3 in vivo, but it nonetheless results in a significant fitness defect that is particularly severe in mutant cells treated with the alkylating agent methyl methanesulfonate. Unexpectedly, we show that Hst3 can be degraded between G(2) and anaphase, a window of the cell cycle where Hst3 normally mediates genome-wide deacetylation of H3K56. Our results suggest an intricate coordination between Hst3 synthesis, genome-wide H3K56 deacetylation by Hst3, and cell cycle-regulated degradation of Hst3 by cyclin-dependent kinases and SCFCdc4.	[Delgoshaie, Neda; Kanshin, Evgeny D.; Thibault, Pierre; Tyers, Mike; Verreault, Alain] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Tang, Xiaojing] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Williams, Elizabeth C.; Rudner, Adam D.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Williams, Elizabeth C.; Rudner, Adam D.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Tyers, Mike] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; University of Ottawa; Universite de Montreal; Universite de Montreal; Universite de Montreal	Verreault, A (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	alain.verreault@umontreal.ca	Kanshin, Evgeny/GXM-7047-2022; Tyers, Michael/ABE-3194-2021	Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes for Health Research [MOP 89928, 123780]; Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research [MOP CPG104289, MOP 177774, MOP 126129]; Cole Foundation; Canadian Institutes for Health Research; "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec; Canada Research Chair in Systems and Synthetic Biology	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cole Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec; Canada Research Chair in Systems and Synthetic Biology	This work was supported in part by Canadian Institutes for Health Research Grants MOP 89928 and 123780 (to A. V.), Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research Grants MOP CPG104289 (to A. V. and P. T.), MOP 177774 (to A. D. R.), and MOP 126129 (M. T.). The Institute for Research in Immunology and Cancer receives infrastructure support from the Centre of Excellence for Commercialization and Research, the Canadian Foundation for Innovation, and the Fonds de Recherche Quebecois en Sante.; Recipient of a Ph.D. award from the Cole Foundation.; Supported by a graduate fellowship from the Canadian Institutes for Health Research.; Supported by the "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec, and a Canada Research Chair in Systems and Synthetic Biology.	Bao MZ, 2010, EUKARYOT CELL, V9, P31, DOI 10.1128/EC.00250-09; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ge ZQ, 2013, MOL CELL BIOL, V33, P3286, DOI 10.1128/MCB.00460-13; Gharib M, 2009, MOL CELL PROTEOMICS, V8, P506, DOI 10.1074/mcp.M800327-MCP200; Goh PY, 1999, MOL CELL BIOL, V19, P5512; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hachinohe M, 2011, GENES CELLS, V16, P467, DOI 10.1111/j.1365-2443.2011.01493.x; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Ikui AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003099; Kanshin E, 2013, J PROTEOME RES, V12, P2905, DOI 10.1021/pr400198e; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	52	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13186	13196		10.1074/jbc.M113.523530	http://dx.doi.org/10.1074/jbc.M113.523530			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648511	Green Published, hybrid			2022-12-28	WOS:000335522800020
J	Shah, S; King, EM; Chandrasekhar, A; Newton, R				Shah, Suharsh; King, Elizabeth M.; Chandrasekhar, Ambika; Newton, Robert			Roles for the Mitogen-activated Protein Kinase ( MAPK) Phosphatase, DUSP1, in Feedback Control of Inflammatory Gene Expression and Repression by Dexamethasone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial Cell; Gene Regulation; Glucocorticoid Receptor; Glucocorticoids; Inflammation; MAP Kinases (MAPKs); MAPK Phosphatase 1 (MKP-1); NR3C1; Anti-inflammatory; Corticosteroid	DUAL-SPECIFICITY PHOSPHATASE-1; INNATE IMMUNE-RESPONSES; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; GLUCOCORTICOID-RECEPTOR; TRISTETRAPROLIN EXPRESSION; MOLECULAR-MECHANISMS; DOWN-REGULATION; MESSENGER-RNA; MKP-1	Background: Inflammatory gene expression is reduced by anti-inflammatory glucocorticoids. Results: With an inflammatory stimulus, glucocorticoids enhance expression of the phosphatase, DUSP1. This plays a transient role in the repression of some inflammatory genes. Conclusion: Glucocorticoids repress inflammatory gene expression via DUSP1-dependent and -independent mechanisms. Significance: Consideration of both DUSP1 and DUSP1-independent effectors is necessary to improve anti-inflammatory glucocorticoid action. Glucocorticoids act on the glucocorticoid receptor (NR3C1) to repress inflammatory gene expression. This is central to their anti-inflammatory effectiveness and rational improvements in therapeutic index depend on understanding the mechanism. Human pulmonary epithelial A549 cells were used to study the role of the mitogen-activated protein kinase (MAPK) phosphatase, dual-specificity phosphatase 1 (DUSP1), in the dexamethasone repression of 11 inflammatory genes induced, in a MAPK-dependent manner, by interleukin-1 (IL1B). Adenoviral over-expression of DUSP1 inactivated MAPK pathways and reduced expression of all 11 inflammatory genes. IL1B rapidly induced DUSP1 expression and RNA silencing revealed a transient role in feedback inhibition of MAPKs and inflammatory gene expression. With dexamethasone, which induced DUSP1 expression, plus IL1B (co-treatment), DUSP1 expression was further enhanced. At 1 h, this was responsible for the dexamethasone inhibition of IL1B-induced MAPK activation and CXCL1 and CXCL2 mRNA expression, with a similar trend for CSF2. Whereas, CCL20 mRNA was not repressed by dexamethasone at 1 h, repression of CCL2, CXCL3, IL6, and IL8 was unaffected, and PTGS2 repression was partially affected by DUSP1 knockdown. At later times, dexamethasone repression of MAPKs was unaffected by DUSP1 silencing. Likewise, 6 h post-IL1B, dexamethasone repression of all 11 mRNAs was essentially unaffected by DUSP1 knockdown. Qualitatively similar data were obtained for CSF2, CXCL1, IL6, and IL8 release. Thus, despite general roles in feedback inhibition, DUSP1 plays a transient, often partial, role in the dexamethasone-dependent repression of certain inflammatory genes. Therefore this also illustrates key roles for DUSP1-independent effectors in mediating glucocorticoid-dependent repression.	[Shah, Suharsh; King, Elizabeth M.; Chandrasekhar, Ambika; Newton, Robert] Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Calgary, AB T2N 4Z6, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Shah, Suharsh/N-1514-2015; Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation (CFI) and the Alberta Science and Research Authority.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Byon JCH, 2001, MOL CELL BIOCHEM, V218, P131, DOI 10.1023/A:1007204508882; Chang TS, 2003, J BIOL CHEM, V278, P48092, DOI 10.1074/jbc.M309421200; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huotari N, 2012, APMIS, V120, P988, DOI 10.1111/j.1600-0463.2012.02927.x; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Stechschulte LA, 2011, CURR OPIN PHARMACOL, V11, P332, DOI 10.1016/j.coph.2011.04.012; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Vollmer TR, 2012, J BIOL CHEM, V287, P35212, DOI 10.1074/jbc.M112.400671; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	50	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13667	13679		10.1074/jbc.M113.540799	http://dx.doi.org/10.1074/jbc.M113.540799			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692548	Green Published, hybrid			2022-12-28	WOS:000335522800060
J	Martinez, A; Peluffo, G; Petruk, AA; Hugo, M; Pineyro, D; Demicheli, V; Moreno, DM; Lima, A; Batthyany, C; Duran, R; Robello, C; Marti, MA; Larrieux, N; Buschiazzo, A; Trujillo, M; Radi, R; Piacenza, L				Martinez, Alejandra; Peluffo, Gonzalo; Petruk, Ariel A.; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Moreno, Diego M.; Lima, Analia; Batthyany, Carlos; Duran, Rosario; Robello, Carlos; Marti, Marcelo A.; Larrieux, Nicole; Buschiazzo, Alejandro; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia			Structural and Molecular Basis of the Peroxynitrite-mediated Nitration and Inactivation of Trypanosoma cruzi Iron-Superoxide Dismutases ( Fe-SODs) A and B DISPARATE SUSCEPTIBILITIES DUE TO THE REPAIR OF TYR35 RADICAL BY CYS83 IN Fe-SODB THROUGH INTRAMOLECULAR ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Free Radicals; Nitric Oxide; Oxidation-Reduction; Superoxide Dismutase (SOD); Trypanosome; Trypanosoma cruzi; Nitration; Peroxynitrite; Superoxide	NITRIC-OXIDE; TYROSINE NITRATION; CYTOCHROME-C; CRYSTAL-STRUCTURE; CARBON-DIOXIDE; TRYPAREDOXIN PEROXIDASES; TRANSFER RATES; PROTEIN; MANGANESE; KINETICS	Background: Superoxide dismutases are inactivated by peroxynitrite. Results:T. cruzi cytosolic Fe-SODB is highly resistant toward peroxynitrite-mediated tyrosine nitration and inactivation as compared with mitochondrial Fe-SODA. Conclusion: Intramolecular electron transfer in Fe-SODB from Cys(83) to critical Tyr(35) prevents enzyme nitration and inactivation. Significance: Disparate susceptibilities of Fe-SODs to peroxynitrite can influence parasite virulence during T. cruzi infection of mammalian cells. Trypanosoma cruzi, the causative agent of Chagas disease, contains exclusively iron-dependent superoxide dismutases (Fe-SODs) located in different subcellular compartments. Peroxynitrite, a key cytotoxic and oxidizing effector biomolecule, reacted with T. cruzi mitochondrial (Fe-SODA) and cytosolic (Fe-SODB) SODs with second order rate constants of 4.6 +/- 0.2 x 10(4) m(-1) s(-1) and 4.3 +/- 0.4 x 10(4) m(-1) s(-1) at pH 7.4 and 37 degrees C, respectively. Both isoforms are dose-dependently nitrated and inactivated by peroxynitrite. Susceptibility of T. cruzi Fe-SODA toward peroxynitrite was similar to that reported previously for Escherichia coli Mn- and Fe-SODs and mammalian Mn-SOD, whereas Fe-SODB was exceptionally resistant to oxidant-mediated inactivation. We report mass spectrometry analysis indicating that peroxynitrite-mediated inactivation of T. cruzi Fe-SODs is due to the site-specific nitration of the critical and universally conserved Tyr(35). Searching for structural differences, the crystal structure of Fe-SODA was solved at 2.2 resolution. Structural analysis comparing both Fe-SOD isoforms reveals differences in key cysteines and tryptophan residues. Thiol alkylation of Fe-SODB cysteines made the enzyme more susceptible to peroxynitrite. In particular, Cys(83) mutation (C83S, absent in Fe-SODA) increased the Fe-SODB sensitivity toward peroxynitrite. Molecular dynamics, electron paramagnetic resonance, and immunospin trapping analysis revealed that Cys(83) present in Fe-SODB acts as an electron donor that repairs Tyr(35) radical via intramolecular electron transfer, preventing peroxynitrite-dependent nitration and consequent inactivation of Fe-SODB. Parasites exposed to exogenous or endogenous sources of peroxynitrite resulted in nitration and inactivation of Fe-SODA but not Fe-SODB, suggesting that these enzymes play distinctive biological roles during parasite infection of mammalian cells.	[Martinez, Alejandra; Peluffo, Gonzalo; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Batthyany, Carlos; Robello, Carlos; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Martinez, Alejandra; Peluffo, Gonzalo; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Batthyany, Carlos; Robello, Carlos; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia] Univ Republica, Fac Med, Ctr Free Radical & Biomed Res, Montevideo 11800, Uruguay; [Pineyro, Dolores; Robello, Carlos] Inst Pasteur Montevideo IIBCE, Mol Biol Unit, Montevideo 11400, Uruguay; [Larrieux, Nicole; Buschiazzo, Alejandro] Inst Pasteur Montevideo IIBCE, Unit Prot Crystallog, Montevideo 11400, Uruguay; [Lima, Analia; Batthyany, Carlos; Duran, Rosario] Inst Pasteur Montevideo IIBCE, Unit Analyt Biochem & Prote, Montevideo 11400, Uruguay; [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France; [Petruk, Ariel A.; Marti, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Petruk, Ariel A.; Marti, Marcelo A.] Univ Buenos Aires, Dept Quim Biol, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Petruk, Ariel A.] CONICET UNT, Inst Quim Noroeste Argentino, San Miguel De Tucuman, Argentina; [Moreno, Diego M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Quim Rosario IQUIR CONICET, RA-2000 Rosario, Santa Fe, Argentina	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy; lpiacenza@fmed.edu.uy	Hugo, Martín/AAW-8351-2020; Lima, Analía/ABD-7806-2022; ROBELLO, CARLOS/M-5609-2019; Durán, Rosario/GQH-8502-2022; Buschiazzo, Alejandro/W-1095-2018	Hugo, Martín/0000-0003-3430-6457; ROBELLO, CARLOS/0000-0001-6985-6171; Buschiazzo, Alejandro/0000-0002-2509-6526; Moreno, Diego/0000-0001-5493-8537; Lima, Analia/0000-0002-1855-2327; Marti, Marcelo/0000-0002-7911-9340; Martinez D'Alto, Alejandra/0000-0002-1850-7446; Duran, Rosario/0000-0002-8575-9651; Batthyany, Carlos/0000-0002-0627-1982; Trujillo, Madia/0000-0003-2087-017X	National Institutes of Health [1R01AI095173]; Universidad de la Republica (CSIC, Uruguay); PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay); CeBEM (Centro de Biolog a Estructural del Mercosur); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); Biriden; ASM; Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de la Republica (CSIC, Uruguay); PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay); CeBEM (Centro de Biolog a Estructural del Mercosur); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); Biriden; ASM; Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI095173. This work was also supported by a grant from the Universidad de la Republica (CSIC, Uruguay) (to R. R.) and by PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay) and CeBEM (Centro de Biolog a Estructural del Mercosur).; Supported by a fellowship from the Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay).; Supported by Biriden, ASM, and Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica.	Abriata LA, 2009, J BIOL CHEM, V284, P17, DOI 10.1074/jbc.M807203200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez-Paggi D, 2010, J AM CHEM SOC, V132, P5769, DOI 10.1021/ja910707r; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Bhattacharjee S, 2007, J AM CHEM SOC, V129, P13493, DOI 10.1021/ja073349w; Boucher IW, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-20; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito C, 1999, J IMMUNOL, V162, P3356; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordes M, 2008, ANGEW CHEM INT EDIT, V47, P3461, DOI 10.1002/anie.200705588; Crow JP, 1997, J NEUROCHEM, V69, P1936; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FASMAN GD, 1976, HDB BIOCH MOL BIOL, V1, P305; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Giese B, 2008, CURR OPIN CHEM BIOL, V12, P755, DOI 10.1016/j.cbpa.2008.08.026; GRACEFFA P, 1983, ARCH BIOCHEM BIOPHYS, V225, P802, DOI 10.1016/0003-9861(83)90092-9; Guan Y, 1998, BIOCHEMISTRY-US, V37, P4722, DOI 10.1021/bi972394l; Hellman U, 2000, EXS, V88, P43; HUGHES MN, 1970, BIOCHIM BIOPHYS ACTA, V222, P660, DOI 10.1016/0304-4165(70)90192-3; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Ismail SO, 1997, MOL BIOCHEM PARASIT, V86, P187, DOI 10.1016/S0166-6851(97)00032-7; KIERSZENBAUM F, 1974, J IMMUNOL, V112, P1839; Koppenol WH, 1998, CHEM RES TOXICOL, V11, P87, DOI 10.1021/tx970200x; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Leach A. R., 2001, MOL MODELLING PRINCI; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ly HK, 2010, CHEMPHYSCHEM, V11, P1225, DOI 10.1002/cphc.200900966; Lymar SV, 1996, CHEM RES TOXICOL, V9, P845, DOI 10.1021/tx960046z; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; MAPLES KR, 1988, DRUG METAB DISPOS, V16, P799; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Moreno DM, 2011, ARCH BIOCHEM BIOPHYS, V507, P304, DOI 10.1016/j.abb.2010.12.011; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Nicholls SJ, 2005, METHOD ENZYMOL, V396, P245, DOI 10.1016/S0076-6879(05)96022-9; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peloso EF, 2012, ARCH BIOCHEM BIOPHYS, V520, P117, DOI 10.1016/j.abb.2012.02.020; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Petruk AA, 2012, ARCH BIOCHEM BIOPHYS, V525, P82, DOI 10.1016/j.abb.2012.05.012; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2008, BIOCHEM J, V410, P359, DOI 10.1042/BJ20071138; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Pryor WA, 1997, FREE RADICAL BIO MED, V23, P331, DOI 10.1016/S0891-5849(97)00121-4; Quijano C, 2001, J BIOL CHEM, V276, P11631, DOI 10.1074/jbc.M009429200; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; STALLINGS WC, 1984, J BIOL CHEM, V259, P695; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Surmeli NB, 2010, J AM CHEM SOC, V132, P17174, DOI 10.1021/ja105684w; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Temperton NJ, 1996, MOL BIOCHEM PARASIT, V76, P339, DOI 10.1016/0166-6851(95)02553-7; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Turko IV, 2005, METHOD ENZYMOL, V396, P266, DOI 10.1016/S0076-6879(05)96023-0; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Valez V, 2013, ARCH BIOCHEM BIOPHYS, V529, P45, DOI 10.1016/j.abb.2012.10.012; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wilkinson SR, 2006, FREE RADICAL BIO MED, V40, P198, DOI 10.1016/j.freeradbiomed.2005.06.022; Witting PK, 2001, J BIOL CHEM, V276, P16540, DOI 10.1074/jbc.M011707200; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699	92	43	44	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12760	12778		10.1074/jbc.M113.545590	http://dx.doi.org/10.1074/jbc.M113.545590			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24616096	Green Published, hybrid			2022-12-28	WOS:000335581400046
J	Luttermann, C; Meyers, G				Luttermann, Christine; Meyers, Gregor			Two Alternative Ways of Start Site Selection in Human Norovirus Reinitiation of Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Protein Expression; RNA Structure; RNA Viruses; Translation; Viral Protein; TURBS; Calicivirus; Norovirus; Reinitiation of Translation	TERMINATION-REINITIATION; COUPLED TRANSLATION; MESSENGER-RNA; CAPSID PROTEIN; INITIATION; VIRUS; CALICIVIRUS; EXPRESSION; CODON; IDENTIFICATION	Background: Reinitiation of translation is rare in eukaryotes and depends on specialized cis-acting RNA sequences tethering ribosomes to the reinitiation site. Results: Ribosomes can reinitiate on calicivirus RNA at different sites. Conclusion: Sites for translation reinitiation are selected either by ribosome positioning or a scanning-like process. Significance: Start site selection in prokaryotic-like translation reinitiation in eukaryotes occurs in different modes. The calicivirus minor capsid protein VP2 is expressed via termination/reinitiation. This process depends on an upstream sequence element denoted termination upstream ribosomal binding site (TURBS). We have shown for feline calicivirus and rabbit hemorrhagic disease virus that the TURBS contains three sequence motifs essential for reinitiation. Motif 1 is conserved among caliciviruses and is complementary to a sequence in the 18 S rRNA leading to the model that hybridization between motif 1 and 18 S rRNA tethers the post-termination ribosome to the mRNA. Motif 2 and motif 2* are proposed to establish a secondary structure positioning the ribosome relative to the start site of the terminal ORF. Here, we analyzed human norovirus (huNV) sequences for the presence and importance of these motifs. The three motifs were identified by sequence analyses in the region upstream of the VP2 start site, and we showed that these motifs are essential for reinitiation of huNV VP2 translation. More detailed analyses revealed that the site of reinitiation is not fixed to a single codon and does not need to be an AUG, even though this codon is clearly preferred. Interestingly, we were able to show that reinitiation can occur at AUG codons downstream of the canonical start/stop site in huNV and feline calicivirus but not in rabbit hemorrhagic disease virus. Although reinitiation at the original start site is independent of the Kozak context, downstream initiation exhibits requirements for start site sequence context known for linear scanning. These analyses on start codon recognition give a more detailed insight into this fascinating mechanism of gene expression.	[Luttermann, Christine; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, D-17493 Greifswald, Insel Riems, Germany	Friedrich Loeffler Institute	Luttermann, C (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Sudufer 10, D-17493 Greifswald, Insel Riems, Germany.	christine.luttermann@fli.bund.de; gregor.meyers@fli.bund.de	Luttermann, Christine/L-5440-2019	Luttermann, Christine/0000-0002-6977-9900	Deutsche Forschungsgemeinschaft [Me 1367/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant Me 1367/3 from the Deutsche Forschungsgemeinschaft.	Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Cuesta R, 2001, COLD SPRING HARB SYM, V66, P259, DOI 10.1101/sqb.2001.66.259; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fricke J, 2004, J VIROL, V78, P5900, DOI 10.1128/JVI.78.11.5900-5912.2004; FUTTERER J, 1993, CELL, V73, P789, DOI 10.1016/0092-8674(93)90257-Q; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; GREEN KY, 2000, VIRUS TAXONOMY, P725; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016822; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Sambrook J., 2001, MOL CLONING LAB MANU; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Smith E, 2005, NUCLEIC ACIDS RES, V33, P1298, DOI 10.1093/nar/gki248; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xi QR, 2005, J VIROL, V79, P5676, DOI 10.1128/JVI.79.9.5676-5683.2005	55	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11739	11754		10.1074/jbc.M114.554030	http://dx.doi.org/10.1074/jbc.M114.554030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599949	Green Published, hybrid			2022-12-28	WOS:000335010600016
J	Wu, J; Bowe, DB; Sadlonova, A; Whisenhunt, TR; Hu, Y; Rustgi, AK; Nie, YZ; Paterson, AJ; Yang, XY				Wu, Jing; Bowe, Damon B.; Sadlonova, Andrea; Whisenhunt, Thomas R.; Hu, Yong; Rustgi, Anil K.; Nie, Yongzhan; Paterson, Andrew J.; Yang, Xiaoyong			O-GlcNAc Transferase Is Critical for Transducin-like Enhancer of Split ( TLE)-mediated Repression of CanonicalWntSignaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Silencing; O-GlcNAc; Signal Transduction; Transcription Repressor; Wnt Pathway; Groucho; TLE; OGT	CARBOXYL-TERMINAL DOMAIN; RNA-POLYMERASE-II; TRANSCRIPTIONAL REPRESSION; SUBSTRATE-SPECIFICITY; MEDIATED REPRESSION; ACTIVATION DOMAIN; WRPW MOTIF; IN-VIVO; GROUCHO; PROTEIN	Background: The molecular mechanisms by which Groucho/TLEs repress canonical Wnt signaling are incompletely understood. Results: OGT interacts with TLEs and facilitates TLE-mediated transcriptional repression. Removal of O-GlcNAc is essential for gene activation from Wnt-responsive promoters. Conclusion: OGT plays a vital role in TLE-mediated repression of Wnt signaling. Significance:O-GlcNAc modification has a profound influence on diverse signaling pathways. The Drosophila Groucho protein and its mammalian orthologues the transducin-like enhancers of split (TLEs) are critical transcriptional corepressors that repress Wnt and other signaling pathways. Although it is known that Groucho/TLEs are recruited to target genes by pathway-specific transcription factors, molecular events after the corepressor recruitment are largely unclear. We report that association of TLEs with O-GlcNAc transferase, an enzyme that catalyzes posttranslational modification of proteins by O-linked N-acetylglucosamine, is essential for TLE-mediated transcriptional repression. Removal of O-GlcNAc from Wnt-responsive gene promoters is critical for gene activation from Wnt-responsive promoters. Thus, these studies identify a molecular mechanism by which Groucho/TLEs repress gene transcription and provide a model whereby O-GlcNAc may control distinct intracellular signaling pathways.	[Wu, Jing] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Wu, Jing] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06519 USA; [Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06519 USA; [Bowe, Damon B.; Whisenhunt, Thomas R.; Hu, Yong; Paterson, Andrew J.] Univ Alabama Birmingham, Div Endocrinol & Metab, Birmingham, AL 35294 USA; [Sadlonova, Andrea] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nie, Yongzhan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Rustgi, Anil K.] Univ Penn, Dept Med GI & Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Yale University; Yale University; University of Alabama System; University of Alabama Birmingham; Emory University; Air Force Military Medical University; Air Force Military Medical University; University of Pennsylvania; Pennsylvania Medicine	Yang, XY (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 333 Cedar St, New Haven, CT 06519 USA.	xiaoyong.yang@yale.edu			National Institutes of Health Grants [R01 DK089098, P01 DK057751, DK043652]; Ellison Medical Foundation; National Natural Science Foundation of China Grant [81120108005/81225003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043652, R01DK089098, P01DK057751, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK089098 and P01 DK057751 (to X. Y.) and DK043652 (to A. J. P.). This work was also supported by a grant from the Ellison Medical Foundation (to X. Y.) and National Natural Science Foundation of China Grant 81120108005/81225003 (to Y. N.).	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Bowe DB, 2006, MOL CELL BIOL, V26, P8539, DOI 10.1128/MCB.01053-06; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Li MD, 2012, J BIOL CHEM, V287, P12904, DOI 10.1074/jbc.M111.303792; Li Steven Shoei-Lung, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P47; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sasaki T, 2003, CANCER RES, V63, P801; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001	44	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12168	12176		10.1074/jbc.M114.553859	http://dx.doi.org/10.1074/jbc.M114.553859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616106	hybrid, Green Published			2022-12-28	WOS:000335010600052
J	Acevedo, KM; Opazo, CM; Norrish, D; Challis, LM; Li, QX; White, AR; Bush, AI; Camakaris, J				Acevedo, Karla M.; Opazo, Carlos M.; Norrish, David; Challis, Leesa M.; Li, Qiao-Xin; White, Anthony R.; Bush, Ashley I.; Camakaris, James			Phosphorylation of Amyloid Precursor Protein at Threonine 668 Is Essential for Its Copper-responsive Trafficking in SH-SY5Y Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein; Confocal Microscopy; Copper; Glycogen Synthase Kinase 3; Phosphorylation; Trafficking	GLYCOGEN-SYNTHASE KINASE-3; CYCLIN-DEPENDENT KINASE-5; SMALL-MOLECULE INHIBITORS; P-TYPE ATPASE; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; BETA-PROTEIN; IN-VITRO; A-BETA	Background: The function, localization, and processing of the amyloid precursor protein (APP) is regulated by phosphorylation. Results: Copper promotes APP trafficking by phosphorylation at threonine 668 in SH-SY5Y cells. Conclusion: By promoting APP phosphorylation, copper regulates its intracellular localization. Significance: Understanding the role copper plays in regulating APP function in normal neuronal cells will provide insight into the interplay between copper and APP in normal and pathological conditions. Amyloid precursor protein (APP) undergoes post-translational modification, including O- and N-glycosylation, ubiquitination, and phosphorylation as it traffics through the secretory pathway. We have previously reported that copper promotes a change in the cellular localization of APP. We now report that copper increases the phosphorylation of endogenous APP at threonine 668 (Thr-668) in SH-SY5Y neuronal cells. The level of APPT668-p (detected using a phospho-site-specific antibody) exhibited a copper-dependent increase. Using confocal microscopy imaging we demonstrate that the phospho-deficient mutant, Thr-668 to alanine (T668A), does not exhibit detectable copper-responsive APP trafficking. In contrast, mutating a serine to an alanine at residue 655 does not affect copper-responsive trafficking. We further investigated the importance of the Thr-668 residue in copper-responsive trafficking by treating SH-SY5Y cells with inhibitors for glycogen synthase kinase 3- (GSK3) and cyclin-dependent kinases (Cdk), the main kinases that phosphorylate APP at Thr-668 in neurons. Our results show that the GSK3 kinase inhibitors LiCl, SB 216763, and SB 415286 prevent copper-responsive APP trafficking. In contrast, the Cdk inhibitors Purvalanol A and B had no significant effect on copper-responsive trafficking in SH-SY5Y cells. In cultured primary hippocampal neurons, copper promoted APP re-localization to the axon, and this effect was inhibited by the addition of LiCl, indicating that a lithium-sensitive kinase(s) is involved in copper-responsive trafficking in hippocampal neurons. This is consistent with APP axonal transport to the synapse, where APP is involved in a number of functions. We conclude that copper promotes APP trafficking by promoting a GSK3-dependent phosphorylation in SH-SY5Y cells.	[Acevedo, Karla M.; Norrish, David; Challis, Leesa M.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Opazo, Carlos M.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Li, Qiao-Xin; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; White, Anthony/P-5596-2016	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Challis, Leesa/0000-0003-2113-0667; Acevedo, Karla/0000-0002-7996-3445; White, Anthony/0000-0003-1802-9891; Opazo, Carlos/0000-0003-3473-7548	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council (to J. C.).	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Ando K, 1999, J NEUROSCI, V19, P4421; Aplin AE, 1996, J NEUROCHEM, V67, P699; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Crespo-Biel N, 2009, NEUROPHARMACOLOGY, V56, P422, DOI 10.1016/j.neuropharm.2008.09.012; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Feyt C, 2007, BIOCHEM BIOPH RES CO, V357, P1004, DOI 10.1016/j.bbrc.2007.04.036; Gray N, 1999, CURR MED CHEM, V6, P859; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Jorda EG, 2005, NEUROSCIENCE, V134, P1001, DOI 10.1016/j.neuroscience.2005.04.061; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; KNOPS J, 1993, BIOCHEM BIOPH RES CO, V197, P380, DOI 10.1006/bbrc.1993.2490; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liu F, 2003, FEBS LETT, V547, P193, DOI 10.1016/S0014-5793(03)00714-2; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; Musardo S, 2013, EUR J PHARMACOL, V719, P84, DOI 10.1016/j.ejphar.2013.07.019; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Naumann N, 2010, HIPPOCAMPUS, V20, P971, DOI 10.1002/hipo.20693; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; SIMONS M, 1995, J NEUROSCI RES, V41, P121, DOI 10.1002/jnr.490410114; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Vagnoni A, 2013, HUM MOL GENET, V22, P4646, DOI 10.1093/hmg/ddt313; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	85	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11007	11019		10.1074/jbc.M113.538710	http://dx.doi.org/10.1074/jbc.M113.538710			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610780	Green Published, hybrid			2022-12-28	WOS:000334638500007
J	Mithu, VS; Sarkar, B; Bhowmik, D; Das, AK; Chandrakesan, M; Maiti, S; Madhu, PK				Mithu, Venus Singh; Sarkar, Bidyut; Bhowmik, Debanjan; Das, Anand Kant; Chandrakesan, Muralidharan; Maiti, Sudipta; Madhu, Perunthiruthy K.			Curcumin Alters the Salt Bridge-containing Turn Region in Amyloid beta (1-42) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Drug Action; NMR; Protein Aggregation; Solid State NMR; Magic-angle Spinning; Salt Bridge	SOLID-STATE NMR; ZINC-BINDING SITE; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; CROSS-POLARIZATION; STRUCTURAL MODEL; PEPTIDES; OLIGOMERS; RAT	Background: Curcumin reduces the risk of Alzheimer disease via an unknown mechanism. Results: Curcumin-incubated A(42) aggregates retain the hairpin architecture but have disruptions in the turn region (surprising similarity with Zn2+ incubation). Conclusion: Salt bridge-containing turn region is a major determinant of morphology and toxicity. Significance: Identification of crucial structural changes provides a checkpoint for developing effective AD therapeutics. Amyloid (A) fibrillar deposits in the brain are a hallmark of Alzheimer disease (AD). Curcumin, a common ingredient of Asian spices, is known to disrupt A fibril formation and to reduce AD pathology in mouse models. Understanding the structural changes induced by curcumin can potentially lead to AD pharmaceutical agents with inherent bio-compatibility. Here, we use solid-state NMR spectroscopy to investigate the structural modifications of amyloid (1-42) (A(42)) aggregates induced by curcumin. We find that curcumin induces major structural changes in the Asp-23-Lys-28 salt bridge region and near the C terminus. Electron microscopy shows that the A(42) fibrils are disrupted by curcumin. Surprisingly, some of these alterations are similar to those reported for Zn2+ ions, another agent known to disrupt the fibrils and alter A(42) toxicity. Our results suggest the existence of a structurally related family of quasi-fibrillar conformers of A(42), which is stabilized both by curcumin and by Zn2+.</SUP	[Mithu, Venus Singh; Sarkar, Bidyut; Bhowmik, Debanjan; Das, Anand Kant; Maiti, Sudipta; Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Chandrakesan, Muralidharan] Seth Gordhandas Sunderdas Med Coll, Dept Biochem, Bombay 400012, Maharashtra, India; [Chandrakesan, Muralidharan] King Edward Mem Hosp, Bombay 400012, Maharashtra, India; [Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Hyderabad 500075, Andhra Pradesh, India	Tata Institute of Fundamental Research (TIFR); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Maiti, S (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	maiti@tifr.res.in; madhu@tifr.res.in	Das, Anand/E-4138-2016	Das, Anand/0000-0003-0740-8140; Sarkar, Bidyut/0000-0001-5023-7581; bhowmik, debanjan/0000-0002-3480-7940; Mithu, Venus Singh/0000-0003-2869-9776; Maiti, Sudipta/0000-0002-6540-7472	SERC scheme from the Department of Science and Technology of India [SR/S1/PC/27/2009]; Department of Biotechnology, Government of India [BT/53/NE/TBP/2010]	SERC scheme from the Department of Science and Technology of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by funding under SERC scheme SR/S1/PC/27/2009 from the Department of Science and Technology of India (to P. K. M.) and Grant BT/53/NE/TBP/2010 from the Department of Biotechnology, Government of India (to S. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Esler WP, 1996, J NEUROCHEM, V66, P723; Gaggelli E, 2008, J PHYS CHEM B, V112, P100, DOI 10.1021/jp075168m; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mithu VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050504; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Narlawar R, 2008, CHEMMEDCHEM, V3, P165, DOI 10.1002/cmdc.200700218; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Park SY, 2002, J NAT PROD, V65, P1227, DOI 10.1021/np010039x; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Rathore P, 2008, NEUROCHEM RES, V33, P1672, DOI 10.1007/s11064-007-9515-6; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhao LN, 2012, J PHYS CHEM B, V116, P7428, DOI 10.1021/jp3034209; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	43	44	45	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11122	11131		10.1074/jbc.M113.519447	http://dx.doi.org/10.1074/jbc.M113.519447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599958	Green Published, hybrid			2022-12-28	WOS:000334638500016
J	Akbari-Birgani, S; Hosseinkhani, S; Mollamohamadi, S; Baharvand, H				Akbari-Birgani, Shiva; Hosseinkhani, Saman; Mollamohamadi, Sepideh; Baharvand, Hossein			Delay in Apoptosome Formation Attenuates Apoptosis in Mouse Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; TERMINAL DIFFERENTIATION; CASPASE ACTIVATION; COMPLEX I; MITOCHONDRIAL; DEATH; ATP; LYMPHOCYTES; DEFICIENCY; COMMITMENT	Differentiation is an inseparable process of development in multicellular organisms. Mouse embryonic stem cells (mESCs) represent a valuable research tool to conduct in vitro studies of cell differentiation. Apoptosis as a well known cell death mechanism shows some common features with cell differentiation, which has caused a number of ambiguities in the field. The research question here is how cells could differentiate these two processes from each other. We have investigated the role of the mitochondrial apoptotic pathway and cell energy level during differentiation of mESCs into the cardiomyocytes and their apoptosis. p53 expression, cytochrome c release, apoptosome formation, and caspase-3/7 activation are observed upon induction of both apoptosis and differentiation. However, remarkable differences are detected in time of cytochrome c appearance, apoptosome formation, and caspase activity upon induction of both processes. In apoptosis, apoptosome formation and caspase activity were observed rapidly following the cytochrome c release. Unlike apoptosis, the release of cytochrome c upon differentiation took more time, and the maximum caspase activity was also postponed for 24 h. This delay suggests that there is a regulatory mechanism during differentiation of mESCs into cardiomyocytes. The highest ATP content of cells was observed immediately after cytochrome c release 6 h after apoptosis induction and then decreased, but it was gradually increased up to 48 h after differentiation. These observations suggest that a delay in the release of cytochrome c or delay in ATP increase attenuate apoptosome formation, and caspase activation thereby discriminates apoptosis from differentiation in mESCs.	[Akbari-Birgani, Shiva; Hosseinkhani, Saman] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran; [Mollamohamadi, Sepideh; Baharvand, Hossein] Iranian Acad Ctr Educ Culture & Res ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, ACECR, Tehran, Iran	Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Hosseinkhani, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.	saman_h@modares.ac.ir; Baharvand@RoyanInstitute.org	Akbari-Birgani, Shiva/X-8696-2019	Akbari-Birgani, Shiva/0000-0001-8826-4083; Hosseinkhani, Saman/0000-0002-0345-7909				Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eguchi Y, 1997, CANCER RES, V57, P1835; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Ghiasi P, 2012, NEUROL RES, V34, P297, DOI 10.1179/1743132812Y.0000000012; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Hassani SN, 2012, STEM CELL REV REP, V8, P472, DOI 10.1007/s12015-011-9306-y; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim J, 2003, BREAST CANCER RES TR, V79, P321, DOI 10.1023/A:1024043302583; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mohammadi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1338, DOI 10.1111/j.1751-1097.2011.00973.x; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nazari M, 2011, PHOTOCH PHOTOBIO SCI, V10, P1203, DOI 10.1039/c1pp05012e; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Sanders EJ, 2002, J ANAT, V201, P121, DOI 10.1046/j.1469-7580.2002.00081.x; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Torkzadeh-Mahani M, 2012, BIOSENS BIOELECTRON, V38, P362, DOI 10.1016/j.bios.2012.06.034; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16905	16913		10.1074/jbc.M113.536730	http://dx.doi.org/10.1074/jbc.M113.536730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755221	Green Published, hybrid			2022-12-28	WOS:000338016200026
J	Patananan, AN; Capri, J; Whitelegge, JP; Clarke, SG				Patananan, Alexander N.; Capri, Joseph; Whitelegge, Julian P.; Clarke, Steven G.			Non-repair Pathways for Minimizing Protein Isoaspartyl Damage in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-METHYLTRANSFERASE; LIFE-SPAN; OXIDATIVE-STRESS; PHYLOGENETIC DISTRIBUTION; OXIDIZED PROTEINS; ASPARTYL RESIDUES; ALTERED PROTEINS; AB-INITIO; DEGRADATION; PROTEASOME	The spontaneous degradation of asparaginyl and aspartyl residues to isoaspartyl residues is a common type of protein damage in aging organisms. Although the protein-L-isoaspartyl (D-aspartyl) O-methyltransferase (EC 2.1.1.77) can initiate the repair of L-isoaspartyl residues to L-aspartyl residues in most organisms, no gene homolog or enzymatic activity is present in the budding yeast Saccharomyces cerevisiae. Therefore, we used biochemical approaches to elucidate how proteins containing isoaspartyl residues are metabolized in this organism. Surprisingly, the level of isoaspartyl residues in yeast proteins (50-300 pmol of isoaspartyl residues/mg of protein extract) is comparable with organisms with protein-L-isoaspartyl (D-aspartyl) O-methyltransferase, suggesting a novel regulatory pathway. Interfering with common protein quality control mechanisms by mutating and inhibiting the proteasomal and autophagic pathways in vivo did not increase isoaspartyl residue levels compared with wild type or uninhibited cells. However, the inhibition of metalloproteases in in vitro aging experiments by EDTA resulted in an similar to 3-fold increase in the level of isoaspartyl-containing peptides. Characterization by mass spectrometry of these peptides identified several proteins involved in metabolism as targets of isoaspartyl damage. Further analysis of these peptides revealed that many have an N-terminal isoaspartyl site and originate from proteins with short half-lives. These results suggest that one or more metalloproteases participate in limiting isoaspartyl formation by robust proteolysis.	[Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Capri, Joseph; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Neuropsychiat Inst, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu			National Institutes of Health [AG032303, GM026020, GM007185]; Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; Ellison Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, T32GM007185, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG032303 and GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to A. N. P.). This work was also supported by the Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center (to S. G. C.) and a Senior Scholar in Aging Award from the Ellison Medical Foundation (to S. G. C.).	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; BALZI E, 1994, J BIOL CHEM, V269, P2206; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Cloos PAC, 2002, MATRIX BIOL, V21, P39, DOI 10.1016/S0945-053X(01)00188-3; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Costa V, 2007, IUBMB LIFE, V59, P293, DOI 10.1080/15216540701225958; Dai SJ, 2013, ANAL CHEM, V85, P2423, DOI 10.1021/ac303428h; DeLuna A, 2005, BIOCHEM BIOPH RES CO, V328, P1083, DOI 10.1016/j.bbrc.2005.01.057; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Doyle HA, 2007, AUTOIMMUNITY, V40, P131, DOI 10.1080/08916930601165180; Doyle HA, 2006, J BIOL CHEM, V281, P32676, DOI 10.1074/jbc.M604847200; Farrar C, 2002, J BIOL CHEM, V277, P27856, DOI 10.1074/jbc.M203911200; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Hecht KA, 2013, FEMS YEAST RES, V13, P471, DOI 10.1111/1567-1364.12050; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Hooi MYS, 2013, EXP EYE RES, V106, P34, DOI 10.1016/j.exer.2012.10.013; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; Ichikawa JK, 1998, ARCH BIOCHEM BIOPHYS, V358, P222, DOI 10.1006/abbi.1998.0830; JOHNSON BA, 1991, BIOCHEM INT, V24, P841; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Khare S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020850; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KODAMA T, 1995, BBA-GEN SUBJECTS, V1245, P269, DOI 10.1016/0304-4165(95)00092-P; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lanthier J, 2006, BIOCHEM CELL BIOL, V84, P684, DOI 10.1139/O06-055; Larsen RA, 2001, J BACTERIOL, V183, P3089, DOI 10.1128/JB.183.10.3089-3097.2001; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1933; LI C, 1992, J BACTERIOL, V174, P355, DOI 10.1128/jb.174.2.355-361.1992; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Meiling-Wesse K, 2002, FEBS LETT, V530, P174, DOI 10.1016/S0014-5793(02)03456-7; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; Nayak NR, 2013, PLANT CELL, V25, P2573, DOI 10.1105/tpc.113.113456; Niewmierzycka A, 1999, ARCH BIOCHEM BIOPHYS, V364, P209, DOI 10.1006/abbi.1999.1114; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; OConnor MB, 1997, INSECT BIOCHEM MOLEC, V27, P49, DOI 10.1016/S0965-1748(96)00071-9; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Patananan AN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1654, DOI 10.1016/B978-0-12-382219-2.00374-4; Qin ZX, 2014, INVEST OPHTH VIS SCI, V55, P1572, DOI 10.1167/iovs.13-13668; Radkiewicz JL, 2001, J AM CHEM SOC, V123, P3499, DOI 10.1021/ja0026814; Radkiewicz JL, 1996, J AM CHEM SOC, V118, P9148, DOI 10.1021/ja953505b; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Sitte N, 1998, FEBS LETT, V440, P399, DOI 10.1016/S0014-5793(98)01495-1; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yang HQ, 2011, J ALZHEIMERS DIS, V27, P113, DOI 10.3233/JAD-2011-110626; Yang ML, 2006, J IMMUNOL, V177, P4541, DOI 10.4049/jimmunol.177.7.4541	89	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16936	16953		10.1074/jbc.M114.564385	http://dx.doi.org/10.1074/jbc.M114.564385			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764295	hybrid, Green Published			2022-12-28	WOS:000338016200029
J	Baker, B; Maitra, U; Geng, S; Li, LW				Baker, Bianca; Maitra, Urmila; Geng, Shuo; Li, Liwu			Molecular and Cellular Mechanisms Responsible for Cellular Stress and Low-grade Inflammation Induced by a Super-low Dose of Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; INSULIN-RESISTANCE; INNATE IMMUNITY; KAPPA-B; NECROPTOSIS; MACROPHAGES; APOPTOSIS; NECROSIS; LIPOPOLYSACCHARIDE; OBESITY	Super-low-dose endotoxemia in experimental animals and humans is linked to low-grade chronic inflammatory diseases. However, the underlying molecular and cellular mechanisms are not well understood. In this study, we examined the effects of a super-low dose of LPS on low-grade inflammation in macrophages as well as underlying mechanisms. We observed that a super-low dose of LPS induces mitochondrial fission and cell necroptosis in primary murine macrophages, dependent upon interleukin 1 receptor-associated kinase (IRAK-1). Mechanistically, our study reveals that a super-low dose of LPS causes protein ubiquitination and degradation of mitofusin 1 (Mfn1), a molecule required for maintaining proper mitochondrial fusion. A super-low dose of LPS also leads to dephosphorylation and activation of Drp1, a molecule responsible for mitochondrial fission and cell necroptosis. Furthermore, we demonstrated that a super-low dose of LPS activates receptor interacting protein 3 kinase (RIP3), a key molecule critical for the assembly of the necrosome complex, the initiation of Drp1 dephosphorylation, and necroptosis. The effects of a super-low dose of LPS are abolished in macrophages harvested from IRAK-1-deficient mice. Taken together, our study identified a novel molecular pathway that leads to cellular stress and necroptosis in macrophages challenged with a super-low dose of endotoxin. This may reconcile low-grade inflammation often associated with low-grade endotoxemia.	[Baker, Bianca; Maitra, Urmila; Geng, Shuo; Li, Liwu] Virginia Tech, Dept Biol Sci, Lab Inflammat Biol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Geng, Shuo/J-3735-2013	Li, Liwu/0000-0001-8870-5299	National Institutes of Health [R01HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL115835.	Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang S., 2011, J MED SCI, V31, P191; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Ferrari LF, 2011, J NEUROSCI, V31, P11404, DOI 10.1523/JNEUROSCI.2223-11.2011; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ishikawa J, 2007, STROKE, V38, P911, DOI 10.1161/01.STR.0000258115.46765.f1; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Li LW, 2003, J ENDOTOXIN RES, V9, P39, DOI 10.1179/096805103125001324; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Lira FS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-82; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Maitra U, 2013, ARTERIOSCL THROM VAS, V33, P24, DOI 10.1161/ATVBAHA.112.300049; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P240, DOI 10.1038/ijo.2009.242; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Shnyra A, 1998, J IMMUNOL, V160, P3729; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	50	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16262	16269		10.1074/jbc.M114.569210	http://dx.doi.org/10.1074/jbc.M114.569210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759105	hybrid, Green Published			2022-12-28	WOS:000337965700030
J	Bos, MP; Grijpstra, J; Boxtel, RTV; Tommassen, J				Bos, Martine P.; Grijpstra, Jan; Boxtel, Ria Tommassen-van; Tommassen, Jan			Involvement of Neisseria meningitidis Lipoprotein GNA2091 in the Assembly of a Subset of Outer Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Membrane Biogenesis; Membrane Protein; Microbiology; Vaccine; BAM Complex; Neisseria meningitidis; YraP	SEROGROUP-B; LIPOPOLYSACCHARIDE TRANSPORT; IDENTIFICATION; BIOGENESIS; COMPLEX; VACCINE; CHAPERONE; BACTERIA; DOMAIN; BAM	GNA2091 of Neisseria meningitidis is a lipoprotein of unknown function that is included in the novel 4CMenB vaccine. Here, we investigated the biological function and the subcellular localization of the protein. We demonstrate that GNA2091 functions in the assembly of outer membrane proteins (OMPs) because its absence resulted in the accumulation of misassembled OMPs. Cell fractionation and protease accessibility experiments showed that the protein is localized at the periplasmic side of the outer membrane. Pulldown experiments revealed that it is not stably associated with the -barrel assembly machinery, the previously identified complex for OMP assembly. Thus, GNA2091 constitutes a novel outer membrane-based lipoprotein required for OMP assembly. Furthermore, its location at the inner side of the outer membrane indicates that protective immunity elicited by this antigen cannot be due to bactericidal or opsonic activity of antibodies.	[Bos, Martine P.; Grijpstra, Jan; Boxtel, Ria Tommassen-van; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University	Bos, MP (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	m.bos@uu.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Pan JY, 2010, J PROTEOME RES, V9, P3730, DOI 10.1021/pr100301f; Pannekoek Y, 2009, FEMS MICROBIOL LETT, V294, P216, DOI 10.1111/j.1574-6968.2009.01568.x; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Veld RAGHI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029002; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yeats C, 2003, TRENDS BIOCHEM SCI, V28, P352, DOI 10.1016/S0968-0004(03)00115-4	39	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15602	15610		10.1074/jbc.M113.539510	http://dx.doi.org/10.1074/jbc.M113.539510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24755216	Green Published, hybrid			2022-12-28	WOS:000337465400042
J	Bao, B; Azmi, AS; Aboukameel, A; Ahmad, A; Bolling-Fischer, A; Sethi, S; Ali, S; Li, YW; Kong, DJ; Banerjee, S; Back, J; Sarkar, FH				Bao, Bin; Azmi, Asfar S.; Aboukameel, Amro; Ahmad, Aamir; Bolling-Fischer, Aliccia; Sethi, Seema; Ali, Shadan; Li, Yiwei; Kong, Dejuan; Banerjee, Sanjeev; Back, Jessica; Sarkar, Fazlul H.			Pancreatic Cancer Stem-like Cells Display Aggressive Behavior Mediated via Activation of FoxQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLATE BINDING-PROTEIN; TUMOR-GROWTH; COLORECTAL-CANCER; RECEPTOR-ALPHA; ANALOG CDF; EXPRESSION; METASTASIS; SURVIVAL; TUMORIGENICITY; CURCUMIN	Subpopulations of cancer stem cells (CSCs) or cancer stem-like cells (CSLCs) have been identified from most tumors, including pancreatic cancer (PC), and the existence of these cells is clinically relevant. Emerging evidence suggests that CSLCs participate in cell growth/proliferation, migration/invasion, metastasis, and chemo-radiotherapy resistance, ultimately contributing to poor clinical outcome. However, the pathogenesis and biological significance of CSLCs in PC has not been well characterized. In the present study, we found that isolated triple-marker-positive (CD44(+)/CD133(+)/EpCAM(+)) cells of human PC MiaPaCa-2 and L3.6pl cells behave as CSLCs. These CSLCs exhibit aggressive behavior, such as increased cell growth, migration, clonogenicity, and self-renewal capacity. The mRNA expression profiling analysis showed that CSLCs (CD44(+)/CD133(+)/EpCAM(+)) exhibit differential expression of more than 1,600 mRNAs, including FoxQ1, compared with the triple-marker-negative (CD44(-)/CD133(-)/EpCAM(-)) cells. The knockdown of FoxQ1 by its siRNA in CSLCs resulted in the inhibition of aggressive behavior, consistent with the inhibition of EpCAM and Snail expression. Mouse xenograft tumor studies showed that CSLCs have a 100-fold higher potential for tumor formation and rapid tumor growth, consistent with overexpression of CSC-associated markers/mediators, including FoxQ1, compared with its parental MiaPaCa-2 cells. The inhibition of FoxQ1 attenuated tumor formation and growth, and expression of CSC markers in the xenograft tumor derived from CSLCs of MiaPaCa-2 cells. These data clearly suggest the role of differentially expressed genes in the regulation of CSLC characteristics, further suggesting that targeting some of these genes could be important for the development of novel therapies for achieving better treatment outcome of PC.	[Bao, Bin; Azmi, Asfar S.; Ahmad, Aamir; Sethi, Seema; Li, Yiwei; Kong, Dejuan; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Aboukameel, Amro; Bolling-Fischer, Aliccia; Sarkar, Fazlul H.] Wayne State Univ, Genom Core Facil, Sch Med, Detroit, MI 48201 USA; [Ali, Shadan] Wayne State Univ, Dept Oncol, Sch Med, Detroit, MI 48201 USA; [Back, Jessica] Wayne State Univ, Flow Cytometry Core Facil, Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, FH (corresponding author), Wayne State Univ, Dept Pathol, Sch Med, Karmanos Canc Inst,Hudson Webber Canc Res Ctr 740, 4100 John R St, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505				Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Allard JE, 2007, GYNECOL ONCOL, V107, P52, DOI 10.1016/j.ygyno.2007.05.018; Altaner C, 2008, NEOPLASMA, V55, P369; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarhaut J, 2013, LEUKEMIA RES, V37, P948, DOI 10.1016/j.leukres.2013.04.026; D'Angelica M, 2011, MODERN PATHOL, V24, P1221, DOI 10.1038/modpathol.2011.82; Ebel W., 2007, CANC IMMUN, V7, P6; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hermann PC, 2009, EXPERT OPIN BIOL TH, V9, P1271, DOI 10.1517/14712590903246362; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; Liang SH, 2013, TUMOR BIOL, V34, P2605, DOI 10.1007/s13277-013-0808-x; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Toffoli G, 1998, INT J CANCER, V79, P121, DOI 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355; Villageois P, 2012, AM J STEM CELLS, V1, P42; Wood LD, 2012, ONCOTARGET, V3, P668; Xia LM, 2014, HEPATOLOGY, V59, P958, DOI 10.1002/hep.26735; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhu ZH, 2013, INT J ONCOL, V42, P1271, DOI 10.3892/ijo.2013.1807	34	43	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14520	14533		10.1074/jbc.M113.532887	http://dx.doi.org/10.1074/jbc.M113.532887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719318	Green Published, hybrid			2022-12-28	WOS:000337248100011
J	Kim, J; Lee, H; Lee, JH; Kwon, DY; Genovesio, A; Fenistein, D; Ogier, A; Brondani, V; Grailhe, R				Kim, Jiho; Lee, Honggun; Lee, Joo Hyun; Kwon, Do-yoon; Genovesio, Auguste; Fenistein, Denis; Ogier, Arnaud; Brondani, Vincent; Grailhe, Regis			Dimerization, Oligomerization, and Aggregation of Human Amyotrophic Lateral Sclerosis Copper/Zinc Superoxide Dismutase 1 Protein Mutant Forms in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; SOD1; MUTATION; COMMON; SUPEROXIDE-DISMUTASE-1; TOXICITY; GENE	More than 100 copper/zinc superoxide dismutase 1 (SOD1) genetic mutations have been characterized. These mutations lead to the death of motor neurons in ALS. In its native form, the SOD1 protein is expressed as a homodimer in the cytosol. In vitro studies have shown that SOD1 mutations impair the dimerization kinetics of the protein, and in vivo studies have shown that SOD1 forms aggregates in patients with familial forms of ALS. In this study, we analyzed WT SOD1 and 9 mutant (mt) forms of the protein by non-invasive fluorescence techniques. Using microscopic techniques such as fluorescence resonance energy transfer, fluorescence complementation, image-based quantification, and fluorescence correlation spectroscopy, we studied SOD1 dimerization, oligomerization, and aggregation. Our results indicate that SOD1 mutations lead to an impairment in SOD1 dimerization and, subsequently, affect protein aggregation. We also show that SOD1 WT and mt proteins can dimerize. However, aggregates are predominantly composed of SOD1 mt proteins.	[Kim, Jiho; Lee, Honggun; Lee, Joo Hyun; Kwon, Do-yoon; Genovesio, Auguste; Fenistein, Denis; Ogier, Arnaud; Brondani, Vincent; Grailhe, Regis] Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea	Institut Pasteur Korea	Grailhe, R (corresponding author), Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea.	regis.grailhe@ip-korea.org	GENOVESIO, Auguste/I-1656-2017; Brondani, Vincent/AAB-8394-2021	Genovesio, Auguste/0000-0003-1877-5595	Basic Science Research Program through the National Research Foundation of Korea Grant - Ministry of Education, Science, and Technology [2012R1A2004980]; National Research Foundation of Korea Grant - Korean government, the Gyeonggi-do [2007-00559]; Korea Institute of Science and Technology Information (KISTI)	Basic Science Research Program through the National Research Foundation of Korea Grant - Ministry of Education, Science, and Technology; National Research Foundation of Korea Grant - Korean government, the Gyeonggi-do; Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by Basic Science Research Program through the National Research Foundation of Korea Grant 2012R1A2004980 funded by the Ministry of Education, Science, and Technology and by National Research Foundation of Korea Grant 2007-00559 funded by the Korean government, the Gyeonggi-do, and Korea Institute of Science and Technology Information (KISTI).	Abe K, 1996, J NEUROL SCI, V136, P108, DOI 10.1016/0022-510X(95)00314-R; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; AOKI M, 1994, J NEUROL SCI, V126, P77, DOI 10.1016/0022-510X(94)90097-3; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Dorval T, 2010, J BIOMOL SCREEN, V15, P847, DOI 10.1177/1087057110374993; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Kim J, 2011, MOL BIOSYST, V7, P2991, DOI 10.1039/c1mb05279a; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Mishra A, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.016; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Puttaparthi K, 2003, J NEUROCHEM, V87, P851, DOI 10.1046/j.1471-4159.2003.02028.x; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	25	32	32	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15094	15103		10.1074/jbc.M113.542613	http://dx.doi.org/10.1074/jbc.M113.542613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24692554	hybrid, Green Published			2022-12-28	WOS:000337248100060
J	Sharonov, GV; Bocharov, EV; Kolosov, PM; Astapova, MV; Arseniev, AS; Feofanov, AV				Sharonov, George V.; Bocharov, Eduard V.; Kolosov, Peter M.; Astapova, Maria V.; Arseniev, Alexander S.; Feofanov, Alexey V.			Point Mutations in Dimerization Motifs of the Transmembrane Domain Stabilize Active or Inactive State of the EphA2 Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GROWTH-FACTOR RECEPTOR-3; MEMBRANE-PROTEINS; BINDING DOMAIN; ACTIVATION; SEQUENCE; DIMER; DIVERSITY; MECHANISM; CLUSTERS	The EphA2 receptor tyrosine kinase plays a central role in the regulation of cell adhesion and guidance in many human tissues. The activation of EphA2 occurs after proper dimerization/ oligomerization in the plasma membrane, which occurs with the participation of extracellular and cytoplasmic domains. Our study revealed that the isolated transmembrane domain (TMD) of EphA2 embedded into the lipid bicelle dimerized via the heptad repeat motif L(535)X(3)G(539)X(2)A(542)X(3)V(546)X(2)L(549) rather than through the alternative glycine zipper motif A(536)X(3)G(540)X(3)G(544) (typical for TMD dimerization in many proteins). To evaluate the significance of TMD interactions for full-length EphA2, we substituted key residues in the heptad repeat motif (HR variant: G539I, A542I, G553I) or in the glycine zipper motif (GZ variant: G540I, G544I) and expressed YFP-tagged EphA2 (WT, HR, and GZ variants) in HEK293T cells. Confocal microscopy revealed a similar distribution of all EphA2-YFP variants in cells. The expression of EphA2-YFP variants and their kinase activity (phosphorylation of Tyr(588) and/or Tyr(594)) and ephrin-A3 binding were analyzed with flow cytometry on a single cell basis. Activation of any EphA2 variant is found to occur even without ephrin stimulation when the EphA2 content in cells is sufficiently high. Ephrin-A3 binding is not affected in mutant variants. Mutations in the TMD have a significant effect on EphA2 activity. Both ligand-dependent and ligand-independent activities are enhanced for the HR variant and reduced for the GZ variant compared with the WT. These findings allow us to suggest TMD dimerization switching between the heptad repeat and glycine zipper motifs, corresponding to inactive and active receptor states, respectively, as a mechanism underlying EphA2 signal transduction.	[Sharonov, George V.; Bocharov, Eduard V.; Astapova, Maria V.; Arseniev, Alexander S.; Feofanov, Alexey V.] Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Dept Biol Struct, Moscow 117997, Russia; [Sharonov, George V.] Moscow MV Lomonosov State Univ, Fac Med, Moscow 119992, Russia; [Kolosov, Peter M.] Inst Higher Nervous Act & Neurophysiol RAS, Dept Mol Neurobiol, Moscow 117485, Russia; [Feofanov, Alexey V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Feofanov, AV (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Dept Biol Struct, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	avfeofanov@yandex.ru	Feofanov, Alexey V/K-3082-2012; Sharonov, George V/B-1323-2014; Kolosov, Peter/T-9631-2017	Feofanov, Alexey V/0000-0002-1596-9506; Sharonov, George V/0000-0001-8610-5054; Kolosov, Peter/0000-0003-1231-7999	Russian Foundation for Basic Research [13-04-40105-H, 12-04-01816-a]; Russian Federation [MK-5003.2013.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	This work was supported by Russian Foundation for Basic Research Grants 13-04-40105-H and 12-04-01816-a).; Supported by President of the Russian Federation Grant MK-5003.2013.4.	Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Becker V, 2008, BIOCHEMISTRY-US, V47, P11771, DOI 10.1021/bi801425e; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; Bocharov EV, 2013, STRUCTURE, V21, P2087, DOI 10.1016/j.str.2013.08.026; Bocharov EV, 2010, CELL ADHES MIGR, V4, P284, DOI 10.4161/cam.4.2.11930; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; CAO H, 1992, EMBO J, V11, P923, DOI 10.1002/j.1460-2075.1992.tb05131.x; Choi Y, 2012, CELL SIGNAL, V24, P1522, DOI 10.1016/j.cellsig.2012.03.020; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fujii H, 2011, HUM REPROD, V26, P1163, DOI 10.1093/humrep/der034; Fuller-Espie S, 1998, INT IMMUNOL, V10, P923, DOI 10.1093/intimm/10.7.923; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Himanen JP, 2012, SEMIN CELL DEV BIOL, V23, P35, DOI 10.1016/j.semcdb.2011.10.025; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Huber O, 1999, J CELL SCI, V112, P4415; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Kaneko M, 2003, J NEUROSCI, V23, P11523; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nekrasova OV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1387, DOI 10.1134/S0006297912120073; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Reddy T, 2014, BIOCHEMISTRY-US, V53, P323, DOI 10.1021/bi401576k; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sharonov G. V., 2012, CURRENT MICROSCOPY C, P140; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Udayakumar D, 2011, ONCOGENE, V30, P4921, DOI 10.1038/onc.2011.210; Velghe AI, 2014, ONCOGENE, V33, P2568, DOI 10.1038/onc.2013.218; Volynsky PE, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016014; Volynsky PE, 2013, J AM CHEM SOC, V135, P8105, DOI 10.1021/ja4011942; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192	51	27	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14955	14964		10.1074/jbc.M114.558783	http://dx.doi.org/10.1074/jbc.M114.558783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733396	Green Published, hybrid			2022-12-28	WOS:000337248100045
J	Yuan, ZH; Syed, MA; Panchal, D; Joo, M; Colonna, M; Brantly, M; Sadikot, RT				Yuan, Zhihong; Syed, Mansoor Ali; Panchal, Dipti; Joo, Myungsoo; Colonna, Marco; Brantly, Mark; Sadikot, Ruxana T.			Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1)-mediated Bcl-2 Induction Prolongs Macrophage Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; KAPPA-B ACTIVATION; GROWTH-RESPONSE 2; TREM-1 EXPRESSION; MITOCHONDRIAL FUSION; TRANSCRIPTION FACTOR; NECROSIS-FACTOR; EGR FAMILY; APOPTOSIS; INFLAMMATION	Triggering receptor expressed on myeloid cells 1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells that plays an important role in the amplification of inflammation. Recent studies suggest a role for TREM-1 in tumor-associated macrophages with relationship to tumor growth and progression. Whether the effects of TREM-1 on inflammation and tumor growth are mediated by an alteration in cell survival signaling is not known. In these studies, we show that TREM-1 knock-out macrophages exhibit an increase in apoptosis of cells in response to lipopolysaccharide (LPS) suggesting a role for TREM-1 in macrophage survival. Specific ligation of TREM-1 with monoclonal TREM-1 (mTREM-1) or overexpression of TREM-1 with adeno-TREM-1 induced B-cell lymphoma-2 (Bcl-2) with depletion of the key executioner caspase-3 prevents the cleavage of poly(ADP-ribose) polymerase. TREM-1 knockout cells showed lack of induction of Bcl2 with an increase in caspase-3 activation in response to lipopolysaccharide. In addition overexpression of TREM-1 with adeno-TREM-1 led to an increase in mitofusins (MFN1 and MFN2) and knockdown of TREM-1 decreased the expression of mitofusins suggesting that TREM-1 contributes to the maintenance of mitochondrial integrity favoring cell survival. Investigations into potential mechanisms by which TREM-1 alters cell survival showed that TREM-1-induced Bcl-2 in an Egr2-dependent manner. Furthermore, our data shows that expression of Egr2 in response to specific ligation of TREM-1 is ERK mediated. These data for the first time provide novel mechanistic insights into the role of TREM-1 as an anti-apoptotic protein that prolongs macrophage survival.	[Yuan, Zhihong; Sadikot, Ruxana T.] Vet Affairs Med Ctr, Gainesville, FL 32610 USA; [Yuan, Zhihong; Brantly, Mark; Sadikot, Ruxana T.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32610 USA; [Syed, Mansoor Ali; Panchal, Dipti] Univ Illinois, Sect Pulm Crit Care & Sleep Med, Chicago, IL 60612 USA; [Joo, Myungsoo] Pusan Univ, Dept Immunol, Yangsan 626870, South Korea; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pusan National University; Pusan National University Hospital; Washington University (WUSTL)	Sadikot, RT (corresponding author), Univ Florida, Sect Pulm Crit Care & Sleep Med, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	rtsadikot@ufl.edu	syed, mansoor ali/I-6957-2018; Brantly, Mark/AAH-2922-2020; syed, Mansoor ali/G-8986-2013	syed, Mansoor ali/0000-0003-2697-7832; Yuan, Zhihong/0000-0002-2300-0463; Colonna, Marco/0000-0001-5222-4987	Department of Veterans Affairs; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Department of Veterans Affairs.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bassiri H, 2009, IMMUNOL CELL BIOL, V87, P361, DOI 10.1038/icb.2009.20; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Byers DE, 2011, CHEST, V140, P768, DOI 10.1378/chest.10-2132; Byrne AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069246; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cleland MM, 2011, CELL DEATH DIFFER, V18, P235, DOI 10.1038/cdd.2010.89; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Devos T, 2008, TRANSPLANTATION, V85, P1489, DOI 10.1097/TP.0b013e31816f24af; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Hirano S, 2002, IMMUNOLOGY, V107, P86, DOI 10.1046/j.1365-2567.2002.01487.x; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Hu WH, 2009, DNA CELL BIOL, V28, P13, DOI 10.1089/dna.2008.0782; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Liao R, 2012, CANCER SCI, V103, P984, DOI 10.1111/j.1349-7006.2012.02273.x; Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Rodrigues MF, 2013, IMMUNOLOGY, V139, P503, DOI 10.1111/imm.12097; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Venken K, 2002, NEUROGENETICS, V4, P37, DOI 10.1007/s10048-001-0124-2; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yuan ZH, 2012, INT J BIOCHEM CELL B, V44, P2032, DOI 10.1016/j.biocel.2012.08.001; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; Zhang Y, 2007, FEBS LETT, V581, P2168, DOI 10.1016/j.febslet.2007.01.095; Zheng H, 2010, EUR J IMMUNOL, V40, P162, DOI 10.1002/eji.200839156; Zhou JG, 2013, INT IMMUNOPHARMACOL, V17, P155, DOI 10.1016/j.intimp.2013.06.009	70	49	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15118	15129		10.1074/jbc.M113.536490	http://dx.doi.org/10.1074/jbc.M113.536490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711453	Green Published, hybrid			2022-12-28	WOS:000337248100062
J	Okumoto, K; Noda, H; Fujiki, Y				Okumoto, Kanji; Noda, Hiromi; Fujiki, Yukio			Distinct Modes of Ubiquitination of Peroxisome-targeting Signal Type 1 ( PTS1) Receptor Pex5p Regulate PTS1 Protein Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peroxisomes; Protein Targeting; Ubiquitin; Ubiquitin Ligase; Ubiquitination; Pex5p; RING Peroxins; Peroxisome Biogenesis	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; DEFICIENT ZELLWEGER-SYNDROME; OVARY CELL MUTANTS; BIOGENESIS DISORDERS; MEMBRANE-PROTEIN; FUNCTIONAL COMPLEMENTATION; 3-KETOACYL-COA THIOLASE; CONSERVED CYSTEINE; CYCLING RECEPTOR; MATRIX PROTEINS	Background: Pex5p translocates the cargo proteins into peroxisomes. Results: Mammalian RING peroxins, the Pex10pPex12p complex, catalyze Lys-linked, multiple monoubiquitination of Pex5p, assuring efficient export of Pex5p from peroxisomes. Conclusion: Distinct Lys- and Cys-linked modes of Pex5p ubiquitination control Pex5p-mediated matrix protein import. Significance: This work provides the first evidence of a functional role of mammalian RING peroxins in Pex5p ubiquitination. Peroxisome targeting signal type-1 (PTS1) receptor, Pex5p, is a key player in peroxisomal matrix protein import. Pex5p recognizes PTS1 cargoes in the cytosol, targets peroxisomes, translocates across the membrane, unloads the cargoes, and shuttles back to the cytosol. Ubiquitination of Pex5p at a conserved cysteine is required for the exit from peroxisomes. However, any potential ubiquitin ligase (E3) remains unidentified in mammals. Here, we establish an in vitro ubiquitination assay system and demonstrate that RING finger Pex10p functions as an E3 with an E2, UbcH5C. The E3 activity of Pex10p is essential for its peroxisome-restoring activity, being enhanced by another RING peroxin, Pex12p. The Pex10pPex12p complex catalyzes monoubiquitination of Pex5p at one of multiple lysine residues in vitro, following the dissociation of Pex5p from Pex14p and the PTS1 cargo. Several lines of evidence with lysine-to-arginine mutants of Pex5p demonstrate that Pex10p RING E3-mediated ubiquitination of Pex5p is required for its efficient export from peroxisomes to the cytosol and peroxisomal matrix protein import. RING peroxins are required for both modes of Pex5p ubiquitination, thus playing a pivotal role in Pex5p shuttling.	[Okumoto, Kanji; Noda, Hiromi; Fujiki, Yukio] Kyushu Univ, Grad Sch, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Okumoto, Kanji] Kyushu Univ, Grad Sch, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Dept Biol, Fac Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp			Global Centers of Excellence Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; SORST grant from the Science and Technology Agency of Japan; CREST grant from the Science and Technology Agency of Japan; Takeda Science Foundation; Japanese Foundation for Applied Enzymology;  [19058011];  [20370039];  [24247038];  [25112518];  [1977087];  [21770117];  [24770130]; Grants-in-Aid for Scientific Research [24770130] Funding Source: KAKEN	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SORST grant from the Science and Technology Agency of Japan; CREST grant from the Science and Technology Agency of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Foundation for Applied Enzymology; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 19058011, 20370039, 24247038, and 25112518 (to Y. F.) and 1977087, 21770117, and 24770130 (to K. O.), the Global Centers of Excellence Program, and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; SORST and CREST grants (to Y. F.) from the Science and Technology Agency of Japan; and grants (to Y. F.) from the Takeda Science Foundation and the Japanese Foundation for Applied Enzymology.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Akiyama N, 2002, BIOCHEM BIOPH RES CO, V293, P1523, DOI 10.1016/S0006-291X(02)00419-9; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; El Magraoui F, 2013, TRAFFIC, V14, P1290, DOI 10.1111/tra.12120; El Magraoui F, 2012, FEBS J, V279, P2060, DOI 10.1111/j.1742-4658.2012.08591.x; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Harano T, 1999, J BIOCHEM-TOKYO, V125, P1168, DOI 10.1093/oxfordjournals.jbchem.a022400; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Kaur N, 2013, J INTEGR PLANT BIOL, V55, P108, DOI 10.1111/jipb.12014; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumoto N, 2003, AM J HUM GENET, V73, P233, DOI 10.1086/377004; MIURA S, 1992, J BIOL CHEM, V267, P14405; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Noguchi M, 2013, GENES CELLS, V18, P476, DOI 10.1111/gtc.12051; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Shimozawa N, 1999, BIOCHEM BIOPH RES CO, V262, P504, DOI 10.1006/bbrc.1999.1232; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Toyama R, 1999, HUM MOL GENET, V8, P1673, DOI 10.1093/hmg/8.9.1673; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	76	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14089	14108		10.1074/jbc.M113.527937	http://dx.doi.org/10.1074/jbc.M113.527937			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24662292	Green Published, hybrid			2022-12-28	WOS:000335984600038
J	Chen, HF; Choi, JH; Bailey, S				Chen, Hongfan; Choi, Jihoon; Bailey, Scott			Cut Site Selection by the Two Nuclease Domains of the Cas9 RNA-guided Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA-binding Protein; DNA Transformation; RNA; RNA-binding Protein; CRISPR; Cas9; Genome Editing; Nuclease	CRISPR RNA; IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; ESCHERICHIA-COLI; TARGETED MUTAGENESIS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; SEED SEQUENCE; PLASMID DNA; COMPLEX	Background: The Cas9 RNA-guided endonuclease has been adapted for genome manipulation and regulation. Results: We have characterized target recognition and cleavage by Streptococcus thermophilus LMG18311 Cas9. Conclusion: The two nuclease domains of Cas9 select their cleavage sites by different mechanisms. Significance: These findings contribute to the molecular basis of Cas9-mediated DNA cleavage. Cas9, the RNA-guided DNA endonuclease from the CRISPR-Cas (clustered regularly interspaced short palindromic repeat-CRISPR-associated) system, has been adapted for genome editing and gene regulation in multiple model organisms. Here we characterize a Cas9 ortholog from Streptococcus thermophilus LMG18311 (LMG18311 Cas9). In vitro reconstitution of this system confirms that LMG18311 Cas9 together with a trans-activating RNA (tracrRNA) and a CRISPR RNA (crRNA) cleaves double-stranded DNA with a specificity dictated by the sequence of the crRNA. Cleavage requires not only complementarity between crRNA and target but also the presence of a short motif called the PAM. Here we determine the sequence requirements of the PAM for LMG18311 Cas9. We also show that both the efficiency of DNA target cleavage and the location of the cleavage sites vary based on the position of the PAM sequence.	[Chen, Hongfan; Choi, Jihoon; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330 (to S. B.).	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Panyutin IV, 2001, RADIAT RES, V156, P158, DOI 10.1667/0033-7587(2001)156[0158:SBIWPD]2.0.CO;2; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	46	57	79	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13284	13294		10.1074/jbc.M113.539726	http://dx.doi.org/10.1074/jbc.M113.539726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634220	hybrid, Green Published			2022-12-28	WOS:000335522800028
J	El-Azzouny, M; Evans, CR; Treutelaar, MK; Kennedy, RT; Burant, CF				El-Azzouny, Mahmoud; Evans, Charles R.; Treutelaar, Mary K.; Kennedy, Robert T.; Burant, Charles F.			Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell; Diabetes; Fatty Acid Metabolism; G Protein-coupled Receptors (GPCR); Glucose Metabolism; Insulin Secretion; Metabolism; Metabolomics; Fatty Acid Potentiation of GSIS; GPR40	PANCREATIC BETA-CELLS; N-ACYL TAURINES; COA ESTERS; PALMITOYLTRANSFERASE-I; ISLETS; STIMULATION; EXOCYTOSIS; MUNC13-1; CHANNELS; HEALTH	Background: Pathways underlying fatty acid potentiation of glucose-stimulated insulin secretion have not been fully elucidated. Results: In INS-1 cells, fatty acids increase de novo production of glycerolipids and simultaneously increase glucose utilization. GPR40 receptor activation increases these activities. Conclusion: Fatty acids enhance the production of multiple signals supporting glucose-stimulated insulin secretion. Significance: The studies clarify the effects of fatty acids and GPR40 activity in cell insulin secretion. Acute fatty acid (FA) exposure potentiates glucose-stimulated insulin secretion in cells through metabolic and receptor-mediated effects. We assessed the effect of fatty acids on the dynamics of the metabolome in INS-1 cells following exposure to [U-C-13]glucose to assess flux through metabolic pathways. Metabolite profiling showed a fatty acid-induced increase in long chain acyl-CoAs that were rapidly esterified with glucose-derived glycerol-3-phosphate to form lysophosphatidic acid, mono- and diacylglycerols, and other glycerolipids, some implicated in augmenting insulin secretion. Glucose utilization and glycolytic flux increased, along with a reduction in the NADH/NAD(+) ratio, presumably by an increase in conversion of dihydroxyacetone phosphate to glycerol-3-phosphate. The fatty acid-induced increase in glycolysis also resulted in increases in tricarboxylic cycle flux and oxygen consumption. Inhibition of fatty acid activation of FFAR1/GPR40 by an antagonist decreased glycerolipid formation, attenuated fatty acid increases in glucose oxidation, and increased mitochondrial FA flux, as evidenced by increased acylcarnitine levels. Conversely, FFAR1/GPR40 activation in the presence of low FA increased flux into glycerolipids and enhanced glucose oxidation. These results suggest that, by remodeling glucose and lipid metabolism, fatty acid significantly increases the formation of both lipid- and TCA cycle-derived intermediates that augment insulin secretion, increasing our understanding of mechanisms underlying cell insulin secretion.	[El-Azzouny, Mahmoud; Evans, Charles R.; Treutelaar, Mary K.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [El-Azzouny, Mahmoud; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burant, CF (corresponding author), Univ Michigan, Dept Internal Med, 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	burantc@umich.edu	Burant, Charles/GPC-5690-2022; Kennedy, Robert/G-9095-2016	Burant, Charles/0000-0001-9189-5003; Kennedy, Robert/0000-0003-2447-7471; Evans, Charles/0000-0001-6698-5330	National Institutes of Health [DK046960, DK079084, K25DK092558]; Michigan Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [P60 DK20572]; Michigan Regional Comprehensive Metabolomics Resource Core Grant [U24 DK097153]; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R01DK046960, P60DK020572, R37DK046960, U24DK097153, R01DK079084, K25DK092558, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Resource Core Grant; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK046960 (to R. T. K.), DK079084 (to C. F. B. and R. T. K.), and K25DK092558 (to C. R. E.). This work was also supported by Michigan Nutrition Obesity Research Center Grant P30 DK089503, by Michigan Diabetes Research and Training Center Grant P60 DK20572, by Michigan Regional Comprehensive Metabolomics Resource Core Grant U24 DK097153, by the Robert C. and Veronica Atkins Foundation (to C. F. B.), and by the A. Alfred Taubman Institute (to C.F.B).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Parker SM, 2003, METABOLISM, V52, P1367, DOI 10.1016/S0026-0495(03)00279-8; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Tan B, 2009, J CHROMATOGR B, V877, P2890, DOI 10.1016/j.jchromb.2009.01.002; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Waluk DP, 2013, BIOCHEM BIOPH RES CO, V430, P54, DOI 10.1016/j.bbrc.2012.11.026; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280	42	45	45	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13575	13588		10.1074/jbc.M113.531970	http://dx.doi.org/10.1074/jbc.M113.531970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675078	Green Published, hybrid			2022-12-28	WOS:000335522800052
J	Kumar, A; Singh, PK; Parihar, R; Dwivedi, V; Lakhotia, SC; Ganesh, S				Kumar, Amit; Singh, Pankaj Kumar; Parihar, Rashmi; Dwivedi, Vibha; Lakhotia, Subhash C.; Ganesh, Subramaniam			Decreased O-Linked GlcNAcylation Protects from Cytotoxicity Mediated by Huntingtin Exon1 Protein Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Neurodegenerative Diseases; O-GlcNAcylation; Post-translational Modification; Protein Aggregation	UBIQUITIN-PROTEASOME SYSTEM; AGGREGATE-PRONE PROTEINS; N-ACETYLGLUCOSAMINE; CELLULAR TOXICITY; MUTANT HUNTINGTIN; GLCNAC MODIFICATION; AUTOPHAGY; DISEASE; DROSOPHILA; MODELS	Background: Earlier reports indicate that O-GlcNAcylation might be protective in neurodegenerative disorders. Results: Suppressing O-GlcNAcylation modulates autophagy to enhance the viability of neuronal cells expressing cytotoxic mutant huntingtin exon 1 protein (mHtt). Conclusion:O-GlcNAcylation regulates the clearance of mHtt by modulating the fusion of autophagosomes with lysosomes. Significance: This regulatory mechanism emerges as a novel therapeutic strategy for Huntington disease. O-GlcNAcylation is an important post-translational modification of proteins and is known to regulate a number of pathways involved in cellular homeostasis. This involves dynamic and reversible modification of serine/threonine residues of different cellular proteins catalyzed by O-linked N-acetylglucosaminyltransferase and O-linked N-acetylglucosaminidase in an antagonistic manner. We report here that decreasing O-GlcNAcylation enhances the viability of neuronal cells expressing polyglutamine-expanded huntingtin exon 1 protein fragment (mHtt). We further show that O-GlcNAcylation regulates the basal autophagic process and that suppression of O-GlcNAcylation significantly increases autophagic flux by enhancing the fusion of autophagosome with lysosome. This regulation considerably reduces toxic mHtt aggregates in eye imaginal discs and partially restores rhabdomere morphology and vision in a fly model for Huntington disease. This study is significant in unraveling O-GlcNAcylation-dependent regulation of an autophagic process in mediating mHtt toxicity. Therefore, targeting the autophagic process through the suppression of O-GlcNAcylation may prove to be an important therapeutic approach in Huntington disease.	[Kumar, Amit; Singh, Pankaj Kumar; Parihar, Rashmi; Ganesh, Subramaniam] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Dwivedi, Vibha; Lakhotia, Subhash C.] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Banaras Hindu University (BHU)	Ganesh, S (corresponding author), Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.	sganesh@iitk.ac.in	Singh, Pankaj K/AAG-7486-2021; Lakhotia, Subhash C/D-2058-2011; Parihar, Rashmi/AAA-7857-2020; Kumar, Amit/L-7132-2017	Singh, Pankaj K/0000-0001-9626-5182; Lakhotia, Subhash C/0000-0003-1842-8411; Parihar, Rashmi/0000-0002-3904-2262; Kumar, Amit/0000-0001-5017-9887	Department of Atomic Energy, Government of India; Department of Biotechnology, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a research grant from the Department of Atomic Energy, Government of India (to S. G.).; Recipient of a post-doctoral fellowship from the Department of Biotechnology, Government of India. Present address: Burke Medical Research Institute, New York, NY 10605.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037113; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jadhav S, 2013, MOL NEUROBIOL, V48, P516, DOI 10.1007/s12035-013-8440-8; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Love D. C., 2005, SCI STKE, V2005, pre13; Mallik M, 2010, J GENET, V89, P497, DOI 10.1007/s12041-010-0072-4; Mallik M, 2009, RNA BIOL, V6, P464, DOI 10.4161/rna.6.4.9268; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mittal S, 2010, NEUROSCI RES, V68, P159, DOI 10.1016/j.neures.2010.08.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Puri R, 2011, FEBS J, V278, P3688, DOI 10.1111/j.1742-4658.2011.08287.x; Rajapakse AG, 2009, AM J PHYSIOL-HEART C, V296, pH815, DOI 10.1152/ajpheart.00756.2008; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Ravikumar Brinda, 2008, V445, P195, DOI 10.1007/978-1-59745-157-4_13; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	53	45	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13543	13553		10.1074/jbc.M114.553321	http://dx.doi.org/10.1074/jbc.M114.553321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648514	Green Published, hybrid			2022-12-28	WOS:000335522800049
J	Liu, S; Sheng, L; Miao, HZ; Saunders, TL; MacDougald, OA; Koenig, RJ; Xu, B				Liu, Shannon; Sheng, Liang; Miao, Hongzhi; Saunders, Thomas L.; MacDougald, Ormond A.; Koenig, Ronald J.; Xu, Bin			SRA Gene Knockout Protects against Diet-induced Obesity and Improves Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Gene Expression; Gene Knockout; Obesity; RNA	RECEPTOR RNA-ACTIVATOR; INSULIN-RESISTANCE; BROWN ADIPOCYTES; ADIPOSE-TISSUE; WHITE FAT; MUSCLE DIFFERENTIATION; SKELETAL-MUSCLE; NONCODING RNA; PPAR-GAMMA; EXPRESSION	Background: The non-coding RNA, steroid receptor RNA activator (SRA), promotes adipocyte differentiation in vitro. Results: SRA gene knock-out protects against obesity and improves glucose tolerance in mice fed a high fat diet. Conclusion: SRA is an important regulator of adiposity in diet-induced obesity. Significance: This is the first report that the Sra1 gene plays an important role in adipose tissue biology in vivo. We have recently shown that the non-coding RNA, steroid receptor RNA activator (SRA), functions as a transcriptional coactivator of PPAR and promotes adipocyte differentiation in vitro. To assess SRA function in vivo, we have generated a whole mouse Sra1 gene knock-out (SRA(-/-)). Here, we show that the Sra1 gene is an important regulator of adipose tissue mass and function. SRA is expressed at a higher level in adipose tissue than other organs in wild type mice. SRA(-/-) mice are resistant to high fat diet-induced obesity, with decreased fat mass and increased lean content. This lean phenotype of SRA(-/-) mice is associated with decreased expression of a subset of adipocyte marker genes and reduced plasma TNF levels. The SRA(-/-) mice are more insulin sensitive, as evidenced by reduced fasting insulin, and lower blood glucoses in response to IP glucose and insulin. In addition, the livers of SRA(-/-) mice have fewer lipid droplets after high fat diet feeding, and the expression of lipogenesis-associated genes is decreased. To our knowledge, these data are the first to indicate a functional role for SRA in adipose tissue biology and glucose homeostasis in vivo.	[Liu, Shannon; MacDougald, Ormond A.; Koenig, Ronald J.; Xu, Bin] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Sheng, Liang; MacDougald, Ormond A.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Miao, Hongzhi] Univ Michigan, Med Ctr, Dept Pathol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Med Ctr, Div Mol Med & Genet, Transgen Anim Model Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Koenig, RJ (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	rkoenig@umich.edu; bxu@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [R01DK62876]; Michigan Diabetes Research Center; NIH [P30DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK062876, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK62876 (to O. A. M.), a Pilot and Feasibility Grant (to B. X.) from the Michigan Diabetes Research Center, and NIH Grant P30DK020572 to the Chemistry Core of the Michigan Diabetes Research Center.	Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hube F, 2011, NUCLEIC ACIDS RES, V39, P513, DOI 10.1093/nar/gkq833; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Leygue E, 1999, CANCER RES, V59, P4190; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Murphy LC, 2000, CANCER RES, V60, P6266; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu B, 2004, J BIOL CHEM, V279, P33051, DOI 10.1074/jbc.M404930200; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	53	87	96	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13000	13009		10.1074/jbc.M114.564658	http://dx.doi.org/10.1074/jbc.M114.564658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675075	Green Published, hybrid			2022-12-28	WOS:000335522800005
J	Masuda, T; Wahlin, K; Wan, J; Hu, JF; Maruotti, J; Yang, X; Iacovelli, J; Wolkow, N; Kist, R; Dunaief, JL; Qian, J; Zack, DJ; Esumi, N				Masuda, Tomohiro; Wahlin, Karl; Wan, Jun; Hu, Jianfei; Maruotti, Julien; Yang, Xue; Iacovelli, Jared; Wolkow, Natalie; Kist, Ralf; Dunaief, Joshua L.; Qian, Jiang; Zack, Donald J.; Esumi, Noriko			Transcription Factor SOX9 Plays a Key Role in the Regulation of Visual Cycle Gene Expression in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eye; Gene Expression; Gene Regulation; MicroRNA; Transcription; SOX9; Retinal Pigment Epithelium; Visual Cycle	GLIAL-CELL DEVELOPMENT; MYELIN PROTEIN ZERO; IN-VIVO; PHOTORECEPTOR DEGENERATION; VERTEBRATE RETINA; BEST1 EXPRESSION; DOWN-REGULATION; MESSENGER-RNA; MOUSE MODEL; STEM-CELLS	Background: The visual cycle is an enzymatic cascade that regenerates the visual chromophore. Results: Visual cycle gene expression is regulated by SOX9 in combination with OTX2 or LHX2 and can be modulated by common microRNAs. Conclusion: A core transcriptional network involving SOX9 regulates visual cycle genes. Significance: Understanding visual cycle gene regulation may have implications for treating retinal degenerative diseases. The retinal pigment epithelium (RPE) performs specialized functions to support retinal photoreceptors, including regeneration of the visual chromophore. Enzymes and carrier proteins in the visual cycle function sequentially to regenerate and continuously supply 11-cis-retinal to retinal photoreceptor cells. However, it is unknown how the expression of the visual cycle genes is coordinated at the transcriptional level. Here, we show that the proximal upstream regions of six visual cycle genes contain chromatin-accessible sex-determining region Y box (SOX) binding sites, that SOX9 and LIM homeobox 2 (LHX2) are coexpressed in the nuclei of mature RPE cells, and that SOX9 acts synergistically with orthodenticle homeobox 2 (OTX2) to activate the RPE65 and retinaldehyde binding protein 1 (RLBP1) promoters and acts synergistically with LHX2 to activate the retinal G protein-coupled receptor (RGR) promoter. ChIP reveals that SOX9 and OTX2 bind to the promoter regions of RPE65, RLBP1, and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE. ChIP with human fetal RPE cells shows that SOX9 and OTX2 also bind to the human RPE65, RLBP1, and RGR promoters. Conditional inactivation of Sox9 in mouse RPE results in reduced expression of several visual cycle genes, most dramatically Rpe65 and Rgr. Furthermore, bioinformatic analysis predicts that multiple common microRNAs (miRNAs) regulate visual cycle genes, and cotransfection of miRNA mimics with luciferase reporter constructs validated some of the predicted miRNAs. These results implicate SOX9 as a key regulator of visual cycle genes, reveal for the first time the functional role of LHX2 in the RPE, and suggest the possible regulation of visual cycle genes by common miRNAs.	[Masuda, Tomohiro; Wahlin, Karl; Wan, Jun; Hu, Jianfei; Maruotti, Julien; Yang, Xue; Qian, Jiang; Zack, Donald J.; Esumi, Noriko] Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Baltimore, MD 21231 USA; [Iacovelli, Jared; Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Kist, Ralf] Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Zack, Donald J.] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Dept Mol Biol, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Dept Genet, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Johns Hopkins Univ, Inst Med Genet, Sch Med, Baltimore, MD 21231 USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, F-75012 Paris, France	Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; Newcastle University - UK; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Esumi, N (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Smith Bldg,Rm 3041,400 N Broadway, Baltimore, MD 21231 USA.	nesumi1@jhmi.edu	Wan, Jun/H-7132-2013; Kist, Ralf/B-4982-2008; Yang, xue/G-3626-2016; Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562; Kist, Ralf/0000-0003-3729-5693; Wan, Jun/0000-0001-9286-6562; Wolkow, Natalie/0000-0003-1524-115X; Zack, Don/0000-0002-7966-1973; Jianfei, Hu/0000-0001-8458-6683; Wahlin, Karl/0000-0002-0494-8304	National Institutes of Health [EY016398, EY009769, EY001765]; Foundation Fighting Blindness; Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016398, P30EY001765, R01EY009769, R01EY015240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016398 (to N.E.) and EY009769 (to (D.J.Z.) and National Institutes of Health Core Grant EY001765 (to the Wilmer Eye Institute). This work was also supported by Foundation Fighting Blindness, by an award from the Wilmer Pooled Professor Research Fund, by unrestricted funds from Research to Prevent Blindness, Inc., and by gifts from Mr. and Mrs. Robert and Clarice Smith and the Guerrieri Family Foundation.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bhutto IA, 2004, INVEST OPHTH VIS SCI, V45, P1544, DOI 10.1167/iovs.03-0862; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; de Melo J, 2012, P NATL ACAD SCI USA, V109, P4657, DOI 10.1073/pnas.1107488109; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagglund AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023387; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Hu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037224; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; Kennedy BN, 1998, J BIOL CHEM, V273, P5591, DOI 10.1074/jbc.273.10.5591; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Mead TJ, 2013, NUCLEIC ACIDS RES, V41, P4459, DOI 10.1093/nar/gkt140; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miller AM, 2010, J COMP NEUROL, V518, P4825, DOI 10.1002/cne.22497; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Porter FD, 1997, DEVELOPMENT, V124, P2935; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vazquez-Chona FR, 2009, INVEST OPHTH VIS SCI, V50, P3996, DOI 10.1167/iovs.08-3189; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vogel JS, 2007, INVEST OPHTH VIS SCI, V48, P3872, DOI 10.1167/iovs.06-1523; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhang L, 2013, MOL VIS, V19, P1371; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	70	35	36	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12908	12921		10.1074/jbc.M114.556738	http://dx.doi.org/10.1074/jbc.M114.556738			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634209	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000335581400059
J	Stemberk, V; Jones, RPO; Moroz, O; Atkin, KE; Edwards, AM; Turkenburg, JP; Leech, AP; Massey, RC; Potts, JR				Stemberk, Vaclav; Jones, Richard P. O.; Moroz, Olga; Atkin, Kate E.; Edwards, Andrew M.; Turkenburg, Johan P.; Leech, Andrew P.; Massey, Ruth C.; Potts, Jennifer R.			Evidence for Steric Regulation of Fibrinogen Binding to Staphylococcus aureus Fibronectin-binding Protein A ( FnBPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrinogen; Fibronectin; Isothermal Titration Calorimetry; Staphylococcus aureus; Surface Plasmon Resonance (SPR); X-ray Crystallography; FnBPA	CLUMPING FACTOR; CRYSTAL-STRUCTURE; GAMMA-CHAIN; AFFINITY; MSCRAMM; SURFACE; DOMAIN; MODEL; VALIDATION; REFINEMENT	Background:Staphylococcus aureus fibronectin-binding protein A (FnBPA) binds fibronectin and fibrinogen at adjacent sites. Results: The fibrinogen-binding mechanism is similar but not identical to homologous bacterial proteins. Ternary complex formation by intact fibronectin and fibrinogen on adjacent FnBPA sites could not be demonstrated. Conclusion: Fibrinogen binding is sterically regulated by fibronectin binding. Significance: Steric regulation might result in targeting of S. aureus to fibrin clots. The adjacent fibrinogen (Fg)- and fibronectin (Fn)-binding sites on Fn-binding protein A (FnBPA), a cell surface protein from Staphylococcus aureus, are implicated in the initiation and persistence of infection. FnBPA contains a single Fg-binding site (that also binds elastin) and multiple Fn-binding sites. Here, we solved the structure of the N2N3 domains containing the Fg-binding site of FnBPA in the apo form and in complex with a Fg peptide. The Fg binding mechanism is similar to that of homologous bacterial proteins but without the requirement for latch strand residues. We show that the Fg-binding sites and the most N-terminal Fn-binding sites are nonoverlapping but in close proximity. Although Fg and a subdomain of Fn can form a ternary complex on an FnBPA protein construct containing a Fg-binding site and single Fn-binding site, binding of intact Fn appears to inhibit Fg binding, suggesting steric regulation. Given the concentrations of Fn and Fg in the plasma, this mechanism might result in targeting of S. aureus to fibrin-rich thrombi or elastin-rich tissues.	[Stemberk, Vaclav; Jones, Richard P. O.; Atkin, Kate E.; Leech, Andrew P.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Moroz, Olga; Turkenburg, Johan P.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Edwards, Andrew M.; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of York - UK; University of York - UK; University of Bath	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jennifer.potts@york.ac.uk	Massey, Ruth/AAT-6415-2021	Massey, Ruth/0000-0002-8154-4039; Moroz, Olga/0000-0002-0354-6119; Turkenburg, Johan/0000-0001-6992-6838; Edwards, Andrew/0000-0002-7173-7355	Biotechnology and Biological Sciences Research Council; MRC [MR/J006874/1] Funding Source: UKRI; British Heart Foundation [PG/09/079/28008, FS/07/034/22969, FS/12/36/29588] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was also supported by the Biotechnology and Biological Sciences Research Council through a doctoral training grant.	Ariens RAS, 2013, J THROMB HAEMOST, V11, P294, DOI 10.1111/jth.12229; Banachewicz W, 2011, P NATL ACAD SCI USA, V108, P5596, DOI 10.1073/pnas.1101752108; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTEIN M, 1992, BIOCHEMISTRY-US, V31, P10692, DOI 10.1021/bi00159a008; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Drenth Jan, 2007, P1, DOI 10.1007/0-387-33746-6_1; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floyd CN, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012007; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Ganesh V. K., 2008, PLOS PATHOG, V4; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matsuda M, 1978, Ann N Y Acad Sci, V312, P74, DOI 10.1111/j.1749-6632.1978.tb16794.x; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MAYO KH, 1990, BIOCHEMISTRY-US, V29, P3277, DOI 10.1021/bi00465a019; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	58	21	22	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12842	12851		10.1074/jbc.M113.543546	http://dx.doi.org/10.1074/jbc.M113.543546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627488	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000335581400053
J	Yu, SL; Levi, L; Casadesus, G; Kunos, G; Noy, N				Yu, Shuiliang; Levi, Liraz; Casadesus, Gemma; Kunos, George; Noy, Noa			Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor beta/delta(PPAR beta/delta) in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Endocannabinoids; Lipids; Lipid-binding Protein; Peroxisome Proliferator-activated Receptor (PPAR)	RETINOIC ACID; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; HIPPOCAMPAL NEUROGENESIS; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; MEMORY; ALPHA; MICE; CB1	Background: FABP5 shuttles ligands to the nuclear receptor PPAR/ and enhances degradation of the endocannabinoid anandamide. Results: Brain level of anandamide is high and PPAR/ activation is low in FABP5-null mice. These mice display impaired learning and memory. Conclusion: FABP5 regulates learning and memory by two distinct mechanisms. Significance: The data suggest that FABP5 may be a novel target for therapy of cognitive dysfunction. Endocannabinoids modulate multiple behaviors, including learning and memory. We show that the endocannabinoid anandamide (AEA) can alter neuronal cell function both through its established role in activation of the G-protein-coupled receptor CB1, and by serving as a precursor for a potent agonist of the nuclear receptor PPAR/, in turn up-regulating multiple cognition-associated genes. We show further that the fatty acid-binding protein FABP5 controls both of these functions in vivo. FABP5 both promotes the hydrolysis of AEA into arachidonic acid and thus reduces brain endocannabinoid levels, and directly shuttles arachidonic acid to the nucleus where it delivers it to PPAR/, enabling its activation. In accordance, ablation of FABP5 in mice results in excess accumulation of AEA, abolishes PPAR/ activation in the brain, and markedly impairs hippocampus-based learning and memory. The data indicate that, by controlling anandamide disposition and activities, FABP5 plays a key role in regulating hippocampal cognitive function.	[Yu, Shuiliang; Levi, Liraz; Noy, Noa] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Casadesus, Gemma] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Kunos, George] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Noy, N (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave W333, Cleveland, OH 44106 USA.	noa.noy@case.edu		Levi, Liraz/0000-0001-7462-2396; Casadesus, Gemma/0000-0002-5206-5637	National Institutes of Health [R01 DK060684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK060684 (to N. N.).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Basavarajappa BS, 2009, MINI-REV MED CHEM, V9, P448, DOI 10.2174/138955709787847921; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Castellano C, 1997, BEHAV PHARMACOL, V8, P707, DOI 10.1097/00008877-199712000-00005; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Goonawardena AV, 2011, NEUROPHARMACOLOGY, V61, P1016, DOI 10.1016/j.neuropharm.2011.07.003; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kobilo T, 2011, LEARN MEMORY, V18, P103, DOI 10.1101/lm.2001611; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Liu J, 2013, P NATL ACAD SCI USA, V110, P18832, DOI 10.1073/pnas.1309469110; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mallet PE, 1996, BEHAV PHARMACOL, V7, P276; Manor D, 2003, CANCER RES, V63, P4426; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Maurelli S, 1995, FEBS LETT, V377, P82, DOI 10.1016/0014-5793(95)01311-3; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Mochizuki K, 2006, LIFE SCI, V80, P140, DOI 10.1016/j.lfs.2006.08.029; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Munguba H, 2011, NEUROBIOL LEARN MEM, V95, P527, DOI 10.1016/j.nlm.2011.03.006; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Norris AW, 1998, METH MOL B, V89, P123; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Paylor R, 1996, BEHAV NEUROSCI, V110, P1415, DOI 10.1037/0735-7044.110.6.1415; Pedroza-Llinas R, 2013, BEHAV BRAIN RES, V237, P141, DOI 10.1016/j.bbr.2012.09.032; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057; Zhou ZK, 2009, NEUROPHARMACOLOGY, V56, P81, DOI 10.1016/j.neuropharm.2008.07.031	54	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12748	12758		10.1074/jbc.M114.559062	http://dx.doi.org/10.1074/jbc.M114.559062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644281	Green Published, hybrid			2022-12-28	WOS:000335581400045
J	Zhang, Y; Lei, CQ; Hu, YH; Xia, T; Li, M; Zhong, B; Shu, HB				Zhang, Yu; Lei, Cao-Qi; Hu, Yun-Hong; Xia, Tian; Li, Mi; Zhong, Bo; Shu, Hong-Bing			Kruppel-like Factor 6 Is a Co-activator of NF- kappa B That Mediates p65-dependent Transcription of Selected Downstream Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Interleukin; Kruppel-like factor (KLF); NF-B (NF-B); Signal Transduction; Transcription; Tumor Necrosis Factor (TNF)	CELLULAR ANTIVIRAL RESPONSE; TNF-ALPHA; ACTIVATION; PROTEINS; EXPRESSION; PATHWAYS; IRF3; DNA	Background: Transcription factor NF-B is involved in various biological processes and regulated at multiple levels. Results: KLF6 modulates NF-B-mediated transcription by promoting binding of p65 to promoters of downstream genes. Conclusion: KLF6 is a co-activator of NF-B-mediated transcription of selected downstream genes. Significance: Our study reveals a new regulatory mechanism for NF-B-mediated transcriptional activation in the nucleus. The transcription factor NF-B plays a pivotal role in a broad range of physiological and pathological processes, including development, inflammation, and immunity. How NF-B integrates activating signals to expression of specific sets of target genes is of great interest. Here, we identified Kruppel-like factor 6 (KLF6) as a co-activator of NF-B after TNF and IL-1 stimulation. Overexpression of KLF6 enhanced TNF- and IL-1-induced activation of NF-B and transcription of a subset of downstream genes, whereas knockdown of KLF6 had opposite effects. KLF6 interacted with p65 in the nucleus and bound to the promoters of target genes. Upon IL-1 stimulation, KLF6 was recruited to promoters of a subset of NF-B target genes in a p65-dependent manner, which was in turn required for the optimal binding of p65 to the target gene promoters. Our findings thus identified KLF6 as a previously unknown but essential co-activator of NF-B and provided new insight into the molecular regulation of p65-dependent gene expression.	[Zhang, Yu; Lei, Cao-Qi; Hu, Yun-Hong; Xia, Tian; Li, Mi; Zhong, Bo; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			Ministry of Science and Technology of China [2012CB910201, 2010CB911800, 2014CB542600]; National Natural Science Foundation of China [31221061, 31130020, 31371427, 91029302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Ministry of Science and Technology of China (2012CB910201, 2010CB911800, 2014CB542600), and the National Natural Science Foundation of China (31221061, 31130020, 31371427, and 91029302).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Liu LJ, 2012, CELL RES, V22, P603, DOI 10.1038/cr.2011.199; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Rodriguez E., 2010, PLOS ONE, V5; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang X, 2012, J CELL SCI, V125, P4058, DOI 10.1242/jcs.103531; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	25	44	46	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12876	12885		10.1074/jbc.M113.535831	http://dx.doi.org/10.1074/jbc.M113.535831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634218	Green Published, hybrid			2022-12-28	WOS:000335581400056
J	Chesarino, NM; McMichael, TM; Hach, JC; Yount, JS				Chesarino, Nicholas M.; McMichael, Temet M.; Hach, Jocelyn C.; Yount, Jacob S.			Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 ( IFITM3) Dually Regulates Its Endocytosis and Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Influenza Virus; Innate Immunity; Interferon; Phosphorylation; Phosphotyrosine; Ubiquitination; IFITM; IFITM3; Posttranslational Modification	WEST NILE VIRUS; S-PALMITOYLATION; DENGUE VIRUS; NEGATIVE REGULATION; INFLUENZA; FAMILY; LOCALIZATION; REPLICATION; RESISTANCE; PROTEOMICS	Background: IFITM3 restricts the fusion of viruses within endolysosomes. Results: Phosphorylation of IFITM3 on Tyr(20) blocks IFITM3 endocytosis and ubiquitination. Conclusion: Tyr(20) of IFITM3 is part of a YXX endocytosis signal and has a dual role in regulating IFITM3 ubiquitination. Significance: Identifying mechanisms regulating IFITM3 trafficking and activity is crucial for understanding and manipulating IFITM3 biology for combating virus infections. Interferon-inducible transmembrane protein 3 (IFITM3) is essential for innate defense against influenza virus in mice and humans. IFITM3 localizes to endolysosomes where it prevents virus fusion, although mechanisms controlling its trafficking to this cellular compartment are not fully understood. We determined that both mouse and human IFITM3 are phosphorylated by the protein-tyrosine kinase FYN on tyrosine 20 (Tyr(20)) and that mouse IFITM3 is also phosphorylated on the non-conserved Tyr(27). Phosphorylation led to a cellular redistribution of IFITM3, including plasma membrane accumulation. Mutation of Tyr(20) caused a similar redistribution of IFITM3 and resulted in decreased antiviral activity against influenza virus, whereas Tyr(27) mutation of mouse IFITM3 showed minimal effects on localization or activity. Using FYN knockout cells, we also found that IFITM3 phosphorylation is not a requirement for its antiviral activity. Together, these results indicate that Tyr(20) is part of an endocytosis signal that can be blocked by phosphorylation or by mutation of this residue. Further mutagenesis narrowed this endocytosis-controlling region to four residues conforming to a YXX phi (where X is any amino acid and phi is Val, Leu, or Ile) endocytic motif that, when transferred to CD4, resulted in its internalization from the cell surface. Additionally, we found that phosphorylation of IFITM3 by FYN and mutagenesis of Tyr(20) both resulted in decreased IFITM3 ubiquitination. Overall, these results suggest that modification of Tyr(20) may serve in a cellular checkpoint controlling IFITM3 trafficking and degradation and demonstrate the complexity of posttranslational regulation of IFITM3.	[Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,790 Biomed Res Tower, Columbus, OH 43210 USA.	yount.37@osu.edu	Chesarino, Nicholas/AAC-3725-2020; Yount, Jacob/F-9905-2014	Chesarino, Nicholas/0000-0002-3582-8508; Yount, Jacob/0000-0002-6128-4575	NIAID, National Institutes of Health [R00AI095348]; Ohio State University Public Health Preparedness for Infectious Disease program; Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health) [T32GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI095348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ohio State University Public Health Preparedness for Infectious Disease program; Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID, National Institutes of Health Grant R00AI095348 (to J. S. Y.). This work was also supported by the Ohio State University Public Health Preparedness for Infectious Disease program.; Supported by The Ohio State University Systems and Integrative Biology Training Program (NIGMS, National Institutes of Health Grant T32GM068412).	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	32	83	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11986	11992		10.1074/jbc.M114.557694	http://dx.doi.org/10.1074/jbc.M114.557694			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627473	Green Published, hybrid			2022-12-28	WOS:000335010600037
J	Michel, LYM; Verkaart, S; Koopman, WJH; Willems, PHGM; Hoenderop, JGJ; Bindels, RJM				Michel, Lauriane Y. M.; Verkaart, Sjoerd; Koopman, Werner J. H.; Willems, Peter H. G. M.; Hoenderop, Joost G. J.; Bindels, Rene J. M.			Function and Regulation of the Na (+) -Ca2+ Exchanger NCX3 Splice Variants in Brain and Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium Transport; Endoplasmic Reticulum (ER); Excitotoxicity; Plasma Membrane; Sodium Calcium Exchange; Forward Mode; Muscle Fatigue; NCX; Reverse Mode	EPITHELIAL CA2+ CHANNEL; CARDIAC NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; SODIUM/CALCIUM EXCHANGER; VENTRICULAR MYOCYTES; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; EXTRACELLULAR CA2+; SMOOTH-MUSCLE	Background: The Na+-Ca2+ exchanger isoform 3 (NCX3) participates in maintaining calcium homeostasis in brain and skeletal muscle. Results: The two splice variants of NCX3 have distinct regulation and capacity of exchange. Conclusion: Distinct calcium uptake capacity of muscle NCX3 suggests a novel function in muscle exercise physiology. Significance: This study brings a new understanding of the role of NCX3 variants in excitable tissues. Isoform 3 of the Na+-Ca2+ exchanger (NCX3) is crucial for maintaining intracellular calcium ([Ca2+](i)) homeostasis in excitable tissues. In this sense NCX3 plays a key role in neuronal excitotoxicity and Ca2+ extrusion during skeletal muscle relaxation. Alternative splicing generates two variants (NCX3-AC and NCX3-B). Here, we demonstrated that NCX3 variants display a tissue-specific distribution in mice, with NCX3-B as mostly expressed in brain and NCX-AC as predominant in skeletal muscle. Using Fura-2-based Ca2+ imaging, we measured the capacity and regulation of the two variants during Ca2+ extrusion and uptake in different conditions. Functional studies revealed that, although both variants are activated by intracellular sodium ([Na+](i)), NCX3-AC has a higher [Na+](i) sensitivity, as Ca2+ influx is observed in the presence of extracellular Na+. This effect could be partially mimicked for NCX3-B by mutating several glutamate residues in its cytoplasmic loop. In addition, NCX3-AC displayed a higher capacity of both Ca2+ extrusion and uptake compared with NCX3-B, together with an increased sensitivity to intracellular Ca2+. Strikingly, substitution of Glu(580) in NCX3-B with its NCX3-AC equivalent Lys(580) recapitulated the functional properties of NCX3-AC regarding Ca2+ sensitivity, Lys(580) presumably acting through a structure stabilization of the Ca2+ binding site. The higher Ca2+ uptake capacity of NCX3-AC compared with NCX3-B is in line with the necessity to restore Ca2+ levels in the sarcoplasmic reticulum during prolonged exercise. The latter result, consistent with the high expression in the slow-twitch muscle, suggests that this variant may contribute to the Ca2+ handling beyond that of extruding Ca2+.	[Michel, Lauriane Y. M.; Verkaart, Sjoerd; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Dept Physiol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Koopman, Werner J. H.; Willems, Peter H. G. M.] Radboud Univ Nijmegen, Dept Biochem, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Michel, Lauriane Y. M.; Koopman, Werner J. H.; Willems, Peter H. G. M.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Ctr Syst Biol & Bioenerget, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Rene.Bindels@radboudumc.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; Willems, P.H.G.M./L-4759-2015; Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Michel, Lauriane Y.M./0000-0001-6733-3510	Netherlands Organization for Scientific Research [911-02-008, CSBR09/013V]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Equipment Grant 911-02-008 from Netherlands Organization for Scientific Research and the Centre for Systems Biology Research Initiative Grant CSBR09/013V from the Netherlands Organization for Scientific Research.	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; BALASUBRAMANYAM M, 1994, J CLIN INVEST, V94, P2002, DOI 10.1172/JCI117553; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Breukels V, 2012, BIOCHEM SOC T, V40, P409, DOI 10.1042/BST20110742; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cairns SP, 1998, J APPL PHYSIOL, V84, P1395, DOI 10.1152/jappl.1998.84.4.1395; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Germinario E, 2008, EUR J APPL PHYSIOL, V104, P445, DOI 10.1007/s00421-008-0796-5; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2007, ANN NY ACAD SCI, V1099, P7, DOI 10.1196/annals.1387.030; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Hinata M, 2002, J PHYSIOL-LONDON, V545, P453, DOI 10.1113/jphysiol.2002.025866; Hirota S, 2007, AM J PHYSIOL-LUNG C, V292, pL438, DOI 10.1152/ajplung.00222.2006; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Huang J, 2007, AM J PHYSIOL-CELL PH, V293, pC1906, DOI 10.1152/ajpcell.00241.2007; HUERTA M, 1991, JPN J PHYSIOL, V41, P933, DOI 10.2170/jjphysiol.41.933; Hurtado C, 2006, AM J PHYSIOL-HEART C, V290, pH2155, DOI 10.1152/ajpheart.00958.2005; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; John SA, 2013, P NATL ACAD SCI USA, V110, P7500, DOI 10.1073/pnas.1218751110; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Jung SY, 2007, EXP MOL MED, V39, P458, DOI 10.1038/emm.2007.50; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Kitao T, 2010, NEUROCHEM INT, V57, P58, DOI 10.1016/j.neuint.2010.04.016; KOFUJI P, 1992, AM J PHYSIOL, V263, pC1241, DOI 10.1152/ajpcell.1992.263.6.C1241; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lindgren RM, 2005, GENE, V348, P143, DOI 10.1016/j.gene.2005.01.003; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Minami A, 2007, J PHYSIOL-LONDON, V585, P413, DOI 10.1113/jphysiol.2007.143032; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Piacentino V, 2002, ANN NY ACAD SCI, V976, P476; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rebolledo A, 2006, BIOCHEM BIOPH RES CO, V339, P840, DOI 10.1016/j.bbrc.2005.11.084; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Szerencsei RT, 2013, CHANNELS, V7, P109, DOI 10.4161/chan.23898; Thurneysen T, 2002, MOL BRAIN RES, V107, P145, DOI 10.1016/S0169-328X(02)00461-8; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Viatchenko-Karpinski S, 2005, J PHYSIOL-LONDON, V567, P493, DOI 10.1113/jphysiol.2005.091280; Yamamura H, 2013, AM J PHYSIOL-CELL PH, V305, pC299, DOI 10.1152/ajpcell.00065.2013	51	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11293	11303		10.1074/jbc.M113.529388	http://dx.doi.org/10.1074/jbc.M113.529388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616101	hybrid, Green Published			2022-12-28	WOS:000334638500032
J	Yeh, YC; Tang, MJ; Parekh, AB				Yeh, Yi-Chun; Tang, Ming-Jer; Parekh, Anant B.			Caveolin-1 Alters the Pattern of Cytoplasmic Ca2+ Oscillations and Ca2+-dependent Gene Expression by Enhancing Leukotriene Receptor Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM CURRENT; ENDOTHELIAL-CELLS; CYSLT(1) RECEPTOR; G-PROTEINS; H-RAS; IDENTIFICATION; GROWTH; INACTIVATION; NEURONS	Cytoplasmic Ca2+ oscillations constitute a widespread signaling mode and are often generated in response to stimulation of G protein-coupled receptors that activate phospholipase C. In mast cells, repetitive Ca2+ oscillations can be evoked by modest activation of cysteinyl leukotriene type I receptors by the physiological trigger, leukotriene C-4. The Ca2+ oscillations arise from regenerative Ca2+ release from inositol 1,4,5-trisphosphate-sensitive stores followed by Ca2+ entry through store-operated Ca2+ channels, and the latter selectively activate the Ca2+-dependent transcription factor NFAT. The cysteinyl leukotriene type I receptors desensitize through negative feedback by protein kinase C, which terminates the oscillatory Ca2+ response. Here, we show that the scaffolding protein caveolin-1 has a profound effect on receptor-driven Ca2+ signals and downstream gene expression. Overexpression of caveolin-1 increased receptor-phospholipase C coupling, resulting in initially larger Ca2+ release transients of longer duration but which then ran down quickly. NFAT-activated gene expression, triggered in response to the Ca2+ signal, was also reduced by caveolin-1. Mutagenesis studies revealed that these effects required a functional scaffolding domain within caveolin-1. Mechanistically, the increase in Ca2+ release in the presence of caveolin-1 activated protein kinase C, which accelerated homologous desensitization of the leukotriene receptor and thereby terminated the oscillatory Ca2+ response. Our results reveal that caveolin-1 is a bimodal regulator of receptor-dependent Ca2+ signaling, which fine-tunes the spatial and temporal profile of the Ca2+ rise and thereby its ability to activate the NFAT pathway.	[Yeh, Yi-Chun; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Tang, Ming-Jer] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Tang, Ming-Jer] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	University of Oxford; National Cheng Kung University; Tunghai University	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Yeh, Yi-Chun/0000-0002-2807-9369; Tang, Ming-Jer/0000-0002-0883-4363	Medical Research Council; National Science Council Fellowship from Taiwan [100-2911-I-006-036]; MRC [G1000813] Funding Source: UKRI; Medical Research Council [G1000813] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science Council Fellowship from Taiwan; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council grant (to A. B. P.).; Y-C.Y. was a recipient of National Science Council Fellowship 100-2911-I-006-036 from Taiwan.	Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dawe GB, 2013, NAT STRUCT MOL BIOL, V20, P1054, DOI 10.1038/nsmb.2654; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kiss AL, 2000, EUR J CELL BIOL, V79, P343, DOI 10.1078/S0171-9335(04)70038-2; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li WP, 2001, J CELL SCI, V114, P1397; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2002, J BIOL CHEM, V277, P20820, DOI 10.1074/jbc.M203163200; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Nash MS, 2001, BIOCHEM J, V356, P137, DOI 10.1042/0264-6021:3560137; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	34	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17843	17853		10.1074/jbc.M114.553453	http://dx.doi.org/10.1074/jbc.M114.553453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24755228	Green Published, hybrid			2022-12-28	WOS:000338018100046
J	Bezsonova, I				Bezsonova, Irina			Solution NMR Structure of the DNA-binding Domain from Scml2 (Sex Comb on Midleg-like 2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Epigenetics; NMR; Polycomb; Protein Structure	BRAIN-TUMOR REPEATS; LYSINE METHYLATION; POLYCOMB; RECOGNITION; PROTEINS; SEQA; CRYSTALLOGRAPHY; IDENTIFICATION; ARCHITECTURE; COMPLEXES	Scml2 is a member of the Polycomb group of proteins involved in epigenetic gene silencing. Human Scml2 is a part of a multisubunit protein complex, PRC1 (Polycomb repressive complex 1), which is responsible for maintenance of gene repression, prevention of chromatin remodeling, preservation of the stemness of the cell, and cell differentiation. Although the majority of PRC1 subunits have been recently characterized, the structure of Scml2 and its role in PRC1-mediated gene silencing remain unknown. In this work a conserved protein domain within human Scml2 has been identified, and its structure was determined by solution NMR spectroscopy. This module was named Scm-like embedded domain, or SLED. Evolutionarily, the SLED domain emerges in the first multicellular organisms, consistent with the role of Scml2 in cell differentiation. Furthermore, it is exclusively found within the Scm-like family of proteins, often accompanied by malignant brain tumor domain (MBT) and sterile motif (SAM) domains. The domain adopts a novel / fold with no structural analogues found in the Protein Data Bank (PDB). The ability of the SLED to bind double-stranded DNA was also examined, and the isolated domain was shown to interact with DNA in a sequence-specific manner. Because PRC1 complexes localize to the promoters of a specific subset of developmental genes in vivo, the SLED domain of Scml2 may provide an important link connecting the PRC1 complexes to their target genes.	[Bezsonova, Irina] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA	University of Connecticut	Bezsonova, I (corresponding author), Univ Connecticut, Ctr Hlth, 263 Farmington Ave, Farmington, CT 06032 USA.	bezsonova@uchc.edu			Charles H. Hood Foundation Child Health Research Fund; Department of Public Health Biomedical Research; Connecticut Stem Cell Research Grant	Charles H. Hood Foundation Child Health Research Fund; Department of Public Health Biomedical Research; Connecticut Stem Cell Research Grant	Supported by the Charles H. Hood Foundation Child Health Research Fund, a Connecticut Department of Public Health Biomedical Research Project Award, and a Connecticut Stem Cell Research Grant.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Bornemann D, 1998, GENETICS, V150, P675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chung YS, 2009, NUCLEIC ACIDS RES, V37, P3143, DOI 10.1093/nar/gkp151; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujikawa N, 2004, NUCLEIC ACIDS RES, V32, P82, DOI 10.1093/nar/gkh173; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Goddard D., 2008, SPARKY 3; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guarne A, 2002, NAT STRUCT BIOL, V9, P839, DOI 10.1038/nsb857; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Kassis JA, 2010, MOL CELL BIOL, V30, P2581, DOI 10.1128/MCB.00231-10; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Montini E, 1999, GENOMICS, V58, P65, DOI 10.1006/geno.1999.5755; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8	43	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15739	15749		10.1074/jbc.M113.524009	http://dx.doi.org/10.1074/jbc.M113.524009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727478	Green Published, hybrid			2022-12-28	WOS:000337465400054
J	Cavalcanti, DMLP; Castro, LM; Neto, JCR; Seelaender, M; Neves, RX; Oliveira, V; Forti, FL; Iwai, LK; Gozzo, FC; Todiras, M; Schadock, I; Barros, CC; Bader, M; Ferro, ES				Cavalcanti, Diogo M. L. P.; Castro, Leandro M.; Rosa Neto, Jose C.; Seelaender, Marilia; Neves, Rodrigo X.; Oliveira, Vitor; Forti, Fabio L.; Iwai, Leo K.; Gozzo, Fabio C.; Todiras, Mihail; Schadock, Ines; Barros, Carlos C.; Bader, Michael; Ferro, Emer S.			Neurolysin Knockout Mice Generation and Initial Phenotype Characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Glucose Metabolism; Insulin; Peptidases; Peptides; Intracellular Peptides; Oligopeptidase	BRAIN SYNAPTIC-MEMBRANES; FALSE DISCOVERY RATE; THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 3.4.24.16; INTRACELLULAR PEPTIDES; SUBCELLULAR-DISTRIBUTION; CONVERTING-ENZYME; SKELETAL-MUSCLE; IN-VIVO; NEUROTENSIN	The oligopeptidase neurolysin (EC 3.4.24.16; Nln) was first identified in rat brain synaptic membranes and shown to ubiquitously participate in the catabolism of bioactive peptides such as neurotensin and bradykinin. Recently, it was suggested that Nln reduction could improve insulin sensitivity. Here, we have shown that Nln KO mice have increased glucose tolerance, insulin sensitivity, and gluconeogenesis. KO mice have increased liver mRNA for several genes related to gluconeogenesis. Isotopic label semiquantitative peptidomic analysis suggests an increase in specific intracellular peptides in gastrocnemius and epididymal adipose tissue, which likely is involved with the increased glucose tolerance and insulin sensitivity in the KO mice. These results suggest the exciting new possibility that Nln is a key enzyme for energy metabolism and could be a novel therapeutic target to improve glucose uptake and insulin sensitivity.	[Cavalcanti, Diogo M. L. P.; Rosa Neto, Jose C.; Seelaender, Marilia; Neves, Rodrigo X.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, BR-05508900 Sao Paulo, Brazil; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Support Ctr Res Proteolysis & Cell Signaling, BR-05508900 Sao Paulo, Brazil; [Castro, Leandro M.; Oliveira, Vitor] Univ Fed Sao Paulo, Dept Biophys, BR-04039032 Sao Paulo, Brazil; [Forti, Fabio L.] Univ Sao Paulo, Inst Chem, Dept Biochem, Support Ctr Res Proteolysis & Cell Signaling, BR-05508000 Sao Paulo, Brazil; [Iwai, Leo K.] Butantan Inst, Special Lab Appl Toxinol, Ctr Toxins Immune Response & Cell Signaling, BR-05503000 Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, BR-13083862 Campinas, SP, Brazil; [Todiras, Mihail; Schadock, Ines; Barros, Carlos C.; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Barros, Carlos C.] Univ Fed Pelotas, Dept Nutr, BR-96010610 Pelotas, RS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual de Campinas; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Federal de Pelotas	Ferro, ES (corresponding author), Av Prof Lineu Prestes 1524,Sala 315, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br	Iwai, Leo K/M-1734-2013; Oliveira, Vitor/AAT-5981-2020; Castro, Leandro M/E-5654-2014; Oliveira, Vitor/L-3709-2013; Castro, Leandro/ABI-5520-2020; Barros, Carlos Castilho/V-8659-2019; Ferro, Emer S/D-3908-2012; Barros, Carlos Castilho C/D-5378-2012; Castro, Leandro/O-6762-2019; Todiras, Mihail/AAT-4426-2020; rosa, jose cesar/C-4359-2014; FORTI, FABIO LUIS/F-8085-2012; Bader, Michael/K-2124-2013; Seelaender, Marilia Cerqueira Leite/B-9101-2011; Neto, Jose Cesar Rosa/I-8145-2015; Neto, Jose Rosa/G-6336-2012	Iwai, Leo K/0000-0002-1571-7763; Oliveira, Vitor/0000-0002-4662-1377; Castro, Leandro/0000-0002-7156-2006; Barros, Carlos Castilho/0000-0002-6926-734X; Ferro, Emer S/0000-0003-1651-9192; Barros, Carlos Castilho C/0000-0002-6926-734X; Castro, Leandro/0000-0002-7156-2006; Todiras, Mihail/0000-0002-9373-4753; FORTI, FABIO LUIS/0000-0002-2278-6396; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Neto, Jose Cesar Rosa/0000-0001-7019-9762; Neto, Jose Rosa/0000-0001-7019-9762; Bader, Michael/0000-0003-4780-4164; Schadock, Ines/0000-0002-6717-6276; Manuel Lopes de Paiva Cavalcanti, Diogo/0000-0002-6395-7809	Brazilian National Research Council [559698/2009-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico [04/04933-2]; Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process [2012.1.17607.1.2]; Brazilian National Research Council Ph.D. Fellowship [GM/GD-140650/2010-5, SWE-200678/2011-6]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico; Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process; Brazilian National Research Council Ph.D. Fellowship	This work was supported by the Brazilian National Research Council Grants 559698/2009-7 (Rede GENOPROT), by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico 04/04933-2 (to E. S. F.), and by the Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process 2012.1.17607.1.2.; Supported by Brazilian National Research Council Ph.D. Fellowship GM/GD-140650/2010-5 and SWE-200678/2011-6.; Supported by Brazilian National Research Council research fellowships.	[Anonymous], 2007, MATH STAT METASTATIS; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; BARELLI H, 1993, EUR J BIOCHEM, V211, P79, DOI 10.1111/j.1432-1033.1993.tb19872.x; BARELLI H, 1994, BRIT J PHARMACOL, V112, P127, DOI 10.1111/j.1476-5381.1994.tb13041.x; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Barros CC, 2012, LAB INVEST, V92, P1419, DOI 10.1038/labinvest.2012.105; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Blais PA, 2005, PEPTIDES, V26, P1317, DOI 10.1016/j.peptides.2005.03.026; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Cardoso CC, 2010, BIOL CHEM, V391, P435, DOI 10.1515/BC.2010.040; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Castro LM, 2014, J PROTEOMICS, V111, P238, DOI 10.1016/j.jprot.2014.03.043; Castro LM, 2010, AAPS J, V12, P608, DOI 10.1208/s12248-010-9224-y; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1983, J NEUROCHEM, V41, P375, DOI 10.1111/j.1471-4159.1983.tb04753.x; CHECLER F, 1984, J NEUROCHEM, V43, P1295, DOI 10.1111/j.1471-4159.1984.tb05386.x; Checler F, 2014, J NEUROCHEM, V129, P1, DOI 10.1111/jnc.12635; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DAUCH P, 1995, J BIOL CHEM, V270, P27266, DOI 10.1074/jbc.270.45.27266; DOULUT S, 1993, J MED CHEM, V36, P1369, DOI 10.1021/jm00062a009; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Garrido PAG, 1999, DNA CELL BIOL, V18, P323, DOI 10.1089/104454999315385; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kato A, 1997, J BIOL CHEM, V272, P15313, DOI 10.1074/jbc.272.24.15313; Krause DR, 1997, J CELL BIOCHEM, V66, P297, DOI 10.1002/(SICI)1097-4644(19970901)66:3<297::AID-JCB3>3.0.CO;2-K; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; MRAD JA, 1992, AM J PHYSIOL, V262, pR684, DOI 10.1152/ajpregu.1992.262.4.R684; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1978, DOI 10.1152/ajpheart.01116.2002; OLIVEIRA EB, 1976, BIOCHEMISTRY-US, V15, P1967, DOI 10.1021/bi00654a026; Oliveira EB, 2007, AM J PHYSIOL-HEART C, V293, pH3550, DOI 10.1152/ajpheart.00784.2007; Panico K, 2013, J PROTEOME RES, V12, P5851, DOI 10.1021/pr400867j; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Rashid M, 2014, J NEUROCHEM, V129, P179, DOI 10.1111/jnc.12513; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Ray K, 2002, PROTEIN SCI, V11, P2237, DOI 10.1110/ps.0216302; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Russo LC, 2012, FEBS LETT, V586, P3287, DOI 10.1016/j.febslet.2012.07.002; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; Smith AI, 2000, HYPERTENSION, V35, P626, DOI 10.1161/01.HYP.35.2.626; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Tian R, 2005, CIRC RES, V96, P139, DOI 10.1161/01.RES.0000156076.17807.1F; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Williamson DL, 2001, J APPL PHYSIOL, V91, P1955, DOI 10.1152/jappl.2001.91.5.1955; WOULFE J, 1992, EUR J NEUROSCI, V4, P1309, DOI 10.1111/j.1460-9568.1992.tb00156.x; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	84	28	29	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15426	15440		10.1074/jbc.M113.539148	http://dx.doi.org/10.1074/jbc.M113.539148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719317	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000337465400026
J	Waight, JD; Banik, D; Griffiths, EA; Nemeth, MJ; Abrams, SI				Waight, Jeremy D.; Banik, Debarati; Griffiths, Elizabeth A.; Nemeth, Michael J.; Abrams, Scott I.			Regulation of the Interferon regulatory factor-8 (IRF-8) Tumor Suppressor Gene by the Signal Transducer and Activator of Transcription 5 (STAT5) Transcription Factor in Chronic Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Death; Leukemia; STAT Transcription Factor; Tumor Suppressor Gene	CHRONIC MYELOGENOUS LEUKEMIA; SEQUENCE BINDING-PROTEIN; PERIPHERAL T-CELLS; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC PROGENITORS; TYROSINE PHOSPHORYLATION; ICSBP DEFICIENCY; WILMS-TUMOR; EXPRESSION; ABL	Tyrosine kinase inhibitors such as imatinib can effectively target the BCR-ABL oncoprotein in a majority of patients with chronic myeloid leukemia (CML). Unfortunately, some patients are resistant primarily to imatinib and others develop drug resistance, prompting interest in the discovery of new drug targets. Although much of this resistance can be explained by the presence of mutations within the tyrosine kinase domain of BCR-ABL, such mutations are not universally identified. Interferon regulatory factor-8 (IRF-8) is a transcription factor that is essential for myelopoiesis. Depressed IRF-8 levels are observed in a majority of CML patients and Irf-8(-/-) mice exhibit a CML-like disease. The underlying mechanisms of IRF-8 loss in CML are unknown. We hypothesized that BCR-ABL suppresses transcription of IRF-8 through STAT5, a proximal BCR-ABL target. Treatment of primary cells from newly diagnosed CML patients in chronic phase as well as BCR-ABL(+) cell lines with imatinib increased IRF-8 transcription. Furthermore, IRF-8 expression in cell line models was necessary for imatinib-induced antitumor responses. We have demonstrated that IRF-8 is a direct target of STAT5 and that silencing of STAT5 induced IRF-8 expression. Conversely, activating STAT5 suppressed IRF-8 transcription. Finally, we showed that STAT5 blockade using a recently discovered antagonist increased IRF-8 expression in patient samples. These data reveal a previously unrecognized BCR-ABL-STAT5-IRF-8 network, which widens the repertoire of potentially new anti-CML targets.	[Waight, Jeremy D.; Banik, Debarati; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Griffiths, Elizabeth A.; Abrams, Scott I.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Griffiths, Elizabeth A.; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Nemeth, MJ (corresponding author), Roswell Pk Canc Inst, Dept Med, Elm & Carlton St, Buffalo, NY 14263 USA.	Michael.Nemeth@RoswellPark.org; Scott.Abrams@RoswellPark.org			NCI, National Institutes of Health [R01CA140622]; National Institutes of Health [T32CA085183]; NCI, National Institutes of Health Cancer Center [CA016056]; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE [P30CA016056, T32CA085183, R01CA140622] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health Cancer Center; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA140622 (to S. I. A.), National Institutes of Health Training Grant T32CA085183 (to J. D. W.), and NCI, National Institutes of Health Cancer Center Support Grant CA016056. This work was also supported by an Alliance Developmental Award from the Roswell Park Alliance Foundation (to S. I. A. and M. J. N.).	Banik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045422; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Koenigsmann J, 2009, BLOOD, V113, P4690, DOI 10.1182/blood-2008-05-158485; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; ODA T, 1994, J BIOL CHEM, V269, P22925; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Shuai K, 1996, ONCOGENE, V13, P247; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TENHOEVE J, 1994, BLOOD, V84, P1731; Vidovic K, 2010, LEUKEMIA, V24, P992, DOI 10.1038/leu.2010.33; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; WeberNordt RM, 1996, BLOOD, V88, P809; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	46	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15642	15652		10.1074/jbc.M113.544320	http://dx.doi.org/10.1074/jbc.M113.544320			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753251	Green Published, hybrid			2022-12-28	WOS:000337465400046
J	Karam, P; Powdrill, MH; Liu, HW; Vasquez, C; Mah, W; Bernatchez, J; Gotte, M; Cosa, G				Karam, Pierre; Powdrill, Megan H.; Liu, Hsiao-Wei; Vasquez, Colins; Mah, Wayne; Bernatchez, Jean; Goette, Matthias; Cosa, Gonzalo			Dynamics of Hepatitis C Virus ( HCV) RNA-dependent RNA Polymerase NS5B in Complex with RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Drug Resistance; Fluorescence Resonance Energy Transfer (FRET); Hepatitis c Virus; RNA Polymerase	DE-NOVO INITIATION; HIV REVERSE-TRANSCRIPTASE; SINGLE-STRANDED-DNA; FLUORESCENCE SPECTROSCOPY; CRYSTAL-STRUCTURE; MOLECULE; INHIBITORS; BINDING; IDENTIFICATION; SITE	Background: The dynamics associated with RNA binding by the hepatitis C virus (HCV) polymerase remain elusive. Results: Single molecule experiments reveal changing populations of binary RNA-enzyme complexes. Conclusion: Rapid enzyme conformational changes facilitate sliding/wrapping of the polymerase along its RNA substrate. Significance: This study provides novel insight into mechanisms associated with viral replication and its inhibition. The hepatitis C virus (HCV) non-structural protein 5B (NS5B) is an RNA-dependent RNA polymerase that is essentially required for viral replication. Although previous studies revealed important properties of static NS5B-RNA complexes, the nature and relevance of dynamic interactions have yet to be elucidated. Here, we devised a single molecule Forster Resonance Energy Transfer (SM-FRET) assay to monitor temporal changes upon binding of NS5B to surface immobilized RNA templates. The data show enzyme association-dissociation events that occur within the time resolution of our setup as well as FRET-fluctuations in association with stable binary complexes that extend over prolonged periods of time. Fluctuations are shown to be dependent on the length of the RNA substrate, and enzyme concentration. Mutations in close proximity to the template entrance (K98E, K100E), and in the center of the RNA binding channel (R394E), reduce both the population of RNA-bound enzyme and the fluctuations associated to the binary complex. Similar observations are reported with an allosteric nonnucleoside NS5B inhibitor. Our assay enables for the first time the visualization of association-dissociation events of HCV-NS5B with RNA, and also the direct monitoring of the interaction between HCV NS5B, its RNA template, and finger loop inhibitors. We observe both a remarkably low dissociation rate for wild type HCV NS5B, and a highly dynamic enzyme-RNA binary complex. These results provide a plausible mechanism for formation of a productive binary NS5B-RNA complex, here NS5B slides along the RNA template facilitating positioning of its 3 terminus at the enzyme active site.	[Karam, Pierre; Liu, Hsiao-Wei; Mah, Wayne; Goette, Matthias; Cosa, Gonzalo] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Cosa, Gonzalo] McGill Univ, Ctr Self Assembled Chem Struct CSACS CRMAA, Montreal, PQ H3A 2K6, Canada; [Powdrill, Megan H.; Vasquez, Colins; Bernatchez, Jean] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Goette, Matthias] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Gotte, M (corresponding author), 3775 Univ St,Room D6, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca; gonzalo.cosa@mcgill.ca		Bernatchez, Jean/0000-0002-8309-1627; Cosa, Gonzalo/0000-0003-0064-1345	Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant; National Science and Engineering Research Council of Canada (NSERC); Nanoquebec; Canadian Institutes of Health Research (CIHR); McGill Chemical Biology Fellowship Program (CIHR); National CIHR Research Training Program in Hepatitis C (NCRTP); CIHR Drug Discovery and Training Program; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant(FQRNT); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nanoquebec; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Chemical Biology Fellowship Program (CIHR)(Canadian Institutes of Health Research (CIHR)); National CIHR Research Training Program in Hepatitis C (NCRTP)(Canadian Institutes of Health Research (CIHR)); CIHR Drug Discovery and Training Program(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	This work was supported by a Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) Team Grant, the National Science and Engineering Research Council of Canada (NSERC), Nanoquebec, and The Canadian Institutes of Health Research (CIHR).; Recipient of the McGill Chemical Biology Fellowship Program (CIHR) for a postgraduate scholarship.; Recipient of a student stipend from the National CIHR Research Training Program in Hepatitis C (NCRTP).; Recipient of postdoctoral fellowships from the CIHR Drug Discovery and Training Program and from the Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Kim MJ, 2000, J VIROL, V74, P10312, DOI 10.1128/JVI.74.22.10312-10322.2000; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Marko RA, 2013, J PHYS CHEM B, V117, P4560, DOI 10.1021/jp308674g; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sun XL, 2000, BIOCHEM BIOPH RES CO, V268, P798, DOI 10.1006/bbrc.2000.2120; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 1998, J VIROL, V72, P9365, DOI 10.1128/JVI.72.11.9365-9369.1998	44	17	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14399	14411		10.1074/jbc.M113.529743	http://dx.doi.org/10.1074/jbc.M113.529743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692556	Green Published, hybrid			2022-12-28	WOS:000335984600065
J	Li, HY; Wang, J; Wu, YX; Zhang, L; Liu, ZP; Filep, JG; Potempa, LA; Wu, Y; Ji, SR				Li, Hai-Yun; Wang, Jing; Wu, Yue-Xin; Zhang, Lin; Liu, Zu-Pei; Filep, Janos G.; Potempa, Lawrence A.; Wu, Yi; Ji, Shang-Rong			Topological Localization of Monomeric C-reactive Protein Determines Proinflammatory Endothelial Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endothelial Dysfunction; Inflammation; Innate Immunity; Pentraxins; C-Reactive Protein; Polarized Activation	COMPLEMENT ACTIVATION; FACTOR-H; DISEASE; ATHEROSCLEROSIS; PLATELETS; INFLAMMATION; MECHANISMS; PLAQUES; LESIONS; CANCER	Background: Monomeric C-reactive protein (mCRP) may contribute to atherogenesis by inducing endothelial activation. Results: mCRP induces much weaker endothelial cell (EC) responses from the basolateral than from the apical surfaces of ECs. Conclusion: Tissue-associated mCRP likely contributes little to EC activation. Significance: Topological localization is an important factor that defines the contribution of inflammatory mediators to chronic vascular inflammation. The activation of endothelial cells (ECs) by monomeric C-reactive protein (mCRP) has been implicated in contributing to atherogenesis. However, the potent proinflammatory actions of mCRP on ECs in vitro appear to be incompatible with the atheroprotective effects of mCRP in a mouse model. Because mCRP is primarily generated within inflamed tissues and is rapidly cleared from the circulation, we tested whether these discrepancies can be explained by topological differences in response to mCRP within blood vessels. In a Transwell culture model, the addition of mCRP to apical (luminal), but not basolateral (abluminal), surfaces of intact human coronary artery EC monolayers evoked a significant up-regulation of MCP-1, IL-8, and IL-6. Such polarized stimulation of mCRP was observed consistently regardless of EC type or experimental conditions (e.g. culture of ECs on filters or extracellular matrix-coated surfaces). Accordingly, we detected enriched lipid raft microdomains, the major surface sensors for mCRP on ECs, in apical membranes, leading to the preferential apical binding of mCRP and activation of ECs through the polarized induction of the phospholipase C, p38 MAPK, and NF-B signaling pathways. Furthermore, LPS and IL-1 induction of EC activation also exhibited topological dependence, whereas TNF- did not. Together, these results indicate that tissue-associated mCRP likely contributes little to EC activation. Hence, topological localization is an important, but often overlooked, factor that determines the contribution of mCRP and other proinflammatory mediators to chronic vascular inflammation.	[Li, Hai-Yun; Wang, Jing; Wu, Yue-Xin; Zhang, Lin; Liu, Zu-Pei; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Minist Educ China, Lanzhou 730000, Peoples R China; [Filep, Janos G.] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Potempa, Lawrence A.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA; [Wu, Yi] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Ministry of Education, China; Universite de Montreal; Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn		Ji, Shang-Rong/0000-0001-8595-3756; Li, Haiyun/0000-0002-7458-7399; Wu, Yi/0000-0003-0365-5590	Ministry of Science and Technology of China [2011CB910500]; National Natural Science Foundation of China [30930024, 31222015, 31270813, 31170696]; Ministry of Education of China [PCSIRT: IRT1137, 121108, 20100211110006, lzujbky-2010-k03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by Ministry of Science and Technology of China grant 2011CB910500; by National Natural Science Foundation of China grants 30930024, 31222015, 31270813, 31170696; and by Ministry of Education of China grants PCSIRT: IRT1137, 121108, 20100211110006, and lzujbky-2010-k03.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; De La Torre R, 2013, J THROMB HAEMOST, V11, P2048, DOI 10.1111/jth.12415; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Filep JG, 2009, CIRC RES, V105, P109, DOI 10.1161/CIRCRESAHA.109.202010; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Lauer N, 2011, J IMMUNOL, V187, P4374, DOI 10.4049/jimmunol.1002488; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Motie M, 1998, DRUG METAB DISPOS, V26, P977; MULLER WA, 1986, J CELL BIOL, V103, P2389, DOI 10.1083/jcb.103.6.2389; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2003, NEPHROL DIAL TRANSPL, V18, P2300, DOI 10.1093/ndt/gfg407; Schwedler SB, 2009, CLIN CHEM, V55, P1728, DOI 10.1373/clinchem.2009.125732; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Strang F, 2012, BRAIN PATHOL, V22, P337, DOI 10.1111/j.1750-3639.2011.00539.x; Triantafilou M, 2002, J CELL SCI, V115, P2603; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	37	29	32	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14283	14290		10.1074/jbc.M114.555318	http://dx.doi.org/10.1074/jbc.M114.555318			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711458	Green Published, hybrid			2022-12-28	WOS:000335984600053
J	Nagpal, K; Watanabe, KS; Tsao, BP; Tsokos, GC				Nagpal, Kamalpreet; Watanabe, Katsue Sunahori; Tsao, Betty P.; Tsokos, George C.			Transcription factor Ikaros Represses Protein Phosphatase 2A ( PP2A) Expression through an Intronic Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Modification; Gene Regulation; Protein Phosphatase; T Cell; Transcription Repressor	SYSTEMIC-LUPUS-ERYTHEMATOSUS; SERINE THREONINE PHOSPHATASES; T-CELLS; LYMPHOCYTE DEVELOPMENT; IL-2 PRODUCTION; FCR-GAMMA; DISEASE; GENE; METHYLATION; DETERMINES	Background: PP2A is a serine/threonine phosphatase playing a central role in the pathology of the autoimmune disease SLE. Results: Ikaros binds to an intronic site in PP2A and modulates its expression. Conclusion: Ikaros represses PP2A expression by recruiting histone deacetylase HDAC1. Significance: This study proposes a novel pathway for regulation of PP2A, a critical molecule in SLE pathogenesis. Protein phosphatase 2A (PP2A) is a highly conserved and ubiquitous serine/threonine phosphatase. We have shown previously that PP2A expression is increased in T cells of systemic lupus erythematosus patients and that this increased expression and activity of PP2A plays a central role in the molecular pathogenesis of systemic lupus erythematosus. Although the control of PP2A expression has been the focus of many studies, many aspects of its regulation still remain poorly understood. In this study, we describe a novel mechanism of PP2A regulation. We propose that the transcription factor Ikaros binds to a variant site in the first intron of PP2A and modulates its expression. Exogenous expression of Ikaros leads to reduced levels of PP2Ac message as well as protein. Conversely, siRNA-enabled silencing of Ikaros enhances the expression of PP2A, suggesting that Ikaros acts as a suppressor of PP2A expression. A ChIP analysis further proved that Ikaros is recruited to this site in T cells. We also attempted to delineate the mechanism of Ikaros-mediated PP2Ac gene suppression. We show that Ikaros-mediated suppression of PP2A expression is at least partially dependent on the recruitment of the histone deacetylase HDAC1 to this intronic site. We conclude that the transcription factor Ikaros can regulate the expression of PP2A by binding to a site in the first intron and modulating chromatin modifications at this site via recruitment of HDAC1.	[Nagpal, Kamalpreet; Watanabe, Katsue Sunahori; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02215 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA 90095 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles	Nagpal, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,CLS 937, Boston, MA 02215 USA.	knagpal@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Tsao, Betty/0000-0001-7938-5975	National Institutes of Health [R01 AI068787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI068787 (to G.C.T.).	COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083426; Hu WL, 2011, RHEUMATOL INT, V31, P819, DOI 10.1007/s00296-010-1576-1; Hu XL, 2001, J BIOL CHEM, V276, P4597, DOI 10.1074/jbc.M005477200; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; McEwen DG, 1998, J BIOL CHEM, V273, P5349, DOI 10.1074/jbc.273.9.5349; Moabbi AM, 2012, P NATL ACAD SCI USA, V109, P8505, DOI 10.1073/pnas.1112400109; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Sellars Maclean, 2011, World J Biol Chem, V2, P132, DOI 10.4331/wjbc.v2.i6.132; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tan WF, 2011, ARTHRITIS RHEUM-US, V63, P2755, DOI 10.1002/art.30452; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	24	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13751	13757		10.1074/jbc.M114.558197	http://dx.doi.org/10.1074/jbc.M114.558197			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692537	Green Published, hybrid			2022-12-28	WOS:000335984600009
J	Tonkin, ML; Beck, JR; Bradley, PJ; Boulanger, MJ				Tonkin, Michelle L.; Beck, Josh R.; Bradley, Peter J.; Boulanger, Martin J.			The Inner Membrane Complex Sub-compartment Proteins Critical for Replication of the Apicomplexan Parasite Toxoplasma gondii Adopt a Pleckstrin Homology Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Parasite; Protein-Protein Interactions; Structural Biology; X-ray Crystallography; Apicomplexa; Inner Membrane Complex; Pleckstrin Homology Fold; Toxoplasma gondii; Endodyogeny	STRUCTURAL BASIS; DOMAINS; IDENTIFICATION; LOCALIZATION; SARCOCYSTIS; GLIDEOSOME; COMPONENT; ALIGNMENT; ACCURACY; SEQUENCE	Background: Inner membrane complex sub-compartment Proteins (ISPs) are critical for proper cell division of apicomplexan parasites, but the mechanism is unknown. Results: ISPs adopt a pleckstrin homology (PH)-fold yet do not retain phospholipid-binding activity. Conclusion: ISPs appear to repurpose the phospholipid-binding site to recruit protein partners. Significance: First structural characterization of an ISP from any organism. Toxoplasma gondii, an apicomplexan parasite prevalent in developed nations, infects up to one-third of the human population. The success of this parasite depends on several unique structures including an inner membrane complex (IMC) that lines the interior of the plasma membrane and contains proteins important for gliding motility and replication. Of these proteins, the IMC sub-compartment proteins (ISPs) have recently been shown to play a role in asexual T. gondii daughter cell formation, yet the mechanism is unknown. Complicating mechanistic characterization of the ISPs is a lack of sequence identity with proteins of known structure or function. In support of elucidating the function of ISPs, we first determined the crystal structures of representative members TgISP1 and TgISP3 to a resolution of 2.10 and 2.32 , respectively. Structural analysis revealed that both ISPs adopt a pleckstrin homology fold often associated with phospholipid binding or protein-protein interactions. Substitution of basic for hydrophobic residues in the region that overlays with phospholipid binding in related pleckstrin homology domains, however, suggests that ISPs do not retain phospholipid binding activity. Consistent with this observation, biochemical assays revealed no phospholipid binding activity. Interestingly, mapping of conserved surface residues combined with crystal packing analysis indicates that TgISPs have functionally repurposed the phospholipid-binding site likely to coordinate protein partners. Recruitment of larger protein complexes may also be aided through avidity-enhanced interactions resulting from multimerization of the ISPs. Overall, we propose a model where TgISPs recruit protein partners to the IMC to ensure correct progression of daughter cell formation.	[Tonkin, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Beck, Josh R.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Victoria; University of California System; University of California Los Angeles	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Canadian Institutes for Health Research [MOP82915]; National Institutes of Health Microbial Pathogenesis [T32 AI07323, RO1 AI064616]; Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship [CGSD3]; Ventura Neale Trust Endowed PEO Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064616, T32AI007323] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Microbial Pathogenesis; Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; Ventura Neale Trust Endowed PEO Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canadian Institutes for Health Research Grant MOP82915 (to M. J. B.), a National Institutes of Health Microbial Pathogenesis Training Grant T32 AI07323 (to J. R. B.), and Grant RO1 AI064616 (to P. J. B.).; Supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship (CGSD3) and a Ventura Neale Trust Endowed PEO Scholar Award.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Chaudhary K, 2005, J BIOL CHEM, V280, P22053, DOI 10.1074/jbc.M503178200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; DHAESE J, 1977, INT J PARASITOL, V7, P505, DOI 10.1016/0020-7519(77)90014-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fung CN, 2012, MOL BIOCHEM PARASIT, V184, P99, DOI 10.1016/j.molbiopara.2012.05.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morrissette NS, 1997, J CELL SCI, V110, P35; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Rayavara K, 2009, MOL BIOCHEM PARASIT, V167, P135, DOI 10.1016/j.molbiopara.2009.05.006; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tonkin ML, 2012, ACTA CRYSTALLOGR F, V68, P832, DOI 10.1107/S174430911202297X; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	50	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13962	13973		10.1074/jbc.M114.548891	http://dx.doi.org/10.1074/jbc.M114.548891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675080	hybrid, Green Published			2022-12-28	WOS:000335984600027
J	Doyle, JR; Krishnaji, ST; Zhu, GL; Xu, ZZ; Heller, D; Ji, RR; Levy, BD; Kumar, K; Kopin, AS				Doyle, Jamie R.; Krishnaji, Subrahmanian T.; Zhu, Guangli; Xu, Zhen-Zhong; Heller, Daniel; Ji, Ru-Rong; Levy, Bruce D.; Kumar, Krishna; Kopin, Alan S.			Development of a Membrane-anchored Chemerin Receptor Agonist as a Novel Modulator of Allergic Airway Inflammation and Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Drug Screening; G Protein-coupled Receptors (GPCR); Inflammation; Pharmacology; CMKLR1; ChemR23; Lipidated Peptides; Membrane-tethered Ligands	RESOLVIN E1; TETHERED LIGANDS; PEPTIDES; ACID; SUBSTITUTION; SPECIFICITY; ACTIVATION; RESOLUTION; ASTHMA; CELLS	Background: The chemerin-CMKLR1 axis modulates inflammation; ligands for CMKLR1 have short half-lives. Results: We have utilized a novel technology to develop a long-acting, high potency membrane-anchored CMKLR1 agonist. Conclusion: This ligand decreases allergic airway inflammation and neuropathic pain in mice. Significance: Our approach can be applied to develop other candidate therapeutics targeting peptide hormone receptors implicated as modulators of disease. The chemerin receptor (CMKLR1) is a G protein-coupled receptor found on select immune, epithelial, and dorsal root ganglion/spinal cord neuronal cells. CMKLR1 is primarily coupled to the inhibitory G protein, G(i), and has been shown to modulate the resolution of inflammation and neuropathic pain. CMKLR1 is activated by both lipid and peptide agonists, resolvin E1 and chemerin, respectively. Notably, these ligands have short half-lives. To expedite the development of long acting, stable chemerin analogs as candidate therapeutics, we used membrane-tethered ligand technology. Membrane-tethered ligands are recombinant proteins comprised of an extracellular peptide ligand, a linker sequence, and an anchoring transmembrane domain. Using this technology, we established that a 9-amino acid-tethered chemerin fragment (amino acids 149-157) activates both mouse and human CMKLR1 with efficacy exceeding that of the full-length peptide (amino acids 21-157). To enable in vivo delivery of a corresponding soluble membrane anchored ligand, we generated lipidated analogs of the 9-amino acid fragment. Pharmacological assessment revealed high potency and wash resistance (an index of membrane anchoring). When tested in vivo, a chemerin SMAL decreased allergic airway inflammation and attenuated neuropathic pain in mice. This compound provides a prototype membrane-anchored peptide for the treatment of inflammatory disease. A parallel approach may be applied to developing therapeutics targeting other peptide hormone G protein-coupled receptors.	[Doyle, Jamie R.; Heller, Daniel; Kopin, Alan S.] Tufts Med Ctr, Mol Pharmacol Res Ctr, Boston, MA 02111 USA; [Doyle, Jamie R.; Heller, Daniel; Kopin, Alan S.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Krishnaji, Subrahmanian T.; Kumar, Krishna] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Zhu, Guangli; Levy, Bruce D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Xu, Zhen-Zhong; Ji, Ru-Rong] Duke Univ, Med Ctr, Sensory Plast Lab, Dept Anesthesiol, Durham, NC 27710 USA; [Xu, Zhen-Zhong; Ji, Ru-Rong] Duke Univ, Med Ctr, Sensory Plast Lab, Dept Neurobiol, Durham, NC 27710 USA	Tufts Medical Center; Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Duke University; Duke University	Kopin, AS (corresponding author), 800 Washington St,POB 7703, Boston, MA 02111 USA.	akopin@tuftsmedicalcenter.org	Kumar, Krishna/B-3151-2009; Ji, Ru-Rong/L-7070-2017	Kumar, Krishna/0000-0002-0548-5014; Ji, Ru-Rong/0000-0002-9355-3688; Tarakkad Krishnaji, Subrahmanian/0000-0001-8950-6072; Heller-Trulli, Daniel/0000-0003-0549-0646; Xu, Zhen-Zhong/0000-0001-6578-211X	National Institutes of Health [R01-DK072497, T32-HL069770, R01-HL068669, P01-GM095467, R01-GM65500, R01-CA125033, R01-NS67686]; NATIONAL CANCER INSTITUTE [R01CA125033] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122531, T32HL069770, R01HL068669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065500, P01GM095467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK072497 (to A. S. K.), T32-HL069770 (to J. R. D.), R01-HL068669 and P01-GM095467 (to B. D. L.), R01-GM65500 and R01-CA125033 (to K. K.), and R01-NS67686 (to R. R. J.).	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Doyle JR, 2013, J LIPID RES, V54, P823, DOI 10.1194/jlr.M034660; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Fortin JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024693; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Jacobsen EA, 2007, CURR ALLERGY ASTHM R, V7, P18, DOI 10.1007/s11882-007-0026-y; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Pennington M W, 1994, Methods Mol Biol, V35, P41; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; ROMANO R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P235, DOI 10.1016/0005-2736(93)90294-A; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Summerhill Susan, 2008, Journal of Pharmacological and Toxicological Methods, V58, P189, DOI 10.1016/j.vascn.2008.06.003; Wegmann M, 2011, AM J RESP CELL MOL, V45, P667, DOI 10.1165/rcmb.2011-0013TR; Weinstock MT, 2012, BIOPOLYMERS, V98, P431, DOI 10.1002/bip.22073; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yoshimura T, 2011, EXP CELL RES, V317, P674, DOI 10.1016/j.yexcr.2010.10.023; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	40	23	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13385	13396		10.1074/jbc.M113.522680	http://dx.doi.org/10.1074/jbc.M113.522680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659779	hybrid, Green Published			2022-12-28	WOS:000335522800037
J	Laass, S; Kleist, S; Bill, N; Druppel, K; Kossmehl, S; Wohlbrand, L; Rabus, R; Klein, J; Rohde, M; Bartsch, A; Wittmann, C; Schmidt-Hohagen, K; Tielen, P; Jahn, D; Schomburg, D				Laass, Sebastian; Kleist, Sarah; Bill, Nelli; Drueppel, Katharina; Kossmehl, Sebastian; Woehlbrand, Lars; Rabus, Ralf; Klein, Johannes; Rohde, Manfred; Bartsch, Annekathrin; Wittmann, Christoph; Schmidt-Hohagen, Kerstin; Tielen, Petra; Jahn, Dieter; Schomburg, Dietmar			Gene Regulatory and Metabolic Adaptation Processes of Dinoroseobacter shibae DFL12T during Oxygen Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Metabolism; Metabolomics; Proteomics; Respiration; Systems Biology; Transcriptomics; Roseobacter; Polyhydroxybutanoate	INHIBENS DSM 17395; PHAEOBACTER-GALLAECIENSIS; ROSEOBACTER CLADE; PROTEIN; EXPRESSION; BACTERIA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DEHYDROGENASE; PURIFICATION; BIOLOGY	Background: The bacterium Dinoroseobacter shibae was exposed to environmental anoxia. Results: Systems biology analyses showed the time-resolved cellular adaptation processes of D. shibae during oxygen depletion. Conclusion: Oxygen depletion led to a metabolic crisis due to the missing regeneration of ATP and reduction equivalents, until denitrification was established. Significance: Here we have elucidated the adaptation processes of marine bacteria to anoxic respiration. Metabolic flexibility is the key to the ecological success of the marine Roseobacter clade bacteria. We investigated the metabolic adaptation and the underlying changes in gene expression of Dinoroseobacter shibae DFL12(T) to anoxic life by a combination of metabolome, proteome, and transcriptome analyses. Time-resolved studies during continuous oxygen depletion were performed in a chemostat using nitrate as the terminal electron acceptor. Formation of the denitrification machinery was found enhanced on the transcriptional and proteome level, indicating that D. shibae DFL12(T) established nitrate respiration to compensate for the depletion of the electron acceptor oxygen. In parallel, arginine fermentation was induced. During the transition state, growth and ATP concentration were found to be reduced, as reflected by a decrease of A(578) values and viable cell counts. In parallel, the central metabolism, including gluconeogenesis, protein biosynthesis, and purine/pyrimidine synthesis was found transiently reduced in agreement with the decreased demand for cellular building blocks. Surprisingly, an accumulation of poly-3-hydroxybutanoate was observed during prolonged incubation under anoxic conditions. One possible explanation is the storage of accumulated metabolites and the regeneration of NADP(+) from NADPH during poly-3-hydroxybutanoate synthesis (NADPH sink). Although D. shibae DFL12(T) was cultivated in the dark, biosynthesis of bacteriochlorophyll was increased, possibly to prepare for additional energy generation via aerobic anoxygenic photophosphorylation. Overall, oxygen depletion led to a metabolic crisis with partly blocked pathways and the accumulation of metabolites. In response, major energy-consuming processes were reduced until the alternative respiratory denitrification machinery was operative.	[Laass, Sebastian; Tielen, Petra; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Kleist, Sarah; Bill, Nelli; Klein, Johannes; Schmidt-Hohagen, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Drueppel, Katharina; Kossmehl, Sebastian; Woehlbrand, Lars; Rabus, Ralf] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm Gen & Mol Microb, D-26111 Oldenburg, Germany; [Bartsch, Annekathrin; Wittmann, Christoph] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res HZI, Dept Med Microbiol, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Carl von Ossietzky Universitat Oldenburg; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Langer Kamp 19 B, D-38106 Braunschweig, Germany.	d.schomburg@tu-bs.de		Schomburg, Dietmar/0000-0002-3354-822X; Wittmann, Christoph/0000-0002-7952-985X; Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [Transregio SFB TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Transregio SFB TRR 51.	Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Borner J, 2007, ANAL BIOCHEM, V367, P143, DOI 10.1016/j.ab.2007.04.036; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buddruhs N, 2013, INT J SYST EVOL MICR, V63, P4340, DOI 10.1099/ijs.0.053900-0; DELDON C, 1994, AQUAT SCI, V56, P1; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; Ebert M, 2013, J BACTERIOL, V195, P4769, DOI 10.1128/JB.00860-13; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Furch T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-209; Gade D, 2003, J MOL MICROB BIOTECH, V5, P240, DOI 10.1159/000071076; Gonzalez B, 2000, YEAST, V16, P483, DOI 10.1002/(SICI)1097-0061(200004)16:6<483::AID-YEA542>3.0.CO;2-E; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; GRAY CT, 1966, BIOCHIM BIOPHYS ACTA, V117, P22, DOI 10.1016/0304-4165(66)90148-6; Hansen T, 2002, FEMS MICROBIOL LETT, V216, P249, DOI 10.1016/S0378-1097(02)01021-2; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Lebedeva NV, 2002, MICROBIOLOGY+, V71, P657, DOI 10.1023/A:1021471621183; LESSMANN D, 1975, EUR J BIOCHEM, V59, P545, DOI 10.1111/j.1432-1033.1975.tb02481.x; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Nam TW, 2005, NUCLEIC ACIDS RES, V33, P6712, DOI 10.1093/nar/gki978; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Pardo MA, 1999, BBA-PROTEIN STRUCT M, V1431, P87, DOI 10.1016/S0167-4838(99)00052-7; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Reusch RN, 2013, INT J MOL SCI, V14, P10727, DOI 10.3390/ijms140610727; Rex R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003224; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHAEFFER F, 1978, ARCH MICROBIOL, V116, P9, DOI 10.1007/BF00408728; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; SENIOR PJ, 1971, BIOCHEM J, V125, P55, DOI 10.1042/bj1250055; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Xiao N, 2011, APPL ENVIRON MICROB, V77, P7445, DOI 10.1128/AEM.05955-11; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zech H, 2011, PROTEOMICS, V11, P3380, DOI 10.1002/pmic.201100071; Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	46	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13219	13231		10.1074/jbc.M113.545004	http://dx.doi.org/10.1074/jbc.M113.545004			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648520	Green Published, hybrid			2022-12-28	WOS:000335522800023
J	Wilhelmsen, K; Khakpour, S; Tran, A; Sheehan, K; Schumacher, M; Xu, FY; Hellman, J				Wilhelmsen, Kevin; Khakpour, Samira; Tran, Alphonso; Sheehan, Kayla; Schumacher, Mark; Xu, Fengyun; Hellman, Judith			The Endocannabinoid/Endovanilloid N-Arachidonoyl Dopamine ( NADA) and Synthetic Cannabinoid WIN55,212-2 Abate the Inflammatory Activation of Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cannabinoid Receptors; Cannabinoids; Endocannabinoids; Endothelial Cell; Endothelial Dysfunction; Endothelium; Sepsis; Toll-like Receptors (TLR); TRP Channels	ANANDAMIDE MEMBRANE TRANSPORTER; RECEPTOR MESSENGER-RNA; GENE-EXPRESSION DATA; TNF-ALPHA; VANILLOID RECEPTOR; CB2 RECEPTOR; IN-VITRO; SIGNAL-TRANSDUCTION; CAPSAICIN RECEPTOR; CALCIUM-CHANNELS	Background: The endothelium is centrally involved in acute inflammatory disorders. Results: WIN55,212-2 and the endocannabinoid N-arachidonoyl dopamine (NADA), but not anandamide nor 2-arachidonoylglycerol, reduce endothelial activation by bacterial Toll-like receptor agonists and TNF. Conclusion: NADA is a newly identified endogenous regulator of endothelial inflammation. Significance: The endothelial endocannabinoid system represents a novel immune regulatory system that could be exploited therapeutically. Although cannabinoids, such as (9)-tetrahydrocannabinol, have been studied extensively for their psychoactive effects, it has become apparent that certain cannabinoids possess immunomodulatory activity. Endothelial cells (ECs) are centrally involved in the pathogenesis of organ injury in acute inflammatory disorders, such as sepsis, because they express cytokines and chemokines, which facilitate the trafficking of leukocytes to organs, and they modulate vascular barrier function. In this study, we find that primary human ECs from multiple organs express the cannabinoid receptors CB1R, GPR18, and GPR55, as well as the ion channel transient receptor potential cation channel vanilloid type 1. In contrast to leukocytes, CB2R is only minimally expressed in some EC populations. Furthermore, we show that ECs express all of the known endocannabinoid (eCB) metabolic enzymes. Examining a panel of cannabinoids, we demonstrate that the synthetic cannabinoid WIN55,212-2 and the eCB N-arachidonoyl dopamine (NADA), but neither anandamide nor 2-arachidonoylglycerol, reduce EC inflammatory responses induced by bacterial lipopeptide, LPS, and TNF. We find that endothelial CB1R/CB2R are necessary for the effects of NADA, but not those of WIN55,212-2. Furthermore, transient receptor potential cation channel vanilloid type 1 appears to counter the anti-inflammatory properties of WIN55,212-2 and NADA, but conversely, in the absence of these cannabinoids, its inhibition exacerbates the inflammatory response in ECs activated with LPS. These data indicate that the eCB system can modulate inflammatory activation of the endothelium and may have important implications for a variety of acute inflammatory disorders that are characterized by EC activation.	[Wilhelmsen, Kevin; Tran, Alphonso; Sheehan, Kayla; Schumacher, Mark; Xu, Fengyun; Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Khakpour, Samira] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Div Crit Care Med, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wilhelmsen, K (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	wilhelmsenk@anesthesia.ucsf.edu			Department of Anesthesia and Perioperative Care; University of California at San Francisco; National Science Foundation [1144247]; University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	Department of Anesthesia and Perioperative Care; University of California at San Francisco(University of California System); National Science Foundation(National Science Foundation (NSF)); University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Anesthesia and Perioperative Care, University of California at San Francisco, National Science Foundation Graduate Research Fellowship Program Grant 1144247, and the University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund).	Agro A, 1996, J RHEUMATOL, V23, P862; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Akimov MG, 2007, RUSS J BIOORG CHEM+, V33, P602, DOI 10.1134/S1068162007060118; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; Bobrov MY, 2008, NEUROSCI LETT, V431, P6, DOI 10.1016/j.neulet.2007.11.010; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Caldwell MD, 2013, BRIT J PHARMACOL, V169, P834, DOI 10.1111/bph.12136; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang WC, 2006, ACTA PHARMACOL SIN, V27, P813, DOI 10.1111/j.1745-7254.2006.00395.x; Chang YH, 2001, J CELL BIOCHEM, V81, P715, DOI 10.1002/jcb.1103; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Croxford JL, 2005, CELL MICROBIOL, V7, P1592, DOI 10.1111/j.1462-5822.2005.00577.x; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; DAMBRA TE, 1992, J MED CHEM, V35, P124, DOI 10.1021/jm00079a016; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; De Petrocellis L, 2007, EXP CELL RES, V313, P1911, DOI 10.1016/j.yexcr.2007.01.008; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Eilers H, 2007, NEUROREPORT, V18, P969, DOI 10.1097/WNR.0b013e328165d1a2; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gokoh M, 2005, FEBS LETT, V579, P6473, DOI 10.1016/j.febslet.2005.10.030; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Goyal RK, 2013, AUTON NEUROSCI-BASIC, V176, P11, DOI 10.1016/j.autneu.2013.02.012; Graham ES, 2010, INT J IMMUNOPATH PH, V23, P25, DOI 10.1177/039463201002300103; Griffith DA, 2009, J MED CHEM, V52, P234, DOI 10.1021/jm8012932; Gui H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/741303; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Hao MX, 2010, J LIPID RES, V51, P2181, DOI 10.1194/jlr.M001511; Harrison S, 2003, EUR J PHARMACOL, V475, P107, DOI 10.1016/S0014-2999(03)02114-9; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; HOLLADAY CS, 1993, PROSTAG LEUKOTR ESS, V49, P915, DOI 10.1016/0952-3278(93)90176-W; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang NL, 2010, ACTA PHARMACOL SIN, V31, P1447, DOI 10.1038/aps.2010.126; Huang SM, 2006, J NEUROPHYSIOL, V95, P1207, DOI 10.1152/jn.00395.2005; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; JEANNIN P, 1994, BLOOD, V84, P2229; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kasten Kevin Richard, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P224; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lee SF, 2001, EUR J PHARMACOL, V423, P235, DOI 10.1016/S0014-2999(01)01122-0; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Li SW, 2002, TRENDS PHARMACOL SCI, V23, P63, DOI 10.1016/S0165-6147(00)01897-6; Li YY, 2013, LAB INVEST, V93, P322, DOI 10.1038/labinvest.2012.177; LITTLE PJ, 1988, J PHARMACOL EXP THER, V247, P1046; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu WL, 2011, CURR OPIN INFECT DIS, V24, P254, DOI 10.1097/QCO.0b013e3283463e5b; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TS, 2008, J IMMUNOL, V181, P6406, DOI 10.4049/jimmunol.181.9.6406; Lu VB, 2013, MOL PHARMACOL, V83, P267, DOI 10.1124/mol.112.081182; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Marinelli S, 2007, NEUROPSYCHOPHARMACOL, V32, P298, DOI 10.1038/sj.npp.1301118; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Millns PJ, 2006, EUR J NEUROSCI, V24, P3489, DOI 10.1111/j.1460-9568.2006.05236.x; Mormina ME, 2006, EUR J PHARMACOL, V540, P183, DOI 10.1016/j.ejphar.2006.04.015; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; O'Sullivan SE, 2009, PPAR RES, V2009, DOI 10.1155/2009/425289; O'Sullivan SE, 2004, BRIT J PHARMACOL, V141, P803, DOI 10.1038/sj.bjp.0705643; Okuno T, 2011, J BIOCHEM, V149, P495, DOI 10.1093/jb/mvr022; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Opitz CA, 2007, FEBS LETT, V581, P4927, DOI 10.1016/j.febslet.2007.09.032; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Piomelli D, 2014, NEUROPHARMACOLOGY, V76, P228, DOI 10.1016/j.neuropharm.2013.07.026; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Premkumar LS, 2004, J NEUROPHYSIOL, V91, P1442, DOI 10.1152/jn.00745.2003; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Price TJ, 2004, BRIT J PHARMACOL, V141, P1118, DOI 10.1038/sj.bjp.0705711; Prusakiewicz JJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P260, DOI 10.1016/j.abb.2007.04.007; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rajesh M, 2010, BRIT J PHARMACOL, V160, P688, DOI 10.1111/j.1476-5381.2010.00712.x; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ross HR, 2009, BRIT J PHARMACOL, V156, P740, DOI 10.1111/j.1476-5381.2008.00072.x; Russo EB, 2005, NEUROCHEM RES, V30, P1037, DOI 10.1007/s11064-005-6978-1; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sancho R, 2005, J IMMUNOL, V175, P3990, DOI 10.4049/jimmunol.175.6.3990; Sancho R, 2004, J IMMUNOL, V172, P2341, DOI 10.4049/jimmunol.172.4.2341; Sasaki Makoto, 2005, BMC Physiol, V5, P3, DOI 10.1186/1472-6793-5-3; Schaefer U, 1998, INFLAMM RES, V47, P256, DOI 10.1007/s000110050327; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; Sugiura T, 2004, J PHARMACOL SCI, V96, P367, DOI 10.1254/jphs.FMJ04003X3; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; Sugiura T, 2009, BIOFACTORS, V35, P88, DOI 10.1002/biof.18; Sun Y, 2006, BIOCHEM SOC T, V34, P1095, DOI 10.1042/BST0341095; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; TSENG CF, 1992, CHEM PHARM BULL, V40, P396, DOI 10.1248/cpb.40.396; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilhelmsen K, 2013, JOVE-J VIS EXP, DOI 10.3791/50677; Wilhelmsen K, 2012, J BIOL CHEM, V287, P26478, DOI 10.1074/jbc.M112.359489; Wilhelmsen K, 2012, INNATE IMMUN-LONDON, V18, P602, DOI 10.1177/1753425911429336; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wojtalla A, 2012, AM J PHYSIOL-GASTR L, V302, pG873, DOI 10.1152/ajpgi.00241.2011; Yoo JM, 2013, LIPIDS, V48, P383, DOI 10.1007/s11745-013-3758-6; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zavala K, 2014, NEUROSCI LETT, V578, P211, DOI 10.1016/j.neulet.2014.01.021	157	36	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13079	13100		10.1074/jbc.M113.536953	http://dx.doi.org/10.1074/jbc.M113.536953			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24644287	hybrid, Green Published			2022-12-28	WOS:000335522800011
J	Mazhab-Jafari, MT; Marshall, CB; Ho, J; Ishiyama, N; Stambolic, V; Ikura, M				Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Ho, Jason; Ishiyama, Noboru; Stambolic, Vuk; Ikura, Mitsuhiko			Structure-guided Mutation of the Conserved G3-box Glycine in Rheb Generates a Constitutively Activated Regulator of Mammalian Target of Rapamycin ( mTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Catalysis; mTOR Complex (mTORC); Protein Engineering; Small GTPases; Constitutively Active; G3-box; Rheb; TSC2GAP	CELL-GROWTH; GTPASE; GAP; RAS; HYDROLYSIS; SYSTEM; TCTP	Background: GTPases regulate cellular signaling by cycling between GDP-(inactive) and GTP-(active) bound states. Results: Rheb GTPase cycling was manipulated by structure-guided mutagenesis of an ultraconserved residue. Conclusion: Constitutively activated or inactive Rheb mutants were generated by substitutions that displace the hydrolytic water or -phosphate, respectively. Significance: These mutants offer new research tools, and the approach may be extended to other GTPases. Constitutively activated variants of small GTPases, which provide valuable functional probes of their role in cellular signaling pathways, can often be generated by mutating the canonical catalytic residue (e.g. Ras Q61L) to impair GTP hydrolysis. However, this general approach is ineffective for a substantial fraction of the small GTPase family in which this residue is not conserved (e.g. Rap) or not catalytic (e.g. Rheb). Using a novel engineering approach, we have manipulated nucleotide binding through structure-guided substitutions of an ultraconserved glycine residue in the G3-box motif (DXXG). Substitution of Rheb Gly-63 with alanine impaired both intrinsic and TSC2 GTPase-activating protein (GAP)-mediated GTP hydrolysis by displacing the hydrolytic water molecule, whereas introduction of a bulkier valine side chain selectively blocked GTP binding by steric occlusion of the -phosphate. Rheb G63A stimulated phosphorylation of the mTORC1 substrate p70S6 kinase more strongly than wild-type, thus offering a new tool for mammalian target of rapamycin (mTOR) signaling.	[Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Ho, Jason; Ishiyama, Noboru; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr & Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Ikura, Mitsuhiko] Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Ikura, M (corresponding author), Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019	Marshall, Christopher/0000-0002-7571-5700; Stambolic, Vuk/0000-0001-8853-3239; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Ikura, Mitsuhiko/0000-0002-9524-1303	Canada Foundation for Innovation	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Aiping Dong from the Structural Genomics Consortium and Doug Kuntz for x-ray data collection. NMR spectrometers were funded by the Canada Foundation for Innovation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Goddard D., 2008, SPARKY 3; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jiang H, 2008, ONCOGENE, V27, P5729, DOI 10.1038/onc.2008.180; JOHN J, 1993, J BIOL CHEM, V268, P923; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee MN, 2013, CELL SIGNAL, V25, P539, DOI 10.1016/j.cellsig.2012.11.006; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mazhab-Jafari MT, 2012, STRUCTURE, V20, P1528, DOI 10.1016/j.str.2012.06.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Sung YJ, 1996, J BIOL CHEM, V271, P30537, DOI 10.1074/jbc.271.48.30537; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	31	10	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12195	12201		10.1074/jbc.C113.543736	http://dx.doi.org/10.1074/jbc.C113.543736			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648513	Green Published, hybrid			2022-12-28	WOS:000335581400002
J	Yamashita, Y; Kadokura, Y; Sotta, N; Fujiwara, T; Takigawa, I; Satake, A; Onouchi, H; Naito, S				Yamashita, Yui; Kadokura, Yoshitomo; Sotta, Naoyuki; Fujiwara, Toru; Takigawa, Ichigaku; Satake, Akiko; Onouchi, Hitoshi; Naito, Satoshi			Ribosomes in a Stacked Array	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MRNA decay; Ribosome function; Ribosomes; Translation; Translation regulation; peptidyl-tRNA; puromycin reaction; ribosome stacking; translation arrest	PEPTIDYL TRANSFERASE CENTER; MESSENGER-RNA DEGRADATION; DOUBLE-ROW POLYRIBOSOMES; GAMMA-SYNTHASE GENE; PROLYL-TRANSFER-RNA; NASCENT PEPTIDE; A-SITE; POSTTRANSCRIPTIONAL AUTOREGULATION; TRANSLATION ELONGATION; NEUROSPORA-CRASSA	Background:S-Adenosyl-l-methionine arrests ribosomes on CGS1 mRNA at the pre-translocation step, and ribosomes stack behind it. Results: Puromycin reactivity of stacked ribosomes was intermediate between ribosomes at the pre- and post-translocation steps. Conclusion: Ribosomes are stacked at nine-codon intervals, and the majority are stalled at an early step of translocation. Significance: This study is the first report of ribosomal states in a stacked array. Expression of CGS1, which codes for an enzyme of methionine biosynthesis, is feedback-regulated by mRNA degradation in response to S-adenosyl-l-methionine (AdoMet). In vitro studies revealed that AdoMet induces translation arrest at Ser-94, upon which several ribosomes stack behind the arrested one, and mRNA degradation occurs at multiple sites that presumably correspond to individual ribosomes in a stacked array. Despite the significant contribution of stacked ribosomes to inducing mRNA degradation, little is known about the ribosomes in the stacked array. Here, we assigned the peptidyl-tRNA species of the stacked second and third ribosomes to their respective codons and showed that they are arranged at nine-codon intervals behind the Ser-94 codon, indicating tight stacking. Puromycin reacts with peptidyl-tRNA in the P-site, releasing the nascent peptide as peptidyl-puromycin. This reaction is used to monitor the activity of the peptidyltransferase center (PTC) in arrested ribosomes. Puromycin reaction of peptidyl-tRNA on the AdoMet-arrested ribosome, which is stalled at the pre-translocation step, was slow. This limited reactivity can be attributed to the peptidyl-tRNA occupying the A-site at this step rather than to suppression of PTC activity. In contrast, puromycin reactions of peptidyl-tRNA with the stacked second and third ribosomes were slow but were not as slow as pre-translocation step ribosomes. We propose that the anticodon end of peptidyl-tRNA resides in the A-site of the stacked ribosomes and that the stacked ribosomes are stalled at an early step of translocation, possibly at the P/E hybrid state.	[Yamashita, Yui; Kadokura, Yoshitomo; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Sotta, Naoyuki; Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Takigawa, Ichigaku] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Satake, Akiko] Hokkaido Univ, Grad Sch Environm Sci, Biosphere Dept, Sapporo, Hokkaido 0600810, Japan; [Onouchi, Hitoshi; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; University of Tokyo; Hokkaido University; Hokkaido University; Hokkaido University	Naito, S (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan.	naito@abs.agr.hokudai.ac.jp	Takigawa, Ichigaku/B-3823-2012; Sotta, Naoyuki/AAH-7816-2020	Takigawa, Ichigaku/0000-0001-5633-995X; Sotta, Naoyuki/0000-0001-5558-5155	Japan Society for the Promotion of Science [23-1971]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22119006]; Japan Science and Technology Agency [PJ34085001]; Grants-in-Aid for Scientific Research [22119011, 22119006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows 23-1971 (to Y. Y.) from the Japan Society for the Promotion of Science; by a Grant-in-Aid for Scientific Research on Innovative Areas 22119006 (to S. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Core Research for Evolutionary Science and Technology (CREST) Grant PJ34085001 (to H. O.) from the Japan Science and Technology Agency.	Afonina ZA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P445, DOI 10.1134/S0006297913050027; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard SC, 2010, CHEM BIOL, V17, P633, DOI 10.1016/j.chembiol.2010.06.003; Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Chiba Y, 2003, P NATL ACAD SCI USA, V100, P10225, DOI 10.1073/pnas.1831512100; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Fang P, 2002, FUNGAL GENET BIOL, V36, P167, DOI 10.1016/S1087-1845(02)00014-2; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2012, CURR OPIN STRUC BIOL, V22, P778, DOI 10.1016/j.sbi.2012.08.001; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Haraguchi Y, 2008, PLANT CELL PHYSIOL, V49, P314, DOI 10.1093/pcp/pcn005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kopeina GS, 2008, NUCLEIC ACIDS RES, V36, P2476, DOI 10.1093/nar/gkm1177; MARTIN KA, 1983, DEV BIOL, V98, P338, DOI 10.1016/0012-1606(83)90364-0; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Ominato K, 2002, J BIOL CHEM, V277, P36380, DOI 10.1074/jbc.M204645200; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onoue N, 2011, J BIOL CHEM, V286, P14903, DOI 10.1074/jbc.M110.211656; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	46	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12693	12704		10.1074/jbc.M113.526616	http://dx.doi.org/10.1074/jbc.M113.526616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652291	Green Published, hybrid			2022-12-28	WOS:000335581400041
J	Grahn, THM; Kaur, R; Yin, J; Schweiger, M; Sharma, VM; Lee, MJ; Ido, Y; Smas, CM; Zechner, R; Lass, A; Puri, V				Grahn, Tan Hooi Min; Kaur, Rajween; Yin, Jun; Schweiger, Martina; Sharma, Vishva Mitra; Lee, Mi-Jeong; Ido, Yasuo; Smas, Cynthia M.; Zechner, Rudolf; Lass, Achim; Puri, Vishwajeet			Fat-specific Protein 27 ( FSP27) Interacts with Adipose Triglyceride Lipase ( ATGL) to Regulate Lipolysis and Insulin Sensitivity in Human Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Adipose Tissue Metabolism; Adipose Triglyceride Lipase; Diabetes; Diacylglycerol; Fatty Acid; Fatty Acid Metabolism; Insulin Resistance; Obesity	LIPID DROPLETS; PERILIPIN-A; MEDIATED LIPOLYSIS; GENE-EXPRESSION; UP-REGULATION; RESISTANCE; ACIDS; BINDING; OBESITY; KINASE	Background: FSP27 depletion increases both basal and stimulated lipolysis. Results: FSP27 interacts with ATGL via amino acids 120-220 to regulate lipolysis and triglyceride storage in human adipocytes. Conclusion: FSP27 inhibits ATGL-mediated lipolysis and protects adipocytes against free fatty acid-impaired insulin signaling. Significance: The novel lipolytic regulation shown here may lead to new treatments for insulin resistance. In adipocytes, lipolysis is a highly regulated process involving hormonal signals, lipid droplet-associated proteins, and lipases. The discovery of new lipid droplet-associated proteins added complexity to the current model of lipolysis. In this study, we used cultured human adipocytes to demonstrate that fat-specific protein 27 (FSP27), an abundantly expressed protein in adipocytes, regulates both basal and stimulated lipolysis by interacting with adipose triglyceride lipase (ATGL, also called desnutrin or PNPLA2). We identified a core domain of FSP27, amino acids 120-220, that interacts with ATGL to inhibit its lipolytic function and promote triglyceride storage. We also defined the role of FSP27 in free fatty acid-induced insulin resistance in adipocytes. FSP27 depletion in human adipocytes increased lipolysis and inhibited insulin signaling by decreasing AKT phosphorylation. However, reducing lipolysis by either depletion of ATGL or expression of exogenous full-length FSP27 or amino acids 120-220 protected human adipocytes against the adverse effects of free fatty acids on insulin signaling. In embryonic fibroblasts derived from ATGL KO mice, exogenous free fatty acids did not affect insulin sensitivity. Our results demonstrate a crucial role for FSP27-ATGL interactions in regulating lipolysis, triglyceride accumulation, and insulin signaling in human adipocytes.	[Grahn, Tan Hooi Min; Kaur, Rajween; Yin, Jun; Sharma, Vishva Mitra; Lee, Mi-Jeong; Ido, Yasuo; Puri, Vishwajeet] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Schweiger, Martina; Zechner, Rudolf; Lass, Achim] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Smas, Cynthia M.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA	Boston University; University of Graz; University System of Ohio; University of Toledo	Puri, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, 650 Albany St, Boston, MA 02118 USA.	vpuri@bu.edu	Lass, Achim/C-3332-2008; Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lass, Achim/0000-0002-8190-7151; Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Grahn, Tan Hooi Min/0000-0002-4737-4320; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182	NIDDK, National Institutes of Health from Boston University Parent Clinical and Translational Science Institute [R56DK094815, P30DK046200, 8KL2TR000158, UL1-TR000157]; Wittgenstein Award [Z136]; Austrian Science Fund (FWF) [P25193]; Foundation Leducq [12CVD04];  [SFB Lipotox F30]; Austrian Science Fund (FWF) [F 3002, Z 136, P 25193] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000158, UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK094815, P30DK046200] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health from Boston University Parent Clinical and Translational Science Institute; Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Foundation Leducq(Leducq Foundation); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants R56DK094815, P30DK046200, and 8KL2TR000158 (to V. P.) from Boston University Parent Clinical and Translational Science Institute Grant UL1-TR000157. This work was also supported by Grant SFB Lipotox F30, Wittgenstein Award Z136 (to R. Z.), and Grant P25193 (to A. L.), which are funded by the Austrian Science Fund (FWF) and Grant 12CVD04 from the Foundation Leducq (to R. Z.).	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee M. J., 2013, OBESITY IN PRESS; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; VanEppsFung M, 1997, ENDOCRINOLOGY, V138, P4338, DOI 10.1210/en.138.10.4338; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WILLIAMS PM, 1992, MOL ENDOCRINOL, V6, P1135, DOI 10.1210/me.6.7.1135; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	62	84	85	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12029	12039		10.1074/jbc.M113.539890	http://dx.doi.org/10.1074/jbc.M113.539890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627478	Green Published, hybrid			2022-12-28	WOS:000335010600041
J	Kurt, TD; Jiang, L; Bett, C; Eisenberg, D; Sigurdson, CJ				Kurt, Timothy D.; Jiang, Lin; Bett, Cyrus; Eisenberg, David; Sigurdson, Christina J.			A Proposed Mechanism for the Promotion of Prion Conversion Involving a Strictly Conserved Tyrosine Residue in the beta(2)-alpha (2) Loop of PrPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Infectious Diseases; Neurodegenerative Diseases; Prions; Protein Aggregation; (2)-(2) Loop; TSE; Steric Zipper; Transmissible Spongiform Encephalopathy	CHRONIC WASTING DISEASE; BETA-2-ALPHA-2 LOOP; NATURAL SCRAPIE; CYCLIC AMPLIFICATION; NMR STRUCTURE; HAMSTER PRP; PROTEIN PRP; TRANSMISSION; SHEEP; PROPAGATION	Background: Single residue differences can block conversion of the cellular prion protein (PrP) to the pathogenic conformation. Results: Prion conversion was reduced by non-aromatic amino acids at PrP position 169 in the (2)-(2) loop. Conclusion: The conserved tyrosine side chain at PrP position 169 promotes efficient prion formation. Significance: These findings are consistent with a steric zipper model of prion conversion. The transmission of infectious prions into different host species requires compatible prion protein (PrP) primary structures, and even one heterologous residue at a pivotal position can block prion infection. Mapping the key amino acid positions that govern cross-species prion conversion has not yet been possible, although certain residue positions have been identified as restrictive, including residues in the (2)-(2) loop region of PrP. To further define how (2)-(2) residues impact conversion, we investigated residue substitutions in PrPC using an in vitro prion conversion assay. Within the (2)-(2) loop, a tyrosine residue at position 169 is strictly conserved among mammals, and transgenic mice expressing mouse PrP having the Y169G, S170N, and N174T substitutions resist prion infection. To better understand the structural requirements of specific residues for conversion initiated by mouse prions, we substituted a diverse array of amino acids at position 169 of PrP. We found that the substitution of glycine, leucine, or glutamine at position 169 reduced conversion by approximate to 75%. In contrast, replacing tyrosine 169 with either of the bulky, aromatic residues, phenylalanine or tryptophan, supported efficient prion conversion. We propose a model based on a requirement for tightly interdigitating complementary amino acid side chains within specific domains of adjacent PrP molecules, known as steric zippers, to explain these results. Collectively, these studies suggest that an aromatic residue at position 169 supports efficient prion conversion.	[Kurt, Timothy D.; Bett, Cyrus; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kurt, Timothy D.; Bett, Cyrus; Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jiang, Lin; Eisenberg, David] UCLA, Howard Hughes Med Inst, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Jiang, Lin; Eisenberg, David] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu			National Institutes of Health [NS076896, NS069566, U54AI0359, AG029430]; Morris Animal Foundation Fellowship [D13ZO-419]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076896, R01NS069566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029430] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD017863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris Animal Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants NS076896, NS069566, and U54AI0359 (to C. J. S.) and AG029430 (to D. E.). This work was also supported by Morris Animal Foundation Fellowship D13ZO-419 (to T. D. K.).	Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bons N, 1996, CR ACAD SCI III-VIE, V319, P733; Christen B, 2013, P NATL ACAD SCI USA, V110, P8549, DOI 10.1073/pnas.1306178110; Christen B, 2012, J MOL BIOL, V423, P496, DOI 10.1016/j.jmb.2012.08.011; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; HUNTER N, 1993, J GEN VIROL, V74, P1025, DOI 10.1099/0022-1317-74-6-1025; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Kreeger TJ, 2006, J WILDLIFE DIS, V42, P640, DOI 10.7589/0090-3558-42.3.640; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mackay GA, 2011, INT J MOL EPIDEMIOL, V2, P217; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Ministry of Agriculture Fisheries and Food, 2000, BOV SPONG ENC GREAT, P71; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Perrott MR, 2013, J GEN VIROL, V94, P432, DOI 10.1099/vir.0.046110-0; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; TAYLOR DM, 1993, DEV BIOL STAND, V80, P215; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	53	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10660	10667		10.1074/jbc.M114.549030	http://dx.doi.org/10.1074/jbc.M114.549030			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596090	Green Published, hybrid			2022-12-28	WOS:000334226400036
J	Duan, RB; Zhang, L; Chen, DF; Yang, F; Yang, JS; Yang, WJ				Duan, Ru-Bing; Zhang, Li; Chen, Dian-Fu; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun			Two p90 Ribosomal S6 Kinase Isoforms Are Involved in the Regulation of Mitotic and Meiotic Arrest in Artemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BOX-BINDING PROTEIN-1; BRINE SHRIMP; CYTOSTATIC FACTOR; METAPHASE ARREST; MAPK PATHWAY; DOCKING SITE; CELL-CYCLE; MEIOSIS I; RSK	There are multiple isoforms of p90 ribosomal S6 kinase (RSK), which regulate diverse cellular functions such as cell growth, proliferation, maturation, and motility. However, the relationship between the structures and functions of RSK isoforms remains undetermined. Artemia is a useful model in which to study cell cycle arrest because these animals undergo prolonged diapauses, a state of obligate dormancy. A novel RSK isoform was identified in Artemia, which was termed Ar-Rsk2. This isoform was compared with an RSK isoform that we previously identified in Artemia, termed Ar-Rsk1. Ar-Rsk2 has an ERK-docking motif, whereas Ar-Rsk1 does not. Western blot analysis revealed that Ar-Rsk1 was activated by phosphorylation, which blocked meiosis in oocytes. Knockdown of Ar-Rsk1 reduced the level of phosphorylated cdc2 and thereby suppressed cytostatic factor activity. This indicates that Ar-Rsk1 regulates the cytostatic factor in meiosis. Expression of Ar-Rsk2 was down-regulated in Artemia cysts in which mitosis was arrested. Knockdown of Ar-Rsk2 resulted in decreased levels of cyclin D3 and phosphorylated histone H3, and the production of pseudo-diapause cysts. This indicates that Ar-Rsk2 regulates mitotic arrest. PLK and ERK RNAi showed that Ar-Rsk2, but not Ar-Rsk1, could be activated by PLK-ERK in Artemia. This is the first study to report that RSK isoforms with and without an ERK-docking motif regulate mitosis and meiosis, respectively. This study provides insight into the relationship between the structures and functions of RSK isoforms.	[Yang, Wei-Jun] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Natural Science Foundation of China [31270424]; National Basic Research Program of China 973 Program [2012CB944903]; National Basic Research Program of China 863 Program [2012AA10A401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Basic Research Program of China 863 Program(National Basic Research Program of ChinaNational High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 31270424, National Basic Research Program of China 973 Program Grant 2012CB944903, and National Basic Research Program of China 863 Program Grant 2012AA10A401.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Arul N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00201; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Clark DE, 2005, CANCER RES, V65, P3108; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; CLEGG JS, 1978, J CELL PHYSIOL, V94, P123, DOI 10.1002/jcp.1040940202; Clegg JS, 1997, J EXP BIOL, V200, P467; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; Feng CZ, 2007, COMP BIOCHEM PHYS B, V147, P191, DOI 10.1016/j.cbpb.2007.01.024; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Imada K, 2013, CLIN CANCER RES, V19, P4638, DOI 10.1158/1078-0432.CCR-12-3705; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Ivanovska I, 2004, CURR BIOL, V14, P75, DOI 10.1016/j.cyb.2003.12.031; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Kondoh E, 2006, DEV BIOL, V293, P228, DOI 10.1016/j.ydbio.2006.02.005; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Lopez-Vicente L, 2009, CLIN CANCER RES, V15, P4546, DOI 10.1158/1078-0432.CCR-08-3159; Ma WM, 2013, BIOCHEM J, V449, P285, DOI 10.1042/BJ20121259; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Moriwaki K, 2013, ZOOL SCI, V30, P975, DOI 10.2108/zsj.30.975; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Neise D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.386; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Rath A, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-6; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmitt A, 2002, J CELL SCI, V115, P2457; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Stratford AL, 2012, STEM CELLS, V30, P1338, DOI 10.1002/stem.1128; Sulzmaier FJ, 2013, CANCER RES, V73, P6099, DOI 10.1158/0008-5472.CAN-13-1087; Thakur A, 2008, CLIN CANCER RES, V14, P4427, DOI 10.1158/1078-0432.CCR-08-0458; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; Yamamoto DS, 2008, MECH DEVELOP, V125, P996, DOI 10.1016/j.mod.2008.08.004; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068374; Zhu XJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-21	52	10	10	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16006	16015		10.1074/jbc.M114.553370	http://dx.doi.org/10.1074/jbc.M114.553370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755224	Green Published, hybrid			2022-12-28	WOS:000337965700011
J	Kato, M; Lin, SJ				Kato, Michiko; Lin, Su-Ju			YCL047C/POF1 Is a Novel Nicotinamide Mononucleotide Adenylyltransferase (NMNAT) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Metabolic Regulation; NAD Biosynthesis; Yeast Genetics; Yeast Metabolism; Nicotinamide Mononucleotide Adenylyltransferase; Nicotinamide Riboside Salvage	LIFE-SPAN EXTENSION; CALORIE RESTRICTION; SALVAGE PATHWAY; NADR PROTEIN; DIPHOSPHOPYRIDINE NUCLEOTIDE; ENZYMATIC-PROPERTIES; NAD(+) BIOSYNTHESIS; GENE DELETION; IDENTIFICATION; REGULATOR	NAD(+) is an essential metabolic cofactor involved in various cellular biochemical processes. Nicotinamide riboside (NR) is an endogenously produced key pyridine metabolite that plays important roles in the maintenance of NAD(+) pool. Using a NR-specific cell-based screen, we identified mutants that exhibit altered NR release phenotype. Yeast cells lacking the ORF YCL047C/POF1 release considerably more NR compared with wild type, suggesting that POF1 plays an important role in NR/NAD(+) metabolism. The amino acid sequence of Pof1 indicates that it is a putative nicotinamide mononucleotide adenylyltransferase (NMNAT). Unlike other yeast NMNATs, Pof1 exhibits NMN-specific adenylyltransferase activity. Deletion of POF1 significantly lowers NAD(+) levels and decreases the efficiency of NR utilization, resistance to oxidative stress, and NR-induced life span extension. We also show that NR is constantly produced by multiple nucleotidases and that the intracellular NR pools are likely to be compartmentalized, which contributes to the regulation of NAD(+) homeostasis. Our findings may contribute to the understanding of the molecular basis and regulation of NAD(+) metabolism in higher eukaryotes.	[Kato, Michiko; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol & Mol Genet, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102297.	AbdelRaheim SR, 2001, ARCH BIOCHEM BIOPHYS, V388, P18, DOI 10.1006/abbi.2000.2268; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brachmann CB, 1998, YEAST, V14, P115; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Costa IM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-268; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; KANEKO Y, 1985, MOL CELL BIOL, V5, P248, DOI 10.1128/MCB.5.1.248; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; NATALINI P, 1986, BIOCHEMISTRY-US, V25, P3725, DOI 10.1021/bi00360a037; Ocampo A, 2013, HUM MOL GENET, V22, P1699, DOI 10.1093/hmg/ddt016; Ohashi K, 2013, EUKARYOT CELL, V12, P648, DOI 10.1128/EC.00339-12; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Raffaelli N, 1999, J BACTERIOL, V181, P5509, DOI 10.1128/JB.181.17.5509-5511.1999; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/NCHEMBIO.1352, 10.1038/nchembio.1352]; Sies H., 1982, METABOLIC COMPARTMEN, P205; Singh SK, 2002, J BIOL CHEM, V277, P33291, DOI 10.1074/jbc.M204368200; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721	50	18	22	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15577	15587		10.1074/jbc.M114.558643	http://dx.doi.org/10.1074/jbc.M114.558643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759102	Green Published, hybrid			2022-12-28	WOS:000337465400040
J	Hoffman, L; Chandrasekar, A; Wang, X; Putkey, JA; Waxham, MN				Hoffman, Laurel; Chandrasekar, Anuja; Wang, Xu; Putkey, John A.; Waxham, M. Neal			Neurogranin Alters the Structure and Calcium Binding Properties of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-ENCODING NEUROGRANIN; C PHOSPHORYLATION SITE; IQ-MOTIF PROTEINS; CA2+ BINDING; TERMINAL DOMAIN; MESSENGER-RNA; KINASE; RC3/NEUROGRANIN; DYNAMICS; NEUROMODULIN	Neurogranin (Ng) is a member of the IQ motif class of calmodulin (CaM)-binding proteins, and interactions with CaM are its only known biological function. In this report we demonstrate that the binding affinity of Ng for CaM is weakened by Ca2+ but to a lesser extent (2-3-fold) than that previously suggested from qualitative observations. We also show that Ng induced a > 10-fold decrease in the affinity of Ca2+ binding to the C-terminal domain of CaM with an associated increase in the Ca2+ dissociation rate. We also discovered a modest, but potentially important, increase in the cooperativity in Ca2+ binding to the C-lobe of CaM in the presence of Ng, thus sharpening the threshold for the C-domain to become Ca2+-saturated. Domain mapping using synthetic peptides indicated that the IQ motif of Ng is a poor mimetic of the intact protein and that the acidic sequence just N-terminal to the IQ motif plays an important role in reproducing Ng-mediated decreases in the Ca2+ binding affinity of CaM. Using NMR, full-length Ng was shown to make contacts largely with residues in the C-domain of CaM, although contacts were also detected in residues in the N-terminal domain. Together, our results can be consolidated into a model where Ng contacts residues in the N- and C-lobes of both apo- and Ca2+-bound CaM and that although Ca2+ binding weakens Ng interactions with CaM, the most dramatic biochemical effect is the impact of Ng on Ca2+ binding to the C-terminal lobe of CaM.	[Hoffman, Laurel; Chandrasekar, Anuja; Waxham, M. Neal] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Wang, Xu; Putkey, John A.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Waxham, MN (corresponding author), Rm 7-254 Med Sch Bldg,6431 Fannin St, Houston, TX 77030 USA.	m.n.waxham@uth.tmc.edu		Wang, Xu/0000-0002-8266-098X; Waxham, M. Neal/0000-0003-4801-1190	National Institutes of Health [GM097553, GM104290]; UT Graduate Initiative in Theoretical and Computational Neuroscience; William Wheless III professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097553, R01GM104290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Graduate Initiative in Theoretical and Computational Neuroscience; William Wheless III professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097553 (NIGMS; to M. N. W.) and GM104290 (NIGMS; to M. N. W. and J. A. P.).; Supported by the UT Graduate Initiative in Theoretical and Computational Neuroscience. Present address: Cytokinetics, 280 East Grand Ave., South San Francisco, CA 94080.; Supported by the William Wheless III professorship. To whom correspondence should be addressed: Rm. 7.254 Medical School Bldg., 6431 Fannin St., Houston TX, 77030. Tel.: 713-500-5621; Fax: 713-500-0621; E-mail: m.n.waxham@uth.tmc.edu.	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BAUDIER J, 1991, J BIOL CHEM, V266, P229; BIBER A, 1984, EXP BRAIN RES, V56, P323; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Coldren CD, 2009, NEUROGENETICS, V10, P89, DOI 10.1007/s10048-008-0157-x; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Ehrhardt MR, 1996, BIOCHEMISTRY-US, V35, P1599, DOI 10.1021/bi951267r; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; George AJ, 2010, NEUROTOX RES, V17, P360, DOI 10.1007/s12640-009-9112-3; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051026; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Kubota Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000987; Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392; LINSE S, 1991, J BIOL CHEM, V266, P8050; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/0006-8993(96)00786-X; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Peersen OB, 1997, PROTEIN SCI, V6, P794; Pohlack ST, 2011, MOL PSYCHIATR, V16, P1072, DOI 10.1038/mp.2011.66; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; SANGAMESWARAN L, 1993, MOL BRAIN RES, V19, P62, DOI 10.1016/0169-328X(93)90149-J; Shen YC, 2012, SCHIZOPHR RES, V137, P7, DOI 10.1016/j.schres.2012.01.011; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Wang X, 2013, J BIOL CHEM, V288, P2040, DOI 10.1074/jbc.M112.411314; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Xiong LW, 2010, J BIOL CHEM, V285, P8094, DOI 10.1074/jbc.M109.065243; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313; Zhong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041275; ZIAI R, 1986, P NATL ACAD SCI USA, V83, P8420, DOI 10.1073/pnas.83.21.8420	65	40	42	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14644	14655		10.1074/jbc.M114.560656	http://dx.doi.org/10.1074/jbc.M114.560656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713697	hybrid, Green Published			2022-12-28	WOS:000337248100021
J	Geist, MM; Pan, XY; Bender, S; Bartenschlager, R; Nickel, W; Fackler, OT				Geist, Miriam M.; Pan, Xiaoyu; Bender, Silke; Bartenschlager, Ralf; Nickel, Walter; Fackler, Oliver T.			Heterologous Src Homology 4 Domains Support Membrane Anchoring and Biological Activity of HIV-1 Nef	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Human Immunodeficiency Virus; Membrane Trafficking; Plasma Membrane; Viral Protein; Nef; SH4 Domain	VIRUS TYPE-1 NEF; CD4 DOWN-REGULATION; T-CELL-ACTIVATION; PLASMA-MEMBRANE; VIRAL INFECTIVITY; VIRION INCORPORATION; SURFACE EXPRESSION; DILEUCINE MOTIF; PROTEIN COMPLEX; IN-VITRO	Background: HIV-1 Nef is a membrane-associated protein that acts as viral pathogenicity factor. Results: Nef function requires regulated membrane interactions along transport pathways to and from the plasma membrane. Conclusion: Nef function is determined by dynamic anterograde and endocytic transport cycles. Significance: Dynamic transport cycles provide the basis for the multifunctionality of Nef. The HIV-1 pathogenicity factor Nef enhances viral replication by modulation of multiple host cell transport and signaling pathways. Nef associates with membranes via an N-terminal Src homology 4 (SH4) domain, and membrane association is believed to be essential for its biological functions. At which subcellular site(s) Nef exerts its different functions and how kinetics of membrane interactions contribute to its biological activity are unknown. To address how specific characteristics of Nef membrane association affect its biological properties, the SH4 domain of Nef was replaced by heterologous membrane targeting domains. The use of a panel of heterologous SH4 domains resulted in chimeric Nef proteins with distinct steady state subcellular localization, membrane association efficiency, and anterograde transport routes. Irrespective of these modifications, cardinal Nef functions affecting host cell vesicular transport and actin dynamics were fully preserved. In contrast, stable targeting of Nef to the surface of mitochondria, peroxisomes, or the Golgi apparatus, and thus prevention of plasma membrane delivery, caused potent and broad loss of Nef activity. These results support the concept that Nef adopts its active conformation in the membrane-associated state but exclude that membrane-associated Nef simply acts by recruiting soluble factors independently of its local microenvironment. Rather than its steady state subcellular localization or membrane affinity, the ability to undergo dynamic anterograde and internalization cycles appear to determine Nef function. These results reveal that functional membrane interactions of Nef underlie critical spatiotemporal regulation and suggest that delivery to distinct subcellular sites via such transport cycles provides the basis for the multifunctionality of Nef.	[Geist, Miriam M.; Pan, Xiaoyu; Bender, Silke; Bartenschlager, Ralf; Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, D-69120 Heidelberg, Germany; [Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de	; Bartenschlager, Ralf/L-2582-2015	Fackler, Oliver Till/0000-0003-2982-4209; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [TRR83]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft TRR83 projects 5 (to W. N.), 13 (to R. B.), and 15 (to O. T. F.).	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Akgun B, 2013, STRUCTURE, V21, P1822, DOI 10.1016/j.str.2013.08.008; Aldrovandi GM, 1998, J VIROL, V72, P7032, DOI 10.1128/JVI.72.9.7032-7039.1998; Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004; Arhel N, 2009, J CLIN INVEST, V119, P2965, DOI 10.1172/JCI38994; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coates K, 1997, J BIOL CHEM, V272, P12289, DOI 10.1074/jbc.272.19.12289; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Morgan CR, 2011, BIOCHEMISTRY-US, V50, P3394, DOI 10.1021/bi200197e; Mossalam M, 2012, MOL PHARMACEUT, V9, P1449, DOI 10.1021/mp3000259; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pan XY, 2013, CELL MICROBIOL, V15, P1605, DOI 10.1111/cmi.12148; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Peng B, 2001, IMMUNOL LETT, V78, P195, DOI 10.1016/S0165-2478(01)00250-4; Pevzner I, 2012, TRAFFIC, V13, P849, DOI 10.1111/j.1600-0854.2012.01349.x; Rahim MMA, 2009, J VIROL, V83, P11830, DOI 10.1128/JVI.01466-09; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ritzerfeld J, 2011, GENOME RES, V21, P1955, DOI 10.1101/gr.116087.110; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sol-Foulon N, 2004, J BIOL CHEM, V279, P31398, DOI 10.1074/jbc.M401621200; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Suzuki H, 2002, J CELL SCI, V115, P1895; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tokarev Andrey, 2011, Cell Logist, V1, P90; Tournaviti S, 2009, TRAFFIC, V10, P1047, DOI 10.1111/j.1600-0854.2009.00921.x; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Witte V, 2008, J IMMUNOL, V181, P8425, DOI 10.4049/jimmunol.181.12.8425; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; ZAZOPOULOS E, 1992, P NATL ACAD SCI USA, V89, P6634, DOI 10.1073/pnas.89.14.6634	84	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14030	14044		10.1074/jbc.M114.563528	http://dx.doi.org/10.1074/jbc.M114.563528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706755	Green Published, hybrid			2022-12-28	WOS:000335984600033
J	Hashimoto, Y; Shirane, M; Matsuzaki, F; Saita, S; Ohnishi, T; Nakayama, KI				Hashimoto, Yutaka; Shirane, Michiko; Matsuzaki, Fumiko; Saita, Shotaro; Ohnishi, Takafumi; Nakayama, Keiichi I.			Protrudin Regulates Endoplasmic Reticulum Morphology and Function Associated with the Pathogenesis of Hereditary Spastic Paraplegia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); Membrane Structure; Neurodegenerative Diseases; Proteomics	HOMOTYPIC FUSION; ER; PROTEINS; NETWORK; MEMBRANES; MUTATION; ORGANIZATION; TRAFFICKING; INHERITANCE; PATHWAYS	Background: Certain hereditary spastic paraplegia (HSP)-related proteins possess hairpin domains and regulate the morphology of the endoplasmic reticulum (ER) network. Results: Protrudin possesses a hairpin domain and interacts with HSP-related proteins. Conclusion: Protrudin regulates ER morphology and function. Significance: Mutant protrudin produced in certain individuals with HSP is prone to form microaggregates that induce ER stress. Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons. The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia (SPG) 33. We have now generated mice that express a transgene for dual epitope-tagged protrudin under control of a neuron-specific promoter, and we have subjected highly purified protrudin-containing complexes isolated from the brain of these mice to proteomics analysis to identify proteins that associate with protrudin. Protrudin was found to interact with other HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, and reticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. The protrudin(G191V) mutant, which has been identified in a subset of HSP patients, manifested an increased intracellular stability, and cells expressing this mutant showed an increased susceptibility to ER stress. Our results thus suggest that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP.	[Hashimoto, Yutaka; Shirane, Michiko; Matsuzaki, Fumiko; Saita, Shotaro; Ohnishi, Takafumi; Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Shirane, M (corresponding author), Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	smichi@bioreg.kyushu-u.ac.jp		Shirane, Michiko/0000-0002-8297-9245; Matsuzaki, Fumiko/0000-0001-9370-6456; Saita, Shotaro/0000-0002-7406-8361	Japan Society for the Promotion of Science KAKENHI	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Young Scientists (S) (to M.S.).	Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Chang J, 2013, P NATL ACAD SCI USA, V110, P14954, DOI 10.1073/pnas.1307391110; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; HARDING AE, 1983, LANCET, V1, P1151; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Martignoni M, 2008, AM J HUM GENET, V83, P127, DOI 10.1016/j.ajhg.2008.05.014; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304; Zhang CL, 2012, J CELL BIOCHEM, V113, P2296, DOI 10.1002/jcb.24100; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	36	43	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12946	12961		10.1074/jbc.M113.528687	http://dx.doi.org/10.1074/jbc.M113.528687			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668814	Green Published, hybrid			2022-12-28	WOS:000335522800001
J	Karamitros, CS; Konrad, M				Karamitros, Christos S.; Konrad, Manfred			Human 60-kDa Lysophospholipase Contains an N-terminal L-Asparaginase Domain That Is Allosterically Regulated by L-Asparagine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Enzyme Mutation; Enzyme Purification; Fluorescence; Leukemia; l-Asparaginases; Allostery; Conformational Stability; Differential Scanning Fluorometry; Human Lysophospholipase	GUANIDINE-HYDROCHLORIDE DENATURATION; ESCHERICHIA-COLI-ASPARAGINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUBSTRATE HYDROLYSIS; COPURIFYING GROEL; MONOMERIC ENZYMES; HUMAN GLUCOKINASE; FUSION PROTEINS	Background: The 60-kDa human lysophospholipase comprises an N-terminal domain with predicted, yet uncharacterized l-asparaginase activity and a C-terminal ankyrin repeat-like domain. Results: The N-terminal domain, termed hASNase1, was identified as a functional structural unit possessing catalytic activity. Conclusion: hASNase1 is an allosterically regulated bacterial-type cytoplasmic l-asparaginase. Significance: Domains of multifunctional human proteins harbor homologs of prokaryotic enzymes displaying similar structural and kinetic features. The structural and functional characterization of human enzymes that are of potential medical and therapeutic interest is of prime significance for translational research. One of the most notable examples of a therapeutic enzyme is l-asparaginase, which has been established as an antileukemic protein drug for more than four decades. Up until now, only bacterial enzymes have been used in therapy despite a plethora of undesired side effects mainly attributed to the bacterial origins of these enzymes. Therefore, the replacement of the currently approved bacterial drugs by human homologs aiming at the elimination of adverse effects is of great importance. Recently, we structurally and biochemically characterized the enzyme human l-asparaginase 3 (hASNase3), which possesses l-asparaginase activity and belongs to the N-terminal nucleophile superfamily of enzymes. Inspired by the necessity for the development of a protein drug of human origin, in the present study, we focused on the characterization of another human l-asparaginase, termed hASNase1. This bacterial-type cytoplasmic l-asparaginase resides in the N-terminal subdomain of an overall 573-residue protein previously reported to function as a lysophospholipase. Our kinetic, mutagenesis, structural modeling, and fluorescence labeling data highlight allosteric features of hASNase1 that are similar to those of its Escherichia coli homolog, EcASNase1. Differential scanning fluorometry and urea denaturation experiments demonstrate the impact of particular mutations on the structural and functional integrity of the l-asparaginase domain and provide a direct comparison of sites critical for the conformational stability of the human and E. coli enzymes.	[Karamitros, Christos S.; Konrad, Manfred] Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany	Max Planck Society	Konrad, M (corresponding author), Max Planck Inst Biophys Chem, Enzyme Biochem Grp, D-37077 Gottingen, Germany.	mkonrad@gwdg.de			Max Planck Society; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	Max Planck Society(Max Planck Society); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	This work was supported by the Max Planck Society (to C. S. K. and M. K.) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (to C. S. K.).	ASSELIN BL, 1989, CANCER RES, V49, P4363; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; Bandyopadhyay D, 1997, MOL CELL BIOCHEM, V167, P73, DOI 10.1023/A:1006815504302; Baryshnikova EN, 2005, PROTEIN SCI, V14, P2658, DOI 10.1110/ps.051402705; Baskakov IV, 1999, PROTEIN SCI, V8, P1314, DOI 10.1110/ps.8.6.1314; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Cardenas ML, 2013, FEBS LETT, V587, P2767, DOI 10.1016/j.febslet.2013.07.014; CARDENAS ML, 1984, EUR J BIOCHEM, V145, P163, DOI 10.1111/j.1432-1033.1984.tb08536.x; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Credali A, 2013, PLANT CELL PHYSIOL, V54, P107, DOI 10.1093/pcp/pcs156; Delano D.W., 2002, PYMOL MOL GRAPHICS S; DERST C, 1992, PROTEIN ENG, V5, P785, DOI 10.1093/protein/5.8.785; Dieterich DC, 2003, J NEUROCHEM, V85, P1117, DOI 10.1046/j.1471-4159.2003.01766.x; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Grimsley G. R., 2013, CURR PROTOC PROTEIN, V71; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; HANSEN HA, 1994, APPL MICROBIOL BIOT, V41, P560, DOI 10.1007/BF00178489; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; Huang ZM, 2014, NUCLEIC ACIDS RES, V42, pD510, DOI 10.1093/nar/gkt1247; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Karamitros CS, 2014, PROTEIN EXPRES PURIF, V93, P1, DOI 10.1016/j.pep.2013.10.007; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li WZ, 2012, ACS CHEM BIOL, V7, P1840, DOI 10.1021/cb300232n; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Menniti M, 2010, CELL PHYSIOL BIOCHEM, V26, P587, DOI 10.1159/000322326; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Modesti M, 2011, METHODS MOL BIOL, V783, P101, DOI 10.1007/978-1-61779-282-3_6; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Nomme J, 2012, BIOCHEMISTRY-US, V51, P6816, DOI 10.1021/bi300870g; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Pace CN, 1999, PROTEIN SCI, V8, P1500, DOI 10.1110/ps.8.7.1500; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Rohman M, 2000, PROTEIN EXPRES PURIF, V20, P45, DOI 10.1006/prep.2000.1271; Saito S, 2008, BIOCHEM BIOPH RES CO, V377, P1168, DOI 10.1016/j.bbrc.2008.10.142; SHE HS, 1994, BIOCHEM J, V298, P23, DOI 10.1042/bj2980023; Shirley Bret A., 1995, V40, P177; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Srikhanta YN, 2013, BIOCHEM BIOPH RES CO, V436, P362, DOI 10.1016/j.bbrc.2013.05.066; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; Su Y, 2013, CHEM BIOL, V20, P533, DOI 10.1016/j.chembiol.2013.03.006; Sugimoto H, 1998, J BIOL CHEM, V273, P12536, DOI 10.1074/jbc.273.20.12536; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Talla-Singh D, 2008, PROTEINS, V71, P1607, DOI 10.1002/prot.22016; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Voronin D A, 2007, Tsitologiia, V49, P989; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidle UH, 2009, ANTICANCER RES, V29, P951; WILLIS RC, 1975, J BACTERIOL, V123, P937, DOI 10.1128/JB.123.3.937-945.1975; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061; Zhang J, 2006, P NATL ACAD SCI USA, V103, P13368, DOI 10.1073/pnas.0605738103	69	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12962	12975		10.1074/jbc.M113.545038	http://dx.doi.org/10.1074/jbc.M113.545038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24657844	Green Published, hybrid			2022-12-28	WOS:000335522800002
J	Michel, M; Wilhelmi, I; Schultz, AS; Preussner, M; Heyd, F				Michel, Monika; Wilhelmi, Ilka; Schultz, Astrid-Solveig; Preussner, Marco; Heyd, Florian			Activation-induced Tumor Necrosis Factor Receptorassociated Factor 3 ( Traf3) Alternative Splicing Controls the Noncanonical Nuclear Factor kappa B Pathway and Chemokine Expression in Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Nuclear Factor B (NFB); RNA Splicing; T Cell; TRAF	PROTEIN-INTERACTION NETWORKS; PRE-MESSENGER-RNA; MESENCHYMAL TRANSITION; HELPER-CELLS; KINASE; REGULATORS; RECEPTOR; VARIANTS; DYNAMICS; PROGRAM	Background: Many pre-mRNAs are alternatively spliced upon T cell activation, but functional implications remain largely unexplored. Results: Alternative splicing of the signaling adaptor Traf3 controls expression of effector proteins in activated T cells. Conclusion: Cell type-specific and activation-dependent alternative splicing regulates signaling and gene expression in T cells. Significance: Alternative splicing plays a fundamental role in regulating functionality upon T cell activation. The noncanonical nuclear factor B (ncNFB) pathway regulates the expression of chemokines required for secondary lymphoid organ formation and thus plays a pivotal role in adaptive immunity. Whereas ncNFB signaling has been well described in stromal cells and B cells, its role and regulation in T cells remain largely unexplored. ncNFB activity critically depends on the upstream NFB-inducing kinase (NIK). NIK expression is negatively regulated by the full-length isoform of TNF receptor-associated factor 3 (Traf3) as formation of a NIK-Traf3-Traf2 complex targets NIK for degradation. Here we show that T cell-specific and activation-dependent alternative splicing generates a Traf3 isoform lacking exon 8 (Traf3DE8) that, in contrast to the full-length protein, activates ncNFB signaling. Traf3DE8 disrupts the NIK-Traf3-Traf2 complex and allows accumulation of NIK to initiate ncNFB signaling in activated T cells. ncNFB activity results in expression of several chemokines, among them B cell chemoattractant (CxCL13), both in a model T cell line and in primary human CD4(+) T cells. Because CxCL13 plays an important role in B cell migration and activation, our data suggest an involvement and provide a mechanistic basis for Traf3 alternative splicing and ncNFB activation in contributing to T cell-dependent adaptive immunity.	[Michel, Monika; Wilhelmi, Ilka; Schultz, Astrid-Solveig; Preussner, Marco; Heyd, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, D-35032 Marburg, Germany	Philipps University Marburg	Heyd, F (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	florian.heyd@fu-berlin.de			Emmy-Noether Fellowship from the Deutsche Forschungsgemeinschaft [HE 5398/3-1]; Fritz Thyssen Foundation [Az. 10.12.1.158]	Emmy-Noether Fellowship from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Foundation	This work was supported by Emmy-Noether Fellowship HE 5398/3-1 from the Deutsche Forschungsgemeinschaft. This work was also supported by Fritz Thyssen Foundation Grant Az. 10.12.1.158.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Heyd F, 2011, BIOCHEM BIOPH RES CO, V414, P743, DOI 10.1016/j.bbrc.2011.09.149; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Heyd F, 2009, MOL CELL, V33, P674, DOI 10.1016/j.molcel.2009.03.001; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hu HB, 2011, P NATL ACAD SCI USA, V108, P12827, DOI 10.1073/pnas.1105774108; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; de Guinoa JS, 2011, BLOOD, V118, P1560, DOI 10.1182/blood-2011-01-332106; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Eyndhoven WG, 1999, MOL IMMUNOL, V36, P647, DOI 10.1016/S0161-5890(99)00079-6; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	40	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13651	13660		10.1074/jbc.M113.526269	http://dx.doi.org/10.1074/jbc.M113.526269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671418	Green Published, hybrid			2022-12-28	WOS:000335522800058
J	Novgorodov, SA; Riley, CL; Yu, J; Borg, KT; Hannun, YA; Proia, RL; Kindy, MS; Gudz, TI				Novgorodov, Sergei A.; Riley, Christopher L.; Yu, Jin; Borg, Keith T.; Hannun, Yusuf A.; Proia, Richard L.; Kindy, Mark S.; Gudz, Tatyana I.			Essential Roles of Neutral Ceramidase and Sphingosine in Mitochondrial Dysfunction Due to Traumatic Brain Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cell Death; Mitochondria; Respiratory Chain; Sphingolipid	CYTOCHROME-C-OXIDASE; SUBCELLULAR-LOCALIZATION; CHRONIC ACTIVATION; RESPIRATORY-CHAIN; MOLECULAR-CLONING; RAT-BRAIN; IN-VITRO; KINASE; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS	Background: A cardinal feature of many neurological disorders is mitochondrial dysfunction. Results: Knocking down neutral ceramidase reduces mitochondrial sphingosine, preserves mitochondrial function, and improves brain function recovery after trauma. Conclusion: Activation of the sphingosine-generating pathway plays a significant role in promoting mitochondrial injury. Significance: This is the first direct evidence of endogenous sphingosine involvement in regulation of mitochondrial function. In addition to immediate brain damage, traumatic brain injury (TBI) initiates a cascade of pathophysiological events producing secondary injury. The biochemical and cellular mechanisms that comprise secondary injury are not entirely understood. Herein, we report a substantial deregulation of cerebral sphingolipid metabolism in a mouse model of TBI. Sphingolipid profile analysis demonstrated increases in sphingomyelin species and sphingosine concurrently with up-regulation of intermediates of de novo sphingolipid biosynthesis in the brain. Investigation of intracellular sites of sphingosine accumulation revealed an elevation of sphingosine in mitochondria due to the activation of neutral ceramidase (NCDase) and the reduced activity of sphingosine kinase 2 (SphK2). The lack of change in gene expression suggested that post-translational mechanisms are responsible for the shift in the activities of both enzymes. Immunoprecipitation studies revealed that SphK2 is complexed with NCDase and cytochrome oxidase (COX) subunit 1 in mitochondria and that brain injury hindered SphK2 association with the complex. Functional studies showed that sphingosine accumulation resulted in a decreased activity of COX, a rate-limiting enzyme of the mitochondrial electron transport chain. Knocking down NCDase reduced sphingosine accumulation in mitochondria and preserved COX activity after the brain injury. Also, NCDase knockdown improved brain function recovery and lessened brain contusion volume after trauma. These studies highlight a novel mechanism of secondary TBI involving a disturbance of sphingolipid-metabolizing enzymes in mitochondria and suggest a critical role for mitochondrial sphingosine in promoting brain injury after trauma.	[Riley, Christopher L.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Yu, Jin; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Borg, Keith T.] Med Univ S Carolina, Dept Emergency Med, Charleston, SC 29425 USA; [Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	National Institutes of Health [P30 GM103339]; Veterans Affairs Merit Awards [I01RX000206, I01BX001104, I01RX000331]; American Diabetes Association [7-12-IN-28]; NATIONAL CANCER INSTITUTE [R01CA172517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056016, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, P30GM103339] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000206, I01RX000331, I01BX001104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant P30 GM103339 (to S. A. N.). This work was also supported by Veterans Affairs Merit Awards I01RX000206 (to T. I. G.), I01BX001104 (to T. I. G.), and I01RX000331 (to M. S. K.). The Lipidomics Core Facility at Medical University of South Carolina is supported in part by National Institutes of Health Grant P30 GM103339.; Supported in part by American Diabetes Association Innovation Grant 7-12-IN-28.	Arnold S, 2012, ADV EXP MED BIOL, V748, P305, DOI 10.1007/978-1-4614-3573-0_13; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Chan HS, 2013, BBA-MOL CELL BIOL L, V1831, P147, DOI 10.1016/j.bbalip.2012.07.005; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2011, J BIOL CHEM, V286, P21565, DOI 10.1074/jbc.M110.193375; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Franzen R, 2001, J BIOL CHEM, V276, P35382, DOI 10.1074/jbc.M102153200; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Novgorodov Sergei A, 2011, Int J Biochem Mol Biol, V2, P347; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; O'Neill SM, 2011, ARCH BIOCHEM BIOPHYS, V511, P31, DOI 10.1016/j.abb.2011.04.009; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zhu Q, 2008, ACTA PHARMACOL SIN, V29, P593, DOI 10.1111/j.1745-7254.2008.00781.x; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	64	30	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13142	13154		10.1074/jbc.M113.530311	http://dx.doi.org/10.1074/jbc.M113.530311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659784	hybrid, Green Published			2022-12-28	WOS:000335522800016
J	Tudor, C; te Riet, J; Eich, C; Harkes, R; Smisdom, N; Wenger, JB; Ameloot, M; Holt, M; Kanger, JS; Figdor, CG; Cambi, A; Subramaniam, V				Tudor, Cicerone; te Riet, Joost; Eich, Christina; Harkes, Rolf; Smisdom, Nick; Wenger, Jessica Bouhuijzen; Ameloot, Marcel; Holt, Matthew; Kanger, Johannes S.; Figdor, Carl G.; Cambi, Alessandra; Subramaniam, Vinod			Syntenin-1 and Ezrin Proteins Link Activated Leukocyte Cell Adhesion Molecule to the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Atomic Force Microscopy; Cell Adhesion; Cytoskeleton; Fluorescence Resonance Energy Transfer (FRET); ALCAM; FRET-FLIM; Single-cell Force Spectroscopy	IMMUNOLOGICAL SYNAPSE FORMATION; CUTTING EDGE; LIVING CELLS; KINASE-C; ALCAM; CD6; EXPRESSION; CLONING; ANTIGEN; CANCER	Background: The activated leukocyte cell adhesion molecule (ALCAM) is involved in immune responses and cancer metastasis. Results: ALCAM is linked to the actin cytoskeleton through a supramolecular complex, including ezrin and syntenin-1. Conclusion: ALCAM supramolecular complex engaged to CD6 stabilizes the immunological synapse. Significance: Insights into the immunological synapse at the dendritic cell side contribute to clarify immune regulation mechanisms. Activated leukocyte cell adhesion molecule (ALCAM) is a type I transmembrane protein member of the immunoglobulin superfamily of cell adhesion molecules. Involved in important pathophysiological processes such as the immune response, cancer metastasis, and neuronal development, ALCAM undergoes both homotypic interactions with other ALCAM molecules and heterotypic interactions with the surface receptor CD6 expressed at the T cell surface. Despite biochemical and biophysical evidence of a dynamic association between ALCAM and the actin cytoskeleton, no detailed information is available about how this association occurs at the molecular level. Here, we exploit a combination of complementary microscopy techniques, including FRET detected by fluorescence lifetime imaging microscopy and single-cell force spectroscopy, and we demonstrate the existence of a preformed ligand-independent supramolecular complex where ALCAM stably interacts with actin by binding to syntenin-1 and ezrin. Interaction with the ligand CD6 further enhances these multiple interactions. Altogether, our results propose a novel biophysical framework to understand the stabilizing role of the ALCAM supramolecular complex engaged to CD6 during dendritic cell-T cell interactions and provide novel information on the molecular players involved in the formation and signaling of the immunological synapse at the dendritic cell side.	[Tudor, Cicerone; Harkes, Rolf; Holt, Matthew; Kanger, Johannes S.; Cambi, Alessandra; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Harkes, Rolf; Holt, Matthew; Kanger, Johannes S.; Cambi, Alessandra; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Wenger, Jessica Bouhuijzen] VIB Ctr Biol Dis, Lab Glia Biol, B-3000 Louvain, Belgium; [Tudor, Cicerone; Wenger, Jessica Bouhuijzen] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [te Riet, Joost; Eich, Christina; Figdor, Carl G.; Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Smisdom, Nick; Ameloot, Marcel] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium; [Smisdom, Nick] Flemish Inst Technol Res, Environm Risk & Hlth Unit, B-2400 Mol, Belgium	University of Twente; University of Twente; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; Hasselt University; VITO	Cambi, A (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	a.cambi@ncmls.ru.nl; subramaniam@amolf.nl	te Riet, Joost/L-1584-2015; Figdor, Carl G/A-4232-2010; Subramaniam, Vinod/B-4197-2010; Smisdom, Nick/U-7567-2019; Holt, Matthew/AAJ-1813-2020; Cambi, Alessandra/L-4242-2015	te Riet, Joost/0000-0002-9093-010X; Figdor, Carl G/0000-0002-2366-9212; Subramaniam, Vinod/0000-0001-6712-7266; Smisdom, Nick/0000-0002-0495-2012; Holt, Matthew/0000-0002-8958-4027; Harkes, Rolf/0000-0001-6592-654X; Eich, Christina/0000-0001-7839-0932; Cambi, Alessandra/0000-0003-1597-1582	Netherlands Organization for Scientific Research Medium Sized Investment Grant [91110007]	Netherlands Organization for Scientific Research Medium Sized Investment Grant	We thank all members of our laboratories for encouragement and constructive criticisms. We acknowledge Christian Blum for help with time-correlated single photon-counting fluorescence lifetime measurements. We thank Pascale Zimmermann for the plasmids for syntenin-1-GFP and syntenin-1-mCherry and Satyajit Mayor for the plasmids for ezrin-GFP and ezrin-RFP. We also thank Theodorus W. J. Gadella and Joachim Goedhart ( Molecular Cytology, University of Amsterdam) for the pmTurquoise2-N1 and mVenus (L68V)-mTurquoise2 plasmids. We thank Ruurd Torensma for providing the AZN-L50 antibody. The atomic force microscope was supported by Netherlands Organization for Scientific Research Medium Sized Investment Grant 91110007.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Bruder SP, 1998, J BONE MINER RES, V13, P655, DOI 10.1359/jbmr.1998.13.4.655; Bucherl C, 2010, METHODS MOL BIOL, V655, P389, DOI 10.1007/978-1-60761-765-5_26; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Emiliani V, 2003, APPL PHYS LETT, V83, P2471, DOI 10.1063/1.1604938; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gilsanz A, 2013, CELL MOL LIFE SCI, V70, P475, DOI 10.1007/s00018-012-1132-0; Gimferrer I, 2005, J IMMUNOL, V175, P1406, DOI 10.4049/jimmunol.175.3.1406; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Ihnen M, 2010, BRIT J CANCER, V103, P1048, DOI 10.1038/sj.bjc.6605840; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; King JA, 2004, BREAST CANCER RES, V6, pR478, DOI 10.1186/bcr815; Kuo WC, 2010, ONCOGENE, V29, P1374, DOI 10.1038/onc.2009.417; Lamers E, 2012, EUR CELLS MATER, V23, P182, DOI 10.22203/eCM.v023a14; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Levesque MC, 1998, ARTHRITIS RHEUM, V41, P2221, DOI 10.1002/1529-0131(199812)41:12<2221::AID-ART18>3.0.CO;2-I; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nelissen JMDT, 2000, MOL BIOL CELL, V11, P2057, DOI 10.1091/mbc.11.6.2057; Nelissen JMDT, 2000, EXP HEMATOL, V28, P422, DOI 10.1016/S0301-472X(00)00127-2; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sala-Valdes M, 2012, J CELL SCI, V125, P1235, DOI 10.1242/jcs.094912; Schlachter S, 2009, OPT EXPRESS, V17, P1557, DOI 10.1364/OE.17.001557; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; te Riet J, 2014, J CELL SCI, V127, P1595, DOI 10.1242/jcs.141077; te Riet J, 2011, ULTRAMICROSCOPY, V111, P1659, DOI 10.1016/j.ultramic.2011.09.012; Tomita K, 2003, UROONCOLOGY, V3, P121, DOI DOI 10.1080/15610950310001632322; Uchida N, 1997, BLOOD, V89, P2706, DOI 10.1182/blood.V89.8.2706; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	63	29	30	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13445	13460		10.1074/jbc.M113.546754	http://dx.doi.org/10.1074/jbc.M113.546754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24662291	hybrid, Green Published			2022-12-28	WOS:000335522800042
J	Uechi, H; Hamazaki, J; Murata, S				Uechi, Hiroyuki; Hamazaki, Jun; Murata, Shigeo			Characterization of the Testis-specific Proteasome Subunit alpha 4s in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Sperm; Spermatogenesis; Testis; Ubiquitin	INTERFERON-GAMMA; 26S PROTEASOMES; 20S PROTEASOMES; DNA-REPAIR; DEGRADATION; COMPLEX; SYSTEM; CELLS; DESTRUCTION; CHAPERONES	Background: Two subtypes of proteasome core particles (CPs) with tissue-specific subunits have been identified in mammals. Results: Mammals have an additional proteasome subunit, 4s, which forms the male germ-specific CP. Conclusion: The 4s-containing CP is a new subtype of CP with unique properties distinct from the constitutive CP. Significance: Our results provide a clue for understanding the role of the proteasome in mammalian testes. The 26 S proteasome is responsible for regulated proteolysis in eukaryotic cells. It is composed of one 20 S core particle (CP) flanked by one or two 19 S regulatory particles. The CP is composed of seven different -type subunits (1-7) and seven different -type subunits, three of which are catalytic. Vertebrates encode four additional catalytic subunits that are expressed predominantly in immune tissues and produce distinct subtypes of CPs particularly well suited for the acquired immune system. In contrast, the diversity of subunits remains poorly understood. Recently, another subunit, referred to as 4s, was reported. However, little is known about 4s. Here we provide a detailed characterization of 4s and the 4s-containing CP. 4s is exclusively expressed in germ cells that enter the meiotic prophase and is incorporated into the CP in place of 4. A comparison of structural models revealed that the differences in the primary sequences between 4 and 4s are located on the outer surface of the CP, suggesting that 4s interacts with specific molecules via these unique regions. 4s-containing CPs account for the majority of the CPs in mouse sperm. The catalytic subunits in the 4s-containing CP are 1, 2, and 5, and immunosubunits are not included in the 4s-containing CP. 4s-containing CPs have a set of peptidase activities almost identical to those of 4-containing CPs. Our results provide a basis for understanding the role of 4s and male germ cell-specific proteasomes in mammals.	[Uechi, Hiroyuki; Hamazaki, Jun; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Murata, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	smurata@mol.f.u-tokyo.ac.jp	hamazaki, jun/AAG-4823-2019; Murata, Shigeo/A-1426-2010	hamazaki, jun/0000-0002-7145-3424; Murata, Shigeo/0000-0002-3177-3503	Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alsheimer M, 2010, CYTOGENET GENOME RES, V128, P162, DOI 10.1159/000303341; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Blanco-Rodriguez J, 1999, BIOL REPROD, V61, P1541, DOI 10.1095/biolreprod61.6.1541; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kent J, 1996, DEVELOPMENT, V122, P2813; Liu X, 2006, MOL CELL, V22, P317, DOI 10.1016/j.molcel.2006.04.007; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; TAJIMA Y, 1991, DEVELOPMENT, V113, P1031; Takahama Y, 2012, CURR OPIN IMMUNOL, V24, P92, DOI 10.1016/j.coi.2012.01.006; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka K, 1998, IMMUNOL REV, V163, P161; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	31	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12365	12374		10.1074/jbc.M114.558866	http://dx.doi.org/10.1074/jbc.M114.558866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668818	Green Published, hybrid			2022-12-28	WOS:000335581400015
J	Kolli, N; Garman, SC				Kolli, Nilima; Garman, Scott C.			Proteolytic Activation of Human Cathepsin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Structure; Lysosomal Glycoproteins; Protease; Proteolytic Enzymes; X-ray Crystallography	LYSOSOMAL PROTECTIVE PROTEIN; 3-DIMENSIONAL STRUCTURE; INSECT CELLS; GLYCOSYLATION; NEURAMINIDASE; INHIBITORS; TRANSPORT; SUGGESTS; COMPLEX; DOMAIN	Background: The human lysosomal protease cathepsin A requires proteolytic activation. Results: The crystal structure of mature and active cathepsin A reveals its mechanism of activation. Conclusion: Removal of a 3.3-kDa peptide (by unidentified proteases) allows substrate access to the active site. Significance: The results revise a 2-decades-old model of cathepsin A activation by proteolysis and subsequent conformational change. Galactosialidosis is a human lysosomal storage disease caused by deficiency in the multifunctional lysosomal protease cathepsin A (also known as protective protein/cathepsin A, PPCA, catA, HPP, and CTSA; EC 3.4.16.5). Previous structural work on the inactive precursor human cathepsin A (zymogen) led to a two-stage model for activation, where proteolysis of a 1.6-kDa excision peptide is followed by a conformational change in a blocking peptide occluding the active site. Here we present evidence for an alternate model of activation of human cathepsin A, needing only cleavage of a 3.3-kDa excision peptide to yield full enzymatic activity, with no conformational change required. We present x-ray crystallographic, mass spectrometric, amino acid sequencing, enzymatic, and cellular data to support the cleavage-only activation model. The results clarify a longstanding question about the mechanism of cathepsin A activation and point to new avenues for the design of mechanism-based inhibitors of the enzyme.	[Kolli, Nilima; Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Kolli, Nilima; Garman, Scott C.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 North Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu	Kolli, nilima/AAC-9038-2020	Kolli, nilima/0000-0001-5012-5344	National Center for Research Resources at the National Institutes of Health [RR-15301]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Rinat Abzalimov of the University of Massachusetts Amherst mass spectrometry center for the mass spectroscopy measurements and Igor Kourinov and the staff of the Advanced Photon Source Northeastern Collaborative Access Team beamlines, which are supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health.	Birkus G, 2011, ANTIMICROB AGENTS CH, V55, P2166, DOI 10.1128/AAC.01603-10; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BONTEN EJ, 1995, J BIOL CHEM, V270, P26441, DOI 10.1074/jbc.270.44.26441; BULLOCK TL, 1994, BIOCHEMISTRY-US, V33, P11127, DOI 10.1021/bi00203a009; Cayot P, 1997, ANAL BIOCHEM, V249, P184, DOI 10.1006/abio.1997.2161; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, P213; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; Dojima T, 2009, J BIOTECHNOL, V143, P27, DOI 10.1016/j.jbiotec.2009.06.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDRIZZI JA, 1994, BIOCHEMISTRY-US, V33, P11106, DOI 10.1021/bi00203a007; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; Gouveia R, 2010, J BIOTECHNOL, V145, P130, DOI 10.1016/j.jbiotec.2009.10.018; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; ITOH K, 1995, J BIOL CHEM, V270, P515, DOI 10.1074/jbc.270.2.515; ITOH K, 1993, J BIOL CHEM, V268, P1180; JACKMAN HL, 1992, J BIOL CHEM, V267, P2872; Jackman HL, 2002, HYPERTENSION, V39, P976, DOI 10.1161/01.HYP.0000017283.67962.02; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORREAU H, 1992, J BIOL CHEM, V267, P17949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OLESEN K, 1995, BIOCHEMISTRY-US, V34, P15689, DOI 10.1021/bi00048a013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PSHEZHETSKY AV, 1995, ANAL BIOCHEM, V230, P303, DOI 10.1006/abio.1995.1478; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; Rudenko G, 1996, ACTA CRYSTALLOGR D, V52, P923, DOI 10.1107/S0907444996004702; Ruf S, 2013, FUTURE MED CHEM, V5, P399, DOI [10.4155/FMC.13.24, 10.4155/fmc.13.24]; Ruf S, 2012, J MED CHEM, V55, P7636, DOI 10.1021/jm300663n; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; van der Spoel A, 1997, AM J HUM GENET, V61, pA27; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittlin S, 1999, EUR J BIOCHEM, V265, P384, DOI 10.1046/j.1432-1327.1999.00747.x	38	15	15	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11592	11600		10.1074/jbc.M113.524280	http://dx.doi.org/10.1074/jbc.M113.524280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599961	Green Published, hybrid			2022-12-28	WOS:000335010600003
J	Laker, RC; Xu, P; Ryall, KA; Sujkowski, A; Kenwood, BM; Chain, KH; Zhang, M; Royal, MA; Hoehn, KL; Driscoll, M; Adler, PN; Wessells, RJ; Saucerman, JJ; Yan, Z				Laker, Rhianna C.; Xu, Peng; Ryall, Karen A.; Sujkowski, Alyson; Kenwood, Brandon M.; Chain, Kristopher H.; Zhang, Mei; Royal, Mary A.; Hoehn, Kyle L.; Driscoll, Monica; Adler, Paul N.; Wessells, Robert J.; Saucerman, Jeffrey J.; Yan, Zhen			A Novel MitoTimer Reporter Gene for Mitochondrial Content, Structure, Stress, and Damage in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Exercise; Mitochondria; Oxidative Stress; Skeletal Muscle; High-fat Diet; Reporter Gene	FLUORESCENT PROTEINS; OXIDATIVE STRESS; SKELETAL-MUSCLE; DYSFUNCTION; DISEASE; EXERCISE; RESTRICTION; RESPIRATION; EXPRESSION; REDUCTION	Background: Mitochondrial health is difficult to assess in vivo. Results: We have generated a reporter gene, MitoTimer, which targets mitochondria, and fluoresces green and shifts to red when oxidized, for assessment of mitochondrial content, structure, stress, and damage under physiological and pathological conditions. Conclusion:MitoTimer is useful for assessment of mitochondrial health in vivo. Significance:MitoTimer could advance mitochondrial research in multiple disciplines. Mitochondrial dysfunction plays important roles in many diseases, but there is no satisfactory method to assess mitochondrial health in vivo. Here, we engineered a MitoTimer reporter gene from the existing Timer reporter gene. MitoTimer encodes a mitochondria-targeted green fluorescent protein when newly synthesized, which shifts irreversibly to red fluorescence when oxidized. Confocal microscopy confirmed targeting of the MitoTimer protein to mitochondria in cultured cells, Caenorhabditis elegans touch receptor neurons, Drosophila melanogaster heart and indirect flight muscle, and mouse skeletal muscle. A ratiometric algorithm revealed that conditions that cause mitochondrial stress led to a significant shift toward red fluorescence as well as accumulation of pure red fluorescent puncta of damaged mitochondria targeted for mitophagy. Long term voluntary exercise resulted in a significant fluorescence shift toward green, in mice and D. melanogaster, as well as significantly improved structure and increased content in mouse FDB muscle. In contrast, high-fat feeding in mice resulted in a significant shift toward red fluorescence and accumulation of pure red puncta in skeletal muscle, which were completely ameliorated by voluntary wheel running. Hence, MitoTimer allows for robust analysis of multiple parameters of mitochondrial health under both physiological and pathological conditions and will be highly useful for future research of mitochondrial health in multiple disciplines in vivo.	[Laker, Rhianna C.; Xu, Peng; Zhang, Mei; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Kenwood, Brandon M.; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Chain, Kristopher H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Adler, Paul N.] Univ Virginia, Dept Biol, Charlottesville, VA 22908 USA; [Ryall, Karen A.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Laker, Rhianna C.; Xu, Peng; Chain, Kristopher H.; Zhang, Mei; Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, Charlottesville, VA 22908 USA; [Royal, Mary A.; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Sujkowski, Alyson; Wessells, Robert J.] Univ Michigan, Dept Geriatr Med, Sch Med, Ann Arbor, MI 48109 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Rutgers State University New Brunswick; University of Michigan System; University of Michigan	Yan, Z (corresponding author), 409 Lane Rd,MR4-6041A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu	Wessells, Robert/AAG-3406-2020	Sujkowski, Alyson/0000-0002-9909-9279; Wessells, Robert/0000-0002-4516-3183; Yan, Zhen/0000-0002-4826-9813; Hoehn, Kyle/0000-0002-0214-3238	National Institutes of Health [AR050429]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047101, R01AG046358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AR050429 (to Z. Y.).	Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Broderick TL, 2002, MOL CELL BIOCHEM, V233, P119, DOI 10.1023/A:1015506327849; CHANG L, 1995, DEMENTIA, V6, P1, DOI 10.1159/000106915; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; DiFranco Marino, 2009, J Vis Exp, DOI 10.3791/1520; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Liu ZH, 2012, NEUROBIOL DIS, V45, P362, DOI 10.1016/j.nbd.2011.08.022; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MILLER SE, 1988, J ELECTRON MICR TECH, V8, P41, DOI 10.1002/jemt.1060080105; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Ponsot E, 2006, J APPL PHYSIOL, V100, P1249, DOI 10.1152/japplphysiol.00361.2005; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Ravid R, 2012, FEBS J, V279, P1167, DOI 10.1111/j.1742-4658.2012.08518.x; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roma LP, 2012, BIOCHEM J, V441, P971, DOI 10.1042/BJ20111770; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tinkerhess MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3786; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wolf Alexander M., 2008, Journal of Nippon Medical School, V75, P66, DOI 10.1272/jnms.75.66; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	43	155	156	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12005	12015		10.1074/jbc.M113.530527	http://dx.doi.org/10.1074/jbc.M113.530527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24644293	Green Published, hybrid			2022-12-28	WOS:000335010600039
J	Mackeh, R; Lorin, S; Ratier, A; Mejdoubi-Charef, N; Baillet, A; Bruneel, A; Hamai, A; Codogno, P; Pous, C; Perdiz, D				Mackeh, Rafah; Lorin, Severine; Ratier, Ameetha; Mejdoubi-Charef, Najet; Baillet, Anita; Bruneel, Arnaud; Hamai, Ahmed; Codogno, Patrice; Poues, Christian; Perdiz, Daniel			Reactive Oxygen Species, AMP-activated Protein Kinase, and the Transcription Cofactor p300 Regulate alpha- Tubulin Acetyltransferase-1 ( alpha TAT-1/MEC-17)- dependent Microtubule Hyperacetylation during Cell Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Microtubules; p300; Reactive Oxygen Species (ROS); Stress; Tubulin; AMPK; MEC-17; ATAT1; Acetylation	DYNAMIC INSTABILITY; AUTOPHAGY; STIMULATION; ACETYLATION; MITOCHONDRIA; INHIBITION; BINDING; MEC-17; GENE; ROS	Background: Tubulin acetylation is a hallmark of microtubule stabilization, which may modulate the binding of microtubule-associated proteins. Results: Microtubules are hyperacetylated because of stress-induced cellular signaling upstream of the tubulin acetyltransferase MEC-17/TAT1. Conclusion: MEC-17/TAT1 is regulated by p300, reactive oxygen species, and AMP-activated protein kinase. Significance: Microtubule hyperacetylation is important for cell adaptation to stress through autophagy induction and for cell survival. Beyond its presence in stable microtubules, tubulin acetylation can be boosted after UV exposure or after nutrient deprivation, but the mechanisms of microtubule hyperacetylation are still unknown. In this study, we show that this hyperacetylation is a common response to several cellular stresses that involves the stimulation of the major tubulin acetyltransferase MEC-17. We also demonstrate that the acetyltransferase p300 negatively regulates MEC-17 expression and is sequestered on microtubules upon stress. We further show that reactive oxygen species of mitochondrial origin are required for microtubule hyperacetylation by activating the AMP kinase, which in turn mediates MEC-17 phosphorylation upon stress. Finally, we show that preventing microtubule hyperacetylation by knocking down MEC-17 affects cell survival under stress conditions and starvation-induced autophagy, thereby pointing out the importance of this rapid modification as a broad cell response to stress.	[Mackeh, Rafah; Lorin, Severine; Ratier, Ameetha; Mejdoubi-Charef, Najet; Baillet, Anita; Bruneel, Arnaud; Poues, Christian; Perdiz, Daniel] Univ Paris 11, Fac Pharm, EA4530, F-92296 Chatenay Malabry, France; [Bruneel, Arnaud] Hop Bichat Claude Bernard, AP HP, Serv Biochim Metab & Cellulaire, F-75018 Paris, France; [Hamai, Ahmed; Codogno, Patrice] Univ Paris 05, INSERM, U845, F-75014 Paris, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Pous, C (corresponding author), Univ Paris 11, UFR Pharm, EA4530, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	POÜS, Christian/R-5089-2018; Baillet, Anita/R-6217-2018; Bruneel, Arnaud/AAD-1338-2021; Lorin, Séverine/R-4689-2018; Perdiz, Daniel/R-4471-2018; MEJDOUBI-CHAREF, Najet/R-4683-2018	Bruneel, Arnaud/0000-0001-8411-3309; Perdiz, Daniel/0000-0002-6804-5980; POUS, Christian/0000-0002-2502-7854	Ministere de l'Enseignement Superieur et de la Recherche [EA 4530]; INSERM [U845]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by Grant EA 4530 from the Ministere de l'Enseignement Superieur et de la Recherche and Grant U845 from INSERM.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen F, 2010, MOL CELL, V40, P175, DOI 10.1016/j.molcel.2010.10.008; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Giustiniani J, 2009, EXP CELL RES, V315, P3509, DOI 10.1016/j.yexcr.2009.07.018; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Mees ST, 2010, INT J CANCER, V126, P114, DOI 10.1002/ijc.24695; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nunes P, 2013, AUTOPHAGY, V9, P550, DOI 10.4161/auto.23662; Park IJ, 2006, ANN NY ACAD SCI, V1091, P102, DOI 10.1196/annals.1378.059; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Sid B, 2013, BIOCHEM PHARMACOL, V86, P200, DOI 10.1016/j.bcp.2013.05.007; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Walter WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042218; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; Zhou XY, 2005, AM J PHYSIOL-RENAL, V289, pF871, DOI 10.1152/ajprenal.00129.2005	53	61	63	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11816	11828		10.1074/jbc.M113.507400	http://dx.doi.org/10.1074/jbc.M113.507400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619423	Green Published, hybrid			2022-12-28	WOS:000335010600022
J	Manhas, R; Tripathi, P; Khan, S; Lakshmi, BS; Lal, SK; Gowri, VS; Sharma, A; Madhubala, R				Manhas, Reetika; Tripathi, Pankaj; Khan, Sameena; Lakshmi, Bhavana Sethu; Lal, Shambhu Krishan; Gowri, Venkatraman Subramanian; Sharma, Amit; Madhubala, Rentala			Identification and Functional Characterization of a Novel Bacterial Type Asparagine Synthetase A A tRNA SYNTHETASE PARALOG FROM LEISHMANIA DONOVANI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl-tRNA Synthetase; Drug Design; Drug Development; Drug Discovery; Drug Resistance; Leishmania; Parasite; Leishmania; Drug Target	RAY-DIFFRACTION DATA; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; TRANSITION; EXPRESSION; ORTHOLOG; CLONING; SYSTEM	Background: Asparagine synthetase A catalyzes the synthesis of asparagine from aspartate in the presence of ammonia as a nitrogen donor. Results:L. donovani ASNA enzyme is of bacterial origin and is both ammonia- and glutamine-dependent. Conclusion:LdASNA is essential for survival of the Leishmania parasite. Significance: The absence of LdASNA homologs from humans validates Leishmania ASNA as a novel drug target. Asparagine is formed by two structurally distinct asparagine synthetases in prokaryotes. One is the ammonia-utilizing asparagine synthetase A (AsnA), and the other is asparagine synthetase B (AsnB) that uses glutamine or ammonia as a nitrogen source. In a previous investigation using sequence-based analysis, we had shown that Leishmania spp. possess asparagine-tRNA synthetase paralog asparagine synthetase A (LdASNA) that is ammonia-dependent. Here, we report the cloning, expression, and kinetic analysis of ASNA from Leishmania donovani. Interestingly, LdASNA was both ammonia- and glutamine-dependent. To study the physiological role of ASNA in Leishmania, gene deletion mutations were attempted via targeted gene replacement. Gene deletion of LdASNA showed a growth delay in mutants. However, chromosomal null mutants of LdASNA could not be obtained as the double transfectant mutants showed aneuploidy. These data suggest that LdASNA is essential for survival of the Leishmania parasite. LdASNA enzyme was recalcitrant toward crystallization so we instead crystallized and solved the atomic structure of its close homolog from Trypanosoma brucei (TbASNA) at 2.2 . A very significant conservation in active site residues is observed between TbASNA and Escherichia coli AsnA. It is evident that the absence of an LdASNA homolog from humans and its essentiality for the parasites make LdASNA a novel drug target.	[Gowri, Venkatraman Subramanian; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Khan, Sameena; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rentala@outlook.com		madhubala, rentala/0000-0002-0034-399X; Manhas, Reetika/0000-0002-0220-2330; V Subramanian, Gowri/0000-0002-4404-6401	Department of Biotechnology, Government of India; Department of Science and Technology Promotion of University Research and Scientific Excellence grant; University Grants Commission, India; Council of Scientific and Industrial Research, India; Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology Promotion of University Research and Scientific Excellence grant; University Grants Commission, India(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India	This work was supported by a grant from the Department of Biotechnology, Government of India and a Department of Science and Technology Promotion of University Research and Scientific Excellence grant (to R. M.).; Recipient of funding from the University Grants Commission, India.; Recipients of funding from the Council of Scientific and Industrial Research, India.; Supported by an Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India and a J. C. Bose National Fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Blaise M, 2011, J MOL BIOL, V412, P437, DOI 10.1016/j.jmb.2011.07.050; Boehlein SK, 2001, BIOCHEMISTRY-US, V40, P11168, DOI 10.1021/bi0155551; BURCHALL JJ, 1964, J BIOL CHEM, V239, P1794; Charron C, 2004, ACTA CRYSTALLOGR D, V60, P767, DOI 10.1107/S0907444904003117; Chauhan SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006805; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francklyn C, 2003, P NATL ACAD SCI USA, V100, P9650, DOI 10.1073/pnas.1934245100; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Garcia-Hernandez R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001974; Gilreath MS, 2011, FEBS LETT, V585, P3284, DOI 10.1016/j.febslet.2011.09.008; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Hughes CA, 1997, PLANT MOL BIOL, V33, P301, DOI 10.1023/A:1005784202450; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Koizumi M, 1999, J AM CHEM SOC, V121, P5799, DOI 10.1021/ja990851a; Loureiro I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002578; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; NAKAMURA M, 1981, NUCLEIC ACIDS RES, V9, P4669, DOI 10.1093/nar/9.18.4669; Nakatsu T, 1998, NAT STRUCT BIOL, V5, P15, DOI 10.1038/nsb0198-15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEREZGONZALEZ JA, 1990, GENE, V86, P129, DOI 10.1016/0378-1119(90)90125-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; REITZER LJ, 1982, J BACTERIOL, V151, P1299, DOI 10.1128/JB.151.3.1299-1313.1982; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCOFIELD MA, 1990, J BIOL CHEM, V265, P12895; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; SUGIYAMA A, 1992, BIOSCI BIOTECH BIOCH, V56, P376, DOI 10.1271/bbb.56.376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANHEEKE G, 1989, J BIOL CHEM, V264, P5503; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yoshida KI, 1999, J BACTERIOL, V181, P6081, DOI 10.1128/JB.181.19.6081-6091.1999	41	9	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12096	12108		10.1074/jbc.M114.554642	http://dx.doi.org/10.1074/jbc.M114.554642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610810	Green Published, hybrid			2022-12-28	WOS:000335010600047
J	Cheng, YS; Chen, CC; Huang, CH; Ko, TP; Luo, WH; Huang, JW; Liu, JR; Guo, RT				Cheng, Ya-Shan; Chen, Chun-Chi; Huang, Chun-Hsiang; Ko, Tzu-Ping; Luo, Wenhua; Huang, Jian-Wen; Liu, Je-Ruei; Guo, Rey-Ting			Structural Analysis of a Glycoside Hydrolase Family 11 Xylanase from Neocallimastix patriciarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mutation; Enzyme Structure; Glycoside Hydrolases; X-ray Crystallography; N-terminal Region; Disulfide Bond; Industrial Enzyme; Xylanase	TERMINAL DISULFIDE BRIDGE; PICHIA-PASTORIS; 3-DIMENSIONAL STRUCTURE; GH11 XYLANASE; THERMOMYCES-LANUGINOSUS; ANGSTROM RESOLUTION; TRICHODERMA-REESEI; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; LOW PH	Background: Thermophilic xylanases are valuable in many industrial applications. Results: The structures of a xylanase XynCDBFV and its complex with xylooligosaccharides were determined, and its N-terminal region (NTR) contributes to thermostability. Conclusion: NTR may stabilize the overall protein folding of XynCDBFV. Significance: The structural and functional investigation of unprecedented NTR of XynCDBFV provides a new insight into the molecular basis of thermophilic xylanases. The catalytic domain of XynCDBFV, a glycoside hydrolase family 11 (GH11) xylanase from ruminal fungus Neocallimastix patriciarum previously engineered to exhibit higher specific activity and broader pH adaptability, holds great potential in commercial applications. Here, the crystal structures of XynCDBFV and its complex with substrate were determined to 1.27-1.43 resolution. These structures revealed a typical GH11 -jelly-roll fold and detailed interaction networks between the enzyme and ligands. Notably, an extended N-terminal region (NTR) consisting of 11 amino acids was identified in the XynCDBFV structure, which is found unique among GH11 xylanases. The NTR is attached to the catalytic core by hydrogen bonds and stacking forces along with a disulfide bond between Cys-4 and Cys-172. Interestingly, the NTR deletion mutant retained 61.5% and 19.5% enzymatic activity at 55 degrees C and 75 degrees C, respectively, compared with the wild-type enzyme, whereas the C4A/C172A mutant showed 86.8% and 23.3% activity. These results suggest that NTR plays a role in XynCDBFV thermostability, and the Cys-4/Cys-172 disulfide bond is critical to the NTR-mediated interactions. Furthermore, we also demonstrated that Pichia pastoris produces XynCDBFV with higher catalytic activity at higher temperature than Escherichia coli, in which incorrect NTR folding and inefficient disulfide bond formation might have occurred. In conclusion, these structural and functional analyses of the industrially favored XynCDBFV provide a molecular basis of NTR contribution to its thermostability.	Genozyme Biotechnol Inc, Taipei 106, Taiwan; [Cheng, Ya-Shan; Guo, Rey-Ting] AsiaPac Biotechnol Co Ltd, Dongguan 523808, Peoples R China; [Chen, Chun-Chi; Huang, Chun-Hsiang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Ind Enzymes Natl Engn Lab, Tianjin 300308, Peoples R China; [Ko, Tzu-Ping] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Luo, Wenhua] South China Agr Univ, Coll Food Sci, Guangzhou 510642, Guangdong, Peoples R China; [Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Academia Sinica - Taiwan; South China Agricultural University; National Taiwan University	Guo, RT (corresponding author), 32 XiQiDao,Tianjin Airport Econ Pk, Tianjin 300308, Peoples R China.	guo_rt@tib.cas.cn		LIU, JE-RUEI/0000-0002-2152-7536; Guo, Rey-Ting/0000-0003-2942-7246; Chen, chun-chi/0000-0002-7459-5591	National High Technology Research and Development Program of China [2012AA022200]; Tianjin Municipal Science and Technology Commission [12ZCZDSY12500]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Tianjin Municipal Science and Technology Commission	This work was supported by the National High Technology Research and Development Program of China (2012AA022200) and the Tianjin Municipal Science and Technology Commission (12ZCZDSY12500).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Chen YL, 2001, CAN J MICROBIOL, V47, P1088, DOI 10.1139/cjm-47-12-1088; Cheng YF, 2005, ENZYME MICROB TECH, V37, P541, DOI 10.1016/j.enzmictec.2005.04.006; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; DeLano W.L, PYMOL MOL GRAPHICS S; Dumon C, 2008, J BIOL CHEM, V283, P22557, DOI 10.1074/jbc.M800936200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenel F, 2004, J BIOTECHNOL, V108, P137, DOI 10.1016/j.jbiotec.2003.11.002; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Janis J, 2004, BIOCHEMISTRY-US, V43, P9556, DOI 10.1021/bi049597b; Khandeparker R, 2008, J IND MICROBIOL BIOT, V35, P635, DOI 10.1007/s10295-008-0342-9; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konig J, 2002, ANAL BIOANAL CHEM, V374, P80, DOI 10.1007/s00216-002-1379-7; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; LEE JMT, 1993, CAN J MICROBIOL, V39, P134, DOI 10.1139/m93-020; Li H, 2013, ENZYME MICROB TECH, V53, P414, DOI 10.1016/j.enzmictec.2013.09.004; Liu JH, 1999, CAN J MICROBIOL, V45, P970, DOI 10.1139/cjm-45-11-970; Liu MQ, 2006, PROTEIN EXPRES PURIF, V48, P292, DOI 10.1016/j.pep.2006.04.007; McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Purmonen M, 2007, PROTEIN ENG DES SEL, V20, P551, DOI 10.1093/protein/gzm056; Ramalingam A. D. H. a. C., 2010, J EXP SCI, V1, P1; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sriyapai T, 2011, J BIOSCI BIOENG, V111, P528, DOI 10.1016/j.jbiosc.2010.12.024; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Sygmund C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; van Bueren AL, 2012, ACTA CRYSTALLOGR F, V68, P141, DOI 10.1107/S1744309111049608; VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1016/0168-6445(94)90090-6; Wan Q, 2014, ACTA CRYSTALLOGR D, V70, P11, DOI 10.1107/S1399004713023626; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; You C, 2010, BIOTECHNOL BIOENG, V105, P861, DOI 10.1002/bit.22623	48	49	57	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11020	11028		10.1074/jbc.M114.550905	http://dx.doi.org/10.1074/jbc.M114.550905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619408	Green Published, hybrid			2022-12-28	WOS:000334638500008
J	Date, DA; Burrows, AC; Summers, MK				Date, Dipali A.; Burrows, Amy C.; Summers, Matthew K.			Phosphorylation Regulates the p31Comet-Mitotic Arrest-deficient 2 ( Mad2) Interaction to Promote Spindle Assembly Checkpoint ( SAC) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Division; Mitosis; Protein Complexes; Protein Phosphorylation; Anaphase-promoting Complex; Mad2; Mitotic Checkpoint Complex; p31Comet; Spindle Assembly Checkpoint	MITOTIC CHECKPOINT; COMPLEX; BINDING; CDC20; P31(COMET); ACTIVATION; PROTEIN; INHIBITION; BUBR1; UBIQUITINATION	Background: p31(Comet) antagonizes the SAC effector Mad2 to promote mitotic progression. Results: p31(Comet) phosphorylation modulates binding to Mad2. Conclusion: Phosphorylation attenuates binding of Mad2 by p31(Comet) to promote SAC activity. Significance: Our study provides the first description of p31(Comet) regulation and new insight into the control of SAC activity. The spindle assembly checkpoint (SAC) ensures the faithful segregation of the genome during mitosis by ensuring that sister chromosomes form bipolar attachments with microtubules of the mitotic spindle. p31(Comet) is an antagonist of the SAC effector Mad2 and promotes silencing of the SAC and mitotic progression. However, p31(Comet) interacts with Mad2 throughout the cell cycle. We show that p31(Comet) binds Mad2 solely in an inhibitory manner. We demonstrate that attenuating the affinity of p31(Comet) for Mad2 by phosphorylation promotes SAC activity in mitosis. Specifically, phosphorylation of Ser-102 weakens p31(Comet)-Mad2 binding and enhances p31(Comet)-mediated bypass of the SAC. Our results provide the first evidence for regulation of p31(Comet) and demonstrate a previously unknown event controlling SAC activity.	[Date, Dipali A.; Burrows, Amy C.; Summers, Matthew K.] Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Summers, MK (corresponding author), Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	summerm@ccf.org			Lerner Research Institute; American Cancer Society [IRG-91-022-15]; Ohio Cancer Research Associates; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Lerner Research Institute; American Cancer Society(American Cancer Society); Ohio Cancer Research Associates; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by seed funds form the Lerner Research Institute, American Cancer Society Grant IRG-91-022-15, and pilot funds from the Ohio Cancer Research Associates (to M. K. S.).	De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kim S, 2010, P NATL ACAD SCI USA, V107, P19772, DOI 10.1073/pnas.1009000107; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mariani L, 2012, CURR BIOL, V22, P1900, DOI 10.1016/j.cub.2012.08.028; Miniowitz-Shemtov S, 2012, P NATL ACAD SCI USA, V109, P8056, DOI 10.1073/pnas.1204081109; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	28	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11367	11373		10.1074/jbc.M113.520841	http://dx.doi.org/10.1074/jbc.M113.520841			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596092	hybrid, Green Published			2022-12-28	WOS:000334638500038
J	Hayashida, C; Ito, J; Nakayachi, M; Okayasu, M; Ohyama, Y; Hakeda, Y; Sato, T				Hayashida, Chiyomi; Ito, Junta; Nakayachi, Mai; Okayasu, Mari; Ohyama, Yoko; Hakeda, Yoshiyuki; Sato, Takuya			Osteocytes Produce Interferon-beta as a Negative Regulator of Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cytokines; Interferon; Osteoclast; Osteocyte; Osteoporosis; Osteoclastogenesis	NF-KAPPA-B; BONE-MARROW; C-FOS; IN-VITRO; CELLS; DIFFERENTIATION; MICE; OSTEOPOROSIS; EXPRESSION; RESORPTION	Background: Global interferon- deficiency causes osteoporosis. Lack of interferon- production by osteoclast precursors is considered to induce excess osteoclastogenesis. Results: Isolated osteocytes express higher amount of interferon- mRNA than osteoclast precursors and inhibit osteoclastogenesis partially in interferon--dependent manner. Conclusion: Osteocytes produce interferon- as an inhibitor of osteoclastogenesis. Significance: Osteocytic interferon- might be involved in the regulation of bone homeostasis. Osteoclastogenesis is controlled by osteocytes; osteocytic osteoclastogenesis regulatory molecules are largely unknown. We searched for such factors using newly developed culture methods. Our culture system mimics the three-dimensional cellular structure of bone, consisting of collagen gel-embedded osteocytic MLO-Y4 cells, stromal ST2 cells on the gel as bone lining cells, and bone marrow cells. The gel-embedded MLO-Y4 cells inhibited the osteoclastogenesis induced by 1,25(OH)(2)D-3 without modulating receptor activator of NF-B ligand (RANKL) and osteoprotegerin (OPG) production by ST2 cells, despite MLO-Y4 cells supported osteoclastogenesis in the absence of ST2 cells. In the bone marrow cell culture, the conditioned medium from MLO-Y4 cells decreased the capability of osteoclastic differentiation from the cells induced by macrophage colony-stimulating factor. This decreased capability was concomitant with an increase in protein kinase R mRNA expression and an inhibition of c-Fos translation. These changes were partially normalized by the simultaneous addition of an anti-interferon (IFN)- neutralizing antibody to MLO-Y4 cell conditioned medium. To study primary osteocytes, we prepared non-osteocytic cell-free osteocyte-enriched bone fragments (OEBFs). When osteoclast precursors were induced by macrophage colony-stimulating factor in the presence of OEBFs, the generated cells exhibited a diminished capacity for osteoclastogenesis. OEBFs prepared from OPG-knock-out mice exhibited a similar effect, indicating OPG-independent inhibition. The addition of anti-IFN- neutralizing antibody during the co-culture with OEBFs partially recovered the osteoclastogenic potential of the generated cells. The MLO-Y4 cells and OEBFs expressed IFN- mRNA. Although osteocytic RANKL is known to be important for osteoclastogenesis, our data suggest that osteocytes also produce IFN- as an inhibitor of osteoclastogenesis.	[Hayashida, Chiyomi; Ito, Junta; Hakeda, Yoshiyuki; Sato, Takuya] Meikai Univ, Sch Dent, Div Oral Anat, Sakado, Saitama 3500283, Japan; [Nakayachi, Mai; Okayasu, Mari] Meikai Univ, Sch Dent, Div Orthodont, Dept Human Dev & Fostering, Sakado, Saitama 3500283, Japan; [Ohyama, Yoko] Meikai Univ, Sch Dent, Div Oral & Maxillofacial Surg, Dept Diagnost & Therapeut Sci, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University; Meikai University	Sato, T (corresponding author), Meikai Univ, Sch Dent, Div Oral Anat, Dept Human Dev & Fostering, Sakado, Saitama 3500283, Japan.	satotaku@dent.meikai.ac.jp			Meikai University School of Dentistry; Onuki Foundation; Japan Society for Promotion of Science [25293376]	Meikai University School of Dentistry; Onuki Foundation; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Miyata Research Grant A from the Meikai University School of Dentistry (to T. S.), the Onuki Foundation (to Y. H.), Grant-in-Aid for Scientific Research (KAKENHI) 25293376 from the Japan Society for Promotion of Science (to Y. H.).	Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chambers TJ, 2011, ANN NY ACAD SCI, V1240, P1, DOI 10.1111/j.1749-6632.2011.06249.x; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kurata K, 2006, J BONE MINER RES, V21, P616, DOI 10.1359/JBMR.060106; LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Okayasu M, 2012, J BIOL CHEM, V287, P19229, DOI 10.1074/jbc.M111.323600; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Sato T, 2007, J BONE MINER METAB, V25, P19, DOI 10.1007/s00774-006-0723-y; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; VANDERPLAS A, 1992, J BONE MINER RES, V7, P389; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	35	26	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11545	11555		10.1074/jbc.M113.523811	http://dx.doi.org/10.1074/jbc.M113.523811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610813	Green Published, hybrid			2022-12-28	WOS:000334638500054
J	Oh, J; Goo, E; Hwang, I; Rhee, S				Oh, Juntaek; Goo, Eunhye; Hwang, Ingyu; Rhee, Sangkee			Structural Basis for Bacterial Quorum Sensing-mediated Oxalogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Bacterial Pathogenesis; Enzyme Catalysis; Protein Structure; X-ray Crystallography; Burkholderia glumae; ObcA; Oxalate Biosynthetic Component; Oxalate	ACETYLTRANSFERASES; MECHANISM; OXALATE; SYNTHASE	Background: Oxalogenesis in the Burkholderia species is an indispensable event for their survival in the stationary phase. Results: Structural and functional analyses of ObcA, the first enzyme in oxalogenesis, unravel an unprecedented reaction mechanism. Conclusion: ObcA produces a tetrahedral CoA adduct. Significance: This study provides a structural basis for understanding the first step in oxalogenesis. The Burkholderia species utilize acetyl-CoA and oxaloacetate, substrates for citrate synthase in the TCA cycle, to produce oxalic acid in response to bacterial cell to cell communication, called quorum sensing. Quorum sensing-mediated oxalogenesis via a sequential reaction by ObcA and ObcB counteracts the population-collapsing alkaline pH of the stationary growth phase. Thus, the oxalic acid produced plays an essential role as an excreted public good for survival of the group. Here, we report structural and functional analyses of ObcA, revealing mechanistic features distinct from those of citrate synthase. ObcA exhibits a unique fold, in which a (/)(8)-barrel fold is located in the C-domain with the N-domain inserted into a loop following 1 in the barrel fold. Structural analyses of the complexes with oxaloacetate and with a bisubstrate adduct indicate that each of the oxaloacetate and acetyl-CoA substrates is bound to an independent site near the metal coordination shell in the barrel fold. In catalysis, oxaloacetate serves as a nucleophile by forming an enolate intermediate mediated by Tyr(322) as a general base, which then attacks the thioester carbonyl carbon of acetyl-CoA to yield a tetrahedral adduct between the two substrates. Therefore, ObcA catalyzes its reaction by combining the enolase and acetyltransferase superfamilies, but the presence of the metal coordination shell and the absence of general acid(s) produces an unusual tetrahedral CoA adduct as a stable product. These results provide the structural basis for understanding the first step in oxalogenesis and constitute an example of the functional diversity of an enzyme for survival and adaptation in the environment.	[Oh, Juntaek; Goo, Eunhye; Hwang, Ingyu; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	Goo, Eunhye/ERO-2624-2022; Oh, Juntaek/AFM-0371-2022	Oh, Juntaek/0000-0002-7625-2779	Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center [PJ008059]; National Research Foundation of Korea [2008-0061897, 2010-0018280]	Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center PJ008059 (to S. R.), by National Research Foundation of Korea Grant 2008-0061897 (to S. R.), and by Creative Research Initiatives Program of the National Research Foundation of Korea Grant 2010-0018280 (to I. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govindasamy L, 2004, J STRUCT BIOL, V148, P226, DOI 10.1016/j.jsb.2004.06.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoppe B, 2012, NAT REV NEPHROL, V8, P467, DOI 10.1038/nrneph.2012.113; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128	29	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11465	11475		10.1074/jbc.M113.543462	http://dx.doi.org/10.1074/jbc.M113.543462			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616091	Green Published, hybrid			2022-12-28	WOS:000334638500047
J	Senning, EN; Collins, MD; Stratiievska, A; Ufret-Vincenty, CA; Gordon, SE				Senning, Eric N.; Collins, Marcus D.; Stratiievska, Anastasiia; Ufret-Vincenty, Carmen A.; Gordon, Sharona E.			Regulation of TRPV1 Ion Channel by Phosphoinositide (4,5)-Bisphosphate THE ROLE OF MEMBRANE ASYMMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ion Channels; Membrane; Membrane Lipids; Phosphoinositides; Phospholipid; PI(4; 5)P-2; TRPV1	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CA2+-DEPENDENT DESENSITIZATION; CAPSAICIN RECEPTOR; LIPIDS; ACTIVATION; BINDS	Background: Whether phosphoinositide 4,5-bisphosphate (PI(4,5)P-2) activates or inhibits TRPV1 is controversial. Results: PI(4,5)P-2 in the intracellular leaflet activates TRPV1, whereas PI(4,5)P-2 in the extracellular leaflet inhibits TRPV1. Conclusion: Inhibition by PI(4,5)P-2 in the extracellular leaflet may explain previous findings that TRPV1 reconstituted into PI(4,5)P-2-containing liposomes is inhibited. Significance: PI(4,5)P-2 in the physiologically relevant leaflet (the intracellular leaflet) of the membrane activates TRPV1. Membrane asymmetry is essential for generating second messengers that act in the cytosol and for trafficking of membrane proteins and membrane lipids, but the role of asymmetry in regulating membrane protein function remains unclear. Here we show that the signaling lipid phosphoinositide 4,5-bisphosphate (PI(4,5)P-2) has opposite effects on the function of TRPV1 ion channels depending on which leaflet of the cell membrane it resides in. We observed potentiation of capsaicin-activated TRPV1 currents by PI(4,5)P-2 in the intracellular leaflet of the plasma membrane but inhibition of capsaicin-activated currents when PI(4,5)P-2 was in both leaflets of the membrane, although much higher concentrations of PI(4,5)P-2 in the extracellular leaflet were required for inhibition compared with the concentrations of PI(4,5)P-2 in the intracellular leaflet that produced activation. Patch clamp fluorometry using a synthetic PI(4,5)P-2 whose fluorescence reports its concentration in the membrane indicates that PI(4,5)P-2 must incorporate into the extracellular leaflet for its inhibitory effects to be observed. The asymmetry-dependent effect of PI(4,5)P-2 may resolve the long standing controversy about whether PI(4,5)P-2 is an activator or inhibitor of TRPV1. Our results also underscore the importance of membrane asymmetry and the need to consider its influence when studying membrane proteins reconstituted into synthetic bilayers.	[Gordon, Sharona E.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Stratiievska, Anastasiia] Int Ctr Mol Physiol, Bogomoletz Inst Physiol, Lab Biophys Ion Channels, Dept Gen Physiol Nervous Syst, UA-01024 Kiev, Ukraine	University of Washington; University of Washington Seattle; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Gordon, SE (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	seg@uw.edu		Collins, Marcus/0000-0002-2342-8056	NIGMS, National Institutes of Health [R01GM100718]; NEI, National Institutes of Health [R01EY017564, P30EY001730]; National Center for Research Resources, National Institutes of Health [S10RR025429]; NIDDK, National Institutes of Health [P30DK017047, T32EY007031, T32HL007312]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, T32EY007031, R01EY017564] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R01GM100718; by NEI, National Institutes of Health Grants R01EY017564 and P30EY001730; by the National Center for Research Resources, National Institutes of Health Grant S10RR025429; and by NIDDK, National Institutes of Health Grants P30DK017047, T32EY007031, and T32HL007312.	Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Cheng H, 2007, J NEUROCHEM, V101, P57, DOI 10.1111/j.1471-4159.2006.04342.x; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Collins MD, 2013, JOVE-J VIS EXP, DOI 10.3791/50227; Collins MD, 2013, BIOPHYS J, V105, P2485, DOI 10.1016/j.bpj.2013.09.035; Dahim M, 2002, BIOPHYS J, V83, P1511, DOI 10.1016/S0006-3495(02)73921-0; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; DOWNES P, 1982, CELL CALCIUM, V3, P467, DOI 10.1016/0143-4160(82)90031-8; GARRETT RJB, 1975, BIOCHIM BIOPHYS ACTA, V382, P58; GASCARD P, 1991, BIOCHIM BIOPHYS ACTA, V1069, P27, DOI 10.1016/0005-2736(91)90100-M; GASCARD P, 1993, BIOCHEM SOC T, V21, P253, DOI 10.1042/bst0210253; Gordon-Shaag A, 2008, CHANNELS, V2, P125, DOI 10.4161/chan.2.2.6026; Jung J, 1999, J NEUROSCI, V19, P529; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Ozato-Sakurai N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023567; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7	32	37	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10999	11006		10.1074/jbc.M114.553180	http://dx.doi.org/10.1074/jbc.M114.553180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599956	Green Published, hybrid			2022-12-28	WOS:000334638500006
J	Slavoff, SA; Heo, JH; Budnik, BA; Hanakahi, LA; Saghatelian, A				Slavoff, Sarah A.; Heo, Jinho; Budnik, Bogdan A.; Hanakahi, Leslyn A.; Saghatelian, Alan			A Human Short Open Reading Frame ( sORF)-encoded Polypeptide That Stimulates DNA End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Peptide Interactions; Peptides; Protein-Protein Interactions; Proteomics; Short ORF	STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; RETROVIRAL INFECTION; HUMAN-CELLS; PEPTIDES; DISCOVERY; PATHWAY; KU; BINDING; LOCALIZATION	Background: Large numbers of peptides encoded in human short open reading frames have been recently identified but not yet functionally characterized. Results: A peptide interacts with the Ku heterodimer and stimulates nonhomologous end-joining DNA repair. Conclusion: Newly discovered cellular peptides can be functionally characterized by identifying their interaction partners. Significance: Short ORF-encoded polypeptides participate in essential cellular processes. The recent discovery of numerous human short open reading frame (sORF)-encoded polypeptides (SEPs) has raised important questions about the functional roles of these molecules in cells. Here, we show that a 69-amino acid SEP, MRI-2, physically interacts with the Ku heterodimer to stimulate DNA double-strand break ligation via nonhomologous end joining. The characterization of MRI-2 suggests that this SEP may participate in DNA repair and underscores the potential of SEPs to serve important biological functions in mammalian cells.	[Slavoff, Sarah A.; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Budnik, Bogdan A.] Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA; [Heo, Jinho; Hanakahi, Leslyn A.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hanakahi, LA (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA.	hanakahi@uic.edu; saghatelian@chemistry.harvard.edu	Budnik, Bogdan/AAH-9987-2019; slavoff, sarah/HIK-2036-2022; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Slavoff, Sarah/0000-0002-4443-2070	National Research Service Award postdoctoral fellowship [1F32GM099408]; National Institutes of Health Grant through the NIGMS [R01GM102491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099408, R01GM102491] Funding Source: NIH RePORTER	National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant through the NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Research Service Award postdoctoral fellowship (1F32GM099408) (to S. A. S.) and National Institutes of Health Grant (R01GM102491) through the NIGMS (to A. S.).	Agarwal S, 2006, P NATL ACAD SCI USA, V103, P15933, DOI 10.1073/pnas.0602674103; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bertinato J, 2001, J CELL SCI, V114, P89; Casson SA, 2002, PLANT CELL, V14, P1705, DOI 10.1105/tpc.002618; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheung JCY, 2008, NUCLEIC ACIDS RES, V36, P5713, DOI 10.1093/nar/gkn572; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi L, 2011, MOL CANCER RES, V9, P1366, DOI 10.1158/1541-7786.MCR-11-0230; Hanakahi LA, 2007, PROTEIN EXPRES PURIF, V52, P139, DOI 10.1016/j.pep.2006.10.002; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Schwaid AG, 2013, J AM CHEM SOC, V135, P16750, DOI 10.1021/ja406606j; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	41	94	96	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10950	10957		10.1074/jbc.C113.533968	http://dx.doi.org/10.1074/jbc.C113.533968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610814	Green Published, hybrid			2022-12-28	WOS:000334638500001
J	Tarafdar, S; Poe, JA; Smithgall, TE				Tarafdar, Sreya; Poe, Jerrod A.; Smithgall, Thomas E.			The Accessory Factor Nef Links HIV-1 to Tec/Btk Kinases in an Src Homology 3 Domain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; HIV-1; Nonreceptor Tyrosine Kinase; SH3 Domains; Src	PROTEIN-TYROSINE KINASES; LONG-TERM SURVIVOR; SH3 DOMAIN; CRYSTAL-STRUCTURE; C-SRC; TRANSGENIC MICE; DOWN-REGULATION; TEC KINASES; TYPE-1 NEF; FAMILY	The HIV-1 Nef virulence factor interacts with multiple host cell-signaling proteins. Nef binds to the Src homology 3 domains of Src family kinases, resulting in kinase activation important for viral infectivity, replication, and MHC-I down-regulation. Itk and other Tec family kinases are also present in HIV target cells, and Itk has been linked to HIV-1 infectivity and replication. However, the molecular mechanism linking Itk to HIV-1 is unknown. In this study, we explored the interaction of Nef with Tec family kinases using a cell-based bimolecular fluorescence complementation assay. In this approach, interaction of Nef with a partner kinase juxtaposes nonfluorescent YFP fragments fused to the C terminus of each protein, resulting in YFP complementation and a bright fluorescent signal. Using bimolecular fluorescence complementation, we observed that Nef interacts with the Tec family members Bmx, Btk, and Itk but not Tec or Txk. Interaction with Nef occurs through the kinase Src homology 3 domains and localizes to the plasma membrane. Allelic variants of Nef from all major HIV-1 subtypes interacted strongly with Itk in this assay, demonstrating the highly conserved nature of this interaction. A selective small molecule inhibitor of Itk kinase activity (BMS-509744) potently blocked wild-type HIV-1 infectivity and replication, but not that of a Nef-defective mutant. Nef induced constitutive Itk activation in transfected cells that was sensitive to inhibitor treatment. Taken together, these results provide the first evidence that Nef interacts with cytoplasmic tyrosine kinases of the Tec family and suggest that Nef provides a mechanistic link between HIV-1 and Itk signaling in the viral life cycle.	[Tarafdar, Sreya; Poe, Jerrod A.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Tarafdar, Sreya] Univ Pittsburgh, Dept Infect Dis & Microbiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102724]; Fogarty International HIV Research Training Program of the National Institutes of Health [TW001038]; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International HIV Research Training Program of the National Institutes of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057083 and AI102724 (to T.E.S.).; Supported by the Fogarty International HIV Research Training Program of the National Institutes of Health (TW001038).	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Joseph RE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004298; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lester GMS, 2013, VIROLOGY, V436, P235, DOI 10.1016/j.virol.2012.11.015; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	48	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15718	15728		10.1074/jbc.M114.572099	http://dx.doi.org/10.1074/jbc.M114.572099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722985	Green Published, hybrid			2022-12-28	WOS:000337465400052
J	Cubillos-Rojas, M; Amair-Pinedo, F; Peiro-Jordan, R; Bartrons, R; Ventura, F; Rosa, JL				Cubillos-Rojas, Monica; Amair-Pinedo, Fabiola; Peiro-Jordan, Roser; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose			The E3 Ubiquitin Protein Ligase HERC2 Modulates the Activity of Tumor Protein p53 by Regulating Its Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMULTANEOUS ELECTROPHORETIC ANALYSIS; GUANINE-NUCLEOTIDE EXCHANGE; DNA-DAMAGE; DEVELOPMENTAL DELAY; GIANT PROTEIN; RAB PROTEINS; LI-FRAUMENI; HECT FAMILY; TARGETS; CANCER	The tumor suppressor p53 is a transcription factor that coordinates the cellular response to several kinds of stress. p53 inactivation is an important step in tumor progression. Oligomerization of p53 is critical for its posttranslational modification and its ability to regulate the transcription of target genes necessary to inhibit tumor growth. Here we report that the HECT E3 ubiquitin ligase HERC2 interacts with p53. This interaction involves the CPH domain of HERC2 (a conserved domain within Cul7, PARC, and HERC2 proteins) and the last 43 amino acid residues of p53. Through this interaction, HERC2 regulates p53 activity. RNA interference experiments showed how HERC2 depletion reduces the transcriptional activity of p53 without affecting its stability. This regulation of p53 activity by HERC2 is independent of proteasome or MDM2 activity. Under these conditions, up-regulation of cell growth and increased focus formation were observed, showing the functional relevance of the HERC2-p53 interaction. This interaction was maintained after DNA damage caused by the chemotherapeutic drug bleomycin. In these stressed cells, p53 phosphorylation was not impaired by HERC2 knockdown. Interestingly, p53 mutations that affect its tetramerization domain disrupted the HERC2-p53 interaction, suggesting a role for HERC2 in p53 oligomerization. This regulatory role was shown using cross-linking assays. Thus, the inhibition of p53 activity after HERC2 depletion can be attributed to a reduction in p53 oligomerization. Ectopic expression of HERC2 (residues 2292-2923) confirmed these observations. Together, these results identify HERC2 as a novel regulator of p53 signaling.	[Cubillos-Rojas, Monica; Amair-Pinedo, Fabiola; Peiro-Jordan, Roser; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Rosa, JL (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Campus Bellvitge, Barcelona 08907, Spain.	joseluisrosa@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688	Spanish Ministerio de Ciencia e Innovacion [BFU2011-22498, BFU2009-07380]; Instituto de Salud Carlos III Grant RETIC [RD06/0020]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III Grant RETIC(Instituto de Salud Carlos III)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2011-22498 and BFU2009-07380) and by Instituto de Salud Carlos III Grant RETIC, RD06/0020.	Al-Hakim AK, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014233; Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Casas-Terradellas E, 2006, ELECTROPHORESIS, V27, P3935, DOI 10.1002/elps.200600141; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cruz C, 2001, FEBS LETT, V488, P74, DOI 10.1016/S0014-5793(00)02371-1; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Garcia-Gonzalo FR, 2003, FEBS LETT, V539, P78, DOI 10.1016/S0014-5793(03)00205-9; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hochrainer K, 2008, CELL MOL LIFE SCI, V65, P2105, DOI 10.1007/s00018-008-8148-5; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Izawa N, 2011, CANCER RES, V71, P5621, DOI 10.1158/0008-5472.CAN-11-0385; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kasper JS, 2006, BIOCHEM BIOPH RES CO, V348, P132, DOI 10.1016/j.bbrc.2006.07.013; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Kawai K, 2010, CANCER SCI, V101, P22, DOI 10.1111/j.1349-7006.2009.01373.x; Kroismayr R, 2004, J CELL SCI, V117, P4749, DOI 10.1242/jcs.01338; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuhnle S, 2011, J BIOL CHEM, V286, P19410, DOI 10.1074/jbc.M110.205211; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Linnert M, 2009, ANTI-CANCER DRUG, V20, P157, DOI 10.1097/CAD.0b013e328325465e; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Mashimo T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000784; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Rosa JL, 1997, ONCOGENE, V15, P1, DOI 10.1038/sj.onc.1201170; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; White D, 2011, J HUM GENET, V56, P5, DOI 10.1038/jhg.2010.126; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009	60	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14782	14795		10.1074/jbc.M113.527978	http://dx.doi.org/10.1074/jbc.M113.527978			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722987	Green Published, hybrid			2022-12-28	WOS:000337248100034
J	Guizzetti, L; McGirr, R; Dhanvantari, S				Guizzetti, Leonardo; McGirr, Rebecca; Dhanvantari, Savita			Two Dipolar alpha-Helices within Hormone-encoding Regions of Proglucagon Are Sorting Signals to the Regulated Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYPEPTIDASE-E; PROHORMONE CONVERTASE-2; NEUROENDOCRINE CELLS; SECRETOGRANIN-III; ALPHA-TC1-6 CELLS; DIBASIC RESIDUES; PEPTIDE-HORMONES; CLEAVAGE SITE; A-CELLS; RECEPTOR	Proglucagon is expressed in pancreatic alpha cells, intestinal L cells, and some hypothalamic and brainstem neurons. Tissue-specific processing of proglucagon yields three major peptide hormones as follows: glucagon in the alpha cells and glucagon-like peptides (GLP)-1 and -2 in the L cells and neurons. Efficient sorting and packaging into the secretory granules of the regulated secretory pathway in each cell type are required for nutrient-regulated secretion of these proglucagon-derived peptides. Our previous work suggested that proglucagon is directed into granules by intrinsic sorting signals after initial processing to glicentin and major proglucagon fragment (McGirr, R., Guizzetti, L., and Dhanvantari, S. (2013) J. Endocrinol. 217, 229240), leading to the hypothesis that sorting signals may be present in multiple domains. In the present study, we show that the alpha-helices within glucagon and GLP-1, but not GLP-2, act as sorting signals by efficiently directing a heterologous secretory protein to the regulated secretory pathway. Biophysical characterization of these peptides revealed that glucagon and GLP-1 each encode a nonamphipathic, dipolar alpha-helix, whereas the helix in GLP-2 is not dipolar. Surprisingly, glicentin and major proglucagon fragment were sorted with different efficiencies, thus providing evidence that proglucagon is first sorted to granules prior to processing. In contrast to many other prohormones in which sorting is directed by ordered prodomains, the sorting determinants of proglucagon lie within the ordered hormone domains of glucagon and GLP-1, illustrating that each prohormone has its own sorting "signature."	[Guizzetti, Leonardo; Dhanvantari, Savita] Univ Western Ontario, Dept Med Biophys, London, ON N6A 3K7, Canada; [Dhanvantari, Savita] Univ Western Ontario, Dept Pathol, London, ON N6A 3K7, Canada; [Dhanvantari, Savita] Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada; [McGirr, Rebecca; Dhanvantari, Savita] Lawson Hlth Res Inst, Metab Diabet Program, London, ON N6A 4V2, Canada; [McGirr, Rebecca; Dhanvantari, Savita] Lawson Hlth Res Inst, Imaging Program, London, ON N6A 4V2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dhanvantari, S (corresponding author), Lawson Hlth Res Inst, 268 Grosvenor St, London, ON N6A 4V2, Canada.	sdhanvan@uwo.ca	Dhanvantari, Savita/B-5362-2015; Guizzetti, Leonardo/H-9346-2012	Guizzetti, Leonardo/0000-0001-5864-8422	Natural Sciences and Engineering Research Council of Canada; Lawson Health Research Institute Internal Research Fund; Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lawson Health Research Institute Internal Research Fund; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada, the Lawson Health Research Institute Internal Research Fund, and an Early Researcher Award from the Ontario Ministry of Research and Innovation.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Assadi M, 2004, BIOCHEMISTRY-US, V43, P7798, DOI 10.1021/bi036331g; Blanco EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059695; Brakch N, 2002, J NEUROCHEM, V81, P1166, DOI 10.1046/j.1471-4159.2002.00919.x; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; CHIDGEY MAJ, 1990, EUR J BIOCHEM, V190, P139, DOI 10.1111/j.1432-1033.1990.tb15556.x; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Damholt AB, 1999, ENDOCRINOLOGY, V140, P4800, DOI 10.1210/en.140.10.4800; Dey A, 2005, ENDOCRINOLOGY, V146, P713, DOI 10.1210/en.2004-1118; Dhanvantari S, 1998, ENDOCRINOLOGY, V139, P1630, DOI 10.1210/en.139.4.1630; Dhanvantari S, 2003, MOL ENDOCRINOL, V17, P1856, DOI 10.1210/me.2002-0380; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Dhanvantari S, 1996, MOL ENDOCRINOL, V10, P342, DOI 10.1210/me.10.4.342; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dikeakos JD, 2007, J BIOL CHEM, V282, P1136, DOI 10.1074/jbc.M605718200; Dikeakos JD, 2009, P NATL ACAD SCI USA, V106, P7408, DOI 10.1073/pnas.0809576106; Dirndorfer D, 2013, J BIOL CHEM, V288, P13961, DOI 10.1074/jbc.M112.430264; Dong CX, 2012, NAT REV GASTRO HEPAT, V9, P705, DOI 10.1038/nrgastro.2012.185; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Feliciangeli S, 2002, BIOCHEM BIOPH RES CO, V290, P191, DOI 10.1006/bbrc.2001.6137; Feliciangeli S, 2001, J BIOL CHEM, V276, P6140, DOI 10.1074/jbc.M009613200; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Garcia AL, 2005, J BIOL CHEM, V280, P41595, DOI 10.1074/jbc.M509122200; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jutras I, 2000, J BIOL CHEM, V275, P40337, DOI 10.1074/jbc.M004757200; Lacombe MJ, 2005, J BIOL CHEM, V280, P4803, DOI 10.1074/jbc.M408658200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li SK, 2014, DIABETOLOGIA, V57, P809, DOI 10.1007/s00125-013-3143-2; Loh YP, 2002, ANN NY ACAD SCI, V971, P416, DOI 10.1111/j.1749-6632.2002.tb04504.x; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Ma GQ, 2008, TRAFFIC, V9, P2165, DOI 10.1111/j.1600-0854.2008.00836.x; McGirr R, 2005, ENDOCRINOLOGY, V146, P4514, DOI 10.1210/en.2005-0402; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; Mouchantaf R, 2001, J BIOL CHEM, V276, P26308, DOI 10.1074/jbc.M102514200; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; NOE BD, 1977, J CELL BIOL, V74, P589, DOI 10.1083/jcb.74.2.589; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; Perello M, 2008, J BIOL CHEM, V283, P19936, DOI 10.1074/jbc.M800732200; RAVAZZOLA M, 1984, ENDOCRINOLOGY, V114, P481, DOI 10.1210/endo-114-2-481; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; SASAKI K, 1975, NATURE, V257, P751, DOI 10.1038/257751a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEINO S, 1986, FEBS LETT, V203, P25, DOI 10.1016/0014-5793(86)81429-6; Sirkis DW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003812; Stridsberg M, 2008, J ANAT, V212, P229, DOI 10.1111/j.1469-7580.2008.00857.x; Sun M, 2013, TRAFFIC, V14, P205, DOI 10.1111/tra.12029; Taupenot L, 2007, CURR PROTOC CELL BIO; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Venneti KC, 2011, FEBS LETT, V585, P346, DOI 10.1016/j.febslet.2010.12.011; Wu Y, 2012, J CELL BIOL, V198, P323, DOI 10.1083/jcb.201106158; Xia FZ, 2007, ENDOCRINOLOGY, V148, P2157, DOI 10.1210/en.2006-1296; Zhang CF, 1999, MOL ENDOCRINOL, V13, P527, DOI 10.1210/me.13.4.527	64	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14968	14980		10.1074/jbc.M114.563684	http://dx.doi.org/10.1074/jbc.M114.563684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727476	Green Published, hybrid			2022-12-28	WOS:000337248100049
J	Rice, AJ; Harrison, A; Alvarez, FJD; Davidson, AL; Pinkett, HW				Rice, Austin J.; Harrison, Alistair; Alvarez, Frances J. D.; Davidson, Amy L.; Pinkett, Heather W.			Small Substrate Transport and Mechanism of a Molybdate ATP Binding Cassette Transporter in a Lipid Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; ABC TRANSPORTER; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; BTUCD-F; PROTEINS; MEDIA; COMPETENCE; MUTANTS	Embedded in the plasma membrane of all bacteria, ATP binding cassette (ABC) importers facilitate the uptake of several vital nutrients and cofactors. The ABC transporter, MolBC-A, imports molybdate by passing substrate from the binding protein MolA to a membrane-spanning translocation pathway of MolB. To understand the mechanism of transport in the biological membrane as a whole, the effects of the lipid bilayer on transport needed to be addressed. Continuous wave-electron paramagnetic resonance and in vivo molybdate uptake studies were used to test the impact of the lipid environment on the mechanism and function of MolBC-A. Working with the bacterium Haemophilus influenzae, we found that MolBC-A functions as a low affinity molybdate transporter in its native environment. In periods of high extracellular molybdate concentration, H. influenzae makes use of parallel molybdate transport systems (MolBC-A and ModBC-A) to take up a greater amount of molybdate than a strain with ModBC-A alone. In addition, the movement of the translocation pathway in response to nucleotide binding and hydrolysis in a lipid environment is conserved when compared with in-detergent analysis. However, electron paramagnetic resonance spectroscopy indicates that a lipid environment restricts the flexibility of the MolBC translocation pathway. By combining continuous wave-electron paramagnetic resonance spectroscopy and substrate uptake studies, we reveal details of molybdate transport and the logistics of uptake systems that employ multiple transporters for the same substrate, offering insight into the mechanisms of nutrient uptake in bacteria.	[Rice, Austin J.; Pinkett, Heather W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Harrison, Alistair] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Alvarez, Frances J. D.; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Northwestern University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pinkett, HW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	h-pinkett@northwestern.edu	Pinkett, Heather Wendy/M-9235-2014	Alvarez, Frances/0000-0001-9742-6064	National Science Foundation [MCB1121872]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant MCB1121872.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Dairies D. A., 2003, J MED MICROBIOL, V52, P277; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gil T, 1998, BBA-REV BIOMEMBRANES, V1376, P245, DOI 10.1016/S0304-4157(98)00022-7; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Grunden AM, 1996, J BACTERIOL, V178, P735, DOI 10.1128/jb.178.3.735-744.1996; Grunden AM, 1997, ARCH MICROBIOL, V168, P345, DOI 10.1007/s002030050508; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Neidhardt FC., 1987, ESCHERICHIA COLI SAL, V2nd ed, P3; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pau RN, 2002, MET IONS BIOL SYST, V39, P31; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; ROSENTEL JK, 1995, J BACTERIOL, V177, P4857, DOI 10.1128/jb.177.17.4857-4864.1995; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT D, 1989, J BACTERIOL, V171, P1284, DOI 10.1128/jb.171.3.1284-1287.1989; Singleton P., 1978, DICT MICROBIOLOGY, P145; SPENCER HT, 1965, J BACTERIOL, V90, P911, DOI 10.1128/JB.90.4.911-920.1965; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110	45	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15005	15013		10.1074/jbc.M114.563783	http://dx.doi.org/10.1074/jbc.M114.563783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722984	hybrid, Green Published			2022-12-28	WOS:000337248100052
J	Abad, E; Rommel, JB; Kastner, J				Abad, Enrique; Rommel, Judith B.; Kaestner, Johannes			Reaction Mechanism of the Bicopper Enzyme Peptidylglycine alpha-Hydroxylating Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Copper; Enzyme Catalysis; Metalloproteins; Post-translational Modification; Kinetic Isotope Effects; PHM; QM; MM Simulation; Quantum Tunneling; Reaction Mechanism	DOPAMINE BETA-MONOOXYGENASE; AMIDATING ENZYME; MOLECULAR-DYNAMICS; MONONUCLEAR COPPER; ELECTRON-TRANSFER; ACTIVE-SITE; BASIS-SETS; CATALYTIC MECHANISM; POTENTIAL SURFACES; QM/MM SIMULATIONS	Background: Peptidylglycine -hydroxylating monooxygenase catalyzes the generation of C-terminal carboxamides of peptide hormones, neurotransmitters, and growth factors for biological activation. Results: We compare several possible reaction mechanisms by means of quantum mechanics/molecular mechanics calculations. Conclusion: Our results suggest that the most likely abstracting species is [CuOOH](2+). Significance: Our computational study proposes a new mechanism, which explains the experimental observations. Peptidylglycine -hydroxylating monooxygenase is a noninteracting bicopper enzyme that stereospecifically hydroxylates the terminal glycine of small peptides for its later amidation. Neuroendocrine messengers, such as oxytocin, rely on the biological activity of this enzyme. Each catalytic turnover requires one oxygen molecule, two protons from the solvent, and two electrons. Despite this enzyme having been widely studied, a consensus on the reaction mechanism has not yet been found. Experiments and theoretical studies favor a pro-S abstraction of a hydrogen atom followed by the rebinding of an OH group. However, several hydrogen-abstracting species have been postulated; because two protons are consumed during the reaction, several protonation states are available. An electron transfer between the copper atoms could play a crucial role for the catalysis as well. This leads to six possible abstracting species. In this study, we compare them on equal footing. We perform quantum mechanics/molecular mechanics calculations, considering the glycine hydrogen abstraction. Our results suggest that the most likely mechanism is a protonation of the abstracting species before the hydrogen abstraction and another protonation as well as a reduction before OH rebinding.	[Abad, Enrique; Rommel, Judith B.; Kaestner, Johannes] Univ Stuttgart, Inst Theoret Chem, Computat Biochem Grp, D-70569 Stuttgart, Germany	University of Stuttgart	Kastner, J (corresponding author), Univ Stuttgart, Inst Theoret Chem, Computat Biochem Grp, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	kaestner@theochem.uni-stuttgart.de	Kästner, Johannes/E-3460-2010; Abad, Enrique/A-1201-2012	Kästner, Johannes/0000-0001-6178-7669; Abad, Enrique/0000-0002-4214-7874; Rommel, Judith B./0000-0001-9082-0798	Alexander von Humboldt Foundation; Landesstiftung Baden-Wurttemberg; Cluster of Excellence in Simulation Technology [EXC 310/1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Landesstiftung Baden-Wurttemberg; Cluster of Excellence in Simulation Technology	This work was supported by the Alexander von Humboldt Foundation, Landesstiftung Baden-Wurttemberg, and Cluster of Excellence in Simulation Technology Grant EXC 310/1 (University of Stuttgart).	Bauman AT, 2006, J BIOL CHEM, V281, P4190, DOI 10.1074/jbc.M511199200; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bell J, 1997, BIOCHEMISTRY-US, V36, P16239, DOI 10.1021/bi970903d; Billeter SR, 2000, PHYS CHEM CHEM PHYS, V2, P2177, DOI 10.1039/a909486e; BRADBURY AF, 1990, EUR J BIOCHEM, V189, P363, DOI 10.1111/j.1432-1033.1990.tb15497.x; Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Crespo A, 2006, J AM CHEM SOC, V128, P12817, DOI 10.1021/ja062876x; de la Lande A, 2008, CHEM-EUR J, V14, P6465, DOI 10.1002/chem.200701595; de la Lande A, 2007, J AM CHEM SOC, V129, P11700, DOI 10.1021/ja070329l; Eckart C, 1930, PHYS REV, V35, P1303, DOI 10.1103/PhysRev.35.1303; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; FARRINGTON GK, 1990, J BIOL CHEM, V265, P1036; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Francisco WA, 2003, BIOCHEMISTRY-US, V42, P1813, DOI 10.1021/bi020592t; FREEMAN JC, 1993, J AM CHEM SOC, V115, P4923, DOI 10.1021/ja00064a077; GILLAN MJ, 1987, J PHYS C SOLID STATE, V20, P3621, DOI 10.1088/0022-3719/20/24/005; Goumans TPM, 2009, PHYS CHEM CHEM PHYS, V11, P5431, DOI 10.1039/b816905e; Henkelman G, 1999, J CHEM PHYS, V111, P7010, DOI 10.1063/1.480097; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwai N., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P266; Jonsson H., 1998, CLASSICAL QUANTUM DY; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2010, MOL PHYS, V108, P293, DOI 10.1080/00268970903446764; Kaestner J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2815812; Kastner J, 2009, J PHYS CHEM A, V113, P11856, DOI 10.1021/jp9028968; Kamachi T, 2005, INORG CHEM, V44, P4226, DOI 10.1021/ic048477p; KATOPODIS AG, 1990, BIOCHEMISTRY-US, V29, P4541, DOI 10.1021/bi00471a006; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; KULATHILA R, 1994, ARCH BIOCHEM BIOPHYS, V311, P191, DOI 10.1006/abbi.1994.1225; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Lonsdale R, 2010, J PHYS CHEM B, V114, P1156, DOI 10.1021/jp910127j; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez A, 1996, MOL CELL ENDOCRINOL, V123, P113, DOI 10.1016/S0303-7207(96)03903-2; Mclntyre NR, 2009, J AM CHEM SOC, V131, P10308, DOI 10.1021/ja902716d; Melia C, 2013, CHEM-EUR J, V19, P17328, DOI 10.1002/chem.201301000; Metz S, 2014, WIRES COMPUT MOL SCI, V4, P101, DOI 10.1002/wcms.1163; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; NOGUCHI M, 1992, BIOCHEM J, V283, P883, DOI 10.1042/bj2830883; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peterson RL, 2013, J AM CHEM SOC, V135, P16454, DOI 10.1021/ja4065377; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; RAMER SE, 1988, J AM CHEM SOC, V110, P8526, DOI 10.1021/ja00233a032; Rommel JB, 2011, J AM CHEM SOC, V133, P10195, DOI 10.1021/ja202312d; Rudzka K, 2013, J BIOL INORG CHEM, V18, P223, DOI 10.1007/s00775-012-0967-z; Saldise L, 1996, J HISTOCHEM CYTOCHEM, V44, P3, DOI 10.1177/44.1.8543779; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; TIAN GC, 1994, BIOCHEMISTRY-US, V33, P226, DOI 10.1021/bi00167a030; University of Karlsruhe and Forschungszentrum Karlsruhe GmbH, 2009, TURBOMOLE VERS 6 0 2; Von Arnim M, 1998, J COMPUT CHEM, V19, P1746, DOI 10.1002/(SICI)1096-987X(19981130)19:15<1746::AID-JCC7>3.0.CO;2-N; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	63	24	25	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13726	13738		10.1074/jbc.M114.558494	http://dx.doi.org/10.1074/jbc.M114.558494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668808	Green Published, hybrid			2022-12-28	WOS:000335984600007
J	Avila, CL; Torres-Bugeau, CM; Barbosa, LRS; Sales, EM; Ouidja, MO; Socias, SB; Celej, MS; Raisman-Vozari, R; Papy-Garcia, D; Itri, R; Chehin, RN				Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Barbosa, Leandro R. S.; Sales, Elisa Morande; Ouidja, Mohand O.; Socias, Sergio B.; Soledad Celej, M.; Raisman-Vozari, Rita; Papy-Garcia, Dulce; Itri, Rosangela; Chehin, Rosana N.			Structural Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Protofibrils Preventing alpha- Synuclein Oligomeric Species Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Cell Permeabilization; Molecular Modeling; Parkinson Disease; X-ray Scattering; GAPDH; Protofibril Structure	PROTEIN-PROTEIN INTERACTIONS; PARKINSONS-DISEASE; CROSS-LINKING; GROWTH-FACTOR; FORCE-FIELD; FORMS; FIBRILS; GAPDH; GLYCOSAMINOGLYCANS; PERMEABILIZATION	Background: Although glycosaminoglycan-induced GAPDH prefibrillar species accelerates -synuclein aggregation, its role in toxicity remains unclear. Results: The toxic effect exerted by -synuclein oligomers on cell culture was abolished by GAPDH protofibril, which was identified and structurally characterized. Conclusion: GAPDH protofibrils can efficiently sequester -synuclein toxic oligomers. Significance: GAPDH protofibrils may play an important role in neuronal proteostasis and could open a novel therapeutic strategy for synucleinopathies. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional enzyme that has been associated with neurodegenerative diseases. GAPDH colocalizes with -synuclein in amyloid aggregates in post-mortem tissue of patients with sporadic Parkinson disease and promotes the formation of Lewy body-like inclusions in cell culture. In a previous work, we showed that glycosaminoglycan-induced GAPDH prefibrillar species accelerate the conversion of -synuclein to fibrils. However, it remains to be determined whether the interplay among glycosaminoglycans, GAPDH, and -synuclein has a role in pathological states. Here, we demonstrate that the toxic effect exerted by -synuclein oligomers in dopaminergic cell culture is abolished in the presence of GAPDH prefibrillar species. Structural analysis of prefibrillar GAPDH performed by small angle x-ray scattering showed a particle compatible with a protofibril. This protofibril is shaped as a cylinder 22 nm long and a cross-section diameter of 12 nm. Using biocomputational techniques, we obtained the first all-atom model of the GAPDH protofibril, which was validated by cross-linking coupled to mass spectrometry experiments. Because GAPDH can be secreted outside the cell where glycosaminoglycans are present, it seems plausible that GAPDH protofibrils could be assembled in the extracellular space kidnapping -synuclein toxic oligomers. Thus, the role of GAPDH protofibrils in neuronal proteostasis must be considered. The data reported here could open alternative ways in the development of therapeutic strategies against synucleinopathies like Parkinson disease.	[Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Chehin, Rosana N.] CONICET UNT, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Argentina; [Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Chehin, Rosana N.] CONICET UNT, Inst Quim Biol Dr Bernabe Bloj, FBQF UNT, San Miguel De Tucuman, Argentina; [Barbosa, Leandro R. S.; Sales, Elisa Morande; Itri, Rosangela] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Ouidja, Mohand O.; Socias, Sergio B.; Raisman-Vozari, Rita] CNRS, INSERM U1127, UMR 7225, Inst Cerveau & Moelle Epiniere, Paris, France; [Ouidja, Mohand O.; Papy-Garcia, Dulce] Univ Paris Est Creteil, CNRS EAC 7149, Lab Croissance Reparat & Regenerat Tissulaires, F-94000 Creteil, France; [Soledad Celej, M.] Univ Nacl Cordoba, Dept Quim, Ctr Invest Quim Biol Cordoba, CONICET,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Chehin, RN (corresponding author), CONICET UNT, Inst Super Invest Biol INSIBIO, Chacabuco 461,T4000ILI, San Miguel De Tucuman, Argentina.	rosana@fbqf.unt.edu.ar	Barbosa, L. R. S./AAN-7787-2020; Itri, Rosangela/B-4312-2014; Celej, Maria Soledad/N-5709-2019; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, Leandro Ramos Souza/E-6577-2012	Celej, Maria Soledad/0000-0002-7831-9244; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Itri, Rosangela/0000-0001-9311-0804; Morande Sales, Elisa/0000-0001-8311-8562; Chehin, Rosana/0000-0003-3504-7952; Avila, Cesar Luis/0000-0003-0187-7915	Florencio Fiorini Foundation [A12S02]; CIUNT [D439-1]; ANPCyT [PICT-2011-0761]; Conselho Nacional de Pesquisa e Desenvolvimento	Florencio Fiorini Foundation; CIUNT; ANPCyT(ANPCyT); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from Florencio Fiorini Foundation; Ecos-Sud Grant A12S02, and CIUNT Grant D439-1.; Supported by ANPCyT Grant PICT-2011-0761.; Supported by research fellowships from Conselho Nacional de Pesquisa e Desenvolvimento.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; ARRONDO JLR, 1994, BIOCHEMISTRY-US, V33, P11650, DOI 10.1021/bi00204a029; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chai YJ, 2013, FEBS LETT, V587, P452, DOI 10.1016/j.febslet.2013.01.008; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; FINER EG, 1972, BIOCHIM BIOPHYS ACTA, V260, P49, DOI 10.1016/0005-2760(72)90073-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Ortore MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061904; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Rzepiela AJ, 2010, J COMPUT CHEM, V31, P1333, DOI 10.1002/jcc.21415; Sacino AN, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt151; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spinozzi F, 2007, J PHYS CHEM B, V111, P3822, DOI 10.1021/jp063427m; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Torres-Bugeau CM, 2012, J BIOL CHEM, V287, P2398, DOI 10.1074/jbc.M111.303503; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Vendruscolo M, 1999, PHYS REV LETT, V82, P656, DOI 10.1103/PhysRevLett.82.656; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Walker, 1955, SMALL ANGLE SCATTERI, P7; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu KY, 1998, J HISTOCHEM CYTOCHEM, V46, P419, DOI 10.1177/002215549804600401; Yang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064389; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	70	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13838	13850		10.1074/jbc.M113.544288	http://dx.doi.org/10.1074/jbc.M113.544288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671416	Green Published, hybrid			2022-12-28	WOS:000335984600017
J	Han, HJ; Kursula, P				Han, Huijong; Kursula, Petri			Periaxin and AHNAK Nucleoprotein 2 Form Intertwined Homodimers through Domain Swapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Myelin; Protein Domains; Protein Structure; Protein-Protein Interactions; X-ray Scattering; PDZ Domain; Dimerization; Domain Swapping	MYELINATING SCHWANN-CELLS; PDZ DOMAIN; BIOLOGICAL MACROMOLECULES; RESOLUTION STRUCTURE; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; COMPLEX REVEALS; PROTEIN COMPLEX; BINDING; RECOGNITION	Background: Periaxin and AHNAK nucleoprotein 2 contain a poorly conserved PDZ domain. Results: The crystal structures for the PDZ domains were determined. Conclusion: Both PDZ domains form intertwined domain-swapped homodimers. Significance: The structures have implications for the organization of complexes involving the periaxin/AHNAK family. Periaxin (PRX) is an abundant protein in the peripheral nervous system, with an important role in myelination. PRX participates in large molecular complexes, most likely through the interactions of its N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain. We present the crystal structures of the PDZ-like domains from PRX and its homologue AHNAK nucleoprotein 2 (AHNAK2). The unique intertwined, domain-swapped dimers provide a structural basis for the homodimerization of both proteins. The core of the homodimer is formed by a 6-stranded antiparallel sheet, with every other strand from a different chain. The AHNAK2 PDZ domain structure contains a bound class III ligand peptide. The binding pocket is preformed, and the peptide-PDZ interactions have unique aspects, including two salt bridges and weak recognition of the peptide C terminus. Tight homodimerization may be central to the scaffolding functions of PRX and AHNAK2 in molecular complexes linking the extracellular matrix to the cytoskeletal network.	[Han, Huijong; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] German Elect Synchrotron DESY, D-22607 Hamburg, Germany; [Kursula, Petri] Univ Hamburg, Dept Chem, D-22607 Hamburg, Germany	University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Kursula, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, POB 3000, Oulu 90014, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Han, Huijong/0000-0002-1197-3014	Hamburg Research and Science Foundation (Germany); Academy of Finland; Sigrid Juselius Foundation (Finland)	Hamburg Research and Science Foundation (Germany); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation)	This work was supported by grants from the Hamburg Research and Science Foundation (Germany), the Academy of Finland, and the Sigrid Juselius Foundation (Finland) (to P. K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albright RA, 1996, BIOCHEMISTRY-US, V35, P735, DOI 10.1021/bi951958n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Morree A, 2012, FASEB J, V26, P93, DOI 10.1096/fj.11-187971; De Seranno S, 2006, J BIOL CHEM, V281, P35030, DOI 10.1074/jbc.M606545200; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Han HJ, 2013, ACTA CRYSTALLOGR F, V69, P804, DOI 10.1107/S1744309113016266; Han HJ, 2013, BIOFACTORS, V39, P233, DOI 10.1002/biof.1076; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huang DB, 2005, STRUCTURE, V13, P1365, DOI 10.1016/j.str.2005.06.018; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kursula P, 2001, INT J MOL MED, V8, P475; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; Marg A, 2010, BIOCHEM BIOPH RES CO, V401, P143, DOI 10.1016/j.bbrc.2010.09.030; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takashima H, 2002, ANN NEUROL, V51, P709, DOI 10.1002/ana.10213; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zacharias U, 2011, J MUSCLE RES CELL M, V32, P271, DOI 10.1007/s10974-011-9271-8; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	61	23	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14121	14131		10.1074/jbc.M114.554816	http://dx.doi.org/10.1074/jbc.M114.554816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675079	Green Published, hybrid			2022-12-28	WOS:000335984600040
J	Korneeva, VA; Trubetskov, MM; Korshunova, AV; Lushchekina, SV; Kolyadko, VN; Sergienko, OV; Lunin, VG; Panteleev, MA; Ataullakhanov, FI				Korneeva, Vera A.; Trubetskov, Mikhail M.; Korshunova, Alena V.; Lushchekina, Sofya V.; Kolyadko, Vladimir N.; Sergienko, Olga V.; Lunin, Vladimir G.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.			Interactions Outside the Proteinase-binding Loop Contribute Significantly to the Inhibition of Activated Coagulation Factor XII by Its Canonical Inhibitor from Corn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Enzyme Kinetics; Enzyme Mechanisms; Protease Inhibitor; Protein Expression; Protein-Protein Interactions; Serine Protease	TRYPSIN-INHIBITOR; HAGEMAN-FACTOR; ESCHERICHIA-COLI; REACTIVE-SITE; WEB SERVER; PEPTIDE; DOCKING; ELECTROSTATICS; PURIFICATION; CHYMOTRYPSIN	Background: Canonical inhibitors interact with cognate proteases through a protease-binding loop. Results: Protease-binding loop of corn Hageman factor inhibitor (CHFI) does not inhibit its cognate enzyme-activated coagulation factor XII (FXIIa). Conclusion: Nonloop regions of CHFI are required for specific inhibition of FXIIa. Significance: CHFI is the first canonical inhibitor whose protease-binding loop is not sufficient for cognate enzyme inhibition. Activated factor XII (FXIIa) is selectively inhibited by corn Hageman factor inhibitor (CHFI) among other plasma proteases. CHFI is considered a canonical serine protease inhibitor that interacts with FXIIa through its protease-binding loop. Here we examined whether the protease-binding loop alone is sufficient for the selective inhibition of serine proteases or whether other regions of a canonical inhibitor are involved. Six CHFI mutants lacking different N- and C-terminal portions were generated. CHFI-234, which lacks the first and fifth disulfide bonds and 11 and 19 amino acid residues at the N and C termini, respectively, exhibited no significant changes in FXIIa inhibition (K-i = 3.2 +/- 0.4 nm). CHFI-123, which lacks 34 amino acid residues at the C terminus and the fourth and fifth disulfide bridges, inhibited FXIIa with a K-i of 116 +/- 16 nm. To exclude interactions outside the FXIIa active site, a synthetic cyclic peptide was tested. The peptide contained residues 20-45 (Protein Data Bank code 1BEA), and a C29D substitution was included to avoid unwanted disulfide bond formation between unpaired cysteines. Surprisingly, the isolated protease-binding loop failed to inhibit FXIIa but retained partial inhibition of trypsin (K-i = 11.7 +/- 1.2 m) and activated factor XI (K-i = 94 +/- 11 m). Full-length CHFI inhibited trypsin with a K-i of 1.3 +/- 0.2 nm and activated factor XI with a K-i of 5.4 +/- 0.2 m. Our results suggest that the protease-binding loop is not sufficient for the interaction between FXIIa and CHFI; other regions of the inhibitor also contribute to specific inhibition.	[Korneeva, Vera A.; Trubetskov, Mikhail M.; Kolyadko, Vladimir N.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Lab Mol Mech Hemostasis, Moscow 119991, Russia; [Trubetskov, Mikhail M.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119992, Russia; [Korshunova, Alena V.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] HemaCore LLC, Res Dept, Moscow 125319, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Lab Comp Modeling Biomol Syst & Nanomat, Moscow 119334, Russia; [Sergienko, Olga V.] Russian Acad Agr Sci, Inst Agr Biotechnol, Lab Mol Diagnost & Genet Engn, Moscow 127550, Russia; [Lunin, Vladimir G.] Minist Hlth & Social Dev, Gamaleya Inst Epidemiol & Microbiol Russian Feder, Lab Biol Act Nanostruct, Moscow 123098, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Minist Hlth Russian Federat, Sci Clin Ctr Pediat Hematol Oncol & Immunol, Div Res, Moscow 117997, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow Inst Phys & Technol, Dept Translat & Regenerat Med, Dolgoprudnyi 141700, Moscow Region, Russia	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; All-Russia Research Institute of Agricultural Biotechnology; Ministry of Health of the Russian Federation; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Ministry of Health of the Russian Federation; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Natl Res Ctr Hematol, 4 Novyi Zykovskii Proezd, Moscow 125167, Russia.	mapanteleev@yandex.ru	Panteleev, Mikhail A/H-5491-2012; Lushchekina, Sofya/F-8469-2010; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019; Zhivotova, Vera/E-4766-2014	Panteleev, Mikhail A/0000-0002-8128-7757; Lushchekina, Sofya/0000-0002-6922-020X; Trubetskov, Mikhail/0000-0003-2049-870X; Zhivotova, Vera/0000-0003-2937-1190; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Foundation for Basic Research [14-04-00670, 12-04-00438]; Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Fund UMA	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Fund UMA	This work was supported by Russian Foundation for Basic Research Grants 14-04-00670 and 12-04-00438 and by the Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology." This work was also supported by a grant from Fund UMA.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behnke CA, 1998, BIOCHEMISTRY-US, V37, P15277, DOI 10.1021/bi9812266; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brauer ABE, 2002, J BIOMOL STRUCT DYN, V20, P59, DOI 10.1080/07391102.2002.10506822; BURKHARD RK, 1979, J AGR FOOD CHEM, V27, P452, DOI 10.1021/jf60222a023; Chelliah V, 2006, J MOL BIOL, V357, P1669, DOI 10.1016/j.jmb.2006.01.001; Chen ZY, 1999, APPL ENVIRON MICROB, V65, P1320; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; Fernandez JH, 2007, GENET MOL RES, V6, P846; Fradera X, 2012, ACTA CRYSTALLOGR F, V68, P404, DOI 10.1107/S1744309112009037; Froger Alexandrine, 2007, J Vis Exp, P253, DOI 10.3791/253; Gailani D, 2009, J THROMB HAEMOST, V7, P1840, DOI 10.1111/j.1538-7836.2009.03591.x; Hazegh-Azam M, 1998, PROTEIN EXPRES PURIF, V13, P143, DOI 10.1006/prep.1998.0882; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOJIMA Y, 1980, THROMB RES, V20, P149, DOI 10.1016/0049-3848(80)90381-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 2000, J MOL BIOL, V296, P325, DOI 10.1006/jmbi.1999.3389; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEI MG, 1987, THROMB RES, V45, P87, DOI 10.1016/0049-3848(87)90259-3; Li JX, 2008, BIOCHIMIE, V90, P1356, DOI 10.1016/j.biochi.2008.04.005; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, GENOMICS, V89, P413, DOI 10.1016/j.ygeno.2006.11.013; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MAHONEY WC, 1984, J BIOL CHEM, V259, P8412; McBride JD, 2002, BIOPOLYMERS, V66, P79, DOI 10.1002/bip.10228; Mucsi Z, 2003, PROTEIN ENG, V16, P673, DOI 10.1093/protein/gzg090; OZAWA K, 1966, J BIOL CHEM, V241, P3955; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Pham M, 2010, NEUROIMAGE, V49, P2907, DOI 10.1016/j.neuroimage.2009.11.061; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105; SWARTZ MJ, 1977, J BIOL CHEM, V252, P8105; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019	59	8	8	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14109	14120		10.1074/jbc.M114.553735	http://dx.doi.org/10.1074/jbc.M114.553735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706752	Green Published, hybrid			2022-12-28	WOS:000335984600039
J	Nicolae, CM; Aho, ER; Vlahos, AHS; Choe, KN; De, S; Karras, GI; Moldovan, GL				Nicolae, Claudia M.; Aho, Erin R.; Vlahos, Alexander H. S.; Choe, Katherine N.; De, Subhajyoti; Karras, Georgios I.; Moldovan, George-Lucian			The ADP-ribosyltransferase PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen ( PCNA) and Is Required for DNA Damage Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; DNA Damage; DNA Repair; DNA Replication; Genomic Instability; PCNA; Translesion Synthesis	REPLICATION FORK; S-PHASE; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED PCNA; GENOME STABILITY; DVC1 C1ORF124; UBIQUITIN; PROTEIN; REPAIR; POLY(ADP-RIBOSE)	Background: PCNA mono-ubiquitination at stalled replication forks recruits translesion synthesis polymerases for fork restart. Results: The mono-ADP-ribosyltransferase PARP10 interacts with PCNA through a PIP-box. PARP10 knockdown results in DNA damage hypersensitivity and defective translesion synthesis. Conclusion: PARP10 participates in PCNA-dependent DNA damage tolerance. Significance: This is the first time that post-translational modification by mono-ADP-ribosylation is implicated in DNA repair. All cells rely on genomic stability mechanisms to protect against DNA alterations. PCNA is a master regulator of DNA replication and S-phase-coupled repair. PCNA post-translational modifications by ubiquitination and SUMOylation dictate how cells stabilize and re-start replication forks stalled at sites of damaged DNA. PCNA mono-ubiquitination recruits low fidelity DNA polymerases to promote error-prone replication across DNA lesions. Here, we identify the mono-ADP-ribosyltransferase PARP10/ARTD10 as a novel PCNA binding partner. PARP10 knockdown results in genomic instability and DNA damage hypersensitivity. Importantly, we show that PARP10 binding to PCNA is required for translesion DNA synthesis. Our work identifies a novel PCNA-linked mechanism for genome protection, centered on post-translational modification by mono-ADP-ribosylation.	[Nicolae, Claudia M.; Aho, Erin R.; Vlahos, Alexander H. S.; Choe, Katherine N.; Moldovan, George-Lucian] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [De, Subhajyoti] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [De, Subhajyoti] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [De, Subhajyoti] Univ Colorado, Ctr Canc, Mol Oncol Program, Aurora, CO 80045 USA; [Karras, Georgios I.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Massachusetts Institute of Technology (MIT); Whitehead Institute	Moldovan, GL (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gmoldovan@hmc.psu.edu		Nicolae, Claudia/0000-0003-4933-5496; George-Lucian, Moldovan/0000-0003-3825-149X; Karras, Georgios/0000-0003-2933-1535	V Foundation Scholar Award; American Cancer Society (ACS IRG) [57-001-53]; Lung Cancer Colorado Fund; United Against Lung Cancer; Human Frontiers Science Program	V Foundation Scholar Award; American Cancer Society (ACS IRG)(American Cancer Society); Lung Cancer Colorado Fund; United Against Lung Cancer; Human Frontiers Science Program(Human Frontier Science Program)	This work was supported in part by the V Foundation Scholar Award (to G. L. M.); American Cancer Society (ACS IRG 57-001-53), Lung Cancer Colorado Fund, and United Against Lung Cancer (to S. D.); and the Human Frontiers Science Program (to G. I. K.).	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Barkauskaite E, 2013, FEBS J, V280, P3491, DOI 10.1111/febs.12358; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Feijs KLH, 2013, FEBS J, V280, P3519, DOI 10.1111/febs.12315; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; Forst AH, 2013, STRUCTURE, V21, P462, DOI 10.1016/j.str.2012.12.019; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Herzog N, 2013, FEBS J, V280, P1330, DOI 10.1111/febs.12124; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kalisch T, 2012, TRENDS BIOCHEM SCI, V37, P381, DOI 10.1016/j.tibs.2012.06.001; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Miller KM, 2012, BIOCHEM SOC T, V40, P370, DOI 10.1042/BST20110747; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070430; O'Connor KW, 2013, CANCER RES, V73, P2529, DOI 10.1158/0008-5472.CAN-12-3313; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Verheugd P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2672; WANG G, 1995, MOL CELL BIOL, V15, P1759; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Yang KL, 2010, J BIOL CHEM, V285, P19085, DOI 10.1074/jbc.M109.100032; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	57	63	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13627	13637		10.1074/jbc.M114.556340	http://dx.doi.org/10.1074/jbc.M114.556340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695737	hybrid, Green Published			2022-12-28	WOS:000335522800056
J	Vande Voorde, J; Sabuncuoglu, S; Noppen, S; Hofer, A; Ranjbarian, F; Fieuws, S; Balzarini, J; Liekens, S				Vande Voorde, Johan; Sabuncuoglu, Suna; Noppen, Sam; Hofer, Anders; Ranjbarian, Farahnaz; Fieuws, Steffen; Balzarini, Jan; Liekens, Sandra			Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Therapy; Nucleoside Nucleotide Analogs; Nucleoside Nucleotide Metabolism; Phosphorylase; Mycoplasma hyorhinis; Cytidine Deaminase; Gemcitabine; Mycoplasma; Pyrimidine Nucleoside Phosphorylase	SENSITIVE PCR-ELISA; CYTIDINE DEAMINASE; PROSTATE-CANCER; IN-VITRO; THYMIDINE PHOSPHORYLASE; CYTOSINE-ARABINOSIDE; HYORHINIS INFECTION; CONSERVED DNA; LUNG-CANCER; INHIBITION	Background: Gemcitabine is used to treat solid tumors. Some mycoplasmas preferentially colonize tumors in patients. Results: Mycoplasma-encoded cytidine deaminase and pyrimidine nucleoside phosphorylase compromise the cytostatic/antitumor activity of gemcitabine in mycoplasma-infected tumor cell cultures and xenografts in mice. Conclusion: Tumor-associated mycoplasmas may decrease the therapeutic efficiency of gemcitabine. Significance: Current treatment of mycoplasma-infected tumors with gemcitabine may be suboptimal. The intracellular metabolism and cytostatic activity of the anticancer drug gemcitabine (2,2-difluoro-2-deoxycytidine; dFdC) was severely compromised in Mycoplasma hyorhinis-infected tumor cell cultures. Pronounced deamination of dFdC to its less cytostatic metabolite 2,2-difluoro-2-deoxyuridine was observed, both in cell extracts and spent culture medium (i.e. tumor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cells. This indicates that the decreased antiproliferative activity of dFdC in such cells is attributed to a mycoplasma cytidine deaminase causing rapid drug catabolism. Indeed, the cytostatic activity of gemcitabine could be restored by the co-administration of tetrahydrouridine (a potent cytidine deaminase inhibitor). Additionally, mycoplasma-derived pyrimidine nucleoside phosphorylase (PyNP) activity indirectly potentiated deamination of dFdC: the natural pyrimidine nucleosides uridine, 2-deoxyuridine and thymidine inhibited mycoplasma-associated dFdC deamination but were efficiently catabolized (removed) by mycoplasma PyNP. The markedly lower anabolism and related cytostatic activity of dFdC in mycoplasma-infected tumor cells was therefore also (partially) restored by a specific TP/PyNP inhibitor (TPI), or by exogenous thymidine. Consequently, no effect on the cytostatic activity of dFdC was observed in tumor cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain. Because it has been reported that some commensal mycoplasma species (including M. hyorhinis) preferentially colonize tumor tissue in cancer patients, our findings suggest that the presence of mycoplasmas in the tumor microenvironment could be a limiting factor for the anticancer efficiency of dFdC-based chemotherapy. Accordingly, a significantly decreased antitumor effect of dFdC was observed in mice bearing M. hyorhinis-infected murine mammary FM3A tumors compared with uninfected tumors.	[Vande Voorde, Johan; Sabuncuoglu, Suna; Noppen, Sam; Balzarini, Jan; Liekens, Sandra] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Hofer, Anders; Ranjbarian, Farahnaz] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Fieuws, Steffen] KU Leuven Univ Leuven, B-3000 Louvain, Belgium; [Fieuws, Steffen] Univ Hasselt, B-3000 Louvain, Belgium	KU Leuven; Umea University; KU Leuven; Hasselt University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10,Blok X Bus 1030, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be	Noppen, Sam/F-8681-2018	Noppen, Sam/0000-0002-2831-5042; Vande Voorde, Johan/0000-0002-7686-0926; Hofer, Anders/0000-0003-2890-2957	Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen [G.0486.08]; KU Leuven [GOA 10/014]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); KU Leuven (BOF-F)	Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO); KU Leuven(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven (BOF-F)(KU Leuven)	This work was supported in part by "Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen" Krediet number G.0486.08 and KU Leuven Grant GOA 10/014.; Supported by a Ph.D. grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).; Supported by a postdoctoral grant of the KU Leuven (BOF-F).	Amit M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27231; Apostolou P, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-137; AYUSAWA D, 1980, SOMAT CELL GENET, V6, P261, DOI 10.1007/BF01538800; BALZARINI J, 1984, BIOCHIM BIOPHYS ACTA, V785, P36, DOI 10.1016/0167-4838(84)90231-0; Bardenheuer W, 2005, LEUKEMIA, V19, P2281, DOI 10.1038/sj.leu.2403977; Barykova YA, 2011, ONCOTARGET, V2, P289; Bergman A. M., 2006, DEOXYNUCLEOSIDE ANAL, P225; Bronckaers A, 2008, BIOCHEM PHARMACOL, V76, P188, DOI 10.1016/j.bcp.2008.04.019; Chan PJ, 1996, GYNECOL ONCOL, V63, P258, DOI 10.1006/gyno.1996.0316; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; Erturhan SM, 2013, INT UROL NEPHROL, V45, P33, DOI 10.1007/s11255-012-0299-5; Essig A, 2000, INT J MED MICROBIOL, V290, P289; Finch Lloyd R., 1992, P211; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Goodison S., 2013, GENOME ANNOUNC, V1, P1; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; HEINEMANN V, 1988, CANCER RES, V48, P4024; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; HIRSCHBERG L, 1989, HYBRIDOMA, V8, P249, DOI 10.1089/hyb.1989.8.249; Huang GC, 2012, J BIOL CHEM, V287, P23196, DOI 10.1074/jbc.M112.351940; HUANG P, 1991, CANCER RES, V51, P6110; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; JAKWAY JP, 1984, J IMMUNOL METHODS, V67, P337, DOI 10.1016/0022-1759(84)90473-3; Kidder M, 1998, GYNECOL ONCOL, V71, P254, DOI 10.1006/gyno.1998.5177; Krause Duncan C., 1992, P417; KREIS W, 1991, LEUKEMIA, V5, P991; Liekens S, 2009, LANCET ONCOL, V10, P628, DOI 10.1016/S1470-2045(09)70037-3; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; MCELWAIN MC, 1988, INT J SYST BACTERIOL, V38, P417, DOI 10.1099/00207713-38-4-417; MERKENSCHLAGER M, 1988, IMMUNOLOGY, V63, P125; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; NAKANO N, 1966, TOHOKU J EXP MED, V88, P69, DOI 10.1620/tjem.88.69; NEALE GAM, 1984, J BACTERIOL, V158, P943, DOI 10.1128/JB.158.3.943-947.1984; Neff T, 1996, EXP HEMATOL, V24, P1340; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; PATTERSON AV, 1995, BRIT J CANCER, V72, P669, DOI 10.1038/bjc.1995.392; Pehlivan M, 2005, UROLOGY, V65, P411, DOI 10.1016/j.urology.2004.10.015; Pehlivan M, 2004, LUNG CANCER, V45, P129, DOI 10.1016/j.lungcan.2004.01.007; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROSS DD, 1994, BIOCHEM PHARMACOL, V48, P1619, DOI 10.1016/0006-2952(94)90207-0; SINIGAGLIA F, 1985, EUR J IMMUNOL, V15, P692, DOI 10.1002/eji.1830150710; THAM TN, 1993, J BACTERIOL, V175, P5281, DOI 10.1128/JB.175.16.5281-5285.1993; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Vande Voorde J, 2012, BIOCHEM J, V445, P113; Vande Voorde J, 2013, MOL PHARMACOL, V84, P865, DOI 10.1124/mol.113.088625; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wang L, 2014, NUCLEOSIDES IN PRESS; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; XU YZ, 1992, BIOCHEM PHARMACOL, V44, P1819; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yoshida T, 2010, DRUG METAB DISPOS, V38, P1814, DOI 10.1124/dmd.110.034397; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5	56	74	75	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13054	13065		10.1074/jbc.M114.558924	http://dx.doi.org/10.1074/jbc.M114.558924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668817	Green Published, hybrid			2022-12-28	WOS:000335522800009
J	Ma, L; Gong, HY; Zhu, HY; Ji, Q; Su, P; Liu, P; Cao, SN; Yao, JF; Jiang, LL; Han, MZ; Ma, XT; Xiong, DS; Luo, HBR; Wang, F; Zhou, JX; Xu, YF				Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Luo, Hongbo R.; Wang, Fei; Zhou, Jiaxi; Xu, Yuanfu			A Novel Small-molecule Tumor Necrosis Factor alpha Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Signaling; Inflammation; Small Molecules; Tumor Necrosis Factor (TNF); Computer Modeling; Surface Plasmon Resonance (SPR)	TNF-ALPHA; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; CELL-DEATH; RECEPTOR SUPERFAMILY; THERAPEUTIC TARGET; JNK ACTIVATION; BINDING; PEPTIDOMIMETICS; GALACTOSAMINE	Background: Most commercial TNF inhibitors are biomacromolecules. Results: A lead compound named C87 was identified using computer-aided drug design and could attenuate murine acute hepatitis. Conclusion: C87 was one of the first effective small-molecule inhibitors of TNF identified to date. Significance: The study highlights the effectiveness of combining virtual screening with functional assays for developing novel small-molecule TNF inhibitors. Overexpression of tumor necrosis factor (TNF) is a hallmark of many inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and septic shock and hepatitis, making it a potential therapeutic target for clinical interventions. To explore chemical inhibitors against TNF activity, we applied computer-aided drug design combined with in vitro and cell-based assays and identified a lead chemical compound, (E)-4-(2-(4-chloro-3-nitrophenyl) (named as C87 thereafter), which directly binds to TNF, potently inhibits TNF-induced cytotoxicity (IC50 = 8.73 m) and effectively blocks TNF-triggered signaling activities. Furthermore, by using a murine acute hepatitis model, we showed that C87 attenuates TNF-induced inflammation, thereby markedly reducing injuries to the liver and improving animal survival. Thus, our results lead to a novel and highly specific small-molecule TNF inhibitor, which can be potentially used to treat TNF-mediated inflammatory diseases.	[Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Zhou, Jiaxi; Xu, Yuanfu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Zhou, Jiaxi; Xu, Yuanfu] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Luo, Hongbo R.] Harvard Univ, Sch Med, Joint Program Transfus Med, Dept Pathol, Boston, MA 02115 USA; [Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Lab Med, Boston, MA 02115 USA; [Luo, Hongbo R.] Childrens Hosp, Boston, MA 02115 USA; [Wang, Fei] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Wang, Fei] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhou, JX (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	zhoujx@ihcams.ac.cn; xuyf@ihcams.ac.cn	zhu, xueqiong/U-1320-2019; Xu, Yuanfu/Z-1135-2019		National Basic Research Program of China [2012CB966403]; Chinese National Natural Science Foundation [31271484, 31171431, 30400405]; Tianjin Natural Science Foundation [12JCZDJC24600, 11JCYBJC27300]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by National Basic Research Program of China Grant 2012CB966403, Chinese National Natural Science Foundation Grants 31271484, 31171431, and 30400405, and Tianjin Natural Science Foundation Grants 12JCZDJC24600 and 11JCYBJC27300.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Davis JM, 2013, FUTURE MED CHEM, V5, P69, DOI 10.4155/fmc.12.192; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Hasegawa Akihiro, 2001, Mini-Reviews in Medicinal Chemistry, V1, P5, DOI 10.2174/1389557013407214; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kubinyi H, 1999, J RECEPT SIGNAL TR R, V19, P15, DOI 10.3109/10799899909036635; Liedtke C, 2012, EUR J CELL BIOL, V91, P582, DOI 10.1016/j.ejcb.2011.10.001; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Nam J, 2010, MOD RHEUMATOL, V20, P325, DOI 10.1007/s10165-010-0277-7; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Saito H, 2007, ARTHRITIS RHEUM-US, V56, P1164, DOI 10.1002/art.22495; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Simsek I, 2010, BULL HOSP JT DIS, V68, P204; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Thurmond RL, 2001, EUR J BIOCHEM, V268, P5747, DOI 10.1046/j.0014-2956.2001.02512.x; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vinay DS, 2011, CLIN EXP IMMUNOL, V164, P145, DOI 10.1111/j.1365-2249.2011.04375.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	40	44	53	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12457	12466		10.1074/jbc.M113.521708	http://dx.doi.org/10.1074/jbc.M113.521708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634219	hybrid, Green Published			2022-12-28	WOS:000335581400022
J	Jing, G; Westwell-Roper, C; Chen, JQ; Xu, GL; Verchere, CB; Shalev, A				Jing, Gu; Westwell-Roper, Clara; Chen, Junqin; Xu, Guanlan; Verchere, C. Bruce; Shalev, Anath			Thioredoxin-interacting Protein Promotes Islet Amyloid Polypeptide Expression through miR-124a and FoxA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Diabetes; MicroRNA; Thioredoxin; Transcription Regulation; Islet Amyloid Polypeptide; Thioredoxin-interacting protein	PANCREATIC BETA-CELLS; CARBOHYDRATE RESPONSE ELEMENT; GENE-TRANSCRIPTION; INSULIN-SECRETION; IAPP GENE; GLUCOSE; TYPE-2; ACTIVATION; APOPTOSIS; INFLAMMASOME	Background: Islet amyloid polypeptide (IAPP) plays an important role in beta-cell biology, but its regulation is not fully understood. Results: Thioredoxin-interacting protein (TXNIP) induces IAPP by inhibiting miR-124a and promoting FoxA2-mediated transcription. Conclusion: The critical beta-cell signaling pathways of TXNIP and IAPP are linked. Significance: Identification of this novel TXNIP/miR-124a/FoxA2/IAPP signaling pathway provides new insight into an important aspect of transcriptional regulation and beta-cell biology. Thioredoxin-interacting protein (TXNIP) is up-regulated by glucose and diabetes and plays a critical role in glucotoxicity, inflammation, and beta-cell apoptosis, whereas we have found that TXNIP deficiency protects against diabetes. Interestingly, human islet amyloid polypeptide (IAPP) is also induced by glucose, aggregates into insoluble amyloid fibrils found in islets of most individuals with type 2 diabetes and promotes inflammation and beta-cell cytotoxicity. However, so far no connection between TXNIP and IAPP signaling had been reported. Using TXNIP gain and loss of function experiments, INS-1 beta-cells and beta-cell-specific Txnip knock-out mice, we now found that TXNIP regulates IAPP expression. Promoter analyses and chromatin-immunoprecipitation assays further demonstrated that TXNIP increases IAPP expression at the transcriptional level, and we discovered that TXNIP-induced FoxA2 (forkhead box A2) transcription factor expression was conferring this effect by promoting FoxA2 enrichment at the proximal FoxA2 site in the IAPP promoter. Moreover, we found that TXNIP down-regulates miR-124a expression, a microRNA known to directly target FoxA2. Indeed, miR-124a overexpression led to decreased FoxA2 expression and IAPP promoter occupancy and to a significant reduction in IAPP mRNA and protein expression and also effectively inhibited TXNIP-induced IAPP expression. Thus, our studies have identified a novel TXNIP/miR-124a/FoxA2/IAPP signaling cascade linking the critical beta-cell signaling pathways of TXNIP and IAPP and thereby provide new mechanistic insight into an important aspect of transcriptional regulation and beta-cell biology.	[Jing, Gu; Chen, Junqin; Xu, Guanlan; Shalev, Anath] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Jing, Gu; Chen, Junqin; Xu, Guanlan; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Westwell-Roper, Clara; Verchere, C. Bruce] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Child & Family Research Institute; University of British Columbia	Shalev, A (corresponding author), Univ Alabama Birmingham, Comprehens Diabet Ctr, 1825 Univ Blvd,SHELBY Bldg 1206, Birmingham, AL 35294 USA.	shalev@uab.edu		Verchere, Cameron Bruce/0000-0002-9262-0586; Westwell-Roper, Clara/0000-0003-4416-3912	National Institutes of Health [R01DK-078752]; American Diabetes Association [7-12-BS-167]; Juvenile Diabetes Research Foundation; JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to A. S. from the National Institutes of Health (R01DK-078752), the American Diabetes Association (7-12-BS-167) and the Juvenile Diabetes Research Foundation and JNJSI (40-2011-1).	Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen F, 2011, ENDOCRINOLOGY, V152, P1779, DOI 10.1210/en.2010-1048; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gasa R, 1997, REGUL PEPTIDES, V68, P99, DOI 10.1016/S0167-0115(96)02109-X; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Marzban L, 2008, DIABETES, V57, P3045, DOI 10.2337/db08-0485; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Shepherd LMA, 2004, BBA-GENE STRUCT EXPR, V1681, P28, DOI 10.1016/j.bbaexp.2004.09.009; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Tokuyama T, 1997, METABOLISM, V46, P1044, DOI 10.1016/S0026-0495(97)90276-6; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhu TH, 2011, DIABETES-METAB RES, V27, P28, DOI 10.1002/dmrr.1140	44	45	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11807	11815		10.1074/jbc.M113.525022	http://dx.doi.org/10.1074/jbc.M113.525022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627476	Green Published, hybrid			2022-12-28	WOS:000335010600021
J	Geng, YT; Ju, YF; Ren, FL; Qiu, Y; Tomita, Y; Tomoeda, M; Kishida, M; Wang, YY; Jin, L; Su, FQ; Wei, CH; Jia, BQ; Li, Y; Chang, ZJ				Geng, Yongtao; Ju, Yanfang; Ren, Fangli; Qiu, Ying; Tomita, Yasuhiko; Tomoeda, Miki; Kishida, Mioka; Wang, Yinyin; Jin, Lian; Su, Fuqin; Wei, Chunhong; Jia, Baoqing; Li, Yi; Chang, Zhijie			Insulin Receptor Substrate 1/2 ( IRS1/2) Regulates Wnt/beta-Catenin Signaling through Blocking Autophagic Degradation of Dishevelled2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; -Catenin; Cell Proliferation; EMT; Wnt Signaling; Dishevelled2; IRS	EPITHELIAL-MESENCHYMAL TRANSITION; LYSINE 63-LINKED UBIQUITINATION; CANCER CELLS; BETA-CATENIN; WNT; PATHWAY; PROTEIN; GROWTH; PHOSPHORYLATION; PROLIFERATION	Background: IRS1/2 is a critical component of insulin signaling, but it remains unclear whether IRS1/2 functions on Wnt signaling. Results: IRS1/2 interacts with and stabilizes Dvl2 by suppressing its autophagic degradation, leading to promotion of Wnt-mediated EMT and cell proliferation. Conclusion: IRS1/2 positively regulates Wnt/-catenin signaling through Dvl2. Significance: The IRS1/2-Dvl2 node might be implicated in tumorigenesis and metastasis. Wnt signaling plays a pivotal role in cell proliferation, tissue homeostasis, and tumorigenesis. Dishevelled (Dvl) is a central node of Wnt signaling. Insulin receptor substrates (IRSs), as a critical component of insulin signaling, are involved in cell proliferation, metabolism, and cancer development. In this study, we report that IRS1/2 promotes Wnt/-catenin signaling by stabilizing Dvl2. We found that IRS1/2 interacts with Dvl2. Overexpression of IRS1/2 increased the protein level of Dvl2 and promoted canonical Wnt signaling, as evidenced by the increased T cell-specific factor 4 transcriptional activity and the up-regulation of expression of CYCLIN D1 and c-MYC, two Wnt target genes critical for cell growth, whereas depletion of IRS1/2 reduced the level of Dvl2 and attenuated Wnt/-catenin signaling. Biochemical analyses revealed that IRS1/2 decreased Lys-63-linked ubiquitination of Dvl2 and stabilized Dvl2 protein via suppressing its autophagy-mediated degradation. We further revealed that IRS1/2 blocks autophagy-induced formation of the Dvl2-p62/SQSTM1 complex, resulting in disabled association of Dvl2 to autophagosomes. We demonstrated that IRS1/2 promoted the induction of epithelial-mesenchymal transition (EMT) and cell proliferation in response to Wnt stimulation, whereas depletion of Dvl2 impaired the IRS1/2-mediated EMT and cell growth. Our findings revealed that IRS1/2 promotes EMT and cell proliferation through stabilizing Dvl2.	[Geng, Yongtao; Jin, Lian; Wei, Chunhong; Li, Yi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Geng, Yongtao; Ren, Fangli; Qiu, Ying; Wang, Yinyin; Su, Fuqin; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Natl Engn Lab Antitumor Therapeut, Beijing 100084, Peoples R China; [Ju, Yanfang; Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing 100853, Peoples R China; [Tomita, Yasuhiko; Tomoeda, Miki; Kishida, Mioka] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan	Peking University; Tsinghua University; Chinese People's Liberation Army General Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases	Li, Y (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	liyi@pku.edu.cn; zhijiec@tsinghua.edu.cn	Chang, Zhijie/AAH-8109-2019; Qiu, Ying/Y-3276-2019	Chang, Zhijie/0000-0003-1567-3227	973 Project [2011CB910502, 2011ZX08011-006]; National Natural Science Foundation of China [81372167, 81301700, 30871286, 31071225, 31030040]; Tsinghua Science Foundation [20121080018]; 863 Project, China [2012AA021730, 2012AA021703]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; 863 Project, China(National High Technology Research and Development Program of China)	This work was supported by 973 Project Grants 2011CB910502 and 2011ZX08011-006, National Natural Science Foundation of China Grants 81372167, 81301700, 30871286, 31071225, and 31030040, Tsinghua Science Foundation Grant 20121080018, and 863 Project Grants 2012AA021730 and 2012AA021703 in China.	Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bao XL, 2012, MOL VIS, V18, P1983; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Carew RM, 2011, FEBS J, V278, P3370, DOI 10.1111/j.1742-4658.2011.08261.x; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalmizrak O, 2007, CANCER RES, V67, P2124, DOI 10.1158/0008-5472.CAN-06-3954; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang YQ, 2011, CELL PHYSIOL BIOCHEM, V27, P503, DOI 10.1159/000329952; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	42	42	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11230	11241		10.1074/jbc.M113.544999	http://dx.doi.org/10.1074/jbc.M113.544999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616100	Green Published, hybrid			2022-12-28	WOS:000334638500026
J	Zhao, J; Fu, Y; Liu, CC; Shinohara, M; Nielsen, HM; Dong, Q; Kanekiyo, T; Bu, GJ				Zhao, Jing; Fu, Yuan; Liu, Chia-Chen; Shinohara, Mitsuru; Nielsen, Henrietta M.; Dong, Qiang; Kanekiyo, Takahisa; Bu, Guojun			Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; ApoE; Cholesterol; Retinoid; Retinoic Acid	UNION-OF-PHARMACOLOGY; A-BETA CLEARANCE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; AMYLOID DEPOSITION; CHOLESTEROL EFFLUX; MEMORY DEFICITS; TYPE-4 ALLELE; APOE LEVELS; ABCA1	Background: Apolipoprotein E (apoE) isoforms influence the risk for Alzheimer disease (AD). Results: All-trans-retinoic acid (RA), 9-cis-RA, and 13-cis-RA were identified as compounds that increase apoE expression and lipidation in astrocytes. Conclusion: RA isomers are effective modulators of apoE production through the retinoid X receptor (RXR) and RA receptor (RAR). Significance: RXR/RAR agonists can be explored for AD therapy. Apolipoprotein E (apoE) is the major cholesterol transport protein in the brain. Among the three human APOE alleles (APOE2, APOE3, and APOE4), APOE4 is the strongest genetic risk factor for late-onset Alzheimer disease (AD). The accumulation of amyloid- (A) is a central event in AD pathogenesis. Increasing evidence demonstrates that apoE isoforms differentially regulate AD-related pathways through both A-dependent and -independent mechanisms; therefore, modulating apoE secretion, lipidation, and function might be an attractive approach for AD therapy. We performed a drug screen for compounds that modulate apoE production in immortalized astrocytes derived from apoE3-targeted replacement mice. Here, we report that retinoic acid (RA) isomers, including all-trans-RA, 9-cis-RA, and 13-cis-RA, significantly increase apoE secretion to approximate to 4-fold of control through retinoid X receptor (RXR) and RA receptor. These effects on modulating apoE are comparable with the effects recently reported for the RXR agonist bexarotene. Furthermore, all of these compounds increased the expression of the cholesterol transporter ABCA1 and ABCG1 levels and decreased cellular uptake of A in an apoE-dependent manner. Both bexarotene and 9-cis-RA promote the lipidation status of apoE, in which 9-cis-RA promotes a stronger effect and exhibits less cytotoxicity compared with bexarotene. Importantly, we showed that oral administration of bexarotene and 9-cis-RA significantly increases apoE, ABCA1, and ABCG1 levels in mouse brains. Taken together, our results demonstrate that RXR/RA receptor agonists, including several RA isomers, are effective modulators of apoE secretion and lipidation and may be explored as potential drugs for AD therapy.	[Zhao, Jing; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200032, Peoples R China; [Zhao, Jing; Fu, Yuan; Liu, Chia-Chen; Shinohara, Mitsuru; Nielsen, Henrietta M.; Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Liu, Chia-Chen; Bu, Guojun] Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Fudan University; Mayo Clinic; Xiamen University	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Fu, Yuan/AAO-6040-2020; Nielsen, Henrietta M/B-1746-2013	Fu, Yuan/0000-0003-2293-814X; Zhao, Jing/0000-0002-4520-6307; Nielsen, Henrietta M/0000-0001-9664-7068	National Institutes of Health [R01AG046205, R01AG035355, R01AG027924, P01AG030128, P01NS074969]; Alzheimer's Drug Discovery Foundation; Alzheimer's Association New Investigator Research Grant; Mayo Clinic Center for Regenerative Medicine Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031784, R01AG046205, R01AG035355, R01AG027924, P01AG030128, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; Alzheimer's Association New Investigator Research Grant; Mayo Clinic Center for Regenerative Medicine Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG046205, R01AG035355, R01AG027924, P01AG030128, and P01NS074969 (to G. B.). This work was also supported by a grant from the Alzheimer's Drug Discovery Foundation, Alzheimer's Association New Investigator Research Grant, and Mayo Clinic Center for Regenerative Medicine Career Development Award (to T. K.).	Ahlemeyer B, 2000, NEUROCHEM INT, V36, P1, DOI 10.1016/S0197-0186(99)00101-1; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Blaner WS, 2001, J AM ACAD DERMATOL, V45, pS129, DOI 10.1067/mjd.2001.113714; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen J, 2011, J PHARMACOL EXP THER, V338, P870, DOI 10.1124/jpet.111.182196; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Grant W B, 1999, J Alzheimers Dis, V1, P197; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Karten B, 2006, J BIOL CHEM, V281, P4049, DOI 10.1074/jbc.M508915200; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; KRUL ES, 1988, J LIPID RES, V29, P1309; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Maden M, 2003, DEV DYNAM, V226, P237, DOI 10.1002/dvdy.10222; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Oram JF, 2001, J LIPID RES, V42, P1173; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Shen H, 2009, J NEUROSCI RES, V87, P545, DOI 10.1002/jnr.21865; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tafti M, 2007, ARCH NEUROL-CHICAGO, V64, P1706, DOI 10.1001/archneur.64.12.1706; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Vakeva L, 2012, ACTA DERM-VENEREOL, V92, P258, DOI 10.2340/00015555-1359; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang Y, 2006, MOL CANCER THER, V5, P1060, DOI 10.1158/1535-7163.MCT-05-0322; Weinstein D. E., 2001, CURR PROTOC NEUROSCI, DOI [10. 1002/0471142301. ns0305s00, DOI 10.1002/0471142301. NS0305S00]; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	73	47	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11282	11292		10.1074/jbc.M113.526095	http://dx.doi.org/10.1074/jbc.M113.526095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599963	hybrid, Green Published			2022-12-28	WOS:000334638500031
J	Cai, Q; Fu, LJ; Wang, Z; Gan, NQ; Dai, XX; Wang, YS				Cai, Qian; Fu, Lijuan; Wang, Zi; Gan, Nanqin; Dai, Xiaoxia; Wang, Yinsheng			alpha-N-Methylation of Damaged DNA-binding Protein 2 (DDB2) and Its Function in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; MASS-SPECTROMETRY; H2B VARIANTS; HISTONE H2B; IDENTIFICATION; TRIMETHYLALANINE; RESIDUE; LYSINE; YEAST; RCC1	DDB2 exhibits a high affinity toward UV-damaged DNA, and it is involved in the initial steps of global genome nucleotide excision repair. Mutations in the DDB2 gene cause the genetic complementation group E of xeroderma pigmentosum, an autosomal recessive disease manifested clinically by hypersensitivity to sunlight exposure and an increased predisposition to skin cancer. Here we found that, in human cells, the initiating methionine residue in DDB2 was removed and that the N-terminal alanine could be methylated on its alpha-amino group in human cells, with trimethylation being the major form. We also demonstrated that the alpha-N-methylation of DDB2 is catalyzed by the N-terminal RCC1 methyltransferase. In addition, a methylation-defective mutant of DDB2 displayed diminished nuclear localization and was recruited at a reduced efficiency to UV-induced cyclobutane pyrimidine dimer foci. Moreover, loss of this methylation conferred compromised ATM (ataxia telangiectasia mutated) activation, decreased efficiency in cyclobutane pyrimidine dimer repair, and elevated sensitivity of cells toward UV light exposure. Our study provides new knowledge about the posttranslational regulation of DDB2 and expands the biological functions of protein alpha-N-methylation to DNA repair.	[Cai, Qian; Fu, Lijuan; Wang, Zi; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Gan, Nanqin; Dai, Xiaoxia; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	CAI, QIAN/E-2352-2017	CAI, QIAN/0000-0002-7865-5993; Dai, Xiaoxia/0000-0002-3514-5061	National Institutes of Health [R01 ES019873]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES019873.	Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Cong F, 2002, J BIOL CHEM, V277, P34870, DOI 10.1074/jbc.M204416200; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DESROSIERS R, 1988, J BIOL CHEM, V263, P4686; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HENRY GD, 1982, FEBS LETT, V144, P11, DOI 10.1016/0014-5793(82)80558-9; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KEENEY S, 1993, J BIOL CHEM, V268, P21293; MARTINAGE A, 1985, EUR J BIOCHEM, V147, P351, DOI 10.1111/j.1432-1033.1985.tb08757.x; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; NOMOTO M, 1982, J BIOCHEM-TOKYO, V92, P1675, DOI 10.1093/oxfordjournals.jbchem.a134096; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; SMITH GM, 1980, EUR J BIOCHEM, V110, P123, DOI 10.1111/j.1432-1033.1980.tb04847.x; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun Nian-Kang, 2002, Chang Gung Med J, V25, P723; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Xiong L, 2010, BIOCHEMISTRY-US, V49, P5236, DOI 10.1021/bi1001322; Xiong L, 2009, J AM SOC MASS SPECTR, V20, P1172, DOI 10.1016/j.jasms.2009.02.014; Zhang F, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016915; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	39	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16046	16056		10.1074/jbc.M114.558510	http://dx.doi.org/10.1074/jbc.M114.558510			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753253	hybrid, Green Published			2022-12-28	WOS:000337965700014
J	Abad, MG; Long, YC; Kinchen, RD; Schindel, ET; Gray, MW; Jackman, JE				Abad, Maria G.; Long, Yicheng; Kinchen, R. Dimitri; Schindel, Elinor T.; Gray, Michael W.; Jackman, Jane E.			Mitochondrial tRNA 5'-Editing in Dictyostelium discoideum and Polysphondylium pallidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dictyostelium; Enzyme; Mitochondria; RNA Editing; Transfer RNA (tRNA); 3-5 Polymerase; tRNA Repair	ACANTHAMOEBA-CASTELLANII MITOCHONDRIA; 3'-5' NUCLEOTIDE ADDITION; TRNA(HIS) GUANYLYLTRANSFERASE; SPIZELLOMYCES-PUNCTATUS; ANTICODON; THG1; MATURATION; MECHANISM; CATALYZES; PROTEINS	Background: Secondary structure modeling predicts 5-editing of mitochondrial tRNAs in amoebozoans Dictyostelium discoideum and Polysphondylium pallidum. Results: Experimental verification reveals unexpected instances of editing and species-specific variations. Conclusion: Mitochondrial tRNA 5-editing is a complex process in which 3-5 RNA polymerases play a key role. Significance: Further biochemical characterization of mitochondrial tRNA 5-editing reactions and enzymes is indicated. Mitochondrial tRNA (mt-tRNA) 5-editing was first described more than 20 years ago; however, the first candidates for 5-editing enzymes were only recently identified in a eukaryotic microbe (protist), the slime mold Dictyostelium discoideum. In this organism, eight of 18 mt-tRNAs are predicted to be edited based on the presence of genomically encoded mismatched nucleotides in their aminoacyl-acceptor stem sequences. Here, we demonstrate that mt-tRNA 5-editing occurs at all predicted sites in D. discoideum as evidenced by changes in the sequences of isolated mt-tRNAs compared with the expected sequences encoded by the mitochondrial genome. We also identify two previously unpredicted editing events in which G-U base pairs are edited in the absence of any other genomically encoded mismatches. A comparison of 5-editing in D. discoideum with 5-editing in another slime mold, Polysphondylium pallidum, suggests organism-specific idiosyncrasies in the treatment of U-G/G-U pairs. In vitro activities of putative D. discoideum editing enzymes are consistent with the observed editing reactions and suggest an overall lack of tRNA substrate specificity exhibited by the repair component of the editing enzyme. Although the presence of terminal mismatches in mt-tRNA sequences is highly predictive of the occurrence of mt-tRNA 5-editing, the variability in treatment of U-G/G-U base pairs observed here indicates that direct experimental evidence of 5-editing must be obtained to understand the complete spectrum of mt-tRNA editing events in any species.	[Abad, Maria G.; Long, Yicheng; Kinchen, R. Dimitri; Jackman, Jane E.] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Long, Yicheng; Jackman, Jane E.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Schindel, Elinor T.; Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Dalhousie University	Jackman, JE (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 West 12th Ave, Columbus, OH 43210 USA.	jackman.14@osu.edu	jackman, jane/AAE-1854-2022	jackman, jane/0000-0001-9291-8852; Long, Yicheng/0000-0002-0714-2322; Long, Yicheng/0000-0003-3578-5197; Gray, Michael/0000-0001-7125-2625	National Institutes of Health [R01 GM087543]; Canadian Institutes of Health Research [MOP-4124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM087543 (to J. E. J.) and Canadian Institutes of Health Research Grant MOP-4124 (to M. W. G.).	Abad MG, 2011, RNA, V17, P613, DOI 10.1261/rna.2517111; Abad MG, 2010, P NATL ACAD SCI USA, V107, P674, DOI 10.1073/pnas.0910961107; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Antes T, 1998, MOL CELL BIOL, V18, P7521, DOI 10.1128/MCB.18.12.7521; Bullerwell CE, 2005, J BIOL CHEM, V280, P2463, DOI 10.1074/jbc.M411273200; Chen WY, 2012, NUCLEIC ACIDS RES, V40, P4666, DOI 10.1093/nar/gks013; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gott JM, 2010, RNA, V16, P482, DOI 10.1261/rna.1958810; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; Heinemann IU, 2010, FEBS LETT, V584, P3567, DOI 10.1016/j.febslet.2010.07.023; Hyde SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067465; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Jackman JE, 2006, RNA, V12, P1007, DOI 10.1261/rna.54706; Jackman JE, 2012, RNA, V18, P886, DOI 10.1261/rna.032300.112; Laforest MJ, 2004, RNA, V10, P1191, DOI 10.1261/rna.7330504; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Leigh J, 2004, RNA, V10, P615, DOI 10.1261/rna.5195504; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; LONERGAN KM, 1993, NUCLEIC ACIDS RES, V21, P4402, DOI 10.1093/nar/21.18.4402; Morl M., 2005, HDB RNA BIOCH, P22; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Price DH, 1999, CURR GENET, V35, P23, DOI 10.1007/s002940050428; Randau L, 2009, SCIENCE, V324, P657, DOI 10.1126/science.1170123; Rao BS, 2013, NUCLEIC ACIDS RES, V41, P1885, DOI 10.1093/nar/gks1242; Rao BS, 2011, NUCLEIC ACIDS RES, V39, P1833, DOI 10.1093/nar/gkq976; Rubio MAT, 2006, J BIOL CHEM, V281, P115, DOI 10.1074/jbc.M510136200; Schindel E. T., 2004, THESIS DALHOUSIE U; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Smith BA, 2014, BIOCHEMISTRY-US, V53, P1380, DOI 10.1021/bi4014648; Smith BA, 2012, BIOCHEMISTRY-US, V51, P453, DOI 10.1021/bi201397f; YOKOBORI S, 1995, NATURE, V377, P490, DOI 10.1038/377490a0; YOKOBORI S, 1995, P NATL ACAD SCI USA, V92, P10432, DOI 10.1073/pnas.92.22.10432	36	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15155	15165		10.1074/jbc.M114.561514	http://dx.doi.org/10.1074/jbc.M114.561514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737330	Green Published, hybrid			2022-12-28	WOS:000337465400003
J	Gudi, R; Zou, CZ; Dhar, J; Gao, QS; Vasu, C				Gudi, Radhika; Zou, Chaozhong; Dhar, Jayeeta; Gao, Qingshen; Vasu, Chenthamarakshan			Centrobin-Centrosomal Protein 4.1-associated Protein (CPAP) Interaction Promotes CPAP Localization to the Centrioles during Centriole Duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centriole; Centrosome; Cloning; Confocal Microscopy; Gene Expression; CEP152; CPAP; Centrobin	MAMMALIAN-CELL; CEP152; KINASE; PLK4; ULTRASTRUCTURE; BIOGENESIS; MECHANISMS; ASTERLESS; SUBSTRATE; SCAFFOLD	Background: The mechanism and players involved in centriole duplication process are not fully understood. Results: Centrobin and centrosomal protein 4.1-associated-protein (CPAP) interact. Depletion of centrobin results in the disappearance of CPAP from centrioles and inhibition of centriole elongation. Conclusion: Centrobin-CPAP interaction promotes centriolar CPAP localization for centriole duplication. Significance: Identifying the key molecular events is crucial for understanding the centriole duplication process. Centriole duplication is the process by which two new daughter centrioles are generated from the proximal end of preexisting mother centrioles. Accurate centriole duplication is important for many cellular and physiological events, including cell division and ciliogenesis. Centrosomal protein 4.1-associated protein (CPAP), centrosomal protein of 152 kDa (CEP152), and centrobin are known to be essential for centriole duplication. However, the precise mechanism by which they contribute to centriole duplication is not known. In this study, we show that centrobin interacts with CEP152 and CPAP, and the centrobin-CPAP interaction is critical for centriole duplication. Although depletion of centrobin from cells did not have an effect on the centriolar levels of CEP152, it caused the disappearance of CPAP from both the preexisting and newly formed centrioles. Moreover, exogenous expression of the CPAP-binding fragment of centrobin also caused the disappearance of CPAP from both the preexisting and newly synthesized centrioles, possibly in a dominant negative manner, thereby inhibiting centriole duplication and the PLK4 overexpression-mediated centrosome amplification. Interestingly, exogenous overexpression of CPAP in the centrobin-depleted cells did not restore CPAP localization to the centrioles. However, restoration of centrobin expression in the centrobin-depleted cells led to the reappearance of centriolar CPAP. Hence, we conclude that centrobin-CPAP interaction is critical for the recruitment of CPAP to procentrioles to promote the elongation of daughter centrioles and for the persistence of CPAP on preexisting mother centrioles. Our study indicates that regulation of CPAP levels on the centrioles by centrobin is critical for preserving the normal size, shape, and number of centrioles in the cell.	[Gudi, Radhika; Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Zou, Chaozhong; Dhar, Jayeeta; Gao, Qingshen] NorthShore Res Inst, Dept Med, Evanston, IL 60201 USA	Medical University of South Carolina; Medical University of South Carolina; NorthShore University Health System	Gudi, R (corresponding author), Med Univ S Carolina, HO602,86 Jonathan Lucas St, Charleston, SC 29425 USA.	gudi@musc.edu			Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina	Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina	We thank Dr. Kunsoo Rhee, Dr. Ingrid Hoffmann, Dr. Tang, Dr. Pierre Gonczy, and Dr. Puligilla for invaluable help in providing reagents. We also thank the Cell and Molecular Imaging Facility and the Regenerative Medicine/Cell Biology and Hollings Cancer Center Flow Cytometry Facility at the Medical University of South Carolina for support and cooperation.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 2001, CURR BIOL, V11, pR698, DOI 10.1016/S0960-9822(01)00412-2; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Issa L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-59; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Paoletti A, 1996, J CELL SCI, V109, P3089; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; VOROBJEV IA, 1980, CELL BIOL INT REP, V4, P1037, DOI 10.1016/0309-1651(80)90177-0; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	51	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15166	15178		10.1074/jbc.M113.531152	http://dx.doi.org/10.1074/jbc.M113.531152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24700465	Green Published, hybrid			2022-12-28	WOS:000337465400004
J	Basak, I; Pal, R; Patil, KS; Dunne, A; Ho, HP; Lee, S; Peiris, D; Maple-Grodem, J; Odell, M; Chang, EJ; Larsen, JP; Moller, SG				Basak, Indranil; Pal, Ramavati; Patil, Ketan S.; Dunne, Aisling; Ho, Hsin-Pin; Lee, Sungsu; Peiris, Diluka; Maple-Grodem, Jodi; Odell, Mark; Chang, Emmanuel J.; Larsen, Jan Petter; Moller, Simon G.			Arabidopsis AtPARK13, Which Confers Thermotolerance, Targets Misfolded Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; NEUROPROTECTIVE ROLE; HTRA2; GENE; MUTATIONS; MITOCHONDRIA; DEGRADATION; OMI/HTRA2; THALIANA	Mutations in HTRA2/Omi/PARK13 have been implicated inParkinson disease (PD). PARK13 is a neuroprotective serine protease; however, little is known about how PARK13 confers stress protection and which protein targets are directly affected by PARK13. We have reported that Arabidopsis thaliana represents a complementary PD model, and here we demonstrate that AtPARK13, similar to human PARK13 (hPARK13), is a mitochondrial protease. We show that the expression/accumulation of AtPARK13 transcripts are induced by heat stress but not by other stress conditions, including oxidative stress and metals. Our data show that elevated levels of AtPARK13 confer thermotolerance in A. thaliana. Increased temperatures accelerate protein unfolding, and we demonstrate that although AtPARK13 can act on native protein substrates, unfolded proteins represent better AtPARK13 substrates. The results further show that AtPARK13 and hPARK13 can degrade the PD proteins alpha-synuclein (SNCA) and DJ-1/PARK7 directly, without autophagy involvement, and that misfolded SNCA and DJ-1 represent better substrates than their native counterparts. Comparative proteomic profiling revealed AtPARK13-mediated proteome changes, and we identified four proteins that show altered abundance in response to AtPARK13 overexpression and elevated temperatures. Our study not only suggests that AtPARK13 confers thermotolerance by degrading misfolded protein targets, but it also provides new insight into possible roles of this protease in neurodegeneration.	[Basak, Indranil; Pal, Ramavati; Patil, Ketan S.; Dunne, Aisling; Lee, Sungsu; Moller, Simon G.] St Johns Univ, Dept Biol Sci, New York, NY 11439 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY York Coll, Dept Chem, New York, NY 11451 USA; [Peiris, Diluka; Odell, Mark] Univ Westminster, Dept Mol & Appl Biosci, London W1W 6UW, England; [Maple-Grodem, Jodi; Larsen, Jan Petter; Moller, Simon G.] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway	Saint John's University; City University of New York (CUNY) System; University of Westminster; Stavanger University Hospital	Moller, SG (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	mollers@stjohns.edu	Basak, Indranil/P-9279-2016; Basak, Indranil/AAH-2593-2020; Grødem, jodi M/H-5482-2012	Basak, Indranil/0000-0001-5009-2845; Maple-Grodem, Jodi/0000-0001-7142-0078; Moller, Simon/0000-0002-0460-3592	Norwegian Research Council; Western Norway Regional Health Authority; Norwegian Centre for Movement Disorders; Department of Biological Sciences at St. John's University	Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority; Norwegian Centre for Movement Disorders; Department of Biological Sciences at St. John's University	This work was supported by grants from the Norwegian Research Council, the Western Norway Regional Health Authority, the Norwegian Centre for Movement Disorders, and the Department of Biological Sciences at St. John's University.	Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen JP, 2006, PLANT J, V48, P73, DOI 10.1111/j.1365-313X.2006.02855.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hirt H., 2004, PLANT RESPONSES ABIO, V4, P73; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Lin CH, 2011, HUM GENET, V130, P817, DOI 10.1007/s00439-011-1041-6; Liu MJ, 2007, BIOCHEM BIOPH RES CO, V362, P295, DOI 10.1016/j.bbrc.2007.07.118; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Mesquita RO, 2012, GENET MOL BIOL, V35, P353, DOI 10.1590/S1415-47572012000200017; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Pliyev BK, 1999, BIOCHEMISTRY-MOSCOW+, V64, P738; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Truscott KN, 2011, IUBMB LIFE, V63, P955, DOI 10.1002/iub.526; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang CY, 2011, BRAIN RES, V1385, P293, DOI 10.1016/j.brainres.2011.02.037; Xu XM, 2011, CURR OPIN BIOTECH, V22, P300, DOI 10.1016/j.copbio.2010.11.007; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang XF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P687, DOI 10.1023/B:BIRY.0000033743.09806.1a; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1	43	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14458	14469		10.1074/jbc.M114.548156	http://dx.doi.org/10.1074/jbc.M114.548156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719325	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000337248100003
J	Gu, XR; Hu, ZB; Ebrahem, Q; Crabb, JS; Mahfouz, RZ; Radivoyevitch, T; Crabb, JW; Saunthararajah, Y				Gu, Xiaorong; Hu, Zhenbo; Ebrahem, Quteba; Crabb, John S.; Mahfouz, Reda Z.; Radivoyevitch, Tomas; Crabb, John W.; Saunthararajah, Yogen			Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE; TRANSCRIPTIONAL CONTROL; DNA METHYLATION; CELLS; AML1; GENE; REPRESSION; BINDING; C/EBP	Gene activation requires cooperative assembly of multiprotein transcription factor-coregulator complexes. Disruption to cooperative assemblage could underlie repression of tumor suppressor genes in leukemia cells. Mechanisms of cooperation and its disruption were therefore examined for PU.1 and RUNX1, transcription factors that cooperate to activate hematopoietic differentiation genes. PU.1 is highly expressed in leukemia cells, whereas RUNX1 is frequently inactivated by mutation or translocation. Thus, coregulator interactions of Pu.1 were examined by immunoprecipitation coupled with tandem mass spectrometry/Western blot in wild-type and Runx1-deficient hematopoietic cells. In wild-type cells, the NuAT and Baf families of coactivators coimmunoprecipitated with Pu.1. Runx1 deficiency produced a striking switch to Pu.1 interaction with the Dnmt1, Sin3A, Nurd, CoRest, and B-Wich corepressor families. Corepressors of the Polycomb family, which are frequently inactivated by mutation or deletion in myeloid leukemia, did not interact with Pu.1. The most significant gene ontology association of Runx1-Pu.1 co-bound genes was with macrophages, therefore, functional consequences of altered corepressor/coactivator exchange were examined at Mcsfr, a key macrophage differentiation gene. In chromatin immunoprecipitation analyses, high level Pu.1 binding to the Mcsfr promoter was not decreased by Runx1 deficiency. However, the Pu.1-driven shift from histone repression to activation marks at this locus, and terminal macrophage differentiation, were substantially diminished. DNMT1 inhibition, but not Polycomb inhibition, in RUNX1-translocated leukemia cells induced terminal differentiation. Thus, RUNX1 and PU.1 cooperate to exchange corepressors for coactivators, and the specific corepressors recruited to PU.1 as a consequence of RUNX1 deficiency could be rational targets for leukemia differentiation therapy.	[Gu, Xiaorong; Hu, Zhenbo; Ebrahem, Quteba; Mahfouz, Reda Z.; Saunthararajah, Yogen] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Crabb, John S.; Crabb, John W.] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA; [Radivoyevitch, Tomas] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Saunthararajah, Y (corresponding author), 9500 Euclid Ave,R40, Cleveland, OH 44195 USA.	saunthy@ccf.org	Mahfouz, Reda Z/G-2307-2011	Mahfouz, Reda Z/0000-0003-4250-9422; Radivoyevitch, Tomas/0000-0002-9701-1851	National Institutes of Health [R01CA138858]; Department of Defense [PR081404]; Case Western Reserve University/Cleveland Clinic [CTSA UL1RR024989]; NATIONAL CANCER INSTITUTE [R01CA138858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Case Western Reserve University/Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA138858, Department of Defense Grant PR081404, and Case Western Reserve University/Cleveland Clinic Grant CTSA UL1RR024989 (to Y. S.).	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grand F, 1999, CANCER RES, V59, P3870; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hu ZB, 2011, BLOOD, V117, P6498, DOI 10.1182/blood-2010-10-312512; Hu ZB, 2010, MOL CANCER THER, V9, P1536, DOI 10.1158/1535-7163.MCT-10-0191; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2009, MOL CELL BIOL, V29, P4103, DOI 10.1128/MCB.00090-09; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kosugi H, 1999, LEUKEMIA, V13, P1316, DOI 10.1038/sj.leu.2401508; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Niimi H, 2006, LEUKEMIA, V20, P635, DOI 10.1038/sj.leu.2404136; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; R Core Team, 2012, R LANG ENV STAT COMP; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rush Margaret, 2009, Epigenetics, V4, P404; Saunthararajah Y, 2013, HEMATOL-AM SOC HEMAT, P511, DOI 10.1182/asheducation-2013.1.511; Saunthararajah Y, 2012, BLOOD, V119, P1097, DOI 10.1182/blood-2011-12-391268; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Wang JX, 1999, CANCER RES, V59, P2766; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xu G, 2006, LEUKEMIA, V20, P1002, DOI 10.1038/sj.leu.2404223; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	47	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14881	14895		10.1074/jbc.M114.562447	http://dx.doi.org/10.1074/jbc.M114.562447			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695740	hybrid, Green Published			2022-12-28	WOS:000337248100040
J	Cragle, C; MacNicol, AM				Cragle, Chad; MacNicol, Angus M.			Musashi Protein-directed Translational Activation of Target mRNAs Is Mediated by the Poly( A) Polymerase, Germ Line Development Defective-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Oocyte; Polyadenylation; RNA-binding Protein; Translation Control; Xenopus	XENOPUS OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION ELEMENTS; FATE DETERMINANT MUSASHI; BINDING-PROTEIN; CELL-CYCLE; MEIOTIC MATURATION; C-MOS; CAENORHABDITIS-ELEGANS; MYELOID-LEUKEMIA; TEMPORAL CONTROL	Background: Although Musashi mediates target mRNA polyadenylation, the underlying molecular mechanism has not been elucidated. Results: Germ line development defective-2, a poly(A) polymerase, associates with Musashi and is necessary and sufficient for Musashi-directed polyadenylation. Conclusion: Germ line development defective-2 mediates Musashi-dependent mRNA translation. Significance: Germ line development defective-2 couples Musashi to polyadenylation and translational activation of target mRNAs. The mRNA-binding protein, Musashi, has been shown to regulate translation of select mRNAs and to control cellular identity in both stem cells and cancer cells. Within the mammalian cells, Musashi has traditionally been characterized as a repressor of translation. However, we have demonstrated that Musashi is an activator of translation in progesterone-stimulated oocytes of the frog Xenopus laevis, and recent evidence has revealed Musashi's capability to function as an activator of translation in mammalian systems. The molecular mechanism by which Musashi directs activation of target mRNAs has not been elucidated. Here, we report a specific association of Musashi with the noncanonical poly(A) polymerase germ line development defective-2 (GLD2) and map the association domain to 31 amino acids within the C-terminal domain of Musashi. We show that loss of GLD2 interaction through deletion of the binding domain or treatment with antisense oligonucleotides compromises Musashi function. Additionally, we demonstrate that overexpression of both Musashi and GLD2 significantly enhances Musashi function. Finally, we report a similar co-association also occurs between murine Musashi and GLD2 orthologs, suggesting that coupling of Musashi to the polyadenylation apparatus is a conserved mechanism to promote target mRNA translation.	[Cragle, Chad] Univ Arkansas Med Sci, Little Rock, AR USA; [Cragle, Chad; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Genet, Little Rock, AR USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 W Markham, Little Rock, AR 72205 USA.	Angus@UAMS.edu			National Institutes of Health [RO1 HD35688]; NCRR [UL1TR000039, KL2TR000063]; Arkansas Breast Cancer Research Program; Sturgis Charitable Trust; University of Arkansas for Medical Sciences College of Medicine Research Council; University of Arkansas for Medical Sciences Translational Research Institute; Arkansas BioSciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000063, UL1TR000039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arkansas Breast Cancer Research Program; Sturgis Charitable Trust; University of Arkansas for Medical Sciences College of Medicine Research Council; University of Arkansas for Medical Sciences Translational Research Institute; Arkansas BioSciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HD35688 and Grants UL1TR000039 and KL2TR000063 from NCRR. This work was also supported by the Arkansas Breast Cancer Research Program, the Sturgis Charitable Trust, intramural funding support from the University of Arkansas for Medical Sciences College of Medicine Research Council, the University of Arkansas for Medical Sciences Translational Research Institute and the Arkansas BioSciences Institute.	Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2012, J BIOL CHEM, V287, P10639, DOI 10.1074/jbc.M111.300681; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Charlesworth A, 2013, WIRES RNA, V4, P437, DOI 10.1002/wrna.1171; Cosson B, 2002, BIOL CELL, V94, P217, DOI 10.1016/S0248-4900(02)01195-4; Cragle C. E., 2014, XENOPUS DEV; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; DWORKIN MB, 1985, P NATL ACAD SCI USA, V82, P7636, DOI 10.1073/pnas.82.22.7636; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; FREEMAN RS, 1991, MOL CELL BIOL, V11, P1713, DOI 10.1128/MCB.11.3.1713; GOOD PJ, 1993, NUCLEIC ACIDS RES, V21, P999, DOI 10.1093/nar/21.4.999; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Howard EL, 1999, MOL CELL BIOL, V19, P1990; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MacNicol MC, 1997, GENE, V196, P25, DOI 10.1016/S0378-1119(97)00171-6; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Murakami MS, 1998, DEVELOPMENT, V125, P237; Nakajo N, 2000, GENE DEV, V14, P328; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Szostak E, 2013, BRIEF FUNCT GENOMICS, V12, P58, DOI 10.1093/bfgp/els056; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039	56	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14239	14251		10.1074/jbc.M114.548271	http://dx.doi.org/10.1074/jbc.M114.548271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24644291	hybrid, Green Published			2022-12-28	WOS:000335984600049
J	Heraud, C; Griffiths, A; Pandruvada, SNM; Kilimann, MW; Pata, M; Vacher, J				Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Kilimann, Manfred W.; Pata, Monica; Vacher, Jean			Severe Neurodegeneration with Impaired Autophagy Mechanism Triggered by Ostm1 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; mTOR; Neurodegeneration; Neurons; Transgenic Mice	AUTOSOMAL RECESSIVE OSTEOPETROSIS; LYSOSOMAL STORAGE DISEASE; MOUSE MODELS; AXONAL-TRANSPORT; REQUIRES OSTM1; INHIBITION; ASTROCYTES; ACTIVATION; REVEALS; DEFECT	Background: Although loss of the Ostm1 gene leads to the most severe form of osteopetrosis, Ostm1 is expressed in other tissues, including the CNS. Results: Independently of hematopoietic lineages, loss of Ostm1 results in acute neurodegeneration with enhanced autophagy. Conclusion: We present evidence for an Ostm1 cell-autonomous role in neurons. Significance: This study shows a novel molecular pathogenic mechanism for neurodegeneration-related diseases. Loss of Ostm1 leads to the most severe form of osteopetrosis in mice and humans. Because functional rescue of the osteopetrotic defect in these mice extended their lifespan from approximate to 3 weeks to 6 weeks, this unraveled a second essential role of Ostm1. We discovered that Ostm1 is highly expressed in the mouse brain in neurons, microglia, and astrocytes. At 3-4 weeks of age, mice with Ostm1 loss showed 3-10-fold stimulation of reactive gliosis, with an increased astrocyte cell population and microglia activation. This inflammatory response was associated with marked retinal photoreceptor degeneration and massive neuronal loss in the brain. Intracellular characterization of neurons revealed abnormal storage of carbohydrates, lipids, and ubiquitinated proteins, combined with marked accumulation of autophagosomes that causes frequent axonal swelling. Stimulation of autophagy was provided by specific markers and by significant down-regulation of the mammalian target of rapamycin signaling, identifying a cellular pathologic mechanism. A series of transgenic mouse lines specifically targeted to distinct central nervous system cell subpopulations determined that Ostm1 has a primary and autonomous role in neuronal homeostasis. Complete functional complementation demonstrated that the development of severe and rapid neurodegeneration in these mice is independent of the hematopoietic lineage and has clinical implications for treatment of osteopetrosis. Importantly, this study establishes a novel neurodegenerative mouse model critical for understanding the multistep pathogenic cascade of cellular autophagy disorders toward therapeutic strategy design.	[Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Pata, Monica; Vacher, Jean] Univ Montreal, Dept Med, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Pata, Monica; Vacher, Jean] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Kilimann, Manfred W.] Univ Gottingen, Med Ctr, Dept Otolaryngol, D-37075 Gottingen, Germany; [Kilimann, Manfred W.] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Gottingen; Max Planck Society	Vacher, J (corresponding author), Clin Res Inst Montreal, 110 Ave Pins Ouest Montreal, Montreal, PQ H2W 1R7, Canada.	vacherj@ircm.qc.ca	pandruvada, subramanya/AAA-3072-2019; Pandruvada, Subramanya/E-4373-2012	Pandruvada, Subramanya/0000-0001-9568-7666; Heraud, Celine/0000-0002-9208-2335	Canadian Institutes of Health Research [86655]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 86655 (to J.V.).	Alroy J, 2007, ULTRASTRUCT PATHOL, V31, P333, DOI 10.1080/01913120701578098; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chiodo DC, 2007, NEUROPEDIATRICS, V38, P154, DOI 10.1055/s-2007-990267; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mazzolari E, 2009, AM J HEMATOL, V84, P473, DOI 10.1002/ajh.21447; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ott CE, 2013, BONE, V55, P292, DOI 10.1016/j.bone.2013.04.007; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Pata M, 2008, J BIOL CHEM, V283, P30522, DOI 10.1074/jbc.M805242200; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Prinetti A, 2009, GLYCOCONJUGATE J, V26, P623, DOI 10.1007/s10719-008-9179-8; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	45	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13912	13925		10.1074/jbc.M113.537233	http://dx.doi.org/10.1074/jbc.M113.537233			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719316	hybrid, Green Published			2022-12-28	WOS:000335984600023
J	Park, MJ; Kim, DI; Lim, SK; Choi, JH; Han, HJ; Yoon, KC; Park, SH				Park, Min-Jung; Kim, Dong-Il; Lim, Seul-Ki; Choi, Joo-Hee; Han, Ho-Jae; Yoon, Kyung-Chul; Park, Soo-Hyun			High Glucose-induced O-GlcNAcylated Carbohydrate Response Element-binding Protein ( ChREBP) Mediates Mesangial Cell Lipogenesis and Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Fibrosis; Kidney Metabolism; Lipogenesis; O-GlcNAcylation	LINKED N-ACETYLGLUCOSAMINE; ENDOTHELIAL GROWTH-FACTOR; RENAL LIPID-METABOLISM; INSULIN-RESISTANCE; TRANSCRIPTIONAL ACTIVITY; DIABETIC-NEPHROPATHY; HEPATIC STEATOSIS; ENZYME GENES; LIVER; EXPRESSION	Background: Abnormal lipid synthesis and fibrosis can lead to diabetic nephropathy. Results: High glucose-induced O-GlcNAcylated ChREBP increases the expression of lipogenic and fibrotic proteins and induces lipid accumulation and fibrosis. Conclusion:O-GlcNAcylated ChREBP mediates lipogenesis and fibrosis in mesangial cells. Significance: This is the first report that O-glycosylated ChREBP plays a pathophysiological role in lipogenesis and fibrosis in mesangial cells. Carbohydrate response element-binding protein (ChREBP) is a transcription factor responsible for carbohydrate metabolism in the liver. However, the role of ChREBP in diabetic nephropathy has not been elucidated. Thus, we investigated the role of ChREBP in mesangial cells in diabetic nephropathy. Treatment with 25 mm glucose (high glucose; HG) increased cellular O-GlcNAc and O-GlcNAcylated ChREBP in mesangial cells compared with normal 5.5 mm glucose. O-(2-acetamido-2-deoxy-d-glucopyranosylidene) amino N-phenylcarbamate (PUGNAc), a drug that increases O-GlcNAc, augmented the expression of ChREBP targets, whereas DON, a drug that decreases O-GlcNAc and O-GlcNAcase overexpression, mitigated the increase with HG. O-GlcNAc augmented the protein stability, transcriptional activity, and nuclear translocation of ChREBP. HG treatment also stimulated lipid accumulation and the contents of triglyceride and cholesterol in mesangial cells. In addition, HG triggered expression of hypoxia-inducible factor 1-, vascular endothelial growth factor, and extracellular matrix components related to nephrosclerosis. The ChREBP mutant, W130A, did not exhibit HG-induced lipid accumulation and fibrotic proteins, suggesting that the Trp-130 residue in the MCR3 domain is important in the development of glomerulosclerosis. O-GlcNAcylated ChREBP was elevated in mesangium cells of streptozotocin-induced diabetic rats. In conclusion, HG increased the O-GlcNAcylated ChREBP level, which resulted in lipid accumulation and up-regulation of fibrotic proteins in mesangial cells. These effects may lead mesangial cells to an ultimately pathological state.	[Park, Min-Jung; Kim, Dong-Il; Lim, Seul-Ki; Choi, Joo-Hee; Park, Soo-Hyun] Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Kwangju 500757, South Korea; [Han, Ho-Jae] Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151741, South Korea; [Yoon, Kyung-Chul] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju 501757, South Korea	Chonnam National University; Seoul National University (SNU); Chonnam National University	Park, SH (corresponding author), Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Kwangju 500757, South Korea.	parksh@chonnam.ac.kr	Han, Ho Jae/M-1476-2016	Han, Ho Jae/0000-0002-0657-1766	Korean Science and Engineering Foundation [2011-0016649]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korean Science and Engineering Foundation Grant 2011-0016649.	Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; Amemiya T, 1999, KIDNEY INT, V56, P2055, DOI 10.1046/j.1523-1755.1999.00796.x; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Cho KH, 2010, BBA-GEN SUBJECTS, V1800, P6, DOI 10.1016/j.bbagen.2009.10.009; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Goldberg H, 2011, AM J PHYSIOL-ENDOC M, V301, pE713, DOI 10.1152/ajpendo.00108.2011; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Guo K, 2012, ONCOL REP, V28, P494, DOI 10.3892/or.2012.1844; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kiss E, 2013, AM J PATHOL, V182, P727, DOI 10.1016/j.ajpath.2012.11.033; KLAHR S, 1989, KIDNEY INT, V36, pS27; Lehir M, 2007, CURR OPIN NEPHROL HY, V16, P184, DOI 10.1097/MNH.0b013e3280c8eed3; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Oda H, 1997, KIDNEY INT, V52, pS36; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Potter KA, 2012, J NEUROSCI METH, V203, P96, DOI 10.1016/j.jneumeth.2011.09.024; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Tovar-Palacio C, 2011, AM J PHYSIOL-RENAL, V300, pF263, DOI 10.1152/ajprenal.00171.2010; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Wu TT, 2013, AM J PHYSIOL-RENAL, V304, pF820, DOI 10.1152/ajprenal.00294.2012; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	48	63	73	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13519	13530		10.1074/jbc.M113.530139	http://dx.doi.org/10.1074/jbc.M113.530139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24616092	Green Published, hybrid			2022-12-28	WOS:000335522800047
J	Marshall, KE; Offerdahl, DK; Speare, JO; Dorward, DW; Hasenkrug, A; Carmody, AB; Baron, GS				Marshall, Karen E.; Offerdahl, Danielle K.; Speare, Jonathan O.; Dorward, David W.; Hasenkrug, Aaron; Carmody, Aaron B.; Baron, Gerald S.			Glycosylphosphatidylinositol Anchoring Directs the Assembly of Sup35NM Protein into Non-fibrillar, Membrane-bound Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Electron Microscopy (EM); Glycosylphosphatidylinositol Anchors; Prions; Protein Aggregation; Protein Misfolding; Protein Self-assembly	SCRAPIE PRION PROTEIN; STRAUSSLER-SCHEINKER DISEASE; YEAST PRION; IN-VIVO; ALZHEIMERS-DISEASE; AMYLOID DEPOSITS; SACCHAROMYCES-CEREVISIAE; NEUROBLASTOMA-CELLS; ELECTRON-MICROSCOPY; BETA-AMYLOIDOSIS	Background: Sup35NM is a soluble protein that when misfolded forms amyloid fibril aggregates. Results: When tethered to membranes via a lipid anchor, Sup35NM aggregates adopt a non-fibrillar, membrane-bound structure. Conclusion: Lipid anchor-directed membrane association prevents assembly into fibrils. Significance: This may explain differences between prion diseases compared with related protein aggregation diseases because only prion diseases involve aggregation of a lipid-anchored protein. In prion-infected hosts, PrPSc usually accumulates as non-fibrillar, membrane-bound aggregates. Glycosylphosphatidylinositol (GPI) anchor-directed membrane association appears to be an important factor controlling the biophysical properties of PrPSc aggregates. To determine whether GPI anchoring can similarly modulate the assembly of other amyloid-forming proteins, neuronal cell lines were generated that expressed a GPI-anchored form of a model amyloidogenic protein, the NM domain of the yeast prion protein Sup35 (Sup35(GPI)). We recently reported that GPI anchoring facilitated the induction of Sup35(GPI) prions in this system. Here, we report the ultrastructural characterization of self-propagating Sup35(GPI) aggregates of either spontaneous or induced origin. Like membrane-bound PrPSc, Sup35(GPI) aggregates resisted release from cells treated with phosphatidylinositol-specific phospholipase C. Sup35(GPI) aggregates of spontaneous origin were detergent-insoluble, protease-resistant, and self-propagating, in a manner similar to that reported for recombinant Sup35NM amyloid fibrils and induced Sup35(GPI) aggregates. However, GPI-anchored Sup35 aggregates were not stained with amyloid-binding dyes, such as Thioflavin T. This was consistent with ultrastructural analyses, which showed that the aggregates corresponded to dense cell surface accumulations of membrane vesicle-like structures and were not fibrillar. Together, these results showed that GPI anchoring directs the assembly of Sup35NM into non-fibrillar, membrane-bound aggregates that resemble PrPSc, raising the possibility that GPI anchor-dependent modulation of protein aggregation might occur with other amyloidogenic proteins. This may contribute to differences in pathogenesis and pathology between prion diseases, which uniquely involve aggregation of a GPI-anchored protein, versus other protein misfolding diseases.	[Marshall, Karen E.; Offerdahl, Danielle K.; Speare, Jonathan O.; Dorward, David W.; Hasenkrug, Aaron; Carmody, Aaron B.; Baron, Gerald S.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baron, GS (corresponding author), 903 S 4th St, Hamilton, MT 59840 USA.	gbaron@niaid.nih.gov		Offerdahl, Danielle K/0000-0002-0736-1664	National Institutes of Health, NIAID, Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001112, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program.	Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Caughey B, 2003, BRIT MED BULL, V66, P109, DOI 10.1093/bmb/66.1.109; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; GABIZON R, 1988, J BIOL CHEM, V263, P4950; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Godsave SF, 2013, NEUROBIOL AGING, V34, P1621, DOI 10.1016/j.neurobiolaging.2012.12.015; Godsave SF, 2008, J NEUROSCI, V28, P12489, DOI 10.1523/JNEUROSCI.4474-08.2008; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Jeffrey M, 2012, BRAIN PATHOL, V22, P58, DOI 10.1111/j.1750-3639.2011.00508.x; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Klingeborn M, 2011, J VIROL, V85, P1484, DOI 10.1128/JVI.02167-10; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; Kneipp J, 2003, BBA-MOL BASIS DIS, V1639, P152, DOI 10.1016/j.bbadis.2003.08.005; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Krzewska J, 2007, J BIOL CHEM, V282, P1679, DOI 10.1074/jbc.M608110200; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P109; Linke RP, 2000, VIRCHOWS ARCH, V436, P439, DOI 10.1007/s004280050471; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PICCARDO P, 1995, J NEUROPATH EXP NEUR, V54, P790, DOI 10.1097/00005072-199511000-00006; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmued L, 2012, J NEUROSCI METH, V209, P120, DOI 10.1016/j.jneumeth.2012.05.019; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Serpell LC, 2007, AMYLOID, V14, P199, DOI 10.1080/13506120701461111; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Speransky VV, 2001, J CELL BIOL, V153, P1327, DOI 10.1083/jcb.153.6.1327; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wolf K, 2005, INFECT IMMUN, V73, P4560, DOI 10.1128/IAI.73.8.4560-4570.2005; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	89	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12245	12263		10.1074/jbc.M114.556639	http://dx.doi.org/10.1074/jbc.M114.556639			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627481	Green Published, hybrid			2022-12-28	WOS:000335581400006
J	Nakano, N; Maeyama, K; Sakata, N; Itoh, F; Akatsu, R; Nakata, M; Katsu, Y; Ikeno, S; Togawa, Y; Nguyen, TTV; Watanabe, Y; Kato, M; Itoh, S				Nakano, Naoko; Maeyama, Kota; Sakata, Nobuo; Itoh, Fumiko; Akatsu, Ryosuke; Nakata, Miki; Katsu, Yuki; Ikeno, Souichi; Togawa, Yoko; Thanh Thao Vo Nguyen; Watanabe, Yukihide; Kato, Mitsuyasu; Itoh, Susumu			C18 ORF1, a Novel Negative Regulator of Transforming Growth Factor- beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Activin; EMT; Receptor Serine; threonine Kinase; SMAD Transcription Factor; Transforming Growth Factor (TGF); C18ORF1; SARA; SIM; TMEPAI	FYVE DOMAIN PROTEIN; TGF-BETA; SMAD PROTEINS; CANCER; GENE; ACTIVATION; FAMILY; SARA; RECEPTOR; DISEASE	Background: The structure of C18ORF1 is similar to that of TMEPAI. Results: C18ORF1 inhibits TGF- signaling, but not BMP signaling, by its competition with SARA for Smad2/3 binding. Conclusion: C18ORF1 is a surveillant during the steady state of TGF- signaling, although it is helped by TMEPAI to inhibit TGF- signaling in a coordinated manner. Significance: C18ORF1 acts as a gatekeeper that abrogates excessive TGF- signaling. Transforming growth factor (TGF)- signaling is deliberately regulated at multiple steps in its pathway from the extracellular microenvironment to the nucleus. However, how TGF- signaling is activated or attenuated is not fully understood. We recently identified transmembrane prostate androgen-induced RNA (TMEPAI), which is involved in a negative feedback loop of TGF- signaling. When we searched for a family molecule(s) for TMEPAI, we found C18ORF1, which, like TMEPAI, possesses two PY motifs and one Smad-interacting motif (SIM) domain. As expected, C18ORF1 could block TGF- signaling but not bone morphogenetic protein signaling. C18ORF1 bound to Smad2/3 via its SIM and competed with the Smad anchor for receptor activation for Smad2/3 binding to attenuate recruitment of Smad2/3 to the TGF- type I receptor (also termed activin receptor-like kinase 5 (ALK5)), in a similar fashion to TMEPAI. Knockdown of C18ORF1 prolonged duration of TGF--induced Smad2 phosphorylation and concomitantly potentiated the expression of JunB, p21, and TMEPAI mRNAs induced by TGF-. Consistently, TGF--induced cell migration was enhanced by the knockdown of C18ORF1. These results indicate that the inhibitory function of C18ORF1 on TGF- signaling is similar to that of TMEPAI. However, in contrast to TMEPAI, C18ORF1 was not induced upon TGF- signaling. Thus, we defined C18ORF1 as a surveillant of steady state TGF- signaling, whereas TMEPAI might help C18ORF1 to inhibit TGF- signaling in a coordinated manner when cells are stimulated with high levels of TGF-.	[Nakano, Naoko; Maeyama, Kota; Itoh, Fumiko; Thanh Thao Vo Nguyen; Watanabe, Yukihide; Kato, Mitsuyasu; Itoh, Susumu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nakano, Naoko; Sakata, Nobuo; Akatsu, Ryosuke; Nakata, Miki; Katsu, Yuki; Ikeno, Souichi; Togawa, Yoko; Itoh, Susumu] Showa Pharmaceut Univ, Biochem Lab, Machida, Tokyo 1948543, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan	University of Tsukuba; Showa Pharmaceutical University; Tokyo University of Pharmacy & Life Sciences	Kato, M (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mit-kato@md.tsukuba.ac.jp; sitoh@ac.shoyaku.ac.jp	Sakata, Nobuo/L-9753-2015	Sakata, Nobuo/0000-0001-9967-8409; Itoh, Susumu/0000-0002-7967-0730; Itoh, Fumiko/0000-0002-6134-5331	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; MEXT; Takeda Science Foundation; Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; Showa Pharmaceutical University; Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [25118728, 23689023, 25670168] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; Showa Pharmaceutical University; Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for young scientists (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to F. I.); a grant-in-aid for exploratory research (A) from Japan Society for the Promotion of Science) (to N. S.); MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (to S. Itoh); the Takeda Science Foundation (to S. Itoh); the Smoking Research Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); a grant-in-aid for young scientists of Showa Pharmaceutical University (to S. Ikeno); the Joint Usage/Research Program of the Medical Research Institute; Tokyo Medical and Dental University (to S. Itoh); and the Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling" of the Japan Society for the Promotion of Science (to S. Itoh).	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Brunschwig EB, 2003, CANCER RES, V63, P1568; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirokawa YS, 2007, CELL MOL BIOL LETT, V12, P370, DOI 10.2478/s11658-007-0009-y; Hofsli E, 2008, BRIT J CANCER, V99, P1330, DOI 10.1038/sj.bjc.6604565; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kikuchi M, 2003, MOL PSYCHIATR, V8, P467, DOI 10.1038/sj.mp.4001280; Kikuchi Mika, 2003, Journal of Medical and Dental Sciences, V50, P225; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meerabux JMA, 2009, J HUM GENET, V54, P386, DOI 10.1038/jhg.2009.47; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakano N, 2010, J BIOL CHEM, V285, P38023, DOI 10.1074/jbc.M110.132209; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Reichling T, 2005, CANCER RES, V65, P166; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	42	34	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12680	12692		10.1074/jbc.M114.558981	http://dx.doi.org/10.1074/jbc.M114.558981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627487	Green Published, hybrid			2022-12-28	WOS:000335581400040
J	Vishwanatha, K; Back, N; Mains, RE; Eipper, BA				Vishwanatha, Kurutihalli; Baeck, Nils; Mains, Richard E.; Eipper, Betty A.			A Histidine-rich Linker Region in Peptidylglycine alpha- Amidating Monooxygenase Has the Properties of a pH Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Glycoprotein Secretion; Neuropeptide; pH Regulation; Protein Secretion	PEPTIDE-PROCESSING ENZYME; GRANULE MEMBRANE-PROTEIN; REGULATED SECRETORY PROTEINS; CYTOSOLIC DOMAIN; ATT-20 CELLS; CARBOXYPEPTIDASE-E; ACIDIC PH; V-ATPASES; TRAFFICKING; PATHWAY	Background: Secretory granule membrane proteins are retrieved and reused or degraded after exocytosis. Results: A pH-sensitive His cluster in the amidating enzyme is essential for its trafficking. Conclusion: Lacking this conserved His cluster, proteolytic maturation and generation of a soluble cytosolic fragment of amidating enzyme fail to occur, disrupting secretion and nuclear signaling. Significance: The storage and regulated secretion of peptides requires intraluminal signaling. Decreasing luminal pH is thought to play a role in the entry of newly synthesized and endocytosed membrane proteins into secretory granules. The two catalytic domains of peptidylglycine -amidating monooxygenase (PAM), a type I integral membrane protein, catalyze the sequential reactions that convert peptidyl-Gly substrates into amidated products. We explored the hypothesis that a conserved His-rich cluster (His-Gly-His-His) in the linker region connecting its two catalytic domains senses pH and affects PAM trafficking by mutating these His residues to Ala (Ala-Gly-Ala-Ala; H3A). Purified recombinant wild-type and H3A linker peptides were examined using circular dichroism and tryptophan fluorescence; mutation of the His cluster largely eliminated its pH sensitivity. An enzymatically active PAM protein with the same mutations (PAM-1/H3A) was expressed in HEK293 cells and AtT-20 corticotrope tumor cells. Metabolic labeling followed by immunoprecipitation revealed more rapid loss of newly synthesized PAM-1/H3A than PAM-1; although release of newly synthesized monofunctional PHM/H3A was increased, release of soluble bifunctional PAM/H3A, a product of the endocytic pathway, was decreased. Surface biotinylation revealed rapid loss of PAM-1/H3A, with no detectable return of the mutant protein to secretory granules. Consistent with its altered endocytic trafficking, little PAM-1/H3A was subjected to regulated intramembrane proteolysis followed by release of a small nuclear-targeted cytosolic fragment. AtT-20 cells expressing PAM-1/H3A adopted the morphology of wild-type AtT-20 cells; secretory products no longer accumulated in the trans-Golgi network and secretory granule exocytosis was more responsive to secretagogue.	[Vishwanatha, Kurutihalli; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Baeck, Nils] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland	University of Connecticut; University of Connecticut; University of Helsinki	Eipper, BA (corresponding author), 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu		Rao, Vishwanatha/0000-0001-9471-807X; Back, Nils/0000-0001-9992-3726	National Institutes of Health [DK-32949]; Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R01DK032949, R56DK032949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janice and Rodney Reynolds Endowment; Scoville Endowment; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Perklen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-32949, the Janice and Rodney Reynolds Endowment, Scoville Endowment, Liv och Halsa Foundation, Magnus Ehrnrooth Foundation, and the Perklen Foundation.	Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Attenborough RMF, 2012, MOL BIOL EVOL, V29, P3095, DOI 10.1093/molbev/mss114; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; Da Poian AT, 2009, PROTEIN PEPTIDE LETT, V16, P779, DOI 10.2174/092986609788681823; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; De M, 2006, J BIOL CHEM, V281, P20873, DOI 10.1074/jbc.M513886200; Dickson EJ, 2012, P NATL ACAD SCI USA, V109, pE3539, DOI 10.1073/pnas.1218247109; Drose S, 1997, J EXP BIOL, V200, P1; EIPPER BA, 1992, J BIOL CHEM, V267, P4008; EIPPER BA, 1993, ANN NY ACAD SCI, V680, P147, DOI 10.1111/j.1749-6632.1993.tb19681.x; EIPPER BA, 1993, PROTEIN SCI, V2, P489; El Kadi N, 2006, BIOPHYS J, V91, P3397, DOI 10.1529/biophysj.106.088963; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; FRICKER LD, 1988, J CELL BIOCHEM, V38, P279, DOI 10.1002/jcb.240380407; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; Hanakam F, 1996, EMBO J, V15, P2935, DOI 10.1002/j.1460-2075.1996.tb00656.x; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; HUSTEN EJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P487, DOI 10.1006/abbi.1994.1336; JENKS BG, 1985, J ENDOCRINOL, V107, P365, DOI 10.1677/joe.0.1070365; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; Lauf PK, 1998, CELL PHYSIOL BIOCHEM, V8, P46, DOI 10.1159/000016270; Lee SN, 2007, BIOCHEM BIOPH RES CO, V355, P825, DOI 10.1016/j.bbrc.2007.02.034; Lee SN, 2004, J ENDOCRINOL, V182, P353, DOI 10.1677/joe.0.1820353; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MAINS RE, 1991, MOL ENDOCRINOL, V5, P187, DOI 10.1210/mend-5-2-187; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Perez-Sayans M, 2012, BRAZ J BIOL, V72, P189, DOI 10.1590/S1519-69842012000100023; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; Rajagopal C, 2010, J BIOL CHEM, V285, P34632, DOI 10.1074/jbc.M110.145334; Rajagopal C, 2009, J BIOL CHEM, V284, P25723, DOI 10.1074/jbc.M109.035782; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Steidl JV, 1999, MOL PHARMACOL, V55, P812; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Williamson DM, 2013, J BIOL CHEM, V288, P19154, DOI 10.1074/jbc.M112.442681; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; YUN HY, 1994, J BIOL CHEM, V269, P10946; YUN HY, 1995, J BIOL CHEM, V270, P30075; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	67	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12404	12420		10.1074/jbc.M113.545947	http://dx.doi.org/10.1074/jbc.M113.545947			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627494	Green Published, hybrid			2022-12-28	WOS:000335581400018
J	Feng, C; Liu, Y; Wang, GQ; Deng, ZQ; Zhang, Q; Wu, W; Tong, YF; Cheng, CM; Chen, ZZ				Feng, Chong; Liu, Yang; Wang, Guoqiang; Deng, Zengqin; Zhang, Qi; Wu, Wei; Tong, Yufeng; Cheng, Changmei; Chen, Zhongzhou			Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Drug Design; Enzyme Inhibitors; mRNA; RNA Modification; AlkB; Alkbh5; Substrate Recognition; m(6)A Demethylase	OXIDATIVE DEMETHYLATION; DNA-DAMAGE; MOLECULAR-REPLACEMENT; PROTEIN COMPLEXES; MESSENGER; REPAIR; MOUSE; GENE; N6-METHYLADENOSINE; 3-METHYLTHYMINE	Background: Human AlkB homolog 5 (Alkbh5) is an RNA demethylase that erases m(6)A modification. Results: Crystal structures of an enzymatically active Alkbh5 construct in complex with cofactors or small molecules were determined. Conclusion: Structure and activity analyses showed that Alkbh5 strongly prefers single-stranded oligos and small molecule inhibitors. Significance: The Alkbh5 structure reveals potential for structure-based design of selective inhibitors. N-6-Methylation of adenosine is the most ubiquitous and abundant modification of nucleoside in eukaryotic mRNA and long non-coding RNA. This modification plays an essential role in the regulation of mRNA translation and RNA metabolism. Recently, human AlkB homolog 5 (Alkbh5) and fat mass- and obesity-associated protein (FTO) were shown to erase this methyl modification on mRNA. Here, we report five high resolution crystal structures of the catalytic core of Alkbh5 in complex with different ligands. Compared with other AlkB proteins, Alkbh5 displays several unique structural features on top of the conserved double-stranded -helix fold typical of this protein family. Among the unique features, a distinct lid region of Alkbh5 plays a vital role in substrate recognition and catalysis. An unexpected disulfide bond between Cys-230 and Cys-267 is crucial for the selective binding of Alkbh5 to single-stranded RNA/DNA by bringing a flipping motif toward the central -helix fold. We generated a substrate binding model of Alkbh5 based on a demethylation activity assay of several structure-guided site-directed mutants. Crystallographic and biochemical studies using various analogs of -ketoglutarate revealed that the active site cavity of Alkbh5 is much smaller than that of FTO and preferentially binds small molecule inhibitors. Taken together, our findings provide a structural basis for understanding the substrate recognition specificity of Alkbh5 and offer a foundation for selective drug design against AlkB members.	[Feng, Chong; Liu, Yang; Wang, Guoqiang; Deng, Zengqin; Zhang, Qi; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Cheng, Changmei] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Tong, Yufeng] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada	China Agricultural University; Tsinghua University; University of Toronto; Structural Genomics Consortium; University of Toronto	Cheng, CM (corresponding author), Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.	chengcm@mail.tsinghua.edu.cn; chenzhongzhou@cau.edu.cn	chen, zhong/E-3900-2015; Tong, Yufeng/D-2785-2011; Deng, Zengqin/AAK-5194-2021	chen, zhong/0000-0003-1319-9664; Tong, Yufeng/0000-0001-7740-1812; Liu, Yang/0000-0003-0679-2275; Deng, Zengqin/0000-0002-5658-2068; Zhang, Qi/0000-0003-1121-8817	National Basic Research Program of China (973 Program) [2011CB965304, 2009CB825501]; National Natural Science Foundation of China [31370720, 31222032, 90919043, 31070664]; Specialized Research Fund for the Doctoral Program of Higher Education [20100008110009]; National Laboratory of Medical Molecular Biology (Peking Union Medical College)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Laboratory of Medical Molecular Biology (Peking Union Medical College)	This work was supported by the National Basic Research Program of China (973 Program Grants 2011CB965304 and 2009CB825501), National Natural Science Foundation of China (Grants 31370720, 31222032, 90919043, and 31070664), Specialized Research Fund for the Doctoral Program of Higher Education (Grant 20100008110009), and National Laboratory of Medical Molecular Biology (Peking Union Medical College) (to Z. C.).	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Meyer KC, 2012, DIFFUSE LUNG DISEASE: A PRACTICAL APPROACH, SECOND EDITION, P3, DOI 10.1007/978-1-4419-9771-5_1; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu LJ, 2009, ACTA CRYSTALLOGR D, V65, P1213, DOI 10.1107/S0907444909037044; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, RNA BIOL, V10, P915, DOI 10.4161/rna.24711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	49	112	116	6	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11571	11583		10.1074/jbc.M113.546168	http://dx.doi.org/10.1074/jbc.M113.546168			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616105	Green Published, hybrid			2022-12-28	WOS:000335010600001
J	Zhang, TH; Muraih, JK; Tishbi, N; Herskowitz, J; Victor, RL; Silverman, J; Uwumarenogie, S; Taylor, SD; Palmer, M; Mintzer, E				Zhang, TianHua; Muraih, Jawad K.; Tishbi, Nasim; Herskowitz, Jennifer; Victor, Rachel L.; Silverman, Jared; Uwumarenogie, Stephanie; Taylor, Scott D.; Palmer, Michael; Mintzer, Evan			Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Antibiotics Action; Cardiolipin; Fluorescence; Isothermal Titration Calorimetry; Liposomes; Phosphatidylglycerol; Langmuir Monolayers; Lipopeptides	RESISTANT STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; OLIGOMER FORMATION; SUSCEPTIBILITY; INHIBITION; STRAINS; BINDING	Background: Daptomycin forms oligomeric pores in bacterial cell membranes. Cardiolipin is a membrane lipid associated with bacterial resistance to the antibiotic. Results: Cardiolipin makes liposomes impervious to daptomycin permeabilization, and it confines daptomycin to the outer membrane leaflet. Conclusion: Preventing daptomycin from reaching the inner membrane leaflet inhibits pore formation. Significance: Bacteria may become resistant to daptomycin by changing their membrane lipid composition. Daptomycin is an acidic lipopeptide antibiotic that, in the presence of calcium, forms oligomeric pores on membranes containing phosphatidylglycerol. It is clinically used against various Gram-positive bacteria such as Staphylococcus aureus and Enterococcus species. Genetic studies have indicated that an increased content of cardiolipin in the bacterial membrane may contribute to bacterial resistance against the drug. Here, we used a liposome model to demonstrate that cardiolipin directly inhibits membrane permeabilization by daptomycin. When cardiolipin is added at molar fractions of 10 or 20% to membranes containing phosphatidylglycerol, daptomycin no longer forms pores or translocates to the inner membrane leaflet. Under the same conditions, daptomycin continues to form oligomers; however, these oligomers contain only close to four subunits, which is approximately half as many as observed on membranes without cardiolipin. The collective findings lead us to propose that a daptomycin pore consists of two aligned tetramers in opposite leaflets and that cardiolipin prevents the translocation of tetramers to the inner leaflet, thereby forestalling the formation of complete, octameric pores. Our findings suggest a possible mechanism by which cardiolipin may mediate resistance to daptomycin, and they provide new insights into the action mode of this important antibiotic.	[Zhang, TianHua; Uwumarenogie, Stephanie; Taylor, Scott D.; Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Muraih, Jawad K.] Univ Al Muthanna, Dept Chem, Samawah, Al Muthanna, Iraq; [Tishbi, Nasim; Herskowitz, Jennifer; Victor, Rachel L.; Mintzer, Evan] Yeshiva Univ, Stern Coll Women, Dept Chem & Biochem, New York, NY 10033 USA; [Silverman, Jared] Cubist Pharmaceut Inc, Lexington, MA 02421 USA	University of Waterloo; Yeshiva University	Palmer, M (corresponding author), Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada.	mpalmer@uwaterloo.ca	Muraih, Jawad K./F-1873-2019; Muraih, Jawad/ABD-1923-2020	Muraih, Jawad K./0000-0003-0720-0876; 	Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CHIR)	Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CHIR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health Research (CHIR) (to S. D. T. and M. P.).	Abraham T, 2005, BIOCHEMISTRY-US, V44, P2103, DOI 10.1021/bi048077d; ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; CLEJAN S, 1986, J BACTERIOL, V168, P334, DOI 10.1128/jb.168.1.334-340.1986; Davlieva M, 2013, ANTIMICROB AGENTS CH, V57, P289, DOI 10.1128/AAC.01743-12; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Jo G, 2011, J MICROBIOL BIOTECHN, V21, P1097, DOI 10.4014/jmb.1103.03026; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Laganas V, 2003, ANTIMICROB AGENTS CH, V47, P2682, DOI 10.1128/AAC.47.8.2682-2684.2003; LAKEY JH, 1988, BIOCHEMISTRY-US, V27, P4639, DOI 10.1021/bi00413a009; Mascio C., 2009, 49 INT C ANT AG CHEM; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mishra NN, 2013, ANTIMICROB AGENTS CH, V57, P1082, DOI 10.1128/AAC.02182-12; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Muraih JK, 2012, BBA-BIOMEMBRANES, V1818, P1642, DOI 10.1016/j.bbamem.2012.02.019; Muraih JK, 2012, BBA-BIOMEMBRANES, V1818, P673, DOI 10.1016/j.bbamem.2011.10.027; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Tran TT, 2013, ANTIMICROB AGENTS CH, V57, P261, DOI 10.1128/AAC.01454-12; Zhang TH, 2013, BBA-BIOMEMBRANES, V1828, P302, DOI 10.1016/j.bbamem.2012.10.008	28	102	103	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11584	11591		10.1074/jbc.M114.554444	http://dx.doi.org/10.1074/jbc.M114.554444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616102	Green Published, hybrid			2022-12-28	WOS:000335010600002
J	Kolesnikoff, N; Attema, JL; Roslan, S; Bert, AG; Schwarz, QP; Gregory, PA; Goodall, GJ				Kolesnikoff, Natasha; Attema, Joanne L.; Roslan, Suraya; Bert, Andrew G.; Schwarz, Quenten P.; Gregory, Philip A.; Goodall, Gregory J.			Specificity Protein 1 ( Sp1) Maintains Basal Epithelial Expression of the miR-200 Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial mesenchymal transition; Metastasis; MicroRNA; Sp1; Transcription; ZEB transcription factor; miR-200	E-CADHERIN GENE; TRANSCRIPTION FACTOR SNAIL; REPRESSES E-CADHERIN; MESENCHYMAL TRANSITION; CANCER-CELLS; BREAST-CANCER; TUMOR PROGRESSION; MIRNA-200 FAMILY; TARGETING ZEB1; METASTASIS	Background: Epithelial-mesenchymal transition (EMT) is a key process in embryonic development and cancer metastasis. Results: Sp1 activates miR-200 transcription in epithelial cells and prevents EMT. Conclusion: miR-200 family members require Sp1 to drive basal expression and maintain an epithelial state. Significance: Defining the mechanisms controlling the epithelial state has implications for understanding early differentiation and for designing interventions to prevent cancer metastasis. Epithelial-mesenchymal transition (EMT) is required for the specification of tissues during embryonic development and is recapitulated during the metastatic progression of tumors. The miR-200 family plays a critical role in enforcing the epithelial state with their expression lost in cells undergoing EMT. EMT can be mediated by activation of the ZEB1 and ZEB2 (ZEB) transcription factors, which repress miR-200 expression via a self-reinforcing double negative feedback loop to promote the mesenchymal state. However, it remains unclear what factors drive and maintain epithelial-specific expression of miR-200 in the absence of EMT-inducing factors. Here, we show that the transcription factor Specificity Protein 1 (Sp1) binds to the miR-200b approximate to 200a approximate to 429 proximal promoter and activates miR-200 expression in epithelial cells. In mesenchymal cells, Sp1 expression is maintained, but its ability to activate the miR-200 promoter is perturbed by ZEB-mediated repression. Reduction of Sp1 expression caused changes in EMT-associated markers in epithelial cells. Furthermore, we observed co-expression of Sp1 and miR-200 during mouse embryonic development wherein miR-200 expression was only lost in regions with high ZEB expression. Together, these findings indicate that miR-200 family members require Sp1 to drive basal expression and to maintain an epithelial state.	[Gregory, Philip A.; Goodall, Gregory J.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Gregory, Philip A.; Goodall, Gregory J.] SA Pathol, Adelaide, SA 5000, Australia; [Attema, Joanne L.; Gregory, Philip A.; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Gregory, PA (corresponding author), SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia.	philip.gregory@health.sa.gov.au; greg.goodall@health.sa.gov.au	Gregory, Philip/F-4089-2013; Schwarz, Quenten/AAC-3726-2019; Schwarz, Quenten/AAE-7513-2021	Gregory, Philip/0000-0002-0999-0632; Schwarz, Quenten/0000-0002-5958-4181; Kolesnikoff Prizzi, Natasha/0000-0003-4314-4779; Bert, Andrew/0000-0003-3876-1537; Goodall, Gregory/0000-0003-1294-0692	National Health and Medical Research Council of Australia [APP1008440]; Cancer Council of South Australia Fellowship; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of South Australia Fellowship(Cancer Council South Australia); National Breast Cancer Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia (APP1008440) and by a Cancer Council of South Australia Fellowship (to P. A. G.).	Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; BUSSEMAKERS MJG, 1994, BIOCHEM BIOPH RES CO, V203, P1284, DOI 10.1006/bbrc.1994.2321; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Frisch SM, 1997, BIOESSAYS, V19, P705, DOI 10.1002/bies.950190811; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Sumigama S, 2004, ONCOGENE, V23, P5496, DOI 10.1038/sj.onc.1207723; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; West-Mays JA, 2003, DIFFERENTIATION, V71, P206, DOI 10.1046/j.1432-0436.2003.710302.x; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13	70	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11194	11205		10.1074/jbc.M113.529172	http://dx.doi.org/10.1074/jbc.M113.529172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24627491	Green Published, hybrid			2022-12-28	WOS:000334638500023
J	Beilhartz, GL; Ngure, M; Johns, BA; DeAnda, F; Gerondelis, P; Gotte, M				Beilhartz, Greg L.; Ngure, Marianne; Johns, Brian A.; DeAnda, Felix; Gerondelis, Peter; Goette, Matthias			Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNASE-H; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; DRUG-RESISTANCE; DNA-POLYMERASE; PRIMER; SITE; SPECIFICITY; MECHANISM	Compounds that efficiently inhibit the ribonuclease (RNase) H activity of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have yet to be developed. Here, we demonstrate that GSK5750, a 1-hydroxy-pyridopyrimidinone analog, binds to the enzyme with an equilibrium dissociation constant (K-d) of similar to 400 nM. Inhibition of HIV-1 RNase H is specific, as DNA synthesis is not affected. Moreover, GSK5750 does not inhibit the activity of Escherichia coli RNase H. Order-of-addition experiments show that GSK5750 binds to the free enzyme in an Mg2+-dependent fashion. However, as reported for other active site inhibitors, binding of GSK5750 to a preformed enzyme-substrate complex is severely compromised. The bound nucleic acid prevents access to the RNase H active site, which represents a possible biochemical hurdle in the development of potent RNase H inhibitors. Previous studies suggested that formation of a complex with the prototypic RNase H inhibitor beta-thujaplicinol is slow, and, once formed, it dissociates rapidly. This unfavorable kinetic behavior can limit the potency of RNase H active site inhibitors. Although the association kinetics of GSK5750 remains slow, our data show that this compound forms a long lasting complex with HIV-1 RT. We conclude that slow dissociation of the inhibitor and HIV-1 RT improves RNase H active site inhibitors and may circumvent the obstacle posed by the inability of these compounds to bind to a preformed enzyme-substrate complex.	[Beilhartz, Greg L.; Ngure, Marianne; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Johns, Brian A.] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA; [DeAnda, Felix] GlaxoSmithKline, Dept Computat Chem, Res Triangle Pk, NC 27709 USA; [Gerondelis, Peter] GlaxoSmithKline, Dept Virol, Infect Dis Therapeut Area Unit, Res Triangle Pk, NC 27709 USA; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Goette, Matthias] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada	McGill University; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; McGill University; McGill University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			Canadian Foundation for AIDS Research (CANFAR); GlaxoSmithKline (GSK); Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec	Canadian Foundation for AIDS Research (CANFAR); GlaxoSmithKline (GSK)(GlaxoSmithKline); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by the Canadian Foundation for AIDS Research (CANFAR) and by GlaxoSmithKline (GSK).; Recipient of a Banting and Best Canada Graduate Scholarship from the Canadian Institutes of Health Research.; Recipient of a Chercheur National career award from the Fonds de la Recherche en Sante du Quebec. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, McGill University, Duff Medical Bldg., 3775 University St., Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1365; Fax: 514-398-7052; E-mail: matthias.gotte@mcgill.ca.	Arion D, 2002, J BIOL CHEM, V277, P1370, DOI 10.1074/jbc.M110254200; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Burney T, 2011, EXPERT REV ANTI-INFE, V9, P151, DOI [10.1586/eri.10.153, 10.1586/ERI.10.153]; Chung SM, 2010, ANTIMICROB AGENTS CH, V54, P3913, DOI 10.1128/AAC.00434-10; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Foote BS, 2011, ANN PHARMACOTHER, V45, P1085, DOI 10.1345/aph.1P744; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Garvey E. P., 2003, AIDS OTHER MANIFESTA, P855; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Herman BD, 2013, BIOCHEM J, V455, P179, DOI 10.1042/BJ20130850; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1990, J BIOL CHEM, V265, P10565; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kirschberg TA, 2009, J MED CHEM, V52, P5781, DOI 10.1021/jm900597q; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; PALANIAPPAN C, 1995, J BIOL CHEM, V270, P4861, DOI 10.1074/jbc.270.9.4861; PULLEN KA, 1990, J VIROL, V64, P6274, DOI 10.1128/JVI.64.12.6274-6277.1990; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; SMITH JS, 1992, J BIOL CHEM, V267, P15071; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tan S. L, 2006, HEPATITIS C VIRUSES, P163; Telesnitsky A., 1997, P121; Tramontano E, 2010, CURR MED CHEM, V17, P2837, DOI 10.2174/092986710792065045; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039	36	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16270	16277		10.1074/jbc.M114.569707	http://dx.doi.org/10.1074/jbc.M114.569707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719329	hybrid, Green Published			2022-12-28	WOS:000337965700031
J	Bhattacharya, D; Dwivedi, VP; Maiga, M; Maiga, M; Van Kaer, L; Bishai, WR; Das, G				Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Maiga, Mamoudou; Maiga, Mariama; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; SUPLATAST TOSILATE IPD-1151T; TUMOR-NECROSIS-FACTOR; TGF-BETA; IN-VIVO; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; IMMUNE-RESPONSES; TH1; GAMMA	Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout, resulting in the development of drug-resistant variants of tuberculosis. Therefore, alternate methods to treat tuberculosis are urgently needed. Mycobacterium tuberculosis evades host immune responses by inducing T helper (Th)2 and regulatory T (Treg) cell responses, which diminish protective Th1 responses. Here, we show that animals (Stat-6(-/-)CD4-TGF beta RIIDN mice) that are unable to generate both Th2 cells and Tregs are highly resistant to M. tuberculosis infection. Furthermore, simultaneous inhibition of these two subsets of Th cells by therapeutic compounds dramatically reduced bacterial burden in different organs. This treatment was associated with the generation of protective Th1 immune responses. As these therapeutic agents are not directed to the harbored organisms, they should avoid the risk of promoting the development of drug-resistant M. tuberculosis variants.	[Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Das, Gobardhan] Univ Kwazulu Natal, Coll Hlth Sci, Lab Med & Med Sci, ZA-4001 Durban, South Africa; [Maiga, Mamoudou; Maiga, Mariama; Bishai, William R.] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21231 USA; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	University of Kwazulu Natal; Johns Hopkins University; Vanderbilt University	Das, G (corresponding author), Jawaharlal Neheru Univ, Special Ctr Mol Med, New Delhi 110067, India.	gobardhan.das07@gmail.com	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Dwivedi, Ved Prakash/0000-0003-4321-2567	Wellcome Trust; Department of Biotechnology India Alliance; Department of Biotechnology; Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India; College of Health Sciences, University of KwaZulu Natal (Durban, South Africa)	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Department of Biotechnology; Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India; College of Health Sciences, University of KwaZulu Natal (Durban, South Africa)	This work was supported by grants from The Wellcome Trust, Department of Biotechnology India Alliance, Department of Biotechnology, Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India, and College of Health Sciences, University of KwaZulu Natal (Durban, South Africa).	Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dlugovitzky D, 1999, RESP MED, V93, P557, DOI 10.1016/S0954-6111(99)90155-5; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Henneekes H., 2002, CURR MED CHEM ANTIIN, P41; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kurokawa M, 2001, MEDIAT INFLAMM, V10, P333, DOI 10.1080/09629350120102352; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oda N, 1999, LIFE SCI, V65, P763, DOI 10.1016/S0024-3205(99)00303-3; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Ordway Diane J, 2005, Acta Med Port, V18, P27; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Roy E, 2008, TUBERCULOSIS, V88, P197, DOI [10.1016/j.tube.2007.11.005, 10.1016/S1472-9792(08)70011-8]; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; SNIDER DE, 1992, NEW ENGL J MED, V326, P703, DOI 10.1056/NEJM199203053261011; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Toossi Z, 1998, CLIN IMMUNOL IMMUNOP, V87, P107, DOI 10.1006/clin.1998.4528; van der Werf N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003215; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	41	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16508	16515		10.1074/jbc.M114.558098	http://dx.doi.org/10.1074/jbc.M114.558098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24711459	Green Published, hybrid			2022-12-28	WOS:000337965700052
J	Arevalo, MT; Navarro, A; Arico, CD; Li, JW; Alkhatib, O; Chen, S; Diaz-Arevalo, D; Zeng, MT				Arevalo, Maria T. l; Navarro, Ashley; Arico, Chenoa D.; Li, Junwei; Alkhatib, Omar; Chen, Shan; Diaz-Arevalo, Diana; Zeng, Mingtao			Targeted Silencing of Anthrax Toxin Receptors Protects against Anthrax Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anthrax Toxin; Bacterial Toxin; Macrophage; Receptor; RNA Interference (RNAi); RNA Silencing	CAPILLARY MORPHOGENESIS PROTEIN-2; LETHAL TOXIN; BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; CELL-LINES; MICE; SUSCEPTIBILITY; IMMUNIZATION; MACROPHAGES; APOPTOSIS	Anthrax spores can be aerosolized and dispersed as a bioweapon. Current postexposure treatments are inadequate at later stages of infection, when high levels of anthrax toxins are present. Anthrax toxins enter cells via two identified anthrax toxin receptors: tumor endothelial marker 8 (TEM8) and capillary morphogenesis protein 2 (CMG2). We hypothesized that host cells would be protected from anthrax toxins if anthrax toxin receptor expression was effectively silenced using RNA interference (RNAi) technology. Thus, anthrax toxin receptors in mouse and human macrophages were silenced using targeted siRNAs or blocked with specific antibody prior to challenge with anthrax lethal toxin. Viability assays were used to assess protection in macrophages treated with specific siRNA or antibody as compared with untreated cells. Silencing CMG2 using targeted siRNAs provided almost complete protection against anthrax lethal toxin-induced cytotoxicity and death in murine and human macrophages. The same results were obtained by prebinding cells with specific antibody prior to treatment with anthrax lethal toxin. In addition, TEM8-targeted siRNAs also offered significant protection against lethal toxin in human macrophage-like cells. Furthermore, silencing CMG2, TEM8, or both receptors in combination was also protective against MEK2 cleavage by lethal toxin or adenylyl cyclase activity by edema toxin in human kidney cells. Thus, anthrax toxin receptor-targeted RNAi has the potential to be developed as a life-saving, postexposure therapy against anthrax.	[Arevalo, Maria T. l; Navarro, Ashley; Arico, Chenoa D.; Li, Junwei; Alkhatib, Omar; Chen, Shan; Diaz-Arevalo, Diana; Zeng, Mingtao] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Zeng, MT (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis, Dept Biomed Sci,Paul L Foster Sch Med, 5001 El Paso Dr, El Paso, TX 79905 USA.	mt.zeng@ttuhsc.edu	Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240; Chen, Shan/0000-0002-1364-4265; Diaz-Arevalo, Diana/0000-0003-3766-5500	Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso	Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso	This work was supported by a grant (to M.Z.) from the Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Bouzianas DG, 2009, TRENDS MICROBIOL, V17, P522, DOI 10.1016/j.tim.2009.08.006; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, BIOCHEM PHARMACOL, V65, P309, DOI 10.1016/S0006-2952(02)01455-7; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Choi B, 2008, J DERMATOL SCI, V52, P87, DOI 10.1016/j.jdermsci.2008.05.001; Comer JE, 2012, CLIN VACCINE IMMUNOL, V19, P1517, DOI 10.1128/CVI.00292-12; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Emergent BioSolutions, 2013, VACCINE PRODUCT SHEE; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Franz DR, 2009, MOL ASPECTS MED, V30, P503, DOI 10.1016/j.mam.2009.07.002; Grabenstein JD, 2008, CLIN INFECT DIS, V46, P129, DOI 10.1086/523578; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hudson MJ, 2008, INT J MED MICROBIOL, V298, P345, DOI 10.1016/j.ijmm.2007.09.007; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Lawrence WS, 2009, COMPARATIVE MED, V59, P257; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Liu SH, 2013, TOXINS, V5, P1, DOI 10.3390/toxins5010001; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Ngundi MM, 2010, CLIN VACCINE IMMUNOL, V17, P895, DOI 10.1128/CVI.00513-09; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Pluvinet R, 2004, BLOOD, V104, P3642, DOI 10.1182/blood-2004-03-0817; Reeves C, 2013, TOXINS, V5, P315, DOI 10.3390/toxins5020315; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; Rolando M, 2010, CELL MICROBIOL, V12, P891, DOI 10.1111/j.1462-5822.2010.01438.x; Sastalla I, 2012, INFECT IMMUN, V80, P529, DOI 10.1128/IAI.05947-11; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sherer K, 2007, AM J RESP CRIT CARE, V175, P211, DOI 10.1164/rccm.200608-1239CP; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Wu WX, 2009, J IMMUNOL, V183, P5799, DOI 10.4049/jimmunol.0803406; Xie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066943; Xu QF, 2008, CLIN VACCINE IMMUNOL, V15, P612, DOI 10.1128/CVI.00402-07; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zeng MT, 2007, VACCINE, V25, P3588, DOI 10.1016/j.vaccine.2007.01.075; Zeng MT, 2006, VACCINE, V24, P662, DOI 10.1016/j.vaccine.2005.08.056; Zhang JY, 2006, ACTA BIOCHIM POL, V53, P525	45	12	13	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15730	15738		10.1074/jbc.M113.538587	http://dx.doi.org/10.1074/jbc.M113.538587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742682	Green Published, hybrid			2022-12-28	WOS:000337465400053
J	Grant, R; Nguyen, KY; Ravussin, A; Albarado, D; Youm, YH; Dixit, VD				Grant, Ryan; Nguyen, Kim Y.; Ravussin, Anthony; Albarado, Diana; Youm, Yun-Hee; Dixit, Vishwa Deep			Inactivation of C/ebp Homologous Protein-driven ImmuneMetabolic Interactions Exacerbate Obesity and Adipose Tissue Leukocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue Metabolism; Cell Metabolism; Energy Metabolism; Immunology; Inflammation; Insulin Resistance	ENDOPLASMIC-RETICULUM STRESS; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; ER STRESS; NLRP3 INFLAMMASOME; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; CHEMICAL CHAPERONES; CELL-DEATH; CHOP; APOPTOSIS	Background: C/ebp homologous protein contributes to ER stress-induced inflammatory cytokine secretion and apoptosis. Results: Loss of Chop increases obesity, insulin resistance, and adipose tissue leukocytosis and inflammation. Conclusion: ER stress signaling through Chop is necessary for adaptation to a high fat diet. Significance: Although in obesity ER stress may impair metabolic health, inactivation of Chop promotes obesity-associated inflammation. Successful adaptation to periods of chronic caloric excess is a highly coordinated event that is critical to the survival and propagation of species. Transcription factor C/ebp homologous protein (Chop) is thought to be an important molecular mediator that integrates nutrient signals to endoplasmic reticulum (ER) stress and innate immune activation. Given that aberrant ER stress response is implicated in inducing metabolic inflammation and insulin resistance, we hypothesized that ER stress target gene Chop integrates immune and metabolic systems to adapt to chronic positive energy balance. Here we report that inactivation of Chop in mice fed a high fat diet led to significant increase in obesity caused by a reduction in energy expenditure without any change in food intake. Importantly, ablation of Chop does not induce metabolically healthy obesity, because Chop-deficient mice fed a high fat diet had increased hepatic steatosis with significantly higher insulin resistance. Quantification of adipose tissue leukocytosis revealed that elimination of Chop during obesity led to substantial increase in number of adipose tissue T and B lymphocytes. In addition, deficiency of Chop led to increase in total number of myeloid subpopulations like neutrophils and F4/80(+) adipose tissue macrophages without any alterations in the frequency of M1- or M2-like adipose tissue macrophages. Further investigation of inflammatory mechanisms revealed that ablation of Chop increases the sensitivity of macrophages to inflammasome-induced activation of IL- in macrophages. Our findings indicate that regulated expression of Chop during obesity is critical for adaptation to chronic caloric excess and maintenance of energy homeostasis via integration of metabolic and immune systems.	[Grant, Ryan; Albarado, Diana; Dixit, Vishwa Deep] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Nguyen, Kim Y.; Ravussin, Anthony; Youm, Yun-Hee; Dixit, Vishwa Deep] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Nguyen, Kim Y.; Ravussin, Anthony; Youm, Yun-Hee; Dixit, Vishwa Deep] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University; Yale University	Dixit, VD (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 310 Cedar St, New Haven, CT 06520 USA.	Vishwa.Dixit@yale.edu		Youm, Yun-Hee/0000-0002-8098-8527; Ravussin, Anthony/0000-0003-4237-3190; Grant, Ryan/0000-0002-8940-4196	National Institutes of Health [AG31797, AG043608, AI105097, DK090556]; T32 Training Grant [DK064584-10]; Pennington Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105097, R01AI105097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556, T32DK064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043608, R01AG031797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Training Grant; Pennington Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG31797, AG043608, AI105097, and DK090556 (to V. D. D.) and T32 Training Grant DK064584-10 (to R. W. G.). This work was also supported by the Pennington Foundation.	Allagnat F, 2012, CELL DEATH DIFFER, V19, P1836, DOI 10.1038/cdd.2012.67; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Dixit VD, 2012, SEMIN IMMUNOL, V24, P321, DOI 10.1016/j.smim.2012.04.002; Dong J, 2007, AM J PHYSIOL-CELL PH, V292, pC209, DOI 10.1152/ajpcell.00157.2006; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Ferrante AW, 2013, J CLIN INVEST, V123, P4992, DOI 10.1172/JCI73658; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	34	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14045	14055		10.1074/jbc.M113.545921	http://dx.doi.org/10.1074/jbc.M113.545921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24662293	Green Published, hybrid			2022-12-28	WOS:000335984600034
J	Guerra, ML; Wauson, EM; McGlynn, K; Cobb, MH				Guerra, Marcy L.; Wauson, Eric M.; McGlynn, Kathleen; Cobb, Melanie H.			Muscarinic Control of MIN6 Pancreatic beta Cells Is Enhanced by Impaired Amino Acid Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Diabetes; ERK; G Protein-coupled Receptors (GPCR); mTOR Complex (mTORC)	OPERATED CA2+ ENTRY; ACETYLCHOLINE-RECEPTORS; REGULATED KINASES; INSULIN-RELEASE; TRPC6 CHANNELS; ACTIVATION; TRANSCRIPTION; GLUCOSE; PRESERVATION; HOMEOSTASIS	Background: Depletion of the GPCR T1R1/T1R3 increased calcium and ERK1/2 signaling by carbachol. Results: T1R3 depletion or reducing amino acids overnight increased M3 muscarinic receptor expression and altered calcium responses. Conclusion: M3 receptor expression in cells is up-regulated by reduced amino acid availability. Significance: The M3 muscarinic receptor is a potential therapeutic target in cells with impaired amino acid sensitivity. We have shown recently that the class C G protein-coupled receptor T1R1/T1R3 taste receptor complex is an early amino acid sensor in MIN6 pancreatic cells. Amino acids are unable to activate ERK1/2 in cells in which T1R3 has been depleted. The muscarinic receptor agonist carbachol activated ERK1/2 better in T1R3-depleted cells than in control cells. Ligands that activate certain G protein-coupled receptors in pancreatic cells potentiate glucose-stimulated insulin secretion. Among these is the M3 muscarinic acetylcholine receptor, the major muscarinic receptor in cells. We found that expression of M3 receptors increased in T1R3-depleted MIN6 cells and that calcium responses were altered. To determine whether these changes were related to impaired amino acid signaling, we compared responses in cells exposed to reduced amino acid concentrations. M3 receptor expression was increased, and some, but not all, changes in calcium signaling were mimicked. These findings suggest that M3 acetylcholine receptors are increased in cells as a mechanism to compensate for amino acid deficiency.	[Guerra, Marcy L.; Wauson, Eric M.; McGlynn, Kathleen; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243.; Supported by a mentor-based postdoctoral fellowship from the American Diabetes Association during the initial part of this study.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BONNER TI, 1989, TRENDS PHARMACOL SCI, P11; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gautam D, 2010, ENDOCRINOLOGY, V151, P5185, DOI 10.1210/en.2010-0519; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139; Zhang L, 2006, J BIOCHEM, V139, P459, DOI 10.1093/jb/mvj065	36	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14370	14379		10.1074/jbc.M114.565069	http://dx.doi.org/10.1074/jbc.M114.565069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695728	Green Published, hybrid			2022-12-28	WOS:000335984600062
J	Larimore, J; Zlatic, SA; Gokhale, A; Tornieri, K; Singleton, KS; Mullin, AP; Tang, JX; Talbot, K; Faundez, V				Larimore, Jennifer; Zlatic, Stephanie A.; Gokhale, Avanti; Tornieri, Karine; Singleton, Kaela S.; Mullin, Ariana P.; Tang, Junxia; Talbot, Konrad; Faundez, Victor			Mutations in the BLOC-1 Subunits Dysbindin and Muted Generate Divergent and Dosage-dependent Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Mouse Genetics; Protein Complexes; Schizophrenia; Synapses	HERMANSKY-PUDLAK-SYNDROME; LYSOSOME-RELATED ORGANELLES; SCHIZOPHRENIA SUSCEPTIBILITY GENE; WORKING-MEMORY; HEALTHY-INDIVIDUALS; BRAIN-DYSFUNCTION; PROTEIN COMPLEXES; MUTANT MICE; MOUSE MODEL; SNAPIN	Background: Genetic defects affecting subunits of protein complexes are presumed to generate identical diseases in mammals. Results: Two mouse mutants in genes belonging to the BLOC-1 complex have divergent brain and pigmentation phenotypes. Conclusion: Genetic defects affecting subunits of a complex manifest by partially overlapping clinical features. Significance: Disease resulting from mutations in protein complexes may generate a wide range of clinically presentations. Post-mortem analysis has revealed reduced levels of the protein dysbindin in the brains of those suffering from the neurodevelopmental disorder schizophrenia. Consequently, mechanisms controlling the cellular levels of dysbindin and its interacting partners may participate in neurodevelopmental processes impaired in that disorder. To address this question, we studied loss of function mutations in the genes encoding dysbindin and its interacting BLOC-1 subunits. We focused on BLOC-1 mutants affecting synapse composition and function in addition to their established systemic pigmentation, hematological, and lung phenotypes. We tested phenotypic homogeneity and gene dosage effects in the mouse null alleles muted (Bloc1s5(mu/mu)) and dysbindin (Bloc1s8(sdy/sdy)). Transcripts of NMDA receptor subunits and GABAergic interneuron markers, as well as expression of BLOC-1 subunit gene products, were affected differently in the brains of Bloc1s5(mu/mu) and Bloc1s8(sdy/sdy) mice. Unlike Bloc1s8(sdy/sdy), elimination of one or two copies of Bloc1s5 generated indistinguishable pallidin transcript phenotypes. We conclude that monogenic mutations abrogating the expression of a protein complex subunit differentially affect the expression of other complex transcripts and polypeptides as well as their downstream effectors. We propose that the genetic disruption of different subunits of protein complexes and combinations thereof diversifies phenotypic presentation of pathway deficiencies, contributing to the wide phenotypic spectrum and complexity of neurodevelopmental disorders.	[Larimore, Jennifer; Singleton, Kaela S.] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Zlatic, Stephanie A.; Gokhale, Avanti; Tornieri, Karine; Mullin, Ariana P.; Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Ctr Social Translat Neurosci, Atlanta, GA 30322 USA; [Tang, Junxia] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Talbot, Konrad] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Emory University; Emory University; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center	Faundez, V (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	vfaunde@emory.edu		Zlatic, Stephanie/0000-0003-0758-9500; Faundez, Victor/0000-0002-2114-5271; Singleton, Kaela/0000-0003-2610-5890; Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health [GM077569, NS42599, R01 MH072880, PP MH064045]; Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience; NIEHS, National Institutes of Health [T32 1P50NS071669]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072880, P50MH064045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS071669, P30NS055077, R01NS042599, R56NS042599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities; Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience; NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077569 and NS42599 (to V. F.), R01 MH072880 and PP MH064045 (to K. T.), and Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077. This work was also supported by funds from the Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience (to V. F.).; Supported by Graduate and Postdoctoral Training in Toxicology Training Grant T32 1P50NS071669 from the NIEHS, National Institutes of Health.	Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Carlson GC, 2011, P NATL ACAD SCI USA, V108, pE962, DOI 10.1073/pnas.1109625108; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Cerasa A, 2011, NEUROIMAGE, V55, P508, DOI 10.1016/j.neuroimage.2010.12.042; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen M, 2005, MOL BIOL CELL, V16, P5103, DOI 10.1091/mbc.E05-02-0165; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Ghiani CA, 2011, ASN NEURO, V3, DOI 10.1042/AN20110010; Gokhale A, 2012, J NEUROSCI, V32, P3697, DOI 10.1523/JNEUROSCI.5640-11.2012; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Hoyle DJ, 2011, PIGM CELL MELANOMA R, V24, P275, DOI 10.1111/j.1755-148X.2010.00815.x; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Larimore J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065069; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Luciano M, 2009, GENES BRAIN BEHAV, V8, P218, DOI 10.1111/j.1601-183X.2008.00462.x; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Markov V, 2009, NEUROIMAGE, V47, P2016, DOI 10.1016/j.neuroimage.2009.05.067; Markov V, 2010, HUM BRAIN MAPP, V31, P266, DOI 10.1002/hbm.20862; Mechelli A, 2010, NEUROIMAGE, V49, P817, DOI 10.1016/j.neuroimage.2009.07.030; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mullin AP, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.108; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Saggu S, 2013, SCHIZOPHR RES, V146, P254, DOI 10.1016/j.schres.2013.01.037; Shao LS, 2011, P NATL ACAD SCI USA, V108, P18831, DOI 10.1073/pnas.1114569108; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tognin S, 2011, J CHILD PSYCHOL PSYC, V52, P1287, DOI 10.1111/j.1469-7610.2011.02427.x; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wolf C, 2011, MOL PSYCHIATR, V16, P145, DOI 10.1038/mp.2009.129; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang Q, 2012, TRAFFIC, V13, P1160, DOI 10.1111/j.1600-0854.2012.01375.x; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	75	28	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14291	14300		10.1074/jbc.M114.553750	http://dx.doi.org/10.1074/jbc.M114.553750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24713699	Green Published, hybrid			2022-12-28	WOS:000335984600054
J	Shibafuji, Y; Nakamura, A; Uchihashi, T; Sugimoto, N; Fukuda, S; Watanabe, H; Samejima, M; Ando, T; Noji, H; Koivula, A; Igarashi, K; Iino, R				Shibafuji, Yusuke; Nakamura, Akihiko; Uchihashi, Takayuki; Sugimoto, Naohisa; Fukuda, Shingo; Watanabe, Hiroki; Samejima, Masahiro; Ando, Toshio; Noji, Hiroyuki; Koivula, Anu; Igarashi, Kiyohiko; Iino, Ryota			Single-molecule Imaging Analysis of Elementary Reaction Steps of Trichoderma reesei Cellobiohydrolase I ( Cel7A) Hydrolyzing Crystalline Cellulose I (alpha) and III (I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Cellulase; Enzyme Kinetics; Molecular Motors; Single-molecule Biophysics; Cellobiohydrolase; Cellulose; High Speed Atomic Force Microscopy; Single-molecule Fluorescence Imaging	NEUTRON FIBER DIFFRACTION; SYNCHROTRON X-RAY; BIOMASS RECALCITRANCE; KRAFT PULP; PROCESSIVITY; SUBSTRATE; BINDING; SURFACE; MICROSCOPY; F-1-ATPASE	Background: The catalytic mechanism of Trichoderma reesei cellobiohydrolase I (TrCel7A) is still unclear. Results:TrCel7A exhibited similar reaction kinetics during crystalline cellulose I and IIII hydrolysis. Conclusion: Not differences in kinetic parameters but surface properties of the crystalline cellulose influence the susceptibilities of cellulose I and IIII to hydrolysis by TrCel7A. Significance: Single-molecule measurements further our understanding of TrCel7A mechanism. Trichoderma reesei cellobiohydrolase I (TrCel7A) is a molecular motor that directly hydrolyzes crystalline celluloses into water-soluble cellobioses. It has recently drawn attention as a tool that could be used to convert cellulosic materials into biofuel. However, detailed mechanisms of action, including elementary reaction steps such as binding, processive hydrolysis, and dissociation, have not been thoroughly explored because of the inherent challenges associated with monitoring reactions occurring at the solid/liquid interface. The crystalline cellulose I and IIII were previously reported as substrates with different crystalline forms and different susceptibilities to hydrolysis by TrCel7A. In this study, we observed that different susceptibilities of cellulose I and IIII are highly dependent on enzyme concentration, and at nanomolar enzyme concentration, TrCel7A shows similar rates of hydrolysis against cellulose I and IIII. Using single-molecule fluorescence microscopy and high speed atomic force microscopy, we also determined kinetic constants of the elementary reaction steps for TrCel7A against cellulose I and IIII. These measurements were performed at picomolar enzyme concentration in which density of TrCel7A on crystalline cellulose was very low. Under this condition, TrCel7A displayed similar binding and dissociation rate constants for cellulose I and IIII and similar fractions of productive binding on cellulose I and IIII. Furthermore, once productively bound, TrCel7A processively hydrolyzes and moves along cellulose I and IIII with similar translational rates. With structural models of cellulose I and IIII, we propose that different susceptibilities at high TrCel7A concentration arise from surface properties of substrate, including ratio of hydrophobic surface and number of available lanes.	[Shibafuji, Yusuke; Noji, Hiroyuki; Iino, Ryota] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Nakamura, Akihiko; Sugimoto, Naohisa; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Uchihashi, Takayuki; Fukuda, Shingo; Watanabe, Hiroki; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Koivula, Anu] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland	University of Tokyo; University of Tokyo; Kanazawa University; Kanazawa University; VTT Technical Research Center Finland	Iino, R (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	iino@appchem.t.u-tokyo.ac.jp	Igarashi, Kiyohiko/E-6799-2016; Iino, Ryota/B-7746-2011; Uchihashi, Takayuki/D-5209-2011; ANDO, Toshio/E-7054-2015; Nakamura, Akihiko/U-1988-2019	Igarashi, Kiyohiko/0000-0001-5152-7177; Iino, Ryota/0000-0003-0110-5704; Uchihashi, Takayuki/0000-0002-0263-5312; ANDO, Toshio/0000-0001-8819-154X; Nakamura, Akihiko/0000-0003-0409-5759; Fukuda, Shingo/0000-0002-0723-2088; Koivula, Anu/0000-0002-7600-5700	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24370062, 24114001, 24114008, 24380089, 23115008, 24241048]; Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24370062 (to R. I.), 24114001, 24114008, and 24380089 (to K. I.), and 23115008 and 24241048 (to T. U.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ando T, 2013, ANNU REV BIOPHYS, V42, P393, DOI 10.1146/annurev-biophys-083012-130324; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; DIVNE C, 1993, J MOL BIOL, V234, P905, DOI 10.1006/jmbi.1993.1640; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Fukuda S, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4813280; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nishizaka T, 2011, METHODS MOL BIOL, V778, P259, DOI 10.1007/978-1-61779-261-8_17; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; REINIKAINEN T, 1995, PROTEINS, V22, P392, DOI 10.1002/prot.340220409; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Wada M, 2006, MACROMOLECULES, V39, P2947, DOI 10.1021/ma060228s; Wada M, 2001, MACROMOLECULES, V34, P1237, DOI 10.1021/ma001406z; Wada M, 2001, J WOOD SCI, V47, P124, DOI 10.1007/BF00780560; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yanagisawa M, 2005, CELLULOSE, V12, P151, DOI 10.1007/s10570-004-0866-8	40	38	40	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14056	14065		10.1074/jbc.M113.546085	http://dx.doi.org/10.1074/jbc.M113.546085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692563	Green Published, hybrid			2022-12-28	WOS:000335984600035
J	Goosens, VJ; Monteferrante, CG; van Dijl, JM				Goosens, Vivianne J.; Monteferrante, Carmine G.; van Dijl, Jan Maarten			Co-factor Insertion and Disulfide Bond Requirements for Twin-arginine Translocase-dependent Export of the Bacillus subtilis Rieske Protein QcrA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Cytochromes; Disulfide; Iron-Sulfur Protein; Protein Translocation; QcrA; Rieske Protein; TatAy; Twin-arginine Translocation	CYTOCHROME BC(1) COMPLEX; WATER-SOLUBLE FRAGMENT; GRAM-POSITIVE BACTERIA; LEADER-BINDING PROTEIN; IRON-SULFUR PROTEIN; ESCHERICHIA-COLI; SIGNAL PEPTIDE; TAT PATHWAY; MEMBRANE-PROTEINS; QUALITY-CONTROL	Background: The Rieske protein QcrA was recently shown to be exported by twin-arginine translocation (Tat) in Bacillus subtilis. Results: QcrA has disulfide bond and co-factor requirements for effective Tat-dependent translocation. Conclusion: A hierarchy exists between disulfide bonding and co-factor insertion in QcrA quality control and translocation. Significance: First studies on Tat-dependent translocation where oxidative folding and co-factor attachment were addressed in a single native molecule. The twin-arginine translocation (Tat) pathway can transport folded and co-factor-containing cargo proteins over bacterial cytoplasmic membranes. Functional Tat machinery components, a folded state of the cargo protein and correct co-factor insertion in the cargo protein are generally considered as prerequisites for successful translocation. The present studies were aimed at a dissection of these requirements with regard to the Rieske iron-sulfur protein QcrA of Bacillus subtilis. Notably, QcrA is a component of the cytochrome bc(1) complex, which is conserved from bacteria to man. Single amino acid substitutions were introduced into the Rieske domain of QcrA to prevent either co-factor binding or disulfide bond formation. Both types of mutations precluded QcrA translocation. Importantly, a proofreading hierarchy was uncovered, where a QcrA mutant defective in disulfide bonding was quickly degraded, whereas mutant QcrA proteins defective in co-factor binding accumulated in the cytoplasm and membrane. Altogether, these are the first studies on Tat-dependent protein translocation where both oxidative folding and co-factor attachment have been addressed in a single native molecule.	[Goosens, Vivianne J.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands	University of Groningen	van Dijl, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	j.m.van.dijl01@umcg.nl		Goosens, Vivianne/0000-0002-7808-5185	CEU [PITN-GA-2008-215524, LSHG-CT-2006-037469, LSHG-CT-2006-244093]; transnational SysMO initiative through projects BACELL SysMO1 and -2; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW)	CEU; transnational SysMO initiative through projects BACELL SysMO1 and -2; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by CEU projects PITN-GA-2008-215524 (TranSys), LSHG-CT-2006-037469 and -244093 (to V. J. G. and J. M. v. D.), and the transnational SysMO initiative through projects BACELL SysMO1 and -2 with funding from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (NWO-ALW).	Ahuja U, 2009, MOL MICROBIOL, V73, P1058, DOI 10.1111/j.1365-2958.2009.06833.x; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bachmann J, 2006, FEBS J, V273, P4817, DOI 10.1111/j.1742-4658.2006.05480.x; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; De Buck E, 2007, FEBS LETT, V581, P259, DOI 10.1016/j.febslet.2006.12.022; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Freudl R, 2013, RES MICROBIOL, V164, P664, DOI 10.1016/j.resmic.2013.03.014; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GASSON MJ, 1983, J BACTERIOL, V154, P1; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Goosens VJ, 2013, ANTIOXID REDOX SIGN, V18, P1159, DOI 10.1089/ars.2012.4664; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Graumann P, 2012, BACILLUS: CELLULAR AND MOLECULAR BIOLOGY, SECOND EDITION, P1; Gubernator B, 2006, BBA-PROTEINS PROTEOM, V1764, P735, DOI 10.1016/j.bbapap.2005.12.013; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Hochgrafe F, 2005, MOL MICROBIOL, V58, P409, DOI 10.1111/j.1365-2958.2005.04845.x; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Hopkins A, 2014, J BACTERIOL, V196, P50, DOI 10.1128/JB.00776-13; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kim JY, 2005, APPL ENVIRON MICROB, V71, P8451, DOI 10.1128/AEM.71.12.8451-8459.2005; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; Kouwen TRHM, 2009, PROTEOMICS, V9, P1018, DOI 10.1002/pmic.200800580; Kouwen TRHM, 2008, APPL ENVIRON MICROB, V74, P7536, DOI 10.1128/AEM.00894-08; Krishnappa L, 2013, J PROTEOME RES, V12, P4101, DOI 10.1021/pr400433h; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Maurer C, 2009, FEBS LETT, V583, P2849, DOI 10.1016/j.febslet.2009.07.038; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Monteferrante CG, 2012, APPL ENVIRON MICROB, V78, P4999, DOI 10.1128/AEM.01108-12; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papish AL, 2003, J BIOL CHEM, V278, P32501, DOI 10.1074/jbc.M301076200; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Sambrook F., 1989, MOL CLONING LAB MANU; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Schneider D, 2005, BBA-BIOENERGETICS, V1710, P1, DOI 10.1016/j.bbabio.2005.09.003; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; van Dijl JM, 2002, J BIOTECHNOL, V98, P243, DOI 10.1016/S0168-1656(02)00135-9; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; Vogtentanz G, 2007, PROTEIN EXPRES PURIF, V55, P40, DOI 10.1016/j.pep.2007.05.001; Whitaker N, 2012, J BIOL CHEM, V287, P11252, DOI 10.1074/jbc.M111.324525; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; YU J, 1995, J BACTERIOL, V177, P6751, DOI 10.1128/jb.177.23.6751-6760.1995	79	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13124	13131		10.1074/jbc.M113.529677	http://dx.doi.org/10.1074/jbc.M113.529677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652282	hybrid, Green Published			2022-12-28	WOS:000335522800014
J	Gurunathan, S; Winkles, JA; Ghosh, S; Hayden, MS				Gurunathan, Sujatha; Winkles, Jeffrey A.; Ghosh, Sankar; Hayden, Matthew S.			Regulation of Fibroblast Growth Factor-inducible 14 ( Fn14) Expression Levels via Ligand-independent Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Receptor Endocytosis; Receptor Regulation; Trafficking; Tumor Necrosis Factor (TNF); Proteostasis; Fn14; Tweak	TNF RECEPTOR 1; FACTOR-KAPPA-B; WEAK INDUCER; TWEAK/FN14 PATHWAY; THERAPEUTIC TARGET; SUPERFAMILY MEMBER; ENDOTHELIAL-CELLS; PROGENITOR CELLS; DOWN-REGULATION; TUMOR-CELLS	Background: Fn14 is a highly inducible TNF superfamily cytokine receptor. Results: Fn14 undergoes rapid, ligand-independent internalization and degradation mediated by the extracellular domain of the receptor. Conclusion: Fn14 expression is regulated through transcription as described previously and through a novel post-translational mechanism. Significance: Receptor trafficking may play an important role in regulating receptor availability, cytokine responses, and ligand-independent signaling. Fibroblast growth factor-inducible 14 (Fn14) is a highly inducible cytokine receptor that engages multiple intracellular signaling pathways, including nuclear factor-B (NF-B) and mitogen-activated protein kinase (MAPK). Fn14 expression is regulated by several cytokines and growth factors, and Fn14 is transiently up-regulated after injury. In contrast, in states of chronic inflammatory disease and in some solid tumors, Fn14 is persistently up-regulated. However, the post-translational regulation of Fn14 expression has not been directly investigated. Thus, we examined Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis (TWEAK). Similar to other TNF receptor superfamily members, we found that TWEAK induces Fn14 internalization and degradation. Surprisingly, we also observed rapid, TWEAK-independent, constitutive Fn14 internalization and turnover. Fn14 levels are maintained in cell culture by ongoing synthesis and trafficking of the receptor, leading to subsequent down-regulation by lysosomal degradation. Unexpectedly, the extracellular domain of Fn14 is necessary and sufficient for constitutive turnover. Based on these findings, we propose a model in which constitutive down-regulation of Fn14 facilitates dynamic regulation of Fn14 protein levels and prevents spontaneous or inappropriate receptor signaling.	[Gurunathan, Sujatha; Ghosh, Sankar; Hayden, Matthew S.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Gurunathan, Sujatha; Hayden, Matthew S.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Winkles, Jeffrey A.] Univ Maryland, Dept Surg, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Winkles, Jeffrey A.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA	Columbia University; Columbia University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, 710W 168th St, New York, NY 10032 USA.	sg2715@columbia.edu		Hayden, Matthew/0000-0003-1670-6430	National Institutes of Health [P30 AR058886, R37 AI33443, R01 CA130967, R01 NS055126]; NATIONAL CANCER INSTITUTE [R01CA130967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886, P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR058886 (to M. S. H.), R37 AI33443 (to S. G.), and R01 CA130967 and R01 NS055126 (to J. A. W.). This work was also supported by institutional support from Columbia University.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Asrani K, 2013, MOL CANCER RES, V11, P393, DOI 10.1158/1541-7786.MCR-12-0542; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Chen YH, 2006, J PINEAL RES, V40, P40, DOI 10.1111/j.1600-079X.2005.00274.x; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Dohi T, 2012, J LEUKOCYTE BIOL, V92, P265, DOI 10.1189/jlb.0112042; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V146, P540, DOI 10.1111/j.1365-2249.2006.03233.x; Jakubowski A, 2002, J CELL SCI, V115, P267; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kwon OH, 2012, CANCER LETT, V314, P73, DOI 10.1016/j.canlet.2011.09.016; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Philipp S, 2010, P NATL ACAD SCI USA, V107, P1112, DOI 10.1073/pnas.0908486107; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; SEGLEN O, 1975, BIOCHEM BIOPH RES CO, V66, P44, DOI 10.1016/S0006-291X(75)80292-0; Serafini B, 2008, J NEUROPATH EXP NEUR, V67, P1137, DOI 10.1097/NEN.0b013e31818dab90; Tanabe K, 2003, J NEUROSCI, V23, P9675; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; TSUJIMOTO M, 1987, J BIOCHEM-TOKYO, V102, P1571, DOI 10.1093/oxfordjournals.jbchem.a122206; Tucker TA, 2008, EUR J IMMUNOL, V38, P864, DOI 10.1002/eji.200737828; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Vince JE, 2006, CELL DEATH DIFFER, V13, P1842, DOI 10.1038/sj.cdd.4402027; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; YELLIN MJ, 1994, J IMMUNOL, V152, P598; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zavzavadjian JR, 2007, MOL CELL PROTEOMICS, V6, P413, DOI 10.1074/mcp.M600437-MCP200; Zhou H, 2013, CANCER RES, V73, P4439, DOI 10.1158/0008-5472.CAN-13-0187; Zhou H, 2013, J INVEST DERMATOL, V133, P1052, DOI 10.1038/jid.2012.402; Zhou H, 2011, MOL CANCER THER, V10, P1276, DOI 10.1158/1535-7163.MCT-11-0161	63	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12976	12988		10.1074/jbc.M114.563478	http://dx.doi.org/10.1074/jbc.M114.563478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652288	Green Published, hybrid			2022-12-28	WOS:000335522800003
J	Stalhberger, T; Simenel, C; Clavaud, C; Eijsink, VGH; Jourdain, R; Delepierre, M; Latge, JP; Breton, L; Fontaine, T				Stalhberger, Thomas; Simenel, Catherine; Clavaud, Cecile; Eijsink, Vincent G. H.; Jourdain, Roland; Delepierre, Muriel; Latge, Jean-Paul; Breton, Lionel; Fontaine, Thierry			Chemical Organization of the Cell Wall Polysaccharide Core of Malassezia restricta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Complex; Carbohydrate Structure; Cell Wall; Chitin; Yeast	SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; FUNGAL CELL; CANDIDA-ALBICANS; GENE-PRODUCT; STRUCTURAL-CHARACTERIZATION; SCHIZOSACCHAROMYCES-POMBE; NMR-SPECTROSCOPY; HUMAN SKIN; IN-VITRO	Background: Cell wall of Malassezia restricta is involved in interactions with human skin. Results: Its core is composed of cross-linked polysaccharides such as chitin, chitosan, -(1,3)-glucan and -(1,6)-glucan. Conclusion: The composition of cell wall polysaccharides of M. restricta is unique in the fungal kingdom. Significance: The cell wall of M. restricta has evolved as a yeast that adapted to the skin microenvironment and host interactions. Malassezia species are ubiquitous residents of human skin and are associated with several diseases such as seborrheic dermatitis, tinea versicolor, folliculitis, atopic dermatitis, and scalp conditions such as dandruff. Host-Malassezia interactions and mechanisms to evade local immune responses remain largely unknown. Malassezia restricta is one of the most predominant yeasts of the healthy human skin, its cell wall has been investigated in this paper. Polysaccharides in the M. restricta cell wall are almost exclusively alkali-insoluble, showing that they play an essential role in the organization and rigidity of the M. restricta cell wall. Fractionation of cell wall polymers and carbohydrate analyses showed that the polysaccharide core of the cell wall of M. restricta contained an average of 5% chitin, 20% chitosan, 5% -(1,3)-glucan, and 70% -(1,6)-glucan. In contrast to other yeasts, chitin and chitosan are relatively abundant, and -(1,3)-glucans constitute a minor cell wall component. The most abundant polymer is -(1,6)-glucans, which are large molecules composed of a linear -(1,6)-glucan chains with -(1,3)-glucosyl side chain with an average of 1 branch point every 3.8 glucose unit. Both -glucans are cross-linked, forming a huge alkali-insoluble complex with chitin and chitosan polymers. Data presented here show that M. restricta has a polysaccharide organization very different of all fungal species analyzed to date.	[Stalhberger, Thomas; Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, F-75724 Paris, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, F-75724 Paris, France; [Clavaud, Cecile; Jourdain, Roland; Breton, Lionel] LOreal Res & Innovat, F-93600 Aulnay Sous Bois, France; [Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Delepierre, Muriel] Inst Pasteur, CNRS, UMR3528, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fontaine, T (corresponding author), Inst Pasteur, Unite Aspergillus, 25 Rue Docteur Roux, F-75724 Paris, France.	thierry.fontaine@pasteur.fr	Fontaine, thierry/Q-2201-2018; Fontaine, Thierry/F-8227-2011	Fontaine, thierry/0000-0002-8184-789X; 	L'Oreal, Paris	L'Oreal, Paris	Supported by L'Oreal, Paris.	Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BOCK K, 1974, J ANTIBIOT, V27, P139, DOI 10.7164/antibiotics.27.139; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cabib E, 2012, EUKARYOT CELL, V11, P388, DOI 10.1128/EC.05328-11; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; David M., 2003, SCRIPTA MED BRNO, V76, P173; de Medina-Redondo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014046; Delay C, 1997, CARBOHYD RES, V302, P67, DOI 10.1016/S0008-6215(97)00101-8; Dimzon IKD, 2013, CARBOHYD POLYM, V92, P564, DOI 10.1016/j.carbpol.2012.09.035; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duenas-Santero E, 2010, EUKARYOT CELL, V9, P1650, DOI 10.1128/EC.00187-10; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fontaine T, 1997, EUR J BIOCHEM, V243, P315, DOI 10.1111/j.1432-1033.1997.0315a.x; FONTAINE T, 1991, ANAL BIOCHEM, V199, P154, DOI 10.1016/0003-2697(91)90083-6; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gastebois A, 2013, J BIOL CHEM, V288, P13387, DOI 10.1074/jbc.M112.440172; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Goldman DL, 2012, MBIO, V3, DOI 10.1128/mBio.00056-12; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; GUILLOT J, 1995, ANTON LEEUW INT J G, V67, P297, DOI 10.1007/BF00873693; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Heggset EB, 2010, BIOMACROMOLECULES, V11, P2487, DOI 10.1021/bm1006745; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Kim YT, 2000, CARBOHYD RES, V328, P331, DOI 10.1016/S0008-6215(00)00105-1; Kobayashi M, 2009, BRIT J DERMATOL, V160, P297, DOI 10.1111/j.1365-2133.2008.08897.x; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Koller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016594; Kruppa MD, 2009, CARBOHYD RES, V344, P2474, DOI 10.1016/j.carres.2009.09.029; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MITTAG H, 1995, MYCOSES, V38, P13, DOI 10.1111/j.1439-0507.1995.tb00003.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; NEBREDA AR, 1987, FEBS LETT, V220, P27, DOI 10.1016/0014-5793(87)80869-4; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; Shibata N, 2009, MICROBIOL-SGM, V155, P3420, DOI 10.1099/mic.0.029967-0; Sugawara T, 2004, CARBOHYD RES, V339, P2255, DOI 10.1016/j.carres.2004.05.033; Vorgias C. E., 1993, PURIFICATION CHARACT, P417; WAGNER G, 1983, J MAGN RESON, V55, P151, DOI 10.1016/0022-2364(83)90284-6; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zhou KQ, 2006, LWT-FOOD SCI TECHNOL, V39, P1087, DOI 10.1016/j.lwt.2005.07.009; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	63	42	46	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12647	12656		10.1074/jbc.M113.547034	http://dx.doi.org/10.1074/jbc.M113.547034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627479	Green Published, hybrid			2022-12-28	WOS:000335581400036
J	Wang, QS; He, YH; Shen, YJ; Zhang, QQ; Chen, D; Zuo, CJ; Qin, J; Wang, H; Wang, JW; Yu, Y				Wang, Qingsong; He, Yuhu; Shen, Yujun; Zhang, Qianqian; Chen, Di; Zuo, Caojian; Qin, Jing; Wang, Hui; Wang, Junwen; Yu, Ying			Vitamin D Inhibits COX-2 Expression and Inflammatory Response by Targeting Thioesterase Superfamily Member 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Lipopolysaccharide (LPS); Macrophages; NF-kappa B (NF-KB); Vitamin D; VDR	NF-KAPPA-B; TERMINAL MODULATOR PROTEIN; GROWTH-PLATE CHONDROCYTES; PROSTATE-CANCER; DNA-BINDING; KINASE-C; CYCLOOXYGENASE-2; RECEPTOR; D-3; HEALTH	Background: Vitamin D insufficiency has been associated with chronic inflammatory diseases. However, the underlying mechanisms remain unclear. Results: Vitamin D inhibits COX-2-mediated inflammatory response by modulating the Akt/NF-B signaling pathway via direct up-regulation of thioesterase superfamily member 4. Conclusion: Vitamin D plays novel roles in anti-inflammation. Significance: Supplemental vitamin D could protect against chronic inflammatory diseases by targeting THEM4/Akt/NF-B signaling. Inadequate vitamin D status has been linked to increased risk of type 2 diabetes and cardiovascular disease. Inducible cyclooxygenase (COX) isoform COX-2 has been involved in the pathogenesis of such chronic inflammatory diseases. We found that the active form of vitamin D, 1,25(OH)(2)D produces dose-dependent inhibition of COX-2 expression in murine macrophages under both basal and LPS-stimulated conditions and suppresses proinflammatory mediators induced by LPS. Administration of 1,25(OH)(2)D significantly alleviated local inflammation in a carrageenan-induced paw edema mouse model. Strikingly, the phosphorylation of both Akt and its downstream target IB in macrophages were markedly suppressed by 1,25(OH)(2)D in the presence and absence of LPS stimulation through up-regulation of THEM4 (thioesterase superfamily member 4), an Akt modulator protein. Knockdown of both vitamin D receptor and THEM4 attenuated the inhibitory effect of 1,25(OH)(2)D on COX-2 expression in macrophages. A functional vitamin D-responsive element in the THEM4 promoter was identified by chromatin immunoprecipitation and luciferase reporter assay. Our results indicate that vitamin D restrains macrophage-mediated inflammatory processes by suppressing the Akt/NF-B/COX-2 pathway, suggesting that vitamin D supplementation might be utilized for adjunctive therapy for inflammatory disease.	[Wang, Qingsong; He, Yuhu; Shen, Yujun; Zhang, Qianqian; Chen, Di; Zuo, Caojian; Wang, Hui; Yu, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China; [Wang, Qingsong] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China; [Wang, Hui; Yu, Ying] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Qin, Jing; Wang, Junwen] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Wang, Junwen] Univ Hong Kong, LKS Fac Med, Ctr Genom Sci, Hong Kong, Peoples R China; [Qin, Jing; Wang, Junwen] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hainan Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	yuying@sibs.ac.cn	CHEN, DI/Y-5795-2019; Wang, Junwen/D-3700-2011	Wang, Junwen/0000-0002-4432-4707; Qin, Jing/0000-0002-8327-8846	Ministry of Science and Technology of China [2012CB945100, 2011CB503906, 2011ZX09307-302-01, 2012BAK01B00]; National Natural Science Foundation of China [81030004, 31200860]; Natural Science Foundation of China-Canadian Institutes of Health Research [NSFC81161120538, CIHR-CCI117951]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]; Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences [CRC2010007]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP514, 2013KIP312, 2010OHTP10]; Pujiang Talents Program of Shanghai Municipality [11PJ1411100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-Canadian Institutes of Health Research; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Pujiang Talents Program of Shanghai Municipality	This work was supported by Grants 2012CB945100, 2011CB503906, 2011ZX09307-302-01, and 2012BAK01B00 from the Ministry of Science and Technology of China and National Natural Science Foundation of China Grants 81030004 and 31200860, Natural Science Foundation of China-Canadian Institutes of Health Research Joint Grants NSFC81161120538 and CIHR-CCI117951, Grant KSCX2-EW-R-09 from the Knowledge Innovation Program of the Chinese Academy of Sciences, funds from the Clinic Research Center at Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences Grant CRC2010007, the Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences, and Chinese Academy of Sciences Grants 2012KIP514 and 2013KIP312.; Supported by Grant 2010OHTP10 from the One Hundred Talents Program of the Chinese Academy of Sciences and Grant 11PJ1411100 from the Pujiang Talents Program of Shanghai Municipality. Fellow at the Jiangsu Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. To whom correspondence should be addressed. Inst. for Nutritional Sciences, Shanghai Inst. for Biological Sciences, Chinese Academy of Sciences, 294 Taiyuan Rd., Shanghai 200031, China. Tel. and Fax: 86-2154920970; E-mail: yuying@sibs.ac.cn.	Adams AE, 1999, J CELL BIOCHEM, V74, P587, DOI 10.1002/(SICI)1097-4644(19990915)74:4<587::AID-JCB8>3.0.CO;2-G; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Aparna R, 2008, J CELL BIOCHEM, V104, P1832, DOI 10.1002/jcb.21749; Boyan BD, 1999, STEROIDS, V64, P129, DOI 10.1016/S0039-128X(98)00099-3; Boyan BD, 2002, CRIT REV ORAL BIOL M, V13, P143, DOI 10.1177/154411130201300205; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Ermert L, 1998, AM J RESP CELL MOL, V18, P479, DOI 10.1165/ajrcmb.18.4.2939; Glade MJ, 2013, NUTRITION, V29, P37, DOI 10.1016/j.nut.2012.05.010; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hinz B, 2007, Handb Exp Pharmacol, P65; Holick MF, 2005, SEMIN DIALYSIS, V18, P266, DOI 10.1111/j.1525-139X.2005.18402.x; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI 10.1359/JBMR.07S213; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Liu XD, 2014, AM J RESP CELL MOL, V50, P40, DOI 10.1165/rcmb.2013-0211OC; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Moreno J, 2005, CANCER RES, V65, P7917, DOI 10.1158/0008-5472.CAN-05-1435; Muszkat P, 2010, ARQ BRAS ENDOCRINOL, V54, P110, DOI 10.1590/S0004-27302010000200005; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schwab M, 2007, MOL IMMUNOL, V44, P3625, DOI 10.1016/j.molimm.2007.04.010; Schwartz Z, 2000, J CELL PHYSIOL, V182, P390, DOI 10.1002/(SICI)1097-4652(200003)182:3<390::AID-JCP10>3.3.CO;2-K; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Sylvia VL, 2001, J CELL BIOCHEM, P32; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Tjandrawinata RR, 1997, ADV EXP MED BIOL, V407, P163; Tsugawa N, 1999, BIOL PHARM BULL, V22, P371; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Winyard P. G., 2003, INFLAMMATION PROTOCO; Wu SP, 2011, DISCOV MED, V11, P325; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhao H, 2009, BIOCHEMISTRY-US, V48, P5507, DOI 10.1021/bi900710w	60	82	86	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11681	11694		10.1074/jbc.M113.517581	http://dx.doi.org/10.1074/jbc.M113.517581			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619416	Green Published, hybrid			2022-12-28	WOS:000335010600011
J	Kang, S; Xu, MX; Cooper, EC; Hoshi, N				Kang, Seungwoo; Xu, Mingxuan; Cooper, Edward C.; Hoshi, Naoto			Channel-anchored Protein Kinase CK2 and Protein Phosphatase 1 Reciprocally Regulate KCNQ2-containing M-channels via Phosphorylation of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; Potassium Channels; PP1; Protein Kinases; Protein Phosphorylation; CK2; KCNQ2	CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; ANKYRIN-G; IDENTIFICATION; MODULATION; PIP2; SUBUNITS; DOMAINS; KCNQ; SITE	Background: Calmodulin binding to KCNQ subunit is required for maintaining the M-current. Results: Protein kinase CK2-mediated phosphorylation of CaM enhances KCNQ2 current. KCNQ2 subunit tethers protein kinase CK2 and protein phosphatase 1. Conclusion: Phosphorylation status of CaM regulates the M-current. Significance: Phosphorylation status of calmodulin regulates neuronal excitability via M-current modulation. M-type potassium channels, encoded by the KCNQ family genes (KCNQ2-5), require calmodulin as an essential co-factor. Calmodulin bound to the KCNQ2 subunit regulates channel trafficking and stabilizes channel activity. We demonstrate that phosphorylation of calmodulin by protein kinase CK2 (casein kinase 2) rapidly and reversibly modulated KCNQ2 current. CK2-mediated phosphorylation of calmodulin strengthened its binding to KCNQ2 channel, caused resistance to phosphatidylinositol 4,5-bisphosphate depletion, and increased KCNQ2 current amplitude. Accordingly, application of CK2-selective inhibitors suppressed KCNQ2 current. This suppression was prevented by co-expression of CK2 phosphomimetic calmodulin mutants or pretreatment with a protein phosphatase inhibitor, calyculin A. We also demonstrated that functional CK2 and protein phosphatase 1 (PP1) were selectively tethered to the KCNQ2 subunit. We identified a functional KVXF consensus site for PP1 binding in the N-terminal tail of KCNQ2 subunit: mutation of this site augmented current density. CK2 inhibitor treatment suppressed M-current in rat superior cervical ganglion neurons, an effect negated by overexpression of phosphomimetic calmodulin or pretreatment with calyculin A Furthermore, CK2 inhibition diminished the medium after hyperpolarization by suppressing the M-current. These findings suggest that CK2-mediated phosphorylation of calmodulin regulates the M-current, which is tonically regulated by CK2 and PP1 anchored to the KCNQ2 channel complex.	[Kang, Seungwoo; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Hoshi, Naoto] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Xu, Mingxuan; Cooper, Edward C.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Baylor College of Medicine; Baylor College of Medicine	Hoshi, N (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	nhoshi@uci.edu	Kang, Seungwoo/K-5130-2015; Cooper, Edward/X-6659-2019; Kang, Seungwoo/L-4841-2019	Kang, Seungwoo/0000-0003-1301-8480; Cooper, Edward/0000-0003-3672-8442; Kang, Seungwoo/0000-0003-1301-8480	National Institutes of Health [R01 NS067288, R01 NS49119]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R21NS042100, R01NS049119, R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS067288 (to N. H.) and R01 NS49119 (to E. C. C.).	Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086711; Arrigoni G, 2004, BIOCHEMISTRY-US, V43, P12788, DOI 10.1021/bi049365c; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Cohen PTW, 2002, J CELL SCI, V115, P241; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Greif DM, 2004, P NATL ACAD SCI USA, V101, P1165, DOI 10.1073/pnas.0306377101; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Le AV, 2011, BIOCHEMISTRY-US, V50, P5279, DOI 10.1021/bi200089z; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Maingret F, 2008, NEURON, V59, P439, DOI 10.1016/j.neuron.2008.05.026; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PLANCKE YD, 1983, MOL CELL BIOL, V3, P1412, DOI 10.1128/MCB.3.8.1412; QUADRONI M, 1994, J BIOL CHEM, V269, P16116; Quadroni M, 1998, BIOCHEMISTRY-US, V37, P6523, DOI 10.1021/bi972930+; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	33	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11536	11544		10.1074/jbc.M113.528497	http://dx.doi.org/10.1074/jbc.M113.528497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24627475	Green Published, hybrid			2022-12-28	WOS:000334638500053
J	Conroy, PJ; Law, RHP; Gilgunn, S; Hearty, S; Caradoc-Davies, TT; Lloyd, G; O'Kennedy, RJ; Whisstock, JC				Conroy, Paul J.; Law, Ruby H. P.; Gilgunn, Sarah; Hearty, Stephen; Caradoc-Davies, Tom T.; Lloyd, Gordon; O'Kennedy, Richard J.; Whisstock, James C.			Reconciling the Structural Attributes of Avian Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cardiovascular Disease; Prostate Cancer; Recombinant Protein Expression; Surface Plasmon Resonance (SPR); X-ray Crystallography; Chicken; Prostate-specific Antigen; Recombinant Antibody; Cardiac Troponin I	RECOMBINANT ANTIBODIES; CHICKEN; PROTEIN; GENE; REPERTOIRE; GENERATION; FRAGMENTS; REVEALS; REGIONS; DISEASE	Background: Antibodies from alternative immune hosts provide insights into novel mechanisms of antibody diversity in restricted germ-line repertoires. Results: The high-resolution crystal structures of the first two chicken single chain antibodies (scFv) with prototypical binding sites are described. Conclusion: Chickens exhibit unique canonical classes in the CDRL1. Significance: Aves employ distinct mechanisms to generate diversity resulting in unique binding-site topologies. Antibodies are high value therapeutic, diagnostic, biotechnological, and research tools. Combinatorial approaches to antibody discovery have facilitated access to unique antibodies by surpassing the diversity limitations of the natural repertoire, exploitation of immune repertoires from multiple species, and tailoring selections to isolate antibodies with desirable biophysical attributes. The V-gene repertoire of the chicken does not utilize highly diverse sequence and structures, which is in stark contrast to the mechanism employed by humans, mice, and primates. Recent exploitation of the avian immune system has generated high quality, high affinity antibodies to a wide range of antigens for a number of therapeutic, diagnostic and biotechnological applications. Furthermore, extensive examination of the amino acid characteristics of the chicken repertoire has provided significant insight into mechanisms employed by the avian immune system. A paucity of avian antibody crystal structures has limited our understanding of the structural consequences of these uniquely chicken features. This paper presents the crystal structure of two chicken single chain fragment variable (scFv) antibodies generated from large libraries by phage display against important human antigen targets, which capture two unique CDRL1 canonical classes in the presence and absence of a non-canonical disulfide constrained CDRH3. These structures cast light on the unique structural features of chicken antibodies and contribute further to our collective understanding of the unique mechanisms of diversity and biochemical attributes that render the chicken repertoire of particular value for antibody generation.	[Conroy, Paul J.; Law, Ruby H. P.; Lloyd, Gordon; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3800, Australia; [Gilgunn, Sarah; O'Kennedy, Richard J.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Hearty, Stephen; O'Kennedy, Richard J.] Dublin City Univ, Biomed Diagnost Inst, Natl Ctr Sensor Res, Dublin 9, Ireland; [Caradoc-Davies, Tom T.] Australian Synchrotron, Melbourne, Vic 3168, Australia	Monash University; Dublin City University; Dublin City University	O'Kennedy, RJ (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	richard.okennedy@dcu.ie; james.whisstock@monash.edu	Conroy, Paul/L-1320-2019	Conroy, Paul/0000-0002-9748-4704; Gilgunn, Sarah/0000-0003-3547-5228; Whisstock, James/0000-0003-4200-5611; law, ruby/0000-0001-5432-5781	Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET) [10/CE/B1821]; SFI Short-term Travel Fellowship; Australian Research Council; National Health and Medical Research Council; Irish Cancer Society program Grant, as part of Prostate Cancer Research Consortium, Dublin, Ireland [PCI11WAT]	Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET)(Science Foundation Ireland); SFI Short-term Travel Fellowship(Science Foundation Ireland); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Irish Cancer Society program Grant, as part of Prostate Cancer Research Consortium, Dublin, Ireland	This work was supported by the Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET) Grant 10/CE/B1821 (to P. J. C., S. H., and R. O. K.) and a SFI Short-term Travel Fellowship (to P. J. C.).; Supported by Australian Research Council and National Health and Medical Research Council grants.; Supported by the Irish Cancer Society program Grant PCI11WAT, as part of the Prostate Cancer Research Consortium, Dublin, Ireland.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Abhinandan KR, 2010, PROTEIN ENG DES SEL, V23, P689, DOI 10.1093/protein/gzq043; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0; Ayyar BV, 2010, ANAL BIOCHEM, V407, P165, DOI 10.1016/j.ab.2010.07.033; Bowes T, 2011, J BIOMOL SCREEN, V16, P744, DOI 10.1177/1087057111407067; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chailyan A, 2011, PROTEINS, V79, P1513, DOI 10.1002/prot.22979; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Conroy PJ, 2012, PROTEIN ENG DES SEL, V25, P295, DOI 10.1093/protein/gzs018; Conroy PJ, 2009, SEMIN CELL DEV BIOL, V20, P10, DOI 10.1016/j.semcdb.2009.01.010; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finlay WJJ, 2006, APPL ENVIRON MICROB, V72, P3343, DOI 10.1128/AEM.72.5.3343-3349.2006; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; Fitzgerald J, 2011, ANAL BIOCHEM, V410, P27, DOI 10.1016/j.ab.2010.11.009; Foord AJ, 2007, J IMMUNOL METHODS, V321, P142, DOI 10.1016/j.jim.2007.01.014; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Hearty Stephen, 2011, Bioeng Bugs, V2, P182; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hu ZQ, 2013, ANAL CHIM ACTA, V764, P84, DOI 10.1016/j.aca.2012.12.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; McDonnell B, 2011, ANAL BIOCHEM, V410, P1, DOI 10.1016/j.ab.2010.09.039; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Reichert JM, 2013, MABS-AUSTIN, V5, P1, DOI 10.4161/mabs.22976; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Safdari Y, 2013, BIOTECHNOL GENET ENG, V29, P175, DOI 10.1080/02648725.2013.801235; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211	51	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15384	15392		10.1074/jbc.M114.562470	http://dx.doi.org/10.1074/jbc.M114.562470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737329	hybrid, Green Published			2022-12-28	WOS:000337465400022
J	Jenkins, RJ; Heslip, KA; Meagher, JL; Stuckey, JA; Dotson, GD				Jenkins, Ronald J.; Heslip, Kyle A.; Meagher, Jennifer L.; Stuckey, Jeanne A.; Dotson, Garry D.			Structural Basis for the Recognition of Peptide RJPXD33 by Acyltransferases in Lipid A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acyl Carrier Protein (ACP); Antimicrobial Peptide (AMP); Enzyme Inhibitor; Lipopolysaccharide (LPS); Peptides; X-ray Crystallography; Acyltransferase; Lipid A; LpxA	N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; PROTEIN-PROTEIN INTERACTIONS; ACYL-CHAIN SELECTIVITY; ESCHERICHIA-COLI; STRUCTURE VALIDATION; 1ST STEP; IDENTIFICATION; MOLPROBITY; NUCLEOTIDE; ASSAY	UDP-N-acetylglucosamine acyltransferase (LpxA) and UDP-3-O-(acyl)-glucosamine acyltransferase (LpxD) constitute the essential, early acyltransferases of lipid A biosynthesis. Recently, an antimicrobial peptide inhibitor, RJPXD33, was identified with dual affinity for LpxA and LpxD. To gain a fundamental understanding of the molecular basis of inhibitor binding, we determined the crystal structure of LpxA from Escherichia coli in complex with RJPXD33 at 1.9 resolutions. Our results suggest that the peptide binds in a unique modality that mimics (R)--hydroxyacyl pantetheine binding to LpxA and displays how the peptide binds exclusive of the native substrate, acyl-acyl carrier protein. Acyltransferase binding studies with photo-labile RJPXD33 probes and truncations of RJPXD33 validated the structure and provided fundamental insights for future design of small molecule inhibitors. Overlay of the LpxA-RJPXD33 structure with E. coli LpxD identified a complementary peptide binding pocket within LpxD and serves as a model for further biochemical characterization of RJPXD33 binding to LpxD.	[Jenkins, Ronald J.; Heslip, Kyle A.; Dotson, Garry D.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Meagher, Jennifer L.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dotson, GD (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA.	gdotson@umich.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). We thank Dr. David Smith of LS-CAT for help with remote data collection.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; Benson RE, 2003, ANTIMICROB AGENTS CH, V47, P2875, DOI 10.1128/AAC.47.9.2875-2881.2003; Bricogne G., 2011, BUSTER; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chan WC, 2000, FMOC SOLID PHASE PEP; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hughes RM, 2006, J AM CHEM SOC, V128, P13586, DOI 10.1021/ja0648460; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Jenkins RJ, 2012, ANAL BIOCHEM, V425, P21, DOI 10.1016/j.ab.2012.02.027; KELLY TM, 1993, J BIOL CHEM, V268, P19866; MAJERUS PW, 1965, P NATL ACAD SCI USA, V53, P410, DOI 10.1073/pnas.53.2.410; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robins LI, 2009, BIOCHEMISTRY-US, V48, P6191, DOI 10.1021/bi900629e; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Ulaganathan V, 2007, J MOL BIOL, V369, P305, DOI 10.1016/j.jmb.2007.03.039; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; Vaara M, 1996, SCIENCE, V274, P939, DOI 10.1126/science.274.5289.939; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	35	21	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15527	15535		10.1074/jbc.M114.564278	http://dx.doi.org/10.1074/jbc.M114.564278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742680	hybrid, Green Published			2022-12-28	WOS:000337465400035
J	Sun, YR; Yin, SH; Feng, YT; Li, J; Zhou, JH; Liu, CD; Zhu, G; Guo, ZH				Sun, Yueru; Yin, Shuhui; Feng, Yitao; Li, Jie; Zhou, Jiahai; Liu, Changdong; Zhu, Guang; Guo, Zhihong			Molecular Basis of the General Base Catalysis of an alpha/beta-Hydrolase Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mechanisms; Hydrolases; Protein Conformation; Vitamin K; Open-Closed Conformational Change	STRONG HYDROGEN-BOND; HYDROXYNITRILE LYASE; ACTIVE-SITE; CONFORMATIONAL SELECTION; MENAQUINONE BIOSYNTHESIS; CRYSTAL-STRUCTURE; HUMAN GLUCOKINASE; ESCHERICHIA-COLI; FOLD ENZYMES; INDUCED FIT	The serine-histidine-aspartate triad is well known for its covalent, nucleophilic catalysis in a diverse array of enzymatic transformations. Here we show that its nucleophilicity is shielded and its catalytic role is limited to being a specific general base by an open-closed conformational change in the catalysis of (1R,6R)-2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (or MenH), a typical /-hydrolase fold enzyme in the vitamin K biosynthetic pathway. This enzyme is found to adopt an open conformation without a functional triad in its ligand-free form and a closed conformation with a fully functional catalytic triad in the presence of its reaction product. The open-to-closed conformational transition involves movement of half of the -helical cap domain, which causes extensive structural changes in the /-domain and forces the side chain of the triad histidine to adopt an energetically disfavored gauche conformation to form the functional triad. NMR analysis shows that the inactive open conformation without a triad prevails in ligand-free solution and is converted to the closed conformation with a properly formed triad by the reaction product. Mutation of the residues crucial to this open-closed transition either greatly decreases or completely eliminates the enzyme activity, supporting an important catalytic role for the structural change. These findings suggest that the open-closed conformational change tightly couples formation of the catalytic triad to substrate binding to enhance the substrate specificities and simultaneously shield the nucleophilicity of the triad, thus allowing it to expand its catalytic power beyond the nucleophilic catalysis.	[Sun, Yueru; Yin, Shuhui; Feng, Yitao; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Liu, Changdong; Zhu, Guang] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Sun, Yueru; Yin, Shuhui; Feng, Yitao; Liu, Changdong; Zhu, Guang; Guo, Zhihong] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Li, Jie; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk	Yin, Shuhui/AAA-4360-2020	Yin, Shuhui/0000-0003-1542-3340; Sun, Yueru/0000-0002-8203-3740	Research Grants Council of the Hong Kong Special Administrative Region government [GRF601413, GRF601209, RPC11SC16]; National Natural Science Foundation of China [NSFC 11079051]	Research Grants Council of the Hong Kong Special Administrative Region government(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grants GRF601413, GRF601209, and RPC11SC16 from the Research Grants Council of the Hong Kong Special Administrative Region government (to Z.G.) and by National Natural Science Foundation of China Grant NSFC 11079051 (to J.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dawson A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-19; DeLano W.L, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Hare S, 2009, ACTA CRYSTALLOGR D, V65, P966, DOI 10.1107/S0907444909023695; Harris TK, 1999, PROTEINS, V35, P275, DOI 10.1002/(SICI)1097-0134(19990515)35:3<275::AID-PROT1>3.0.CO;2-V; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnston JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061325; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDermott A., 1996, ENCY NMR, P3820; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pletnev S, 2009, ACTA CRYSTALLOGR D, V65, P906, DOI 10.1107/S0907444909020927; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Ruzzini AC, 2012, BIOCHEMISTRY-US, V51, P5831, DOI 10.1021/bi300663r; Ruzzini AC, 2012, J AM CHEM SOC, V134, P4615, DOI 10.1021/ja208544g; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Speare DM, 2004, ORG BIOMOL CHEM, V2, P2942, DOI 10.1039/b410322j; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Viragh C, 2000, BIOCHEMISTRY-US, V39, P16200, DOI 10.1021/bi0022644; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wei Y., 1999, MODEL NMR CHEM SHIFT, P177, DOI [10.1021/bk-1999-0732.ch013, DOI 10.1021/BK-1999-0732.CH013]; Zhang T., 2010, CHINESE PHYS B, V19; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	65	19	19	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15867	15879		10.1074/jbc.M113.535641	http://dx.doi.org/10.1074/jbc.M113.535641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737327	Green Published, hybrid			2022-12-28	WOS:000337465400065
J	Ansari, SA; Paul, E; Sommer, S; Lieleg, C; He, QY; Daly, AZ; Rode, KA; Barber, WT; Ellis, LC; LaPorta, E; Orzechowski, AM; Taylor, E; Reeb, T; Wong, J; Korber, P; Morse, RH				Ansari, Suraiya A.; Paul, Emily; Sommer, Sebastian; Lieleg, Corinna; He, Qiye; Daly, Alexandre Z.; Rode, Kara A.; Barber, Wesley T.; Ellis, Laura C.; LaPorta, Erika; Orzechowski, Amanda M.; Taylor, Emily; Reeb, Tanner; Wong, Jason; Korber, Philipp; Morse, Randall H.			Mediator, TATA-binding Protein, and RNA Polymerase II Contribute to Low Histone Occupancy at Active Gene Promoters in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; PHO5 PROMOTER; SRB MEDIATOR; DISASSEMBLY RATHER; CHAPERONE ASF1; CHROMATIN; COMPLEX; SWI/SNF	Transcription by RNA polymerase II (Pol II) in eukaryotes requires the Mediator complex, and often involves chromatin remodeling and histone eviction at active promoters. Here we address the role of Mediator in recruitment of the Swi/Snf chromatin remodeling complex and its role, along with components of the preinitiation complex (PIC), in histone eviction at inducible and constitutively active promoters in the budding yeast Saccharomyces cerevisiae. We show that recruitment of the Swi/Snf chromatin remodeling complex to the induced CHA1 promoter, as well as its association with several constitutively active promoters, depends on the Mediator complex but is independent of Mediator at the induced MET2 and MET6 genes. Although transcriptional activation and histone eviction at CHA1 depends on Swi/Snf, Swi/Snf recruitment is not sufficient for histone eviction at the induced CHA1 promoter. Loss of Swi/ Snf activity does not affect histone occupancy of several constitutively active promoters; in contrast, higher histone occupancy is seen at these promoters in Mediator and PIC component mutants. We propose that an initial activator-dependent, nucleosome remodeling step allows PIC components to outcompete histones for occupancy of promoter sequences. We also observe reduced promoter association of Mediator and TATA-binding protein in a Pol II (rpb1-1) mutant, indicating mutually cooperative binding of these components of the transcription machinery and indicating that it is the PIC as a whole whose binding results in stable histone eviction.	[Ansari, Suraiya A.; Paul, Emily; He, Qiye; Daly, Alexandre Z.; Rode, Kara A.; Barber, Wesley T.; Ellis, Laura C.; LaPorta, Erika; Orzechowski, Amanda M.; Taylor, Emily; Reeb, Tanner; Wong, Jason; Morse, Randall H.] New York State Dept Hlth, Mol Genet Lab, Wadsworth Ctr, Albany, NY 12201 USA; [He, Qiye; LaPorta, Erika; Morse, Randall H.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Sommer, Sebastian; Lieleg, Corinna; Korber, Philipp] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Munich	Morse, RH (corresponding author), New York State Dept Hlth, Mol Genet Lab, Wadsworth Ctr, Albany, NY 12201 USA.	randall.morse@wadsworth.org	Korber, Philipp/AAN-7633-2021	Korber, Philipp/0000-0001-7526-6549; Morse, Randall/0000-0003-0000-8718; Wong, Jason/0000-0002-0710-3112; Daly, Alexandre/0000-0002-1924-0755; Ansari, Suraiya/0000-0002-0483-4235	National Science Foundation [MCB0517825, MCB0949722]; German Research Community [DFG KO2945/1-1]; program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich; National Science Foundation REU [DBI1062963]; Wadsworth Center; Direct For Biological Sciences [0949722, 1359413] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062963] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); German Research Community(German Research Foundation (DFG)); program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich; National Science Foundation REU(National Science Foundation (NSF)); Wadsworth Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Science Foundation Grants MCB0517825 and MCB0949722 (to R. H. M.), German Research Community Grant DFG KO2945/1-1 (to P. K.), a scholarship within the program Molecular Medicine (FoFoLe) of the Medical Faculty of the University of Munich (to S. S.), National Science Foundation REU Program Grant DBI1062963, and the Wadsworth Center.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; BORNAES C, 1992, GENETICS, V131, P531; Brachmann CB, 1998, YEAST, V14, P115; Brown CR, 2011, J BIOL CHEM, V286, P40556, DOI 10.1074/jbc.M111.289918; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Cormier L, 2010, NUCLEIC ACIDS RES, V38, P4998, DOI 10.1093/nar/gkq257; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Gregory PD, 1999, METH MOL B, V119, P417; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lacombe T, 2013, NUCLEIC ACIDS RES, V41, P9651, DOI 10.1093/nar/gkt701; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Mukundan B, 2013, J BIOL CHEM, V288, P11384, DOI 10.1074/jbc.M112.446773; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; PINTO I, 1994, J BIOL CHEM, V269, P30569; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TSANG SS, 1993, BIOTECHNIQUES, V14, P380; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Wippo CJ, 2009, MOL CELL BIOL, V29, P2960, DOI 10.1128/MCB.01054-08; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200	75	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14981	14995		10.1074/jbc.M113.529354	http://dx.doi.org/10.1074/jbc.M113.529354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727477	hybrid, Green Published			2022-12-28	WOS:000337248100050
J	Kunchithapautham, K; Atkinson, C; Rohrer, B				Kunchithapautham, Kannan; Atkinson, Carl; Rohrer, Baerbel			Smoke Exposure Causes Endoplasmic Reticulum Stress and Lipid Accumulation in Retinal Pigment Epithelium through Oxidative Stress and Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CIGARETTE-SMOKE; BRUCHS MEMBRANE; CHOROIDAL NEOVASCULARIZATION; REGULATORY PROTEINS; ALTERNATIVE PATHWAY; GEOGRAPHIC ATROPHY; APOLIPOPROTEIN-E	Age-related macular degeneration (AMD) is a complex disease caused by genetic and environmental factors, including genetic variants in complement components and smoking. Smoke exposure leads to oxidative stress, complement activation, endoplasmic reticulum (ER) stress, and lipid dysregulation, which have all been proposed to be associated with AMD pathogenesis. Here we examine the effects of smoke exposure on the retinal pigment epithelium (RPE). Mice were exposed to cigarette smoke or filtered air for 6 months. RPE cells grown as stable monolayers were exposed to 5% cigarette smoke extract (CSE). Effects of smoke were determined by biochemical, molecular, and histological measures. Effects of the alternative pathway (AP) of complement and complement C3a anaphylatoxin receptor signaling were analyzed using knock-out mice or specific inhibitors. ER stress markers were elevated after smoke exposure in RPE of intact mice, which was eliminated in AP-deficient mice. To examine this relationship further, RPE monolayers were exposed to CSE. Short term smoke exposure resulted in production and release of complement C3, the generation of C3a, oxidative stress, complement activation on the cell membrane, and ER stress. Long term exposure to CSE resulted in lipid accumulation, and secretion. All measures were reversed by blocking C3a complement receptor (C3aR), alternative complement pathway signaling, and antioxidant therapy. Taken together, our results provide clear evidence that smoke exposure results in oxidative stress and complement activation via the AP, resulting in ER stress-mediated lipid accumulation, and further suggesting that oxidative stress and complement act synergistically in the pathogenesis of AMD.	[Kunchithapautham, Kannan; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Atkinson, Carl] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Rohrer, Baerbel] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), 167 Ashley Ave, Charleston, SC 29425 USA.	rohrer@musc.edu			National Institutes of Health [C06RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091944] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Animal studies were conducted in a facility constructed with support from the National Institutes of Health Grant C06RR015455.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Davis KS, 2010, OTOLARYNG HEAD NECK, V143, P152, DOI 10.1016/j.otohns.2010.02.022; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Ebrahimi KB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/802059; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Freund KB, 2010, RETINA-J RET VIT DIS, V30, P1333, DOI 10.1097/IAE.0b013e3181e7976b; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haimovici R, 2001, INVEST OPHTH VIS SCI, V42, P1592; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Ishida BY, 2004, J LIPID RES, V45, P263, DOI 10.1194/jlr.M300306-JLR200; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kunchithapautham K, 2012, ADV EXP MED BIOL, V723, P23, DOI 10.1007/978-1-4614-0631-0_4; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lin Y., 2012, C53 COPD PATHOGENESI, pA4561; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Luo C, 2011, MOL VIS, V17, P1588; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Mulligan RM, 2009, AM J RHINOL ALLERGY, V23, pE1, DOI 10.2500/ajra.2009.23.3400; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; PLATEL D, 1994, EUR CYTOKINE NETW, V5, P405; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sanai M, 2011, AFR J BIOTECHNOL, V10, P19211, DOI 10.5897/AJB11.254; TATE DJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P963, DOI 10.1001/archopht.1993.01090070083023; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tweed JO, 2012, TRENDS ENDOCRIN MET, V23, P334, DOI 10.1016/j.tem.2012.03.006; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/348092; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005; Yu AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048501; Yu MZ, 2012, INVEST OPHTH VIS SCI, V53, P7684, DOI 10.1167/iovs.12-10069; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	78	105	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14534	14546		10.1074/jbc.M114.564674	http://dx.doi.org/10.1074/jbc.M114.564674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711457	Green Published, hybrid			2022-12-28	WOS:000337248100012
J	Perler, FB; Allewell, NM				Perler, Francine B.; Allewell, Norma M.			Evolution, Mechanisms, and Applications of Intein-mediated Protein Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								Intein-mediated protein splicing raises questions and creates opportunities in many scientific areas. Evolutionary biologists question whether inteins are primordial enzymes or simply selfish elements, whereas biochemists seek to understand how inteins work. Synthetic chemists exploit inteins in the semi-synthesis of proteins with or without nonribosomal modifications, whereas biotechnologists use modified inteins in an ever increasing variety of applications. The four minireviews in this series explore these themes. The first minireview focuses on the evolution and biological function of inteins, whereas the second describes the mechanisms that underlie the remarkable ability of inteins to perform complex sets of choreographed enzymatic reactions. The third explores the relationship between the three-dimensional structure and dynamics of inteins and their biochemical capabilities. The fourth describes intein applications that have moved beyond simple technology development to utilizing inteins in more sophisticated applications, such as biosensors for identifying ligands of human hormone receptors or improved methods of biofuel and plant-based sugar production.	[Perler, Francine B.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Allewell, Norma M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	New England Biolabs; University System of Maryland; University of Maryland College Park	Perler, FB (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	perler@neb.com						Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Novikova O, 2014, J BIOL CHEM, V289, P14490, DOI 10.1074/jbc.R114.548255; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653	5	7	7	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14488	14489		10.1074/jbc.R114.570531	http://dx.doi.org/10.1074/jbc.R114.570531			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695739	hybrid, Green Published			2022-12-28	WOS:000337248100006
J	Sileikyte, J; Blachly-Dyson, E; Sewell, R; Carpi, A; Menabo, R; Di Lisa, F; Ricchelli, F; Bernardi, P; Forte, M				Sileikyte, Justina; Blachly-Dyson, Elizabeth; Sewell, Randall; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Ricchelli, Fernanda; Bernardi, Paolo; Forte, Michael			Regulation of the Mitochondrial Permeability Transition Pore by the Outer Membrane Does Not Involve the Peripheral Benzodiazepine Receptor ( Translocator Protein of 18 kDa ( TSPO))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Action; Gene Knockout; Mitochondria; Mitochondrial Permeability Transition; Porphyrin; Photodynamic Effect	DEPENDENT ANION CHANNEL; CYTOCHROME-C RELEASE; ATP SYNTHASE; CYCLOPHILIN-D; CHOLESTEROL-BINDING; PHOTODYNAMIC-ACTION; MOLECULAR TARGET; CELL-DEATH; LIGANDS; INHIBITION	Background: TSPO has been proposed to be a critical regulator of the permeability transition pore (PTP). Results: TSPO-null mitochondria and cardiac tissue show no difference from controls in pore function, response to ligands, or response to ischemia/reperfusion injury. Conclusion: Regulation of the PTP by the outer membrane must rely on unknown proteins. Significance: Our results call into question studies implicating TSPO in pathological processes through the PTP. Translocator protein of 18 kDa (TSPO) is a highly conserved, ubiquitous protein localized in the outer mitochondrial membrane, where it is thought to play a key role in the mitochondrial transport of cholesterol, a key step in the generation of steroid hormones. However, it was first characterized as the peripheral benzodiazepine receptor because it appears to be responsible for high affinity binding of a number of benzodiazepines to non-neuronal tissues. Ensuing studies have employed natural and synthetic ligands to assess the role of TSPO function in a number of natural and pathological circumstances. Largely through the use of these compounds and biochemical associations, TSPO has been proposed to play a role in the mitochondrial permeability transition pore (PTP), which has been associated with cell death in many human pathological conditions. Here, we critically assess the role of TSPO in the function of the PTP through the generation of mice in which the Tspo gene has been conditionally eliminated. Our results show that 1) TSPO plays no role in the regulation or structure of the PTP, 2) endogenous and synthetic ligands of TSPO do not regulate PTP activity through TSPO, 3) outer mitochondrial membrane regulation of PTP activity occurs though a mechanism that does not require TSPO, and 4) hearts lacking TSPO are as sensitive to ischemia-reperfusion injury as hearts from control mice. These results call into question a wide variety of studies implicating TSPO in a number of pathological processes through its actions on the PTP.	[Sileikyte, Justina; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Sileikyte, Justina; Carpi, Andrea; Menabo, Roberta; Di Lisa, Fabio; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Blachly-Dyson, Elizabeth; Sewell, Randall; Forte, Michael] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Ricchelli, Fernanda] Univ Padua, Dept Biol, Consiglio Nazl Ric Inst Biomed Technol, I-35121 Padua, Italy	University of Padua; University of Padua; Oregon Health & Science University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua	Bernardi, P (corresponding author), Univ Padua, Consiglio Nazl Ric Inst Neurosci, Via Ugo Bassi 58-B, I-35121 Padua, Italy.	bernardi@bio.unipd.it; forte@ohsu.edu	Bernardi, Paolo/C-3656-2008	Bernardi, Paolo/0000-0001-9187-3736; Di Lisa, Fabio/0000-0001-9757-8818; Sileikyte, Justina/0000-0002-6795-6344	National Institutes of Health [1R01GM069883]; Telethon; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione; dell'Universita e della Ricerca; University of Padova Progetto Strategico di Ateneo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova Progetto Strategico di Ateneo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM069883. This work was also supported by Telethon, Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione, dell'Universita e della Ricerca, and the University of Padova Progetto Strategico di Ateneo "Models of Mitochondrial Diseases."	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fan J, 2012, CURR MOL MED, V12, P369; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Gastaldello A, 2010, AUTOPHAGY, V6, P607, DOI 10.4161/auto.6.5.11964; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; LENARTOWICZ E, 1991, J BIOENERG BIOMEMBR, V23, P679, DOI 10.1007/BF00785817; LEQUOC K, 1982, ARCH BIOCHEM BIOPHYS, V216, P639, DOI 10.1016/0003-9861(82)90254-5; LEQUOC K, 1985, J BIOL CHEM, V260, P7422; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li JY, 2007, EUR J PHARMACOL, V560, P117, DOI 10.1016/j.ejphar.2006.12.027; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moreno G, 2001, ARCH BIOCHEM BIOPHYS, V386, P243, DOI 10.1006/abbi.2000.2200; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Parker MA, 2002, J NEUROSCI RES, V69, P39, DOI 10.1002/jnr.10235; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Petronilli V, 2009, BBA-BIOENERGETICS, V1787, P897, DOI 10.1016/j.bbabio.2009.03.014; Pinton P, 2014, NAT CHEM BIOL, V10, P89, DOI 10.1038/nchembio.1440; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pocock SJ, 2006, BRIT MED J, V332, P1256, DOI 10.1136/bmj.332.7552.1256; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Ravagnan L, 1999, ONCOGENE, V18, P2537, DOI 10.1038/sj.onc.1202625; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; ROMEO E, 1992, J PHARMACOL EXP THER, V262, P971; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; Scarf AM, 2012, CURR MOL MED, V12, P488; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHLUTER KD, 1991, AM J PHYSIOL, V261, pH416, DOI 10.1152/ajpheart.1991.261.2.H416; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Seneviratne MSD, 2012, CURR MOL MED, V12, P476; Sileikyte J, 2011, J BIOL CHEM, V286, P1046, DOI 10.1074/jbc.M110.172486; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stelzer AC, 2010, BIOPOLYMERS, V93, P85, DOI 10.1002/bip.21306; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Surinkaew S, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2010.12.023; SZABO I, 1991, J BIOL CHEM, V266, P3376; VERMA A, 1988, MOL PHARMACOL, V34, P800; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006	86	140	142	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13769	13781		10.1074/jbc.M114.549634	http://dx.doi.org/10.1074/jbc.M114.549634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692541	Green Published, hybrid			2022-12-28	WOS:000335984600011
J	Winardhi, RS; Gulvady, R; Mellies, JL; Yan, J				Winardhi, Ricksen S.; Gulvady, Ranjit; Mellies, Jay L.; Yan, Jie			Locus of Enterocyte Effacement-encoded Regulator ( Ler) of Pathogenic Escherichia coli Competes Off Histone-like Nucleoid-structuring Protein ( H-NS) through Noncooperative DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; DNA-binding Protein; Gene Regulation; Protein-DNA Interaction; Single Molecule Biophysics; H-NS; Ler; Magnetic Tweezers	TRANSCRIPTIONAL REGULATION; NUCLEOPROTEIN FILAMENT; OLIGOMERIZATION; FORCE; EXPRESSION; MOLECULES; VIRULENCE; DOMAIN; GENES; ORGANIZATION	Background: Ler alleviates H-NS-mediated gene silencing. Results: LerDNA binding properties and Ler effects on H-NSDNA binding are investigated using magnetic tweezers and atomic force microscopy. Conclusion: Ler binds noncooperatively to stiffen and fold DNA, and it can replace prebound H-NS in the conditions tested. Significance: The findings provide new insights into the molecular mechanism of anti-silencing by Ler. The locus of enterocyte effacement-encoded regulator (Ler) of enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) functions to activate transcription of virulence genes silenced by the histone-like nucleoid-structuring protein (H-NS). Despite its important role in the bacterial gene regulation, the binding mode of Ler to DNA and its mechanism in alleviating genes repressed by H-NS are largely unknown. In this study, we use magnetic tweezers to demonstrate that Ler binds extended DNA through a largely noncooperative process, which results in DNA stiffening and DNA folding depending on protein concentration. We also show that Ler can replace prebound H-NS on DNA over a range of potassium and magnesium concentrations. Our findings reveal the DNA binding properties of Ler and shed light to further understand the anti-silencing activity of Ler.	[Winardhi, Ricksen S.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Winardhi, Ricksen S.; Gulvady, Ranjit; Yan, Jie] Mechanobiol Inst, Singapore 117411, Singapore; [Winardhi, Ricksen S.; Gulvady, Ranjit; Yan, Jie] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117543, Singapore; [Mellies, Jay L.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	National University of Singapore; National University of Singapore; Reed College - Oregon; National University of Singapore	Mellies, JL (corresponding author), Reed Coll, Dept Biol, 3203 SE Woodstock Blvd, Portland, OR 97202 USA.	jay.mellies@reed.edu; phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	Ministry of Education of Singapore, National Research Foundation of Singapore [MOE 2013-T2-1-154]; Mechanobiology Institute Singapore	Ministry of Education of Singapore, National Research Foundation of Singapore; Mechanobiology Institute Singapore	This work was supported by the Ministry of Education of Singapore, National Research Foundation of Singapore Grant MOE 2013-T2-1-154, and by the Mechanobiology Institute Singapore (to J.Y.).	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; CHRISTIAN J, 1961, J GEN MICROBIOL, V25, P97, DOI 10.1099/00221287-25-1-97; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 1999, TRENDS MICROBIOL, V7, P124, DOI 10.1016/S0966-842X(99)01455-9; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fu HX, 2013, NUCLEIC ACIDS RES, V41, P924, DOI 10.1093/nar/gks1162; Fu HX, 2011, CHROMOSOMA, V120, P245, DOI 10.1007/s00412-010-0307-4; Garcia J, 2012, NUCLEIC ACIDS RES, V40, P10254, DOI 10.1093/nar/gks846; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Holbrook JA, 2001, J MOL BIOL, V310, P379, DOI 10.1006/jmbi.2001.4768; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049885; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; LUSK JE, 1968, J BIOL CHEM, V243, P2618; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; Mellies JL, 2011, MICROBIOL-SGM, V157, P1123, DOI 10.1099/mic.0.046094-0; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Steinmann R, 2013, FUTURE MICROBIOL, V8, P85, DOI [10.2217/FMB.12.129, 10.2217/fmb.12.129]; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905; Yerushalmi G, 2008, J BACTERIOL, V190, P7808, DOI 10.1128/JB.00663-08	45	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13739	13750		10.1074/jbc.M113.545954	http://dx.doi.org/10.1074/jbc.M113.545954			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668810	hybrid, Green Published			2022-12-28	WOS:000335984600008
J	Herzog, C; Haun, RS; Ludwig, A; Shah, SV; Kaushal, GP				Herzog, Christian; Haun, Randy S.; Ludwig, Andreas; Shah, Sudhir V.; Kaushal, Gur P.			ADAM10 Is the Major Sheddase Responsible for the Release of Membrane-associated Meprin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Kidney; Metalloprotease; Mouse; Shedding; siRNA; ADAM10; ADAM17; Meprin	AMINOBENZOIC ACID HYDROLASE; AMYLOID PRECURSOR PROTEIN; EPITHELIAL-CELL INJURY; NECROSIS-FACTOR-ALPHA; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; METALLOPROTEASE MEPRIN; IN-VITRO; DISINTEGRIN/METALLOPROTEINASE ADAM10; DIFFERENTIAL EXPRESSION	Background: Meprin A is a membrane-associated metalloproteinase in proximal tubules that plays an important role in acute kidney injury (AKI). Results: In ischemia-reperfusion injury, meprin A is shed from the membranes, and ADAM10 was identified as the major sheddase. Conclusion: ADAM10 is the major sheddase involved in the release of meprin A. Significance: These studies identify ADAM10 as a potential therapeutic target for AKI. Meprin A, composed of and subunits, is a membrane-bound metalloproteinase in renal proximal tubules. Meprin A plays an important role in tubular epithelial cell injury during acute kidney injury (AKI). The present study demonstrated that during ischemia-reperfusion-induced AKI, meprin A was shed from proximal tubule membranes, as evident from its redistribution toward the basolateral side, proteolytic processing in the membranes, and excretion in the urine. To identify the proteolytic enzyme responsible for shedding of meprin A, we generated stable HEK cell lines expressing meprin alone and both meprin and meprin for the expression of meprin A. Phorbol 12-myristate 13-acetate and ionomycin stimulated ectodomain shedding of meprin and meprin A. Among the inhibitors of various proteases, the broad spectrum inhibitor of the ADAM family of proteases, tumor necrosis factor- protease inhibitor (TAPI-1), was most effective in preventing constitutive, phorbol 12-myristate 13-acetate-, and ionomycin-stimulated shedding of meprin and meprin A in the medium of both transfectants. The use of differential inhibitors for ADAM10 and ADAM17 indicated that ADAM10 inhibition is sufficient to block shedding. In agreement with these results, small interfering RNA to ADAM10 but not to ADAM9 or ADAM17 inhibited meprin and meprin A shedding. Furthermore, overexpression of ADAM10 resulted in enhanced shedding of meprin from both transfectants. Our studies demonstrate that ADAM10 is the major ADAM metalloproteinase responsible for the constitutive and stimulated shedding of meprin and meprin A. These studies further suggest that inhibiting ADAM 10 activity could be of therapeutic benefit in AKI.	[Herzog, Christian; Haun, Randy S.; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Herzog, Christian; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA; [Haun, Randy S.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52062 Aachen, Germany; [Ludwig, Andreas] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, D-52062 Aachen, Germany	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; RWTH Aachen University; RWTH Aachen University	Kaushal, GP (corresponding author), Cent Arkansas Vet Healthcare Syst, 4300 West 7th St,111D, Little Rock, AR 72205 USA.	kaushalgurp@uams.edu	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986; Herzog, Christian/0000-0001-6024-3491	National Institutes of Health [R01 DK081690]; Veterans Affairs Merit Awards [BX000538, BX000828]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000828, I01BX000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK081690. This work was also supported by Veterans Affairs Merit Awards BX000538 and BX000828 (to G. P. K. and R. K. H., respectively).	Ambort D, 2010, MATRIX BIOL, V29, P31, DOI 10.1016/j.matbio.2009.08.007; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Bao JL, 2013, AM J PHYSIOL-RENAL, V305, pF714, DOI 10.1152/ajprenal.00179.2012; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bylander J, 2008, AM J PHYSIOL-RENAL, V294, pF480, DOI 10.1152/ajprenal.00214.2007; Carmago S, 2002, KIDNEY INT, V61, P959, DOI 10.1046/j.1523-1755.2002.00209.x; Cong R, 2011, AM J PHYSIOL-CELL PH, V300, pC1366, DOI 10.1152/ajpcell.00451.2010; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Garcia-Caballero A, 2011, CHANNELS, V5, P14, DOI 10.4161/chan.5.1.13759; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2007, KIDNEY INT, V71, P1009, DOI 10.1038/sj.ki.5002189; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumar JM, 2001, BBA-GENE STRUCT EXPR, V1518, P106, DOI 10.1016/S0167-4781(01)00188-9; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; Pischitzis A, 1999, EUR J BIOCHEM, V261, P421, DOI 10.1046/j.1432-1327.1999.00268.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schramme A, 2008, KIDNEY INT, V74, P328, DOI 10.1038/ki.2008.181; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sterchi EE, 2008, MOL ASPECTS MED, V29, P255, DOI 10.1016/j.mam.2008.08.007; Takayama J, 2008, EUR J PHARMACOL, V581, P157, DOI 10.1016/j.ejphar.2007.11.044; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; YAMAGUCHI T, 1994, BIOL CHEM H-S, V375, P821; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008	71	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13308	13322		10.1074/jbc.M114.559088	http://dx.doi.org/10.1074/jbc.M114.559088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24662289	hybrid, Green Published			2022-12-28	WOS:000335522800030
J	Liu, SQ; Jiang, S; Li, CR; Zhang, BJ; Li, QJ				Liu, Si-Qi; Jiang, Shan; Li, Chaoran; Zhang, Baojun; Li, Qi-Jing			miR-17-92 Cluster Targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to Promote TH17-mediated Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Cell Differentiation; Inflammation; MicroRNA; Pten; T Cell; IKZF4; Th17; miR-17-92	REGULATORY T-CELLS; ROR-GAMMA; MIR-17-SIMILAR-TO-92 FAMILY; IMMUNE FUNCTION; HELPER-CELLS; TH17 CELLS; DIFFERENTIATION; EXPRESSION; MICRORNA; LYMPHOCYTES	Background: miRNA is a key component of post-transcriptional network governing the fate of T cells. Results: By targeting PTEN and IKZF4, miR-17-92 cluster promotes T(H)17 differentiation and T(H)17-related inflammation. Conclusion: miR-19b and miR-17 within the cluster additively promote T(H)17 responses through distinct regulatory networks. Significance: Our study provides novel regulatory mechanisms and potential therapeutic candidates against autoimmunity. The miR-17-92 cluster regulates a broad spectrum of biological processes of T cell immunity. This cluster was found to facilitate T cell proliferation, enhance antitumor activities and promote T cell-dependent antibody responses. However, little is known about the role of this miRNA cluster in the development of autoimmune diseases. Multiple sclerosis is a neuro-destructive autoimmune disease caused by the pathogenicity of T(H)17 cells, whose differentiation is tightly controlled by a variety of transcriptional and post-transcriptional regulators. Our study unveils the critical role of miR-17-92 in T(H)17 differentiation: T cell-specific miR-17-92 deficiency reduced T(H)17 differentiation and ameliorated experimental autoimmune encephalomyelitis (EAE) symptoms. We demonstrated that miR-17 and miR-19b are the two miRNAs in this cluster responsible for promoting T(H)17 responses. MiR-19b represses the expression of Phosphatase and Tensin Homology (PTEN), thereby augmenting the PI3K-AKT-mTOR axis essential for proper T(H)17 differentiation. Meanwhile, miR-17 enhances T(H)17 polarization by inhibiting a novel target, Ikaros Family Zinc Finger 4 (IKZF4). By establishing the miR-17-92 cluster as a key driver of T(H)17 responses, our data identify this miRNA cluster as a potential therapeutic target for the clinical intervention of multiple sclerosis.	[Liu, Si-Qi; Jiang, Shan; Li, Chaoran; Zhang, Baojun; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, 207 Res Dr, Durham, NC 27710 USA.	Qi-Jing.Li@Duke.edu	ZHANG, BAOJUN/N-3863-2014; Liu, Siqi/AAL-6891-2020; Zhang, Baojun/AAN-8246-2020	ZHANG, BAOJUN/0000-0002-7786-4304; Liu, Siqi/0000-0001-9727-9498; 	NIAID, National Institutes of Health [RAI091878A, RAI091878B]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878, R56AI091878] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Grants RAI091878A and RAI091878B from the NIAID, National Institutes of Health.	Alkhatib A, 2012, J EXP MED, V209, P395, DOI 10.1084/jem.20110216; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lindberg RLP, 2010, EUR J IMMUNOL, V40, P888, DOI 10.1002/eji.200940032; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Lykken EA, 2011, IMMUNOL RES, V49, P87, DOI 10.1007/s12026-010-8196-4; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rottiers V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006840; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	49	115	119	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12446	12456		10.1074/jbc.M114.550723	http://dx.doi.org/10.1074/jbc.M114.550723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644282	Green Published, hybrid			2022-12-28	WOS:000335581400021
J	Yang, XL; Smith, AA; Williams, MS; Pal, U				Yang, Xiuli; Smith, Alexis A.; Williams, Mark S.; Pal, Utpal			A Dityrosine Network Mediated by Dual Oxidase and Peroxidase Influences the Persistence of Lyme Disease Pathogens within the Vector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Infectious Diseases; Innate Immunity; Microbiology; NADPH Oxidase; Nitric-oxide Synthase; Peroxidase; Protein Cross-linking	IXODES-SCAPULARIS TICKS; INNATE IMMUNE-RESPONSE; BORRELIA-BURGDORFERI; CAENORHABDITIS-ELEGANS; NITRIC-OXIDE; EXTRACELLULAR-MATRIX; ANNOTATED CATALOG; ANOPHELES-GAMBIAE; CROSS-LINKING; IMD PATHWAYS	Background: How tick immune components influence persistence of pathogens remains unknown. Results: Impairment of dityrosine network formed by a dual oxidase and a peroxidase activates specific immune genes and reduces pathogen survival. Conclusion: A dityrosine network influences persistence of Lyme disease pathogens. Significance: Knowledge of a Duox system in protein cross-linking may offer new strategies to disrupt pathogen life cycle. Ixodes scapularis ticks transmit a wide array of human and animal pathogens including Borrelia burgdorferi; however, how tick immune components influence the persistence of invading pathogens remains unknown. As originally demonstrated in Caenorhabditis elegans and later in Anopheles gambiae, we show here that an acellular gut barrier, resulting from the tyrosine cross-linking of the extracellular matrix, also exists in I. scapularis ticks. This dityrosine network (DTN) is dependent upon a dual oxidase (Duox), which is a member of the NADPH oxidase family. The Ixodes genome encodes for a single Duox and at least 16 potential peroxidase proteins, one of which, annotated as ISCW017368, together with Duox has been found to be indispensible for DTN formation. This barrier influences pathogen survival in the gut, as an impaired DTN in Doux knockdown or in specific peroxidase knockdown ticks, results in reduced levels of B. burgdorferi persistence within ticks. Absence of a complete DTN formation in knockdown ticks leads to the activation of specific tick innate immune pathway genes that potentially resulted in the reduction of spirochete levels. Together, these results highlighted the evolution of the DTN in a diverse set of arthropod vectors, including ticks, and its role in protecting invading pathogens like B. burgdorferi. Further understanding of the molecular basis of tick innate immune responses, vector-pathogen interaction, and their contributions in microbial persistence may help the development of new targets for disrupting the pathogen life cycle.	[Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Yang, Xiuli; Smith, Alexis A.; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Williams, Mark S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Pal, U (corresponding author), Univ Maryland, Dept Vet Med, Bldg 795,Rm 1341, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015		National Institutes of Health [R01AI080615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI080615 (to U. P.).	Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; de Silva AM, 2009, FRONT BIOSCI-LANDMRK, V14, P3051, DOI 10.2741/3434; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002; Govind S, 2004, PLOS BIOL, V2, P1065, DOI 10.1371/journal.pbio.0020276; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hynes WL, 2005, MED VET ENTOMOL, V19, P339, DOI 10.1111/j.1365-2915.2005.00579.x; Kariu T., 2011, J VIS EXP, V48, P2544; Kariu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078376; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Meitzler JL, 2010, J BIOL CHEM, V285, P40991, DOI 10.1074/jbc.M110.170902; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MODOLELL M, 1994, IMMUNOL LETT, V40, P139, DOI 10.1016/0165-2478(94)90185-6; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Pal U., 2010, BORRELIA MOL BIOL HO, P279; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Sonenshine DE, 2005, EXP APPL ACAROL, V36, P207, DOI 10.1007/s10493-005-2564-0; Sonenshine DE., 1993, BIOL TICKS; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tyson KR, 2009, ADV INSECT PHYSIOL, V37, P243, DOI 10.1016/S0065-2806(09)37005-8; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; ZHU Z, 1991, PARASITOL RES, V77, P635, DOI 10.1007/BF00931028	45	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12813	12822		10.1074/jbc.M113.538272	http://dx.doi.org/10.1074/jbc.M113.538272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24662290	Green Published, hybrid			2022-12-28	WOS:000335581400050
J	Zhang, WN; He, T; Wang, Q; Li, X; Wei, JM; Hou, XQ; Zhang, B; Huang, L; Wang, L				Zhang, Weina; He, Tao; Wang, Qiong; Li, Xin; Wei, Jianming; Hou, Xiaoqiang; Zhang, Bin; Huang, Lei; Wang, Li			Interleukin-1 Receptor-associated Kinase-2 Genetic Variant rs708035 Increases NF-kappa B Activity through Promoting TRAF6 Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Gene Regulation; Inflammation; Signal Transduction; Toll-like Receptors (TLR)	TOLL-LIKE RECEPTOR-3; INFLUENZA-A-VIRUS; IRAK-M; SIGNALING COMPLEXES; IMMUNE-RESPONSE; MICE LACKING; ACTIVATION; FAMILY; CANCER; TAB2	Background: Single nucleotide polymorphisms (SNPs) within the IRAK genes have been discovered recently. However, the functions of these IRAK SNPs remain largely unknown. Results: Non-synonymous IRAK2 variant, rs708035, increases NF-B activity through promoting TRAF6 ubiquitination. Conclusion: Genetic alteration of IRAK2 affects its regulation on NF-B activation. Significance: Our study provides an important insight of IRAK2 SNP in the regulation of NF-B activation. The IL-1 receptor-associated kinases (IRAKs) are key regulators of Toll-like receptor (TLR)/IL-1 signaling, which are critical regulators of mammalian inflammation and innate immune response. Single nucleotide polymorphisms (SNPs) within the IRAK genes have been discovered recently. However, the functions of these IRAK SNPs remain largely unknown. Here, we found that the non-synonymous IRAK2 variant rs708035 (coding D431E) increases NF-B activity and leads to more expression of NF-B-dependent proinflammatory cytokines compared with IRAK2 wild type. Moreover, when IRAK2 knockdown cells reconstituted with siRNA-resistant WT-IRAK2 or D431E-IRAK2 were infected with influenza virus, a more obvious induction of IL-6 and a stronger anti-apoptosis effect were observed in D431E-IRAK2 expressing cells. Notably, we also found that the levels of proinflammatory cytokine-IL-6 were indeed higher in people carrying D431E-IRAK2 than those carrying WT-IRAK2. Further study demonstrated that elevated NF-B activation mediated by the IRAK2 variant was due to increased TRAF6 ubiquitination and faster IB degradation. Our study provides important insight of IRAK2 SNP in the regulation of NF-B activation and indicates that IRAK2 rs708035 might be associated with human diseases caused by hyper-activation of NF-B.	[Zhang, Weina; He, Tao; Wang, Qiong; Li, Xin; Wei, Jianming; Hou, Xiaoqiang; Zhang, Bin; Wang, Li] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Wei, Jianming] PLA, Hosp 307, Beijing 100071, Peoples R China; [Huang, Lei] PLA, Hosp 302, Beijing 100071, Peoples R China	Academy of Military Medical Sciences - China; Fifth Medical Center of Chinese PLA General Hospital	Huang, L (corresponding author), PLA, Hosp 302, Beijing 100071, Peoples R China.	huangleiwa@sina.com; liwang@tsinghua.edu.cn	lei, huang/AFS-7785-2022		National Hi-tech Research and Development Program of China [2012AA022002, 2012AA02207]; Chinese Key Program for Drug Invention Grant [2012ZX09J12106-03]; National Natural Science Foundation of China [30800644, 31100940, 31271447, 61308103]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA022002] Funding Source: NIH RePORTER	National Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Key Program for Drug Invention Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Hi-tech Research and Development Program of China Grants 2012AA022002 and 2012AA02207, Chinese Key Program for Drug Invention Grant 2012ZX09J12106-03, and National Natural Science Foundation of China Grants 30800644, 31100940, 31271447, and 61308103.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishida R, 2003, J BONE MINER RES, V18, P419, DOI 10.1359/jbmr.2003.18.3.419; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mills Kingston H G, 2009, Nat Med, V15, P1363, DOI 10.1038/nm1209-1363; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thomas JA, 1999, J IMMUNOL, V163, P978; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2	43	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12507	12519		10.1074/jbc.M113.538009	http://dx.doi.org/10.1074/jbc.M113.538009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24662294	hybrid, Green Published			2022-12-28	WOS:000335581400026
J	Ewens, CA; Panico, S; Kloppsteck, P; McKeown, C; Ebong, IO; Robinson, C; Zhang, XD; Freemont, PS				Ewens, Caroline A.; Panico, Silvia; Kloppsteck, Patrik; McKeown, Ciaran; Ebong, Ima-Obong; Robinson, Carol; Zhang, Xiaodong; Freemont, Paul S.			The p97-FAF1 Protein Complex Reveals a Common Mode of p97 Adaptor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Electron Microscopy (EM); Fas; Isothermal Titration Calorimetry; Protein Cross-linking; FAF1; p97	VALOSIN-CONTAINING PROTEIN; FAS-ASSOCIATED FACTOR-1; AAA-ATPASE; KAPPA-B; PROTEASOME; VCP/P97; P97/VCP; DOMAIN; FAF1	Background: p97 function is facilitated by a huge array of varied adaptor proteins, including FAF1. Results: FAF1 binds over the AAA rings of p97 alone and in a trimer-hexamer arrangement. Conclusion: p97 and FAF1 bind with a similar affinity and in a similar conformation to other p97-adaptor complexes. Significance: p97 binds multiple different adaptors by a common mode. p97, also known as valosin-containing protein, is a versatile participant in the ubiquitin-proteasome system. p97 interacts with a large network of adaptor proteins to process ubiquitylated substrates in different cellular pathways, including endoplasmic reticulum-associated degradation and transcription factor activation. p97 and its adaptor Fas-associated factor-1 (FAF1) both have roles in the ubiquitin-proteasome system during NF-B activation, although the mechanisms are unknown. FAF1 itself also has emerging roles in other cell-cycle pathways and displays altered expression levels in various cancer cell lines. We have performed a detailed study the p97-FAF1 interaction. We show that FAF1 binds p97 stably and in a stoichiometry of 3 to 6. Cryo-EM analysis of p97-FAF1 yielded a 17 reconstruction of the complex with FAF1 above the p97 ring. Characteristics of p97-FAF1 uncovered in this study reveal common features in the interactions of p97, providing mechanistic insight into how p97 mediates diverse functionalities.	[Ewens, Caroline A.; Panico, Silvia; Kloppsteck, Patrik; McKeown, Ciaran; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Struct Biol Ctr, London SW7 2AZ, England; [Ebong, Ima-Obong; Robinson, Carol] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	Imperial College London; University of Oxford	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Zhang, Xiaodong/0000-0001-9786-7038; Panico, Silvia/0000-0002-2196-0727; Freemont, Paul/0000-0002-5658-8486; robinson, carol/0000-0001-7829-5505	Biotechnology and Biological Sciences Research Council; Wellcome Trust; CRUK; Cancer Research UK [13449] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and CRUK.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Grant T., 2007, THESIS IMPERIAL COLL; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644	31	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12077	12084		10.1074/jbc.M114.559591	http://dx.doi.org/10.1074/jbc.M114.559591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619421	hybrid, Green Published			2022-12-28	WOS:000335010600045
J	Ivanova, AA; East, MP; Yi, SL; Kahn, RA				Ivanova, Anna A.; East, Michael P.; Yi, Slee L.; Kahn, Richard A.			Characterization of Recombinant ELMOD ( Cell Engulfment and Motility Domain) Proteins as GTPase-activating Proteins ( GAPs) for ARF Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ARF; Enzyme Kinetics; GTPase; Sigma Receptor; Signal Transduction; ARL2; ELMOD; GTPase-activating Protein (GAP); HEK Cell Expression; Sigma-1 Receptor (S1R)	ADP-RIBOSYLATION FACTOR; ACID PHOSPHOLIPIDS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; THERAPEUTIC DRUGS; RECEPTOR LIGANDS; STRUCTURAL BASIS; RNA-POLYMERASE; CLONED GENES; EXPRESSION; COMPLEX	Background: ELMOD proteins are atypical GAPs for the ARF family with links to deafness. Results: ELMOD proteins have distinct specific activities for ARF proteins and bind the non-opioid sigma-1 receptor. Conclusion: Different specific activities of ELMOD1-3 are predicted to underlie different cellular functions. Significance: Specificities and regulation of ELMODs contribute to understanding their roles in cell signaling and the inner ear. The ARF family of regulatory GTPases, within the RAS superfamily, is composed of approximate to 30 members in mammals, including up to six ARF and at least 18 ARF-like (ARL) proteins. They exhibit significant structural and biochemical conservation and regulate a variety of essential cellular processes, including membrane traffic, cell division, and energy metabolism; each with links to human diseases. We previously identified members of the ELMOD family as GTPase-activating proteins (GAPs) for ARL2 that displayed crossover activity for ARFs as well. To further characterize the GAP activities of the three human ELMODs as GAPs we developed new preparations of each after overexpression in human embryonic kidney (HEK293T) cells. This allowed much higher specific activities and enhanced stability and solubility of the purified proteins. The specificities of ELMOD1-3 as GAPs for six different members of the ARF family were determined and found to display wide variations, which we believe will reveal differences in cellular functions of family members. The non-opioid sigma-1 receptor (S1R) was identified as a novel effector of GAP activity of ELMOD1-3 proteins as its direct binding to either ELMOD1 or ELMOD2 resulted in loss of GAP activity. These findings are critical to understand the roles of ELMOD proteins in cell signaling in general and in the inner ear specifically, and open the door to exploration of the regulation of their GAP activities via agonists or antagonists of the S1R.	[Ivanova, Anna A.; East, Michael P.; Yi, Slee L.; Kahn, Richard A.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), 1510 Clifton Rd,Room G-217, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; Ivanova, Anna/GZK-6458-2022	Kahn, Richard/0000-0002-0259-0601; 	National Institutes of Health [GM090158, GM61268]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110663, R01GM090158, R01GM061268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM090158 and GM61268 (to A. A. I. and R. A. K.).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Jaworek TJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003774; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 1996, J LIPID MEDIAT CELL, V14, P209, DOI 10.1016/0929-7855(96)00527-5; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; POLAKIS P, 1992, CANCER SURV, V12, P25; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Skuza G, 2004, PHARMACOPSYCHIATRY, V37, pS183, DOI 10.1055/s-2004-832676; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TERUI T, 1994, J BIOL CHEM, V269, P28130; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Zheng Y, 1996, J BIOL CHEM, V271, P23815, DOI 10.1074/jbc.271.39.23815	52	28	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11111	11121		10.1074/jbc.M114.548529	http://dx.doi.org/10.1074/jbc.M114.548529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616099	Green Published, hybrid			2022-12-28	WOS:000334638500015
J	Peyrot, SM; Nachtergaele, S; Luchetti, G; Mydock-McGrane, LK; Fujiwara, H; Scherrer, D; Jallouk, A; Schlesinger, PH; Ory, DS; Covey, DF; Rohatgi, R				Peyrot, Sara M.; Nachtergaele, Sigrid; Luchetti, Giovanni; Mydock-McGrane, Laurel K.; Fujiwara, Hideji; Scherrer, David; Jallouk, Andrew; Schlesinger, Paul H.; Ory, Daniel S.; Covey, Douglas F.; Rohatgi, Rajat			Tracking the Subcellular Fate of 20( S)-Hydroxycholesterol with Click Chemistry Reveals a Transport Pathway to the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Imaging; Lipids; Lysosomes; Signaling; Trafficking; Oxysterol	CELLULAR CHOLESTEROL HOMEOSTASIS; OXYSTEROL-BINDING PROTEINS; PICK C1 DISEASE; IN-VIVO; LIVING CELLS; ENDOPLASMIC-RETICULUM; STROMAL CELLS; MEMBRANE; STEROL; TRAFFICKING	Background: Oxysterols are a class of emerging signaling molecules whose cell biology is poorly understood. Results: A click chemistry-based imaging strategy shows that 20(S)-hydroxycholesterol accumulates in Golgi membranes in a process that depends on ATP and lysosome function. Conclusion: 20(S)-Hydroxycholesterol is transported through a vesicular pathway to the Golgi. Significance: Specific transport pathways may regulate the oxysterol content of cellular membranes. Oxysterols, oxidized metabolites of cholesterol, are endogenous small molecules that regulate lipid metabolism, immune function, and developmental signaling. Although the cell biology of cholesterol has been intensively studied, fundamental questions about oxysterols, such as their subcellular distribution and trafficking pathways, remain unanswered. We have therefore developed a useful method to image intracellular 20(S)-hydroxycholesterol with both high sensitivity and spatial resolution using click chemistry and fluorescence microscopy. The metabolic labeling of cells with an alkynyl derivative of 20(S)-hydroxycholesterol has allowed us to directly visualize this oxysterol by attaching an azide fluorophore through cyclo-addition. Unexpectedly, we found that this oxysterol selectively accumulates in the Golgi membrane using a pathway that is sensitive to ATP levels, temperature, and lysosome function. Although previous models have proposed nonvesicular pathways for the rapid equilibration of oxysterols between membranes, direct imaging of oxysterols suggests that a vesicular pathway is responsible for differential accumulation of oxysterols in organelle membranes. More broadly, clickable alkynyl sterols may represent useful tools for sterol cell biology, both to investigate the functions of these important lipids and to decipher the pathways that determine their cellular itineraries.	[Peyrot, Sara M.; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Nachtergaele, Sigrid; Luchetti, Giovanni; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Mydock-McGrane, Laurel K.; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Jallouk, Andrew; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fujiwara, Hideji; Scherrer, David; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	rrohatgi@stanford.edu			National Institutes of Health [GM47969, HL67773, 5 T32 HL007275]; Stand Up to Cancer Innovation Award from the American Association for Cancer Research; National Science Foundation Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [R00CA129174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, P01GM047969, R01GM106078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Innovation Award from the American Association for Cancer Research; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47969 and HL67773 (to D. F. C.), HL67773 (to D. S. O.), and Training Grant 5 T32 HL007275 (to L. K. M.). This work was also supported by a Stand Up to Cancer Innovation Award from the American Association for Cancer Research (to R. R.) and by a National Science Foundation Graduate Research Fellowship (to S. N.).	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Bernardin A, 2010, BIOCONJUGATE CHEM, V21, P583, DOI 10.1021/bc900564w; Bielska AA, 2012, TRENDS ENDOCRIN MET, V23, P99, DOI 10.1016/j.tem.2011.12.002; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang PV, 2012, CHEM COMMUN, V48, P8864, DOI 10.1039/c2cc31845h; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Christian AE, 1997, J LIPID RES, V38, P2264; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; DUNN WA, 1980, J BIOL CHEM, V255, P5971; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hofmann K, 2014, J LIPID RES, V55, P583, DOI 10.1194/jlr.D044727; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Kim WK, 2010, J BONE MINER RES, V25, P782, DOI 10.1359/jbmr.091024; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LANGE Y, 1995, J LIPID RES, V36, P1092; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Lin YY, 2003, J STEROID BIOCHEM, V85, P57, DOI 10.1016/S0960-0760(03)00137-7; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Marks DL, 2002, TRENDS CELL BIOL, V12, P605, DOI 10.1016/S0962-8924(02)02399-1; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; ROBERTS KD, 1969, BIOCHEMISTRY-US, V8, P1259, DOI 10.1021/bi00831a061; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHATTNER A, 1991, POSTGRAD MED J, V67, P223, DOI 10.1136/pgmj.67.785.223; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; THEUNISSEN JJH, 1986, BIOCHIM BIOPHYS ACTA, V860, P66, DOI 10.1016/0005-2736(86)90499-2; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	72	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11095	11110		10.1074/jbc.M113.540351	http://dx.doi.org/10.1074/jbc.M113.540351			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596093	Green Published, hybrid			2022-12-28	WOS:000334638500014
J	Morone, S; Augeri, S; Cuccioloni, M; Mozzicafreddo, M; Angeletti, M; Lo Buono, N; Giacomino, A; Ortolan, E; Funaro, A				Morone, Simona; Augeri, Stefania; Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Angeletti, Mauro; Lo Buono, Nicola; Giacomino, Alice; Ortolan, Erika; Funaro, Ada			Binding of CD157 Protein to Fibronectin Regulates Cell Adhesion and Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Receptor; Extracellular Matrix; Fibronectin; Membrane Protein; BST-1; CD157; Heparin-binding Domain	ADP-RIBOSYL CYCLASE; EXTRACELLULAR-MATRIX; SURFACE-MOLECULE; ECTOENZYMES; KINASE; CD38; BST-1/CD157; PHYSIOLOGY; RECEPTOR; COMPLEX	CD157/BST-1 behaves both as an ectoenzyme and signaling receptor and is an important regulator of leukocyte trafficking and ovarian cancer progression. However, the molecular interactions underpinning the role of CD157 in these processes remain obscure. The biological functions of CD157 and its partnership with members of the integrin family prompted us to assume the existence of a direct interaction between CD157 and an unknown component of the extracellular matrix. Using solid-phase binding assays and surface plasmon resonance analysis, we demonstrated that CD157 binds fibronectin with high affinity within its heparin-binding domains 1 and 2. Furthermore, we found that CD157 binds to other extracellular matrix proteins containing heparin-binding domains. Finally, we proved that the CD157-fibronectin interaction occurs with living cells, where it elicits CD157-mediated cell responses. Indeed, knockdown of CD157 in Met-5A mesothelial cells changed their morphology and cytoskeleton organization and attenuated the activation of intracellular signaling pathways triggered by fibronectin. This led to impaired cell spreading and adhesion to selected extracellular matrix proteins. Collectively, these findings indicate a central role of CD157 in cell-extracellular matrix interactions and make CD157 an attractive therapeutic target in inflammation and cancer.	[Morone, Simona; Augeri, Stefania; Lo Buono, Nicola; Giacomino, Alice; Ortolan, Erika; Funaro, Ada] Univ Turin, Dept Med Sci, Immunogenet Lab, I-10126 Turin, Italy; [Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Angeletti, Mauro] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy	University of Turin; University of Camerino	Funaro, A (corresponding author), Univ Turin, Dept Med Sci, 10126 Via Santena 19, Turin, Italy.	ada.funaro@unito.it	Angeletti, Mauro/AAC-5597-2019; Cuccioloni, Massimiliano/X-7188-2019; Mozzicafreddo, M./AAW-2816-2021; Funaro, Ada/AAC-3203-2019; Lo Buono, Nicola/F-4817-2013	Angeletti, Mauro/0000-0001-6719-5517; Mozzicafreddo, M./0000-0001-9835-8446; Funaro, Ada/0000-0001-6341-1817; Lo Buono, Nicola/0000-0001-5538-6869; ORTOLAN, Erika/0000-0003-2287-9020; Cuccioloni, Massimiliano/0000-0002-6025-1990	Italian Association for Cancer Research [IG 11602]; Italian Ministry for University and Scientific Research; International Foundation for Research in Experimental Medicine; Fondazione Umberto Veronesi	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); International Foundation for Research in Experimental Medicine; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was supported by Italian Association for Cancer Research Grant IG 11602 (to E. O.), Italian Ministry for University and Scientific Research 60% Projects (to A. F.), and The International Foundation for Research in Experimental Medicine.; Supported by a fellowship from the Fondazione Umberto Veronesi.	BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Funaro A, 2004, BLOOD, V104, P4269, DOI 10.1182/blood-2004-06-2129; Funaro A, 2009, FRONT BIOSCI-LANDMRK, V14, P929, DOI 10.2741/3287; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hussain AMM, 1999, CELL SIGNAL, V11, P891, DOI 10.1016/S0898-6568(99)00057-1; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; Lo Buono N, 2011, J BIOL CHEM, V286, P18681, DOI 10.1074/jbc.M111.227876; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morone S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043649; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Okuyama Y, 1996, BIOCHEM BIOPH RES CO, V228, P838, DOI 10.1006/bbrc.1996.1741; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Ortolan E, 2006, BLOOD, V108, P4214, DOI 10.1182/blood-2006-04-017160; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pirazzoli V, 2013, BLOOD, V121, P2316, DOI 10.1182/blood-2012-08-451187; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Todd 3rd R.F., 1995, LEUKOCYTE TYPING, P991; TODD RF, 1985, BLOOD, V65, P964; Yamamoto-Katayama S, 2001, BIOCHEM J, V357, P385, DOI 10.1042/0264-6021:3570385; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386	41	20	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15588	15601		10.1074/jbc.M113.535070	http://dx.doi.org/10.1074/jbc.M113.535070			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753259	Green Published, hybrid			2022-12-28	WOS:000337465400041
J	Moktan, H; Guiraldelli, MF; Eyster, CA; Zhao, WX; Lee, CY; Mather, T; Camerini-Otero, RD; Sung, P; Zhou, DHH; Pezza, RJ				Moktan, Hem; Guiraldelli, Michel F.; Eyster, Craig A.; Zhao, Weixing; Lee, Chih-Ying; Mather, Timothy; Camerini-Otero, R. Daniel; Sung, Patrick; Zhou, Donghua H.; Pezza, Roberto J.			Solution Structure and DNA-binding Properties of the Winged Helix Domain of the Meiotic Recombination HOP2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; CHROMOSOME SEGREGATION; HOP2-MND1 COMPLEX; OPERATOR COMPLEX; CHEMICAL-SHIFTS; MEIOSIS; MND1; INSIGHTS; REVEALS; RAD51	The HOP2 protein is required for efficient double-strand break repair which ensures the proper synapsis of homologous chromosomes and normal meiotic progression. We previously showed that in vitro HOP2 shows two distinctive activities: when it is incorporated into a HOP2-MND1 heterodimer, it stimulates DMC1 and RAD51 recombination activities, and the purified HOP2 alone is proficient in promoting strand invasion. The structural and biochemical basis of HOP2 action in recombination are poorly understood; therefore, they are the focus of this work. Herein, we present the solution structure of the amino-terminal portion of mouse HOP2, which contains a typical winged helix DNA-binding domain. Together with NMR spectral changes in the presence of double-stranded DNA, protein docking on DNA, and mutation analysis to identify the amino acids involved in DNA coordination, our results on the three-dimensional structure of HOP2 provide key information on the fundamental structural and biochemical requirements directing the interaction of HOP2 with DNA. These results, in combination with mutational experiments showing the role of a coiled-coil structural feature involved in HOP2 self-association, allow us to explain important aspects of the function of HOP2 in recombination.	[Moktan, Hem; Zhou, Donghua H.] Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA; [Guiraldelli, Michel F.; Eyster, Craig A.; Lee, Chih-Ying; Pezza, Roberto J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Program, Oklahoma City, OK 73104 USA; [Zhao, Weixing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Mather, Timothy] Oklahoma Med Res Fdn, Cardiovasc Biol Program, Oklahoma City, OK 73104 USA; [Mather, Timothy] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73126 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma Medical Research Foundation; Yale University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		zhao, weixing/0000-0001-5746-3696; Zhou, Donghua/0000-0002-6638-4014	NIGMS, National Institutes of Health [1P20GM103636]; Oklahoma Center for the Advancement of Science and Technology Grant [HR10-48S]; National Institutes of Health [GM097713]; Oklahoma Center for the Advancement of Science and Technology [HR12-050]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052033] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIGMS, National Institutes of Health Award 1P20GM103636 and by Oklahoma Center for the Advancement of Science and Technology Grant HR10-48S (to R. J. P.). This work was also supported by National Institutes of Health Grant GM097713 (to D. H. Z.) and Oklahoma Center for the Advancement of Science and Technology Grant HR12-050 (to D. H. Z.).	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BascomSlack CA, 1997, ADV GENET, V35, P253, DOI 10.1016/S0065-2660(08)60452-6; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boudet J, 2007, NUCLEIC ACIDS RES, V35, P4384, DOI 10.1093/nar/gkm448; Boura E, 2010, ACTA CRYSTALLOGR D, V66, P1351, DOI 10.1107/S0907444910042228; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finnin MS, 1997, EMBO J, V16, P1992, DOI 10.1093/emboj/16.8.1992; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Raman S, 2010, J AM CHEM SOC, V132, P202, DOI 10.1021/ja905934c; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Tang Yuefeng, 2010, Journal of Structural and Functional Genomics, V11, P223, DOI 10.1007/s10969-010-9095-6; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Van Melckebeke H, 2003, J MOL BIOL, V333, P711, DOI 10.1016/j/jmb.2003.09.005; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	43	10	10	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14682	14691		10.1074/jbc.M114.548180	http://dx.doi.org/10.1074/jbc.M114.548180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711446	Green Published, hybrid			2022-12-28	WOS:000337248100025
J	Chen, SR; Chen, H; Yuan, WX; Wess, J; Pan, HL				Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Wess, Juergen; Pan, Hui-Lin			Differential Regulation of Primary Afferent Input to Spinal Cord by Muscarinic Receptor Subtypes Delineated Using Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetylcholinesterase; Cholinergic Receptor; Gene Knockout; Glutamate; Neurons; Pain; Synaptic Plasticity; Acetylcholine; Muscarinic; Spinal Cord	DORSAL-HORN NEURONS; METABOTROPIC GLUTAMATE RECEPTORS; SUBSTANTIA GELATINOSA NEURONS; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTORS; AUTORADIOGRAPHIC LOCALIZATION; CHOLINESTERASE INHIBITION; SYNAPTIC-TRANSMISSION; GABA(B) RECEPTORS; GLYCINERGIC INPUT	Background: Activation of muscarinic receptors reduces pain at the spinal level. Results: M-2 and M-4 subtypes mediate muscarinic inhibition of sensory nerve input. M-5 subtype stimulation directly increases sensory input or indirectly inhibits it through metabotropic glutamate receptors. Conclusion: M-2, M-4, and M-5 subtypes differentially regulate nociceptive input to the spinal cord. Significance: This study demonstrates how individual muscarinic receptor subtypes control pain transmission. Stimulation of muscarinic acetylcholine receptors (mAChRs) inhibits nociceptive transmission at the spinal level. However, it is unclear how each mAChR subtype regulates excitatory synaptic input from primary afferents. Here we examined excitatory postsynaptic currents (EPSCs) of dorsal horn neurons evoked by dorsal root stimulation in spinal cord slices from wild-type and mAChR subtype knock-out (KO) mice. In wild-type mice, mAChR activation with oxotremorine-M decreased the amplitude of monosynaptic EPSCs in approximate to 67% of neurons but increased it in approximate to 10% of neurons. The inhibitory effect of oxotremorine-M was attenuated by the M-2/M-4 antagonist himbacine in the majority of neurons, and the remaining inhibition was abolished by group II/III metabotropic glutamate receptor (mGluR) antagonists in wild-type mice. In M-2/M-4 double-KO mice, oxotremorine-M inhibited monosynaptic EPSCs in significantly fewer neurons (approximate to 26%) and increased EPSCs in significantly more neurons (33%) compared with wild-type mice. Blocking group II/III mGluRs eliminated the inhibitory effect of oxotremorine-M in M-2/M-4 double-KO mice. In M-2 single-KO and M-4 single-KO mice, himbacine still significantly reduced the inhibitory effect of oxotremorine-M. However, the inhibitory and potentiating effects of oxotremorine-M on EPSCs in M-3 single-KO and M-1/M-3 double-KO mice were similar to those in wild-type mice. In M-5 single-KO mice, oxotremorine-M failed to potentiate evoked EPSCs, and its inhibitory effect was abolished by himbacine. These findings indicate that activation of presynaptic M-2 and M-4 subtypes reduces glutamate release from primary afferents. Activation of the M-5 subtype either directly increases primary afferent input or inhibits it through indirectly stimulating group II/III mGluRs.	[Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Wess, Juergen] NIDDK, Bioorgan Chem Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [NS073935, NS045602]; N. G. and Helen T. Hawkins Endowment; Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935, R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS073935 and NS045602. This work was also supported by a grant from the N. G. and Helen T. Hawkins Endowment (to H.-L. P.).; Supported by the Intramural Research Program of NIDDK, National Institutes of Health.	Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cao XH, 2011, J NEUROCHEM, V119, P594, DOI 10.1111/j.1471-4159.2011.07456.x; Chen SR, 2010, J BIOL CHEM, V285, P40427, DOI 10.1074/jbc.M110.176966; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doller D, 1999, BIOORG MED CHEM LETT, V9, P901, DOI 10.1016/S0960-894X(99)00101-8; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; Gerber G, 2000, NEUROSCIENCE, V100, P393, DOI 10.1016/S0306-4522(00)00269-4; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Hoglund AU, 1997, J PHARMACOL EXP THER, V281, P470; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; MCKINNEY M, 1993, PROG BRAIN RES, V98, P333; MILLER JH, 1992, J PHARMACOL EXP THER, V263, P663; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; NAGUIB M, 1994, ANESTHESIOLOGY, V80, P1338, DOI 10.1097/00000542-199406000-00022; Nakayama M, 2001, J CLIN ANESTH, V13, P86, DOI 10.1016/S0952-8180(01)00218-5; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; SCATTON B, 1984, NEUROSCI LETT, V49, P239, DOI 10.1016/0304-3940(84)90296-9; Stefani A, 1998, EXP BRAIN RES, V119, P237, DOI 10.1007/s002210050337; VILLIGER JW, 1985, BRAIN RES, V345, P196, DOI 10.1016/0006-8993(85)90854-6; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; YAMAMURA HI, 1983, EUR J PHARMACOL, V91, P147, DOI 10.1016/0014-2999(83)90379-5; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Yung KKL, 1997, NEUROSCI LETT, V229, P81, DOI 10.1016/S0304-3940(97)00426-6; Zhang HM, 2009, NEUROSCIENCE, V158, P875, DOI 10.1016/j.neuroscience.2008.10.042; Zhang HM, 2006, MOL PHARMACOL, V69, P1048, DOI 10.1124/mol.105.018069; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhang HM, 2007, J PHARMACOL EXP THER, V323, P963, DOI 10.1124/jpet.107.127795; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	44	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14321	14330		10.1074/jbc.M114.550384	http://dx.doi.org/10.1074/jbc.M114.550384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695732	hybrid, Green Published			2022-12-28	WOS:000335984600057
J	Foradori, MJ; Chen, Q; Fernandez, CA; Harper, J; Li, X; Tsang, PCW; Langer, R; Moses, MA				Foradori, Matthew J.; Chen, Qian; Fernandez, Cecilia A.; Harper, Jay; Li, Xin; Tsang, Paul C. W.; Langer, Robert; Moses, Marsha A.			Matrilin-1 Is an Inhibitor of Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cartilage; Endothelium; Mass Spectrometry (MS); Matrix Metalloproteinase (MMP)	CARTILAGE MATRIX PROTEIN; RENAL-CELL CARCINOMA; PHASE-III TRIAL; CHONDROMODULIN-I; SHARK CARTILAGE; ANGIOGENESIS INHIBITOR; NEOVASTAT AE-941; TUMOR-GROWTH; TISSUE INHIBITOR; ENDOCHONDRAL OSSIFICATION	Background: The relative avascularity of cartilage has made it a promising source of angiogenesis inhibitors. Results: MATN-1, identified by mass spectrometry, suppresses capillary endothelial cell proliferation and migration. Conclusion: MATN-1 is a novel inhibitor of neovascularization in vivo and in vitro. Significance: This is the first demonstration that MATN-1 is an inhibitor of both normal and pathological neovascularization. In the course of conducting a series of studies whose goal was to discover novel endogenous angiogenesis inhibitors, we have purified matrilin-1 (MATN-1) and have demonstrated, for the first time, that it inhibits neovascularization both in vitro and in vivo. Proteins were extracted from cartilage using a 2 m NaCl, 0.01 m HEPES buffer at 4 degrees C, followed by concentration of the extract. The concentrate was fractionated by size exclusion chromatography, and fractions were then screened for their ability to inhibit capillary endothelial cell (EC) proliferation in vitro. Fractions containing EC inhibitory activity were pooled and further purified by cation exchange chromatography. The resulting fractions from this step were then screened to isolate the antiangiogenic activity in vitro. This activity was identified by tandem mass spectrometry as being MATN-1. Human MATN-1 was cloned and expressed in Pichia pastoris and purified to homogeneity. Purified recombinant MATN-1, along with purified native protein, was shown to inhibit angiogenesis in vivo using the chick chorioallantoic membrane assay by the inhibition of capillary EC proliferation and migration. Finally, using a MATN-1-deficient mouse, we showed that angiogenesis during fracture healing was significantly higher in MATN-1(-/-) mice compared with the wild type mice as demonstrated by in vivo imaging and by elevated expression of angiogenesis markers including PECAM1, VEGFR, and VE-cadherin.	[Moses, Marsha A.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Moses, Marsha A.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Foradori, Matthew J.; Fernandez, Cecilia A.; Harper, Jay; Moses, Marsha A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Qian; Li, Xin] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA; [Tsang, Paul C. W.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Langer, Robert] MIT, Dept Biochem Engn, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University System Of New Hampshire; University of New Hampshire; Massachusetts Institute of Technology (MIT)	Moses, MA (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Karp Family Res Bldg,Rm 12-214,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; LI, XIN/0000-0003-0003-8554	National Institutes of Health [AT00650, AG017021, GM104937]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AT00650, AG017021, and GM104937.	Batist G, 2002, ANN ONCOL, V13, P1259, DOI 10.1093/annonc/mdf195; Beliveau R, 2002, CLIN CANCER RES, V8, P1242; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Davies CD, 2001, BRIT J CANCER, V85, P1968, DOI 10.1054/bjoc.2001.2180; Dupont E, 2002, CLIN EXP METASTAS, V19, P145, DOI 10.1023/A:1014546909573; Escudier B, 2007, J UROLOGY, V178, P1901, DOI 10.1016/j.juro.2007.07.035; Falardeau P, 2001, SEMIN ONCOL, V28, P620, DOI 10.1053/sonc.2001.28598; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gingras D, 2001, ANTICANCER RES, V21, P145; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Harper J, 2006, EXP SUPPL, V96, P223; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hiraki Y, 2005, CONNECT TISSUE RES, V46, P44, DOI 10.1080/03008200590935547; Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kang JA, 2003, BBA-GEN SUBJECTS, V1620, P59, DOI 10.1016/S0304-4165(02)00508-1; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; Kim JT, 2001, BBA-GENE STRUCT EXPR, V1517, P311, DOI 10.1016/S0167-4781(00)00255-4; Kusafuka K, 2002, ACTA HISTOCHEM, V104, P167, DOI 10.1078/0065-1281-00642; Langer R., 1991, BIOTECHNOLOGY, V9, P630; Latreille Jean, 2003, Clin Lung Cancer, V4, P231, DOI 10.3816/CLC.2003.n.003; LEE A, 1983, SCIENCE, V221, P1185, DOI 10.1126/science.6193581; Liang JH, 2000, ADV EXP MED BIOL, V476, P209; Lu C, 2010, JNCI-J NATL CANCER I, V102, P859, DOI 10.1093/jnci/djq179; Luo HY, 2007, ASIA PAC J CLIN NUTR, V16, P286; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MOSES MA, 1992, J CELL BIOL, V119, P475, DOI 10.1083/jcb.119.2.475; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Rabbani-Chadegani A, 2008, J PHARMACEUT BIOMED, V46, P563, DOI 10.1016/j.jpba.2007.10.029; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Sauder DN, 2002, J AM ACAD DERMATOL, V47, P535, DOI 10.1067/mjd.2002.124702; Shen XR, 2001, ACTA BIOCH BIOPH SIN, V33, P99; Sheu JR, 1998, ANTICANCER RES, V18, P4435; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Sund M, 2010, PHARMACEUTICALS, V3, P3021, DOI 10.3390/ph3103021; Wen W, 1999, CANCER RES, V59, P6052; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zilberman Y, 2008, J ORTHOP RES, V26, P522, DOI 10.1002/jor.20518	56	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14301	14309		10.1074/jbc.M113.529982	http://dx.doi.org/10.1074/jbc.M113.529982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692560	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000335984600055
J	Kopecka, M; Kosek, D; Kukacka, Z; Rezabkova, L; Man, P; Novak, P; Obsil, T; Obsilova, V				Kopecka, Miroslava; Kosek, Dalibor; Kukacka, Zdenek; Rezabkova, Lenka; Man, Petr; Novak, Petr; Obsil, Tomas; Obsilova, Veronika			Role of the EF-hand-like Motif in the 14-3-3 Protein- mediated Activation of Yeast Neutral Trehalase Nth1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Enzyme Mechanisms; Mass Spectrometry (MS); Protein Cross-linking; Protein Structure; 14-3-3; Bmh; H; D Exchange; SAXS; Neutral Trehalase	STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; 14-3-3-PROTEINS; PHOSPHORYLATION; GENE; MACROMOLECULES; INHIBITION; METABOLISM; CALCIUM	Background: The yeast neutral trehalase Nth1 is activated by the 14-3-3 protein binding. Results: The 14-3-3 protein induces a structural rearrangement of Nth1 with changes within the EF-hand like motif being essential for the activation process. Conclusion: The EF-hand-like motif-containing domain is crucial for the 14-3-3-dependent activation of Nth1. Significance: Structural basis of the mechanism of Nth1 activation. Trehalases hydrolyze the non-reducing disaccharide trehalose amassed by cells as a universal protectant and storage carbohydrate. Recently, it has been shown that the activity of neutral trehalase Nth1 from Saccharomyces cerevisiae is mediated by the 14-3-3 protein binding that modulates the structure of both the catalytic domain and the region containing the EF-hand-like motif, whose role in the activation of Nth1 is unclear. In this work, the structure of the Nth114-3-3 complex and the importance of the EF-hand-like motif were investigated using site-directed mutagenesis, hydrogen/deuterium exchange coupled to mass spectrometry, chemical cross-linking, and small angle x-ray scattering. The low resolution structural views of Nth1 alone and the Nth114-3-3 complex show that the 14-3-3 protein binding induces a significant structural rearrangement of the whole Nth1 molecule. The EF-hand-like motif-containing region forms a separate domain that interacts with both the 14-3-3 protein and the catalytic trehalase domain. The structural integrity of the EF-hand like motif is essential for the 14-3-3 protein-mediated activation of Nth1, and calcium binding, although not required for the activation, facilitates this process by affecting its structure. Our data suggest that the EF-hand like motif-containing domain functions as the intermediary through which the 14-3-3 protein modulates the function of the catalytic domain of Nth1.	[Kopecka, Miroslava; Kosek, Dalibor; Rezabkova, Lenka; Obsil, Tomas; Obsilova, Veronika] Acad Sci Czech Republ, Inst Physiol, Vvi, CR-14220 Prague, Czech Republic; [Kukacka, Zdenek; Man, Petr; Novak, Petr] Acad Sci Czech Republ, Inst Microbiol, Vvi, CR-14220 Prague, Czech Republic; [Kopecka, Miroslava] Charles Univ Prague, Fac Med 2, Prague 15006, Czech Republic; [Kosek, Dalibor; Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Kukacka, Zdenek; Man, Petr; Novak, Petr] Charles Univ Prague, Dept Biochem, Prague 12843, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Charles University Prague	Obsilova, V (corresponding author), Acad Sci Czech Republ, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague, Czech Republic.	obsilova@biomed.cas.cz	Rezabkova, Lenka/O-8229-2017; Kukacka, Zdenek/J-8816-2014; Novak, Petr/F-9655-2014; Alblova, Miroslava/A-4436-2015; Obsilova, Veronika/B-7116-2012; Man, Petr/H-2451-2014; Obsil, Tomas/B-7142-2012; Košek, Dalibor/AAD-4715-2021	Rezabkova, Lenka/0000-0002-7274-8080; Kukacka, Zdenek/0000-0001-7569-843X; Novak, Petr/0000-0001-8688-529X; Alblova, Miroslava/0000-0002-8073-8544; Obsilova, Veronika/0000-0003-4887-0323; Man, Petr/0000-0002-1485-2197; Obsil, Tomas/0000-0003-4602-1272; 	Czech Science Foundation [P207/11/0455]; Grant Agency of Charles University [644313, 800413]; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology [RVO: 67985823]; Academy of Sciences of the Czech Republic Research Project of the Institute of Microbiology [RVO: 61388971]; Academy of Sciences of the Czech Republic [OPPK CZ.2.16/3.1.00/24023]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology; Academy of Sciences of the Czech Republic Research Project of the Institute of Microbiology; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by Czech Science Foundation Project P207/11/0455; Grant Agency of Charles University Grants 644313 and 800413; and Academy of Sciences of the Czech Republic Research Projects RVO: 67985823 of the Institute of Physiology and RVO: 61388971 of the Institute of Microbiology. Access to MS facilities was supported by Academy of Sciences of the Czech Republic Project OPPK CZ.2.16/3.1.00/24023.	Alizadeh P, 1996, FEBS LETT, V391, P273, DOI 10.1016/0014-5793(96)00751-X; Amaral FC, 1997, ARCH MICROBIOL, V167, P202, DOI 10.1007/s002030050436; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Franco A, 2003, BIOCHEM J, V376, P209, DOI 10.1042/BJ20030825; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Iacob RE, 2012, J AM SOC MASS SPECTR, V23, P1003, DOI 10.1007/s13361-012-0377-z; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOPP M, 1993, J BIOL CHEM, V268, P4766; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Macakova E, 2013, BBA-GEN SUBJECTS, V1830, P4491, DOI 10.1016/j.bbagen.2013.05.025; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NWAKA S, 1995, FEBS LETT, V360, P286, DOI 10.1016/0014-5793(95)00105-I; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oesterreicher TJ, 2001, GENE, V270, P211, DOI 10.1016/S0378-1119(01)00474-7; ORITZ CH, 1983, J BACTERIOL, V153, P644, DOI 10.1128/JB.153.2.644-651.1983; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Panni S, 2008, FEMS YEAST RES, V8, P53, DOI 10.1111/j.1567-1364.2007.00312.x; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Pisackova J, 2013, CRYST GROWTH DES, V13, P844, DOI 10.1021/cg301551v; Rashidi Hooman H., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P175; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Schepers W, 2012, J BIOL CHEM, V287, P44130, DOI 10.1074/jbc.M112.421503; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; UNO I, 1983, J BIOL CHEM, V258, P867; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Veisova D, 2012, BIOCHEM J, V443, P663, DOI 10.1042/BJ20111615; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	47	21	22	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13948	13961		10.1074/jbc.M113.544551	http://dx.doi.org/10.1074/jbc.M113.544551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24713696	hybrid, Green Published			2022-12-28	WOS:000335984600026
J	Oh, YT; Park, Y; Yoon, MY; Bari, W; Go, J; Min, KB; Raskin, DM; Lee, KM; Yoon, SS				Oh, Young Taek; Park, Yongjin; Yoon, Mi Young; Bari, Wasimul; Go, Junhyeok; Min, Kyung Bae; Raskin, David M.; Lee, Kang-Mu; Yoon, Sang Sun			Cholera Toxin Production during Anaerobic Trimethylamine N-Oxide Respiration Is Mediated by Stringent Response in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cholera Toxin; Respiration; Stress Response; Virulence Factors; Anaerobic Respiration; Stringent Response; Vibrio cholerae	VIRULENCE GENE-EXPRESSION; OUTER-MEMBRANE PROTEINS; RIBOSOMAL-RNA PROMOTERS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; OMEGA-SUBUNIT; EL-TOR; MYCOBACTERIUM-TUBERCULOSIS; BIOFILM FORMATION; STRESS SURVIVAL	Background: Cholera toxin (CT) production is induced during anaerobic respiration with trimethylamine N-oxide (TMAO) in Vibrio cholerae. Results: A bacterial stringent response to nutrient starvation was activated during anaerobic TMAO respiration and influenced CT production. Conclusion: CT production during anaerobic TMAO respiration is mediated by stringent response in V. cholerae.Significance: A mechanism of TMAO-stimulated CT production is uncovered. As a facultative anaerobe, Vibrio cholerae can grow by anaerobic respiration. Production of cholera toxin (CT), a major virulence factor of V. cholerae, is highly promoted during anaerobic growth using trimethylamine N-oxide (TMAO) as an alternative electron acceptor. Here, we investigated the molecular mechanisms of TMAO-stimulated CT production and uncovered the crucial involvement of stringent response in this process. V. cholerae 7th pandemic strain N16961 produced a significantly elevated level of ppGpp, the bacterial stringent response alarmone, during anaerobic TMAO respiration. Bacterial viability was impaired, and DNA replication was also affected under the same growth condition, further suggesting that stringent response is induced. A relA spoT ppGpp overproducer strain produced an enhanced level of CT, whereas anaerobic growth via TMAO respiration was severely inhibited. In contrast, a ppGpp-null strain (relA spoT relV) grew substantially better, but produced no CT, suggesting that CT production and bacterial growth are inversely regulated in response to ppGpp accumulation. Bacterial capability to produce CT was completely lost when the dksA gene, which encodes a protein that works cooperatively with ppGpp, was deleted. In the dksA mutant, stringent response growth inhibition was alleviated, further supporting the inverse regulation of CT production and anaerobic growth. In vivo virulence of relA spoT relV or dksA mutants was significantly attenuated. The relA spoT mutant maintained virulence when infected with exogenous TMAO despite its defective growth. Together, our results reveal that stringent response is activated under TMAO-stimulated anaerobic growth, and it regulates CT production in a growth-dependent manner in V. cholerae.	[Oh, Young Taek; Park, Yongjin; Yoon, Mi Young; Bari, Wasimul; Go, Junhyeok; Min, Kyung Bae; Lee, Kang-Mu; Yoon, Sang Sun] Yonsei Univ, Dept Microbiol & Immunol, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul 120752, South Korea; [Raskin, David M.] Marian Univ, Coll Osteopath Med, Indianapolis, IN 46222 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, KM (corresponding author), Yonsei Univ, Dept Microbiol & Immunol, Coll Med, 250 Seongsanno, Seoul 120752, South Korea.	kmlee@yuhs.ac; sangsun_yoon@yuhs.ac	Raskin, David/AAZ-5973-2021; Yoon, Mi Young/ACQ-1374-2022	Raskin, David/0000-0001-7421-7809; LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea - Korean Government (MEST) [2011-0016210]; NRF of Korea - Ministry of Education [2013R1A6A3A01064850]	National Research Foundation (NRF) of Korea - Korean Government (MEST); NRF of Korea - Ministry of Education	This work was supported by National Research Foundation (NRF) of Korea Grant 2011-0016210, funded by the Korean Government (MEST). This work was also supported by Basic Science Research Program Grant 2013R1A6A3A01064850, through the NRF of Korea, funded by the Ministry of Education.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Balzer GJ, 2002, CAN J MICROBIOL, V48, P675, DOI 10.1139/W02-060; Bari W, 2012, J MICROBIOL, V50, P631, DOI 10.1007/s12275-012-2116-3; Bernardo LMD, 2009, J BIOL CHEM, V284, P828, DOI 10.1074/jbc.M807707200; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; GENTRY DR, 1989, J BACTERIOL, V171, P1271, DOI 10.1128/jb.171.3.1271-1277.1989; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jain V, 2006, J MICROBIOL, V44, P1; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Klose KE, 2001, INT J MED MICROBIOL, V291, P81, DOI 10.1078/1438-4221-00104; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Krishnan HH, 2004, INFECT IMMUN, V72, P3961, DOI 10.1128/IAI.72.7.3961-3967.2004; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Pal RR, 2011, INDIAN J MED RES, V133, P212; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	65	18	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13232	13242		10.1074/jbc.M113.540088	http://dx.doi.org/10.1074/jbc.M113.540088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648517	Green Published, hybrid			2022-12-28	WOS:000335522800024
J	Hendrix, J; van Heertum, B; Vanstreels, E; Daelemans, D; De Rijck, J				Hendrix, Jelle; van Heertum, Bart; Vanstreels, Els; Daelemans, Dirk; De Rijck, Jan			Dynamics of the Ternary Complex Formed by c-Myc Interactor JPO2, Transcriptional Co- activator LEDGF/p75, and Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Coactivator Transcription; Fluorescence Correlation Spectroscopy; Integrase; Protein Dynamics; Protein-Protein Interactions; Transcription Factors; JPO2; LEDGF; p75; PogZ	FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; PULSED INTERLEAVED EXCITATION; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 INTEGRASE; IN-VIVO; GROWTH-FACTOR; COACTIVATOR P75; LIVE CELLS; MONOAMINE-OXIDASE	Background: The function of transcription factors can be investigated by monitoring their movement inside the nucleus of cells with biophysical techniques. Results: A model for interaction of JPO2 with chromatin in the absence and presence of its interaction partner LEDGF/p75 is proposed. Conclusion: JPO2 adopts the dynamics of LEDGF/p75. Significance: Our approach is generic for the study of transcription factor dynamics. Lens epithelium-derived growth factor (LEDGF/p75) is a transcriptional co-activator involved in targeting human immunodeficiency virus (HIV) integration and the development of MLL fusion-mediated acute leukemia. A previous study revealed that LEDGF/p75 dynamically scans the chromatin, and upon interaction with HIV-1 integrase, their complex is locked on chromatin. At present, it is not known whether LEDGF/p75-mediated chromatin locking is typical for interacting proteins. Here, we employed continuous photobleaching and fluorescence correlation and cross-correlation spectroscopy to investigate in vivo chromatin binding of JPO2, a LEDGF/p75- and c-Myc-interacting protein involved in transcriptional regulation. In the absence of LEDGF/p75, JPO2 performs chromatin scanning inherent to transcription factors. However, whereas the dynamics of JPO2 chromatin binding are decelerated upon interaction with LEDGF/p75, very strong locking of their complex onto chromatin is absent. Similar results were obtained with the domesticated transposase PogZ, another cellular interaction partner of LEDGF/p75. We furthermore show that diffusive JPO2 can oligomerize; that JPO2 and LEDGF/p75 interact directly and specifically in vivo through the specific interaction domain of JPO2 and the C-terminal domain of LEDGF/p75, comprising the integrase-binding domain; and that modulation of JPO2 dynamics requires a functional PWWP domain in LEDGF/p75. Our results suggest that the dynamics of the LEDGF/p75-chromatin interaction depend on the specific partner and that strong chromatin locking is not a property of all LEDGF/p75-binding proteins.	[Hendrix, Jelle] Univ Louvain, Dept Chem, Lab Photochem & Spect, B-3001 Louvain, Belgium; [van Heertum, Bart; De Rijck, Jan] Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium; [Vanstreels, Els; Daelemans, Dirk] Univ Louvain, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, B-3000 Louvain, Belgium	KU Leuven	De Rijck, J (corresponding author), Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, Kapucijnenvoer 33, B-3000 Louvain, Belgium.	jan.derijck@med.kuleuven.be	De Rijck, Jan/A-2729-2013; Vanstreels, Els/I-2366-2018; Daelemans, Dirk/P-7923-2017; HENDRIX, Jelle/H-1721-2018	Vanstreels, Els/0000-0002-7814-8035; Daelemans, Dirk/0000-0001-7092-1153; HENDRIX, Jelle/0000-0001-5731-1297	Bijzonder Onderzoeksfonds (BOF) KU Leuven; Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO); European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)); Research Foundation Flanders (FWO Vlaanderen); agency for Innovation by Science and Technology (IWT Flanders)	Bijzonder Onderzoeksfonds (BOF) KU Leuven; Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO)(FWO); European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)); Research Foundation Flanders (FWO Vlaanderen)(FWO); agency for Innovation by Science and Technology (IWT Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Bijzonder Onderzoeksfonds (BOF) KU Leuven, Fonds voor Wetenschappelijk Onderzoek in Vlaanderen (FWO), and European Union (EU) (Framework Programme 7 (FP7) Combined Highly Active Anti-Retroviral Microbicides (CHAARM)).; Supported by a postdoctoral scholarship from the Research Foundation Flanders (FWO Vlaanderen).; Supported by a doctoral fellowship from the agency for Innovation by Science and Technology (IWT Flanders).	Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2011, MOL PHARMACOL, V79, P308, DOI 10.1124/mol.110.067439; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Delon A, 2004, J FLUORESC, V14, P255, DOI 10.1023/B:JOFL.0000024557.73246.f9; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hendrix J, 2008, BIOPHYS J, V94, P4103, DOI 10.1529/biophysj.107.123596; Hendrix J, 2014, METHODS MOL BIOL, V1076, P653, DOI 10.1007/978-1-62703-649-8_30; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hendrix J, 2013, METHOD ENZYMOL, V518, P205, DOI 10.1016/B978-0-12-388422-0.00009-1; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Hwang LC, 2004, CHEMPHYSCHEM, V5, P549, DOI 10.1002/cphc.200301057; Johnson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2139, DOI 10.1038/npp.2011.105; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2005, FASEB J, V19, P1039, DOI 10.1096/fj.04-3373fje; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mazza D, 2012, METHODS MOL BIOL, V833, P177, DOI 10.1007/978-1-61779-477-3_12; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mereau H, 2013, LEUKEMIA, V27, P1245, DOI 10.1038/leu.2013.10; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; PETERS R, 1981, P NATL ACAD SCI-BIOL, V78, P962, DOI 10.1073/pnas.78.2.962; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rauer B, 1996, BIOPHYS CHEM, V58, P3, DOI 10.1016/0301-4622(95)00080-1; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Rivera-Gonzalez GC, 2012, NUCLEIC ACIDS RES, V40, P4825, DOI 10.1093/nar/gks143; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vukojevic V, 2010, P NATL ACAD SCI USA, V107, P4093, DOI 10.1073/pnas.0914612107; Wachsmuth M, 2003, BIOPHYS J, V84, P3353, DOI 10.1016/S0006-3495(03)70059-9; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	86	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12494	12506		10.1074/jbc.M113.525964	http://dx.doi.org/10.1074/jbc.M113.525964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634210	Green Published, hybrid			2022-12-28	WOS:000335581400025
J	Li, W; Sharma, M; Kaur, P				Li, Wen; Sharma, Madhu; Kaur, Parjit			The DrrAB Efflux System of Streptomyces peucetius Is a Multidrug Transporter of Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Anticancer Drug; Drug Resistance; Multidrug Transporters; Protein Drug Interactions; Competitive Inhibition; Drug Binding Sites; Inside-out Membrane Vesicles; Non-competitive Inhibition; Single-drug Transporters	NUCLEOTIDE-BINDING DOMAINS; P-GLYCOPROTEIN; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; ATPASE ACTIVITY; CRYSTAL-STRUCTURE; LIPID-BILAYER; DRUG-BINDING; RESISTANCE; MECHANISM	Background: DrrAB is dedicated to export of doxorubicin in Streptomyces peucetius, an organism that produces this anticancer drug. Whether this prototype system can export other drugs has not been investigated. Results: DrrAB exports multiple drugs efficiently. Conclusion: Substrate specificity of DrrAB overlaps with known bacterial and human multidrug resistance proteins. Significance: This study suggests common mechanisms and origin for DrrAB and other MDR proteins. The soil bacterium Streptomyces peucetius produces two widely used anticancer antibiotics, doxorubicin and daunorubicin. Present within the biosynthesis gene cluster in S. peucetius is the drrAB operon, which codes for a dedicated ABC (ATP binding cassette)-type transporter for the export of these two closely related antibiotics. Because of its dedicated nature, the DrrAB system is believed to belong to the category of single-drug transporters. However, whether it also contains specificity for other known substrates of multidrug transporters has never been tested. In this study we demonstrate under both in vivo and in vitro conditions that the DrrAB system can transport not only doxorubicin but is also able to export two most commonly studied MDR substrates, Hoechst 33342 and ethidium bromide. Moreover, we demonstrate that many other substrates (including verapamil, vinblastine, and rifampicin) of the well studied multidrug transporters inhibit DrrAB-mediated Dox transport with high efficiency, indicating that they are also substrates of the DrrAB pump. Kinetic studies show that inhibition of doxorubicin transport by Hoechst 33342 and rifampicin occurs by a competitive mechanism, whereas verapamil inhibits transport by a non-competitive mechanism, thus suggesting the possibility of more than one drug binding site in the DrrAB system. This is the first in-depth study of a drug resistance system from a producer organism, and it shows that a dedicated efflux system like DrrAB contains specificity for multiple drugs. The significance of these findings in evolution of poly-specificity in drug resistance systems is discussed.	[Li, Wen; Sharma, Madhu; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, 161 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981, R29GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51981-09 (to P. K.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANGOV E, 1988, J BACTERIOL, V170, P459, DOI 10.1128/jb.170.1.459-462.1988; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7; BLANC V, 1995, MOL MICROBIOL, V17, P989, DOI 10.1111/j.1365-2958.1995.mmi_17050989.x; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Chambon MH, 1998, ANAL BIOCHEM, V263, P198, DOI 10.1006/abio.1998.2790; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Ernst R, 2006, J BIOL CHEM, V281, P27471, DOI 10.1074/jbc.M601131200; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Holland I.B., 2003, ABC PROTEINS BACTERI, P3; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Li W, 2013, J BIOL CHEM, V288, P11854, DOI 10.1074/jbc.M112.441915; Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Mazurkiewicz P, 2004, BBA-BIOENERGETICS, V1658, P252, DOI 10.1016/j.bbabio.2004.06.004; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Parveen Z, 2011, MOL PHARMACOL, V79, P443, DOI 10.1124/mol.110.067611; PAWAGI AB, 1994, J MOL BIOL, V235, P554, DOI 10.1006/jmbi.1994.1013; Poelarends GJ, 2002, BBA-BIOENERGETICS, V1555, P1, DOI 10.1016/S0005-2728(02)00246-3; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Rao DK, 2008, BIOCHEMISTRY-US, V47, P3038, DOI 10.1021/bi701699a; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SAFA AR, 1987, J BIOL CHEM, V262, P7884; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P115, DOI 10.1111/j.1432-1033.1997.00115.x; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Sharom F.J., 2007, DRUG TRANSPORTERS MO, P223; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang H, 2010, J BIOL CHEM, V285, P38324, DOI 10.1074/jbc.M110.131540	71	30	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12633	12646		10.1074/jbc.M113.536136	http://dx.doi.org/10.1074/jbc.M113.536136			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634217	hybrid, Green Published			2022-12-28	WOS:000335581400035
J	Maier, PJ; Zemoura, K; Acuna, MA; Yevenes, GE; Zeilhofer, HU; Benke, D				Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar			Ischemia-like Oxygen and Glucose Deprivation Mediates Down-regulation of Cell Surface gamma-Aminobutyric Acid(B) Receptors via the Endoplasmic Reticulum (ER) Stress-induced Transcription Factor CCAAT/Enhancer-binding Protein (C/EBP)-homologous Protein (CHOP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface; Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); G Protein-coupled Receptors (GPCR); GABA Receptors; Neurons; Trafficking; CHOP; Cerebral Ischemia	TRANSIENT FOREBRAIN ISCHEMIA; GABA(B) RECEPTOR; CEREBRAL-ISCHEMIA; PROXIMITY LIGATION; GERBIL HIPPOCAMPUS; IN-SITU; EXPRESSION; DEATH; PHOSPHORYLATION; ACTIVATION	Background: ER stress associated with cerebral ischemia induces the expression of the transcription factor CHOP. Results: Interaction with CHOP down-regulates cell surface GABA(B) receptors and, thus, GABA(B) receptor-mediated neuronal inhibition. Conclusion: Interaction of CHOP with GABA(B) receptors in the ER prevents forward trafficking of the receptors. Significance: This mechanism is expected to contribute to excitotoxicity in cerebral ischemia. Cerebral ischemia frequently leads to long-term disability and death. Excitotoxicity is believed to be the main cause for ischemia-induced neuronal death. Although a role of glutamate receptors in this process has been firmly established, the contribution of metabotropic GABA(B) receptors, which control excitatory neurotransmission, is less clear. A prominent characteristic of ischemic insults is endoplasmic reticulum (ER) stress associated with the up-regulation of the transcription factor CCAAT/enhancer-binding protein-homologous protein (CHOP). After inducing ER stress in cultured cortical neurons by sustained Ca2+ release from intracellular stores or by a brief episode of oxygen and glucose deprivation (in vitro model of cerebral ischemia), we observed an increased expression of CHOP accompanied by a strong reduction of cell surface GABA(B) receptors. Our results indicate that down-regulation of cell surface GABA(B) receptors is caused by the interaction of the receptors with CHOP in the ER. Binding of CHOP prevented heterodimerization of the receptor subunits GABA(B1) and GABA(B2) and subsequent forward trafficking of the receptors to the cell surface. The reduced level of cell surface receptors diminished GABA(B) receptor signaling and, thus, neuronal inhibition. These findings indicate that ischemia-mediated up-regulation of CHOP down-regulates cell surface GABA(B) receptors by preventing their trafficking from the ER to the plasma membrane. This mechanism leads to diminished neuronal inhibition and may contribute to excitotoxicity in cerebral ischemia.	[Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Acuna, Mario A./0000-0002-0673-5150; Yevenes, Gonzalo/0000-0003-0294-4075	Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by Swiss National Science Foundation grants 31003A_121963 and 31003A_138382 (to D.B.).	Babcock AM, 2002, J NEUROSCI RES, V67, P804, DOI 10.1002/jnr.10169; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; BENKE D, 1991, J BIOL CHEM, V266, P4478; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Calver AR, 2001, J NEUROSCI, V21, P1203; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Francis J, 1999, J NEUROCHEM, V72, P87, DOI 10.1046/j.1471-4159.1999.0720087.x; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Han D, 2008, FEBS LETT, V582, P1298, DOI 10.1016/j.febslet.2008.02.044; HOSSMANN KA, 1993, PROG BRAIN RES, V96, P161; Im BH, 2012, NEUROSCI LETT, V513, P89, DOI 10.1016/j.neulet.2012.02.014; JacksonFriedman C, 1997, EXP NEUROL, V147, P346, DOI 10.1006/exnr.1997.6637; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Kulinskii VI, 2000, B EXP BIOL MED+, V130, P772, DOI 10.1007/BF02766091; LAL S, 1995, NEUROCHEM RES, V20, P115, DOI 10.1007/BF00970534; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Morimoto N, 2007, NEUROSCIENCE, V147, P957, DOI 10.1016/j.neuroscience.2007.04.017; Oida Y, 2008, NEUROSCIENCE, V151, P111, DOI 10.1016/j.neuroscience.2007.10.047; Osada N, 2010, NEUROCHEM INT, V57, P1, DOI 10.1016/j.neuint.2010.03.017; Osada N, 2009, NEUROCHEM INT, V54, P403, DOI 10.1016/j.neuint.2009.01.010; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pagano A, 2001, J NEUROSCI, V21, P1189; Paschen W, 1999, ACT NEUR S, V73, P1; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Pooler AM, 2009, EUR J NEUROSCI, V29, P869, DOI 10.1111/j.1460-9568.2009.06636.x; Ren XH, 2003, J BIOL CHEM, V278, P42006, DOI 10.1074/jbc.M304238200; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Vollenweider F, 2006, NEUROSCI LETT, V395, P118, DOI 10.1016/j.neulet.2005.10.079; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	37	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12896	12907		10.1074/jbc.M114.550517	http://dx.doi.org/10.1074/jbc.M114.550517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668805	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000335581400058
J	Eom, S; Kim, Y; Park, D; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Eom, Sangkyung; Kim, Youngmi; Park, Deokbum; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			Histone Deacetylase-3 Mediates Positive Feedback Relationship between Anaphylaxis and Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Cell-Cell Interaction; Histone Deacetylase; MicroRNA; Tumor Metastases; Anaphylaxis; Histone Deacetylase-3; Positive Feedback Regulatory Loop; MicroRNA-384	EPITHELIAL-MESENCHYMAL TRANSITION; ALLERGIC AIRWAY INFLAMMATION; MOUSE ASTHMA MODEL; MAST-CELLS; SYSTEMIC-ANAPHYLAXIS; SKIN INFLAMMATION; ACTIVATION; EXPRESSION; GROWTH; OVEREXPRESSION	Background: The relationship between anaphylaxis and tumor metastasis remains unknown at the molecular level. Results: The miR-384/HDAC3 axis regulates an interaction between tumor cells and mast cells. Conclusion: HDAC3 mediates a positive feedback loop between anaphylaxis and tumor metastasis. Significance: HDAC3 can be a target for the development of allergy and cancer therapeutics. Allergic inflammation has been known to enhance the metastatic potential of tumor cells. The role of histone deacetylase-3 (HDAC3) in allergic skin inflammation was reported. We investigated HDAC3 involvement in the allergic inflammation-promotion of metastatic potential of tumor cells. Passive systemic anaphylaxis (PSA) induced HDAC3 expression and FcERI signaling in BALB/c mice. PSA enhanced the tumorigenic and metastatic potential of mouse melanoma cells in HDAC3- and monocyte chemoattractant protein 1-(MCP1)-dependent manner. The PSA-mediated enhancement of metastatic potential involved the induction of HDAC3, MCP1, and CD11b (a macrophage marker) expression in the lung tumor tissues. We examined an interaction between anaphylaxis and tumor growth and metastasis at the molecular level. Conditioned medium from antigen-stimulated bone marrow-derived mouse mast cell cultures induced the expression of HDAC3, MCP1, and CCR2, a receptor for MCP1, in B16F1 mouse melanoma cells and enhanced migration and invasion potential of B16F1 cells. The conditioned medium from B16F10 cultures induced the activation of FcERI signaling in lung mast cells in an HDAC3-dependent manner. FcERI signaling was observed in lung tumors derived from B16F10 cells. Target scan analysis predicted HDAC3 to be as a target of miR-384, and miR-384 and HDAC3 were found to form a feedback regulatory loop. miR-384, which is decreased by PSA, negatively regulated HDAC3 expression, allergic inflammation, and the positive feedback regulatory loop between anaphylaxis and tumor metastasis. We show the miR-384/HDAC3 feedback loop to be a novel regulator of the positive feedback relationship between anaphylaxis and tumor metastasis.	[Eom, Sangkyung; Kim, Youngmi; Park, Deokbum; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [20100021357, 2011-0010867, 2012H1B8A2025495, C1008749-01-01]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 20100021357, 2011-0010867, 2012H1B8A2025495, and C1008749-01-01 and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea, Grant 1320160.	Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chang DZ, 2012, ONCOIMMUNOLOGY, V1, P754, DOI 10.4161/onci.19612; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; de Souza DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040790; Falanga YT, 2012, J IMMUNOL, V188, P4360, DOI 10.4049/jimmunol.1003223; Hayashi A, 2010, INT J CANCER, V127, P1332, DOI 10.1002/ijc.25151; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jeong HJ, 2013, INT J CANCER, V132, P2492, DOI 10.1002/ijc.27937; Khan BQ, 2011, CURR OPIN ALLERGY CL, V11, P319, DOI 10.1097/ACI.0b013e3283481ab6; Kim Y, 2013, MOL IMMUNOL, V53, P1, DOI 10.1016/j.molimm.2012.06.010; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lee SH, 2012, LAB INVEST, V92, P1698, DOI 10.1038/labinvest.2012.132; Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093; Mayoral RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026133; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Mizuno H, 2012, LEUKEMIA, V26, P2269, DOI 10.1038/leu.2012.81; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Nakayama T, 2004, J CLIN INVEST, V114, P1317, DOI 10.1172/JCI200422089; Olivera A, 2013, IMMUNOL LETT, V150, P89, DOI 10.1016/j.imlet.2013.01.005; Pande K, 2009, MOL THER, V17, P508, DOI 10.1038/mt.2008.280; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; Raica M, 2013, ANTICANCER RES, V33, P957; Rudolph MI, 2008, J PHARMACOL SCI, V106, P208, DOI 10.1254/jphs.FP0070736; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Song C, 2012, SCAND J IMMUNOL, V75, P599, DOI 10.1111/j.1365-3083.2012.02693.x; Song Y, 2010, J ALLERGY CLIN IMMUN, V126, P1208, DOI 10.1016/j.jaci.2010.09.013; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Taranova AG, 2008, CANCER RES, V68, P8582, DOI 10.1158/0008-5472.CAN-08-1673; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274	47	24	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12126	12144		10.1074/jbc.M113.521245	http://dx.doi.org/10.1074/jbc.M113.521245			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619412	Green Published, hybrid			2022-12-28	WOS:000335010600049
J	Briseno-Roa, L; Bessereau, JL				Briseno-Roa, Luis; Bessereau, Jean-Louis			Proteolytic Processing of the Extracellular Scaffolding Protein LEV-9 Is Required for Clustering Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix Proteins; Nicotinic Acetylcholine Receptors; Post-translational Modification; Scaffold Proteins; Synapses; CCP Domain; Limited Proteolysis	CAENORHABDITIS-ELEGANS; ECTODOMAIN CLEAVAGE; PREDICTION; PLASTICITY; SEQUENCE; CALPAIN; SERVER; SITES	Background: LEV-9 is an extracellular scaffolding protein required for synaptic clustering of acetylcholine receptors in C. elegans.Results: C-terminal cleavage of LEV-9 is necessary for its synaptic function. Conclusion: LEV-9 is activated by proteolytic cleavage following the final tandem complement control protein (CCP) modules. Significance: Many LEV-9-related factors are likely cleaved after CCP domains, suggesting that cleavage location can be conserved in distant architecturally related proteins. Correct positioning of neurotransmitter-gated receptors at postsynapses is essential for synaptic transmission. At Caenorhabditis elegans neuromuscular junctions, clustering of levamisole-sensitive acetylcholine receptors (L-AChRs) requires the muscle-secreted scaffolding protein LEV-9, a multidomain factor containing complement control protein (CCP) modules. Here we show that LEV-9 needs to be cleaved at its C terminus to exert its function. LEV-9 cleavage is not required for trafficking nor secretion but directly controls scaffolding activity. The cleavage site is evolutionarily conserved, and post-translational cleavage ensures the structural and functional decoupling between different isoforms encoded by the lev-9 gene. Data mining indicates that most human CCP-containing factors are likely cleaved C-terminally from CCP tandems, suggesting that not only domain architectures but also cleavage location can be conserved in distant architecturally related proteins.	[Briseno-Roa, Luis; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Briseno-Roa, Luis; Bessereau, Jean-Louis] INSERM, U1024, F-75005 Paris, France; [Bessereau, Jean-Louis] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire CGphiMC, CNRS, UMR 5534, F-69622 Villeurbanne, France; [Briseno-Roa, Luis] Inst Jacques Monod, CNRS, UMR 7592, F-75013 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Briseno-Roa, L (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592, Bt Buffon,15 Rue Helene Brion, F-75205 Paris, France.	briseno-roa@ijm.univ-paris-diderot.fr; jean-louis.bessereau@univ-lyon1.fr	Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621	INSERM; Agence Nationale de la Recherche (ANR) [11-BSV4-019]; Association Francaise contre les Myopathies; INSERM Jeunes Chercheurs Confirmes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM Jeunes Chercheurs Confirmes	This work was supported by INSERM, Agence Nationale de la Recherche (ANR) Grant 11-BSV4-019, and the Association Francaise contre les Myopathies.; Supported by INSERM Jeunes Chercheurs Confirmes. To whom correspondence may be addressed: Institut Jacques Monod, UMR CNRS 7592, Universite Paris Diderot, Bt. Buffon, 15 rue Helene Brion, F-75205 Paris, France. Tel.: 33-157278092; Fax 33-157278087; E-mail: briseno-roa@ijm.univ-paris-diderot.fr.	Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hakulinen J, 2004, EUR J IMMUNOL, V34, P2620, DOI 10.1002/eji.200424969; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; Nakagawa H, 2009, BLOOD, V114, P2553, DOI 10.1182/blood-2008-12-190629; Nakayama M, 2011, NEUROSCI RES, V69, P87, DOI 10.1016/j.neures.2010.11.006; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Vinade L, 2001, SYNAPSE, V40, P302, DOI 10.1002/syn.1053; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091	24	5	6	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10967	10974		10.1074/jbc.C113.534677	http://dx.doi.org/10.1074/jbc.C113.534677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619422	Green Published, hybrid			2022-12-28	WOS:000334638500003
J	Chaar, V; Laurance, S; Lapoumeroulie, C; Cochet, S; De Grandis, M; Colin, Y; Elion, J; Le Van Kim, C; El Nemer, W				Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim			\Hydroxycarbamide Decreases Sickle Reticulocyte Adhesion to Resting Endothelium by Inhibiting Endothelial Lutheran/Basal Cell Adhesion Molecule ( Lu/BCAM) through Phosphodiesterase 4A Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Blood; Cell Signaling; Endothelial Cell; Protein Phosphorylation; Hydroxycarbamide; Lu; BCAM; Sickle Cell Disease	BLOOD-GROUP GLYCOPROTEIN; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; VASOOCCLUSIVE EVENTS; BINDING DOMAINS; HYDROXYUREA; DISEASE; LAMININ; ERYTHROCYTES; EXPRESSION; EPINEPHRINE	Background: Hydroxycarbamide treatment may inhibit the proadhesive features of vascular endothelium in sickle cell disease. Results: Hydroxycarbamide treatment of endothelial cells inhibits the interaction between erythroid integrin (41) and endothelial Lu/BCAM. Conclusion: Hydroxycarbamide increases the expression of phosphodiesterase 4A, which decreases cAMP levels leading to less Lu/BCAM phosphorylation and less cell adhesion. Significance: This is the first example of a phosphodiesterase being regulated by hydroxycarbamide. Vaso-occlusive crises are the main acute complication in sickle cell disease. They are initiated by abnormal adhesion of circulating blood cells to vascular endothelium of the microcirculation. Several interactions involving an intricate network of adhesion molecules have been described between sickle red blood cells and the endothelial vascular wall. We have shown previously that young sickle reticulocytes adhere to resting endothelial cells through the interaction of (41) integrin with endothelial Lutheran/basal cell adhesion molecule (Lu/BCAM). In the present work, we investigated the functional impact of endothelial exposure to hydroxycarbamide (HC) on this interaction using transformed human bone marrow endothelial cells and primary human pulmonary microvascular endothelial cells. Adhesion of sickle reticulocytes to HC-treated endothelial cells was decreased despite the HC-derived increase of Lu/BCAM expression. This was associated with decreased phosphorylation of Lu/BCAM and up-regulation of the cAMP-specific phosphodiesterase 4A expression. Our study reveals a novel mechanism for HC in endothelial cells where it could modulate the function of membrane proteins through the regulation of phosphodiesterase expression and cAMP-dependent signaling pathways.	[Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] INSERM, U1134, F-75739 Paris, France; [Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] Univ Paris Diderot, Sorbonne Paris Cite, UMR S 1134, F-75739 Paris, France; [Chaar, Vicky; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Le Van Kim, Caroline; El Nemer, Wassim] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Chaar, Vicky; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] Lab Excellence GR Ex, F-75238 Paris, France; [Elion, Jacques] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	El Nemer, W (corresponding author), INSERM, UMR S 1134, INTS, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	wassim.el-nemer@inserm.fr	Cochet, sylvie/I-2721-2015; LAURANCE, Sandrine/AAT-9715-2021; Lapoumeroulie, Claudine/P-3515-2018; Elion, Jacques/A-1048-2014; colin, yves/O-1910-2017; Nemer, Wassim El/N-4247-2017; le van kim, caroline/O-7030-2017	Elion, Jacques/0000-0002-8407-1783; colin, yves/0000-0001-5196-4254; Nemer, Wassim El/0000-0001-8184-427X; LAURANCE, Sandrine/0000-0002-2595-7031; LAPOUMEROULIE, Claudine/0000-0001-6665-3598; le van kim, caroline/0000-0002-3251-1310	Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION) [1134]; Region Ile-de-France (SESAME) [F-08-1104/R]; Laboratory of Excellence GR-Ex [ANR-11-LABX-0051]; program "Investissements d'avenir" of the French National Research Agency [ANR-11-IDEX-0005-02]; French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI	Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION)(French National Research Agency (ANR)); Region Ile-de-France (SESAME)(Region Ile-de-France); Laboratory of Excellence GR-Ex; program "Investissements d'avenir" of the French National Research Agency(French National Research Agency (ANR)); French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI	This work was supported by institutional funding to the INSERM unit 1134, Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION 2007) and Region Ile-de-France (SESAME 2007. F-08-1104/R) and by grants from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. The labex GR-Ex is funded by the program "Investissements d'avenir" of the French National Research Agency, reference ANR-11-IDEX-0005-02.; Recipient of a doctoral fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI.	Adderley SP, 2010, PHARMACOL REP, V62, P475, DOI 10.1016/S1734-1140(10)70303-0; Almeida CB, 2012, BLOOD, V120, P2879, DOI 10.1182/blood-2012-02-409524; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bartolucci P, 2010, BLOOD, V116, P2152, DOI 10.1182/blood-2009-12-257444; Brun M, 2003, PHARMACOGENOMICS J, V3, P215, DOI 10.1038/sj.tpj.6500176; Cartron JP, 2008, TRANSFUS CLIN BIOL, V15, P39, DOI 10.1016/j.tracli.2008.05.001; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Cokic VP, 2006, BLOOD, V108, P184, DOI 10.1182/blood-2005-11-4454; COLLINS FS, 1982, AM J MED, V73, P814, DOI 10.1016/0002-9343(82)90763-X; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 2001, J BIOL CHEM, V276, P23757, DOI 10.1074/jbc.M102978200; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; El Nemer W, 2012, BLOOD, V120, P2777, DOI 10.1182/blood-2012-08-447102; Embury S. H., 1994, PATHOGENESIS VASOOCC; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; GEE BE, 1995, BLOOD, V85, P268, DOI 10.1182/blood.V85.1.268.bloodjournal851268; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; Hermand P, 2004, EUR J BIOCHEM, V271, P3729, DOI 10.1111/j.1432-1033.2004.04313.x; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Hines PC, 2003, BLOOD, V101, P3281, DOI 10.1182/blood-2001-12-0289; HOOVER R, 1979, BLOOD, V54, P872; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2006, AM J PHYSIOL-CELL PH, V291, pC922, DOI 10.1152/ajpcell.00639.2005; Kim SK, 2002, J NUCL MED, V43, P896; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; Lapoumeroulie C, 2005, HAEMATOLOGICA, V90, P401; Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740; Laurance S, 2010, PHARMACOGENET GENOM, V20, P257, DOI 10.1097/FPC.0b013e32833854d6; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; Lonergan GJ, 2001, RADIOGRAPHICS, V21, P971, DOI 10.1148/radiographics.21.4.g01jl23971; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mankelow TJ, 2004, BLOOD, V103, P1503, DOI 10.1182/blood-2003-08-2792; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Odievre MH, 2008, HAEMATOLOGICA, V93, P502, DOI 10.3324/haematol.12070; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Rahuel C, 1996, BLOOD, V88, P1865; Smith JA, 1996, HEMATOL ONCOL CLIN N, V10, P1345, DOI 10.1016/S0889-8588(05)70405-6; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SWERLICK RA, 1993, BLOOD, V82, P1891; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101	46	28	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11512	11521		10.1074/jbc.M113.506121	http://dx.doi.org/10.1074/jbc.M113.506121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616094	Green Published, hybrid			2022-12-28	WOS:000334638500051
J	de Araujo, CB; Russo, LC; Castro, LM; Forti, FL; do Monte, ER; Rioli, V; Gozzo, FC; Colquhoun, A; Ferro, ES				de Araujo, Christiane B.; Russo, Lilian C.; Castro, Leandro M.; Forti, Fabio L.; do Monte, Elisabete R.; Rioli, Vanessa; Gozzo, Fabio C.; Colquhoun, Alison; Ferro, Emer S.			A Novel Intracellular Peptide Derived from G(1)/S Cyclin D2 Induces Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; CB1 CANNABINOID RECEPTORS; NF-KAPPA-B; THIMET OLIGOPEPTIDASE; PROTEASOME INHIBITORS; ANTIGEN PRESENTATION; NATURAL REGULATORS; MASS-SPECTROMETRY; PROTEIN-KINASE; WILD-TYPE	Intracellular peptides are constantly produced by the ubiquitin-proteasome system, and many are probably functional. Here, the peptide WELVVLGKL (pep5) from G(1)/S-specific cyclin D2 showed a 2-fold increase during the S phase of HeLa cell cycle. pep5 (25-100 mu M) induced cell death in several tumor cells only when it was fused to a cell-penetrating peptide (pep5-cpp), suggesting its intracellular function. In vivo, pep5-cpp reduced the volume of the rat C6 glioblastoma by almost 50%. The tryptophan at the N terminus of pep5 is essential for its cell death activity, and N terminus acetylation reduced the potency of pep5-cpp. WELVVL is the minimal active sequence of pep5, whereas Leu-Ala substitutions totally abolished pep5 cell death activity. Findings from the initial characterization of the cell death/signaling mechanism of pep5 include caspase 3/7 and 9 activation, inhibition of Akt2 phosphorylation, activation of p38 alpha and -gamma, and inhibition of proteasome activity. Further pharmacological analyses suggest that pep5 can trigger cell death by distinctive pathways, which can be blocked by IM-54 or a combination of necrostatin-1 and q-VD-OPh. These data further support the biological and pharmacological potential of intracellular peptides.	[de Araujo, Christiane B.; Castro, Leandro M.; do Monte, Elisabete R.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Pharmacol, BR-05508000 Sao Paulo, Brazil; [Colquhoun, Alison] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Cell Biol & Dev, BR-05508000 Sao Paulo, Brazil; [Russo, Lilian C.; Forti, Fabio L.] Univ Sao Paulo, Inst Chem, Support Ctr Res Proteolysis & Cell Signaling NAPP, Dept Biochem, BR-05508000 Sao Paulo, Brazil; [Rioli, Vanessa] Butantan Inst, Ctr Toxins Immune Response & Cell Signaling CETIC, Special Lab Appl Toxinol LETA, BR-05503000 Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, BR-13083862 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual de Campinas	Ferro, ES (corresponding author), Univ Sao Paulo, Dept Pharmacol, Av Prof Lineu Prestes 1524,S315, BR-05508000 Sao Paulo, Brazil.	eferro@usp.br	Ferro, Emer S/D-3908-2012; Colquhoun, Alison/C-4031-2012; Rioli, Vanessa/A-7913-2013; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; FORTI, FABIO LUIS/F-8085-2012; Russo, Lilian Cristina/O-7838-2014; Castro, Leandro/O-6762-2019; Castro, Leandro/ABI-5520-2020; Rodrigues do Monte Silva, Elisabete/M-7528-2017	Ferro, Emer S/0000-0003-1651-9192; Colquhoun, Alison/0000-0002-0691-2364; FORTI, FABIO LUIS/0000-0002-2278-6396; Russo, Lilian Cristina/0000-0002-9846-1352; Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Rodrigues do Monte Silva, Elisabete/0000-0001-8480-9154; Araujo, Christiane/0000-0002-6801-4367; Rioli, Vanessa/0000-0003-3285-306X	Brazilian National Research Council (CNPq) [559698/2009-7]; Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS) [2012.1.17607.1.2]; CAPES; CNPq	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian National Research Council (CNPq) Grant 559698/2009-7 (Rede GENOPROT) and by the Pro-Reitoria de Pesquisa, University of Sao Paulo, through the Support Center for Research in Proteolysis and Cell Signaling (NAPPS; Grant 2012.1.17607.1.2).; Recipient of research fellowship from CAPES.; Recipient of research fellowship from CNPq. To whom correspondence should be addressed: Dept. of Pharmacology, University of Sao Paulo. Av. Prof. Lineu Prestes 1524, S315, Cid. Universitaria, SP, 05508-000, Brazil. Tel.: 55-11-3091-7493; Fax: 55-11-3091-7322; E-mail: eferro@usp.br.	Adams J, 1999, CANCER RES, V59, P2615; Arboleda MJ, 2003, CANCER RES, V63, P196; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Castro LM, 2010, AAPS J, V12, P608, DOI 10.1208/s12248-010-9224-y; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J MASS SPECTROM, V40, P227, DOI 10.1002/jms.742; Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911; Chun K T, 1996, Prog Cell Cycle Res, V2, P115; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Dodo K, 2005, BIOORG MED CHEM LETT, V15, P3114, DOI 10.1016/j.bmcl.2005.04.016; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Ferguson Sherise, 2007, Current Drug Delivery, V4, P169, DOI 10.2174/156720107780362302; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; GALLO CJ, 1986, BIOCHEM J, V238, P37, DOI 10.1042/bj2380037; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gelman JS, 2013, BBA-PROTEINS PROTEOM, V1834, P2408, DOI 10.1016/j.bbapap.2013.01.043; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Jiang H, 2006, EXPERT REV ANTICANC, V6, P1585, DOI 10.1586/14737140.6.11.1585; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim Lyndon, 2006, Curr Treat Options Oncol, V7, P467, DOI 10.1007/s11864-006-0022-9; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lee MW, 2011, CANCER SCI, V102, P1822, DOI 10.1111/j.1349-7006.2011.02025.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Murray RZ, 2000, ANTI-CANCER DRUG, V11, P407, DOI 10.1097/00001813-200007000-00001; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rammensee HG, 2002, NATURE, V419, P443, DOI 10.1038/419443a; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Russo LC, 2012, FEBS LETT, V586, P3287, DOI 10.1016/j.febslet.2012.07.002; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; Spataro V, 1998, BRIT J CANCER, V77, P448, DOI 10.1038/bjc.1998.71; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Wang GF, 2010, J AM CHEM SOC, V132, P16417, DOI 10.1021/ja106506k; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Wen PY, 2006, EXPERT REV ANTICANC, V6, P733, DOI 10.1586/14737140.6.5.733; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w; Zhou JY, 2009, BMB REP, V42, P593, DOI 10.5483/BMBRep.2009.42.9.593; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604	84	34	36	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16711	16726		10.1074/jbc.M113.537118	http://dx.doi.org/10.1074/jbc.M113.537118			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24764300	Green Published, hybrid			2022-12-28	WOS:000338016200011
J	Liu, YC; Chen, ZJ; Neller, MA; Miles, JJ; Purcell, AW; McCluskey, J; Burrows, SR; Rossjohn, J; Gras, S				Liu, Yu Chih; Chen, Zhenjun; Neller, Michelle A.; Miles, John J.; Purcell, Anthony W.; McCluskey, James; Burrows, Scott R.; Rossjohn, Jamie; Gras, Stephanie			A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; MHC CLASS-I; SEQUENCE VARIATION; PERIPHERAL-BLOOD; NUCLEAR ANTIGEN; RECEPTOR; POLYMORPHISM; VARIANTS; FEATURES; IMPACT	Mutations within T cell epitopes represent a common mechanism of viral escape from the host protective immune response. The diverse T cell repertoire and the extensive human leukocyte antigen (HLA) polymorphism across populations is the evolutionary response to viral mutation. However, the molecular basis underpinning the interplay between HLA polymorphism, the T cell repertoire, and viral escape is unclear. Here we investigate the T cell response to a HLA-B*35:01- and HLA-B*35:08-restricted (407)HPVGEADYFEY(417) epitope from Epstein-Barr virus and naturally occurring variants at positions 4 and 5 thereof. Each viral variant differently impacted on the epitope's flexibility and conformation when bound to HLA-B*35:08 or HLA-B*35:01. We provide a molecular basis for understanding how the single residue polymorphism that discriminates between HLA-B*35:01/08 profoundly impacts on T cell receptor recognition. Surprisingly, one viral variant (P5-Glu to P5-Asp) effectively changed restriction preference from HLA-B*35:01 to HLA-B*35:08. Collectively, our study portrays the interplay between the T cell response, viral escape, and HLA polymorphism, whereby HLA polymorphism enables altered presentation of epitopes from different strains of Epstein-Barr virus.	[Liu, Yu Chih; Purcell, Anthony W.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Chen, Zhenjun; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Neller, Michelle A.; Miles, John J.; Burrows, Scott R.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Neller, Michelle A.; Miles, John J.; Burrows, Scott R.] QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Brisbane, Qld 4006, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia	Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute; Cardiff University; Monash University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	jamie.rossjohn@monash.edu; stephanie.gras@monash.edu	Purcell, Anthony/AAH-1942-2019; Rossjohn, Jamie/F-9032-2013; Miles, John J/ABC-1105-2020; McCluskey, James/A-1291-2007; Burrows, Scott/G-2050-2011	Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; Miles, John J/0000-0001-5506-6304; McCluskey, James/0000-0002-8597-815X; Burrows, Scott/0000-0002-1430-0472; gras, stephanie/0000-0001-7416-038X; Neller, Michelle/0000-0002-2457-1508	Australian Research Council; National Health and Medical Research Council of Australia [APP1067374, APP1021620]; National Health and Medical Research Council of Australia Career Development Fellowship; National Health and Medical Research Council of Australia Senior Research Fellowship; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and National Health and Medical Research Council of Australia Grants APP1067374 and APP1021620.; Supported by a National Health and Medical Research Council of Australia Career Development Fellowship.; Supported by a National Health and Medical Research Council of Australia Senior Research Fellowship.; Supported by an Australia Fellowship from the National Health and Medical Research Council. To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Vic 3800 Australia. Tel.: 613-99029236; Fax: 613-9902500; E-mail: jamie.rossjohn@monash.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell MJ, 2008, J INFECT DIS, V197, P1594, DOI 10.1086/587848; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows JM, 2007, EUR J IMMUNOL, V37, P946, DOI 10.1002/eji.200636588; DAMBAUGH T, 1984, P NATL ACAD SCI-BIOL, V81, P7632, DOI 10.1073/pnas.81.23.7632; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALK K, 1993, IMMUNOGENETICS, V38, P161, DOI 10.1007/BF00190906; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Parham P, 1996, NATURE, V384, P109, DOI 10.1038/384109a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sitki-Green D, 2002, J VIROL, V76, P9645, DOI 10.1128/JVI.76.19.9645-9656.2002; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; SNUDDEN DK, 1995, ONCOGENE, V10, P1545; Stewart-Jones GB, 2012, P NATL ACAD SCI USA, V109, pE3483, DOI 10.1073/pnas.1207896109; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Varro Rudolf, 2007, Methods Mol Biol, V378, P125, DOI 10.1007/978-1-59745-323-3_9; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Wang WY, 2002, CLIN CANCER RES, V8, P2586; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Zhang XS, 2004, CANCER LETT, V211, P11, DOI 10.1016/j.canlet.2004.01.035	42	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16688	16698		10.1074/jbc.M114.563502	http://dx.doi.org/10.1074/jbc.M114.563502			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24759101	Green Published, hybrid			2022-12-28	WOS:000338016200009
J	Hong, IK; Byun, HJ; Lee, J; Jin, YJ; Wang, SJ; Jeoung, DI; Kim, YM; Lee, H				Hong, In-Kee; Byun, Hee-Jung; Lee, Jaeseob; Jin, Young-June; Wang, Sun-Ju; Jeoung, Doo-Il; Kim, Young-Myeong; Lee, Hansoo			The Tetraspanin CD81 Protein Increases Melanoma Cell Motility by Up-regulating Metalloproteinase MT1-MMP Expression through the Pro-oncogenic Akt-dependent Sp1 Activation Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Motility; Cell Signaling; Invasion; Melanoma; Sp1; Tetraspanins	MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; HEPATOCELLULAR-CARCINOMA; GENE-TRANSCRIPTION; BETA(1) INTEGRINS; CANCER CELLS; TUMOR-CELLS; IN-VIVO; MIGRATION; CD151; PHOSPHORYLATION	Despite the importance of multiple tetraspanin proteins in cancer invasion and metastasis, little is known about the role and significance of tetraspanin CD81 in these processes. In the present study, we examined CD81 effects on melanoma cell invasiveness and metastasis. Transfection of CD81 into melanoma cells lacking endogenous CD81 expression significantly enhanced the migrating, invasive, and metastatic abilities of melanoma cells. Interestingly, membrane type 1 matrix metalloproteinase (MT1-MMP) expression was found in CD81-expressing melanoma cells but not in CD81-deficient cells. siRNA knockdown of CD81 in melanoma cells with endogenous CD81 demonstrated decreased MT1-MMP levels and cell motility. Notably, CD81-induced cell migration was abrogated by antibody blocking and siRNA knockdown of MT1-MMP, indicating that MT1-MMP is responsible for CD81-stimulated melanoma cell migration. Promoter analysis revealed an essential role of the Sp1 transcription factor in CD81-induced MT1-MMP transcription. We also demonstrate that the Sp1-activating Akt pathway is involved in adhesion-dependent CD81 signaling to induce MT1-MMP expression and cell motility. Importantly, human skin cancer tissue specimens displayed a positive correlation of CD81 with MT1-MMP expression levels and a close association of CD81 with malignant melanomas. Taken together, these results strongly suggest that CD81 stimulates melanoma cell motility by inducing MT1-MMP expression through the Akt-dependent Sp1 activation signaling pathway, leading to increased melanoma invasion and metastasis.	[Hong, In-Kee; Byun, Hee-Jung; Jin, Young-June; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Lee, Jaeseob; Lee, Hansoo] Kangwon Natl Univ, Brain Korea Grad Program 21, Chunchon 200701, Kangwon Do, South Korea; [Lee, Jaeseob; Wang, Sun-Ju; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr			National Research Foundation of Korea - Ministry of Education [2011-0024380]; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI13C1819]	National Research Foundation of Korea - Ministry of Education; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program Grant 2011-0024380 through the National Research Foundation of Korea funded by the Ministry of Education and by Grant HI13C1819 of the Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea.	Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Choi NS, 2000, ANAL BIOCHEM, V281, P236, DOI 10.1006/abio.2000.4572; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; Inoue G, 2001, INT J MOL MED, V7, P67; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mou LY, 2013, J BIOL CHEM, V288, P306, DOI 10.1074/jbc.M112.389783; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Schroder HM, 2013, INT J BIOCHEM CELL B, V45, P1133, DOI 10.1016/j.biocel.2013.02.020; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	42	49	52	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15691	15704		10.1074/jbc.M113.534206	http://dx.doi.org/10.1074/jbc.M113.534206			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733393	Green Published, hybrid			2022-12-28	WOS:000337465400050
J	Kang, I; Yoon, DW; Braun, KR; Wight, TN				Kang, Inkyung; Yoon, Dong Won; Braun, Kathleen R.; Wight, Thomas N.			Expression of Versican V3 by Arterial Smooth Muscle Cells Alters Tumor Growth Factor beta (TGF beta)-, Epidermal Growth Factor (EGF)-, and Nuclear Factor kappa B (NF kappa B)-dependent Signaling Pathways, Creating a Microenvironment That Resists Monocyte Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Elastin; Epidermal Growth Factor Receptor (EGFR); Extracellular Matrix; Hyaluronate; Monocytes; NFkappaB; Transforming Growth Factor Beta (TGFbeta); Vascular Smooth Muscle Cells; Versican	RETROVIRALLY MEDIATED OVEREXPRESSION; ACTIVATES LATENT TGF-BETA-1; ELASTIN-BINDING PROTEIN; EXTRACELLULAR-MATRIX; HYALURONAN SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; POLYCYTIDYLIC ACID; VCAM-1 EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION	Background: Monocyte accumulation contributes to inflammatory disease progression. Results: ASMCs overexpressing V3 resist monocyte adhesion by promoting elastogenesis, depleting hyaluronan, and reducing VCAM1, via differentially regulating TGF-, EGF-, and NFB-signaling pathways. Conclusion: V3 expression by ASMCs generates a microenvironment resistant to monocyte adhesion. Significance: Modifying ECM components via V3 expression alters monocyte adhesion, which suggests therapeutic possibilities to treat inflammation. Monocyte/macrophage accumulation plays a critical role during progression of cardiovascular diseases, such as atherosclerosis. Our previous studies demonstrated that retrovirally mediated expression of the versican V3 splice variant (V3) by arterial smooth muscle cells (ASMCs) decreases monocyte adhesion in vitro and macrophage accumulation in a model of lipid-induced neointimal formation in vivo. We now demonstrate that V3-expressing ASMCs resist monocyte adhesion by altering the composition of the microenvironment surrounding the cells by affecting multiple signaling pathways. Reduction of monocyte adhesion to V3-expressing ASMCs is due to the generation of an extracellular matrix enriched in elastic fibers and depleted in hyaluronan, and reduction of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1). Blocking these changes reverses the protective effect of V3 on monocyte adhesion. The enhanced elastogenesis induced by V3 expression is mediated by TGF signaling, whereas the reduction in hyaluronan cable formation induced by V3 expression is mediated by the blockade of epidermal growth factor receptor and NFB activation pathways. In addition, expression of V3 by ASMCs induced a marked decrease in NFB-responsive proinflammatory cell surface molecules that mediate monocyte adhesion, such as VCAM1. Overall, these results indicate that V3 expression by ASMCs creates a microenvironment resistant to monocyte adhesion via differentially regulating multiple signaling pathways.	[Kang, Inkyung; Yoon, Dong Won; Braun, Kathleen R.; Wight, Thomas N.] Virginia Mason, Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center	Wight, TN (corresponding author), Virginia Mason, Benaroya Res Inst, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org			National Institutes of Health [EB012558, HL098067, HL106967, HL018645]; American Heart Association [09POST2050065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL106967, P01HL018645, P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB012558, HL098067, HL106967, and HL018645 (to T. N. W.). This work was also supported by American Heart Association Grant 09POST2050065 (to I. K.).	Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Bandyopadhyay SK, 2008, AM J PATHOL, V173, P1361, DOI 10.2353/ajpath.2008.080444; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hinek A, 1996, BIOL CHEM, V377, P471; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kothapalli CR, 2008, J TISSUE ENG REGEN M, V2, P106, DOI 10.1002/term.70; Landry DB, 1997, AM J PATHOL, V151, P1085; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Leask A., 2014, J CELL COMM IN PRESS; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McGowan SE, 1997, AM J RESP CELL MOL, V17, P25, DOI 10.1165/ajrcmb.17.1.2686; MCGOWAN SE, 1990, AM J RESP CELL MOL, V3, P369, DOI 10.1165/ajrcmb/3.4.369; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; NEEDHAM LA, 1994, CELL ADHES COMMUN, V2, P87, DOI 10.3109/15419069409004429; Oertli B, 1998, J IMMUNOL, V161, P3431; Ohkawa T, 1999, BBA-MOL CELL RES, V1448, P416, DOI 10.1016/S0167-4889(98)00155-4; Parks WC, 1997, AM J RESP CELL MOL, V17, P1; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schawalder A, 1999, NEPHROL DIAL TRANSPL, V14, P2130, DOI 10.1093/ndt/14.9.2130; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhang MC, 1999, MOL CELL BIOL, V19, P7314; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	85	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15393	15404		10.1074/jbc.M113.544338	http://dx.doi.org/10.1074/jbc.M113.544338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719328	Green Published, hybrid			2022-12-28	WOS:000337465400023
J	Zhu, GX; Fan, ZY; Ding, M; Mu, LB; Liang, J; Ding, YJ; Fu, Y; Huang, BL; Wu, W				Zhu, Guixin; Fan, Zhongyun; Ding, Miao; Mu, Libing; Liang, Juan; Ding, Yajie; Fu, Yu; Huang, Binlu; Wu, Wei			DNA Damage Induces the Accumulation of Tiam1 by Blocking beta-TrCP-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage; E3 Ubiquitin Ligase; c-Jun N-terminal Kinase (JNK); Rac1; Tiam1; Chemotherapy	EXCHANGE FACTOR TIAM1; E3 UBIQUITIN LIGASES; RAC ACTIVATOR TIAM1; DESTRUCTION MOTIF; JNK ACTIVATION; RHO-GTPASES; PHOSPHORYLATION; APOPTOSIS; PROTEIN; INVASION	The Rac1/JNK cascade plays important roles in DNA damage-induced apoptosis. However, how this cascade is activated upon DNA damage remains to be fully understood. We show here that, in untreated cells, Tiam1, a Rac1-specific guanine nucleotide exchange factor, is phosphorylated by casein kinase 1 (CK1) at its C terminus, leading to Skp, Cullin, F-box-containing(-TrCP) recognition, ubiquitination, and proteasome-mediated degradation. Upon DNA-damaging anticancer drug treatment, CK1/-TrCP-mediated Tiam1 degradation is abolished, and the accumulated Tiam1 contributes to downstream activation of Rac1/JNK. Consistently, tumor cells overexpressing Tiam1 are hypersensitive to DNA-damaging drug treatment. In xenograft mice, Tiam1-high cells are more susceptible to doxorubicin treatment. Thus, our results uncover that inhibition of proteasome-mediated Tiam1 degradation is an upstream event leading to Rac1/JNK activation and cell apoptosis in response to DNA-damaging drug treatment.	[Zhu, Guixin; Fan, Zhongyun; Mu, Libing; Liang, Juan; Ding, Yajie; Fu, Yu; Huang, Binlu; Wu, Wei] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhu, Guixin] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ding, Miao] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University	Wu, W (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31221064, 81272235]; Tsinghua-Peking Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences	This work was supported by National Natural Science Foundation of China Grants 31221064 and 81272235 (to W.W).; Postdoctoral fellow supported by the Tsinghua-Peking Center for Life Sciences.	Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Habas R, 2006, METHOD ENZYMOL, V406, P500, DOI 10.1016/S0076-6879(06)06038-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kadara H, 2008, CANCER RES, V68, P4416, DOI 10.1158/0008-5472.CAN-08-0031; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kawazoe N, 1999, ONCOGENE, V18, P2413, DOI 10.1038/sj.onc.1202555; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Liang J, 2011, MOL CELL BIOL, V31, P2577, DOI 10.1128/MCB.05103-11; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oberoi-Khanuja Tripat Kaur, 2012, Small GTPases, V3, P131, DOI 10.4161/sgtp.19988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Santos JA, 1996, J CELL SCI, V109, P1847; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shibayama-Imazu CHT, 2007, ANTICANCER RES, V27, P245; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Suarez Y, 2006, MOL PHARMACOL, V70, P1654, DOI 10.1124/mol.106.025569; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Wang ZW, 2012, ONCOTARGET, V3, P1026; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	59	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15482	15494		10.1074/jbc.M114.553388	http://dx.doi.org/10.1074/jbc.M114.553388			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737324	hybrid, Green Published			2022-12-28	WOS:000337465400031
J	Luz, S; Cihil, KM; Brautigan, DL; Amaral, MD; Farinha, CM; Swiatecka-Urban, A				Luz, Simao; Cihil, Kristine M.; Brautigan, David L.; Amaral, Margarida D.; Farinha, Carlos M.; Swiatecka-Urban, Agnieszka			LMTK2-mediated Phosphorylation Regulates CFTR Endocytosis in Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; DARBY CANINE KIDNEY; TYROSINE KINASE; MYOSIN-VI; ION-TRANSPORT; CL-SECRETION; HALF-LIFE; PROTEIN; TRAFFICKING	Cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- -selective ion channel expressed in fluid-transporting epithelia. Lemur tyrosine kinase 2 (LMTK2) is a transmembrane protein with serine and threonine but not tyrosine kinase activity. Previous work identified CFTR as an in vitro substrate of LMTK2, suggesting a functional link. Here we demonstrate that LMTK2 co-immunoprecipitates with CFTR and phosphorylates CFTR-Ser737 inhumanairway epithelial cells. LMTK2knockdown or expression of inactive LMTK2 kinase domain increases cell surface density of CFTR by attenuating its endocytosis in human airway epithelial cells. Moreover, LMTK2 knockdown increases Cl- secretion mediated by the wild-type and rescued Delta F508-CFTR. Compared with the wild-type CFTR, the phosphorylation-deficient mutant CFTR-S737A shows increased cell surface density and decreased endocytosis. These results demonstrate a novel mechanism of the phospho-dependent inhibitory effect of CFTR-Ser(737) mediated by LMTK2 via endocytosis and inhibition of the cell surface density of CFTRCl- channels. These data indicate that targeting LMTK2 may increase the cell surface density of CFTR Cl- channels and improve stability of pharmacologically rescued Delta F508-CFTR in patients with cystic fibrosis.	[Luz, Simao; Amaral, Margarida D.; Farinha, Carlos M.] Univ Lisbon, Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Cihil, Kristine M.; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15201 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Universidade de Lisboa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Amaral, Margarida D/E-5748-2012; Cunha da Luz, Simao/U-5699-2017; Swiatecka-Urban, Agnieszka/AAP-6041-2020; Farinha, Carlos/A-7110-2010	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; Amaral, Margarida D/0000-0002-0828-8630; Cunha da Luz, Simao/0000-0001-5649-583X; Farinha, Carlos/0000-0002-5467-1710	National Institutes of Health [R01HL090767, R01HL090767-02S1, P30DK072506]; Cystic Fibrosis Foundation [SWIATE14P0]; University of Pittsburgh Bridge Founding; Portuguese FCT [PEst-OE/BIA/UI4046/2011, MCTES PTDC/BIA-BCM/112635/2009, EXPL/BIM-MEC/1451/2013]; Romain Pauwels Research Award;  [SFRH/BD/47445/2008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Pittsburgh Bridge Founding; Portuguese FCT(Portuguese Foundation for Science and Technology); Romain Pauwels Research Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01HL090767, R01HL090767-02S1, the Cystic Fibrosis Foundation SWIATE14P0, and the University of Pittsburgh Bridge Founding (to A. S-U.), the National Institutes of Health Grant P30DK072506 (to J. M. P., Cystic Fibrosis Research Center Epithelial Cell Core at the University of Pittsburgh School of Medicine, Pittsburgh, PA), the Portuguese FCT grants PEst-OE/BIA/UI4046/2011, MCTES PTDC/BIA-BCM/112635/2009, EXPL/BIM-MEC/1451/2013, and Romain Pauwels Research Award (to C. M. F.), and the Fellowship Grant SFRH/BD/47445/2008 (to S. L.).	Alzamora R, 2011, METHODS MOL BIOL, V741, P471, DOI 10.1007/978-1-61779-117-8_29; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chang CW, 1997, J NEUROCHEM, V69, P859; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cihil KM, 2013, JOVE-J VIS EXP, DOI 10.3791/50867; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Guggino WB, 2004, AM J RESP CRIT CARE, V170, P815, DOI 10.1164/rccm.200403-381WS; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Holy M, 2012, TOXINS, V4, P940, DOI 10.3390/toxins4100940; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Kesavapany S, 2003, J NEUROSCI, V23, P4975; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Lukacs GL, 1997, BIOCHEM J, V328, P353; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Madden Dean R, 2012, Commun Integr Biol, V5, P473, DOI 10.4161/cib.21375; Manser C, 2012, ONCOGENE, V31, P2773, DOI 10.1038/onc.2011.437; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mendes AI, 2011, MOL CELL BIOL, V31, P4076, DOI 10.1128/MCB.05152-11; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Nixon A, 2013, AM J PHYSIOL-CELL PH, V304, pC164, DOI 10.1152/ajpcell.00288.2012; Peter K, 2002, J BIOL CHEM, V277, P49952, DOI 10.1074/jbc.M209275200; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Rattray M, 2012, J NEUROCHEM, V121, P327, DOI 10.1111/j.1471-4159.2012.07654.x; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Snodgrass SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063167; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Wang H, 2006, MOL CELL PROTEOMICS, V5, P2124, DOI 10.1074/mcp.M600188-MCP200; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881	71	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15080	15093		10.1074/jbc.M114.563742	http://dx.doi.org/10.1074/jbc.M114.563742			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727471	Green Published, hybrid			2022-12-28	WOS:000337248100059
J	Novikova, O; Topilina, N; Belfort, M				Novikova, Olga; Topilina, Natalya; Belfort, Marlene			Enigmatic Distribution, Evolution, and Function of Inteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HORIZONTAL GENE-TRANSFER; RIBONUCLEOTIDE REDUCTASE GENES; IN-VITRO; MULTIDRUG-RESISTANCE; DIRECTED EVOLUTION; GENOME REDUCTION; PROTEIN-ACTIVITY; DISULFIDE BOND; ATP SYNTHASE; REDOX TRAP	Inteins are mobile genetic elements capable of self-splicing post-translationally. They exist in all three domains of life including in viruses and bacteriophage, where they have a sporadic distribution even among very closely related species. In this review, we address this anomalous distribution from the point of view of the evolution of the host species as well as the intrinsic features of the inteins that contribute to their genetic mobility. We also discuss the incidence of inteins in functionally important sites of their host proteins. Finally, we describe instances of conditional protein splicing. These latter observations lead us to the hypothesis that some inteins have adapted to become sensors that play regulatory roles within their host protein, to the advantage of the organism in which they reside.	[Novikova, Olga] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Novikova, Olga] SUNY Albany, RNA Inst, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Novikova, O (corresponding author), SUNY Albany, Dept Biol Sci, Life Sci Bldg 2065,1400 Washington Ave, Albany, NY 12222 USA.	onovikova@albany.edu		Belfort, Marlene/0000-0002-1592-5618	National Institutes of Health [GM39422, GM44844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, R01GM044844, R01GM039422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM39422 and GM44844 (to M. B.). This is the first article in the Thematic Minireview Series "Inteins."	Allen MJ, 2011, MAR GENOM, V4, P1, DOI 10.1016/j.margen.2010.11.001; Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; BELFORT M, 1989, TRENDS GENET, V5, P209, DOI 10.1016/0168-9525(89)90083-8; Bigot Y, 2013, MOL PHYLOGENET EVOL, V67, P246, DOI 10.1016/j.ympev.2013.01.017; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Callahan BP, 2013, BIOTECHNOL BIOENG, V110, P1565, DOI 10.1002/bit.24821; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Cambon-Bonavita MA, 2000, EXTREMOPHILES, V4, P215, DOI 10.1007/PL00010714; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Carvalho CM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-35; Chen W, 2012, J AM CHEM SOC, V134, P2500, DOI 10.1021/ja211010g; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Cui CX, 2006, PROTEIN EXPRES PURIF, V50, P74, DOI 10.1016/j.pep.2006.05.019; Culley AI, 2009, ISME J, V3, P409, DOI 10.1038/ismej.2008.120; DAVIS EO, 1991, J BACTERIOL, V173, P5653, DOI 10.1128/jb.173.18.5653-5662.1991; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dwivedi B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-33; Dzidic S, 2003, ACTA PHARMACOL SIN, V24, P519; Emera D, 2012, BRIEF FUNCT GENOMICS, V11, P267, DOI 10.1093/bfgp/els013; Faulkner GJ, 2009, CELL CYCLE, V8, P2895, DOI 10.4161/cc.8.18.9536; Ferber D, 2003, SCIENCE, V302, P1488, DOI 10.1126/science.302.5650.1488; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Gierach I, 2012, FEBS OPEN BIO, V2, P247, DOI 10.1016/j.fob.2012.08.002; Gill JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-542; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Goodwin Timothy J D, 2006, BMC Biol, V4, P38, DOI 10.1186/1741-7007-4-38; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Hambly E, 2005, CURR OPIN MICROBIOL, V8, P444, DOI 10.1016/j.mib.2005.06.005; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hessen DO, 2010, TRENDS ECOL EVOL, V25, P75, DOI 10.1016/j.tree.2009.08.004; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang JL, 2013, BIOESSAYS, V35, P868, DOI 10.1002/bies.201300007; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kaneko T, 1995, DNA Res, V2, P153, DOI 10.1093/dnares/2.4.153; KANEKO T, 1995, DNA RES, V2, P191, DOI DOI 10.1093/DNARES/2.4.191; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Larsen JB, 2008, APPL ENVIRON MICROB, V74, P3048, DOI 10.1128/AEM.02548-07; Lazarevic V, 2001, NUCLEIC ACIDS RES, V29, P3212, DOI 10.1093/nar/29.15.3212; Lazarevic V, 1998, P NATL ACAD SCI USA, V95, P1692, DOI 10.1073/pnas.95.4.1692; Li JJ, 2011, BIOSENS BIOELECTRON, V29, P132, DOI 10.1016/j.bios.2011.08.006; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Mills KV, 2005, J BIOL CHEM, V280, P2714, DOI 10.1074/jbc.M412313200; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mootz HD, 2002, J AM CHEM SOC, V124, P9044, DOI 10.1021/ja026769o; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3599, DOI 10.1128/AEM.71.7.3599-3607.2005; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Nicastri MC, 2013, BIOCHEMISTRY-US, V52, P5920, DOI 10.1021/bi400736c; Ogata H, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-8; Paulus H, 2001, BIOORG CHEM, V29, P119, DOI 10.1006/bioo.2001.1203; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Santos F, 2011, ISME J, V5, P1621, DOI 10.1038/ismej.2011.34; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g; Shao Y, 1997, J PEPT RES, V50, P193; SHAO Y, 1995, BIOCHEMISTRY-US, V34, P10844, DOI 10.1021/bi00034a017; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Sorci M, 2013, ANAL CHEM, V85, P6080, DOI 10.1021/ac400949t; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Swithers Kristen S, 2012, Int J Evol Biol, V2012, P418964, DOI 10.1155/2012/418964; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Topilina NI, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-5; Volkmann G, 2013, CELL MOL LIFE SCI, V70, P1185, DOI 10.1007/s00018-012-1120-4; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 2005, CURR OPIN BIOTECH, V16, P440, DOI 10.1016/j.copbio.2005.06.012; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	94	71	76	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14490	14497		10.1074/jbc.R114.548255	http://dx.doi.org/10.1074/jbc.R114.548255			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695741	Green Published, hybrid			2022-12-28	WOS:000337248100007
J	Wang, JM; Huang, FC; Kuo, MHJ; Wang, ZF; Tseng, TY; Chang, LC; Yen, SJ; Chang, TC; Lin, JJ				Wang, Jing-Ming; Huang, Fong-Chun; Kuo, Margaret Hsin-Jui; Wang, Zi-Fu; Tseng, Ting-Yuan; Chang, Lien-Cheng; Yen, Shao-Jung; Chang, Ta-Chau; Lin, Jing-Jer			Inhibition of Cancer Cell Migration and Invasion through Suppressing the Wnt1-mediating Signal Pathway by G-quadruplex Structure Stabilizers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER REGION; WNT1 EXPRESSION; DNA; GENE; NUCLEOLIN; PARALLEL; TELOMERASE; ACTIVATION; SENESCENCE; CARCINOMA	WNT1 encodes a multifunctional signaling glycoprotein that is highly expressed in several malignant tumors. Patients with Wnt1-positive cancer are usually related to advanced metastasis. Here, we found that a stretch of G-rich sequences located at the WNT1 promoter region is capable of forming G-quadruplex structures. The addition of G-quadruplex structure stabilizers, BMVC and BMVC4, raises the melting temperature of the oligonucleotide formed by the WNT1 promoter G-rich sequences. Significantly, the expression of WNT1 was repressed by BMVC or BMVC4 in a G-quadruplex-dependent manner, suggesting that they can be used to modulate WNT1 expression. The role of G-quadruplex stabilizers on Wnt1-mediated cancer migration and invasion was further analyzed. The protein levels of beta-catenin, a mediator of the Wnt-mediated signaling pathway, and the downstream targets MMP7 and survivin were down-regulated upon BMVC or BMVC4 treatments. Moreover, the migration and invasion activities of cancer cells were inhibited by BMVC and BMVC4, and the inhibitory effects can be reversed by WNT1-overexpression. Thus the Wnt1 expression and its downstream signaling pathways can be regulated through the G-quadruplex sequences located at its promoter region. These findings provide a novel approach for future drug development to inhibit migration and invasion of cancer cells.	[Wang, Jing-Ming; Chang, Lien-Cheng; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Huang, Fong-Chun; Yen, Shao-Jung; Lin, Jing-Jer] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Kuo, Margaret Hsin-Jui; Wang, Zi-Fu; Tseng, Ting-Yuan; Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei 106, Taiwan; [Wang, Zi-Fu; Chang, Ta-Chau] Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan; [Tseng, Ting-Yuan; Chang, Ta-Chau] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Chang, Lien-Cheng] Minist Hlth & Welf, Food & Drug Adm, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University	Chang, TC (corresponding author), Acad Sinica, Inst Atom & Mol Sci, POB 23-166, Taipei 106, Taiwan.	tcchang@po.iams.sinica.edu.tw; jingjerlin@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012; Lin, Jing-Jer/G-8068-2015	Chang, Ta-Chau/0000-0001-5878-8556; LIN, JING-JER/0000-0001-8250-7398	Academia Sinica [AS-98-TP-A04, AS-102-TP-A07]; National Science Council [100-2311-B-002-016, 100-2311-B-010-001]; National Health Research Institute [NHRI-EX101-10050SI]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by Academia Sinica AS-98-TP-A04 and AS-102-TP-A07, the National Science Council (100-2311-B-002-016 and 100-2311-B-010-001), and the National Health Research Institute (NHRI-EX101-10050SI).	BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Feigon J, 1995, METHOD ENZYMOL, V261, P225; Fenby BT, 2008, BBA-GENE REGUL MECH, V1779, P115, DOI 10.1016/j.bbagrm.2007.11.008; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; He WC, 2012, J AM SOC NEPHROL, V23, P294, DOI 10.1681/ASN.2011050490; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huang FC, 2008, MOL CANCER RES, V6, P955, DOI 10.1158/1541-7786.MCR-07-0260; Huang FC, 2012, BRIT J PHARMACOL, V167, P393, DOI 10.1111/j.1476-5381.2012.01997.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kang CC, 2013, INTEGR BIOL-UK, V5, P1217, DOI 10.1039/c3ib40058a; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lin CT, 2011, J PHYS CHEM B, V115, P2360, DOI 10.1021/jp107623n; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Nakashima T, 2008, ONCOL REP, V19, P203; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; NUSSE R, 1990, MOL CELL BIOL, V10, P4170, DOI 10.1128/MCB.10.8.4170; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; PATEL DJ, 1974, BIOPOLYMERS, V13, P1943, DOI 10.1002/bip.1974.360131003; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Sack U, 2011, MOL BIOL CELL, V22, P3344, DOI 10.1091/mbc.E10-09-0739; Siddiqui-Jain A., 2002, P NATL ACAD SCI USA, V34, P11593; STARNAUD R, 1993, MOL CELL BIOL, V13, P1590, DOI 10.1128/MCB.13.3.1590; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tsai YL, 2011, NUCLEIC ACIDS RES, V39, pE114, DOI 10.1093/nar/gkr499; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Wei PC, 2013, NUCLEIC ACIDS RES, V41, P1533, DOI 10.1093/nar/gks1232; Wei W, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-76; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Xu LF, 2000, GENE DEV, V14, P585; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485	60	30	31	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14612	14623		10.1074/jbc.M114.548230	http://dx.doi.org/10.1074/jbc.M114.548230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713700	Green Published, hybrid			2022-12-28	WOS:000337248100018
J	Matsui, T; Noguchi, K; Fukuda, M				Matsui, Takahide; Noguchi, Kenta; Fukuda, Mitsunori			Dennd3 Functions as a Guanine Nucleotide Exchange Factor for Small GTPase Rab12 in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acids Transport; Autophagy; Endosomes; G Proteins; Guanine Nucleotide Exchange Factor (GEF); Low Molecular Weight G Proteins; Membrane Trafficking; mTOR Complex (mTORC); Rab Proteins	BINDING-SPECIFICITY; AUTOPHAGY; COMPLEX; MTOR; INSULIN; PROTEINS; PHOSPHORYLATION; DEGRADATION; ACTIVATION; MEMBRANE	Background: The physiological function of Dennd3, a putative Rab12-GEF, was unknown. Results: Dennd3 regulates degradation of the amino acid transporter PAT4 through Rab12 activation and also modulates Akt activity. Conclusion: Dennd3 functions as a Rab12-GEF in MEF cells. Significance: Our findings provide a novel insight into the cross-talk between an amino acid signaling pathway and a growth factor signaling pathway through Dennd3. Small GTPase Rab12 regulates mTORC1 (mammalian target of rapamycin complex 1) activity and autophagy through controlling PAT4 (proton/amino acid transporter 4) trafficking from recycling endosomes to lysosomes, where PAT4 is degraded. However, the precise regulatory mechanism of the Rab12-mediated membrane trafficking pathway remained to be determined because a physiological Rab12-GEF (guanine nucleotide exchange factor) had yet to be identified. In this study we performed functional analyses of Dennd3, which has recently been shown to possess a GEF activity toward Rab12 in vitro. The results showed that knockdown of Dennd3 in mouse embryonic fibroblast cells caused an increase in the amount of PAT4 protein, the same as Rab12 knockdown did, and knockdown of Dennd3 and overexpression of Dennd3 were found to result in an increase and a decrease, respectively, in the intracellular amino acid concentration. Dennd3 overexpression was also found to reduce mTORC1 activity and promoted autophagy in a Rab12-dependent manner. Unexpectedly, however, Dennd3 knockdown had no effect on mTORC1 activity or autophagy despite increasing the intracellular amino acid concentration. Further study showed that Dennd3 knockdown reduced Akt activity, and the reduction in Akt activity is likely to have canceled out amino acid-induced mTORC1 activation through PAT4. These findings indicated that Dennd3 not only functions as a Rab12-GEF but also modulates Akt signaling in mouse embryonic fibroblast cells.	[Matsui, Takahide; Noguchi, Kenta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Matsui, Takahide/S-4986-2018; Fukuda, MItsunori/I-1511-2015	Matsui, Takahide/0000-0002-3342-0170; Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26111501] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to M. F.).; Supported by the Japan Society for the Promotion of Science.	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Matsui T, 2013, EMBO REP, V14, P450, DOI 10.1038/embor.2013.32; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13986	13995		10.1074/jbc.M113.546689	http://dx.doi.org/10.1074/jbc.M113.546689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719330	Green Published, hybrid			2022-12-28	WOS:000335984600029
J	Ohashi, K; Enomoto, T; Joki, Y; Shibata, R; Ogura, Y; Kataoka, Y; Shimizu, Y; Kambara, T; Uemura, Y; Yuasa, D; Matsuo, K; Hayakawa, S; Hiramatsu-Ito, M; Murohara, T; Ouchi, N				Ohashi, Koji; Enomoto, Takashi; Joki, Yusuke; Shibata, Rei; Ogura, Yasuhiro; Kataoka, Yoshiyuki; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Murohara, Toyoaki; Ouchi, Noriyuki			Neuron-derived Neurotrophic Factor Functions as a Novel Modulator That Enhances Endothelial Cell Function and Revascularization Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Angiogenesis; Apoptosis; Endothelial Cell; Ischemia; Nitric Oxide Synthase; Neuron-derived Neurotrophic Factor	ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; ADIPONECTIN STIMULATES ANGIOGENESIS; COLLATERAL VESSEL DEVELOPMENT; FOLLISTATIN-LIKE 1; GROWTH-FACTOR; MOUSE MODEL; IN-VIVO; PROMOTES ANGIOGENESIS; METABOLIC SYNDROME	Background: Tissue ischemia stimulates production of secreted factors that regulate angiogenesis. Results: Neuron-derived neurotrophic factor (NDNF) is up-regulated in endothelial cells in ischemic limbs of mice. NDNF stimulates endothelial cell function and promotes ischemia-induced revascularization through NOS-dependent mechanisms. Conclusion: NDNF functions as a novel modulator that stimulates revascularization processes. Significance: NDNF represents a novel therapeutic target for ischemic vascular diseases. Strategies to stimulate revascularization are valuable for cardiovascular diseases. Here we identify neuron-derived neurotrophic factor (NDNF)/epidermacan as a secreted molecule that is up-regulated in endothelial cells in ischemic limbs of mice. NDNF was secreted from cultured human endothelial cells, and its secretion was stimulated by hypoxia. NDNF promoted endothelial cell network formation and survival in vitro through activation of Akt/endothelial NOS (eNOS) signaling involving integrin v3. Conversely, siRNA-mediated knockdown of NDNF in endothelial cells led to reduction of cellular responses and basal Akt signaling. Intramuscular overexpression of NDNF led to enhanced blood flow recovery and capillary density in ischemic limbs of mice, which was accompanied by enhanced phosphorylation of Akt and eNOS. The stimulatory actions of NDNF on perfusion recovery in ischemic muscles of mice were abolished by eNOS deficiency or NOS inhibition. Furthermore, siRNA-mediated reduction of NDNF in muscles of mice resulted in reduction of perfusion recovery and phosphorylation of Akt and eNOS in response to ischemia. Our data indicate that NDNF acts as an endogenous modulator that promotes endothelial cell function and ischemia-induced revascularization through eNOS-dependent mechanisms. Thus, NDNF can represent a therapeutic target for the manipulation of ischemic vascular disorders.	[Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Enomoto, Takashi; Joki, Yusuke; Shibata, Rei; Ogura, Yasuhiro; Kataoka, Yoshiyuki; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nouchi@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014	Enomoto, Takashi/0000-0002-7370-8013; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Akeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Cardiovascular Research Fund, Tokyo, Japan	Akeda Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Cardiovascular Research Fund, Tokyo, Japan	This work was supported by a grant-in-aid for scientific research; a grant-in-aid for challenging exploratory research; and grants from the Akeda Science Foundation, the Uehara Memorial Foundation, the Daiichi-Sankyo Foundation of Life Science, and the SENSHIN Medical Research Foundation (to N. O.).; Supported by a Grant-in-aid for Young Scientists B and by the Cardiovascular Research Fund, Tokyo, Japan.	Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Emanueli C, 2001, CIRCULATION, V103, P125; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kuang XL, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-137; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Takemura Y, 2004, HYPERTENSION, V43, P880, DOI 10.1161/01.HYP.0000120124.27641.03; Turhan H, 2005, CORONARY ARTERY DIS, V16, P281, DOI 10.1097/00019501-200508000-00004; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474	49	31	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14132	14144		10.1074/jbc.M114.555789	http://dx.doi.org/10.1074/jbc.M114.555789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706764	Green Published, hybrid			2022-12-28	WOS:000335984600041
J	Liu, CH; Sheng, JZ; Krahn, JM; Perera, L; Xu, YM; Hsieh, PH; Dou, WF; Liu, J; Pedersen, LC				Liu, Chunhui; Sheng, Juzheng; Krahn, Juno M.; Perera, Lalith; Xu, Yongmei; Hsieh, Po-Hung; Dou, Wenfang; Liu, Jian; Pedersen, Lars C.			Molecular Mechanism of Substrate Specificity for Heparan Sulfate 2-O-Sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heparan Sulfate; Heparin; Heparin-binding Protein; Oligosaccharide; Sulfotransferase	3-O-SULFOTRANSFERASE; BIOSYNTHESIS; PROTEOGLYCANS; C-5-EPIMERASE; DIVERSITY; SYSTEM; MODE	Background: Sulfotransferases with distinct specificities act in sequence in the heparan sulfate biosynthetic pathway. Results: The crystal structure of 2-O-sulfotransferase with bound substrate reveals its requirements for substrate recognition. Conclusion: The 2-O-sulfotransferase recognizes N-sulfate but excludes 6-O-sulfate on substrates. Significance: The results advance the understanding of cellular control for the biosynthesis of heparan sulfate. Heparan sulfate (HS) is an abundant polysaccharide in the animal kingdom with essential physiological functions. HS is composed of sulfated saccharides that are biosynthesized through a complex pathway involving multiple enzymes. In vivo regulation of this process remains unclear. HS 2-O-sulfotransferase (2OST) is a key enzyme in this pathway. Here, we report the crystal structure of the ternary complex of 2OST, 3-phosphoadenosine 5-phosphate, and a heptasaccharide substrate. Utilizing site-directed mutagenesis and specific oligosaccharide substrate sequences, we probed the molecular basis of specificity and 2OST position in the ordered HS biosynthesis pathway. These studies revealed that Arg-80, Lys-350, and Arg-190 of 2OST interact with the N-sulfo groups near the modification site, consistent with the dependence of 2OST on N-sulfation. In contrast, 6-O-sulfo groups on HS are likely excluded by steric and electrostatic repulsion within the active site supporting the hypothesis that 2-O-sulfation occurs prior to 6-O-sulfation. Our results provide the structural evidence for understanding the sequence of enzymatic events in this pathway.	[Liu, Chunhui; Sheng, Juzheng; Xu, Yongmei; Hsieh, Po-Hung; Dou, Wenfang; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Liu, Chunhui; Sheng, Juzheng] Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drug, Jinan 250012, Peoples R China; [Krahn, Juno M.; Perera, Lalith; Pedersen, Lars C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Dou, Wenfang] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; Shandong University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Jiangnan University	Liu, J (corresponding author), Univ N Carolina, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Sheng, Juzheng/G-2693-2013; perera, Lalith/B-6879-2012; Perera, Lalith/ABB-9995-2021; Pedersen, Lars/C-6173-2019	Sheng, Juzheng/0000-0003-2856-9162; perera, Lalith/0000-0003-0823-1631; Pedersen, Lars/0000-0002-4488-4077	National Institutes of Health [GM102137, HL094463]; National Institutes of Health, NIEHS [ZIAES102645, ZICES043010-28]; China Scholarship Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102137 and HL094463 and by the Intramural Research Program of the National Institutes of Health, NIEHS Project ZIAES102645 and ZICES043010-28 (to L. C. P.).; Supported by the China Scholarship Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Case DA, 2012, AMBER 12; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Linhardt RJ, 2003, J MED CHEM, V46, P2551, DOI 10.1021/jm030176m; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Witt RM, 2013, J BIOL CHEM, V288, P26275, DOI 10.1074/jbc.M112.438937; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	38	34	35	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13407	13418		10.1074/jbc.M113.530535	http://dx.doi.org/10.1074/jbc.M113.530535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652287	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000335522800039
J	Liu, W; Cai, MJ; Zheng, CC; Wang, JX; Zhao, XF				Liu, Wen; Cai, Mei-Juan; Zheng, Chuan-Chuan; Wang, Jin-Xing; Zhao, Xiao-Fan			Phospholipase C gamma 1 Connects the Cell Membrane Pathway to the Nuclear Receptor Pathway in Insect Steroid Hormone Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Gene Transcription; Phosphotyrosine; Protein Phosphorylation; Steroid Hormone Receptor; 20-Hydroxyecdysone; Calcium Influx; Phospholipase C1	PROTEIN-COUPLED RECEPTOR; IN-VITRO; TYROSINE PHOSPHORYLATION; ECDYSTEROID RECEPTOR; NONGENOMIC ACTION; GROWTH-FACTOR; PLC-GAMMA; ACTIVATION; KINASE; SURAMIN	Background: PLCG1 plays an important role in calcium signaling. Results: PLCG1 up-regulates 20E-induced calcium signaling and regulates USP1 PKC phosphorylation in the lepidopteran insect Helicoverpa armigera. Conclusion: 20E activates PLCG1 to induce calcium influx to regulate USP1 PKC phosphorylation for gene expression. Significance: Our study establishes a link between the nongenomic pathway and genomic pathway in steroid hormone 20E signaling. In addition to the classical nuclear receptor pathway, there is a nongenomic pathway in the cell membrane that regulates gene expression in animal steroid hormone signaling; however, this mechanism is unclear. Here, we report that the insect steroid hormone 20-hydroxyecdysone (20E) regulates calcium influx via phospholipase C1 (PLCG1) to modulate the protein kinase C phosphorylation of the transcription factor ultraspiracle (USP1) in the lepidopteran insect Helicoverpa armigera. The PLCG1 mRNA levels are increased during the molting and metamorphic stages. The depletion of PLCG1 by RNA interference can block 20E-enhanced pupation, cause larvae death and pupation defects, and repress 20E-induced gene expression. 20E may induce the tyrosine phosphorylation of PLCG1 at the cytosolic tyrosine kinase (Src) homology 2 domains and then determine the migration of PLCG1 toward the plasma membrane. The G-protein-coupled receptor (GPCR) inhibitor suramin, Src family kinase inhibitor PP2, and the depletions of ecdysone-responsible GPCR (ErGPCR) and G(q) restrain the 20E-induced tyrosine phosphorylation of PLCG1. PLCG1 participates in the 20E-induced Ca2+ influx. The inhibition of GPCR, PLC, inositol 1,4,5-trisphosphate receptor, and calcium channels represses the 20E-induced Ca2+ influx. Through calcium signaling, PLCG1 mediates the transcriptional activation driven by the ecdysone-response element. Through PLCG1 and calcium signaling, 20E regulates PKC phosphorylation of USP1 at Ser-21 to determine its ecdysone-response element binding activity. These results suggest that 20E activates PLCG1 via the ErGPCR and Src family kinases to regulate Ca2+ influx and PKC phosphorylation of USP1 to subsequently modulate gene transcription for metamorphosis.	[Liu, Wen; Cai, Mei-Juan; Zheng, Chuan-Chuan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ,Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021; Liu, Wen/S-8027-2019	Liu, Wen/0000-0002-4985-0618; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067]; National Basic Research Program of China 973 Program [2012CB114101]; Ph.D. Programs Foundation of Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China 973 Program, Grant 2012CB114101, and Ph.D. Programs Foundation of Ministry of Education of China Grant 20120131110025.	Abdollahi A, 2003, CANCER RES, V63, P3755; Beindl W, 1996, MOL PHARMACOL, V50, P415; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buitrago C, 2002, EUR J BIOCHEM, V269, P2506, DOI 10.1046/j.1432-1033.2002.02915.x; BUTLER SJ, 1988, BIOCHEM J, V251, P201, DOI 10.1042/bj2510201; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; CHATILA T, 1989, J IMMUNOL, V143, P1283; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; De Smet P, 1999, CELL CALCIUM, V26, P9; Dedos SG, 1999, MOL CELL ENDOCRINOL, V154, P63, DOI 10.1016/S0303-7207(99)00082-9; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; Gorelick-Feldman J, 2010, STEROIDS, V75, P632, DOI 10.1016/j.steroids.2010.03.008; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HUANG RRC, 1990, MOL PHARMACOL, V37, P304; Iga M, 2007, MOL CELL ENDOCRINOL, V263, P18, DOI 10.1016/j.mce.2006.08.005; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lehmann N, 2002, BIOPHYS J, V82, P793, DOI 10.1016/S0006-3495(02)75441-6; Liu DY, 2009, HYPERTENSION, V53, P70, DOI 10.1161/HYPERTENSIONAHA.108.116947; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Manaboon M, 2009, J INSECT PHYSIOL, V55, P122, DOI 10.1016/j.jinsphys.2008.10.013; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Morris DD, 1998, APPL ENVIRON MICROB, V64, P1759; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nicolai M, 2000, INSECT MOL BIOL, V9, P241, DOI 10.1046/j.1365-2583.2000.00181.x; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Putney JW, 2002, NAT CELL BIOL, V4, pE280, DOI 10.1038/ncb1202-e280; Rauch P, 1998, INSECT BIOCHEM MOLEC, V28, P265, DOI 10.1016/S0965-1748(98)00026-5; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Schauer S, 2011, J STEROID BIOCHEM, V124, P84, DOI 10.1016/j.jsbmb.2011.01.013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stoica B, 1998, J IMMUNOL, V160, P1059; Terland O, 1999, NEUROPHARMACOLOGY, V38, P879, DOI 10.1016/S0028-3908(98)00233-0; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018	57	43	46	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13026	13041		10.1074/jbc.M113.547018	http://dx.doi.org/10.1074/jbc.M113.547018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692553	Green Published, hybrid			2022-12-28	WOS:000335522800007
J	Moykkynen, T; Coleman, SK; Semenov, A; Keinanen, K				Moykkynen, Tommi; Coleman, Sarah K.; Semenov, Artur; Keinanen, Kari			The N-terminal Domain Modulates alpha-Amino-3-hydroxy-5methyl-4-isoxazolepropionic acid ( AMPA) Receptor Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Ionotropic Glutamate Receptors (AMPA; NMDA); Ion Channels; Protein Domains; Receptor Desensitization; Receptor Structure-Function	IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING DOMAIN; NMDA RECEPTOR; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; KAINATE RECEPTORS; ION CHANNELS; SUBUNIT; TRAFFICKING	Background: The function of the AMPA receptor N-terminal domain (NTD) is unknown. Results: Deletion of the NTD leads to reduced desensitization and surface expression of GluA1-4 AMPA receptors. Conclusion: The NTD has a strong influence on the function and biosynthetic maturation of AMPA receptors. Significance: The NTD has the potential to mediate allosteric regulation of AMPA receptor signaling. AMPA receptors are tetrameric glutamate-gated ion channels that mediate fast synaptic neurotransmission in mammalian brain. Their subunits contain a two-lobed N-terminal domain (NTD) that comprises over 40% of the mature polypeptide. The NTD is not obligatory for the assembly of tetrameric receptors, and its functional role is still unclear. By analyzing full-length and NTD-deleted GluA1-4 AMPA receptors expressed in HEK 293 cells, we found that the removal of the NTD leads to a significant reduction in receptor transport to the plasma membrane, a higher steady state-to-peak current ratio of glutamate responses, and strongly increased sensitivity to glutamate toxicity in cell culture. Further analyses showed that NTD-deleted receptors display both a slower onset of desensitization and a faster recovery from desensitization of agonist responses. Our results indicate that the NTD promotes the biosynthetic maturation of AMPA receptors and, for membrane-expressed channels, enhances the stability of the desensitized state. Moreover, these findings suggest that interactions of the NTD with extracellular/synaptic ligands may be able to fine-tune AMPA receptor-mediated responses, in analogy with the allosteric regulatory role demonstrated for the NTD of NMDA receptors.	[Moykkynen, Tommi; Coleman, Sarah K.; Semenov, Artur; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, POB 56 Viikinkaari 5, FIN-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi		Coleman, Sarah/0000-0002-1066-8296	Academy of Finland [137596]; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation	This study was supported by Academy of Finland grant 137596 (to K. K.), by the Sigrid Juselius Foundation (to K. K.), and by the Magnus Ehrnrooth Foundation (to T. M. and S. K. C.).	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Baranovic J, 2013, J BIOL CHEM, V288, P8647, DOI 10.1074/jbc.M112.422105; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Chaudhry C, 2009, P NATL ACAD SCI USA, V106, P12329, DOI 10.1073/pnas.0904175106; Christie LA, 2010, P NATL ACAD SCI USA, V107, P9412, DOI 10.1073/pnas.0908206107; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jensen MH, 2011, J MOL BIOL, V414, P96, DOI 10.1016/j.jmb.2011.09.037; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Midgett CR, 2008, J MOL BIOL, V382, P578, DOI 10.1016/j.jmb.2008.07.021; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sirrieh RE, 2013, J BIOL CHEM, V288, P22555, DOI 10.1074/jbc.M113.482356; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yao GR, 2011, BIOCHEM J, V438, P255, DOI 10.1042/BJ20110801; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	65	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13197	13205		10.1074/jbc.M113.526301	http://dx.doi.org/10.1074/jbc.M113.526301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652293	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000335522800021
J	Fukumoto, Y; Morii, M; Miura, T; Kubota, S; Ishibashi, K; Honda, T; Okamoto, A; Yamaguchi, N; Iwama, A; Nakayama, Y; Yamaguchi, N				Fukumoto, Yasunori; Morii, Mariko; Miura, Takahito; Kubota, Sho; Ishibashi, Kenichi; Honda, Takuya; Okamoto, Aya; Yamaguchi, Noritaka; Iwama, Atsushi; Nakayama, Yuji; Yamaguchi, Naoto			Src Family Kinases Promote Silencing of ATR-Chk1 Signaling in Termination of DNA Damage Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Checkpoint Control; DNA Damage; DNA Damage Response; Src; Checkpoint Recovery	DOUBLE-STRAND BREAKS; LYN TYROSINE KINASE; POLO-LIKE KINASE-1; CELL-CYCLE CHECKPOINTS; IONIZING-RADIATION; GENOTOXIC STRESS; PROTEIN-KINASE; REPLICATION STRESS; MEDIATED PHOSPHORYLATION; NUCLEAR-LOCALIZATION	Background: Once DNA repair is completed, the DNA damage checkpoint is terminated, and the cell cycle is resumed. Results: Src inhibition induced a delay in G(2) checkpoint recovery and persistent ATR-Chk1 activation. Conclusion: Src inhibits ATR signaling to promote recovery from G(2) checkpoint arrest. Significance: Src sends a termination signal between the completion of DNA repair and the initiation of checkpoint termination. The DNA damage checkpoint arrests cell cycle progression to allow time for repair. Once DNA repair is completed, checkpoint signaling is terminated. Currently little is known about the mechanism by which checkpoint signaling is terminated, and the disappearance of DNA lesions is considered to induce the end of checkpoint signaling; however, here we show that the termination of checkpoint signaling is an active process promoted by Src family tyrosine kinases. Inhibition of Src activity delays recovery from the G(2) phase DNA damage checkpoint following DNA repair. Src activity is required for the termination of checkpoint signaling, and inhibition of Src activity induces persistent activation of ataxia telangiectasia mutated (ATM)- and Rad3-related (ATR) and Chk1 kinases. Src-dependent nuclear protein tyrosine phosphorylation and v-Src expression suppress the ATR-mediated Chk1 and Rad17 phosphorylation induced by DNA double strand breaks or DNA replication stress. Thus, Src family kinases promote checkpoint recovery through termination of ATR- and Chk1-dependent G(2) DNA damage checkpoint. These results suggest a model according to which Src family kinases send a termination signal between the completion of DNA repair and the initiation of checkpoint termination.	[Fukumoto, Yasunori; Morii, Mariko; Miura, Takahito; Kubota, Sho; Ishibashi, Kenichi; Honda, Takuya; Okamoto, Aya; Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan	Chiba University; Chiba University	Fukumoto, Y (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	fukumoto@faculty.chiba-u.jp		Honda, Takuya/0000-0002-7141-0088; Kubota, Sho/0000-0001-6119-1259; Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nanohana Competition Award of Chiba University; Futaba Electronics Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nanohana Competition Award of Chiba University; Futaba Electronics Memorial Foundation	This work was supported in part by grants-in-aid for scientific research, the Global Centers of Excellence (COE) Program (Global Center for Education and Research in Immune Regulation and Treatment), and Special Funds for Education and Research (Development of single photon emission computed tomography (SPECT) Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and a research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research.; Recipient of a research grant from the Nanohana Competition 2011 Award of Chiba University and the Futaba Electronics Memorial Foundation. To whom correspondence should be addressed: Dept. of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan. Tel. and Fax: 81-43-226-2869; E-mail: fukumoto@faculty.chiba-u.jp.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Calonge TM, 2008, DNA REPAIR, V7, P136, DOI 10.1016/j.dnarep.2007.07.017; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; He ZW, 2005, J BIOL CHEM, V280, P2446, DOI 10.1074/jbc.M402053200; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; KHARBANDA S, 1994, J BIOL CHEM, V269, P20739; Kharbanda S, 1996, CANCER RES, V56, P3617; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; Kohn EA, 2003, CANCER RES, V63, P31; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Madoz-Gurpide J, 2007, MOL CELL PROTEOMICS, V6, P2150, DOI 10.1074/mcp.M700006-MCP200; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Maruo A, 1999, INT IMMUNOL, V11, P1371, DOI 10.1093/intimm/11.9.1371; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MOHN H, 1995, BIOCHEM J, V309, P657; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Paliwal P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-45; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Qin SF, 1997, J BIOL CHEM, V272, P17994, DOI 10.1074/jbc.272.29.17994; Radha V, 1996, EUR J BIOCHEM, V236, P352, DOI 10.1111/j.1432-1033.1996.00352.x; Riffell JL, 2009, CELL CYCLE, V8, P3025; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Shangary S, 2003, EXP CELL RES, V289, P67, DOI 10.1016/S0014-4827(03)00234-9; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vavrova J, 2013, RADIAT ENVIRON BIOPH, V52, P471, DOI 10.1007/s00411-013-0486-5; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	95	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12313	12329		10.1074/jbc.M113.533752	http://dx.doi.org/10.1074/jbc.M113.533752			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634213	Green Published, hybrid			2022-12-28	WOS:000335581400011
J	Grove, LM; Southern, BD; Jin, TH; White, KE; Paruchuri, S; Harel, E; Wei, Y; Rahaman, SO; Gladson, CL; Ding, Q; Craik, CS; Chapman, HA; Olman, MA				Grove, Lisa M.; Southern, Brian D.; Jin, Tong H.; White, Kimberly E.; Paruchuri, Sailaja; Harel, Efrat; Wei, Ying; Rahaman, Shaik O.; Gladson, Candece L.; Ding, Qiang; Craik, Charles S.; Chapman, Harold A.; Olman, Mitchell A.			Urokinase-type Plasminogen Activator Receptor ( uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast; Fibrosis; Integrin; Lipid Raft; Urokinase Receptor	IDIOPATHIC PULMONARY-FIBROSIS; LIPID RAFTS; CELL-ADHESION; LUNG FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; GLIOBLASTOMA CELLS; DOWN-REGULATION; MIGRATION; KINASE; GROWTH	Background: Fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) overexpress the urokinase-type plasminogen activator receptor (uPAR) and are hypermotile. Results: uPAR ligation increases fibroblast motility by localizing 51 integrin-Fyn signaling complexes to lipid rafts. Conclusion: The hypermotile phenotype of IPF fibroblasts is due to lipid raft-localized uPAR-integrin-Fyn signaling complexes. Significance: These unique lipid raft signals may be therapeutic targets for IPF. The urokinase-type plasminogen activator receptor (uPAR) is a glycosylphosphatidylinositol-linked membrane protein with no cytosolic domain that localizes to lipid raft microdomains. Our laboratory and others have documented that lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) exhibit a hypermotile phenotype. This study was undertaken to elucidate the molecular mechanism whereby uPAR ligation with its cognate ligand, urokinase, induces a motile phenotype in human lung fibroblasts. We found that uPAR ligation with the urokinase receptor binding domain (amino-terminal fragment) leads to enhanced migration of fibroblasts on fibronectin in a protease-independent, lipid raft-dependent manner. Ligation of uPAR with the amino-terminal fragment recruited 51 integrin and the acylated form of the Src family kinase, Fyn, to lipid rafts. The biological consequences of this translocation were an increase in fibroblast motility and a switch of the integrin-initiated signal pathway for migration away from the lipid raft-independent focal adhesion kinase pathway and toward a lipid raft-dependent caveolin-Fyn-Shc pathway. Furthermore, an integrin homologous peptide as well as an antibody that competes with 1 for uPAR binding have the ability to block this effect. In addition, its relative insensitivity to cholesterol depletion suggests that the interactions of 51 integrin and uPAR drive the translocation of 51 integrin-acylated Fyn signaling complexes into lipid rafts upon uPAR ligation through protein-protein interactions. This signal switch is a novel pathway leading to the hypermotile phenotype of IPF patient-derived fibroblasts, seen with uPAR ligation. This uPAR dependent, fibrotic matrix-selective, and profibrotic fibroblast phenotype may be amenable to targeted therapeutics designed to ameliorate IPF.	[Grove, Lisa M.; Southern, Brian D.; Paruchuri, Sailaja; Rahaman, Shaik O.; Olman, Mitchell A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Gladson, Candece L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Jin, Tong H.; White, Kimberly E.; Ding, Qiang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wei, Ying; Chapman, Harold A.] Univ Calif San Francisco, Pulm & Crit Care Div, San Francisco, CA 94143 USA; [Wei, Ying; Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Harel, Efrat; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Olman, MA (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave NC-22, Cleveland, OH 44195 USA.	Olmanm@ccf.org		Southern, Brian/0000-0003-2983-5741	National Institutes of Health (NIH) [HL-58655, HL-103553, HL-085324, HL-44712]; NIH, NCI [R01 CA152883, CA127620]; Veterans Administration MERIT Review; Department of Defense Idea Development Award [PC 111318]; NATIONAL CANCER INSTITUTE [R01CA152883, R01CA127620, R01CA175120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655, R01HL119792, R01HL103553, R01HL044712, R01HL085324] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration MERIT Review(US Department of Veterans Affairs); Department of Defense Idea Development Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants HL-58655 and HL-103553 (to M. A. O.), HL-085324 (to Q. D. and M. A. O.), and HL-44712 (to H. A. C.) and NIH, NCI, Grants R01 CA152883 and CA127620 (to C. L. G.). This work was also supported by grants from the Veterans Administration MERIT Review (to M. A. O.) and Department of Defense Idea Development Award PC 111318 (to C. S. C.).	Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Donadello K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-2; DUNN TL, 1988, AM J MED, V85, P221; Duriseti S, 2010, J BIOL CHEM, V285, P26878, DOI 10.1074/jbc.M109.077677; Fell CD, 2007, CHEST, V131, P641, DOI 10.1378/chest.07-0057; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Goel HL, 2013, J CELL PHYSIOL, V228, P1601, DOI 10.1002/jcp.24323; Gunther A, 2003, AM J RESP CRIT CARE, V168, P1358, DOI 10.1164/rccm.2201082; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Lagares D, 2012, ARTHRITIS RHEUM-US, V64, P1653, DOI 10.1002/art.33482; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-41; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Monaghan-Benson E, 2006, J BIOL CHEM, V281, P9450, DOI 10.1074/jbc.M501901200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Olman MA, 1996, AM J PHYSIOL-LUNG C, V271, pL519, DOI 10.1152/ajplung.1996.271.4.L519; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; PORN MI, 1995, BIOCHEM J, V308, P269; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P444, DOI 10.1164/ajrccm.149.2.8306043; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Sisson TH, 1999, HUM GENE THER, V10, P2315, DOI 10.1089/10430349950016960; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Veeravalli KK, 2012, CELL ADHES MIGR, V6, P509, DOI 10.4161/cam.21673; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Zhou Y, 2010, J BIOL CHEM, V285, P22382, DOI 10.1074/jbc.M110.126227; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	75	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12791	12804		10.1074/jbc.M113.498576	http://dx.doi.org/10.1074/jbc.M113.498576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644284	Green Published, hybrid			2022-12-28	WOS:000335581400048
J	Baier, A; Winkler, W; Korte, T; Lockau, W; Karradt, A				Baier, Antje; Winkler, Wiebke; Korte, Thomas; Lockau, Wolfgang; Karradt, Anne			Degradation of Phycobilisomes in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Fluorescence Resonance Energy Transfer (FRET); Protease; Protein Degradation; Protein Synthesis; NblA; Synechocystis; Nitrogen Starvation; Phycobilisome Degradation	CYANOBACTERIAL CLP PROTEASE; ESCHERICHIA-COLI; STRAIN PCC-7942; LIGHT-INTENSITY; ADAPTER PROTEIN; GENE-EXPRESSION; PCC 7120; SYNECHOCOCCUS; NBLA; COMPONENTS	Background: In cyanobacteria, starvation-induced phycobilisome degradation is caused by NblA. Results:Synechocystis expresses two NblA proteins that form a heterodimer. The heterodimer binds phycobiliproteins and ClpC and is degraded by a ClpC-ClpP1ClpR protease in vitro. Conclusion: NblA1/NblA2 is an adaptor protein that mediates degradation of phycobilisomes by the ATP-dependent protease ClpC-ClpP1ClpR. Significance: These findings improve our understanding of the mechanisms by which cyanobacteria adapt to changing environmental conditions. When cyanobacteria acclimate to nitrogen deficiency, they degrade their large (3-5-MDa), light-harvesting complexes, the phycobilisomes. This massive, yet specific, intracellular degradation of the pigmented phycobiliproteins causes a color change of cyanobacterial cultures from blue-green to yellow-green, a process referred to as chlorosis or bleaching. Phycobilisome degradation is induced by expression of the nblA gene, which encodes a protein of approximate to 7 kDa. NblA most likely acts as an adaptor protein that guides a Clp protease to the phycobiliproteins, thereby initiating the degradation process. Most cyanobacteria and red algae possess just one nblA-homologous gene. As an exception, the widely used model organism Synechocystis sp. PCC6803 expresses two such genes, nblA1(6803) and nblA2(6803), both of whose products are required for phycobilisome degradation. Here, we demonstrate that the two NblA proteins heterodimerize in vitro and in vivo using pull-down assays and a Forster energy-transfer approach, respectively. We further show that the NblA proteins form a ternary complex with ClpC (the HSP100 chaperone partner of Clp proteases) and phycobiliproteins in vitro. This complex is susceptible to ATP-dependent degradation by a Clp protease, a finding that supports a proposed mechanism of the degradation process. Expression of the single nblA gene encoded by the genome of the N-2-fixing, filamentous cyanobacterium Nostoc sp. PCC7120 in the nblA1/nblA2 mutant of Synechocystis sp. PCC6803 induced phycobilisome degradation, suggesting that the function of the NblA heterodimer of Synechocystis sp. PCC6803 is combined in the homodimeric protein of Nostoc sp. PCC7120.	[Baier, Antje; Winkler, Wiebke; Lockau, Wolfgang; Karradt, Anne] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Korte, Thomas] Humboldt Univ, Grp Mol Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Lockau, W (corresponding author), Humboldt Univ, Inst Biol, Chausseestr 117, D-10115 Berlin, Germany.	wolfgang.lockau@biologie.hu-berlin.de		Winkler, Wiebke/0000-0001-8807-9259				Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; DELORIMIER RM, 1992, PLANT PHYSIOL, V98, P1003, DOI 10.1104/pp.98.3.1003; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Ducret A, 1996, EUR J BIOCHEM, V236, P1010, DOI 10.1111/j.1432-1033.1996.01010.x; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Herskovits T. T., 1966, BIOCHEMISTRY-US, P1018; KALLA R, 1993, GENE, V126, P77, DOI 10.1016/0378-1119(93)90592-Q; Kappell AD, 2006, ARCH MICROBIOL, V186, P403, DOI 10.1007/s00203-006-0154-0; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Ke S, 2013, MICROBIOL-SGM, V159, P253, DOI 10.1099/mic.0.064220-0; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 1998, BIOCHEMISTRY-US, V37, P417, DOI 10.1021/bi971453s; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Piven I, 2005, J BIOL CHEM, V280, P21667, DOI 10.1074/jbc.m412967200; RAPS S, 1985, PLANT PHYSIOL, V79, P983, DOI 10.1104/pp.79.4.983; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schelin J, 2002, MICROBIOL-SGM, V148, P2255, DOI 10.1099/00221287-148-7-2255; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Tryggvesson A, 2012, BIOCHEM J, V446, P311, DOI 10.1042/BJ20120649; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; WOLK CP, 1984, P NATL ACAD SCI-BIOL, V81, P1561, DOI 10.1073/pnas.81.5.1561; YAMANAKA G, 1980, J BIOL CHEM, V255, P1004; Zacharias David A, 2002, Sci STKE, V2002, ppe23, DOI 10.1126/stke.2002.131.pe23; Zinchenko VV, 1999, RUSS J GENET+, V35, P228	51	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11755	11766		10.1074/jbc.M113.520601	http://dx.doi.org/10.1074/jbc.M113.520601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610785	hybrid, Green Published			2022-12-28	WOS:000335010600017
J	Ghalali, A; Ye, ZW; Hogberg, J; Stenius, U				Ghalali, Aram; Ye, Zhi-wei; Hogberg, Johan; Stenius, Ulla			Phosphatase and Tensin Homolog Deleted on Chromosome 10 ( PTEN) and PH Domain and Leucine-rich Repeat Phosphatase Cross-talk ( PHLPP) in Cancer Cells and in Transforming Growth Factor beta- Activated Stem Cells (Withdrawn Publication)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication						Akt; Prostate Cancer; Protein Phosphatase; PTEN; Stem Cells; PHLPP1; PHLPP2	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; SELF-RENEWAL; SIGNALING PATHWAYS; OVARIAN-CANCER; EXPRESSION; METASTASIS; AKT; BMI-1; SUPPRESSION	Background: The oncogene Akt is regulated by phosphatases. Results: Akt phosphatases cross-talk in prostate cancer cells and in transforming growth factor 1-activated stem cells but not in non-transformed cells. Conclusion: This back-up mechanism facilitates invasive migration of prostate stem and cancer cells. Significance: Characterization of Akt regulation may lead to a better understanding of tumor development and to novel strategies for treatment. Akt kinase controls cell survival, proliferation, and invasive growth and is a critical factor for cancer development. Here we describe a cross-talk between phosphatases that may preserve levels of activated/phosphorylated Akt and confer aggressive growth of cancer cells. In prostatic cancer cells, but not in non-transformed cells or in prostate stem cells, we found that the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) overexpression down-regulated PH domain and leucine-rich repeat phosphatase (PHLPP) and that PHLPP overexpression down-regulated PTEN. We also show that silencing PTEN by siRNA increased the levels of PHLPPs. This cross-talk facilitated invasive migration and was mediated by epigenetic alterations, including activation of miR-190, miR-214, polycomb group of proteins, as well as DNA methylation. A role for the purinergic receptor P2X4, previously associated with wound healing, was indicated. We also show that TGF-1 induced cross-talk concomitant with epithelial-mesenchymal transition in stem cells. The cross-talk emerged as an integrated part of epithelial-mesenchymal transition. We conclude that cross-talk between PTEN and PHLPPs is silenced in normal prostate cells but activated in TGF-1 transformed prostate stem and cancer cells and facilitates invasive growth.	[Ghalali, Aram; Ye, Zhi-wei; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet	Ghalali, A (corresponding author), Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.	aram.ghalali@ki.se			Karolinska Institutet	Karolinska Institutet(Karolinska Institutet)	This work was supported by the Karolinska Institutet.	Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Beezhold K, 2011, TOXICOL SCI, V123, P411, DOI 10.1093/toxsci/kfr188; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Bian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060184; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Costello JC, 2011, CONNECT TISSUE RES, V52, P139, DOI 10.3109/03008207.2010.491928; Davies MA, 2002, CLIN CANCER RES, V8, P1904; DEAL FH, 1989, CANCER RES, V49, P6985; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fan C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-98; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Freeman KW, 2011, FASEB J, V25, P907, DOI 10.1096/fj.10-169417; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Glass R, 2002, CELL MOL LIFE SCI, V59, P870, DOI 10.1007/s00018-002-8474-y; IDOINE JB, 1976, IN VITRO CELL DEV B, V12, P541; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lou CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050956; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mistafa O, 2010, J BIOL CHEM, V285, P27900, DOI 10.1074/jbc.M110.117093; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Silins I, 2006, FOOD CHEM TOXICOL, V44, P1552, DOI 10.1016/j.fct.2006.04.001; Takahashi M, 2008, CARCINOGENESIS, V29, P2218, DOI 10.1093/carcin/bgn135; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinhold K, 2010, CELL MOL LIFE SCI, V67, P2631, DOI 10.1007/s00018-010-0355-1; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoshimi A, 2011, ONCOTARGET, V2, P575, DOI 10.18632/oncotarget.304; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zippel N, 2012, STEM CELLS DEV, V21, P884, DOI 10.1089/scd.2010.0576	57	12	15	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11601	11615		10.1074/jbc.M113.537241	http://dx.doi.org/10.1074/jbc.M113.537241			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599953	Green Published, hybrid			2022-12-28	WOS:000335010600004
J	Marion, S; Urs, NM; Peterson, SM; Sotnikova, TD; Beaulieu, JM; Gainetdinov, RR; Caron, MG				Marion, Sebastien; Urs, Nikhil M.; Peterson, Sean M.; Sotnikova, Tatyana D.; Beaulieu, Jean-Martin; Gainetdinov, Raul R.; Caron, Marc G.			Dopamine D2 Receptor Relies upon PPM/PP2C Protein Phosphatases to Dephosphorylate Huntingtin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Arrestin; Dopamine Receptors; G Protein-coupled Receptors (GPCR); G Proteins; Phosphatase; PP2C; Dopamine D2 Receptor; Huntingtin	MUTANT HUNTINGTIN; STRIATAL NEURONS; IN-VIVO; PHOSPHORYLATION; DISEASE; DEGENERATION; TOXICITY; BINDING; TETRABENAZINE; CALCINEURIN	Background: Motor function and emotions are regulated by dopamine and dopaminergic receptors. Results: Pharmacological inhibition of PPM/PP2C phosphatases prevents dopamine D2 receptor-mediated dephosphorylation of the huntingtin protein. Conclusion: A previously unappreciated signaling pathway exists downstream of dopamine D2 receptor activation. Significance: This pathway may have therapeutic potential in dopamine-related disorders. Striatal dopamine D2 receptor (D2R) relies upon G protein- and -arrestin-dependent signaling pathways to convey its action on motor control and behavior. Considering that D2R activation inhibits Akt in the striatum and that huntingtin physiological functions are affected by Akt phosphorylation, we sought to investigate whether D2R-mediated signaling could regulate huntingtin phosphorylation. We demonstrate that D2R activation decreases huntingtin phosphorylation on its Akt site. This dephosphorylation event depends upon the G(i)-dependent engagement of specific members of the protein phosphatase metallo-dependent (PPM/PP2C) family and is independent of -arrestin 2. These observations identify the PPM/PP2C family as a mediator of G protein-coupled receptor signaling and thereby suggest a novel mechanism of dopaminergic signaling.	[Marion, Sebastien; Urs, Nikhil M.; Peterson, Sean M.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Sotnikova, Tatyana D.; Gainetdinov, Raul R.] Univ Laval IUSMQ, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1J 2G3, Canada; [Beaulieu, Jean-Martin] Italian Inst Technol, Dept Neurosci, I-16163 Genoa, Italy	Duke University; Duke University; Duke University; Laval University; Istituto Italiano di Tecnologia - IIT; University of Genoa	Caron, MG (corresponding author), 487 CARL Bldg,Res Dr, Durham, NC 27710 USA.	marc.caron@dm.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Peterson, Sean/0000-0003-4873-0283; Marion, Sebastien/0000-0002-3302-3845	National Institutes of Health [NS-19576, MH073853]; Natural Sciences and Engineering Research Council of Canada (NSERC); Hereditary Disease Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH073853, R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hereditary Disease Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-19576 and MH073853 (to M. G. C.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (to J. M. B.).; Recipient of a fellowship award from the Hereditary Disease Foundation.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; COHEN P, 1989, J BIOL CHEM, V264, P21435; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Cyr M, 2006, FASEB J, V20, P2541, DOI 10.1096/fj.06-6533fje; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jan G, 2007, BIOCHEM J, V401, P711, DOI 10.1042/BJ20061324; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Pan C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02333; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Rosenstock TR, 2011, NEUROCHEM INT, V59, P600, DOI 10.1016/j.neuint.2011.04.009; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Weiser D. C., 2003, CURR PROTOC PROTEIN; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zheng GR, 2006, AAPS J, V8, pE682, DOI 10.1208/aapsj080478	41	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11715	11724		10.1074/jbc.M113.544312	http://dx.doi.org/10.1074/jbc.M113.544312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619418	hybrid, Green Published			2022-12-28	WOS:000335010600014
J	Mi, YL; Lin, A; Fiete, D; Steirer, L; Baenziger, JU				Mi, Yiling; Lin, Angela; Fiete, Dorothy; Steirer, Lindsay; Baenziger, Jacques U.			Modulation of Mannose and Asialoglycoprotein Receptor Expression Determines Glycoprotein Hormone Half-life at Critical Points in the Reproductive Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Function; Carbohydrate Glycoprotein; Endocrinology; Endocytosis; Hormones; Circulatory Half-life	ASPARAGINE-LINKED OLIGOSACCHARIDES; TRANSFERASE 3 BETA-4GALNAC-T3; CYSTEINE-RICH DOMAIN; BETA 1,4GLCNAC BETA; MICE LACKING; RAT-LIVER; SIALYLATED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE; BOVINE LUTROPIN; STRUCTURAL ELUCIDATION	Background: Unique glycan structures on glycoprotein hormones are recognized by glycan-specific receptors that control hormone half-life in the blood. Results: Clearance rates for recognized glycoproteins are determined by the level of receptor expression in the liver. Conclusion: Expression of glycan-specific receptors is modulated at critical points in the reproductive cycle. Significance: Glycans and glycan-specific receptors play critical roles in reproduction. The rate at which glycoproteins are cleared from the circulation has a critical impact on their biologic activity in vivo. We have shown that clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release into the circulation determine their potency. Two highly abundant, carbohydrate-specific, endocytic receptors, the asialoglycoprotein receptor (ASGR) and the mannose receptor (ManR) are expressed in the liver by parenchymal and sinusoidal endothelial cells, respectively. We demonstrate that the ManR mediates the clearance of glycoproteins such as LH that bear N-linked glycans terminating with 1,4-linked GalNAc-4-SO4, as well as glycoproteins bearing glycans that terminate with Man. Steady state levels of mRNA encoding the ASGR and the ManR are regulated by progesterone in pregnant mice, reaching maximal levels on day 12.5 of pregnancy. Protein expression and glycan-specific binding activity also increase in the livers of pregnant mice. In contrast, ManR mRNA, but not ASGR mRNA, decreases in male mice at the time of sexual maturation. We show that levels of ManR and ASGR expression control the clearance rate for glycoproteins bearing recognized glycans. Thus, reduced expression of the ManR at the time of sexual maturation will increase the potency of LH in vivo, whereas increased expression during pregnancy will reduce LH potency until progesterone and receptor levels fall prior to parturition.	[Mi, Yiling; Lin, Angela; Fiete, Dorothy; Steirer, Lindsay; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 South Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health Grants [R01-CA21923, R01-HD058474]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA21923 and R01-HD058474 (to J. U. B.).	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; COLLINS JC, 1984, HEPATOLOGY, V4, P80, DOI 10.1002/hep.1840040114; Dai GL, 2011, EXP BIOL MED, V236, P1322, DOI 10.1258/ebm.2011.011076; DRICKAMER K, 1984, J BIOL CHEM, V259, P770; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fiete D, 2012, J BIOL CHEM, V287, P29194, DOI 10.1074/jbc.M112.371567; Fiete D, 2012, J BIOL CHEM, V287, P29204, DOI 10.1074/jbc.M112.371880; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Milona A, 2010, AM J PHYSIOL-GASTR L, V298, pG151, DOI 10.1152/ajpgi.00336.2009; PAIETTA E, 1992, J BIOL CHEM, V267, P11078; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; SMITH PL, 1990, J BIOL CHEM, V265, P874; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200	36	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12157	12167		10.1074/jbc.M113.544973	http://dx.doi.org/10.1074/jbc.M113.544973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619407	Green Published, hybrid			2022-12-28	WOS:000335010600051
J	Shi, YX; Zhao, G; Kong, W				Shi, Yixin; Zhao, Guang; Kong, Wei			Genetic Analysis of Riboswitch-mediated Transcriptional Regulation Responding to Mn2(+) in Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Magnesium; Manganese; Riboswitch; Transcription Regulation; Transcription Termination; 5-Untranslated Region	ENTERICA SEROVAR TYPHIMURIUM; ION-INDUCED CLEAVAGES; LEAD BINDING-SITES; ESCHERICHIA-COLI; MANGANESE TRANSPORT; BACILLUS-SUBTILIS; MN2+ TRANSPORTER; NRAMP PROTEINS; RNA; MNTH	Background: Divalent cation binding to riboswitch RNAs regulates expression of their transporter genes in bacteria. Results: Mn2+ interacts with Salmonella riboswitches characterized from Mn2+ transporter mntH and Mg2+ transporter mgtA to modulate transcription of the downstream coding region. Conclusion: Specific riboswitches control gene expression in response to Mn2+ in bacteria. Significance: This is the discovery of a Mn2+ riboswitch. Riboswitches are a class of cis-acting regulatory RNAs normally characterized from the 5-UTR of bacterial transcripts that bind a specific ligand to regulate expression of associated genes by forming alternative conformations. Here, we present a riboswitch that contributes to transcriptional regulation through sensing Mn2+ in Salmonella typhimurium. We characterized a 5-UTR (UTR1) from the mntH locus encoding a Mn2+ transporter, which forms a Rho-independent terminator to implement transcription termination with a high Mn2+ selectivity both in vivo and in vitro. Nucleotide substitutions that cause disruption of the terminator interfere with the regulatory function of UTR1. RNA probing analyses outlined a specific UTR1 conformation that favors the terminator structure in Mn2+-replete condition. Switch sequence GCUAUG can alternatively base pair duplicated hexanucleotide CAUAGC to form either a pseudoknot or terminator stem. Mn2+, but not Mg2+, and Ca2+, can enhance cleavage at specific nucleotides in UTR1. We conclude that UTR1 is a riboswitch that senses cytoplasmic Mn2+ and therefore participates in Mn2+-responsive mntH regulation in Salmonella. This riboswitch domain is also conserved in several Gram-negative enteric bacteria, indicating that this Mn2+-responsive mechanism could have broader implications in bacterial gene expression. Additionally, a high level of cytoplasmic Mn2+ can down-regulate transcription of the Salmonella Mg2+ transporter mgtA locus in a Mg2+ riboswitch-dependent manner. On the other hand, these two types of cation riboswitches do not share similarity at the primary or secondary structural levels. Taken together, characterization of Mn2+-responsive riboswitches should expand the scope of RNA regulatory elements in response to inorganic ions.	[Shi, Yixin; Zhao, Guang; Kong, Wei] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	SHI, YIXIN/M-5751-2019; zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972	State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China [KF-GW-201202]	State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China	This study was supported in part by Open Research Grant KF-GW-201202 from the State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China (to Y. S.).	Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; CIESIOLKA J, 1989, EUR J BIOCHEM, V186, P71, DOI 10.1111/j.1432-1033.1989.tb15179.x; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEUEL TF, 1974, J BIOL CHEM, V249, P257; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Ferre-D'Amare AR, 2011, METAL IONS LIFE SCI, V9, P141, DOI 10.1039/978184973251200141; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Garst AD, 2011, COLD SPRING HARB PER, V3; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Haemig HAH, 2004, J MEMBRANE BIOL, V201, P97, DOI 10.1007/s00232-004-0711-x; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kehres DG, 2002, J BACTERIOL, V184, P3159, DOI 10.1128/JB.184.12.3159-3166.2002; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; MARCINIEC T, 1989, FEBS LETT, V243, P293, DOI 10.1016/0014-5793(89)80148-6; Miller J. H, 1972, EXPT MOL GENETICS; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; WRZESINSKI J, 1995, FEBS LETT, V374, P62, DOI 10.1016/0014-5793(95)01077-R; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zhao G, 2011, EMBO J, V30, P1485, DOI 10.1038/emboj.2011.66; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	45	16	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11353	11366		10.1074/jbc.M113.517516	http://dx.doi.org/10.1074/jbc.M113.517516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596096	Green Published, hybrid			2022-12-28	WOS:000334638500037
J	Radhakrishnan, A; Kumar, N; Wright, CC; Chou, TH; Tringides, ML; Bolla, JR; Lei, HT; Rajashankar, KR; Su, CC; Purdy, GE; Yu, EW				Radhakrishnan, Abhijith; Kumar, Nitin; Wright, Catherine C.; Chou, Tsung-Han; Tringides, Marios L.; Bolla, Jani Reddy; Lei, Hsiang-Ting; Rajashankar, Kanagalaghatta R.; Su, Chih-Chia; Purdy, Georgiana E.; Yu, Edward W.			Crystal Structure of the Transcriptional Regulator Rv0678 of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; DNA-BINDING MECHANISM; COMPLEX; VIRULENCE; SOFTWARE; REVEALS; MARR; BIOSYNTHESIS; EVOLUTION; FAMILY	Recent work demonstrates that the MmpL(mycobacterial membrane protein large) transporters are dedicated to the export of mycobacterial lipids for cell wall biosynthesis. An MmpL transporter frequently works with an accessory protein, belonging to the MmpS (mycobacterial membrane protein small) family, to transport these key virulence factors. One such efflux system in Mycobacterium tuberculosis is the MmpS5-MmpL5 transporter. The expression of MmpS5-MmpL5 is controlled by the MarR-like transcriptional regulator Rv0678, whose open reading frame is located downstream of the mmpS5-mmpL5 operon. To elucidate the structural basis of Rv0678 regulation, we have determined the crystal structure of this regulator, to 1.64 angstrom resolution, revealing a dimeric two-domain molecule with an architecture similar to members of the MarR family of transcriptional regulators. Rv0678 is distinct from other MarR regulators in that its DNA-binding and dimerization domains are clustered together. These two domains seemingly cooperate to bind an inducing ligand that we identified as 2-stearoylglycerol, which is a fatty acid glycerol ester. The structure also suggests that the conformational change leading to substrate-mediated derepression is primarily caused by a rigid body rotational motion of the entire DNA-binding domain of the regulator toward the dimerization domain. This movement results in a conformational state that is incompatible with DNA binding. We demonstrate using electrophoretic mobility shift assays that Rv0678 binds to the mmpS5-mmpL5, mmpS4-mmpL4, and the mmpS2-mmpL2 promoters. Binding by Rv0678 was reversed upon the addition of the ligand. These findings provide new insight into the mechanisms of gene regulation in the MarR family of regulators.	[Radhakrishnan, Abhijith; Kumar, Nitin; Tringides, Marios L.; Bolla, Jani Reddy; Lei, Hsiang-Ting; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Chou, Tsung-Han; Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Wright, Catherine C.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Iowa State University; Iowa State University; Oregon Health & Science University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Radhakrishnan, Abhijith/V-6182-2019; Bolla, Jani Reddy/AAT-1370-2020; , Nitin/J-8078-2019	Radhakrishnan, Abhijith/0000-0001-8107-3487; Bolla, Jani Reddy/0000-0003-4346-182X; Tringides, Marios/0000-0002-3800-2365	NIGMS, National Institutes of Health [GM103403]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, P41GM103403] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by NIGMS, National Institutes of Health, Grant GM103403. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. We are grateful to Louis Messerle (University of Iowa) for providing the (NH<INF>4</INF>)<INF>2</INF>W<INF>6</INF>(mu-O)<INF>6</INF>(mu-Cl)<INF>6</INF>Cl<INF>6</INF> complex used in this study.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ML PHARE CCP4 PROC 8; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Zianni Michael, 2006, J Biomol Tech, V17, P103	40	45	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16526	16540		10.1074/jbc.M113.538959	http://dx.doi.org/10.1074/jbc.M113.538959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737322	hybrid, Green Published			2022-12-28	WOS:000337965700054
J	Schiebel, J; Chang, A; Shah, S; Lu, Y; Liu, L; Pan, P; Hirschbeck, MW; Tareilus, M; Eltschkner, S; Yu, WX; Cummings, JE; Knudson, SE; Bommineni, GR; Walker, SG; Slayden, RA; Sotriffer, CA; Tonge, PJ; Kisker, C				Schiebel, Johannes; Chang, Andrew; Shah, Sonam; Lu, Yang; Liu, Li; Pan, Pan; Hirschbeck, Maria W.; Tareilus, Mona; Eltschkner, Sandra; Yu, Weixuan; Cummings, Jason E.; Knudson, Susan E.; Bommineni, Gopal R.; Walker, Stephen G.; Slayden, Richard A.; Sotriffer, Christoph A.; Tonge, Peter J.; Kisker, Caroline			Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SLOW-ONSET INHIBITION; FATTY-ACID SYNTHESIS; CRYSTAL-STRUCTURE; SCORING FUNCTION; 4-PYRIDONE DERIVATIVES; TRICLOSAN RESISTANCE; RESIDENCE TIME; DRUG-TARGET; FABI	Determining the molecular basis for target selectivity is of particular importance in drug discovery. The ideal antibiotic should be active against a broad spectrum of pathogenic organisms with a minimal effect on human targets. CG400549, a Staphylococcus-specific 2-pyridone compound that inhibits the enoyl-acyl carrier protein reductase (FabI), has recently been shown to possess human efficacy for the treatment of methicillin-resistant Staphylococcus aureus infections, which constitute a serious threat to human health. In this study, we solved the structures of three different FabI homologues in complex with several pyridone inhibitors, including CG400549. Based on these structures, we rationalize the 65-fold reduced affinity of CG400549 toward Escherichia coli versus S. aureus FabI and implement concepts to improve the spectrum of antibacterial activity. The identification of different conformational states along the reaction coordinate of the enzymatic hydride transfer provides an elegant visual depiction of the relationship between catalysis and inhibition, which facilitates rational inhibitor design. Ultimately, we developed the novel 4-pyridone-based FabI inhibitor PT166 that retained favorable pharmacokinetics and efficacy in a mouse model of S. aureus infection with extended activity against Gram-negative and mycobacterial organisms.	[Schiebel, Johannes; Hirschbeck, Maria W.; Tareilus, Mona; Eltschkner, Sandra; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Schiebel, Johannes; Sotriffer, Christoph A.] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany; [Chang, Andrew; Shah, Sonam; Lu, Yang; Liu, Li; Pan, Pan; Yu, Weixuan; Bommineni, Gopal R.; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Chang, Andrew; Lu, Yang; Walker, Stephen G.] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA; [Cummings, Jason E.; Knudson, Susan E.; Slayden, Richard A.] Colorado State Univ, Rocky Mt Reg Ctr Excellence, Ft Collins, CO 80523 USA; [Cummings, Jason E.; Knudson, Susan E.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Wurzburg; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University; Colorado State University	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	peter.tonge@stonybrook.edu; caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019; Tonge, Peter J/A-7443-2009; Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021	Tonge, Peter J/0000-0003-1606-3471; Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277; Eltschkner, Sandra/0000-0002-9854-0800; Chang, Andrew/0000-0002-8416-359X; Lu, Yang/0000-0003-2717-9656; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [GM102864, AI044639, AI070383]; Deutsche Forschungsgemeinschaft [SFB630, FZ82]; German Excellence Initiative; Chemical Biology Training Program (National Institutes of Health) [T32GM092714]; Medical Scientist Training Program (National Institutes of Health) [T32GM008444]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044639, U01AI070383, R01AI044639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM092714, T32GM008444, R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative; Chemical Biology Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102864, AI044639, and AI070383 (to P. J. T.) This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB630 (to C. A. S. and C. K.) and Forschungszentrum Grant FZ82 (to C. K.).; Supported by a grant from the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. Present address: Dept. of Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 6, D-35032 Marburg, Germany.; Supported by the Chemical Biology Training Program (National Institutes of Health Grant T32GM092714) and by the Medical Scientist Training Program (National Institutes of Health Grant T32GM008444).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Brameld KA, 2008, J CHEM INF MODEL, V48, P1, DOI 10.1021/ci7002494; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Chemical Computing Group, 2010, MOL OP ENV VERS 2010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clinical and Laboratory Standards Institute, 2006, M7A5 CLIN LAB STAND; DeLano W.L, PYMOL MOL GRAPHICS S; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; GERBER AU, 1982, J INFECT DIS, V146, P691, DOI 10.1093/infdis/146.5.691; Gerusz V, 2012, J MED CHEM, V55, P9914, DOI 10.1021/jm301113w; Gerusz V, 2010, ANNU REP MED CHEM, V45, P295, DOI 10.1016/S0065-7743(10)45018-6; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Kitagawa H, 2007, BIOORGAN MED CHEM, V15, P1106, DOI 10.1016/j.bmc.2006.10.012; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Li HJ, 2014, ACS CHEM BIOL, V9, P986, DOI 10.1021/cb400896g; Liu NN, 2011, J ANTIMICROB CHEMOTH, V66, P564, DOI 10.1093/jac/dkq509; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Neudert G, 2011, BIOINFORMATICS, V27, P1021, DOI 10.1093/bioinformatics/btr055; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pantosti A, 2009, EUR RESPIR J, V34, P1190, DOI 10.1183/09031936.00007709; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ro S., 2009, INT C ANT AG CHEM SA; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seefeld MA, 2003, J MED CHEM, V46, P1627, DOI 10.1021/jm0204035; Shin K. J., 2011, Korea Patent, Patent No. [WO/2011/014008 A2, 2011014008]; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; Smart O.S., 2011, GRADE; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Takahata S, 2007, J ANTIBIOT, V60, P123, DOI 10.1038/ja.2007.11; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Tipparaju SK, 2008, BIOORG MED CHEM LETT, V18, P3565, DOI 10.1016/j.bmcl.2008.05.004; Tripos, 2009, SYBYL X VERS 1 0; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Wang LQ, 2004, DRUG METAB DISPOS, V32, P1162, DOI 10.1124/dmd.104.000273; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yum JH, 2007, ANTIMICROB AGENTS CH, V51, P2591, DOI 10.1128/AAC.01562-06; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	82	48	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15987	16005		10.1074/jbc.M113.532804	http://dx.doi.org/10.1074/jbc.M113.532804			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24739388	hybrid, Green Published			2022-12-28	WOS:000337965700010
J	Hattori, Y; Morita, D; Fujiwara, N; Mori, D; Nakamura, T; Harashima, H; Yamasaki, S; Sugita, M				Hattori, Yuki; Morita, Daisuke; Fujiwara, Nagatoshi; Mori, Daiki; Nakamura, Takashi; Harashima, Hideyoshi; Yamasaki, Sho; Sugita, Masahiko			Glycerol Monomycolate Is a Novel Ligand for the Human, but Not Mouse Macrophage Inducible C-type Lectin, Mincle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Innate Immunity; Lipids; Macrophages; Mycobacteria; Transgenic Mice; Glycerol Monomycolate; Mincle	MYCOBACTERIUM-TUBERCULOSIS; GUINEA-PIGS; DC-SIGN; ACTIVATING RECEPTOR; CELLS; RECOGNITION; HYPERSENSITIVITY; EXPRESSION; GRANULOMAS; ANTIGENS	Background: A host receptor has not yet been identified for glycerol monomycolate (GroMM), an immunostimulatory lipid of mycobacteria. Results: GroMM recognition occurred in cell transfectants expressing human, but not mouse Mincle. Human Mincle transgenic mice acquired the ability to respond to GroMM. Conclusion: GroMM is a ligand for human Mincle. Significance: The molecular basis underlying the innate immune recognition of GroMM has been elucidated. An array of lipidic compounds that constitute the cell wall of mycobacteria is recognized by host receptors. Examples include trehalose dimycolate (TDM), which is a major surface-exposed glycolipid of mycobacteria, that interacts with the macrophage inducible C-type lectin, Mincle, and exerts its highly potent adjuvant functions. Recent evidence has suggested that glycerol monomycolate (GroMM), another mycolate-containing lipid species produced by mycobacteria, can stimulate innate immune cells; however, its specific host receptors have yet to be identified. We here demonstrated that cell transfectants expressing human Mincle (hMincle) reacted to both TDM and GroMM, while those expressing mouse Mincle (mMincle) only reacted to TDM and failed to recognize GroMM. Studies using domain swap chimeras confirmed that the ectodomain of hMincle, but not that of mMincle, interacted with GroMM, and site-directed mutagenesis analyses revealed that short stretches of amino acid residues at positions 174-176 and 195-196 were involved in GroMM recognition. To further substantiate the differential recognition of GroMM by hMincle and mMincle, hMincle transgenic/mMincle knock-out mice (i.e. hMincle(+) mice) were established and compared with non-transgenic mice (i.e. mMincle(+) mice). We showed that macrophages derived from hMincle(+) mice were activated by GroMM and produced inflammatory cytokines, whereas those derived from mMincle(+) mice did not exhibit any reactivity to GroMM. Furthermore, local inflammatory responses were elicited in the GroMM-injected skin of hMincle(+), but not mMincle(+) mice. These results demonstrated that GroMM is a unique ligand for hMincle that is not recognized by mMincle.	[Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Lab Cell Regulat, Kyoto 6068507, Japan; [Hattori, Yuki; Morita, Daisuke; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Mol Network, Kyoto 6068507, Japan; [Fujiwara, Nagatoshi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara 6318585, Japan; [Mori, Daiki; Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Nakamura, Takashi; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Kyoto University; Kyoto University; Kyoto University; Kyushu University; Hokkaido University	Yamasaki, S (corresponding author), Kyushu Univ, Div Mol Immunol, Res Ctr Infect Dis, Med Inst Bioregulat,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp; msugita@virus.kyoto-u.ac.jp	Nakamura, Takashi/F-4419-2016; Hattori, Yuki/AAW-2061-2021	Nakamura, Takashi/0000-0001-9019-1426; Sugita, Masahiko/0000-0001-5511-1304; MORI, Daiki/0000-0002-3596-0840; Hattori, Yuki/0000-0001-6576-0121	Japan Society for the Promotion of Science [24390255]; Ministry of Health, Labor and Welfare; Institute for Virus Research, Kyoto University; Grants-in-Aid for Scientific Research [12J04754] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Institute for Virus Research, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science (grant-in-aid for Scientific Research (B); grant number 24390255). This work was also supported by a grant from the Ministry of Health, Labor and Welfare, and by Joint Usage/Research Center program of Institute for Virus Research, Kyoto University.	Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Dascher CC, 2003, INT IMMUNOL, V15, P915, DOI 10.1093/intimm/dxg091; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Miyake Yasunobu, 2010, Self Nonself, V1, P310, DOI 10.4161/self.1.4.13736; Otsuka A, 2008, J IMMUNOL, V181, P8528, DOI 10.4049/jimmunol.181.12.8528; Pirson C, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-54; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Sakamoto K, 2013, INFECT IMMUN, V81, P764, DOI 10.1128/IAI.00906-12; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang Y., 2014, HYDROLASE TREHALOSE	35	61	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15405	15412		10.1074/jbc.M114.566489	http://dx.doi.org/10.1074/jbc.M114.566489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733387	hybrid, Green Published			2022-12-28	WOS:000337465400024
J	Pitsawong, W; Hoben, JP; Miller, AF				Pitsawong, Warintra; Hoben, John P.; Miller, Anne-Frances			Understanding the Broad Substrate Repertoire of Nitroreductase Based on Its Kinetic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Flavin; Flavoproteins; Reductase; Nitroreductase; Substrate Specificity	PENTAERYTHRITOL TETRANITRATE REDUCTASE; ESCHERICHIA-COLI NITROREDUCTASE; P-HYDROXYBENZOATE HYDROXYLASE; ENTEROBACTER-CLOACAE; BAMBERGER REARRANGEMENT; NITROAROMATIC COMPOUNDS; IRON ENZYMES; SPECIFICITY; IDENTIFICATION; RESISTANCE	Background: Nitroreductase reduces a broad range of nitroaromatics. Results: Steady-state and pre-steady-state kinetics were combined with tests for aminoaromatic product formation. Conclusion: Both half-reactions occur via a simple mechanism lacking detectable gating steps consistent with the broad substrate repertoire. Significance: Nitroreductase does not generate p-aminobenzoic acid and, therefore, appears not to reduce nitro groups to amines. The oxygen-insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reduction of nitroaromatics to the corresponding nitroso compounds and, subsequently, to hydroxylamine products. NR has an unusually broad substrate repertoire, which may be related to protein dynamics (flexibility) and/or a simple non-selective kinetic mechanism. To investigate the possible role of mechanism in the broad substrate repertoire of NR, the kinetics of oxidation of NR by para-nitrobenzoic acid (p-NBA) were investigated using stopped-flow techniques at 4 degrees C. The results revealed a hyperbolic dependence on the p-NBA concentration with a limiting rate of 1.90 +/- 0.09 s(-1), indicating one-step binding before the flavin oxidation step. There is no evidence for a distinct binding step in which specificity might be enforced. The reduction of p-NBA is rate-limiting in steady-state turnover (1.7 +/- 0.3 s(-1)). The pre-steady-state reduction kinetics of NR by NADH indicate that NADH reduces the enzyme with a rate constant of 700 +/- 20 s(-1) and a dissociation constant of 0.51 +/- 0.04 mm. Thus, we demonstrate simple transient kinetics in both the reductive and oxidative half-reactions that help to explain the broad substrate repertoire of NR. Finally, we tested the ability of NR to reduce para-hydroxylaminobenzoic acid, demonstrating that the corresponding amine does not accumulate to significant levels even under anaerobic conditions. Thus E. cloacae NR is not a good candidate for enzymatic production of aromatic amines.	[Pitsawong, Warintra; Hoben, John P.; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afm@uky.edu	Miller, Anne-Frances/M-7703-2017; pitsawong, warintra/G-1760-2018	pitsawong, warintra/0000-0001-5438-1783	Department of Chemistry of the University of Kentucky; Research Challenge Trust Fund Fellowship	Department of Chemistry of the University of Kentucky; Research Challenge Trust Fund Fellowship	This work was supported by the Vice President for Research of the University of Kentucky, the Center for Pharmaceutical Development (to A.-F. M.), the Department of Chemistry of the University of Kentucky, and a Research Challenge Trust Fund Fellowship (to W. P.).	Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT C, 1991, J BIOL CHEM, V266, P4126; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cleland W W, 1979, Methods Enzymol, V63, P500; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P129; Defoin A, 2004, SYNTHESIS-STUTTGART, P706, DOI 10.1055/s-2004-815964; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; ELKOMMOS ME, 1987, ANALYST, V112, P1253, DOI 10.1039/an9871201253; Frederick KK, 2005, BIOCHEMISTRY-US, V44, P13304, DOI 10.1021/bi051119t; French CE, 1996, J BACTERIOL, V178, P6623, DOI 10.1128/jb.178.22.6623-6627.1996; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; GASPARIC J, 1977, MIKROCHIM ACTA, V1, P241; GOLDMAN P, 1986, BIOCHEM PHARMACOL, V35, P43, DOI 10.1016/0006-2952(86)90553-8; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Johansson E, 2003, J MED CHEM, V46, P4009, DOI 10.1021/jm030843b; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; Kim HY, 2005, APPL MICROBIOL BIOT, V68, P766, DOI 10.1007/s00253-005-1950-1; KNOX RJ, 1993, CANCER METAST REV, V12, P195, DOI 10.1007/BF00689810; KNOX RJ, 1993, BIOCHEM PHARMACOL, V46, P797, DOI 10.1016/0006-2952(93)90487-H; Koder RL, 1998, BBA-PROTEIN STRUCT M, V1387, P395, DOI 10.1016/S0167-4838(98)00151-4; Koder RL, 2002, BIOCHEMISTRY-US, V41, P14197, DOI 10.1021/bi025805t; Koder RL, 1998, PROTEIN EXPRES PURIF, V13, P53, DOI 10.1006/prep.1997.0866; Linwu SW, 2012, BIOCHEM PHARMACOL, V83, P1690, DOI 10.1016/j.bcp.2012.03.003; LIU D, 1984, APPL ENVIRON MICROB, V47, P1295, DOI 10.1128/AEM.47.6.1295-1298.1984; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Lu ZB, 2011, PROTEINS, V79, P3099, DOI 10.1002/prot.23137; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; OGATA Y, 1958, J AM CHEM SOC, V80, P3591, DOI 10.1021/ja01547a026; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Perez-Reinado E, 2008, ENVIRON MICROBIOL, V10, P3174, DOI 10.1111/j.1462-2920.2008.01585.x; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; Race PR, 2005, J BIOL CHEM, V280, P13256, DOI 10.1074/jbc.M409652200; Schenzle A, 1999, J BACTERIOL, V181, P1444, DOI 10.1128/JB.181.5.1444-1450.1999; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SONE T, 1981, J CHEM SOC PERK T 2, P298, DOI 10.1039/p29810000298; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; WHITMORE GF, 1986, BIOCHEM PHARMACOL, V35, P97, DOI 10.1016/0006-2952(86)90565-4; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yanto Y, 2010, ORG BIOMOL CHEM, V8, P1826, DOI 10.1039/b926274a; Yasutake Y, 2004, J MOL BIOL, V344, P325, DOI 10.1016/j.jmb.2004.09.035; YOST Y, 1969, J MED CHEM, V12, P961, DOI 10.1021/jm00305a077; Zhao R, 2011, TETRAHEDRON LETT, V52, P3805, DOI 10.1016/j.tetlet.2011.05.054	53	32	34	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15203	15214		10.1074/jbc.M113.547117	http://dx.doi.org/10.1074/jbc.M113.547117			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24706760	hybrid, Green Published			2022-12-28	WOS:000337465400007
J	Pustelny, K; Zdzalik, M; Stach, N; Stec-Niemczyk, J; Cichon, P; Czarna, A; Popowicz, G; Mak, P; Drag, M; Salvesen, GS; Wladyka, B; Potempa, J; Dubin, A; Dubin, G				Pustelny, Katarzyna; Zdzalik, Michal; Stach, Natalia; Stec-Niemczyk, Justyna; Cichon, Przemyslaw; Czarna, Anna; Popowicz, Grzegorz; Mak, Pawel; Drag, Marcin; Salvesen, Guy S.; Wladyka, Benedykt; Potempa, Jan; Dubin, Adam; Dubin, Grzegorz			Staphylococcal SplB Serine Protease Utilizes a Novel Molecular Mechanism of Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Inactivation; Protease; Serine Protease; Staphylococcus aureus; Signal Peptide; Zymogen Activation	PROTEOLYTIC-ENZYMES; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURES; AUREUS; CHYMOTRYPSINOGEN; METALLOPROTEASE; SPECIFICITY; INHIBITION; REFINEMENT; PROPEPTIDE	Staphylococcal SplB protease belongs to the chymotrypsin family. Chymotrypsin zymogen is activated by proteolytic processing at the N terminus, resulting in significant structural rearrangement at the active site. Here, we demonstrate that the molecular mechanism of SplB protease activation differs significantly and we characterize the novel mechanism in detail. Using peptide and protein substrates we show that the native signal peptide, or any N-terminal extension, has an inhibitory effect on SplB. Only precise N-terminal processing releases the full proteolytic activity of the wild type analogously to chymotrypsin. However, comparison of the crystal structures of mature SplB and a zymogen mimic show no rearrangement at the active site whatsoever. Instead, only the formation of a unique hydrogen bond network, distant form the active site, by the new N-terminal glutamic acid of mature SplB is observed. The importance of this network and influence of particular hydrogen bond interactions at the N terminus on the catalytic process is demonstrated by evaluating the kinetics of a series of mutants. The results allow us to propose a consistent model where changes in the overall protein dynamics rather than structural rearrangement of the active site are involved in the activation process.	[Pustelny, Katarzyna; Stec-Niemczyk, Justyna; Czarna, Anna; Mak, Pawel; Wladyka, Benedykt; Dubin, Adam] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Pustelny, Katarzyna] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Zdzalik, Michal; Stach, Natalia; Cichon, Przemyslaw; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Czarna, Anna; Popowicz, Grzegorz] Max Planck Inst Biochem, NMR Grp, D-82152 Martinsried, Germany; [Popowicz, Grzegorz] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, D-85764 Neuherberg, Germany; [Drag, Marcin] Wroclaw Univ Technol, Div Bioorgan Chem, Fac Chem, PL-50370 Wroclaw, Poland; [Drag, Marcin; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Cell Death Res, La Jolla, CA 92037 USA; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40202 USA; [Mak, Pawel; Wladyka, Benedykt; Dubin, Grzegorz] Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; University of Louisville; Jagiellonian University	Dubin, G (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	grzegorz.dubin@uj.edu.pl	Potempa, Jan/AAA-6850-2021; Władyka, Benedykt/T-7039-2019; Dubin, Grzegorz/J-8168-2014; Popowicz, Grzegorz/G-4769-2017	Władyka, Benedykt/0000-0002-9075-3529; Dubin, Grzegorz/0000-0002-5535-5760; Popowicz, Grzegorz/0000-0003-2818-7498; Pustelny, Katarzyna/0000-0001-8430-8608; Mak, Pawel/0000-0002-5222-3922; Czarna, Anna/0000-0003-1068-0671; Potempa, Jan/0000-0002-3600-7461	Foundation for Polish Science-PARENT-BRIDGE Programme; Polish Ministry of Science and Higher Education [N N301 032834]; National Science Center [UMO-2011/01/D/NZ1/01169, UMO-2011/01/N/NZ1/00208]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]; Foundation for Polish Science	Foundation for Polish Science-PARENT-BRIDGE Programme; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the Foundation for Polish Science-PARENT-BRIDGE Programme (to K. P.) and in part by Grants N N301 032834 (to G. D.) from the Polish Ministry of Science and Higher Education, UMO-2011/01/D/NZ1/01169 (to G. D.) and UMO-2011/01/N/NZ1/00208 (to M. Z.) from the National Science Center. The research was carried out with the equipment purchased from support of the European Union structural funds (Grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08).; Supported by the Foundation for Polish Science.	Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BERTHOLD H, 1992, BIOTECHNOL LETT, V14, P245, DOI 10.1007/BF01022318; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Fersht A., 1985, ENZYME STRUCTURE MEC; Filipek R, 2004, BIOCHEMISTRY-US, V43, P14306, DOI 10.1021/bi048661m; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Khan AR, 1998, PROTEIN SCI, V7, P815; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie A. G., 1992, JOIN CCP4 ESF EAMCB, V26; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rzychon M, 2003, MOL MICROBIOL, V49, P1051, DOI 10.1046/j.1365-2958.2003.03613.x; STEER ML, 1987, NEW ENGL J MED, V316, P144; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P8112, DOI 10.1021/bi00083a009; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Wadyka B., 2008, CELL MOL BIOL LETT, V13, P212; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WILKES SH, 1973, EUR J BIOCHEM, V34, P459, DOI 10.1111/j.1432-1033.1973.tb02780.x; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330	33	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15544	15553		10.1074/jbc.M113.507616	http://dx.doi.org/10.1074/jbc.M113.507616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24713703	Green Published, hybrid			2022-12-28	WOS:000337465400037
J	Shearn, CT; Backos, DS; Orlicky, DJ; Smathers-McCullough, RL; Petersen, DR				Shearn, Colin T.; Backos, Donald S.; Orlicky, David J.; Smathers-McCullough, Rebecca L.; Petersen, Dennis R.			Identification of 5 ' AMP-activated Kinase as a Target of Reactive Aldehydes during Chronic Ingestion of High Concentrations of Ethanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alcohol; AMP-activated Kinase (AMPK); Lipid Peroxidation; Liver; Oxidative Stress	BLOOD-ALCOHOL CONCENTRATIONS; IN-SITU DETECTION; PROTEIN-KINASE; MURINE MODEL; FATTY LIVER; LIPID-PEROXIDATION; PROTECTIVE ACTION; OXIDATIVE STRESS; EXPOSURE OCCURS; PEROXIREDOXIN 6	The production of reactive aldehydes including 4-hydroxy-2-nonenal (4-HNE) is a key component of the pathogenesis in a spectrum of chronic inflammatory hepatic diseases including alcoholic liver disease (ALD). One consequence of ALD is increased oxidative stress and altered -oxidation in hepatocytes. A major regulator of -oxidation is 5 AMP protein kinase (AMPK). In an in vitro cellular model, we identified AMPK as a direct target of 4-HNE adduction resulting in inhibition of both H2O2 and 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced downstream signaling. By employing biotin hydrazide capture, it was confirmed that 4-HNE treatment of cells resulted in carbonylation of AMPK/, which was not observed in untreated cells. Using a murine model of alcoholic liver disease, treatment with high concentrations of ethanol resulted in an increase in phosphorylated as well as carbonylated AMPK. Despite increased AMPK phosphorylation, there was no significant change in phosphorylation of acetyl CoA carboxylase. Mass spectrometry identified Michael addition adducts of 4-HNE on Cys(130), Cys(174), Cys(227), and Cys(304) on recombinant AMPK and Cys(225) on recombinant AMPK. Molecular modeling analysis of identified 4-HNE adducts on AMPK suggest that inhibition of AMPK occurs by steric hindrance of the active site pocket and by inhibition of hydrogen peroxide induced oxidation. The observed inhibition of AMPK by 4-HNE provides a novel mechanism for altered -oxidation in ALD, and these data demonstrate for the first time that AMPK is subject to regulation by reactive aldehydes in vivo.	[Shearn, Colin T.; Backos, Donald S.; Petersen, Dennis R.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Smathers-McCullough, Rebecca L.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cleveland Clinic Foundation	Petersen, DR (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Sch Pharm, Anschutz Med Campus,12850 East Montview Blvd Box, Denver, CO 80217 USA.	Dennis.Petersen@ucdenver.edu	Backos, Donald/N-5265-2019; Backos, Donald/Q-4791-2018	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210	Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility; Colorado Clinical Translational Science Institute; University of Colorado Cancer Center Grants Clinical and Translational Science Award [UL1 RR025780]; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018613, R56AA009300, R37AA009300] Funding Source: NIH RePORTER	Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute; University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility; Colorado Clinical Translational Science Institute; University of Colorado Cancer Center Grants Clinical and Translational Science Award; University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the Computational Chemistry and Biology Core Facility at the University of Colorado Anschutz Medical Campus and the University of Colorado Denver Cancer Center Research Histology Core (E. Erin Smith, April Otero, and Kathy Lux). The mass spectrometry and histology experiments were supported in part by Center for Research Resources, National Institutes of Health Colorado Clinical and Translational Sciences Institute Grant UL1 RR025780 and the University of Colorado Denver-Anchutz Medical Campus Proteomic Mass Spectrometry Facility, by the Colorado Clinical Translational Science Institute, and University of Colorado Cancer Center Grants Clinical and Translational Science Award UL1 RR025780 and the University of Colorado Cancer Center Grant P30 CA046934.	Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; BADGER TM, 1993, BIOCHEM BIOPH RES CO, V190, P780, DOI 10.1006/bbrc.1993.1117; Baio DL, 1998, ARCH BIOCHEM BIOPHYS, V350, P193, DOI 10.1006/abbi.1997.0514; BENEDETTI A, 1982, BIOCHIM BIOPHYS ACTA, V712, P628, DOI 10.1016/0005-2760(82)90292-2; BENEDETTI A, 1984, BIOCHIM BIOPHYS ACTA, V792, P172, DOI 10.1016/0005-2760(84)90219-4; BENEDETTI A, 1982, BIOCHIM BIOPHYS ACTA, V711, P345, DOI 10.1016/0005-2760(82)90044-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaudhary P, 2010, BIOCHEMISTRY-US, V49, P6263, DOI 10.1021/bi100517x; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Deguchi JO, 2009, LAB INVEST, V89, P315, DOI 10.1038/labinvest.2008.167; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Everitt H, 2013, AM J PHYSIOL-GASTR L, V304, pG38, DOI 10.1152/ajpgi.00309.2012; FRENCH SW, 1989, CLIN BIOCHEM, V22, P41, DOI 10.1016/S0009-9120(89)80067-0; Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; Gao XX, 2005, PROTEIN EXPRES PURIF, V43, P44, DOI 10.1016/j.pep.2005.03.017; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARRIS RA, 1978, ARCH BIOCHEM BIOPHYS, V189, P364, DOI 10.1016/0003-9861(78)90223-0; Jones AW, 2003, J FORENSIC SCI, V48, P874; JONES AW, 1992, ALCOHOL ALCOHOLISM, V27, P641; Kohjima M, 2008, INT J MOL MED, V21, P507; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Liangpunsakul S, 2008, AM J PHYSIOL-GASTR L, V295, pG1173, DOI 10.1152/ajpgi.90349.2008; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Paradis V, 1997, HEPATOLOGY, V26, P135; Paradis V, 1997, J CLIN PATHOL, V50, P401, DOI 10.1136/jcp.50.5.401; Qin SF, 2010, EXP EYE RES, V91, P818, DOI 10.1016/j.exer.2010.10.007; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Roede JR, 2009, J PHARMACOL EXP THER, V330, P79, DOI 10.1124/jpet.109.152983; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; RONIS MJJ, 1993, J PHARMACOL EXP THER, V264, P944; Sampey BP, 2003, ALCOHOL CLIN EXP RES, V27, P1015, DOI 10.1097/01.ALC.0000071928.16732.26; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Setshedi M, 2011, ALCOHOL CLIN EXP RES, V35, P2139, DOI 10.1111/j.1530-0277.2011.01569.x; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Shearn CT, 2011, BIOCHEMISTRY-US, V50, P3984, DOI 10.1021/bi200029w; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shearn CT, 2012, FREE RADICAL BIO MED, V53, P1, DOI 10.1016/j.freeradbiomed.2012.04.021; Shearn CT, 2011, MOL PHARMACOL, V79, P941, DOI 10.1124/mol.110.069534; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Smathers RL, 2013, J LIPID RES, V54, P1335, DOI 10.1194/jlr.M034892; Smathers RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038459; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; WILLIAMS SP, 1987, INT J BIOCHEM, V19, P879, DOI 10.1016/0020-711X(87)90249-7; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu J, 2011, J HEPATOL, V55, P673, DOI 10.1016/j.jhep.2010.12.034; Ye Qinyuan, 2012, Hepatobiliary Surg Nutr, V1, P5; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	63	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15449	15462		10.1074/jbc.M113.543942	http://dx.doi.org/10.1074/jbc.M113.543942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722988	Green Published, hybrid			2022-12-28	WOS:000337465400028
J	Li, XW; Rees, JS; Xue, P; Zhang, H; Hamaia, SW; Sanderson, B; Funk, PE; Farndale, RW; Lilley, KS; Perrett, S; Jackson, AP				Li, Xue-Wen; Rees, Johanna S.; Xue, Peng; Zhang, Hong; Hamaia, Samir W.; Sanderson, Bailey; Funk, Phillip E.; Farndale, Richard W.; Lilley, Kathryn S.; Perrett, Sarah; Jackson, Antony P.			New Insights into the DT40 B Cell Receptor Cluster Using a Proteomic Proximity Labeling Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; SIGNAL AMPLIFICATION; PROTEIN COMPLEXES; IN-SITU; LYMPHOCYTE; ACTIVATION; IDENTIFICATION; SEQUENCE; ADHESION; REQUIREMENT	In the vertebrate immune system, each B-lymphocyte expresses a surface IgM-class B cell receptor (BCR). When cross-linked by antigen or anti-IgM antibody, the BCR accumulates with other proteins into distinct surface clusters that activate cell signaling, division, or apoptosis. However, the molecular composition of these clusters is not well defined. Here we describe a quantitative assay we call selective proteomic proximity labeling using tyramide (SPPLAT). It allows proteins in the immediate vicinity of a target to be selectively biotinylated, and hence isolated for mass spectrometry analysis. Using the chicken B cell line DT40 as a model, we use SPPLAT to provide the first proteomic analysis of any BCR cluster using proximity labeling. We detect known components of the BCR cluster, including integrins, together with proteins not previously thought to be BCR-associated. In particular, we identify the chicken B-lymphocyte allotypic marker chB6. We show that chB6 moves to within about 30 - 40 nm of the BCR following BCR cross-linking, and we show that cross-linking chB6 activates cell binding to integrin substrates laminin and gelatin. Our work provides new insights into the nature and composition of the BCR cluster, and confirms SPPLAT as a useful research tool in molecular and cellular proteomics.	[Li, Xue-Wen; Xue, Peng; Zhang, Hong; Perrett, Sarah; Jackson, Antony P.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Rees, Johanna S.; Hamaia, Samir W.; Farndale, Richard W.; Lilley, Kathryn S.; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Rees, Johanna S.; Lilley, Kathryn S.] Univ Cambridge, Cambridge Ctr Prote, Cambridge CB2 1QR, England; [Sanderson, Bailey; Funk, Phillip E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Li, Xue-Wen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Cambridge; University of Cambridge; DePaul University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@cantab.net; apj10@cam.ac.uk	Perrett, Sarah/AAS-9483-2020; Lilley, Kathryn/ABF-5787-2020	Perrett, Sarah/0000-0003-0137-0997; Lilley, Kathryn/0000-0003-0594-6543; Jackson, Antony Philip/0000-0002-2895-7387; Rees, Johanna/0000-0003-2066-8617	Chinese Ministry of Science and Technology 973 Program [2012CB911000, 2013CB910700]; National Natural Science Foundation of China [31110103914, 31070656, 31000342, 31270794]; Biotechnology and Biological Sciences Research Council (UK) [BB/J021091, H024085/1]; Medical Research Council (UK) [G0500707]; Wellcome Trust [094470/Z/10/Z]; DePaul University Research Council; Chinese Academy of Sciences [2010T1S11]; BBSRC [BB/H024085/1, BB/J021091/1] Funding Source: UKRI; MRC [G0500707] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H024085/1, BB/J021091/1] Funding Source: researchfish; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); DePaul University Research Council; Chinese Academy of Sciences(Chinese Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Chinese Ministry of Science and Technology 973 Program (2012CB911000 and 2013CB910700) and the National Natural Science Foundation of China (31110103914, 31070656, 31000342, and 31270794).; Supported by Grants BB/J021091 and H024085/1 from the Biotechnology and Biological Sciences Research Council (UK).; Supported by Grant G0500707 from the Medical Research Council (UK) and Grant 094470/Z/10/Z from the Wellcome Trust.; Supported by the DePaul University Research Council.; Supported by a Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant 2010T1S11. To whom correspondence may be addressed: Dept. of Biochemistry, University of Cambridge, Tennis Court Rd., Cambridge CB2 1QW, United Kingdom. Tel.: 44-1223-765951; E-mail: apj10@cam.ac.uk.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Arana E, 2008, J CELL SCI, V121, P2279, DOI 10.1242/jcs.017905; Avram D, 2004, PROTEOMICS, V4, P2397, DOI 10.1002/pmic.200300755; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Cheng PC, 2001, SEMIN IMMUNOL, V13, P107, DOI 10.1006/smim.2000.0302; Chiampanichayakul S, 2002, INT IMMUNOL, V14, P1407, DOI 10.1093/intimm/dxf112; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Earnshaw JC, 1999, CYTOMETRY, V35, P176, DOI 10.1002/(SICI)1097-0320(19990201)35:2<176::AID-CYTO10>3.0.CO;2-S; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Funk PE, 2003, CELL IMMUNOL, V226, P95, DOI 10.1016/j.cellimm.2003.11.009; Funk PE, 2003, ARCH IMMUNOL THER EX, V51, P389; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hall SL, 2009, MOL CELL PROTEOMICS, V8, P1295, DOI 10.1074/mcp.M800394-MCP200; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Harwood NE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002360; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Igyarto BZ, 2008, POULTRY SCI, V87, P351, DOI 10.3382/ps.2007-00365; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kivens WJ, 1998, MOL CELL BIOL, V18, P5291, DOI 10.1128/MCB.18.9.5291; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; McCarthy FM, 2006, PROTEOMICS, V6, P2759, DOI 10.1002/pmic.200500648; MOINGEON P, 1989, IMMUNOL REV, V111, P111, DOI 10.1111/j.1600-065X.1989.tb00544.x; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Rees JS, 2011, METHODS, V54, P407, DOI 10.1016/j.ymeth.2011.06.004; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schofer C, 1997, HISTOCHEM CELL BIOL, V108, P313, DOI 10.1007/s004180050171; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shenoi H, 1999, J IMMUNOL, V162, P7120; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Spessotto P, 2001, CANCER RES, V61, P339; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; Treanor B, 2012, IMMUNOLOGY, V136, P21, DOI 10.1111/j.1365-2567.2012.03564.x; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; VEROMAA T, 1988, HYBRIDOMA, V7, P41, DOI 10.1089/hyb.1988.7.41; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Williams MG, 2001, PROTEINS, P92; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487; Yang W, 2008, PROTEOMICS, V8, P832, DOI 10.1002/pmic.200700650; Yasuda Tomoharu, 2004, Methods Mol Biol, V271, P261; Zheng YZ, 2009, J PROTEOMICS, V72, P12, DOI 10.1016/j.jprot.2008.09.003	72	80	81	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14434	14447		10.1074/jbc.M113.529578	http://dx.doi.org/10.1074/jbc.M113.529578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706754	Green Published, hybrid			2022-12-28	WOS:000337248100001
J	Rotzer, V; Breit, A; Waschke, J; Spindler, V				Roetzer, Vera; Breit, Andreas; Waschke, Jens; Spindler, Volker			Adducin Is Required for Desmosomal Cohesion in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PEMPHIGUS-VULGARIS-IGG; CELL CARCINOMA LINE; ACTIN CYTOSKELETON; DESMOGLEIN 3; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CALCIUM; DJM-1 CELLS; RHO GTPASES; SH2 DOMAIN	Adducin is a protein organizing the cortical actin cytoskeleton and a target of RhoA and PKC signaling. However, the role for intercellular cohesion is unknown. We found that adducin silencing induced disruption of the actin cytoskeleton, reduced intercellular adhesion of human keratinocytes, and decreased the levels of the desmosomal adhesion molecule desmoglein (Dsg) 3 by reducing its membrane incorporation. Because loss of cell cohesion and Dsg3 depletion is observed in the autoanti-body-mediated blistering skin disease pemphigus vulgaris (PV), we applied antibody fractions of PV patients. A rapid phosphorylation of adducin at serine 726 was detected in response to these autoantibodies. To mechanistically link autoantibody binding and adducin phosphorylation, we evaluated the role of several disease-relevant signaling molecules. Adducin phosphorylation at serine 726 was dependent on Ca2+ influx and PKC but occurred independent of p38 MAPK and PKA. Adducin phosphorylation is protective, because phosphorylation-deficient mutants resulted in loss of cell cohesion and Dsg3 fragmentation. Thus, PKC elicits both positive and negative effects on cell adhesion, since its contribution to cell dissociation in pemphigus is well established. We additionally evaluated the effect of RhoA on adducin phosphorylation because RhoA activation was shown to block pemphigus autoantibody-induced cell dissociation. Our data demonstrate that the protective effect of RhoA activation was dependent on the presence of adducin and its phosphorylation at serine 726. These experiments provide novel mechanisms for regulation of desmosomal adhesion by RhoA- and PKC-mediated adducin phosphorylation in keratinocytes.	[Roetzer, Vera; Waschke, Jens; Spindler, Volker] Univ Munich, Inst Anat & Cell Biol, D-80336 Munich, Germany; [Breit, Andreas] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany	University of Munich; University of Munich	Waschke, J (corresponding author), Pettenkoferstr 11, D-80336 Munich, Germany.	jens.waschke@med.uni-muenchen.de; volker.spindler@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421	Deutsche Forschungsgemeinschaft [DFG SP1300-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG SP1300-1 (to V. S.).	Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Baumgartner W, 2003, J CELL SCI, V116, P1001, DOI 10.1242/jcs.00322; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Cirillo N, 2010, EXP CELL RES, V316, P580, DOI 10.1016/j.yexcr.2009.10.005; DONG LQ, 1995, J BIOL CHEM, V270, P25534, DOI 10.1074/jbc.270.43.25534; ESAKI C, 1995, J INVEST DERMATOL, V105, P329, DOI 10.1111/1523-1747.ep12319948; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Hobbs RP, 2012, J INVEST DERMATOL, V132, P482, DOI 10.1038/jid.2011.318; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Kirkbride KC, 2012, CYTOSKELETON, V69, P625, DOI 10.1002/cm.21051; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nieto-Pelegrin E, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-11; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2014, CELL COMMUN ADHES, V21, P77, DOI 10.3109/15419061.2013.877000; Spindler V, 2013, J CLIN INVEST, V123, P800, DOI 10.1172/JCI60139; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tsang SM, 2012, EXP CELL RES, V318, P2269, DOI 10.1016/j.yexcr.2012.07.002; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Waschke J, 2014, MED RES REV, V34, P1127, DOI 10.1002/med.21310; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200	57	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14925	14940		10.1074/jbc.M113.527127	http://dx.doi.org/10.1074/jbc.M113.527127			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711455	hybrid, Green Published			2022-12-28	WOS:000337248100043
J	Qin, Y; Fu, MY; Takahashi, M; Iwanami, A; Kuga, D; Rao, RG; Sudhakar, D; Huang, T; Kiyohara, M; Torres, K; Dillard, C; Inagaki, A; Kasahara, N; Goodglick, L; Braun, J; Mischel, PS; Gordon, LK; Wadehra, M				Qin, Yu; Fu, Maoyong; Takahashi, Masamichi; Iwanami, Akio; Kuga, Daisuke; Rao, Rajiv G.; Sudhakar, Deepthi; Huang, Tiffany; Kiyohara, Meagan; Torres, Kathleen; Dillard, Christen; Inagaki, Akihito; Kasahara, Noriyuki; Goodglick, Lee; Braun, Jonathan; Mischel, Paul S.; Gordon, Lynn K.; Wadehra, Madhuri			Epithelial Membrane Protein-2 ( EMP2) Activates Src Protein and Is a Novel Therapeutic Target for Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Glioblastoma; Immunotherapy; Tetraspanins; Tumor Marker; EMP2	ALPHA-V-BETA-3 INTEGRIN; MOLECULAR DETERMINANTS; IN-VITRO; CANCER; EXPRESSION; GROWTH; CELLS; ANTIBODY; ANGIOGENESIS; VITRONECTIN	Background: EMP2 is a tetraspan protein linked with aggressive disease. Results: EMP2 correlates with activated Src in patients with GBM. Using intracranial mouse models, EMP2 promotes tumor cell invasiveness. Antibodies to EMP2 reduce GBM tumor load. Conclusion: EMP2 is a novel therapeutic target in GBM. Significance: The clinical outcome for patients with GBM remains poor, and thus new targeted therapies are needed. Despite recent advances in molecular classification, surgery, radiotherapy, and targeted therapies, the clinical outcome of patients with malignant brain tumors remains extremely poor. In this study, we have identified the tetraspan protein epithelial membrane protein-2 (EMP2) as a potential target for glioblastoma (GBM) killing. EMP2 had low or undetectable expression in normal brain but was highly expressed in GBM as 95% of patients showed some expression of the protein. In GBM cells, EMP2 enhanced tumor growth in vivo in part by up-regulating v3 integrin surface expression, activating focal adhesion kinase and Src kinases, and promoting cell migration and invasion. Consistent with these findings, EMP2 expression significantly correlated with activated Src kinase in patient samples and promoted tumor cell invasion using intracranial mouse models. As a proof of principle to determine whether EMP2 could serve as a target for therapy, cells were treated using specific anti-EMP2 antibody reagents. These reagents were effective in killing GBM cells in vitro and in reducing tumor load in subcutaneous mouse models. These results support the role of EMP2 in the pathogenesis of GBM and suggest that anti-EMP2 treatment may be a novel therapeutic treatment.	[Qin, Yu; Gordon, Lynn K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Fu, Maoyong; Iwanami, Akio; Kuga, Daisuke; Rao, Rajiv G.; Sudhakar, Deepthi; Huang, Tiffany; Kiyohara, Meagan; Torres, Kathleen; Dillard, Christen; Goodglick, Lee; Braun, Jonathan; Wadehra, Madhuri] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Goodglick, Lee; Braun, Jonathan; Wadehra, Madhuri] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Takahashi, Masamichi; Inagaki, Akihito; Kasahara, Noriyuki] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Wadehra, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Box 951732,675 Charles Young Dr South, Los Angeles, CA 90095 USA.	mwadehra@mednet.ucla.edu	Takahashi, Masamichi/GRJ-2866-2022	Dillard, Christen/0000-0002-7218-9960; Kasahara, Noriyuki/0000-0002-6069-9082; Takahashi, Masamichi/0000-0001-8792-1993; Braun, Jonathan/0000-0003-1646-2974	National Institutes of Health from NCI Early Detection Research Network [CA-86366, R01 CA163971, CA 143931CDU/UCLA, P30 CA016042]; CFAR [5P30 AI028697]; Stein Oppenheimer seed grant; NATIONAL CANCER INSTITUTE [R01CA163971, P30CA016042, U54CA143931, U24CA086366] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health from NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Stein Oppenheimer seed grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-86366 from NCI Early Detection Research Network (to L. G.), R01 CA163971 (to M. W.), CA 143931CDU/UCLA Cancer Center Partnership U54 (to M. W.), Grant P30 CA016042 to Jonsson Comprehensive Cancer Center, and Grant 5P30 AI028697 from CFAR. This work was also supported by a Stein Oppenheimer seed grant (to L. G.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Agus DB, 1999, CANCER RES, V59, P4761; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Chang MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037935; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; de Groot J, 2009, J NEURO-ONCOL, V95, P151, DOI 10.1007/s11060-009-9916-2; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Frank RT, 2011, BBA-REV CANCER, V1816, P191, DOI 10.1016/j.bbcan.2011.07.002; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fu M, 2014, MOL CANCER THER, V13, P902, DOI 10.1158/1535-7163.MCT-13-0199; Fu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019945; Fu MY, 2010, CLIN CANCER RES, V16, P3954, DOI 10.1158/1078-0432.CCR-10-0368; Fukai J, 2008, CANCER SCI, V99, P2062, DOI 10.1111/j.1349-7006.2008.00945.x; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gordon LK, 2013, ONCOGENE, V32, P5369, DOI 10.1038/onc.2012.622; Habeeb O, 2010, CANCER-AM CANCER SOC, V116, P4718, DOI 10.1002/cncr.25259; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang TT, 2013, CANCER GENE THER, V20, P544, DOI 10.1038/cgt.2013.51; JIAO Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0041591; Kanamori M, 2006, J BIOL CHEM, V281, P37256, DOI 10.1074/jbc.M605344200; Kawaguchi T, 2006, CANCER RES, V66, P11331, DOI 10.1158/0008-5472.CAN-06-1540; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerr JS, 2000, EXPERT OPIN INV DRUG, V9, P1271, DOI 10.1517/13543784.9.6.1271; Kim K, 2008, MOL CANCER RES, V6, P426, DOI 10.1158/1541-7786.MCR-07-0313; Lorger M., 2012, INTEGRIN SIGNALING A, P311; McEarchern JA, 2007, BLOOD, V109, P1185, DOI 10.1182/blood-2006-07-034017; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P462, DOI 10.1167/iovs.07-1598; Petras Miklos, 2009, Magy Onkol, V53, P253, DOI 10.1556/MOnkol.53.2009.3.3; Rolle CE, 2010, NEUROSURG CLIN N AM, V21, P201, DOI 10.1016/j.nec.2009.08.002; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Shimazaki K, 2008, CLIN CANCER RES, V14, P7367, DOI 10.1158/1078-0432.CCR-08-1016; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; Wadehra M, 2006, DEV BIOL, V292, P430, DOI 10.1016/j.ydbio.2006.01.015; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2003, EXP MOL PATHOL, V74, P106, DOI 10.1016/S0014-4800(03)00009-1; Wadehra M, 2002, J BIOL CHEM, V277, P41094, DOI 10.1074/jbc.M206868200; Wadehra M, 2006, CANCER-AM CANCER SOC, V107, P90, DOI 10.1002/cncr.21957; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Wang WJ, 2005, J NEUROSURG, V103, P1058, DOI 10.3171/jns.2005.103.6.1058; Wang YL, 2004, ONCOGENE, V23, P1283, DOI 10.1038/sj.onc.1207244; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	51	20	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13974	13985		10.1074/jbc.M113.543728	http://dx.doi.org/10.1074/jbc.M113.543728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24644285	Green Published, hybrid			2022-12-28	WOS:000335984600028
J	Hong, SK; Zhao, B; Lombard, DB; Fingar, DC; Inoki, K				Hong, Sungki; Zhao, Bin; Lombard, David B.; Fingar, Diane C.; Inoki, Ken			Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 ( mTORC1) Signaling in the Regulation of S6 Kinase 1 ( S6K1) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR; mTOR Complex (mTORC); Phosphorylation; S6 Kinase; Sirt1; Sirtuins; Acetylation; Rapamycin	EXTENDS LIFE-SPAN; PROTEIN-KINASE; CELL-GROWTH; DEPENDENT REGULATION; DEACETYLASE SIRT1; HYDROPHOBIC MOTIF; ACETYLATION SITE; AGC KINASES; TOS MOTIF; IN-VIVO	Background: The mTOR complex 1 (mTORC1) phosphorylates ribosomal S6 kinase (S6K1) on Thr-389, leading to S6K1 activation. Results: Inhibition of SIRT1/2, members of the sirtuin family of proteins, induces S6K1 acetylation and inhibits mTORC1-dependent S6K1 phosphorylation. Conclusion: The SIRT1/2 support mTORC1-induced S6K1 activation by inhibiting S6K1 acetylation. Significance: The study provides a novel mechanistic insight into the cross-talk between sirtuins and mTORC1 signaling. p70 ribosomal S6 kinase (S6K1), a major substrate of the mammalian target of rapamycin (mTOR) kinase, regulates diverse cellular processes including protein synthesis, cell growth, and survival. Although it is well known that the activity of S6K1 is tightly coupled to its phosphorylation status, the regulation of S6K1 activity by other post-translational modifications such as acetylation has not been well understood. Here we show that the acetylation of the C-terminal region (CTR) of S6K1 blocks mTORC1-dependent Thr-389 phosphorylation, an essential phosphorylation site for S6K1 activity. The acetylation of the CTR of S6K1 is inhibited by the class III histone deacetylases, SIRT1 and SIRT2. An S6K1 mutant lacking acetylation sites in its CTR shows enhanced Thr-389 phosphorylation and kinase activity, whereas the acetylation-mimetic S6K1 mutant exhibits decreased Thr-389 phosphorylation and kinase activity. Interestingly, relative to the acetylation-mimetic S6K1 mutant, the acetylation-defective mutant displays higher affinity toward Raptor, an essential scaffolding component of mTORC1 that recruits mTORC1 substrates. These observations indicate that sirtuin-mediated regulation of S6K1 acetylation is an additional important regulatory modification that impinges on the mechanisms underlying mTORC1-dependent S6K1 activation.	[Hong, Sungki; Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Ann Arbor, MI 48109 USA; [Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Zhejiang University; Zhejiang University	Inoki, K (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	inokik@umich.edu		Lombard, David/0000-0002-4292-0185	National Institutes of Health [DK083491, GM101171, CA177925]; NATIONAL CANCER INSTITUTE [R21CA177925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083491 (to K. I.) and GM101171 and CA177925 (to D. B. L.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Guo WJ, 2011, J NEUROSCI RES, V89, P1723, DOI 10.1002/jnr.22725; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang JC, 2013, BIOCHEM J, V454, P39, DOI 10.1042/BJ20121863; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401	63	65	66	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13132	13141		10.1074/jbc.M113.520734	http://dx.doi.org/10.1074/jbc.M113.520734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652283	Green Published, hybrid			2022-12-28	WOS:000335522800015
J	Salinas, M; Besson, T; Delettre, Q; Diochot, S; Boulakirba, S; Douguet, D; Lingueglia, E				Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric			Binding Site and Inhibitory Mechanism of the Mambalgin-2 Pain-relieving Peptide on Acid-sensing Ion Channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channels (ASIC); Pain; Pharmacology; Sodium Channels; Toxins	TARANTULA TOXIN PSALMOTOXIN-1; INFLAMMATORY PAIN; ASIC1A; TARGET; SELECTIVITY; NEURONS; COMPLEX; SENSOR; STATE; ZDOCK	Background: Mambalgin-2 is a snake venom peptide that blocks acid-sensing ion channels (ASICs) to relieve pain. Results: Mambalgin-2 interacts with at least three different regions of ASICs and exerts both stimulatory and inhibitory effects. Conclusion: Binding of mambalgin-2 into the pH sensor traps the channels in the closed conformation. Significance: This might allow development of optimized blockers of ASICs of therapeutic value. Acid-sensing ion channels (ASICs) are neuronal proton-gated cation channels associated with nociception, fear, depression, seizure, and neuronal degeneration, suggesting roles in pain and neurological and psychiatric disorders. We have recently discovered black mamba venom peptides called mambalgin-1 and mambalgin-2, which are new three-finger toxins that specifically inhibit with the same pharmacological profile ASIC channels to exert strong analgesic effects in vivo. We now combined bioinformatics and functional approaches to uncover the molecular mechanism of channel inhibition by the mambalgin-2 pain-relieving peptide. Mambalgin-2 binds mainly in a region of ASIC1a involving the upper part of the thumb domain (residues Asp-349 and Phe-350), the palm domain of an adjacent subunit, and the -ball domain (residues Arg-190, Asp-258, and Gln-259). This region overlaps with the acidic pocket (pH sensor) of the channel. The peptide exerts both stimulatory and inhibitory effects on ASIC1a, and we propose a model where mambalgin-2 traps the channel in a closed conformation by precluding the conformational change of the palm and -ball domains that follows proton activation. These data help to understand inhibition by mambalgins and provide clues for the development of new optimized blockers of ASIC channels.	[Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Delettre, Quentin; Diochot, Sylvie; Boulakirba, Sonia; Douguet, Dominique; Lingueglia, Eric] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Diochot, Sylvie; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, LabEx Ion Channel Sci & Therapeut, F-06560 Valbonne, France; [Salinas, Miguel; Besson, Thomas; Diochot, Sylvie; Lingueglia, Eric] Univ Nice Sophia Antipolis, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), CNRS UNS, Inst Pharmacol Mol & Cellulaire, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	lingueglia@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013; Diochot, Sylvie/ABG-5495-2020; SALINAS, Miguel/N-6380-2016; douguet, dominique/D-5644-2017	LINGUEGLIA, Eric/0000-0003-3902-3405; SALINAS, Miguel/0000-0002-7445-123X; boulakirba, sonia/0000-0001-7089-0860	Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-13-BSV4-0009]; Association Francaise contre les Myopathies	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the Fondation pour la Recherche Medicale, Agence Nationale de la Recherche Grant ANR-13-BSV4-0009, and the Association Francaise contre les Myopathies.	Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Blanchard MG, 2012, BRIT J PHARMACOL, V165, P2167, DOI 10.1111/j.1476-5381.2011.01674.x; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Noel Jacques, 2010, Expert Rev Clin Pharmacol, V3, P331, DOI 10.1586/ecp.10.13; Peigneur S, 2012, FASEB J, V26, P5141, DOI 10.1096/fj.12-218479; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Smoller JW, 2014, BIOL PSYCHIAT, V76, P902, DOI 10.1016/j.biopsych.2013.12.018; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Woolf CJ, 2013, LANCET NEUROL, V12, P18, DOI 10.1016/S1474-4422(12)70287-9; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	40	44	45	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13363	13373		10.1074/jbc.M114.561076	http://dx.doi.org/10.1074/jbc.M114.561076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695733	Green Published, hybrid			2022-12-28	WOS:000335522800035
J	Tonin, Y; Heckel, AM; Vysokikh, M; Dovydenko, I; Meschaninova, M; Rotig, A; Munnich, A; Venyaminova, A; Tarassov, I; Entelis, N				Tonin, Yann; Heckel, Anne-Marie; Vysokikh, Mikhail; Dovydenko, Ilya; Meschaninova, Mariya; Roetig, Agnes; Munnich, Arnold; Venyaminova, Alya; Tarassov, Ivan; Entelis, Nina			Modeling of Antigenomic Therapy of Mitochondrial Diseases by Mitochondrially Addressed RNA Targeting a Pathogenic Point Mutation in Mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast; Mitochondrial Diseases; Mitochondrial DNA; Mitochondrial Transport; Respiratory Chain; RNA Transport; Heteroplasmy; RNA-based Therapeutics; Cybrid Cells	RESPIRATORY COMPLEX I; 5S RIBOSOMAL-RNA; RESTRICTION-ENDONUCLEASE; COLOCALIZATION ANALYSIS; MTDNA HETEROPLASMY; FREQUENT CAUSE; ND5 SUBUNIT; DEFICIENCY; IMPORT; CELLS	Background: Point mutations in mitochondrial genome cause severe clinical disorders. Results: We designed recombinant RNA molecules imported into mitochondria of human cells, which are able to decrease the proportion of mitochondrial DNA molecules bearing a pathogenic point mutation. Conclusion: Imported recombinant RNAs can function as anti-replicative agents in human mitochondria. Significance: This is a new approach for therapy of mitochondrial diseases. Defects in mitochondrial genome can cause a wide range of clinical disorders, mainly neuromuscular diseases. Presently, no efficient therapeutic treatment has been developed against this class of pathologies. Because most of deleterious mitochondrial mutations are heteroplasmic, meaning that wild type and mutated forms of mitochondrial DNA (mtDNA) coexist in the same cell, the shift in proportion between mutant and wild type molecules could restore mitochondrial functions. Recently, we developed mitochondrial RNA vectors that can be used to address anti-replicative oligoribonucleotides into human mitochondria and thus impact heteroplasmy level in cells bearing a large deletion in mtDNA. Here, we show that this strategy can be also applied to point mutations in mtDNA. We demonstrate that specifically designed RNA molecules containing structural determinants for mitochondrial import and 20-nucleotide sequence corresponding to the mutated region of mtDNA, are able to anneal selectively to the mutated mitochondrial genomes. After being imported into mitochondria of living human cells in culture, these RNA induced a decrease of the proportion of mtDNA molecules bearing a pathogenic point mutation in the mtDNA ND5 gene.	[Tonin, Yann; Heckel, Anne-Marie; Vysokikh, Mikhail; Dovydenko, Ilya; Tarassov, Ivan; Entelis, Nina] Strasbourg Univ, CNRS, UMR Genet Mol Genom Microbiol 7156, F-67084 Strasbourg, France; [Dovydenko, Ilya; Meschaninova, Mariya; Venyaminova, Alya] Inst Chem Biol & Fundamental Med SB RAS, Lab RNA Chem, Novosibirsk 630090, Russia; [Roetig, Agnes; Munnich, Arnold] Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, INSERM,U781, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Entelis, N (corresponding author), Univ Strasbourg, CNRS, UMR 7156, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	n.entelis@unistra.fr	Rötig, Agnès/G-9592-2017; Vyssokikh, Mikhail/H-4744-2014; Meschaninova, Mariya I/G-3496-2013	Rötig, Agnès/0000-0003-0589-0703; Vyssokikh, Mikhail/0000-0002-4047-6201; Meschaninova, Mariya I/0000-0003-0045-2413; Dovydenko, Ilya/0000-0002-6890-4538; Entelis, Nina/0000-0002-7915-5528; Tarassov, Ivan/0000-0001-8763-6703	CNRS; University of Strasbourg; Association Francaise contre les Myopathies; Agence Nationale de la Recherche [ANR-06-MRAR-37-01, BLAN08-2-309449]; Fondation pour la Recherche Medicale [DEQ20081214003]; ARCUS/Suprachem Collaboration Program; LIA Collaboration Program (ARNmitocure); French National Research Agency; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ARCUS/Suprachem Collaboration Program; LIA Collaboration Program (ARNmitocure); French National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The work was supported by CNRS, the University of Strasbourg, Association Francaise contre les Myopathies, Agence Nationale de la Recherche (ANR-06-MRAR-37-01; BLAN08-2-309449), Fondation pour la Recherche Medicale (DEQ20081214003), ARCUS/Suprachem Collaboration Program and LIA Collaboration Program (ARNmitocure). This work has also been published under the framework of the LABEX ANR-11-LABX-0057_MITOCROSS and is supported by the state managed by the French National Research Agency as part of the Investment for the Future program.; Supported by Fondation pour la Recherche Medicale and Association Francaise contre les Myopathies Ph.D. fellowships.	Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981; Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102; Bellon L, 2001, CURRENT PROTOCOLS NU, V1:3.6.1-3.6.13; Blok MJ, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045716; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965; Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Gowher A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066228; Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546; Kohrer C, 2001, P NATL ACAD SCI USA, V98, P14310, DOI 10.1073/pnas.251438898; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Mager-Heckel Anne-Marie, 2007, Methods Mol Biol, V372, P235, DOI 10.1007/978-1-59745-365-3_17; Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851; Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852; Ohnishi T, 2012, BBA-BIOENERGETICS, V1817, P1803, DOI 10.1016/j.bbabio.2012.03.032; Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Rustin P, 2007, M S-MED SCI, V23, P519, DOI 10.1051/medsci/2007235519; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Tonin Y, 2014, BIOCHIMIE, V100, P192, DOI 10.1016/j.biochi.2013.08.020; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	30	32	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13323	13334		10.1074/jbc.M113.528968	http://dx.doi.org/10.1074/jbc.M113.528968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692550	Green Published, hybrid			2022-12-28	WOS:000335522800031
J	Rappe, U; Schlechter, T; Aschoff, M; Hotz-Wagenblatt, A; Hofmann, I				Rappe, Ulrike; Schlechter, Tanja; Aschoff, Moritz; Hotz-Wagenblatt, Agnes; Hofmann, Ilse			Nuclear ARVCF Protein Binds Splicing Factors and Contributes to the Regulation of Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adherens Junction; Alternative Splicing; Catenin; Cell Junctions; Molecular Cell Biology; Ribonuclear Protein (RNP); Post-transcriptional Gene Expression Regulation; Arm Repeat Protein	EXPANDED CUG REPEATS; CELL-CELL ADHESION; MESSENGER-RNA; PLAQUE PROTEIN; CYTOPLASMIC PARTICLES; EPITHELIAL-CELLS; LIGHT-CHAINS; CATENIN; EXPRESSION; GENE	Background: ARVCF occurs both at adherens junctions and in the nucleus, but little is known about its nuclear function. Results: ARVCF interacts with RNA-binding proteins involved in splicing and contributes to alternative splicing of specific transcripts. Conclusion: ARVCF influences splicing of specific pre-mRNAs. Significance: We propose a new role of nuclear ARVCF in post-transcriptional regulation of gene expression. The armadillo repeat protein ARVCF is a component of adherens junctions. Similar to related proteins, such as p120-catenin and -catenin, with known signaling functions, localization studies indicate a cytoplasmic and a nuclear pool of ARVCF. We find that ARVCF interacts with different proteins involved in mRNA-processing: the splicing factor SRSF1 (SF2/ASF), the RNA helicase p68 (DDX5), and the heterogeneous nuclear ribonucleoprotein hnRNP H2. All three proteins bind to ARVCF in an RNA-independent manner. Furthermore, ARVCF occurs in large RNA-containing complexes that contain both spliced and unspliced mRNAs of housekeeping genes. By domain analysis, we show that interactions occur via the ARVCF C terminus. Overexpression of ARVCF, p68, SRSF1, and hnRNP H2 induces a significant increase in splicing activity of a reporter mRNA. Upon depletion of ARVCF followed by RNA sequence analysis, several alternatively spliced transcripts are significantly changed. Therefore, we conclude that nuclear ARVCF influences splicing of pre-mRNAs. We hypothesize that ARVCF is involved in alternative splicing, generating proteomic diversity, and its deregulation may contribute to diseased states, such as cancer and neurological disorders.	[Rappe, Ulrike; Schlechter, Tanja; Hofmann, Ilse] DKFZ ZMBH Alliance, German Canc Res Ctr, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany; [Rappe, Ulrike; Schlechter, Tanja; Hofmann, Ilse] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Aschoff, Moritz; Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Genom Prote Core Facil, Bioinformat HUSAR, D-69120 Heidelberg, Germany; [Aschoff, Moritz] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hofmann, I (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Div Vasc Oncol & Metastasis, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	i.hofmann@dkfz.de			German Cancer Aid [108978]	German Cancer Aid(Deutsche Krebshilfe)	This work was supported by Grant 108978 from the German Cancer Aid (to I. H.).	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Cho K, 2010, J CELL SCI, V123, P4128, DOI 10.1242/jcs.072041; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2002, MOL BIOL CELL, V13, P1665, DOI 10.1091/mbc.01-12-0567; Hofmann I, 2008, CELL TISSUE RES, V334, P381, DOI 10.1007/s00441-008-0725-2; HONORE B, 1995, J BIOL CHEM, V270, P28780; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kaufmann U, 2000, J CELL SCI, V113, P4121; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Laurent FX, 2012, NUCLEIC ACIDS RES, V40, P3159, DOI 10.1093/nar/gkr1228; LENZ S, 1989, J BIOL CHEM, V264, P9009; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; LIEW CC, 1989, FEBS LETT, V248, P101, DOI 10.1016/0014-5793(89)80440-5; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Mariner DJ, 2000, J CELL SCI, V113, P1481; Mas S, 2010, AM J MED GENET B, V153B, P1052, DOI 10.1002/ajmg.b.31073; Mas S, 2009, PROG NEURO-PSYCHOPH, V33, P1064, DOI 10.1016/j.pnpbp.2009.06.001; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mohr K, 2012, METHODS MOL BIOL, V812, P89, DOI 10.1007/978-1-61779-455-1_5; Morikawa T, 2010, NEUROCHEM INT, V57, P691, DOI 10.1016/j.neuint.2010.08.012; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; Paul S, 2011, J BIOL CHEM, V286, P38427, DOI 10.1074/jbc.M111.255224; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rajan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029088; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sirotkin H, 1997, GENOMICS, V41, P75, DOI 10.1006/geno.1997.4627; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Waibler Z, 2001, J CELL SCI, V114, P3873; Walter B, 2008, HISTOCHEM CELL BIOL, V130, P943, DOI 10.1007/s00418-008-0456-1; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2013, NAT STRUCT MOL BIOL, V20, P36, DOI 10.1038/nsmb.2459; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; Yang C, 2013, VIRCHOWS ARCH, V463, P379, DOI 10.1007/s00428-013-1452-y; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995	72	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12421	12434		10.1074/jbc.M113.530717	http://dx.doi.org/10.1074/jbc.M113.530717			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644279	Green Published, hybrid			2022-12-28	WOS:000335581400019
J	Rossi, A; Riccio, A; Coccia, M; Trotta, E; La Frazia, S; Santoro, MG				Rossi, Antonio; Riccio, Anna; Coccia, Marta; Trotta, Edoardo; La Frazia, Simone; Santoro, M. Gabriella			The Proteasome Inhibitor Bortezomib Is a Potent Inducer of Zinc Finger AN1-type Domain 2a Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Heat Shock Protein; Proteasome; Stress Response; Transcription Regulation	HEAT-SHOCK FACTOR-1; DNA-BINDING ACTIVITY; FACTOR-KAPPA-B; TRANSCRIPTION-FACTOR; ENDOTHELIAL-CELLS; FACTOR-I; POSTTRANSLATIONAL MODIFICATION; PROSTAGLANDIN A(1); MULTIPLE-MYELOMA; FACTOR FAMILY	Background: AIRAP is a recently identified heat shock protein whose function and regulation are still not well defined. Results: Proteasome inhibition causes abundant AIRAP expression in human primary cells. Conclusion: The anticancer drug bortezomib regulates AIRAP expression through HSF1-HSF2 interplay. Significance: This study reveals how persistent proteasomal inhibition by clinically relevant concentrations of bortezomib affects heat shock response regulation and HSF-mediated AIRAP induction. The zinc finger AN1-type domain 2a gene, also known as arsenite-inducible RNA-associated protein (AIRAP), was recently identified as a novel human canonical heat shock gene strictly controlled by heat shock factor (HSF) 1. Little is known about AIRAP gene regulation in human cells. Here we report that bortezomib, a proteasome inhibitor with anticancer and antiangiogenic properties used in the clinic for treatment of multiple myeloma, is a potent inducer of AIRAP expression in human cells. Using endothelial cells as a model, we unraveled the molecular mechanism regulating AIRAP expression during proteasome inhibition. Bortezomib induces AIRAP expression at the transcriptional level early after treatment, concomitantly with polyubiquitinated protein accumulation and HSF activation. AIRAP protein is detected at high levels for at least 48 h after bortezomib exposure, together with the accumulation of HSF2, a factor implicated in differentiation and development regulation. Different from heat-mediated induction, in bortezomib-treated cells, HSF1 and HSF2 interact directly, forming HSF1-HSF2 heterotrimeric complexes recruited to a specific heat shock element in the AIRAP promoter. Interestingly, whereas HSF1 has been confirmed to be critical for AIRAP gene transcription, HSF2 was found to negatively regulate AIRAP expression after bortezomib treatment, further emphasizing an important modulatory role of this transcription factor under stress conditions. AIRAP function is still not defined. However, the fact that AIRAP is expressed abundantly in primary human cells at bortezomib concentrations comparable with plasma levels in treated patients suggests that AIRAP may participate in the regulatory network controlling proteotoxic stress during bortezomib treatment.	[Rossi, Antonio; Riccio, Anna; Coccia, Marta; Trotta, Edoardo; Santoro, M. Gabriella] CNR, Inst Translat Pharmacol, I-00133 Rome, Italy; [Riccio, Anna; Coccia, Marta; La Frazia, Simone; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020; Riccio, Anna/HHC-2105-2022	Trotta, Edoardo/0000-0002-1417-9238; Riccio, Anna/0000-0002-1140-1366; La Frazia, Simone/0000-0002-6987-5409; ROSSI, ANTONIO/0000-0003-0383-3828; Santoro, Maria Gabriella/0000-0003-1432-4949	Italian Ministry of University and Scientific Research PRIN project [N 2010PHT9NF-006]	Italian Ministry of University and Scientific Research PRIN project	This work was supported by Italian Ministry of University and Scientific Research PRIN project Grant N 2010PHT9NF-006.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Dy GK, 2005, CLIN CANCER RES, V11, P3410, DOI 10.1158/1078-0432.CCR-04-2068; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Eriksson M, 2000, INT J DEV BIOL, V44, P471; Ferrarini M, 2011, CURR MED CHEM, V18, P5185, DOI 10.2174/092986711798184316; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lecomte S, 2010, ONCOGENE, V29, P4216, DOI 10.1038/onc.2010.171; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pirkkala L, 1999, FASEB J, V13, P1089, DOI 10.1096/fasebj.13.9.1089; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Rossi A, 1998, J BIOL CHEM, V273, P16446, DOI 10.1074/jbc.273.26.16446; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Rossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031304; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schwartz Rowena, 2004, Oncology (Williston Park), V18, P14; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Turturici G, 2009, BIOCHEM J, V421, P193, DOI 10.1042/BJ20082309; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	58	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12705	12715		10.1074/jbc.M113.513242	http://dx.doi.org/10.1074/jbc.M113.513242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619424	hybrid, Green Published			2022-12-28	WOS:000335581400042
J	Cai, BS; Xie, SW; Liu, FM; Simone, LC; Caplan, S; Qin, XB; Naslavsky, N				Cai, Bishuang; Xie, Shuwei; Liu, Fengming; Simone, Laura C.; Caplan, Steve; Qin, Xuebin; Naslavsky, Naava			Rapid Degradation of the Complement Regulator, CD59, by a Novel Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement; Endocytosis; Endosomes; Glycosyl Phosphatidylinositol Anchors; Intracellular Trafficking; Lysosomes; Shedding; CD59; Bacterial Toxin; Degradation	GPI-ANCHORED PROTEIN; ENDOCYTIC PATHWAY; PROTECTIN CD59; LYMPHOMA-CELLS; CANCER-CELLS; MEMBRANE; RITUXIMAB; CYTOTOXICITY; EXPRESSION; ENDOSOMES	Background: Surface expression of complement inhibitors, such as the glycosylphosphatidylinositol-anchored protein CD59, prevent complement-dependent lysis of cancer cells. Results: The non-toxic domain-4 of the bacterial toxin intermedilysin (rILYd4) blocks CD59 complement inhibitory activity. Conclusion: rILYd4 induces CD59 internalization and rapid degradation in lysosomes in non-small lung carcinoma cells. Significance: CD59 serves as a model for glycosylphosphatidylinositol-anchored protein trafficking and rILYd4 shows potential for immunotherapy. There is increased interest in immune-based monoclonal antibody therapies for different malignancies because of their potential specificity and limited toxicity. The activity of some therapeutic monoclonal antibodies is partially dependent on complement-dependent cytolysis (CDC), in which the immune system surveys for invading pathogens, infected cells, and malignant cells and facilitates their destruction. CD59 is a ubiquitously expressed cell-surface glycosylphosphatidylinositol-anchored protein that protects cells from CDC. However, in certain tumors, CD59 expression is enhanced, posing a significant obstacle for treatment, by hindering effective monoclonal antibody-induced CDC. In this study, we used non-small lung carcinoma cells to characterize the mechanism of a novel CD59 inhibitor: the 114-amino acid recombinant form of the 4th domain of intermedilysin (rILYd4), a pore forming toxin secreted by Streptococcus intermedius. We compared the rates of internalization of CD59 in the presence of rILYd4 or anti-CD59 antibodies and determined that rILYd4 induces more rapid CD59 uptake at early time points. Most significantly, upon binding to rILYd4, CD59 is internalized and undergoes massive degradation in lysosomes within minutes. The remaining rILYd4CD59 complexes recycle to the PM and are shed from the cell. In comparison, upon internalization of CD59 via anti-CD59 antibody binding, the antibodyCD59 complex is recycled via early and recycling endosomes, mostly avoiding degradation. Our study supports a novel role for rILYd4 in promoting internalization and rapid degradation of the complement inhibitor CD59, and highlights the potential for improving CDC-based immunotherapy.	[Cai, Bishuang; Xie, Shuwei; Simone, Laura C.; Caplan, Steve; Naslavsky, Naava] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cai, Bishuang; Xie, Shuwei; Simone, Laura C.; Caplan, Steve; Naslavsky, Naava] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Liu, Fengming; Qin, Xuebin] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA; [Liu, Fengming; Qin, Xuebin] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19140 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	scaplan@unmc.edu; xuebin.qin@temple.edu; nnaslavsky@unmc.edu	Cai, Bishuang/AAE-4334-2020; Cai, Bishuang/ABG-4817-2020; Xie, Shuwei/ABA-4923-2021		National Institutes of Health [NIHR21CA141324, 1R01CA166144, R01GM087455, R01GM074876]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [5P20GM103489-10]; Nebraska Department of Health; NATIONAL CANCER INSTITUTE [R01CA166144, R21CA141324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, P20GM103489, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Nebraska Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIHR21CA141324 and 1R01CA166144 (to X. B. Q.), R01GM087455, R01GM074876, by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant 5P20GM103489-10 (to S. C. and N. N.), and a grant from the Nebraska Department of Health (to N. N.).	Ajona D, 2007, J IMMUNOL, V178, P5991, DOI 10.4049/jimmunol.178.9.5991; Bjorge L, 1997, INT J CANCER, V70, P14, DOI 10.1002/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO;2-9; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown Deborah A., 2007, V398, P9, DOI 10.1007/978-1-59745-513-8_2; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Cai BS, 2011, TRAFFIC, V12, P102, DOI 10.1111/j.1600-0854.2010.01135.x; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Cohen D, 2001, TRAFFIC, V2, P556, DOI 10.1034/j.1600-0854.2001.20805.x; Coral S, 2000, J CELL PHYSIOL, V185, P317, DOI 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fonsatti E, 2000, Clin Ter, V151, P187; Ge XW, 2011, CLIN CANCER RES, V17, P6702, DOI 10.1158/1078-0432.CCR-11-0647; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Golay J, 2000, BLOOD, V95, P3900; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Hayashi H, 2012, AM J PHYSIOL-CELL PH, V302, pC781, DOI 10.1152/ajpcell.00165.2011; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Hu WG, 2010, J IMMUNOL, V184, P359, DOI 10.4049/jimmunol.0902278; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Juhl H, 1997, J SURG ONCOL, V64, P222, DOI 10.1002/(SICI)1096-9098(199703)64:3<222::AID-JSO9>3.0.CO;2-C; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; MERI S, 1990, IMMUNOLOGY, V71, P1; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Veen HA, 2004, EUR J BIOCHEM, V271, P678, DOI 10.1111/j.1432-1033.2003.03965.x; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wickham SE, 2011, J BIOL CHEM, V286, P20952, DOI 10.1074/jbc.M111.237446; Wu L, 2012, CURR PHARM DESIGN, V18, P4187, DOI 10.2174/138161212802430486; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; Yan J, 2008, ADV EXP MED BIOL, V632, P159, DOI 10.1007/978-0-387-78952-1_12; You T, 2011, CELL MOL IMMUNOL, V8, P157, DOI 10.1038/cmi.2010.35; ZALMAN LS, 1987, J EXP MED, V166, P947, DOI 10.1084/jem.166.4.947; Zhao WP, 2009, ONCOL REP, V21, P1405, DOI 10.3892/or_00000368; Zhou XH, 2008, ONCOLOGIST, V13, P954, DOI 10.1634/theoncologist.2008-0089; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	47	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12109	12125		10.1074/jbc.M113.547083	http://dx.doi.org/10.1074/jbc.M113.547083			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616098	Green Published, hybrid			2022-12-28	WOS:000335010600048
J	Saino, H; Shimizu, T; Hiratake, J; Nakatsu, T; Kato, H; Sakata, K; Mizutani, M				Saino, Hiromichi; Shimizu, Tetsuya; Hiratake, Jun; Nakatsu, Toru; Kato, Hiroaki; Sakata, Kanzo; Mizutani, Masaharu			Crystal Structures of beta-Primeverosidase in Complex with Disaccharide Amidine Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE AGLYCONE SPECIFICITY; OOLONG TEA; FURCATIN HYDROLASE; PLANT VOLATILES; AROMA FORMATION; KEY ENZYME; GLUCOSIDASE; GLYCOSIDASE; EXPRESSION; GLYCOSYLAMIDINES	beta-Primeverosidase (PD) is a disaccharide-specific beta-glycosidase in tea leaves. This enzyme is involved in aroma formation during the manufacturing process of oolong tea and black tea. PD hydrolyzes beta-primeveroside (6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside) at the beta-glycosidic bond of primeverose to aglycone, and releases aromatic alcoholic volatiles of aglycones. PD only accepts primeverose as the glycone substrate, but broadly accepts various aglycones, including 2-phenylethanol, benzyl alcohol, linalool, and geraniol. We determined the crystal structure of PD complexes using highly specific disaccharide amidine inhibitors, N-beta-primeverosylamidines, and revealed the architecture of the active site responsible for substrate specificity. We identified three subsites in the active site: subsite -2 specific for 6-O-beta-Dxylopyranosyl, subsite -1 well conserved among beta-glucosidases and specific for beta-D-glucopyranosyl, and wide subsite +1 for hydrophobic aglycone. Glu-470, Ser-473, and Gln-477 act as the specific hydrogen bond donors for 6-O-beta-D-xylopyranosyl in subsite -2. On the other hand, subsite +1 was a large hydrophobic cavity that accommodates various aromatic aglycones. Compared with aglycone-specific beta-glucosidases of the glycoside hydrolase family 1, PD lacks the Trp crucial for aglycone recognition, and the resultant large cavity accepts aglycone and 6-O-beta-D-xylopyranosyl together. PD recognizes the beta-primeverosides in subsites -1 and -2 by hydrogen bonds, whereas the large subsite +1 loosely accommodates various aglycones. The glycone-specific activity of PD for broad aglycone substrates results in selective and multiple release of temporally stored alcoholic volatile aglycones of beta-primeveroside.	[Saino, Hiromichi] Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa 2525258, Japan; [Shimizu, Tetsuya] Okayama Univ, Fac Sci, Okayama 7008530, Japan; [Hiratake, Jun; Sakata, Kanzo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Nakatsu, Toru; Kato, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan	Aoyama Gakuin University; Okayama University; Kyoto University; Kyoto University; Kobe University	Saino, H (corresponding author), Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa 2525258, Japan.	saino@chem.aoyama.ac.jp		Nakatsu, Toru/0000-0002-9582-4023; Kato, Hiroaki/0000-0002-5993-4532; Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Education, Culture, Sports, Science, and Technology of Japan [13460049, 16380079]; MEXT (Ministry of Education, Culture, Sports, Science and Technology)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aids 13460049 and 16380079 and the MEXT (Ministry of Education, Culture, Sports, Science and Technology)-supported Program for the Strategic Research Foundation at Private Universities (2013-2017).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn YO, 2004, J BIOL CHEM, V279, P23405, DOI 10.1074/jbc.M311379200; Ahn YO, 2007, PLANT CELL PHYSIOL, V48, P938, DOI 10.1093/pcp/pcm065; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; BERRAH G, 1962, J BACTERIOL, V83, P738, DOI 10.1128/JB.83.4.738-744.1962; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708; Chuankhayan P, 2007, ARCH BIOCHEM BIOPHYS, V468, P205, DOI 10.1016/j.abb.2007.09.015; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Daiyasu H, 2008, J BIOCHEM, V144, P467, DOI 10.1093/jb/mvn095; DeLano W. L., 2002, CCP4 NEWSLETT PROTEI, V40, P44; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Griffin SG, 1999, FLAVOUR FRAG J, V14, P322, DOI [10.1002/(SICI)1099-1026(199909/10)14:5<322::AID-FFJ837>3.3.CO;2-W, 10.1002/(SICI)1099-1026(199909/10)14:5&lt;322::AID-FFJ837&gt;3.0.CO;2-4]; GUO WF, 1995, BIOSCI BIOTECH BIOCH, V59, P962, DOI 10.1271/bbb.59.962; GUO WF, 1993, PHYTOCHEMISTRY, V33, P1373, DOI 10.1016/0031-9422(93)85093-7; GUO WF, 1994, BIOSCI BIOTECH BIOCH, V58, P1532, DOI 10.1271/bbb.58.1532; Guo WF, 2001, BIOORG MED CHEM LETT, V11, P467, DOI 10.1016/S0960-894X(00)00706-X; Hancock SM, 2005, CHEMBIOCHEM, V6, P866, DOI 10.1002/cbic.200400341; Himeno N, 2013, BIOSCI BIOTECH BIOCH, V77, P934, DOI 10.1271/bbb.120889; Hiratake J, 2003, METHOD ENZYMOL, V363, P421; Hua YL, 2013, ARCH BIOCHEM BIOPHYS, V537, P39, DOI 10.1016/j.abb.2013.06.005; Inoue K, 2003, CARBOHYD RES, V338, P1477, DOI 10.1016/S0008-6215(03)00201-5; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; KIM JM, 1995, J AGR FOOD CHEM, V43, P2839, DOI 10.1021/jf00059a013; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma SJ, 2001, BIOSCI BIOTECH BIOCH, V65, P2719, DOI 10.1271/bbb.65.2719; Meyer BK, 2007, J PHARM SCI-US, V96, P3155, DOI 10.1002/jps.20976; Mizutani M, 2002, PLANT PHYSIOL, V130, P2164, DOI 10.1104/pp.102.011023; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Saino H, 2008, BIOSCI BIOTECH BIOCH, V72, P376, DOI 10.1271/bbb.70447; Sakata K, 2003, METHOD ENZYMOL, V363, P444; Sue M, 2011, PLANT SCI, V180, P268, DOI 10.1016/j.plantsci.2010.09.001; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; Utama IMS, 2002, J AGR FOOD CHEM, V50, P6371, DOI 10.1021/jf020484d; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia LQ, 2012, ACS CHEM BIOL, V7, P226, DOI 10.1021/cb200267w; Zhu YJ, 2011, FOOD CHEM, V124, P298, DOI 10.1016/j.foodchem.2010.06.036	47	14	15	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16826	16834		10.1074/jbc.M114.553271	http://dx.doi.org/10.1074/jbc.M114.553271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753293	Green Published, hybrid			2022-12-28	WOS:000338016200020
J	Hresko, RC; Kraft, TE; Tzekov, A; Wildman, SA; Hruz, PW				Hresko, Richard C.; Kraft, Thomas E.; Tzekov, Anatoly; Wildman, Scott A.; Hruz, Paul W.			Isoform-selective Inhibition of Facilitative Glucose Transporters ELUCIDATION OF THE MOLECULAR MECHANISM OF HIV PROTEASE INHIBITOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; INSULIN-RESISTANCE; SCANNING-MUTAGENESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; CYTOCHALASIN-B; GLUT1; SURFACE; CELLS	Pharmacologic HIV protease inhibitors (PIs) and structurally related oligopeptides are known to reversibly bind and inactivate the insulin-responsive facilitative glucose transporter 4 (GLUT4). Several PIs exhibit isoform selectivity with little effect on GLUT1. The ability to target individual GLUT isoforms in an acute and reversible manner provides novel means both to investigate the contribution of individual GLUTs to health and disease and to develop targeted treatment of glucose-dependent diseases. To determine the molecular basis of transport inhibition, a series of chimeric proteins containing transmembrane and cytosolic domains from GLUT1 and GLUT4 and/or point mutations were generated and expressed in HEK293 cells. Structural integrity was confirmed via measurement of N-[2-[2[ 2-[(N-biotinylcaproylamino) ethoxy) ethoxyl]-4-[2-(trifluoromethyl)- 3H-diazirin-3-yl] benzoyl]-1,3-bis(mannopyranosyl- 4-yloxy)-2-propylamine (ATB-BMPA) labeling of the chimeric proteins in low density microsome fractions isolated from stably transfected 293 cells. Functional integrity was assessed via measurement of zero-trans 2-deoxyglucose (2-DOG) uptake. ATB-BMPA labeling studies and 2-DOG uptake revealed that transmembrane helices 1 and 5 contain amino acid residues that influence inhibitor access to the transporter binding domain. Substitution of Thr-30 and His-160 in GLUT1 to the corresponding positions in GLUT4 is sufficient to completely transform GLUT1 into GLUT4 with respect to indinavir inhibition of 2-DOG uptake and ATB-BMPA binding. These data provide a structural basis for the selectivity of PIs toward GLUT4 over GLUT1 that can be used in ongoing novel drug design.	[Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wildman, Scott A.] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hruz, PW (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Kraft, Thomas/0000-0002-5528-3197; Wildman, Scott/0000-0002-8598-0751; Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064572 and HL092798.	Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Haspel HC, 1999, J MEMBRANE BIOL, V169, P45, DOI 10.1007/PL00005900; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Hresko RC, 2011, DIABETES, V60, pA409; Hresko RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025237; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Hruz PW, 2011, ANTIMICROB AGENTS CH, V55, P1377, DOI 10.1128/AAC.01184-10; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; Koumanov F, 1998, BIOCHEM J, V330, P1209, DOI 10.1042/bj3301209; Lachaal M, 1996, J BIOL CHEM, V271, P5225; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Michau A, 2013, J BIOL CHEM, V288, P31080, DOI 10.1074/jbc.M113.469189; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Noel LE, 1997, BIOCHEMISTRY-US, V36, P5465, DOI 10.1021/bi9630624; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; TAMORI Y, 1994, J BIOL CHEM, V269, P2982; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	43	13	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16100	16113		10.1074/jbc.M113.528430	http://dx.doi.org/10.1074/jbc.M113.528430			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24706759	hybrid, Green Published			2022-12-28	WOS:000337965700018
J	Nonaka, M; Fukuda, MN; Gao, C; Li, Z; Zhang, HT; Greene, MI; Peehl, DM; Ten, FZ; Fukuda, M				Nonaka, Motohiro; Fukuda, Michiko N.; Gao, Chao; Li, Zhen; Zhang, Hongtao; Greene, Mark I.; Peehl, Donna M.; Ten Feizi; Fukuda, Minoru			Determination of Carbohydrate Structure Recognized by Prostate-specific F77 Monoclonal Antibody through Expression Analysis of Glycosyltransferase Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE GENE; O-GLYCANS; CORE 2; CANCER; GLYCOSYLATION; CARCINOMA; HYPOXIA; CELLS; RITUXIMAB; LYMPHOMA	This study reports the determination of the carbohydrate epitope of monoclonal antibody F77 previously raised against human prostate cancer PC-3 cells (Zhang, G., Zhang, H., Wang, Q., Lal, P., Carroll, A. M., de la Llera-Moya, M., Xu, X., and Greene, M. I. (2010) Proc. Natl. Acad. Sci. U. S. A. 107, 732-737). We performed a series of co-transfections using mammalian expression vectors encoding specific glycosyltransferases. We thereby identified branching enzymes and FUT1 (required for Fuc alpha 1 -> 2Gal linkage) as being essential for F77 antigen formation. When immortalized normal prostate 267B1 cells were transfected with FUT1 alone, cells showed weak expression of F77 antigen. By contrast, cells co-transfected with FUT1 plus either GCNT1, GCNT2, or GCNT3(an enzyme required to form GlcNAc beta -> 6Gal/GalNAc) showed robust F77 antigen expression, suggesting that F77 specifically binds to Fuc alpha 1 -> 2-Gal beta -> GlcNAc beta 1 -> 6Gal/GalNAc. RT-PCR for FUT1, GCNT1, GCNT2, and GCNT3 showed that F77-positive cell lines indeed express transcripts encoding FUT1 plus one GCNT. F77-positive prostate cancer cells transfected with siRNAs targeting FUT1, GCNT2, and GCNT3 showed significantly reduced F77 antigen, confirming the requirement of these enzymes for epitope synthesis. We also found that hypoxia induces F77 epitope expression in immortalized prostate RWPE1 cells, which express F77 antigen moderately under normoxia but at an elevated level under hypoxia. Quantitative RT-PCR demonstrated up-regulation of FUT1, GCNT2, and GCNT3 transcripts in RWPE1 cells under hypoxia, suggesting that hypoxia up-regulates glycosyltransferase expression required for F77 antigen synthesis. These results define the F77 epitope and provide a potential mechanism for F77 antigen synthesis in malignant prostate cancer.	[Nonaka, Motohiro; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, La Jolla, CA 92037 USA; [Zhang, Hongtao; Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Peehl, Donna M.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Gao, Chao; Li, Zhen; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England	Sanford Burnham Prebys Medical Discovery Institute; University of Pennsylvania; Stanford University; Imperial College London	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org		Li, Zhen/0000-0002-8853-4941; Feizi, Ten/0000-0001-6495-0329; Gao, Chao/0000-0003-3489-3989; Zhang, Hongtao/0000-0001-9173-0049	National Institutes of Health [GM62116, GM098791]; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520, P01CA071932, U01CA168925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791, U54GM062116] Funding Source: NIH RePORTER; EPSRC [EP/G037604/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Dr. Elise Lamar for editing the manuscript. Synthetic oligosaccharides were provided as core D by the Consortium for Functional Glycomics supported by National Institutes of Health Grants GM62116 and GM098791.	ABE K, 1983, J BIOL CHEM, V258, P1793; Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; Bakovic MP, 2013, J PROTEOME RES, V12, P821, DOI 10.1021/pr300887z; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Carrington SD, 2012, METHODS MOL BIOL, V842, P191, DOI 10.1007/978-1-61779-513-8_11; CARROLL AM, 1984, CLIN IMMUNOL IMMUNOP, V33, P268, DOI 10.1016/0090-1229(84)90081-3; Feizi T, 2000, GLYCOCONJUGATE J, V17, P553, DOI 10.1023/A:1011022509500; Feizi T, 2013, ANN NY ACAD SCI, V1292, P33, DOI 10.1111/nyas.12210; Gao C, 2014, J BIOL CHEM, V289, P16462, DOI 10.1074/jbc.M114.558932; Gornik O, 2012, BBA-GEN SUBJECTS, V1820, P1318, DOI 10.1016/j.bbagen.2011.12.004; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HELLSTROM I, 1990, CANCER RES, V50, P2183; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Huang XM, 2004, PROSTATE, V61, P1, DOI 10.1002/pros.20074; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lauc G, 2010, MOL BIOSYST, V6, P329, DOI 10.1039/b910377e; Liu L, 2013, GLYCOCONJUGATE J, V30, P791, DOI 10.1007/s10719-013-9483-9; Maeda T, 2001, INT J HEMATOL, V74, P70, DOI 10.1007/BF02982552; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; Nakamori S, 1997, J CLIN ONCOL, V15, P816, DOI 10.1200/JCO.1997.15.2.816; Nozawa S, 2004, CLIN CANCER RES, V10, P7071, DOI 10.1158/1078-0432.CCR-04-0802; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shimodaira K, 1997, CANCER RES, V57, P5201; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; Talwar GP, 2001, PROSTATE, V46, P207; Tobinai K, 2001, CANCER CHEMOTH PHARM, V48, pS85, DOI 10.1007/s002800100313; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zhang G, 2010, P NATL ACAD SCI USA, V107, P732, DOI 10.1073/pnas.0911397107; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414; Zitzmann N, 2005, ADV EXP MED BIOL, V564, P1; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	43	23	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16478	16486		10.1074/jbc.M114.559047	http://dx.doi.org/10.1074/jbc.M114.559047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753248	Green Published, hybrid			2022-12-28	WOS:000337965700049
J	Poluzzi, C; Casulli, J; Goyal, A; Mercer, TJ; Neill, T; Iozzo, RV				Poluzzi, Chiara; Casulli, Joshua; Goyal, Atul; Mercer, Thomas J.; Neill, Thomas; Iozzo, Renato V.			Endorepellin Evokes Autophagy in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FIBROBLAST-GROWTH-FACTOR; PERLECAN PROTEIN CORE; BASEMENT-MEMBRANE PROTEOGLYCANS; DENSITY-LIPOPROTEIN-RECEPTOR; COLON CARCINOMA-CELLS; IMPRINTED GENE; CANCER GROWTH; TUMOR-GROWTH; ALPHA(2)BETA(1) INTEGRINS	Endorepellin, the C-terminal fragment of the heparan sulfate proteoglycan perlecan, possesses angiostatic activity via dual receptor antagonism, through concurrent binding to the alpha 2 beta 1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2). Here, we discovered that soluble endorepellin induced autophagy in endothelial cells by modulating the expression of Beclin 1, LC3, and p62, three established autophagic markers. Moreover, endorepellin evoked expression of the imprinted tumor suppressor gene Peg3 and its co-localization with Beclin 1 and LC3 in autophagosomes, suggesting a major role for this gene in endothelial cell autophagy. Mechanistically, endorepellin induced autophagy by down-regulating VEGFR2 via the two LG1/2 domains, whereas the C-terminal LG3 domain, the portion responsible for binding the alpha 2 beta 1 integrin, was ineffective. Endorepellin also induced transcriptional activity of the BECN1 promoter in endothelial cells, and the VEGFR2-specific tyrosine kinase inhibitor, SU5416, blocked this effect. Finally, we found a correlation between endorepellin-evoked inhibition of capillary morphogenesis and enhanced autophagy. Thus, we have identified a new role for this endogenous angiostatic fragment in inducing autophagy through a VEGFR2-dependent but alpha 2 beta 1 integrin-independent pathway. This novel mechanism specifically targets endothelial cells and could represent a promising new strategy to potentiate the angiostatic effect of endorepellin and perhaps other angiostatic matrix proteins.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Poluzzi, Chiara/T-3376-2019	Iozzo, Renato/0000-0002-5908-5112; Casulli, Joshua/0000-0002-3733-7614	National Institutes of Health [RO1 CA3948, RO1 CA47282, RO1 CA164462, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, P30CA056036, R01CA039481, R01CA164462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA3948, RO1 CA47282, and RO1 CA164462 (to R. V. I.).; Supported by National Institutes of Health Training Grant T32 AA07463.	Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Gonzalez-Iriarte M, 2003, J MOL CELL CARDIOL, V35, P795, DOI 10.1016/S0022-2828(03)00134-2; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gustafsson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053715; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Howell A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2435; Ida-Yonemochi H, 2011, MATRIX BIOL, V30, P379, DOI 10.1016/j.matbio.2011.08.001; Inomata T, 2012, INVEST OPHTH VIS SCI, V53, P1277, DOI 10.1167/iovs.11-8742; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; IOZZO RV, 1988, CANCER METAST REV, V7, P39, DOI 10.1007/BF00048277; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; Ishijima M, 2012, MATRIX BIOL, V31, P234, DOI 10.1016/j.matbio.2012.02.006; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Mathiak M, 1997, CANCER RES, V57, P2130; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Murphy-Ullrich JE, 2012, MATRIX BIOL, V31, P152, DOI 10.1016/j.matbio.2012.01.002; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Sanderson RD, 2012, MATRIX BIOL, V31, P283, DOI 10.1016/j.matbio.2012.05.001; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Thadikkaran L, 2005, CLIN CHIM ACTA, V360, P27, DOI 10.1016/j.cccn.2005.04.018; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Willis CD, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P171; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilusz RE, 2012, MATRIX BIOL, V31, P320, DOI 10.1016/j.matbio.2012.05.002; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	101	65	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16114	16128		10.1074/jbc.M114.556530	http://dx.doi.org/10.1074/jbc.M114.556530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737315	Green Published, hybrid			2022-12-28	WOS:000337965700019
J	Sugiyama, K; Iyori, M; Sawaguchi, A; Akashi, S; Tame, JRH; Park, SY; Yoshida, S				Sugiyama, Kanako; Iyori, Mitsuhiro; Sawaguchi, Asuka; Akashi, Satoko; Tame, Jeremy R. H.; Park, Sam-Yong; Yoshida, Shigeto			The Crystal Structure of the Active Domain of Anopheles Anti-platelet Protein, a Powerful Anti-coagulant, in Complex with an Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APTAMER ARC1779; PLATELET-AGGREGATION; THROMBUS FORMATION; COLLAGEN; MOSQUITO; AEGYPTIN; EFFICACY; SAFETY; SALIVA	Blood clotting is a vitally important process that must be carefully regulated to prevent blood loss on one hand and thrombosis on the other. Severe injury and hemophilia may be treated with pro-coagulants, whereas risk of obstructive clotting or embolism may be reduced with anti-coagulants. Anti-coagulants are an extremely important class of drug, one of the most widely used types of medication, but there remains a pressing need for novel treatments, however, as present drugs such as warfarin have significant drawbacks. Nature provides a number of examples of anti-coagulant proteins produced by blood-sucking animals, which may provide templates for the development of new small molecules with similar physiological effects. We have, therefore, studied an Anopheles anti-platelet protein from a malaria vector mosquito and report its crystal structure in complex with an antibody. Overall the protein is extremely sensitive to proteolysis, but the crystal structure reveals a stable domain built from two helices and a turn, which corresponds to the functional region. The antibody raised against Anopheles anti-platelet protein prevents it from binding collagen. Our work, therefore, opens new avenues to the development of both novel small molecule anti-clotting agents and anti-malarials.	[Sugiyama, Kanako; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, Yokohama, Kanagawa 2300045, Japan; [Iyori, Mitsuhiro; Sawaguchi, Asuka; Yoshida, Shigeto] Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kanazawa, Ishikawa 9201192, Japan; [Akashi, Satoko] Yokohama City Univ, Grad Sch Med Life Sci, Struct Epigenet Lab, Yokohama, Kanagawa 2300045, Japan	Yokohama City University; Kanazawa University; Yokohama City University	Park, SY (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	park@tsurumi.yokohama-cu.ac.jp; shigeto@p.kanazawa-u.ac.jp	IYORI, MITSUHIRO/D-8395-2015	IYORI, MITSUHIRO/0000-0001-9940-7342; Akashi, Satoko/0000-0002-8978-6358	Japan Society for the Promotion of Science [25305007]; Grants-in-Aid for Scientific Research [24659460] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 25305007 from the Japan Society for the Promotion of Science (to S.Y.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2010, FEBS J, V277, P413, DOI 10.1111/j.1742-4658.2009.07494.x; CARTER PB, 1986, VET CLIN N AM-SMALL, V16, P1171, DOI 10.1016/S0195-5616(86)50135-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; FUSTER V, 1992, NEW ENGL J MED, V326, P310; GARDELL SJ, 1989, J BIOL CHEM, V264, P17947; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Hayashi H, 2013, PLATELETS, V24, P324, DOI 10.3109/09537104.2012.698430; Hayashi H, 2012, THROMB RES, V129, P169, DOI 10.1016/j.thromres.2011.09.015; Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9; Knobl P, 2009, TRANSFUSION, V49, P2181, DOI 10.1111/j.1537-2995.2009.02232.x; Kuruvilla M, 2001, Proc (Bayl Univ Med Cent), V14, P305; Mayr FB, 2010, TRANSFUSION, V50, P1079, DOI 10.1111/j.1537-2995.2009.02554.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mizurini DM, 2013, BIOCHEM BIOPH RES CO, V436, P235, DOI 10.1016/j.bbrc.2013.05.082; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paciaroni M, 2009, EXPERT OPIN BIOL TH, V9, P773, DOI 10.1517/14712590902991497; Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com; Reininger AJ, 2008, THROMB RES, V122, pS9, DOI 10.1016/S0049-3848(08)70028-8; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Uysal H, 2008, MOL IMMUNOL, V45, P2196, DOI 10.1016/j.molimm.2007.12.005; Van de Werf F, 2010, CIRCULATION, V121, P5, DOI 10.1161/CIR.0b013e3181cd3d17; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warkentin TE, 2008, THROMB HAEMOSTASIS, V99, P830, DOI 10.1160/TH07-10-0644; Yamamoto DS, 2010, INSECT MOL BIOL, V19, P391, DOI 10.1111/j.1365-2583.2010.01000.x; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	34	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16303	16312		10.1074/jbc.M114.564526	http://dx.doi.org/10.1074/jbc.M114.564526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24764297	hybrid, Green Published			2022-12-28	WOS:000337965700034
J	Barrios-Garcia, T; Tecalco-Cruz, A; Gomez-Romero, V; Reyes-Carmona, S; Meneses-Morales, I; Leon-Del-Rio, A				Barrios-Garcia, Tonatiuh; Tecalco-Cruz, Angeles; Gomez-Romero, Vania; Reyes-Carmona, Sandra; Meneses-Morales, Ivan; Leon-Del-Rio, Alfonso			Tristetraprolin Represses Estrogen Receptor alpha Transactivation in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Corepressor Transcription; Estrogen Receptor; Gene Regulation; Hormone Receptors; Nuclear Receptors; Tristetraprolin	LIGAND-INDEPENDENT ACTIVATION; HISTONE DEACETYLASES; PROTEIN TRISTETRAPROLIN; MOLECULAR DETERMINANTS; COREPRESSOR COMPLEX; STEROID-HORMONE; N-COR; NUCLEAR; BINDING; RECRUITMENT	Estrogen receptor (ER) mediates the effects of 17-estradiol (E2) in normal mammary gland, and it is a key participant in breast cancer tumor development. ER transactivation activity is mediated by the synergistic interaction of two domains designated AF1 and AF2. The function of AF2 is to recruit coactivator and corepressor proteins that allow ER to oscillate between the roles of transcriptional activator and repressor. In contrast, the mechanism responsible for AF-1 transcriptional activity is not completely understood. In this study, we identified tristetraproline (TTP) as a novel ER-associated protein. TTP expression in MCF7 cells repressed ER transactivation and reduced MCF7 cell proliferation and the ability of the cells to form tumors in a mouse model. We show that TTP transcriptional activity is mediated through its recruitment to the promoter region of ER target genes and its interaction with histone deacetylases, in particular with HDAC1. TTP expression attenuates the coactivating activity of SRC-1, suggesting that exchange between TTP and other coactivators may play an important role in fine-tuning ER transactivation. These results indicate that TTP acts as a bona fide ER corepressor and suggest that this protein may be a contributing factor in the development of E2-dependent tumors in breast cancer.	[Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Leon-Del-Rio, A (corresponding author), Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	leon@biomedicas.unam.mx	Tecalco-Cruz, Angeles C./ABA-7761-2020; Meneses-Morales, Ivan/F-6765-2018; TECALCO-CRUZ, ANGELES C./K-1983-2019; Leon-Del-Rio, Alfonso/L-5932-2019	Meneses-Morales, Ivan/0000-0002-3146-1374; TECALCO-CRUZ, ANGELES C./0000-0001-9199-3834; Reyes, Sandra/0000-0002-1015-5079; Leon-Del-Rio, Alfonso/0000-0001-7683-5109	Programa de Investigacion de Cancer de Mama; Instituto de Investigaciones Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia [SALUD-CONACYT 14467, 183069]; Fundacion Miguel Aleman (Estimulo a la Investigacion Medica) [2013-1]; Consejo Nacional de Ciencia y Tecnologia; DGAPA, Universidad Nacional Autonoma de Mexico	Programa de Investigacion de Cancer de Mama; Instituto de Investigaciones Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman (Estimulo a la Investigacion Medica); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Programa de Investigacion de Cancer de Mama, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and Consejo Nacional de Ciencia y Tecnologia (Grants SALUD-CONACYT 14467 and 183069), and Fundacion Miguel Aleman (Estimulo a la Investigacion Medica 2013-1).; Students of Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico and are recipients of a scholarship from Consejo Nacional de Ciencia y Tecnologia.; Recipient of a Posdoctoral Scholarship from DGAPA, Universidad Nacional Autonoma de Mexico.	Ahn BY, 2010, CANCER RES, V70, P3013, DOI 10.1158/0008-5472.CAN-09-3108; Al-Ahmadi W, 2013, J PATHOL, V230, P28, DOI 10.1002/path.4178; Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Gburcik Valentina, 2006, Nucl Recept Signal, V4, pe005; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Glass CK, 2000, GENE DEV, V14, P121; Green CD, 2007, MOL CANCER RES, V5, P1191, DOI 10.1158/1541-7786.MCR-07-0123; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Guenther MG, 2000, GENE DEV, V14, P1048; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; JORDAN VC, 1995, BREAST CANCER RES TR, V36, P267, DOI 10.1007/BF00713399; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; MA QF, 1991, ONCOGENE, V6, P1277; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Osborne CK, 2000, J CLIN ONCOL, V18, P3172, DOI 10.1200/JCO.2000.18.17.3172; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Upadhyay R, 2013, INT J CANCER, V132, pE128, DOI 10.1002/ijc.27789; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VARNUM BC, 1989, ONCOGENE, V4, P119; Vermeulen M, 2004, MOL CELL BIOL, V24, P2364, DOI 10.1128/MCB.24.6.2364-2372.2004; Goddio MV, 2012, BREAST CANCER RES TR, V135, P749, DOI 10.1007/s10549-012-2216-0; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Wu LY, 2003, J BIOL CHEM, V278, P15192, DOI 10.1074/jbc.M212332200; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	58	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15554	15565		10.1074/jbc.M114.548552	http://dx.doi.org/10.1074/jbc.M114.548552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737323	hybrid, Green Published			2022-12-28	WOS:000337465400038
J	Ghosh, A; Stasch, JP; Papapetropoulos, A; Stuehr, DJ				Ghosh, Arnab; Stasch, Johannes-Peter; Papapetropoulos, Andreas; Stuehr, Dennis J.			Nitric Oxide and Heat Shock Protein 90 Activate Soluble Guanylate Cyclase by Driving Rapid Change in Its Subunit Interactions and Heme Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Guanylate Cyclase (Guanylyl Cyclase); Heme; Hsp90; Nitric Oxide; Nitrosative Stress; Signal Transduction	THERAPEUTIC TARGET; S-NITROSYLATION; HSP90; RECEPTOR; OXIDATION; DESENSITIZATION; STABILIZATION; INSERTION; INSIGHTS; REVEALS	Background: Heme insertion into souble guanylate cyclase (sGC) enables it to bind nitric oxide (NO) for cell signaling. Results: NO triggered a rapid, reversible, and hsp90-dependent heme insertion into sGC-1 and an association with sGC-1 subunit. sGC activator BAY 60-2770 did the same. Conclusion: NO dynamically impacts the maturation and stability of active sGC heterodimer. Significance: The data uncover new mechanisms that regulate cellular NO signaling cascades. The chaperone heat shock protein 90 (hsp90) associates with signaling proteins in cells including soluble guanylate cyclase (sGC). hsp90 associates with the heme-free (apo) sGC-1 subunit and helps to drive heme insertion during maturation of sGC to its NO-responsive active form. Here, we found that NO caused apo-sGC-1 to rapidly and transiently dissociate from hsp90 and associate with sGC-1 in cells. This NO response (i) required that hsp90 be active and that cellular heme be available and be capable of inserting into apo-sGC-1; (ii) was associated with an increase in sGC-1 heme content; (iii) could be mimicked by the heme-independent sGC activator BAY 60-2770; and (iv) was followed by desensitization of sGC toward NO, sGC-1 disassociation, and reassociation with hsp90. Thus, NO promoted a rapid, transient, and hsp90-dependent heme insertion into the apo-sGC-1 subpopulation in cells, which enabled it to combine with the sGC-1 subunit to form the mature enzyme. The driving mechanism likely involves conformational changes near the heme site in sGC-1 that can be mimicked by the pharmacologic sGC activator. Such dynamic interplay between hsp90, apo-sGC-1, and sGC-1 in response to NO is unprecedented and represent new steps by which cells can modulate the heme content and activity of sGC for signaling cascades.	[Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Stasch, Johannes-Peter] Bayer Pharma AG, D-42096 Wuppertal, Germany; [Papapetropoulos, Andreas] Univ Patras, Dept Pharm, Patras 26504, Greece	Cleveland Clinic Foundation; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Patras	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol NC22, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Andreas, Papapetropoulos/AAJ-3089-2020	GHOSH, ARNAB/0000-0002-7498-1994; Papapetropoulos, Andreas/0000-0002-4253-5930	National Institutes of Health [GM51491, HL076491, GM 097041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM097041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, HL076491, and GM 097041 (to D. J. S.).	Becker E M, 2001, BMC Pharmacol, V1, P13, DOI 10.1186/1471-2210-1-13; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fernhoff NB, 2012, J BIOL CHEM, V287, P43053, DOI 10.1074/jbc.M112.393892; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Fritz BG, 2011, BIOCHEMISTRY-US, V50, P5813, DOI 10.1021/bi200794c; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hu XH, 2008, J AM CHEM SOC, V130, P15748, DOI 10.1021/ja804103y; Ibrahim M, 2010, BIOCHEMISTRY-US, V49, P4864, DOI 10.1021/bi100506j; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kots AY, 2011, CURR MED CHEM, V18, P3299, DOI 10.2174/092986711796504646; Kumar V, 2013, BIOCHEMISTRY-US, V52, P3601, DOI 10.1021/bi301657w; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lucas KA, 2000, PHARMACOL REV, V52, P375; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Miller TW, 2010, BRIT J PHARMACOL, V159, P1542, DOI 10.1111/j.1476-5381.2009.00631.x; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Pal B, 2010, BIOCHEM BIOPH RES CO, V397, P375, DOI 10.1016/j.bbrc.2010.05.122; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Sharina IG, 2011, NITRIC OXIDE-BIOL CH, V25, P265, DOI 10.1016/j.niox.2011.08.001; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Torregrossa AC, 2011, J GERIATR CARDIOL, V8, P230, DOI 10.3724/SP.J.1263.2011.00230; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539	41	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15259	15271		10.1074/jbc.M114.559393	http://dx.doi.org/10.1074/jbc.M114.559393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733395	Green Published, hybrid			2022-12-28	WOS:000337465400011
J	Nomura, Y; Izumi, A; Fukunaga, Y; Kusumi, K; Iba, K; Watanabe, S; Nakahira, Y; Weber, APM; Nozawa, A; Tozawa, Y				Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Kusumi, Kensuke; Iba, Koh; Watanabe, Seiya; Nakahira, Yoichi; Weber, Andreas P. M.; Nozawa, Akira; Tozawa, Yuzuru			Diversity in Guanosine 3 ',5 '-Bisdiphosphate (ppGpp) Sensitivity among Guanylate Kinases of Bacteria and Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chloroplast; Enzymes; Metabolism; Nucleoside Nucleotide Biosynthesis; Plant; Oryza Sativa; Guanylate Kinase; ppGpp; Stringent Response	5'-DIPHOSPHATE 3'-DIPHOSPHATE PPGPP; BACILLUS-SUBTILIS; ARABIDOPSIS-THALIANA; STRINGENT RESPONSE; ESCHERICHIA-COLI; RNA-POLYMERASE; AMP-DEAMINASE; LAND PLANTS; TRANSCRIPTION; CHLOROPLASTS	The guanosine 3,5-bisdiphosphate (ppGpp) signaling system is shared by bacteria and plant chloroplasts, but its role in plants has remained unclear. Here we show that guanylate kinase (GK), a key enzyme in guanine nucleotide biosynthesis that catalyzes the conversion of GMP to GDP, is a target of regulation by ppGpp in chloroplasts of rice, pea, and Arabidopsis. Plants have two distinct types of GK that are localized to organelles (GKpm) or to the cytosol (GKc), with both enzymes being essential for growth and development. We found that the activity of rice GKpm in vitro was inhibited by ppGpp with a K-i of 2.8 m relative to the substrate GMP, whereas the K-m of this enzyme for GMP was 73 m. The IC50 of ppGpp for GKpm was approximate to 10 m. In contrast, the activity of rice GKc was insensitive to ppGpp, as was that of GK from bakers' yeast, which is also a cytosolic enzyme. These observations suggest that ppGpp plays a pivotal role in the regulation of GTP biosynthesis in chloroplasts through specific inhibition of GKpm activity, with the regulation of GTP biosynthesis in chloroplasts thus being independent of that in the cytosol. We also found that GKs of Escherichia coli and Synechococcus elongatus PCC 7942 are insensitive to ppGpp, in contrast to the ppGpp sensitivity of the Bacillus subtilis enzyme. Our biochemical characterization of GK enzymes has thus revealed a novel target of ppGpp in chloroplasts and has uncovered diversity among bacterial GKs with regard to regulation by ppGpp.	[Nomura, Yuhta; Fukunaga, Yoshinori] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Nakahira, Yoichi; Nozawa, Akira; Tozawa, Yuzuru] Ehime Univ, Proteo Sci Ctr, Matsuyama, Ehime 7908577, Japan; [Nomura, Yuhta; Izumi, Atsushi; Fukunaga, Yoshinori; Nakahira, Yoichi; Nozawa, Akira; Tozawa, Yuzuru] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Kusumi, Kensuke; Iba, Koh] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Watanabe, Seiya] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, Cluster Excellence Plant Sci, D-40225 Dusseldorf, Germany	Ehime University; Ehime University; Ehime University; Kyushu University; Ehime University; Heinrich Heine University Dusseldorf	Tozawa, Y (corresponding author), 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	tozawa.yuzuru.mx@ehime-u.ac.jp	Tozawa, Yuzuru/AAM-9620-2020; Nomura, Yuhta/F-4362-2018; Weber, Andreas PM/A-6250-2011; Weber, Andreas Paul Michael/O-3043-2019	Nomura, Yuhta/0000-0002-4954-4653; Weber, Andreas PM/0000-0003-0970-4672; Weber, Andreas Paul Michael/0000-0003-0970-4672; Nozawa, Akira/0000-0003-4886-0213	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24570054]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24570054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research 24570054 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant-in-Aid for JSPS Fellows (to Y. Nomura) from the Japan Society for the Promotion of Science.	Agarwal K C, 1978, Methods Enzymol, V51, P483; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Cao YJ, 2001, BBA-GENE STRUCT EXPR, V1520, P242, DOI 10.1016/S0167-4781(01)00269-X; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Collart FR, 1996, GENE, V174, P217, DOI 10.1016/0378-1119(96)00045-5; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; GENTRY D, 1993, J BIOL CHEM, V268, P14316; Kasai K, 2004, NUCLEIC ACIDS RES, V32, P5732, DOI 10.1093/nar/gkh916; Kihara A, 2011, BIOSCI BIOTECH BIOCH, V75, P1740, DOI 10.1271/bbb.110285; KONRAD M, 1992, J BIOL CHEM, V267, P25652; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Kumar V, 2000, EUR J BIOCHEM, V267, P606, DOI 10.1046/j.1432-1327.2000.01045.x; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Masuda S, 2008, PLANT CELL PHYSIOL, V49, P135, DOI 10.1093/pcp/pcm177; Mizusawa K, 2008, PLANTA, V228, P553, DOI 10.1007/s00425-008-0758-5; Nomura Y, 2012, PLANT MOL BIOL, V78, P185, DOI 10.1007/s11103-011-9858-x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Sabina RL, 2007, PLANT PHYSIOL, V143, P1752, DOI 10.1104/pp.107.096487; Sato M, 2009, CHEMBIOCHEM, V10, P1227, DOI 10.1002/cbic.200800737; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tojo S, 2008, J BACTERIOL, V190, P6134, DOI 10.1128/JB.00606-08; Tojo S, 2013, J BACTERIOL, V195, P1656, DOI 10.1128/JB.02131-12; Tozawa Y, 2011, PLANT BIOLOGY, V13, P699, DOI 10.1111/j.1438-8677.2011.00484.x; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Xu J, 2005, PLANT J, V42, P743, DOI 10.1111/j.1365-313X.2005.02411.x; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	36	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15631	15641		10.1074/jbc.M113.534768	http://dx.doi.org/10.1074/jbc.M113.534768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722991	hybrid, Green Published			2022-12-28	WOS:000337465400045
J	Pereira, NA; Pu, HX; Goh, H; Song, ZW				Pereira, Natasha A.; Pu, Helen X.; Goh, Hazel; Song, Zhiwei			Golgi Phosphoprotein 3 Mediates the Golgi Localization and Function of Protein O-Linked Mannose beta-1,2-N-Acetlyglucosaminyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; DYSTROGLYCAN FUNCTION; PHAGE DISPLAY; GLYCOPROTEIN COMPLEX; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; GLYCOSYLATION; DISEASE; MUSCLE; GLYCOSYLTRANSFERASES	GOLPH3 is a highly conserved protein found across the eukaryotic lineage. The yeast homolog, Vps74p, interacts with and maintains the Golgi localization of several mannosyltransferases, which is subsequently critical for N- and O-glycosylation in yeast. Through the use of a T7 phage display, we discovered a novel interaction between GOLPH3 and a mammalian glycosyltransferase, POMGnT1, which is involved in the O-mannosylation of alpha-dystroglycan. The cytoplasmic tail of POMGnT1 was found to be critical for mediating its interaction with GOLPH3. Loss of this interaction resulted in the inability of POMGnT1 to localize to the Golgi and reduced the functional glycosylation of alpha-dystroglycan. In addition, we showed that three clinically relevant mutations present in the stem domain of POMGnT1 mislocalized to the endoplasmic reticulum, high-lighting the importance of identifying the molecular mechanisms responsible for Golgi localization of glycosyltransferases. Our findings reveal a novel role for GOLPH3 in mediating the Golgi localization of POMGnT1.	[Pereira, Natasha A.; Pu, Helen X.; Goh, Hazel; Song, Zhiwei] ASTAR, Bioproc Technol Inst, Singapore 138668, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Song, ZW (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	song_zhiwei@bti.a-star.edu.sg			Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Danner S, 2001, P NATL ACAD SCI USA, V98, P12954, DOI 10.1073/pnas.211439598; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kuga A, 2012, J BIOL CHEM, V287, P9560, DOI 10.1074/jbc.M111.271767; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Nagano-Ito M, 2007, GENE, V400, P82, DOI 10.1016/j.gene.2007.06.007; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Taniguchi K, 2003, HUM MOL GENET, V12, P527, DOI 10.1093/hmg/ddg043; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Vervoort VS, 2004, ANN NEUROL, V56, P143, DOI 10.1002/ana.20172; Voglmeir J, 2011, BIOCHEM J, V436, P447, DOI 10.1042/BJ20101059; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto M, 1999, BIOCHEM BIOPH RES CO, V255, P194, DOI 10.1006/bbrc.1999.0175; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	39	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14762	14770		10.1074/jbc.M114.548305	http://dx.doi.org/10.1074/jbc.M114.548305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733390	hybrid, Green Published			2022-12-28	WOS:000337248100032
J	Peters, DE; Szabo, R; Friis, S; Shylo, NA; Sales, KU; Holmbeck, K; Bugge, TH				Peters, Diane E.; Szabo, Roman; Friis, Stine; Shylo, Natalia A.; Sales, Katiuchia Uzzun; Holmbeck, Kenn; Bugge, Thomas H.			The Membrane-anchored Serine Protease Prostasin (CAP1/PRSS8) Supports Epidermal Development and Postnatal Homeostasis Independent of Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC CASCADE; BARRIER FUNCTION; ACTIVATION; MUTATIONS; CHANNELS; CLOSURE; CELL	The membrane-anchored serine protease prostasin (CAP1/PRSS8) is part of a cell surface proteolytic cascade that is essential for epithelial barrier formation and homeostasis. Here, we report the surprising finding that prostasin executes these functions independent of its own enzymatic activity. Prostasin null (Prss8(-/-)) mice lack barrier formation and display fatal postnatal dehydration. In sharp contrast, mice homozygous for a point mutation in the Prss8 gene, which causes the substitution of the active site serine within the catalytic histidine-aspartate-serine triad with alanine and renders prostasin catalytically inactive (Prss8(Cat-/Cat-) mice), develop barrier function and are healthy when followed for up to 20 weeks. This striking difference could not be explained by genetic modifiers or by maternal effects, as these divergent phenotypes were displayed by Prss8(-/-) and Prss8Cat(-/Cat-) mice born within the same litter. Furthermore, Prss8Cat(-/Cat-) mice were able to regenerate epidermal covering following cutaneous wounding. This study provides the first demonstration that essential in vivo functions of prostasin are executed by a non-enzymatic activity of this unique membrane-anchored serine protease.	[Peters, Diane E.; Szabo, Roman; Friis, Stine; Shylo, Natalia A.; Sales, Katiuchia Uzzun; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Friis, Stine] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Holmbeck, Kenn] Natl Inst Dent & Craniofacial Res, Connect Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Shylo, Natalia/0000-0002-0466-896X; Peters, Diane/0000-0003-4185-6203; sales, katiuchia/0000-0002-3768-5790	NIDCR Intramural Research Program; Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676, ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIDCR Intramural Research Program (to K. H. and T. H. B.), by The Harboe Foundation, The Lundbeck Foundation, and the Foundation of 17.12.1981 (to S. F.).	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Sanford LP, 2000, METH MOL B, V158, P217; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247	24	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14740	14749		10.1074/jbc.M113.541318	http://dx.doi.org/10.1074/jbc.M113.541318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706745	hybrid, Green Published			2022-12-28	WOS:000337248100030
J	Choi, BH; Pagano, M; Dai, W				Choi, Byeong Hyeok; Pagano, Michele; Dai, Wei			Plk1 Protein Phosphorylates Phosphatase and Tensin Homolog ( PTEN) and Regulates Its Mitotic Activity during the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Signaling; Chromatin; Mitosis; PTEN; Kinase; Phosphorylation; Plk1	POLO-LIKE KINASE-1; TUMOR-SUPPRESSOR; SPLICE VARIANT; CANCER-THERAPY; NUCLEAR PTEN; CHECKPOINT; STABILITY; G2; POLO-LIKE-KINASE-1; CENTROSOMES	Background: PTEN localizes to the nucleus, whose molecular regulation remains unknown. Results: Plk1 phosphorylates PTEN on Ser-380 and regulates its function in mitosis. Conclusion: Plk1 is an important regulator of PTEN during the cell cycle. Significance: PTEN plays a key role in regulating mitotic progression. PTEN is a well known tumor suppressor through the negative regulation of the PI3K signaling pathway. Here we report that PTEN plays an important role in regulating mitotic timing, which is associated with increased PTEN phosphorylation in the C-terminal tail and its localization to chromatin. Pulldown analysis revealed that Plk1 physically interacted with PTEN. Biochemical studies showed that Plk1 phosphorylates PTEN in vitro in a concentration-dependent manner and that the phosphorylation was inhibited by Bi2635, a Plk1-specific inhibitor. Deletional and mutational analyses identified that Plk1 phosphorylated Ser-380, Thr-382, and Thr-383, but not Ser-385, a cluster of residues known to affect the PTEN stability. Interestingly, a combination of molecular and genetic analyses revealed that only Ser-380 was significantly phosphorylated in vivo and that Plk1 regulated the phosphorylation, which was associated with the accumulation of PTEN on chromatin. Moreover, expression of phospho-deficient mutant, but not wild-type PTEN, caused enhanced mitotic exit. Taken together, our studies identify Plk1 as an important regulator of PTEN during the cell cycle.	[Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Biochem, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Mol Pharmacol, Tuxedo Pk, NY 10987 USA; [Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; New York University; New York University; Howard Hughes Medical Institute; New York University	Dai, W (corresponding author), Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; pagano, michele/0000-0003-3210-2442; Choi, Byeong Hyeok/0000-0002-8866-1131	United States Public Service Awards [CA090658, CA150512]; National Institutes of Health NIEHS Center Grant [ES000260, R01-GM057587, R21-AG032560]; NATIONAL CANCER INSTITUTE [R01CA090658, R37CA076584, R01CA150512, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES020591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	United States Public Service Awards; National Institutes of Health NIEHS Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by United States Public Service Awards CA090658 and CA150512 (to W. D.) and National Institutes of Health NIEHS Center Grant ES000260 and Grants R01-GM057587 and R21-AG032560 (to M. P.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Choi BH, 2013, CELL CYCLE, V12, P3442, DOI 10.4161/cc.26465; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Soung NK, 2006, MOL CELL BIOL, V26, P8316, DOI 10.1128/MCB.00671-06; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	42	41	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14066	14074		10.1074/jbc.M114.558155	http://dx.doi.org/10.1074/jbc.M114.558155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706748	Green Published, hybrid			2022-12-28	WOS:000335984600036
J	Nemec, AA; Murphy, DL; Donigan, KA; Sweasy, JB				Nemec, Antonia A.; Murphy, Drew L.; Donigan, Katherine A.; Sweasy, Joann B.			The S229L Colon Tumor- associated Variant of DNA Polymerase beta Induces Cellular Transformation as a Result of Decreased Polymerization Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; Cancer; Genetics; Genomic Instability; Mutagenesis	CONSEQUENCES; INSTABILITY; MUTATOR; REPAIR; CELLS; LYASE	Background: The POLB gene is mutated in 40% of human colorectal tumors. Results: The S229L variant is a slow DNA polymerase that leads to the accumulation of BER intermediates and induces cellular transformation. Conclusion: The S229L variant transforms cells by inducing genomic instability. Significance: Tumor-associated variants of DNA polymerase can affect DNA repair efficiency and drive cancer. DNA polymerase (Pol ) plays a key role in base excision repair (BER) by filling in small gaps that are generated after base adducts are excised from the DNA. Pol is mutated in a large number of colorectal tumors, and these mutations may drive carcinogenesis. In the present study, we wished to determine whether the S229L somatic Pol variant identified in a stage 3 colorectal tumor is a driver of carcinogenesis. We show that S229L does not possess any defects in binding to either DNA or nucleotides compared with the WT enzyme, but exhibits a significant loss of polymerization efficiency, largely due to an 8-fold decrease in the polymerization rate. S229L participates in BER, but due to its lower catalytic rate, does so more slowly than WT. Expression of S229L in mammalian cells induces the accumulation of BER intermediate substrates, chromosomal aberrations, and cellular transformation. Our results are consistent with the interpretation that S229L is a driver of carcinogenesis, likely as a consequence of its slow polymerization activity during BER in vivo.	[Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu			National Institutes of Health [F32 CA156843]; NCI [T32 CA009259]; NIEHS [ES019179]; NATIONAL CANCER INSTITUTE [T32CA009259, F32CA156843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants F32 CA156843 and T32 CA009259 from the NCI (to A.A.N.) and ES019179 from the NIEHS (to J.B.S.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2012, DNA REPAIR, V11, P381, DOI 10.1016/j.dnarep.2012.01.004; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1974, CANCER RES, V34, P2311; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; LOWY DR, 1978, J VIROL, V26, P291, DOI 10.1128/JVI.26.2.291-298.1978; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nemec AA, 2012, J BIOL CHEM, V287, P23840, DOI 10.1074/jbc.M112.362111; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005	17	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13708	13716		10.1074/jbc.M114.550400	http://dx.doi.org/10.1074/jbc.M114.550400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668809	Green Published, hybrid			2022-12-28	WOS:000335984600005
J	Patterson, JN; Cousteils, K; Lou, JW; Fox, JEM; MacDonald, PE; Joseph, JW				Patterson, Jessica N.; Cousteils, Katelyn; Lou, Jennifer W.; Fox, Jocelyn E. Manning; MacDonald, Patrick E.; Joseph, Jamie W.			Mitochondrial Metabolism of Pyruvate Is Essential for Regulating Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Cell; Cell Metabolism; Glucose Metabolism; Mitochondria; Pancreatic Islets; Pyruvate	PANCREATIC BETA-CELLS; SENSITIVE K+ CHANNELS; LACTATE-DEHYDROGENASE; MALONYL-COA; CARRIER; ISLETS; RAT; CARBOXYLASE; EXOCYTOSIS; INHIBITION	Background: Pyruvate metabolism plays an essential role in pancreatic -cells. Results: Pharmacological and siRNA-mediated inhibition of mitochondrial pyruvate carrier-1 and -2 inhibit -cell metabolism and insulin secretion. Conclusion: Pyruvate entry into -cell mitochondria is critical for regulating insulin release. Significance: Mitochondrial metabolism of pyruvate plays a key role in generating signals in response to nutrients that control insulin release. It is well known that mitochondrial metabolism of pyruvate is critical for insulin secretion; however, we know little about how pyruvate is transported into mitochondria in -cells. Part of the reason for this lack of knowledge is that the carrier gene was only discovered in 2012. In the current study, we assess the role of the recently identified carrier in the regulation of insulin secretion. Our studies show that -cells express both mitochondrial pyruvate carriers (Mpc1 and Mpc2). Using both pharmacological inhibitors and siRNA-mediated knockdown of the MPCs we show that this carrier plays a key role in regulating insulin secretion in clonal 832/13 -cells as well as rat and human islets. We also show that the MPC is an essential regulator of both the ATP-regulated potassium (K-ATP) channel-dependent and -independent pathways of insulin secretion. Inhibition of the MPC blocks the glucose-stimulated increase in two key signaling molecules involved in regulating insulin secretion, the ATP/ADP ratio and NADPH/NADP(+) ratio. The MPC also plays a role in in vivo glucose homeostasis as inhibition of MPC by the pharmacological inhibitor -cyano--(1-phenylindol-3-yl)-acrylate (UK5099) resulted in impaired glucose tolerance. These studies clearly show that the newly identified mitochondrial pyruvate carrier sits at an important branching point in nutrient metabolism and that it is an essential regulator of insulin secretion.	[Patterson, Jessica N.; Cousteils, Katelyn; Lou, Jennifer W.; Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2G 1C5, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada	University of Waterloo; University of Alberta; University of Alberta	Joseph, JW (corresponding author), Univ Waterloo, Sch Pharm, Hlth Sci Campus Bldg A,Rm 4008,10A Victoria St S, Kitchener, ON N2G 1C5, Canada.	j3joseph@uwaterloo.ca		MacDonald, Patrick/0000-0002-5439-6288	Canadian Institute of Health Research [MOP 86638]; Natural Sciences and Engineering Research Council of Canada [RGPIN 371723-2009]; Alberta Diabetes Foundation; University of Alberta; Alberta Innovates-Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Diabetes Foundation; University of Alberta(University of Alberta); Alberta Innovates-Health Solutions	This work was supported in part by Canadian Institute of Health Research Grant MOP 86638 and Natural Sciences and Engineering Research Council of Canada Grant RGPIN 371723-2009. Human islet isolation was funded by the Alberta Diabetes Foundation and the University of Alberta (to P. E. M.).; Supported by a scholarship from Alberta Innovates-Health Solutions and holds the Canada Research Chair in Islet Biology.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BEST L, 1991, BIOCHEM PHARMACOL, V41, P405, DOI 10.1016/0006-2952(91)90537-F; BEST L, 1988, BIOCHEM PHARMACOL, V37, P2019, DOI 10.1016/0006-2952(88)90550-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; HALESTRAP AP, 1976, BIOCHEM J, V156, P181, DOI 10.1042/bj1560181; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Huypens PR, 2012, ISLETS, V4, DOI 10.4161/isl.18338; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; JUNTTIBERGGREN L, 1994, J BIOL CHEM, V269, P14391; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kin T, 2010, ISLETS, V2, P265, DOI 10.4161/isl.2.5.13019; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Pillai R, 2011, J BIOL CHEM, V286, P1014, DOI 10.1074/jbc.M110.149062; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; SATO Y, 1992, DIABETES, V41, P438, DOI 10.2337/diabetes.41.4.438; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Skelly RH, 1998, BIOCHEM J, V331, P553, DOI 10.1042/bj3310553; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Sugden MC, 2011, ISLETS, V3, P302, DOI 10.4161/isl.3.6.17806; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	56	54	56	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13335	13346		10.1074/jbc.M113.521666	http://dx.doi.org/10.1074/jbc.M113.521666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675076	Green Published, hybrid			2022-12-28	WOS:000335522800032
J	Trane, AE; Pavlov, D; Sharma, A; Saqib, U; Lau, K; van Petegem, F; Minshall, RD; Roman, LJ; Bernatchez, PN				Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Saqib, Uzma; Lau, Kelvin; van Petegem, Filip; Minshall, Richard D.; Roman, Linda J.; Bernatchez, Pascal N.			Deciphering the Binding of Caveolin-1 to Client Protein Endothelial Nitric-oxide Synthase ( eNOS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caveolae; Caveolin; Endothelium; Nitric Oxide; Nitric-oxide Synthase	MICROVASCULAR PERMEABILITY; SCAFFOLDING DOMAIN; PULMONARY DEFECTS; KNOCKOUT MICE; NULL MICE; IN-VIVO; ATHEROSCLEROSIS; DYSFUNCTION; HYPERTENSION; ACTIVATION	Background: One of the most significant client proteins of Cav-1 is the endothelial nitric-oxide synthase (eNOS), but their specific binding site is unknown. Results: We describe how Cav-1 binds to eNOS and how biologically active NO can be increased. Conclusion: We provide the most detailed characterization of eNOS binding to Cav-1. Significance: Our data provide a deeper understanding of Cav-1 signaling and NO generation in physiological processes. Caveolin-1 (Cav-1) gene inactivation interferes with caveolae formation and causes a range of cardiovascular and pulmonary complications in vivo. Recent evidence suggests that blunted Cav-1/endothelial nitric-oxide synthase (eNOS) interaction, which occurs specifically in vascular endothelial cells, is responsible for the multiple phenotypes observed in Cav-1-null animals. Under basal conditions, Cav-1 binds eNOS and inhibits nitric oxide (NO) production via the Cav-1 scaffolding domain (CAV; amino acids 82-101). Although we have recently shown that CAV residue Phe-92 is responsible for eNOS inhibition, the inactive F92A Cav-1 mutant unexpectedly retains its eNOS binding ability and can increase NO release, indicating the presence of a distinct eNOS binding domain within CAV. Herein, we identified and characterized a small 10-amino acid CAV subsequence (90-99) that accounted for the majority of eNOS association with Cav-1 (K-d = 49 nm), and computer modeling of CAV(90-99) docking to eNOS provides a rationale for the mechanism of eNOS inhibition by Phe-92. Finally, using gene silencing and reconstituted cell systems, we show that intracellular delivery of a F92A CAV(90-99) peptide can promote NO bioavailability in eNOS- and Cav-1-dependent fashions. To our knowledge, these data provide the first detailed analysis of Cav-1 binding to one of its most significant client proteins, eNOS.	[Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Bernatchez, Pascal N.] Univ British Columbia, St Pauls Hosp, Ctr Heart & Lung Innovat, Vancouver, BC V6T 1Z3, Canada; [Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Bernatchez, Pascal N.] Univ British Columbia, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Lau, Kelvin; van Petegem, Filip] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Saqib, Uzma; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Minshall, Richard D.] Univ Illinois, Dept Anaesthesiol, Chicago, IL 60612 USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of British Columbia; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bernatchez, PN (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, St Pauls Hosp, Ctr Heart & Lung Innovat, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	pascal.bernatchez@ubc.ca	Lau, Kelvin/M-2639-2019; Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Lau, Kelvin/0000-0002-9040-7597	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [GM052419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, British Columbia, and Yukon (to A. E. T. and P. N. B.), the Canada Foundation for Innovation, British Columbia Knowledge Development Fund, Natural Sciences and Engineering Research Council of Canada (to A. S.).; Supported by National Institutes of Health Grant GM052419.	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Babak R., 2002, PHARMACOL REV, V54, P431; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; BUSCONI L, 1995, MOL PHARMACOL, V47, P655; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; GRIFFITH TM, 1984, NATURE, V308, P645, DOI 10.1038/308645a0; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kaplanek R, 2012, J MED CHEM, V55, P9541, DOI 10.1021/jm300805x; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Maniatis NA, 2008, AM J PHYSIOL-LUNG C, V294, pL865, DOI 10.1152/ajplung.00079.2007; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2001, J BIOL CHEM, V276, P38121; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Sharma A, 2011, EUR J PHARMACOL, V659, P206, DOI 10.1016/j.ejphar.2011.03.028; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Taddei S, 2000, Curr Hypertens Rep, V2, P64, DOI 10.1007/s11906-000-0061-8; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	56	48	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13273	13283		10.1074/jbc.M113.528695	http://dx.doi.org/10.1074/jbc.M113.528695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648521	hybrid, Green Published			2022-12-28	WOS:000335522800027
J	Argyri, L; Dafnis, I; Theodossiou, TA; Gantz, D; Stratikos, E; Chroni, A				Argyri, Letta; Dafnis, Ioannis; Theodossiou, Theodossis A.; Gantz, Donald; Stratikos, Efstratios; Chroni, Angeliki			Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; ApoE; Apolipoproteins; Biophysics; Lipoprotein; Reactive Oxygen Species (ROS); Amyloid Peptide; Mutation; Thermodynamic Stability; Toxicity	E CONCENTRATION DECREASES; AMYLOID-BETA; SECONDARY STRUCTURE; OXIDATIVE STRESS; AQUEOUS-SOLUTION; LIPID-BINDING; A-I; E3; ASSOCIATION; STABILITY	Background: The apoE4 mutant apoE4[L28P] is associated with an increased risk for Alzheimer disease (AD) in addition to the known effect of apoE4. Results: ApoE4[L28P] displays folding defects and aberrant functions associated with AD pathogenesis. Conclusion: The structural integrity of apoE4 is an important component of its role in AD pathogenesis. Significance: We provide insights into the molecular basis for the added risk for AD in apoE4[L28P] carriers. The apolipoprotein (apo) E4 isoform has consistently emerged as a susceptibility factor for late-onset Alzheimer disease (AD), although the exact mechanism is not clear. A rare apoE4 mutant, apoE4[L28P] Pittsburgh, burdens carriers with an added risk for late-onset AD and may be a useful tool for gaining insights into the role of apoE4 in disease pathogenesis. Toward this end, we evaluated the effect of the L28P mutation on the structural and functional properties of apoE4. ApoE4[L28P] was found to have significantly perturbed thermodynamic properties, to have reduced helical content, and to expose a larger portion of the hydrophobic surface to the solvent. Furthermore, this mutant is thermodynamically destabilized and more prone to proteolysis. When interacting with lipids, apoE4[L28P] formed populations of lipoprotein particles with structural defects. The structural perturbations brought about by the mutation were accompanied by aberrant functions associated with the pathogenesis of AD. Specifically, apoE4[L28P] promoted the cellular uptake of extracellular amyloid peptide 42 (A42) by human neuroblastoma SK-N-SH cells as well as by primary mouse neuronal cells and led to increased formation of intracellular reactive oxygen species that persisted for at least 24 h. Furthermore, lipoprotein particles containing apoE4[L28P] induced intracellular reactive oxygen species formation and reduced SK-N-SH cell viability. Overall, our findings suggest that the L28P mutation leads to significant structural and conformational perturbations in apoE4 and can induce functional defects associated with neuronal A42 accumulation and oxidative stress. We propose that these structural and functional changes underlie the observed added risk for AD development in carriers of apoE4[L28P].	[Argyri, Letta; Dafnis, Ioannis; Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece; [Theodossiou, Theodossis A.] Natl Ctr Sci Res Demokritos, Inst Adv Mat Physicochem Proc Nanotechnol & Micro, Phys Chem Sect, Athens 15310, Greece; [Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Prot Chem Lab, Inst Nucl & Radiol Sci & Technol Energy & Safety, Athens 15310, Greece; [Gantz, Donald] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; Boston University	Stratikos, E (corresponding author), Natl Ctr Sci Res Demokritos, Prot Chem Lab, Inst Nucl & Radiol Sci & Technol Energy & Safety, Aghia Paraskevi 15310, Greece.	stratos@rrp.demokritos.gr; achroni@bio.demokritos.gr	Stratikos, Efstratios/N-2969-2014; Theodossiou, Theodossis/AAC-2075-2022	Stratikos, Efstratios/0000-0002-3566-2309; Theodossiou, Theodossis/0000-0002-1982-8372; Chroni, Angeliki/0000-0003-3107-1189	ARISTEIA II program [4839]; European Social Fund; European Union; Greek National Resources	ARISTEIA II program; European Social Fund(European Social Fund (ESF)); European Union(European Commission); Greek National Resources(Greek Ministry of Development-GSRT)	This work was supported by the ARISTEIA II program (project code 4839), which is cofunded by the European Social Fund, European Union and Greek National Resources, under the Operational Program "Education and Lifelong Learning."	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Argyri L, 2011, PROTEIN EXPRES PURIF, V79, P251, DOI 10.1016/j.pep.2011.06.011; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bayer TA, 2008, GENES BRAIN BEHAV, V7, P6, DOI 10.1111/j.1601-183X.2007.00372.x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Chou CY, 2005, BIOPHYS J, V88, P455, DOI 10.1529/biophysj.104.046813; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Clement-Collin V, 2006, BIOPHYS CHEM, V119, P170, DOI 10.1016/j.bpc.2005.07.009; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Dafnis I, 2012, NEUROSCIENCE, V210, P21, DOI 10.1016/j.neuroscience.2012.03.013; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Georgiadou D, 2013, J LIPID RES, V54, P164, DOI 10.1194/jlr.M030965; Georgiadou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027037; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; Gorshkova IN, 2008, BIOCHEMISTRY-US, V47, P12644, DOI 10.1021/bi8015857; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huber G, 2000, NEUROSCIENCE, V101, P211, DOI 10.1016/S0306-4522(00)00341-9; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kamboh MI, 1999, NEUROSCI LETT, V263, P129, DOI 10.1016/S0304-3940(99)00129-9; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; Scacchi R, 2003, NEUROBIOL AGING, V24, P339, DOI 10.1016/S0197-4580(02)00089-1; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; Wang L, 2010, SEIZURE-EUR J EPILEP, V19, P79, DOI 10.1016/j.seizure.2009.12.001; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zannis V. I., 2004, MOL MECH ATHEROSCLER, P111; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028; Zhao W., 2013, HUM MOL GENET	62	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12931	12945		10.1074/jbc.M113.538124	http://dx.doi.org/10.1074/jbc.M113.538124			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644280	Green Published, hybrid			2022-12-28	WOS:000335581400061
J	Guo, JN; Turek, ME; Price, DH				Guo, Jiannan; Turek, Michael E.; Price, David H.			Regulation of RNA Polymerase II Termination by Phosphorylation of Gdown1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitosis; Phosphorylation; RNA Polymerase II; Transcription Elongation Factors; Transcription Termination; Gdown1; TFIIF; TTF2	TRANSCRIPTION ELONGATION; P-TEFB; PRODUCTIVE ELONGATION; INITIATION-COMPLEXES; MEDIATOR COMPLEX; IN-VITRO; DSIF; ORGANIZATION; TRANSITION; MITOSIS	Background: Gdown1 is a substoichiometric subunit of RNA polymerase II that blocks termination by TTF2 and the function of TFIIF during initiation and elongation. Results: Domains of Gdown1 responsible for inhibiting TTF2 and TFIIF as well as a controlling phosphorylation site are identified. Conclusion: Gdown1 can be regulated by phosphorylation of Ser-270. Significance: Our results reveal a mechanism that allows termination of all polymerases during mitosis. Gdown1 is a substoichiometric subunit of RNA polymerase II (Pol II) that has been recently demonstrated to be involved in stabilizing promoter-proximal paused Pol II. It was shown to inhibit termination of Pol II by transcription termination factor 2 (TTF2) as well as block elongation stimulation by transcription factor IIF (TFIIF). Here, using in vitro transcription assays, we identified two functional domains in Gdown1. Although both are required to maintain a tight association with Pol II, the N- and C-terminal domains are responsible for blocking TTF2 and TFIIF, respectively. A highly conserved LPDKG motif found in the N-terminal domain of Gdown1 is also highly conserved in TTF2. Deletion of this motif eliminated the TTF2 inhibitory activity of Gdown1. We identified a phosphorylated form of Gdown1 with altered mobility in SDS-PAGE that appears during mitosis. A kinase in HeLa nuclear extract that caused the shift was partially purified. In vitro, Gdown1 phosphorylated by this kinase demonstrated reduced activity in blocking both TTF2 and TFIIF because of its reduced affinity for Pol II. Mass spectrometry identified Ser-270 as the site of this phosphorylation. An S270A mutation was not phosphorylated by the partially purified kinase, and an S270E mutation partially mimicked the properties of phospho-Gdown1. Gdown1 Ser-270 phosphorylation occurs predominately during mitosis, and we suggest that this would enable TTF2 to terminate all Pol II even if it is associated with Gdown1.	[Guo, Jiannan; Turek, Michael E.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu		Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; American Heart Association [12POST12040106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35500 (to D. H. P.). This work was also supported by American Heart Association Postdoctoral Fellowship 12POST12040106 (to J. G.).	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Liang XQ, 2007, J AM SOC MASS SPECTR, V18, P1932, DOI 10.1016/j.jasms.2007.08.001; Luse DS, 2012, TRANSCR-AUSTIN, V3, P156, DOI 10.4161/trns.20725; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Peng J, 1998, COLD SPRING HARB SYM, V63, P365, DOI 10.1101/sqb.1998.63.365; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	40	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12657	12665		10.1074/jbc.M113.537662	http://dx.doi.org/10.1074/jbc.M113.537662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634214	Green Published, hybrid			2022-12-28	WOS:000335581400037
J	Hewit, KD; Fraser, A; Nibbs, RJB; Graham, GJ				Hewit, Kay D.; Fraser, Alasdair; Nibbs, Robert J. B.; Graham, Gerard J.			The N-terminal Region of the Atypical Chemokine Receptor ACKR2 Is a Key Determinant of Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Chemokines; Flow Cytometry; Inflammation; Mutagenesis	HIV-1 ENVELOPE GLYCOPROTEIN; DECOY RECEPTOR; TYROSINE SULFATION; AMINO-TERMINUS; D6; INFLAMMATION; IMMUNE; EXPRESSION; PEPTIDES; SYSTEM	Background: ACKR2 is an atypical chemokine receptor that is biologically distinct from conventional chemokine receptors. Results: An N-terminal sulfated tyrosine motif is essential for ligand binding by ACKR2. Conclusion: The structure/function basis for ligand binding by ACKR2 is similar to that of conventional chemokine receptors. Significance: ACKR2 N-terminal peptides may be therapeutically useful as pan-chemokine blockers in inflammatory pathologies. The atypical chemokine receptor, ACKR2 is a pivotal regulator of chemokine-driven inflammatory responses and works by binding, internalizing, and degrading inflammatory CC-chemokines. ACKR2 displays promiscuity of ligand binding and is capable of interacting with up to 14 different inflammatory CC-chemokines. Despite its prominent biological role, little is known about the structure/function relationship within ACKR2, which regulates ligand binding. Here we demonstrate that a conserved tyrosine motif at the N terminus of ACKR2 is essential for ligand binding, internalization, and scavenging. In addition we demonstrate that sulfation of this motif contributes to ligand internalization. Furthermore, a peptide derived from this region is capable of binding inflammatory chemokines and inhibits their interaction with their cognate signaling receptors. Importantly, the peptide is only active in the sulfated form, further confirming the importance of the sulfated tyrosines for function. Finally, we demonstrate that the bacterial protease, staphopain A, can cleave the N terminus of ACKR2 and suppress its ligand internalization activity. Overall, these results shed new light on the nature of the structural motifs in ACKR2 that are responsible for ligand binding. The study also highlights ACKR2-derived N-terminal peptides as being of potential therapeutic significance.	[Hewit, Kay D.; Fraser, Alasdair; Nibbs, Robert J. B.; Graham, Gerard J.] Univ Glasgow, Chemokine Res Grp, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Graham, GJ (corresponding author), Univ Glasgow, Chemokine Res Grp, Glasgow Biomed Res Ctr, Rm B3-27, Glasgow G12 8TA, Lanark, Scotland.	gerard.graham@glasgow.ac.uk		Graham, Gerard/0000-0002-7801-204X; Nibbs, Robert/0000-0002-8150-0044; Hewit, Kay/0000-0003-1671-6604	Medical Research Council Programme Grant; MRC [G0901113] Funding Source: UKRI; Medical Research Council [G0901113] Funding Source: researchfish; Versus Arthritis [19656] Funding Source: researchfish	Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was funded by a Medical Research Council Programme Grant (to G. J. G. and R. J. B. N.).	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Codullo V, 2011, ANN RHEUM DIS, V70, P1115, DOI 10.1136/ard.2010.137349; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Graham GJ, 2013, J PATHOL, V229, P168, DOI 10.1002/path.4123; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Hansell CAH, 2011, BLOOD, V117, P5413, DOI 10.1182/blood-2010-11-317115; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kwong JA, 2011, J VIROL, V85, P7563, DOI 10.1128/JVI.00630-11; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Lee KM, 2013, TRENDS IMMUNOL, V34, P7, DOI 10.1016/j.it.2012.08.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Madigan J, 2010, J IMMUNOL, V184, P3202, DOI 10.4049/jimmunol.0902118; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; McKimmie CS, 2008, J IMMUNOL, V181, P3353, DOI 10.4049/jimmunol.181.5.3353; McKimmie CS, 2013, BLOOD, V121, P3768, DOI 10.1182/blood-2012-04-425314; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Singh MD, 2012, AM J PATHOL, V181, P1158, DOI 10.1016/j.ajpath.2012.06.042; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	53	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12330	12342		10.1074/jbc.M113.534545	http://dx.doi.org/10.1074/jbc.M113.534545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644289	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000335581400012
J	Schredelseker, J; Paz, A; Lopez, CJ; Altenbach, C; Leung, CS; Drexler, MK; Chen, JN; Hubbell, WL; Abramson, J				Schredelseker, Johann; Paz, Aviv; Lopez, Carlos J.; Altenbach, Christian; Leung, Calvin S.; Drexler, Maria K.; Chen, Jau-Nian; Hubbell, Wayne L.; Abramson, Jeff			High Resolution Structure and Double Electron-Electron Resonance of the Zebrafish Voltage-dependent Anion Channel 2 Reveal an Oligomeric Population	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Ion Channels; Mitochondria; X-ray Crystallography; Zebrafish; DEER; VDAC2	OUTER MITOCHONDRIAL-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; VDAC; PROTEIN; BAK; INSIGHTS; SYSTEM; PROBES; MODEL	Background: Biochemical characterization of voltage-dependent anion channel 2 (VDAC2) is limited due to an inability to obtain functional protein. Results: The crystal structure of VDAC2 suggests a dimer interface that is confirmed by double electron-electron resonance and cross-linking. Conclusion: zfVDAC2 has a fractional dimeric population. Significance: VDAC isoforms are structurally similar, but this study has identified a number of hot spots that require further exploration. In recent years, there has been a vast increase in structural and functional understanding of VDAC1, but VDAC2 and -3 have been understudied despite having many unique phenotypes. One reason for the paucity of structural and biochemical characterization of the VDAC2 and -3 isoforms stems from the inability of obtaining purified, functional protein. Here we demonstrate the expression, isolation, and basic characterization of zebrafish VDAC2 (zfVDAC2). Further, we resolved the structure of zfVDAC2 at 2.8 resolution, revealing a crystallographic dimer. The dimer orientation was confirmed in solution by double electron-electron resonance spectroscopy and by cross-linking experiments disclosing a dimer population of approximate to 20% in lauryldimethine amine oxide detergent micelles, whereas in lipidic bicelles a higher population of dimeric and higher order oligomers species were observed. The present study allows for a more accurate structural comparison between VDAC2 and its better-studied counterpart VDAC1.	[Schredelseker, Johann; Chen, Jau-Nian] Univ Munich, Dept Mol Cell & Dev Biol, D-80336 Munich, Germany; [Schredelseker, Johann; Paz, Aviv; Leung, Calvin S.; Abramson, Jeff] Univ Munich, Dept Physiol, D-80336 Munich, Germany; [Schredelseker, Johann; Drexler, Maria K.] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Lopez, Carlos J.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Lopez, Carlos J.; Altenbach, Christian; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Abramson, Jeff] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med inStem, Bangalore 560065, Karnataka, India	University of Munich; University of Munich; University of Munich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Chen, JN (corresponding author), Univ Munich, Dept Mol Cell & Dev Biol, D-80336 Munich, Germany.	chenjn@mcdb.ucla.edu; hubbellw@jsei.ucla.edu; jabramson@mednet.ucla.edu	Paz, Aviv/AAN-3966-2021; Chen, Jau-Nian/AAM-7808-2020	Paz, Aviv/0000-0003-0792-492X; Schredelseker, Johann/0000-0002-6657-0466; Chen, Jau-Nian/0000-0001-8807-3607; Schweitzer, Maria Katharina/0000-0002-9977-019X	National Institutes of Health [RO1 GM078844, 5R01 EY005216]; Austrian Science Fund FWF Erwin-Schrodinger Fellowship [J3065-B11]; Jules Stein Eye Institute Training Grant [2T32EY007026-36A1]; Jules Stein Professor Endowment; NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF Erwin-Schrodinger Fellowship(Austrian Science Fund (FWF)); Jules Stein Eye Institute Training Grant; Jules Stein Professor Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM078844 (to J. A.) and 5R01 EY005216 (to C. J. L.). This work was also supported by Austrian Science Fund FWF Erwin-Schrodinger Fellowship J3065-B11 (to J. S.), Jules Stein Eye Institute Training Grant 2T32EY007026-36A1 (to C. J. L.), and the Jules Stein Professor Endowment (to W. L. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvira CM, 2012, AM J RESP CELL MOL, V47, P669, DOI 10.1165/rcmb.2011-0436OC; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 2007, J MEMBRANE BIOL, V216, P93, DOI 10.1007/s00232-007-9038-8; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Min CK, 2012, BIOCHEM J, V447, P371, DOI 10.1042/BJ20120705; Naghdi S, 2012, BIOPHYS J, V102, p437A, DOI 10.1016/j.bpj.2011.11.2391; Naghdi S, 2013, BIOPHYS J, V104, p656A, DOI 10.1016/j.bpj.2012.11.3621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palaniappan KK, 2013, CELL REP, V5, P546, DOI 10.1016/j.celrep.2013.08.048; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R., 2012, JOVE-J VIS EXP, V59, pe3383; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859	45	104	107	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12566	12577		10.1074/jbc.M113.497438	http://dx.doi.org/10.1074/jbc.M113.497438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627492	Green Published, hybrid			2022-12-28	WOS:000335581400030
J	Sun, YF; Kasiappan, R; Tang, JF; Webb, PL; Quarni, W; Zhang, XH; Bai, WL				Sun, Yuefeng; Kasiappan, Ravi; Tang, Jinfu; Webb, Panida L.; Quarni, Waise; Zhang, Xiaohong; Bai, Wenlong			A Novel Function of the Fe65 Neuronal Adaptor in Estrogen Receptor Action in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; DNA Transcription; Endocrinology; Gene Transcription; Hormone Receptors; Hormones; Nuclear Receptors; Breast Cancer; Estrogens; Estrogen Receptor; Fe65; Tamoxifen	AMYLOID PRECURSOR PROTEIN; TISSUE-SPECIFICITY; ANDROGEN RECEPTOR; BINDING PROTEIN; NUCLEAR-MATRIX; GROWTH; TRANSCRIPTION; TIP60; APP; STABILIZATION	Background: Fe65 is a neuronal adaptor with essential roles in neuronal cells. Results: Fe65 regulates promoter recruitments of the estrogen receptor and growth response of breast cancers to estrogens and tamoxifen. Conclusion: Fe65 is a positive regulator of estrogen actions in breast cancer cells. Significance: The studies define a novel role for a neuronal adaptor in estrogen actions in breast cancer cells. Fe65 is a multidomain adaptor with established functions in neuronal cells and neurodegeneration diseases. It binds to the C terminus of the A amyloid precursor protein and is involved in regulating gene transcription. The present studies show that Fe65 is expressed in breast cancer (BCa) cells and acts as an ER transcriptional coregulator that is recruited by 17-estradiol to the promoters of estrogen target genes. Deletion analyses mapped the ER binding domain to the phosphotyrosine binding domain 2 (PTB2). Ectopic Fe65 increased the transcriptional activity of the ER in a PTB2-dependent manner in reporter assays. Fe65 knockdown decreased, whereas its stable expression increased the transcriptional activity of endogenous ER in BCa cells and the ability of estrogens to stimulate target gene expression, ER, and coactivator recruitment to target gene promoters and cell growth. Furthermore, Fe65 expression decreased the antagonistic activity of tamoxifen (TAM), suggesting a role for Fe65 in TAM resistance. Overall, the studies define a novel role for the neuronal adaptor in estrogen actions in BCa cells.	[Sun, Yuefeng; Kasiappan, Ravi; Tang, Jinfu; Webb, Panida L.; Quarni, Waise; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Canc Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Evolut, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	wbai@health.usf.edu	Quarni, Waise/J-1095-2019; Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Kasiappan, Ravi/0000-0002-5351-9098; Sun, Yuefeng/0000-0003-4578-856X	National Institutes of Health Public Health Service [R01 CA111334]; Breast Cancer Research Program of United States Department of Defense [W81XWH-09-1-0574]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA111334] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Breast Cancer Research Program of United States Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant R01 CA111334. This work was also supported by an Idea Award from the Breast Cancer Research Program of United States Department of Defense Grant W81XWH-09-1-0574.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bao JY, 2007, MOL CELL BIOL, V27, P1321, DOI 10.1128/MCB.01280-06; Borquez Daniel A, 2012, Int J Alzheimers Dis, V2012, P353145, DOI 10.1155/2012/353145; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gradishar WJ, 2005, BREAST CANCER RES TR, V89, pS17, DOI 10.1007/s10549-005-0144-y; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Kasiappan R, 2012, J BIOL CHEM, V287, P41297, DOI 10.1074/jbc.M112.407189; Kawai T, 2010, FEBS LETT, V584, P765, DOI 10.1016/j.febslet.2009.12.040; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lee EJ, 2008, BMB REP, V41, P41, DOI 10.5483/BMBRep.2008.41.1.041; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Nakaya T, 2009, FEBS J, V276, P6364, DOI 10.1111/j.1742-4658.2009.07349.x; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SAVOURET JF, 1994, J BIOL CHEM, V269, P28955; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12217	12231		10.1074/jbc.M113.526194	http://dx.doi.org/10.1074/jbc.M113.526194			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619425	Green Published, hybrid			2022-12-28	WOS:000335581400004
J	Takahashi, K; Furuya, F; Shimura, H; Kaneshige, M; Kobayashi, T				Takahashi, Kazuya; Furuya, Fumihiko; Shimura, Hiroki; Kaneshige, Masahiro; Kobayashi, Tetsuro			Impaired Oxidative Endoplasmic Reticulum Stress Response Caused by Deficiency of Thyroid Hormone Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Endoplasmic Reticulum Stress; Islet; Thyroid; Thyroid Hormone	UNFOLDED PROTEIN RESPONSE; BETA-CELL; INSULIN-SECRETION; REPLACEMENT THERAPY; GLUCOSE; HYPOTHYROIDISM; SENSITIVITY; METABOLISM; EXPRESSION; APOPTOSIS	Background: Endoplasmic reticulum (ER) stress is involved in -cell failure and apoptotic death. Results: Upon endogenous TR knockdown, ER stress significantly enhanced apoptosis in pancreatic -cells. Conclusion: TR facilitates reduced apoptosis in pancreatic -cells under ER stress. Significance: TR is coupled to stress response modulation and improved survival of pancreatic -cells. Thyroid hormone receptor (TR) is critical to postnatal pancreatic -cell maintenance. To investigate the association between TR and the survival of pancreatic -cells under endoplasmic reticulum (ER) stress, the expression of endogenous TR was inhibited by infection with an adenovirus expressing double-stranded short hairpin RNA against TR (AdshTR). In control adenovirus-infected pancreatic -cells, palmitate enhanced the expression of activating transcription factor 4 (ATF4) and heme oxygenase 1, which facilitates adaptation to oxidative ER stress. However, in AdshTR-infected pancreatic -cells, palmitate did not induce ATF4-mediated integrated stress response, and oxidative stress-associated apoptotic cell death was significantly enhanced. TR-deficient mice or wild-type mice (WT) were fed a high fat diet (HFD) for 30 weeks, and the effect of oxidative ER stress on pancreatic -cells was analyzed. HFD-treated TR-deficient mice had high blood glucose levels and low plasma insulin levels. In HFD-treated TR-deficient mice, ATF4 was not induced, and apoptosis was enhanced compared with HFD-treated WT mice. Furthermore, the expression level of 8-hydroxydeoxyguanosine, an oxidative stress marker, was enhanced in the -cells of HFD-treated TR-deficient mice. These results indicate that endogenous TR plays an important role for the expression of ATF4 and facilitates reduced apoptosis in pancreatic -cells under ER stress.	[Takahashi, Kazuya; Furuya, Fumihiko; Kaneshige, Masahiro; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo, Yamanashi 4093898, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima 9601247, Japan	University of Yamanashi; Fukushima Medical University	Furuya, F (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	ffuruya@yamanashi.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24591359]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 24591359.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; Furuya F, 2013, J BIOL CHEM, V288, P16155, DOI 10.1074/jbc.M112.438192; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Handisurya A, 2008, CLIN ENDOCRINOL, V69, P963, DOI 10.1111/j.1365-2265.2008.03280.x; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hassani Z., 2007, NUCLEIC ACIDS RES, V35, pe65; Hill JO, 2000, J NUTR, V130, p284S, DOI 10.1093/jn/130.2.284S; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; LENZEN S, 1976, ENDOCRINOLOGY, V99, P125, DOI 10.1210/endo-99-1-125; LENZEN S, 1978, METABOLISM, V27, P81, DOI 10.1016/0026-0495(78)90126-9; Lin KH, 1997, BIOCHEM BIOPH RES CO, V238, P280, DOI 10.1006/bbrc.1997.7285; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; Macchia PE, 2001, P NATL ACAD SCI USA, V98, P349, DOI 10.1073/pnas.011306998; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stanicka S, 2005, CLIN CHEM LAB MED, V43, P715, DOI 10.1515/CCLM.2005.121; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Woods SC, 2004, PHYSIOL BEHAV, V82, P187, DOI 10.1016/j.physbeh.2004.04.050; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	34	11	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12485	12493		10.1074/jbc.M113.544122	http://dx.doi.org/10.1074/jbc.M113.544122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644288	hybrid, Green Published			2022-12-28	WOS:000335581400024
J	Wang, YL; Shen, G; Gong, JJ; Shen, DY; Whittington, A; Qing, J; Treloar, JS; Boisvert, S; Zhang, ZG; Yang, C; Wang, P				Wang, Yanli; Shen, Gui; Gong, Jinjun; Shen, Danyu; Whittington, Amy; Qing, Jiang; Treloar, Joshua; Boisvert, Scott; Zhang, Zhengguang; Yang, Cai; Wang, Ping			Noncanonical G beta Gib2 Is a Scaffolding Protein Promoting cAMP Signaling through Functions of Ras1 and Cac1 Proteins in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Cyclic AMP (cAMP); G Proteins; Ras; Signal Transduction; G-like; RACK1; Fungal Growth and Virulence; Protein Interactive Network	HETEROTRIMERIC G-PROTEINS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN RACK1; SCHIZOSACCHAROMYCES-POMBE; ADENYLATE-CYCLASE; KINASE-C; VIRULENCE; SUBUNIT; HOMOLOG; YEAST	Background: Gib2 interacts with Gpa1, Gpg1, Gpg2, Cin1, and Pkc1. Gib2 overexpression promotes cAMP levels in cells lacking Gpa1. Results: Gib2 regulates cAMP through a novel mechanism involving functions of Ras1 and Cac1. Conclusion: Gib2 functions as a scaffolding adaptor protein. Significance: This study reveals a novel mechanism of cAMP signaling and identifies Gib2 as a key element in fungal regulatory networks. G-like/RACK1 functions as a key mediator of various pathways and contributes to numerous cellular functions in eukaryotic organisms. In the pathogenic fungus Cryptococcus neoformans, noncanonical G Gib2 promotes cAMP signaling in cells lacking normal Gpa1 function while displaying versatility in interactions with G Gpa1, protein kinase Pkc1, and endocytic intersectin Cin1. To elucidate the Gib2 functional mechanism(s), we demonstrate that Gib2 is required for normal growth and virulence. We show that Gib2 directly binds to Gpa1 and G Gpg1/Gpg2 and that it interacts with phosphodiesterase Pde2 and monomeric GTPase Ras1. Pde2 remains functionally dispensable, but Ras1 is found to associate with adenylyl cyclase Cac1 through the conserved Ras association domain. In addition, the ras1 mutant exhibits normal capsule formation, whereas the ras1 gpa1 mutant displays enhanced capsule formation, and the ras1 gpa1 cac1 mutant is acapsular. Collectively, these findings suggest that Gib2 promotes cAMP levels by relieving an inhibitory function of Ras1 on Cac1 in the absence of Gpa1. In addition, using GST affinity purification combined with mass spectrometry, we identified 47 additional proteins that interact with Gib2. These proteins have putative functions ranging from signal transduction, energy generation, metabolism, and stress response to ribosomal function. After establishing and validating a protein-protein interactive network, we believe Gib2 to be a key adaptor/scaffolding protein that drives the formation of various protein complexes required for growth and virulence. Our study reveals Gib2 as an essential component in deciphering the complexity of regulatory networks that control growth and virulence in C. neoformans.	[Wang, Yanli; Shen, Gui; Gong, Jinjun; Qing, Jiang; Yang, Cai; Wang, Ping] Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA; [Shen, Danyu; Zhang, Zhengguang] Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China; [Whittington, Amy; Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Treloar, Joshua] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70118 USA; [Boisvert, Scott] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA	Children's Hospital of New Orleans; Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Duke University	Wang, P (corresponding author), Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA.	pwang@lsuhsc.edu	Shen, Danyu/AAF-1644-2019		National Institutes of Health [R01AI054958, R01AI074001]; Research Institute for Children, Children's Hospital of New Orleans, Louisiana; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958, R01AI074001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute for Children, Children's Hospital of New Orleans, Louisiana; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI054958 and R01AI074001 (to P. W.). This work was also supported by a fund from The Research Institute for Children, Children's Hospital of New Orleans, Louisiana (to P. W.). Research in the Zhang laboratory was supported in part by an especially appointed professorship (Jiangsu, China).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Bolger GB, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-24; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; EDMAN JC, 1992, MOL CELL BIOL, V12, P2777, DOI 10.1128/MCB.12.6.2777; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; James P, 1996, GENETICS, V144, P1425; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; Kays AM, 2004, MYCOTA, V3, P175; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; KOZEL TR, 1995, TRENDS MICROBIOL, V3, P295, DOI 10.1016/S0966-842X(00)88957-X; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; LINDER P, 1989, P NATL ACAD SCI USA, V86, P2286, DOI 10.1073/pnas.86.7.2286; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; MOHSENIZADEH S, 2004, GENOME INFORM 2004; Mudge DK, 2014, EUKARYOT CELL, V13, P202, DOI 10.1128/EC.00277-13; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Qian JA, 2011, J MASS SPECTROM, V46, P1, DOI 10.1002/jms.1854; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sambrook J., 2001, MOL CLONING LAB MANU; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Shen G, 2012, EUKARYOT CELL, V11, P471, DOI 10.1128/EC.00011-12; Shen G, 2010, MOL MICROBIOL, V76, P662, DOI 10.1111/j.1365-2958.2010.07121.x; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TOLKACHEVA T, 1994, INFECT IMMUN, V62, P2849, DOI 10.1128/IAI.62.7.2849-2856.1994; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Wang L, 2011, MOL MICROBIOL, V81, P1484, DOI 10.1111/j.1365-2958.2011.07783.x; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wang P, 2004, CURR GENET, V46, P247, DOI 10.1007/s00294-004-0529-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Xue CY, 2008, MOL MICROBIOL, V70, P379, DOI 10.1111/j.1365-2958.2008.06417.x; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	63	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12202	12216		10.1074/jbc.M113.537183	http://dx.doi.org/10.1074/jbc.M113.537183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24659785	hybrid, Green Published			2022-12-28	WOS:000335581400003
J	Lee, H; Yoon, Y				Lee, Hakjoo; Yoon, Yisang			Transient Contraction of Mitochondria Induces Depolarization through the Inner Membrane Dynamin OPA1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer; Membrane; Membrane Fusion; Mitochondria; Drp1; OPA1; Dynamin; Mitochondrial Fission; Proton Leak	PERMEABILITY TRANSITION PORE; TRANSMITTING CABLES; CARDIAC MYOCYTES; OXIDATIVE STRESS; FUSION; RELEASE; ORGANIZATION; MORPHOLOGY; FISSION; CARDIOMYOCYTES	Background: Simultaneous fluctuation of the inner membrane potential in filamentous mitochondria suggests electrical and functional connection. Results: Transient contraction of mitochondrial matrix induces depolarization through the inner membrane fusion dynamin OPA1. Conclusion: Transient mitochondrial contraction is a previously unrecognized cellular mechanism that induces depolarization. Significance: Transient morphological contraction of mitochondria represents a new mechanism regulating mitochondrial activity. Dynamin-related membrane remodeling proteins regulate mitochondrial morphology by mediating fission and fusion. Although mitochondrial morphology is considered an important factor in maintaining mitochondrial function, a direct mechanistic link between mitochondrial morphology and function has not been defined. We report here a previously unrecognized cellular process of transient contraction of the mitochondrial matrix. Importantly, we found that this transient morphological contraction of mitochondria is accompanied by a reversible loss or decrease of inner membrane potential. Fission deficiency greatly amplified this phenomenon, which functionally exhibited an increase of inner membrane proton leak. We found that electron transport activity is necessary for the morphological contraction of mitochondria. Furthermore, we discovered that silencing the inner membrane-associated dynamin optic atrophy 1 (OPA1) in fission deficiency prevented mitochondrial depolarization and decreased proton leak without blocking mitochondrial contraction, indicating that OPA1 is a factor in coupling matrix contraction to mitochondrial depolarization. Our findings show that transient matrix contraction is a novel cellular mechanism regulating mitochondrial activity through the function of the inner membrane dynamin OPA1.	[Lee, Hakjoo; Yoon, Yisang] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Yoon, Y (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	yyoon@gru.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK078618, DK061991]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078618, R01DK061991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078618 and DK061991 (to Y.Y.).	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Diaz G, 2000, FEBS LETT, V475, P218, DOI 10.1016/S0014-5793(00)01683-5; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Galloway CA, 2012, DIABETES, V61, P2093, DOI 10.2337/db11-1640; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hattori T, 2005, BIOPHYS J, V88, P2340, DOI 10.1529/biophysj.104.041483; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jacobson J, 2002, J CELL SCI, V115, P1175; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Santo-Domingo J, 2013, EMBO J, V32, P1927, DOI 10.1038/emboj.2013.124; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	39	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11862	11872		10.1074/jbc.M113.533299	http://dx.doi.org/10.1074/jbc.M113.533299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627489	Green Published, hybrid			2022-12-28	WOS:000335010600028
J	Fye, JM; Coffin, SR; Orebaugh, CD; Hollis, T; Perrino, FW				Fye, Jason M.; Coffin, Stephanie R.; Orebaugh, Clinton D.; Hollis, Thomas; Perrino, Fred W.			The Arg-62 Residues of the TREX1 Exonuclease Act Across the Dimer Interface Contributing to Catalysis in the Opposing Protomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; DNA; DNase; Enzyme Mechanisms; Nucleic Acid; TREX1; Dimer; Exonuclease	AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DOMINANT MUTATIONS; GENE; TERMINI; IDENTIFICATION; ERYTHEMATOSUS; ENCEPHALITIS; EXPRESSION; REVEALS	Background: The structure of TREX1 exonuclease identifies key residues positioned at the stable dimer interface. Results: The TREX1 Arg-62 acts across the dimer interface to affect DNA binding and catalysis in the opposing protomer. Conclusion: TREX1 is a functional dimer. Significance: These data help us understand how heterozygous TREX1 mutations can contribute to disease. TREX1 is a 3-deoxyribonuclease that degrades single- and double-stranded DNA (ssDNA and dsDNA) to prevent inappropriate nucleic acid-mediated immune activation. More than 40 different disease-causing TREX1 mutations have been identified exhibiting dominant and recessive genetic phenotypes in a spectrum of autoimmune disorders. Mutations in TREX1 at positions Asp-18 and Asp-200 to His and Asn exhibit dominant autoimmune phenotypes associated with the clinical disorders familial chilblain lupus and Aicardi-Goutieres syndrome. Our previous biochemical studies showed that the TREX1 dominant autoimmune disease phenotype depends upon an intact DNA-binding process coupled with dysfunctional active site chemistry. Studies here show that the TREX1 Arg-62 residues extend across the dimer interface into the active site of the opposing protomer to coordinate substrate DNA and to affect catalysis in the opposing protomer. The TREX1(R62A/R62A) homodimer exhibits approximate to 50-fold reduced ssDNA and dsDNA degradation activities relative to TREX1(WT). The TREX1 D18H, D18N, D200H, and D200N dominant mutant enzymes were prepared as compound heterodimers with the TREX1 R62A substitution in the opposing protomer. The TREX1(D18H/R62A), TREX1(D18N/R62A), TREX1(D200H/R62A), and TREX1(D200N/R62A) compound heterodimers exhibit higher levels of ss- and dsDNA degradation activities than the homodimers demonstrating the requirement for TREX1 Arg-62 residues to provide necessary structural elements for full catalytic activity in the opposing TREX1 protomer. This concept is further supported by the loss of dominant negative effects in the TREX1 D18H, D18N, D200H, and D200N compound heterodimers. These data provide compelling evidence for the required TREX1 dimeric structure for full catalytic function.	[Fye, Jason M.; Coffin, Stephanie R.; Orebaugh, Clinton D.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wakehealth.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [257437]; American Heart Association [10GRNT3650033]; Wake Forest School of Medicine Postdoctoral Fellowship Award [F32GM095290]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095290, R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); Wake Forest School of Medicine Postdoctoral Fellowship Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM069962 (to F. W. P.), Alliance for Lupus Research Grant 257437 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T. H.), and by Wake Forest School of Medicine Postdoctoral Fellowship Award F32GM095290 (to S. R. C.).	Bailey SL, 2012, DNA REPAIR, V11, P65, DOI 10.1016/j.dnarep.2011.10.007; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Vries B, 2010, ANN RHEUM DIS, V69, P1886, DOI 10.1136/ard.2009.114157; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gruver AM, 2011, J NEURO-OPHTHALMOL, V31, P20, DOI 10.1097/WNO.0b013e3181f45dba; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Harrigan JA, 2007, MECH AGEING DEV, V128, P259, DOI 10.1016/j.mad.2006.12.005; Hedrich CM, 2008, CLIN RHEUMATOL, V27, P949, DOI 10.1007/s10067-008-0942-9; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P5955, DOI 10.1021/bi030046f; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Orebaugh CD, 2013, J BIOL CHEM, V288, P28881, DOI 10.1074/jbc.M113.503391; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Perrino Fred W., 1999, Cell Biochemistry and Biophysics, V30, P331, DOI 10.1007/BF02738118; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Prendiville JS, 2009, J AM ACAD DERMATOL, V61, P727, DOI 10.1016/j.jaad.2009.05.002; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stam AH, 2009, CEPHALALGIA, V29, P1006, DOI 10.1111/j.1468-2982.2009.01940.x; Stephenson JBP, 2008, EUR J PAEDIATR NEURO, V12, P355, DOI 10.1016/j.ejpn.2007.11.010; Tungler V, 2012, BRIT J DERMATOL, V167, P212, DOI 10.1111/j.1365-2133.2012.10813.x	39	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11556	11565		10.1074/jbc.M114.559252	http://dx.doi.org/10.1074/jbc.M114.559252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616097	Green Published, hybrid			2022-12-28	WOS:000334638500055
J	Wei, Y; Li, LM; Wang, D; Zhang, CY; Zen, K				Wei, Yao; Li, Limin; Wang, Dong; Zhang, Chen-Yu; Zen, Ke			Importin 8 Regulates the Transport of Mature MicroRNAs into the Cell Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MicroRNA; Nuclear Transport; Polymerase Chain Reaction (PCR); RNA Processing; siRNA	PORE COMPLEX; EXPORT; BIOGENESIS; CYTOPLASM; ARGONAUTE; SIRNAS	Background: The mechanism underlying the re-entering of mature miRNAs into the nucleus remains unknown. Results: IPO8 mediates the transport of mature miRNAs into the nucleus through binding to Ago2. Conclusion: IPO8 is a candidate carrier for nuclear import of mature miRNAs. Significance: This finding extends the gene regulatory network of miRNAs. Mature microRNAs (miRNAs), approximate to 22-nucleotide noncoding RNAs regulating target gene expression at the post-transcriptional level, have been recently shown to be transported into the nucleus where they modulate the biogenesis of other miRNAs or their own expression. However, the mechanism that governs the transport of mature miRNAs from cytoplasm to nucleus remains unknown. Here, we report that importin 8 (IPO8), a member of the karyopherin (also named the protein import receptor importin ) family, plays a critical role in mediating the cytoplasm-to-nucleus transport of mature miRNAs. Specifically knocking down IPO8 but not other karyopherin family proteins via siRNA significantly decreases the nuclear transport of various known nucleus-enriched miRNAs without affecting their total cellular levels. IPO8-mediated nuclear transport of mature miRNAs is also dependent on the association of IPO8 with the Argonaute 2 (Ago2) complex. Cross-immunoprecipitation and Western blot analysis show that IPO8 is physically associated with Ago2. Knocking down IPO8 via siRNA markedly decreases the nuclear transport of Ago2 but does not affect the total cellular Ago2 level. Furthermore, dissociating the binding of miRNAs with Ago2 by trypaflavine strongly reduces the IPO8-mediated nuclear transport of miRNAs.	[Wei, Yao; Li, Limin; Wang, Dong; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Li, LM (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	bixuehan2005@163.com; cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China [2012CB517603, 2011CB504803863]; National Natural Science Foundation of China [31301061, 30890044, 30800946]; Natural Science Foundation of Jiangsu Province [BK2011013, BK20130564]; Specialized Research Fund for the Doctoral Program of Higher Education [20130091120037]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Basic Research Program of China Grants 2012CB517603 and 2011CB504803863, National Natural Science Foundation of China Grants 31301061, 30890044, 30800946, the Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK20130564), and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130091120037.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Foldes-Papp Z, 2009, CURR PHARM BIOTECHNO, V10, P569, DOI 10.2174/138920109789069332; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	22	86	87	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10270	10275		10.1074/jbc.C113.541417	http://dx.doi.org/10.1074/jbc.C113.541417			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596094	Green Published, hybrid			2022-12-28	WOS:000334226400004
J	Al-Huseini, LMA; Yeang, HXA; Hamdam, JM; Sethu, S; Alhumeed, N; Wong, W; Sathish, JG				Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.			Heme Oxygenase-1 Regulates Dendritic Cell Function through Modulation of p38 MAPK-CREB/ATF1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-CELLS; NF-KAPPA-B; TRANSCRIPTION FACTOR; CARBON-MONOXIDE; ACTIVATION; MATURATION; LIPOPOLYSACCHARIDE; RECEPTOR; NRF2; COSTIMULATION	Dendritic cells (DCs) are critical for the initiation of immune responses including activation of CD8T cells. Intracellular reactive oxygen species (ROS) levels influence DC maturation and function. Intracellular heme, a product of catabolism of heme-containing metalloproteins, is a key inducer of ROS. Intracellular heme levels are regulated by heme oxygenase-1 (HO-1), which catalyzes the degradation of heme. Heme oxygenase-1 has been implicated in regulating DC maturation; however, its role in other DC functions is unclear. Furthermore, the signaling pathways modulated by HO-1 in DCs are unknown. In this study, we demonstrate that inhibition of HO-1 activity in murine bone marrow-derived immature DCs (iDCs) resulted in DCs with raised intracellular ROS levels, a mature phenotype, impaired phagocytic and endocytic function, and increased capacity to stimulate antigen-specific CD8 T cells. Interestingly, our results reveal that the increased ROS levels following HO-1 inhibition did not underlie the changes in phenotype and functions observed in these iDCs. Importantly, we show that the p38 mitogen-activated protein kinase (p38 MAPK), cAMP-responsive element binding protein (CREB), and activating transcription factor 1 (ATF1) pathway is involved in the mediation of the phenotypic and functional changes arising from HO-1 inhibition. Furthermore, up-regulation of HO-1 activity rendered iDCs refractory to lipopolysaccharide-induced activation of p38 MAPK-CREB/ATF1 pathway and DC maturation. Finally, we demonstrate that treatment of iDC with the HO-1 substrate, heme, recapitulates the effects that result from HO-1 inhibition. Based on these results, we conclude that HO-1 regulates DC maturation and function by modulating the p38 MAPK-CREB/ATF1 signaling axis.	[Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.] Univ Liverpool, Ctr Drug Safety Sci, MRC, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Hamdam, Junnat M.; Sethu, Swaminathan; Alhumeed, Naif; Wong, Wai; Sathish, Jean G.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.] Al Qadisiyah Univ, Coll Med, Dept Pharmacol & Therapeut, Diwaniyah 58001, Iraq	University of Liverpool; University of Liverpool; University of Al-Qadisiyah	Sathish, JG (corresponding author), Univ Liverpool, Ctr Drug Safety Sci, MRC, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	Jean.Sathish@liv.ac.uk	Sethu, Swaminathan/R-8577-2019; Alhumeed, Naif/AAR-7956-2021; Al-Huseini, Laith M Abbas/S-6613-2019	Alhumeed, Naif/0000-0001-5221-3073; Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility	University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility	We thank the University of Liverpool Technology Directorate Flow Cytometry and Cell Sorting Facility for expert advice and support.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Al-Huseini LMA, 2013, J BIOL CHEM, V288, P22281, DOI 10.1074/jbc.M113.483420; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bachmann MF, 1999, EUR J IMMUNOL, V29, P2156, DOI 10.1002/(SICI)1521-4141(199907)29:07<2156::AID-IMMU2156>3.0.CO;2-P; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Burnaugh L, 2007, THERIOGENOLOGY, V67, P580, DOI 10.1016/j.theriogenology.2006.07.021; Casals C, 2007, J IMMUNOL, V178, P6307, DOI 10.4049/jimmunol.178.10.6307; Chai JG, 1999, J IMMUNOL, V163, P1298; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Cheng C, 2010, CIRC RES, V106, P1656, DOI 10.1161/CIRCRESAHA.110.216945; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dang TN, 2011, NEUROCHEM INT, V58, P804, DOI 10.1016/j.neuint.2011.03.006; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fanger NA, 1996, J IMMUNOL, V157, P541; FIBACH E, 1995, BLOOD, V85, P2967, DOI 10.1182/blood.V85.10.2967.bloodjournal85102967; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kemball CC, 2006, J IMMUNOL, V176, P1814, DOI 10.4049/jimmunol.176.3.1814; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Matos TJ, 2005, IMMUNOL CELL BIOL, V83, P607, DOI 10.1111/j.1440-1711.2005.01378.x; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Schumacher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042301; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	52	45	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16442	16451		10.1074/jbc.M113.532069	http://dx.doi.org/10.1074/jbc.M113.532069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719331	Green Published, hybrid			2022-12-28	WOS:000337965700046
J	Ding, KS; Banerjee, A; Tan, S; Zhao, JS; Zhuang, Q; Li, R; Qian, PX; Liu, SL; Wu, ZS; Lobie, PE; Zhu, T				Ding, Keshuo; Banerjee, Arindam; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Lobie, Peter E.; Zhu, Tao			Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BCL-2 EXPRESSION; GROWTH; RECEPTOR; ACTIVATION; HERCEPTIN; GDNF; HER2; NEU	Previous studies have demonstrated that Artemin (ARTN) functions as a cancer stem cell (CSC) and metastatic factor in mammary carcinoma. Herein, we report that ARTN mediates acquired resistance to trastuzumab in HER2-positive mammary carcinoma cells. Ligands that increase HER2 activity increased ARTN expression in HER2-positive mammary carcinoma cells, whereas trastuzumab inhibited ARTN expression. Forced expression of ARTN decreased the sensitivity of HER2-positive mammary carcinoma cells to trastuzumab both in vitro and in vivo. Conversely, siRNA-mediated depletion of ARTN enhanced trastuzumab efficacy. Cells with acquired resistance to trastuzumab exhibited increased ARTN expression, the depletion of which restored trastuzumab sensitivity. Trastuzumab resistance produced an increased CSC population concomitant with enhanced mammospheric growth. ARTN mediated the enhancement of the CSC population by increased BCL-2 expression, and the CSC population in trastuzumab-resistant cells was abrogated upon inhibition of BCL-2. Hence, we conclude that ARTN is one mediator of acquired resistance to trastuzumab in HER2-positive mammary carcinoma cells.	[Ding, Keshuo; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Ding, Keshuo; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wu, Zheng-Sheng] Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China; [Wu, Zheng-Sheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Banerjee, Arindam; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Banerjee, Arindam; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Hlth Syst, Natl Canc Inst Singapore, Singapore 119074, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Fudan University; National University of Singapore; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	liu, suling/AAF-5249-2019; Zhu, Tao/H-3495-2018; Liu, Suling/N-2796-2013; tan, sheng/GSN-2599-2022; Qian, Pengxu/B-9376-2016	liu, suling/0000-0002-0475-0242; Liu, Suling/0000-0002-0475-0242; Qian, Pengxu/0000-0001-5636-6704	National Key Scientific Programme of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [1272925, 31201022]; Chinese Academy of Sciences [XDA01040410]; Cancer Science Institute through Ministry of Education, Singapore; National Research Foundation, Singapore	National Key Scientific Programme of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Cancer Science Institute through Ministry of Education, Singapore(Ministry of Education, Singapore); National Research Foundation, Singapore(National Research Foundation, Singapore)	This work was funded by The National Key Scientific Programme of China Grants 2012CB934002 and 2010CB912804, The National Natural Science Foundation of China Grants 1272925 and 31201022, Chinese Academy of Sciences Grant XDA01040410, and The Cancer Science Institute through grants from The Ministry of Education, Singapore and National Research Foundation, Singapore. P. E. L. is an inventor on PCT/NZ2008/000152 and derivatives thereof and on PCT/NZ2010/000207 and derivatives thereof. Z. T. and P. E. L. previously received consultancies from Saratan Therapeutics Ltd. (a biotech company formed around the potential to use Artemin as a target for breast cancer).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Banerjee A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050098; Banerjee A, 2012, J BIOL CHEM, V287, P42502, DOI 10.1074/jbc.M112.365163; Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Bedard PL, 2009, J MAMMARY GLAND BIOL, V14, P55, DOI 10.1007/s10911-009-9116-x; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Bilak MM, 2001, NEUROREPORT, V12, P2531, DOI 10.1097/00001756-200108080-00048; Chakrabarty A, 2013, CANCER RES, V73, P1190, DOI 10.1158/0008-5472.CAN-12-2440; Crawford Anatasha, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P184; D'Costa AP, 1998, J NEUROBIOL, V36, P379; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Duru N, 2012, CLIN CANCER RES, V18, P6634, DOI 10.1158/1078-0432.CCR-12-1436; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gradishar WJ, 2013, ANN ONCOL, V24, P2492, DOI 10.1093/annonc/mdt217; Huang Y, 2013, CURR DRUG TARGETS, V14, P889, DOI 10.2174/13894501113149990161; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kurokawa H, 2000, CANCER RES, V60, P5887; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Milella M, 2004, CLIN CANCER RES, V10, P7747, DOI 10.1158/1078-0432.CCR-04-0908; Minami T, 2012, MOL CANCER THER, V11, P830, DOI 10.1158/1535-7163.MCT-11-0884; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2012, BREAST CANCER-TARGET, V4, P53, DOI 10.2147/BCTT.S24976; Nahta R, 2012, BREAST CANCER RES TR, V135, P39, DOI 10.1007/s10549-012-2067-8; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Park BH, 2007, CANCER CELL, V12, P297, DOI 10.1016/j.ccr.2007.10.004; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Tawfik K, 2012, HUM PATHOL, V43, P23, DOI 10.1016/j.humpath.2011.04.011; Tseng PH, 2006, MOL PHARMACOL, V70, P1534, DOI 10.1124/mol.106.023911; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wong ALA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/415170; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Wu ZS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-34; Yang QF, 2009, BREAST CANCER RES TR, V115, P343, DOI 10.1007/s10549-008-0068-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	52	24	34	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16057	16071		10.1074/jbc.M113.529552	http://dx.doi.org/10.1074/jbc.M113.529552			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737320	Green Published, hybrid			2022-12-28	WOS:000337965700015
J	Don-Doncow, N; Escobar, Z; Johansson, M; Kjellstrom, S; Garcia, V; Munoz, E; Sterner, O; Bjartell, A; Hellsten, R				Don-Doncow, Nicholas; Escobar, Zilma; Johansson, Martin; Kjellstrom, Sven; Garcia, Victor; Munoz, Eduardo; Sterner, Olov; Bjartell, Anders; Hellsten, Rebecka			Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING STAT3; PATHWAY; ACTIVATION; PROTEINS; TRANSDUCER; EXPRESSION; MUTATIONS	The transcription factor STAT3 is constitutively active in several malignancies including castration-resistant prostate cancer and has been identified as a promising therapeutic target. The fungal metabolite galiellalactone, a STAT3 signaling inhibitor, inhibits the growth, both in vitro and in vivo, of prostate cancer cells expressing active STAT3 and induces apoptosis of prostate cancer stem cell-like cells expressing phosphorylated STAT3 (pSTAT3). However, the molecular mechanism of this STAT3-inhibiting effect by galiellalactone has not been clarified. A biotinylated analogue of galiellalactone (GL-biot) was synthesized to be used for identification of galiellalactone target proteins. By adding streptavidin-Sepharose beads to GL-biot-treated DU145 cell lysates, STAT3 was isolated and identified as a target protein. Confocal microscopy revealed GL-biot in both the cytoplasm and the nucleus of DU145 cells treated with GL-biot, appearing to co-localize with STAT3 in the nucleus. Galiellalactone inhibited STAT3 binding to DNA in DU145 cell lysates without affecting phosphorylation status of STAT3. Mass spectrometry analysis of recombinant STAT3 protein pretreated with galiellalactone revealed three modified cysteines (Cys-367, Cys-468, and Cys-542). Here we demonstrate with chemical and molecular pharmacological methods that galiellalactone is a cysteine reactive inhibitor that covalently binds to one or more cysteines in STAT3 and that this leads to inhibition of STAT3 binding to DNA and thus blocks STAT3 signaling without affecting phosphorylation. This further validates galiellalactone as a promising direct STAT3 inhibitor for treatment of castration-resistant prostate cancer.	[Don-Doncow, Nicholas; Johansson, Martin; Bjartell, Anders; Hellsten, Rebecka] Lund Univ, Div Urol Canc, SE-20502 Malmo, Sweden; [Escobar, Zilma; Sterner, Olov] Lund Univ, Div Organ Chem, SE-22100 Lund, Sweden; [Kjellstrom, Sven] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Garcia, Victor; Munoz, Eduardo] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Inst Res Biomed Cordoba, E-14004 Cordoba, Spain	Lund University; Lund University; Lund University; Universidad de Cordoba	Hellsten, R (corresponding author), Lund Univ, CMP, Div Urol Canc, Malmo Univ Hosp, Jan Waldenstroms Gata 59, SE-20502 Malmo, Sweden.	rebecka.hellsten@med.lu.se	Munoz, Eduardo/I-5225-2012; Don-Doncow, Nicholas/ABB-7450-2020	Munoz, Eduardo/0000-0001-8478-5842; Kjellstrom, Sven/0000-0003-4646-5279	Swedish Cancer Society; Swedish Research Council Medicine; National Health Service, Lund University (Sweden); Lund University (BioCare); Goteborg University (BioCare); Percy Falk Foundation; Gunnar Nilsson Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); National Health Service, Lund University (Sweden); Lund University (BioCare); Goteborg University (BioCare); Percy Falk Foundation; Gunnar Nilsson Cancer Foundation	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council Medicine, government funding of clinical research within the National Health Service, Lund University (Sweden), governmental strategic funding for cancer research at Lund and Goteborg Universities (BioCare), the Percy Falk Foundation, and the Gunnar Nilsson Cancer Foundation.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hellsten R, 2008, PROSTATE, V68, P269, DOI 10.1002/pros.20699; Hellsten R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022118; Horinaga M, 2005, UROLOGY, V66, P671, DOI 10.1016/j.urology.2005.03.066; Johansson M, 2001, ORG LETT, V3, P2843, DOI 10.1021/ol016286+; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081, DOI 10.6004/jnccn.2012.0114; Mora LB, 2002, CANCER RES, V62, P6659; Perez M, 2014, CHEM-BIOL INTERACT, V214, P69, DOI 10.1016/j.cbi.2014.02.012; Peyser ND, 2013, ONCOTARGETS THER, V6, P999, DOI 10.2147/OTT.S47903; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Quintas-Cardama A., 2013, CLIN CANCER RES, V19, P1933; Rudolph K, 2013, CYTOKINE, V61, P285, DOI 10.1016/j.cyto.2012.10.011; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sellier H., 2013, JAK STAT, V2; Shodeinde AL, 2012, ONCOTARGETS THER, V5, P119, DOI 10.2147/OTT.S32559; Sridhar SS, 2014, EUR UROL, V65, P289, DOI 10.1016/j.eururo.2013.08.008; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; von Nussbaum F, 2004, EUR J ORG CHEM, V2004, P2783, DOI 10.1002/ejoc.200400137; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3; Yang J, 2005, CANCER RES, V65, P939; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zgheib C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043313	36	69	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15969	15978		10.1074/jbc.M114.564252	http://dx.doi.org/10.1074/jbc.M114.564252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755219	hybrid, Green Published			2022-12-28	WOS:000337965700008
J	Fjaere, E; Aune, UL; Roen, K; Keenan, AH; Ma, T; Borkowski, K; Kristensen, DM; Novotny, GW; Mandrup-Poulsen, T; Hudson, BD; Milligan, G; Xi, YN; Newman, JW; Haj, FG; Liaset, B; Kristiansen, K; Madsen, L				Fjaere, Even; Aune, Ulrike L.; Roen, Kristin; Keenan, Alison H.; Ma, Tao; Borkowski, Kamil; Kristensen, David M.; Novotny, Guy W.; Mandrup-Poulsen, Thomas; Hudson, Brian D.; Milligan, Graeme; Xi, Yannan; Newman, John W.; Haj, Fawaz G.; Liaset, Bjorn; Kristiansen, Karsten; Madsen, Lise			Indomethacin Treatment Prevents High Fat Diet-induced Obesity and Insulin Resistance but Not Glucose Intolerance in C57BL/6J Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID; CYCLOOXYGENASE-2; HOMEOSTASIS; SECRETION; PROSTAGLANDIN-E2; ACCUMULATION; INFLAMMATION; FFA1/GPR40; METABOLISM; DISCOVERY	Chronic low grade inflammation is closely linked to obesity-associated insulin resistance. To examine how administration of the anti-inflammatory compound indomethacin, a general cyclooxygenase inhibitor, affected obesity development and insulin sensitivity, we fed obesity-prone male C57BL/6J mice a high fat/high sucrose (HF/HS) diet or a regular diet supplemented or not with indomethacin (+/- INDO) for 7 weeks. Development of obesity, insulin resistance, and glucose intolerance was monitored, and the effect of indomethacin on glucose-stimulated insulin secretion (GSIS) was measured in vivo and in vitro using MIN6 beta-cells. We found that supplementation with indomethacin prevented HF/HS-induced obesity and diet-induced changes in systemic insulin sensitivity. Thus, HF/HS+INDO-fed mice remained insulin-sensitive. However, mice fed HF/HS+INDO exhibited pronounced glucose intolerance. Hepatic glucose output was significantly increased. Indomethacin had no effect on adipose tissue mass, glucose tolerance, or GSIS when included in a regular diet. Indomethacin administration to obese mice did not reduce adipose tissue mass, and the compensatory increase in GSIS observed in obese mice was not affected by treatment with indomethacin. We demonstrate that indomethacin did not inhibit GSIS per se, but activation of GPR40 in the presence of indomethacin inhibited glucose-dependent insulin secretion in MIN6 cells. We conclude that constitutive high hepatic glucose output combined with impaired GSIS in response to activation of GPR40-dependent signaling in the HF/HS+INDO-fed mice contributed to the impaired glucose clearance during a glucose challenge and that the resulting lower levels of plasma insulin prevented the obesogenic action of the HF/HS diet.	[Fjaere, Even; Aune, Ulrike L.; Roen, Kristin; Keenan, Alison H.; Ma, Tao; Borkowski, Kamil; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Fjaere, Even; Aune, Ulrike L.; Milligan, Graeme; Liaset, Bjorn; Madsen, Lise] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Keenan, Alison H.; Xi, Yannan; Newman, John W.; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Kristensen, David M.] Univ Rennes 1, INSERM, U1085, IRSET, Rennes, France; [Kristensen, David M.] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Novotny, Guy W.; Mandrup-Poulsen, Thomas] Univ 2200 Copenhagen, Dept Biomed Sci, Sect Endocrinol Res, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, S-17177 Solna, Sweden; [Hudson, Brian D.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Newman, John W.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA 95616 USA	University of Copenhagen; University of California System; University of California Davis; University of California System; University of California Davis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Copenhagen; Karolinska Institutet; University of Glasgow; United States Department of Agriculture (USDA)	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kk@bio.ku.dk; lise.madsen@nifes.no	Hudson, B. D./H-4845-2013; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Hudson, B. D./0000-0001-7059-0091; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Kristensen, David Mobjerg/0000-0003-0657-1632; Newman, John/0000-0001-9632-6571; Liaset, Bjorn/0000-0002-8652-7801; Novotny, Guy/0000-0002-1828-1053	National Institutes of Health [RO1DK090492]; European Union FP7 project DIABAT [HEALTH-F2-2011-278373]; Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen; NIFES; Danish Council for Strategic Research Grant [2101 06 0005, 11-116196]; Juvenile Diabetes Research Foundation [1-2009-337]; United States Department of Agriculture Agricultural Research Service Grants [5306-51000-016-00D, 5306-51000-019-00D]; National Institute of Food and Agriculture National Needs Fellowship [2008-38420-04759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492, R01DK095359, U24DK092993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FP7 project DIABAT; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen; NIFES; Danish Council for Strategic Research Grant(Danske Strategiske Forskningsrad (DSF)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United States Department of Agriculture Agricultural Research Service Grants; National Institute of Food and Agriculture National Needs Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK090492 (to F. G. H.). This work was also supported by the European Union FP7 project DIABAT (HEALTH-F2-2011-278373), the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen, and NIFES. Part of this work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by Danish Council for Strategic Research Grant 2101 06 0005. Part of this work was also supported by Danish Council for Strategic Research Grant 11-116196 for the FFARMED project. The laboratory of F. G. H. is supported by Juvenile Diabetes Research Foundation Grant 1-2009-337. This study was supported in part by intramural funds from United States Department of Agriculture Agricultural Research Service Grants 5306-51000-016-00D (to J. W. N.) and 5306-51000-019-00D (to J. W. N.) and National Institute of Food and Agriculture National Needs Fellowship 2008-38420-04759 (to A. H. K.).	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Arias AMP, 2000, METABOLISM, V49, P839, DOI 10.1053/meta.2000.6748; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brown PJ, 1997, CHEM BIOL, V4, P909, DOI 10.1016/S1074-5521(97)90299-4; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Christiansen E, 2013, ACS MED CHEM LETT, V4, P441, DOI 10.1021/ml4000673; Christiansen E, 2010, ACS MED CHEM LETT, V1, P345, DOI 10.1021/ml100106c; Dikopoulos N, 2007, EUR J CLIN INVEST, V37, P222, DOI 10.1111/j.1365-2362.2007.01779.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Jaradat MS, 2001, BIOCHEM PHARMACOL, V62, P1587, DOI 10.1016/S0006-2952(01)00822-X; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Malaisse WJ, 2012, ARCH BIOCHEM BIOPHYS, V517, P138, DOI 10.1016/j.abb.2011.11.014; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Poitout V, 2013, DIABETOLOGIA, V56, P231, DOI 10.1007/s00125-012-2788-6; RICHELSEN B, 1987, ENDOCRINOLOGY, V121, P1221, DOI 10.1210/endo-121-4-1221; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; SEIBERT K, 1994, RECEPTOR, V4, P17; Stephensen CB, 2011, J LIPID RES, V52, P991, DOI 10.1194/jlr.P012864; TOPOL E, 1980, DIABETES, V29, P379, DOI 10.2337/diabetes.29.5.379; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wan SG, 2011, INT J CANCER, V129, P331, DOI 10.1002/ijc.25688; YAMAMOTO F, 1980, Gastroenterologia Japonica, V15, P433	44	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16032	16045		10.1074/jbc.M113.525220	http://dx.doi.org/10.1074/jbc.M113.525220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742673	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000337965700013
J	Mills, LD; Zhang, LZ; Marler, R; Svingen, P; Fernandez-Barrena, MG; Dave, M; Bamlet, W; McWilliams, RR; Petersen, GM; Faubion, W; Fernandez-Zapico, ME				Mills, Lisa D.; Zhang, Lizhi; Marler, Ronald; Svingen, Phyllis; Fernandez-Barrena, Maite G.; Dave, Maneesh; Bamlet, William; McWilliams, Robert R.; Petersen, Gloria M.; Faubion, William; Fernandez-Zapico, Martin E.			Inactivation of the Transcription Factor GLI1 Accelerates Pancreatic Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; BREAST-CANCER; TUMOR MICROENVIRONMENT; INTRAEPITHELIAL NEOPLASIA; MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; BLADDER-CANCER; IMMUNE EVASION; SELF-RENEWAL; EXPRESSION	The role of GLI1 in pancreatic tumor initiation promoting the progression of preneoplastic lesions into tumors is well established. However, its function at later stages of pancreatic carcinogenesis remains poorly understood. To address this issue, we crossed the gli1 knock-out (GKO) animal with cre-dependent pancreatic activation of oncogenic kras concomitant with loss of the tumor suppressor tp53 (KPC). Interestingly, in this model, GLI1 played a tumor-protective function, where survival of GKO/KPC mice was reduced compared with KPC littermates. Both cohorts developed pancreatic cancer without significant histopathological differences in survival studies. However, analysis of mice using ultrasound-based imaging at earlier time points showed increased tumor burden in GKO/KPC mice. These animals have larger tumors, decreased body weight, increased lactate dehydrogenase production, and severe leukopenia. In vivo and in vitro expression studies identified FAS and FAS ligand (FASL) as potential mediators of this phenomenon. The FAS/FASL axis, an apoptotic inducer, plays a role in the progression of pancreatic cancer, where its expression is usually lost or significantly reduced in advanced stages of the disease. Chromatin immunoprecipitation and reporter assays identified FAS and FASL as direct targets of GLI1, whereas GKO/KPC mice showed lower levels of this ligand compared with KPC animals. Finally, decreased levels of apoptosis were detected in tumor tissue in the absence of GLI1 by TUNEL staining. Together, these findings define a novel pathway regulated by GLI1 controlling pancreatic tumor progression and provide a new theoretical framework to help with the design and analysis of trials targeting GLI1-related pathways.	[Mills, Lisa D.; Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Zhang, Lizhi] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA; [Svingen, Phyllis; Dave, Maneesh; Faubion, William] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Bamlet, William] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [McWilliams, Robert R.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Petersen, Gloria M.] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA; [Marler, Ronald] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Bamlet, William/0000-0003-2903-1284	National Institutes of Health from NCI [CA136526, P50 CA102701, P30 DK84567]; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136526, Grant P50 CA102701 (Mayo Clinic Pancreatic SPORE), and P30 DK84567 (Mayo Clinic Center for Cell Signaling in Gastroenterology) (to M. E. F.-Z.) from NCI.	Balmanoukian A, 2012, CANCER INVEST, V30, P571, DOI 10.3109/07357907.2012.700987; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bennett MW, 2001, J CLIN PATHOL, V54, P598, DOI 10.1136/jcp.54.8.598; Boldrini L, 2001, ONCOGENE, V20, P6632, DOI 10.1038/sj.onc.1204727; Butt Adeel A., 2002, International Journal of Infectious Diseases, V6, P178, DOI 10.1016/S1201-9712(02)90107-4; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Chen MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061901; Ciucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060145; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cui DM, 2010, J NEUROL SCI, V288, P156, DOI 10.1016/j.jns.2009.09.006; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; FERRARIS AM, 1979, BLOOD, V54, P928; Fogar P, 2011, PANCREAS, V40, P1131, DOI 10.1097/MPA.0b013e31822077b8; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Harmsma M, 2013, BBA-REV CANCER, V1836, P255, DOI 10.1016/j.bbcan.2013.06.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang FT, 2012, INT J ONCOL, V41, P1707, DOI 10.3892/ijo.2012.1597; Husain K, 2013, CARCINOGENESIS, V34, P858, DOI 10.1093/carcin/bgt002; Inoue K, 2000, CANCER RES, V60, P2290; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Kornmann M, 1999, CANCER RES, V59, P3505; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Li Y, 2012, HISTOL HISTOPATHOL, V27, P475, DOI 10.14670/HH-27.475; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Lu JT, 2012, ACTA PHARMACOL SIN, V33, P691, DOI 10.1038/aps.2012.24; Maas S, 2004, UROLOGY, V63, P392, DOI 10.1016/j.urology.2003.08.023; Maftouh M, 2014, BRIT J CANCER, V110, P172, DOI 10.1038/bjc.2013.681; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Moutasim KA, 2014, J PATHOL, V233, P196, DOI 10.1002/path.4342; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orchekowski R, 2005, CANCER RES, V65, P11193, DOI 10.1158/0008-5472.CAN-05-1436; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sastra Stephen A, 2013, Methods Mol Biol, V980, P249, DOI 10.1007/978-1-62703-287-2_13; Sheng WW, 2014, HISTOPATHOLOGY, V64, P523, DOI 10.1111/his.12273; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tredan O, 2013, EUR J CANCER, V49, P1673, DOI 10.1016/j.ejca.2012.11.028; Volkmann M, 2001, J MOL MED-JMM, V79, P594, DOI 10.1007/s001090100244; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yang SH, 2013, ONCOLOGY-BASEL, V85, P86, DOI 10.1159/000353452	61	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16516	16525		10.1074/jbc.M113.539031	http://dx.doi.org/10.1074/jbc.M113.539031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737325	hybrid, Green Published			2022-12-28	WOS:000337965700053
J	Chen, DN; Ma, YT; Liu, H; Zhou, QY; Li, JD				Chen, Dan-Na; Ma, Yan-Tao; Liu, Huadie; Zhou, Qun-Yong; Li, Jia-Da			Functional Rescue of Kallmann Syndrome-associated Prokineticin Receptor 2 (PKR2) Mutants Deficient in Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Molecular Chaperone; Protein Misfolding; Signal Transduction; Trafficking; PKR2; Kallmann Syndrome	PHARMACOLOGICAL CHAPERONES; QUALITY-CONTROL; INTRACELLULAR LOOP; COMPLEX GENETICS; OLFACTORY-BULB; PROTEIN; MUTATIONS; PROKR2; EXPRESSION; TRANSPORT	Mutations in the G protein-coupled prokineticin receptor 2 (PKR2) are known to cause Kallmann syndrome and idiopathic hypogonadotropic hypogonadism manifesting with delayed puberty and infertility. Some of the mutant receptors are not routed to the cell surface; instead, they are trapped in the cellular secretory pathway. The cell-permeant agonists/antagonists have been used to rescue some membrane receptors that are not targeted onto the cell membrane. Here, we chose three disease-associated mutations (W178S, G234D, and P290S), which all resulted in retention of PKR2 intracellularly. We show that a small molecule PKR2 antagonist (A457) dramatically increased cell surface expression and rescued the function of P290S PKR2, but had no effect on W178S and G234D PKR2. Furthermore, we also tested chemical chaperone glycerol on the cell surface expression and function of PKR2 mutants. Treatment with 10% glycerol significantly increased the cell surface expression and signaling of P290S and W178S PKR2. These data demonstrate that some Kallmann syndrome-associated, intracellularly retained mutant PKR2 receptors can be functionally rescued, suggesting a potential treatment strategy for patients bearing such mutations.	[Chen, Dan-Na; Ma, Yan-Tao; Liu, Huadie; Li, Jia-Da] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha 410219, Hunan, Peoples R China; [Li, Jia-Da] Hubei Univ Sci & Technol, Dept Pharmacol, Xianning 437100, Hubei, Peoples R China; [Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	Central South University; Changsha Medical University; Hubei University of Science & Technology; University of California System; University of California Irvine	Li, JD (corresponding author), Cent S Univ, State Key Lab Med Genet, 110 Xiangya St, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Li, Jia-Da/0000-0002-4236-3518	National Basic Research Program of China [2012CB517904]; National Natural Science Foundation of China [31371187, 30970958, 81070481]; Graduate Research and Innovation Projects of Hunan Province [CX2013B090]; Fundamental Research Fund for the Central Universities of Central South University [2013zzts270]; Ministry of Education of China; Lotus Scholar Professorship Funds from Hunan Province Government; Central South University of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Research and Innovation Projects of Hunan Province; Fundamental Research Fund for the Central Universities of Central South University; Ministry of Education of China(Ministry of Education, China); Lotus Scholar Professorship Funds from Hunan Province Government; Central South University of China	This work was supported by National Basic Research Program of China Grant 2012CB517904, National Natural Science Foundation of China Grants 31371187, 30970958, and 81070481, Graduate Research and Innovation Projects of Hunan Province Grant CX2013B090, Fundamental Research Fund for the Central Universities of Central South University Grant 2013zzts270, grants from the Ministry of Education of China, the Lotus Scholar Professorship Funds from Hunan Province Government, and a research grant provided by the Central South University of China.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bomberger JM, 2012, ADV EXP MED BIOL, V744, P25, DOI 10.1007/978-1-4614-2364-5_3; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Conn PM, 2010, TRENDS ENDOCRIN MET, V21, P190, DOI 10.1016/j.tem.2009.11.003; Conn PM, 2009, TRENDS PHARMACOL SCI, V30, P228, DOI 10.1016/j.tips.2009.02.002; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Dode C, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00019; Dode C, 2009, EUR J HUM GENET, V17, P139, DOI 10.1038/ejhg.2008.206; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Hardelin JP, 2008, SEX DEV, V2, P181, DOI 10.1159/000152034; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Janovick JA, 2013, P NATL ACAD SCI USA, V110, P21030, DOI 10.1073/pnas.1315194110; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Layman LC, 2013, J CLIN ENDOCR METAB, V98, P1860, DOI 10.1210/jc.2013-1624; Li JD, 2012, PROG BRAIN RES, V199, P119, DOI 10.1016/B978-0-444-59427-3.00028-9; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; NAFTOLIN F, 1971, NATURE, V232, P496, DOI 10.1038/232496a0; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Peng Z, 2011, J BIOL CHEM, V286, P16615, DOI 10.1074/jbc.M111.223784; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2010, FRONT HORM RES, V39, P142, DOI 10.1159/000312700; Raibekas AA, 1997, J BIOL CHEM, V272, P22248, DOI 10.1074/jbc.272.35.22248; Rajan RS, 2011, CURR MED CHEM, V18, P1; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020263; Sarfati J, 2013, EUR J ENDOCRINOL, V169, P805, DOI 10.1530/EJE-13-0419; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x; Zhou XT, 2013, BIOCHEM BIOPH RES CO, V439, P12, DOI 10.1016/j.bbrc.2013.08.039	46	15	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15518	15526		10.1074/jbc.M114.556381	http://dx.doi.org/10.1074/jbc.M114.556381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753254	hybrid, Green Published			2022-12-28	WOS:000337465400034
J	Chutake, YK; Costello, WN; Lam, C; Bidichandani, SI				Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina; Bidichandani, Sanjay I.			Altered Nucleosome Positioning at the Transcription Start Site and Deficient Transcriptional Initiation in Friedreich Ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Heterochromatin; Neurological Diseases; Nucleotide Repeat Disease; Transcription Promoter; Friedreich Ataxia; Expanded Triplet Repeat; Nucleosome Positioning; Transcription Start Site	DOT-TTC REPEATS; TRIPLET-REPEAT; FRATAXIN GENE; EPIGENETIC CHANGES; CLINICAL-FEATURES; DNA METHYLATION; STICKY DNA; GAA; EXPANSION; PROMOTERS	Background: Friedreich ataxia (FRDA) is caused by an expanded GAA triplet repeat (GAA-TR) mutation that results in FXN transcriptional deficiency. Results: Repressive chromatin spreads from the expanded GAA-TR mutation, switching off the FXN gene promoter. Conclusion: Reduced transcriptional initiation is the major cause of FXN transcriptional deficiency in FRDA. Significance: Reactivation of FXN transcriptional initiation is a potential therapeutic strategy in FRDA. Most individuals with Friedreich ataxia (FRDA) are homozygous for an expanded GAA triplet repeat (GAA-TR) mutation in intron 1 of the FXN gene, which results in deficiency of FXN transcript. Consistent with the expanded GAA-TR sequence as a cause of variegated gene silencing, evidence for heterochromatin has been detected in intron 1 in the immediate vicinity of the expanded GAA-TR mutation in FRDA. Transcriptional deficiency in FRDA is thought to result from deficient elongation through the expanded GAA-TR sequence because of repeat-proximal heterochromatin and abnormal DNA structures adopted by the expanded repeat. There is also evidence for deficient transcriptional initiation in FRDA, but its relationship to the expanded GAA-TR mutation remains unclear. We show that repressive chromatin extends from the expanded GAA-TR in intron 1 to the upstream regions of the FXN gene, involving the FXN transcriptional start site. Using a chromatin accessibility assay and a high-resolution nucleosome occupancy assay, we found that the major FXN transcriptional start site, which is normally in a nucleosome-depleted region, is rendered inaccessible by altered nucleosome positioning in FRDA. Consistent with the altered epigenetic landscape the FXN gene promoter, a typical CpG island promoter, was found to be in a transcriptionally non-permissive state in FRDA. Both metabolic labeling of nascent transcripts and an unbiased whole transcriptome analysis revealed a severe deficiency of transcriptional initiation in FRDA. Deficient transcriptional initiation, and not elongation, is the major cause of FXN transcriptional deficiency in FRDA, and it is related to the spread of repressive chromatin from the expanded GAA-TR mutation.	[Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina; Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bidichandani, SI (corresponding author), 1200 Childrens Ave,Ste 12100, Oklahoma City, OK 73104 USA.	Sanjay-Bidichandani@ouhsc.edu	Costello, Whitney/W-1204-2018	Costello, Whitney/0000-0001-6731-8978; Bidichandani, Sanjay/0000-0001-6191-6475	National Institutes of Health [R01 NS072418]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS072418 (to S. I. B.).	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Clark RM, 2006, GENOMICS, V87, P57, DOI 10.1016/j.ygeno.2005.09.006; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Kumari D, 2011, J BIOL CHEM, V286, P4209, DOI 10.1074/jbc.M110.194035; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Plasterer HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063958; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110	33	30	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15194	15202		10.1074/jbc.M114.566414	http://dx.doi.org/10.1074/jbc.M114.566414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737321	Green Published, hybrid			2022-12-28	WOS:000337465400006
J	Coey, CT; Fitzgerald, ME; Maiti, A; Reiter, KH; Guzzo, CM; Matunis, MJ; Drohat, AC				Coey, Christopher T.; Fitzgerald, Megan E.; Maiti, Atanu; Reiter, Katherine H.; Guzzo, Catherine M.; Matunis, Michael J.; Drohat, Alexander C.			E2-mediated Small Ubiquitin-like Modifier (SUMO) Modification of Thymine DNA Glycosylase Is Efficient but Not Selective for the Enzyme-Product Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); DNA Methylation; DNA Repair; Enzyme Turnover; Post-translational Modification (PTM); Small Ubiquitin-like Modifier (SUMO); Sumoylation; Ubiquitin-conjugating Enzyme (E2 Enzyme)	CONJUGATING ENZYME; PROTEIN MODIFICATION; CRYSTAL-STRUCTURE; BINDING; 5-FORMYLCYTOSINE; EXCISION; TDG; SUMOYLATION; 5-CARBOXYLCYTOSINE; PURIFICATION	Thymine DNA glycosylase (TDG) initiates the repair of GT mismatches that arise by deamination of 5-methylcytosine (mC), and it excises 5-formylcytosine and 5-carboxylcytosine, oxidized forms of mC. TDG functions in active DNA demethylation and is essential for embryonic development. TDG forms a tight enzyme-product complex with abasic DNA, which severely impedes enzymatic turnover. Modification of TDG by small ubiquitin-like modifier (SUMO) proteins weakens its binding to abasic DNA. It was proposed that sumoylation of product-bound TDG regulates product release, with SUMO conjugation and deconjugation needed for each catalytic cycle, but this model remains unsubstantiated. We examined the efficiency and specificity of TDG sumoylation using in vitro assays with purified E1 and E2 enzymes, finding that TDG is modified efficiently by SUMO-1 and SUMO-2. Remarkably, we observed similar modification rates for free TDG and TDG bound to abasic or undamaged DNA. To examine the conjugation step directly, we determined modification rates (k(obs)) using preformed E2 approximate to SUMO-1 thioester. The hyperbolic dependence of k(obs) on TDG concentration gives k(max) = 1.6 min(-1) and K-1/2 = 0.55 m, suggesting that E2 approximate to SUMO-1 has higher affinity for TDG than for the SUMO targets RanGAP1 and p53 (peptide). Whereas sumoylation substantially weakens TDG binding to DNA, TDG approximate to SUMO-1 still binds relatively tightly to AP-DNA (K-d approximate to 50 nm). Although E2 approximate to SUMO-1 exhibits no specificity for product-bound TDG, the relatively high conjugation efficiency raises the possibility that E2-mediated sumoylation could stimulate product release in vivo. This and other implications for the biological role and mechanism of TDG sumoylation are discussed.	[Coey, Christopher T.; Fitzgerald, Megan E.; Maiti, Atanu; Drohat, Alexander C.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Reiter, Katherine H.; Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Drohat, AC (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu		Maiti, Atanu/0000-0002-9080-1025; Matunis, Michael/0000-0002-9350-6611; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [S10-OD011969]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, R01GM060980] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Prof. F. Melchior (University of Heidelberg) for expression plasmids for Ubc9 and SUMO-1 (mature form), Prof. M. Shirakawa (Kyoto University) for a plasmid for the co-expression of human SUMO-1 and the E1 and E2 enzymes, and Dr. Bor-Jang Hwang and Dr. Aparna Kishor for assistance with immunoblotting. Support for procuring the imaging system (GE Typhoon FLA 9500) used in these studies was provided by the National Institutes of Health Grant S10-OD011969 (to A.L. Lu).	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Choi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Liu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063680; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Maiti A, 2013, J AM CHEM SOC, V135, P15813, DOI 10.1021/ja406444x; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Sjolund AB, 2013, MUTAT RES-FUND MOL M, V743, P12, DOI 10.1016/j.mrfmmm.2012.11.001; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Stindt Maren H, 2011, Cell Cycle, V10, P3176; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Xu XH, 2014, J BIOL CHEM, V289, P8881, DOI 10.1074/jbc.M113.538835; Yunus AA, 2005, METHOD ENZYMOL, V398, P74, DOI 10.1016/S0076-6879(05)98008-7; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zilio N, 2013, DNA REPAIR, V12, P761, DOI 10.1016/j.dnarep.2013.07.001	65	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15810	15819		10.1074/jbc.M114.572081	http://dx.doi.org/10.1074/jbc.M114.572081			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753249	Green Published, hybrid			2022-12-28	WOS:000337465400060
J	Gupta, RP; Kueppers, P; Hanekop, N; Schmitt, L				Gupta, Rakeshkumar P.; Kueppers, Petra; Hanekop, Nils; Schmitt, Lutz			Generating Symmetry in the Asymmetric ATP-binding Cassette (ABC) Transporter Pdr5 from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; ATPases; Membrane Proteins; Membrane Transport; Multidrug Transporters; Coupling Mechanism	MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; NUCLEOTIDE; YEAST; DOMAIN; HYDROLYSIS; MECHANISM; HLYB; RESISTANCE; PROTEINS	Background: Fungal multidrug efflux pumps possess a degenerate nucleotide-binding site (NBS). Results: Restoring all the nonconserved amino acids in the degenerate NBS of Pdr5 leads to complete loss of function of the protein. Conclusion: The degenerate NBS is essential and acts as a structural platform supporting the canonical NBS. Significance: This is the first study dealing with the entire degenerate NBS and its functional role. Pdr5 is a plasma membrane-bound ABC transporter from Saccharomyces cerevisiae and is involved in the phenomenon of resistance against xenobiotics, which are clinically relevant in bacteria, fungi, and humans. Many fungal ABC transporters such as Pdr5 display an inherent asymmetry in their nucleotide-binding sites (NBS) unlike most of their human counterparts. This degeneracy of the NBSs is very intriguing and needs explanation in terms of structural and functional relevance. In this study, we mutated nonconsensus amino acid residues in the NBSs to its consensus counterpart and studied its effect on the function of the protein and effect on yeast cells. The completely regenerated Pdr5 protein was severely impaired in its function of ATP hydrolysis and of rhodamine 6G transport. Moreover, we observe alternative compensatory mechanisms to counteract drug toxicity in some of the mutants. In essence, we describe here the first attempts to restore complete symmetry in an asymmetric ABC transporter and to study its effects, which might be relevant to the entire class of asymmetric ABC transporters.	[Gupta, Rakeshkumar P.; Kueppers, Petra; Hanekop, Nils; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de			Deutsche Forschungsgemeinschaft [Schm1279/5-3]; European Drug Initiative on Channels and Transporters [Health-2007-2.1.1.-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters	This work was supported by Deutsche Forschungsgemeinschaft Grant Schm1279/5-3 and European Drug Initiative on Channels and Transporters FP7 Theme Health-2007-2.1.1.-5 (to L. S.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DUFOUR JP, 1988, METHOD ENZYMOL, V157, P513; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Furman C, 2013, J BIOL CHEM, V288, P30420, DOI 10.1074/jbc.M113.494682; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Hanekop N, 2006, FEBS LETT, V580, P1036, DOI 10.1016/j.febslet.2005.11.012; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Wada S, 2002, J BIOL CHEM, V277, P46809, DOI 10.1074/jbc.M207817200; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2004, ACTA CRYSTALLOGR D, V60, P1076, DOI 10.1107/S0907444904007437; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	36	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15272	15279		10.1074/jbc.M114.553065	http://dx.doi.org/10.1074/jbc.M114.553065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733388	Green Published, hybrid			2022-12-28	WOS:000337465400012
J	Harris, DP; Bandyopadhyay, S; Maxwell, TJ; Willard, B; DiCorleto, PE				Harris, Daniel P.; Bandyopadhyay, Smarajit; Maxwell, Tyler J.; Willard, Belinda; DiCorleto, Paul E.			Tumor Necrosis Factor (TNF)-alpha Induction of CXCL10 in Endothelial Cells Requires Protein Arginine Methyltransferase 5 (PRMT5)-mediated Nuclear Factor (NF)-kappa B p65 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Gene Expression; NF-Kappa B (NF-KB); Post-Translational Modification (PTM); Protein Methylation; Tumor Necrosis Factor (TNF)	NF-KAPPA-B; INTERFERON-INDUCIBLE PROTEIN-10; CORONARY-ARTERY-DISEASE; IFN-GAMMA; INFLAMMATORY RESPONSE; GENE-EXPRESSION; CHEMOKINE; PRMT5; TRANSCRIPTION; IP-10	Background: NF-B post-translational modifications contribute to gene-specific transcriptional activation. Results: Symmetrical dimethylation of NF-B p65 by PRMT5 enhances CXCL10 induction in response to TNF-. Conclusion: Arginine methylation of p65 is a novel mechanism regulating inflammatory chemokine induction. Significance: Methylation of specific NF-B arginine residues contributes to promoter targeting and transcriptional activation. The chemokine CXCL10/IP-10 facilitates recruitment of Th1-type leukocytes to inflammatory sites. In this study, we show that the arginine methyltransferase PRMT5 is critical for CXCL10 transcription in TNF--activated human endothelial cells (EC). We found that depletion of PRMT5 results in significantly reduced levels of CXCL10 mRNA, demonstrating a positive role for PRMT5 in CXCL10 induction. Chromatin immunoprecipitation experiments revealed the presence of the symmetrical dimethylarginine modification catalyzed by PRMT5 associated with the CXCL10 promoter in response to TNF-. However, symmetrical dimethylarginine-modified proteins were not detected at the promoter in the absence of PRMT5, indicating that PRMT5 is essential for methylation to occur. Furthermore, NF-B p65, a critical driver of TNF--mediated CXCL10 induction, was determined to be methylated at arginine residues. Crucially, RNAi-mediated PRMT5 depletion abrogated p65 methylation and CXCL10 promoter binding. Mass spectrometric analysis in EC identified five dimethylated arginine residues in p65, four of which are uncharacterized in the literature. Expression of Arg-to-Lys point mutants of p65 demonstrated that both Arg-30 and Arg-35 must be dimethylated to achieve full CXCL10 expression. In conclusion, we have identified previously uncharacterized p65 post-translational modifications critical for CXCL10 induction.	[Harris, Daniel P.; Bandyopadhyay, Smarajit; Maxwell, Tyler J.; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Harris, Daniel P.; DiCorleto, Paul E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	dicorlp@ccf.org		Harris, Daniel/0000-0002-1852-0683	National Center for Advancing Translational Sciences component of the NIH [UL1TR000439]; NIH Roadmap for Medical Research; National Institutes of Health [1S10RR031537-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Lisa Dechert, Chad Braley, and Emily Tillmaand for cell culture assistance. We thank Unni Chandrasekharan, Matthew Waitkus, and Joel Boerckel for helpful comments during manuscript preparation. Human umbilical vein endothelial cells were harvested from human umbilical cords collected from the Birthing Services Department at the Cleveland Clinic (Hillcrest Hospital) and the Perinatal Clinical Research Center (PCRC) at the Cleveland MetroHealth Hospital. The PCRC has been supported by a grant (UL1TR000439) awarded to the Clinical and Translational Science Collaborative of Cleveland by the National Center for Advancing Translational Sciences component of the NIH and the NIH Roadmap for Medical Research. The Orbitrap Elite instrument was purchased via a National Institutes of Health shared instrument grant (1S10RR031537-01).	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bandyopadhyay S, 2007, MOL CELL BIOL, V27, P4207, DOI 10.1128/MCB.00052-07; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Boisvert FM, 2004, MOL CELL, V15, P492, DOI 10.1016/j.molcel.2004.08.011; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hamilton TA, 2007, J LEUKOCYTE BIOL, V82, P213, DOI 10.1189/jlb.1206754; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kawamura A, 2003, CIRC J, V67, P851, DOI 10.1253/circj.67.851; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Majumder S, 1998, J IMMUNOL, V161, P4736; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Molina-Serrano D, 2013, BIOCHEM SOC T, V41, P751, DOI 10.1042/BST20130003; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Scarpati EM, 1996, J BIOL CHEM, V271, P3025, DOI 10.1074/jbc.271.6.3025; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Tweedie-Cullen RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036980; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	41	51	53	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15328	15339		10.1074/jbc.M114.547349	http://dx.doi.org/10.1074/jbc.M114.547349			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753255	Green Published, hybrid			2022-12-28	WOS:000337465400017
J	Lopert, P; Patel, M				Lopert, Pamela; Patel, Manisha			Nicotinamide Nucleotide Transhydrogenase (Nnt) Links the Substrate Requirement in Brain Mitochondria for Hydrogen Peroxide Removal to the Thioredoxin/Peroxiredoxin (Trx/Prx) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species (ROS); Thioredoxin Reductase; Nicotinamide Nucleotide Transhydrogenase	FAMILIAL GLUCOCORTICOID DEFICIENCY; ALPHA-KETOGLUTARATE DEHYDROGENASE; NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; CELL-DEATH; RAT-BRAIN; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; OXYGEN	Mitochondrial reactive oxygen species are implicated in the etiology of multiple neurodegenerative diseases, including Parkinson disease. Mitochondria are known to be net producers of ROS, but recently we have shown that brain mitochondria can consume mitochondrial hydrogen peroxide (H2O2) in a respiration-dependent manner predominantly by the thioredoxin/peroxiredoxin system. Here, we sought to determine the mechanism linking mitochondrial respiration with H2O2 catabolism in brain mitochondria and dopaminergic cells. We hypothesized that nicotinamide nucleotide transhydrogenase (Nnt), which utilizes the proton gradient to generate NADPH from NADH and NADP(+), provides the link between mitochondrial respiration and H2O2 detoxification through the thioredoxin/peroxiredoxin system. Pharmacological inhibition of Nnt in isolated brain mitochondria significantly decreased their ability to consume H2O2 in the presence, but not absence, of respiration substrates. Nnt inhibition in liver mitochondria, which do not require substrates to detoxify H2O2, had no effect. Pharmacological inhibition or lentiviral knockdown of Nnt in N27 dopaminergic cells (a) decreased H2O2 catabolism, (b) decreased NADPH and increased NADP(+) levels, and (c) decreased basal, spare, and maximal mitochondrial oxygen consumption rates. Nnt-deficient cells possessed higher levels of oxidized mitochondrial Prx, which rendered them more susceptible to steady-state increases in H2O2 and cell death following exposure to subtoxic levels of paraquat. These data implicate Nnt as the critical link between the metabolic and H2O2 antioxidant function in brain mitochondria and suggests Nnt as a potential therapeutic target to improve the redox balance in conditions of oxidative stress associated with neurodegenerative diseases.	[Lopert, Pamela] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Patel, M (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA.	Manisha.Patel@ucdenver.edu		Lopert, Pamela/0000-0002-6625-7832	National Institutes of Health [RO1NS04748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045748, R01NS086423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1NS04748 (to M. P.).	Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bergmeyer H. U., 1983, METHOD ENZYMAT AN, P118; Bizouarn T, 2000, BBA-BIOENERGETICS, V1457, P211, DOI 10.1016/S0005-2728(00)00103-1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Cox A. G., METHODS ENZYMOL, V474, P51; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Halliwell B., 2007, FREE RADICAL BIO MED, P25; Heiker JT, 2013, OBESITY, V21, P529, DOI 10.1002/oby.20095; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JENNER P, 1992, NEUROLOGY, V42, P2241, DOI 10.1212/WNL.42.12.2241; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; KALHORN TF, 1985, ANAL BIOCHEM, V151, P343, DOI 10.1016/0003-2697(85)90185-X; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; MAVELLI I, 1982, BIOCHEM J, V204, P535, DOI 10.1042/bj2040535; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x; PRASAD KN, 1994, RESTOR NEUROL NEUROS, V7, P13, DOI 10.3233/RNN-1994-7103; RADI R, 1991, J BIOL CHEM, V266, P22028; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; RYDSTROM J, 1972, EUR J BIOCHEM, V31, P496, DOI 10.1111/j.1432-1033.1972.tb02557.x; Rydstrom J, 1979, Methods Enzymol, V55, P261; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tretter L, 2000, J NEUROSCI, V20, P8972; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Yamaguchi R, 2013, ENDOCR J, V60, P855, DOI 10.1507/endocrj.EJ13-0024; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200	60	61	63	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15611	15620		10.1074/jbc.M113.533653	http://dx.doi.org/10.1074/jbc.M113.533653			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722990	hybrid, Green Published			2022-12-28	WOS:000337465400043
J	Nye, MD; Almada, LL; Fernandez-Barrena, MG; Marks, DL; Elsawa, SF; Vrabel, A; Tolosa, EJ; Ellenrieder, V; Fernandez-Zapico, ME				Nye, Monica D.; Almada, Luciana L.; Fernandez-Barrena, Maite G.; Marks, David L.; Elsawa, Sherine F.; Vrabel, Anne; Tolosa, Ezequiel J.; Ellenrieder, Volker; Fernandez-Zapico, Martin E.			The Transcription Factor GLI1 Interacts with SMAD Proteins to Modulate Transforming Growth Factor beta-Induced Gene Expression in a p300/CREB-binding Protein-associated Factor (PCAF)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Gene Expression; SMAD Transcription Factor; Transcription Factor; Transforming Growth Factor (TGF); GLI1; PCAF	HISTONE ACETYLTRANSFERASE PCAF; HEDGEHOG SIGNALING PATHWAY; PANCREATIC-CANCER; TGF-BETA; TARGET GENES; IN-VITRO; ACTIVATION; MECHANISMS; INHIBITION; APOPTOSIS	The biological role of the transcription factor GLI1 in the regulation of tumor growth is well established; however, the molecular events modulating this phenomenon remain elusive. Here, we demonstrate a novel mechanism underlying the role of GLI1 as an effector of TGF signaling in the regulation of gene expression in cancer cells. TGF stimulates GLI1 activity in cancer cells and requires its transcriptional activity to induce BCL2 expression. Analysis of the mechanism regulating this interplay identified a new transcriptional complex including GLI1 and the TGF-regulated transcription factor, SMAD4. We demonstrate that SMAD4 physically interacts with GLI1 for concerted regulation of gene expression and cellular survival. Activation of the TGF pathway induces GLI1-SMAD4 complex binding to the BCL2 promoter whereas disruption of the complex through SMAD4 RNAi depletion impairs GLI1-mediated transcription of BCL2 and cellular survival. Further characterization demonstrated that SMAD2 and the histone acetyltransferase, PCAF, participate in this regulatory mechanism. Both proteins bind to the BCL2 promoter and are required for TGF- and GLI1-stimulated gene expression. Moreover, SMAD2/4 RNAi experiments showed that these factors are required for the recruitment of GLI1 to the BCL2 promoter. Finally, we determined whether this novel GLI1 transcriptional pathway could regulate other TGF targets. We found that two additional TGF-stimulated genes, INTERLEUKIN-7 and CYCLIN D1, are dependent upon the intact GLI1-SMAD-PCAF complex for transcriptional activation. Collectively, these results define a novel epigenetic mechanism that uses the transcription factor GLI1 and its associated complex as a central effector to regulate gene expression in cancer cells.	[Nye, Monica D.; Almada, Luciana L.; Fernandez-Barrena, Maite G.; Marks, David L.; Vrabel, Anne; Tolosa, Ezequiel J.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Elsawa, Sherine F.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Ellenrieder, Volker] Univ Marburg, Dept Gastroenterol, Signaling & Transcript Lab, D-35037 Marburg, Germany; [Fernandez-Zapico, Martin E.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Northern Illinois University; Philipps University Marburg; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Tolosa, Ezequiel J/AAD-9799-2019	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Tolosa, Ezequiel J/0000-0001-5167-0782	National Institutes of Health [GM55252, CA136526]; Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic); Mayo Clinic Pancreatic SPORE [CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Deutsche Forschungsgemeinschaft [KFO210, SFB-TR17]; German Cancer Research Foundation [109423]; NATIONAL CANCER INSTITUTE [R25CA057726, P30CA015083, P20CA102701, P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic); Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55252 and by National Institutes of Health Grant CA136526 (to M. E. F.-Z.). This work was also supported by the Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic), and Mayo Clinic Pancreatic SPORE P50 Grant CA102701 (to M. E. F.-Z.), Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.-Z.), Deutsche Forschungsgemeinschaft Grant KFO210 (to V. E.), SFB-TR17, and the German Cancer Research Foundation 109423 "Inflammation and Cancer" (to V. E.).	Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Ciucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060145; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duan H, 2007, ONCOGENE, V26, P2635, DOI 10.1038/sj.onc.1210061; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Fiaschi M, 2011, AM J PATHOL, V179, P2569, DOI 10.1016/j.ajpath.2011.07.033; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Guo JF, 2013, CANCER LETT, V339, P185, DOI 10.1016/j.canlet.2013.06.010; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Love IM, 2012, CELL CYCLE, V11, P2458, DOI 10.4161/cc.20864; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Savani M, 2012, THER ADV MED ONCOL, V4, P225, DOI 10.1177/1758834012450362; Saze Z, 2012, DIGEST SURG, V29, P115, DOI 10.1159/000336949; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thomas ZI, 2011, BRIT J CANCER, V104, P1575, DOI 10.1038/bjc.2011.133; Wanshura LEC, 2011, CANCER RES, V71, P5336, DOI 10.1158/0008-5472.CAN-10-2633; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Wu JY, 2011, HEPATO-GASTROENTEROL, V58, P1511, DOI 10.5754/hge10765; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581	52	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15495	15506		10.1074/jbc.M113.545194	http://dx.doi.org/10.1074/jbc.M113.545194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739390	Green Published, hybrid			2022-12-28	WOS:000337465400032
J	Shin, M; Bryant, JD; Momb, J; Appling, DR				Shin, Minhye; Bryant, Joshua D.; Momb, Jessica; Appling, Dean R.			Mitochondrial MTHFD2L Is a Dual Redox Cofactor-specific Methylenetetrahydrofolate Dehydrogenase/Methenyltetrahydrofolate Cyclohydrolase Expressed in Both Adult and Embryonic Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Folate Metabolism; Mitochondrial Metabolism; Multifunctional Enzymes; NAD; Neurodevelopment	DEPENDENT 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE; POLYMERASE-CHAIN-REACTION; ONE-CARBON METABOLISM; SACCHAROMYCES-CEREVISIAE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; C-1-TETRAHYDROFOLATE SYNTHASE; C1-TETRAHYDROFOLATE SYNTHASE; RAT-LIVER; CELLS; YEAST	Mammalian mitochondria are able to produce formate from one-carbon donors such as serine, glycine, and sarcosine. This pathway relies on the mitochondrial pool of tetrahydrofolate (THF) and several folate-interconverting enzymes in the mitochondrial matrix. We recently identified MTHFD2L as the enzyme that catalyzes the oxidation of 5,10-methylenetetrahydrofolate (CH2-THF) in adult mammalian mitochondria. We show here that the MTHFD2L enzyme is bifunctional, possessing both CH2-THF dehydrogenase and 5,10-methenyl-THF cyclohydrolase activities. The dehydrogenase activity can use either NAD(+) or NADP(+) but requires both phosphate and Mg2+ when using NAD(+). The NADP(+)-dependent dehydrogenase activity is inhibited by inorganic phosphate. MTHFD2L uses the mono- and polyglutamylated forms of CH2-THF with similar catalytic efficiencies. Expression of the MTHFD2L transcript is low in early mouse embryos but begins to increase at embryonic day 10.5 and remains elevated through birth. In adults, MTHFD2L is expressed in all tissues examined, with the highest levels observed in brain and lung.	[Shin, Minhye; Bryant, Joshua D.; Momb, Jessica; Appling, Dean R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Mol Biosci, Welch Hall A5300, Austin, TX 78712 USA.	dappling@austin.utexas.edu			National Institutes of Health from the Eunice Kennedy Shriver NICHD [F32HD074428]; NIGMS [GM086856]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver NICHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HD074428 (to J. M.) from the Eunice Kennedy Shriver NICHD and GM086856 (to D. R. A.) from NIGMS.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; ALEXIOU M, 1992, DEVELOPMENT, V114, P185; Appling DR, 1997, METHOD ENZYMOL, V281, P178; BARLOWE CK, 1990, BIOCHEMISTRY-US, V29, P7089, DOI 10.1021/bi00482a020; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BLAKLEY RL, 1957, BIOCHEM J, V65, P331, DOI 10.1042/bj0650331; Bolusani S, 2011, J BIOL CHEM, V286, P5166, DOI 10.1074/jbc.M110.196840; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2005, J BIOL CHEM, V280, P34316, DOI 10.1074/jbc.M505210200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; CURTHOYS NP, 1971, J BIOL CHEM, V246, P6942; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Dihazi H, 2001, PROTEIN EXPRES PURIF, V21, P201, DOI 10.1006/prep.2000.1369; ETO I, 1982, ANAL BIOCHEM, V120, P323, DOI 10.1016/0003-2697(82)90353-0; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Jafri MS, 2006, J THEOR BIOL, V242, P801, DOI 10.1016/j.jtbi.2006.05.007; KALLEN RG, 1966, J BIOL CHEM, V241, P5851; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Nijhout HF, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-40; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Pawelek PD, 1998, BIOCHEMISTRY-US, V37, P1109, DOI 10.1021/bi971906t; PELLETIER JN, 1995, BIOCHEMISTRY-US, V34, P12673, DOI 10.1021/bi00039a025; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; SEITHER RL, 1989, J BIOL CHEM, V264, P17016; Sies H., 1982, METABOLIC COMPARTMEN, P205; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Veech R. L., 1987, PYRIDINE NUCLEOTIDE, P79; Wagner W, 2005, BIOCHEMISTRY-US, V44, P13163, DOI 10.1021/bi051038x; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; WEST MG, 1993, J BIOL CHEM, V268, P153; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang X. M., 1993, BIOCHEMISTRY-US, V32, P11118; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	49	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15507	15517		10.1074/jbc.M114.555573	http://dx.doi.org/10.1074/jbc.M114.555573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733394	Green Published, hybrid			2022-12-28	WOS:000337465400033
J	Adams, MK; Belyaeva, OV; Wu, LZ; Kedishvili, NY				Adams, Mark K.; Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.			The Retinaldehyde Reductase Activity of DHRS3 Is Reciprocally Activated by Retinol Dehydrogenase 10 to Control Retinoid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; ACID BIOSYNTHESIS; VITAMIN-A; CELL-LINES; RDH10; METABOLISM; MECHANISM; CLONING; ENZYME; LIVER	The retinoic acid-inducible dehydrogenase reductase 3 (DHRS3) is thought to function as a retinaldehyde reductase that controls the levels of all-trans-retinaldehyde, the immediate precursor for bioactive all-trans-retinoic acid. However, the weak catalytic activity of DHRS3 and the lack of changes in retinaldehyde conversion to retinol and retinoic acid in the cells overexpressing DHRS3 undermine its role as a physiologically important all-transretinaldehyde reductase. This study demonstrates that DHRS3 requires the presence of retinol dehydrogenase 10 (RDH10) to display its full catalytic activity. The RDH10-activated DHRS3 acts as a robust high affinity all-trans-retinaldehyde-specific reductase that effectively converts retinaldehyde back to retinol, decreasing the rate of retinoic acid biosynthesis. In turn, the retinol dehydrogenase activity of RDH10 is reciprocally activated by DHRS3. At E13.5, DHRS3-null embryos have similar to 4-fold lower levels of retinol and retinyl esters, but only slightly elevated levels of retinoic acid. The membrane-associated retinaldehyde reductase and retinol dehydrogenase activities are decreased by similar to 4- and similar to 2-fold, respectively, in Dhrs3(-/-) embryos, and Dhrs3(-/-) mouse embryonic fibroblasts exhibit reduced metabolism of both retinaldehyde and retinol. Neither RDH10 nor DHRS3 has to be itself catalytically active to activate each other. The transcripts encoding DHRS3 and RDH10 are co-localized at least in some tissues during development. The mutually activating interaction between the two related proteins may represent a highly sensitive and conserved mechanism for precise control over the rate of retinoic acid biosynthesis.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, 720 20th St S,Kaul 440B, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	National Institutes of Health [P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, P60 DK079626]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Services provided in this publication through the University of Alabama Transgenic Mouse Facility (RAK) are supported by National Institutes of Health Grants P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, and P60 DK079626. We thank Dr. Hengbin Wang (University of Alabama School of Medicine, Birmingham, AL) for antibodies against the HA tag. We are also very grateful to Dr. Chesnokov for allowing us to use the confocal microscope in his laboratory, and especially to Katarina Akhmetova for excellent technical assistance with confocal microscopy analysis.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Cerignoli F, 2002, CANCER RES, V62, P1196; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hauptmann G, 2001, METHODS, V23, P359, DOI 10.1006/meth.2000.1148; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Nagy A., 2003, MANIPULATING MOUSE E; Napoli J. L., 1998, METHODS MOL BIOL RET, V89; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012	29	63	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14868	14880		10.1074/jbc.M114.552257	http://dx.doi.org/10.1074/jbc.M114.552257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733397	Green Published, hybrid			2022-12-28	WOS:000337248100039
J	Campos-Salinas, J; Cavazzuti, A; O'Valle, F; Forte-Lago, I; Caro, M; Beverley, SM; Delgado, M; Gonzalez-Rey, E				Campos-Salinas, Jenny; Cavazzuti, Antonio; O'Valle, Francisco; Forte-Lago, Irene; Caro, Marta; Beverley, Stephen M.; Delgado, Mario; Gonzalez-Rey, Elena			Therapeutic Efficacy of Stable Analogues of Vasoactive Intestinal Peptide against Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; LEISHMANIA-MAJOR; ANTIMICROBIAL PEPTIDES; FORMULATION DESIGN; SCORING FUNCTION; MICE; VIP; NEUROPEPTIDES; PROTEIN; MODEL	Vasoactive intestinal peptide (VIP) is an anti-inflammatory neuropeptide recently identified as a potential antimicrobial peptide. To overcome the metabolic limitations of VIP, we modified the native peptide sequence and generated two stable synthetic analogues (VIP51 and VIP51(6-30)) with better antimicrobial profiles. Herein we investigate the effects of both VIP analogues on cell viability, membrane integrity, and ultrastructure of various bacterial strains and Leishmania species. We found that the two VIP derivatives kill various non-pathogenic and pathogenic Gram-positive and Gram-negative bacteria as well as the parasite Leishmania major through a mechanism that depends on the interaction with certain components of the microbial surface, the formation of pores, and the disruption of the surface membrane. The cytotoxicity of the VIP derivatives is specific for pathogens, because they do not affect the viability of mammalian cells. Docking simulations indicate that the chemical changes made in the analogues are critical to increase their antimicrobial activities. Consequently, we found that the native VIP is less potent as an antibacterial and fails as a leishmanicidal. Noteworthy from a therapeutic point of view is that treatment with both derivatives increases the survival and reduces bacterial load and inflammation in mice with polymicrobial sepsis. Moreover, treatment with VIP51(6-30) is very effective at reducing lesion size and parasite burden in a model of cutaneous leishmaniasis. These results indicate that the VIP analogues emerge as attractive alternatives for treating drug-resistant infectious diseases and provide key insights into a rational design of novel agents against these pathogens.	[Campos-Salinas, Jenny; Cavazzuti, Antonio; Forte-Lago, Irene; Caro, Marta; Delgado, Mario; Gonzalez-Rey, Elena] CSIC, Inst Parasitol & Biomed, Granada 18016, Spain; [O'Valle, Francisco] Med Sch Granada, Dept Pathol Anat, Granada 18012, Spain; [Beverley, Stephen M.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Gonzalez-Rey, Elena] Med Sch Seville, Dept Biochem & Mol Biol, Seville 41009, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Washington University (WUSTL)	Gonzalez-Rey, E (corresponding author), CSIC, Inst Parasitol & Biomed, PT Ciencias Salud, Avd Conocimiento, Granada 18016, Spain.	elenag@ipb.csic.es	Forte-Lago, Irene/ABG-9980-2020; GONZALEZ-REY, ELENA/L-3296-2014; Delgado, Mario/P-1524-2016; Caro, Marta/ABG-9963-2020; OValle, Francisco/AAA-9151-2019	GONZALEZ-REY, ELENA/0000-0003-3917-9020; Delgado, Mario/0000-0003-1893-5982; Forte Lago, Irene/0000-0002-3998-0398; Caro, Marta/0000-0003-3385-4734; Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [RO1 AI031078]; Excellence Grants from Junta de Andalucia [P09/CTS-4705]; European Cost Action [BM0802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Grants from Junta de Andalucia(Junta de Andalucia); European Cost Action; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI031078 (to S. M. B.). This work was also supported by Excellence Grants from Junta de Andalucia (P09/CTS-4705) (to E. G.-R.) and European Cost Action (BM0802) (to E. G.-R.).	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139; Baltzer SA, 2011, J MOL MICROB BIOTECH, V20, P228, DOI 10.1159/000331009; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; El Karim IA, 2008, J NEUROIMMUNOL, V200, P11, DOI 10.1016/j.jneuroim.2008.05.014; Epand RF, 2005, MOL MEMBR BIOL, V22, P457, DOI 10.1080/09687860500370562; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; He J, 2007, ANTIMICROB AGENTS CH, V51, P1351, DOI 10.1128/AAC.01270-06; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Mayer M. L., 2011, ADV MOL CELLULAR MIC, P195; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mor A, 2009, FEBS J, V276, P6474, DOI 10.1111/j.1742-4658.2009.07358.x; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Nevot M, 2006, MICROB ECOL, V51, P501, DOI 10.1007/s00248-006-9065-5; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ohta K, 2011, J NEUROIMMUNOL, V233, P37, DOI 10.1016/j.jneuroim.2010.11.009; Onoue S, 2004, EUR J BIOCHEM, V271, P1757, DOI 10.1111/j.1432-1033.2004.04086.x; Onoue S, 2008, N-S ARCH PHARMACOL, V377, P579, DOI 10.1007/s00210-007-0232-0; Onoue S, 2013, EUR J PHARM SCI, V49, P382, DOI 10.1016/j.ejps.2013.04.009; Onoue S, 2011, INT J PHARMACEUT, V410, P54, DOI 10.1016/j.ijpharm.2011.03.021; Onoue S, 2009, EUR J PHARM BIOPHARM, V73, P95, DOI 10.1016/j.ejpb.2009.05.013; Pulido D, 2012, ANTIMICROB AGENTS CH, V56, P2378, DOI 10.1128/AAC.06107-11; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; SAID SI, 1991, TRENDS ENDOCRIN MET, V2, P107, DOI 10.1016/S1043-2760(05)80006-2; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; Sun QQ, 2003, J NEUROSCI, V23, P2751; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaudry D, 2000, PHARMACOL REV, V52, P269; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	56	30	35	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14583	14599		10.1074/jbc.M114.560573	http://dx.doi.org/10.1074/jbc.M114.560573			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706753	Green Published, hybrid			2022-12-28	WOS:000337248100016
J	Strachan, RT; Sun, JP; Rominger, DH; Violin, JD; Ahn, S; Thomsen, ARB; Zhu, X; Kleist, A; Costa, T; Lefkowitz, RJ				Strachan, Ryan T.; Sun, Jin-peng; Rominger, David H.; Violin, Jonathan D.; Ahn, Seungkirl; Thomsen, Alex Rojas Bie; Zhu, Xiao; Kleist, Andrew; Costa, Tommaso; Lefkowitz, Robert J.			Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor ( GPCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Drug Discovery; G Protein-coupled Receptors (GPCR); Molecular Pharmacology; Signal Transduction	BETA-ADRENERGIC-RECEPTOR; ALPHA FUSION PROTEINS; TERNARY COMPLEX MODEL; FUNCTIONAL SELECTIVITY; BETA(2)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; SIGNAL-TRANSDUCTION; LIGAND-BINDING; DRUG DISCOVERY; HEART-FAILURE	Background: Biased agonism is an incompletely understood phenomenon describing the unequal activation of different signal transduction pathways by a G protein-coupled receptor (GPCR). Results: A cell-free approach using GPCR-transducer fusion proteins (G-protein or -arrestin) quantifies signaling in vitro to elucidate the molecular basis of biased agonism. Conclusion: Differences in ligand-receptor-transducer coupling account for biased agonism in cells. Significance: Biased agonism is a bona fide molecular property of GPCR ligands. The concept of biased agonism arises from the recognition that the ability of an agonist to induce a receptor-mediated response (i.e. efficacy) can differ across the multiple signal transduction pathways (e.g. G protein and -arrestin (arr)) emanating from a single GPCR. Despite the therapeutic promise of biased agonism, the molecular mechanism(s) whereby biased agonists selectively engage signaling pathways remain elusive. This is due in large part to the challenges associated with quantifying ligand efficacy in cells. To address this, we developed a cell-free approach to directly quantify the transducer-specific molecular efficacies of balanced and biased ligands for the angiotensin II type 1 receptor (AT(1)R), a prototypic GPCR. Specifically, we defined efficacy in allosteric terms, equating shifts in ligand affinity (i.e. K-Lo/K-Hi) at AT(1)R-G(q) and AT(1)R-arr2 fusion proteins with their respective molecular efficacies for activating G(q) and arr2. Consistent with ternary complex model predictions, transducer-specific molecular efficacies were strongly correlated with cellular efficacies for activating G(q) and arr2. Subsequent comparisons across transducers revealed that biased AT(1)R agonists possess biased molecular efficacies that were in strong agreement with the signaling bias observed in cellular assays. These findings not only represent the first measurements of the thermodynamic driving forces underlying differences in ligand efficacy between transducers but also support a molecular mechanism whereby divergent transducer-specific molecular efficacies generate biased agonism at a GPCR.	[Strachan, Ryan T.; Ahn, Seungkirl; Thomsen, Alex Rojas Bie; Zhu, Xiao; Kleist, Andrew; Lefkowitz, Robert J.] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Sun, Jin-peng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Rominger, David H.; Violin, Jonathan D.] Trevena Inc, King Of Prussia, PA 19406 USA; [Costa, Tommaso] Ist Super Sanita, Dipartimento Farmaco, I-00161 Rome, Italy; [Lefkowitz, Robert J.] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Howard Hughes Med Inst, Med Ctr, Durham, NC 27710 USA	Duke University; Shandong University; Istituto Superiore di Sanita (ISS); Duke University; Duke University; Howard Hughes Medical Institute	Costa, T (corresponding author), Ist Super Sanita, Dip Farmaco, Viale Regina Elena 299, I-00161 Rome, Italy.	tommaso.costa@iss.it; lefko001@receptor-biol.duke.edu	costa, tommaso/AAD-3714-2019; sun, Jinpeng/AAR-9196-2020; Lefkowitz, Robert/AAW-2649-2021	costa, tommaso/0000-0002-8729-3357; Thomsen, Alex/0000-0003-1638-8911	National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631. R. J. L. is a co-founder of Trevena, Inc., a privately held clinical stage pharmaceutical company dedicated to the discovery and development of biased GPCR ligands. J. D. V. and D. H. R. are both employed by Trevena, Inc.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bohinc BN, 2012, MINI-REV MED CHEM, V12, P856; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c2; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-3; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; KENT RS, 1980, MOL PHARMACOL, V17, P14; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Molinari P, 2003, J BIOL CHEM, V278, P15778, DOI 10.1074/jbc.M300731200; Monasky MM, 2013, AM J PHYSIOL-HEART C, V305, pH856, DOI 10.1152/ajpheart.00327.2013; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c1; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Soergel DG, 2013, J CLIN PHARMACOL, V53, P892, DOI 10.1002/jcph.111; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Strachan RT, 2010, MOL PHARMACOL, V77, P327, DOI 10.1124/mol.109.061440; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2013, TRENDS CARDIOVAS MED, V23, P242, DOI 10.1016/j.tcm.2013.01.002; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	63	77	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14211	14224		10.1074/jbc.M114.548131	http://dx.doi.org/10.1074/jbc.M114.548131			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668815	hybrid, Green Published			2022-12-28	WOS:000335984600047
J	Wang, Y; Li, GL; Mao, FB; Li, XF; Liu, Q; Chen, L; Lv, L; Wang, X; Wu, JY; Dai, W; Wang, G; Zhao, EF; Tang, KF; Sun, ZS				Wang, Yan; Li, Guiling; Mao, Fengbiao; Li, Xianfeng; Liu, Qi; Chen, Lin; Lv, Lu; Wang, Xin; Wu, Jinyu; Dai, Wei; Wang, Guan; Zhao, Enfeng; Tang, Kai-Fu; Sun, Zhong Sheng			Ras-induced Epigenetic Inactivation of the RRAD ( Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Metabolism; Ovarian Cancer; Ras; Tumor Suppressor Gene; Oncogenic Transformation; RRAD	MEDIATED ONCOGENIC TRANSFORMATION; DNA METHYLATION; MICROARRAY ANALYSIS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GTPASE GENE; CELLS; EXPRESSION; CARCINOMA; MUTATIONS	Background: Increased glucose uptake is essential for carcinogenesis. Results: Ras(V12)-induced epigenetic inactivation of RRAD promotes glucose uptake and tumor formation. Conclusion: RRAD might act as a functional tumor suppressor by inhibiting glucose uptake. Significance: Down-regulation of RRAD in tumor tissues might be associated with the Warburg effect. RRAD (Ras-related associated with diabetes) is a small Ras-related GTPase that is frequently inactivated by DNA methylation of the CpG island in its promoter region in cancer tissues. However, the role of the methylation-induced RRAD inactivation in tumorigenesis remains unclear. In this study, the Ras-regulated transcriptome and epigenome were profiled by comparing T29H (a Ras(V12)-transformed human ovarian epithelial cell line) with T29 (an immortalized but non-transformed cell line) through reduced representation bisulfite sequencing and digital gene expression. We found that Ras(V12)-mediated oncogenic transformation was accompanied by RRAD promoter hypermethylation and a concomitant loss of RRAD expression. In addition, we found that the RRAD promoter was hypermethylated, and its transcription was reduced in ovarian cancer versus normal ovarian tissues. Treatment with the DNA methyltransferase inhibitor 5-aza-2-deoxycytidine resulted in demethylation in the RRAD promoter and restored RRAD expression in T29H cells. Additionally, treatment with farnesyltransferase inhibitor FTI277 resulted in restored RRAD expression and inhibited DNA methytransferase expression and activity in T29H cells. By employing knockdown and overexpression techniques in T29 and T29H, respectively, we found that RRAD inhibited glucose uptake and lactate production by repressing the expression of glucose transporters. Finally, RRAD overexpression in T29H cells inhibited tumor formation in nude mice, suggesting that RRAD is a tumor suppressor gene. Our results indicate that Ras(V12)-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer tumorigenesis.	[Wang, Yan; Dai, Wei] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Wang, Yan; Mao, Fengbiao] Univ Chinese Acad Sci, Beijing 100080, Peoples R China; [Li, Guiling; Liu, Qi; Lv, Lu; Wang, Xin; Wu, Jinyu; Tang, Kai-Fu; Sun, Zhong Sheng] Wenzhou Med Univ, Inst Genom Med, Wenzhou 325000, Zhejiang, Peoples R China; [Mao, Fengbiao; Chen, Lin; Sun, Zhong Sheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Li, Xianfeng] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Wang, Guan; Zhao, Enfeng] Chinese Peoples Liberat Army, Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wenzhou Medical University; Chinese Academy of Sciences; Central South University; Chinese People's Liberation Army General Hospital	Tang, KF (corresponding author), Wenzhou Med Univ, Inst Genom Med, 268 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China.	tangkaifu@hotmail.com; zhongshengsun@yeah.net	Sun, Zhongsheng/AAS-4883-2020; li, xianfeng/GYD-5825-2022; fengbiao, mao/AAB-5632-2019; Wang, Xin/AAD-2149-2019; Mao, Feng/B-8280-2019	Sun, Zhongsheng/0000-0002-7640-5026; fengbiao, mao/0000-0003-0852-4266; Wang, Xin/0000-0001-8866-5223; Tang, Kai-Fu/0000-0002-2657-4163; Tang, Kai-Fu/0000-0002-6892-1207	Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant [81161120541]; National High-tech RD Program Grant [2012AA02A202]; NSFC [31171236/C060503, 31200976]; Zhejiang Provincial Natural Science Foundation of China [Z2110521]; Innovation Center China of AstraZeneca	Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant; National High-tech RD Program Grant; NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Innovation Center China of AstraZeneca	This work was supported by Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant 81161120541, National High-tech R&D Program Grant 2012AA02A202, NSFC Grants 31171236/C060503 and 31200976, Zhejiang Provincial Natural Science Foundation of China Grant Z2110521, and the Innovation Center China of AstraZeneca.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BOS JL, 1989, CANCER RES, V49, P4682; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cormont M, 2001, MOL MEMBR BIOL, V18, P213; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Gao F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r100; Ghezzi C, 2012, AM J PHYSIOL-CELL PH, V303, pC348, DOI 10.1152/ajpcell.00115.2012; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirabayashi S, 2013, CELL, V154, P664, DOI 10.1016/j.cell.2013.06.030; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsiao BY, 2011, J MOL MED, V89, P481, DOI 10.1007/s00109-010-0717-z; Huang RL, 2013, EPIGENETICS-US, V8, P624, DOI 10.4161/epi.24816; Ilany J, 2006, P NATL ACAD SCI USA, V103, P4481, DOI 10.1073/pnas.0511246103; Kalamanathan S, 2011, ANTICANCER RES, V31, P2661; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laville M, 1996, J CLIN INVEST, V98, P43, DOI 10.1172/JCI118775; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MARBACH EP, 1967, CLIN CHEM, V13, P314; Mei FC, 2005, FASEB J, V19, P497, DOI 10.1096/fj.05-4586fje; Mo YX, 2012, CANCER LETT, V323, P147, DOI 10.1016/j.canlet.2012.03.042; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Moyers JS, 1998, BIOCHEM J, V333, P609, DOI 10.1042/bj3330609; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ojuka EO, 2012, AM J PHYSIOL-ENDOC M, V303, pE322, DOI 10.1152/ajpendo.00091.2012; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Suzuki M, 2007, ANN SURG ONCOL, V14, P1397, DOI 10.1245/s10434-006-9089-6; Suzuki M, 2006, CANCER LETT, V242, P222, DOI 10.1016/j.canlet.2005.11.002; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Tseng YH, 2001, CANCER RES, V61, P2071; Varras MN, 1999, ONCOLOGY-BASEL, V56, P89, DOI 10.1159/000011946; Wang T, 2013, HUM MUTAT, V34, P1606, DOI 10.1002/humu.22444; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Weisenberger DJ, 2014, J CLIN INVEST, V124, P17, DOI 10.1172/JCI69740; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Young T, 2005, ONCOGENE, V24, P6174, DOI 10.1038/sj.onc.1208753; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222; Zeimet AG, 2011, GYNECOL ONCOL, V121, P24, DOI 10.1016/j.ygyno.2010.12.332; ZHU JH, 1995, J BIOL CHEM, V270, P4805, DOI 10.1074/jbc.270.9.4805	55	23	25	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14225	14238		10.1074/jbc.M113.527671	http://dx.doi.org/10.1074/jbc.M113.527671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24648519	hybrid, Green Published			2022-12-28	WOS:000335984600048
J	Lutz, D; Loers, G; Kleene, R; Oezen, I; Kataria, H; Katagihallimath, N; Braren, I; Harauz, G; Schachner, M				Lutz, David; Loers, Gabriele; Kleene, Ralf; Oezen, Iris; Kataria, Hardeep; Katagihallimath, Nainesh; Braren, Ingke; Harauz, George; Schachner, Melitta			Myelin Basic Protein Cleaves Cell Adhesion Molecule L1 and Promotes Neuritogenesis and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Carbohydrate-binding Protein; Cell Adhesion; Cell Death; Cell Surface; Myelin; Neurite Outgrowth; Neurobiology; Protease; Protein Processing	SPINAL-CORD-INJURY; NEURITE OUTGROWTH; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; IMMUNOGLOBULIN-SUPERFAMILY; RECOGNITION MOLECULES; NEURONAL MIGRATION; RAT-BRAIN; EXPRESSION; GENE	Background: The cell adhesion molecule L1 plays important roles in the developing and adult nervous system. Results: L1 is cleaved by myelin basic protein (MBP) yielding a L1 fragment that promotes L1-dependent functions. Conclusion: L1 functions in the nervous system depend on MBP. Significance: Study of the L1 and MBP functions may contribute to understanding the pathogenesis of demyelinating and neurodegenerative diseases. The cell adhesion molecule L1 is a Lewis(x)-carrying glycoprotein that plays important roles in the developing and adult nervous system. Here we show that myelin basic protein (MBP) binds to L1 in a Lewis(x)-dependent manner. Furthermore, we demonstrate that MBP is released by murine cerebellar neurons as a sumoylated dynamin-containing protein upon L1 stimulation and that this MBP cleaves L1 as a serine protease in the L1 extracellular domain at Arg(687) yielding a transmembrane fragment that promotes neurite outgrowth and neuronal survival in cell culture. L1-induced neurite outgrowth and neuronal survival are reduced in MBP-deficient cerebellar neurons and in wild-type cerebellar neurons in the presence of an MBP antibody or L1 peptide containing the MBP cleavage site. Genetic ablation of MBP in shiverer mice and mutagenesis of the proteolytically active site in MBP or of the MBP cleavage site within L1 as well as serine protease inhibitors and an L1 peptide containing the MBP cleavage site abolish generation of the L1 fragment. Our findings provide evidence for novel functions of MBP in the nervous system.	[Lutz, David; Loers, Gabriele; Kleene, Ralf; Oezen, Iris; Kataria, Hardeep; Katagihallimath, Nainesh; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Braren, Ingke] Univ Klinikum Hamburg Eppendorf, Inst Expt Pharmakol & Toxikol, Hamburg Zentrum Expt Therapieforsch HEXT, Vector Core Unit, D-20246 Hamburg, Germany; [Harauz, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Guelph; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Kataria, Hardeep/AAI-8411-2020; Lutz, David/AAX-1607-2021	Kataria, Hardeep/0000-0001-8413-0600; Lutz, David/0000-0001-9171-4081; Harauz, George/0000-0002-6114-9947	Deutsche Forschungsgemeinschaft [KL1378/2-2, SFB470/C3]; New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	This work was supported by the Deutsche Forschungsgemeinschaft (KL1378/2-2 and SFB470/C3).; Supported by the New Jersey Commission for Spinal Cord Research and the Li Ka-Shing Foundation at Shantou University Medical College.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Barbin G, 2004, NEURON GLIA BIOL, V1, P65, DOI 10.1017/s1740925x04000092; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Chignola R, 2000, CLIN EXP IMMUNOL, V122, P429, DOI 10.1046/j.1365-2249.2000.01363.x; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; D'Souza CA, 2005, BIOCHEMISTRY-US, V44, P12905, DOI 10.1021/bi051152f; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Derfuss T, 2012, CURR OPIN NEUROL, V25, P231, DOI 10.1097/WCO.0b013e3283533a64; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Guerriero C, 2003, J NEUROIMMUNOL, V141, P83, DOI 10.1016/S0165-5728(03)00226-1; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Heller M, 2003, J NEUROCHEM, V84, P557, DOI 10.1046/j.1471-4159.2003.01537.x; Hosono H, 2008, BIOL PHARM BULL, V31, P834, DOI 10.1248/bpb.31.834; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Katagihallimath N, 2010, EUR J CELL BIOL, V89, P77, DOI 10.1016/j.ejcb.2009.10.007; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kurumaji A, 2001, AM J MED GENET, V105, P99; Landry CF, 1996, J NEUROSCI, V16, P2452; Lavdas AA, 2010, EXP NEUROL, V221, P206, DOI 10.1016/j.expneurol.2009.10.024; Liao MC, 2009, J BIOL CHEM, V284, P28917, DOI 10.1074/jbc.M109.050856; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; MIKOSHIBA K, 1983, DEV BRAIN RES, V7, P71, DOI 10.1016/0165-3806(83)90082-2; MILLER SL, 1989, J NEUROSCI RES, V22, P262, DOI 10.1002/jnr.490220305; Musse AA, 2007, INT REV NEUROBIOL, V79, P149, DOI 10.1016/S0074-7742(07)79007-4; Nagasato K, 1997, J NEUROIMMUNOL, V72, P21, DOI 10.1016/S0165-5728(96)00137-3; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Sajdel-Sulkowska EM, 1998, ACTA BIOCHIM POL, V45, P781, DOI 10.18388/abp.1998_4272; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Smith GST, 2011, J NEUROSCI RES, V89, P467, DOI 10.1002/jnr.22570; STAUGAITIS SM, 1990, J CELL BIOL, V110, P1719, DOI 10.1083/jcb.110.5.1719; Streit A, 1996, J NEUROCHEM, V66, P834; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; URSELL MRM, 1995, J NEUROSCI RES, V42, P41, DOI 10.1002/jnr.490420106; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; WING DR, 1992, BIOCHEM SOC T, V20, P386, DOI 10.1042/bst0200386; WOLF MK, 1984, ADV EXP MED BIOL, V181, P115; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109	67	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13503	13518		10.1074/jbc.M113.530238	http://dx.doi.org/10.1074/jbc.M113.530238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671420	Green Published, hybrid			2022-12-28	WOS:000335522800046
J	Rayala, S; Francis, VG; Sivagnanam, U; Gummadi, SN				Rayala, Sarika; Francis, Vincent G.; Sivagnanam, Ulaganathan; Gummadi, Sathyanarayana N.			N-terminal Proline-rich Domain Is Required for Scrambling Activity of Human Phospholipid Scramblases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Fluorescence; Membrane Biophysics; Membrane Proteins; Membrane Reconstitution; Protein Aggregation; Human Phospholipid Scramblase; Proline-rich Domain	NUCLEAR-LOCALIZATION SIGNAL; PLASMA-MEMBRANE; BINDING-SITE; SUBCELLULAR-LOCALIZATION; TRANSBILAYER MOVEMENT; PROTEIN; CELLS; IDENTIFICATION; APOPTOSIS; REGION	Background: The role of PRD in scrambling of phospholipids by hPLSCR1 is not known. Results: The addition of PRD of hPLSCR1 to hPLSCR2 restored its PL scrambling activity, which in turn leads to aggregation of the protein. Conclusion: PRD is crucial for PL scrambling activity and could probably mediate its function by metal ion-dependent oligomerization. Significance: The results provide an insight in understanding the mechanism of scramblases. Human phospholipid scramblase 1 (hPLSCR1), a type II integral class membrane protein, is known to mediate bidirectional scrambling of phospholipids in a Ca2+-dependent manner. hPLSCR2, a homolog of hPLSCR1 that lacks N-terminal proline-rich domain (PRD), did not show scramblase activity. We attribute this absence of scramblase activity of hPLSCR2 to the lack of N-terminal PRD. Hence to investigate the above hypothesis, we added the PRD of hPLSCR1 to hPLSCR2 (PRD-hPLSCR2) and checked whether scramblase activity was restored. Functional assays showed that the addition of PRD to hPLSCR2 restored scrambling activity, and deletion of PRD in hPLSCR1 (PRD-hPLSCR1) resulted in a lack of activity. These results suggest that PRD is crucial for the function of the protein. The effects of the PRD deletion in hPLSCR1 and the addition of PRD to hPLSCR2 were characterized using various spectroscopic techniques. Our results clearly showed that hPLSCR1 and PRD-hPLSCR2 showed Ca2+-dependent aggregation and scrambling activity, whereas hPLSCR2 and PRD-hPLSCR1 did not show aggregation and activity. Thus we conclude that scramblases exhibit Ca2+-dependent scrambling activity by aggregation of protein. Our results provide a possible mechanism for phospholipid scrambling mediated by PLSCRs and the importance of PRD in its function and cellular localization.	[Rayala, Sarika; Francis, Vincent G.; Sivagnanam, Ulaganathan; Gummadi, Sathyanarayana N.] Indian Inst Technol, Appl & Ind Microbiol Lab, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gummadi, SN (corresponding author), Indian Inst Technol, Appl & Ind Microbiol Lab, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.	gummadi@iitm.ac.in	Gummadi, Sathyanarayana Naidu/K-2303-2019; Gummadi, Sathyanarayana/W-5354-2019	Gummadi, Sathyanarayana Naidu/0000-0003-0707-5710; Sivagnanam, Ulaganathan/0000-0003-1351-2518	Department of Science and Technology	Department of Science and Technology(Department of Science & Technology (India))	We thank the Department of Science and Technology for financial support for CD spectroscopy. We also thank Dr. Suresh Kumar Rayala, IIT Madras for providing anti-GFP monoclonal antibody.	Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Damer CK, 1996, J NEUROCHEM, V67, P1661; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Edwards SJ, 2003, ONCOGENE, V22, P4517, DOI 10.1038/sj.onc.1206726; Fan CW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-254; Francis VG, 2013, FEBS J, V280, P2855, DOI 10.1111/febs.12289; Francis VG, 2012, BIOL CHEM, V393, P1173, DOI 10.1515/hsz-2012-0129; Francis VG, 2012, J IND MICROBIOL BIOT, V39, P1041, DOI 10.1007/s10295-012-1105-1; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Li YJ, 2006, MOL CELL BIOL, V26, P3401, DOI 10.1128/MCB.26.9.3401-3413.2006; Liu JH, 2003, MOL CANCER RES, V1, P892; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sanyal S., 2009, CHEM BIOL, V4, P895; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Stout JG, 1997, J CLIN INVEST, V99, P2232, DOI 10.1172/JCI119397; Stout JG, 1998, BIOCHEMISTRY-US, V37, P14860, DOI 10.1021/bi9812930; Sudo T, 1999, FEBS LETT, V444, P11, DOI 10.1016/S0014-5793(99)00014-9; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Yu A, 2003, J BIOL CHEM, V278, P9706, DOI 10.1074/jbc.M204614200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zamparelli C, 1997, FEBS LETT, V409, P1, DOI 10.1016/S0014-5793(97)00464-X; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	44	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13206	13218		10.1074/jbc.M113.522953	http://dx.doi.org/10.1074/jbc.M113.522953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648509	hybrid, Green Published			2022-12-28	WOS:000335522800022
J	Zhang, SZ; Zhu, YT; Chen, SY; He, H; Tseng, SCG				Zhang, Suzhen; Zhu, Ying-Ting; Chen, Szu-Yu; He, Hua; Tseng, Scheffer C. G.			Constitutive Expression of Pentraxin 3 ( PTX3) Protein by Human Amniotic Membrane Cells Leads to Formation of the Heavy Chain ( HC)-Hyaluronan ( HA)-PTX3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Extracellular Matrix; Gene Expression; Protein Synthesis; Stromal Cell; Amniotic Membrane Cells; Heavy Chain-Hyaluronan Complex; Pentraxin 3	ALPHA-TRYPSIN INHIBITOR; RECOGNITION RECEPTOR PTX3; HUMORAL INNATE IMMUNITY; STIMULATED GENE-6 TSG-6; SHAP-HYALURONAN COMPLEX; STRUCTURAL-CHARACTERIZATION; EXTRACELLULAR-MATRIX; ACTIVATED MACROPHAGE; EPITHELIAL-CELLS; PROGENITOR CELLS	Background: HC-HA from the amniotic membrane (AM) is produced by AM cells. Results: Pentraxin 3 tightly binds to purified AM HC-HA and is constitutively secreted by AM cells, leading to HC-HA-PTX3 complex formation. Conclusion: PTX3 is an integral component of AM HC-HA-PTX3 complexes. Significance: HC-HA-PTX3, produced endogenously by the AM, may play an important protective role during fetal development and can be an active therapeutic agent. Heavy chain (HC)-hyaluronan (HA), a complex formed by the covalent linkage between HC1 from the inter--trypsin inhibitor (II) and HA, purified from the human amniotic membrane (AM), is responsible for the anti-inflammatory, antiscarring, and antiangiogenic actions of the AM. This HC-HA complex is produced by constitutive expression of TNF-stimulated gene 6 and endogenous production of II by AM cells. Pentraxin 3 (PTX3), a prototypic long pentraxin that plays a non-redundant role in innate immunity against selected pathogens, also helps stabilize HC-HA to ensure female fertility. Here we noted strong positive PTX3 staining in the AM epithelium and compact stroma. PTX3 was constitutively expressed and secreted by cultured AM epithelial and stromal cells and, further, greatly up-regulated by TNF and IL-1. Using an agarose overlay to trap the HA-containing matrix, the HC-HA-PTX3 complex was formed, as analyzed by Western blot analysis, by AM cells but not human skin fibroblasts, despite being cultured in the presence of serum and TNF. However, exogenous PTX3 helps human skin fibroblasts form the HC-HA-PTX3 complex with an agarose overlay. Furthermore, PTX3 can be coimmunoprecipitated with the HC-HA complex from agarose-overlaid AM cell extracts by an anti-human II antibody. Such a HC-HA-PTX3 complex can be reconstituted in vitro and exhibit similar effects as those reported for AM HC-HA-PTX3 on polarization of M2 macrophages. The tight binding between PTX3 and AM HC-HA withstands four runs of CsCl ultracentrifugation in the presence of 4 m GnHCl. These results indicate that PTX3 is constitutively expressed and secreted by AM cells as an integral component of the AM HC-HA-PTX3 complex and contributes to the biological function of AM HC-HA-PTX3.	[Zhang, Suzhen; Zhu, Ying-Ting; Chen, Szu-Yu; He, Hua; Tseng, Scheffer C. G.] TissueTech Inc, Miami, FL 33173 USA; [Tseng, Scheffer C. G.] Ocular Surface Ctr, Miami, FL 33173 USA		Tseng, SCG (corresponding author), Ocular Surface Ctr, 7000 SW 97th Ave,Suite 213, Miami, FL 33173 USA.	stseng@ocularsurface.com		Zhu, Yingting/0000-0002-3332-9713	NEI, National Institutes of Health [RO1 EY06819, R44 EY017497, R43 EY021045]; TissueTech, Inc.; Ocular Surface Research and Education Foundation; NATIONAL EYE INSTITUTE [R44EY017497, R01EY006819, R43EY021045] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); TissueTech, Inc.; Ocular Surface Research and Education Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health grants RO1 EY06819, R44 EY017497, and R43 EY021045 (to S. C. G. T.). This work was also supported by a research grant from TissueTech, Inc. and by an unrestricted grant from the Ocular Surface Research and Education Foundation (Miami, FL).	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bouchard Charles S, 2004, Ocul Surf, V2, P201; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.tec.2010.0609, 10.1089/ten.TEC.2010.0609]; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Etheredge L, 2010, MATRIX BIOL, V29, P519, DOI 10.1016/j.matbio.2010.05.003; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; Han B, 2012, LAB INVEST, V92, P1285, DOI 10.1038/labinvest.2012.92; Hassell JR, 2008, EXP EYE RES, V87, P604, DOI 10.1016/j.exer.2008.09.010; He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; HUANG L, 1993, J BIOL CHEM, V268, P26725; Inforzato A, 2011, TISSUE ANTIGENS, V77, P271, DOI 10.1111/j.1399-0039.2011.01645.x; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; LEE GW, 1993, J IMMUNOL, V150, P1804; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MURAMATU M, 1980, J BIOCHEM-TOKYO, V88, P1317, DOI 10.1093/oxfordjournals.jbchem.a133100; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Nauta AJ, 2003, TRENDS IMMUNOL, V24, P148, DOI 10.1016/S1471-4906(03)00030-9; Rovere P, 2000, BLOOD, V96, P4300; Rovere-Querini P, 2006, OBSTET GYNECOL, V108, P148, DOI 10.1097/01.AOG.0000224607.46622.bc; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	54	48	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13531	13542		10.1074/jbc.M113.525287	http://dx.doi.org/10.1074/jbc.M113.525287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652286	hybrid, Green Published			2022-12-28	WOS:000335522800048
J	Bendrioua, L; Smedh, M; Almquist, J; Cvijovic, M; Jirstrand, M; Goksor, M; Adiels, CB; Hohmann, S				Bendrioua, Loubna; Smedh, Maria; Almquist, Joachim; Cvijovic, Marija; Jirstrand, Mats; Goksor, Mattias; Adiels, Caroline B.; Hohmann, Stefan			Yeast AMP-activated Protein Kinase Monitors Glucose Concentration Changes and Absolute Glucose Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Glucose Metabolism; Nuclear Translocation; Signal Transduction; Yeast Physiology; Dynamic Control	SACCHAROMYCES-CEREVISIAE; MIG1 REPRESSOR; SNF1 KINASE; NUCLEAR-LOCALIZATION; ENERGY SENSOR; SUC2 GENE; PHOSPHORYLATION; BINDING; SIGNAL; ADP	Background: Little is known about the signaling dynamics of AMP-activated protein kinase. Results: We define the dynamics of yeast AMPK signaling under different glucose concentrations. Conclusion: The Snf1-Mig1 signaling system monitors glucose concentration changes and absolute glucose levels to adjust the metabolism to a wide range of conditions. Significance: This description of AMPK signaling dynamics will stimulate studies defining the integration of signaling and metabolism. Analysis of the time-dependent behavior of a signaling system can provide insight into its dynamic properties. We employed the nucleocytoplasmic shuttling of the transcriptional repressor Mig1 as readout to characterize Snf1-Mig1 dynamics in single yeast cells. Mig1 binds to promoters of target genes and mediates glucose repression. Mig1 is predominantly located in the nucleus when glucose is abundant. Upon glucose depletion, Mig1 is phosphorylated by the yeast AMP-activated kinase Snf1 and exported into the cytoplasm. We used a three-channel microfluidic device to establish a high degree of control over the glucose concentration exposed to cells. Following regimes of glucose up- and downshifts, we observed a very rapid response reaching a new steady state within less than 1 min, different glucose threshold concentrations depending on glucose up- or downshifts, a graded profile with increased cell-to-cell variation at threshold glucose concentrations, and biphasic behavior with a transient translocation of Mig1 upon the shift from high to intermediate glucose concentrations. Fluorescence loss in photobleaching and fluorescence recovery after photobleaching data demonstrate that Mig1 shuttles constantly between the nucleus and cytoplasm, although with different rates, depending on the presence of glucose. Taken together, our data suggest that the Snf1-Mig1 system has the ability to monitor glucose concentration changes as well as absolute glucose levels. The sensitivity over a wide range of glucose levels and different glucose concentration-dependent response profiles are likely determined by the close integration of signaling with the metabolism and may provide for a highly flexible and fast adaptation to an altered nutritional status.	[Bendrioua, Loubna; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Smedh, Maria] Univ Gothenburg, Ctr Cellular Imaging, Sahlgrenska Core Facil, S-40530 Gothenburg, Sweden; [Almquist, Joachim; Jirstrand, Mats] Fraunhofer Chalmers Res Ctr Ind Math, S-41288 Gothenburg, Sweden; [Almquist, Joachim] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Cvijovic, Marija] Chalmers, Dept Math Sci, S-41296 Gothenburg, Sweden; [Cvijovic, Marija] Univ Gothenburg, S-41296 Gothenburg, Sweden; [Goksor, Mattias; Adiels, Caroline B.] Univ Gothenburg, Dept Phys, S-41296 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Chalmers University of Technology; Fraunhofer-Chalmers Research Centre for Industrial Mathematics; Chalmers University of Technology; Chalmers University of Technology; University of Gothenburg; University of Gothenburg	Hohmann, S (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, S-40530 Gothenburg, Sweden.	stefan.hohmann@gu.se	Almquist, Joachim/U-8894-2019; Hohmann, Stefan/K-9895-2013	Almquist, Joachim/0000-0002-4745-9332; Hohmann, Stefan/0000-0002-0809-1985; Beck Adiels, Caroline/0000-0002-2403-2213; Jirstrand, Mats/0000-0002-6612-8037	European Commission [201142]; ISOLATE project [289995]	European Commission(European CommissionEuropean Commission Joint Research Centre); ISOLATE project	This work was supported by European Commission UNICELLSYS project contract 201142 (to S. H., M. G., and M.J.) and by ISOLATE project contract 289995 (to S.H. and M.G).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chandrashekarappa DG, 2013, J BIOL CHEM, V288, P89, DOI 10.1074/jbc.M112.422659; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Eriksson E, 2010, LAB CHIP, V10, P617, DOI 10.1039/b913587a; Frey S, 2011, MOL BIOSYST, V7, P215, DOI 10.1039/c005305h; Frolova E, 1999, NUCLEIC ACIDS RES, V27, P1350, DOI 10.1093/nar/27.5.1350; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Garcia-Salcedo R, 2014, FEBS J, V281, P1901, DOI 10.1111/febs.12753; Geijer C, 2013, FEBS J, V280, P3854, DOI 10.1111/febs.12382; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; Gustavsson AK, 2012, FEBS J, V279, P2837, DOI 10.1111/j.1742-4658.2012.08639.x; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Meijer MMC, 1998, J BIOL CHEM, V273, P24102, DOI 10.1074/jbc.273.37.24102; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Ostling J, 1996, MOL CELL BIOL, V16, P753; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Ozcan S, 1997, YEAST, V13, P127; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; ROSE M, 1991, EUR J BIOCHEM, V199, P511, DOI 10.1111/j.1432-1033.1991.tb16149.x; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Scrimgeour J, 2007, METHOD CELL BIOL, V82, P629, DOI 10.1016/S0091-679X(06)82022-4; Smedh M, 2010, PROC SPIE, V7762, DOI 10.1117/12.860403; Sunnaker M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003621; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; VANAELST L, 1993, MOL MICROBIOL, V8, P927; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x	53	21	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12863	12875		10.1074/jbc.M114.547976	http://dx.doi.org/10.1074/jbc.M114.547976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627493	Green Published, hybrid			2022-12-28	WOS:000335581400055
J	Koshy, S; Huq, R; Tanner, MR; Atik, MA; Porter, PC; Khan, FS; Pennington, MW; Hanania, NA; Corry, DB; Beeton, C				Koshy, Shyny; Huq, Redwan; Tanner, Mark R.; Atik, Mustafa A.; Porter, Paul C.; Khan, Fatima S.; Pennington, Michael W.; Hanania, Nicola A.; Corry, David B.; Beeton, Christine			Blocking K(V)1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Animal Models; Asthma; Cellular Immune Response; Potassium Channels; KCNA3; K(V)1; 3; T Lymphocyte; Airway Inflammation; Therapy	MEMORY T-CELLS; GATED K+ CHANNELS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POTASSIUM CHANNEL; KV1.3 CHANNEL; SHK TOXIN; PHARMACOLOGICAL RESPONSES; AIRWAY INFLAMMATION; MULTIPLE-SCLEROSIS; UP-REGULATION	Background: CCR7(-) effector memory T lymphocytes are major players in lung inflammation that characterizes allergic asthma. Results: Blocking K(V)1.3 channels reduced the severity of an ovalbumin-induced model of asthma in rats. Conclusion: K(V)1.3 channels are attractive targets for immunomodulation and the treatment of allergic asthma. Significance: Selective K(V)1.3 channel blockers may prove beneficial in the treatment of asthma. Allergic asthma is a chronic inflammatory disease of the airways. Of the different lower airway-infiltrating immune cells that participate in asthma, T lymphocytes that produce Th2 cytokines play important roles in pathogenesis. These T cells are mainly fully differentiated CCR7(-) effector memory T (T-EM) cells. Targeting T-EM cells without affecting CCR7(+) naive and central memory (T-CM) cells has the potential of treating T-EM-mediated diseases, such as asthma, without inducing generalized immunosuppression. The voltage-gated K(V)1.3 potassium channel is a target for preferential inhibition of T-EM cells. Here, we investigated the effects of ShK-186, a selective K(V)1.3 channel blocker, for the treatment of asthma. A significant proportion of T lymphocytes in the lower airways of subjects with asthma expressed high levels of K(V)1.3 channels. ShK-186 inhibited the allergen-induced activation of peripheral blood T cells from those subjects. Immunization of F344 rats against ovalbumin followed by intranasal challenges with ovalbumin induced airway hyper-reactivity, which was reduced by the administration of ShK-186. ShK-186 also reduced total immune infiltrates in the bronchoalveolar lavage and number of infiltrating lymphocytes, eosinophils, and neutrophils assessed by differential counts. Rats with the ovalbumin-induced model of asthma had elevated levels of the Th2 cytokines IL-4, IL-5, and IL-13 measured by ELISA in their bronchoalveolar lavage fluids. ShK-186 administration reduced levels of IL-4 and IL-5 and induced an increase in the production of IL-10. Finally, ShK-186 inhibited the proliferation of lung-infiltrating ovalbumin-specific T cells. Our results suggest that K(V)1.3 channels represent effective targets for the treatment of allergic asthma.	[Koshy, Shyny; Huq, Redwan; Tanner, Mark R.; Khan, Fatima S.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Huq, Redwan] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Tanner, Mark R.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Atik, Mustafa A.; Hanania, Nicola A.] Baylor Coll Med, Asthma Clin Res Ctr, Houston, TX 77030 USA; [Atik, Mustafa A.; Porter, Paul C.; Hanania, Nicola A.; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int, Louisville, KY 40299 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA.	beeton@bcm.edu	Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530; pennington, michael/0000-0001-5446-3447; Tanner, Mark/0000-0002-6516-0166	National Institutes of Health [RR024574, AI036211, CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831, R56AI084981, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The Cytometry and Cell Sorting Core at Baylor College of Medicine is supported in part by National Institutes of Health Grants RR024574, AI036211, and CA125123.	Agbetile J, 2012, CLIN EXP ALLERGY, V42, P782, DOI 10.1111/j.1365-2222.2012.03987.x; Baiz N, 2012, CLIN CHEST MED, V33, P419, DOI 10.1016/j.ccm.2012.06.001; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Chung F, 2001, MEDIAT INFLAMM, V10, P51, DOI 10.1080/09629350120054518; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; de Pater-Huijsen FL, 2000, HISTOCHEM J, V32, P3, DOI 10.1023/A:1003967726621; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Fadool DA, 1998, J NEUROSCI, V18, P6126; Femling JK, 2006, J GEN PHYSIOL, V127, P659, DOI 10.1085/jgp.200609504; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Follenweider LM, 2013, NURS CLIN N AM, V48, P1, DOI 10.1016/j.cnur.2012.12.008; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gilhar A, 2011, J INVEST DERMATOL, V131, P118, DOI 10.1038/jid.2010.245; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Koshy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076740; Krampera M, 1999, ANN ALLERG ASTHMA IM, V83, P144, DOI 10.1016/S1081-1206(10)62626-9; Kruschinski C, 2005, CLIN EXP IMMUNOL, V139, P17, DOI 10.1111/j.1365-2249.2005.02666.x; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Machura E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/606139; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Norton R. S., 2013, VENOMS DRUG IN PRESS; Ohtsuka R, 2005, EXP TOXICOL PATHOL, V56, P361, DOI 10.1016/j.etp.2005.02.002; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pizzichini MMM, 1996, AM J RESP CRIT CARE, V154, P866, DOI 10.1164/ajrccm.154.4.8887576; Polikepahad S., 2010, J VIS EXP, V38, P1720; Porter P, 2011, MED MYCOL, V49, pS158, DOI 10.3109/13693786.2010.509743; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013; Schwingshackl A, 2002, J LEUKOCYTE BIOL, V71, P807; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Syed F, 1999, QJM-MON J ASSOC PHYS, V92, P463, DOI 10.1093/qjmed/92.8.463; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Van Woerden H. C., 2013, BMC INFECT DIS, V13; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921	53	50	53	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12623	12632		10.1074/jbc.M113.517037	http://dx.doi.org/10.1074/jbc.M113.517037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644290	Green Published, hybrid			2022-12-28	WOS:000335581400034
J	Stockdreher, Y; Sturm, M; Josten, M; Sahl, HG; Dobler, N; Zigann, R; Dahl, C				Stockdreher, Yvonne; Sturm, Marga; Josten, Michaele; Sahl, Hans-Georg; Dobler, Nadine; Zigann, Renate; Dahl, Christiane			New Proteins Involved in Sulfur Trafficking in the Cytoplasm of Allochromatium vinosum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Intracellular Trafficking; Microbiology; Sulfur; Thiol; Allochromatium vinosum; Purple Sulfur Bacteria; Sulfur Oxidation; Sulfur Relay System; TusA	INVITRO INSERTIONAL MUTAGENESIS; ESCHERICHIA-COLI; SULFITE REDUCTASE; NMR STRUCTURE; OXIDATION; BACTERIUM; INSIGHTS; GROWTH; IRON; YHHP	Background: Sulfur carrier proteins Rhd_2599, TusA, and DsrE2 occur in many sulfur oxidizing prokaryotes. Results: Rhd_2599, TusA, and possibly DsrE2 are involved in cytoplasmic sulfur trafficking during dissimilatory sulfur oxidation. Conclusion: Sulfur transfer from persulfide intermediates to dissimilatory sulfite reductase involves Rhd_2599, TusA, and possibly DsrE2. Significance: Proteins involved in dissimilatory sulfur oxidation have been identified. The formation of periplasmic sulfur globules is an intermediate step during the oxidation of reduced sulfur compounds in various sulfur-oxidizing microorganisms. The mechanism of how this sulfur is activated and crosses the cytoplasmic membrane for further oxidation to sulfite by the dissimilatory reductase DsrAB is incompletely understood, but it has been well documented that the pathway involves sulfur trafficking mediated by sulfur-carrying proteins. So far sulfur transfer from DsrEFH to DsrC has been established. Persulfurated DsrC very probably serves as a direct substrate for DsrAB. Here, we introduce further important players in oxidative sulfur metabolism; the proteins Rhd_2599, TusA, and DsrE2 are strictly conserved in the Chromatiaceae, Chlorobiaceae, and Acidithiobacillaceae families of sulfur-oxidizing bacteria and are linked to genes encoding complexes involved in sulfur oxidation (Dsr or Hdr) in the latter two. Here we show via relative quantitative real-time PCR and microarray analysis an increase of mRNA levels under sulfur-oxidizing conditions for rhd_2599, tusA, and dsrE2 in Allochromatium vinosum. Transcriptomic patterns for the three genes match those of major genes for the sulfur-oxidizing machinery rather than those involved in biosynthesis of sulfur-containing biomolecules. TusA appears to be one of the major proteins in A. vinosum. A rhd_2599-tusA-dsrE2-deficient mutant strain, although not viable in liquid culture, was clearly sulfur oxidation negative upon growth on solid media containing sulfide. Rhd_2599, TusA, and DsrE2 bind sulfur atoms via conserved cysteine residues, and experimental evidence is provided for the transfer of sulfur between these proteins as well as to DsrEFH and DsrC.	[Stockdreher, Yvonne; Sturm, Marga; Dobler, Nadine; Zigann, Renate; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Abt Pharmazeut Mikrobiol, Inst Med Mikrobiol Immunol & Parasitol, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Dahl, C (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Meckenheimer Allee 168, D-53115 Bonn, Germany.	ChDahl@uni-bonn.de	Dahl, Christiane/H-4786-2019	Dahl, Christiane/0000-0001-8288-7546	Deutsche Forschungsgemeinschaft [Da 351/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Da 351/6-1 (to C. D.).	Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl Christiane, 2008, V27, P289; Dahl C, 2007, ACTA CRYSTALLOGR F, V63, P890, DOI 10.1107/S1744309107041188; Dahl C, 2013, MICROBIOL-SGM, V159, P2626, DOI 10.1099/mic.0.071019-0; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dahl JU, 2013, J BIOL CHEM, V288, P5426, DOI 10.1074/jbc.M112.431569; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Frigaard Niels-Ulrik, 2008, V27, P337; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Grein F, 2010, J BACTERIOL, V192, P6369, DOI 10.1128/JB.00849-10; Grimm F, 2010, J BACTERIOL, V192, P1652, DOI 10.1128/JB.01269-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heising S, 1999, ARCH MICROBIOL, V172, P116, DOI 10.1007/s002030050748; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kelly DP, 2008, POL J MICROBIOL, V57, P275; KELLY DP, 1969, ANAL CHEM, V41, P898, DOI 10.1021/ac60276a029; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Numata T, 2006, STRUCTURE, V14, P357, DOI 10.1016/j.str.2005.11.009; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; PATTARAGULWANIT K, 1995, ARCH MICROBIOL, V164, P217, DOI 10.1007/BF02529974; Pfennig N., 1992, PROKARYOTES, P3200; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Rethmeier J, 1997, J CHROMATOGR A, V760, P295, DOI 10.1016/S0021-9673(96)00809-6; Riederer BM, 2009, CURR PROTEOMICS, V6, P51, DOI 10.2174/157016409787847448; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solovyev V., 2010, METAGENOMICS ITS APP, P71; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Venceslau SS, 2014, BBA-BIOENERGETICS, V1837, P1148, DOI 10.1016/j.bbabio.2014.03.007; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Weissgerber T, 2014, APPL ENVIRON MICROB, V80, P2279, DOI 10.1128/AEM.04182-13; Weissgerber T, 2013, J BACTERIOL, V195, P4231, DOI 10.1128/JB.00154-13; Yamashino T, 1998, J BACTERIOL, V180, P2257, DOI 10.1128/JB.180.8.2257-2261.1998; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	54	24	27	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12390	12403		10.1074/jbc.M113.536425	http://dx.doi.org/10.1074/jbc.M113.536425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648525	Green Published, hybrid			2022-12-28	WOS:000335581400017
J	Ding, JZ; Mooers, BHM; Zhang, Z; Kale, J; Falcone, D; McNichol, J; Huang, B; Zhang, XJC; Xing, CG; Andrews, DW; Lin, JL				Ding, Jingzhen; Mooers, Blaine H. M.; Zhang, Zhi; Kale, Justin; Falcone, Domina; McNichol, Jamie; Huang, Bo; Zhang, Xuejun C.; Xing, Chengguo; Andrews, David W.; Lin, Jialing			After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bax; Bcl-2 Proteins; Membrane Proteins; Mitochondrial Apoptosis; Protein Cross-linking; Bcl-XL	CROSS-LINKING; CONFORMATIONAL-CHANGE; BH3 DOMAINS; FAMILY; ACTIVATION; BCL-X(L); OLIGOMERIZATION; INTERFACE; DIMER; FORMS	Background: Bcl-XL binds Bax at mitochondria, inhibiting Bax oligomerization and apoptosis. Results: Anchored in membranes, Bcl-XLBax heterodimer is formed from a rigid helix-in-groove interface plus a flexible helical dimer interface. Conclusion: Two interfaces contribute equally to the heterodimer stability required to inhibit Bax. Significance: This novel kind of protein-protein interaction stabilizes the membrane-bound heterodimer that is pivotal to apoptosis regulation. Bcl-XL binds to Bax, inhibiting Bax oligomerization required for mitochondrial outer membrane permeabilization (MOMP) during apoptosis. How Bcl-XL binds to Bax in the membrane is not known. Here, we investigated the structural organization of Bcl-XLBax complexes formed in the MOM, including the binding interface and membrane topology, using site-specific cross-linking, compartment-specific labeling, and computational modeling. We found that one heterodimer interface is formed by a specific interaction between the Bcl-2 homology 1-3 (BH1-3) groove of Bcl-XL and the BH3 helix of Bax, as defined previously by the crystal structure of a truncated Bcl-XL protein and a Bax BH3 peptide (Protein Data Bank entry 3PL7). We also discovered a novel interface in the heterodimer formed by equivalent interactions between the helix 1 regions of Bcl-XL and Bax when their helical axes are oriented either in parallel or antiparallel. The two interfaces are located on the cytosolic side of the MOM, whereas helix 9 of Bcl-XL is embedded in the membrane together with helices 5, 6, and 9 of Bax. Formation of the helix 1helix 1 interface partially depends on the formation of the grooveBH3 interface because point mutations in the latter interface and the addition of ABT-737, a groove-binding BH3 mimetic, blocked the formation of both interfaces. The mutations and ABT-737 also prevented Bcl-XL from inhibiting Bax oligomerization and subsequent MOMP, suggesting that the structural organization in which interactions at both interfaces contribute to the overall stability and functionality of the complex represents antiapoptotic Bcl-XLBax complexes in the MOM.	[Ding, Jingzhen; Mooers, Blaine H. M.; Zhang, Zhi; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Mooers, Blaine H. M.; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73126 USA; [Kale, Justin; Falcone, Domina; McNichol, Jamie; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Huang, Bo; Zhang, Xuejun C.] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Xing, Chengguo] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Andrews, David W.] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Andrews, David W.] Univ Toronto, Dept Biochem, Toronto, ON M4N 3M5, Canada	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	ding, Jingzhen/B-5427-2015; Kale, Justin/AAO-6023-2020; Mooers, Blaine/S-4383-2017	Kale, Justin/0000-0002-4915-0806; Mooers, Blaine/0000-0001-8181-8987; Huang, Bo/0000-0003-3822-9110; Andrews, David/0000-0002-9266-7157	National Institutes of Health [R01GM062964, R01AI088011, P20GM103640]; OCAST [HR10-121]; Canadian Institutes of Health Research [FRN 12517]; NATIONAL CANCER INSTITUTE [R01CA163864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640, R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM062964 (to J. L.) and R01AI088011 and P20GM103640 (to B. H. M. M.). This work was also supported by OCAST Grant HR10-121 (to J. L.), and Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A. and Brian Leber).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Czabotar PE, 2011, J BIOL CHEM, V286, P7123, DOI 10.1074/jbc.M110.161281; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gautier F, 2011, MOL CELL BIOL, V31, P832, DOI 10.1128/MCB.00161-10; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; London N, 2012, BIOCHEMISTRY-US, V51, P5841, DOI 10.1021/bi3003567; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottilie S, 1997, J BIOL CHEM, V272, P16955, DOI 10.1074/jbc.272.27.16955; Ozhogina OA, 2009, J STRUCT BIOL, V168, P223, DOI 10.1016/j.jsb.2009.06.003; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Trakselis MA, 2005, BIOCONJUGATE CHEM, V16, P741, DOI 10.1021/bc050043a; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014	61	60	62	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11873	11896		10.1074/jbc.M114.552562	http://dx.doi.org/10.1074/jbc.M114.552562			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616095	Green Published, hybrid			2022-12-28	WOS:000335010600029
J	Sobolewska-Stawiarz, A; Leferink, NGH; Fisher, K; Heyes, DJ; Hay, S; Rigby, SEJ; Scrutton, NS				Sobolewska-Stawiarz, Anna; Leferink, Nicole G. H.; Fisher, Karl; Heyes, Derren J.; Hay, Sam; Rigby, Stephen E. J.; Scrutton, Nigel S.			Energy Landscapes and Catalysis in Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; Enzyme Kinetics; Flavoproteins; Nitric-oxide Synthase; Protein Dynamics; PELDOR Spectroscopy; Free Energy Landscapes; High Pressure Stopped Flow	REGULATE ELECTRON-TRANSFER; C-TERMINAL TAIL; CYTOCHROME-P450 REDUCTASE; KINETIC-PARAMETERS; HYDRIDE TRANSFER; STRUCTURAL BASIS; DOMAIN; CALMODULIN; MECHANISM; NADPH	Background: Protein domain dynamics and calmodulin binding are implicated in regulating electron flow in NO synthase. Results: A dynamic conformational landscape important for enzyme catalysis is demonstrated. Conclusion: NO synthesis requires a complex landscape of conformations, with calmodulin as a key driver of chemistry through modulation of the dynamic landscape. Significance: Detailed understanding of conformational landscapes provides new opportunities for inhibitor discovery targeted at the dynamic interfaces. Nitric oxide (NO) plays diverse roles in mammalian physiology. It is involved in blood pressure regulation, neurotransmission, and immune response, and is generated through complex electron transfer reactions catalyzed by NO synthases (NOS). In neuronal NOS (nNOS), protein domain dynamics and calmodulin binding are implicated in regulating electron flow from NADPH, through the FAD and FMN cofactors, to the heme oxygenase domain, the site of NO generation. Simple models based on crystal structures of nNOS reductase have invoked a role for large scale motions of the FMN-binding domain in shuttling electrons from the FAD-binding domain to the heme oxygenase domain. However, molecular level insight of the dynamic structural transitions in NOS enzymes during enzyme catalysis is lacking. We use pulsed electron-electron double resonance spectroscopy to derive inter-domain distance relationships in multiple conformational states of nNOS. These distance relationships are correlated with enzymatic activity through variable pressure kinetic studies of electron transfer and turnover. The binding of NADPH and calmodulin are shown to influence interdomain distance relationships as well as reaction chemistry. An important effect of calmodulin binding is to suppress adventitious electron transfer from nNOS to molecular oxygen and thereby preventing accumulation of reactive oxygen species. A complex landscape of conformations is required for nNOS catalysis beyond the simple models derived from static crystal structures of nNOS reductase. Detailed understanding of this landscape advances our understanding of nNOS catalysis/electron transfer, and could provide new opportunities for the discovery of small molecule inhibitors that bind at dynamic protein interfaces of this multidimensional energy landscape.	[Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.as.uk	Hay, Sam/D-5974-2012; Fisher, Karl/A-5956-2013; Leferink, Nicole G H/I-6867-2012; Scrutton, Nigel/B-7352-2017	Hay, Sam/0000-0003-3274-0938; Fisher, Karl/0000-0003-3539-8939; Leferink, Nicole G H/0000-0003-4134-4339; Scrutton, Nigel/0000-0002-4182-3500; Heyes, Derren/0000-0002-7453-1571	United Kingdom Biotechnological Sciences Research Council [BB/1019928]; Bruker UK; BBSRC [BB/E013007/1, BB/I019928/1, BB/H021523/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019928/1, BB/E013007/1, BB/H021523/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	United Kingdom Biotechnological Sciences Research Council; Bruker UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by United Kingdom Biotechnological Sciences Research Council Grant BB/1019928 and Bruker UK.	Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Brenner S, 2008, FEBS J, V275, P4540, DOI 10.1111/j.1742-4658.2008.06597.x; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Davidson VL, 2000, ACCOUNTS CHEM RES, V33, P87, DOI 10.1021/ar9900616; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dunford AJ, 2004, EUR J BIOCHEM, V271, P2548, DOI 10.1111/j.1432-1033.2004.04185.x; Dutton P L, 1978, Methods Enzymol, V54, P411; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Feng CJ, 2012, COORDIN CHEM REV, V256, P393, DOI 10.1016/j.ccr.2011.10.011; Gao YT, 2007, J BIOL CHEM, V282, P7921, DOI 10.1074/jbc.M609814200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2013, FEBS J, V280, P4439, DOI 10.1111/febs.12404; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hay S, 2007, P NATL ACAD SCI USA, V104, P507, DOI 10.1073/pnas.0608408104; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Kay CWM, 2006, J AM CHEM SOC, V128, P76, DOI 10.1021/ja057308g; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Leys D, 2004, CURR OPIN STRUC BIOL, V14, P642, DOI 10.1016/j.sbi.2004.10.002; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; Northrop DB, 2002, BBA-PROTEIN STRUCT M, V1595, P71, DOI 10.1016/S0167-4838(01)00335-1; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Persechini A, 2013, FEBS LETT, V587, P297, DOI 10.1016/j.febslet.2012.12.012; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Pudney CR, 2009, CHEMBIOCHEM, V10, P1379, DOI 10.1002/cbic.200900071; Rigby SEJ, 2011, CHEMBIOCHEM, V12, P863, DOI 10.1002/cbic.201000630; SALERNO JC, 1995, J BIOL CHEM, V270, P27423, DOI 10.1074/jbc.270.46.27423; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SCHWEIGER A, 2001, PRINCIPLES PULSE ELE, P183; SHETA EA, 1994, J BIOL CHEM, V269, P15147; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1996, METHOD ENZYMOL, V268, P324; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m; Welland A, 2010, FEBS J, V277, P3833, DOI 10.1111/j.1742-4658.2010.07787.x; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wolthers KR, 2002, BIOCHEMISTRY-US, V41, P196, DOI 10.1021/bi0109461	52	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11725	11738		10.1074/jbc.M114.548834	http://dx.doi.org/10.1074/jbc.M114.548834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610812	Green Published, hybrid			2022-12-28	WOS:000335010600015
J	Schurek, EM; Volker, LA; Tax, J; Lamkemeyer, T; Rinschen, MM; Ungrue, D; Kratz, JE; Sirianant, L; Kunzelmann, K; Chalfie, M; Schermer, B; Benzing, T; Hohne, M				Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Lamkemeyer, Tobias; Rinschen, Markus M.; Ungrue, Denise; Kratz, John E., III; Sirianant, Lalida; Kunzelmann, Karl; Chalfie, Martin; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin			A Disease-causing Mutation Illuminates the Protein Membrane Topology of the Kidney-expressed Prohibitin Homology ( PHB) Domain Protein Podocin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans; Cholesterol-binding Protein; Glycosylation; Lipid Raft; Protein Conformation; PHB Domain; Membrane Topology; Podocin; Steroid-resistant Nephrotic Syndrome; Stomatin Family Proteins	RESISTANT NEPHROTIC SYNDROME; MULTIPLE SEQUENCE ALIGNMENT; GLOMERULAR SLIT DIAPHRAGM; TURKISH CHILDREN; N-GLYCOSYLATION; NPHS2 MUTATIONS; NEPHRIN; MEC-2; TRPC6; GENE	Background: Mutations in the stomatin family protein podocin are the most common genetic cause of proteinuria. Results: A conserved proline residue of podocin is essential for its membrane topology. Conclusion: This study confirms a hairpin-like structure of the membrane-attached PHB domain protein and its significance for cholesterol recruitment. Significance: Podocin(P118L) elucidates the pathogenic implication in kidney disease and identifies a novel family of PHB domain proteins. Mutations in the NPHS2 gene are a major cause of steroid-resistant nephrotic syndrome, a severe human kidney disorder. The NPHS2 gene product podocin is a key component of the slit diaphragm cell junction at the kidney filtration barrier and part of a multiprotein-lipid supercomplex. A similar complex with the podocin ortholog MEC-2 is required for touch sensation in Caenorhabditis elegans. Although podocin and MEC-2 are membrane-associated proteins with a predicted hairpin-like structure and amino and carboxyl termini facing the cytoplasm, this membrane topology has not been convincingly confirmed. One particular mutation that causes kidney disease in humans (podocin(P118L)) has also been identified in C. elegans in genetic screens for touch insensitivity (MEC-2(P134S)). Here we show that both mutant proteins, in contrast to the wild-type variants, are N-glycosylated because of the fact that the mutant C termini project extracellularly. Podocin(P118L) and MEC-2(P134S) did not fractionate in detergent-resistant membrane domains. Moreover, mutant podocin failed to activate the ion channel TRPC6, which is part of the multiprotein-lipid supercomplex, indicative of the fact that cholesterol recruitment to the ion channels, an intrinsic function of both proteins, requires C termini facing the cytoplasmic leaflet of the plasma membrane. Taken together, this study demonstrates that the carboxyl terminus of podocin/MEC-2 has to be placed at the inner leaflet of the plasma membrane to mediate cholesterol binding and contribute to ion channel activity, a prerequisite for mechanosensation and the integrity of the kidney filtration barrier.	[Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Lamkemeyer, Tobias; Ungrue, Denise; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Kratz, John E., III; Chalfie, Martin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sirianant, Lalida; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Columbia University; University of Regensburg	Benzing, T (corresponding author), Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany.	thomas.benzing@uk-koeln.de	Benzing, Thomas/X-5476-2019; Rinschen, Markus/N-7283-2019; Schermer, Bernhard/E-9972-2014; Völker, Linus Alexander/GLV-0326-2022	Rinschen, Markus/0000-0002-9252-1342; Schermer, Bernhard/0000-0002-5194-9000; Völker, Linus Alexander/0000-0002-4461-6128; Hohne, Martin/0000-0001-8698-5389	National Institutes of Health [GM30997]; Deutsche Forschungsgemeinschaft [SFB699, SFB572, SFB635, BE2212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R01GM030997, R37GM030997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30997 (to M. C.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB699 (to K. K.) and SFB572, SFB635, and BE2212 (to T. B.).	Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Berdeli A, 2007, PEDIATR NEPHROL, V22, P2031, DOI 10.1007/s00467-007-0595-y; Bouchireb K, 2014, HUM MUTAT, V35, P178, DOI 10.1002/humu.22485; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brand J, 2012, EMBO J, V31, P3635, DOI 10.1038/emboj.2012.203; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Caridi G, 2005, PEDIATR RES, V57, p54R, DOI 10.1203/01.PDR.0000160446.01907.B1; Eckhardt M, 2002, BIOCHEM J, V368, P317, DOI 10.1042/BJ20020946; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekim M, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.04.044; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Ozer EA, 2004, NEPHROLOGY, V9, P310, DOI 10.1111/j.1440-1797.2004.00324.x; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Schermer B, 2009, J AM SOC NEPHROL, V20, P473, DOI 10.1681/ASN.2008070694; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Volker LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-102; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	38	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11262	11271		10.1074/jbc.M113.521773	http://dx.doi.org/10.1074/jbc.M113.521773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596097	Green Published, hybrid			2022-12-28	WOS:000334638500029
J	Lang, MJ; Martinez-Marquez, JY; Prosser, DC; Ganser, LR; Buelto, D; Wendland, B; Duncan, MC				Lang, Michael J.; Martinez-Marquez, Jorge Y.; Prosser, Derek C.; Ganser, Laura R.; Buelto, Destiney; Wendland, Beverly; Duncan, Mara C.			Glucose Starvation Inhibits Autophagy via Vacuolar Hydrolysis and Induces Plasma Membrane Internalization by Down-regulating Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE COMPLEX; CLATHRIN ADAPTER; TRANSLATION INITIATION; GENE ENCODES; H+-ATPASE; PEP4 GENE; V-ATPASE; IN-VIVO	Cellular energy influences all aspects of cellular function. Although cells can adapt to a gradual reduction in energy, acute energy depletion poses a unique challenge. Because acute depletion hampers the transport of new energy sources into the cell, the cell must use endogenous substrates to replenish energy after acute depletion. In the yeast Saccharomyces cerevisiae, glucose starvation causes an acute depletion of intracellular energy that recovers during continued glucose starvation. However, how the cell replenishes energy during the early phase of glucose starvation is unknown. In this study, we investigated the role of pathways that deliver proteins and lipids to the vacuole during glucose starvation. We report that in response to glucose starvation, plasma membrane proteins are directed to the vacuole through reduced recycling at the endosomes. Furthermore, we found that vacuolar hydrolysis inhibits macroautophagy in a target of rapamycin complex 1-dependent manner. Accordingly, we found that endocytosis and hydrolysis are required for survival in glucose starvation, whereas macroautophagy is dispensable. Together, these results suggest that hydrolysis of components delivered to the vacuole independent of autophagy is the cell survival mechanism used by S. cerevisiae in response to glucose starvation.	[Lang, Michael J.; Martinez-Marquez, Jorge Y.; Duncan, Mara C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Ganser, Laura R.; Duncan, Mara C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Prosser, Derek C.; Wendland, Beverly] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Buelto, Destiney; Duncan, Mara C.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Duncan, MC (corresponding author), Univ Michigan, Dept Cell & Dev Biol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	mcduncan@umich.edu	Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109; Martinez-Marquez, Jorge/0000-0003-1485-4800; Prosser, Derek/0000-0002-6738-2758; Ganser, Laura/0000-0002-7357-4588; lang, michael/0000-0003-3544-5221	National Institutes of Health through NIGMS [GM092741, GM60979]; National Institutes of Health [T32 709237]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060979, R01GM092741] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM092741 (to M. C. D.) and GM60979 (to B. W.) through the NIGMS.; Supported by National Institutes of Health Grant T32 709237.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Aoh QL, 2013, MOL BIOL CELL, V24, P832, DOI 10.1091/mbc.E12-10-0750; Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Aravamudhan P, 2013, CURR BIOL, V23, P770, DOI 10.1016/j.cub.2013.03.042; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; CLARKE BL, 1985, J BIOL CHEM, V260, P128; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; INDGE KJ, 1968, J GEN MICROBIOL, V51, P447, DOI 10.1099/00221287-51-3-447; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Juhasz G, 2012, AUTOPHAGY, V8, P1875, DOI 10.4161/auto.21544; Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2011, AUTOPHAGY, V7, P1093, DOI 10.4161/auto.7.10.15492; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; LIAO JF, 1993, MOL PHARMACOL, V44, P364; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; MANOLSON MF, 1992, J EXP BIOL, V172, P105; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Perzov N, 2002, J EXP BIOL, V205, P1209; PODBILEWICZ B, 1990, EMBO J, V9, P3477, DOI 10.1002/j.1460-2075.1990.tb07556.x; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Uesono Y, 2004, MOL BIOL CELL, V15, P1544, DOI 10.1091/mbc.E03-12-0877; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	67	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16736	16747		10.1074/jbc.M113.525782	http://dx.doi.org/10.1074/jbc.M113.525782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24753258	Green Published, hybrid			2022-12-28	WOS:000338016200013
J	Podobnik, M; Siddiqui, N; Rebolj, K; Nambi, S; Merzel, F; Visweswariah, SS				Podobnik, Marjetka; Siddiqui, Nida; Rebolj, Katja; Nambi, Subhalaxmi; Merzel, Franci; Visweswariah, Sandhya S.			Allostery and Conformational Dynamics in cAMP-binding Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GNAT SUPERFAMILY; PROTEIN; ACETYLTRANSFERASE; EVOLUTION	Mycobacteria harbor unique proteins that regulate protein lysine acylation in a cAMP-regulated manner. These lysine acyltransferases from Mycobacterium smegmatis (KATms) and Mycobacterium tuberculosis (KATmt) show distinctive biochemical properties in terms of cAMP binding affinity to the N-terminal cyclic nucleotide binding domain and allosteric activation of the C-terminal acyltransferase domain. Here we provide evidence for structural features in KATms that account for high affinity cAMP binding and elevated acyltransferase activity in the absence of cAMP. Structure-guided mutational analysis converted KATms from a cAMP-regulated to a cAMP-dependent acyltransferase and identified a unique asparagine residue in the acyltransferase domain of KATms that assists in the enzymatic reaction in the absence of a highly conserved glutamate residue seen in Gcn5-related N-acetyltransferase-like acyltransferases. Thus, we have identified mechanisms by which properties of similar proteins have diverged in two species of mycobacteria by modifications in amino acid sequence, which can dramatically alter the abundance of conformational states adopted by a protein.	[Podobnik, Marjetka; Rebolj, Katja] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia; [Merzel, Franci] Natl Inst Chem, Lab Biomol Struct, Ljubljana 1000, Slovenia; [Siddiqui, Nida; Nambi, Subhalaxmi; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	National Institute of Chemistry - Slovenia; National Institute of Chemistry - Slovenia; Indian Institute of Science (IISC) - Bangalore	Podobnik, M (corresponding author), Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	marjetka.podobnik@ki.si; sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Merzel, Franci/0000-0002-2748-4901; Siddiqui, Nida/0000-0002-5416-8533; Nambi, Subhalaxmi/0000-0001-7104-659X	Slovenian Research Agency; Department of Science and Technology Indo-Slovene Joint Science and Technology Program; Intensification of Research in High Priority Area proposal	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Department of Science and Technology Indo-Slovene Joint Science and Technology Program; Intensification of Research in High Priority Area proposal	This work was supported by the Slovenian Research Agency (to M. P., K. R., and F. M.), the Department of Science and Technology Indo-Slovene Joint Science and Technology Program (to M. P. and S. S. V), and an Intensification of Research in High Priority Area proposal (to S. S. V).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Nasuno R, 2013, P NATL ACAD SCI USA, V110, P11821, DOI 10.1073/pnas.1300558110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020	26	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16588	16600		10.1074/jbc.M114.560086	http://dx.doi.org/10.1074/jbc.M114.560086			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24748621	Green Published, hybrid			2022-12-28	WOS:000337965700059
J	Shang, LM; Daubeuf, B; Triantafilou, M; Olden, R; Depis, F; Raby, AC; Herren, S; Dos Santos, A; Malinge, P; Dunn-Siegrist, I; Benmkaddem, S; Geinoz, A; Magistrelli, G; Rousseau, F; Buatois, V; Salgado-Pires, S; Reith, W; Monteiro, R; Pugin, J; Leger, O; Ferlin, W; Kosco-Vilbois, M; Triantafilou, K; Elson, G				Shang, Limin; Daubeuf, Bruno; Triantafilou, Martha; Olden, Robin; Depis, Fabien; Raby, Anne-Catherine; Herren, Suzanne; Dos Santos, Anaelle; Malinge, Pauline; Dunn-Siegrist, Irene; Benmkaddem, Sanae; Geinoz, Antoine; Magistrelli, Giovanni; Rousseau, Francois; Buatois, Vanessa; Salgado-Pires, Susana; Reith, Walter; Monteiro, Renato; Pugin, Jerome; Leger, Olivier; Ferlin, Walter; Kosco-Vilbois, Marie; Triantafilou, Kathy; Elson, Greg			Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc gamma Receptor Tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Fc gamma Receptor; Inflammation; Lipid Raft; Toll-like Receptor (TLR); Toll-like Receptor 4; Monoclonal Antibody	MONOCLONAL-ANTIBODY; TLR4 ACTIVATION; DENDRITIC CELLS; IMMUNE-SYSTEM; LIPOPOLYSACCHARIDE; RECOGNITION; MECHANISMS; REGULATORS; RESPONSES; DISEASES	Background: Dysregulated leukocyte activation via Toll-like receptor 4 (TLR4) is central to numerous inflammatory disorders. Results: A novel mechanism of action involving Fc receptor tethering allows anti-TLR4 blocking antibodies to achieve increased potency on inflammatory leukocytes. Conclusion: This novel mechanism of action allows selective targeting of TLR4 activation during inflammation. Significance: The data provide a novel mechanism to dampen TLR4-mediated inflammatory disorders. Inflammation is mediated mainly by leukocytes that express both Toll-like receptor 4 (TLR4) and Fc receptors (FcR). Dysregulated activation of leukocytes via exogenous and endogenous ligands of TLR4 results in a large number of inflammatory disorders that underlie a variety of human diseases. Thus, differentially blocking inflammatory cells while sparing structural cells, which are FcR-negative, represents an elegant strategy when targeting the underlying causes of human diseases. Here, we report a novel tethering mechanism of the Fv and Fc portions of anti-TLR4 blocking antibodies that achieves increased potency on inflammatory cells. In the presence of ligand (e.g. lipopolysaccharide (LPS)), TLR4 traffics into glycolipoprotein microdomains, forming concentrated protein platforms that include FcRs. This clustering produces a microenvironment allowing anti-TLR4 antibodies to co-engage TLR4 and FcRs, increasing their avidity and thus substantially increasing their inhibitory potency. Tethering of antibodies to both TLR4 and FcRs proves valuable in ameliorating inflammation in vivo. This novel mechanism of action therefore has the potential to enable selective intervention of relevant cell types in TLR4-driven diseases.	[Shang, Limin; Daubeuf, Bruno; Depis, Fabien; Raby, Anne-Catherine; Herren, Suzanne; Dos Santos, Anaelle; Malinge, Pauline; Magistrelli, Giovanni; Rousseau, Francois; Buatois, Vanessa; Salgado-Pires, Susana; Leger, Olivier; Ferlin, Walter; Kosco-Vilbois, Marie; Elson, Greg] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland; [Triantafilou, Martha; Olden, Robin; Triantafilou, Kathy] Cardiff Univ, Sch Med, Dept Child Hlth, Univ Wales Hosp, Cardiff CF10 3AX, S Glam, Wales; [Dunn-Siegrist, Irene; Pugin, Jerome] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Benmkaddem, Sanae; Monteiro, Renato] Fac Med Paris Diderot, INSERM, UMR 699, F-75018 Paris 18, France; [Geinoz, Antoine; Reith, Walter] Univ Geneva, Dept Pathol & Immunol, Sch Med, CH-1211 Geneva, Switzerland	NovImmune SA; Cardiff University; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Shang, LM (corresponding author), NovImmune SA, 14 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland.	lshang@novimmune.com	Monteiro, Renato C/U-8633-2017	Monteiro, Renato C/0000-0001-5202-5646				Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Haegel H, 2013, MABS-AUSTIN, V5, P736, DOI 10.4161/mabs.25743; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Magistrelli G, 2012, J IMMUNOL METHODS, V375, P20, DOI 10.1016/j.jim.2011.09.002; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pfirsch-Maisonnas S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001309; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shalova IN, 2012, J IMMUNOL, V188, P3584, DOI 10.4049/jimmunol.1100244; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsukamoto H, 2012, INT IMMUNOL, V24, P495, DOI 10.1093/intimm/dxs053; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	34	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15309	15318		10.1074/jbc.M113.537936	http://dx.doi.org/10.1074/jbc.M113.537936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737331	hybrid, Green Published			2022-12-28	WOS:000337465400015
J	Yeatman, HR; Lane, JR; Choy, KHC; Lambert, NA; Sexton, PM; Christopoulos, A; Canals, M				Yeatman, Holly R.; Lane, J. Robert; Choy, Kwok Ho Christopher; Lambert, Nevin A.; Sexton, Patrick M.; Christopoulos, Arthur; Canals, Meritxell			Allosteric Modulation of M-1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Arrestin; G Protein-coupled Receptor (GPCR); Receptor Endocytosis; Trafficking; GPCR Regulation; Allosteric Modulator	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; KINASE 2; PHOSPHORYLATION; ENDOCYTOSIS; LIGANDS; SEQUESTRATION; PHARMACOLOGY; SELECTIVITY; MECHANISMS	Allosteric modulators are an attractive approach to achieve receptor subtype-selective targeting of G protein-coupled receptors. Benzyl quinolone carboxylic acid (BQCA) is an unprecedented example of a highly selective positive allosteric modulator of the M-1 muscarinic acetylcholine receptor (mAChR). However, despite favorable pharmacological characteristics of BQCA in vitro and in vivo, there is limited evidence of the impact of allosteric modulation on receptor regulatory mechanisms such as -arrestin recruitment or receptor internalization and endocytic trafficking. In the present study we investigated the impact of BQCA on M-1 mAChR regulation. We show that BQCA potentiates agonist-induced -arrestin recruitment to M-1 mAChRs. Using a bioluminescence resonance energy transfer approach to monitor intracellular trafficking of M-1 mAChRs, we show that once internalized, M-1 mAChRs traffic to early endosomes, recycling endosomes and late endosomes. We also show that BQCA potentiates agonist-induced subcellular trafficking. M-1 mAChR internalization is both -arrestin and G protein-dependent, with the third intracellular loop playing an important role in the dynamics of -arrestin recruitment. As the global effect of receptor activation ultimately depends on the levels of receptor expression at the cell surface, these results illustrate the need to extend the characterization of novel allosteric modulators of G protein-coupled receptors to encapsulate the consequences of chronic exposure to this family of ligands.	[Yeatman, Holly R.; Lane, J. Robert; Choy, Kwok Ho Christopher; Sexton, Patrick M.; Christopoulos, Arthur; Canals, Meritxell] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia; [Lambert, Nevin A.] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	Monash University; University System of Georgia; Augusta University	Christopoulos, A (corresponding author), Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia.	arthur.christopoulos@monash.edu; meri.canals@monash.edu	Sexton, Patrick M/B-1319-2008; Choy, Kwok Ho Christopher/AAA-6128-2021; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Yeatman, Holly/0000-0002-3963-4540; Lane, J. Robert/0000-0002-7361-7875; Canals, Meritxell/0000-0002-7942-5006; Choy, K.H. Christopher/0000-0002-4650-2220	National Health and Medical Research Council [519461, APP1011796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Health and Medical Research Council Program Grant 519461 (to A. C. and P. M. S.) and Project Grant APP1011796 (to M.C.).	Abdul-Ridha A, 2013, MOL PHARMACOL, V83, P521, DOI 10.1124/mol.112.083006; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Haga K, 1996, J BIOL CHEM, V271, P2776, DOI 10.1074/jbc.271.5.2776; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Keov P, 2013, MOL PHARMACOL, V84, P425, DOI 10.1124/mol.113.087320; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lane JR, 2013, ACS CHEM NEUROSCI, V4, P527, DOI 10.1021/cn400005t; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; May LT, 2005, J PHARMACOL EXP THER, V312, P382, DOI 10.1124/jpet.104.073767; Messer WS, 2002, J MOL NEUROSCI, V19, P187, DOI 10.1007/s12031-002-0031-5; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Raote I, 2013, MOL PHARMACOL, V83, P42, DOI 10.1124/mol.112.078626; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Wu DF, 2008, J NEUROCHEM, V104, P1132, DOI 10.1111/j.1471-4159.2007.05063.x; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	41	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15856	15866		10.1074/jbc.M113.536672	http://dx.doi.org/10.1074/jbc.M113.536672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753247	Green Published, hybrid			2022-12-28	WOS:000337465400064
J	Yeh, CW; Yu, ZC; Chen, PH; Cheng, YC; Shieh, SY				Yeh, Chun-Wei; Yu, Zheng-Cheng; Chen, Peng-Hsu; Cheng, Yu-Che; Shieh, Sheau-Yann			Phosphorylation at Threonine 288 by Cell Cycle Checkpoint Kinase 2 (CHK2) Controls Human Monopolar Spindle 1 (Mps1) Kinetochore Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Chromosomes; Kinetochore; Mitosis; Phosphorylation; CHK2; HEC1; Mps1; Mitotic Checkpoint	TPR DOMAIN; STABILIZATION; ANEUPLOIDY; PATHWAY; BRCA1; HEC1; ATM	Background: hMps1 and CHK2 are both required to safeguard the mitotic checkpoint, and yet the relationship between the two proteins is unclear. Results: hMps1 Thr-288 mutation causes misaligned chromosomes and polyploidy as a result of defective kinetochore localization. Conclusion: Phosphorylation of hMps1 Thr-288 by CHK2 facilitates kinetochore localization of hMps1. Significance: The study provides insights on the involvement of CHK2 in SAC through hMps1. Human Mps1 (hMps1) is a mitotic checkpoint kinase responsible for sensing the unattached and tensionless kinetochore. Despite its importance in safeguarding proper chromosome segregation, how hMps1 is recruited to the kinetochore remains incompletely understood. Here, we demonstrate that phosphorylation at Thr-288 by the cell cycle checkpoint kinase CHK2 is involved in this process. We discovered that the phosphorylation-deficient T288A mutant has an impaired ability to localize to the kinetochore and cannot reestablish the mitotic checkpoint in hMps1-depleted cells. In support, we found that nocodazole induced hMps1 phosphorylation at the previously identified CHK2 site Thr-288 and that this could be detected at the kinetochore in a CHK2-dependent manner. Mechanistically, phosphorylation at Thr-288 promoted the interaction with the KMN (KNL1-Mis12-Ndc80 network) protein HEC1. Forced kinetochore localization corrected the defects associated with the T288A mutant. Our results provide evidence of a newly identified hMps1 phosphorylation site that is involved in the mitotic checkpoint and that CHK2 contributes to chromosomal stability through hMps1.	[Yeh, Chun-Wei; Yu, Zheng-Cheng; Chen, Peng-Hsu; Cheng, Yu-Che; Shieh, Sheau-Yann] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	Academia Sinica; National Science Council Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and National Science Council Taiwan.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yeh YH, 2009, ONCOGENE, V28, P1366, DOI 10.1038/onc.2008.477; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	23	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15319	15327		10.1074/jbc.M114.552273	http://dx.doi.org/10.1074/jbc.M114.552273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24764296	hybrid, Green Published			2022-12-28	WOS:000337465400016
J	Chiu, J; Wong, JWH; Hogg, PJ				Chiu, Joyce; Wong, Jason W. H.; Hogg, Philip J.			Redox Regulation of Methionine Aminopeptidase 2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC DISULFIDE BONDS; INHIBITION; LIBRARIES; TNP-470	Protein translation is initiated with methionine in eukaryotes, and the majority of proteins have their N-terminal methionine removed by methionine aminopeptidases (MetAP1 and MetAP2) prior to action. Methionine removal can be important for protein function, localization, or stability. No mechanism of regulation of MetAP activity has been identified. MetAP2, but not MetAP1, contains a single Cys(228)-Cys(448) disulfide bond that has an -RHStaple configuration and links two beta-loop structures, which are hallmarks of allosteric disulfide bonds. From analysis of crystal structures and using mass spectrometry and activity assays, we found that the disulfide bond exists in oxidized and reduced states in the recombinant enzyme. The disulfide has a standard redox potential of -261mV and is efficiently reduced by the protein reductant, thioredoxin, with a rate constant of 16,180 M-1 s(-1). The MetAP2 disulfide bond also exists in oxidized and reduced states in glioblastoma tumor cells, and stressing the cells by oxygen or glucose deprivation results in more oxidized enzyme. The Cys(228)-Cys(448) disulfide is at the rim of the active site and is only three residues distant from the catalytic His(231), which suggested that cleavage of the bond would influence substrate hydrolysis. Indeed, oxidized and reduced isoforms have different catalytic efficiencies for hydrolysis of MetAP2 peptide substrates. These findings indicate that MetAP2 is post-translationally regulated by an allosteric disulfide bond, which controls substrate specificity and catalytic efficiency.	[Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Chiu, Joyce/H-7772-2017; Wong, Jason/A-9466-2008	Chiu, Joyce/0000-0001-8910-8664; Wong, Jason/0000-0003-2953-7728; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council; Cancer Council New South Wales; New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from the National Health and Medical Research Council and the Cancer Council New South Wales. Mass spectrometric analysis for this work was carried out at the Bioanalytical Mass Spectrometry Facility, University of New South Wales, and was supported in part by infrastructure funding from the New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy.	Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Catalano A, 2001, AM J PATHOL, V159, P721, DOI 10.1016/S0002-9440(10)61743-9; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dummitt B, 2003, J CELL BIOCHEM, V89, P964, DOI 10.1002/jcb.10566; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Garrabrant Thomas, 2004, Angiogenesis, V7, P91, DOI 10.1007/s10456-004-6089-7; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hu XY, 2006, P NATL ACAD SCI USA, V103, P18148, DOI 10.1073/pnas.0608389103; JACKSON R, 1970, NATURE, V227, P672, DOI 10.1038/227672a0; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Nonato MC, 2006, BIOORG MED CHEM LETT, V16, P2580, DOI 10.1016/j.bmcl.2006.02.047; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, V2007, P18; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Selvakumar P, 2006, BBA-REV CANCER, V1765, P148, DOI 10.1016/j.bbcan.2005.11.001; Turk BE, 1999, CHEM BIOL, V6, P823, DOI 10.1016/S1074-5521(99)80129-X; Warder SE, 2008, J PROTEOME RES, V7, P4807, DOI 10.1021/pr800388p; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	33	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15035	15043		10.1074/jbc.M114.554253	http://dx.doi.org/10.1074/jbc.M114.554253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24700462	hybrid, Green Published			2022-12-28	WOS:000337248100055
J	Salanga, CL; Dyer, DP; Kiselar, JG; Gupta, S; Chance, MR; Handel, TM				Salanga, Catherina L.; Dyer, Douglas P.; Kiselar, Janna G.; Gupta, Sayan; Chance, Mark R.; Handel, Tracy M.			Multiple Glycosaminoglycan-binding Epitopes of Monocyte Chemoattractant Protein-3/CCL7 Enable It to Function as a Non-oligomerizing Chemokine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOMER-DIMER EQUILIBRIUM; HEPARAN-SULFATE; DIFFERENT AFFINITIES; CCR2 CHEMOKINES; RECEPTOR; SITE; IDENTIFICATION; OLIGOSACCHARIDES; ACTIVATION; DYNAMICS	The interaction of chemokines with glycosaminoglycans (GAGs) facilitates the formation of localized chemokine gradients that provide directional signals for migrating cells. In this study, we set out to understand the structural basis and impact of the differing oligomerization propensities of the chemokines monocyte chemoattractant protein (MCP)-1/CCL2 and MCP3/CCL7 on their ability to bind GAGs. These chemokines provide a unique comparison set because CCL2 oligomerizes and oligomerization is required for its full in vivo activity, whereas CCL7 functions as a monomer. To identify the GAG-binding determinants of CCL7, an unbiased hydroxyl radical footprinting approach was employed, followed by a focused mutagenesis study. Compared with the size of the previously defined GAG-binding epitope of CCL2, CCL7 has a larger binding site, consisting of multiple epitopes distributed along its surface. Furthermore, surface plasmon resonance (SPR) studies indicate that CCL7 is able to bind GAGs with an affinity similar to CCL2 but higher than the non-oligomerizing variant, CCL2(P8A), suggesting that, in contrast to CCL2, the large cluster of GAG-binding residues in CCL7 renders oligomerization unnecessary for high affinity binding. However, the affinity of CCL7 is more sensitive than CCL2 to the density of heparan sulfate on the SPR surfaces; this is likely due to the inability of CCL7 to oligomerize because CCL2(P8A) also binds significantly less tightly to low than high density heparan sulfate surfaces compared with CCL2. Together, the data suggest that CCL7 and CCL2 are non-redundant chemokines and that GAG chain density may provide a mechanism for regulating the accumulation of chemokines on cell surfaces.	[Salanga, Catherina L.; Dyer, Douglas P.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kiselar, Janna G.; Gupta, Sayan; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Gupta, Sayan; Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	University of California System; University of California San Diego; Case Western Reserve University; Case Western Reserve University	Handel, TM (corresponding author), 9500 Gilman Dr,MC0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Dyer, Douglas/J-2675-2015; Dyer, Douglas/L-9679-2019	Dyer, Douglas/0000-0001-5567-6241; Dyer, Douglas/0000-0001-5567-6241	Department of Energy [DE-AC02-98CH10886]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688, P30EB009998] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge Dr. Parminder Kaur for assistance with ProtMapMS data analysis. The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the Department of Energy Contract DE-AC02-98CH10886.	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blanpain C, 1999, BLOOD, V94, P1899; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081454; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kiselar JG, 2003, MOL CELL PROTEOMICS, V2, P1120, DOI 10.1074/mcp.M300068-MCP200; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Koopmann W, 1999, J IMMUNOL, V163, P2120; Krohn SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072321; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1997, METHOD ENZYMOL, V287, P369; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Menten P, 2001, EUR CYTOKINE NETW, V12, P554; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Richardson RM, 2000, J BIOL CHEM, V275, P9201, DOI 10.1074/jbc.275.13.9201; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saesen E, 2013, J AM CHEM SOC, V135, P9384, DOI 10.1021/ja4000867; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schenauer MR, 2007, J BIOL CHEM, V282, P25182, DOI 10.1074/jbc.M703387200; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447; Soria G, 2012, NEOPLASIA, V14, P1, DOI 10.1593/neo.111122; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	57	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14896	14912		10.1074/jbc.M114.547737	http://dx.doi.org/10.1074/jbc.M114.547737			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727473	Green Published, hybrid			2022-12-28	WOS:000337248100041
J	Bernard, MP; Lin, W; Kholodovych, V; Moyle, WR				Bernard, Michael P.; Lin, Win; Kholodovych, Vladyslav; Moyle, William R.			Human Lutropin ( hLH) and Choriogonadotropin ( CG) Are Assembled by Different Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Hormones; Mutagenesis; Protein Chimeras; Protein Cross-linking; Protein Folding; Human Choriogonadotropin; Human Follitropin; Human Lutropin; Human Thyrotropin	HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; FREE ALPHA-SUBUNIT; BETA-SUBUNIT; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN HORMONE; LUTEINIZING-HORMONE; SECRETION; PROTEIN; RECEPTOR	Background: Lutropin and choriogonadotropin are essential for human fertility. Results: Human lutropin and choriogonadotropin assemble by two separate folding pathways. Conclusion: The -subunit of lutropin has a key role in -subunit folding. Significance: The unique folding properties of LH were retained by having an evolutionary advantage for most vertebrate fertility. The glycoprotein hormones are all structurally related heterodimers consisting of an -subunit and a ligand-specific -subunit that confers their unique biological activity. Crystal structures showed how the -subunit surrounds a part of the -subunit, and we showed the existence of the two mechanisms responsible for that assembly. In human choriogonadotropin, the -subunit is folded before the subunits dock, and the -subunit becomes incorporated into the dimer by a mechanism we termed threading, passing between parts of the preassembled -subunit. Here, we show that the human lutropin -subunit is not folded completely prior to its interaction with the -subunit and show that docking of the subunits enables the -subunit to serve as a chaperone to the -subunit. Based on data described here, we propose that the -subunit facilitates formation of the human lutropin -subunit by two mechanisms. First, the cystine knot of the -subunit potentiates formation of the -subunit cystine knot, and second, contacts between -subunit loop 2 and a hydrophobic tail in the -subunit facilitate formation of the seatbelt latch disulfide, which stabilizes the heterodimer. The primary influence of the -subunit was seen when the hydrophobic tail was present or absent, but the secondary mechanism was required only when the hydrophobic tail of the -subunit was present. During the evolution of human choriogonadotropin, neither of these -subunit roles was necessary for folding of the -subunit. The complex mechanism for lutropin assembly may be required to provide an additional control on its positive feedback function in vertebrate reproduction.	Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Off Informat Technol OIT High Performance & Res C, Piscataway, NJ 08854 USA; [Kholodovych, Vladyslav] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center		moyle@rwjms.rutgers.edu						BOUSFIELD GR, 1987, J BIOL CHEM, V262, P8610; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; COLE LA, 1983, ENDOCRINOLOGY, V113, P1176, DOI 10.1210/endo-113-3-1176; DeBeer T, 1996, EUR J BIOCHEM, V241, P229; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Jablonka-Shariff A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065002; Jablonka-Shariff A, 2011, MOL CELL ENDOCRINOL, V339, P7, DOI 10.1016/j.mce.2011.03.013; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Moyle W.R., 1996, REPROD ENDOCRINOLOGY, P683; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; MOYLE WR, 1987, J BIOL CHEM, V262, P16920; MOYLE WR, 1982, P NATL ACAD SCI-BIOL, V79, P2245, DOI 10.1073/pnas.79.7.2245; Muller T, 2004, J MOL ENDOCRINOL, V32, P115, DOI 10.1677/jme.0.0320115; Muyan M, 1996, MOL ENDOCRINOL, V10, P1678, DOI 10.1210/me.10.12.1678; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Okayama H, 1991, Methods Mol Biol, V7, P15, DOI 10.1385/0-89603-178-0:15; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; REEVE JR, 1975, BIOCHEM BIOPH RES CO, V67, P149, DOI 10.1016/0006-291X(75)90295-8; Ruddon RW, 1996, PROTEIN SCI, V5, P1443, DOI 10.1002/pro.5560050801; WEISS J, 1990, ENDOCRINOLOGY, V127, P2364, DOI 10.1210/endo-127-5-2364; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Xing YN, 2004, J BIOL CHEM, V279, P35449, DOI 10.1074/jbc.M403054200; Xing YN, 2004, J BIOL CHEM, V279, P35437, DOI 10.1074/jbc.M403053200; Xing YN, 2004, J BIOL CHEM, V279, P35458, DOI 10.1074/jbc.M403055200; Xing YN, 2004, J BIOL CHEM, V279, P35426, DOI 10.1074/jbc.M403052200; Xing YN, 2001, J BIOL CHEM, V276, P46953, DOI 10.1074/jbc.M108374200; Xing YN, 2001, PROTEIN SCI, V10, P226, DOI 10.1110/ps.25901	31	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14360	14369		10.1074/jbc.M113.535609	http://dx.doi.org/10.1074/jbc.M113.535609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692561	Green Published, hybrid			2022-12-28	WOS:000335984600061
J	Dasgupta, T; Croll, DH; Owen, JA; Vander Heiden, MG; Locasale, JW; Alon, U; Cantley, LC; Gunawardena, J				Dasgupta, Tathagata; Croll, David H.; Owen, Jeremy A.; Vander Heiden, Matthew G.; Locasale, Jason W.; Alon, Uri; Cantley, Lewis C.; Gunawardena, Jeremy			A Fundamental Trade-off in Covalent Switching and Its Circumvention by Enzyme Bifunctionality in Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Covalent Regulation; Glucose Metabolism; Mathematical Modeling; Multifunctional Enzymes; Phosphorylation; 6-Phosphofructo-2-kinase; Fructose-2; 6-bisphosphatase; Goldbeter-Koshland Loop; Covalent Modification Cycle; Linear Framework	SIGNAL-TRANSDUCTION CASCADES; MULTISITE PHOSPHORYLATION; ISOCITRATE DEHYDROGENASE; PROTEIN-PHOSPHORYLATION; REGULATORY SYSTEM; ROBUST-CONTROL; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; SENSITIVITY; ULTRASENSITIVITY; METABOLISM	Background: Covalent modification cycles are widely used as regulatory switches. Results: Mathematical analysis reveals, under very general assumptions, an unavoidable trade-off between switching efficiency and cell-to-cell coherence. Conclusion: Enzyme bifunctionality offers a way to circumvent this trade-off. Significance: This may explain the bifunctionality of PFK-2/FBPase-2 in controlling the switch between glycolysis and gluconeogenesis in the mammalian liver. Covalent modification provides a mechanism for modulating molecular state and regulating physiology. A cycle of competing enzymes that add and remove a single modification can act as a molecular switch between on and off and has been widely studied as a core motif in systems biology. Here, we exploit the recently developed linear framework for time scale separation to determine the general principles of such switches. These methods are not limited to Michaelis-Menten assumptions, and our conclusions hold for enzymes whose mechanisms may be arbitrarily complicated. We show that switching efficiency improves with increasing irreversibility of the enzymes and that the on/off transition occurs when the ratio of enzyme levels reaches a value that depends only on the rate constants. Fluctuations in enzyme levels, which habitually occur due to cellular heterogeneity, can cause flipping back and forth between on and off, leading to incoherent mosaic behavior in tissues, that worsens as switching becomes sharper. This trade-off can be circumvented if enzyme levels are correlated. In particular, if the competing catalytic domains are on the same protein but do not influence each other, the resulting bifunctional enzyme can switch sharply while remaining coherent. In the mammalian liver, the switch between glycolysis and gluconeogenesis is regulated by the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2). We suggest that bifunctionality of PFK-2/FBPase-2 complements the metabolic zonation of the liver by ensuring coherent switching in response to insulin and glucagon.	[Dasgupta, Tathagata; Owen, Jeremy A.; Cantley, Lewis C.; Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Croll, David H.] Regis Coll, Dept Chem & Phys, Weston, MA 02493 USA; [Vander Heiden, Matthew G.] MIT, Koch Inst Canc Res, Cambridge, MA 02139 USA; [Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14850 USA; [Alon, Uri] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Regis University; Massachusetts Institute of Technology (MIT); Cornell University; Weizmann Institute of Science; Harvard University; Beth Israel Deaconess Medical Center	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	jeremy@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Locasale, Jason W/ABE-6505-2020	Cantley, Lewis C/0000-0002-1298-7653; Locasale, Jason W/0000-0002-7766-3502	National Institutes of Health from NCRR [1S10RR028832-01]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Raafat El-Maghrabi for helpful information on PFK-2/FBPase-2; Jeremy Muhlich for assistance with cluster computing, support for which was partially provided by National Institutes of Health Grant 1S10RR028832-01 from NCRR; Joseph Dexter for helpful discussions, and Rebecca Ward for generous assistance with Tex to Word conversion.	Anderson Karen S., 2003, P19; Atsumi T, 2002, CANCER RES, V62, P5881; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Beard D., 2008, CAMB TEXT BIOMED ENG; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; Dexter JP, 2013, J BIOL CHEM, V288, P5770, DOI 10.1074/jbc.M112.339226; El-Maghrabi MR, 2001, CURR OPIN CLIN NUTR, V4, P411, DOI 10.1097/00075197-200109000-00012; ELMAGHRABI MR, 1984, BIOCHEM BIOPH RES CO, V123, P749; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fersht A., 1985, ENZYME STRUCTURE MEC; Gibson D., 2002, METABOLIC REGULATION; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldstein BN, 2002, FEBS LETT, V532, P295, DOI 10.1016/S0014-5793(02)03639-6; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Gunawardena J, 2014, FEBS J, V281, P473, DOI 10.1111/febs.12532; Gunawardena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036321; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hart Y, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-171; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; Karp RL, 2012, J THEOR BIOL, V311, P130, DOI 10.1016/j.jtbi.2012.07.004; Kurland IJ, 2000, BIOCHEM J, V347, P459, DOI 10.1042/0264-6021:3470459; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Mirzaev I, 2013, B MATH BIOL, V75, P2118, DOI 10.1007/s11538-013-9884-8; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Pilkis S. J., 1987, ENZYMES, VXVIII, P4; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Saier M. H, 1987, ENZYMES METABOLIC PA; SHACTERNOIMAN E, 1983, PHILOS T ROY SOC B, V302, P157, DOI 10.1098/rstb.1983.0049; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Straube R, 2013, BIOPHYS J, V105, P1925, DOI 10.1016/j.bpj.2013.09.010; Thomson M, 2009, J THEOR BIOL, V261, P626, DOI 10.1016/j.jtbi.2009.09.003; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Torre C, 2010, PROG MOL BIOL TRANSL, V97, P127, DOI 10.1016/B978-0-12-385233-5.00005-2; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; Xu YQ, 2012, J THEOR BIOL, V311, P139, DOI 10.1016/j.jtbi.2012.07.012	57	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13010	13025		10.1074/jbc.M113.546515	http://dx.doi.org/10.1074/jbc.M113.546515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634222	hybrid, Green Published			2022-12-28	WOS:000335522800006
J	Hiemer, SE; Szymaniak, AD; Varelas, X				Hiemer, Samantha E.; Szymaniak, Aleksander D.; Varelas, Xaralabos			The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor beta-induced Tumorigenic Phenotypes in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; Cell Signaling; Coregulator Transcription; Signal Transduction; Transforming Growth Factor (TGF); Hippo Pathway; Signaling Cross-talk; YAP; TAZ	EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; TGF-BETA; IN-VITRO; PROLIFERATION; COACTIVATOR; INHIBITION; INDUCTION; CARCINOMA	Background: The TGF and Hippo pathways are dysregulated in metastatic breast cancers. Results: TGF-induced cues and nuclear TAZ/YAP converge at the transcriptional level to control gene expression important for tumorigenesis. Conclusion: TAZ/YAP are required to promote TGF-induced tumorigenic phenotypes in breast cancer cells. Significance: Our study reveals novel cross-talk between the TGF pathway and TAZ/YAP in late-stage breast cancers. Uncontrolled transforming growth factor- (TGF) signaling promotes aggressive metastatic properties in late-stage breast cancers. However, how TGF-mediated cues are directed to induce tumorigenic events is poorly understood, particularly given that TGF has clear tumor suppressing activity in other contexts. Here, we demonstrate that the transcriptional regulators TAZ and YAP (TAZ/YAP), key effectors of the Hippo pathway, are necessary to promote and maintain TGF-induced tumorigenic phenotypes in breast cancer cells. Interactions between TAZ/YAP, TGF-activated SMAD2/3, and TEAD transcription factors reveal convergent roles for these factors in the nucleus. Genome-wide expression analyses indicate that TAZ/YAP, TEADs, and TGF-induced signals coordinate a specific pro-tumorigenic transcriptional program. Importantly, genes cooperatively regulated by TAZ/YAP, TEAD, and TGF, such as the novel targets NEGR1 and UCA1, are necessary for maintaining tumorigenic activity in metastatic breast cancer cells. Nuclear TAZ/YAP also cooperate with TGF signaling to promote phenotypic and transcriptional changes in nontumorigenic cells to overcome TGF-repressive effects. Our work thus identifies cross-talk between nuclear TAZ/YAP and TGF signaling in breast cancer cells, revealing novel insight into late-stage disease-driving mechanisms.	[Hiemer, Samantha E.; Szymaniak, Aleksander D.; Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Varelas, X (corresponding author), Boston Univ, Sch Med, Dept Biochem, Rm K225, Boston, MA 02118 USA.	xvarelas@bu.edu	Varelas, Xaralabos/ABB-9141-2020	/0000-0003-1913-0465; Varelas, Xaralabos/0000-0002-2882-4541	Boston University Clinical and Translational Science Institute (CTSA Grant) [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER	Boston University Clinical and Translational Science Institute (CTSA Grant); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the Boston University Clinical and Translational Science Institute for funds to perform the microarray analysis (CTSA Grant UL1-TR000157) and Adam Gower and the Boston University Microarray Core for help with microarray data analysis. We thank Alicia Viloria-Petit (University of Guelph, Canada) for the LM2-4 cells; Kathrin Kirsch (Boston University) for the BT20, HS578T, MCF7, and SKBR3 cells; and David Sherr (Boston University) for the SUM149 cells.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bakin AV, 2002, J CELL SCI, V115, P3193; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bayarmagnai B, 2012, CELL CYCLE, V11, P4191, DOI 10.4161/cc.22486; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Choki I, 1998, ANTICANCER RES, V18, P4213; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hashimoto T, 2009, CELL BIOCHEM FUNCT, V27, P496, DOI 10.1002/cbf.1600; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Iavarone A, 1997, NATURE, V387, P417; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spaltmann F, 1996, J NEUROSCI, V16, P1770; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wu JH, 2011, MOL CANCER RES, V9, P1562, DOI 10.1158/1541-7786.MCR-11-0340; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie D, 2001, CANCER RES, V61, P8917; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	73	164	170	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13461	13474		10.1074/jbc.M113.529115	http://dx.doi.org/10.1074/jbc.M113.529115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648515	hybrid, Green Published			2022-12-28	WOS:000335522800043
J	Kim, SJ; Cho, J; Song, EJ; Kim, SJ; Kim, HM; Lee, KE; Suh, SW; Kim, EE				Kim, Su Jin; Cho, Jinhong; Song, Eun Joo; Kim, Soo Jin; Kim, Ho Min; Lee, Kyung Eun; Suh, Se Won; Kim, Eunice EunKyeong			Structural Basis for Ovarian Tumor Domain-containing Protein 1 ( OTU1) Binding to p97/Valosin-containing Protein ( VCP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Deubiquitination; Electron Microscopy (EM); ER-associated Degradation; Isothermal Titration Calorimetry; Protein-Protein Interactions; Site-directed Mutagenesis	UBIQUITIN-PROTEASOME SYSTEM; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; DEGRADATION ERAD; QUALITY CONTROL; P97; COMPLEX; COFACTORS; SUITE	Background: Ovarian tumor domain-containing protein 1 (OTU1) acts as a deubiquitinating enzyme in the endoplasmic reticulum-associated degradation (ERAD) pathway by associating with valosin-containing protein (VCP). Results: One OTU1 binds to a VCP hexamer with a K-D of 0.71 m. Conclusion: The (39)GYPP(42) (S3/S4) loop of OTU1 is critical for interaction with VCP. Significance: This is the first structural study of VCP and OTU1 complex. Valosin-containing protein (VCP), also known as p97, is an AAA(+) ATPase that plays an essential role in a broad array of cellular processes including the endoplasmic reticulum-associated degradation (ERAD) pathway. Recently, ERAD-specific deubiquitinating enzymes have been reported to be physically associated with VCP, although the exact mechanism is not yet clear. Among these enzymes is ovarian tumor domain-containing protein 1 (OTU1). Here, we report the structural basis for interaction between VCP and OTU1. The crystal structure of the ubiquitin regulatory X-like (UBXL) domain of OTU1 (UBXLOTU1) complexed to the N-terminal domain of VCP (N-VCP) at 1.8- resolution reveals that UBXLOTU1 adopts a ubiquitin-like fold and binds at the interface of two subdomains of N-VCP using the (39)GYPP(42) loop of UBXLOTU1 with the two prolines in cis- and trans-configurations, respectively. A mutagenesis study shows that this loop is not only critical for the interaction with VCP but also for its role in the ERAD pathway. Negative staining EM shows that one molecule of OTU1 binds to one VCP hexamer, and isothermal titration calorimetry suggests that the two proteins bind with a K-D of 0.71 m. Analytical size exclusion chromatography and isothermal titration calorimetry demonstrates that OTU1 can bind VCP in both the presence and absence of a heterodimer formed by ubiquitin fusion degradation protein 1 and nuclear localization protein 4.	[Kim, Su Jin; Cho, Jinhong; Song, Eun Joo; Lee, Kyung Eun; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea; [Kim, Su Jin; Suh, Se Won] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Kim, Soo Jin; Kim, Ho Min] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Suh, SW (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea.	sewonsuh@snu.ac.kr; eunice@kist.re.kr	Kim, Ho Min/G-2712-2011	Song, Eun Joo/0000-0002-2420-6666	Global Research Laboratory Program Grant of the Ministry of Science, Information and Communication Technology and Future Planning of Korea [2013056409]; Korea Institute of Science and Technology	Global Research Laboratory Program Grant of the Ministry of Science, Information and Communication Technology and Future Planning of Korea; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported by Global Research Laboratory Program Grant 2013056409 of the Ministry of Science, Information and Communication Technology and Future Planning of Korea and an institutional grant from the Korea Institute of Science and Technology.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bang D, 2005, ANGEW CHEM INT EDIT, V44, P3852, DOI 10.1002/anie.200463040; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chia WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050490; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Goder V, 2012, CURR PROTEIN PEPT SC, V13, P425, DOI 10.2174/138920312802430572; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12264	12274		10.1074/jbc.M113.523936	http://dx.doi.org/10.1074/jbc.M113.523936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24610782	hybrid, Green Published			2022-12-28	WOS:000335581400007
J	Niu, XB; Hong, J; Zheng, XF; Melville, DB; Knapik, EW; Meng, AM; Peng, JR				Niu, Xubo; Hong, Jian; Zheng, Xiaofeng; Melville, David B.; Knapik, Ela W.; Meng, Anming; Peng, Jinrong			The Nuclear Pore Complex Function of Sec13 Protein Is Required for Cell Survival during Retinal Development*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endoplasmic Reticulum (ER); Molecular Genetics; p53; Zebrafish; Sec13; Sec31; Nuclear Pore Complexes; Retina Development	ZEBRAFISH DEVELOPMENT; VESICLE COATS; EXPRESSION; P53; DIFFERENTIATION; SECRETION; APOPTOSIS; GENE; ORGANOGENESIS; ORGANIZATION	Background: Sec13 is a core component in both the protein trafficking complex and the nuclear pore complex (NPC). Results: The role of Sec13 in retina development has been investigated. Conclusion: The NPC function of Sec13 is essential for retina development. Significance: This is the first genetic evidence to differentiate the contributions of the two functions of Sec13 during organogenesis. Sec13 is a dual function protein, being a core component of both the COPII coat, which mediates protein trafficking from the endoplasmic reticulum to the Golgi apparatus, and the nuclear pore complex (NPC), which facilitates nucleo-cytoplasmic traffic. Here, we present a genetic model to differentiate the roles of these two functions of Sec13 in vivo. We report that sec13(sq198) mutant embryos develop small eyes that exhibit disrupted retinal lamination and that the mutant retina contains an excessive number of apoptotic cells. Surprisingly, we found that loss of COPII function by oligonucleotide-mediated gene knockdown of sec31a and sec31b or brefeldin A treatment did not disrupt retinal lamination, although it did result in digestive organ defects similar to those seen in sec13(sq198), suggesting that the digestive organ defects observed in sec13(sq198) are due to loss of COPII function, whereas the retinal lamination defects are due to loss of the NPC function. We showed that the retinal cells of sec13(sq198) failed to form proper nuclear pores, leading to a nuclear accumulation of total mRNA and abnormal activation of the p53-dependent apoptosis pathway, causing the retinal defect in sec13(sq198). Furthermore, we found that a mutant lacking Nup107, a key NPC-specific component, phenocopied the retinal lamination phenotype as observed in sec13(sq198). Our results demonstrate a requirement for the nuclear pore function of Sec13 in development of the retina and provide the first genetic evidence to differentiate the contributions of the NPC and the COPII functions of Sec13 during organogenesis.	[Niu, Xubo; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Hong, Jian] Zhejiang Univ, Inst Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China; [Zheng, Xiaofeng; Meng, Anming] Tsinghua Univ, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Melville, David B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA	Zhejiang University; Zhejiang University; Tsinghua University; University of California System; University of California Berkeley; Vanderbilt University	Peng, JR (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Niu, Xubo/AAH-7166-2021; Meng, Anming/A-4785-2012; Knapik, Ela W./J-6172-2014	Knapik, Ela W./0000-0002-2977-3619; Peng, Jinrong/0000-0002-0793-4848	"973 Program" Grant [2012CB944550]; National Natural Science Foundation of China [31330050]; National Institutes of Health Grant from NIDCR [R01 DE018477]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	"973 Program" Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health Grant from NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by "973 Program" Grant 2012CB944550 and National Natural Science Foundation of China Grant 31330050 (to J. R. P.). This work was also supported in part by National Institutes of Health Grant R01 DE018477 from NIDCR (to E. W. K.).	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cerveny KL, 2010, DEVELOPMENT, V137, P2107, DOI 10.1242/dev.047753; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Melville DB, 2011, CELL ADHES MIGR, V5, P114, DOI 10.4161/cam.5.2.14377; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Pujic Z, 2004, SEMIN CELL DEV BIOL, V15, P105, DOI 10.1016/j.semcdb.2003.09.008; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schmidt K, 2013, BIOL OPEN, V2, P256, DOI 10.1242/bio.20133251; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Townley AK, 2012, J CELL SCI, V125, P673, DOI 10.1242/jcs.091355; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Zheng XF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408997	51	26	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11971	11985		10.1074/jbc.M114.547190	http://dx.doi.org/10.1074/jbc.M114.547190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627485	Green Published, hybrid			2022-12-28	WOS:000335010600036
J	Chaubey, S; Grover, M; Tatu, U				Chaubey, Shweta; Grover, Manish; Tatu, Utpal			Endoplasmic Reticulum Stress Triggers Gametocytogenesis in the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PLASMODIUM-FALCIPARUM MALARIA; KAR2 BIP GENE; TRANSCRIPTION FACTORS; HUMAN ERYTHROCYTES; GLUTATHIONE; SIGNAL; INDUCTION; PATHWAY; VIRULENCE	The malaria parasite experiences a significant amount of redox stress during its growth in human erythrocytes and heavily relies on secretory functions for pathogenesis. Most certainly, the parasite is equipped with machinery to tackle perturbations in the secretory pathway, like the unfolded protein response pathway in higher eukaryotes. Our bioinformatics analysis revealed the complete absence of genes involved in the canonical unfolded protein response pathway in Plasmodium falciparum. Accordingly, the parasite was unable to up-regulate endoplasmic reticulum (ER) chaperones or ER-associated degradation in response to DTT-mediated ER stress. Global profiling of gene expression upon DTT treatment revealed a network of AP2 transcription factors and their targets being activated. The overall outcome was up-regulation of genes involved in protein export and the sexual stage of the parasite life cycle culminating in gametocytogenesis. Our results suggest that the malaria parasite uses ER stress as a cue to switch to the transmissible sexual stages.	[Chaubey, Shweta; Grover, Manish; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Tatu, U (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in		GROVER, MANISH/0000-0002-1625-7930; Tatu, Utpal/0000-0003-0404-8872	Council for Scientific and Industrial Research, Delhi, India (CSIR); Department of Biotechnology, India; Department of Science and Technology, India; MALSIG Indo-EU grant; Roche through University of Bern, Switzerland	Council for Scientific and Industrial Research, Delhi, India (CSIR); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology, India(Department of Science & Technology (India)); MALSIG Indo-EU grant; Roche through University of Bern, Switzerland	Recipients of senior research fellowships from Council for Scientific and Industrial Research, Delhi, India (CSIR).; Recipient of funding from Department of Biotechnology, India, Department of Science and Technology, India, a MALSIG Indo-EU grant, and a Roche grant facilitated through University of Bern, Switzerland. To whom correspondence should be addressed. E-mail: tatu@biochem.iisc.ernet.in.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Barrand MA, 2012, BIOCHEM J, V448, P389, DOI 10.1042/BJ20121050; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berhe S, 2000, EXP PARASITOL, V94, P194, DOI 10.1006/expr.1999.4481; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Chillemi R, 2004, CLIN CHIM ACTA, V348, P113, DOI 10.1016/j.cccn.2004.05.007; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Gosline SJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019118; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Joyce BR, 2013, EUKARYOT CELL, V12, P979, DOI 10.1128/EC.00021-13; Kangwanrangsan N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-129; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kehr S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001242; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li FW, 2004, J BIOL CHEM, V279, P26635, DOI 10.1074/jbc.M401385200; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Patzewitz EM, 2012, MOL MICROBIOL, V83, P304, DOI 10.1111/j.1365-2958.2011.07933.x; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sheikh MS, 1999, J BIOL CHEM, V274, P16487, DOI 10.1074/jbc.274.23.16487; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spycher C, 2013, MOL MICROBIOL, V88, P754, DOI 10.1111/mmi.12218; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; Tiburcio M, 2013, CELL MICROBIOL, V15, P647, DOI 10.1111/cmi.12062; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109	47	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16662	16674		10.1074/jbc.M114.551549	http://dx.doi.org/10.1074/jbc.M114.551549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755215	hybrid, Green Published			2022-12-28	WOS:000338016200007
J	Jin, Y; Nair, A; van Veen, HW				Jin, Yoonhee; Nair, Asha; van Veen, Hendrik W.			Multidrug Transport Protein NorM from Vibrio cholerae Simultaneously Couples to Sodium- and Proton-Motive Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; STAPHYLOCOCCUS-AUREUS; MATE FAMILY; EFFLUX PUMP; EXTRUSION; RESISTANCE; BINDING; DISRUPTION; ANTIPORTER; PRINCIPLES	Membrane transporters belonging to the multidrug and toxic compound extrusion family mediate the efflux of unrelated pharmaceuticals from the interior of the cell in organisms ranging from bacteria to human. These proteins are thought to fall into two classes that couple substrate efflux to the influx of either Na+ or H+. We studied the energetics of drug extrusion by NorM from Vibrio cholerae in proteoliposomes in which purified NorM protein was functionally reconstituted in an inside-out orientation. We establish that NorM simultaneously couples to the sodium-motive force and proton-motive force, and biochemically identify protein regions and residues that play important roles in Na+ or H+ binding. As the positions of protons are not available in current medium and high-resolution crystal structures of multidrug and toxic compound extrusion transporters, our findings add a previously unrecognized parameter to mechanistic models based of these structures.	[Jin, Yoonhee; Nair, Asha; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; V Nair, Asha/0000-0002-2037-1138	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/K017713/1] Funding Source: researchfish; BBSRC [BB/K017713/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC).	AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Matsushima S, 2009, DRUG METAB DISPOS, V37, P555, DOI 10.1124/dmd.108.023911; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Nakamura T, 2010, BIOCHEM PHARMACOL, V80, P1762, DOI 10.1016/j.bcp.2010.08.019; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Putman M, 1999, BIOCHEMISTRY-US, V38, P1002, DOI 10.1021/bi981863w; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; van Veen HW, 2010, NATURE, V467, P926, DOI 10.1038/467926a; Vanni S, 2012, BIOCHEMISTRY-US, V51, P1281, DOI 10.1021/bi2015184; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038715; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	34	43	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14624	14632		10.1074/jbc.M113.546770	http://dx.doi.org/10.1074/jbc.M113.546770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711447	Green Published, hybrid			2022-12-28	WOS:000337248100019
J	Klein, G; Kobylak, N; Lindner, B; Stupak, A; Raina, S				Klein, Gracjana; Kobylak, Natalia; Lindner, Buko; Stupak, Anna; Raina, Satish			Assembly of Lipopolysaccharide in Escherichia coli Requires the Essential LapB Heat Shock Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; OUTER-MEMBRANE; FATTY-ACID; LIPID-A; NEISSERIA-MENINGITIDIS; FUNCTIONAL-ANALYSIS; CHROMOSOMAL GENES; EXPORT PATHWAY; CELL-ENVELOPE; TERMINAL END	Here, we describe two new heat shock proteins involved in the assembly of LPS in Escherichia coli, LapA and LapB (lipopolysaccharide assembly protein A and B). lapB mutants were identified based on an increased envelope stress response. Envelope stress-responsive pathways control key steps in LPS biogenesis and respond to defects in the LPS assembly. Accordingly, the LPS content in Delta lapB or Delta(lapA lapB) mutants was elevated, with an enrichment of LPS derivatives with truncations in the core region, some of which were pentaacylated and exhibited carbon chain polymorphism. Further, the levels of LpxC, the enzyme that catalyzes the first committed step of lipid A synthesis, were highly elevated in the Delta(lapA lapB) mutant. Delta(lapA lapB) mutant accumulated extragenic suppressors that mapped either to lpxC, waaC, and gmhA, or to the waaQ operon (LPS biosynthesis) and lpp (Braun's lipoprotein). Increased synthesis of either FabZ (3-R-hydroxymyristoyl acyl carrier protein dehydratase), slrA (novel RpoE-regulated non-coding sRNA), lipoprotein YceK, toxin HicA, or MurA (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) suppressed some of the Delta(lapA lapB) defects. LapB contains six tetratricopeptide repeats and, at the C-terminal end, a rubredoxin-like domain that was found to be essential for its activity. In pull-down experiments, LapA and LapB co-purified with LPS, Lpt proteins, FtsH (protease), DnaK, and DnaJ (chaperones). A specific interaction was also observed between WaaC and LapB. Our data suggest that LapB coordinates assembly of proteins involved in LPS synthesis at the plasma membrane and regulates turnover of LpxC, thereby ensuring balanced biosynthesis of LPS and phospholipids consistent with its essentiality.	[Klein, Gracjana; Kobylak, Natalia; Stupak, Anna; Raina, Satish] Gdansk Univ Technol, Fac Chem, PL-80233 Gdansk, Poland; [Klein, Gracjana; Lindner, Buko; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Fac Chem, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Stupak, Anna/0000-0003-4731-8879; Klein, Gracjana/0000-0001-8695-8065; Kobylak, Natalia/0000-0002-7908-2613	National Science Grant [2011/03/B/NZ1/02825]	National Science Grant	This work was supported by National Science Grant 2011/03/B/NZ1/02825 (to S. R.).	Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; BAIRD L, 1991, J BACTERIOL, V173, P5763, DOI 10.1128/jb.173.18.5763-5770.1991; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; BEALL B, 1987, J BACTERIOL, V169, P5408, DOI 10.1128/jb.169.12.5408-5415.1987; Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Frirdich E, 2005, J ENDOTOXIN RES, V11, P133, DOI 10.1179/096805105X46592; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kadrmas JL, 1998, J BIOL CHEM, V273, P2799, DOI 10.1074/jbc.273.5.2799; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Putker F, 2014, J BACTERIOL, V196, P780, DOI 10.1128/JB.00943-13; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; SAMPSON BA, 1989, GENETICS, V122, P491; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schwalm J, 2013, J BACTERIOL, V195, P3734, DOI 10.1128/JB.00431-13; Schweiger R, 2013, J BIOL CHEM, V288, P30614, DOI 10.1074/jbc.M113.493015; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Xiao XR, 2013, BIOCHEMISTRY-US, V52, P8304, DOI 10.1021/bi401116n; Zeng DN, 2013, J BIOL CHEM, V288, P5475, DOI 10.1074/jbc.M112.447607; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	68	65	69	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14829	14853		10.1074/jbc.M113.539494	http://dx.doi.org/10.1074/jbc.M113.539494			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722986	Green Published, hybrid			2022-12-28	WOS:000337248100037
J	Mohammadi, T; Sijbrandi, R; Lutters, M; Verheul, J; Martin, NI; den Blaauwen, T; de Kruijff, B; Breukink, E				Mohammadi, Tamimount; Sijbrandi, Robert; Lutters, Mandy; Verheul, Jolanda; Martin, Nathaniel I.; den Blaauwen, Tanneke; de Kruijff, Ben; Breukink, Eefjan			Specificity of the Transport of Lipid II by FtsW in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSW; CELL-DIVISION; BACTERIAL-MEMBRANES; IDENTIFICATION; PHOSPHOLIPIDS; TRANSLOCATION; PRECURSORS; PBP3; WALL	Synthesis of biogenic membranes requires transbilayer movement of lipid-linked sugar molecules. This biological process, which is fundamental in prokaryotic cells, remains as yet not clearly understood. In order to obtain insights into the molecular basis of its mode of action, we analyzed the structure-function relationship between Lipid II, the important building block of the bacterial cell wall, and its inner membrane-localized transporter FtsW. Here, we show that the predicted transmembrane helix 4 of Escherichia coli FtsW (this protein consists of 10 predicted transmembrane segments) is required for the transport activity of the protein. We have identified two charged residues (Arg(145) and Lys(153)) within this segment that are specifically involved in the flipping of Lipid II. Mutating these two amino acids to uncharged ones affected the transport activity of FtsW. This was consistent with loss of in vivo activity of the mutants, as manifested by their inability to complement a temperature-sensitive strain of FtsW. The transport activity of FtsW could be inhibited with a Lipid II variant having an additional size of 420 Da. Reducing the size of this analog by about 274 Da resulted in the resumption of the transport activity of FtsW. This suggests that the integral membrane protein FtsW forms a size-restricted porelike structure, which accommodates Lipid II during transport across the bacterial cytoplasmic membrane.	[Mohammadi, Tamimount; Sijbrandi, Robert; Lutters, Mandy; de Kruijff, Ben; Breukink, Eefjan] Univ Utrecht, Dept Chem, Fac Sci, NL-3584 CH Utrecht, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands; [Martin, Nathaniel I.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3584 CG Utrecht, Netherlands; [Sijbrandi, Robert; Verheul, Jolanda] Acad Technol Gezondheid & Milieu, Avans Hogesch, NL-4818 AJ Breda, Netherlands	Utrecht University; University of Amsterdam; Utrecht University	Breukink, E (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.j.breukink@uu.nl	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; den Blaauwen, Tanneke/0000-0002-5403-5597	European Commission EUR-INTAFAR [KSHM-CT-2004-512138]; ZonMW [20500001]; EU [FP7-Health-2007-B-223431]	European Commission EUR-INTAFAR; ZonMW(Netherlands Organization for Health Research and Development); EU(European Commission)	This work was supported by European Commission EUR-INTAFAR Grant KSHM-CT-2004-512138, ZonMW Project 20500001, and EU Project FP7-Health-2007-B-223431.	Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Ehlert K, 1996, J BACTERIOL, V178, P6766, DOI 10.1128/jb.178.23.6766-6771.1996; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Goddard-Borger ED, 2007, ORG LETT, V9, P3797, DOI 10.1021/ol701581g; ISHINO F, 1989, J BACTERIOL, V171, P5523, DOI 10.1128/jb.171.10.5523-5530.1989; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Kol MA, 2004, BIOCHEMISTRY-US, V43, P2673, DOI 10.1021/bi036200f; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lara B, 2002, FEMS MICROBIOL LETT, V216, P23, DOI 10.1111/j.1574-6968.2002.tb11409.x; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Pera NP, 2010, ORG BIOMOL CHEM, V8, P2425, DOI 10.1039/c000819b; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; van Dam V, 2007, MOL MICROBIOL, V64, P1105, DOI 10.1111/j.1365-2958.2007.05722.x; van der Ploeg R, 2013, MOL MICROBIOL, V87, P1074, DOI 10.1111/mmi.12150; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Williamson P, 2011, CURR BIOL, V21, pR168, DOI 10.1016/j.cub.2011.01.030; Zhang L, 2007, ANGEW CHEM INT EDIT, V46, P1798, DOI 10.1002/anie.200604222	25	55	57	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14707	14718		10.1074/jbc.M114.557371	http://dx.doi.org/10.1074/jbc.M114.557371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711460	Green Published, hybrid			2022-12-28	WOS:000337248100027
J	Davis, MI; Gross, S; Shen, M; Straley, KS; Pragani, R; Lea, WA; Popovici-Muller, J; DeLaBarre, B; Artin, E; Thorne, N; Auld, DS; Li, ZY; Dang, L; Boxer, MB; Simeonov, A				Davis, Mindy I.; Gross, Stefan; Shen, Min; Straley, Kimberly S.; Pragani, Rajan; Lea, Wendy A.; Popovici-Muller, Janeta; DeLaBarre, Byron; Artin, Erin; Thorne, Natasha; Auld, Douglas S.; Li, Zhuyin; Dang, Lenny; Boxer, Matthew B.; Simeonov, Anton			Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dehydrogenase; Drug Discovery; Enzyme Inhibitors; Glioblastoma; Small Molecules; AML; IDH1; Isocitrate Dehydrogenase; Enzyme	ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATION; LEUKEMIA	Background: IDH1 R132H, implicated in glioblastoma and AML, produces the oncometabolite 2-HG. Results: A detailed binding mechanism of a small molecule inhibitor (ML309) is proposed. Conclusion: ML309 competes with -KG but is uncompetitive with NADPH and rapidly and reversibly affects cellular 2-HG levels. Significance: Understanding IDH1 R132H inhibition sets the stage for targeting IDH1 R132H for the treatment of cancer. Two mutant forms (R132H and R132C) of isocitrate dehydrogenase 1 (IDH1) have been associated with a number of cancers including glioblastoma and acute myeloid leukemia. These mutations confer a neomorphic activity of 2-hydroxyglutarate (2-HG) production, and 2-HG has previously been implicated as an oncometabolite. Inhibitors of mutant IDH1 can potentially be used to treat these diseases. In this study, we investigated the mechanism of action of a newly discovered inhibitor, ML309, using biochemical, cellular, and biophysical approaches. Substrate binding and product inhibition studies helped to further elucidate the IDH1 R132H catalytic cycle. This rapidly equilibrating inhibitor is active in both biochemical and cellular assays. The (+) isomer is active (IC50 = 68 nm), whereas the (-) isomer is over 400-fold less active (IC50 = 29 m) for IDH1 R132H inhibition. IDH1 R132C was similarly inhibited by (+)-ML309. WT IDH1 was largely unaffected by (+)-ML309 (IC50 >36 m). Kinetic analyses combined with microscale thermophoresis and surface plasmon resonance indicate that this reversible inhibitor binds to IDH1 R132H competitively with respect to -ketoglutarate and uncompetitively with respect to NADPH. A reaction scheme for IDH1 R132H inhibition by ML309 is proposed in which ML309 binds to IDH1 R132H after formation of the IDH1 R132H NADPH complex. ML309 was also able to inhibit 2-HG production in a glioblastoma cell line (IC50 = 250 nm) and had minimal cytotoxicity. In the presence of racemic ML309, 2-HG levels drop rapidly. This drop was sustained until 48 h, at which point the compound was washed out and 2-HG levels recovered.	[Davis, Mindy I.; Shen, Min; Pragani, Rajan; Lea, Wendy A.; Thorne, Natasha; Auld, Douglas S.; Li, Zhuyin; Boxer, Matthew B.; Simeonov, Anton] NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD 20892 USA; [Gross, Stefan; Straley, Kimberly S.; Popovici-Muller, Janeta; DeLaBarre, Byron; Artin, Erin; Dang, Lenny] Agios Pharmaceut Inc, Cambridge, MA 02139 USA; [Auld, Douglas S.] Ctr Prote Chem, Novartis Inst Biomed Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Agios Pharmaceuticals; Novartis	Simeonov, A (corresponding author), NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Rockville, MD 20892 USA.	asimeono@mail.nih.gov		Dang, Lenny/0000-0002-2073-6109	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health [U54 MH084681]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health (U54 MH084681).	Avdeef A, 2001, PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH, P305, DOI 10.1002/9783906390437.ch18; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Copeland R. A., 2005, EVALUATION ENZYME IN, P125; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Korfmacher WA, 2009, MINI-REV MED CHEM, V9, P703, DOI 10.2174/138955709788452694; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Miyata S, 2013, NEUROL MED-CHIR, V53, P645, DOI 10.2176/nmc.oa2012-0409; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	24	65	83	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13717	13725		10.1074/jbc.M113.511030	http://dx.doi.org/10.1074/jbc.M113.511030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668804	Green Published, hybrid			2022-12-28	WOS:000335984600006
J	Lan, JP; Zhu, YY; Xu, LL; Yu, HJ; Yu, J; Liu, X; Fu, CH; Wang, XG; Ke, YW; Huang, H; Dou, Z				Lan, Jianping; Zhu, Yuanyuan; Xu, Leilei; Yu, Huijuan; Yu, Jian; Liu, Xing; Fu, Chuanhai; Wang, Xiaogang; Ke, Yuwen; Huang, He; Dou, Zhen			The 68-kDa Telomeric Repeat Binding Factor 1 ( TRF1)-associated Protein ( TAP68) Interacts with and Recruits TRF1 to the Spindle Pole during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Centriole; Mitosis; Phosphorylation; Telomeres; Nek2A Kinase; TAP68; TRF1	FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; CENTROSOME ABERRATIONS; MITOTIC SPINDLE; DOMAIN PROTEIN; NEK2 KINASE; HUMAN-CELLS; PHOSPHORYLATION; CHECKPOINT; TANKYRASE	Background: The significance of telomeric protein translocation to the spindle pore is unknown. Results: TAP68 mediates TRF1 transit to the centrosome in mitotic cells. Conclusion: Repression of TAP68 induces genomic instability possibly through inhibition of TRF1 and tankyrase recruitment to centrosomes. Significance: Identifying TRF1-interacting proteins that regulate its localization is crucial for understanding the role of telomeric proteins in mitosis. The telomere capping protein TRF1 is a component of the multiprotein complex shelterin, which organizes the telomere into a high order structure. Besides telomere maintenance, telomere-associated proteins also have nontelomeric functions. For example, tankyrase 1 and TRF1 are required for the maintenance of faithful mitotic progression. However, the functional relevance of their centrosomal localization has not been established. Here, we report the identification of a TRF1-binding protein, TAP68, that interacts with TRF1 in mitotic cells. TAP68 contains two coiled-coil domains and a structural maintenance of chromosome motifs and co-localizes with TRF1 to telomeres during interphase. Immediately after nuclear envelope breakdown, TAP68 translocates toward the spindle poles followed by TRF1. Dissociation of TAP68 from the telomere is concurrent with the Nek2A-dependent phosphorylation at Thr-221. Biochemical characterization demonstrated that the first coiled-coil domain of TAP68 binds and recruits TRF1 to the centrosome. Inhibition of TAP68 expression by siRNA blocked the localization of TRF1 and tankyrase 1 to the centrosome. Furthermore, siRNA-mediated depletion of TAP68 perturbed faithful chromosome segregation and genomic stability. These findings suggest that TAP68 functions in mediating TRF1-tankyrase 1 localization to the centrosome and in mitotic regulation.	[Lan, Jianping; Wang, Xiaogang] Zhejiang Prov Peoples Hosp, Dept Hematol, Hangzhou 310014, Zhejiang, Peoples R China; [Lan, Jianping; Wang, Xiaogang] Zhejiang Prov Peoples Hosp, Hematopoiet Stem Cell Transplant Ctr, Hangzhou 310014, Zhejiang, Peoples R China; [Zhu, Yuanyuan; Yu, Jian; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yuanyuan; Yu, Jian; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplant Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Leilei; Yu, Huijuan; Liu, Xing; Fu, Chuanhai; Ke, Yuwen; Dou, Zhen] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Xu, Leilei; Yu, Huijuan; Liu, Xing; Fu, Chuanhai; Ke, Yuwen; Dou, Zhen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dou, Z (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Fu, Chuanhai/G-8303-2016; Liu, Xing/H-2989-2018	Fu, Chuanhai/0000-0003-4354-3796; Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393	Chinese 973 Project [2002CB713704, 2012CB917204, 2013CB911203]; National Natural Science Foundation of China [30871109, 30770919, 30900640, 81000896, 81300418, 31371363]; Zhejiang Provincial Natural Science Foundation of China [Y2090885]	Chinese 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by Chinese 973 Project Grants 2002CB713704, 2012CB917204, and 2013CB911203, National Natural Science Foundation of China Grants 30871109, 30770919, 30900640, 81000896, 81300418, and 31371363, and Zhejiang Provincial Natural Science Foundation of China Grant Y2090885.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang P, 2009, MOL BIOL CELL, V20, P4575, DOI 10.1091/mbc.E09-06-0477; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Ha GH, 2012, CELL DEATH DIFFER, V19, P321, DOI 10.1038/cdd.2011.101; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kramer A, 2005, LEUKEMIA, V19, P1142, DOI 10.1038/sj.leu.2403780; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Lu KP, 1996, NATURE, V380, P544; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Munoz P, 2009, MOL CELL BIOL, V29, P1608, DOI 10.1128/MCB.01339-08; Nakamura M, 2002, FEBS LETT, V514, P193, DOI 10.1016/S0014-5793(02)02363-3; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; Ohishi T, 2010, CANCER RES, V70, P2041, DOI 10.1158/0008-5472.CAN-09-2008; Prime G, 2005, CELL CYCLE, V4, P121, DOI 10.4161/cc.4.1.1351; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang C, 2010, EUR J CELL BIOL, V89, P748, DOI 10.1016/j.ejcb.2010.05.005; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	54	7	8	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14145	14156		10.1074/jbc.M113.526244	http://dx.doi.org/10.1074/jbc.M113.526244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692559	Green Published, hybrid			2022-12-28	WOS:000335984600042
J	Dai, G; Sherpa, T; Varnum, MD				Dai, Gucan; Sherpa, Tshering; Varnum, Michael D.			Alternative Splicing Governs Cone Cyclic Nucleotidegated ( CNG) Channel Sensitivity to Regulation by Phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Alternative Splicing; Ion Channels; Phosphoinositides; Photoreceptors	CGMP-GATED CHANNEL; ACID-RICH PROTEINS; ROD OUTER SEGMENT; BETA-SUBUNIT; ION-CHANNEL; SIGNALING PATHWAY; SENSORY NEURONS; PHOTORECEPTOR; MODULATION; CALMODULIN	Background: Variants of photoreceptor CNG channels are produced by alternative splicing of precursor mRNA. Results: Inclusion of an optional exon in human CNGA3 transcripts produces channel isoforms with enhanced sensitivity to phosphoinositides via an allosteric mechanism. Conclusion: Alternative splicing of CNGA3 transcripts controls phosphoinositide regulation of cone CNG channels. Significance: These findings reveal the functional importance of CNGA3 alternative splicing. Precursor mRNA encoding CNGA3 subunits of cone photoreceptor cyclic nucleotide-gated (CNG) channels undergoes alternative splicing, generating isoforms differing in the N-terminal cytoplasmic region of the protein. In humans, four variants arise from alternative splicing, but the functional significance of these changes has been a persistent mystery. Heterologous expression of the four possible CNGA3 isoforms alone or with CNGB3 subunits did not reveal significant differences in basic channel properties. However, inclusion of optional exon 3, with or without optional exon 5, produced heteromeric CNGA3 + CNGB3 channels exhibiting an approximate to 2-fold greater shift in K-1/2,K-cGMP after phosphatidylinositol 4,5-biphosphate or phosphatidylinositol 3,4,5-trisphosphate application compared with channels lacking the sequence encoded by exon 3. We have previously identified two structural features within CNGA3 that support phosphoinositides (PIPn) regulation of cone CNG channels: N- and C-terminal regulatory modules. Specific mutations within these regions eliminated PIPn sensitivity of CNGA3 + CNGB3 channels. The exon 3 variant enhanced the component of PIPn regulation that depends on the C-terminal region rather than the nearby N-terminal region, consistent with an allosteric effect on PIPn sensitivity because of altered N-C coupling. Alternative splicing of CNGA3 occurs in multiple species, although the exact variants are not conserved across CNGA3 orthologs. Optional exon 3 appears to be unique to humans, even compared with other primates. In parallel, we found that a specific splice variant of canine CNGA3 removes a region of the protein that is necessary for high sensitivity to PIPn. CNGA3 alternative splicing may have evolved, in part, to tune the interactions between cone CNG channels and membrane-bound phosphoinositides.	[Dai, Gucan; Sherpa, Tshering; Varnum, Michael D.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Dai, Gucan; Varnum, Michael D.] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Varnum, Michael D.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Varnum, MD (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, Box 647620, Pullman, WA 99164 USA.	varnum@wsu.edu		Dai, Gucan/0000-0002-4692-4060	NEI, National Institutes of Health [EY12836]; NATIONAL EYE INSTITUTE [R01EY012836] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health grant EY12836 (to M. D. V.).	Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonigk W, 1996, J NEUROSCI, V16, P7458; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Cassar S, 2004, MOL VIS, V10, P808; Chen SK, 2007, J NEUROSCI, V27, P12168, DOI 10.1523/JNEUROSCI.3541-07.2007; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Dai G, 2013, AM J PHYSIOL-CELL PH, V305, pC147, DOI 10.1152/ajpcell.00037.2013; Dai GC, 2013, J GEN PHYSIOL, V141, P413, DOI 10.1085/jgp.201210944; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Isacoff EY, 2013, NEURON, V80, P658, DOI 10.1016/j.neuron.2013.10.040; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Lin L, 2010, HUM MOL GENET, V19, P2958, DOI 10.1093/hmg/ddq201; Meighan PC, 2012, CHANNELS, V6, P181, DOI 10.4161/chan.20904; Meighan SE, 2013, BIOCHEMISTRY-US, V52, P8352, DOI 10.1021/bi400824x; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2011, J NEUROSCI, V31, P133, DOI 10.1523/JNEUROSCI.4735-10.2011; Molokanova E, 1999, J NEUROSCI, V19, P4786; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Womack KB, 2000, J NEUROSCI, V20, P2792; Yu WP, 1996, FEBS LETT, V393, P211, DOI 10.1016/0014-5793(96)00889-7; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zheng J, 2003, J NEUROSCI, V23, P8167	53	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13680	13690		10.1074/jbc.M114.562272	http://dx.doi.org/10.1074/jbc.M114.562272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675082	hybrid, Green Published			2022-12-28	WOS:000335522800061
J	Villinger, S; Giller, K; Bayrhuber, M; Lange, A; Griesinger, C; Becker, S; Zweckstetter, M				Villinger, Saskia; Giller, Karin; Bayrhuber, Monika; Lange, Adam; Griesinger, Christian; Becker, Stefan; Zweckstetter, Markus			Nucleotide Interactions of the Human Voltage-dependent Anion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Membrane Proteins; NMR; Nucleotide; Organic Anion Channels; Interactions	MITOCHONDRIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; VDAC CHANNELS; SUGAR TRANSLOCATION; MOLECULAR-DYNAMICS; DETERGENT MICELLES; CRYSTAL-STRUCTURES; SELECTIVE CHANNEL; NEUROSPORA-CRASSA; STRUCTURAL BASIS	Background: Human VDAC1 mediates and controls the transport of metabolites across the outer mitochondrial membrane. Results: The N-terminal helix of hVDAC1 is involved in binding to charged forms of ATP, UTP, and GTP with an important contribution from lysine 20. Conclusion: Weak binding of ATP confers specificity for ATP transport. Significance: ATP interaction mapped at residue resolution supports metabolite selectivity of VDAC. The voltage-dependent anion channel (VDAC) mediates and gates the flux of metabolites and ions across the outer mitochondrial membrane and is a key player in cellular metabolism and apoptosis. Here we characterized the binding of nucleotides to human VDAC1 (hVDAC1) on a single-residue level using NMR spectroscopy and site-directed mutagenesis. We find that hVDAC1 possesses one major binding region for ATP, UTP, and GTP that partially overlaps with a previously determined NADH binding site. This nucleotide binding region is formed by the N-terminal -helix, the linker connecting the helix to the first -strand and adjacent barrel residues. hVDAC1 preferentially binds the charged forms of ATP, providing support for a mechanism of metabolite transport in which direct binding to the charged form exerts selectivity while at the same time permeation of the Mg2+-complexed ATP form is possible.	[Villinger, Saskia; Giller, Karin; Bayrhuber, Monika; Lange, Adam; Griesinger, Christian; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de		Lange, Adam/0000-0002-7534-5973; Zweckstetter, Markus/0000-0002-2536-6581	Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft (DFG); DFG collaborative research center SFB803; ERC [282008]	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG collaborative research center SFB803; ERC(European Research Council (ERC)European Commission)	This work was supported by a Fonds der Chemischen Industrie scholarship (to S. V.), a Deutsche Forschungsgemeinschaft (DFG) Emmy Noether Fellowship (to A. L.), DFG collaborative research center SFB803 (to A. L., C. G., and M. Z.), and the ERC Grant Agreement 282008 (to M. Z.).	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1990, BIOCHIM BIOPHYS ACTA, V1022, P311, DOI 10.1016/0005-2736(90)90279-W; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; De Stefano C, 2006, BIOPHYS CHEM, V121, P121, DOI 10.1016/j.bpc.2005.12.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; FEENEY J, 1979, J MAGN RESON, V33, P519, DOI 10.1016/0022-2364(79)90163-X; FLORKE H, 1994, BIOL CHEM H-S, V375, P513, DOI 10.1515/bchm3.1994.375.8.513; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Goddard T. D., 2006, SPARKY 3; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; GUO XW, 1993, BIOPHYS J, V64, P545, DOI 10.1016/S0006-3495(93)81399-7; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Kim BH, 2002, J MEMBRANE BIOL, V187, P239, DOI 10.1007/s00232-001-0167-1; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KOBAYASHI Y, 1985, EUR J BIOCHEM, V151, P231, DOI 10.1111/j.1432-1033.1985.tb09093.x; LEE AC, 1994, J BIOL CHEM, V269, P30974; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Malia T. J., 2006, THESIS MIT; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Mertins B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047938; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; Rostovtseva TK, 2002, J MEMBRANE BIOL, V187, P147, DOI 10.1007/s00232-001-0159-1; Runke G, 2000, J BIOENERG BIOMEMBR, V32, P563, DOI 10.1023/A:1005618510502; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SCHULEIN K, 1990, MOL MICROBIOL, V4, P625, DOI 10.1111/j.1365-2958.1990.tb00631.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sukhan A, 1996, J BIOL CHEM, V271, P21239, DOI 10.1074/jbc.271.35.21239; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIZI M, 1994, J BIOL CHEM, V269, P1614; Zou HJ, 2008, J PHYS CHEM B, V112, P13070, DOI 10.1021/jp710964x	64	27	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13397	13406		10.1074/jbc.M113.524173	http://dx.doi.org/10.1074/jbc.M113.524173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668813	Green Published, hybrid			2022-12-28	WOS:000335522800038
J	Munch, D; Muller, A; Schneider, T; Kohl, B; Wenzel, M; Bandow, JE; Maffioli, S; Sosio, M; Donadio, S; Wimmer, R; Sahl, HG				Muench, Daniela; Mueller, Anna; Schneider, Tanja; Kohl, Bastian; Wenzel, Michaela; Bandow, Julia Elisabeth; Maffioli, Sonia; Sosio, Margherita; Donadio, Stefano; Wimmer, Reinhard; Sahl, Hans-Georg			The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Wall; Membrane; Nuclear Magnetic Resonance; Peptidoglycan; Staphylococcus aureus; Teichoic Acid; Lantibiotics; Lipid II; Nisin	PEPTIDE ANTIBIOTIC NISIN; LIPID-II; PEPTIDOGLYCAN BIOSYNTHESIS; PORE FORMATION; TEICHOIC-ACID; MODE; MICROBISPORICIN; EPIDERMIN; INHIBITION; STRATEGIES	Background: NAI-107 is a potent lantibiotic with an unknown mode of action. Results: NAI-107 targets bactoprenol-bound cell envelope precursors, e.g. lipid II, and in addition affects the bacterial membrane. Conclusion: Cell wall biosynthesis is blocked by sequestration of lipid II and functional disorganization of the cell wall machinery. Significance: The dual mechanism of action may explain the potency of NAI-107 and related lantibiotics. The lantibiotic NAI-107 is active against Gram-positive bacteria including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. To identify the molecular basis of its potency, we studied the mode of action in a series of whole cell and in vitro assays and analyzed structural features by nuclear magnetic resonance (NMR). The lantibiotic efficiently interfered with late stages of cell wall biosynthesis and induced accumulation of the soluble peptidoglycan precursor UDP-N-acetylmuramic acid-pentapeptide (UDP-MurNAc-pentapeptide) in the cytoplasm. Using membrane preparations and a complete cascade of purified, recombinant late stage peptidoglycan biosynthetic enzymes (MraY, MurG, FemX, PBP2) and their respective purified substrates, we showed that NAI-107 forms complexes with bactoprenol-pyrophosphate-coupled precursors of the bacterial cell wall. Titration experiments indicate that first a 1:1 stoichiometric complex occurs, which then transforms into a 2:1 (peptide: lipid II) complex, when excess peptide is added. Furthermore, lipid II and related molecules obviously could not serve as anchor molecules for the formation of defined and stable nisin-like pores, however, slow membrane depolarization was observed after NAI-107 treatment, which could contribute to killing of the bacterial cell.	[Muench, Daniela; Mueller, Anna; Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Sect, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany; [Kohl, Bastian; Wenzel, Michaela; Bandow, Julia Elisabeth] Ruhr Univ Bochum, Dept Biol Microorganisms, D-44780 Bochum, Germany; [Maffioli, Sonia; Sosio, Margherita; Donadio, Stefano] NAICONS Srl, I-20139 Milan, Italy; [Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark	University of Bonn; Ruhr University Bochum; Aalborg University	Munch, D (corresponding author), Meckenheimer Allee 168, D-53115 Bonn, Germany.	dmuench@uni-bonn.de; hgsahl@uni-bonn.de	Wenzel, Michaela/D-5643-2015; Mueller, Anna/L-9779-2017; Wenzel, Michaela/M-5445-2019; Wimmer, Reinhard/M-2346-2019; Bandow, Julia/K-8854-2012; maffioli, sonia/K-7575-2019; Schneider, Tanja/L-8049-2013; Wimmer, Reinhard/A-7901-2012	Wenzel, Michaela/0000-0001-9969-6113; Mueller, Anna/0000-0001-6420-3868; Wenzel, Michaela/0000-0001-9969-6113; Bandow, Julia/0000-0003-4100-8829; Wimmer, Reinhard/0000-0001-6942-5056; Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745; Sosio, Margherita/0000-0003-4297-6936	Obel Foundation; SparNord Foundation; Carlsberg Foundation; Danish Center for Antibiotic Research and Development (DanCARD) - Danish Council for Strategic Research Grant [09-067075]; state of North Rhine Westphalia (Forschungsgrossgerate der Lander)	Obel Foundation; SparNord Foundation; Carlsberg Foundation(Carlsberg Foundation); Danish Center for Antibiotic Research and Development (DanCARD) - Danish Council for Strategic Research Grant; state of North Rhine Westphalia (Forschungsgrossgerate der Lander)	We thank Dirk Albrecht (University of Greifswald, Germany) for MALDI-TOF analysis. We thank the Centre for Biomolecular Magnetic Resonance, Frankfurt, Germany, for access to NMR equipment and Dr. Frank Lohr for expert assistance. Michaele Josten provided excellent technical help. The NMR laboratory at Aalborg University is supported by the Obel, SparNord, and Carlsberg Foundations as well as part of the Danish Center for Antibiotic Research and Development (DanCARD) financed by Danish Council for Strategic Research Grant 09-067075. The Synapt G2S mass spectrometer was supported by the state of North Rhine Westphalia (Forschungsgrossgerate der Lander).	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Bandow JE, 2008, PROTEOMICS, V8, P3030, DOI 10.1002/pmic.200701184; Barrett John F, 2005, Curr Opin Investig Drugs, V6, P781; Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Breukink E, 2000, BIOCHEMISTRY-US, V39, P10247, DOI 10.1021/bi000915q; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Castiglione F, 2008, CHEM BIOL, V15, P22, DOI 10.1016/j.chembiol.2007.11.009; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Foulston L, 2011, J BACTERIOL, V193, P3064, DOI 10.1128/JB.00250-11; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; Jabes D, 2010, METHODS MOL BIOL, V618, P31, DOI 10.1007/978-1-60761-594-1_3; Kim SJ, 2008, J MOL BIOL, V377, P281, DOI 10.1016/j.jmb.2008.01.031; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lazzarini A, 2008, US Patent, Patent No. 07351687; Muller A, 2012, MICROB DRUG RESIST, V18, P261, DOI 10.1089/mdr.2011.0242; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Orlov DS, 2002, J MICROBIOL METH, V49, P325, DOI 10.1016/S0167-7012(01)00383-9; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rogers LA, 1928, J BACTERIOL, V16, P321, DOI 10.1128/JB.16.5.321-325.1928; Rohrer S, 2003, ANTIMICROB AGENTS CH, V47, P837, DOI 10.1128/AAC.47.3.837-846.2003; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; SAHL HG, 1982, ZBL BAKT-INT J MED M, V252, P166, DOI 10.1016/S0174-3031(82)80114-5; SAHL HG, 1987, ARCH MICROBIOL, V149, P120, DOI 10.1007/BF00425076; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Scherer K, 2013, BBA-BIOMEMBRANES, V1828, P2628, DOI 10.1016/j.bbamem.2013.07.014; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; UMBREIT JN, 1972, J BACTERIOL, V112, P1306, DOI 10.1128/JB.112.3.1306-1309.1972; VANHEIJENOORT Y, 1978, FEBS LETT, V89, P141, DOI 10.1016/0014-5793(78)80540-7; Vasile F, 2012, J PEPT SCI, V18, P129, DOI 10.1002/psc.1425; Wenzel M., 2014, P NATL ACAD IN PRESS, DOI [10.1073/pnas.131199001, DOI 10.1073/PNAS.131199001]; Wenzel M, 2013, ACS CHEM BIOL, V8, P1442, DOI 10.1021/cb4000844; Wenzel M, 2012, ANTIMICROB AGENTS CH, V56, P5749, DOI 10.1128/AAC.01380-12; Wenzel M, 2011, PROTEOMICS, V11, P3256, DOI 10.1002/pmic.201100046; Wenzel M, 2011, ANTIMICROB AGENTS CH, V55, P2590, DOI 10.1128/AAC.00078-11; Wiedemann I, 2004, J BACTERIOL, V186, P3259, DOI 10.1128/JB.186.10.3259-3261.2004; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	58	57	58	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12063	12076		10.1074/jbc.M113.537449	http://dx.doi.org/10.1074/jbc.M113.537449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627484	Green Published, hybrid			2022-12-28	WOS:000335010600044
J	Chai, Q; Singh, B; Peisker, K; Metzendorf, N; Ge, XL; Dasgupta, S; Sanyal, S				Chai, Qian; Singh, Bhupender; Peisker, Kristin; Metzendorf, Nicole; Ge, Xueliang; Dasgupta, Santanu; Sanyal, Suparna			Organization of Ribosomes and Nucleoids in Escherichia coli Cells during Growth and in Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Division; Cytoskeleton; DNA Replication; Ribosomes; Subcellular Organelles; Transcription; Translation; FtsZ Ring; Nucleoid	BACTERIAL CHROMOSOME; BACILLUS-SUBTILIS; RNA-POLYMERASE; ACTIVE TRANSCRIPTION; GENETIC INFORMATION; DNA-REPLICATION; E. COLI; Z-RING; TRANSLATION; PROTEIN	Background: We studied ribosome and nucleoid distribution in Escherichia coli under growth and quiescence. Results: Spatially segregated ribosomes and nucleoids show drastically altered distribution in stationary phase or when treated with drugs affecting translation, transcription, nucleoid-topology, or cytoskeleton. Ribosome inheritance in daughter cells is frequently unequal. Conclusion: Cellular growth processes modulate ribosome and nucleoid distribution. Significance: This provides insight into subcellular organization of molecular machines. We have examined the distribution of ribosomes and nucleoids in live Escherichia coli cells under conditions of growth, division, and in quiescence. In exponentially growing cells translating ribosomes are interspersed among and around the nucleoid lobes, appearing as alternative bands under a fluorescence microscope. In contrast, inactive ribosomes either in stationary phase or after treatment with translation inhibitors such as chloramphenicol, tetracycline, and streptomycin gather predominantly at the cell poles and boundaries with concomitant compaction of the nucleoid. However, under all conditions, spatial segregation of the ribosomes and the nucleoids is well maintained. In dividing cells, ribosomes accumulate on both sides of the FtsZ ring at the mid cell. However, the distribution of the ribosomes among the new daughter cells is often unequal. Both the shape of the nucleoid and the pattern of ribosome distribution are also modified when the cells are exposed to rifampicin (transcription inhibitor), nalidixic acid (gyrase inhibitor), or A22 (MreB-cytoskeleton disruptor). Thus we conclude that the intracellular organization of the ribosomes and the nucleoids in bacteria are dynamic and critically dependent on cellular growth processes (replication, transcription, and translation) as well as on the integrity of the MreB cytoskeleton.	[Chai, Qian; Singh, Bhupender; Peisker, Kristin; Metzendorf, Nicole; Ge, Xueliang; Dasgupta, Santanu; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se	Singh, Bhupender/B-6817-2009	Singh, Bhupender/0000-0001-5634-6252; Ge, Xueliang/0000-0001-7954-3195	Swedish Research Council [2010-2619, 2011-6088, 2008-6593]; Carl-Tryggers Foundation [CTS 09:341, 10:330]; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation [KAW 2011.0081]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl-Tryggers Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the research grants from the Swedish Research Council (2010-2619 (M), 2011-6088 (NT), and 2008-6593 (Linnaeus grant to Uppsala RNA Research Center)), the Carl-Tryggers Foundation (CTS 09:341 and 10: 330), the Wenner-Gren Foundation, and the Knut and Alice Wallenberg Foundation (KAW 2011.0081 to RiboCORE (to S. S.).	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Cabrera JE, 2009, J BACTERIOL, V191, P4180, DOI 10.1128/JB.01707-08; Campos M, 2013, CURR OPIN MICROBIOL, V16, P171, DOI 10.1016/j.mib.2013.01.007; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; DWORSKY P, 1973, J BACTERIOL, V116, P1364, DOI 10.1128/JB.116.3.1364-1374.1973; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fishov I, 2012, CURR OPIN MICROBIOL, V15, P724, DOI 10.1016/j.mib.2012.11.001; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Han XL, 2011, J ANTIMICROB CHEMOTH, V66, P323, DOI 10.1093/jac/dkq427; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Mondal J, 2011, BIOPHYS J, V100, P2605, DOI 10.1016/j.bpj.2011.04.030; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Norris V, 2007, ANNU REV MICROBIOL, V61, P309, DOI 10.1146/annurev.micro.61.081606.103348; Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007; Osborn MJ, 2007, CURR OPIN MICROBIOL, V10, P606, DOI 10.1016/j.mib.2007.09.004; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Tao WT, 2000, MOL MICROBIOL, V38, P392, DOI 10.1046/j.1365-2958.2000.02138.x; Tao WT, 2000, PLASMID, V43, P200, DOI 10.1006/plas.1999.1457; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Zimmerman SB, 2006, J STRUCT BIOL, V156, P255, DOI 10.1016/j.jsb.2006.03.022	53	54	55	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11342	11352		10.1074/jbc.M114.557348	http://dx.doi.org/10.1074/jbc.M114.557348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599955	Green Published, hybrid			2022-12-28	WOS:000334638500036
J	Gee, CE; Peterlik, D; Neuhauser, C; Bouhelal, R; Kaupmann, K; Laue, G; Uschold-Schmidt, N; Feuerbach, D; Zimmermann, K; Ofner, S; Cryan, JF; van der Putten, H; Fendt, M; Vranesic, I; Glatthar, R; Flor, PJ				Gee, Christine E.; Peterlik, Daniel; Neuhaeuser, Christoph; Bouhelal, Rochdi; Kaupmann, Klemens; Laue, Grit; Uschold-Schmidt, Nicole; Feuerbach, Dominik; Zimmermann, Kaspar; Ofner, Silvio; Cryan, John F.; van der Putten, Herman; Fendt, Markus; Vranesic, Ivo; Glatthar, Ralf; Flor, Peter J.			Blocking Metabotropic Glutamate Receptor Subtype 7 ( mGlu7) via the Venus Flytrap Domain ( VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors Metabotropic; Neurotransmitter Release; Pharmacology; Stress; Synaptic Plasticity; Elevated Plus-Maze; Fear Conditioning; XAP044	NEGATIVE ALLOSTERIC MODULATOR; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; MICE LACKING; ACTIVATION; PROTEIN; AGONIST; EXTINCTION; ANTIDEPRESSANT	Background: Behavioral genetics identified mGlu7 as a key regulator of brain emotion circuits. Results: An mGlu7-selective, Venus flytrap domain (VFTD)-directed antagonist inhibits fear, synaptic plasticity, stress, and anxiety in rodents. Conclusion: Pharmacological blockers of mGlu7 may represent promising future anxiolytics and antidepressants in man. Significance: The VFTD region of class C GPCRs provides a promising target for computer-assisted drug design. The metabotropic glutamate receptor subtype 7 (mGlu7) is an important presynaptic regulator of neurotransmission in the mammalian CNS. mGlu7 function has been linked to autism, drug abuse, anxiety, and depression. Despite this, it has been difficult to develop specific blockers of native mGlu7 signaling in relevant brain areas such as amygdala and limbic cortex. Here, we present the mGlu7-selective antagonist 7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one (XAP044), which inhibits lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm. There was no effect of XAP044 on LTP of mGlu7-deficient mice, indicating that this pharmacological effect is mGlu7-dependent. Unexpectedly and in contrast to all previous mGlu7-selective drugs, XAP044 does not act via the seven-transmembrane region but rather via a binding pocket localized in mGlu7's extracellular Venus flytrap domain, a region generally known for orthosteric agonist binding. This was shown by chimeric receptor studies in recombinant cell line assays. XAP044 demonstrates good brain exposure and wide spectrum anti-stress and antidepressant- and anxiolytic-like efficacy in rodent behavioral paradigms. XAP044 reduces freezing during acquisition of Pavlovian fear and reduces innate anxiety, which is consistent with the phenotypes of mGlu7-deficient mice, the results of mGlu7 siRNA knockdown studies, and the inhibition of amygdala LTP by XAP044. Thus, we present an mGlu7 antagonist with a novel molecular mode of pharmacological action, providing significant application potential in psychiatry. Modeling the selective interaction between XAP044 and mGlu7's Venus flytrap domain, whose three-dimensional structure is already known, will facilitate future drug development supported by computer-assisted drug design.	[Gee, Christine E.; Bouhelal, Rochdi; Kaupmann, Klemens; Laue, Grit; Feuerbach, Dominik; Zimmermann, Kaspar; Ofner, Silvio; Cryan, John F.; van der Putten, Herman; Fendt, Markus; Vranesic, Ivo; Glatthar, Ralf; Flor, Peter J.] Novartis AG, Novartis Inst BioMed Res, CH-4057 Basel, Switzerland; [Gee, Christine E.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, D-20249 Hamburg, Germany; [Peterlik, Daniel; Neuhaeuser, Christoph; Uschold-Schmidt, Nicole; Flor, Peter J.] Univ Regensburg, Fac Biol & Preclin Med, Lab Mol & Cellular Neurobiol, D-93053 Regensburg, Germany; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Fendt, Markus] Univ Magdeburg, Inst Pharmacol & Toxicol, D-39120 Magdeburg, Germany; [Fendt, Markus] Univ Magdeburg, Ctr Behav Brain Sci, D-39120 Magdeburg, Germany	Novartis; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University College Cork; Otto von Guericke University; Otto von Guericke University	Glatthar, R (corresponding author), Novartis Pharma AG, CH-4057 Basel, Switzerland.	ralf.glatthar@novartis.com; peter.flor@biologie.uni-regensburg.de	Cryan, John F./A-6950-2013; Fendt, Markus/G-1888-2013; Gee, Christine E/E-9241-2013	Cryan, John F./0000-0001-5887-2723; Fendt, Markus/0000-0002-3451-1226; Gee, Christine E/0000-0003-0345-3665; Kaupmann, Klemens/0000-0001-8903-2508	German Research Foundation [FL 729/2-1]	German Research Foundation(German Research Foundation (DFG))	Supported by Grant FL 729/2-1 from the German Research Foundation. To whom correspondence may be addressed: Faculty of Biology and Preclinical Medicine, University of Regensburg, D-93053 Regensburg, Germany. Tel.: 49-941-3079; Fax: 49-941-3052; E-mail: peter.flor@biologie.uni-regensburg.de.	Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Bhattacharya S, 2013, PROTEINS, V81, P729, DOI 10.1002/prot.24195; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Chaperon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034963; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dobi A, 2013, NEUROPHARMACOLOGY, V66, P274, DOI 10.1016/j.neuropharm.2012.05.025; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fendt M, 2008, MOL PSYCHIATR, V13, P970, DOI 10.1038/sj.mp.4002073; Fendt M, 2013, NEUROPHARMACOLOGY, V72, P215, DOI 10.1016/j.neuropharm.2013.04.052; Flor PJ, 2012, BIOCHEM PHARMACOL, V84, P414, DOI 10.1016/j.bcp.2012.04.013; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; FLOR PJ, 1995, NEUROPHARMACOLOGY, V34, P149, DOI 10.1016/0028-3908(94)00149-M; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Goddyn H, 2008, NEUROBIOL LEARN MEM, V90, P103, DOI 10.1016/j.nlm.2008.01.001; Hikichi H, 2010, EUR J PHARMACOL, V639, P106, DOI 10.1016/j.ejphar.2009.08.047; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kalinichev M, 2013, J PHARMACOL EXP THER, V344, P624, DOI 10.1124/jpet.112.200915; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Lin FF, 1997, NEUROPHARMACOLOGY, V36, P917, DOI 10.1016/S0028-3908(97)00078-6; Litschig S, 1999, MOL PHARMACOL, V55, P453; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Martin R, 2010, J BIOL CHEM, V285, P17907, DOI 10.1074/jbc.M109.080838; Masugi M, 1999, J NEUROSCI, V19, P955; Maurer TS, 2005, DRUG METAB DISPOS, V33, P175, DOI 10.1124/dmd.104.001222; Mitsukawa K, 2005, P NATL ACAD SCI USA, V102, P18712, DOI 10.1073/pnas.0508063102; Mitsukawa K, 2006, NEUROPSYCHOPHARMACOL, V31, P1112, DOI 10.1038/sj.npp.1300926; Muto T, 2007, ACTA CRYSTALLOGR F, V63, P627, DOI 10.1107/S1744309107030059; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nakamura M, 2010, BIOORG MED CHEM LETT, V20, P726, DOI 10.1016/j.bmcl.2009.11.070; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2010, MOL PHARMACOL, V77, P459, DOI 10.1124/mol.109.058768; O'Connor RM, 2013, NEUROPHARMACOLOGY, V72, P66, DOI 10.1016/j.neuropharm.2013.03.028; O'Connor RM, 2010, EUR J PHARMACOL, V639, P123, DOI 10.1016/j.ejphar.2010.02.059; Palazzo E, 2008, NEUROPHARMACOLOGY, V55, P537, DOI 10.1016/j.neuropharm.2008.05.007; Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2008, J PHYSIOL-LONDON, V586, P1495, DOI 10.1113/jphysiol.2007.148635; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Rizzo SJS, 2011, J PHARMACOL EXP THER, V338, P345, DOI 10.1124/jpet.110.177378; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rosemond E, 2004, MOL PHARMACOL, V66, P834, DOI 10.1124/mol.104.002956; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Slattery DA, 2012, PSYCHONEUROENDOCRINO, V37, P702, DOI 10.1016/j.psyneuen.2011.09.002; Stachowicz K, 2008, BEHAV PHARMACOL, V19, P597, DOI 10.1097/FBP.0b013e32830cd839; Suzuki G, 2007, J PHARMACOL EXP THER, V323, P147, DOI 10.1124/jpet.107.124701; Tones MA, 1995, NEUROREPORT, V7, P117, DOI 10.1097/00001756-199512290-00028; Topiol S, 2011, NEUROPHARMACOLOGY, V60, P93, DOI 10.1016/j.neuropharm.2010.08.001; Toth I, 2012, NEUROPHARMACOLOGY, V62, P1619, DOI 10.1016/j.neuropharm.2011.10.021; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; Weng K, 1997, J BIOL CHEM, V272, P33100, DOI 10.1074/jbc.272.52.33100; Wootten DL, 2010, PROG MOL BIOL TRANSL, V91, P53, DOI 10.1016/S1877-1173(10)91003-X; Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b	63	55	59	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10975	10987		10.1074/jbc.M113.542654	http://dx.doi.org/10.1074/jbc.M113.542654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596089	Green Published, hybrid			2022-12-28	WOS:000334638500004
J	Li, Z; Gherasim, C; Lesniak, NA; Banerjee, R				Li, Zhu; Gherasim, Carmen; Lesniak, Nicholas A.; Banerjee, Ruma			Glutathione-dependent One-electron Transfer Reactions Catalyzed by a B-12 Trafficking Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; REDUCED GLUTATHIONE; VITAMIN-B-12; MUTATIONS; MMACHC; DOMAIN; IDENTIFICATION; CHAPERONE; REDUCTASE; BINDING	CblC is involved in an early step in cytoplasmic cobalamin processing following entry of the cofactor into the cytoplasm. CblC converts the cobalamin cargo arriving from the lysosome to a common cob(II) alamin intermediate, which can be subsequently converted to the biologically active forms. Human CblC exhibits glutathione (GSH)-dependent alkyltransferase activity and flavin-dependent reductive decyanation activity with cyanocobalamin (CNCbl). In this study, we discovered two new GSH-dependent activities associated with the Caenorhabditis elegans CblC for generating cob(II) alamin: decyanation of CNCbl and reduction of aquocobalamin (OH(2)Cbl). We subsequently found that human CblC also catalyzes GSH-dependent decyanation of CNCbl and reduction of OH(2)Cbl, albeit efficiently only under anaerobic conditions. The air sensitivity of the human enzyme suggests interception by oxygen during the single-electron transfer step from GSH to CNCbl. These newly discovered GSH-dependent single-electron transfer reactions expand the repertoire of catalytic activities supported by CblC, a versatile B-12-processing enzyme.	[Li, Zhu; Gherasim, Carmen; Lesniak, Nicholas A.; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Li, Zhu/0000-0003-1536-9401; Lesniak, Nicholas/0000-0001-9359-5194	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R. B.).	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Gherasim CG, 2008, BIOCHEMISTRY-US, V47, P12515, DOI 10.1021/bi8008328; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; HARMAN LS, 1986, J BIOL CHEM, V261, P1642; HOFFMAN MZ, 1973, J PHYS CHEM-US, V77, P990, DOI 10.1021/j100627a005; Jeong J, 2011, BIOCHEM BIOPH RES CO, V412, P360, DOI 10.1016/j.bbrc.2011.07.103; Jeong J, 2011, BMB REP, V44, P170, DOI 10.5483/BMBRep.2011.44.3.170; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; LEXA D, 1980, J AM CHEM SOC, V102, P2654, DOI 10.1021/ja00528a023; Mc Guire PJ, 2009, MOL GENET METAB, V98, P173, DOI 10.1016/j.ymgme.2009.06.007; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; NAKAMURA M, 1986, J BIOL CHEM, V261, P13923; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zheng DH, 1997, J ELECTROANAL CHEM, V429, P61, DOI 10.1016/S0022-0728(96)05021-8	33	27	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16487	16497		10.1074/jbc.M114.567339	http://dx.doi.org/10.1074/jbc.M114.567339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742678	hybrid, Green Published			2022-12-28	WOS:000337965700050
J	Figaj, D; Gieldon, A; Polit, A; Sobiecka-Szkatula, A; Koper, T; Denkiewicz, M; Banecki, B; Lesner, A; Ciarkowski, J; Lipinska, B; Skorko-Glonek, J				Figaj, Donata; Gieldon, Artur; Polit, Agnieszka; Sobiecka-Szkatula, Anna; Koper, Tomasz; Denkiewicz, Milena; Banecki, Bogdan; Lesner, Adam; Ciarkowski, Jerzy; Lipinska, Barbara; Skorko-Glonek, Joanna			The LA Loop as an Important Regulatory Element of the HtrA (DegP) Protease from Escherichia coli STRUCTURAL AND FUNCTIONAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Fluorescence; Molecular Biology; Molecular Modeling; Protein Structure; Serine Protease	LOW-RESOLUTION MODELS; PROTEOLYTIC ACTIVITY; MOLECULAR-DYNAMICS; SUBSTRATE-SPECIFICITY; REPLICA EXCHANGE; SERINE-PROTEASE; E-CADHERIN; CHAPERONE; PROTEINS; SURVIVAL	Bacterial HtrAs are serine proteases engaged in extracytoplasmic protein quality control and are required for the virulence of several pathogenic species. The proteolytic activity of HtrA (DegP) from Escherichia coli, a model prokaryotic HtrA, is stimulated by stressful conditions; the regulation of this process is mediated by the LA, LD, L1, L2, and L3 loops. The precise mechanism of action of the LA loop is not known due to a lack of data concerning its three-dimensional structure as well as its mode of interaction with other regulatory elements. To address these issues we generated a theoretical model of the three-dimensional structure of the LA loop as per the resting state of HtrA and subsequently verified its correctness experimentally. We identified intra- and intersubunit contacts that formed with the LA loops; these played an important role in maintaining HtrA in its inactive conformation. The most significant proved to be the hydrophobic interactions connecting the LA loops of the hexamer and polar contacts between the LA (the LA loop on an opposite subunit) and L1 loops on opposite subunits. Disturbance of these interactions caused the stimulation of HtrA proteolytic activity. We also demonstrated that LA loops contribute to the preservation of the integrity of the HtrA oligomer and to the stability of the monomer. The model presented in this work explains the regulatory role of the LA loop well; it should also be applicable to numerous Enterobacteriaceae pathogenic species as the amino acid sequences of the members of this bacterial family are highly conserved.	[Figaj, Donata; Sobiecka-Szkatula, Anna; Koper, Tomasz; Denkiewicz, Milena; Lipinska, Barbara; Skorko-Glonek, Joanna] Univ Gdansk, Dept Biochem, Fac Biol, PL-80308 Gdansk, Poland; [Gieldon, Artur; Ciarkowski, Jerzy] Univ Gdansk, Dept Theoret Chem, Fac Chem, PL-80952 Gdansk, Poland; [Polit, Agnieszka] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, PL-30387 Krakow, Poland; [Banecki, Bogdan] Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Banecki, Bogdan] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Lesner, Adam] Univ Gdansk, Dept Biochem, Fac Chem, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk	Skorko-Glonek, J (corresponding author), Univ Gdansk, Dept Biochem, Fac Biol, Wita Stwosza 59, PL-80308 Gdansk, Poland.	joanna.skorko-glonek@biol.ug.edu.pl	Skorko-Glonek, Joanna/AAF-5516-2020; Lipinska, Barbara/ABA-6124-2020; Lesner, Adam/M-2732-2019	Skorko-Glonek, Joanna/0000-0002-8084-5251; Lipinska, Barbara/0000-0001-9510-4811; Polit, Agnieszka/0000-0001-5811-9838; Figaj, Donata/0000-0002-0625-2968; Lesner, Adam/0000-0001-8335-3431; Denkiewicz-Kruk, Milena/0000-0002-4357-9636; Banecki, Bogdan/0000-0003-3286-2388; Gieldon, Artur/0000-0003-0415-9214	Ministry of Science and Higher Education (Poland) [0393/B/P01/40]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education (Poland) Grant 0393/B/P01/40.	CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Creighton T. E, 1992, PROTEINS STRUCTURE M, p[182, 221]; Czaplewski C, 2009, J CHEM THEORY COMPUT, V5, P627, DOI 10.1021/ct800397z; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; Graf L., 2004, HDB PROTEOLYTIC ENZY, P1495; Hagen M, 2007, J PHYS CHEM B, V111, P1416, DOI 10.1021/jp064479e; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Keskin O, 1998, FOLD DES, V3, P469, DOI 10.1016/S1359-0278(98)00064-9; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Oberfelder R., 1993, METHODS NONRADIOACTI, P83; Park IH, 2012, J PHYS CHEM B, V116, P2365, DOI 10.1021/jp209657n; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V; Sobiecka-Szkatula A, 2010, ARCH BIOCHEM BIOPHYS, V500, P123, DOI 10.1016/j.abb.2010.05.028; Sobiecka-Szkatula A, 2009, BBA-PROTEINS PROTEOM, V1794, P1573, DOI 10.1016/j.bbapap.2009.07.002; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takatsuka Y, 2010, METHODS MOL BIOL, V634, P343, DOI 10.1007/978-1-60761-652-8_24; Wysocka M, 2010, ANAL BIOCHEM, V399, P196, DOI 10.1016/j.ab.2010.01.007; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1	42	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15880	15893		10.1074/jbc.M113.532895	http://dx.doi.org/10.1074/jbc.M113.532895			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737328	Green Published, hybrid			2022-12-28	WOS:000337465400066
J	Wang, JJ; Nemeria, NS; Chandrasekhar, K; Kumaran, S; Arjunan, P; Reynolds, S; Calero, G; Brukh, R; Kakalis, L; Furey, W; Jordan, F				Wang, Junjie; Nemeria, Natalia S.; Chandrasekhar, Krishnamoorthy; Kumaran, Sowmini; Arjunan, Palaniappa; Reynolds, Shelley; Calero, Guillermo; Brukh, Roman; Kakalis, Lazaros; Furey, William; Jordan, Frank			Structure and Function of the Catalytic Domain of the Dihydrolipoyl Acetyltransferase Component in Escherichia coli Pyruvate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Enzyme Catalysis; Mass Spectrometry (MS); Nuclear Magnetic Resonance (NMR); Pyruvate Dehydrogenase Complex (PDC); X-ray Crystallography; HD Exchange	SITE-DIRECTED MUTAGENESIS; THIAMIN DIPHOSPHATE; MULTIENZYME COMPLEX; AZOTOBACTER-VINELANDII; NUCLEOTIDE-SEQUENCE; 1',4'-IMINOPYRIMIDINE TAUTOMER; TRANSACETYLASE COMPONENT; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; E1 SUBUNIT	Background: The E. coli pyruvate dehydrogenase complex catalyzes conversion of pyruvate to acetyl-CoA and comprises E1p, E2p, and E3 components. Results: The structure of the E2 core domain was solved and shown to efficiently catalyze acetyl transfer between domains. Conclusion: Mass spectrometry revealed hitherto unrecognized domain-induced interactions between E1 and E2 core domain. Significance: A multifaceted approach is required to understand communication between intact multidomain components. The Escherichia coli pyruvate dehydrogenase complex (PDHc) catalyzing conversion of pyruvate to acetyl-CoA comprises three components: E1p, E2p, and E3. The E2p is the five-domain core component, consisting of three tandem lipoyl domains (LDs), a peripheral subunit binding domain (PSBD), and a catalytic domain (E2pCD). Herein are reported the following. 1) The x-ray structure of E2pCD revealed both intra- and intertrimer interactions, similar to those reported for other E2pCDs. 2) Reconstitution of recombinant LD and E2pCD with E1p and E3p into PDHc could maintain at least 6.4% activity (NADH production), confirming the functional competence of the E2pCD and active center coupling among E1p, LD, E2pCD, and E3 even in the absence of PSBD and of a covalent link between domains within E2p. 3) Direct acetyl transfer between LD and coenzyme A catalyzed by E2pCD was observed with a rate constant of 199 s(-1), comparable with the rate of NADH production in the PDHc reaction. Hence, neither reductive acetylation of E2p nor acetyl transfer within E2p is rate-limiting. 4) An unprecedented finding is that although no interaction could be detected between E1p and E2pCD by itself, a domain-induced interaction was identified on E1p active centers upon assembly with E2p and C-terminally truncated E2p proteins by hydrogen/deuterium exchange mass spectrometry. The inclusion of each additional domain of E2p strengthened the interaction with E1p, and the interaction was strongest with intact E2p. E2p domain-induced changes at the E1p active site were also manifested by the appearance of a circular dichroism band characteristic of the canonical 4-aminopyrimidine tautomer of bound thiamin diphosphate (AP).	[Wang, Junjie; Nemeria, Natalia S.; Kumaran, Sowmini; Brukh, Roman; Kakalis, Lazaros; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Chandrasekhar, Krishnamoorthy; Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Furey, William] Vet Affairs Med Ctr, Pittsburgh, PA 15240 USA; [Reynolds, Shelley; Calero, Guillermo] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15261 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Furey, W (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu; frjordan@rutgers.edu	Wang, Junjie/K-7509-2014	Wang, Junjie/0000-0002-0587-2209	National Institutes of Health [GM061791, GM050380]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061791 (to W. F.) and GM050380 (to F. J.). This work was also supported by a Veterans Affairs Merit Review (to W. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Allen MD, 1997, FEBS LETT, V413, P339, DOI 10.1016/S0014-5793(97)00932-0; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; BLEILE DM, 1979, P NATL ACAD SCI USA, V76, P4385, DOI 10.1073/pnas.76.9.4385; BUTTERWORTH PJ, 1975, J BIOL CHEM, V250, P1921; CAJACOB CA, 1985, J BIOL CHEM, V260, P4610; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GREEN JDF, 1992, J BIOL CHEM, V267, P23484; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; HUPE DJ, 1977, J AM CHEM SOC, V99, P451, DOI 10.1021/ja00444a023; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Jones DD, 2000, BIOCHEMISTRY-US, V39, P8448, DOI 10.1021/bi992978i; Jones DD, 2000, J MOL BIOL, V295, P289, DOI 10.1006/jmbi.1999.3335; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2005, BIOORG CHEM, V33, P190, DOI 10.1016/j.bioorg.2005.02.001; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Jordan F, 2009, J MOL CATAL B-ENZYM, V61, P14, DOI 10.1016/j.molcatb.2009.04.008; Kato M, 2006, EMBO J, V25, P5983, DOI 10.1038/sj.emboj.7601444; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Keller R., 2004, COMPUTER AIDED RESON, V1; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Knapp JE, 2000, PROTEIN SCI, V9, P37; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; LIVE DH, 1984, J AM CHEM SOC, V106, P6104, DOI 10.1021/ja00332a071; Marrott NL, 2012, FEBS J, V279, P713, DOI 10.1111/j.1742-4658.2011.08461.x; MATTEVI A, 1993, BIOCHEMISTRY-US, V32, P3887, DOI 10.1021/bi00066a007; MATTEVI A, 1993, J MOL BIOL, V230, P1183, DOI 10.1006/jmbi.1993.1235; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; NIU XD, 1990, BIOCHEMISTRY-US, V29, P8614, DOI 10.1021/bi00489a017; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Perham RN, 2002, BIOCHEM SOC T, V30, P47, DOI 10.1042/bst0300047; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; REED LJ, 1975, P NATL ACAD SCI USA, V72, P3068, DOI 10.1073/pnas.72.8.3068; RUSSELL GC, 1990, BIOCHEM J, V269, P443, DOI 10.1042/bj2690443; RUSSELL GC, 1991, P ROY SOC B-BIOL SCI, V243, P155, DOI 10.1098/rspb.1991.0025; RUSSELL GC, 1991, BIOCHIM BIOPHYS ACTA, V1076, P225, DOI 10.1016/0167-4838(91)90271-Z; SCHULZE E, 1991, EUR J BIOCHEM, V201, P561, DOI 10.1111/j.1432-1033.1991.tb16315.x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Song JY, 2010, J BIOL CHEM, V285, P4680, DOI 10.1074/jbc.M109.082842; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; STEPHENS PE, 1983, EUR J BIOCHEM, V135, P519, DOI 10.1111/j.1432-1033.1983.tb07683.x; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Tompa P, 2014, CHEM REV, V114, P6715, DOI 10.1021/cr4005082; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; YANG YS, 1986, BIOCHEMISTRY-US, V25, P8173, DOI 10.1021/bi00373a008; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	62	29	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15215	15230		10.1074/jbc.M113.544080	http://dx.doi.org/10.1074/jbc.M113.544080			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742683	hybrid, Green Published			2022-12-28	WOS:000337465400008
J	Abbas, M; Shanmugam, I; Bsaili, M; Hromas, R; Shaheen, M				Abbas, Mohammad; Shanmugam, Ilanchezhian; Bsaili, Manal; Hromas, Robert; Shaheen, Monte			The Role of the Human Psoralen 4 ( hPso4) Protein Complex in Replication Stress and Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; DNA Damage; DNA Repair; DNA Replication; Homologous Recombination	DOUBLE-STRAND BREAKS; CROSS-LINK REPAIR; DNA-REPAIR; CELL-CYCLE; U-BOX; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; DIRECTED REPAIR; BRCA1; DAMAGE	Background: hPso4 has been implicated in the resistance to interstrand cross-linking DNA-damaging agents. Results: hPso4 complex is involved in normal replication, and it has a role in DNA repair by homologous recombination through the regulation of DNA strand resection. Conclusion: hPso4 has a function in DNA double strand break repair by homologous recombination. Significance: hPso4 complex levels could predict sensitivity of cancer cells to PARP inhibitors. Psoralen 4 (Pso4) is an evolutionarily conserved protein that has been implicated in a variety of cellular processes including RNA splicing and resistance to agents that cause DNA interstrand cross-links. Here we show that the hPso4 complex is required for timely progression through S phase and transition through the G(2)/M checkpoint, and it functions in the repair of DNA lesions that arise during replication. Notably, hPso4 depletion results in delayed resumption of DNA replication after hydroxyurea-induced stalling of replication forks, reduced repair of spontaneous and hydroxyurea-induced DNA double strand breaks (DSBs), and increased sensitivity to a poly(ADP-ribose) polymerase inhibitor. Furthermore, we show that hPso4 is involved in the repair of DSBs by homologous recombination, probably by regulating the BRCA1 protein levels and the generation of single strand DNA at DSBs. Together, our results demonstrate that hPso4 participates in cell proliferation and the maintenance of genome stability by regulating homologous recombination. The involvement of hPso4 in the recombinational repair of DSBs provides an explanation for the sensitivity of Pso4-deficient cells to DNA interstrand cross-links.	[Abbas, Mohammad; Shanmugam, Ilanchezhian; Bsaili, Manal; Shaheen, Monte] Univ New Mexico, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32611 USA	University of New Mexico; State University System of Florida; University of Florida	Shaheen, M (corresponding author), Univ New Mexico, Ctr Canc, 1201 Camino Salud NE, Albuquerque, NM 87131 USA.	moshaheen@salud.unm.edu			National Institutes of Health [5K01HL103182-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K01HL103182-03 (to M. S.).	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Brendel M, 2001, MUTAT RES-REV MUTAT, V489, P79, DOI 10.1016/S1383-5742(01)00066-7; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2012, NUCLEIC ACIDS RES, V40, P726, DOI 10.1093/nar/gkr748; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shaheen M, 2011, BLOOD, V117, P6074, DOI 10.1182/blood-2011-01-313734; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Yang ES, 2010, FEBS J, V277, P3079, DOI 10.1111/j.1742-4658.2010.07734.x; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	43	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14009	14019		10.1074/jbc.M113.520056	http://dx.doi.org/10.1074/jbc.M113.520056			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675077	Green Published, hybrid			2022-12-28	WOS:000335984600031
J	Berkut, AA; Usmanova, DR; Peigneur, S; Oparin, PB; Mineev, KS; Odintsova, TI; Tytgat, J; Arseniev, AS; Grishin, EV; Vassilevski, AA				Berkut, Antonina A.; Usmanova, Dinara R.; Peigneur, Steve; Oparin, Peter B.; Mineev, Konstantin S.; Odintsova, Tatyana I.; Tytgat, Jan; Arseniev, Alexander S.; Grishin, Eugene V.; Vassilevski, Alexander A.			Structural Similarity between Defense Peptide from Wheat and Scorpion Neurotoxin Permits Rational Functional Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Plant Defense; Potassium Channels; Protein Design; Protein Engineering; Protein Folding; Hairpin; Hefutoxin	HELICAL HAIRPIN STRUCTURE; CHANNEL-BLOCKING ACTIVITY; DE-NOVO PROTEIN; K+ CHANNEL; ANTIMICROBIAL PEPTIDES; COUPLING-CONSTANTS; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; NMR STRUCTURE; SHK TOXIN	Background: Protein folds differ in size and complexity and hence in their utility for engineering purposes. Results: The three-dimensional structure of wheat antifungal peptide Tk-AMP-X2 was investigated, and a new functionality was engineered based on its -hairpin scaffold. Conclusion: -Hairpinins are an attractive simple structural template for functional engineering and drug design. Significance: The repertoire of available scaffolds for protein engineering is broadened. In this study, we present the spatial structure of the wheat antimicrobial peptide (AMP) Tk-AMP-X2 studied using NMR spectroscopy. This peptide was found to adopt a disulfide-stabilized -helical hairpin fold and therefore belongs to the -hairpinin family of plant defense peptides. Based on Tk-AMP-X2 structural similarity to cone snail and scorpion potassium channel blockers, a mutant molecule, Tk-hefu, was engineered by incorporating the functionally important residues from -hefutoxin 1 onto the Tk-AMP-X2 scaffold. The designed peptide contained the so-called essential dyad of amino acid residues significant for channel-blocking activity. Electrophysiological studies showed that although the parent peptide Tk-AMP-X2 did not present any activity against potassium channels, Tk-hefu blocked Kv1.3 channels with similar potency (IC50 approximate to 35 m) to -hefutoxin 1 (IC50 approximate to 40 m). We conclude that -hairpinins are attractive in their simplicity as structural templates, which may be used for functional engineering and drug design.	[Berkut, Antonina A.; Usmanova, Dinara R.; Oparin, Peter B.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.; Vassilevski, Alexander A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Berkut, Antonina A.; Usmanova, Dinara R.] State Univ, Moscow Inst Phys & Technol, Moscow 117303, Russia; [Peigneur, Steve; Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Louvain, Belgium; [Odintsova, Tatyana I.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119991, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; KU Leuven; Russian Academy of Sciences; Vavilov Institute of General Genetics	Vassilevski, AA (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	avas@ibch.ru	Mineev, Konstantin S/Q-3948-2018; Oparin, Peter/M-3305-2017; Usmanova, Dinara Ravilevna/I-9370-2014; Berkut, Antonina/AAE-4247-2019; Mineev, Konstantin/E-4151-2010; Vassilevski, Alexander/S-3824-2016; Mineev, Konstantin/AAC-6662-2019	Mineev, Konstantin S/0000-0002-2418-9421; Oparin, Peter/0000-0002-5713-0960; Mineev, Konstantin/0000-0002-2418-9421; Vassilevski, Alexander/0000-0002-1359-0076; Mineev, Konstantin/0000-0002-2418-9421; Peigneur, Steve/0000-0003-0504-5702; Tytgat, Jan/0000-0003-1778-6022	Russian Foundation for Basic Research [11-04-00190]; Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Federation [1924.2014.4]; F.W.O. Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy [IUAP 7/10]; KU Leuven [OT/12/081]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); F.W.O. Vlaanderen(FWO); Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy; KU Leuven(KU Leuven)	This work was supported in part by Russian Foundation for Basic Research Grant 11-04-00190, the Molecular and Cell Biology Program of the Russian Academy of Sciences, and Grant 1924.2014.4 from the President of Russian Federation.; Supported by F.W.O. Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; Inter-University Attraction Poles Program Grant IUAP 7/10 from Belgian State, Belgian Science Policy; and KU Leuven Grant OT/12/081.	Barnham KJ, 1997, J MOL BIOL, V268, P886, DOI 10.1006/jmbi.1997.0980; Camargos TS, 2011, PEPTIDES, V32, P1509, DOI 10.1016/j.peptides.2011.05.017; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Conners R, 2007, J BIOL CHEM, V282, P27760, DOI 10.1074/jbc.M703871200; DeLano WL, 2002, PYMOL USERS MANUAL; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; DOLGIKH DA, 1991, DOKL AKAD NAUK SSSR+, V320, P1266; Dolgikh DA, 1996, PROTEIN ENG, V9, P195, DOI 10.1093/protein/9.2.195; DUVICK JP, 1992, J BIOL CHEM, V267, P18814; Dux P, 1997, J BIOMOL NMR, V10, P301, DOI 10.1023/A:1018393225804; EFREMOV RG, 1995, J BIOMOL STRUCT DYN, V12, P971, DOI 10.1080/07391102.1995.10508791; Egorov Ts A, 2012, Bioorg Khim, V38, P7; FEDOROV AN, 1992, J MOL BIOL, V225, P927, DOI 10.1016/0022-2836(92)90092-X; Gasparian ME, 2003, PROTEIN EXPRES PURIF, V31, P133, DOI 10.1016/S1046-5928(03)00159-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gracy J, 2011, CURR PHARM DESIGN, V17, P4337, DOI 10.2174/138161211798999339; HANDLOSER CS, 1973, J CHEM EDUC, V50, P510, DOI 10.1021/ed050p510; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huys I, 2004, J BIOL CHEM, V279, P2781, DOI 10.1074/jbc.M311029200; Juers DH, 1999, PROTEIN SCI, V8, P122; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; Keller R., 2004, COMPUTER AIDED RESON, V1; Koide A, 2007, METH MOL B, V352, P95; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laederach A, 2002, BIOCHEMISTRY-US, V41, P12359, DOI 10.1021/bi026185z; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lombardo A, 1996, PROTEIN SCI, V5, P1934, DOI 10.1002/pro.5560050922; Mandard N, 2002, EUR J BIOCHEM, V269, P1190, DOI 10.1046/j.0014-2956.2002.02760.x; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; McCoy J., 2001, CURR PROTOC MOL BIOL, V16, P18; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ng YM, 2011, J STRUCT BIOL, V174, P164, DOI 10.1016/j.jsb.2010.12.007; Nicastro G, 2009, PROTEIN SCI, V18, P1786, DOI 10.1002/pro.168; Nirthanan S, 2005, BIOCHEM PHARMACOL, V69, P669, DOI 10.1016/j.bcp.2004.10.018; Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378; Oparin PB, 2012, BIOCHEM J, V446, P69, DOI 10.1042/BJ20120548; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Peigneur S, 2013, TOXICON, V71, P25, DOI 10.1016/j.toxicon.2013.05.010; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Rogozhin EA, 2012, PEPTIDES, V38, P33, DOI 10.1016/j.peptides.2012.08.009; Saucedo AL, 2012, J BIOL CHEM, V287, P12321, DOI 10.1074/jbc.M111.329607; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Slavokhotova AA, 2014, PLANT MOL BIOL, V84, P189, DOI 10.1007/s11103-013-0127-z; Song JX, 1997, BIOCHEMISTRY-US, V36, P3760, DOI 10.1021/bi962720h; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Utkina LL, 2013, FEBS J, V280, P3594, DOI 10.1111/febs.12349; Vandendriessche T, 2012, BIOCHEM PHARMACOL, V83, P1307, DOI 10.1016/j.bcp.2012.01.021; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563; Zhu LM, 2012, TOXICON, V59, P402, DOI 10.1016/j.toxicon.2011.11.016; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6	68	20	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14331	14340		10.1074/jbc.M113.530477	http://dx.doi.org/10.1074/jbc.M113.530477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671422	Green Published, hybrid			2022-12-28	WOS:000335984600058
J	Miyashita, A; Kizaki, H; Kawasaki, K; Sekimizu, K; Kaito, C				Miyashita, Atsushi; Kizaki, Hayato; Kawasaki, Kiyoshi; Sekimizu, Kazuhisa; Kaito, Chikara			Primed Immune Responses to Gram-negative Peptidoglycans Confer Infection Resistance in Silkworms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Immunology; Insect; Invertebrates; Jun N-terminal Kinase (JNK); Peptidoglycan; Silkworm; Tolerance	STAPHYLOCOCCUS-AUREUS VIRULENCE; DROSOPHILA; RECOGNITION; MEMORY; LARVAE; MODEL; IDENTIFICATION; PROTECTION; BACTERIA; INSECT	Background: Primed immune responses contribute to vertebrate host defense. Results: Silkworms acquire resistance to a pathogen by a preinjection of its heat-killed cells or its cell surface peptidoglycans. The amount of antimicrobial peptides is increased at the second round of infection. Conclusion: Invertebrates acquire infection resistance by peptidoglycan recognition and antimicrobial peptide increase. Significance: Molecular mechanisms of invertebrate primed immunity were revealed. A heightened immune response, in which immune responses are primed by repeated exposure to a pathogen, is an important characteristic of vertebrate adaptive immunity. In the present study, we examined whether invertebrate animals also exhibit a primed immune response. The LD50 of Gram-negative enterohemorrhagic Escherichia coli O157:H7 Sakai in silkworms was increased 100-fold by pre-injection of heat-killed Sakai cells. Silkworms pre-injected with heat-killed cells of a Gram-positive bacterium, Staphylococcus aureus, did not have resistance to Sakai. Silkworms preinjected with enterohemorrhagic E. coli peptidoglycans, cell surface components of bacteria, were resistant to Sakai infection. Silkworms preinjected with S. aureus peptidoglycans, however, were not resistant to Sakai. Silkworms preinjected with heat-killed Sakai cells showed persistent resistance to Sakai infection even after pupation. Repeated injection of heat-killed Sakai cells into the silkworms induced earlier and greater production of antimicrobial peptides than a single injection of heat-killed Sakai cells. These findings suggest that silkworm recognition of Gram-negative peptidoglycans leads to a primed immune reaction and increased resistance to a second round of bacterial infection.	[Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kawasaki, Kiyoshi] Doshisha Womens Coll, Fac Pharmaceut Sci, Microbiol Lab, Kyotanabe 6100395, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Japan Society for the Promotion of Science [25-8664]; Mochida Memorial Foundation; Genome Pharmaceuticals Institute;  [23249009];  [24590519];  [25117507]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation; Genome Pharmaceuticals Institute; ; ; 	This work was supported by Grants-in-aid for Scientific Research 23249009, 24590519, 25117507 and Japan Society for the Promotion of Science research fellowships for young scientists Grant 25-8664 (to A. M.). This study was also supported in part by the Mochida Memorial Foundation and the Genome Pharmaceuticals Institute.	Babayan SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001297; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hossain MS, 2006, J BIOCHEM, V140, P439, DOI 10.1093/jb/mvj171; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miyashita A, 2012, FEMS MICROBIOL LETT, V333, P59, DOI 10.1111/j.1574-6968.2012.02599.x; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009	27	18	19	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14412	14421		10.1074/jbc.M113.525139	http://dx.doi.org/10.1074/jbc.M113.525139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706746	Green Published, hybrid			2022-12-28	WOS:000335984600066
J	Ozeki, N; Mogi, M; Yamaguchi, H; Hiyama, T; Kawai, R; Hase, N; Nakata, K; Nakamura, H; Kramer, RH				Ozeki, Nobuaki; Mogi, Makio; Yamaguchi, Hideyuki; Hiyama, Taiki; Kawai, Rie; Hase, Naoko; Nakata, Kazuhiko; Nakamura, Hiroshi; Kramer, Randall H.			RETRACTED: Differentiation of Human Skeletal Muscle Stem Cells into Odontoblasts Is Dependent on Induction of alpha 1 Integrin Expression (Retracted article. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						Bone Morphogenetic Protein (BMP); Cell Adhesion; Cell Motility; Integrins; Stem Cells; Muscle; BMP-4; Odontoblast; Retinoic Acid	DENTAL-PULP; GENE-EXPRESSION; NEURAL CREST; TOOTH; BONE; ADHESION; MATRIX; MINERALIZATION; SIALOPROTEIN; REGENERATION	Background: Human skeletal muscle stem cells (hSMSCs) can differentiate into bone and fat cells. Results: hSMSCs could also differentiate into odontoblasts but required an extracellular matrix scaffold and changes in their integrin profile. Conclusion: The present results identify an odontoblast differentiation pathway dependent on adhesion receptor expression. Significance: The data provide insight into how hSMSC adhesion receptors interact with the microenvironment to regulate lineage specification. Skeletal muscle stem cells represent an abundant source of autologous cells with potential for regenerative medicine that can be directed to differentiate into multiple lineages including osteoblasts and adipocytes. In the current study, we found that 7 integrin-positive human skeletal muscle stem cells (7(+)hSMSCs) could differentiate into the odontoblast lineage under specific inductive conditions in response to bone morphogenetic protein-4 (BMP-4). Cell aggregates of FACS-harvested 7(+)hSMSCs were treated in suspension with retinoic acid followed by culture on a gelatin scaffold in the presence of BMP-4. Following this protocol, 7(+)hSMSCs were induced to down-regulate myogenic genes (MYOD and 7 integrin) and up-regulate odontogenic markers including dentin sialophosphoprotein, matrix metalloproteinase-20 (enamelysin), dentin sialoprotein, and alkaline phosphatase but not osteoblastic genes (osteopontin and osteocalcin). Following retinoic acid and gelatin scaffold/BMP-4 treatment, there was a coordinated switch in the integrin expression profile that paralleled odontoblastic differentiation where 11 integrin was strongly up-regulated with the attenuation of muscle-specific 71 integrin expression. Interestingly, using siRNA knockdown strategies revealed that the differentiation-related expression of the 1 integrin receptor positively regulates the expression of the odontoblastic markers dentin sialophosphoprotein and matrix metalloproteinase-20. These results strongly suggest that the differentiation of 7(+)hSMSCs along the odontogenic lineage is dependent on the concurrent expression of 1 integrin.	[Ozeki, Nobuaki; Yamaguchi, Hideyuki; Hiyama, Taiki; Kawai, Rie; Hase, Naoko; Nakata, Kazuhiko; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 4648651, Japan; [Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 4648650, Japan; [Kramer, Randall H.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	Aichi Gakuin University; Aichi Gakuin University; University of California System; University of California San Francisco	Kramer, RH (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	randall.kramer@ucsf.edu			National Institutes of Health [R01DE015404]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24659849, 22791853, 25253101]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE015404 (to R. K.). This work was also supported by Grant-in-aid for Exploratory Research 24659849 (to H. N.), Grant-in-aid for Young Scientists (B) 22791853 (to N. O.), and Grant-in-aid for Scientific Research (A) 25253101 (to N. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aguiar MC, 2007, J ANAT, V210, P418, DOI 10.1111/j.1469-7580.2007.00708.x; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Casagrande L, 2010, J DENT RES, V89, P603, DOI 10.1177/0022034510364487; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huo N, 2010, STEM CELLS DEV, V19, P93, DOI 10.1089/scd.2009.0048; Huojia M, 2005, DEV GROWTH DIFFER, V47, P141; Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Lee HK, 2012, GENE EXPR PATTERNS, V12, P102, DOI 10.1016/j.gep.2012.02.002; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; MacDougall M, 1998, EUR J ORAL SCI, V106, P227, DOI 10.1111/j.1600-0722.1998.tb02180.x; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Noguchi F, 2009, J ENDODONT, V35, P668, DOI 10.1016/j.joen.2009.01.016; Oh SH, 2012, J DENT RES, V91, P1124, DOI 10.1177/0022034512461916; Ozeki N, 2007, BIOCHEM BIOPH RES CO, V353, P54, DOI 10.1016/j.bbrc.2006.11.110; Ozeki N, 2006, EXP CELL RES, V312, P4162, DOI 10.1016/j.yexcr.2006.09.017; Pawlikowski B, 2009, DEV DYNAM, V238, P138, DOI 10.1002/dvdy.21833; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Roberts AI, 1999, IMMUNOLOGY, V97, P679; Salmela E, 2012, CELLS TISSUES ORGANS, V195, P287, DOI 10.1159/000327529; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Simon S, 2009, BONE, V45, P693, DOI 10.1016/j.bone.2009.06.018; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Vizirianakis IS, 2001, ARCH BIOCHEM BIOPHYS, V385, P108, DOI 10.1006/abbi.2000.2134; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yan ZB, 2006, CELLS TISSUES ORGANS, V183, P123, DOI 10.1159/000095986; Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097; Yu YC, 2011, MOL CELL BIOCHEM, V351, P85, DOI 10.1007/s11010-011-0714-8; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	54	23	23	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14380	14391		10.1074/jbc.M113.526772	http://dx.doi.org/10.1074/jbc.M113.526772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692545	hybrid, Green Published			2022-12-28	WOS:000335984600063
J	Sasi, SP; Song, J; Park, D; Enderling, H; McDonald, JT; Gee, H; Garrity, B; Shtifman, A; Yan, XH; Walsh, K; Natarajan, M; Kishore, R; Goukassian, DA				Sasi, Sharath P.; Song, Jin; Park, Daniel; Enderling, Heiko; McDonald, J. Tyson; Gee, Hannah; Garrity, Brittany; Shtifman, Alexander; Yan, Xinhua; Walsh, Kenneth; Natarajan, Mohan; Kishore, Raj; Goukassian, David A.			TNF-TNFR2/p75 Signaling Inhibits Early and Increases Delayed Nontargeted Effects in Bone Marrow-derived Endothelial Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; DNA Damage Response; Radiation Biology; Receptors; Tumor Necrosis Factor (TNF); Nontargeted Effects	NECROSIS-FACTOR-ALPHA; INDUCED GENOMIC INSTABILITY; MEDIATED INTERCELLULAR COMMUNICATION; GLOBAL GENE-EXPRESSION; IONIZING-RADIATION; TNF-ALPHA; HUMAN FIBROBLASTS; IN-VIVO; KAPPA-B; CHROMOSOMAL INSTABILITY	Background: Ionizing radiation can induce DNA damage in nonirradiated (N-IR) cells via nontargeted effects (NTE). Results: TNF- and IL-1 mediate NTE in N-IR bone marrow-derived EPCs, and neutralizing TNF- diminishes NTE in WT and p55 knock-out BM-EPCs. Conclusion: TNF-TNFR2/p75 signaling alters accumulation of inflammatory cytokines that attenuate NTE in N-IR EPCs. Significance: TNFR2/p75 may represent a gene target for mitigation of delayed RBR in BM-EPCs. TNF-, a pro-inflammatory cytokine, is highly expressed after being irradiated (IR) and is implicated in mediating radiobiological bystander responses (RBRs). Little is known about specific TNF receptors in regulating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs). Full body -IR WT BM-EPCs showed a biphasic response: slow decay of p-H2AX foci during the initial 24 h and increase between 24 h and 7 days post-IR, indicating a significant RBR in BM-EPCs in vivo. Individual TNF receptor (TNFR) signaling in RBR was evaluated in BM-EPCs from WT, TNFR1/p55KO, and TNFR2/p75KO mice, in vitro. Compared with WT, early RBR (1-5 h) were inhibited in p55KO and p75KO EPCs, whereas delayed RBR (3-5 days) were amplified in p55KO EPCs, suggesting a possible role for TNFR2/p75 signaling in delayed RBR. Neutralizing TNF in -IR conditioned media (CM) of WT and p55KO BM-EPCs largely abolished RBR in both cell types. ELISA protein profiling of WT and p55KO EPC -IR-CM over 5 days showed significant increases in several pro-inflammatory cytokines, including TNF-, IL-1 (Interleukin-1 alpha), RANTES (regulated on activation, normal T cell expressed and secreted), and MCP-1. In vitro treatments with murine recombinant (rm) TNF- and rmIL-1, but not rmMCP-1 or rmRANTES, increased the formation of p-H2AX foci in nonirradiated p55KO EPCs. We conclude that TNF-TNFR2 signaling may induce RBR in naive BM-EPCs and that blocking TNF-TNFR2 signaling may prevent delayed RBR in BM-EPCs, conceivably, in bone marrow milieu in general.	[Sasi, Sharath P.; Song, Jin; Park, Daniel; Gee, Hannah; Garrity, Brittany; Shtifman, Alexander; Yan, Xinhua; Goukassian, David A.] Steward Res & Specialty Projects Corp, Cardiovasc Res Ctr, Brighton, MA 02135 USA; [Enderling, Heiko; McDonald, J. Tyson; Yan, Xinhua] GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02135 USA; [Enderling, Heiko] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA; [Enderling, Heiko; McDonald, J. Tyson; Shtifman, Alexander; Yan, Xinhua; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Walsh, Kenneth; Goukassian, David A.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Natarajan, Mohan] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Tufts University; Boston University; University of Texas System; University of Texas Health San Antonio; Northwestern University	Goukassian, DA (corresponding author), Tufts Univ, Sch Med, GeneSys Res Inst, 736 Cambridge St,CBR 340, Brighton, MA 02135 USA.	david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270; McDonald, John/0000-0003-4300-6827	National Aeronautic and Space Administration [NNJ10ZSA001N]; AHA [14GRNT18860032, 10GRNT4710003]; NHLBI [HL106098]; NIH [HL091983]; NASA [NNX11AK26G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); AHA(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by the National Aeronautic and Space Administration under Grant No. NNJ10ZSA001N and AHA Grant No. 14GRNT18860032 to D. A. G. and in part by grants from AHA 10GRNT4710003 and NHLBI HL106098 to X. Y., NIH HL091983 to R. K. and NASA NNX11AK26G to Dr. L. Hlatky.	Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Ansari R, 2007, RADIAT RES, V167, P80, DOI 10.1667/RR0616.1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Averbeck D, 2010, MUTAT RES-FUND MOL M, V687, P7, DOI 10.1016/j.mrfmmm.2010.01.004; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Barbara JAJ, 1996, IMMUNOL CELL BIOL, V74, P434, DOI 10.1038/icb.1996.73; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burr KL, 2010, RADIAT RES, V173, P760, DOI 10.1667/RR1937.1; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Daigle JL, 2001, CANCER RES, V61, P8859; Djordjevic B, 2000, BIOESSAYS, V22, P286, DOI 10.1002/(SICI)1521-1878(200003)22:3<286::AID-BIES10>3.3.CO;2-J; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Gill M, 2001, CIRC RES, V88, P167; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Ihnatko R, 2007, GEN PHYSIOL BIOPHYS, V26, P159; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; JACOBSEN SEW, 1994, STEM CELLS, V12, P111; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Ksontini R, 1998, ARCH SURG-CHICAGO, V133, P558, DOI 10.1001/archsurg.133.5.558; Lee CM, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-30; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Little JB, 2006, HEALTH PHYS, V91, P416, DOI 10.1097/01.HP.0000232847.23192.3e; Little JB, 2006, MUTAT RES-FUND MOL M, V597, P113, DOI 10.1016/j.mrfmmm.2005.12.001; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Mitchell SA, 2004, INT J RADIAT BIOL, V80, P465, DOI 10.1080/09553000410001725116; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2006, RADIAT RES, V165, P26, DOI 10.1667/RR3488.1; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pandey R, 2005, INT J RADIAT BIOL, V81, P801, DOI 10.1080/09553000500531886; Pastorino F, 2008, J CONTROL RELEASE, V126, P85, DOI 10.1016/j.jconrel.2007.11.010; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Rastogi S, 2012, RADIAT RES, V177, P244, DOI 10.1667/RR2805.1; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Sasi SP, 2012, ONCOGENE, V31, P4117, DOI 10.1038/onc.2011.567; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Seed TM, 2002, ADV SPACE RES, V30, P945, DOI 10.1016/S0273-1177(02)00159-X; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; SHERMAN ML, 1991, J CLIN INVEST, V87, P1794, DOI 10.1172/JCI115199; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Todd P, 1999, MUTAT RES-FUND MOL M, V430, P211, DOI 10.1016/S0027-5107(99)00132-3; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VANOS R, 1993, INT J RADIAT BIOL, V64, P761, DOI 10.1080/09553009314552011; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Watson GE, 2000, CANCER RES, V60, P5608; Watson GE, 2001, INT J RADIAT BIOL, V77, P409, DOI 10.1080/09553000010028476; Westbrook AM, 2012, MUTAGENESIS, V27, P77, DOI 10.1093/mutage/ger063; Wright EG, 1998, INT J RADIAT BIOL, V74, P681, DOI 10.1080/095530098140943; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Yang HY, 2011, INT J RADIAT BIOL, V87, P311, DOI 10.3109/09553002.2010.537431; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	96	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14178	14193		10.1074/jbc.M114.567743	http://dx.doi.org/10.1074/jbc.M114.567743			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711449	Green Published, hybrid			2022-12-28	WOS:000335984600045
J	Ikari, A; Tonegawa, C; Sanada, A; Kimura, T; Sakai, H; Hayashi, H; Hasegawa, H; Yamaguchi, M; Yamazaki, Y; Endo, S; Matsunaga, T; Sugatani, J				Ikari, Akira; Tonegawa, Chie; Sanada, Ayumi; Kimura, Toru; Sakai, Hideki; Hayashi, Hisayoshi; Hasegawa, Hajime; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Endo, Satoshi; Matsunaga, Toshiyuki; Sugatani, Junko			Tight Junctional Localization of Claudin-16 Is Regulated by Syntaxin 8 in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Kidney; Magnesium Homeostasis; Tight Junctions; Trafficking; Claudin; Syntaxin	THICK ASCENDING LIMB; PROTEIN-KINASE-A; MAGNESIUM TRANSPORT; HYPERTENSIVE-RATS; MEDIATED PATHWAY; MEMBRANE-FUSION; SODIUM-CHANNEL; MG2+ TRANSPORT; HENLES LOOP; TRAFFICKING	Background: Disease-associated claudin-16 mutants cause mislocalization and decrease reabsorption of Mg2+ in the kidney. Results: Knockdown of syntaxin 8 in kidney cells decreased the tight junctional localization of claudin-16 in parallel with a decrease in Mg2+ permeability. Conclusion: Syntaxin 8 controls the localization of claudin-16. Significance: Our findings provide a new insight into the trafficking mechanism of tight junctional proteins. Claudin-16 (CLDN16) regulates the paracellular reabsorption of Mg2+ in the thick ascending limb of Henle's loop. However, the mechanism regulating the tight junctional localization of CLDN16 remains unknown. In yeast two-hybrid systems, we found that CLDN16 bound to syntaxin 8 (STX8), a target soluble N-ethylmaleimide-sensitive factor attachment protein receptor. We have examined the effect of STX8 on the localization and function of CLDN16 using Madin-Darby canine kidney cells expressing FLAG-tagged CLDN16. A pulldown assay showed that the carboxyl cytoplasmic region of human CLDN16 bound to STX8. CLDN16 was localized in the thick ascending limb, whereas STX8 was widely distributed throughout the rat kidney. An association between CLDN16 and STX8 was observed in rat renal homogenates and Madin-Darby canine kidney cells. STX8 siRNA decreased the cell surface localization of CLDN16 and transepithelial electrical resistance and permeability to Mg2+ but increased the co-localization of CLDN16 with early endosome and lysosome markers. Dephosphorylation of CLDN16 by protein kinase A inhibitors and S217A mutant, a dephosphorylated form, decreased the association with STX8 and the cell surface localization of CLDN16. Recycling assays indicated that STX8 siRNA decreased the trafficking of CLDN16 to the plasma membrane without affecting endocytosis. Dominant negative Rab11 and recycling inhibitor primaquine decreased the cell surface localization of CLDN16, which was similar to that in STX8 siRNA-transfected cells. These results suggest that STX8 mediates the recycling of CLDN16 and constitutes an important component of the CLDN16 trafficking machinery in the kidney.	[Ikari, Akira; Endo, Satoshi; Matsunaga, Toshiyuki] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, Gifu 5011196, Japan; [Ikari, Akira; Tonegawa, Chie; Sanada, Ayumi; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Kimura, Toru] Kyorin Univ, Sch Med, Tokyo 1818611, Japan; [Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Hayashi, Hisayoshi] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Hasegawa, Hajime] Saitama Med Univ, Saitama Med Ctr, Saitama 3508550, Japan	Gifu Pharmaceutical University; University of Shizuoka; Kyorin University; University of Toyama; University of Shizuoka; Saitama Medical University	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Hayashi, Hisayoshi/K-5883-2013; Endo, Satoshi/F-8059-2011	Endo, Satoshi/0000-0003-0578-9672	Japan Society for the Promotion of Science KAKENHI [23590263]; Salt Science Research Foundation [1124]; Takeda Science Foundation; Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research [23590263] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science KAKENHI 23590263 and by grants from the Salt Science Research Foundation (1124), Takeda Science Foundation, and Research Foundation for Pharmaceutical Sciences (to A. I.).	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Cayouette S, 2010, BBA-MOL CELL RES, V1803, P805, DOI 10.1016/j.bbamcr.2010.03.010; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Gunzel D, 2009, ANN NY ACAD SCI, V1165, P152, DOI 10.1111/j.1749-6632.2009.04051.x; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Ikari A, 2004, J BIOL CHEM, V279, P54826, DOI 10.1074/jbc.M406331200; Ikari A, 2001, BIOCHEM BIOPH RES CO, V287, P671, DOI 10.1006/bbrc.2001.5644; Ikari A, 2008, BBA-BIOMEMBRANES, V1778, P283, DOI 10.1016/j.bbamem.2007.10.002; Ikari A, 2008, J CELL PHYSIOL, V214, P221, DOI 10.1002/jcp.21178; Ikari A, 2006, J PHYSIOL SCI, V56, P379, DOI 10.2170/physiolsci.SC008906; Ikari A, 2013, BBA-MOL CELL RES, V1833, P2617, DOI 10.1016/j.bbamcr.2013.06.016; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Murata M, 2005, CELL TISSUE RES, V319, P341, DOI 10.1007/s00441-004-1017-0; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Ohta H, 2006, J VET MED SCI, V68, P453, DOI 10.1292/jvms.68.453; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Quamme GA, 2000, FRONT BIOSCI-LANDMRK, V5, pD694, DOI 10.2741/Quamme; Saxena S, 1999, J BIOL CHEM, V274, P20812, DOI 10.1074/jbc.274.30.20812; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Subramaniam VN, 2000, J CELL SCI, V113, P997; Touyz RM, 1999, AM J HYPERTENS, V12, P757, DOI 10.1016/S0895-7061(99)00064-3; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; WHELTON PK, 1989, AM J CARDIOL, V63, pG26, DOI 10.1016/0002-9149(89)90215-4; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	47	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13112	13123		10.1074/jbc.M113.541193	http://dx.doi.org/10.1074/jbc.M113.541193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659781	Green Published, hybrid			2022-12-28	WOS:000335522800013
J	Guan, BJ; Krokowski, D; Majumder, M; Schmotzer, CL; Kimball, SR; Merrick, WC; Koromilas, AE; Hatzoglou, M				Guan, Bo-Jhih; Krokowski, Dawid; Majumder, Mithu; Schmotzer, Christine L.; Kimball, Scot R.; Merrick, William C.; Koromilas, Antonis E.; Hatzoglou, Maria			Translational Control during Endoplasmic Reticulum Stress beyond Phosphorylation of the Translation Initiation Factor eIF2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Endoplasmic Reticulum Stress; Gene Expression; Translation Control; Unfolded Protein Response; ATF4; eIF2; Integrated Stress Response; p62; Sequestosome; Autophagy	UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; INDUCED GENE-EXPRESSION; AMINO-ACID-TRANSPORT; ER-STRESS; RIBOSOMAL-RNA; SIGNAL INTEGRATION; CELL-SURVIVAL; RAG GTPASES; S6 KINASE	Background: Chronic ER stress suppresses mTORC1 activity. Results: mTORC1-mediated suppression of translation during chronic ER stress is independent of the stress-induced eIF2-P/ATF4 signaling. Conclusion: The eIF2-P/ATF4-induced network of amino acid transporters promotes protein synthesis in part by increasing mTORC1-mediated translational control. Significance: The eIF2-P/ATF4/mTORC1 network controls protein synthesis rates during chronic ER stress and mediates the degree of stress response and survival outcomes. The accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER) causes stress to which an unfolded protein response is activated to render cell survival or apoptosis (chronic stress). Transcriptional and translational reprogramming is tightly regulated during the unfolded protein response to ensure specific gene expression. The master regulator of this response is the PERK/eIF2/ATF4 signaling where eIF2 is phosphorylated (eIF2-P) by the kinase PERK. This signal leads to global translational shutdown, but it also enables translation of the transcription factor ATF4 mRNA. We showed recently that ATF4 induces an anabolic program through the up-regulation of selected amino acid transporters and aminoacyl-tRNA synthetases. Paradoxically, this anabolic program led cells to apoptosis during chronic ER stress in a manner that involved recovery from stress-induced protein synthesis inhibition. By using eIF2-P-deficient cells as an experimental system, we identified a communicating network of signaling pathways that contribute to the inhibition of protein synthesis during chronic ER stress. This eIF2-P-independent network includes (i) inhibition of mammalian target of rapamycin kinase protein complex 1 (mTORC1)-targeted protein phosphorylation, (ii) inhibited translation of a selective group of 5-terminal oligopyrimidine mRNAs (encoding proteins involved in the translation machinery and translationally controlled by mTORC1 signaling), and (iii) inhibited translation of non-5-terminal oligopyrimidine ribosomal protein mRNAs and ribosomal RNA biogenesis. We propose that the PERK/eIF2-P/ATF4 signaling acts as a brake in the decline of protein synthesis during chronic ER stress by positively regulating signaling downstream of the mTORC1 activity. These studies advance our knowledge on the complexity of the communicating signaling pathways in controlling protein synthesis rates during chronic stress.	[Guan, Bo-Jhih; Krokowski, Dawid; Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Schmotzer, Christine L.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Merrick, William C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Koromilas, Antonis E.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lady Davis Institute; McGill University; McGill University	Krokowski, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	dmk102@case.edu; mxh8@case.edu			National Institutes of Health [R37-DK060596, R01-DK053307, R01-DK013499]; Canadian Institutes of Health Research [MOP-38160]; Quebec Breast Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK013499, R37DK060596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Breast Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK060596 and R01-DK053307 (to M. H.) and R01-DK013499 (to S. R. K.). This work was also supported by Canadian Institutes of Health Research Grant MOP-38160 (to A. E. K.) and a Quebec Breast Cancer Foundation grant (to A. E. K.).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; BARBER EF, 1983, J BIOL CHEM, V258, P1851; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Buel GR, 2013, CELL METAB, V17, P633, DOI 10.1016/j.cmet.2013.04.018; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Conn CS, 2011, CELL CYCLE, V10, P1940, DOI 10.4161/cc.10.12.15858; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kimball SR, 2005, SEMIN CELL DEV BIOL, V16, P21, DOI 10.1016/j.semcdb.2004.11.009; Kimball SR, 2002, J NUTR, V132, P883; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Koromilas AE, 2013, FUTURE ONCOL, V9, P1005, DOI [10.2217/fon.13.49, 10.2217/FON.13.49]; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Kubica N, 2006, PROG NUCLEIC ACID RE, V81, P271, DOI 10.1016/S0079-6603(06)81007-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Reiling JH, 2008, MOL CELL, V29, P533, DOI 10.1016/j.molcel.2008.02.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang H, 1996, J VIROL, V70, P6884, DOI 10.1128/JVI.70.10.6884-6891.1996; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	98	90	96	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12593	12611		10.1074/jbc.M113.543215	http://dx.doi.org/10.1074/jbc.M113.543215			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648524	Green Published, hybrid			2022-12-28	WOS:000335581400032
J	Unno, H; Goda, S; Hatakeyama, T				Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu			Hemolytic Lectin CEL-III Heptamerizes via a Large Structural Transition from alpha- Helices to a beta- Barrel during the Transmembrane Pore Formation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Lectin; Membrane; Toxins; X-ray Crystallography; -Barrel; Hemolysin; Oligomer; Pore-forming Toxin	INVERTEBRATE CUCUMARIA-ECHINATA; CRYSTAL-STRUCTURE; OLIGOMERIZATION; FEATURES; REVEALS; BINDING	Background: The hemolytic lectin CEL-III self-oligomerizes upon binding to cell surface carbohydrates to form transmembrane pores. Results: The CEL-III oligomer crystal structure revealed a membrane-inserted pore structure. Conclusion: CEL-III forms a heptamer containing a long -barrel as the pore structure, resulting from large conformational changes. Significance: The heptameric structure of CEL-III provides insights into the action mechanisms of pore-forming proteins. CEL-III is a hemolytic lectin isolated from the sea cucumber Cucumaria echinata. This lectin is composed of two carbohydrate-binding domains (domains 1 and 2) and one oligomerization domain (domain 3). After binding to the cell surface carbohydrate chains through domains 1 and 2, domain 3 self-associates to form transmembrane pores, leading to cell lysis or death, which resembles other pore-forming toxins of diverse organisms. To elucidate the pore formation mechanism of CEL-III, the crystal structure of the CEL-III oligomer was determined. The CEL-III oligomer has a heptameric structure with a long -barrel as a transmembrane pore. This -barrel is composed of 14 -strands resulting from a large structural transition of -helices accommodated in the interface between domains 1 and 2 and domain 3 in the monomeric structure, suggesting that the dissociation of these -helices triggered their structural transition into a -barrel. After heptamerization, domains 1 and 2 form a flat ring, in which all carbohydrate-binding sites remain bound to cell surface carbohydrate chains, stabilizing the transmembrane -barrel in a position perpendicular to the plane of the lipid bilayer.	[Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu] Nagasaki Univ, Grad Sch Engn, Lab Biomol Chem, Nagasaki 8528521, Japan	Nagasaki University	Hatakeyama, T (corresponding author), Nagasaki Univ, Grad Sch Engn, Lab Biomol Chem, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X; Hatakeyama, Tomomitsu/0000-0002-9505-1980	Japan Society for the Promotion of Science [23580137, 24570135, 25450133]; Grants-in-Aid for Scientific Research [25450133] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (C) 23580137 (to T. H.) and Grants-in-aid for Young Scientists (B) 24570135 (to H. U.) and 25450133 (to S. G.) from the Japan Society for the Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujisawa T, 1997, FEBS LETT, V414, P79, DOI 10.1016/S0014-5793(97)00976-9; Goda S, 2013, BIOSCI BIOTECH BIOCH, V77, P679, DOI 10.1271/bbb.120981; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 1996, J BIOL CHEM, V271, P16915, DOI 10.1074/jbc.271.28.16915; Hatakeyama T, 2007, J BIOL CHEM, V282, P37826, DOI 10.1074/jbc.M705604200; Hisamatsu K, 2013, BBA-GEN SUBJECTS, V1830, P4211, DOI 10.1016/j.bbagen.2013.04.010; Hisamatsu K, 2009, PROTEIN PEPTIDE LETT, V16, P411, DOI 10.2174/092986609787848054; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Unno H, 2013, ACTA CRYSTALLOGR F, V69, P416, DOI 10.1107/S1744309113004065; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	32	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12805	12812		10.1074/jbc.M113.541896	http://dx.doi.org/10.1074/jbc.M113.541896			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652284	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000335581400049
J	Chen, X; Khambu, B; Zhang, H; Gao, WT; Li, M; Chen, XY; Yoshimori, T; Yin, XM				Chen, Xi; Khambu, Bilon; Zhang, Hao; Gao, Wentao; Li, Min; Chen, Xiaoyun; Yoshimori, Tamotsu; Yin, Xiao-Ming			Autophagy Induced by Calcium Phosphate Precipitates Targets Damaged Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Signaling; Endosomes; Lysosomes; Signaling; Autophagosome; Calcium Phosphate Precipitate; Endosomal Damage	MEDIATED GENE-TRANSFER; MAMMALIAN-CELLS; DNA; MEMBRANE; CHOLESTEROL; UBIQUITIN; RECRUITMENT; MECHANISMS; MATURATION; INHIBITORS	Background: Relationship of autophagosomes with endosomal vesicles varies in different conditions. Results: Calcium phosphate precipitates required endocytosis to induce autophagy, caused endosome damage, and recruited autophagosomes to the damaged vesicles. Conclusion: Damaged endosomes can be targeted by autophagosomes. Significance: Autophagy may play a role in endosomal homeostasis. Calcium phosphate precipitates (CPPs) form complexes with DNA, which enter cells via endocytosis. Under this condition CPPs induce autophagy via the canonic autophagy machinery. Here we showed that CPP-induced autophagy was also dependent on endocytosis as the process was significantly inhibited by methyl--cyclodextrin and dynasore, which suppress clathrin-dependent endocytosis. Consistently, CPP treatment triggered the formation of filipin-positive intracellular vesicles whose membranes are rich in cholesterol. Unexpectedly, these vesicles were also positive for galectin 3, suggesting that they were damaged and the membrane glycans became accessible to galectins to bind. Endosome damage was caused by endocytosis of CPPs and was reversed by calcium chelators or by endocytosis inhibitors. Notably, CPP-induced LC3-positive autophagosomes were colocalized with galectin 3, ubiquitin, and p62/SQSTM1. Inhibition of galectin 3 reduced p62 puncta and autophagosome formation. Knockdown of p62 additionally inhibited the colocalization of autophagosomes with galectins. Furthermore, most of the galectin 3-positive vesicles were colocalized with Rab7 or LAMP1. Agents that affect endosome/lysosome maturation and function, such as bafilomycin A(1), also significantly affected CPP-induced tubulovesicular autophagosome formation. These findings thus indicate that endocytosed CPPs caused endosome damage and recruitment of galectins, particularly at the later endosome stage, which led to the interaction of the autophagosomal membranes with the damaged endosome in the presence of p62.	[Chen, Xi] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Chen, Xi; Khambu, Bilon; Zhang, Hao; Li, Min; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Gao, Wentao] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15261 USA; [Li, Min] Sun Yat Sen Univ, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Suita, Osaka 5650871, Japan	Zhejiang University; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sun Yat Sen University; Osaka University	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, W 350 11th St, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Li, Min/B-1281-2011; Khambu, Bilon/P-6148-2019	Khambu, Bilon/0000-0002-9432-2064	National Institutes of Health from the NCI [R01CA111456, R01CA 83817]; National Institute of Mental Health; NATIONAL CANCER INSTITUTE [R01CA111456, R01CA083817] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26251020] Funding Source: KAKEN	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111456 and R01CA 83817 from the NCI and the National Institute of Mental Health (to X.-M. Y).	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052347; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; EGE T, 1984, EXP CELL RES, V155, P9, DOI 10.1016/0014-4827(84)90762-6; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; GINSBACH C, 1987, HISTOCHEMISTRY, V86, P241, DOI 10.1007/BF00490254; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Lechardeur Delphine, 2002, Current Gene Therapy, V2, P183, DOI 10.2174/1566523024605609; LOYTER A, 1982, EXP CELL RES, V139, P223, DOI 10.1016/0014-4827(82)90336-6; LOYTER A, 1982, P NATL ACAD SCI-BIOL, V79, P422, DOI 10.1073/pnas.79.2.422; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Man N, 2010, AUTOPHAGY, V6, P449, DOI 10.4161/auto.6.4.11612; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; ORRANTIA E, 1990, EXP CELL RES, V190, P170, DOI 10.1016/0014-4827(90)90181-9; ORRANTIA E, 1990, SOMAT CELL MOLEC GEN, V16, P305, DOI 10.1007/BF01232458; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Roberts R, 2013, AUTOPHAGY, V9, P667, DOI 10.4161/auto.23877; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831	40	59	60	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11162	11174		10.1074/jbc.M113.531855	http://dx.doi.org/10.1074/jbc.M113.531855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619419	Green Published, hybrid			2022-12-28	WOS:000334638500020
J	Kizuka, Y; Kitazume, S; Okahara, K; Villagra, A; Sotomayor, EM; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Okahara, Kyohei; Villagra, Alejandro; Sotomayor, Eduardo M.; Taniguchi, Naoyuki			Epigenetic Regulation of a Brain-specific Glycosyltransferase N-Acetylglucosaminyltransferase-IX ( GnT-IX) by Specific Chromatin Modifiers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Glycobiology; Glycosyltransferases; Histone Deacetylase; O-GlcNAc; Transcription; GnT-IX; NeuroD1; TET3	O-GLCNAC TRANSFERASE; HISTONE DEACETYLASE; GENE-EXPRESSION; TET PROTEINS; IN-VIVO; GLCNACYLATION; OGT; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; GLYCOSYLATION	Background: Epigenetic mechanisms of regulating expression of glycosyltransferase genes are largely unknown. Results: Novel epigenetic factors were identified that specifically regulate a brain-specific glycosyltransferase gene, GnT-IX (Mgat5b). Conclusion:GnT-IX is epigenetically regulated by a combination of specific chromatin modifiers (HDAC11, OGT, and TET3) and a transcriptional factor NeuroD1. Significance: This is the first study showing that a glycosyltransferase gene is regulated by another glycosyltransferase, OGT, in combination with histone modifications. Expression of glycosyltransferase genes is essential for glycosylation. However, the detailed mechanisms of how glycosyltransferase gene expression is regulated in a specific tissue or during disease progression are poorly understood. In particular, epigenetic studies of glycosyltransferase genes are limited, although epigenetic mechanisms, such as histone and DNA modifications, are central to establish tissue-specific gene expression. We previously found that epigenetic histone activation is essential for brain-specific expression of N-acetylglucosaminyltransferase-IX (GnT-IX, also designated GnT-Vb), but the mechanism of brain-specific chromatin activation around GnT-IX gene (Mgat5b) has not been clarified. To reveal the mechanisms regulating the chromatin surrounding GnT-IX, we have investigated the epigenetic factors that are specifically involved with the mouse GnT-IX locus by comparing their involvement with other glycosyltransferase loci. We first found that a histone deacetylase (HDAC) inhibitor enhanced the expression of GnT-IX but not of other glycosyltransferases tested. By overexpression and knockdown of a series of HDACs, we found that HDAC11 silenced GnT-IX. We also identified the O-GlcNAc transferase (OGT) and ten-eleven translocation-3 (TET3) complex as a specific chromatin activator of GnT-IX gene. Moreover, chromatin immunoprecipitation (ChIP) analysis in combination with OGT or TET3 knockdown showed that this OGT-TET3 complex facilitates the binding of a potent transactivator, NeuroD1, to the GnT-IX promoter, suggesting that epigenetic chromatin activation by the OGT-TET3 complex is a prerequisite for the efficient binding of NeuroD1. These results reveal a new epigenetic mechanism of brain-specific GnT-IX expression regulated by defined chromatin modifiers, providing new insights into the tissue-specific expression of glycosyltransferases.	[Kizuka, Yasuhiko; Kitazume, Shinobu; Okahara, Kyohei; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Villagra, Alejandro; Sotomayor, Eduardo M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33613 USA	RIKEN; H Lee Moffitt Cancer Center & Research Institute	Taniguchi, N (corresponding author), RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Ctr Syst Chem Biol, Dis Glyc Team,Syst Glycobiol Res Grp,Global Res C, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743; Villagra, Alejandro/0000-0001-9346-8355	RIKEN (Systems Glycobiology Research Project); Japan Society for the Promotion of Science (JSPS) (KAKENHI) [23770163]; Grants-in-Aid for Scientific Research [23770163] Funding Source: KAKEN	RIKEN (Systems Glycobiology Research Project); Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by RIKEN (Systems Glycobiology Research Project) (to N. T.) and Japan Society for the Promotion of Science (JSPS) (KAKENHI Grant 23770163).	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Horvat T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054672; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Inamori KI, 2006, BBA-GEN SUBJECTS, V1760, P678, DOI 10.1016/j.bbagen.2005.11.019; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Lopez-Atalaya JP, 2013, NUCLEIC ACIDS RES, V41, P8072, DOI 10.1093/nar/gkt590; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Miyoshi E, 1997, INT J CANCER, V72, P1117; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Taniguchi N, 2009, J BIOL CHEM, V284, P34469, DOI 10.1074/jbc.X109.023150; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	49	37	37	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11253	11261		10.1074/jbc.M114.554311	http://dx.doi.org/10.1074/jbc.M114.554311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619417	hybrid, Green Published			2022-12-28	WOS:000334638500028
J	Parente, J; Casabuono, A; Ferrari, MC; Paggi, RA; De Castro, RE; Couto, AS; Gimenez, MI				Parente, Juliana; Casabuono, Adriana; Celeste Ferrari, Maria; Alejandro Paggi, Roberto; Esther De Castro, Rosana; Susana Couto, Alicia; Ines Gimenez, Maria			A Rhomboid Protease Gene Deletion Affects a Novel Oligosaccharide N-Linked to the S-layer Glycoprotein of Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Glycoprotein; Glycosylation; Mass Spectrometry (MS); Rhomboid Protease; Halophiles	INTRAMEMBRANE PROTEOLYSIS; GLYCOSYLATION PATHWAY; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; GROWTH; SMART; RNA	Background: Rhomboid proteases are ubiquitous, and their role in Archaea has not been explored. Results: We generated a rhomboid deletion mutant that displayed a glycosylation defect. Conclusion: Deletion of a rhomboid protease gene altered S-layer glycoprotein N-glycosylation. Significance: This work provides structural characterization of a novel oligosaccharide bound to H. volcanii S-layer glycoprotein and relates a rhomboid protease with the protein glycosylation process. Rhomboid proteases occur in all domains of life; however, their physiological role is not completely understood, and nothing is known of the biology of these enzymes in Archaea. One of the two rhomboid homologs of Haloferax volcanii (RhoII) is fused to a zinc finger domain. Chromosomal deletion of rhoII was successful, indicating that this gene is not essential for this organism; however, the mutant strain (MIG1) showed reduced motility and increased sensitivity to novobiocin. Membrane preparations of MIG1 were enriched in two glycoproteins, identified as the S-layer glycoprotein and an ABC transporter component. The H. volcanii S-layer glycoprotein has been extensively used as a model to study haloarchaeal protein N-glycosylation. HPLC analysis of oligosaccharides released from the S-layer glycoprotein after PNGase treatment revealed that MIG1 was enriched in species with lower retention times than those derived from the parent strain. Mass spectrometry analysis showed that the wild type glycoprotein released a novel oligosaccharide species corresponding to GlcNAc-GlcNAc(Hex)(2)-(SQ-Hex)(6) in contrast to the mutant protein, which contained the shorter form GlcNAc(2)(Hex)(2)-SQ-Hex-SQ. A glycoproteomics approach of the wild type glycopeptide fraction revealed Asn-732 peptide fragments linked to the sulfoquinovose-containing oligosaccharide. This work describes a novel N-linked oligosaccharide containing a repeating SQ-Hex unit bound to Asn-732 of the H. volcanii S-layer glycoprotein, a position that had not been reported as glycosylated. Furthermore, this study provides the first insight on the biological role of rhomboid proteases in Archaea, suggesting a link between protein glycosylation and this protease family.	[Parente, Juliana; Casabuono, Adriana; Susana Couto, Alicia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina; [Celeste Ferrari, Maria; Alejandro Paggi, Roberto; Esther De Castro, Rosana; Ines Gimenez, Maria] Univ Nacl Mar del Plata, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol, RA-7600 Mar Del Plata, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Gimenez, MI (corresponding author), Univ Nacl Mar del Plata, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol, Funes 3250 4To Nivel, RA-7600 Mar Del Plata, Buenos Aires, Argentina.	migimen@mdp.edu.ar		Paggi, Roberto/0000-0003-0059-9343	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-1783, 1548]; Universidad Nacional de Mar del Plata Grant [Exa 454/09]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-01824]; Universidad de Buenos Aires Grant [20020100100517]; ANPCyT [PME 125]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Mar del Plata Grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires Grant; ANPCyT(ANPCyT)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grants PIP-1783 and 1548, Universidad Nacional de Mar del Plata Grant Exa 454/09 (to R. E. D. C.), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-01824 (to M. I. G.), and Universidad de Buenos Aires Grant 20020100100517 (to A. C.). The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by ANPCyT Grant PME 125.	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; DUBRAY G, 1982, ANAL BIOCHEM, V119, P325, DOI 10.1016/0003-2697(82)90593-0; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Jarrell Ken F, 2010, Int J Microbiol, V2010, P470138, DOI 10.1155/2010/470138; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kandiba L, 2012, MOL MICROBIOL, V84, P578, DOI 10.1111/j.1365-2958.2012.08045.x; Kateete DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045741; Konrad Z, 2002, FEMS MICROBIOL LETT, V209, P197, DOI 10.1111/j.1574-6968.2002.tb11131.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; MARINUS MG, 1973, MOL GEN GENET, V127, P47, DOI 10.1007/BF00267782; Maupin-Furlow JA, 2005, CURR OPIN MICROBIOL, V8, P720, DOI 10.1016/j.mib.2005.10.005; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; MENGELE R, 1992, J BIOL CHEM, V267, P8182; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Nieuwlandt D. T., 1995, P161; Paggi RA, 2010, LETT APPL MICROBIOL, V51, P36, DOI 10.1111/j.1472-765X.2010.02855.x; Palmieri G, 2013, J PROTEOME RES, V12, P2779, DOI 10.1021/pr400123z; Sambrook J., 2001, MOL CLONING LAB MANU; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116; Shlay JC, 2007, JAIDS-J ACQ IMM DEF, V44, P506, DOI 10.1097/QAI.0b013e31804216cf; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Wan CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037452; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; ZHU BCR, 1995, ARCH BIOCHEM BIOPHYS, V319, P355, DOI 10.1006/abbi.1995.1305	46	24	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11304	11317		10.1074/jbc.M113.546531	http://dx.doi.org/10.1074/jbc.M113.546531			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596091	hybrid, Green Published			2022-12-28	WOS:000334638500033
J	Yoder, SM; Dineen, SL; Wang, ZX; Thurmond, DC				Yoder, Stephanie M.; Dineen, Stacey L.; Wang, Zhanxiang; Thurmond, Debbie C.			YES, a Src Family Kinase, Is a Proximal Glucose-specific Activator of Cell Division Cycle Control Protein 42 ( Cdc42) in Pancreatic Islet beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cdc42; Insulin Secretion; Pancreatic Islets; Src	STIMULATED INSULIN-SECRETION; GTP-BINDING PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; TYROSINE KINASE; B-CELLS; RAT ISLETS; IN-VIVO; PHOSPHORYLATION; GROWTH; ACTIN	Background: Although Cdc42 signaling is a known requirement for insulin secretion to occur, how it is initiated remains unknown. Results: YES kinase is required for Cdc42 activation in human islets and cells. Conclusion: YES is a proximal, glucose-specific activator of Cdc42 and glucose-simulated insulin secretion. Significance: YES may provide a novel target for improvement of functional cell mass. Second-phase insulin secretion sustains insulin release in the face of hyperglycemia associated with insulin resistance, requiring the continued mobilization of insulin secretory granules to the plasma membrane. Cdc42, the small Rho family GTPase recognized as the proximal glucose-specific trigger to elicit second-phase insulin secretion, signals downstream to activate the p21-activated kinase (PAK1), which then signals to Raf-1/MEK/ERK to induce filamentous actin (F-actin) remodeling, to ultimately mobilize insulin granules to the plasma membrane. However, the steps required to initiate Cdc42 activation in a glucose-specific manner in cells have remained elusive. Toward this, we identified the involvement of the Src family kinases (SFKs), based upon the ability of SFK inhibitors to block glucose-stimulated Cdc42 and PAK1 activation events as well as the amplifying pathway of glucose-stimulated insulin release, in MIN6 cells. Indeed, subsequent studies performed in human islets revealed that SFK phosphorylation was induced only by glucose and within 1 min of stimulation before the activation of Cdc42 at 3 min. Furthermore, pervanadate treatment validated the phosphorylation event to be tyrosine-specific. Although RT-PCR showed cells to express five different SFK proteins, only two of these, YES and Fyn kinases, were found localized to the plasma membrane, and of these two, only YES kinase underwent glucose-stimulated tyrosine phosphorylation. Immunodetection and RNAi analyses further established YES kinase as a proximal glucose-specific signal in the Cdc42-signaling cascade. Identification of YES kinase provides new insight into the mechanisms underlying the sustainment of insulin secretion via granule mobilization/replenishment and F-actin remodeling.	[Yoder, Stephanie M.; Wang, Zhanxiang; Thurmond, Debbie C.] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Dineen, Stacey L.; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iu.edu			National Institutes of Health [F32 DK094488, CTSI-KL2 RR025760, DK067912, DK076614]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, R01DK076614, F32DK094488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 DK094488 (to S. M. Y.), CTSI-KL2 RR025760 (to Z. W.), and DK067912 and DK076614 (to D. C. T).	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Amin R, 2002, J PHARMACOL EXP THER, V303, P82, DOI 10.1124/jpet.102.036160; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Chen YC, 2013, ISLETS, V5, P22, DOI 10.4161/isl.24029; Cheng HY, 2007, AM J PHYSIOL-ENDOC M, V292, pE845, DOI 10.1152/ajpendo.00103.2006; Civelek VN, 1996, BIOCHEM J, V315, P1015, DOI 10.1042/bj3151015; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jayaram B, 2011, BIOCHEM PHARMACOL, V81, P1016, DOI 10.1016/j.bcp.2011.01.006; Kalwat MA, 2013, BIOCHEM PHARMACOL, V85, P808, DOI 10.1016/j.bcp.2012.12.003; Kepner EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1072, DOI 10.1152/ajpendo.00312.2011; Kowluru A, 1996, BIOCHEM J, V313, P97, DOI 10.1042/bj3130097; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; LI GD, 1993, BIOCHEM J, V289, P379, DOI 10.1042/bj2890379; Li SW, 1996, J BIOL CHEM, V271, P3863; Lim GE, 2009, ENDOCRINOLOGY, V150, P5249, DOI 10.1210/en.2009-0508; Liu BA, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-27; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; METZ SA, 1993, BIOCHEM J, V295, P31, DOI 10.1042/bj2950031; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Nie J, 2012, J BIOL CHEM, V287, P26435, DOI 10.1074/jbc.M112.378372; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; RORSMAN P, 1988, PFLUG ARCH EUR J PHY, V412, P597, DOI 10.1007/BF00583760; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Singh NK, 2011, BLOOD, V118, P5701, DOI 10.1182/blood-2011-04-347468; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Veluthakal R, 2007, DIABETES, V56, P204, DOI 10.2337/db06-0668; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2012, FEBS OPEN BIO, V2, P273, DOI 10.1016/j.fob.2012.09.001; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wasmeier C, 1999, BIOCHEM J, V341, P563, DOI 10.1042/0264-6021:3410563; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Wiseman DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214031; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	74	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11476	11487		10.1074/jbc.M114.559328	http://dx.doi.org/10.1074/jbc.M114.559328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610809	hybrid, Green Published			2022-12-28	WOS:000334638500048
J	Shaik, MM; Maccagni, A; Tourcier, G; Di Guilmi, AM; Dessen, A				Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea			Structural Basis of Pilus Anchoring by the Ancillary Pilin RrgC of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SURFACE; SORTASE; PROTEINS; VIRULENCE; STABILIZE; MECHANISM; ALIGNMENT; PYOGENES; SUBUNITS	Pili are surface-attached, fibrous virulence factors that play key roles in the pathogenesis process of a number of bacterial agents. Streptococcus pneumoniae is a causative agent of pneumonia and meningitis, and the appearance of drug-resistance organisms has made its treatment challenging, especially in developing countries. Pneumococcus-expressed pili are composed of three structural proteins: RrgB, which forms the polymerized backbone, RrgA, the tip-associated adhesin, and RrgC, which presumably associates the pilus with the bacterial cell wall. Despite the fact that the structures of both RrgA and RrgB were known previously, structural information for RrgC was still lacking, impeding the analysis of a complete model of pilus architecture. Here, we report the structure of RrgC to 1.85 and reveal that it is a three-domain molecule stabilized by two intradomain isopeptide bonds. RrgC does not depend on pilus-specific sortases to become attached to the cell wall; instead, it binds the preformed pilus to the peptidoglycan by employing the catalytic activity of SrtA. A comprehensive model of the type 1 pilus from S. pneumoniae is also presented.	[Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] CEA, F-38000 Grenoble, France; [Shaik, Md Munan; Maccagni, Amandine; Tourcier, Guillaume; Di Guilmi, Anne Marie; Dessen, Andrea] CNRS, UMR 5075, Grenoble, France; [Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, BR-13083100 Campinas, SP, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Dessen, A (corresponding author), Inst Biol Struct, Bacterial Pathogenesis Grp, 41 Ave Martyrs, F-38044 Grenoble, France.	andrea.dessen@ibs.fr		Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470	FRISBI [ANR-10-INBS-05-02]; GRAL [ANR-10-LABX-49-01];  [ANR-11-BSV8-005-02]	FRISBI; GRAL; 	This work was supported by ANR-11-BSV8-005-02, including a postdoctoral fellowship (to M. M. S.) and used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INBS-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; El Mortaji L, 2012, BIOCHEMISTRY-US, V51, P342, DOI 10.1021/bi201591n; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Kwon H, 2014, P NATL ACAD SCI USA, V111, P1367, DOI 10.1073/pnas.1316855111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Persson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048364; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; SHOCKMAN GD, 1967, J BACTERIOL, V94, P1525, DOI 10.1128/JB.94.5.1525-1530.1967; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613	60	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16988	16997		10.1074/jbc.M114.555854	http://dx.doi.org/10.1074/jbc.M114.555854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24755220	hybrid, Green Published			2022-12-28	WOS:000338016200033
J	Yasuda, S; Sato, T; Maekawa, S; Aoyama, S; Fukao, Y; Yamaguchi, J				Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Fukao, Yoichiro; Yamaguchi, Junji			Phosphorylation of Arabidopsis Ubiquitin Ligase ATL31 Is Critical for Plant Carbon/Nitrogen Nutrient Balance Response and Controls the Stability of 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Plasma Membrane; Protein Phosphorylation; Protein Stability; Protein-Protein Interactions; Signal Transduction	SUCROSE-PHOSPHATE SYNTHASE; MEMBRANE H+-ATPASE; NITRATE REDUCTASE; GENE-EXPRESSION; LARGE NUMBER; C-TERMINUS; THALIANA; BINDING; SYSTEM; FAMILY	Background: Ubiquitin ligase ATL31 and the target, 14-3-3 proteins, function in plant nutrient response. Results: ATL31 binds to 14-3-3 proteins via phosphorylation of specific residues. These residues are essential for the function of ATL31. Conclusion: ATL31 targets 14-3-3 proteins for degradation in a phosphorylation-dependent manner to regulate nutrient response. Significance: Phosphorylation of ubiquitin ligase ATL31 controls plant nutrient response. Ubiquitin ligase plays a fundamental role in regulating multiple cellular events in eukaryotes by fine-tuning the stability and activity of specific target proteins. We have previously shown that ubiquitin ligase ATL31 regulates plant growth in response to nutrient balance between carbon and nitrogen (C/N) in Arabidopsis. Subsequent study demonstrated that ATL31 targets 14-3-3 proteins for ubiquitination and modulates the protein abundance in response to C/N-nutrient status. However, the underlying mechanism for the targeting of ATL31 to 14-3-3 proteins remains unclear. Here, we show that ATL31 interacts with 14-3-3 proteins in a phosphorylation-dependent manner. We identified Thr(209), Ser(247), Ser(270), and Ser(303) as putative 14-3-3 binding sites on ATL31 by motif analysis. Mutation of these Ser/Thr residues to Ala in ATL31 inhibited the interaction with 14-3-3 proteins, as demonstrated by yeast two-hybrid and co-immunoprecipitation analyses. Additionally, we identified in vivo phosphorylation of Thr(209) and Ser(247) on ATL31 by MS analysis. A peptide competition assay showed that the application of synthetic phospho-Thr(209) peptide, but not the corresponding unphosphorylated peptide, suppresses the interaction between ATL31 and 14-3-3 proteins. Moreover, Arabidopsis plants overexpressing mutated ATL31, which could not bind to 14-3-3 proteins, showed accumulation of 14-3-3 proteins and growth arrest in disrupted C/N-nutrient conditions similar to wild-type plants, although overexpression of intact ATL31 resulted in repression of 14-3-3 accumulation and tolerance to the conditions. Together, these results demonstrate that the physiological role of phosphorylation at 14-3-3 binding sites on ATL31 is to modulate the binding ability and stability of 14-3-3 proteins to control plant C/N-nutrient response.	[Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Yamaguchi, Junji] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Yasuda, Shigetaka; Sato, Takeo; Maekawa, Shugo; Aoyama, Shoki; Yamaguchi, Junji] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma 6300192, Japan	Hokkaido University; Hokkaido University; Nara Institute of Science & Technology	Yamaguchi, J (corresponding author), Hokkaido Univ, Fac Sci, Kita Ku, N10-W8, Sapporo, Hokkaido 0600810, Japan.	jjyama@sci.hokudai.ac.jp	Yamaguchi, Junji/AAG-9118-2021	Maekawa, Shugo/0000-0002-6021-505X; Yasuda, Shigetaka/0000-0002-4602-6404	Japan Society for the Promotion of Science (JSPS) [24770035, 24114701, 25112501]; Akiyama Foundation; JSPS; Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research [23380198] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Akiyama Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research 24770035 (to T. S.) and on Innovation Areas 24114701 and 25112501 (to J. Y.) and in part by The Akiyama Foundation (to T. S.).; Supported by a JSPS Research Fellowship for Young Scientists (2012-2013) and also by the Plant Global Education Project from the Nara Institute of Science and Technology (2012).	Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Bachmann M, 1996, FEBS LETT, V387, P127, DOI 10.1016/0014-5793(96)00478-4; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Bornke F, 2005, J PLANT PHYSIOL, V162, P161, DOI 10.1016/j.jplph.2004.09.006; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Fukao Y, 2009, PLANT CELL PHYSIOL, V50, P2234, DOI 10.1093/pcp/pcp154; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Jaspert N, 2002, PLANTA, V216, P136, DOI 10.1007/s00425-002-0915-1; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim SJ, 2013, FEBS LETT, V587, P2584, DOI 10.1016/j.febslet.2013.06.038; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Menges Margit, 2006, V323, P45; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Sako K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037086; Sato T, 2011, PLANT SIGNAL BEHAV, V6, P1465, DOI 10.4161/psb.6.10.17343; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Sulpice R, 2013, PLANT PHYSIOL, V162, P347, DOI 10.1104/pp.112.210104; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Tsunoda Y, 2005, PROTEIN EXPRES PURIF, V42, P268, DOI 10.1016/j.pep.2005.04.002; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	59	47	48	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15179	15193		10.1074/jbc.M113.533133	http://dx.doi.org/10.1074/jbc.M113.533133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24722992	Green Published, hybrid			2022-12-28	WOS:000337465400005
J	Armstrong, EH; Goswami, D; Griffin, PR; Noy, N; Ortlund, EA				Armstrong, Eric H.; Goswami, Devrishi; Griffin, Patrick R.; Noy, Noa; Ortlund, Eric A.			Structural Basis for Ligand Regulation of the Fatty Acid-binding Protein 5, Peroxisome Proliferator-activated Receptor beta/delta (FABP5-PPAR beta/delta) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; NUCLEAR-LOCALIZATION; PPAR-BETA/DELTA; L-FABP; ALPHA; GLUCOSE; TRANSPORT; DIFFERENTIATION; ELECTROSTATICS; PURIFICATION	Fatty acid-binding proteins (FABPs) are a widely expressed group of calycins that play a well established role in solubilizing cellular fatty acids. Recent studies, however, have recast FABPs as active participants in vital lipid-signaling pathways. FABP5, like its family members, displays a promiscuous ligand binding profile, capable of interacting with numerous long chain fatty acids of varying degrees of saturation. Certain "activating" fatty acids induce the protein's cytoplasmic to nuclear translocation, stimulating PPAR beta/delta transactivation; however, the rules that govern this process remain unknown. Using a range of structural and biochemical techniques, we show that both linoleic and arachidonic acid elicit FABP5's translocation by permitting allosteric communication between the ligand-sensing beta 2 loop and a tertiary nuclear localization signal within the alpha-helical cap of the protein. Furthermore, we show that more saturated, non-activating fatty acids inhibit nuclear localization signal formation by destabilizing this activation loop, thus implicating FABP5 specifically in cis-bonded, polyunsaturated fatty acid signaling.	[Armstrong, Eric H.; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Armstrong, Eric H.; Ortlund, Eric A.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Noy, Noa] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA	Emory University; Emory University; Scripps Research Institute; Case Western Reserve University; Case Western Reserve University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Alexa Mattheyses, Jason Fritz, and Debby Martinson (Integrated Cellular Imaging Core, Emory University) and Shuiliang Yu (Case Western Reserve University) for training in microscopy methods, and Katie Doud (Case Western Reserve University) for generous assistance with the PPAR beta/delta activation assays. Data for 4LKP were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Angelucci F, 2004, BIOCHEMISTRY-US, V43, P13000, DOI 10.1021/bi048505f; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANNER CD, 1993, J LIPID RES, V34, P1583; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Gutierrez-Gonzalez LH, 2002, BIOCHEM J, V364, P725, DOI 10.1042/BJ20020039; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Hostetler HA, 2010, J LIPID RES, V51, P3103, DOI 10.1194/jlr.M005041; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Jeong CY, 2012, ONCOL REP, V28, P1283, DOI 10.3892/or.2012.1922; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Majumdar A, 2011, J BIOL CHEM, V286, P42749, DOI 10.1074/jbc.M111.293464; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Newcomer M. E., 1994, RETINOIDS BIOL CHEM, P288; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Petrescu AD, 2013, BBA-MOL CELL BIOL L, V1831, P1412, DOI 10.1016/j.bbalip.2013.05.008; Petrescu AD, 2013, AM J PHYSIOL-GASTR L, V304, pG241, DOI 10.1152/ajpgi.00334.2012; RICHIERI GV, 1994, J BIOL CHEM, V269, P23918; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson MA, 1999, MOL CELL BIOCHEM, V192, P33, DOI 10.1023/A:1006819715146; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Velkov T, 2013, PPAR RES, V2013, DOI 10.1155/2013/938401; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; XU ZH, 1993, J BIOL CHEM, V268, P7874; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295	75	67	69	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14941	14954		10.1074/jbc.M113.514646	http://dx.doi.org/10.1074/jbc.M113.514646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24692551	hybrid, Green Published			2022-12-28	WOS:000337248100044
J	Juneja, P; Horlacher, R; Bertrand, D; Krause, R; Marger, F; Welte, W				Juneja, Puneet; Horlacher, Reinhold; Bertrand, Daniel; Krause, Ryoko; Marger, Fabrice; Welte, Wolfram			An Internally Modulated, Thermostable, pH-sensitive Cys Loop Receptor from the Hydrothermal Vent Worm Alvinella pompejana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; CHLORIDE CHANNEL; PARASITIC NEMATODE; IVERMECTIN; DESENSITIZATION; ACTIVATION; MECHANISMS; MUSCLE	Cys loop receptors (CLRs) are commonly known as ligand-gated channels that transiently open upon binding of neurotransmitters to modify the membrane potential. However, a class of cation-selective bacterial homologues of CLRs have been found to open upon a sudden pH drop, suggesting further ligands and more functions of the homologues in prokaryotes. Here we report an anion-selective CLR from the hydrothermal vent annelid worm Alvinella pompejana that opens at low pH. A. pompejana expressed sequence tag databases were explored by us, and two full-length CLR sequences were identified, synthesized, cloned, expressed in Xenopus oocytes, and studied by two-electrode voltage clamp. One channel, named Alv-a1-pHCl, yielded functional receptors and opened upon a sudden pH drop but not by other known agonists. Sequence comparison showed that both CLR proteins share conserved characteristics with eukaryotic CLRs, such as an N-terminal helix, a cysteine loop motif, and an intracellular loop intermediate in length between the long loops of other eukaryotic CLRs and those of prokaryotic CLRs. Both full-length Alv-a1-pHCl and a truncated form, termed tAlv-a1-pHCl, lacking 37 amino-terminal residues that precede the N-terminal helix, formed functional channels in oocytes. After pH activation, tAlv-a1-pHCl showed desensitization and was not modulated by ivermectin. In contrast, pH-activated, full-length Alv-a1-pHCl showed a marked rebound current and was modulated significantly by ivermectin. A thermostability assay indicated that purified tAlv-a1-pHCl expressed in Sf9 cells denatured at a higher temperature than the nicotinic acetylcholine receptor from Torpedo californica.	[Juneja, Puneet; Welte, Wolfram] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Horlacher, Reinhold] Trenzyme, D-78467 Constance, Germany; [Bertrand, Daniel; Krause, Ryoko; Marger, Fabrice] HiQScreen Sarl, CH-1222 Geneva, Switzerland	University of Konstanz	Welte, W (corresponding author), Univ Konstanz, Fachbereich Biol, Univ Str 10, D-78457 Constance, Germany.	wolfram.welte@uni-konstanz.de	Juneja, Puneet/ABF-2997-2020; Juneja, Puneet/ABC-2748-2020; Juneja, Puneet/HHC-1232-2022	Juneja, Puneet/0000-0002-6774-2821; Miyazaki-Krause, Ryoko/0000-0003-1273-0417; Juneja, Puneet/0000-0002-8934-4509	EU [202088]; Konstanz Research School of Chemical Biology (KoRS-CB)	EU(European Commission); Konstanz Research School of Chemical Biology (KoRS-CB)	This work was supported by EU grant 202088 (Neurocypres) and by the Konstanz Research School of Chemical Biology (KoRS-CB).	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESBRUYERES D, 1980, OCEANOL ACTA, V3, P267; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084; Gondhalekar AD, 2012, J MED ENTOMOL, V49, P122, DOI 10.1603/ME11106; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hoda JC, 2008, MOL PHARMACOL, V74, P379, DOI 10.1124/mol.107.044545; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Holder T, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-2; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kashiwagi S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701472; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Le Bris N., 2007, Reviews in Environmental Science and Bio/Technology, V6, P197, DOI 10.1007/s11157-006-9112-1; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart T. G., 2012, COLD SPRING HARB PER, V4, P1; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	47	4	4	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15130	15140		10.1074/jbc.M113.525576	http://dx.doi.org/10.1074/jbc.M113.525576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719323	Green Published, hybrid			2022-12-28	WOS:000337248100063
J	Tan, EP; Villar, MT; E, L; Lu, JH; Selfridge, JE; Artigues, A; Swerdlow, RH; Slawson, C				Tan, Ee Phie; Villar, Maria T.; E, Lezi; Lu, Jianghua; Selfridge, J. Eva; Artigues, Antonio; Swerdlow, Russell H.; Slawson, Chad			Altering O-Linked beta-N-Acetylglucosamine Cycling Disrupts Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN MODIFICATION; GLCNAC TRANSFERASE; CARDIAC MYOCYTES; GLCNACYLATION; GLUCOSE; HYPERGLYCEMIA; CANCER; MICE	Mitochondrial impairment is commonly found in many diseases such as diabetes, cancer, and Alzheimer disease. We demonstrate that the enzymes responsible for the addition or removal of the O-GlcNAc modification, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively, are critical regulators of mitochondrial function. Using a SILAC (stable isotope labeling of amino acids in cell culture)-based proteomics screen, we quantified the changes in mitochondrial protein expression in OGT- and OGA-overexpressing cells. Strikingly, overexpression of OGT or OGA showed significant decreases in mitochondria-localized proteins involved in the respiratory chain and the tricarboxylic acid cycle. Furthermore, mitochondrial morphology was altered in these cells. Both cellular respiration and glycolysis were reduced in OGT/OGA-overexpressing cells. These data demonstrate that alterations in O-GlcNAc cycling profoundly affect energy and metabolite production.	[Tan, Ee Phie; Villar, Maria T.; Artigues, Antonio; Swerdlow, Russell H.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, MO 64108 USA; [E, Lezi; Lu, Jianghua; Selfridge, J. Eva; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, MO 64108 USA; [Swerdlow, Russell H.; Slawson, Chad] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, MO 64108 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas	Slawson, C (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd, Kansas City, MO 64108 USA.	cslawson@kumc.edu	E, Lezi/Q-4124-2017; Tan, Ee Phie/AAC-8378-2021	Selfridge, Jennifer/0000-0001-8979-1416	National Institutes of Health COBRE [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Electron Microscopy Research Laboratory (EMRL) for assistance with the electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936. The JEOL JEM-1400 TEM used in the study was purchased with funds from National Institutes of Health Grant S10RR027564.	Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Bennett CE, 2013, LIFE SCI, V92, P657, DOI 10.1016/j.lfs.2012.09.007; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Burnham-Marusich AR, 2012, MITOCHONDRION, V12, P423, DOI 10.1016/j.mito.2012.04.004; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Medford HM, 2012, LIFE SCI, V90, P883, DOI 10.1016/j.lfs.2012.04.030; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941	28	68	70	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14719	14730		10.1074/jbc.M113.525790	http://dx.doi.org/10.1074/jbc.M113.525790			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713701	hybrid, Green Published			2022-12-28	WOS:000337248100028
J	Friedberg, EC				Friedberg, Errol C.			Master Molecule, Heal Thyself	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; DNA Repair; Transcription Factors; Pyrimidine; Bacteriophage	NUCLEOTIDE-EXCISION-REPAIR; IRRADIATED DEOXYRIBONUCLEIC-ACID; YEAST SACCHAROMYCES-CEREVISIAE; PYRIMIDINE DIMER EXCISION; TRANSLESION DNA-SYNTHESIS; II BASAL TRANSCRIPTION; XERODERMA-PIGMENTOSUM; ESCHERICHIA-COLI; ENDONUCLEASE 2; FACTOR-B		[Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Friedberg, EC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	errol.friedberg@southwestern.edu						Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; BARDWELL AJ, 1994, ANN NY ACAD SCI, V726, P281, DOI 10.1111/j.1749-6632.1994.tb52829.x; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BARDWELL L, 1990, BIOCHEMISTRY-US, V29, P3119, DOI 10.1021/bi00464a031; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; Betous R, 2013, EMBO J, V32, P2172, DOI 10.1038/emboj.2013.148; Cheo DL, 1999, CANCER RES, V59, P771; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; CONE R, 1977, BIOCHEMISTRY-US, V16, P3194, DOI 10.1021/bi00633a024; CONE R, 1980, J BIOL CHEM, V255, P354; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEER R, 1987, MOL CELL BIOL, V7, P1180, DOI 10.1128/MCB.7.3.1180; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg E.C., 2005, WRITING LIFE JD WATS; Friedberg E. C., 2007, RAGS RICHES PHENOMEN; Friedberg E.C., 2014, BIOGRAPHY P BERG REC; FRIEDBERG EC, 1969, P NATL ACAD SCI USA, V62, P934, DOI 10.1073/pnas.62.3.934; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; FRIEDBERG EC, 1969, BIOCHEM BIOPH RES CO, V37, P646, DOI 10.1016/0006-291X(69)90859-6; FRIEDBERG EC, 1992, CELL, V71, P887, DOI 10.1016/0092-8674(92)90384-O; FRIEDBERG EC, 1971, J BACTERIOL, V106, P500, DOI 10.1128/JB.106.2.500-507.1971; FRIEDBERG EC, 1969, J BIOL CHEM, V244, P5879; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; FRIEDBERG EC, 1968, COLD SPRING HARB SYM, V33, P271, DOI 10.1101/SQB.1968.033.01.031; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; FRIEDBERG EC, 1997, CORRECTING BLUEPRINT; Friedberg EC, 2008, CELL RES, V18, P3, DOI 10.1038/cr.2007.113; Friedberg EC, 2010, SYDNEY BRENNER: A BIOGRAPHY, pIX; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; HASELTINE WA, 1980, NATURE, V285, P634, DOI 10.1038/285634a0; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Lv LN, 2013, NUCLEIC ACIDS RES, V41, P10312, DOI 10.1093/nar/gkt793; MAHLER I, 1974, J VIROL, V13, P765, DOI 10.1128/JVI.13.3.765-767.1974; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; NAUMOVSKI L, 1983, P NATL ACAD SCI-BIOL, V80, P4818, DOI 10.1073/pnas.80.15.4818; NAUMOVSKI L, 1982, J BACTERIOL, V152, P323; NICOLET CM, 1985, GENE, V36, P225, DOI 10.1016/0378-1119(85)90177-5; RADANY EH, 1980, NATURE, V286, P182, DOI 10.1038/286182a0; Reynolds R. J., 1980, DNA REPAIR MUTAGENES, P121; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; REYNOLDS RJ, 1981, J BACTERIOL, V147, P705, DOI 10.1128/JB.147.2.705-708.1981; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0; WANG ZG, 1993, P NATL ACAD SCI USA, V90, P4907, DOI 10.1073/pnas.90.11.4907; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; YANG E, 1984, MOL CELL BIOL, V4, P2161, DOI 10.1128/MCB.4.10.2161; YASUDA S, 1970, P NATL ACAD SCI USA, V67, P1839, DOI 10.1073/pnas.67.4.1839	50	1	2	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13691	13700		10.1074/jbc.X114.572115	http://dx.doi.org/10.1074/jbc.X114.572115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711456	Green Published, hybrid			2022-12-28	WOS:000335984600001
J	Mukherjee, A; Mueller, GM; Kinlough, CL; Sheng, N; Wang, ZJ; Mustafa, SA; Kashlan, OB; Kleyman, TR; Hughey, RP				Mukherjee, Anindit; Mueller, Gunhild M.; Kinlough, Carol L.; Sheng, Nan; Wang, Zhijian; Mustafa, S. Atif; Kashlan, Ossama B.; Kleyman, Thomas R.; Hughey, Rebecca P.			Cysteine Palmitoylation of the gamma Subunit Has a Dominant Role in Modulating Activity of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channel (ASIC); ENaC; Gating; Ion Channels; Protein Palmitoylation	NA+ CHANNEL; ALPHA-SUBUNIT; PROTEIN PALMITOYLATION; FURIN; DISTAL; SITES; IDENTIFICATION; ACTIVATION; EXPRESSION; PROTEASES	Background: Epithelial sodium channel (ENaC) and subunits are modified by Cys palmitoylation. Results: Palmitoylation of the subunit activates ENaCs by increasing channel open probability. Conclusion: subunit palmitoylation has a dominant role in activating ENaCs compared with subunit palmitoylation. Significance: ENaC palmitoylation is an important post-translational mechanism of channel regulation. The epithelial sodium channel (ENaC) is composed of three homologous subunits (, , and ) with cytoplasmic N and C termini. Our previous work revealed that two cytoplasmic Cys residues in the subunit, Cys-43 and Cys-557, are Cys-palmitoylated. ENaCs with mutant C43A/C557A exhibit normal surface expression but enhanced Na+ self-inhibition and reduced channel open probability. Although the subunit is not palmitoylated, we now show that the two cytoplasmic Cys residues in the subunit are palmitoylated. ENaCs with mutant C33A, C41A, or C33A/C41A exhibit reduced activity compared with wild type channels but normal surface expression and normal levels of and subunit-activating cleavage. These mutant channels have significantly enhanced Na+ self-inhibition and reduced open probability compared with wild type ENaCs. Channel activity was enhanced by co-expression with the palmitoyltransferase DHHC2 that also co-immunoprecipitates with ENaCs. Secondary structure prediction of the N terminus of the subunit places Cys-33 within an -helix and Cys-44 on a coil before the first transmembrane domain within a short tract that includes a well conserved His-Gly motif, where mutations have been associated with altered channel gating. Our current and previous results suggest that palmitoylation of the and subunits of ENaCs enhances interactions of their respective cytoplasmic domains with the plasma membrane and stabilizes the open state of the channel. Comparison of activities of channels lacking palmitoylation sites in individual or multiple subunits revealed that subunit palmitoylation has a dominant role over subunit palmitoylation in modulating ENaC gating.	[Mukherjee, Anindit; Mueller, Gunhild M.; Kinlough, Carol L.; Sheng, Nan; Wang, Zhijian; Mustafa, S. Atif; Kashlan, Ossama B.; Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15626 USA.	kleyman@pitt.edu	Yang, Wei/HIA-0360-2022		National Institutes of Health [R01 DK065161, K01 DK078734, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, P30DK079307, K01DK078734, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065161, K01 DK078734, and P30 DK079307.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mueller GM, 2012, AM J PHYSIOL-RENAL, V303, pF220, DOI 10.1152/ajprenal.00493.2011; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x	34	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14351	14359		10.1074/jbc.M113.526020	http://dx.doi.org/10.1074/jbc.M113.526020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692558	Green Published, hybrid			2022-12-28	WOS:000335984600060
J	Lin, XY; Ruiz, J; Bajraktari, I; Ohman, R; Banerjee, S; Gribble, K; Kaufman, JD; Wingfield, PT; Griggs, RC; Fischbeck, KH; Mankodi, A				Lin, Xiaoyan; Ruiz, Janelle; Bajraktari, Ilda; Ohman, Rachel; Banerjee, Soojay; Gribble, Katherine; Kaufman, Joshua D.; Wingfield, Paul T.; Griggs, Robert C.; Fischbeck, Kenneth H.; Mankodi, Ami			Z-disc-associated, Alternatively Spliced, PDZ Motif-containing Protein ( ZASP) Mutations in the Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Muscular Dystrophy; Protein Complex; Protein-Protein Interaction; Skeletal Muscle; Actinin; Myofibrillar Myopathy; Myotilin; Z-disc; ZASP	GIRDLE MUSCULAR-DYSTROPHY; ONSET DISTAL MYOPATHY; ALPHA-ACTININ; DILATED CARDIOMYOPATHY; LIM PROTEIN; Z-BAND; DESMIN POSITIVITY; SEVERE FORM; IN-VIVO; Z-LINE	Background: The binding partners of the ZASP internal region that is mutated in zaspopathy are not yet known. Results: The internal region of ZASP binds to skeletal muscle -actin, and zaspopathy mutations cause actin disruption. Conclusion: ZASP mutations in the actin-binding domain are deleterious to the muscle Z-disc structure. Significance: ZASP-actin interaction expands the role of ZASP and defines the mechanism of zaspopathy. The core of skeletal muscle Z-discs consists of actin filaments from adjacent sarcomeres that are cross-linked by -actinin homodimers. Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP)/Cypher interacts with -actinin, myotilin, and other Z-disc proteins via the PDZ domain. However, these interactions are not sufficient to maintain the Z-disc structure. We show that ZASP directly interacts with skeletal actin filaments. The actin-binding domain is between the modular PDZ and LIM domains. This ZASP region is alternatively spliced so that each isoform has unique actin-binding domains. All ZASP isoforms contain the exon 6-encoded ZASP-like motif that is mutated in zaspopathy, a myofibrillar myopathy (MFM), whereas the exon 8-11 junction-encoded peptide is exclusive to the postnatal long ZASP isoform (ZASP-Lex10). MFM is characterized by disruption of skeletal muscle Z-discs and accumulation of myofibrillar degradation products. Wild-type and mutant ZASP interact with -actin, -actinin, and myotilin. Expression of mutant, but not wild-type, ZASP leads to Z-disc disruption and F-actin accumulation in mouse skeletal muscle, as in MFM. Mutations in the actin-binding domain of ZASP-Lex10, but not other isoforms, cause disruption of the actin cytoskeleton in muscle cells. These isoform-specific mutation effects highlight the essential role of the ZASP-Lex10 isoform in F-actin organization. Our results show that MFM-associated ZASP mutations in the actin-binding domain have deleterious effects on the core structure of the Z-discs in skeletal muscle.	[Lin, Xiaoyan; Ruiz, Janelle; Bajraktari, Ilda; Ohman, Rachel; Banerjee, Soojay; Gribble, Katherine; Fischbeck, Kenneth H.; Mankodi, Ami] NINDS, NIH, Neurogenet Branch, Bethesda, MD 20892 USA; [Kaufman, Joshua D.; Wingfield, Paul T.] NIAMS, NIH, Prot Express Lab, Bethesda, MD 20892 USA; [Griggs, Robert C.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Rochester	Mankodi, A (corresponding author), NINDS, NIH, Neurogenet Branch, 35 Convent Dr,Bldg 35,Rm 2A-1002, Bethesda, MD 20892 USA.	ami.mankodi@nih.gov		Griggs, Robert/0000-0001-7988-4854; Gribble, Katherine/0000-0001-7050-5184; Wingfield, Paul/0000-0002-9515-4752; Mankodi, Ami/0000-0002-5131-7767	NINDS, National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003038, ZIANS003131] Funding Source: NIH RePORTER	NINDS, National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institute of Health intramural research funds, including the Henry F. McFarland Transition to Independence Award (to A. M.).	Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Conover GM, 2011, J CELL SCI, V124, P3464, DOI 10.1242/jcs.087080; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006; Griggs RC, 2011, NEUROMOL MED, V13, P27, DOI 10.1007/s12017-010-8134-6; Hishiya A, 2010, CIRC RES, V107, P1220, DOI 10.1161/CIRCRESAHA.110.225649; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; KNAPPEIS GG, 1962, J CELL BIOL, V13, P323, DOI 10.1083/jcb.13.2.323; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; LUTHER PK, 1991, J CELL BIOL, V113, P1043, DOI 10.1083/jcb.113.5.1043; Luther PK, 2000, J STRUCT BIOL, V129, P1, DOI 10.1006/jsbi.1999.4207; MARKESBERY WR, 1974, NEUROLOGY, V24, P127, DOI 10.1212/WNL.24.2.127; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Passier R, 2000, MECH DEVELOP, V92, P277, DOI 10.1016/S0925-4773(99)00330-5; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Selcen Duygu, 2011, Neuromuscul Disord, V21, P161, DOI [10.1016/B978-0-08-045031-5.00011-6, 10.1016/j.nmd.2010.12.007]; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; VANDEKERCKHOVE J, 1986, J BIOL CHEM, V261, P1838; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	41	30	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13615	13626		10.1074/jbc.M114.550418	http://dx.doi.org/10.1074/jbc.M114.550418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668811	Green Published, hybrid			2022-12-28	WOS:000335522800055
J	Usatyuk, PV; Fu, PF; Mohan, V; Epshtein, Y; Jacobson, JR; Gomez-Cambronero, J; Wary, KK; Bindokas, V; Dudek, SM; Salgia, R; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Fu, Panfeng; Mohan, Vijay; Epshtein, Yulia; Jacobson, Jeffrey R.; Gomez-Cambronero, Julian; Wary, Kishore K.; Bindokas, Vytas; Dudek, Steven M.; Salgia, Ravi; Garcia, Joe G. N.; Natarajan, Viswanathan			Role of c-Met/Phosphatidylinositol 3-Kinase (PI3k)/Akt Signaling in Hepatocyte Growth Factor (HGF)- mediated Lamellipodia Formation, Reactive Oxygen Species (ROS) Generation, and Motility of Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Cell Migration; Endothelial Cell; Hepatocyte Growth Factor; NADPH Oxidase	NADPH OXIDASE ACTIVATION; F-ACTIN; HYDROGEN-PEROXIDE; NAD(P)H OXIDASE; LEADING-EDGE; MET; MIGRATION; CORTACTIN; P47(PHOX); PATHWAY	Background: Lamellipodia structures provide a platform for the spatio-temporal localization of key components necessary for cell migration. Results: HGF activates c-Met/PI3k/Akt signaling axis, which is essential for the recruitment of actin, cortactin, p47(phox), and Rac1and ROS production in lamellipodia. Conclusion: HGF-induced spatio-temporal localization of cytoskeletal proteins and NADPH oxidase components regulate lamellipodial ROS and cell migration. Significance: This study identifies a novel role for lamellipodial ROS in cell motility. Hepatocyte growth factor (HGF) mediated signaling promotes cell proliferation and migration in a variety of cell types and plays a key role in tumorigenesis. As cell migration is important to angiogenesis, we characterized HGF-mediated effects on the formation of lamellipodia, a pre-requisite for migration using human lung microvascular endothelial cells (HLMVECs). HGF, in a dose-dependent manner, induced c-Met phosphorylation (Tyr-1234/1235, Tyr-1349, Ser-985, Tyr-1003, and Tyr-1313), activation of PI3k (phospho-Yp85) and Akt (phospho-Thr-308 and phospho-Ser-473) and potentiated lamellipodia formation and HLMVEC migration. Inhibition of c-Met kinase by SU11274 significantly attenuated c-Met, PI3k, and Akt phosphorylation, suppressed lamellipodia formation and endothelial cell migration. LY294002, an inhibitor of PI3k, abolished HGF-induced PI3k (Tyr-458), and Akt (Thr-308 and Ser-473) phosphorylation and suppressed lamellipodia formation. Furthermore, HGF stimulated p47(phox)/Cortactin/Rac1 translocation to lamellipodia and ROS generation. Moreover, inhibition of c-Met/PI3k/Akt signaling axis and NADPH oxidase attenuated HGF- induced lamellipodia formation, ROS generation and cell migration. Ex vivo experiments with mouse aortic rings revealed a role for c-Met signaling in HGF-induced sprouting and lamellipodia formation. Taken together, these data provide evidence in support of a significant role for HGF-induced c-Met/PI3k/Akt signaling and NADPH oxidase activation in lamellipodia formation and motility of lung endothelial cells.	[Usatyuk, Peter V.; Fu, Panfeng; Mohan, Vijay; Wary, Kishore K.; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Epshtein, Yulia; Jacobson, Jeffrey R.; Dudek, Steven M.; Garcia, Joe G. N.] Univ Illinois, Sect Pulm & Crit Care Med, Chicago, IL 60612 USA; [Epshtein, Yulia; Jacobson, Jeffrey R.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Bindokas, Vytas] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; University System of Ohio; Wright State University Dayton	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, COMRB, Room 3137,835 South Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Fu, Panfeng/F-7345-2015	Fu, Panfeng/0000-0001-8813-9258; Gomez-Cambronero, Julian/0000-0002-7581-9227; Wary, Kishore/0000-0001-8851-8565	National Institutes of Health [P01 HL098050, 2R01HL079356]; AHA [12GRNT12070159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL079356, P01HL098050, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grants P01 HL098050 (to V. N.) and 2R01HL079356 (to K. K. W.) from the National Institutes of Health and the AHA Grant 12GRNT12070159 (to K. K. W.).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clavijo-Cornejo D, 2013, BIOCHIMIE, V95, P1177, DOI 10.1016/j.biochi.2013.01.005; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Fountoulaki K, 2012, CARDIOLOGY, V121, P237, DOI 10.1159/000338158; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Graupera M, 2013, EXP CELL RES, V319, P1348, DOI 10.1016/j.yexcr.2013.02.021; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hodara R, 2011, ARTERIOSCL THROM VAS, V31, P2203, DOI 10.1161/ATVBAHA.111.233247; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jagadeeswaran R, 2007, AM J PHYSIOL-LUNG C, V292, pL1488, DOI 10.1152/ajplung.00147.2006; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuhlmann CRW, 2005, J THROMB HAEMOST, V3, P2089, DOI 10.1111/j.1538-7836.2005.01541.x; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Madonna R, 2013, J CARDIOVASC MED, V14, P249, DOI 10.2459/JCM.0b013e3283542017; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; Martinez-Palacian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053108; McKinnon H, 2006, AM J PATHOL, V168, P340, DOI 10.2353/ajpath.2006.050379; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Mishina NM, 2013, METHOD ENZYMOL, V526, P45, DOI 10.1016/B978-0-12-405883-5.00003-X; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohsawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054503; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Ruggeri RM, 2010, EUR J HISTOCHEM, V54, P118, DOI 10.4081/ejh.2010.e24; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Sala V, 2011, CELL MOL LIFE SCI, V68, P1703, DOI 10.1007/s00018-011-0633-6; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Stampoulis P, 2012, J BIOL CHEM, V287, P17848, DOI 10.1074/jbc.M111.332874; Sung BH, 2011, CURR BIOL, V21, P1460, DOI 10.1016/j.cub.2011.06.065; Taulet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041342; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zhao YT, 2007, CELL SIGNAL, V19, P2329, DOI 10.1016/j.cellsig.2007.07.005; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	81	59	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13476	13491		10.1074/jbc.M113.527556	http://dx.doi.org/10.1074/jbc.M113.527556			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634221	Green Published, hybrid			2022-12-28	WOS:000335522800044
J	Bill, A; Hall, ML; Borawski, J; Hodgson, C; Jenkins, J; Piechon, P; Popa, O; Rothwell, C; Tranter, P; Tria, S; Wagner, T; Whitehead, L; Gaither, LA				Bill, Anke; Hall, Michelle Lynn; Borawski, Jason; Hodgson, Catherine; Jenkins, Jeremy; Piechon, Philippe; Popa, Oana; Rothwell, Christopher; Tranter, Pamela; Tria, Scott; Wagner, Trixie; Whitehead, Lewis; Gaither, L. Alex			Small Molecule-facilitated Degradation of ANO1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Biology; Cancer Therapy; Chloride Channels; Computational Biology; ER-associated Degradation; Ion Channels; Molecular Modeling; Protein Degradation; Small Molecules	ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; SQUAMOUS-CELL CARCINOMA; FINGERPRINT METHODS; CANCER PROGRESSION; BREFELDIN-A; TMEM16A; IDENTIFICATION; CONTRIBUTES; INHIBITORS	Background: The calcium-activated chloride channel ANO1 is highly expressed in cancer. Results: Inhibition of ANO1 activity alone is not sufficient to inhibit cancer cell proliferation, suggesting a novel function of ANO1 protein in cancer. Conclusion: The ANO1 inhibitor CaCCinh-A01 inhibits cancer cell proliferation by facilitating degradation of ANO1. Significance: Our results may provide a new targeting approach for antitumor therapy in ANO1-amplified cancers. ANO1, a calcium-activated chloride channel, is highly expressed and amplified in human cancers and is a critical survival factor in these cancers. The ANO1 inhibitor CaCCinh-A01 decreases proliferation of ANO1-amplified cell lines; however, the mechanism of action remains elusive. We explored the mechanism behind the inhibitory effect of CaCCinh-A01 on cell proliferation using a combined experimental and in silico approach. We show that inhibition of ANO1 function is not sufficient to diminish proliferation of ANO1-dependent cancer cells. We report that CaCCinh-A01 reduces ANO1 protein levels by facilitating endoplasmic reticulum-associated, proteasomal turnover of ANO1. Washout of CaCCinh-A01 rescued ANO1 protein levels and resumed cell proliferation. Proliferation of newly derived CaCCinh-A01-resistant cell pools was not affected by CaCCinh-A01 as compared with the parental cells. Consistently, CaCCinh-A01 failed to reduce ANO1 protein levels in these cells, whereas ANO1 currents were still inhibited by CaCCinh-A01, indicating that CaCCinh-A01 inhibits cell proliferation by reducing ANO1 protein levels. Furthermore, we employed in silico methods to elucidate novel biological functions of ANO1 inhibitors. Specifically, we derived a pharmacophore model to describe inhibitors capable of promoting ANO1 degradation and report new inhibitors of ANO1-dependent cell proliferation. In summary, our data demonstrate that inhibition of the channel activity of ANO1 is not sufficient to inhibit ANO1-dependent cell proliferation, indicating that the role of ANO1 in cancer only partially depends on its function as a channel. Our results provide an impetus for gaining a deeper understanding of ANO1 modulation in cells and introduce a new targeting approach for antitumor therapy in ANO1-amplified cancers.	[Bill, Anke; Hall, Michelle Lynn; Borawski, Jason; Jenkins, Jeremy; Rothwell, Christopher; Tria, Scott; Whitehead, Lewis; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hodgson, Catherine; Popa, Oana; Tranter, Pamela] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Piechon, Philippe; Wagner, Trixie] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gaither, LA (corresponding author), Novartis Inst Biomed Res, 500 Technology Sq, Cambridge, MA 02139 USA.	alex.gaither@novartis.com		Popa, Mariana Oana/0000-0002-2766-6801; Bill, Anke/0000-0003-1244-7574; Whitehead, Lewis/0000-0002-6125-0893				Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Cheeseright T, 2006, J CHEM INF MODEL, V46, P665, DOI 10.1021/ci050357s; Cheeseright TJ, 2008, J CHEM INF MODEL, V48, P2108, DOI 10.1021/ci800110p; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tian YM, 2013, BRIT J PHARMACOL, V168, P253, DOI 10.1111/j.1476-5381.2012.02193.x; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0	43	60	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11029	11041		10.1074/jbc.M114.549188	http://dx.doi.org/10.1074/jbc.M114.549188			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599954	hybrid, Green Published			2022-12-28	WOS:000334638500009
J	Ma, B; Wells, A				Ma, Bo; Wells, Alan			The Mitogen-activated Protein ( MAP) Kinases p38 and Extracellular Signal-regulated Kinase ( ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E-cadherin; EMT; Epidermal Growth Factor Receptor (EGFR); Epithelial to Mesenchymal Transition; Metastasis; Mesenchymal to Epithelial Reverting Transition	EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; CARCINOMA-CELLS; BREAST-CANCER; GROWTH; PATHWAY; AMPLIFICATION; METASTASIS; INHIBITION; P38-ALPHA	Background: Epithelial mesenchymal phenotypic switching enables cancers to seed and survive in metastatic sites. Results: Both p38 and ERK1/2 MAP kinases need to be inhibited to allow for an epithelial reversion but activated to provide survival advantage in the face of chemotherapy. Conclusion: Distinct p38/ERK signaling outcomes are involved in hepatocytes-mediated MErT and tumor cells survival. Significance: Provides insights in understanding approaches to p38 or ERK1/2 activity regulation for cancer therapy. The greatest challenge for the seeding of cancer in metastatic sites is integration into the ectopic microenvironment despite the lack of an orthotopic supportive environment and presence of pro-death signals concomitant with a localized foreign-body inflammatory response. In this metastatic location, many carcinoma cells display a reversion of the epithelial-to-mesenchymal transition that marks dissemination in the primary tumor mass. This mesenchymal to epithelial reverting transition (MErT) is thought to help seeding and colonization by protecting against cell death. We have previously shown that hepatocyte coculture induces the re-expression of E-cadherin via abrogation of autocrine EGFR signaling pathway in prostate cancer (PCa) cells and that this confers a survival advantage. Herein, we show that hepatocytes educate PCa to undergo MErT by modulating the activity of p38 and ERK1/2. Hepatocytes inhibited p38 and ERK1/2 activity in prostate cancer cells, which allowed E-cadherin re-expression. Introduction of constitutively active MEK6 and MEK1 to DU145 cells cocultured with hepatocytes abrogated E-cadherin re-expression. At least a partial phenotypic reversion can be achieved by suppression of p38 and ERK1/2 activation in DU145 cells even in the absence of hepatocytes. Interestingly, these mitogen-activated protein kinase activities were also triggered by re-expressed E-cadherin leading to p38 and ERK1/2 activity in PCa cells; these signals provide protection to PCa cells upon challenge with chemotherapy and cell death-inducing cytokines. We propose that distinct p38/ERK pathways are related to E-cadherin levels and function downstream of E-cadherin allowing, respectively, for hepatocyte-mediated MErT and tumor cell survival in the face of death signals.	[Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Wells, Alan] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, 3550 Terrace St,Scaife Hall S713, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	; ma, bo/B-1163-2019	Wells, Alan/0000-0002-1637-8150; ma, bo/0000-0003-0816-6630	National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program; Veterans Affairs Merit Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001017] Funding Source: NIH RePORTER	National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program; Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the National Institutes of Health National Center for Advancing Translational Sciences Microphysiological Systems (MPS) program. This work was also supported by a Veterans Affairs Merit Award.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chao Y, 2012, CLIN EXP METASTAS, V29, P39, DOI 10.1007/s10585-011-9427-3; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Elenitoba-Johnson KSJ, 2003, P NATL ACAD SCI USA, V100, P7259, DOI 10.1073/pnas.1137463100; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Horn G, 2009, EXP CELL RES, V315, P1490, DOI 10.1016/j.yexcr.2009.02.011; JACKSON RC, 1989, ADV ENZYME REGUL, V29, P27, DOI 10.1016/0065-2571(89)90092-7; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Krysan K, 2008, J THORAC ONCOL, V3, P107, DOI 10.1097/JTO.0b013e3181630ece; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lim Minyoung, 2011, Hormones & Cancer, V2, P298, DOI 10.1007/s12672-011-0084-4; Liu Y, 2008, DEV BIOL, V314, P224, DOI 10.1016/j.ydbio.2007.12.003; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Munshi A, 2002, CANCER CHEMOTH PHARM, V50, P46, DOI 10.1007/s00280-002-0465-z; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Saha B, 2007, ANTICANCER RES, V27, P3903; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Yates C, 2005, BRIT J CANCER, V92, P366, DOI 10.1038/sj.bjc.6602350; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	39	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11153	11161		10.1074/jbc.M113.540237	http://dx.doi.org/10.1074/jbc.M113.540237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24619413	hybrid, Green Published			2022-12-28	WOS:000334638500019
J	Gao, C; Liu, Y; Zhang, HT; Zhang, YB; Fukuda, MN; Palma, AS; Kozak, RP; Childs, RA; Nonaka, M; Li, Z; Siegel, DL; Hanfland, P; Peehl, DM; Chai, WG; Greene, MI; Ten, FZ				Gao, Chao; Liu, Yan; Zhang, Hongtao; Zhang, Yibing; Fukuda, Michiko N.; Palma, Angelina S.; Kozak, Radoslaw P.; Childs, Robert A.; Nonaka, Motohiro; Li, Zhen; Siegel, Don L.; Hanfland, Peter; Peehl, Donna M.; Chai, Wengang; Greene, Mark I.; Ten Feizi			Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT ERYTHROCYTE-MEMBRANES; MILD PERIODATE-OXIDATION; BLOOD-GROUP ANTIGENS; GROUP-B; MASS-SPECTROMETRY; GROUP-A; GROUP-I; GROUP-H; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES	Monoclonal antibody F77 was previously raised against human prostate cancer cells and has been shown to recognize a carbohydrate antigen, but the carbohydrate sequence of the antigen was elusive. Here, we make multifaceted approaches to characterize F77 antigen, including binding analyses with the glycolipid extract of the prostate cancer cell line PC3, microarrays with sequence-defined glycan probes, and designer arrays from the O-glycome of an antigen-positive mucin, in conjunction with mass spectrometry. Our results reveal F77 antigen to be expressed on blood group H on a 6-linked branch of a poly-N-acetyllactosamine backbone. We show that mAb F77 can also bind to blood group A and B analogs but with lower intensities. We propose that the close association of F77 antigen with prostate cancers is a consequence of increased blood group H expression together with up-regulated branching enzymes. This is in contrast to other epithelial cancers that have up-regulated branching enzymes but diminished expression of H antigen. With knowledge of the structure and prevalence of F77 antigen in prostate cancer, the way is open to explore rationally its application as a biomarker to detect F77-positive circulating prostate cancer-derived glycoproteins and tumor cells.	[Gao, Chao; Liu, Yan; Zhang, Yibing; Palma, Angelina S.; Childs, Robert A.; Li, Zhen; Chai, Wengang; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Zhang, Hongtao; Siegel, Don L.; Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fukuda, Michiko N.; Nonaka, Motohiro] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, La Jolla, CA 92037 USA; [Palma, Angelina S.] New Univ, Dept Chem, P-2829516 Lisbon, Portugal; [Kozak, Radoslaw P.] Ludger Ltd, Culham Sci Ctr, Abingdon OX14 3EB, Oxon, England; [Hanfland, Peter] Univ Bonn, Fdn Haemotherapy Res, Inst Expt Haematol & Transfus Med, D-53127 Bonn, Germany; [Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA	Imperial College London; University of Pennsylvania; Sanford Burnham Prebys Medical Discovery Institute; Universidade Nova de Lisboa; Culham Science Centre; UK Atomic Energy Authority; University of Bonn; Stanford University	Liu, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, Hammersmith Campus,Burlington Danes Bldg, London W12 0NN, England.	yan.liu2@imperial.ac.uk; w.chai@imperial.ac.uk; t.feizi@imperial.ac.uk	Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013	Palma, Angelina S/0000-0001-5797-6555; Liu, Yan/0000-0002-2566-6867; Gao, Chao/0000-0003-3489-3989; Li, Zhen/0000-0002-8853-4941; Feizi, Ten/0000-0001-6495-0329; Zhang, Hongtao/0000-0001-9173-0049	National Institutes of Health [U01 CA128416, U01 CA168925]; NCI Alliance of Glycobiologists; Wellcome Trust [WT093378MA, WT099197MA]; United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant [GRS/79268]; UK Engineering and Physical Sciences Research Council [EP/G037604/1]; China Scholarship Council; Fundacao para a Ciencia e Tecnologia Portugal Grant [BPD SFRH/26515/2006]; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA030199, U01CA128416, P30CA016520, U01CA168925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Alliance of Glycobiologists(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); China Scholarship Council(China Scholarship Council); Fundacao para a Ciencia e Tecnologia Portugal Grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 CA128416 and U01 CA168925, NCI Alliance of Glycobiologists. This work was also supported by Wellcome Trust Grants WT093378MA and WT099197MA, United Kingdom Research Council Basic Technology Initiative "Glycoarrays" Grant GRS/79268, and UK Engineering and Physical Sciences Research Council Grant EP/G037604/1.; Recipients of fellowships from China Scholarship Council.; Supported by Fundacao para a Ciencia e Tecnologia Portugal Grant BPD SFRH/26515/2006.	ABEL PD, 1987, BRIT J UROL, V59, P430, DOI 10.1111/j.1464-410X.1987.tb04841.x; BENDICH A, 1947, J AM CHEM SOC, V69, P2163, DOI 10.1021/ja01201a031; CARROLL AM, 1984, CLIN IMMUNOL IMMUNOP, V33, P268, DOI 10.1016/0090-1229(84)90081-3; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; CHAI WG, 1993, CARBOHYD RES, V239, P107, DOI 10.1016/0008-6215(93)84207-M; CHAI WG, 1992, EUR J BIOCHEM, V203, P257, DOI 10.1111/j.1432-1033.1992.tb19855.x; Cheng PF, 2013, ANAL BIOANAL CHEM, V405, P6683, DOI 10.1007/s00216-013-7128-2; Dean L., 2005, BLOOD GROUPS RED CEL; EGGE H, 1985, J BIOL CHEM, V260, P4927; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; FEIZI T, 1981, IMMUNOL COMMUN, V10, P127, DOI 10.3109/08820138109050693; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FEIZI T, 1971, J EXP MED, V133, P39, DOI 10.1084/jem.133.1.39; FEIZI T, 1979, J EXP MED, V149, P975, DOI 10.1084/jem.149.4.975; FEIZI T, 1985, CANCER SURV, V4, P245; FUKUDA MN, 1983, BIOCHEMISTRY-US, V22, P5034, DOI 10.1021/bi00290a024; FUKUDA MN, 1982, J BIOL CHEM, V257, P446; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HANFLAND P, 1981, BIOCHEMISTRY-US, V20, P5310, DOI 10.1021/bi00521a034; HANFLAND P, 1988, CARBOHYD RES, V178, P1, DOI 10.1016/0008-6215(88)80098-3; HANFLAND P, 1984, EUR J BIOCHEM, V145, P531, DOI 10.1111/j.1432-1033.1984.tb08589.x; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; HOUNSELL EF, 1985, EUR J BIOCHEM, V148, P367, DOI 10.1111/j.1432-1033.1985.tb08848.x; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; IYER RN, 1971, ARCH BIOCHEM BIOPHYS, V142, P101, DOI 10.1016/0003-9861(71)90263-3; KABAT EA, 1982, AM J CLIN PATHOL, V78, P281, DOI 10.1093/ajcp/78.3.281; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Klein H, 2005, MOLLISONS BLOOD TRAN, P114; Kozak RP, 2012, ANAL BIOCHEM, V423, P119, DOI 10.1016/j.ab.2012.01.002; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; Le Pendu J, 2001, APMIS, V109, P9; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Machida E, 2001, CANCER RES, V61, P2226; Miyamoto T, 2013, HISTOPATHOLOGY, V62, P986, DOI 10.1111/his.12107; NISHI K, 1992, INT J LEGAL MED, V105, P75, DOI 10.1007/BF02340827; Nonaka M, 2014, J BIOL CHEM, V289, P16478, DOI 10.1074/jbc.M114.559047; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PERLMAN EJ, 1990, AM J SURG PATHOL, V14, P810, DOI 10.1097/00000478-199009000-00002; Rabu C, 2012, FUTURE ONCOL, V8, P943, DOI [10.2217/FON.12.88, 10.2217/fon.12.88]; Shimodaira K, 1997, CANCER RES, V57, P5201; Stoll M. S., 2009, P BEILST S GLYC BIOI, P123; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; STOLL MS, 1990, EUR J BIOCHEM, V189, P499, DOI 10.1111/j.1432-1033.1990.tb15515.x; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; VOWDEN P, 1986, BRIT J CANCER, V53, P307, DOI 10.1038/bjc.1986.53; Wang LZ, 2005, BIOCHEM BIOPH RES CO, V331, P958, DOI 10.1016/j.bbrc.2005.04.022; Watkins W M, 1980, Adv Hum Genet, V10, P1; WOOD E, 1979, FEBS LETT, V104, P135, DOI 10.1016/0014-5793(79)81100-X; Zhang G, 2010, P NATL ACAD SCI USA, V107, P732, DOI 10.1073/pnas.0911397107; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414	57	36	36	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16462	16477		10.1074/jbc.M114.558932	http://dx.doi.org/10.1074/jbc.M114.558932			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24753245	hybrid, Green Published			2022-12-28	WOS:000337965700048
J	Paul, A; Garcia, YA; Zierer, B; Patwardhan, C; Gutierrez, O; Hildenbrand, Z; Harris, DC; Balsiger, HA; Sivils, JC; Johnson, JL; Buchner, J; Chadli, A; Cox, MB				Paul, Atanu; Garcia, Yenni A.; Zierer, Bettina; Patwardhan, Chaitanya; Gutierrez, Omar; Hildenbrand, Zacariah; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Johnson, Jill L.; Buchner, Johannes; Chadli, Ahmed; Cox, Marc B.			The Cochaperone SGTA (Small Glutamine-rich Tetratricopeptide Repeat-containing Protein Alpha) Demonstrates Regulatory Specificity for the Androgen, Glucocorticoid, and Progesterone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; Glucocorticoid Receptor; Heat Shock Protein 90 (Hsp90); Progesterone; Prostate Cancer; Steroid Hormone Receptor; FKBP52; Hsp70; SGTA; Cochaperone	PROSTATE-CANCER; BINDING-PROTEIN; IDENTIFICATION; DOMAIN; HOP; INTERACTS; COMPLEX	Background: Cochaperones are important for the folding and activation of steroid hormone receptors. Results: The androgen receptor-associated cochaperone SGTA binds both Hsp70 and Hsp90 and regulates progesterone and glucocorticoid receptors. Conclusion: SGTA is a receptor-specific cochaperone that regulates distinct steps in the receptor chaperoning cycle. Significance: SGTA is a relevant factor in diseases that depend on androgens, progestins and/or glucocorticoids. Steroid hormone receptors are ligand-dependent transcription factors that require the ordered assembly of multichaperone complexes for transcriptional activity. Although heat shock protein (Hsp) 90 and Hsp70 are key players in this process, multiple Hsp70- and Hsp90-associated cochaperones associate with receptor-chaperone complexes to regulate receptor folding and activation. Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) was recently characterized as an Hsp70 and Hsp90-associated cochaperone that specifically regulates androgen receptor activity. However, the specificity of SGTA for additional members of the steroid hormone receptor superfamily and the mechanism by which SGTA regulates receptor activity remain unclear. Here we report that SGTA associates with and specifically regulates the androgen, glucocorticoid, and progesterone receptors and has no effect on the mineralocorticoid and estrogen receptors in both yeast and mammalian cell-based reporter assays. In both systems, SGTA knockdown/deletion enhances receptor activity, whereas SGTA overexpression suppresses receptor activity. We demonstrate that SGTA binds directly to Hsp70 and Hsp90 in vitro with similar affinities yet predominately precipitates with Hsp70 from cell lysates, suggesting a role for SGTA in early, Hsp70-mediated folding. Furthermore, SGTA expression completely abrogates the regulation of receptor function by FKBP52 (52-kDa FK506-binding protein), which acts at a later stage of the chaperone cycle. Taken together, our data suggest a role for SGTA at distinct steps in the chaperone-dependent modulation of androgen, glucocorticoid, and progesterone receptor activity.	[Paul, Atanu; Garcia, Yenni A.; Gutierrez, Omar; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Paul, Atanu; Garcia, Yenni A.; Gutierrez, Omar; Harris, Diondra C.; Balsiger, Heather A.; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Hildenbrand, Zacariah] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Zierer, Bettina; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Garching, Germany; [Patwardhan, Chaitanya; Chadli, Ahmed] Georgia Regents Univ, Canc Res Ctr, Augusta, GA 30912 USA; [Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Technical University of Munich; University System of Georgia; Augusta University; Idaho; University of Idaho	Cox, MB (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	mbcox@utep.edu	Paul, Atanu/J-5720-2019; Buchner, Johannes/A-2651-2010	Paul, Atanu/0000-0002-9967-6005; Gutierrez-Ruiz, Omar/0000-0002-9561-7067; Cox, Marc/0000-0001-7854-2676; Buchner, Johannes/0000-0003-1282-7737	National Institutes of Health [5 G12 RR008124, 8 G12 MD007592, SC1GM084863, R01 GM102443-01]; Direct For Biological Sciences [0744522] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102443, SC1GM084863] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR008124, 8 G12 MD007592, SC1GM084863 (to M. B. C.), and R01 GM102443-01 (to A. C.).	Angeletti PC, 2002, CELL STRESS CHAPERON, V7, P258, DOI 10.1379/1466-1268(2002)007<0258:SGRPVP>2.0.CO;2; Balsiger Heather A., 2009, V505, P141, DOI 10.1007/978-1-60327-575-0_8; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Butler MS, 2013, FERTIL STERIL, V99, P2076, DOI 10.1016/j.fertnstert.2013.01.140; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cox MB, 2007, MOL ENDOCRINOL, V21, P2956, DOI 10.1210/me.2006-0547; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Goodarzi MO, 2008, HUM REPROD, V23, P1214, DOI 10.1093/humrep/den065; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; Laschober GT, 2010, AGING CELL, V9, P1084, DOI 10.1111/j.1474-9726.2010.00637.x; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Liu JW, 1998, FEMS MICROBIOL LETT, V159, P167, DOI 10.1111/j.1574-6968.1998.tb12856.x; McKeen HD, 2008, ENDOCRINOLOGY, V149, P5724, DOI 10.1210/en.2008-0168; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Ommen G, 2010, CELL STRESS CHAPERON, V15, P443, DOI 10.1007/s12192-009-0160-7; Patwardhan CA, 2013, J BIOL CHEM, V288, P7313, DOI 10.1074/jbc.M112.427328; Philp LK, 2013, HORM CANCER-US, V4, P343, DOI 10.1007/s12672-013-0151-0; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Trotta AP, 2013, INT J CANCER, V133, P2812, DOI 10.1002/ijc.28310; Trotta AP, 2012, J MOL ENDOCRINOL, V49, P57, DOI 10.1530/JME-11-0152; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	45	25	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15297	15308		10.1074/jbc.M113.535229	http://dx.doi.org/10.1074/jbc.M113.535229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753260	Green Published, hybrid			2022-12-28	WOS:000337465400014
J	Eryilmaz, E; Shah, NH; Muir, TW; Cowburn, D				Eryilmaz, Ertan; Shah, Neel H.; Muir, Tom W.; Cowburn, David			Structural and Dynamical Features of Inteins and Implications on Protein Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; NOSTOC-PUNCTIFORME; HIGHLY EFFICIENT; SPLIT INTEINS; DNAE INTEIN; BRANCHED INTERMEDIATE; PENULTIMATE HISTIDINE; SUCCINIMIDE FORMATION; CONSERVED ASPARTATE; DIRECTED EVOLUTION	Protein splicing is a posttranslational modification where intervening proteins (inteins) cleave themselves from larger precursor proteins and ligate their flanking polypeptides (exteins) through a multistep chemical reaction. First thought to be an anomaly found in only a few organisms, protein splicing by inteins has since been observed in microorganisms from all domains of life. Despite this broad phylogenetic distribution, all inteins share common structural features such as a horseshoe-like pseudo two-fold symmetric fold, several canonical sequence motifs, and similar splicing mechanisms. Intriguingly, the splicing efficiencies and substrate specificity of different inteins vary considerably, reflecting subtle changes in the chemical mechanism of splicing, linked to their local structure and dynamics. As intein chemistry has widespread use in protein chemistry, understanding the structural and dynamical aspects of inteins is crucial for intein engineering and the improvement of intein-based technologies.	[Eryilmaz, Ertan; Cowburn, David] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Shah, Neel H.; Muir, Tom W.] Princeton Univ, Dept Chem, Frick Lab, Princeton, NJ 08544 USA	Yeshiva University; Albert Einstein College of Medicine; Princeton University	Cowburn, D (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	david.cowburn@einstein.yu.edu	eryilmaz, ertan/G-1372-2010; Muir, Tom/AHD-0860-2022; Shah, Neel H/AAD-9217-2022	eryilmaz, ertan/0000-0002-8839-7094; Muir, Tom/0000-0001-9635-0344; Shah, Neel H/0000-0002-1186-0626; Cowburn, David/0000-0001-6770-7172	National Institutes of Health [GM086868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086868, R37GM086868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086868 (to D. C.). This is the third article in the Thematic Minireview Series "Inteins."	Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Aranko AS, 2013, NAT CHEM BIOL, V9, P616, DOI [10.1038/NCHEMBIO.1320, 10.1038/nchembio.1320]; Aranko AS, 2013, FEBS J, V280, P3256, DOI 10.1111/febs.12307; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Caspi J, 2003, MOL MICROBIOL, V50, P1569, DOI 10.1046/j.1365-2958.2003.03825.x; Chen LX, 2000, J BIOL CHEM, V275, P20431, DOI 10.1074/jbc.M000178200; Cheriyan M, 2013, J BIOL CHEM, V288, P6202, DOI 10.1074/jbc.M112.433094; Dearden AK, 2013, PROTEIN SCI, V22, P557, DOI 10.1002/pro.2236; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2010, J MOL BIOL, V400, P755, DOI 10.1016/j.jmb.2010.05.044; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hiraga K, 2009, J MOL BIOL, V393, P1106, DOI 10.1016/j.jmb.2009.08.074; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Matsumura H, 2006, PROTEINS, V63, P711, DOI 10.1002/prot.20858; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarzer D, 2012, BIOCHEMISTRY-US, V51, P233, DOI 10.1021/bi2014823; Shah NH, 2013, J AM CHEM SOC, V135, P18673, DOI 10.1021/ja4104364; Shah NH, 2013, J AM CHEM SOC, V135, P5839, DOI 10.1021/ja401015p; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shah NH, 2011, ANGEW CHEM INT EDIT, V50, P6511, DOI 10.1002/anie.201102909; SHAO Y, 1995, BIOCHEMISTRY-US, V34, P10844, DOI 10.1021/bi00034a017; Shemella PT, 2011, BIOPHYS J, V100, P2217, DOI 10.1016/j.bpj.2011.02.037; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Volkmann G, 2013, CELL MOL LIFE SCI, V70, P1185, DOI 10.1007/s00018-012-1120-4; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Zheng YC, 2012, BIOSCIENCE REP, V32, P433, DOI 10.1042/BSR20120049	50	48	53	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14506	14511		10.1074/jbc.R113.540302	http://dx.doi.org/10.1074/jbc.R113.540302			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695731	Green Published, hybrid			2022-12-28	WOS:000337248100009
J	Fu, Q; Kim, S; Soto, D; De Arcangelis, V; DiPilato, L; Liu, SB; Xu, B; Shi, Q; Zhang, J; Xiang, YK				Fu, Qin; Kim, Sungjin; Soto, Dagoberto; De Arcangelis, Vania; DiPilato, Lisa; Liu, Shubai; Xu, Bing; Shi, Qian; Zhang, Jin; Xiang, Yang K.			A Long Lasting beta(1) Adrenergic Receptor Stimulation of cAMP/Protein Kinase A (PKA) Signal in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; PHOSPHODIESTERASE; PHOSPHORYLATION; CARDIOMYOCYTES; HOLOENZYME; ARRESTINS; BINDING; CELLS; HEART	Small-molecule, ligand-activated G protein-coupled receptors are generally thought to be rapidly desensitized within a period of minutes through receptor phosphorylation and internalization after repeated or prolonged stimulation. This transient G protein-coupled receptor activation remains at odds with many observed long-lasting cellular and physiological responses. Here, using live cell imaging of cAMP with a FRET-based biosensor and myocyte contraction assay, we show that the catecholamine-activated beta(1) adrenergic receptor (beta(1)AR) continuously stimulates second messenger cAMP synthesis in primary cardiac myocytes and neurons, which lasts for more than 8 h (a decay t(1/2) of 3.9 h) in cardiac myocytes. However, the beta(1)AR-induced cAMP signal is counterbalanced and masked by the receptor-bound phosphodiesterase (PDE) 4D8-dependent cAMP hydrolysis. Inhibition of PDE4 activity recovers the receptor-induced cAMP signal and promotes contractile response in mouse hearts during extended periods of agonist stimulation. beta(1)AR associates with PDE4D8 through the receptor C-terminal PDZ motif-dependent binding to synaptic-associated protein 97 (SAP97). Knockdown of SAP97 or mutation of the beta(1)AR PDZ motif disrupts the complex and promotes sustained agonist-induced cAMP activity, PKA phosphorylation, and cardiac myocyte contraction response. Together, these findings unveil a long lasting adrenergic signal in neurons and myocytes under prolonged stimulation and an underappreciated role of PDE that is essential in classic receptor signaling desensitization and in maintaining a long lasting cAMP equilibrium for ligand-induced physiological response.	[Fu, Qin; Kim, Sungjin; Xu, Bing; Shi, Qian; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Fu, Qin] Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Fu, Qin; Kim, Sungjin; Soto, Dagoberto; De Arcangelis, Vania; Liu, Shubai; Shi, Qian; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [DiPilato, Lisa; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	University of California System; University of California Davis; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Fu, Q (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	fu_qin@aliyun.com; ykxiang@ucdavis.edu	Soto, Dagoberto I/N-6817-2014; Fu, Qin/O-6960-2014	Soto, Dagoberto I/0000-0002-7350-1530; Fu, Qin/0000-0002-7954-7708; liu, shubai/0000-0001-8929-4209; Shi, Qian/0000-0003-2634-9553	National Institutes of Health [DK073368, HL082646]; American Heart Association [0635331N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073368 (to J. Z.) and HL082646 (to Y. X.). This work was also supported by American Heart Association Grant 0635331N (to Y. X.).	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Liu SB, 2012, P NATL ACAD SCI USA, V109, P6578, DOI 10.1073/pnas.1117862109; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Nooh MM, 2014, J BIOL CHEM, V289, P2277, DOI 10.1074/jbc.M113.513481; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Schweizer PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P542, DOI 10.1161/CIRCEP.110.949768; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; St Clair JR, 2013, CHANNELS, V7, P318, DOI 10.4161/chan.25293; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	33	21	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14771	14781		10.1074/jbc.M113.542589	http://dx.doi.org/10.1074/jbc.M113.542589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713698	Green Published, hybrid			2022-12-28	WOS:000337248100033
J	Mailloux, RJ; Xuan, JY; McBride, S; Maharsy, W; Thorn, S; Holterman, CE; Kennedy, CRJ; Rippstein, P; deKemp, R; da Silva, J; Nemer, M; Lou, M; Harper, ME				Mailloux, Ryan J.; Xuan, Jian Ying; McBride, Skye; Maharsy, Wael; Thorn, Stephanie; Holterman, Chet E.; Kennedy, Christopher R. J.; Rippstein, Peter; deKemp, Robert; da Silva, Jean; Nemer, Mona; Lou, Marjorie; Harper, Mary-Ellen			Glutaredoxin-2 Is Required to Control Oxidative Phosphorylation in Cardiac Muscle by Mediating Deglutathionylation Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; COMPLEX-I; REDOX REGULATION; REVERSIBLE GLUTATHIONYLATION; PROTEIN GLUTATHIONYLATION; S-GLUTATHIONYLATION; THIOL PROTEINS; POTENTIAL ROLE; CYS RESIDUES; MECHANISMS	Glutaredoxin-2 (Grx2) modulates the activity of several mitochondrial proteins in cardiac tissue by catalyzing deglutathionylation reactions. However, it remains uncertain whether Grx2 is required to control mitochondrial ATP output in heart. Here, we report that Grx2 plays a vital role modulating mitochondrial energetics and heart physiology by mediating the deglutathionylation of mitochondrial proteins. Deletion of Grx2 (Grx2(-/-)) decreased ATP production by complex I-linked substrates to half that in wild type (WT) mitochondria. Decreased respiration was associated with increased complex I glutathionylation diminishing its activity. Tissue glucose uptake was concomitantly increased. Mitochondrial ATP output and complex I activity could be recovered by restoring the redox environment to that favoring the deglutathionylated states of proteins. Grx2(-/-) hearts also developed left ventricular hypertrophy and fibrosis, and mice became hypertensive. Mitochondrial energetics from Grx2 heterozygotes (Grx2(+/-)) were also dysfunctional, and hearts were hypertrophic. Intriguingly, Grx2(+/-) mice were far less hypertensive than Grx2(-/-) mice. Thus, Grx2 plays a vital role in modulating mitochondrial metabolism in cardiac muscle, and Grx2 deficiency leads to pathology. As mitochondrial ATP production was restored by the addition of reductants, these findings may be relevant to novel redox-related therapies in cardiac disease.	[Mailloux, Ryan J.; Xuan, Jian Ying; McBride, Skye; Maharsy, Wael; Nemer, Mona; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Thorn, Stephanie; Rippstein, Peter; deKemp, Robert; da Silva, Jean] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Holterman, Chet E.; Kennedy, Christopher R. J.] Ottawa Gen Hosp, Kidney Res Ctr, Res Inst, Ottawa, ON K1H 8L6, Canada; [Lou, Marjorie] Univ Nebraska, Ctr Redox Biol, Lincoln, NE 68583 USA; [Lou, Marjorie] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Harper, ME (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca	Thorn, Stephanie/AAD-6988-2022	Mailloux, Ryan/0000-0003-3986-9830; Holterman, Chet/0000-0002-9002-6073; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research [INMD MOP57810]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant INMD MOP57810 (to M. E. H.).	Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Diotte NM, 2009, BBA-MOL CELL RES, V1793, P427, DOI 10.1016/j.bbamcr.2008.10.014; Drose S, 2014, BBA-PROTEINS PROTEOM, V1844, P1344, DOI 10.1016/j.bbapap.2014.02.006; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Giangregorio N, 2013, BBA-GEN SUBJECTS, V1830, P5299, DOI 10.1016/j.bbagen.2013.08.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kang PT, 2012, FREE RADICAL BIO MED, V53, P962, DOI 10.1016/j.freeradbiomed.2012.05.025; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kumar V, 2013, FREE RADICAL BIO MED, V58, P109, DOI 10.1016/j.freeradbiomed.2013.01.021; Lee DW, 2009, ANTIOXID REDOX SIGN, V11, P2083, DOI [10.1089/ars.2009.2489, 10.1089/ARS.2009.2489]; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Passarelli C, 2010, INT J MOL MED, V26, P95, DOI 10.3892/ijmm_00000439; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Schagger H, 2001, J BIOL CHEM, V276, P37861; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Taegtmeyer H, 2002, CIRCULATION, V106, P2043, DOI 10.1161/01.CIR.0000036760.42319.3F; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578	63	70	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14812	14828		10.1074/jbc.M114.550574	http://dx.doi.org/10.1074/jbc.M114.550574			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24727547	Green Published, hybrid			2022-12-28	WOS:000337248100036
J	King, IN; Yartseva, V; Salas, D; Kumar, A; Heidersbach, A; Ando, DM; Stallings, NR; Elliott, JL; Srivastava, D; Ivey, KN				King, Isabelle N.; Yartseva, Valeria; Salas, Donaldo; Kumar, Abhishek; Heidersbach, Amy; Ando, D. Michael; Stallings, Nancy R.; Elliott, Jeffrey L.; Srivastava, Deepak; Ivey, Kathryn N.			The RNA-binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-induced Silencing Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac muscle; Gene Regulation; MicroRNA; RNA-binding Protein; RNA-Protein Interaction; Skeletal Muscle	AMYOTROPHIC-LATERAL-SCLEROSIS; MUSCLE; DIFFERENTIATION; PROLIFERATION; EXPRESSION; PROMOTES; MIR-1; HEART; MICE; CARDIOGENESIS	Background: Regulation of microRNA activity independent of processing and biogenesis has not been demonstrated. Results: The RNA-binding protein, TDP-43, interacts with mature miR-1/miR-206, limiting their RNA-induced silencing complex (RISC) association and activity. Conclusion: RNA-binding proteins can selectively control microRNA activity by disrupting RISC incorporation. Significance: This is the first known microRNA-protein interaction that controls microRNA activity independent of processing. MicroRNA (miRNA) maturation is regulated by interaction of particular miRNA precursors with specific RNA-binding proteins. Following their biogenesis, mature miRNAs are incorporated into the RNA-induced silencing complex (RISC) where they interact with mRNAs to negatively regulate protein production. However, little is known about how mature miRNAs are regulated at the level of their activity. To address this, we screened for proteins differentially bound to the mature form of the miR-1 or miR-133 miRNA families. These muscle-enriched, co-transcribed miRNA pairs cooperate to suppress smooth muscle gene expression in the heart. However, they also have opposing roles, with the miR-1 family, composed of miR-1 and miR-206, promoting myogenic differentiation, whereas miR-133 maintains the progenitor state. Here, we describe a physical interaction between TDP-43, an RNA-binding protein that forms aggregates in the neuromuscular disease, amyotrophic lateral sclerosis, and the miR-1, but not miR-133, family. Deficiency of the TDP-43 Drosophila ortholog enhanced dmiR-1 activity in vivo. In mammalian cells, TDP-43 limited the activity of both miR-1 and miR-206, but not the miR-133 family, by disrupting their RISC association. Consistent with TDP-43 dampening miR-1/206 activity, protein levels of the miR-1/206 targets, IGF-1 and HDAC4, were elevated in TDP-43 transgenic mouse muscle. This occurred without corresponding Igf-1 or Hdac4 mRNA increases and despite higher miR-1 and miR-206 expression. Our findings reveal that TDP-43 negatively regulates the activity of the miR-1 family of miRNAs by limiting their bioavailability for RISC loading and suggest a processing-independent mechanism for differential regulation of miRNA activity.	[King, Isabelle N.; Yartseva, Valeria; Salas, Donaldo; Kumar, Abhishek; Heidersbach, Amy; Srivastava, Deepak; Ivey, Kathryn N.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ando, D. Michael] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [King, Isabelle N.; Srivastava, Deepak; Ivey, Kathryn N.] Univ Calif San Francisco, Dept Pediat, Grad Program, San Francisco, CA 94158 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, Grad Program, San Francisco, CA 94158 USA; [Heidersbach, Amy; Ando, D. Michael] Univ Calif San Francisco, Dept Biomed Sci, Grad Program, San Francisco, CA 94158 USA; [Stallings, Nancy R.; Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75235 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ivey, KN (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	kivey@gladstone.ucsf.edu		Stallings, Nancy/0000-0001-6132-1586; Srivastava, Deepak/0000-0002-3480-5953; Ando, Michael/0000-0001-9022-8444	National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant [P41GM103481]; March of Dimes; National Science Foundation; National Institutes of Health/NHLBI Grant [R01HL057181]; William Younger Family Foundation; L. K. Whittier Foundation; Eugene Roddenberry Foundation; American Heart Association [11SDG5190024]; Amyotrophic Lateral Sclerosis Association [679Y22]; National Institutes of Health/National Center for Research Resources Grant [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant; March of Dimes(March of Dimes); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NHLBI Grant; William Younger Family Foundation; L. K. Whittier Foundation; Eugene Roddenberry Foundation; American Heart Association(American Heart Association); Amyotrophic Lateral Sclerosis Association; National Institutes of Health/National Center for Research Resources Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health/NIGMS/Biomedical Technology Research Centers Grant P41GM103481 to the UCSF Mass Spectrometry Facility; The March of Dimes (to I. N. K.); the National Science Foundation (to A. H.); the National Institutes of Health/NHLBI Grant R01HL057181 (to D. S.); the William Younger Family Foundation (to D. S.); the L. K. Whittier Foundation (to D. S.); the Eugene Roddenberry Foundation (to D. S.); the American Heart Association Grant 11SDG5190024 (to K. N. I.); the Amyotrophic Lateral Sclerosis Association Grant 679Y22 (to K. N. I.); and the National Institutes of Health/National Center for Research Resources Grant RR18928 to The Gladstone Institutes.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bruneteau G, 2013, BRAIN, V136, P2359, DOI 10.1093/brain/awt164; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; Darnell Robert, 2012, Cold Spring Harb Protoc, V2012, P1146, DOI 10.1101/pdb.prot072132; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Gagan J, 2012, CURR OPIN PHARMACOL, V12, P383, DOI 10.1016/j.coph.2012.02.001; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; King IN, 2011, DEV CELL, V20, P497, DOI 10.1016/j.devcel.2011.03.010; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wei YS, 2014, CELL RES, V24, P278, DOI 10.1038/cr.2014.12; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	29	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14263	14271		10.1074/jbc.M114.561902	http://dx.doi.org/10.1074/jbc.M114.561902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719334	Green Published, hybrid			2022-12-28	WOS:000335984600051
J	Andersen, JT; Dalhus, B; Viuff, D; Ravn, BT; Gunnarsen, KS; Plumridge, A; Bunting, K; Antunes, F; Williamson, R; Athwal, S; Allan, E; Evans, L; Bjoras, M; Kjaerulff, S; Sleep, D; Sandlie, I; Cameron, J				Andersen, Jan Terje; Dalhus, Bjorn; Viuff, Dorthe; Ravn, Birgitte Thue; Gunnarsen, Kristin Stoen; Plumridge, Andrew; Bunting, Karen; Antunes, Filipa; Williamson, Rebecca; Athwal, Steven; Allan, Elizabeth; Evans, Leslie; Bjoras, Magnar; Kjaerulff, Soren; Sleep, Darrell; Sandlie, Inger; Cameron, Jason			Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor ( FcRn) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Animal Models; Antibody Engineering; Biodegradation; Bioengineering; FC Receptors; pH Regulation; Pharmacokinetics	I-RELATED RECEPTOR; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; THERAPEUTIC ANTIBODIES; HUMAN-IGG; COMPLEX; REVEALS; PHARMACOKINETICS; MUTAGENESIS; EXPRESSION	Background: FcRn controls the long serum half-life of albumin. Results: A single amino acid substitution of albumin considerably improved binding to FcRn and extended serum half-life in mice and rhesus monkeys. Conclusion: Serum half-life of albumin may be tailored by engineering the FcRn-albumin interaction. Significance: This study reports on engineered albumin that may be attractive for improving the serum half-life of biopharmaceuticals. A major challenge for the therapeutic use of many peptides and proteins is their short circulatory half-life. Albumin has an extended serum half-life of 3 weeks because of its size and FcRn-mediated recycling that prevents intracellular degradation, properties shared with IgG antibodies. Engineering the strictly pH-dependent IgG-FcRn interaction is known to extend IgG half-life. However, this principle has not been extensively explored for albumin. We have engineered human albumin by introducing single point mutations in the C-terminal end that generated a panel of variants with greatly improved affinities for FcRn. One variant (K573P) with 12-fold improved affinity showed extended serum half-life in normal mice, mice transgenic for human FcRn, and cynomolgus monkeys. Importantly, favorable binding to FcRn was maintained when a single-chain fragment variable antibody was genetically fused to either the N- or the C-terminal end. The engineered albumin variants may be attractive for improving the serum half-life of biopharmaceuticals.	[Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Natl Hosp Norway, Ctr Immune Regulat, Oslo Univ Hosp, N-0424 Oslo, Norway; [Andersen, Jan Terje; Gunnarsen, Kristin Stoen; Sandlie, Inger] Natl Hosp Norway, Dept Immunol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn] Natl Hosp Norway, Dept Med Biochem, Oslo Univ Hosp, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, N-0424 Oslo, Norway; [Viuff, Dorthe; Plumridge, Andrew; Bunting, Karen; Williamson, Rebecca; Athwal, Steven; Allan, Elizabeth; Evans, Leslie; Kjaerulff, Soren; Sleep, Darrell; Cameron, Jason] Novozymes Biopharma UK, Nottingham NG7 1FD, England; [Ravn, Birgitte Thue; Antunes, Filipa] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Novozymes; Novozymes	Andersen, JT (corresponding author), Natl Hosp Norway, Dept Immunol, Oslo Univ Hosp, POB 4950, N-0424 Oslo, Norway.	j.t.andersen@ibv.uio.no; jsoc@novozymes.com	Andersen, Jan Terje/AAB-6209-2020; Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017	Sleep, Darrell/0000-0001-8287-9538; Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway through Centres of Excellence Funding Scheme Project [179573]; Norwegian Research Council [179573, 179573/V40]; South-Eastern Norway Regional Health Authority [39375]; South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants [2009100, 2011040, 2012085]	Research Council of Norway through Centres of Excellence Funding Scheme Project; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants	This work was supported in part by the Research Council of Norway through Centres of Excellence Funding Scheme Project Number 179573. This work was also supported by Norwegian Research Council Grant 179573/V40 and South-Eastern Norway Regional Health Authority Grant 39375 (to J. T. A.), Norwegian Research Council Grant 179573 (to K. S. G.), and South-Eastern Norway Regional Health Authority through Regional Technology Platform for Structural Biology and Bioinformatics Grants 2009100, 2011040, and 2012085 (to M. B. and B. D.). I. S., J. T. A., B. D., J. C., A. P., L. E., and D. S. are co-inventors of pending patent applications related to the data described in this paper.	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VANZETTI G, 1979, HUM GENET, V46, P5, DOI 10.1007/BF00278896; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	36	103	123	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13492	13502		10.1074/jbc.M114.549832	http://dx.doi.org/10.1074/jbc.M114.549832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652290	Green Published, hybrid			2022-12-28	WOS:000335522800045
J	Fukunaga, T; Zou, W; Warren, JT; Teitelbaum, SL				Fukunaga, Tomohiro; Zou, Wei; Warren, Julia T.; Teitelbaum, Steven L.			Vinculin Regulates Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Biology; Cytoskeleton; Integrins; Osteoclast; Vinculin	ALPHA-V-BETA-3 INTEGRIN; RESORBING OSTEOCLASTS; FOCAL ADHESIONS; ACTIN DYNAMICS; CYTOSKELETON; ACTIVATION; LIGAND; SYK; MACROPHAGES; PHENOTYPE	Background: Vinculin, an actin-binding protein, is essential for cytoskeletal organization. Results: Vinculin deficiency in osteoclasts impairs osteoclast function, not differentiation, leading to increased bone mass in vivo. Conclusion: Vinculin expression regulates osteoclast function in a talin-dependent, v3 integrin-independent manner. Significance: This is the first demonstration that vinculin regulates osteoclast function. Osteoclastic bone resorption depends upon the cell's ability to organize its cytoskeleton. Because vinculin (VCL) is an actin-binding protein, we asked whether it participates in skeletal degradation. Thus, we mated VCLfl/fl mice with those expressing cathepsin K-Cre (CtsK-VCL) to delete the gene in mature osteoclasts or lysozyme M-Cre (LysM-VCL) to target all osteoclast lineage cells. VCL-deficient osteoclasts differentiate normally but, reflecting cytoskeletal disorganization, form small actin rings and fail to effectively resorb bone. In keeping with inhibited resorptive function, CtsK-VCL and LysM-VCL mice exhibit a doubling of bone mass. Despite cytoskeletal disorganization, the capacity of VCL-/- osteoclastic cells to normally phosphorylate c-Src in response to v3 integrin ligand is intact. Thus, integrin-activated signals are unrelated to the means by which VCL organizes the osteoclast cytoskeleton. WT VCL completely rescues actin ring formation and bone resorption, as does VCLP878A, which is incapable of interacting with Arp2/3. As expected, deletion of the VCL tail domain (VCL1-880), which binds actin, does not normalize VCL-/- osteoclasts. The same is true regarding VCLI997A, which also prevents VCL/actin binding, and VCLA50I and VCL811-1066, both of which arrest talin association. Thus, VCL binding talin, but not Arp2/3, is critical for osteoclast function, and its selective inhibition retards physiological bone loss.	[Fukunaga, Tomohiro; Zou, Wei; Warren, Julia T.; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Fukunaga, Tomohiro/T-4339-2019	Fukunaga, Tomohiro/0000-0003-0533-6454; Zou, Wei/0000-0001-8081-268X; Warren, Julia/0000-0003-2017-6444; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [R01 AR032788, R01 AR057037, R01 AR046523, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057037, R01AR046523, R01AR032788, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR032788, R01 AR057037, R01 AR046523, and P30 AR057235.	Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croke M, 2011, J CELL SCI, V124, P3811, DOI 10.1242/jcs.086280; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2002, J CELL SCI, V115, P2919; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Pollard TD, 2001, J CELL SCI, V114, P3; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2013, J CELL BIOCHEM, V114, P1871, DOI 10.1002/jcb.24531; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12; Zou W, 2012, J BONE MINER RES, V27, P2490, DOI 10.1002/jbmr.1706	36	33	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13554	13564		10.1074/jbc.M114.550731	http://dx.doi.org/10.1074/jbc.M114.550731			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675074	hybrid, Green Published			2022-12-28	WOS:000335522800050
J	Porcelli, V; Fiermonte, G; Longo, A; Palmieri, F				Porcelli, Vito; Fiermonte, Giuseppe; Longo, Antonella; Palmieri, Ferdinando			The Human Gene SLC25A29, of Solute Carrier Family 25, Encodes a Mitochondrial Transporter of Basic Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Liposomes; Mitochondrial Transport; Recombinant Protein Expression; Reconstitution of Membrane Transporters; SLC25 Family; SLC25A29; Basic Amino Acids; Membrane Transport Protein; Mitochondrial Carrier	BACTERIAL EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; TISSUE DISTRIBUTION; CARNITINE/ACYLCARNITINE CARRIER; CARNITINE CARRIER; OXOGLUTARATE CARRIER; ARGINASE-II; IDENTIFICATION; RECONSTITUTION	Background: SLC25A29 encoded by the human SLC25A29 gene was suggested to be a mitochondrial carnitine/acylcarnitine- or ornithine-like transporter. Results: The recombinant, purified SLC25A29 transports arginine, lysine, and to a lesser extent ornithine and histidine but not carnitine and acylcarnitines. Conclusion: SLC25A29 is a mitochondrial transporter for basic amino acids. Significance: Another member of the mitochondrial carrier superfamily responsible for 12 monogenic diseases has been thoroughly characterized. The human genome encodes 53 members of the solute carrier family 25 (SLC25), also called the mitochondrial carrier family, many of which have been shown to transport carboxylates, amino acids, nucleotides, and cofactors across the inner mitochondrial membrane, thereby connecting cytosolic and matrix functions. In this work, a member of this family, SLC25A29, previously reported to be a mitochondrial carnitine/acylcarnitine- or ornithine-like carrier, has been thoroughly characterized biochemically. The SLC25A29 gene was overexpressed in Escherichia coli, and the gene product was purified and reconstituted in phospholipid vesicles. Its transport properties and kinetic parameters demonstrate that SLC25A29 transports arginine, lysine, homoarginine, methylarginine and, to a much lesser extent, ornithine and histidine. Carnitine and acylcarnitines were not transported by SLC25A29. This carrier catalyzed substantial uniport besides a counter-exchange transport, exhibited a high transport affinity for arginine and lysine, and was saturable and inhibited by mercurial compounds and other inhibitors of mitochondrial carriers to various degrees. The main physiological role of SLC25A29 is to import basic amino acids into mitochondria for mitochondrial protein synthesis and amino acid degradation.	[Porcelli, Vito; Fiermonte, Giuseppe; Longo, Antonella; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Lab Biochem & Mol Biol, I-70125 Bari, Italy; [Fiermonte, Giuseppe; Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Palmieri, F (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	ferdpalmieri@gmail.com	Fiermonte, Giuseppe/D-3680-2018	Fiermonte, Giuseppe/0000-0002-6764-9395; PORCELLI, Vito/0000-0002-3634-9613	Ministero dell'Universita e della Ricerca (MIUR); National Research Council (CNR); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet Grant (MIUR) [RBRN07BMCT_009]	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet Grant (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MIUR), the National Research Council (CNR), Centro di Eccellenza in Genomica Comparata (CEGBA), Apulia Region, and the Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR).	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; BLEMINGS KP, 1994, J NUTR, V124, P1215, DOI 10.1093/jn/124.8.1215; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Camacho JA, 2009, PEDIATR RES, V66, P35, DOI 10.1203/PDR.0b013e3181a283c1; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Giangregorio N, 2010, BBA-BIOENERGETICS, V1797, P839, DOI 10.1016/j.bbabio.2010.03.017; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; INDIVERI C, 1990, BIOCHIM BIOPHYS ACTA, V1020, P81, DOI 10.1016/0005-2728(90)90096-M; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 1979, Methods Enzymol, V56, P279; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Sekoguchi E, 2003, J BIOL CHEM, V278, P38796, DOI 10.1074/jbc.M306372200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todisco S, 2014, BBA-BIOENERGETICS, V1837, P326, DOI 10.1016/j.bbabio.2013.11.013; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	56	60	64	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13374	13384		10.1074/jbc.M114.547448	http://dx.doi.org/10.1074/jbc.M114.547448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652292	hybrid, Green Published			2022-12-28	WOS:000335522800036
J	Gyore, J; Parameswar, AR; Hebbard, CFF; Oh, Y; Bi, EF; Demchenko, AV; Price, NP; Orlean, P				Gyore, Jacob; Parameswar, Archana R.; Hebbard, Carleigh F. F.; Oh, Younghoon; Bi, Erfei; Demchenko, Alexei V.; Price, Neil P.; Orlean, Peter			2-Acylamido Analogues of N-Acetylglucosamine Prime Formation of Chitin Oligosaccharides by Yeast Chitin Synthase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Chitin; Glycosyltransferases; Polysaccharide; Yeast Physiology	SACCHAROMYCES-CEREVISIAE; CELLULOSE SYNTHESIS; CELL-WALL; PURIFICATION; BIOSYNTHESIS; SYNTHETASE; EXTRACTION; BINDING; SITES; FUNGI	Background: Chitin synthases are stimulated by N-acetylglucosamine (GlcNAc). Results: GlcNAc and 2-acylamido analogues of GlcNAc stimulate formation of chitin oligosaccharides by yeast chitin synthase, and GlcNAc is transferred to the 2-acylamido analogues. Conclusion: Chitin synthases use GlcNAc analogues as primers and transfer one GlcNAc at a time. Significance: Results are new insights into polysaccharide synthase mechanism and suggest ways of synthesizing novel modified polysaccharides. Chitin, a homopolymer of 1,4-linked N-acetylglucosamine (GlcNAc) residues, is a key component of the cell walls of fungi and the exoskeletons of arthropods. Chitin synthases transfer GlcNAc from UDP-GlcNAc to preexisting chitin chains in reactions that are typically stimulated by free GlcNAc. The effect of GlcNAc was probed by using a yeast strain expressing a single chitin synthase, Chs2, by examining formation of chitin oligosaccharides (COs) and insoluble chitin, and by replacing GlcNAc with 2-acylamido analogues of GlcNAc. Synthesis of COs was strongly dependent on inclusion of GlcNAc in chitin synthase incubations, and N,N-diacetylchitobiose (GlcNAc(2)) was the major reaction product. Formation of both COs and insoluble chitin was also stimulated by GlcNAc(2) and by N-propanoyl-, N-butanoyl-, and N-glycolylglucosamine. MALDI analyses of the COs made in the presence of 2-acylamido analogues of GlcNAc showed they that contained a single GlcNAc analogue and one or more additional GlcNAc residues. These results indicate that Chs2 can use certain 2-acylamido analogues of GlcNAc, and likely free GlcNAc and GlcNAc(2) as well, as GlcNAc acceptors in a UDP-GlcNAc-dependent glycosyltransfer reaction. Further, formation of modified disaccharides indicates that CSs can transfer single GlcNAc residues.	[Gyore, Jacob; Hebbard, Carleigh F. F.; Orlean, Peter] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Parameswar, Archana R.; Demchenko, Alexei V.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA; [Oh, Younghoon; Bi, Erfei] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Price, Neil P.] ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Saint Louis; University of Pennsylvania; Pennsylvania Medicine; United States Department of Agriculture (USDA)	Orlean, P (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	p-orlean@illinois.edu		Demchenko, Alexei/0000-0003-3515-212X	National Institutes of Health [GM077170, GM87365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM077170, R01GM087365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077170 (to A.V.D.) and GM87365 (to E.B.).	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Becker Hubert F, 2011, BMC Res Notes, V4, P454, DOI 10.1186/1756-0500-4-454; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CABIB E, 1987, METHOD ENZYMOL, V138, P643; CABIB E, 1987, ADV ENZYMOL RAMB, V59, P59; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrano L, 1997, J ANTIBIOT, V50, P177, DOI 10.7164/antibiotics.50.177; FAHNRICH M, 1981, EUR J BIOCHEM, V121, P113, DOI 10.1111/j.1432-1033.1981.tb06438.x; Horsch M, 1996, EUR J BIOCHEM, V237, P476, DOI 10.1111/j.1432-1033.1996.0476k.x; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; KANG MS, 1984, J BIOL CHEM, V259, P4966; KELLER FA, 1971, J BIOL CHEM, V246, P160; Kristova V, 2005, J BIOTECHNOL, V115, P157, DOI 10.1016/j.jbiotec.2004.08.007; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Lubineau A, 1994, Bioorg Med Chem, V2, P669, DOI 10.1016/0968-0896(94)85016-X; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Oh Y, 2012, MOL BIOL CELL, V23, P2445, DOI 10.1091/mbc.E12-01-0033; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Redmond JW, 1999, CARBOHYD RES, V319, P74, DOI 10.1016/S0008-6215(99)00130-5; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; SBURLATI A, 1986, J BIOL CHEM, V261, P5147; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Tanaka T, 1999, APPL ENVIRON MICROB, V65, P5338; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yabe T, 1998, EUR J BIOCHEM, V258, P941, DOI 10.1046/j.1432-1327.1998.2580941.x	33	8	8	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12835	12841		10.1074/jbc.M114.550749	http://dx.doi.org/10.1074/jbc.M114.550749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24619411	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000335581400052
J	Koie, M; Okumura, K; Hisanaga, A; Kamei, T; Sasaki, K; Deng, M; Baba, A; Kohno, T; Hattori, M				Koie, Mari; Okumura, Kyoko; Hisanaga, Arisa; Kamei, Takana; Sasaki, Kazutomo; Deng, Mengyan; Baba, Atsushi; Kohno, Takao; Hattori, Mitsuharu			Cleavage within Reelin Repeat 3 Regulates the Duration and Range of the Signaling Activity of Reelin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Brain; Endosomes; Neurons; Protein Degradation; Signal Transduction; Dab1; Reelin	C-TERMINAL REGION; APOE RECEPTOR 2; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; BRAIN-DEVELOPMENT; TYROSINE PHOSPHORYLATION; LIPOPROTEIN RECEPTORS; NEURONAL MIGRATION; VLDL RECEPTOR; BINDING	Background: The physiological role of Reelin proteolysis is largely uncharacterized. Results: An uncleavable Reelin mutant remains active for a long time, and the cleaved Reelin fragment localizes differently than full-length Reelin. Conclusion: Extracellular and intracellular Reelin cleavage is required for halting downstream signaling and transport of the cleaved product. Significance: Inhibition of Reelin cleavage will be beneficial for treating neuropsychiatric diseases. Reelin is a secreted glycoprotein that plays essential roles in the brain. Reelin is specifically cleaved at two distinct sites, called N-t and C-t, with the former being the major one. N-t cleavage can occur both in the extracellular space and in the endosomes, although the physiological importance of endosomal N-t cleavage has not been investigated. In this study, we first determined the exact N-t cleavage site catalyzed by a protease secreted by cerebral cortical neurons. Cleavage occurred between Pro-1244 and Ala-1245 within Reelin repeat 3. A Reelin mutant in which Pro-1244 was replaced with aspartate (Reelin-PD) was resistant to a protease secreted by cultured cerebral cortical neurons, and its biological activity stayed active longer than that of wild-type Reelin. Interestingly, Reelin-PD remained in the intracellular compartments longer than wild-type Reelin and persistently activated downstream signaling. Therefore, N-t cleavage of Reelin is required for halting the signaling machinery in the extracellular space as well as within endosomes of target neurons. We established a monoclonal antibody specific to uncleaved Reelin protein and found that it is localized in the vicinity of Reelin-producing cells, whereas the N-terminal fragment diffuses, or is transported, to distant regions. These data demonstrate that N-t cleavage of Reelin plays critical roles in regulating the duration and range of Reelin functions both in the extracellular milieu and in the intracellular compartments.	[Koie, Mari; Okumura, Kyoko; Hisanaga, Arisa; Kamei, Takana; Sasaki, Kazutomo; Deng, Mengyan; Baba, Atsushi; Kohno, Takao; Hattori, Mitsuharu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Nagoya, Aichi 4678603, Japan	Nagoya City University	Hattori, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	mhattori@phar.nagoya-cu.ac.jp	Hattori, Mitsuharu/F-3859-2010	Hattori, Mitsuharu/0000-0002-0503-4969; Kohno, Takao/0000-0003-2557-4281; Baba, Atsushi/0000-0002-6871-7249	Ministry of Education, Culture, Sports, Science, and Technology [KAKENHI 22390016, 23123519, 22890155, 24790081]; Center for Intellectual Property Strategies of Japan Science and Technology Agency; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Intellectual Property Strategies of Japan Science and Technology Agency; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants KAKENHI 22390016 and 23123519 (to M. H.) and 22890155 and 24790081 (to T. K.), by grants from the Center for Intellectual Property Strategies of Japan Science and Technology Agency and from the Takeda Science Foundation (to M.H.).	Absil P, 2003, CELL TISSUE RES, V312, P81, DOI 10.1007/s00441-003-0701-9; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bock HH, 2004, J BIOL CHEM, V279, P33471, DOI 10.1074/jbc.M401770200; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P1245, DOI 10.1016/j.joca.2008.02.013; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hibi T, 2009, FEBS LETT, V583, P1299, DOI 10.1016/j.febslet.2009.03.024; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hisanaga A, 2012, FEBS LETT, V586, P3349, DOI 10.1016/j.febslet.2012.07.017; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Krstic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047793; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Rogers JT, 2013, J PSYCHOPHARMACOL, V27, P386, DOI 10.1177/0269881112463468; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Saez-Valero J, 2003, J NEUROSCI RES, V72, P132, DOI 10.1002/jnr.10554; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Simo S, 2013, DEV CELL, V27, P399, DOI 10.1016/j.devcel.2013.09.022; Stranahan AM, 2013, AGEING RES REV, V12, P815, DOI 10.1016/j.arr.2013.01.005; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Tinnes S, 2011, FASEB J, V25, P1002, DOI 10.1096/fj.10-168294; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Verbrugghe P, 2012, AM J MED GENET B, V159B, P392, DOI 10.1002/ajmg.b.32042; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015	55	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12922	12930		10.1074/jbc.M113.536326	http://dx.doi.org/10.1074/jbc.M113.536326			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644294	Green Published, hybrid			2022-12-28	WOS:000335581400060
J	Iannotti, MJ; Figard, L; Sokac, AM; Sifers, RN				Iannotti, Michael J.; Figard, Lauren; Sokac, Anna M.; Sifers, Richard N.			A Golgi-localized Mannosidase ( MAN1B1) Plays a Nonenzymatic Gatekeeper Role in Protein Biosynthetic Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Glycoprotein; ER Quality Control; ER-associated Degradation; ERAD; Glycoprotein Secretion; Glycosidases; Protein Degradation; Protein Evolution; Protein Misfolding; Protein Sorting	RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; FAMILY-47 ALPHA-MANNOSIDASES; N-GLYCAN BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; STRUCTURAL BASIS; EDEM1 PROTEIN; ALPHA-1,2-MANNOSIDASE	Background: The capacity of Golgi-localized MAN1B1 to promote ERAD was investigated. Results: The MAN1B1 catalytic domain is dispensable for ERAD, which helped identify an important conserved, non-enzymatic decapeptide sequence within the luminal stem. Conclusion: The tempo-spatial expansion of quality control in the secretory pathway includes evolutionary gain-of-function for MAN1B1. Significance: Evolutionary distinctions can exist in how quality control systems operate. Conformation-based disorders are manifested at the level of protein structure, necessitating an accurate understanding of how misfolded proteins are processed by the cellular proteostasis network. Asparagine-linked glycosylation plays important roles for protein quality control within the secretory pathway. The suspected role for the MAN1B1 gene product MAN1B1, also known as ER mannosidase I, is to function within the ER similar to the yeast ortholog Mns1p, which removes a terminal mannose unit to initiate a glycan-based ER-associated degradation (ERAD) signal. However, we recently discovered that MAN1B1 localizes to the Golgi complex in human cells and uncovered its participation in ERAD substrate retention, retrieval to the ER, and subsequent degradation from this organelle. The objective of the current study was to further characterize the contribution of MAN1B1 as part of a Golgi-based quality control network. Multiple lines of experimental evidence support a model in which neither the mannosidase activity nor catalytic domain is essential for the retention or degradation of the misfolded ERAD substrate Null Hong Kong. Instead, a highly conserved, vertebrate-specific non-enzymatic decapeptide sequence in the luminal stem domain plays a significant role in controlling the fate of overexpressed Null Hong Kong. Together, these findings define a new functional paradigm in which Golgi-localized MAN1B1 can play a mannosidase-independent gatekeeper role in the proteostasis network of higher eukaryotes.	[Iannotti, Michael J.; Figard, Lauren; Sokac, Anna M.; Sifers, Richard N.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Figard, Lauren; Sokac, Anna M.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Iannotti, Michael J.; Sifers, Richard N.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Sifers, RN (corresponding author), Dept Pathol & Immunol, 1 Baylor Plaza,Rm T228, Houston, TX 77030 USA.	rsifers@bcm.edu	Sifers, Richard Norman/AGQ-7262-2022		National Institutes of Health [RO1 DK064232]; Alpha1-Foundation; Huffington Center on Aging Biology of Aging Training Grant [T32AG000183-19]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha1-Foundation; Huffington Center on Aging Biology of Aging Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK064232. This work has also been supported by a grant from the Alpha1-Foundation (to R. N. S.) and Huffington Center on Aging Biology of Aging Training Grant T32AG000183-19 (to M. J. I.).	Anelli T, 2010, SEMIN CELL DEV BIOL, V21, P520, DOI 10.1016/j.semcdb.2010.02.006; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Burke J, 1996, EUR J CELL BIOL, V70, P298; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dole K, 1997, J STRUCT BIOL, V120, P69, DOI 10.1006/jsbi.1997.3903; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Groisman B, 2011, J BIOL CHEM, V286, P1292, DOI 10.1074/jbc.M110.154849; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; JELINEKKELLY S, 1985, J BIOL CHEM, V260, P2253; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; KLUG WS, 2006, CONCEPTS GENETICS; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Nyfeler B., 2008, GOLGI APPARATUS; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Pan SJ, 2013, MOL BIOL CELL, V24, P1111, DOI 10.1091/mbc.E12-12-0886; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200	58	29	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11844	11858		10.1074/jbc.M114.552091	http://dx.doi.org/10.1074/jbc.M114.552091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627495	Green Published, hybrid			2022-12-28	WOS:000335010600024
J	Kopach, P; Lockatell, V; Pickering, EM; Haskell, RE; Anderson, RD; Hasday, JD; Todd, NW; Luzina, IG; Atamas, SP				Kopach, Pavel; Lockatell, Virginia; Pickering, Edward M.; Haskell, Ronald E.; Anderson, Richard D.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.			IFN-gamma Directly Controls IL-33 Protein Level through a STAT1and LMP2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Cytokines; Interferon; Immunology; Inflammation; Interleukin; LMP2; STAT1; Interferon-; Interleukin-33; Interleukin-4	RECEPTOR FAMILY-MEMBER; INNATE LYMPHOID-CELLS; INTERFERON-GAMMA; CYTOKINE IL-33; UP-REGULATION; INTRATRACHEAL INSTILLATION; TRANSCRIPTIONAL RESPONSE; PULMONARY INFLAMMATION; COLLAGEN PRODUCTION; PROGENITOR CELLS	Background: IL-33 levels are regulated through poorly understood cytokine-dependent mechanisms. Results: IFN- but not IL-4 down-regulates IL-33 protein by activating STAT1 and LMP2 proteasome, without engaging caspase-1, -3, or -8. Conclusion: Down-regulation of IL-33 protein by IFN- requires STAT1 and non-canonical involvement of LMP2 proteasome. Significance: Understanding the mechanisms of IL-33 regulation is important for the development of IL-33-targeting therapies. IL-33 contributes to disease processes in association with Th1 and Th2 phenotypes. IL-33 mRNA is rapidly regulated, but the fate of synthesized IL-33 protein is unknown. To understand the interplay among IL-33, IFN-, and IL-4 proteins, recombinant replication-deficient adenoviruses were produced and used for dual expression of IL-33 and IFN- or IL-33 and IL-4. The effects of such dual gene delivery were compared with the effects of similar expression of each of these cytokines alone. In lung fibroblast culture, co-expression of IL-33 and IFN- resulted in suppression of the levels of both proteins, whereas co-expression of IL-33 and IL-4 led to mutual elevation. In vivo, co-expression of IL-33 and IFN- in the lungs led to attenuation of IL-33 protein levels. Purified IFN- also attenuated IL-33 protein in fibroblast culture, suggesting that IFN- controls IL-33 protein degradation. Specific inhibition of caspase-1, -3, and -8 had minimal effect on IFN--driven IL-33 protein down-regulation. Pharmacological inhibition, siRNA-mediated silencing, or gene deficiency of STAT1 potently up-regulated IL-33 protein expression levels and attenuated the down-regulating effect of IFN- on IL-33. Stimulation with IFN- strongly elevated the levels of the LMP2 proteasome subunit, known for its role in IFN--regulated antigen processing. siRNA-mediated silencing of LMP2 expression abrogated the effect of IFN- on IL-33. Thus, IFN-, IL-4, and IL-33 are engaged in a complex interplay. The down-regulation of IL-33 protein levels by IFN- in pulmonary fibroblasts and in the lungs in vivo occurs through STAT1 and non-canonical use of the LMP2 proteasome subunit in a caspase-independent fashion.	[Kopach, Pavel; Lockatell, Virginia; Pickering, Edward M.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pickering, Edward M.; Hasday, Jeffrey D.; Todd, Nevins W.; Luzina, Irina G.; Atamas, Sergei P.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Haskell, Ronald E.; Anderson, Richard D.] ViraQuest Inc, North Liberty, IA 52317 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Atamas, SP (corresponding author), Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA.	satamas@umaryland.edu			National Institutes of Health from NHLBI [R21HL106196]; Veterans Affairs Merit Awards [I01CX000101, I01CX000107]; Mark Flapan Award from the Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106196] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000101, I01CX000107] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Mark Flapan Award from the Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in whole or in part, by National Institutes of Health Grant R21HL106196 from NHLBI (to S. P. A.). This study was also supported by Veterans Affairs Merit Awards I01CX000101 (to I. G. L.) and I01CX000107 (to S. P. A.) and a Mark Flapan Award from the Scleroderma Foundation (to I. G. L.).	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Ando M, 2012, J GENE MED, V14, P288, DOI 10.1002/jgm.2616; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Atamas SP, 2002, J IMMUNOL, V168, P1139, DOI 10.4049/jimmunol.168.3.1139; Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L; Badea I, 2012, GENE THER, V19, P978, DOI 10.1038/gt.2011.159; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Demyanets S, 2013, J MOL CELL CARDIOL, V60, P16, DOI 10.1016/j.yjmcc.2013.03.020; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Hoey T, 1997, SCIENCE, V278, P1578, DOI 10.1126/science.278.5343.1578; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liang YJ, 2013, J IMMUNOL, V190, P5666, DOI 10.4049/jimmunol.1300117; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luzina IG, 2006, AM J RESP CELL MOL, V35, P298, DOI 10.1165/rcmb.2006-0033OC; Luzina IG, 2006, ARTHRITIS RHEUM-US, V54, P2643, DOI 10.1002/art.21950; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; Luzina IG, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-2; Luzina IG, 2011, IMMUNOLOGY, V132, P385, DOI 10.1111/j.1365-2567.2010.03393.x; Luzina IG, 2011, J LEUKOCYTE BIOL, V89, P763, DOI 10.1189/jlb.0510271; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; Martin S, 2004, NEUROSCI LETT, V357, P76, DOI 10.1016/j.neulet.2003.10.085; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; MONACO JJ, 1986, HUM IMMUNOL, V15, P416, DOI 10.1016/0198-8859(86)90019-4; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pochetuhen K, 2007, AM J PATHOL, V171, P428, DOI 10.2353/ajpath.2007.061167; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Rathbun RK, 2000, BLOOD, V96, P4204; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SINGAL DP, 1995, J BIOL CHEM, V270, P1966, DOI 10.1074/jbc.270.4.1966; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sponheim J, 2010, AM J PATHOL, V177, P2804, DOI 10.2353/ajpath.2010.100378; STARCHER B, 1989, LAB ANIM, V23, P234, DOI 10.1258/002367789780810536; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tanaka K, 1998, IMMUNOL REV, V163, P161; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yanaba K, 2011, CLIN RHEUMATOL, V30, P825, DOI 10.1007/s10067-011-1686-5; Yang XZ, 2003, CANCER RES, V63, P1122; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af; Zhao WH, 2012, CYTOKINE, V58, P267, DOI 10.1016/j.cyto.2012.01.019; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	97	30	32	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11829	11843		10.1074/jbc.M113.534396	http://dx.doi.org/10.1074/jbc.M113.534396			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619410	hybrid, Green Published			2022-12-28	WOS:000335010600023
J	Manna, P; Gungor, N; McVie, R; Jain, SK				Manna, Prasenjit; Gungor, Neslihan; McVie, Robert; Jain, Sushil K.			Decreased Cystathionine-gamma- lyase ( CSE) Activity in Livers of Type 1 Diabetic Rats and Peripheral Blood Mononuclear Cells ( PBMC) of Type 1 Diabetic Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetoacetate; Diabetes; Glucose; Hydrogen Sulfide; Ketone Bodies	ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; CULTURED U937 MONOCYTES; VITAMIN-D DEFICIENCY; ACID-LABILE SULFUR; HYDROGEN-SULFIDE; HIGH-GLUCOSE; OXIDATIVE STRESS; LIPID-PEROXIDATION; KETONE-BODIES	Background: Mechanism of impaired H2S signaling in diabetes is not clear. Results: Livers from type 1 diabetic (T1D) rats and PBMC isolated from T1D patients have lower cystathionine--lyase activity. High glucose and/or high ketone treatment also decreased cystathionine--lyase activity in U937 monocytes and PBMC of healthy subjects. Conclusion: Uncontrolled glycemia and ketosis down-regulate cystathionine--lyase activity in T1D. Significance: Impaired cystathionine--lyase can dysregulate H2S signaling in diabetes. The liver plays a major role in the formation of H2S, a novel signaling molecule. Diabetes is associated with lower blood levels of H2S. This study investigated the activities of cystathionine--lyase (CSE, the enzyme that catalyzes H2S formation) in livers of type 1 diabetic (T1D) animals and in peripheral blood mononuclear cells (PBMC) isolated from T1D patients. T1D is associated with both hyperketonemia (acetoacetate and -hydroxybutyrate) and hyperglycemia. This study also examined the role of hyperglycemia and hyperketonemia per se in decreased CSE activity using U937 monocytes and PBMC isolated from healthy subjects. Livers from streptozotocin-treated T1D rats demonstrated a significantly higher reactive oxygen species production, lower CSE protein expression and activity, and lower H2S formation compared with those of controls. Studies with T1D patients showed a decrease in CSE protein expression and activity in PBMC compared with those of age-matched normal subjects. Cell culture studies demonstrated that high glucose (25 mm) and/or acetoacetate (4 mm) increased reactive oxygen species, decreased CSE mRNA expression, protein expression, and enzymatic activity, and reduced H2S levels; however, -hydroxybutyrate treatment had no effect. A similar effect, which was also observed in PBMC treated with high glucose alone or along with acetoacetate, was prevented by vitamin D supplementation. Studies with CSE siRNA provide evidence for a relationship between impaired CSE expression and reduced H2S levels. This study demonstrates for the first time that both hyperglycemia and hyperketonemia mediate a reduction in CSE expression and activity, which can contribute to the impaired H2S signaling associated with diabetes.	[Manna, Prasenjit; Gungor, Neslihan; McVie, Robert; Jain, Sushil K.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71103 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, 1501 Kings Hwy, Shreveport, LA 71103 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	National Institutes of Health grant (NIDDK); Office of Dietary Supplements of the National Institutes of Health [RO1 DK072433]; Malcolm Feist Endowed Chair in Diabetes; Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health grant (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant (NIDDK) and Office of Dietary Supplements of the National Institutes of Health Grant RO1 DK072433. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes and by a fellowship from the Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport.	Abdelmegeed MA, 2004, J PHARMACOL EXP THER, V310, P728, DOI 10.1124/jpet.104.066522; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; ARTUCH R, 1995, EUR J CLIN CHEM CLIN, V33, P529; Biermann J, 2011, MOL VIS, V17, P1275; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; BRAND FN, 1989, DIABETES, V38, P504, DOI 10.2337/diabetes.38.4.504; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; Chang L, 2008, AMINO ACIDS, V34, P573, DOI 10.1007/s00726-007-0011-8; DENHOLM EM, 1991, J IMMUNOL METHODS, V144, P247, DOI 10.1016/0022-1759(91)90092-T; Devrajani B., 2012, WORLD APPL SCI J, V16, P1269; El-Seweidy MM, 2011, ARCH BIOCHEM BIOPHYS, V506, P48, DOI 10.1016/j.abb.2010.10.014; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; HARRISON JE, 1981, BIOCHEM MED METAB B, V26, P339, DOI 10.1016/0006-2944(81)90010-7; Hoogeveen EK, 1998, ARTERIOSCL THROM VAS, V18, P133, DOI 10.1161/01.ATV.18.1.133; HULTBERG B, 1991, SCAND J CLIN LAB INV, V51, P277, DOI 10.3109/00365519109091615; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Jain SK, 1999, DIABETES CARE, V22, P1171, DOI 10.2337/diacare.22.7.1171; Jain SK, 1999, DIABETES, V48, P1850, DOI 10.2337/diabetes.48.9.1850; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jain SK, 2002, DIABETES, V51, P2287, DOI 10.2337/diabetes.51.7.2287; Jain SK, 2003, DIABETES CARE, V26, P2139, DOI 10.2337/diacare.26.7.2139; Jain SK, 2007, ANTIOXID REDOX SIGN, V9, P1581, DOI 10.1089/ars.2007.1577; Jain SK, 2013, BIOCHEM BIOPH RES CO, V437, P7, DOI 10.1016/j.bbrc.2013.06.004; Jain SK, 2013, ANTIOXID REDOX SIGN, V18, P1154, DOI 10.1089/ars.2012.4843; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko Y, 2009, FEBS LETT, V583, P377, DOI 10.1016/j.febslet.2008.12.026; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; KOCH DD, 1987, CLIN CHEM, V33, P1761; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Manna P, 2013, J CELL BIOCHEM, V114, P2334, DOI 10.1002/jcb.24578; Manna P, 2012, CELL PHYSIOL BIOCHEM, V30, P1363, DOI 10.1159/000343325; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; MUDD SH, 1985, AM J HUM GENET, V37, P1; Newton CA, 2004, ARCH INTERN MED, V164, P1925, DOI 10.1001/archinte.164.17.1925; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Norris EJ, 2011, SHOCK, V36, P242, DOI 10.1097/SHK.0b013e3182252ee7; OGASAWARA Y, 1994, BIOL PHARM BULL, V17, P1535; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; ROBILLON JF, 1994, DIABETES METAB, V20, P494; Roe TF, 1996, J DIABETES COMPLICAT, V10, P100, DOI 10.1016/1056-8727(94)00058-1; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; Schwalfenberg G, 2008, CAN FAM PHYSICIAN, V54, P864; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STEPHENS JM, 1971, DIABETES, V20, P485, DOI 10.2337/diab.20.7.485; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Szabo C, 2012, ANTIOXID REDOX SIGN, V17, P68, DOI 10.1089/ars.2011.4451; Tang XQ, 2011, J MOL NEUROSCI, V45, P60, DOI 10.1007/s12031-010-9477-z; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Ubuka T, 2001, J CHROMATOGR B, V757, P31, DOI 10.1016/S0378-4347(01)00046-9; Umpierrez Guillermo E, 2003, Treat Endocrinol, V2, P95, DOI 10.2165/00024677-200302020-00003; Wang KQ, 2013, CIRCULATION, V127, P2514, DOI 10.1161/CIRCULATIONAHA.113.001631; Wang YF, 2006, BIOCHEM BIOPH RES CO, V345, P851, DOI 10.1016/j.bbrc.2006.04.162; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; WESTLEY AM, 1991, ANAL BIOCHEM, V195, P63, DOI 10.1016/0003-2697(91)90295-5; White NH, 2003, REV ENDOCR METAB DIS, V4, P343, DOI 10.1023/A:1027350028584; White NH, 2000, ENDOCRIN METAB CLIN, V29, P657, DOI 10.1016/S0889-8529(05)70158-4; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Wilinski B, 2012, FOLIA BIOL-KRAKOW, V60, P243, DOI 10.3409/fb60_3-4.243-247; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Xue R, 2013, ANTIOXID REDOX SIGN, V19, P5, DOI 10.1089/ars.2012.5024; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yokoo H, 2003, J PHARMACOL EXP THER, V304, P994, DOI 10.1124/jpet.102.044115; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Yusuf M, 2005, BIOCHEM BIOPH RES CO, V333, P1146, DOI 10.1016/j.bbrc.2005.06.021; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; ZUCKERFR.D, 1974, J IMMUNOL, V112, P234	88	53	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11767	11778		10.1074/jbc.M113.524645	http://dx.doi.org/10.1074/jbc.M113.524645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610811	Green Published, hybrid			2022-12-28	WOS:000335010600018
J	Divekar, SD; Burrell, TC; Lee, JE; Weeber, EJ; Rebeck, GW				Divekar, Shailaja D.; Burrell, Teal C.; Lee, Jennifer E.; Weeber, Edwin J.; Rebeck, G. William			Ligand-induced Homotypic and Heterotypic Clustering of Apolipoprotein E Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; F-SPONDIN; VLDL RECEPTOR; SYNAPTIC PLASTICITY; TAU PHOSPHORYLATION; SIGNAL-TRANSDUCTION; NEURONAL MIGRATION; BRAIN-DEVELOPMENT	ApoE Receptor 2 (ApoER2) and the very low density lipoprotein receptor (VLDLR) are type I transmembrane proteins belonging to the LDLR family of receptors. They are neuronal proteins found in synaptic compartments that play an important role in neuronal migration during development. ApoER2 and VLDLR bind to extracellular glycoproteins, such as Reelin and F-spondin, which leads to phosphorylation of adaptor proteins and subsequent activation of downstream signaling pathways. It is thought that ApoER2 and VLDLR undergo clustering upon binding to their ligands, but no direct evidence of clustering has been shown. Here we show strong clustering of ApoER2 induced by the dimeric ligands Fc-RAP, F-spondin, and Reelin but relatively weak clustering with the ligand apoE in the absence of lipoproteins. This clustering involves numerous proteins besides ApoER2, including amyloid precursor protein and the synaptic adaptor protein PSD-95. Interestingly, we did not observe strong clustering of ApoER2 with VLDLR. Clustering was modulated by both extracellular and intracellular domains of ApoER2. Together, our data demonstrate that several multivalent ligands for ApoER2 induce clustering in transfected cells and primary neurons and that these complexes included other synaptic molecules, such as APP and PSD-95.	[Divekar, Shailaja D.; Burrell, Teal C.; Lee, Jennifer E.; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Weeber, Edwin J.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33613 USA	Georgetown University; State University System of Florida; University of South Florida	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20007 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012; Weeber, Edwin J/A-5396-2012	Rebeck, George William/0000-0001-6276-248X; 	National Institutes of Health [P01 AG030128, R01 AG035379]; NATIONAL INSTITUTE ON AGING [R01AG035379, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG030128 and R01 AG035379.	Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Arneja A, 2014, J IMMUNOL, V192, P123, DOI 10.4049/jimmunol.1302291; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Bustos FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094037; Care BR, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012720; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Cheng YC, 2012, MOL NEUROBIOL, V45, P536, DOI 10.1007/s12035-012-8275-8; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Feinstein Y, 2004, INT J BIOCHEM CELL B, V36, P975, DOI 10.1016/j.biocel.2004.01.002; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hoe HS, 2008, MOL NEUROBIOL, V37, P64, DOI 10.1007/s12035-008-8017-0; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, BRAIN RES, V1112, P70, DOI 10.1016/j.brainres.2006.07.035; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Hsu CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032398; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Ketchum C, 2014, BIOPHYS J, V106, P26, DOI 10.1016/j.bpj.2013.10.043; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kozer N, 2014, BIOCHEMISTRY-US, V53, P2594, DOI 10.1021/bi500182x; Kozer N, 2013, MOL BIOSYST, V9, P1849, DOI 10.1039/c3mb70073a; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Laffont I, 2002, BIOCHEM BIOPH RES CO, V292, P83, DOI 10.1006/bbrc.2002.6586; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Li XP, 2003, BIOCHEMISTRY-US, V42, P10406, DOI 10.1021/bi027093c; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Lohmuller T, 2013, NANO LETT, V13, P3059, DOI 10.1021/nl400874v; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Reddy SS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-30; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Rogers JT, 2008, NEURON GLIA BIOL, V4, P259, DOI 10.1017/S1740925X09990184; Royaux I, 1997, GENOMICS, V46, P240, DOI 10.1006/geno.1997.4983; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tamboli IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093120; Tanaka T, 2000, ALZ DIS ASSOC DIS, V14, pS18, DOI 10.1097/00002093-200000001-00004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	85	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15894	15903		10.1074/jbc.M113.537548	http://dx.doi.org/10.1074/jbc.M113.537548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755222	Green Published, hybrid			2022-12-28	WOS:000337965700001
J	Chan, YGY; Kim, HK; Schneewind, O; Missiakas, D				Chan, Yvonne Gar-Yun; Kim, Hwan Keun; Schneewind, Olaf; Missiakas, Dominique			The Capsular Polysaccharide of Staphylococcus aureus Is Attached to Peptidoglycan by the LytR-CpsA-Psr (LCP) Family of Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Cell Wall; Peptidoglycan; Staphylococcus aureus (S; aureus); Teichoic Acid; LytR-CpsA-Psr; Capsular Polysaccharide; Hydrolase; Undecaprenol	GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; WALL TEICHOIC-ACIDS; CELL-WALL; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; SURFACE-PROTEINS; O-ACETYLATION	Envelope biogenesis in bacteria involves synthesis of intermediates that are tethered to the lipid carrier undecaprenol-phosphate. LytR-CpsA-Psr (LCP) enzymes have been proposed to catalyze the transfer of undecaprenol-linked intermediates onto the C6-hydroxyl of MurNAc in peptidoglycan, thereby promoting attachment of wall teichoic acid (WTA) in bacilli and staphylococci and capsular polysaccharides (CPS) in streptococci. S. aureus encodes three lcp enzymes, and a variant lacking all three genes (lcp) releases WTA from the bacterial envelope and displays a growth defect. Here, we report that the type 5 capsular polysaccharide (CP5) of Staphylococcus aureus Newman is covalently attached to the glycan strands of peptidoglycan. Cell wall attachment of CP5 is abrogated in the lcp variant, a defect that is best complemented via expression of lcpC in trans. CP5 synthesis and peptidoglycan attachment are not impaired in the tagO mutant, suggesting that CP5 synthesis does not involve the GlcNAc-ManNAc linkage unit of WTA and may instead utilize another Wzy-type ligase to assemble undecaprenyl-phosphate intermediates. Thus, LCP enzymes of S. aureus are promiscuous enzymes that attach secondary cell wall polymers with discrete linkage units to peptidoglycan.	[Chan, Yvonne Gar-Yun; Kim, Hwan Keun; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Schneewind, Olaf; Missiakas, Dominique] Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, 920 East 58th Str, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	National Institutes of Health from the NIAID [AI38897]; Novartis Vaccines and Diagnostics (Siena, Italy); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE); National Institutes of Health NIAID [1-U54-AI-057153]; American Heart Association [13POST16980091]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novartis Vaccines and Diagnostics (Siena, Italy); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI38897 from the NIAID and Novartis Vaccines and Diagnostics (Siena, Italy). The authors acknowledge membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE) supported by National Institutes of Health NIAID Award 1-U54-AI-057153.; Supported by American Heart Association Award 13POST16980091.	ARBEIT RD, 1984, DIAGN MICR INFEC DIS, V2, P85, DOI 10.1016/0732-8893(84)90002-6; ARMSTRONG JJ, 1959, NATURE, V184, P248, DOI 10.1038/184248a0; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bhasin N, 1998, MOL MICROBIOL, V27, P9, DOI 10.1046/j.1365-2958.1998.00646.x; BRAY D, 1967, BIOCHEM BIOPH RES CO, V28, P334, DOI 10.1016/0006-291X(67)90314-2; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Caliot E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002756; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cartee RT, 2005, J BACTERIOL, V187, P7425, DOI 10.1128/JB.187.21.7425-7433.2005; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Chen C, 2013, J BIOL CHEM, V288, P29440, DOI 10.1074/jbc.M113.502039; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Deng LY, 2000, J BIOL CHEM, V275, P7497, DOI 10.1074/jbc.275.11.7497; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; FATTOM A, 1990, INFECT IMMUN, V58, P2367, DOI 10.1128/IAI.58.7.2367-2374.1990; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; FOURNIER JM, 1984, INFECT IMMUN, V45, P87, DOI 10.1128/IAI.45.1.87-93.1984; Gilbert I, 1931, J BACTERIOL, V21, P157, DOI 10.1128/JB.21.3.157-160.1931; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; KARAKAWA WW, 1985, J CLIN MICROBIOL, V22, P445, DOI 10.1128/JCM.22.3.445-447.1985; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; KOJIMA N, 1983, J BIOL CHEM, V258, P9043; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Pelosi L, 2005, BIOCHEM BIOPH RES CO, V327, P857, DOI 10.1016/j.bbrc.2004.12.082; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sau S, 1997, J BACTERIOL, V179, P1614, DOI 10.1128/jb.179.5.1614-1621.1997; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; SORENSEN UBS, 1990, MICROB PATHOGENESIS, V8, P325, DOI 10.1016/0882-4010(90)90091-4; von Eiff C, 2007, DIAGN MICR INFEC DIS, V58, P297, DOI 10.1016/j.diagmicrobio.2007.01.016; Wacker M, 2014, J INFECT DIS, V209, P1551, DOI 10.1093/infdis/jit800; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WYKE AW, 1977, J BACTERIOL, V130, P1055, DOI 10.1128/JB.130.3.1055-1063.1977; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; YOKOYAMA K, 1986, EUR J BIOCHEM, V161, P479, DOI 10.1111/j.1432-1033.1986.tb10469.x; Yother J, 1997, MOL MICROBIOL, V25, P201, DOI 10.1046/j.1365-2958.1997.4361798.x; Yother J, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P161; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	72	68	70	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15680	15690		10.1074/jbc.M114.567669	http://dx.doi.org/10.1074/jbc.M114.567669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24753256	Green Published, hybrid			2022-12-28	WOS:000337465400049
J	Li, YJ; Wei, ZY; Zhang, JY; Yang, Z; Zhang, MJ				Li, Youjun; Wei, Zhiyi; Zhang, Junyi; Yang, Zhou; Zhang, Mingjie			Structural Basis of the Binding of Merlin FERM Domain to the E3 Ubiquitin Ligase Substrate Adaptor DCAF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF2 TUMOR-SUPPRESSOR; ERM PROTEINS; NEUROFIBROMATOSIS TYPE-2; CARGO RECOGNITION; CRYSTAL-STRUCTURE; GENE; MOESIN; TAIL; TUMORIGENESIS; ORGANIZATION	The tumor suppressor gene Nf2 product, Merlin, plays vital roles in controlling proper development of organ sizes by specifically binding to a large number of target proteins localized both in cytoplasm and nuclei. The FERM domain of Merlin is chiefly responsible for its binding to target proteins, although the molecular basis governing these interactions are poorly understood due to lack of structural information. Here, we report the crystal structure of the Merlin FERM domain in complex with its binding domain derived from the E3 ubiquitin ligase substrate adaptor DCAF1 (also known as VPRBP). Unlike target binding modes found in ERM proteins, the Merlin-FERM binding domain of DCAF1 folds as a beta-hairpin and binds to the alpha 1/beta 5-groove of the F3 lobe of Merlin-FERM via extensive hydrophobic interactions. In addition to providing the first structural glimpse of a Merlin-FERM.target complex, the structure of the Merlin.DCAF1 complex is likely to be valuable for understanding the interactions of Merlin with its binding partners other than DCAF1.	[Li, Youjun; Wei, Zhiyi; Zhang, Junyi; Yang, Zhou; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Southern University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Yang, Zhou/AAE-2295-2019; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Yang, Zhou/0000-0003-4400-0902; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grant Council of Hong Kong [663610, 663811, 663812, HKUST6/CRF/10, SEG_HKUST06, AoE/M09/12, T13-607/12R]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grant Council of Hong Kong Grants 663610, 663811, 663812, HKUST6/CRF/10, SEG_HKUST06, AoE/M09/12, and T13-607/12R (to M. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025	37	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14674	14681		10.1074/jbc.M114.551184	http://dx.doi.org/10.1074/jbc.M114.551184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706749	Green Published, hybrid			2022-12-28	WOS:000337248100024
J	Song, D; Li, LS; Arsenault, PR; Tan, Q; Bigham, AW; Heaton-Johnson, KJ; Master, SR; Lee, FS				Song, Daisheng; Li, Lin-Sheng; Arsenault, Patrick R.; Tan, Qiulin; Bigham, Abigail W.; Heaton-Johnson, Katherine J.; Master, Stephen R.; Lee, Frank S.			Defective Tibetan PHD2 Binding to p23 Links High Altitude Adaption to Altered Oxygen Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NITRIC-OXIDE SYNTHASE; PULMONARY-HYPERTENSION; FUNCTION MUTATION; MOUSE MODEL; ADAPTATION; ERYTHROCYTOSIS; PATHWAY; ACTIVATION; PROTEIN	The Tibetan population has adapted to the chronic hypoxia of high altitude. Tibetans bear a genetic signature in the prolyl hydroxylase domain protein 2 (PHD2/EGLN1) gene, which encodes for the central oxygen sensor of the hypoxia-inducible factor (HIF) pathway. Recent studies have focused attention on two nonsynonymous coding region substitutions, D4E and C127S, both of which are markedly enriched in the Tibetan population. These amino acids reside in a region of PHD2 that harbors a zinc finger, which we have previously discovered binds to a Pro-Xaa-Leu-Glu (PXLE) motif in the HSP90 cochaperone p23, thereby recruiting PHD2 to the HSP90 pathway to facilitate HIF-alpha hydroxylation. We herein report that the Tibetan PHD2 haplotype (D4E/C127S) strikingly diminishes the interaction of PHD2 with p23, resulting in impaired PHD2 down-regulation of the HIF pathway. The defective binding to p23 depends on both the D4E and C127S substitutions. We also identify a PXLE motif in HSP90 itself that can mediate binding to PHD2 but find that this interaction is maintained with the D4E/C127S PHD2 haplotype. We propose that the Tibetan PHD2 variant is a loss of function (hypomorphic) allele, leading to augmented HIF activation to facilitate adaptation to high altitude.	[Song, Daisheng; Li, Lin-Sheng; Arsenault, Patrick R.; Tan, Qiulin; Heaton-Johnson, Katherine J.; Master, Stephen R.; Lee, Frank S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bigham, Abigail W.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Lee, FS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X	National Institutes of Health [R21-HL120751, R01-CA153347, R01-GM090301]; NATIONAL CANCER INSTITUTE [R01CA153347, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL120751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-HL120751 (to F. S. L.), R01-CA153347 (to F. S. L.), and R01-GM090301 (to F. S. L. and S. R. M.).	Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Beall CM, 2013, AM J HUM BIOL, V25, P141, DOI 10.1002/ajhb.22355; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lorenzo F. R., 2010, AM SOC HEM ANN M DEC; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wochnik GM, 2004, FEBS LETT, V560, P35, DOI 10.1016/S0014-5793(04)00066-3; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu F, 2001, CANCER RES, V61, P4136; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002	48	56	59	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14656	14665		10.1074/jbc.M113.541227	http://dx.doi.org/10.1074/jbc.M113.541227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711448	hybrid, Green Published			2022-12-28	WOS:000337248100022
J	Estrada, DF; Skinner, AL; Laurence, JS; Scott, EE				Estrada, D. Fernando; Skinner, Andria L.; Laurence, Jennifer S.; Scott, Emily E.			Human Cytochrome P450 17A1 Conformational Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Membrane Proteins; NMR; Protein Structure; Steroidogenesis; Cytochrome b5	NMR-SPECTROSCOPY; LIGAND-BINDING; B(5); STATE; HETEROGENEITY; ABIRATERONE; MODULATION; DYNAMICS; COMPLEX; MODEL	Background: Crystallography provides a static structure of cytochrome P450 17A1 (CYP17A1). Results: Solution NMR reveals an ensemble of CYP17A1 conformational substates. Conclusion: Ligand, cytochrome b(5), or temperature alters the conformational CYP17A1 substates present. Significance: Changes in conformations probably modulate human steroidogenesis by CYP17A1. Crystallographic studies of different membrane cytochrome P450 enzymes have provided examples of distinct structural conformations, suggesting protein flexibility. It has been speculated that conformational selection is an integral component of substrate recognition and access, but direct evidence of such substate interconversion has thus far remained elusive. In the current study, solution NMR revealed multiple and exchanging backbone conformations for certain structural features of the human steroidogenic cytochrome P450 17A1 (CYP17A1). This bifunctional enzyme is responsible for pregnenolone C17 hydroxylation, followed by a 17,20-lyase reaction to produce dehydroepiandrosterone, the key intermediate in human synthesis of androgen and estrogen sex steroids. The distribution of CYP17A1 conformational states was influenced by temperature, binding of these two substrates, and binding of the soluble domain of cytochrome b(5) (b(5)). Notably, titration of b(5) to CYP17A1pregnenolone induced a set of conformational states closely resembling those of CYP17A1<bold>17</bold>-hydroxypregnenolone without b(5,) providing structural evidence consistent with the reported ability of b(5) to selectively enhance 17,20-lyase activity. Solution NMR thus revealed a set of conformations likely to modulate human steroidogenesis by CYP17A1, demonstrating that this approach has the potential to make similar contributions to understanding the functions of other membrane P450 enzymes involved in drug metabolism and disease states.	[Estrada, D. Fernando; Skinner, Andria L.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Laurence, Jennifer S.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Laurence, JS (corresponding author), Univ Kansas, Dept Pharmaceut Chem, 2095 Constant Ave, Lawrence, KS 66047 USA.	laurencj@ku.edu; eescott@ku.edu	Chadwick, Jennifer/N-8027-2013	Chadwick, Jennifer/0000-0002-1686-5979	National Institutes of Health [T32 GM08545]; Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health) [RR01778, GM103420]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, R01GM076343, F32GM103069, T32GM008545, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Abiraterone was a gift synthesized by Charlie Fehl (supported by National Institutes of Health Grant T32 GM08545) in the laboratory of Dr. Jeff Aube, University of Kansas Department of Medicinal Chemistry. NMR data were collected at the University of Kansas Biomolecular NMR Laboratory, supported in part by the Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health Grants RR01778 and GM103420).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Ciaccio NA, 2008, PROTEIN EXPRES PURIF, V62, P235, DOI 10.1016/j.pep.2008.07.011; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2009, CHEM BIOL, V16, P1215, DOI 10.1016/j.chembiol.2009.12.002; Haider SM, 2010, J MOL BIOL, V400, P1078, DOI 10.1016/j.jmb.2010.05.069; HILDEBRANDT P, 1994, BIOCHEMISTRY-US, V33, P12920, DOI 10.1021/bi00209a024; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson EF, 2014, DRUG METAB DISPOS, V42, P9, DOI 10.1124/dmd.113.054627; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Jovanovic T, 2005, J AM CHEM SOC, V127, P13816, DOI 10.1021/ja0438314; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; LANGE R, 1992, EUR J BIOCHEM, V207, P75, DOI 10.1111/j.1432-1033.1992.tb17022.x; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; Lian LY, 2001, PROG NUCL MAG RES SP, V39, P171, DOI 10.1016/S0079-6565(01)00034-6; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shi RW, 2011, J MOL MODEL, V17, P1941, DOI 10.1007/s00894-010-0903-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilderman PR, 2012, FEBS J, V279, P1607, DOI 10.1111/j.1742-4658.2011.08411.x; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zhang ZG, 2009, J BIOTECHNOL, V139, P12, DOI 10.1016/j.jbiotec.2008.09.010	44	48	48	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14310	14320		10.1074/jbc.M114.560144	http://dx.doi.org/10.1074/jbc.M114.560144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671419	hybrid, Green Published			2022-12-28	WOS:000335984600056
J	Gupta, R; Ghosh, S; Monks, B; DeOliveira, RB; Tzeng, TC; Kalantari, P; Nandy, A; Bhattacharjee, B; Chan, JN; Ferreira, F; Rathinam, V; Sharma, S; Lien, E; Silverman, N; Fitzgerald, K; Firon, A; Trieu-Cuot, P; Henneke, P; Golenbock, DT				Gupta, Rahul; Ghosh, Shubhendu; Monks, Brian; DeOliveira, Rosane B.; Tzeng, Te-Chen; Kalantari, Parisa; Nandy, Anubhab; Bhattacharjee, Bornali; Chan, Jennie; Ferreira, Fabianno; Rathinam, Vijay; Sharma, Shruti; Lien, Egil; Silverman, Neal; Fitzgerald, Katherine; Firon, Arnaud; Trieu-Cuot, Patrick; Henneke, Philipp; Golenbock, Douglas T.			RNA and beta-Hemolysin of Group B Streptococcus Induce Interleukin-1 beta ( IL-1 beta) by Activating NLRP3 Inflammasomes in Mouse Macrophages*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Immunology; Innate Immunity; Interleukin; RNA	NALP3 INFLAMMASOME; DNA; HELICASE; CELLS	Background: Group B Streptococcus (GBS) activates the NLRP3 inflammasome. Results: GBS RNA escapes the phagolysosome and activates the NLRP3 inflammasome in a -hemolysin-dependent fashion. RNA-NLRP3 interaction and activation are enhanced by lysosomal leakage. Conclusion: RNA activates the NLRP3 inflammasome in synergy with phagolysosomal proteins. Significance: The NLRP3 inflammasome responds to bacterial invasion via RNA recognition subsequent to phagolysosomal degradation. The inflammatory cytokine IL-1 is critical for host responses against many human pathogens. Here, we define Group B Streptococcus (GBS)-mediated activation of the Nod-like receptor-P3 (NLRP3) inflammasome in macrophages. NLRP3 activation requires GBS expression of the cytolytic toxin, -hemolysin, lysosomal acidification, and leakage. These processes allow the interaction of GBS RNA with cytosolic NLRP3. The present study supports a model in which GBS RNA, along with lysosomal components including cathepsins, leaks out of lysosomes and interacts with NLRP3 to induce IL-1 production.	[Gupta, Rahul; Ghosh, Shubhendu; Monks, Brian; DeOliveira, Rosane B.; Tzeng, Te-Chen; Kalantari, Parisa; Nandy, Anubhab; Bhattacharjee, Bornali; Chan, Jennie; Rathinam, Vijay; Sharma, Shruti; Lien, Egil; Silverman, Neal; Fitzgerald, Katherine; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Firon, Arnaud; Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75724 Paris 15, France; [Ferreira, Fabianno] Univ Fed Rio de Janeiro, Lab Inflamacao & Imunidade, Dept Imunol, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg Im Breisgau, Germany; [Henneke, Philipp] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg Im Breisgau, Germany	University of Massachusetts System; University of Massachusetts Worcester; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Federal do Rio de Janeiro	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	Douglas.Golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020; Dutra, Fabianno F/C-1387-2015; Monks, Brian/B-8362-2015; Ferreira Dutra, Fabianno/AAE-2895-2022	Rathinam, Vijay/0000-0002-8009-3977; Dutra, Fabianno F/0000-0003-3106-7585; Monks, Brian/0000-0003-4008-3093; Ferreira Dutra, Fabianno/0000-0003-3106-7585; Bhattacharjee, Bornali/0000-0002-0801-1543; FIRON, Arnaud/0000-0002-5323-5212; Silverman, Neal/0000-0002-4259-456X; Fitzgerald, Kate/0000-0003-3175-609X; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Gupta, Rahul/0000-0001-8634-2439	National Institutes of Health [RO1 AI52455, U24 AI082663]; German Research Council [DFG HE 3127/5-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082663, R01AI052455, T32AI095213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI52455 (to D. T. G., P. H., and P. T.-C.) and U24 AI082663 (to D. T. G., N.S., E. L., and S. G.) and by the German Research Council (DFG HE 3127/5-1 to P.H.).	BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753	17	54	57	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13701	13705		10.1074/jbc.C114.548982	http://dx.doi.org/10.1074/jbc.C114.548982			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692555	Green Published, hybrid			2022-12-28	WOS:000335984600002
J	Rosenbaek, LL; Kortenoeven, MLA; Aroankins, TS; Fenton, RA				Rosenbaek, Lena L.; Kortenoeven, Marleen L. A.; Aroankins, Takwa S.; Fenton, Robert A.			Phosphorylation Decreases Ubiquitylation of the Thiazide-sensitive Cotransporter NCC and Subsequent Clathrin-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Epithelium; Phosphorylation; Plasma Membrane; Trafficking; Ubiquitylation	NA+-CL-COTRANSPORTER; SODIUM-CHLORIDE COTRANSPORTER; NACL COTRANSPORTER; PLASMA-MEMBRANE; DIETARY SALT; LOCALIZATION; EXPRESSION; MUTATIONS; WNK4; STIMULATION	Background: The sodium chloride cotransporter NCC mediates NaCl reabsorption in the kidney distal convoluted tubule. Results: NCC internalization from the plasma membrane is clathrin-mediated and regulated by NCC phosphorylation and ubiquitylation. Conclusion: Phosphorylation of NCC can regulate NCC internalization and ubiquitylation. Significance: Impaired NCC endocytosis could be implicated in salt-sensitive hypertension in vivo. The thiazide-sensitive sodium chloride cotransporter, NCC, is the major NaCl transport protein in the distal convoluted tubule (DCT). The transport activity of NCC can be regulated by phosphorylation, but knowledge of modulation of NCC trafficking by phosphorylation is limited. In this study, we generated novel tetracycline-inducible Madin-Darby canine kidney type I (MDCKI) cell lines expressing NCC to examine the role of NCC phosphorylation and ubiquitylation on NCC endocytosis. In MDCKI-NCC cells, NCC was highly glycosylated at molecular weights consistent with NCC monomers and dimers. NCC constitutively cycles to the apical plasma membrane of MDCKI-NCC cells, with 20-30% of the membrane pool of NCC internalized within 30 min. The use of dynasore, PitStop2, methyl--cyclodextrin, nystatin, and filipin (specific inhibitors of either clathrin-dependent or -independent endocytosis) demonstrated that NCC is internalized via a clathrin-mediated pathway. Reduction of endocytosis resulted in greater levels of NCC in the plasma membrane. Immunogold electron microscopy confirmed the association of NCC with the clathrin-mediated internalization pathway in rat DCT cells. Compared with controls, inducing phosphorylation of NCC via low chloride treatment or mimicking phosphorylation by replacing Thr-53, Thr-58, and Ser-71 residues with Asp resulted in increased membrane abundance and reduced rates of NCC internalization. NCC ubiquitylation was lowest in the conditions with greatest NCC phosphorylation, thus providing a mechanism for the reduced endocytosis. In conclusion, our data support a model where NCC is constitutively cycled to the plasma membrane, and upon stimulation, it can be phosphorylated to both increase NCC activity and decrease NCC endocytosis, together increasing NaCl transport in the DCT.	[Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; Aarhus Univ, Ctr Interact Prot Epithelial Transport, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Fenton, RA (corresponding author), Aarhus Univ, Dept Biomed, Bldg 1233,Rm 213, DK-8000 Aarhus, Denmark.	ROFE@ana.au.dk	Kortenoeven, Marleen/B-8565-2014; Fenton, Robert A/ABD-9824-2021; Fenton, Robert/AFR-6983-2022	Fenton, Robert/0000-0003-1623-199X; Kortenoeven, Marleen/0000-0001-9962-8276	Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; Aarhus University Research Foundation; Lundbeck Foundation [R44-2009-4252] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation, and the Aarhus University Research Foundation.	Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; Glover M, 2010, CAN J PHYSIOL PHARM, V88, P986, DOI [10.1139/y10-080, 10.1139/Y10-080]; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Ko B, 2007, P NATL ACAD SCI USA, V104, P20120, DOI 10.1073/pnas.0709506104; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Mastroianni N, 1996, AM J HUM GENET, V59, P1019; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Monkawa T, 2000, J AM SOC NEPHROL, V11, P65, DOI 10.1681/ASN.V11165; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Peng KC, 1999, J HISTOCHEM CYTOCHEM, V47, P757, DOI 10.1177/002215549904700605; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rosenbaek LL, 2012, J PHYSIOL-LONDON, V590, P6121, DOI 10.1113/jphysiol.2012.240986; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Sandberg MB, 2006, AM J PHYSIOL-RENAL, V291, pF503, DOI 10.1152/ajprenal.00482.2005; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Yang SS, 2005, BIOCHEM BIOPH RES CO, V330, P410, DOI 10.1016/j.bbrc.2005.02.172; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	54	51	51	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13347	13361		10.1074/jbc.M113.543710	http://dx.doi.org/10.1074/jbc.M113.543710			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668812	Green Published, hybrid			2022-12-28	WOS:000335522800033
J	Xu, HF; Abe, T; Liu, JKH; Zalivina, I; Hohenester, E; Leitinger, B				Xu, Huifang; Abe, Takemoto; Liu, Justin K. H.; Zalivina, Irina; Hohenester, Erhard; Leitinger, Birgit			Normal Activation of Discoidin Domain Receptor 1 Mutants with Disulfide Cross-links, Insertions, or Deletions in the Extracellular Juxtamembrane Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Mutagenesis Site-specific; Receptor Regulation; Receptor Structure-Function; Receptor Tyrosine Kinase; Signal Transduction; Activation Mechanism; Cysteine Scanning	GROWTH-FACTOR RECEPTOR; TYROSINE KINASES; TRANSMEMBRANE DOMAINS; LIGAND-BINDING; EGF RECEPTOR; ERYTHROPOIETIN RECEPTOR; COLLAGEN RECOGNITION; STRUCTURAL BASIS; MEMBRANE; DDR2	Background: DDR1 is a constitutively dimeric receptor tyrosine kinase that is activated by collagen. The mechanism of transmembrane signaling is unknown. Results: DDR1 activation is unaffected by disulfide cross-links, insertions, or deletions in the extracellular juxtamembrane region. Conclusion: The extracellular juxtamembrane region of DDR1 does not transmit a conformational change across the cell membrane. Significance: The activation mechanism of DDR1 appears to be unique among receptor tyrosine kinases. The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that are activated by collagen. DDR activation does not appear to occur by the common mechanism of ligand-induced receptor dimerization: the DDRs form stable noncovalent dimers in the absence of ligand, and ligand-induced autophosphorylation of cytoplasmic tyrosines is unusually slow and sustained. Here we sought to identify functionally important dimer contacts within the extracellular region of DDR1 by using cysteine-scanning mutagenesis. Cysteine substitutions close to the transmembrane domain resulted in receptors that formed covalent dimers with high efficiency, both in the absence and presence of collagen. Enforced covalent dimerization did not result in constitutive activation and did not affect the ability of collagen to induce receptor autophosphorylation. Cysteines farther away from the transmembrane domain were also cross-linked with high efficiency, but some of these mutants could no longer be activated. Furthermore, the extracellular juxtamembrane region of DDR1 tolerated large deletions as well as insertions of flexible segments, with no adverse effect on activation. These findings indicate that the extracellular juxtamembrane region of DDR1 is exceptionally flexible and does not constrain the basal or ligand-activated state of the receptor. DDR1 transmembrane signaling thus appears to occur without conformational coupling through the juxtamembrane region, but requires specific receptor interactions farther away from the cell membrane. A plausible mechanism to explain these findings is signaling by DDR1 clusters.	[Xu, Huifang; Abe, Takemoto; Liu, Justin K. H.; Zalivina, Irina; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London; Imperial College London	Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, NHLI, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	b.leitinger@imperial.ac.uk		Liu, Justin/0000-0002-4665-737X	Biotechnology and Biological Sciences Research Council United Kingdom [BB/I011226/1]; Biotechnology and Biological Sciences Research Council [BB/I011226/1] Funding Source: researchfish; BBSRC [BB/I011226/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/I011226/1 from the Biotechnology and Biological Sciences Research Council United Kingdom.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Carafoli F, 2013, BBA-PROTEINS PROTEOM, V1834, P2187, DOI 10.1016/j.bbapap.2012.10.014; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Foehr ED, 2000, FASEB J, V14, P973, DOI 10.1096/fasebj.14.7.973; Fu HL, 2014, J BIOL CHEM, V289, P9275, DOI 10.1074/jbc.M113.541102; Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mangasarian K, 1997, J CELL PHYSIOL, V172, P117, DOI 10.1002/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.3.CO;2-S; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Parat M, 2010, BIOCHEMISTRY-US, V49, P4601, DOI 10.1021/bi901711w; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004	51	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13565	13574		10.1074/jbc.M113.536144	http://dx.doi.org/10.1074/jbc.M113.536144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671415	Green Published, hybrid			2022-12-28	WOS:000335522800051
J	Di Jeso, B; Morishita, Y; Treglia, AS; Lofrumento, DD; Nicolardi, G; Beguinot, F; Kellogg, AP; Arvan, P				Di Jeso, Bruno; Morishita, Yoshiaki; Treglia, Antonella S.; Lofrumento, Dario D.; Nicolardi, Giuseppe; Beguinot, Francesco; Kellogg, Aaron P.; Arvan, Peter			Transient Covalent Interactions of Newly Synthesized Thyroglobulin with Oxidoreductases of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Endoplasmic Reticulum (ER); Molecular Chaperone; Protein Folding; Thyroid	PROTEIN-DISULFIDE-ISOMERASE; CHOLINESTERASE-LIKE DOMAIN; MOLECULAR CHAPERONE; SECRETORY PATHWAY; ERP57; CALNEXIN; CELLS; CALRETICULIN; COMPLEXES; CATALYSIS	Background: Secretory proteins acquire their native three-dimensional conformation through repeated brief interactions with ER chaperones and oxidoreductases. Results: We have captured and defined previously unidentified disulfide adducts of newly synthesized thyroglobulin with ERp72 and CaBP1/P5. Conclusion: Multiple oxidoreductases simultaneously engage thyroglobulin during its early folding in the ER. Significance: Distinct chaperone/oxidoreductase partners coordinately engage this multi-domain secretory protein to promote its advancement to the native state. Newly synthesized thyroglobulin (Tg), the thyroid prohormone, forms detectable high molecular weight mixed disulfide adducts: until now, only Tg adduct B was identified as primarily engaging the endoplasmic reticulum oxidoreductases ERp57 and protein disulfide isomerase. Here, we demonstrate that the faster migrating Tg adduct C primarily engages the CaBP1/P5 oxidoreductase, whereas the slower migrating Tg adduct A primarily engages ERp72. Upon siRNA-mediated knockdown of CaBP1/P5 or ERp72, adducts C or A, respectively, are decreased. Within the three Tg adduct bands that do not exhibit a precursor-product relationship, Tg exhibits distinct oxidation patterns. We present evidence suggesting that disulfide maturation occurs within Tg monomers engaged in each of the adduct bands. Moreover, the same Tg substrate molecules can form simultaneous mixed disulfides with both CaBP1/P5 and protein disulfide isomerase, although these are generally viewed as components of distinct oxidoreductase-chaperone protein complexes. Such substrate-oxidoreductase combinations offer Tg the potential for simultaneous oxidative maturation along different parallel tracks leading to the native state.	[Di Jeso, Bruno; Treglia, Antonella S.] Univ Salento, Lab Patol Gen, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Morishita, Yoshiaki; Kellogg, Aaron P.; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Lofrumento, Dario D.; Nicolardi, Giuseppe] Univ Salento, Lab Anat Umana, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Beguinot, Francesco] Univ Naples Federico II, Ctr Nazl Ric, Dipartimento Sci Med Traslaz, I-80131 Naples, Italy; [Beguinot, Francesco] Univ Naples Federico II, Ctr Nazl Ric, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Salento; University of Michigan System; University of Michigan; University of Salento; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Di Jeso, B (corresponding author), Univ Salento, Fac Sci MFN, Dipartimento Sci & Tecnol Biol & Ambientali, Lab Patol Gen,Ctr Ecotekne, I-73100 Lecce, Italy.	bruno.dijeso@unisalento.it; parvan@umich.edu	Morishita, Yoshiaki/AAX-6552-2021; lofrumento, dario domenico/K-9529-2015; Morishita, Yoshiaki/GWQ-6726-2022; Nicolardi, Giuseppe/N-7744-2015	Morishita, Yoshiaki/0000-0003-4733-7981; lofrumento, dario domenico/0000-0002-0106-3615; di jeso, bruno/0000-0001-8713-5984; Nicolardi, Giuseppe/0000-0003-3007-4468	Fondazione Cassa di Risparmio di Puglia; National Institutes of Health [R01 DK40344]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344] Funding Source: NIH RePORTER	Fondazione Cassa di Risparmio di Puglia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant of "Fondazione Cassa di Risparmio di Puglia" (to B. D. J.) and National Institutes of Health Grant R01 DK40344 (to P. A.).	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; Chong JM, 2001, J BIOL CHEM, V276, P5804, DOI 10.1074/jbc.M008839200; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; DIJESO B, 1992, J BIOL CHEM, V267, P1938; DIJESO B, 2004, THYROID, P77; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; KIM PS, 1991, J BIOL CHEM, V266, P12412; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P33045, DOI 10.1074/jbc.M111.281337; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	41	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11488	11496		10.1074/jbc.M113.520767	http://dx.doi.org/10.1074/jbc.M113.520767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599957	hybrid, Green Published			2022-12-28	WOS:000334638500049
J	Saha, K; Adhikary, G; Kanade, SR; Rorke, EA; Eckert, RL				Saha, Kamalika; Adhikary, Gautam; Kanade, Santosh R.; Rorke, Ellen A.; Eckert, Richard L.			p38 delta Regulates p53 to Control p21(Cip1) Expression in Human Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Proliferation; Cell Signaling; MAP Kinases (MAPKs); p38 MAPK	PROTEIN-KINASE-C; INVOLUCRIN GENE-EXPRESSION; CALCIUM-INDUCED DIFFERENTIATION; TUMOR SUPPRESSION; PROMOTER ACTIVITY; PKC-DELTA; PROLIFERATION; ACTIVATION; APOPTOSIS; SKIN	Background: Keratinocytes cease proliferation during differentiation, and the mechanism that mediates these events is not well understood. Results: PKC increases p38 activity, which increases p53 transcription and acts to increase p21(Cip1) promoter activity. Conclusion: PKC drives a MAPK cascade to increase p53 to control keratinocyte proliferation. Significance: This study provides detailed information regarding the mechanisms that control cell proliferation. PKC suppresses keratinocyte proliferation via a mechanism that involves increased expression of p21(Cip1). However, the signaling mechanism that mediates this regulation is not well understood. Our present studies suggest that PKC activates p38 leading to increased p21(Cip1) promoter activity and p21(Cip1) mRNA/protein expression. We further show that exogenously expressed p38 increases p21(Cip1) mRNA and protein and that p38 knockdown or expression of dominant-negative p38 attenuates this increase. Moreover, p53 is an intermediary in this regulation, as p38 expression increases p53 mRNA, protein, and promoter activity, and p53 knockdown attenuates the activation. We demonstrate a direct interaction of p38 with PKC and MEK3 and show that exogenous agents that suppress keratinocyte proliferation activate this pathway. We confirm the importance of this regulation using a stratified epidermal equivalent model, which mimics in vivo-like keratinocyte differentiation. In this model, PKC or p38 knockdown results in reduced p53 and p21(Cip1) levels and enhanced cell proliferation. We propose that PKC activates a MEKK1/MEK3/p38 MAPK cascade to increase p53 levels and p53 drives p21(Cip1) gene expression.	[Saha, Kamalika; Adhikary, Gautam; Kanade, Santosh R.; Eckert, Richard L.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Obstet & Gynecol, Sch Med, Baltimore, MD 21201 USA; [Rorke, Ellen A.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR046494, R01 AR053851, R21 AR065266]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494, R01AR053851, R21AR065266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494, R01 AR053851, and R21 AR065266 (to R. E.).	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bollag WB, 2009, J INVEST DERMATOL, V129, P2330, DOI 10.1038/jid.2009.165; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2012, J BIOL CHEM, V287, P16168, DOI 10.1074/jbc.M111.305292; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; GHERZI R, 1992, BIOCHEM BIOPH RES CO, V184, P283, DOI 10.1016/0006-291X(92)91190-2; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hauser P, 2004, MOL CANCER RES, V2, P96; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; Lee SJ, 2006, J BIOL CHEM, V281, P2215, DOI 10.1074/jbc.M509509200; Li JJ, 2000, MOL CARCINOGEN, V29, P159, DOI 10.1002/1098-2744(200011)29:3<159::AID-MC5>3.0.CO;2-W; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Niwa K, 2002, FREE RADICAL RES, V36, P1147, DOI 10.1080/1071576021000016409; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; OSADA S, 1990, J BIOL CHEM, V265, P22434; Papp H, 2004, CELL MOL LIFE SCI, V61, P1095, DOI 10.1007/s00018-004-4014-2; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Praskova M, 2002, EXP DERMATOL, V11, P344, DOI 10.1034/j.1600-0625.2002.110408.x; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Szegedi A, 2009, EXP DERMATOL, V18, P122, DOI 10.1111/j.1600-0625.2008.00771.x; Wheeler DL, 2002, ONCOGENE, V21, P3620, DOI 10.1038/sj.onc.1205451; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Wu HM, 2010, CANCER LETT, V298, P16, DOI 10.1016/j.canlet.2010.05.022	52	20	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11443	11453		10.1074/jbc.M113.543165	http://dx.doi.org/10.1074/jbc.M113.543165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599959	hybrid, Green Published			2022-12-28	WOS:000334638500045
J	Patra, A; Nagy, LD; Zhang, QQ; Su, Y; Muller, L; Guengerich, FP; Egli, M				Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Mueller, Livia; Guengerich, F. Peter; Egli, Martin			Kinetics, Structure, and Mechanism of 8-Oxo-7,8-dihydro-2 '-deoxyguanosine Bypass by Human DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-FREE BYPASS; LESION-BYPASS; TRANSLESION SYNTHESIS; SACCHAROMYCES-CEREVISIAE; 8-OXO-GUANINE BYPASS; ESCHERICHIA-COLI; FINGER DOMAIN; THYMINE DIMER; REPLICATION; EFFICIENT	DNA damage incurred by a multitude of endogenous and exogenous factors constitutes an inevitable challenge for the replication machinery. Cells rely on various mechanisms to either remove lesions or bypass them in a more or less error-prone fashion. The latter pathway involves the Y-family polymerases that catalyze trans-lesion synthesis across sites of damaged DNA. 7,8-Dihydro-8-oxo-2'-deoxyguanosine (8-oxoG) is a major lesion that is a consequence of oxidative stress and is associated with cancer, aging, hepatitis, and infertility. We have used steady-state and transient-state kinetics in conjunction with mass spectrometry to analyze in vitro bypass of 8-oxoG by human DNA polymerase eta (hpol eta). Unlike the high fidelity polymerases that show preferential insertion of A opposite 8-oxoG, hpol eta is capable of bypassing 8-oxoG in a mostly error-free fashion, thus preventing GC -> AT transversion mutations. Crystal structures of ternary hpol eta-DNA complexes and incoming dCTP, dATP, or dGTP opposite 8-oxoG reveal that an arginine from the finger domain assumes a key role in avoiding formation of the nascent 8-oxoG: A pair. That hpol eta discriminates against dATP exclusively at the insertion stage is confirmed by structures of ternary complexes that allow visualization of the extension step. These structures with G: dCTP following either 8-oxoG: C or 8-oxoG: A pairs exhibit virtually identical active site conformations. Our combined data provide a detailed understanding of hpol eta bypass of the most common oxidative DNA lesion.	[Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Patra, Amritraj; Nagy, Leslie D.; Zhang, Qianqian; Su, Yan; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Mueller, Livia] Eidgenoss Tech Hsch Zentrum, Lab Food & Nutr Toxicol, CH-8092 Zurich, Switzerland	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 868A Robinson Res Bldg, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA160032, R01CA055678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Dr. L. Lei for help with protein expression and purification, Dr. Z. Wawrzak for assistance with x-ray diffraction data collection at the Advanced Photon Source, Dr. W. Yang for helpful discussions, and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Bridges BA, 2005, DNA REPAIR, V4, P725, DOI 10.1016/j.dnarep.2004.12.009; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Chowdhury G., 2011, CURRENT PROTOCOLS NU; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865; Earley MC, 1998, P NATL ACAD SCI USA, V95, P15487, DOI 10.1073/pnas.95.26.15487; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Guengerich F. P, 2010, CHEM BIOL DNA DAMAGE, P299; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hogg M, 2005, CURR OPIN STRUC BIOL, V15, P86, DOI 10.1016/j.sbi.2005.01.014; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jaloszynski P, 2003, NUCLEIC ACIDS RES, V31, P6085, DOI 10.1093/nar/gkg829; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kamiya H, 2004, BIOL PHARM BULL, V27, P475, DOI 10.1248/bpb.27.475; Lamoureux JS, 2004, J MOL BIOL, V335, P399, DOI 10.1016/j.jmb.2003.10.071; Lee DH, 2008, MUTAT RES-FUND MOL M, V641, P19, DOI 10.1016/j.mrfmmm.2008.02.006; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; MALINS DC, 1991, CANCER RES, V51, P5430; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P20401, DOI 10.1073/pnas.1211532109; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rodriguez GP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003682; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIMODA R, 1994, CANCER RES, V54, P3171; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Yung Chinwei, 2007, Nucleic Acids Symp Ser (Oxf), P49; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	71	65	67	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16867	16882		10.1074/jbc.M114.551820	http://dx.doi.org/10.1074/jbc.M114.551820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24759104	Green Published, hybrid			2022-12-28	WOS:000338016200024
J	Liu, LQ; Richard, J; Kim, S; Wojcik, EJ				Liu, Liqiong; Richard, Jessica; Kim, Sunyoung; Wojcik, Edward J.			Small Molecule Screen for Candidate Antimalarials Targeting Plasmodium Kinesin-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM DIHYDROOROTATE DEHYDROGENASE; TRITYL-L-CYSTEINE; ESCHERICHIA-COLI; APICOMPLEXAN PARASITES; CELL-CYCLE; HUMAN EG5; IN-VITRO; INHIBITORS; MALARIA; DISCOVERY	Plasmodium falciparum and vivax are responsible for the majority of malaria infections worldwide, resulting in over a million deaths annually. Malaria parasites now show measured resistance to all currently utilized drugs. Novel antimalarial drugs are urgently needed. The Plasmodium Kinesin-5 mechanoenzyme is a suitable "next generation" target. Discovered via small molecule screen experiments, the human Kinesin-5 has multiple allosteric sites that are "druggable." One site in particular, unique in its sequence divergence across all homologs in the superfamily and even within the same family, exhibits exquisite drug specificity. We propose that Plasmodium Kinesin-5 shares this allosteric site and likewise can be targeted to uncover inhibitors with high specificity. To test this idea, we performed a screen for inhibitors selective for Plasmodium Kinesin-5 ATPase activity in parallel with human Kinesin-5. Our screen of nearly 2000 compounds successfully identified compounds that selectively inhibit both P. vivax and falciparum Kinesin-5 motor domains but, as anticipated, do not impact human Kinesin-5 activity. Of note is a candidate drug that did not biochemically compete with the ATP substrate for the conserved active site or disrupt the microtubule-binding site. Together, our experiments identified MMV666693 as a selective allosteric inhibitor of Plasmodium Kinesin-5; this is the first identified protein target for the Medicines of Malaria Venture validated collection of parasite proliferation inhibitors. This work demonstrates that chemical screens against human kinesins are adaptable to homologs in disease organisms and, as such, extendable to strategies to combat infectious disease.	[Liu, Liqiong; Richard, Jessica; Kim, Sunyoung; Wojcik, Edward J.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wojcik, EJ (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	ewojci@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [R01GM066328, R01GM097350]; Louisiana State University School of Graduate Studies; LSU School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350, R01GM066328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University School of Graduate Studies; LSU School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM066328 (to E. W.) and R01GM097350 (to S. K.). This work was also supported by the Louisiana State University School of Graduate Studies (to J. R.) and the LSU School of Medicine (to L. L.).	Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Arnot DE, 2011, INT J PARASITOL, V41, P71, DOI 10.1016/j.ijpara.2010.07.012; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Biamonte MA, 2013, BIOORG MED CHEM LETT, V23, P2829, DOI 10.1016/j.bmcl.2013.03.067; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Chakrabarti R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057302; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; Dempsey E, 2013, MOL BIOCHEM PARASIT, V188, P116, DOI 10.1016/j.molbiopara.2013.03.001; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Francia ME, 2014, NAT REV MICROBIOL, V12, P125, DOI 10.1038/nrmicro3184; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Goedken ER, 2012, J BIOMOL SCREEN, V17, P857, DOI 10.1177/1087057112447108; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Harris MT, 2013, ANTIMICROB AGENTS CH, V57, P3731, DOI 10.1128/AAC.00662-13; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Imwong M, 2011, J INFECT DIS, V203, P207, DOI 10.1093/infdis/jiq024; Indorato RL, 2013, BIOCHEM PHARMACOL, V86, P1441, DOI 10.1016/j.bcp.2013.09.003; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kappes B, 2007, FUTURE MICROBIOL, V2, P409, DOI 10.2217/17460913.2.4.409; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu LQ, 2011, J BIOL CHEM, V286, P6201, DOI 10.1074/jbc.M110.154989; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Mahajan B, 2008, J BIOL CHEM, V283, P31871, DOI 10.1074/jbc.M800028200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Preuss J, 2012, J MED CHEM, V55, P7262, DOI 10.1021/jm300833h; Rackham MD, 2013, J MED CHEM, V56, P371, DOI 10.1021/jm301474t; Rickert KW, 2008, ARCH BIOCHEM BIOPHYS, V469, P220, DOI 10.1016/j.abb.2007.10.016; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Stock MF, 2001, METH MOL B, V164, P43; Tilley L, 2011, RSC DRUG DISCOV, V14, P33, DOI 10.1039/9781849733496-00033; Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039; Wojcik EJ, 2013, GENE, V531, P133, DOI 10.1016/j.gene.2013.08.004; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Xue HY, 2003, MOL BIOCHEM PARASIT, V128, P21, DOI 10.1016/S0166-6851(03)00039-2; Yang L, 2008, BIOL PHARM BULL, V31, P1397, DOI 10.1248/bpb.31.1397; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang W, 2011, J PHYS CHEM B, V115, P784, DOI 10.1021/jp107255t; Zhang Y, 2013, J BIOL CHEM, V288, P34746, DOI 10.1074/jbc.M113.521955; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	65	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16601	16614		10.1074/jbc.M114.551408	http://dx.doi.org/10.1074/jbc.M114.551408			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737313	Green Published, hybrid			2022-12-28	WOS:000337965700060
J	Parker-Duffen, JL; Nakamura, K; Silver, M; Zuriaga, MA; MacLauchlan, S; Aprahamian, TR; Walsh, K				Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Zuriaga, Maria A.; MacLauchlan, Susan; Aprahamian, Tamar R.; Walsh, Kenneth			Divergent Roles for Adiponectin Receptor 1 (AdipoR1) and AdipoR2 in Mediating Revascularization and Metabolic Dysfunction in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED INSULIN-RESISTANCE; MICE LACKING ADIPONECTIN; HIGH-MOLECULAR-WEIGHT; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; STIMULATES ANGIOGENESIS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; GAMMA AGONIST	Adiponectin is a well described anti-inflammatory adipokine that is highly abundant in serum. Previous reports have found that adiponectin deficiency promotes cardiovascular and metabolic dysfunction in murine models, whereas its overexpression is protective. Two candidate adiponectin receptors, AdipoR1 and AdipoR2, are uncharacterized with regard to cardiovascular tissue homeostasis, and their in vivo metabolic functions remain controversial. Here we subjected AdipoR1- and AdipoR2-deficient mice to chronic hind limb ischemic surgery. Blood flow recovery in AdipoR1-deficient mice was similar to wild-type; however, revascularization in AdipoR2-deficient mice was severely attenuated. Treatment with adiponectin enhanced the recovery of wild-type mice but failed to rescue the impairment observed in AdipoR2-deficient mice. In view of this divergent receptor function in the hind limb ischemia model, AdipoR1-and AdipoR2-deficient mice were also evaluated in a model of diet-induced obesity. Strikingly, AdipoR1-deficient mice developed severe metabolic dysfunction compared with wild type, whereas AdipoR2-deficient mice were protected from diet-induced weight gain and metabolic perturbations. These data show that AdipoR2, but not AdipoR1, is functionally important in an in vivo model of ischemia-induced revascularization and that its expression is essential for the revascularization actions of adiponectin. These data also show that, in contrast to revascularization responses, AdipoR1, but not AdipoR2 deficiency, leads to diet-induced metabolic dysfunction, revealing that these receptors have highly divergent roles in vascular and metabolic homeostasis.	[Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Zuriaga, Maria A.; MacLauchlan, Susan; Aprahamian, Tamar R.; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Parker-Duffen, Jennifer L.; Walsh, Kenneth] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Aprahamian, Tamar R.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Zuriaga, María/P-4616-2017	Zuriaga, María/0000-0003-0422-2965; MacLauchlan, Susan/0000-0001-9689-0826; Aprahamian, Tamar/0000-0001-9295-5995	National Institutes of Health [AG34972, HL81587, HL68758, K01 AR055965-02]; Pre-doctoral Training Grant in Cardiovascular Biology [HL007969]; Pre-doctoral Training Grant in Biomolecular Pharmacology [GM008541]; T32 Training Grant [HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL126141, T32HL007969, P01HL068758, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pre-doctoral Training Grant in Cardiovascular Biology; Pre-doctoral Training Grant in Biomolecular Pharmacology; T32 Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG34972, HL81587, and HL68758 (to K. W.), K01 AR055965-02 (to T. A.), and by Pre-doctoral Training Grants in Cardiovascular Biology HL007969 and Biomolecular Pharmacology GM008541 (to J. L. P.-D.).; A postdoctoral fellow on T32 Training Grant HL007224 (to the Whitaker Cardiovascular Institute).	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Aprahamian TR, 2013, METABOLISM, V62, P1730, DOI 10.1016/j.metabol.2013.07.010; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Ding M, 2012, J MOL CELL CARDIOL, V52, P474, DOI 10.1016/j.yjmcc.2011.09.008; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Fasshauer M, 2004, FEBS LETT, V558, P27, DOI 10.1016/S0014-5793(03)01525-4; Higuchi A, 2010, ARTERIOSCL THROM VAS, V30, P46, DOI 10.1161/ATVBAHA.109.198465; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Rizvi YQ, 2013, VASC PHARMACOL, V59, P144, DOI 10.1016/j.vph.2013.09.001; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Wang YJ, 2014, CIRC RES, V114, P792, DOI 10.1161/CIRCRESAHA.114.302439; Wang YJ, 2012, ARTERIOSCL THROM VAS, V32, P934, DOI 10.1161/ATVBAHA.111.242164; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang P, 2009, ARTERIOSCL THROM VAS, V29, P67, DOI 10.1161/ATVBAHA.108.178061; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	56	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16200	16213		10.1074/jbc.M114.548115	http://dx.doi.org/10.1074/jbc.M114.548115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742672	hybrid, Green Published			2022-12-28	WOS:000337965700025
J	Akazawa-Ogawa, Y; Takashima, M; Lee, YH; Ikegami, T; Goto, Y; Uegaki, K; Hagihara, Y				Akazawa-Ogawa, Yoko; Takashima, Mizuki; Lee, Young-Ho; Ikegami, Takahisa; Goto, Yuji; Uegaki, Koichi; Hagihara, Yoshihisa			Heat-induced Irreversible Denaturation of the Camelid Single Domain VHH Antibody Is Governed by Chemical Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody Engineering; Protein Aggregation; Protein Chemical Modification; Protein Denaturation; Protein Folding; Protein Stability	DISULFIDE BOND; NONENZYMATIC DEAMIDATION; BIOPHYSICAL PROPERTIES; PROTEIN AGGREGATION; INACTIVATION; FRAGMENTS; IMMUNOGLOBULIN; ASPARAGINYL; RESIDUES; STABILIZATION	The variable domain of camelid heavy chain antibody (VHH) is highly heat-resistant and is therefore ideal for many applications. Although understanding the process of heat-induced irreversible denaturation is essential to improve the efficacy of VHH, its inactivation mechanism remains unclear. Here, we showed that chemical modifications predominantly governed the irreversible denaturation of VHH at high temperatures. After heat treatment, the activity of VHH was dependent only on the incubation time at 90 degrees C and was insensitive to the number of heating (90 degrees C)-cooling (20 degrees C) cycles, indicating a negligible role for folding/unfolding intermediates on permanent denaturation. The residual activity was independent of concentration; therefore, VHH lost its activity in a unimolecular manner, not by aggregation. A VHH mutant lacking Asn, which is susceptible to chemical modifications, had significantly higher heat resistance than did the wild-type protein, indicating the importance of chemical modifications to VHH denaturation.	[Akazawa-Ogawa, Yoko; Takashima, Mizuki; Uegaki, Koichi; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Lee, Young-Ho; Ikegami, Takahisa; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Uegaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	k-uegaki@aist.go.jp; hagihara-kappael@aist.go.jp	HAGIHARA, Yoshihisa/K-4996-2016; Ikegami, Takahisa/I-9626-2017; Akazawa-Ogawa, Yoko/L-9333-2018	HAGIHARA, Yoshihisa/0000-0002-5980-1764; Ikegami, Takahisa/0000-0002-1429-1844; Akazawa-Ogawa, Yoko/0000-0001-5919-3036	National Institutes of Health from the NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Lilian Kaede Komaba for critical reading of the manuscript. A part of the molecular graphics and analyses was performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from the NIGMS).	AHERN TJ, 1987, P NATL ACAD SCI USA, V84, P675, DOI 10.1073/pnas.84.3.675; AHERN TJ, 1985, SCIENCE, V228, P1280, DOI 10.1126/science.4001942; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DAVIES RB, 1974, BIOCHEM J, V143, P115, DOI 10.1042/bj1430115; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Dunkelberger EB, 2012, J AM CHEM SOC, V134, P12658, DOI 10.1021/ja3039486; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hagihara Yoshihisa, 2012, Methods Mol Biol, V911, P399, DOI 10.1007/978-1-61779-968-6_24; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HOROWITZ PM, 1993, ACS SYM SER, V516, P167; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kabat EA, 1991, NIH PUBLICATION; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; KLIBANOV AM, 1983, ADV APPL MICROBIOL, V29, P1, DOI 10.1016/S0065-2164(08)70352-6; Ladenson RC, 2006, ANAL CHEM, V78, P4501, DOI 10.1021/ac058044j; Le Bon C, 1999, MACROMOLECULES, V32, P6120, DOI 10.1021/ma9905775; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li B, 2003, J AM CHEM SOC, V125, P11486, DOI 10.1021/ja0360992; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; Omidfar K, 2007, BIOTECHNOL APPL BIOC, V46, P41, DOI 10.1042/BA20060104; PATEL K, 1990, PHARMACEUT RES, V7, P787, DOI 10.1023/A:1015999012852; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Rodriguez-Rodriguez ER, 2012, J MOL BIOL, V423, P337, DOI 10.1016/j.jmb.2012.07.007; Renisio JG, 2002, PROTEINS, V47, P546, DOI 10.1002/prot.10096; Riha WE, 1996, CRIT REV FOOD SCI, V36, P225, DOI 10.1080/10408399609527724; Rombouts I, 2011, J AGR FOOD CHEM, V59, P1236, DOI 10.1021/jf103579u; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, SENSORS-BASEL, V8, P4669, DOI 10.3390/s8084669; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Tomita S, 2011, BIOTECHNOL PROGR, V27, P855, DOI 10.1002/btpr.597; TOMIZAWA H, 1994, BIOCHEMISTRY-US, V33, P13032, DOI 10.1021/bi00248a012; van Boekel MAJS, 1999, INT DAIRY J, V9, P237, DOI 10.1016/S0958-6946(99)00068-0; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; ZALE SE, 1983, BIOTECHNOL BIOENG, V25, P2221, DOI 10.1002/bit.260250908; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014; ZHAO MX, 1989, BIOORG CHEM, V17, P36, DOI 10.1016/0045-2068(89)90005-9; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024; Zhou YF, 2001, PROTEIN SCI, V10, P378, DOI 10.1110/ps.34201	64	27	27	8	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15666	15679		10.1074/jbc.M113.534222	http://dx.doi.org/10.1074/jbc.M113.534222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739391	Green Published, hybrid			2022-12-28	WOS:000337465400048
J	Cuadrado, A; Martin-Moldes, Z; Ye, JP; Lastres-Becker, I				Cuadrado, Antonio; Martin-Moldes, Zaira; Ye, Jianping; Lastres-Becker, Isabel			Transcription Factors NRF2 and NF-kappa B Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Lipopolysaccharide (LPS); Microglia; NF- B (NF-KB); Nuclear Factor 2 (Erythroid-derived 2-like Factor) (NFE2L2) (Nrf2); Oxidative Stress; Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Rho GTPases	SIGNALING CASCADE; PARKINSONS-DISEASE; HEME OXYGENASE-1; IKK-BETA; EXPRESSION; ACTIVATION; INHIBITION; PATHWAY; PHAGOCYTOSIS; REDOX	Background: RAC1 is a small G-protein of the Rho family that activates the transcription factor NF-B to elicit an inflammatory response. Results: We have found that RAC1 also induces the NRF2/ARE pathway, which in term blocks RAC1-dependent NF-B activation. Conclusion: RAC1 modulates inflammation by coordinating the activity of pro-inflammatory NF-B and anti-oxidant NRF2 transcription factors. Significance: Therapeutic intervention on RAC1 could help modulate pro- and anti-inflammatory processes. The small GTPase protein RAC1 participates in innate immunity by activating a complex program that includes cytoskeleton remodeling, chemotaxis, activation of NADPH oxidase, and modulation of gene expression. However, its role in regulating the transcriptional signatures that in term control the cellular inflammatory profiles are not well defined. Here we investigated the functional and mechanistic connection between RAC1 and the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2), master regulator of the anti-oxidant response. Lipopolysaccharide and constitutively active RAC1(Q61L) mutant induced the anti-oxidant enzyme heme-oxygenase-1 (HO-1) through activation of NRF2. The use of KEAP1-insensitive NRF2 mutants indicated that RAC1 regulation of NRF2 is KEAP1-independent. Interestingly, NRF2 overexpression inhibited, whereas a dominant-negative mutant of NRF2 exacerbated RAC1-dependent activation of nuclear factor-B (NF-B), suggesting that NRF2 has an antagonistic effect on the NF-B pathway. Moreover, we found that RAC1 acts through NF-B to induce NRF2 because either expression of a dominant negative mutant of IB that leads to NF-B degradation or the use of p65-NF-B-deficient cells demonstrated lower NRF2 protein levels and basally impaired NRF2 signature compared with control cells. In contrast, NRF2-deficient cells showed increased p65-NF-B protein levels, although the mRNA levels remain unchanged, indicating post-translational alterations. Our results demonstrate a new mechanism of modulation of RAC1 inflammatory pathway through a cross-talk between NF-B and NRF2.	[Cuadrado, Antonio; Martin-Moldes, Zaira; Lastres-Becker, Isabel] Univ Autonoma Madrid, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Invest Sanitaria La Paz IdiPAZ, Dept Bioquim, Madrid 28029, Spain; [Cuadrado, Antonio; Martin-Moldes, Zaira; Lastres-Becker, Isabel] Univ Autonoma Madrid, Fac Med, Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain; [Martin-Moldes, Zaira] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Autonomous University of Madrid; CIBERNED; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lastres-Becker, I (corresponding author), Inst Invest Biomed Alberto Sols UAM CSIC, C Arturo Duperier 4, Madrid 28029, Spain.	ilbecker@iib.uam.es	Lastres-Becker, Isabel/R-3403-2018; Ye, Jianping/N-1998-2017; Becker, Isabel Lastres/AAB-6788-2019	Lastres-Becker, Isabel/0000-0002-4968-2175; Ye, Jianping/0000-0003-3875-365X; Becker, Isabel Lastres/0000-0002-4968-2175; Cuadrado, Antonio/0000-0002-3444-9012; Cuadrado, Antonio/0000-0002-4039-7140	Spanish Ministerio de Ciencia e Innovacion [SAF2010-17822]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036, R01DK085495] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grant SAF2010-17822.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Atreya R, 2006, ANN NY ACAD SCI, V1072, P98, DOI 10.1196/annals.1326.001; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Espada S, 2009, J NEUROCHEM, V110, P1107, DOI 10.1111/j.1471-4159.2009.06208.x; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hong HY, 2008, FEBS LETT, V582, P861, DOI 10.1016/j.febslet.2008.02.012; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517; Jiang Z. Y., 2013, PLOS ONE, V8; Joshi Gururaj, 2012, Recent Pat CNS Drug Discov, V7, P218; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Kusano Y, 2008, BIOCHEMISTRY-US, V47, P6169, DOI 10.1021/bi800199z; Lastres-Becker I, 2014, BRAIN, V137, P78, DOI 10.1093/brain/awt323; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pan QT, 2003, MOL CANCER RES, V1, P701; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Suganuma H, 2011, BIOCHEM BIOPH RES CO, V405, P146, DOI 10.1016/j.bbrc.2011.01.025; Tanaka T, 2010, BIOCHEM BIOPH RES CO, V399, P677, DOI 10.1016/j.bbrc.2010.07.141; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang PL, 2009, J NEUROSCI RES, V87, P2105, DOI 10.1002/jnr.22039; Wang XF, 2011, J IMMUNOL, V186, P5791, DOI 10.4049/jimmunol.1002127	49	205	209	4	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15244	15258		10.1074/jbc.M113.540633	http://dx.doi.org/10.1074/jbc.M113.540633			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24759106	Green Published, hybrid			2022-12-28	WOS:000337465400010
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			A Method for Activation of Endogenous Acid-sensing Ion Channel 1a (ASIC1a) in the Nervous System with High Spatial and Temporal Precision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acidosis; Astrocytes; Optogenetics; pH Regulation; Proton Pumps; ASIC1a; ArchT; Extracellular pH	CONTRIBUTES; EXPRESSION; BRAIN; PROMOTERS; PAIN	Protons activate acid-sensing ion channel 1a (ASIC1a) in the central nervous system (CNS) although the impact of such activation on brain outputs remains elusive. Progress elucidating the functional roles of ASIC1a in the CNS has been hindered by technical difficulties of achieving acidification with spatial and temporal precision. We have implemented a method to control optically the opening of ASIC1a in brain slices and also in awake animals. The light-driven H+ pump ArchT was expressed in astrocytes of mouse cortex by injection of adenoviral vectors containing a strong and astrocyte-specific promoter. Illumination with amber light acidified the surrounding interstitium and led to activation of endogenous ASIC1a channels and firing of action potentials in neurons localized in close proximity to ArchT-expressing astrocytes. We conclude that this optogenetic method offers a minimally invasive approach that enables examining the biological consequences of ASIC1a currents in any structure of the CNS and in the modulation of animal behaviors.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	cecilia.canessa@yale.edu						Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Figueiredo M, 2011, EXP PHYSIOL, V96, P40, DOI 10.1113/expphysiol.2010.052597; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Li TB, 2012, J BIOL CHEM, V287, P40680, DOI 10.1074/jbc.M112.418400; Liu BH, 2006, MOL THER, V14, P872, DOI 10.1016/j.ymthe.2006.05.020; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Musa-Aziz R, 2010, METHODS, V51, P134, DOI 10.1016/j.ymeth.2009.12.012; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; van Dijk KW, 2011, METHODS MOL BIOL, V693, P321, DOI 10.1007/978-1-60761-974-1_20; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	27	10	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15441	15448		10.1074/jbc.M114.550012	http://dx.doi.org/10.1074/jbc.M114.550012			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727474	Green Published, hybrid			2022-12-28	WOS:000337465400027
J	Gray, EE; Guglietta, R; Khakh, BS; O'Dell, TJ				Gray, Erin E.; Guglietta, Ryan; Khakh, Baljit S.; O'Dell, Thomas J.			Inhibitory Interactions between Phosphorylation Sites in the C Terminus of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-type Glutamate Receptor GluA1 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; AMPA RECEPTORS; SYNAPTIC PLASTICITY; GLUR1 SUBUNIT; REGULATORY PHOSPHORYLATION; PKA PHOSPHORYLATION; UNITARY CONDUCTANCE; DENDRITIC SPINES; NMDA RECEPTORS; PHOSPHATASE 2A	The C terminus of AMPA-type glutamate receptor (AMPAR) GluA1 subunits contains several phosphorylation sites that regulate AMPAR activity and trafficking at excitatory synapses. Although many of these sites have been extensively studied, little is known about the signaling mechanisms regulating GluA1 phosphorylation at Thr-840. Here, we report that neuronal depolarization in hippocampal slices induces a calcium and protein phosphatase 1/2A-dependent dephosphorylation of GluA1 at Thr-840 and a nearby site at Ser-845. Despite these similarities, inhibitors of NMDA-type glutamate receptors and protein phosphatase 2B prevented depolarization-induced Ser-845 dephosphorylation but had no effect on Thr-840 dephosphorylation. Instead, depolarization-induced Thr-840 dephosphorylation was prevented by blocking voltage-gated calcium channels, indicating that distinct Ca2+ sources converge to regulate GluA1 dephosphorylation at Thr-840 and Ser-845 in separable ways. Results from immunoprecipitation/depletion assays indicate that Thr-840 phosphorylation inhibits protein kinase A (PKA)-mediated increases in Ser-845 phosphorylation. Consistent with this, PKA-mediated increases in AMPAR currents, which are dependent on Ser-845 phosphorylation, were inhibited in HEK-293 cells expressing a Thr-840 phosphomimetic version of GluA1. Conversely, mimicking Ser-845 phosphorylation inhibited protein kinase C phosphorylation of Thr-840 in vitro, and PKA activation inhibited Thr-840 phosphorylation in hippocampal slices. Together, the regulation of Thr-840 and Ser-845 phosphorylation by distinct sources of Ca2+ influx and the presence of inhibitory interactions between these sites high-light a novel mechanism for conditional regulation of AMPAR phosphorylation and function.	[Gray, Erin E.; Guglietta, Ryan; Khakh, Baljit S.; O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Gray, Erin E.; Guglietta, Ryan] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; [O'Dell, Thomas J.] UCLA Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	O'Dell, TJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Ctr Hlth Sci 53 231, Box 951751, Los Angeles, CA 90095 USA.	todell@mednet.ucla.edu			National Institutes of Health [MH609197, T32MH85462, MH91384]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085462, R01MH060919, R34MH091384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH609197 (to T. J. O.) and T32MH85462 and MH91384 (to E. E. G.).	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ahn JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026292; Balasuriya D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.469205; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jenkins MA, 2014, MOL PHARMACOL, V85, P618, DOI 10.1124/mol.113.091488; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Yuste R, 1999, J NEUROSCI, V19, P1976	53	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14600	14611		10.1074/jbc.M114.553537	http://dx.doi.org/10.1074/jbc.M114.553537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706758	hybrid, Green Published			2022-12-28	WOS:000337248100017
J	Guo, L; Zheng, Z; Ai, JT; Huang, B; Li, XA				Guo, Ling; Zheng, Zhong; Ai, Junting; Huang, Bin; Li, Xiang-An			Hepatic Scavenger Receptor BI Protects Against Polymicrobial-induced Sepsis through Promoting LPS Clearance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NITRIC-OXIDE SYNTHASE; HDL CHOLESTEROL LEVELS; E-DEFICIENT MICE; SR-BI; APOLIPOPROTEIN-E; SELECTIVE UPTAKE; SUBCLINICAL ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; INFLAMMATORY RESPONSE	Recent studies revealed that scavenger receptor BI (SR-BI or Scarb1) plays a critical protective role in sepsis. However, the mechanisms underlying this protection remain largely unknown. In this study, using Scarb1(I179N) mice, a mouse model specifically deficient in hepatic SR-BI, we report that hepatic SR-BI protects against cecal ligation and puncture (CLP)-induced sepsis as shown by 75% fatality in Scarb1(I179N) mice, but only 21% fatality in C57BL/6J control mice. The increase in fatality in Scarb1(I179N) mice was associated with an exacerbated inflammatory cytokine production. Further study demonstrated that hepatic SR-BI exerts its protection against sepsis through its role in promoting LPS clearance without affecting the inflammatory response in macrophages, the glucocorticoid production in adrenal glands, the leukocyte recruitment to peritoneum or the bacterial clearance in liver. Our findings reveal hepatic SR-BI as a critical protective factor in sepsis and point out that promoting hepatic SR-BI-mediated LPS clearance may provide a therapeutic approach for sepsis.	[Guo, Ling; Zheng, Zhong; Ai, Junting; Li, Xiang-An] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Guo, Ling; Li, Xiang-An] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Zheng, Zhong; Ai, Junting] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Huang, Bin; Li, Xiang-An] Univ Kentucky, Coll Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Li, XA (corresponding author), BBSRB B255,741 S Limestone ST, Lexington, KY 40536 USA.	xli2@email.uky.edu			NIGMS/National Institutes of Health [R01GM085231, R01GM085231-2S1, R01GM085231-5S1]; Children's Miracle Network; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Miracle Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01GM085231, R01GM085231-2S1, and R01GM085231-5S1 from NIGMS/National Institutes of Health. This work was also supported by a grant from the Children's Miracle Network.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brodde MF, 2011, ATHEROSCLEROSIS, V215, P374, DOI 10.1016/j.atherosclerosis.2010.12.026; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Brundert M, 2006, J LIPID RES, V47, P2408, DOI 10.1194/jlr.M600136-JLR200; Brunham LR, 2011, CLIN GENET, V79, P575, DOI 10.1111/j.1399-0004.2011.01682.x; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Cai L, 2012, J LIPID RES, V53, P1472, DOI 10.1194/jlr.M023234; CALVO D, 1993, J BIOL CHEM, V268, P18929; Chadwick AC, 2013, CURR OPIN ENDOCRINOL, V20, P124, DOI 10.1097/MED.0b013e32835ed575; Clifford AJ, 2012, J NUTR, V142, P1764, DOI 10.3945/jn.112.160333; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716; Feng H, 2011, LIFE SCI, V88, P606, DOI 10.1016/j.lfs.2011.01.020; FREUDENBERG N, 1985, PATHOL RES PRACT, V179, P517, DOI 10.1016/S0344-0338(85)80193-X; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; GE YM, 1994, J INFECT DIS, V169, P95, DOI 10.1093/infdis/169.1.95; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; Guo L, 2014, ARTERIOSCL THROM VAS, V34, P966, DOI 10.1161/ATVBAHA.113.302484; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Guo L, 2012, J IMMUNOL, V189, P501, DOI 10.4049/jimmunol.1290035; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; HAN A, 1983, J BIOL CHEM, V258, P3703; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Holmes RS, 2012, RES REP BIOCHEM, V2, P9, DOI 10.2147/RRBC.S31749; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Kamimoto M, 2005, BIOMED RES-TOKYO, V26, P99, DOI 10.2220/biomedres.26.99; Khovidhunkit W, 2001, J LIPID RES, V42, P1636; Korporaal SJA, 2011, ARTERIOSCL THROM VAS, V31, P34, DOI 10.1161/ATVBAHA.110.210252; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li XA, 2006, CIRC RES, V98, pE60, DOI 10.1161/01.RES.0000219310.00308.10; Li XA, 2005, J BIOL CHEM, V280, P19087, DOI 10.1074/jbc.M500944200; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; Manichaikul A, 2012, ARTERIOSCL THROM VAS, V32, P1991, DOI 10.1161/ATVBAHA.112.249714; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Mayumi T, 1999, SHOCK, V11, P82, DOI 10.1097/00024382-199902000-00002; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Naj AC, 2010, CIRC-CARDIOVASC GENE, V3, P47, DOI 10.1161/CIRCGENETICS.109.903195; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Raubenheimer PJ, 2006, CLIN ENDOCRINOL, V65, P22, DOI 10.1111/j.1365-2265.2006.02540.x; Rejeb J, 2012, GENE, V511, P383, DOI 10.1016/j.gene.2012.09.070; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Roberts CGP, 2007, HUM HERED, V64, P107, DOI 10.1159/000101962; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Stylianou IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006521; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Viet LDT, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001785; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Yates M, 2011, HUM REPROD, V26, P1910, DOI 10.1093/humrep/der124; Yeh YC, 2002, ATHEROSCLEROSIS, V161, P95, DOI 10.1016/S0021-9150(01)00642-6; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	75	32	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14666	14673		10.1074/jbc.M113.537258	http://dx.doi.org/10.1074/jbc.M113.537258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719333	hybrid, Green Published			2022-12-28	WOS:000337248100023
J	Lee, M; Lee, CH; Demin, AA; Munashingha, PR; Amangyeld, T; Kwon, B; Formosa, T; Seo, YS				Lee, Miju; Lee, Chul-Hwan; Demin, Annie Albert; Munashingha, Palinda Ruvan; Amangyeld, Tamir; Kwon, Buki; Formosa, Tim; Seo, Yeon-Soo			Rad52/Rad59-dependent Recombination as a Means to Rectify Faulty Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; SISTER-CHROMATID COHESION; YEAST RAD52 PROTEIN; DNA-DAMAGE RESPONSE; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; END RESECTION; GENOME STABILITY	The correct removal of 5'-flap structures by Rad27 and Dna2 during Okazaki fragment maturation is crucial for the stable maintenance of genetic materials and cell viability. In this study, we identified RAD52, a key recombination protein, as a multicopy suppressor of dna2-K1080E, a lethal helicase-negative mutant allele of DNA2 in yeasts. In contrast, the overexpression of Rad51, which works conjointly with Rad52 in canonical homologous recombination, failed to suppress the growth defect of the dna2-K1080E mutation, indicating that Rad52 plays a unique and distinct role in Okazaki fragment metabolism. We found that the recombination-defective Rad52QDDD/AAAA mutant did not rescue dna2-K1080E, suggesting that Rad52-mediated recombination is important for suppression. The Rad52-mediated enzymatic stimulation of Dna2 or Rad27 is not a direct cause of suppression observed in vivo, as both Rad52 and Rad52-QDDD/AAAA proteins stimulated the endonuclease activities of both Dna2 and Rad27 to a similar extent. The recombination mediator activity of Rad52 was dispensable for the suppression, whereas both the DNA annealing activity and its ability to interact with Rad59 were essential. In addition, we found that several cohesion establishment factors, including Rsc2 and Elg1, were required for the Rad52-dependent suppression of dna2-K1080E. Our findings suggest a novel Rad52/Rad59-dependent, but Rad51-independent recombination pathway that could ultimately lead to the removal of faulty flaps in conjunction with cohesion establishment factors.	[Lee, Miju; Lee, Chul-Hwan; Demin, Annie Albert; Munashingha, Palinda Ruvan; Amangyeld, Tamir; Kwon, Buki; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Korea Advanced Institute of Science & Technology (KAIST); Utah System of Higher Education; University of Utah	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Formosa, Tim/0000-0002-8477-2483; Kwon, Buki/0000-0002-7860-0458; Lee, Chul-Hwan/0000-0003-0643-0100	National Research Foundation of Korea Grant from the Ministry of Education, Science, and Technology [2012R1A2A2A01047260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043424] Funding Source: NIH RePORTER	National Research Foundation of Korea Grant from the Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Foundation of Korea Grant 2012R1A2A2A01047260 from the Ministry of Education, Science, and Technology.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bi BY, 2004, P NATL ACAD SCI USA, V101, P9568, DOI 10.1073/pnas.0403205101; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chai WH, 2013, CELL CYCLE, V12, P1985, DOI 10.4161/cc.25306; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gary R, 1999, MOL CELL BIOL, V19, P5373; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; Hanawalt PC, 2007, MOL CELL, V28, P702, DOI 10.1016/j.molcel.2007.11.014; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hoopes LLM, 2002, MOL CELL BIOL, V22, P4136, DOI 10.1128/MCB.22.12.4136-4146.2002; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Huang JA, 2004, CELL CYCLE, V3, P973; Hubscher U, 2001, MOL CELLS, V12, P149; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kang HY, 2000, GENETICS, V155, P1055; Kang MJ, 2010, NUCLEIC ACIDS RES, V38, P7611, DOI 10.1093/nar/gkq651; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kang YH, 2009, J BIOL CHEM, V284, P10376, DOI 10.1074/jbc.M808894200; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee CH, 2013, J BIOL CHEM, V288, P9468, DOI 10.1074/jbc.M112.418715; Lee CH, 2010, NUCLEIC ACIDS RES, V38, P1583, DOI 10.1093/nar/gkp1135; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Li FY, 2013, EMBO J, V32, P461, DOI 10.1038/emboj.2012.345; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liddell LC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-229; Liefshitz B, 2011, MOL CELL BIOL, V31, P3921, DOI 10.1128/MCB.05974-11; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Munashingha PR, 2012, J BIOL CHEM, V287, P8675, DOI 10.1074/jbc.M111.326470; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066379; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Oum JH, 2011, MOL CELL BIOL, V31, P3924, DOI 10.1128/MCB.01269-10; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Pohl TJ, 2008, MOL CELL BIOL, V28, P897, DOI 10.1128/MCB.00524-07; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tsukamoto M, 2003, GENETICS, V165, P1703; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Van Dyck E, 2001, EMBO REP, V2, P905, DOI 10.1093/embo-reports/kve201; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	103	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15064	15079		10.1074/jbc.M114.548388	http://dx.doi.org/10.1074/jbc.M114.548388			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711454	Green Published, hybrid			2022-12-28	WOS:000337248100058
J	Sun, LL; Dong, YY; Shi, MM; Jin, M; Zhou, Q; Luo, ZQ; Gao, HC				Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Zhou, Qing; Luo, Zhao-Qing; Gao, Haichun			Two Residues Predominantly Dictate Functional Difference in Motility between Shewanella oneidensis Flagellins FlaA and FlaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; FILAMENT; ROLES; SYSTEMS; POLAR; GLYCOSYLATION; PROTOFILAMENT; EXPRESSION; SEQUENCE; SWITCH	Nearly half of flagellated microorganisms possess a multiple-flagellin system. Although a functional filament can be formed from one of multiple flagellins alone in many bacteria, it is more common that one flagellin is the major constituent and others contribute. Underlying mechanisms proposed for such scenarios cover flagellin regulation of various levels, including transcription, translation, post-translational modification, secretion, and filament assembly. In Shewanella oneidensis, the flagellar filament is composed of FlaA and FlaB flagellins; the latter is the major one in terms of motility. In this study, we showed that regulation of all levels except for filament assembly is indistinguishable between these two flagellins. Further analyses revealed that two amino acid residues predominantly dictated functional difference with respect to motility. Given that Shewanella prefer a solid surface-associated life style, of which filaments consisting of either FlaA or FlaB are equally supportive, we envision that roles of flagella in surface adhesion and formation of bacterial communities are particularly important for their survival and proliferation in these specific niches.	[Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Linlin; Dong, Yangyang; Shi, Miaomiao; Jin, Miao; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Qing; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Zhejiang University; Zhejiang University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Doctoral Fund of the Ministry of Education of China [20130101110142]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the Major State Basic Research Development Program (973 Program Grant 2010CB833803), National Natural Science Foundation of China Grant 31270097, and Doctoral Fund of the Ministry of Education of China Grant 20130101110142 (to H. G.).	Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Bubendorfer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073444; Bubendorfer S, 2012, MOL MICROBIOL, V83, P335, DOI 10.1111/j.1365-2958.2011.07934.x; Canals R, 2007, MICROBIOL-SGM, V153, P1165, DOI 10.1099/mic.0.2006/000687-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deakin WJ, 1999, MICROBIOL-UK, V145, P1397, DOI 10.1099/13500872-145-6-1397; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Faulds-Pain A, 2011, J BACTERIOL, V193, P2695, DOI 10.1128/JB.01172-10; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu HH, 2014, ENVIRON MICROBIOL, V16, P3181, DOI 10.1111/1462-2920.12457; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Iida Y, 2009, J MOL BIOL, V394, P1011, DOI 10.1016/j.jmb.2009.10.003; Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075610; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; Koerdt A, 2009, J BACTERIOL, V191, P5085, DOI 10.1128/JB.00206-09; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; LEYING H, 1992, MOL MICROBIOL, V6, P2863, DOI 10.1111/j.1365-2958.1992.tb01466.x; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Luo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062064; Malapaka RRV, 2007, J MOL BIOL, V365, P1102, DOI 10.1016/j.jmb.2006.10.054; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; PLEIER E, 1991, J BACTERIOL, V173, P2077, DOI 10.1128/jb.173.6.2077-2085.1991; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Scharf B, 2001, J BACTERIOL, V183, P5334, DOI 10.1128/JB.183.18.5334-5342.2001; Shi MM, 2013, J BACTERIOL, V195, P1463, DOI 10.1128/JB.02187-12; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SUERBAUM S, 1995, TRENDS MICROBIOL, V3, P168, DOI 10.1016/S0966-842X(00)88913-1; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Warren SM, 2005, J BACTERIOL, V187, P6075, DOI 10.1128/JB.187.17.6075-6083.2005; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yuan J, 2013, BBA-GEN SUBJECTS, V1830, P5248, DOI 10.1016/j.bbagen.2013.07.023	52	16	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14547	14559		10.1074/jbc.M114.552000	http://dx.doi.org/10.1074/jbc.M114.552000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24733391	Green Published, hybrid			2022-12-28	WOS:000337248100013
J	Kwartler, CS; Chen, JY; Thakur, D; Li, SM; Baskin, K; Wang, S; Wang, ZV; Walker, L; Hill, JA; Epstein, HF; Taegtmeyer, H; Milewicz, DM				Kwartler, Callie S.; Chen, Jiyuan; Thakur, Dhananjay; Li, Shumin; Baskin, Kedryn; Wang, Shanzhi; Wang, Zhao V.; Walker, Lori; Hill, Joseph A.; Epstein, Henry F.; Taegtmeyer, Heinrich; Milewicz, Dianna M.			Overexpression of Smooth Muscle Myosin Heavy Chain Leads to Activation of the Unfolded Protein Response and Autophagic Turnover of Thick Filament-associated Proteins in Vascular Smooth Muscle Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; ER Stress; Myosin; Protein Turnover; Unfolded Protein Response; Vascular Smooth Muscle Cells; Thoracic Aortic Aneurysms and Dissections	ENDOPLASMIC-RETICULUM STRESS; THORACIC AORTIC-ANEURYSMS; ANGIOTENSIN-II; LIGHT-CHAIN; DISSECTIONS; MUTATIONS; KINASE; MECHANISMS; ISOFORMS; DISEASE	Background: Genomic duplications involving the smooth muscle myosin heavy chain gene, MYH11, are associated with increased risk for acute aortic dissections. Results:MYH11 overexpression causes increased turnover of contractile proteins through increased autophagy. Conclusion:MYH11 duplications may predispose to aortic disease through increased turnover of contractile proteins and disruption of contractile signaling. Significance: Increased protein turnover may be an important mechanism by which genomic duplications cause human disease. Duplications spanning nine genes at the genomic locus 16p13.1 predispose individuals to acute aortic dissections. The most likely candidate gene in this region leading to the predisposition for dissection is MYH11, which encodes smooth muscle myosin heavy chain (SM-MHC). The effects of increased expression of MYH11 on smooth muscle cell (SMC) phenotypes were explored using mouse aortic SMCs with transgenic overexpression of one isoform of SM-MHC. We found that these cells show increased expression of Myh11 and myosin filament-associated contractile genes at the message level when compared with control SMCs, but not at the protein level due to increased protein degradation. Increased expression of Myh11 resulted in endoplasmic reticulum (ER) stress in SMCs, which led to a paradoxical decrease of protein levels through increased autophagic degradation. An additional consequence of ER stress in SMCs was increased intracellular calcium ion concentration, resulting in increased contractile signaling and contraction. The increased signals for contraction further promote transcription of contractile genes, leading to a feedback loop of metabolic abnormalities in these SMCs. We suggest that overexpression of MYH11 can lead to increased ER stress and autophagy, findings that may be globally implicated in disease processes associated with genomic duplications.	[Kwartler, Callie S.; Chen, Jiyuan; Baskin, Kedryn; Wang, Shanzhi; Taegtmeyer, Heinrich; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Kwartler, Callie S.; Chen, Jiyuan; Baskin, Kedryn; Wang, Shanzhi; Taegtmeyer, Heinrich; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Li, Shumin; Epstein, Henry F.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Walker, Lori] Univ Colorado, Dept Med, Denver, CO 80217 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	Dianna.M.Milewicz@uth.tmc.edu	Kwartler, Callie/AGB-4204-2022	Kwartler, Callie/0000-0002-3722-9939; Wang, Zhao/0000-0002-9904-9538	National Institutes of Health [RO1HL62594, P50HL083794-01, P01HL110869-01]; Richard T. Pisani Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, P50HL083794, R01HL061483, P01HL110869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007257, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard T. Pisani Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL62594, P50HL083794-01 and P01HL110869-01 (to D. M. M.) and a grant from the Richard T. Pisani Fund (to D. M. M.).	Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cao JM, 2010, HUM MOL GENET, V19, P1908, DOI 10.1093/hmg/ddq066; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Croons V, 2008, J PHARMACOL EXP THER, V325, P824, DOI 10.1124/jpet.107.132944; Croons V, 2007, J PHARMACOL EXP THER, V320, P986, DOI 10.1124/jpet.106.113944; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Katsanos CS, 2005, AM J PHYSIOL-ENDOC M, V289, pE1064, DOI 10.1152/ajpendo.00141.2005; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Liang B, 2013, ARTERIOSCL THROM VAS, V33, P595, DOI 10.1161/ATVBAHA.112.300606; Lichter-Konecki U, 2011, MOL GENET METAB, V103, P323, DOI 10.1016/j.ymgme.2011.04.013; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; MARTIN AF, 1977, J BIOL CHEM, V252, P3422; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Narita Masashi, 2012, Small GTPases, V3, P111, DOI 10.4161/sgtp.19422; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Salazar M, 2011, METHOD ENZYMOL, V489, P297, DOI 10.1016/B978-0-12-385116-1.00017-0; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Szymanski PT, 1999, BIOCHEMISTRY-US, V38, P3778, DOI 10.1021/bi981394y; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Young ARJ, 2011, AUTOPHAGY, V7, P1387, DOI 10.4161/auto.7.11.17348; ZAK R, 1977, J BIOL CHEM, V252, P3430; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	61	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14075	14088		10.1074/jbc.M113.499277	http://dx.doi.org/10.1074/jbc.M113.499277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711452	hybrid, Green Published			2022-12-28	WOS:000335984600037
J	Brash, AR; Niraula, NP; Boeglin, WE; Mashhadi, Z				Brash, Alan R.; Niraula, Narayan P.; Boeglin, William E.; Mashhadi, Zahra			An Ancient Relative of Cyclooxygenase in Cyanobacteria Is a Linoleate 10S-Dioxygenase That Works in Tandem with a Catalase-related Protein with Specific 10S-Hydroperoxide Lyase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Dioxygenase; Fatty Acid Metabolism; Peroxidase; Polyunsaturated Fatty Acids; HPODE; Catalase; Cyclooxygenase; Linoleic Acid	ALLENE OXIDE SYNTHASE; LIPOXYGENASE FUSION PROTEIN; FATTY-ACID HYDROPEROXIDES; 10-HYDROPEROXIDE ISOMER; GENE-TRANSFER; 1-OCTEN-3-OL; IDENTIFICATION; BIOSYNTHESIS; PRODUCTS; ANABAENA	Background: Fatty acid heme dioxygenases occur in eukaryotes, often associated with a cytochrome P450 that transforms the peroxide product. Results: Neighboring cyanobacterial genes, dioxygenase and catalase, are identified as linoleate 10S-dioxygenase and 10S-hydroperoxide lyase, respectively. Conclusion: These Nostoc hemoproteins show novel activities. Significance: Our results identify a heme dioxygenase ancestor and a catalase that substitutes in function for a cytochrome P450. In the course of exploring the scope of catalase-related hemoprotein reactivity toward fatty acid hydroperoxides, we detected a novel candidate in the cyanobacterium Nostoc punctiforme PCC 73102. The immediate neighboring upstream gene, annotated as cyclooxygenase-2, appeared to be a potential fatty acid heme dioxygenase. We cloned both genes and expressed the cDNAs in Escherichia coli, confirming their hemoprotein character. Oxygen electrode recordings demonstrated a rapid (>100 turnovers/s) reaction of the heme dioxygenase with oleic and linoleic acids. HPLC, including chiral column analysis, UV, and GC-MS of the oxygenated products, identified a novel 10S-dioxygenase activity. The catalase-related hemoprotein reacted rapidly and specifically with linoleate 10S-hydroperoxide (>2,500 turnovers/s) with a hydroperoxide lyase activity specific for the 10S-hydroperoxy enantiomer. The products were identified by NMR as (8E)10-oxo-decenoic acid and the C8 fragments, 1-octen-3-ol and 2Z-octen-1-ol, in approximate to 3:1 ratio. Chiral HPLC analysis established strict enzymatic control in formation of the 3R alcohol configuration (99% enantiomeric excess) and contrasted with racemic 1-octen-3-ol formed in reaction of linoleate 10S-hydroperoxide with hematin or ferrous ions. The Nostoc linoleate 10S-dioxygenase, the sequence of which contains the signature catalytic sequence of cyclooxygenases and fungal linoleate dioxygenases (YRWH), appears to be a heme dioxygenase ancestor. The novel activity of the lyase expands the known reactions of catalase-related proteins and functions in Nostoc in specific transformation of the 10S-hydroperoxylinoleate.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM-074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.).	Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; ASSAF S, 1995, J AGR FOOD CHEM, V43, P2173, DOI 10.1021/jf00056a040; Barofsky A, 2007, ORG LETT, V9, P1017, DOI 10.1021/ol063051v; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1991, J BIOL CHEM, V266, P22926; CAUDALES R, 1992, INT J SYST BACTERIOL, V42, P246, DOI 10.1099/00207713-42-2-246; CHACON JN, 1987, CHEM PHYS LIPIDS, V43, P81; De Luna P, 2013, J PHYS CHEM B, V117, P14635, DOI 10.1021/jp408486n; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; Hamberg M, 1999, J BIOL CHEM, V274, P24503, DOI 10.1074/jbc.274.35.24503; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; IMAI T, 1993, J BIOL CHEM, V268, P19681; Klotz MG, 2003, MOL BIOL EVOL, V20, P1098, DOI 10.1093/molbev/msg129; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; LABEQUE R, 1988, BIOCHEMISTRY-US, V27, P7060, DOI 10.1021/bi00418a059; Lang I, 2008, BIOCHEM J, V410, P347, DOI 10.1042/BJ20071277; Liu XJ, 2003, CURR MICROBIOL, V47, P467, DOI 10.1007/s00284-003-4059-8; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Martinez E, 2010, J BIOL CHEM, V285, P9339, DOI 10.1074/jbc.M109.078147; Maruyama S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-197; Meeks JC, 1998, BIOSCIENCE, V48, P266, DOI 10.2307/1313353; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Ni T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-83; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; PEERS KE, 1981, J SCI FOOD AGR, V32, P898, DOI 10.1002/jsfa.2740320908; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Spiteller P, 2008, CHEM-EUR J, V14, P9100, DOI 10.1002/chem.200800292; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Watson SB, 2003, PHYCOLOGIA, V42, P332, DOI 10.2216/i0031-8884-42-4-332.1; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P25, DOI 10.1016/0005-2760(84)90293-5; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V795, P163, DOI 10.1016/0005-2760(84)90117-6; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P18, DOI 10.1016/0005-2760(84)90292-3; WURZENBERGER M, 1982, Z LEBENSM UNTERS FOR, V175, P186, DOI 10.1007/BF01139769; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	48	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13101	13111		10.1074/jbc.M114.555904	http://dx.doi.org/10.1074/jbc.M114.555904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659780	Green Published, hybrid			2022-12-28	WOS:000335522800012
J	Dadi, PK; Vierra, NC; Ustione, A; Piston, DW; Colbran, RJ; Jacobson, DA				Dadi, Prasanna K.; Vierra, Nicholas C.; Ustione, Alessandro; Piston, David W.; Colbran, Roger J.; Jacobson, David A.			Inhibition of Pancreatic beta-Cell Ca2+/Calmodulin-dependent Protein Kinase II Reduces Glucose-stimulated Calcium Influx and Insulin Secretion, Impairing Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Calcium Imaging; CaMKII; Diabetes; Insulin; Insulin Secretion; Islet; Pancreatic Islets	CARDIAC SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; SYNAPSIN-I; B-CELLS; PHOSPHORYLATION; CHANNELS; FACILITATION; ACTIVATION; EXOCYTOSIS; CAMKII	Background: Glucose activates CaMKII in -cells, how this influences glucose homeostasis has not been determined. Results: Inhibiting CaMKII in mouse -cells causes glucose intolerance by reducing Ca2+ entry and insulin secretion. Conclusion: CaMKII is a -cell Ca2+ sensor that amplifies secretagogue-induced Ca2+ entry and insulin secretion to maintain glucose homeostasis. Significance: This provides the first evidence that -cell CaMKII modulates glucose homeostasis under physiological and insulin resistant states. Glucose-stimulated insulin secretion (GSIS) from pancreatic -cells is caused by Ca2+ entry via voltage-dependent Ca2+ channels. CaMKII is a key mediator and feedback regulator of Ca2+ signaling in many tissues, but its role in -cells is poorly understood, especially in vivo. Here, we report that mice with conditional inhibition of CaMKII in -cells show significantly impaired glucose tolerance due to decreased GSIS. Moreover, -cell CaMKII inhibition dramatically exacerbates glucose intolerance following exposure to a high fat diet. The impairment of islet GSIS by -cell CaMKII inhibition is not accompanied by changes in either glucose metabolism or the activities of K-ATP and voltage-gated potassium channels. However, glucose-stimulated Ca2+ entry via voltage-dependent Ca2+ channels is reduced in islet -cells with CaMKII inhibition, as well as in primary wild-type -cells treated with a peptide inhibitor of CaMKII. The levels of basal -cell cytoplasmic Ca2+ and of endoplasmic reticulum Ca2+ stores are also decreased by CaMKII inhibition. In addition, CaMKII inhibition suppresses glucose-stimulated action potential firing frequency. These results reveal that CaMKII is a Ca2+ sensor with a key role as a feed-forward stimulator of -cell Ca2+ signals that enhance GSIS under physiological and pathological conditions.	[Dadi, Prasanna K.; Vierra, Nicholas C.; Ustione, Alessandro; Piston, David W.; Colbran, Roger J.; Jacobson, David A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Jacobson, DA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 7425B MRB 4,2213 Garland Ave, Nashville, TN 37232 USA.	david.a.jacobson@vanderbilt.edu	Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Jacobson, David A./0000-0003-1816-5375	National Institutes of Health [DK096122, DK081666, DK20593]; Pilot and Feasibility Grant through the Vanderbilt University Diabetes Research Training Center [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098659, P60DK020593, R01DK097392, K01DK081666, P30DK020593, R03DK096122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot and Feasibility Grant through the Vanderbilt University Diabetes Research Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant DK096122 (to D. A. J.), DK081666 (to D. A. J.) as well as Pilot and Feasibility Grant P60 DK20593 through the Vanderbilt University Diabetes Research Training Center. The Vanderbilt Islet Procurement and Analysis Core was also supported by National Institutes of Health Grant DK20593.	Abiria SA, 2010, J NEUROCHEM, V112, P150, DOI 10.1111/j.1471-4159.2009.06436.x; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Anthony DF, 2007, J MOL CELL CARDIOL, V43, P492, DOI 10.1016/j.yjmcc.2007.07.003; ASHCROFT SJH, 1994, DIABETOLOGIA, V37, pS21, DOI 10.1007/BF00400822; Babb EL, 1996, BIOCHEM J, V317, P167, DOI 10.1042/bj3170167; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Currie S, 2004, BIOCHEM J, V377, P357, DOI 10.1042/BJ20031043; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Kline CF, 2013, P NATL ACAD SCI USA, V110, P17576, DOI 10.1073/pnas.1314195110; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; KRANIAS EG, 1988, MOL CELL BIOCHEM, V82, P37; Krueger KA, 1999, DIABETES, V48, P499, DOI 10.2337/diabetes.48.3.499; Krueger KA, 1997, J BIOL CHEM, V272, P27464, DOI 10.1074/jbc.272.43.27464; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATSUMOTO K, 1995, ENDOCRINOLOGY, V136, P3784, DOI 10.1210/en.136.9.3784; MATTHEWS EK, 1975, J PHYSIOL-LONDON, V246, P421, DOI 10.1113/jphysiol.1975.sp010897; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; NORLING LL, 1994, CELL CALCIUM, V16, P137, DOI 10.1016/0143-4160(94)90008-6; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; PRENTKI M, 1984, EXPERIENTIA, V40, P1052, DOI 10.1007/BF01971451; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Watson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025975; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WENHAM RM, 1994, J BIOL CHEM, V269, P4947; WOLLHEIM CB, 1981, UPSALA J MED SCI, V86, P149, DOI 10.3109/03009738109179223; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Wu YJ, 2004, J PHYSIOL-LONDON, V554, P145, DOI 10.1113/jphysiol.2003.053314; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; XU A, 1993, J BIOL CHEM, V268, P8394; Yamamoto H, 2003, J PHARMACOL SCI, V93, P30, DOI 10.1254/jphs.93.30; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	53	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12435	12445		10.1074/jbc.M114.562587	http://dx.doi.org/10.1074/jbc.M114.562587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627477	Green Published, hybrid			2022-12-28	WOS:000335581400020
J	Li, Y; Surya, W; Claudine, S; Torres, J				Li, Yan; Surya, Wahyu; Claudine, Stephanie; Torres, Jaume			Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Nuclear Magnetic Resonance (NMR); Protein Structure; Structural Biology; Viral Protein; Virus Assembly; Golgi Targeting; SARS; Coronavirus; Envelope Protein	RESPIRATORY SYNDROME CORONAVIRUS; INFECTIOUS-BRONCHITIS-VIRUS; NUCLEAR-MAGNETIC-RESONANCE; TORSION ANGLE DYNAMICS; SARS-CORONAVIRUS; MEMBRANE-PROTEIN; MUTATIONAL ANALYSIS; MURINE CORONAVIRUS; CYTOPLASMIC TAIL; TERMINAL DOMAIN	Background: Coronavirus envelope (CoV E) proteins have a predicted -coil- motif reported to target the Golgi complex. Results: This conserved domain forms -structure on its own but is -helical in the context of full-length SARS-CoV E protein. Conclusion: This domain is potentially involved in large conformational transitions. Significance: This is the first structural data of the extramembrane domain of any coronavirus E protein. Coronavirus envelope (CoV E) proteins are approximate to 100-residue polypeptides with at least one channel-forming -helical transmembrane (TM) domain. The extramembrane C-terminal tail contains a completely conserved proline, at the center of a predicted -coil- motif. This hydrophobic motif has been reported to constitute a Golgi-targeting signal or a second TM domain. However, no structural data for this or other extramembrane domains in CoV E proteins is available. Herein, we show that the E protein in the severe acute respiratory syndrome virus has only one TM domain in micelles, whereas the predicted -coil- motif forms a short membrane-bound -helix connected by a disordered loop to the TM domain. However, complementary results suggest that this motif is potentially poised for conformational change or in dynamic exchange with other conformations.	[Li, Yan; Surya, Wahyu; Claudine, Stephanie; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	jtorres@ntu.edu.sg	Torres, Jaume/A-2179-2011; Li, Yan/G-4642-2013; Torres, Jaume/AAJ-4510-2020	Torres, Jaume/0000-0002-1282-9727; Li, Yan/0000-0003-1963-839X; Surya, Wahyu/0000-0001-9240-371X				Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Al-Ahdal MN, 2012, J INFECT DEV COUNTR, V6, P692, DOI 10.3855/jidc.3084; Alvarez E, 2010, VIROLOGY, V402, P281, DOI 10.1016/j.virol.2010.03.015; Anderson LJ, 2012, NEW ENGL J MED, V367, P1850, DOI 10.1056/NEJMe1212300; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cohen JR, 2011, J VIROL, V85, P5794, DOI 10.1128/JVI.00060-11; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2; Corse E, 2002, J VIROL, V76, P1273, DOI 10.1128/JVI.76.3.1273-1284.2002; Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Enjuanes L, 2011, BIRKHAUSER ADV INFEC, P73, DOI 10.1007/978-3-0346-0277-8_4; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Fischer F, 1998, J VIROL, V72, P7885, DOI 10.1128/JVI.72.10.7885-7894.1998; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Gan SW, 2011, ANAL BIOCHEM, V416, P100, DOI 10.1016/j.ab.2011.05.007; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hernandez LD, 1998, J VIROL, V72, P3259, DOI 10.1128/JVI.72.4.3259-3267.1998; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hogue BG, 2008, NIDOVIRUSES, P179; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Kasai T., 2007, JAPAN MED ASS J, V50, P117; KAUPPINEN JK, 1981, APPL OPTICS, V20, P1866, DOI 10.1364/AO.20.001866; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Kuo LL, 2007, J VIROL, V81, P2249, DOI 10.1128/JVI.01577-06; Kuo LL, 2010, J VIROL, V84, P12872, DOI 10.1128/JVI.01850-10; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Netland J, 2010, VIROLOGY, V399, P120, DOI 10.1016/j.virol.2010.01.004; Nieto-Torres JL, 2011, VIROLOGY, V415, P69, DOI 10.1016/j.virol.2011.03.029; Ortego J, 2002, J VIROL, V76, P11518, DOI 10.1128/JVI.76.22.11518-11529.2002; Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041; Parthasarathy K, 2012, PROTEIN EXPRES PURIF, V85, P133, DOI 10.1016/j.pep.2012.07.005; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Ruch TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002674; Ruch TR, 2011, J VIROL, V85, P675, DOI 10.1128/JVI.01570-10; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Serrano P, 2007, J VIROL, V81, P12049, DOI 10.1128/JVI.00969-07; SIDDELL SG, 1995, CORONAVIRIDAE INTRO; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Surya W., 2013, RESP DIS INFECT NEW, DOI [10.5772/53957, DOI 10.5772/53957]; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Torres J, 2005, BIOPHYS J, V88, P1283, DOI 10.1529/biophysj.104.051730; Torres J, 2007, PROTEIN SCI, V16, P2065, DOI 10.1110/ps.062730007; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Van Horn WD, 2010, BBA-BIOMEMBRANES, V1798, P140, DOI 10.1016/j.bbamem.2009.08.022; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Verdia-Baguena C, 2012, VIROLOGY, V432, P485, DOI 10.1016/j.virol.2012.07.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Wilson L, 2006, VIROLOGY, V353, P294, DOI 10.1016/j.virol.2006.05.028; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	79	64	65	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12535	12549		10.1074/jbc.M114.560094	http://dx.doi.org/10.1074/jbc.M114.560094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668816	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000335581400028
J	Zacchi, LF; Wu, HC; Bell, SL; Millen, L; Paton, AW; Paton, JC; Thomas, PJ; Zolkiewski, M; Brodsky, JL				Zacchi, Lucia F.; Wu, Hui-Chuan; Bell, Samantha L.; Millen, Linda; Paton, Adrienne W.; Paton, James C.; Thomas, Philip J.; Zolkiewski, Michal; Brodsky, Jeffrey L.			The BiP Molecular Chaperone Plays Multiple Roles during the Biogenesis of TorsinA, an AAA(+) ATPase Associated with the Neurological Disease Early-onset Torsion Dystonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Molecular Chaperone; Neurological Diseases; Protein Degradation; Protein Folding; Yeast; BiP; DYT1; GRP78; torsinA	RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; ER-ASSOCIATED DEGRADATION; GLUCOSE-REGULATED PROTEIN-78; YEAST ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE FACTOR; DNAJ-LIKE PROTEIN; DELTA-E-TORSINA; NUCLEAR-ENVELOPE; SACCHAROMYCES-CEREVISIAE	Background: The E mutation in the AAA(+) ATPase torsinA is associated with the neurological disease torsion dystonia. Results: BiP and its co-factors maintain torsinA and torsinAE stability, glycosylation, and solubility. Conclusion: torsinA/E, a chaperone-like protein, requires the assistance of other chaperones to fold. Significance: Therapeutics that modulate BiP may counteract torsinAE-associated physiological defects. Early-onset torsion dystonia (EOTD) is a neurological disorder characterized by involuntary and sustained muscle contractions that can lead to paralysis and abnormal posture. EOTD is associated with the deletion of a glutamate (E) in torsinA, an endoplasmic reticulum (ER) resident AAA(+) ATPase. To date, the effect of E on torsinA and the reason that this mutation results in EOTD are unclear. Moreover, there are no specific therapeutic options to treat EOTD. To define the underlying biochemical defects associated with torsinAE and to uncover factors that might be targeted to offset defects associated with torsinAE, we developed a yeast torsinA expression system and tested the roles of ER chaperones in mediating the folding and stability of torsinA and torsinAE. We discovered that the ER lumenal Hsp70, BiP, an associated Hsp40, Scj1, and a nucleotide exchange factor, Lhs1, stabilize torsinA and torsinAE. BiP also maintained torsinA and torsinAE solubility. Mutations predicted to compromise specific torsinA functional motifs showed a synthetic interaction with the E mutation and destabilized torsinAE, suggesting that the E mutation predisposes torsinA to defects in the presence of secondary insults. In this case, BiP was required for torsinAE degradation, consistent with data that specific chaperones exhibit either pro-degradative or pro-folding activities. Finally, using two independent approaches, we established that BiP stabilizes torsinA and torsinAE in mammalian cells. Together, these data define BiP as the first identified torsinA chaperone, and treatments that modulate BiP might improve symptoms associated with EOTD.	[Zacchi, Lucia F.; Bell, Samantha L.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Wu, Hui-Chuan; Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Millen, Linda; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kansas State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Adelaide	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Zacchi, Lucia/F-7494-2016; Zacchi, Lucia/N-6484-2019; Bell, Samantha L./AAZ-3080-2021	Zacchi, Lucia/0000-0001-6217-1380; Zacchi, Lucia/0000-0001-6217-1380; Bell, Samantha L./0000-0002-5453-3203	National Institutes of Health [GM75061]; Dystonia Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystonia Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM75061 (to J. L. B.).; Supported by a postdoctoral fellowship from the Dystonia Medical Research Foundation.; Supported by a research grant from the Dystonia Medical Research Foundation.	Adams A, 1997, METHODS YEAST GENETI; Amberg D. C., 2005, METHODS YEAST GENETI, P149; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Becker D. M., 2008, CURR PROTOC MOL BIOL; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Bharadwaj P, 2010, FEMS YEAST RES, V10, P961, DOI 10.1111/j.1567-1364.2010.00658.x; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Blandy MA, 1920, J NEUROL PSYCHOPATHO, V1, P148, DOI 10.1136/jnnp.s1-1.2.148; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Eletto D, 2012, J CELL SCI, V125, P4865, DOI 10.1242/jcs.108928; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gelling Cristy L, 2010, Proc Am Thorac Soc, V7, P363, DOI 10.1513/pats.201001-007AW; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Giles LM, 2009, J BIOL CHEM, V284, P21765, DOI 10.1074/jbc.M109.004838; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gorbatyuk M.S., 2013, J GENET SYNDR GENE T, V4, DOI [10.4172/2157-7412.1000128, DOI 10.4172/2157-7412.1000128]; Gordon KL, 2012, NEUROSCIENCE, V224, P160, DOI 10.1016/j.neuroscience.2012.08.023; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Gordon KL, 2011, NEUROCHEM RES, V36, P452, DOI 10.1007/s11064-010-0363-4; Granata A, 2010, EUR J NEUROL, V17, P81, DOI 10.1111/j.1468-1331.2010.03057.x; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HEMMINGS BA, 1981, P NATL ACAD SCI-BIOL, V78, P435, DOI 10.1073/pnas.78.1.435; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Hoffman C. S., 2008, CURR PROTOC MOL BIOL; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Jakob CA, 2001, EMBO REP, V2, P423; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kamm C, 2008, NEUROLOGY, V70, P2261, DOI 10.1212/01.wnl.0000313838.05734.8a; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Kister AE, 2013, BIOCHEM SOC T, V41, P616, DOI 10.1042/BST20120308; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Kornfeld S, 1998, J CLIN INVEST, V101, P1293, DOI 10.1172/JCI3140; KRAMER PL, 1994, AM J HUM GENET, V55, P468; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; LEPPERT G, 1990, GENETICS, V125, P13; Lim HA, 2006, J MED FOOD, V9, P28, DOI 10.1089/jmf.2006.9.28; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Morawe T, 2012, MOL NEUROBIOL, V46, P41, DOI 10.1007/s12035-012-8246-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Panayi Gabriel S, 2008, Novartis Found Symp, V291, P212; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pham P, 2006, NEUROREPORT, V17, P1725, DOI 10.1097/WNR.0b013e3280101220; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; POLAINA J, 1982, MOL GEN GENET, V186, P253, DOI 10.1007/BF00331858; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Qiu W, 2005, ARTERIOSCL THROM VAS, V25, P571, DOI 10.1161/01.ATV.0000154142.61859.94; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; SCHMITZ A, 1995, EMBO J, V14, P1091, DOI 10.1002/j.1460-2075.1995.tb07092.x; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; SEGUIREAL B, 1995, EMBO J, V14, P5476, DOI 10.1002/j.1460-2075.1995.tb00234.x; Shashidharan P, 2000, BRAIN RES, V877, P379, DOI 10.1016/S0006-8993(00)02702-5; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; SIMON K, 1988, J CELL BIOL, V107, P2163, DOI 10.1083/jcb.107.6.2163; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Takeuchi M, 2006, J BIOCHEM, V139, P597, DOI 10.1093/jb/mvj063; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Tiffany-Castiglioni E, 2012, NEUROTOXICOLOGY, V33, P545, DOI 10.1016/j.neuro.2012.02.007; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Urano F, 2000, J CELL SCI, V113, P3697; Valastyan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022744; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vendruscolo M, 2012, CURR OPIN STRUC BIOL, V22, P138, DOI 10.1016/j.sbi.2012.01.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Weibezahn J, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-1; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471; Zolkiewski M., 2011, PROTEIN CHAPERONES P	166	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12727	12747		10.1074/jbc.M113.529123	http://dx.doi.org/10.1074/jbc.M113.529123			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627482	Green Published, hybrid			2022-12-28	WOS:000335581400044
J	Suzuki, N; Fujimoto, Z; Kim, YM; Momma, M; Kishine, N; Suzuki, R; Suzuki, S; Kitamura, S; Kobayashi, M; Kimura, A; Funane, K				Suzuki, Nobuhiro; Fujimoto, Zui; Kim, Young-Min; Momma, Mitsuru; Kishine, Naomi; Suzuki, Ryuichiro; Suzuki, Shiho; Kitamura, Shinichi; Kobayashi, Mikihiko; Kimura, Atsuo; Funane, Kazumi			Structural Elucidation of the Cyclization Mechanism of alpha-1,6-Glucan by Bacillus circulans T-3040 Cycloisomaltooligosaccharide Glucanotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Structure; Crystal Structure; Enzyme Catalysis; Enzyme Structure; Glycoside Hydrolases; X-ray Crystallography; Cycloisomaltooligosaccharide Glucanotransferase; Dextran	CARBOHYDRATE-BINDING MODULE; CATALYTIC AMINO-ACIDS; HYDROLASE FAMILY 66; CYCLODEXTRIN GLYCOSYLTRANSFERASE; ALPHA-AMYLASE; CYCLIC ISOMALTOOLIGOSACCHARIDES; STREPTOCOCCUS-MUTANS; ENZYMATIC PRODUCTION; PRODUCT SPECIFICITY; GAMMA-CYCLODEXTRIN	Background: Cycloisomaltooligosaccharide glucanotransferase catalyzes an intramolecular transglucosylation reaction and produces cycloisomaltooligosaccharides from dextran. Results: The crystal structure of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase was determined. Conclusion: The enzyme structures complexed with isomaltooligosaccharides and cycloisomaltooctaose revealed the molecular mechanism of action. Significance: CBM35 functions in the product size determination and substrate recruitment. Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase belongs to the glycoside hydrolase family 66 and catalyzes an intramolecular transglucosylation reaction that produces cycloisomaltooligosaccharides from dextran. The crystal structure of the core fragment from Ser-39 to Met-738 of B. circulans T-3040 cycloisomaltooligosaccharide glucanotransferase, devoid of its N-terminal signal peptide and C-terminal nonconserved regions, was determined. The structural model contained one catalytic (/)(8)-barrel domain and three -domains. Domain N with an immunoglobulin-like -sandwich fold was attached to the N terminus; domain C with a Greek key -sandwich fold was located at the C terminus, and a carbohydrate-binding module family 35 (CBM35) -jellyroll domain B was inserted between the 7th -strand and the 7th -helix of the catalytic domain A. The structures of the inactive catalytic nucleophile mutant enzyme complexed with isomaltohexaose, isomaltoheptaose, isomaltooctaose, and cycloisomaltooctaose revealed that the ligands bound in the catalytic cleft and the sugar-binding site of CBM35. Of these, isomaltooctaose bound in the catalytic site extended to the second sugar-binding site of CBM35, which acted as subsite -8, representing the enzymesubstrate complex when the enzyme produces cycloisomaltooctaose. The isomaltoheptaose and cycloisomaltooctaose bound in the catalytic cleft with a circular structure around Met-310, representing the enzymeproduct complex. These structures collectively indicated that CBM35 functions in determining the size of the product, causing the predominant production of cycloisomaltooctaose by the enzyme. The canonical sugar-binding site of CBM35 bound the mid-part of isomaltooligosaccharides, indicating that the original function involved substrate binding required for efficient catalysis.	[Suzuki, Nobuhiro; Fujimoto, Zui; Kim, Young-Min; Momma, Mitsuru; Kishine, Naomi; Kobayashi, Mikihiko] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Kim, Young-Min; Kimura, Atsuo] Hokkaido Univ, Div Appl Biosci, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Suzuki, Ryuichiro; Kobayashi, Mikihiko; Funane, Kazumi] Natl Agr & Food Res Org, Appl Microbiol Div, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Suzuki, Shiho; Kitamura, Shinichi] Osaka Prefecture Univ, Coll Life Environm & Adv Sci, Sakai, Osaka 5998531, Japan; [Kobayashi, Mikihiko] Jissen Womens Univ, Dept Food & Hlth Sci, Hino, Tokyo 1918510, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Osaka Metropolitan University	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; funane@affrc.go.jp	Suzuki, Nobuhiro/M-7238-2015; Suzuki, Shiho/B-2797-2016; Kitamura, Shinichi/F-4290-2011	Suzuki, Nobuhiro/0000-0001-8420-5852; Fujimoto, Zui/0000-0002-3551-6854; Kitamura, Shinichi/0000-0001-7115-6561	Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan); scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan)	Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan); scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan)	This work was supported in part by the Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan) and by the scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan).	Aoki H, 1997, BIOCHEM J, V323, P859, DOI 10.1042/bj3230859; Astray G, 2009, FOOD HYDROCOLLOID, V23, P1631, DOI 10.1016/j.foodhyd.2009.01.001; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Beier L, 2000, PROTEIN ENG, V13, P509, DOI 10.1093/protein/13.7.509; Biwer A, 2002, APPL MICROBIOL BIOT, V59, P609, DOI 10.1007/s00253-002-1057-x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funane K, 2007, J BIOTECHNOL, V130, P188, DOI 10.1016/j.jbiotec.2007.03.009; Funane K, 2011, BBA-PROTEINS PROTEOM, V1814, P428, DOI 10.1016/j.bbapap.2010.12.009; Funane K, 2008, BIOSCI BIOTECH BIOCH, V72, P3277, DOI 10.1271/bbb.80384; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Igarashi T, 2002, ORAL MICROBIOL IMMUN, V17, P193, DOI 10.1034/j.1399-302X.2002.170310.x; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Imamura K, 2005, ACTA CRYSTALLOGR F, V61, P109, DOI 10.1107/S1744309104030829; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kim YM, 2012, FEBS J, V279, P3185, DOI 10.1111/j.1742-4658.2012.08698.x; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Kim YM, 2010, APPL MICROBIOL BIOT, V85, P581, DOI 10.1007/s00253-009-2121-6; KOBAYASHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P1861, DOI 10.1271/bbb.59.1861; LAWSON CL, 1994, J MOL BIOL, V236, P590, DOI 10.1006/jmbi.1994.1168; Leemhuis H, 2003, BIOCHEMISTRY-US, V42, P7518, DOI 10.1021/bi034439q; Leemhuis H, 2010, APPL MICROBIOL BIOT, V85, P823, DOI 10.1007/s00253-009-2221-3; Li ZF, 2007, APPL MICROBIOL BIOT, V77, P245, DOI 10.1007/s00253-007-1166-7; Loftsson T, 2007, J PHARM PHARMACOL, V59, P629, DOI 10.1211/jpp.59.5.0002; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAKAJIMA R, 1986, APPL MICROBIOL BIOT, V23, P355; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; OGUMA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1225, DOI 10.1271/bbb.57.1225; Oguma T., 1995, Journal of Applied Glycoscience, V42, P415; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; PENNINGA D, 1995, BIOCHEMISTRY-US, V34, P3368, DOI 10.1021/bi00010a028; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Qi QS, 2005, APPL MICROBIOL BIOT, V66, P475, DOI 10.1007/s00253-004-1781-5; Robyt JF, 2008, CARBOHYD RES, V343, P3039, DOI 10.1016/j.carres.2008.09.012; Suzuki M., 1999, Journal of Applied Glycoscience, V46, P469; Suzuki N, 2013, ACTA CRYSTALLOGR F, V69, P946, DOI 10.1107/S174430911301991X; Suzuki N, 2012, J BIOL CHEM, V287, P19916, DOI 10.1074/jbc.M112.342444; Suzuki R, 2012, BBA-PROTEINS PROTEOM, V1824, P919, DOI 10.1016/j.bbapap.2012.04.001; Suzuki S, 2014, CARBOHYD POLYM, V99, P432, DOI 10.1016/j.carbpol.2013.07.089; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tilden EB, 1939, J AM CHEM SOC, V61, P2900, DOI DOI 10.1021/JA01265A091; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Veen BA, 2000, BBA-PROTEIN STRUCT M, V1543, P336, DOI 10.1016/S0167-4838(00)00233-8; Wind RD, 1998, EUR J BIOCHEM, V253, P598, DOI 10.1046/j.1432-1327.1998.2530598.x; Yamamoto T, 2006, BIOSCI BIOTECH BIOCH, V70, P1947, DOI 10.1271/bbb.60105	55	26	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12040	12051		10.1074/jbc.M114.547992	http://dx.doi.org/10.1074/jbc.M114.547992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616103	Green Published, hybrid			2022-12-28	WOS:000335010600042
J	Zehavi, Y; Kuznetsov, O; Ovadia-Shochat, A; Juven-Gershon, T				Zehavi, Yonathan; Kuznetsov, Olga; Ovadia-Shochat, Avital; Juven-Gershon, Tamar			Core Promoter Functions in the Regulation of Gene Expression of Drosophila Dorsal Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Gene Expression; RNA Polymerase II; Transcription Regulation; Transcription; Developmental Factors; DPE (Downstream Core Promoter Element); Dorsal; Core Promoter; Gene Network	GENOME-WIDE ANALYSIS; RNA-POLYMERASE; TRANSCRIPTION FACTORS; MORPHOGEN GRADIENT; BINDING-SITES; KEY COMPONENT; TATA-BOX; DPE; ELEMENT; TWIST	Background: The Dorsal transcription factor regulates the dorsal-ventral developmental gene regulatory network by binding to enhancers. Results: The core promoters of multiple Dorsal target genes are evolutionarily conserved and functionally dependent on specific elements. Conclusion: The core promoter composition is an important determinant of the transcriptional outcome. Significance: Transcriptional regulation results from an interplay between enhancers and core promoter composition. Developmental processes are highly dependent on transcriptional regulation by RNA polymerase II. The RNA polymerase II core promoter is the ultimate target of a multitude of transcription factors that control transcription initiation. Core promoters consist of core promoter motifs, e.g. the initiator, TATA box, and the downstream core promoter element (DPE), which confer specific properties to the core promoter. Here, we explored the importance of core promoter functions in the dorsal-ventral developmental gene regulatory network. This network includes multiple genes that are activated by different nuclear concentrations of Dorsal, an NFB homolog transcription factor, along the dorsal-ventral axis. We show that over two-thirds of Dorsal target genes contain DPE sequence motifs, which is significantly higher than the proportion of DPE-containing promoters in Drosophila genes. We demonstrate that multiple Dorsal target genes are evolutionarily conserved and functionally dependent on the DPE. Furthermore, we have analyzed the activation of key Dorsal target genes by Dorsal, as well as by another Rel family transcription factor, Relish, and the dependence of their activation on the DPE motif. Using hybrid enhancer-promoter constructs in Drosophila cells and embryo extracts, we have demonstrated that the core promoter composition is an important determinant of transcriptional activity of Dorsal target genes. Taken together, our results provide evidence for the importance of core promoter composition in the regulation of Dorsal target genes.	[Zehavi, Yonathan; Kuznetsov, Olga; Ovadia-Shochat, Avital; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476	Israel Science Foundation [798/10]; European Union Seventh Framework Programme Marie Curie International Reintegration Grant [256491]; National Institutes of Health [GM041249]; United States-Israel Binational Science Foundation [2009428]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); European Union Seventh Framework Programme Marie Curie International Reintegration Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Israel Science Foundation Grant 798/10 (to T.J.-G.), European Union Seventh Framework Programme Marie Curie International Reintegration Grant 256491 (to T.J.-G.) and National Institutes of Health Grant GM041249 (to James T. Kadonaga). The analysis of the transcriptional activity of Biocoid was supported by United States-Israel Binational Science Foundation Grant 2009428 (to T.J.-G. and James T. Kadonaga).	BODMER R, 1990, DEVELOPMENT, V110, P661; Bonn S, 2008, CURR OPIN GENET DEV, V18, P513, DOI 10.1016/j.gde.2008.09.005; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Copley RR, 2007, GENOME RES, V17, P1327, DOI 10.1101/gr.6490707; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; de Navascues J, 2007, DEVELOPMENT, V134, P1779, DOI 10.1242/dev.02844; Dikstein R, 2011, TRANSCR-AUSTIN, V2, P201, DOI 10.4161/trns.2.5.17271; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GOLDBERG ML, 1979, THESIS STANFORD U; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; PAN DJ, 1991, GENE DEV, V5, P1892, DOI 10.1101/gad.5.10.1892; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	68	24	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11993	12004		10.1074/jbc.M114.550251	http://dx.doi.org/10.1074/jbc.M114.550251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634215	Green Published, hybrid			2022-12-28	WOS:000335010600038
J	Liu, QY; Tan, QC; Zheng, YY; Chen, K; Qian, C; Li, N; Wang, QQ; Cao, XT				Liu, Qiuyan; Tan, Qinchun; Zheng, Yuanyuan; Chen, Kun; Qian, Cheng; Li, Nan; Wang, Qingqing; Cao, Xuetao			Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis via Disruption of Fas Signaling-initiated Cancer-related Inflammation (Publication with Expression of Concern. See vol. 295, pg. 8886, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication						Breast Cancer; Fas; Inflammation; Prostaglandins; Tumor Metastases; IL-6; MDSC; PGE2	DENDRITIC CELLS; ANTITUMOR IMMUNITY; CD95; PROMOTES; ACTIVATION; APOPTOSIS; RECEPTOR; EXPRESSION; INVASION; LIVER	Background: The non-apoptotic functions of Fas signaling have been proposed to play an important role in promoting tumor progression. Results: Blockade of Fas signaling suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation. Conclusion: Fas signaling-initiated cancer-related inflammation in breast cancer cells may be a potential target for cancer treatment. Significance: This study provides mechanistic insight into the role of Fas signaling in cancer-related inflammation. Mechanisms for cancer-related inflammation remain to be fully elucidated. Non-apoptotic functions of Fas signaling have been proposed to play an important role in promoting tumor progression. It has yet to be determined if targeting Fas signaling can control tumor progression through suppression of cancer-related inflammation. In the current study we found that breast cancer cells with constitutive Fas expression were resistant to apoptosis induction by agonistic anti-Fas antibody (Jo2) ligation or Fas ligand cross-linking. Higher expression of Fas in human breast cancer tissue has been significantly correlated with poorer prognosis in breast cancer patients. To determine whether blockade of Fas signaling in breast cancer could suppress tumor progression, we prepared an orthotopic xenograft mouse model with mammary cancer cells 4T1 and found that blockade of Fas signaling in 4T1 cancer cells markedly reduced tumor growth, inhibited tumor metastasis in vivo, and prolonged survival of tumor-bearing mice. Mechanistically, blockade of Fas signaling in cancer cells significantly decreased systemic or local recruitment of myeloid derived suppressor cells (MDSCs) in vivo. Furthermore, blockade of Fas signaling markedly reduced IL-6, prostaglandin E2 production from breast cancer cells by impairing p-p38, and activity of the NFB pathway. In addition, administration of a COX-2 inhibitor and anti-IL-6 antibody significantly reduced MDSC accumulation in vivo. Therefore, blockade of Fas signaling can suppress breast cancer progression by inhibiting proinflammatory cytokine production and MDSC accumulation, indicating that Fas signaling-initiated cancer-related inflammation in breast cancer cells may be a potential target for treatment of breast cancer.	[Liu, Qiuyan; Zheng, Yuanyuan; Qian, Cheng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Liu, Qiuyan; Zheng, Yuanyuan; Qian, Cheng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Tan, Qinchun; Chen, Kun; Wang, Qingqing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, QY (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	liuqy@immunol.org; caoxt@immunol.org			National Key Basic Research Program of China [2014CB542102, 2013CB530502]; National Natural Science Foundation of China [30772688, 31170844, 81230074]; National 125 Key Project [2012ZX10002-014]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project	The work was supported by National Key Basic Research Program of China Grants 2014CB542102 and 2013CB530502, National Natural Science Foundation of China Grants 30772688, 31170844, and 81230074, and National 125 Key Project Grant 2012ZX10002-014.	Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Chen TY, 2009, J IMMUNOL, V182, P1449, DOI 10.4049/jimmunol.182.3.1449; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Farley SM, 2008, J BIOL CHEM, V283, P919, DOI 10.1074/jbc.M705852200; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Guo ZH, 2005, BLOOD, V106, P2033, DOI 10.1182/blood-2004-12-4831; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoogwater FJH, 2012, BBA-REV CANCER, V1826, P189, DOI 10.1016/j.bbcan.2012.03.007; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Keane MM, 1996, CANCER RES, V56, P4791; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu QY, 2007, MOL IMMUNOL, V44, P2686, DOI 10.1016/j.molimm.2006.12.003; Macher-Goeppinger S, 2011, CANCER LETT, V301, P203, DOI 10.1016/j.canlet.2010.12.005; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Mitsiades CS, 2006, CLIN CANCER RES, V12, P3705, DOI 10.1158/1078-0432.CCR-05-2493; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nijkamp MW, 2010, J HEPATOL, V53, P1069, DOI 10.1016/j.jhep.2010.04.040; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Qian C, 2013, J BIOL CHEM, V288, P27825, DOI 10.1074/jbc.M112.425751; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Rothstein TL, 2000, CELL RES, V10, P245, DOI 10.1038/sj.cr.7290053; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; Steller EJA, 2011, CELL CYCLE, V10, P3857, DOI 10.4161/cc.10.22.18290; Steller EJA, 2011, EMBO REP, V12, P931, DOI 10.1038/embor.2011.129; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wisniewski P, 2010, CELL SIGNAL, V22, P212, DOI 10.1016/j.cellsig.2009.09.016; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang Y, 2013, CELL RES, V23, P394, DOI 10.1038/cr.2012.178; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548; Zheng HX, 2013, ONCOGENE, V32, P1183, DOI 10.1038/onc.2012.126	50	21	23	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11522	11535		10.1074/jbc.M113.525014	http://dx.doi.org/10.1074/jbc.M113.525014			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24627480	Green Published, hybrid			2022-12-28	WOS:000334638500052
J	Oleson, BJ; Broniowska, KA; Schreiber, KH; Tarakanova, VL; Corbett, JA				Oleson, Bryndon J.; Broniowska, Katarzyna A.; Schreiber, Katherine H.; Tarakanova, Vera L.; Corbett, John A.			Nitric Oxide Induces Ataxia Telangiectasia Mutated ( ATM) Protein-dependent gamma H2AX Protein Formation in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell; Cytokine; DNA Repair; Nitric Oxide; ATM; H2AX	DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; REQUIRES GENE-TRANSCRIPTION; PHOSPHORYLATES HISTONE H2AX; INSULIN-SECRETION; RAT ISLETS; INTERFERON-GAMMA; LANGERHANS; INHIBITION; KINASE	Background: The mechanisms that control cell fate following cytokine- and nitric oxide-induced damage remain unknown. Results: Cytokine-induced nitric oxide activates ATM and ATM-dependent caspase activation in cells. Conclusion: ATM regulates the induction of apoptosis in cytokine-treated cells. Significance: These studies define a role for DNA damage and ATM activation in nitric oxide-induced cell apoptosis. In this study, the effects of cytokines on the activation of the DNA double strand break repair factors histone H2AX (H2AX) and ataxia telangiectasia mutated (ATM) were examined in pancreatic cells. We show that cytokines stimulate H2AX phosphorylation (H2AX formation) in rat islets and insulinoma cells in a nitric oxide- and ATM-dependent manner. In contrast to the well documented role of ATM in DNA repair, ATM does not appear to participate in the repair of nitric oxide-induced DNA damage. Instead, nitric oxide-induced H2AX formation correlates temporally with the onset of irreversible DNA damage and the induction of apoptosis. Furthermore, inhibition of ATM attenuates cytokine-induced caspase activation. These findings show that the formation of DNA double strand breaks correlates with ATM activation, irreversible DNA damage, and ATM-dependent induction of apoptosis in cytokine-treated cells.	[Oleson, Bryndon J.; Broniowska, Katarzyna A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Tarakanova, Vera L.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Schreiber, Katherine H.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, Sch Med, St Louis, MO 63104 USA	Medical College of Wisconsin; Medical College of Wisconsin; Saint Louis University	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK52194 and AI-44458 (to J. A. C.).	Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HUGHES JH, 1990, J CLIN INVEST, V86, P856, DOI 10.1172/JCI114785; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Jang ER, 2010, EXP MOL MED, V42, P195, DOI 10.3858/emm.2010.42.3.020; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; LACY PE, 1994, MT SINAI J MED, V61, P170; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schroder Heinz C, 2006, Methods Mol Biol, V314, P287; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; Ullmann K, 2008, ARCH TOXICOL, V82, P861, DOI 10.1007/s00204-008-0356-0; Wang ZQ, 2009, J CELL PHYSIOL, V221, P213, DOI 10.1002/jcp.21844; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang YC, 2013, ANTIOXID REDOX SIGN, V18, P1129, DOI 10.1089/ars.2012.4620	60	24	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11454	11464		10.1074/jbc.M113.531228	http://dx.doi.org/10.1074/jbc.M113.531228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610783	hybrid, Green Published			2022-12-28	WOS:000334638500046
J	Wang, WY; Kim, HJ; Lee, JH; Wong, V; Sihn, CR; Lv, P; Flores, MCP; Mousavi-Nik, A; Doyle, KJ; Xu, YF; Yamoah, EN				Wang, Wenying; Kim, Hyo Jeong; Lee, Jeong-Han; Wong, Victor; Sihn, Choong-Ryoul; Lv, Ping; Flores, Maria Cristina Perez; Mousavi-Nik, Atefeh; Doyle, Karen Jo; Xu, Yanfang; Yamoah, Ebenezer N.			Functional Significance of K+ Channel beta-Subunit KCNE3 in Auditory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIRAL GANGLION NEURONS; GATED POTASSIUM CHANNELS; LANGE-NIELSEN-SYNDROME; INNER HAIR-CELLS; LONG QT SYNDROME; HEARING-LOSS; PLASMA-MEMBRANE; FIRING FEATURES; XENOPUS-OOCYTES; CAUSE JERVELL	The KCNE3 beta-subunit interacts with and regulates the voltage-dependent gating, kinetics, and pharmacology of a variety of Kv channels in neurons. Because a single neuron may express multiple KCNE3 partners, it is impossible to predict the overall functional relevance of the single transmembrane domain peptide on the pore-forming K+ channel subunits with which it associates. In the inner ear, the role of KCNE3 is undefined, despite its association with Meniere disease and tinnitus. To gain insights on the functional significance of KCNE3 in auditory neurons, we examined the properties of spiral ganglion neurons (SGNs) in Kcne3 null mutant neurons relative to their age-matched controls. We demonstrate that null deletion of Kcne3 abolishes characteristic wide variations in the resting membrane potentials of SGNs and yields age-dependent alterations in action potential and firing properties of neurons along the contour of the cochlear axis, in comparison with age-matched wild-type neurons. The properties of basal SGNs were markedly altered in Kcne3(-/-) mice compared with the wild-type controls; these include reduced action potential latency, amplitude, and increased firing frequency. Analyses of the underlying conductance demonstrate that null mutation of Kcne3 results in enhanced outward K+ currents, which is sufficient to explain the ensuing membrane potential changes. Additionally, we have demonstrated that KCNE3 may regulate the activity of Kv4.2 channels in SGNs. Finally, there were developmentally mediated compensatory changes that occurred such that, by 8 weeks after birth, the electrical properties of the null mutant neurons were virtually indistinguishable from the wild-type neurons, suggesting that ion channel remodeling in auditory neurons progresses beyond hearing onset.	[Wang, Wenying; Xu, Yanfang] Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China; [Wang, Wenying; Kim, Hyo Jeong; Lee, Jeong-Han; Wong, Victor; Sihn, Choong-Ryoul; Lv, Ping; Flores, Maria Cristina Perez; Mousavi-Nik, Atefeh; Doyle, Karen Jo; Yamoah, Ebenezer N.] Univ Calif Davis, Sch Med, Program Commun & Sensory Sci, Dept Anesthesiol & Pain Med, Davis, CA 95618 USA; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Peoples R China	Hebei Medical University; University of California System; University of California Davis; Hebei Medical University	Xu, YF (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China.	yanfangxu@hotmail.com; enyamoah@ucdavis.edu	Wong, Victor/I-7722-2019	Wong, Victor/0000-0003-1415-2825	National Institutes of Health, NIDCD [DC-010386]; National Natural Science Foundation of China [1200746]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC003826] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant DC-010386 (to E. N. Y.) from NIDCD. This work was also supported by National Natural Science Foundation of China Grant 1200746 (to P. L.).; Supported by the Canadian Institutes of Health Research.	Abbott G W, 2001, Mol Interv, V1, P95; Adamson CL, 2002, J NEUROSCI, V22, P1385, DOI 10.1523/JNEUROSCI.22-04-01385.2002; Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; BLUMENTHAL EM, 1994, J NEUROSCI, V14, P3097; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; De Castro MP, 2006, ANAT REC PART A, V288A, P304, DOI 10.1002/ar.a.20312; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Doi K, 2005, ORL-J OTO-RHIN-LARYN, V67, P289, DOI 10.1159/000089410; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Lv P, 2012, J NEUROSCI, V32, P16314, DOI 10.1523/JNEUROSCI.2097-12.2012; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nin F, 2012, P NATL ACAD SCI USA, V109, P9191, DOI 10.1073/pnas.1120067109; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Oliver D, 2003, J NEUROSCI, V23, P2141; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; ROMAND R, 1983, NEUROSCI LETT, V35, P271, DOI 10.1016/0304-3940(83)90329-4; Sand PG, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-39; Sanguinetti MC, 2000, J CARDIOVASC ELECTR, V11, P710, DOI 10.1111/j.1540-8167.2000.tb00035.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Sonntag M, 2011, J NEUROSCI, V31, P6699, DOI 10.1523/JNEUROSCI.0575-11.2011; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang ZR, 2013, J GEN PHYSIOL, V141, P431, DOI 10.1085/jgp.201210942; Wei L, 2004, PFLUG ARCH EUR J PHY, V448, P325, DOI 10.1007/s00424-004-1277-2; Werner L. A, 1998, DEV AUDITORY SYSTEM, P12; Wu T, 2010, J NEUROPHYSIOL, V103, P1969, DOI 10.1152/jn.01057.2009; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yamoah EN, 1998, J NEUROSCI, V18, P610	49	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16802	16813		10.1074/jbc.M113.545236	http://dx.doi.org/10.1074/jbc.M113.545236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24727472	hybrid, Green Published			2022-12-28	WOS:000338016200018
J	Jin, SX; Bartolome, C; Arai, JA; Hoffman, L; Uzturk, BG; Kumar-Singh, R; Waxham, MN; Feig, LA				Jin, Shan-Xue; Bartolome, Christopher; Arai, Junko A.; Hoffman, Laurel; Uzturk, B. Gizem; Kumar-Singh, Rajendra; Waxham, M. Neal; Feig, Larry A.			Domain Contributions to Signaling Specificity Differences Between Ras-Guanine Nucleotide Releasing Factor (Ras-GRF) 1 and Ras-GRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE CASCADE; SYNAPTIC PLASTICITY; MAP KINASE; COMPLEX-FORMATION; NMDA RECEPTOR; ERK PATHWAY; CALMODULIN; ACTIVATION; CALCIUM	Ras-GRF1 (GRF1) and Ras-GRF2 (GRF2) constitute a family of similar calcium sensors that regulate synaptic plasticity. They are both guanine exchange factors that contain a very similar set of functional domains, including N-terminal pleckstrin homology, coiled-coil, and calmodulin-binding IQ domains and C-terminal Dbl homology Rac-activating domains, Ras-exchange motifs, and CDC25 Ras-activating domains. Nevertheless, they regulate different forms of synaptic plasticity. Although both GRF proteins transduce calcium signals emanating from NMDA-type glutamate receptors in the CA1 region of the hippocampus, GRF1 promotes LTD, whereas GRF2 promotes theta-burst stimulation-induced LTP (TBS-LTP). GRF1 can also mediate high frequency stimulation-induced LTP (HFS-LTP) in mice over 2-months of age, which involves calcium-permeable AMPA-type glutamate receptors. To add to our understanding of how proteins with similar domains can have different functions, WT and various chimeras between GRF1 and GRF2 proteins were tested for their abilities to reconstitute defective LTP and/or LTD in the CA1 hippocampus of Grf1/Grf2 double knock-out mice. These studies revealed a critical role for the GRF2 CDC25 domain in the induction of TBS-LTP by GRF proteins. In contrast, the N-terminal pleckstrin homology and/or coiled-coil domains of GRF1 are key to the induction of HFS-LTP by GRF proteins. Finally, the IQ motif of GRF1 determines whether a GRF protein can induce LTD. Overall, these findings show that for the three forms of synaptic plasticity that are regulated by GRF proteins in the CA1 hippocampus, specificity is encoded in only one or two domains, and a different set of domains for each form of synaptic plasticity.	[Jin, Shan-Xue; Bartolome, Christopher; Arai, Junko A.; Uzturk, B. Gizem; Kumar-Singh, Rajendra; Feig, Larry A.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Hoffman, Laurel; Waxham, M. Neal] Univ Texas Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA	Tufts University; University of Texas System; University of Texas Health Science Center Houston	Feig, LA (corresponding author), 136 Harrison Ave, Boston, MA 02111 USA.	larry.feig@tufts.edu		Waxham, M. Neal/0000-0003-4801-1190; Kumar-Singh, Rajendra/0000-0002-7754-0713	National Institutes of Health through the Tufts Center for Neuroscience Research [RO1 MH083324, RO1 GM097553, P30 NS047243]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097553, R25GM066567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health through the Tufts Center for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 MH083324 (to L. A. F.) and RO1 GM097553 (to M. N. W.) and Grant P30 NS047243 through the Tufts Center for Neuroscience Research.	Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; d'Isa R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00078; Darcy MJ, 2014, HIPPOCAMPUS, V24, P315, DOI 10.1002/hipo.22225; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Jin SX, 2013, J BIOL CHEM, V288, P21703, DOI 10.1074/jbc.M113.471904; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silingardi D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00084; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zippel R, 1997, MOL BRAIN RES, V48, P140	36	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16551	16564		10.1074/jbc.M114.557959	http://dx.doi.org/10.1074/jbc.M114.557959			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755227	Green Published, hybrid			2022-12-28	WOS:000337965700056
J	Valapala, M; Maji, S; Borejdo, J; Vishwanatha, JK				Valapala, Mallika; Maji, Sayantan; Borejdo, Julian; Vishwanatha, Jamboor K.			Cell Surface Translocation of Annexin A2 Facilitates Glutamate-induced Extracellular Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMINOGEN ACTIVATION; INTRACELLULAR CALCIUM; MEMBRANE-BINDING; DEATH; PHOSPHORYLATION; EXCITOTOXICITY; DEGENERATION; RECEPTORS; APOPTOSIS	Glutamate-induced elevation in intracellular Ca2+ has been implicated in excitotoxic cell death. Neurons respond to increased glutamate levels by activating an extracellular proteolytic cascade involving the components of the plasmin-plasminogen system. AnxA2 is a Ca2+ -dependent phospholipid binding protein and serves as an extracellular proteolytic center by recruiting the tissue plasminogen activator and plasminogen and mediating the localized generation of plasmin. Ratiometric Ca2+ imaging and time-lapse confocal microscopy demonstrated glutamate-induced Ca2+ influx. We showed that glutamate translocated both endogenous and AnxA2-GFP to the cell surface in a process dependent on the activity of the NMDA receptor. Glutamate-induced translocation of AnxA2 is dependent on the phosphorylation of tyrosine 23 at the N terminus, and mutation of tyrosine 23 to a non-phosphomimetic variant inhibits the translocation process. The cell surface-translocated AnxA2 forms an active plasmin-generating complex, and this activity can be neutralized by a hexapeptide directed against the N terminus. These results suggest an involvement of AnxA2 in potentiating glutamate-induced cell death processes.	[Valapala, Mallika; Maji, Sayantan; Vishwanatha, Jamboor K.] Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA; [Borejdo, Julian] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Vishwanatha, JK (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	jamboor.vishwanatha@unthsc.edu	Maji, Sayantan/AAB-7080-2019; Maji, Sayantan/AAB-7070-2019	Vishwanatha, Jamboor/0000-0002-0266-6020	National Institute on Minority Health and Health Disparities [1P20 MD006882]; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institute on Minority Health and Health Disparities Grant 1P20 MD006882 (to J. K. V.).	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bellagamba C, 1997, J BIOL CHEM, V272, P3195, DOI 10.1074/jbc.272.6.3195; Blanchard S, 1996, J NEUROCHEM, V67, P805; Burghardt TP, 2006, BIOCHEMISTRY-US, V45, P4058, DOI 10.1021/bi052097d; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Chintala SK, 2006, EXP EYE RES, V82, P5, DOI 10.1016/j.exer.2005.07.013; Delyfer MN, 2005, MOL VIS, V11, P688; Deshet N, 2008, J CELL PHYSIOL, V216, P632, DOI 10.1002/jcp.21441; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Ferreira IL, 1996, EUR J PHARMACOL, V302, P153, DOI 10.1016/0014-2999(96)00044-1; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajjar KA, 2000, ANN NY ACAD SCI, V902, P265; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Jacovina AT, 2001, J BIOL CHEM, V276, P49350, DOI 10.1074/jbc.M106289200; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Lin YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-7; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu J, 2007, MOL CELL BIOCHEM, V303, P211, DOI 10.1007/s11010-007-9477-7; Longstaff C, 2002, FRONT BIOSCI-LANDMRK, V7, pD244, DOI 10.2741/longstaf; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nixon E, 2012, INVEST OPHTH VIS SCI, V53, P4739, DOI 10.1167/iovs.12-9517; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prasanna G, 2002, INVEST OPHTH VIS SCI, V43, P2704; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roda O, 2003, J BIOL CHEM, V278, P5702, DOI 10.1074/jbc.M207605200; Santos-Carvalho A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.160; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Strickland S, 1996, COLD SPRING HARB SYM, V61, P739; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P2577, DOI 10.1167/iovs.07-1101; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Valapala M, 2011, J CELL SCI, V124, P1453, DOI 10.1242/jcs.079236; Vorwerk CK, 1999, SURV OPHTHALMOL, V43, pS142, DOI 10.1016/S0039-6257(99)00017-X	45	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15915	15926		10.1074/jbc.M113.511550	http://dx.doi.org/10.1074/jbc.M113.511550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742684	Green Published, hybrid			2022-12-28	WOS:000337965700003
J	Tulley, S; Chen, WT				Tulley, Shaun; Chen, Wen-Tien			Transcriptional Regulation of Seprase in Invasive Melanoma Cells by Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Gene Transcription; Invasion; Melanoma; Serine Protease; Transcription Promoter; Transcription Regulation	FIBROBLAST-ACTIVATION-PROTEIN; HUMAN-MALIGNANT MELANOMA; REACTIVE STROMAL FIBROBLASTS; MEMBRANE-BOUND PROTEASE; SKI-MEDIATED REPRESSION; TGF-BETA; SERINE-PROTEASE; C-SKI; DIFFERENTIAL EXPRESSION; CLINICAL-IMPLICATIONS	Background: Seprase is an integral membrane serine protease implicated in the cellular invasiveness of tumor, endothelial, and fibroblast cells of various human tumors. Results: Seprase is transcriptionally targeted in invasive melanoma cells via TGF- signaling. Conclusion: Seprase-expressing melanoma cells produce high levels of autocrine TGF- and display invasive phenotypes in vitro. Significance: This study provides the first insight into TGF--driven seprase transcription in cancer. The tumor invasive phenotype driven by seprase expression/activity has been widely examined in an array of malignant tumor cell types; however, very little is known about the transcriptional regulation of this critical protease. Seprase (also named fibroblast activation protein-, antiplasmin-cleaving enzyme, and dipeptidyl prolyl peptidase 5) is expressed at high levels by stromal fibroblast, endothelial, and tumor cells in a variety of invasive tumors but is undetectable in the majority of normal adult tissues. To examine the transcriptional regulation of the gene, we cloned the human seprase promoter and demonstrated that endogenous seprase expression and exogenous seprase promoter activity are high in invasive melanoma cells but not in non-invasive melanoma cells/primary melanocytes. In addition, we identified a crucial TGF--responsive cis-regulatory element in the proximal seprase promoter region that enabled robust transcriptional activation of the gene. Treatment of metastatic but not normal/non-invasive cells with TGF-1 caused a rapid and profound up-regulation of endogenous seprase mRNA, which coincided with an abolishment of the negative regulator c-Ski, and an increase in binding of Smad3/4 to the seprase promoter in vivo. Blocking TGF- signaling in invasive melanoma cells through overexpression of c-Ski, chemically using SB-431542, or with a neutralizing antibody against TGF- significantly reduced seprase mRNA levels. Strikingly, RNAi of seprase in invasive cells greatly diminished their invasive potential in vitro as did blocking TGF- signaling using SB-431542. Altogether, we found that seprase is transcriptionally up-regulated in invasive melanoma cells via the canonical TGF- signaling pathway, supporting the roles of both TGF- and seprase in tumor invasion and metastasis.	[Tulley, Shaun; Chen, Wen-Tien] Stony Brook Med, Div Gynecol Oncol, Metastasis Res Lab, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Chen, WT (corresponding author), Stony Brook Med, HSC,T9,Rm 027-028, Stony Brook, NY 11794 USA.	Wen-Tien.Chen@stonybrookmedicine.edu			National Institutes of Health [R01CA0039077, R01EB002065]; NATIONAL CANCER INSTITUTE [R01CA039077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA0039077 and R01EB002065 (to W.-T. C.).	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; ALBINO AP, 1991, CANCER RES, V51, P4815; AOYAMA A, 1990, P NATL ACAD SCI USA, V87, P8296, DOI 10.1073/pnas.87.21.8296; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen DH, 2006, CANCER RES, V66, P9977, DOI 10.1158/0008-5472.CAN-06-1499; Chen H, 2009, EXP MOL PATHOL, V87, P189, DOI 10.1016/j.yexmp.2009.09.001; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Freudenberg JA, 2007, INT J CANCER, V121, P966, DOI 10.1002/ijc.22754; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; Goscinski MA, 2008, ULTRASTRUCT PATHOL, V32, P89, DOI 10.1080/01913120802034934; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Iwasa S, 2003, CANCER LETT, V199, P91, DOI 10.1016/S0304-3835(03)00315-X; Jin X, 2003, ANTICANCER RES, V23, P3195; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Kelly T, 1998, MODERN PATHOL, V11, P855; Kennedy A, 2009, INT J CANCER, V124, P27, DOI 10.1002/ijc.23871; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Krasagakis K, 1999, J CELL PHYSIOL, V178, P179, DOI 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5; KRASAGAKIS K, 1994, ANTICANCER RES, V14, P2565; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1877; MONSKY WL, 1994, CANCER RES, V54, P5702; Mori Y, 2004, ONCOLOGY-BASEL, V67, P411, DOI 10.1159/000082926; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; Nicol R, 1998, J BIOL CHEM, V273, P3588, DOI 10.1074/jbc.273.6.3588; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; RETTIG WJ, 1994, INT J CANCER, V58, P385, DOI 10.1002/ijc.2910580314; RETTIG WJ, 1986, CANCER RES, V46, P6406; Rodeck U, 1999, CANCER RES, V59, P547; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; RODECK U, 1994, CANCER RES, V54, P575; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Ueki N, 2003, J BIOL CHEM, V278, P32489, DOI 10.1074/jbc.C300276200; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Yang WW, 2013, EXP MOL PATHOL, V95, P105, DOI 10.1016/j.yexmp.2013.06.007; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Jiping, 2010, Front Biosci (Elite Ed), V2, P1154; Zhang MZ, 2007, CHINESE MED J-PEKING, V120, P663, DOI 10.1097/00029330-200704020-00010	66	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15280	15296		10.1074/jbc.M114.568501	http://dx.doi.org/10.1074/jbc.M114.568501			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24727589	Green Published, hybrid			2022-12-28	WOS:000337465400013
J	Wu, D; Chen, LX; Sun, QR; Wu, XT; Jia, SJ; Meng, AM				Wu, Di; Chen, Luxi; Sun, Qingrui; Wu, Xiaotong; Jia, Shunji; Meng, Anming			Uracil-DNA Glycosylase Is Involved in DNA Demethylation and Required for Embryonic Development in the Zebrafish Embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); Zebrafish; DNA Demethylation; DNA Transcription; Embryo; DNA Glycosylase; Zygotic Genome Activation; Nuclear Reprogramming	ZYGOTIC PATERNAL GENOME; BASE EXCISION-REPAIR; ESCHERICHIA-COLI; 5-METHYLCYTOSINE-DNA GLYCOSYLASE; ACTIVE DEMETHYLATION; GENE ACTIVATION; METHYLATION; MOUSE; DEAMINASE; COMPLEX	Uracil-DNA glycosylase (Ung) is a component of the base excision repair process and has the ability to remove uracil from U:G mispairs in DNA. However, its implications in development of vertebrate embryos are poorly understood. In this study, we found that zebrafish uracil-DNA glycosylase a (Unga) is maternally expressed at high levels and accumulated in nuclei during cleavage and blastulation periods. Knockdown of unga in zebrafish embryos causes an increase of the global DNA methylation level concomitantly with a reduction of overall transcriptional activity in the nucleus, ultimately resulting in embryonic lethality during segmentation period. Conversely, unga overexpression is sufficient to reduce the global DNA methylation level, to increase H3K4me3 and H3K27me3 marks, and to activate genome transcription. Furthermore, overexpression of unga(D132A) mRNA, encoding a mutant Unga without DNA glycosylase activity, does not affect global DNA methylation level, indicating that its involvement in DNA demethylation is dependent on its glycosylase activity. These results together suggest that Unga is implicated in postfertilization genomic DNA demethylation, zygotic gene transcription, and normal embryonic development in zebrafish.	[Wu, Di; Chen, Luxi; Sun, Qingrui; Wu, Xiaotong; Jia, Shunji; Meng, Anming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Wu, Xiaotong/AAH-4566-2021; Meng, Anming/A-4785-2012	Meng, Anming/0000-0001-7228-3431; Wu, Xiaotong/0000-0002-4109-9444	Major Science Programs of China [2011CB943800]; National Natural Science Foundation of China [31330052, 31221064]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grant 2011CB943800 and by National Natural Science Foundation of China Grants 31330052 and 31221064.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gongal PA, 2011, DEV BIOL, V355, P55, DOI 10.1016/j.ydbio.2011.04.018; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hamm S, 2008, BIOORG MED CHEM LETT, V18, P1046, DOI 10.1016/j.bmcl.2007.12.027; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin SG, 2008, DEV DYNAM, V237, P3435, DOI 10.1002/dvdy.21767; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Jost JP, 2002, FEBS LETT, V519, P128, DOI 10.1016/S0014-5793(02)02737-0; JOST JP, 1995, GENE, V157, P265, DOI 10.1016/0378-1119(95)00036-6; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; MacKay AB, 2007, GENOME, V50, P778, DOI 10.1139/G07-055; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Roy TW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm1031; Sanchez A, 2012, MOL CELL BIOL, V32, P4445, DOI 10.1128/MCB.01062-12; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Vanderlaan G, 2005, DEV BIOL, V282, P550, DOI 10.1016/j.ydbio.2005.04.010; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yergeau DA, 2005, DEV BIOL, V283, P97, DOI 10.1016/j.ydbio.2005.04.006; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	55	19	23	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15463	15473		10.1074/jbc.M114.561019	http://dx.doi.org/10.1074/jbc.M114.561019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739389	Green Published, hybrid			2022-12-28	WOS:000337465400029
J	Breuer, R; Becker, MS; Brechmann, M; Mock, T; Arnold, R; Krammer, PH				Breuer, Rebecca; Becker, Michael S.; Brechmann, Markus; Mock, Thomas; Arnold, Ruediger; Krammer, Peter H.			The Protein Phosphatase 2A Regulatory Subunit B56 gamma Mediates Suppression of T Cell Receptor (TCR)-induced Nuclear Factor-kappa B (NF-kappa B) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; OKADAIC ACID; ACTIVATION; PP2A; LYMPHOMA; MALT1; ALPHA; GENE; IDENTIFICATION; HOMEOSTASIS	NF-kappa B is an important transcription factor in the immune system, and aberrant NF-kappa B activity contributes to malignant diseases and autoimmunity. In T cells, NF-kappa B is activated upon TCR stimulation, and signal transduction to NF-kappa B activation is triggered by a cascade of phosphorylation events. However, fine tuning and termination of TCR signaling are only partially understood. Phosphatases oppose the role of kinases by removing phosphate moieties. The catalytic activity of the protein phosphatase PP2A has been implicated in the regulation of NF-kappa B. PP2A acts in trimeric complexes in which the catalytic subunit is promiscuous and the regulatory subunit confers substrate specificity. To understand and eventually target NF-kappa Bspecific PP2A functions it is essential to define the regulatory PP2A subunit involved. So far, the regulatory PP2A subunit that mediates NF-kappa B suppression in T cells remained undefined. By performing a siRNA screen in Jurkat T cells harboring a NF-kappa B-responsive luciferase reporter, we identified the PP2A regulatory subunit B56 gamma as negative regulator of NF-kappa B in TCR signaling. B56 gamma was strongly up-regulated upon primary human T cell activation, and B56 gamma silencing induced increased I kappa B kinase (IKK) and I kappa B alpha phosphorylation upon TCR stimulation. B56 gamma silencing enhanced NF-kappa B activity, resulting in increased NF-kappa B target gene expression including the T cell cytokine IL-2. In addition, T cell proliferation was increased upon B56 gamma silencing. These data help to understand the physiology of PP2A function in T cells and the pathophysiology of diseases involving PP2A and NF-kappa B.	[Breuer, Rebecca; Becker, Michael S.; Brechmann, Markus; Mock, Thomas; Arnold, Ruediger; Krammer, Peter H.] German Canc Res Ctr, Div Immunogenet, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krammer, PH (corresponding author), German Canc Res Ctr, Div Immunogenet D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.krammer@dkfz.de		Becker, Michael/0000-0001-5502-7444	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture, and Sport (MOST); Deutsche Krebshilfe; Wilhelm Sander Stiftung; Helmholtz Alliance-Immunotherapy of Cancer [HA202]; Jose Carreras Leukamie-Stiftung	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science, Culture, and Sport (MOST); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Stiftung; Helmholtz Alliance-Immunotherapy of Cancer; Jose Carreras Leukamie-Stiftung	This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and the Israeli Ministry of Science, Culture, and Sport (MOST), the Deutsche Krebshilfe, the Wilhelm Sander Stiftung, and Helmholtz Alliance-Immunotherapy of Cancer Grant HA202.; Supported by the Jose Carreras Leukamie-Stiftung.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Deichmann M, 2001, MELANOMA RES, V11, P577, DOI 10.1097/00008390-200112000-00004; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Morgan JA, 1999, CANCER RES, V59, P6205; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; RIECKMANN P, 1992, BIOCHEM BIOPH RES CO, V187, P51, DOI 10.1016/S0006-291X(05)81457-3; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Weyd H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062449; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200	39	29	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14996	15004		10.1074/jbc.M113.533547	http://dx.doi.org/10.1074/jbc.M113.533547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719332	hybrid, Green Published			2022-12-28	WOS:000337248100051
J	Wood, DW; Camarero, JA				Wood, David W.; Camarero, Julio A.			Intein Applications: From Protein Purification and Labeling to Metabolic Control Methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SINGLE-COLUMN PURIFICATION; SPLIT-INTEIN; IN-VIVO; RECOMBINANT PROTEINS; BACTERIAL BIOSENSORS; CYCLIC LUCIFERASE; DNAE INTEIN; REDOX TRAP; EXPRESSION; BIOSYNTHESIS	The discovery of inteins in the early 1990s opened the door to a wide variety of new technologies. Early engineered inteins from various sources allowed the development of self-cleaving affinity tags and new methods for joining protein segments through expressed protein ligation. Some applications were developed around native and engineered split inteins, which allow protein segments expressed separately to be spliced together in vitro. More recently, these early applications have been expanded and optimized through the discovery of highly efficient trans-splicing and trans-cleaving inteins. These new inteins have enabled a wide variety of applications in metabolic engineering, protein labeling, biomaterials construction, protein cyclization, and protein purification.	[Wood, David W.] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Camarero, Julio A.] Univ So Calif, Dept Pharmacol, Los Angeles, CA 90033 USA; [Camarero, Julio A.] Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA 90033 USA; [Camarero, Julio A.] Univ So Calif, Dept Chem, Los Angeles, CA 90033 USA	University System of Ohio; Ohio State University; University of Southern California; University of Southern California; University of Southern California	Wood, DW (corresponding author), Ohio State Univ, Dept Chem & Biomol Engn, Koffolt Labs 435, 140 W 19th Ave, Columbus, OH 43210 USA.	wood.750@osu.edu; jcamarer@usc.edu	Camarero, Julio A./A-9628-2015; Wood, David W/B-2992-2012	Camarero, Julio A./0000-0001-9150-0665; 	National Institutes of Health [R01-GM090323]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01-GM090323 (to J. A. C.). This is the fourth article in the Thematic Minireview Series "Inteins."	Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Austin J, 2010, AMINO ACIDS, V38, P1313, DOI 10.1007/s00726-009-0338-4; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; Banki MR, 2005, PROTEIN SCI, V14, P1387, DOI 10.1110/ps.041296305; Berrade L, 2009, CELL MOL LIFE SCI, V66, P3909, DOI 10.1007/s00018-009-0122-3; Borra R, 2012, J AM CHEM SOC, V134, P6344, DOI 10.1021/ja300209u; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Callahan BP, 2013, BIOTECHNOL BIOENG, V110, P1565, DOI 10.1002/bit.24821; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Camarero JA, 1999, J AM CHEM SOC, V121, P5597, DOI 10.1021/ja990929n; Camarero JA, 2001, BIOORGAN MED CHEM, V9, P2479, DOI 10.1016/S0968-0896(01)00217-6; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Camarero JA, 2007, CHEMBIOCHEM, V8, P1363, DOI 10.1002/cbic.200700183; Charalambous Anna, 2012, Methods Mol Biol, V906, P157, DOI 10.1007/978-1-61779-953-2_11; Charalambous Anna, 2009, Journal of Nanobiotechnology, V7, P9, DOI 10.1186/1477-3155-7-9; Chin HG, 2003, P NATL ACAD SCI USA, V100, P4510, DOI 10.1073/pnas.0736538100; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Deschuyteneer G, 2010, ACS CHEM BIOL, V5, P691, DOI 10.1021/cb100072u; Dhar T, 2011, CHEM COMMUN, V47, P3063, DOI 10.1039/c0cc04172f; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Evans TC, 2005, ANNU REV PLANT BIOL, V56, P375, DOI 10.1146/annurev.arplant.56.032604.144242; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Garcia AE, 2011, BIOCHEMISTRY-US, V50, P10508, DOI 10.1021/bi201430f; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Gierach I, 2012, FEBS OPEN BIO, V2, P247, DOI 10.1016/j.fob.2012.08.002; Gierach I, 2013, ENVIRON TOXICOL, V28, P179, DOI 10.1002/tox.20708; Gould A, 2012, MOL BIOSYST, V8, P1359, DOI 10.1039/c2mb05451e; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; Guan DL, 2013, BIOTECHNOL BIOENG, V110, P2471, DOI 10.1002/bit.24913; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hong SH, 2001, PROTEIN EXPRES PURIF, V21, P243, DOI 10.1006/prep.2000.1372; Huang XD, 2012, DNA CELL BIOL, V31, pS2, DOI 10.1089/dna.2011.1537; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Iwai Hideo, 2007, Biotechnol Genet Eng Rev, V24, P129; Jagadish K, 2013, ANGEW CHEM INT EDIT, V52, P3126, DOI 10.1002/anie.201209219; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kanno A, 2011, METHODS MOL BIOL, V705, P251, DOI 10.1007/978-1-61737-967-3_15; Kanno A, 2009, METHODS MOL BIOL, V574, P185, DOI 10.1007/978-1-60327-321-3_15; Kanno A, 2009, METHODS MOL BIOL, V574, P105, DOI 10.1007/978-1-60327-321-3_9; Kimura RH, 2006, ANGEW CHEM INT EDIT, V45, P973, DOI 10.1002/anie.200503882; Li JJ, 2011, BIOSENS BIOELECTRON, V29, P132, DOI 10.1016/j.bios.2011.08.006; Liang RB, 2011, APPL ENVIRON MICROB, V77, P2488, DOI 10.1128/AEM.02336-10; Liu F, 2013, BIOTECHNOL PROGR, V29, P968, DOI 10.1002/btpr.1757; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Myscofski DM, 2001, PREP BIOCHEM BIOTECH, V31, P275, DOI 10.1081/PB-100104909; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Ramirez M, 2013, PROTEIN ENG DES SEL, V26, P215, DOI 10.1093/protein/gzs097; Sancheti H, 2009, ADV DRUG DELIVER REV, V61, P908, DOI 10.1016/j.addr.2009.07.003; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shen BZ, 2012, NAT BIOTECHNOL, V30, P1131, DOI 10.1038/nbt.2402; Shi CH, 2013, APPL MICROBIOL BIOT, V97, P829, DOI 10.1007/s00253-012-4601-3; Shingledecker K, 1998, GENE, V207, P187, DOI 10.1016/S0378-1119(97)00624-0; Skretas G, 2005, J MOL BIOL, V349, P464, DOI 10.1016/j.jmb.2005.04.009; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Skretas G, 2007, J AM CHEM SOC, V129, P8443, DOI 10.1021/ja067754j; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Sudheer PDVN, 2013, ANAL BIOCHEM, V436, P137, DOI 10.1016/j.ab.2013.02.009; Sun L, 2001, APPL ENVIRON MICROB, V67, P1025, DOI 10.1128/AEM.67.3.1025-1029.2001; Szweda P, 2001, PROTEIN EXPRES PURIF, V22, P467, DOI 10.1006/prep.2001.1454; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Thomson CA, 2001, PROTEIN EXPRES PURIF, V23, P8, DOI 10.1006/prep.2001.1470; Volkmann G, 2012, FEBS LETT, V586, P79, DOI 10.1016/j.febslet.2011.11.028; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; Volkmann G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008381; Volkmann G, 2009, PROTEIN SCI, V18, P2393, DOI 10.1002/pro.249; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00497; Wang ZY, 2012, PROTEIN EXPRES PURIF, V82, P174, DOI 10.1016/j.pep.2011.11.017; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu C, 2000, MOL CELL ENDOCRINOL, V170, P163, DOI 10.1016/S0303-7207(00)00323-3; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Xie YG, 2013, PROTEIN PEPTIDE LETT, V20, P54, DOI 10.2174/092986613804096775; Yang JJ, 2006, TRANSGENIC RES, V15, P583, DOI 10.1007/s11248-006-9004-8; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Young TS, 2011, P NATL ACAD SCI USA, V108, P11052, DOI 10.1073/pnas.1108045108; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zhu FX, 2013, SCI CHINA LIFE SCI, V56, P262, DOI 10.1007/s11427-013-4455-7; Zhu FX, 2010, SCI CHINA LIFE SCI, V53, P683, DOI 10.1007/s11427-010-4011-7; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	90	94	104	5	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14512	14519		10.1074/jbc.R114.552653	http://dx.doi.org/10.1074/jbc.R114.552653			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24700459	Green Published, hybrid			2022-12-28	WOS:000337248100010
J	Chawla, Y; Upadhyay, S; Khan, S; Nagarajan, SN; Forti, F; Nandicoori, VK				Chawla, Yogesh; Upadhyay, Sandeep; Khan, Shazia; Nagarajan, Sathya Narayanan; Forti, Francesca; Nandicoori, Vinay Kumar			Protein Kinase B ( PknB) of Mycobacterium tuberculosis Is Essential for Growth of the Pathogen in Vitro as well as for Survival within the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Protein Kinases; Cell Growth; Cell Signaling; Mycobacteria; Protein Phosphorylation; PASTA Domain; PknB	MYCOLIC ACID BIOSYNTHESIS; SERINE/THREONINE KINASE; CELL-DIVISION; ACTIVATION MECHANISM; CATALYTIC DOMAIN; SER/THR KINASE; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; GENE REPLACEMENT; BINDING DOMAIN	Background:Mycobacterium tuberculosis PknB plays a critical role in modulating cell division and cell wall synthesis. Results: We present a comprehensive evaluation of the importance of various domains of PknB in modulating cell survival. Conclusion: The intracellular kinase domain and extracytoplasmic PASTA domains of PknB are essential for cell survival. Significance: PknB is essential for both in vitro growth and survival of the pathogen in vivo. The Mycobacterium tuberculosis protein kinase B (PknB) comprises an intracellular kinase domain, connected through a transmembrane domain to an extracellular region that contains four PASTA domains. The present study describes the comprehensive analysis of different domains of PknB in the context of viability in avirulent and virulent mycobacteria. We find stringent regulation of PknB expression necessary for cell survival, with depletion or overexpression of PknB leading to cell death. Although PknB-mediated kinase activity is essential for cell survival, active kinase lacking the transmembrane or extracellular domain fails to complement conditional mutants not expressing PknB. By creating chimeric kinases, we find that the intracellular kinase domain has unique functions in the virulent strain, which cannot be substituted by other kinases. Interestingly, we find that although the presence of the C-terminal PASTA domain is dispensable in the avirulent M. smegmatis, all four PASTA domains are essential in M. tuberculosis. The differential behavior of PknB vis-a-vis the number of essential PASTA domains and the specificity of kinase domain functions suggest that PknB-mediated growth and signaling events differ in virulent compared with avirulent mycobacteria. Mouse infection studies performed to determine the role of PknB in mediating pathogen survival in the host demonstrate that PknB is not only critical for growth of the pathogen in vitro but is also essential for the survival of the pathogen in the host.	[Chawla, Yogesh; Upadhyay, Sandeep; Khan, Shazia; Nagarajan, Sathya Narayanan; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Forti, Francesca] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Milan	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	Vinaykn@nii.ac.in	Chawla, Yogesh/AAB-8025-2019; Upadhyay, Sandeep/X-5218-2019; Upadhyay, Sandeep/ABF-5956-2020	Chawla, Yogesh/0000-0002-6679-518X; Upadhyay, Sandeep/0000-0001-5958-5419; Nandicoori, Vinay/0000-0002-5682-4178; NAGARAJAN, Sathya Narayanan/0000-0002-3902-3678	National Institute of Immunology (New Delhi, India); Department of Biotechnology, India	National Institute of Immunology (New Delhi, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grants from the National Institute of Immunology (New Delhi, India) and the Department of Biotechnology, India (to V.K.N.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jayachandran R, 2014, CURR TOP MICROBIOL, V374, P189, DOI 10.1007/82_2012_273; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Ruggiero A, 2012, CURR PROTEIN PEPT SC, V13, P756, DOI 10.2174/138920312804871201; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	54	80	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13858	13875		10.1074/jbc.M114.563536	http://dx.doi.org/10.1074/jbc.M114.563536			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706757	Green Published, hybrid			2022-12-28	WOS:000335984600019
J	Lee, JH; Kwon, JH; Jeon, YH; Ko, KY; Lee, SR; Kim, IY				Lee, Jea Hwang; Kwon, Joon Hyun; Jeon, Yeong Ha; Ko, Kwan Young; Lee, Seung-Rock; Kim, Ick Young			Pro(178) and Pro(183) of Selenoprotein S Are Essential Residues for Interaction with p97( VCP) during Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; ER-associated Degradation; Protein-Protein Interactions; Selenium; Selenoprotein; p97(VCP)	STRESS-INDUCED APOPTOSIS; AAA-ATPASE; MEMBRANE-PROTEIN; QUALITY-CONTROL; DROSOPHILA-MELANOGASTER; MULTIPROTEIN COMPLEXES; MISFOLDED PROTEINS; MAMMALIAN-CELLS; ER; UBIQUITIN	Background: SelS is a binding partner of p97(VCP) for endoplasmic reticulum-associated degradation (ERAD). Results: The proline mutants at SelS positions at 178 or 183 did not interact with p97(VCP). Conclusion: Both Pro(178) and Pro(183) of SelS are essential for SelS function during ERAD. Significance: The essential SelS amino acid residues for binding to p97(VCP) are identified. During endoplasmic reticulum (ER)-associated degradation, p97(VCP) is recruited to the ER membrane through interactions with transmembrane proteins, such as selenoprotein S (SelS), selenoprotein K (SelK), hrd1, and gp78. SelS has a single-spanning transmembrane domain and protects cells from ER stress-induced apoptosis through interaction with p97(VCP). The cytosolic tail of SelS consists of a coiled-coil domain, a putative VCP-interacting motif (VIM), and an unpronounced glycine- and proline-rich secondary structure. To understand the regulatory mechanism of SelS during ER stress, we investigated the interaction of the protein with p97(VCP) using mouse neuroblastoma cells and human embryonic kidney 293 cells. The SelS expression level increased when ER stress was induced. In addition, the effect of ER stress was enhanced, and recruitment of p97(VCP) to the ER membrane was inhibited in SelS knockdown cells. The effect of SelS knockdown was rescued by ectopic expression of SelS U188C. p97(VCP) interacted with SelS U188C and was recruited to the ER membrane. The expression of SelS[VIM], which is a VIM deletion mutant of SelS, also showed both a recovery effect and an interaction with p97(VCP) in cells. However, mutants in which the proline residue positions 178 or 183 of SelS were changed to alanine or were deleted did not interact with p97(VCP). The proline mutants did not rescue ER stress in SelS knockdown cells. These results suggest that both Pro(178) and Pro(183) of SelS play important roles in the translocation of p97(VCP) to the ER membrane and protect cells from ER stress.	[Lee, Jea Hwang; Kwon, Joon Hyun; Jeon, Yeong Ha; Ko, Kwan Young; Kim, Ick Young] Korea Univ, Div Life Sci, Lab Cellular & Mol Biochem, Seoul 136701, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med,Res Inst Med Sci, Dept Biochem, Dept Biomed Sci,Res Ctr Aging & Geriatr, Kwangju 501190, South Korea	Korea University; Chonnam National University	Kim, IY (corresponding author), Korea Univ, Div Life Sci, 1,5 Ka, Seoul 136701, South Korea.	ickkim@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013R1A2A2A01067149]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, which was funded by Ministry of Science, ICT, and Future Planning Grant 2013R1A2A2A01067149.	Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Foldi I, 2013, NEUROCHEM INT, V62, P58, DOI 10.1016/j.neuint.2012.11.003; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Jeon YH, 2013, BBA-MOL CELL RES, V1833, P2135, DOI 10.1016/j.bbamcr.2013.05.005; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu J, 2013, BIOCHEMISTRY-US, V52, P5514, DOI 10.1021/bi400741c; Liu J, 2012, PROTEIN EXPRES PURIF, V86, P27, DOI 10.1016/j.pep.2012.08.014; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Park YH, 2012, BBA-MOL CELL RES, V1823, P2217, DOI 10.1016/j.bbamcr.2012.09.001; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	55	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13758	13768		10.1074/jbc.M113.534529	http://dx.doi.org/10.1074/jbc.M113.534529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700463	hybrid, Green Published			2022-12-28	WOS:000335984600010
J	Song, HW; Wohltmann, M; Tan, M; Ladenson, JH; Turk, J				Song, Haowei; Wohltmann, Mary; Tan, Min; Ladenson, Jack H.; Turk, John			Group VIA Phospholipase A2 Mitigates Palmitate-induced beta-Cell Mitochondrial Injury and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Apoptosis; Cardiolipin; Diabetes; ER Stress; Lipid Peroxidation; Mass Spectrometry (MS); Mitochondrial Apoptosis; Oxidative Stress; Pancreatic Islets; Reactive Oxygen Species (ROS)	ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; NITRIC-OXIDE SYNTHASE; CYTOCHROME-C RELEASE; CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; TRANSFECTED INSULINOMA CELLS; HUMAN PANCREATIC-ISLETS; OXIDATIVE STRESS; LIPID-PEROXIDATION; ELECTROSPRAY-IONIZATION	Background: Lipid-induced -cell loss contributes to type 2 diabetes mellitus (T2DM). Results: Palmitate-induced -cell lipid oxidation, mitochondrial dysfunction, and apoptosis correlate inversely with expression of iPLA(2), which associates with mitochondria, generates monolysocardiolipin, and lowers oxidized phospholipid content. Conclusion: iPLA(2) mitigates palmitate-induced -cell mitochondrial injury and apoptosis and may facilitate repair of oxidized lipids. Significance: Understanding lipid-induced -cell loss could lead to T2DM therapies. Palmitate (C16:0) induces apoptosis of insulin-secreting -cells by processes that involve generation of reactive oxygen species, and chronically elevated blood long chain free fatty acid levels are thought to contribute to -cell lipotoxicity and the development of diabetes mellitus. Group VIA phospholipase A(2) (iPLA(2)) affects -cell sensitivity to apoptosis, and here we examined iPLA(2) effects on events that occur in -cells incubated with C16:0. Such events in INS-1 insulinoma cells were found to include activation of caspase-3, expression of stress response genes (C/EBP homologous protein and activating transcription factor 4), accumulation of ceramide, loss of mitochondrial membrane potential, and apoptosis. All of these responses were blunted in INS-1 cells that overexpress iPLA(2), which has been proposed to facilitate repair of oxidized mitochondrial phospholipids, e.g. cardiolipin (CL), by excising oxidized polyunsaturated fatty acid residues, e.g. linoleate (C18:2), to yield lysophospholipids, e.g. monolysocardiolipin (MLCL), that can be reacylated to regenerate the native phospholipid structures. Here the MLCL content of mouse pancreatic islets was found to rise with increasing iPLA(2) expression, and recombinant iPLA(2) hydrolyzed CL to MLCL and released oxygenated C18:2 residues from oxidized CL in preference to native C18:2. C16:0 induced accumulation of oxidized CL species and of the oxidized phospholipid (C18:0/hydroxyeicosatetraenoic acid)-glycerophosphoethanolamine, and these effects were blunted in INS-1 cells that overexpress iPLA(2), consistent with iPLA(2)-mediated removal of oxidized phospholipids. C16:0 also induced iPLA(2) association with INS-1 cell mitochondria, consistent with a role in mitochondrial repair. These findings indicate that iPLA(2) confers significant protection of -cells against C16:0-induced injury.	[Song, Haowei; Wohltmann, Mary; Tan, Min; Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@dom.wustl.edu			National Institutes of Health [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R37DK034388, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; Andersen AD, 2009, AM J PHYSIOL-CELL PH, V296, pC1227, DOI 10.1152/ajpcell.00370.2008; Balazy M, 2003, AGEING RES REV, V2, P191, DOI 10.1016/S1568-1637(02)00065-X; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chen X, 2008, J LIPID RES, V49, P832, DOI 10.1194/jlr.M700598-JLR200; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Guo Y, 2012, EUR J LIPID SCI TECH, V114, P233, DOI 10.1002/ejlt.201100309; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jeon MJ, 2012, EXP MOL MED, V44, P562, DOI 10.3858/emm.2012.44.9.064; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Korper S, 2003, EXP HEMATOL, V31, P815, DOI 10.1016/S0301-472X(03)00199-1; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Leonardi O, 2003, EUR J ENDOCRINOL, V149, P99, DOI 10.1530/eje.0.1490099; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma BJ, 1999, J LIPID RES, V40, P1837; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Ma ZA, 2012, CURR DIABETES REV, V8, P69; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Ma ZM, 2001, LIPIDS, V36, P689, DOI 10.1007/s11745-001-0774-9; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Martinez J, 2001, ARCH BIOCHEM BIOPHYS, V392, P257, DOI 10.1006/abbi.2001.2439; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Michalska M, 2010, BIOSCIENCE REP, V30, P445, DOI 10.1042/BSR20090138; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Montero J, 2010, BBA-BIOENERGETICS, V1797, P1217, DOI 10.1016/j.bbabio.2010.02.010; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; O'Donnell VB, 2011, BBA-MOL CELL BIOL L, V1811, P818, DOI 10.1016/j.bbalip.2011.07.018; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pappan KL, 2005, J BIOL CHEM, V280, P9023, DOI 10.1074/jbc.M409706200; PARADIES G, 1993, ARCH BIOCHEM BIOPHYS, V307, P91, DOI 10.1006/abbi.1993.1565; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Salamon Z, 1997, J BIOENERG BIOMEMBR, V29, P211, DOI 10.1023/A:1022401825287; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Song HW, 2012, J BIOL CHEM, V287, P5528, DOI 10.1074/jbc.M111.285114; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Ushmorov A, 1999, BLOOD, V93, P2342, DOI 10.1182/blood.V93.7.2342.407k09_2342_2352; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; Veluthakal R, 2005, APOPTOSIS, V10, P841, DOI 10.1007/s10495-005-0431-4; VIK SB, 1977, BIOCHEMISTRY-US, V16, P5755, DOI 10.1021/bi00645a016; Wang WF, 2011, BBA-MOL BASIS DIS, V1812, P1532, DOI 10.1016/j.bbadis.2011.07.016; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Wiederkehr A, 2009, DIABETES, V58, P2185, DOI 10.2337/db09-0967; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Won JS, 2004, J NEUROCHEM, V88, P583, DOI 10.1046/j.1471-4159.2003.02165.x; Xu M, 2011, J BIOL CHEM, V286, P11141, DOI 10.1074/jbc.M110.196543; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang WY, 2012, MOL PLANT, V5, P452, DOI 10.1093/mp/ssr118; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	110	24	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14194	14210		10.1074/jbc.M114.561910	http://dx.doi.org/10.1074/jbc.M114.561910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24648512	Green Published, hybrid			2022-12-28	WOS:000335984600046
J	Ma, XJ; Espana-Serrano, L; Kim, WJ; Purayil, HT; Nie, ZZ; Daaka, Y				Ma, Xiaojie; Espana-Serrano, Laura; Kim, Wan-ju; Purayil, Hamsa Thayele; Nie, Zhongzhen; Daaka, Yehia			beta Arrestin1 Regulates the Guanine Nucleotide Exchange Factor RasGRF2 Expression and the Small GTPase Rac- mediated Formation of Membrane Protrusion and Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arrestin; Cell Migration; G Protein-coupled Receptors (GPCR); Guanine Nucleotide Exchange Factor (GEF); Rac; Protrusion	COFILIN PHOSPHORYLATION; BETA-ARRESTINS; LIM-KINASE; RECEPTOR; IDENTIFICATION; DOWNSTREAM; MIGRATION; PATHWAY; SIGNAL; GENES	Background: G protein-coupled receptors (GPCRs) and arrestins have been shown to regulate cell motility. Results: Arrestin1 regulates cell migration through RasGRF2 (a dual guanine nucleotide exchange factor) gene expression and the small GTPase Rac activity. Conclusion: Arrestin1 may regulate cellular functions at the gene expression level. Significance: Arrestins may function at transcriptional and post-translational levels to regulate cell migration. Arrestin proteins shuttle between the cytosol and nucleus and have been shown to regulate G protein-coupled receptor signaling, actin remodeling, and gene expression. Here, we tested the hypothesis that arrestin1 regulates actin remodeling and cell migration through the small GTPase Rac. Depletion of arrestin1 promotes Rac activation, leading to the formation of multipolar protrusions and increased cell circularity, and overexpression of a dominant negative form of Rac reverses these morphological changes. Small interfering RNA library screen identifies RasGRF2 as a target of arrestin1. RasGRF2 gene and protein expression levels are elevated following depletion of arrestin1, and the consequent activation of Rac results in dephosphorylation of cofilin that can promote actin polymerization and formation of multipolar protrusions, thereby retarding cell migration and invasion. Together, these results suggest that arrestin1 regulates rasgrf2 gene expression and Rac activation to affect membrane protrusion and cell migration and invasion.	[Ma, Xiaojie; Espana-Serrano, Laura; Kim, Wan-ju; Purayil, Hamsa Thayele; Nie, Zhongzhen; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Nie, ZZ (corresponding author), NIGMS, NIH, Div Cell Biol & Biophys, 45 Ctr Dr,Rm 2AS13H,MSC6200, Bethesda, MD 20892 USA.	niezhong@nigms.nih.gov	PURAYIL, HAMSA THAYELE/E-7533-2015	THAYELE PURAYIL, HAMSA/0000-0002-7211-3659	National Institutes of Health from USPHS [K22CA124578]; NCI [R01CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155, K22CA124578] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA124578 from USPHS (to Z. N.) and R01CA129155 from NCI (to Y. D.).	Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Chen H, 2006, ONCOL REP, V15, P1281; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fan WT, 1998, CURR BIOL, V8, P935, DOI 10.1016/S0960-9822(07)00376-4; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Fereshteha M, 2012, P NATL ACAD SCI USA, V109, P12532, DOI 10.1073/pnas.1209815109; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hoeppner CZ, 2012, J BIOL CHEM, V287, P8932, DOI 10.1074/jbc.M111.294058; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kim JS, 2010, MICROFLOW CYTOMETER, P1, DOI 10.1201/b11115; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Ma XJ, 2012, J BIOL CHEM, V287, P18925, DOI 10.1074/jbc.M112.352260; Michal AM, 2011, BREAST CANCER RES TR, V130, P791, DOI 10.1007/s10549-011-1374-9; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Qiu CP, 2003, ONCOGENE, V22, P1253, DOI 10.1038/sj.onc.1206233; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ruiz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008229; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	44	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13638	13650		10.1074/jbc.M113.511360	http://dx.doi.org/10.1074/jbc.M113.511360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692549	hybrid, Green Published			2022-12-28	WOS:000335522800057
J	Shi, S; Leites, C; He, DL; Schwartz, D; Moy, W; Shi, JX; Duan, JB				Shi, Sandra; Leites, Catherine; He, Deli; Schwartz, Daniel; Moy, Winton; Shi, Jianxin; Duan, Jubao			MicroRNA-9 and MicroRNA-326 Regulate Human Dopamine D2 Receptor Expression, and the MicroRNA-mediated Expression Regulation Is Altered by a Genetic Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine Receptors; Gene Expression; Gene Regulation; Genetic Polymorphism; MicroRNA; Pharmacogenetics; DRD2	C957T POLYMORPHISM; PREFRONTAL CORTEX; MESSENGER-RNA; NT2 CELLS; DRD2 GENE; EXPERIMENTAL VALIDATION; ASSOCIATION ANALYSIS; ANTIPSYCHOTIC-DRUGS; WORKING-MEMORY; SCHIZOPHRENIA	Background: Regulation of dopamine D2 receptor (DRD2) is pathophysiologically and pharmacologically important. Results: miR-9 and miR-326 target to the 3-UTR of DRD2, and endogenously inhibit DRD2 expression. A functional single nucleotide polymorphism alters such regulation. Conclusion:DRD2 is post-transcriptionally regulated by miR-326 and miR-9. Significance: The study suggests a pathophysiological and pharmacological role of miR-9 and miR-326 in neuropsychiatric disorders. The human dopamine receptor D2 (DRD2) has been implicated in the pathophysiology of schizophrenia and other neuropsychiatric disorders. Most antipsychotic drugs influence dopaminergic transmission through blocking dopamine receptors, primarily DRD2. We report here the post-transcriptional regulation of DRD2 expression by two brain-expressed microRNAs (miRs), miR-326 and miR-9, in an ex vivo mode, and show the relevance of miR-mediated DRD2 expression regulation in human dopaminergic neurons and in developing human brains. Both miRs targeted the 3-UTR (untranslated region) of DRD2 in NT2 (neuron-committed teratocarcinoma, which endogenously expresses DRD2) and CHO (Chinese hamster ovary) cell lines, decreasing luciferase activity measured by a luciferase reporter gene assay. miR-326 overexpression reduced DRD2 mRNA and DRD2 receptor synthesis. Both antisense miR-326 and antisense miR-9 increased DRD2 protein abundance, suggesting an endogenous repression of DRD2 expression by both miRs. Furthermore, a genetic variant (rs1130354) within the DRD2 3-UTR miR-targeting site interferes with miR-326-mediated repression of DRD2 expression. Finally, co-expression analysis identified an inverse correlation of DRD2 expression with both miR-326 and miR-9 in differentiating dopaminergic neurons derived from human induced pluripotent stem cells (iPSCs) and in developing human brain regions implicated in schizophrenia. Our study provides empirical evidence suggesting that miR-326 and miR-9 may regulate dopaminergic signaling, and miR-326 and miR-9 may be considered as potential drug targets for the treatment of disorders involving abnormal DRD2 function, such as schizophrenia.	[Shi, Sandra; Leites, Catherine; He, Deli; Schwartz, Daniel; Moy, Winton; Duan, Jubao] NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; [Shi, Sandra; Duan, Jubao] Univ Chicago, Dept Psychiat & Behav Sci, Chicago, IL 60637 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	NorthShore University Health System; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Duan, JB (corresponding author), NorthShore Univ HealthSyst, Res Inst, 1001 Univ Pl, Evanston, IL 60201 USA.	jduan@uchicago.edu			National Institutes of Health [R21MH102685]; Brain and Behavior Research Foundation Young Investigator Award; NorthShore University HealthSystem Research Career Development Award; NorthShore University HealthSystem Pilot Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation Young Investigator Award; NorthShore University HealthSystem Research Career Development Award; NorthShore University HealthSystem Pilot Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R21MH102685 (to J.D.). This work was also supported by a Brain and Behavior Research Foundation (formerly NARSAD) Young Investigator Award, NorthShore University HealthSystem Research Career Development Award, and the NorthShore University HealthSystem 2011 Pilot Award (all to J.D.).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2005, EUR PSYCHIAT, V20, P15, DOI 10.1016/j.eurpsy.2004.11.003; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Fang H, 2003, J BIOL CHEM, V278, P26401, DOI 10.1074/jbc.M211539200; Farde L, 1997, NATURE, V385, P590, DOI 10.1038/385590a0; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Goldsmith SK, 1997, ARCH GEN PSYCHIAT, V54, P649; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Gunter KK, 2006, NEUROBIOL AGING, V27, P1816, DOI 10.1016/j.neurobiolaging.2005.10.003; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Jacobsen LK, 2006, PSYCHOPHARMACOLOGY, V188, P530, DOI 10.1007/s00213-006-0469-1; Jonsson EG, 2003, BIOL PSYCHIAT, V53, P577, DOI 10.1016/S0006-3223(02)01732-8; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; LIEBERMAN JA, 1987, PSYCHOPHARMACOLOGY, V91, P415, DOI 10.1007/BF00216006; MACKAY AVP, 1982, ARCH GEN PSYCHIAT, V39, P991; Misiuta IE, 2006, J NEUROSCI RES, V83, P668, DOI 10.1002/jnr.20718; MITA T, 1986, BIOL PSYCHIAT, V21, P1407, DOI 10.1016/0006-3223(86)90332-X; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park In-Hyun, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a01s8; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; SNYDER S H, 1974, Psychopharmacology Bulletin, V10, P4; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Sodja C, 2002, MOL BRAIN RES, V99, P83, DOI 10.1016/S0169-328X(01)00324-2; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sullivan D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.146; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tallerico T, 2001, MOL BRAIN RES, V87, P160, DOI 10.1016/S0169-328X(00)00293-X; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Voisey J, 2010, PSYCHIAT RES, V177, P367, DOI 10.1016/j.psychres.2010.02.015; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P741, DOI 10.3758/s13415-012-0112-z; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zakzanis KK, 1998, SCHIZOPHR RES, V32, P201, DOI 10.1016/S0920-9964(98)00041-3; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; ZHANG LJ, 1994, MOL PHARMACOL, V45, P878; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhao CN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01329	83	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13434	13444		10.1074/jbc.M113.535203	http://dx.doi.org/10.1074/jbc.M113.535203			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675081	Green Published, hybrid			2022-12-28	WOS:000335522800041
J	Anamika; Markin, CJ; Rout, MK; Spyracopoulos, L				Anamika; Markin, Craig J.; Rout, Manoj K.; Spyracopoulos, Leo			Molecular Basis for Impaired DNA Damage Response Function Associated with the RAP80 Delta E81 Defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; DNA Damage Response; NMR; Protein-Protein Interactions; Ubiquitination	CHEMICAL-SHIFT TITRATIONS; N-15 NMR RELAXATION; POLYUBIQUITIN CHAINS; IMPROVED SENSITIVITY; BACKBONE DYNAMICS; GENERALIZED BORN; PROTEINS; BINDING; BREAST; DOMAIN	Background: RAP80 recruits repair protein complexes to DNA damage sites through multivalent polyubiquitin binding. Results: A single point deletion (E81) in RAP80 abrogates multivalent interactions with polyubiquitin. Conclusion: Disruption of multivalent binding arises from loss of electrostatic interactions between Glu-81 and ubiquitin. Significance: A single residue deletion mutation in RAP80 impairs DNA damage repair and is implicated in the pathogenesis of cancer. Signal transduction within the DNA damage response is driven by the flux of protein-protein interaction cascades that ultimately recruit repair complexes to sites of damage. The protein RAP80 plays a central role in the damage response by targeting BRCA1/BRCA2 tumor suppressors to DNA damage foci through multivalent binding of Lys-63-linked polyubiquitin chains. Mutations within the high penetrance BRCA1/BRCA2 genes account for approximate to 20% of familial breast cancers. The genetic basis for the remaining cancers remains unknown, but may involve defects in binding partners for BRCA1 and BRCA2 that lead to impaired targeting to foci and a concomitant role in the pathogenesis of cancer. Recently, an in-frame deletion mutation (E81) in a conserved region from the first ubiquitin interaction motif of RAP80 has been linked to an increase in chromosomal abnormalities. Using NMR spectroscopy, we demonstrate that the N-cap motif within the -helix of the first ubiquitin interaction motif from E81 undergoes a structural frameshift that leads to abolishment of multivalent binding of polyubiquitin chains. Loss of this single glutamate residue disrupts favorable electrostatic interactions between RAP80 and ubiquitin, establishing a plausible molecular basis for a potential predisposition to cancer unrelated to mutations within BRCA1/BRCA2 genes.	[Anamika; Markin, Craig J.; Rout, Manoj K.; Spyracopoulos, Leo] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Spyracopoulos, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	leo.spyracopoulos@ualberta.ca		Markin, Craig/0000-0002-2147-0744	University of Alberta	University of Alberta(University of Alberta)	We thank the Canadian National High Field NMR Centre (NANUC) for assistance and for use of the facilities. Operation of NANUC is funded by the University of Alberta. Computational studies were enabled by the use of computing resources provided by WestGrid and Compute/Calcul Canada.	Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Case D. A., 2021, AMBER 2022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Goddard D., 2008, SPARKY 3; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller R., 2004, COMPUTER AIDED RESON, V1; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Markin CJ, 2012, J BIOMOL NMR, V54, P355, DOI 10.1007/s10858-012-9678-6; Markin CJ, 2012, J BIOMOL NMR, V53, P125, DOI 10.1007/s10858-012-9630-9; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nesmelova I, 2001, BIOCHEMISTRY-US, V40, P2844, DOI 10.1021/bi001293b; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Rebbeck TR, 2011, CANCER RES, V71, P5792, DOI 10.1158/0008-5472.CAN-11-0773; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEALE JW, 1994, PROTEIN SCI, V3, P1741, DOI 10.1002/pro.5560031014; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wolfram S., 2003, MATH BOOK; Yin ZY, 2012, CANCER RES, V72, P5080, DOI 10.1158/0008-5472.CAN-12-1484; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	41	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12852	12862		10.1074/jbc.M113.538280	http://dx.doi.org/10.1074/jbc.M113.538280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627472	Green Published, hybrid			2022-12-28	WOS:000335581400054
J	Du, J; An, R; Chen, LJ; Shen, YX; Chen, Y; Cheng, L; Jiang, ZR; Zhang, AM; Yu, L; Chu, DY; Shen, YJ; Luo, QL; Chen, H; Wan, LJ; Li, M; Xu, XC; Shen, JL				Du, Jian; An, Ran; Chen, Lijian; Shen, Yuxian; Chen, Ying; Cheng, Li; Jiang, Zhongru; Zhang, Aimei; Yu, Li; Chu, Deyong; Shen, Yujun; Luo, Qingli; Chen, He; Wan, Lijuan; Li, Min; Xu, Xiucai; Shen, Jilong			Toxoplasma gondii Virulence Factor ROP18 Inhibits the Host NF- kappa B Pathway by Promoting p65 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; NF-B (NF-KB); NF-kB Transcription Factor; Parasite; Parasitology; Pathogenesis; Signal Transduction	KINASE; ACTIVATION; PHOSPHORYLATION; MACROPHAGES; TARGET; PROLIFERATION; EXPRESSION; INFECTION; PROTEINS; IMMUNITY	Background: ROP18 is a Toxoplasma secreted Ser/Thr protein kinase important for acute virulence. Results: ROP18 phosphorylates host p65 at Ser-468 and target this protein to the ubiquitin-dependent degradation. Conclusion: ROP18 inhibits the host NF-B pathway by promoting p65 degradation. Significance: These findings reveal a novel molecular mechanism by which type I strain manipulates the host immune system to facilitate infection. The obligate intracellular parasite Toxoplasma gondii secretes effector molecules into the host cell to modulate host immunity. Previous studies have shown that T. gondii could interfere with host NF-B signaling to promote their survival, but the effectors of type I strains remain unclear. The polymorphic rhoptry protein ROP18 is a key serine/threonine kinase that phosphorylates host proteins to modulate acute virulence. Our data demonstrated that the N-terminal portion of ROP18 is associated with the dimerization domain of p65. ROP18 phosphorylates p65 at Ser-468 and targets this protein to the ubiquitin-dependent degradation pathway. The kinase activity of ROP18 is required for p65 degradation and suppresses NF-B activation. Consistently, compared with wild-type ROP18 strain, ROP18 kinase-deficient type I parasites displayed a severe inability to inhibit NF-B, culminating in the enhanced production of IL-6, IL-12, and TNF- in infected macrophages. In addition, studies have shown that transgenic parasites carrying kinase-deficient ROP18 induce M1-biased activation. These results demonstrate for the first time that the virulence factor ROP18 in T. gondii type I strains is responsible for inhibiting the host NF-B pathway and for suppressing proinflammatory cytokine expression, thus providing a survival advantage to the infectious agent.	[Du, Jian; An, Ran; Cheng, Li; Jiang, Zhongru; Wan, Lijuan] Anhui Med Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Hefei 230032, Peoples R China; [Chen, Lijian] Anhui Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Hefei 230032, Peoples R China; [Shen, Yuxian; Chen, Ying; Shen, Yujun] Anhui Med Univ, Inst Biopharmaceut, Hefei 230032, Peoples R China; [Zhang, Aimei; Xu, Xiucai] Anhui Med Univ, Affiliated Prov Hosp, Cent Lab, Hefei 230001, Peoples R China; [Yu, Li; Chu, Deyong; Luo, Qingli; Chen, He; Li, Min; Shen, Jilong] Anhui Med Univ, Anhui Prov Lab Microbiol & Parasitol, Hefei 230032, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Du, J (corresponding author), Anhui Med Univ, Dept Biochem & Mol Biol, 81 Meishan Rd,POB 71, Hefei 230032, Anhui, Peoples R China.	dujane@163.com; shenjilong53@126.com	wan, li/GRY-7634-2022	Shen, Yuxian/0000-0002-0916-0743	National Basic Research Program of China (973 program) [2010CB530001]; National Natural Science Foundation of China [81271864, 30801329, 81171605]; Fok Ying Tung College Young Teachers Fund, Chinese Ministry of Education [131033]; Distinguished Young Scholar of Anhui Province Grants [10040606Y19, 1308085JGD11]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung College Young Teachers Fund, Chinese Ministry of Education; Distinguished Young Scholar of Anhui Province Grants	This work was supported by the National Basic Research Program of China (973 program; Grant 2010CB530001; to J. S.), National Natural Science Foundation of China Grants 81271864 and 30801329, Fok Ying Tung College Young Teachers Fund Grant 131033 from the Chinese Ministry of Education, Distinguished Young Scholar of Anhui Province Grants 10040606Y19 and 1308085JGD11 (to J. D.), and National Natural Science Foundation of China Grant 81171605 (to X. X.).	Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Butcher BA, 2001, J IMMUNOL, V167, P2193, DOI 10.4049/jimmunol.167.4.2193; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Cheng L, 2012, ACTA TROP, V122, P255, DOI [10.1016/j.actatropica.2012.02.001, 10.1016/j.actatropica.2012.02.065]; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Du Jian, 2012, Front Biosci (Schol Ed), V4, P639; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Ferguson DJP, 2013, CLIN INFECT DIS, V56, P204, DOI 10.1093/cid/cis882; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Harris TH, 2010, J NEUROIMMUNOL, V222, P19, DOI 10.1016/j.jneuroim.2009.12.009; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kim JY, 2006, YONSEI MED J, V47, P862, DOI 10.3349/ymj.2006.47.6.862; Kim L, 2004, J IMMUNOL, V172, P3003, DOI 10.4049/jimmunol.172.5.3003; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Minbaeva G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002043; Molestina RE, 2005, J CELL SCI, V118, P5785, DOI 10.1242/jcs.02709; Molestina RE, 2005, CELL MICROBIOL, V7, P351, DOI 10.1111/j.1462-5822.2004.00463.x; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murray PJ, 2011, CELL HOST MICROBE, V9, P445, DOI 10.1016/j.chom.2011.05.010; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Payne TM, 2003, J CELL SCI, V116, P4345, DOI 10.1242/jcs.00756; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Shapira S, 2005, J CELL SCI, V118, P3501, DOI 10.1242/jcs.02428; Shapira S, 2002, J INFECT DIS, V185, pS66, DOI 10.1086/338000; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Tait ED, 2009, MEM I OSWALDO CRUZ, V104, P201, DOI 10.1590/S0074-02762009000200013; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	42	56	62	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12578	12592		10.1074/jbc.M113.544718	http://dx.doi.org/10.1074/jbc.M113.544718			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648522	Green Published, hybrid			2022-12-28	WOS:000335581400031
J	Pohane, AA; Joshi, H; Jain, V				Pohane, Amol Arunrao; Joshi, Himanshu; Jain, Vikas			Molecular Dissection of Phage Endolysin AN INTERDOMAIN INTERACTION CONFERS HOST SPECIFICITY IN LYSIN A OF MYCOBACTERIUM PHAGE D29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Mycobacteria; Peptidoglycan; Protein-Protein Interactions; Surface Plasmon Resonance (SPR); Periplasmic Expression; Zymography	FUNCTIONAL-ANALYSIS; LYTIC ACTIVITY; DOMAIN; FLUORESCENT; EXPRESSION; HYDROLASE; BINDING; PROTEIN; GENES; IDENTIFICATION	Background: Bacteriophages produce endolysins to hydrolyze host cell wall for their progeny release. Results:Mycobacterium phage endolysin is inactive in E. coli but is active in mycobacteria. Conclusion: An interdomain interaction makes Lysin A inactive in E. coli. Significance: A hydrolase with built-in mechanism attains host specificity. An in-depth study can help in developing strong anti-tuberculosis agents. Mycobacterium tuberculosis has always been recognized as one of the most successful pathogens. Bacteriophages that attack and kill mycobacteria offer an alternate mechanism for the curtailment of this bacterium. Upon infection, mycobacteriophages produce lysins that catalyze cell wall peptidoglycan hydrolysis and mycolic acid layer breakdown of the host resulting in bacterial cell rupture and virus release. The ability to lyse bacterial cells make lysins extremely significant. We report here a detailed molecular dissection of the function and regulation of mycobacteriophage D29 Lysin A. Several truncated versions of Lysin A were constructed, and their activities were analyzed by zymography and by expressing them in both Escherichia coli and Mycobacterium smegmatis. Our experiments establish that Lysin A harbors two catalytically active domains, both of which show E. coli cell lysis upon their expression exclusively in the periplasmic space. However, the expression of only one of these domains and the full-length Lysin A caused M. smegmatis cell lysis. Interestingly, full-length protein remained inactive in E. coli periplasm. Our data suggest that the inactivity is ensued by a C-terminal domain that interacts with the N-terminal domain. This interaction was affirmed by surface plasmon resonance. Our experiments also demonstrate that the C-terminal domain of Lysin A selectively binds to M. tuberculosis and M. smegmatis peptidoglycans. Our methodology of studying E. coli cell lysis by Lysin A and its truncations after expressing these proteins in the bacterial periplasm with the help of signal peptide paves the way for a large scale identification and analysis of such proteins obtained from other bacteriophages.	[Pohane, Amol Arunrao; Joshi, Himanshu; Jain, Vikas] Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal 462023, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Jain, V (corresponding author), Indian Inst Sci Educ & Res IISER, Microbiol & Mol Biol Lab, Transit Campus ITI Gas Rahat Bldg, Bhopal 462023, Madhya Pradesh, India.	vikas@iiserb.ac.in	JAIN, VIKAS/B-3142-2008	JAIN, VIKAS/0000-0003-0238-8144	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a rapid grant from the Department of Biotechnology, Government of India.; Recipients of Council of Scientific and Industrial Research, Government of India senior research fellowships.	Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Catalao MJ, 2013, FEMS MICROBIOL REV, V37, P554, DOI 10.1111/1574-6976.12006; Catalao MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020515; Catalao MJ, 2011, J BACTERIOL, V193, P2793, DOI 10.1128/JB.01519-10; Dinh T, 2011, J BACTERIOL, V193, P4984, DOI 10.1128/JB.00315-11; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Garcia M, 2002, J BACTERIOL, V184, P3034, DOI 10.1128/JB.184.11.3034-3043.2002; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Hassan S., 2010, OPEN SYS BIOL J, V3, DOI [10.2174/1876392801003010021, DOI 10.2174/18763]; HENRICH B, 1995, J BACTERIOL, V177, P723, DOI 10.1128/jb.177.3.723-732.1995; Henry M, 2010, FEMS MICROBIOL LETT, V311, P126, DOI 10.1111/j.1574-6968.2010.02080.x; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hernandez VEB, 2008, PROTEIN EXPRES PURIF, V59, P169, DOI 10.1016/j.pep.2008.01.019; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Kana BD, 2010, J BACTERIOL, V192, P2220, DOI 10.1128/JB.01135-09; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Lella M, 2013, CHEM COMMUN, V49, P9594, DOI 10.1039/c3cc45058a; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Mahapatra S, 2013, APPL ENVIRON MICROB, V79, P768, DOI 10.1128/AEM.02263-12; McNerney R, 1998, RES MICROBIOL, V149, P487, DOI 10.1016/S0923-2508(98)80003-X; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Raghunand TR, 2006, MICROBIOL-SGM, V152, P2735, DOI 10.1099/mic.0.28911-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schmelcher M, 2011, MICROB BIOTECHNOL, V4, P651, DOI 10.1111/j.1751-7915.2011.00263.x; Schofield David A, 2012, Bacteriophage, V2, P105; Schuch Raymond, 2009, V502, P307, DOI 10.1007/978-1-60327-565-1_18; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Simboli N, 2005, ANTIMICROB AGENTS CH, V49, P425, DOI 10.1128/AAC.49.1.425-427.2005; Singh MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063922; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Sudiarta IP, 2010, J BIOL CHEM, V285, P41232, DOI 10.1074/jbc.M110.156273; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Wang S, 2008, J APPL MICROBIOL, V105, P1939, DOI 10.1111/j.1365-2672.2008.03953.x; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	56	32	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12085	12095		10.1074/jbc.M113.529594	http://dx.doi.org/10.1074/jbc.M113.529594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24627486	Green Published, hybrid			2022-12-28	WOS:000335010600046
J	Senatore, A; Guan, W; Boone, AN; Spafford, JD				Senatore, Adriano; Guan, Wendy; Boone, Adrienne N.; Spafford, J. David			T-type Channels Become Highly Permeable to Sodium Ions Using an Alternative Extracellular Turret Region ( S5-P) Outside the Selectivity Filter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium Channels; Heart; Patch Clamp Electrophysiology; Permeability; Sodium Channels	CRYSTAL-STRUCTURE; CALCIUM-CHANNEL; K+ CHANNEL; POTASSIUM CHANNEL; CA2+ CHANNELS; MUSCLE CELLS; VOLTAGE; INHIBITOR; LYMNAEA; PORE	Background: Ion selectivity of voltage-gated channels is governed by selectivity filters. Results: Alternative turret region in domain II promotes highly sodium-permeable T-type channels without major changes to gating and kinetic features. Conclusion: T-type channels can generate variable sodium or calcium permeability by gene splicing. Significance: Ion selectivity in T-type channels can be altered using extracellular domains outside the ion selectivity filter. T-type (Ca(v)3) channels are categorized as calcium channels, but invertebrate ones can be highly sodium-selective channels. We illustrate that the snail LCa(v)3 T-type channel becomes highly sodium-permeable through exon splicing of an extracellular turret and descending helix in domain II of the four-domain Ca(v)3 channel. Highly sodium-permeable T-type channels are generated without altering the invariant ring of charged residues in the selectivity filter that governs calcium selectivity in calcium channels. The highly sodium-permeant T-type channel expresses in the brain and is the only splice isoform expressed in the snail heart. This unique splicing of turret residues offers T-type channels a capacity to serve as a pacemaking sodium current in the primitive heart and brain in lieu of Na(v)1-type sodium channels and to substitute for voltage-gated sodium channels lacking in many invertebrates. T-type channels would also contribute substantially to sodium leak conductances at rest in invertebrates because of their large window currents.	[Senatore, Adriano; Guan, Wendy; Boone, Adrienne N.; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada Graduate Scholarship; Ontario Graduate Scholarship award	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship award(Ontario Graduate Scholarship)	This work was supported in part by a Heart and Stroke Foundation of Canada grant-in-aid and Natural Sciences and Engineering Research Council of Canada discovery grant ( to J. D. S.).; Supported by Natural Sciences and Engineering Research Council of Canada Graduate Scholarship and Ontario Graduate Scholarship award.	Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brezden BL, 1999, J NEUROPHYSIOL, V81, P1818, DOI 10.1152/jn.1999.81.4.1818; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P839, DOI 10.1007/s00249-009-0574-2; Dawson T. F., 2014, PLOS ONE IN PRESS; Doering CJ, 2003, J BIOENERG BIOMEMBR, V35, P491, DOI 10.1023/B:JOBB.0000008022.50702.1a; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1967, SCIENCE, V155, P965, DOI 10.1126/science.155.3765.965; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hill, 2001, ION CHANNELS EXCITAB, P441; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Khan N, 2008, J GEN PHYSIOL, V132, P223, DOI 10.1085/jgp.200809986; KOSTYUK PG, 1983, J MEMBRANE BIOL, V76, P83, DOI 10.1007/BF01871455; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; Nikitin ES, 2008, CURR BIOL, V18, P1221, DOI 10.1016/j.cub.2008.07.030; Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2; OPDYKE CA, 1994, J COMP PHYSIOL A, V175, P781; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Senatore A, 2014, PFLUG ARCH EUR J PHY, V466, P645, DOI 10.1007/s00424-014-1449-7; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2013, CHANNELS, V7, P60, DOI 10.4161/chan.23981; Senatore A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055088; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shcheglovitov A, 2007, BBA-BIOMEMBRANES, V1768, P1406, DOI 10.1016/j.bbamem.2007.02.017; Spafford J. D., 2011, JOVE-J VIS EXP, V47, P2314; STRONG M, 1993, MOL BIOL EVOL, V10, P221; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Yeoman MS, 1999, J NEUROPHYSIOL, V82, P2428, DOI 10.1152/jn.1999.82.5.2428; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	49	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11952	11969		10.1074/jbc.M114.551473	http://dx.doi.org/10.1074/jbc.M114.551473			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24596098	Green Published, hybrid			2022-12-28	WOS:000335010600035
J	Buttner, FM; Zoll, S; Nega, M; Gotz, F; Stehle, T				Buettner, Felix Michael; Zoll, Sebastian; Nega, Mulugeta; Goetz, Friedrich; Stehle, Thilo			Structure-Function Analysis of Staphylococcus aureus Amidase Reveals the Determinants of Peptidoglycan Recognition and Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Design; Enzyme Mechanisms; Peptidoglycan; Staphylococcus aureus; X-ray Crystallography; Zinc; MRSA; Amidase; Autolysin; Complex Structure	MAJOR AUTOLYSIN; CELL-WALLS; BIOFILMS; EPIDERMIDIS; LYSOZYME; FEATURES; ENZYMES; ACID; AMPD	Background: Autolysins ensure the plasticity of bacterial cell walls, and deletion leads to impaired cell clusters. Results: High resolution structures of Staphylococcus aureus amidase AmiA shed light on peptidoglycan binding and cleavage. Conclusion: AmiA distinguishes peptidoglycan mostly by the peptide, and cleavage is facilitated by a zinc-activated water molecule. Significance: These structures will inform strategies to develop new therapeutics against MRSA. The bifunctional major autolysin AtlA of Staphylococcus aureus cleaves the bacterium's peptidoglycan network (PGN) at two distinct sites during cell division. Deletion of the enzyme results in large cell clusters with disordered division patterns, indicating that AtlA could be a promising target for the development of new antibiotics. One of the two functions of AtlA is performed by the N-acetylmuramyl-l-alanine amidase AmiA, which cleaves the bond between the carbohydrate and the peptide moieties of PGN. To establish the structural requirements of PGN recognition and the enzymatic mechanism of cleavage, we solved the crystal structure of the catalytic domain of AmiA (AmiA-cat) in complex with a peptidoglycan-derived ligand at 1.55 resolution. The peptide stem is clearly visible in the structure, forming extensive contacts with protein residues by docking into an elongated groove. Less well defined electron density and the analysis of surface features indicate likely positions of the carbohydrate backbone and the pentaglycine bridge. Substrate specificity analysis supports the importance of the pentaglycine bridge for fitting into the binding cleft of AmiA-cat. PGN of S. aureus with l-lysine tethered with d-alanine via a pentaglycine bridge is completely hydrolyzed, whereas PGN of Bacillus subtilis with meso-diaminopimelic acid directly tethered with d-alanine is not hydrolyzed. An active site mutant, H370A, of AmiA-cat was completely inactive, providing further support for the proposed catalytic mechanism of AmiA. The structure reported here is not only the first of any bacterial amidase in which both the PGN component and the water molecule that carries out the nucleophilic attack on the carbonyl carbon of the scissile bond are present; it is also the first peptidoglycan amidase complex structure of an important human pathogen.	[Buettner, Felix Michael; Zoll, Sebastian; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Nega, Mulugeta; Goetz, Friedrich] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de		Zoll, Sebastian/0000-0001-5376-9698	Collaborative Research Center TRR34	Collaborative Research Center TRR34	This work was supported by the Collaborative Research Center TRR34.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht T, 2012, J BACTERIOL, V194, P2630, DOI 10.1128/JB.06609-11; [Anonymous], 2012, ACD CHEMSKETCH FREEW; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron Samuel, 1996, MED MICROBIOLOGY; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boneca IG, 2000, J BIOL CHEM, V275, P9910, DOI 10.1074/jbc.275.14.9910; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11255; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; European Antimicrobial Resistance Surveillance System, 2009, EARSS ANN REP 2008, P55; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gotz F, 2000, INFECT ASS INDWELLIN, P55; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kohlenberg A, 2008, CLIN MICROBIOL INFEC, V14, P93, DOI 10.1111/j.1469-0691.2007.01879.x; Kresken M., 2009, RESISTENZSITUATION B, P9; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Martinez-Caballero S, 2013, J AM CHEM SOC, V135, P10318, DOI 10.1021/ja405464b; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stratagene, 2006, QUIKCHANGE SIT DIR M; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WARTH AD, 1971, BIOCHEMISTRY-US, V10, P4349, DOI 10.1021/bi00800a001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; Zeller John L, 2007, JAMA, V298, P1826, DOI 10.1001/jama.298.15.1826; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	59	23	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11083	11094		10.1074/jbc.M114.557306	http://dx.doi.org/10.1074/jbc.M114.557306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599952	hybrid, Green Published			2022-12-28	WOS:000334638500013
J	Yuan, G; Yan, SF; Xue, H; Zhang, P; Sun, JT; Li, G				Yuan, Guang; Yan, Shao-Feng; Xue, Hao; Zhang, Ping; Sun, Jin-Tang; Li, Gang			Cucurbitacin I Induces Protective Autophagy in Glioblastoma in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Glioblastoma; Hypoxia-inducible Factor (HIF); Signal Transduction; Chloroquine; Cucurbitacin I	CELL-CYCLE ARREST; SIGNAL TRANSDUCER; MEDIATED APOPTOSIS; CANCER-CELLS; STAT3; INHIBITION; ACTIVATION; INDUCTION; TARGET; DEATH	Background: Targeting disruption of STAT3 results in inhibition of tumor growth and survival in malignant glioma. Results: Cucurbitacin I triggers protective autophagy through the AMPK/mTOR/p70S6K pathway and down-regulates HIF-1. Conclusion: Autophagy blockade sensitizes glioblastoma to cucurbitacin I treatment. Significance: This study provides new insights into the biological and antiproliferative activities of cucurbitacin I against glioblastoma. There is an urgent need for new therapeutic avenues to improve the outcome of patients with glioblastoma multiforme (GBM). Current studies have suggested that cucurbitacin I, a natural selective inhibitor of JAK2/STAT3, has a potent anticancer effect on a variety of cancer cell types. This study showed that autophagy and apoptosis were induced by cucurbitacin I. Exposure of GBM cells to cucurbitacin I resulted in pronounced apoptotic cell death through activating bcl-2 family proteins. Cells treatment with cucurbitacin I up-regulated Beclin 1 and triggered autophagosome formation and accumulation as well as conversion of LC3I to LC3II. Activation of the AMP-activated protein kinase/mammalian target of rapamycin/p70S6K pathway, but not the PI3K/AKT pathway, occurred in autophagy induced by cucurbitacin I, which was accompanied by decreased hypoxia-inducible factor 1. Stable overexpression of hypoxia-inducible factor 1 induced by FG-4497 prevented cucurbitacin I-induced autophagy and down-regulation of bcl-2. Knockdown of beclin 1 or treatment with the autophagy inhibitor 3-methyladenine also inhibited autophagy induced by cucurbitacin I. A coimmunoprecipitation assay showed that the interaction of Bcl-2 and Beclin 1/hVps34 decreased markedly in cells treated with cucurbitacin I. Furthermore, knockdown of beclin 1 or treatment with the lysosome inhibitor chloroquine sensitized cancer cells to cucurbitacin I-induced apoptosis. Finally, a xenograft model provided additional evidence for the occurrence of cucurbitacin I-induced apoptosis and autophagy in vitro. Our findings provide new insights into the molecular mechanisms underlying cucurbitacin I-mediated GBM cell death and may provide an efficacious therapy for patients harboring GBM.	[Yuan, Guang; Yan, Shao-Feng; Xue, Hao; Zhang, Ping; Li, Gang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Yuan, Guang; Li, Gang] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China; [Sun, Jin-Tang] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Sun, Jin-Tang] Shandong Univ, Key Lab Cardiovasc Prote Shandong Prov, Qilu Hosp, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, G (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, 107 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	doctorligang@126.com	Xue, Hao/GXV-4717-2022		Natural Science Foundation of China [81172403]; Independent Innovation Foundation of Shandong University [IIFSDU2009TS067]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2010YY022]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This work was supported by Natural Science Foundation of China Grant 81172403, by Independent Innovation Foundation of Shandong University Grant IIFSDU2009TS067, and by Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province Grant BS2010YY022.	Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Cao Yiting, 2010, Genes Cancer, V1, P50; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Garner JM, 2013, J BIOL CHEM, V288, P26167, DOI 10.1074/jbc.M113.477950; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molavi O, 2008, IMMUNOL CELL BIOL, V86, P506, DOI 10.1038/icb.2008.27; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040531; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu HC, 2013, J BIOL CHEM, V288, P18249, DOI 10.1074/jbc.M112.446385; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	62	66	68	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10607	10619		10.1074/jbc.M113.528760	http://dx.doi.org/10.1074/jbc.M113.528760			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24599950	Green Published, hybrid			2022-12-28	WOS:000334226400032
J	Haji-Ghassemi, O; Muller-Loennies, S; Saldova, R; Muniyappa, M; Brade, L; Rudd, PM; Harvey, DJ; Kosma, P; Brade, H; Evans, SV				Haji-Ghassemi, Omid; Mueller-Loennies, Sven; Saldova, Radka; Muniyappa, Mohankumar; Brade, Lore; Rudd, Pauline M.; Harvey, David J.; Kosma, Paul; Brade, Helmut; Evans, Stephen V.			Groove-type Recognition of Chlamydiaceae-specific Lipopolysaccharide Antigen by a Family of Antibodies Possessing an Unusual Variable Heavy Chain N-Linked Glycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS-SPECIFIC EPITOPE; MOUSE MONOCLONAL-ANTIBODIES; LASER-DESORPTION IONIZATION; CHLAMYDOPHILA-PSITTACI 6BC; FACTOR-VIII ANTIBODY; ACID KDO RESIDUES; SOMATIC HYPERMUTATION; STRUCTURAL-ANALYSIS; MASS-SPECTROMETRY; GLYCOSYLATION DETERMINES	The structure of the antigen binding fragment ofmAb S25-26, determined to 1.95 angstrom resolution in complex with the Chlamydiaceae family-specific trisaccharide antigen Kdo(2 -> 8) Kdo-(2 -> 4) Kdo (Kdo = 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid), displays a germ-line-coded paratope that differs significantly from previously characterized Chlamydiaceae-specific mAbs despite being raised against the identical immunogen. Unlike the terminal Kdo recognition pocket that promotes cross-reactivity in S25-2-type antibodies, S25-26 and the closely related S25-23 utilize a groove composed of germ-line residues to recognize the entire trisaccharide antigen and so confer strict specificity. Interest in S25-23 was sparked by its rare high mu M affinity and strict specificity for the family-specific trisaccharide antigen; however, only the related antibody S25-26 proved amenable to crystallization. The structures of three unliganded forms of S25-26 have a labile complementary-determining region H3 adjacent to significant glycosylation of the variable heavy chain on asparagine 85 in Framework Region 3. Analysis of the glycan reveals a heterogeneous mixture with a common root structure that contains an unusually high number of terminal alpha Gal-Gal moieties. One of the few reported structures of glycosylated mAbs containing these epitopes is the therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows significant order in the glycan with appropriate electron density for nine residues. The elucidation of the three-dimensional structure of an alpha Gal-containing N-linked glycan on a mAb variable heavy chain has potential clinical interest, as it has been implicated in allergic response in patients receiving therapeutic antibodies.	[Haji-Ghassemi, Omid; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada; [Mueller-Loennies, Sven; Brade, Lore; Brade, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Saldova, Radka; Muniyappa, Mohankumar; Rudd, Pauline M.] NIBRT, GlycoSci Grp, Dublin 4, Ireland; [Kosma, Paul] Univ Nat Resources & Life Sci, Vienna, Austria; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	University of Victoria; Forschungszentrum Borstel; University of Natural Resources & Life Sciences, Vienna; University of Oxford	Muller-Loennies, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Pk Allee 22, D-23845 Borstel, Germany.	sml@fz-borstel.de; svevans@uvic.ca	Harvey, David/A-5579-2013; Kosma, Paul/Y-7443-2019	Kosma, Paul/0000-0001-5342-7161; Evans, Stephen/0000-0002-0366-4027; Haji-Ghassemi, Omid/0000-0003-0116-005X; Fahey (Saldova), Radka/0000-0001-5085-5080; Harvey, David/0000-0003-0544-771X	Natural Sciences and Engineering Research Council of Canada; European Union [260600]; Fonds zur Forderung der wissenschaftlichen Forschung [P22909]; Michael Smith Foundation for Health Research Senior Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Union(European Commission); Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Michael Smith Foundation for Health Research Senior Scholarship(Michael Smith Foundation for Health Research)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to S. V. E.), European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 260600 ("GlycoHIT") (to R. S.), and by Fonds zur Forderung der wissenschaftlichen Forschung Grant P22909 (to P. K.).; Recipient of a Michael Smith Foundation for Health Research Senior Scholarship.	ANDERSSON B, 1971, CELL IMMUNOL, V2, P411, DOI 10.1016/0008-8749(71)90052-9; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; Bogart JA, 2006, CLIN LUNG CANCER, V7, P285, DOI 10.3816/CLC.2006.n.009; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; BORREBAECK CAK, 1993, IMMUNOL TODAY, V14, P477, DOI 10.1016/0167-5699(93)90259-N; BRADE H, 1987, P NATL ACAD SCI USA, V84, P2508, DOI 10.1073/pnas.84.8.2508; Brade L, 1997, GLYCOBIOLOGY, V7, P819, DOI 10.1093/glycob/7.6.819; Brade L, 2002, J ENDOTOXIN RES, V8, P357, DOI 10.1179/096805102125000687; BRADE L, 1994, FEMS IMMUNOL MED MIC, V8, P27, DOI 10.1111/j.1574-695X.1994.tb00422.x; Brade L, 2000, J ENDOTOXIN RES, V6, P361, DOI 10.1179/096805100101532289; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Brooks CL, 2013, ACTA CRYSTALLOGR F, V69, P2, DOI 10.1107/S1744309112047422; Brooks CL, 2010, BIOCHEMISTRY-US, V49, P570, DOI 10.1021/bi9011308; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DW, 2011, GLYCOBIOLOGY, V21, P1049, DOI 10.1093/glycob/cwr041; FU YC, 1992, INFECT IMMUN, V60, P1314, DOI 10.1128/IAI.60.4.1314-1321.1992; Garcia-Ojeda PA, 2004, INFECT IMMUN, V72, P3451, DOI 10.1128/IAI.72.6.3451-3460.2004; Gaspal FMC, 2006, EUR J IMMUNOL, V36, P1665, DOI 10.1002/eji.200535339; Gerstenbruch S, 2010, GLYCOBIOLOGY, V20, P461, DOI 10.1093/glycob/cwp198; GREENSPAN NS, 1988, J IMMUNOL, V141, P4276; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2011, J AM SOC MASS SPECTR, V22, P568, DOI 10.1007/s13361-010-0053-0; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; HELLSTROM I, 1990, CANCER RES, V50, P2183; HOLST O, 1995, EUR J BIOCHEM, V229, P194, DOI 10.1111/j.1432-1033.1995.tb20455.x; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Igietseme JU, 2011, EXPERT REV VACCINES, V10, P1585, DOI [10.1586/erv.11.139, 10.1586/ERV.11.139]; Jacquemin M, 2006, J THROMB HAEMOST, V4, P1047, DOI 10.1111/j.1538-7836.2006.01900.x; Jacquemin M, 2010, HAEMOPHILIA, V16, P16, DOI 10.1111/j.1365-2516.2010.02233.x; KIMURA H, 1989, EUR J IMMUNOL, V19, P1741, DOI 10.1002/eji.1830190932; KOSMA P, 1987, CARBOHYD RES, V167, P39, DOI 10.1016/0008-6215(87)80266-5; Kosma P, 1999, BBA-MOL BASIS DIS, V1455, P387, DOI 10.1016/S0925-4439(99)00061-7; KOSMA P, 1994, CARBOHYD RES, V254, P105, DOI 10.1016/0008-6215(94)84246-9; KOSMA P, 1989, CARBOHYD RES, V190, P191, DOI 10.1016/0008-6215(89)84125-4; KOSMA P, 1988, CARBOHYD RES, V183, P183, DOI 10.1016/0008-6215(88)84073-4; KOSMA P, 1990, CARBOHYD RES, V208, P37, DOI 10.1016/0008-6215(90)80083-F; Kosma P, 2000, J ENDOTOXIN RES, V6, P57, DOI 10.1177/09680519000060010801; Kosma P., 2008, CARBOHYDRATE BASED V, V989, P211; Leibiger H, 1999, BIOCHEM J, V338, P529, DOI 10.1042/0264-6021:3380529; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Muller-Loennies S, 2006, GLYCOBIOLOGY, V16, P184, DOI 10.1093/glycob/cwj055; Muller-Loennies S, 2002, J ENDOTOXIN RES, V8, P295, DOI 10.1179/096805102125000506; Muller-Loennies S, 2000, GLYCOBIOLOGY, V10, P121, DOI 10.1093/glycob/10.2.121; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Nguyen HP, 2001, ACTA CRYSTALLOGR D, V57, P1872, DOI 10.1107/S0907444901014536; PASCUAL V, 1992, J IMMUNOL, V149, P2337; PATEL TP, 1992, BIOCHEM J, V285, P839, DOI 10.1042/bj2850839; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Royle L., 2006, GLYCOBIOLOGY PROTOCO; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Rund S, 2000, EUR J BIOCHEM, V267, P5717, DOI 10.1046/j.1432-1327.2000.01635.x; SHARON J, 1990, P NATL ACAD SCI USA, V87, P4814, DOI 10.1073/pnas.87.12.4814; Sheeley DM, 1997, ANAL BIOCHEM, V247, P102, DOI 10.1006/abio.1997.2036; Sheriff S, 1996, J MOL BIOL, V259, P938, DOI 10.1006/jmbi.1996.0371; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Stein K. E., 1992, J INFECT DIS S1, V165, pS49; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Theillet FX, 2009, J MOL BIOL, V388, P839, DOI 10.1016/j.jmb.2009.03.057; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie KF, 2005, ACTA CRYSTALLOGR D, V61, P1386, DOI 10.1107/S0907444905023851; Zhou JH, 2004, INFECT IMMUN, V72, P3505, DOI 10.1128/IAI.72.6.3505-3514.2004	74	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16644	16661		10.1074/jbc.M113.528224	http://dx.doi.org/10.1074/jbc.M113.528224			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24682362	Green Published, hybrid			2022-12-28	WOS:000338016200006
J	Elies, J; Dallas, ML; Boyle, JP; Scragg, JL; Duke, A; Steele, DS; Peers, C				Elies, Jacobo; Dallas, Mark L.; Boyle, John P.; Scragg, Jason L.; Duke, Adrian; Steele, Derek S.; Peers, Chris			Inhibition of the Cardiac Na+ Channel Nav1.5 by Carbon Monoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; SODIUM-CHANNEL; NITRIC-OXIDE; CA2+ CHANNELS; SMOOTH-MUSCLE; QT DISPERSION; EXPRESSION; MICE; CARBOXYHEMOGLOBIN; MODULATION	Sublethal carbon monoxide (CO) exposure is frequently associated with myocardial arrhythmias, and our recent studies have demonstrated that these may be attributable to modulation of cardiac Na+ channels, causing an increase in the late current and an inhibition of the peak current. Using a recombinant expression system, we demonstrate that CO inhibits peak human Nav1.5 current amplitude without activation of the late Na+ current observed in native tissue. Inhibition was associated with a hyperpolarizing shift in the steady-state inactivation properties of the channels and was unaffected by modification of channel gating induced by anemone toxin (rATX-II). Systematic pharmacological assessment indicated that no recognized CO-sensitive intracellular signaling pathways appeared to mediate CO inhibition of Nav1.5. Inhibition was, however, markedly suppressed by inhibition of NO formation, but NO donors did not mimic or occlude channel inhibition by CO, indicating that NO alone did not account for the actions of CO. Exposure of cells to DTT immediately before CO exposure also dramatically reduced the magnitude of current inhibition. Similarly, L-cysteine and N-ethylmaleimide significantly attenuated the inhibition caused by CO. In the presence of DTT and the NO inhibitor N-omega-nitro-L-arginine methyl ester hydrochloride, the ability of CO to inhibit Nav1.5 was almost fully prevented. Our data indicate that inhibition of peak Na+ current (which can lead to Brugada syndrome-like arrhythmias) occurs via a mechanism distinct from induction of the late current, requires NO formation, and is dependent on channel redox state.	[Elies, Jacobo; Dallas, Mark L.; Boyle, John P.; Scragg, Jason L.; Peers, Chris] Univ Leeds, Dept Cardiovasc & Diabet Res, LIGHT, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Duke, Adrian; Steele, Derek S.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Dept Cardiovasc & Diabet Res, LIGHT, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark L/A-6654-2013; Elies, Jacobo/K-7684-2017; Dallas, Mark/Q-6117-2019	Elies, Jacobo/0000-0002-2518-8412; Dallas, Mark/0000-0002-5190-0522; Steele, Derek/0000-0002-1339-784X; Peers, Chris/0000-0002-8354-346X	British Heart Foundation; British Heart Foundation [PG/13/61/30410, RG/11/10/28924, PG/09/013/26885] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	ADAMS KF, 1988, J AM COLL CARDIOL, V12, P900, DOI 10.1016/0735-1097(88)90452-4; Ahmmed GU, 2001, CIRC RES, V89, P1005, DOI 10.1161/hh2301.100801; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Bhatia A, 2012, CURR PROB CARDIOLOGY, V37, P317, DOI 10.1016/j.cpcardiol.2012.03.004; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Carnevali R, 1987, Minerva Med, V78, P175; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; COSBY RS, 1963, AM J CARDIOL, V11, P93, DOI 10.1016/0002-9149(63)90039-0; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dallas ML, 2012, AM J RESP CRIT CARE, V186, P648, DOI 10.1164/rccm.201204-0688OC; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878; Harper A, 2004, AGE AGEING, V33, P105, DOI 10.1093/ageing/afh038; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Henry TD, 2008, CIRCULATION, V118, P792, DOI 10.1161/CIRCULATIONAHA.107.750778; Hettiarachchi NT, 2012, ANTIOXID REDOX SIGN, V17, P744, DOI 10.1089/ars.2011.4398; KATZMAN GM, 1993, TOXICOL LETT, V69, P139, DOI 10.1016/0378-4274(93)90099-J; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kurata Y, 1998, LIFE SCI, V63, P1023, DOI 10.1016/S0024-3205(98)00364-6; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Luo AT, 2007, CELL PHYSIOL BIOCHEM, V19, P9, DOI 10.1159/000099188; Macmillan CSA, 2001, ACTA ANAESTH SCAND, V45, P396, DOI 10.1034/j.1399-6576.2001.045003396.x; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; MEREDITH T, 1988, BMJ-BRIT MED J, V296, P77, DOI 10.1136/bmj.296.6615.77; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; ROMEY G, 1976, P NATL ACAD SCI USA, V73, P4055, DOI 10.1073/pnas.73.11.4055; Ryter Stefan W, 2004, Sci STKE, V2004, pRE6, DOI 10.1126/stke.2302004re6; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sari I, 2008, INHAL TOXICOL, V20, P879, DOI [10.1080/08958370801958622, 10.1080/08958370801958622 ]; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; SHEPS DS, 1990, ANN INTERN MED, V113, P343, DOI 10.7326/0003-4819-113-5-343; Strege PR, 2011, AM J PHYSIOL-GASTR L, V300, pG1105, DOI 10.1152/ajpgi.00556.2010; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Von Burg R, 1999, J APPL TOXICOL, V19, P379; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yatsuhashi T, 2002, CIRC J, V66, P846, DOI 10.1253/circj.66.846; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4	51	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16421	16429		10.1074/jbc.M114.569996	http://dx.doi.org/10.1074/jbc.M114.569996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719320	Green Published, hybrid			2022-12-28	WOS:000337965700044
J	Akiyama, T; Miyamoto, Y; Yoshimura, K; Yamada, A; Takami, M; Suzawa, T; Hoshino, M; Imamura, T; Akiyama, C; Yasuhara, R; Mishima, K; Maruyama, T; Kohda, C; Tanaka, K; Potempa, J; Yasuda, H; Baba, K; Kamijo, R				Akiyama, Tomohito; Miyamoto, Yoichi; Yoshimura, Kentaro; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Hoshino, Marie; Imamura, Takahisa; Akiyama, Chie; Yasuhara, Rika; Mishima, Kenji; Maruyama, Toshifumi; Kohda, Chikara; Tanaka, Kazuo; Potempa, Jan; Yasuda, Hisataka; Baba, Kazuyoshi; Kamijo, Ryutaro			Porphyromonas gingivalis-derived Lysine Gingipain Enhances Osteoclast Differentiation Induced by Tumor Necrosis Factor-alpha and Interleukin-1 beta but Suppresses That by Interleukin-17A IMPORTANCE OF PROTEOLYTIC DEGRADATION OF OSTEOPROTEGERIN BY LYSINE GINGIPAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cytokine; Inflammation; Osteoclast; Proteolytic Enzyme; Gingipain; Osteoprotegerin	ARGININE-SPECIFIC PROTEINASES; ALVEOLAR BONE LOSS; CYSTEINE PROTEINASES; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; INHIBITORY FACTOR; VITAMIN-D; LIGAND; EXPRESSION; CYTOKINE	Periodontitis is a chronic inflammatory disease accompanied by alveolar bone resorption by osteoclasts. Porphyromonas gingivalis, an etiological agent for periodontitis, produces cysteine proteases called gingipains, which are classified based on their cleavage site specificity (i.e. arginine (Rgps) and lysine (Kgps) gingipains). We previously reported that Kgp degraded osteoprotegerin (OPG), an osteoclastogenesis inhibitory factor secreted by osteoblasts, and enhanced osteoclastogenesis induced by various Toll-like receptor (TLR) ligands (Yasuhara, R., Miyamoto, Y., Takami, M., Imamura, T., Potempa, J., Yoshimura, K., and Kamijo, R. (2009) Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D-3-induced osteoclast differentiation by degrading osteoprotegerin. Biochem. J. 419, 159-166). Osteoclastogenesis is induced not only by TLR ligands but also by proinflammatory cytokines, including tumor necrosis factor- (TNF-), interleukin (IL)-1, and IL-17A, in inflammatory conditions, such as periodontitis. Although Kgp augmented osteoclastogenesis induced by TNF- and IL-1 in co-cultures of mouse osteoblasts and bone marrow cells, it suppressed that induced by IL-17A. In a comparison of proteolytic degradation of these cytokines by Kgp in a cell-free system with that of OPG, TNF- and IL-1 were less susceptible, whereas IL-17A and OPG were equally susceptible to degradation by Kgp. These results indicate that the enhancing effect of Kgp on cytokine-induced osteoclastogenesis is dependent on the difference in degradation efficiency between each cytokine and OPG. In addition, elucidation of the N-terminal amino acid sequences of OPG fragments revealed that Kgp primarily cleaved OPG in its death domain homologous region, which might prevent dimer formation of OPG required for inhibition of receptor activator of nuclear factor B ligand. Collectively, our results suggest that degradation of OPG by Kgp is a crucial event in the development of osteoclastogenesis and bone loss in periodontitis.	[Akiyama, Tomohito; Miyamoto, Yoichi; Yoshimura, Kentaro; Yamada, Atsushi; Takami, Masamichi; Suzawa, Tetsuo; Hoshino, Marie; Maruyama, Toshifumi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan; [Hoshino, Marie; Maruyama, Toshifumi; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo 1428555, Japan; [Imamura, Takahisa; Mishima, Kenji] Showa Univ, Sch Dent, Div Pathol, Dept Oral Diagnost Sci, Tokyo 1428555, Japan; [Akiyama, Chie; Yasuhara, Rika] Kumamoto Univ, Fac Iife Sci, Dept Mol Pathol, Kumamoto 8608556, Japan; [Kohda, Chikara; Tanaka, Kazuo] Showa Univ, Sch Med, Dept Microbiol, Tokyo 1428555, Japan; [Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & System Dis Grp, Louisville, KY 40202 USA; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Tokyo 1748505, Japan	Showa University; Showa University; Showa University; Kumamoto University; Showa University; Jagiellonian University; University of Louisville; Oriental Yeast Co., Ltd.	Miyamoto, Y (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	yoichim@dent.showa-u.ac.jp	Potempa, Jan/AAA-6850-2021; Baba, Kazuyoshi/AAY-2304-2021	Baba, Kazuyoshi/0000-0001-8025-2168; Takami, Masamichi/0000-0002-4506-3975; Potempa, Jan/0000-0002-3600-7461; Yasuhara, Rika/0000-0003-2282-6295	National Institutes of Health, NIDCR [DE22597]; Japan Society for the Promotion of Sciences; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23591876, 24592813] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health, NIDCR, Grant DE22597 (to J. P.). This work was also supported in part by the Japan Society for the Promotion of Sciences and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075; BROMER WW, 1967, BIOCHEMISTRY-US, V6, P2378, DOI 10.1021/bi00860a013; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Fitzpatrick RE, 2009, J PERIODONTAL RES, V44, P565, DOI 10.1111/j.1600-0765.2008.01151.x; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Graves DT, 2001, J DENT RES, V80, P1875, DOI 10.1177/00220345010800100301; Gron H, 1997, J PERIODONTAL RES, V32, P61, DOI 10.1111/j.1600-0765.1997.tb01383.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hans Mayank, 2011, J Oral Sci, V53, P263; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hernandez M, 2011, J DENT RES, V90, P1164, DOI 10.1177/0022034511401405; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Kontani M, 1997, MOL MICROBIOL, V24, P1179, DOI 10.1046/j.1365-2958.1997.4321788.x; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Liu XH, 2006, ANN NY ACAD SCI, V1068, P225, DOI 10.1196/annals.1346.047; Miyachi K, 2007, J DENT RES, V86, P446, DOI 10.1177/154405910708600511; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Rajapakse PS, 2002, INFECT IMMUN, V70, P2480, DOI 10.1128/IAI.70.5.2480-2486.2002; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yasuhara R, 2011, J ORAL BIOSCI, V53, P197, DOI 10.2330/joralbiosci.53.197; Yasuhara R, 2009, BIOCHEM J, V419, P159, DOI 10.1042/BJ20081469; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	44	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15621	15630		10.1074/jbc.M113.520510	http://dx.doi.org/10.1074/jbc.M113.520510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24755218	Green Published, hybrid			2022-12-28	WOS:000337465400044
J	Rowley, SM; Kuriakose, T; Dockery, LM; Tran-Ngyuen, T; Gingerich, AD; Wei, L; Watford, WT				Rowley, Sean M.; Kuriakose, Teneema; Dockery, Lee M.; Thi Tran-Ngyuen; Gingerich, Aaron D.; Wei, Lai; Watford, Wendy T.			Tumor Progression Locus 2 (Tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration during Acute Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Chemokines; Inflammation; Lipopolysaccharide (LPS); Macrophages	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SIGNAL-REGULATED KINASE; NF-KAPPA-B; MICE LACKING; HOST-DEFENSE; MOUSE MODEL; T-CELLS; IN-VIVO; BACTERIAL LIPOPOLYSACCHARIDE; ACTIVATED MACROPHAGES	In autoimmune diseases, the accumulation of activated leukocytes correlates with inflammation and disease progression, and, therefore, the disruption of leukocyte trafficking is an active area of research. The serine/threonine protein kinase Tpl2 (MAP3K8) regulates leukocyte inflammatory responses and is also being investigated for therapeutic inhibition during autoimmunity. Here we addressed the contribution of Tpl2 to the regulation of macrophage chemokine receptor expression and migration in vivo using a mouse model of Tpl2 ablation. LPS stimulation of bone marrow-derived macrophages induced early CCR1 chemokine receptor expression but repressed CCR2 and CCR5 expression. Notably, early induction of CCR1 expression by LPS was dependent upon a signaling pathway involving Tpl2, PI3K, and ERK. On the contrary, Tpl2 was required to maintain the basal expression of CCR2 and CCR5 as well as to stabilize CCR5 mRNA expression. Consistent with impairments in chemokine receptor expression, tpl2(-/-) macrophages were defective in trafficking to the peritoneal cavity following thioglycollate-induced inflammation. Overall, this study demonstrates a Tpl2-dependent mechanism for macrophage expression of select chemokine receptors and provides further insight into how Tpl2 inhibition may be used therapeutically to disrupt inflammatory networks in vivo.	[Rowley, Sean M.; Kuriakose, Teneema; Dockery, Lee M.; Thi Tran-Ngyuen; Gingerich, Aaron D.; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China	University System of Georgia; University of Georgia; Sun Yat Sen University	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, Coll Vet Med, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu		Watford, Wendy/0000-0003-4261-5399; Kuriakose, Teneema/0000-0003-4032-1290	Office of the Vice President for Research, University of Georgia	Office of the Vice President for Research, University of Georgia	This work was supported by a startup fund from the Office of the Vice President for Research, University of Georgia (to W.T.W.).	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Clark RA, 2006, J CLIN INVEST, V116, P2084, DOI 10.1172/JCI29441; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; Dairaghi DJ, 2011, CLIN PHARMACOL THER, V89, P726, DOI 10.1038/clpt.2011.33; Dairaghi DJ, 2012, BLOOD, V120, P1449, DOI 10.1182/blood-2011-10-384784; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Foti M, 1999, INT IMMUNOL, V11, P979, DOI 10.1093/intimm/11.6.979; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Khan IA, 2001, J IMMUNOL, V166, P1930, DOI 10.4049/jimmunol.166.3.1930; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lopez-Pelaez M, 2012, MOL BIOL CELL, V23, P2982, DOI 10.1091/mbc.E12-02-0135; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Raborn ES, 2008, J NEUROIMMUNE PHARM, V3, P117, DOI 10.1007/s11481-007-9077-z; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Rodriguez-Sosa M, 2003, IMMUNOL CELL BIOL, V81, P114, DOI 10.1046/j.0818-9641.2002.01132.x; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Soria-Castro I, 2010, J BIOL CHEM, V285, P33805, DOI 10.1074/jbc.M110.169409; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Verani A, 1997, J EXP MED, V185, P805, DOI 10.1084/jem.185.5.805; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou YH, 1998, J IMMUNOL, V160, P4018	63	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15788	15797		10.1074/jbc.M114.559344	http://dx.doi.org/10.1074/jbc.M114.559344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24713702	Green Published, hybrid			2022-12-28	WOS:000337465400058
J	Dixit, G; Baker, R; Sacks, CM; Torres, MP; Dohlman, HG				Dixit, Gauri; Baker, Rachael; Sacks, Carly M.; Torres, Matthew P.; Dohlman, Henrik G.			Guanine Nucleotide-binding Protein (G alpha) Endocytosis by a Cascade of Ubiquitin Binding Domain Proteins Is Required for Sustained Morphogenesis and Proper Mating in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; CELL-SURFACE RECEPTORS; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; PLASMA-MEMBRANE; HELICAL DOMAIN; K-RAS; SUBUNIT; REGULATORS; LIGASE	Heterotrimeric G proteins are well known to transmit signals from cell surface receptors to intracellular effector proteins. There is growing appreciation that G proteins are also present at endomembrane compartments, where they can potentially interact with a distinct set of signaling proteins. Here, we examine the cellular trafficking function of the G protein alpha subunit in yeast, Gpa1. Gpa1 contains a unique 109-amino acid insert within the alpha-helical domain that undergoes a variety of post-translational modifications. Among these is monoubiquitination, catalyzed by the NEDD4 family ubiquitin ligase Rsp5. Using a newly optimized method for G protein purification together with biophysical measures of structure and function, we show that the ubiquitination domain does not influence enzyme activity. By screening a panel of 39 gene deletion mutants, each lacking a different ubiquitin binding domain protein, we identify seven that are necessary to deliver Gpa1 to the vacuole compartment including four proteins (Ede1, Bul1, Ddi1, and Rup1) previously not known to be involved in this process. Finally, we show that proper endocytosis of the G protein is needed for sustained cellular morphogenesis and mating in response to pheromone stimulation. We conclude that a cascade of ubiquitin-binding proteins serves to deliver the G protein to its final destination within the cell. In this instance and in contrast to the previously characterized visual system, endocytosis from the plasma membrane is needed for proper signal transduction rather than for signal desensitization.	[Dixit, Gauri; Baker, Rachael; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sacks, Carly M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Torres, Matthew P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Torres, Matthew/0000-0001-7296-4536; Shanks, Carly/0000-0001-6229-6845; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [GM101560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101560 (to H. G. D.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Brachmann CB, 1998, YEAST, V14, P115; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Dores MR, 2010, TRAFFIC, V11, P151, DOI 10.1111/j.1600-0854.2009.01003.x; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Gabriely G, 2008, MOL BIOL CELL, V19, P3625, DOI 10.1091/mbc.E07-05-0462; Gagny B, 2000, J CELL SCI, V113, P3309; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Lam MHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075372; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu YL, 1997, MOL MICROBIOL, V23, P777, DOI 10.1046/j.1365-2958.1997.2701631.x; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Pruyne D, 2000, J CELL SCI, V113, P571; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rojas AM, 2012, J CELL BIOL, V196, P545, DOI 10.1083/jcb.2011030081964c; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shaw JD, 2001, EXP CELL RES, V271, P1, DOI 10.1006/excr.2001.5373; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tanaka H, 2010, BIOPHYS J, V99, P1007, DOI 10.1016/j.bpj.2010.04.078; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Wedegaertner Philip B, 2012, Subcell Biochem, V63, P193, DOI 10.1007/978-94-007-4765-4_11; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zhu M, 2011, J BIOL CHEM, V286, P27147, DOI 10.1074/jbc.M111.254193; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	73	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15052	15063		10.1074/jbc.M114.566117	http://dx.doi.org/10.1074/jbc.M114.566117			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24722989	Green Published, hybrid			2022-12-28	WOS:000337248100057
J	Singh, M; Kaur, R; Lee, MJ; Pickering, RT; Sharma, VM; Puri, V; Kandror, KV				Singh, Maneet; Kaur, Rajween; Lee, Mi-Jeong; Pickering, R. Taylor; Sharma, Vishva Mitra; Puri, Vishwajeet; Kandror, Konstantin V.			Fat-specific Protein 27 Inhibits Lipolysis by Facilitating the Inhibitory Effect of Transcription Factor Egr1 on Transcription of Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LIPID DROPLETS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; FSP27; METABOLISM; STORAGE; EXPRESSION; PROMOTES; TISSUE	Lipolysis in fat tissue represents a major source of circulating fatty acids. Previously, we have found that lipolysis in adipocytes is controlled by early growth response transcription factor Egr1 that directly inhibits transcription of adipose triglyceride lipase, ATGL (Chakrabarti, P., Kim, J. Y., Singh, M., Shin, Y. K., Kim, J., Kumbrink, J., Wu, Y., Lee, M. J., Kirsch, K. H., Fried, S. K., and Kandror, K. V. (2013) Mol. Cell. Biol. 33, 3659-3666). Here we demonstrate that knockdown of the lipid droplet protein FSP27 (a.k.a. CIDEC) in human adipocytes increases expression of ATGL at the level of transcription, whereas overexpression of FSP27 has the opposite effect. FSP27 suppresses the activity of the ATGL promoter in vitro, and the proximal Egr1 binding site is responsible for this effect. FSP27 co-immunoprecipitates with Egr1 and increases its association with and inhibition of the ATGL promoter. Knockdown of Egr1 attenuates the inhibitory effect of FSP27. These results provide a new model of transcriptional regulation of ATGL.	[Singh, Maneet; Kaur, Rajween; Lee, Mi-Jeong; Pickering, R. Taylor; Sharma, Vishva Mitra; Puri, Vishwajeet; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Puri, V (corresponding author), Boston Univ, Sect Endocrinol Diabet & Nutr, Dept Med, Sch Med, 650 Albany St, Boston, MA 02118 USA.	vpuri@bu.edu; kkandror@bu.edu	Lee, Mi-Jeong/GXV-9843-2022; Lee, Mi-Jeong/ABE-1084-2020	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Kandror, Konstantin/0000-0002-8601-9313; Pickering, Richard/0000-0002-5243-4068	National Institutes of Health [DK52057, AG039612, R56DK094815, 8KL2TR000158, UL1-TR000157]; American Diabetes Association [7-11-BS-76]; Allen Foundation; Boston Nutrition and Obesity Research Center Pilot Grant [P30DK046200]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157, KL2TR000158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK052057, R56DK094815, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Allen Foundation; Boston Nutrition and Obesity Research Center Pilot Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grants DK52057 and AG039612 from the National Institutes of Health, Grant 7-11-BS-76 from the American Diabetes Association, and a research award from the Allen Foundation (to K. V. K.); National Institutes of Health Grants R56DK094815 and 8KL2TR000158 (from the parent grant UL1-TR000157 to the Clinical and Translational Science Institute, Boston University); and Boston Nutrition and Obesity Research Center Pilot Grant P30DK046200 (to V. P.).	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-446; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oliver P, 2012, INT J OBESITY, V36, P225, DOI 10.1038/ijo.2011.92; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	54	42	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14481	14487		10.1074/jbc.C114.563080	http://dx.doi.org/10.1074/jbc.C114.563080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24742676	Green Published, hybrid			2022-12-28	WOS:000337248100005
J	Sukackaite, R; Jensen, MR; Mas, PJ; Blackledge, M; Buonomo, SB; Hart, DJ				Sukackaite, Rasa; Jensen, Malene Ringkjobing; Mas, Philippe J.; Blackledge, Martin; Buonomo, Sara B.; Hart, Darren J.			Structural and Biophysical Characterization of Murine Rif1 C Terminus Reveals High Specificity for DNA Cruciform Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Directed Evolution; DNA Replication; Intrinsically Disordered Proteins; NMR	SUSCEPTIBILITY PROTEIN BRCA1; AMINO-ACID-SEQUENCE; NUCLEAR-MATRIX; ENERGY CONTENT; END RESECTION; WEB SERVER; REPLICATION; BINDING; REPAIR; REGIONS	Background: Mammalian Rif1 is a regulator of DNA replication timing and repair. Results: We characterized DNA binding by Rif1 C terminus and identified the critical residues. Conclusion: Rif1 shows a highly selective binding of DNA cruciform structures. Significance: This is a step forward in the understanding of Rif1 functions. Mammalian Rif1 is a key regulator of DNA replication timing, double-stranded DNA break repair, and replication fork restart. Dissecting the molecular functions of Rif1 is essential to understand how it regulates such diverse processes. However, Rif1 is a large protein that lacks well defined functional domains and is predicted to be largely intrinsically disordered; these features have hampered recombinant expression of Rif1 and subsequent functional characterization. Here we applied ESPRIT (expression of soluble proteins by random incremental truncation), an in vitro evolution-like approach, to identify high yielding soluble fragments encompassing conserved regions I and II (CRI and CRII) at the C-terminal region of murine Rif1. NMR analysis showed CRI to be intrinsically disordered, whereas CRII is partially folded. CRII binds cruciform DNA with high selectivity and micromolar affinity and thus represents a functional DNA binding domain. Mutational analysis revealed an -helical region of CRII to be important for cruciform DNA binding and identified critical residues. Thus, we present the first structural study of the mammalian Rif1, identifying a domain that directly links its function to DNA binding. The high specificity of Rif1 for cruciform structures is significant given the role of this key protein in regulating origin firing and DNA repair.	[Sukackaite, Rasa; Mas, Philippe J.; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstat, F-38042 Grenoble, France; [Sukackaite, Rasa; Mas, Philippe J.; Hart, Darren J.] Univ Grenoble Alpes, Unit Virus Host Cell Interact, EMBL, CNRS, F-38042 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38027 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] IBS, CEA, DSV, F-38027 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] CNRS, IBS, F-38027 Grenoble, France; [Sukackaite, Rasa; Buonomo, Sara B.] European Mol Biol Lab, Monterotondo Outstat, I-00015 Monterotondo, Italy	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL)	Buonomo, SB (corresponding author), European Mol Biol Lab, Monterotondo Outstat, Adriano Buzzati Traverso Campus,Via Ramarini 32, I-00015 Monterotondo, Italy.	sara.buonomo@embl.it; hart@embl.fr	; Hart, Darren/C-4858-2015	Buonomo, Sara/0000-0002-0177-2884; Hart, Darren/0000-0002-3502-2002; Jensen, Malene R./0000-0003-0419-2196; Mas, Philippe/0000-0002-8060-0289	EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND [229597]; French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder; ANR MALZ TAUSTRUCT; TGIR-RMN-THC [FR3050 CNRS]	EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND; French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder(French National Research Agency (ANR)); ANR MALZ TAUSTRUCT(French National Research Agency (ANR)); TGIR-RMN-THC	This work was supported by an EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND (229597) (to R. S.). This work was also supported by the French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder (to M.R.J.); ANR MALZ TAUSTRUCT (to M. B); and TGIR-RMN-THC FR3050 CNRS. D.J.H. is an inventor on an EMBL patent for the ESPRIT technology used to express Rif1 fragments.	Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Assenberg R, 2008, BIOCHEM J, V411, P553, DOI 10.1042/BJ20071613; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Rivera-Mulia JC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-3; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; Grasser KD, 1998, EUR J BIOCHEM, V253, P787, DOI 10.1046/j.1432-1327.1998.2530787.x; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hart DJ, 2013, CURR OPIN STRUC BIOL, V23, P403, DOI 10.1016/j.sbi.2013.03.004; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Karsten R., 1997, BIF FUTURA, V12, P20; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Naseem R, 2006, BIOCHEM J, V395, P529, DOI 10.1042/BJ20051646; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Sturdy A, 2004, J MOL BIOL, V340, P469, DOI 10.1016/j.jmb.2004.05.005; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	41	24	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13903	13911		10.1074/jbc.M114.557843	http://dx.doi.org/10.1074/jbc.M114.557843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24634216	hybrid, Green Published			2022-12-28	WOS:000335984600022
J	Wakabayashi, H; Monaghan, M; Fay, PJ				Wakabayashi, Hironao; Monaghan, Morgan; Fay, Philip J.			Cofactor Activity in Factor VIIIa of the Blood Clotting Pathway Is Stabilized by an Interdomain Bond between His281 and Ser524 Formed in Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Factor VIII; Mutagenesis; Protein Stability; Protein Structure	THROMBIN-CATALYZED ACTIVATION; A2 DOMAIN INTERFACE; PROTEIN-C; CRYSTAL-STRUCTURE; CHARGED RESIDUES; CA2+ BINDING; FACTOR XASE; SUBUNIT; COAGULATION; GENERATION	Background: Intermediate resolution FVIII x-ray structures show His(281) (A1) and Ser(524) (A2) in close proximity. Ala mutations at these residues show functional defects. Results: Residue swap (H281S/S524H) or disulfide bridge (H281C/S524C) variants possess WT-like stability and function. Conclusion: Side chains of His(281) and Ser(524) form a bond in FVIII that is retained in FVIIIa. Significance: This bond stabilizes the FVIIIa A2 subunit from dissociation. The factor VIII (FVIII) crystal structure suggests a possible bonding interaction of His(281) (A1 domain) with Ser(524) (A2 domain), although the resolution of the structure (approximate to 4 ) does not firmly establish this bonding. To establish that side chains of these residues participate in an interdomain bond, we prepared and examined the functional properties of a residue swap variant (H281S/S524H) where His(281) and Ser(524) residues were exchanged with one another and a disulfide-bridged variant (H281C/S524C) where the two residues were replaced with Cys. The latter variant showed efficient disulfide bonding of the A1 and A2 domains. The swap variant showed WT-like FVIII and FVIIIa stability, which were markedly reduced for H281A and S524A variants in an earlier study. The disulfide-bridged variant showed approximate to 20% increased FVIII stability, and FVIIIa did not decay during the time course measured. This variant also yielded 35% increased thrombin peak values compared with WT in a plasma-based thrombin generation assay. Binding analyses of H281S-A1/A3C1C2 dimer with S524H-A2 subunit yielded a near WT-like affinity value, whereas combining the variant dimer or A2 subunit with the WT complement yielded approximate to 5- and approximate to 10-fold reductions, respectively, in affinity. Other functional properties including thrombin generation potential, FIXa binding affinity, K-m for FX of FXase complexes, thrombin activation efficiency, and down-regulation by activated protein C showed similar results for the two variants compared with WT FVIII. These results indicate that the side chains of His(281) and Ser(524) are in close proximity and contribute to a bonding interaction in FVIII that is retained in FVIIIa.	[Wakabayashi, Hironao; Monaghan, Morgan; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199]; National Institutes of Health Predoctoral Trainee Grant from the Institutional Ruth L. Kirschstein National Research Award [GM068411]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Trainee Grant from the Institutional Ruth L. Kirschstein National Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL38199 (to P. J. F.). This work was also supported by National Institutes of Health Predoctoral Trainee Grant GM068411 from the Institutional Ruth L. Kirschstein National Research Award (to M. M.).	Ansong C, 2006, BIOCHEMISTRY-US, V45, P13140, DOI 10.1021/bi061202w; Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Gale AJ, 2006, J THROMB HAEMOST, V4, P1315, DOI 10.1111/j.1538-7836.2006.01951.x; Griffiths AE, 2013, J BIOL CHEM, V288, P15057, DOI 10.1074/jbc.M113.456467; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Jagannathan I, 2009, J BIOL CHEM, V284, P32248, DOI 10.1074/jbc.M109.050781; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; Machlus KR, 2009, THROMB HAEMOSTASIS, V102, P936, DOI 10.1160/TH09-03-0180; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Radtke KP, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2006.02283.x; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Varfaj F, 2007, J BIOL CHEM, V282, P20264, DOI 10.1074/jbc.M701327200; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2013, BIOCHEMISTRY-US, V52, P3921, DOI 10.1021/bi400295x; Wakabayashi H, 2013, BIOCHEM J, V452, P293, DOI 10.1042/BJ20130025; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109	32	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14020	14029		10.1074/jbc.M114.550566	http://dx.doi.org/10.1074/jbc.M114.550566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692542	Green Published, hybrid			2022-12-28	WOS:000335984600032
J	Walinda, E; Morimoto, D; Sugase, K; Konuma, T; Tochio, H; Shirakawa, M				Walinda, Erik; Morimoto, Daichi; Sugase, Kenji; Konuma, Tsuyoshi; Tochio, Hidehito; Shirakawa, Masahiro			Solution Structure of the Ubiquitin-associated ( UBA) Domain of Human Autophagy Receptor NBR1 and Its Interaction with Ubiquitin and Polyubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Nuclear Magnetic Resonance; Protein Degradation; Protein Structure; Ubiquitin	SELECTIVE AUTOPHAGY; NMR-SPECTROSCOPY; RECOGNITION; P62; BINDING; CHAINS; SOFTWARE; PROTEINS; MICE; DIMERIZATION	Background: The autophagic receptor NBR1 is commonly found in ubiquitin-positive inclusions in neurodegenerative diseases. Results: Molecular recognition of ubiquitin and polyubiquitin by NBR1 is described. Conclusion: The ubiquitin-associated domain of NBR1 shows unexpectedly high affinity for monoubiquitin but lacks polyubiquitin linkage specificity. Significance: NBR1 may be highly efficient at forming intracellular inclusions with ubiquitylated proteins via non-linkage-specific association with ubiquitin. NBR1 (neighbor of BRCA1 gene 1) is a protein commonly found in ubiquitin-positive inclusions in neurodegenerative diseases. Due to its high architectural similarity to the well studied autophagy receptor protein p62/SQSTM1, NBR1 has been thought to analogously bind to ubiquitin-marked autophagic substrates via its C-terminal ubiquitin-associated (UBA) domain and deliver them to autophagosomes for degradation. Unexpectedly, we find that NBR1 differs from p62 in its UBA structure and accordingly in its interaction with ubiquitin. Structural differences are observed on helix -3, which is tilted farther from helix -2 and extended by approximately one turn in NBR1. This results not only in inhibition of a p62-type self-dimerization of NBR1 UBA but also in a significantly higher affinity for monoubiquitin as compared with p62 UBA. Importantly, the NBR1 UBA-ubiquitin complex structure shows that the negative charge of the side chain in front of the conserved MGF motif in the UBA plays an integral role in the recognition of ubiquitin. In addition, NMR and isothermal titration calorimetry experiments show that NBR1 UBA binds to each monomeric unit of polyubiquitin with similar affinity and by the same surface used for binding to monoubiquitin. This indicates that NBR1 lacks polyubiquitin linkage-type specificity, in good agreement with the nonspecific linkages observed in intracellular ubiquitin-positive inclusions. Consequently, our results demonstrate that the structural differences between NBR1 UBA and p62 UBA result in a much higher affinity of NBR1 for ubiquitin, which in turn suggests that NBR1 may form intracellular inclusions with ubiquitylated autophagic substrates more efficiently than p62.	[Walinda, Erik; Morimoto, Daichi; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Sugase, Kenji; Konuma, Tsuyoshi] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan	Kyoto University; Suntory Holdings Ltd	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Sugase, Kenji/S-3132-2016; Tochio, Hidehito/GWV-0429-2022; Sugase, Kenji/AAF-4552-2021	Sugase, Kenji/0000-0001-8623-7743; Tochio, Hidehito/0000-0003-3843-3330; Sugase, Kenji/0000-0001-8623-7743; Konuma, Tsuyoshi/0000-0002-4412-2849; Morimoto, Daichi/0000-0002-7672-2136	Grants-in-Aid for Scientific Research [11J06373] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hubbard S. J., 1993, NACCESS; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Kobayashi N, 2012, J BIOMOL NMR, V53, P311, DOI 10.1007/s10858-012-9641-6; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Press W H, 2007, NUMERICAL RECIPES AR, P807; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sugase K, 2013, J BIOMOL NMR, V56, P275, DOI 10.1007/s10858-013-9747-5; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	43	44	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13890	13902		10.1074/jbc.M114.555441	http://dx.doi.org/10.1074/jbc.M114.555441			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692539	Green Published, hybrid			2022-12-28	WOS:000335984600021
J	Calinescu, O; Paulino, C; Kuhlbrandt, W; Fendler, K				Calinescu, Octavian; Paulino, Cristina; Kuehlbrandt, Werner; Fendler, Klaus			Keeping It Simple, Transport Mechanism and pH Regulation in Na (+)/H (+) Exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Electrophysiology; Membrane Transport; pH Regulation; Sodium Proton Exchange; EcNhaA; MjNhaP1; Cation Proton Antiporter; Solid Supported Membrane	NA+/H+ ANTIPORTER; METHANOCOCCUS-JANNASCHII; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; MEMBRANE; RESIDUES; BINDING; MODELS; NHAA; NHE1	Background: Na+/H+ exchangers have a pronounced pH dependence previously explained by pH sensors. Results: Electrophysiological investigation of NhaP1 from Methanocaldococcus jannaschii (MjNhaP1), a prototype of electroneutral Na+/H+ exchangers, allowed its kinetic characterization. Conclusion: The pH dependence of Na+/H+ exchangers is an inherent property of their transport mechanism. Significance: The proposed mechanism of transport and pH regulation applies to all Na+/H+ exchangers. Na+/H+ exchangers are essential for regulation of intracellular proton and sodium concentrations in all living organisms. We examined and experimentally verified a kinetic model for Na+/H+ exchangers, where a single binding site is alternatively occupied by Na+ or one or two H+ ions. The proposed transport mechanism inherently down-regulates Na+/H+ exchangers at extreme pH, preventing excessive cytoplasmic acidification or alkalinization. As an experimental test system we present the first electrophysiological investigation of an electroneutral Na+/H+ exchanger, NhaP1 from Methanocaldococcus jannaschii (MjNhaP1), a close homologue of the medically important eukaryotic NHE Na+/H+ exchangers. The kinetic model describes the experimentally observed substrate dependences of MjNhaP1, and the transport mechanism explains alkaline down-regulation of MjNhaP1. Because this model also accounts for acidic down-regulation of the electrogenic NhaA Na+/H+ exchanger from Escherichia coli (EcNhaA, shown in a previous publication) we conclude that it applies generally to all Na+/H+ exchangers, electrogenic as well as electroneutral, and elegantly explains their pH regulation. Furthermore, the electrophysiological analysis allows insight into the electrostatic structure of the translocation complex in electroneutral and electrogenic Na+/H+ exchangers.	[Calinescu, Octavian; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Paulino, Cristina; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society; Max Planck Society	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Max von Laue Str 3, D-60438 Frankfurt, Germany.	klaus.fendler@biophys.mpg.de	Paulino, Cristina/ABB-7205-2021; Paulino, Cristina/A-2192-2016; Calinescu, Octavian/P-4278-2014	Paulino, Cristina/0000-0001-7017-109X; Paulino, Cristina/0000-0001-7017-109X; Calinescu, Octavian/0000-0001-8003-0442; Kuhlbrandt, Werner/0000-0002-2013-4810; Fendler, Klaus/0000-0002-5699-7060	Deutsche Forschungsgemeinschaft [SFB 807]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 807.	Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; Hellmer J, 2003, FEBS LETT, V542, P32, DOI 10.1016/S0014-5793(03)00332-6; Hellmer J, 2002, FEBS LETT, V527, P245, DOI 10.1016/S0014-5793(02)03244-1; Hisamitsu T, 2007, FEBS J, V274, P4326, DOI 10.1111/j.1742-4658.2007.05962.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Klingenberg M, 2005, BIOCHEMISTRY-US, V44, P8563, DOI 10.1021/bi050543r; KLINGENBERG M, 1992, STUDY ENZYMES, P367; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; STEIN WD, 1977, MOL CELL BIOCHEM, V15, P27, DOI 10.1007/BF01731287; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200	23	29	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13168	13176		10.1074/jbc.M113.542993	http://dx.doi.org/10.1074/jbc.M113.542993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24644283	hybrid, Green Published			2022-12-28	WOS:000335522800018
J	Haraguchi, T; Tominaga, M; Matsumoto, R; Sato, K; Nakano, A; Yamamoto, K; Ito, K				Haraguchi, Takeshi; Tominaga, Motoki; Matsumoto, Rie; Sato, Kei; Nakano, Akihiko; Yamamoto, Keiichi; Ito, Kohji			Molecular Characterization and Subcellular Localization of Arabidopsis Class VIII Myosin, ATM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; ATPases; Kinetics; Molecular Motors; Myosin	INTRACELLULAR FREE MG2+; DUTY RATIO MOTOR; SMOOTH-MUSCLE; KINETIC MECHANISM; FLUORESCENT INDICATOR; PLANT MYOSIN; 2ND-MESSENGER ROLE; ADP DISSOCIATION; SKELETAL-MUSCLE; ATP HYDROLYSIS	Background: Molecular properties of class VIII myosin are not characterized. Results:Arabidopsis class VIII myosin, ATM1, has low enzymatic activity and high affinity for actin and is primarily localized at the cell cortex. Conclusion: Our data suggest that ATM1 functions as a tension sensor/generator. Significance: This is the first report of enzymatic and motile properties of class VIII myosin. Land plants possess myosin classes VIII and XI. Although some information is available on the molecular properties of class XI myosins, class VIII myosins are not characterized. Here, we report the first analysis of the enzymatic properties of class VIII myosin. The motor domain of Arabidopsis class VIII myosin, ATM1 (ATM1-MD), and the motor domain plus one IQ motif (ATM1-1IQ) were expressed in a baculovirus system and characterized. ATM1-MD and ATM1-1IQ had low actin-activated Mg2+-ATPase activity (V-max = 4 s(-1)), although their affinities for actin were high (K-actin = 4 m). The actin-sliding velocities of ATM1-MD and ATM1-1IQ were 0.02 and 0.089 m/s, respectively, from which the value for full-length ATM1 is calculated to be approximate to 0.2 m/s. The results of actin co-sedimentation assay showed that the duty ratio of ATM1 was approximate to 90%. ADP dissociation from the actinATM1 complex (acto-ATM1) was extremely slow, which accounts for the low actin-sliding velocity, low actin-activated ATPase activity, and high duty ratio. The rate of ADP dissociation from acto-ATM1 was markedly biphasic with fast and slow phase rates (5.1 and 0.41 s(-1), respectively). Physiological concentrations of free Mg2+ modulated actin-sliding velocity and actin-activated ATPase activity by changing the rate of ADP dissociation from acto-ATM1. GFP-fused full-length ATM1 expressed in Arabidopsis was localized to plasmodesmata, plastids, newly formed cell walls, and actin filaments at the cell cortex. Our results suggest that ATM1 functions as a tension sensor/generator at the cell cortex and other structures in Arabidopsis.	[Haraguchi, Takeshi; Matsumoto, Rie; Yamamoto, Keiichi; Ito, Kohji] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Tominaga, Motoki; Nakano, Akihiko] RIKEN, Ctr Adv Photon, Live Cell Mol Imaging Res Team, Wako, Saitama 3510198, Japan; [Tominaga, Motoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sato, Kei; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Chiba University; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Ito, K (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan.	k-ito@faculty.chiba-u.jp	Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014; Ito, Kohji/K-8441-2017	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Ito, Kohji/0000-0001-9573-432X; Haraguchi, Takeshi/0000-0001-7542-1473	Japan Society for the Promotion of Science KAKENHI [21570159, 20001009, 23770060]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 21570159, 20001009, and 23770060.	ALTURA BM, 1993, EUR J PHARM-MOLEC PH, V246, P299, DOI 10.1016/0922-4106(93)90046-C; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Avisar D, 2008, J VIROL, V82, P2836, DOI 10.1128/JVI.02246-07; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; DAI LJ, 1992, AM J PHYSIOL, V262, pF1100; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Delva P, 2004, J MEMBRANE BIOL, V199, P163, DOI 10.1007/s00232-004-0686-7; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; GOLDSTEIN DA, 1979, BIOPHYS J, V26, P235, DOI 10.1016/S0006-3495(79)85247-9; Golomb L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-3; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hachikubo Y, 2007, PLANT CELL PHYSIOL, V48, P886, DOI 10.1093/pcp/pcm054; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Hashimoto K, 2005, PLANT CELL PHYSIOL, V46, P782, DOI 10.1093/pcp/pci085; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Iotti S, 2008, MAGNESIUM RES, V21, P157, DOI 10.1684/mrh.2008.0142; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; Ito K, 2003, J BIOL CHEM, V278, P31049, DOI 10.1074/jbc.M304138200; Ito K, 2007, J BIOL CHEM, V282, P19534, DOI 10.1074/jbc.M611802200; Ito K, 2009, P NATL ACAD SCI USA, V106, P21585, DOI 10.1073/pnas.0910787106; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, P NATL ACAD SCI USA, V94, P14332, DOI 10.1073/pnas.94.26.14332; Kambara T, 2006, J BIOL CHEM, V281, P37291, DOI 10.1074/jbc.M603823200; KNIGHT AE, 1993, J MOL BIOL, V231, P148, DOI 10.1006/jmbi.1993.1266; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Mitsuda N, 2004, PLANT CELL PHYSIOL, V45, P845, DOI 10.1093/pcp/pch101; MURPHY E, 1989, P NATL ACAD SCI USA, V86, P2981, DOI 10.1073/pnas.86.8.2981; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; OKADA K, 1992, AM J PHYSIOL, V263, pC873, DOI 10.1152/ajpcell.1992.263.4.C873; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; PETERSEN A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P169, DOI 10.1016/0304-4165(90)90112-A; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reichelt S, 1999, PLANT J, V19, P555, DOI 10.1046/j.1365-313X.1999.00553.x; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; RIJKERS GT, 1993, BIOCHEM J, V289, P373, DOI 10.1042/bj2890373; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sattarzadeh A, 2008, CELL MOTIL CYTOSKEL, V65, P457, DOI 10.1002/cm.20271; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SINGH J, 1995, MOL CELL BIOCHEM, V149, P175, DOI 10.1007/BF01076575; Sparkes I, 2011, MOL PLANT, V4, P805, DOI 10.1093/mp/ssr063; Tashiro M, 1997, BIOPHYS J, V73, P3358, DOI 10.1016/S0006-3495(97)78360-7; Thaler M., 1991, THESIS U WURZBURG GE; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Tominaga M, 2013, DEV CELL, V27, P345, DOI 10.1016/j.devcel.2013.10.005; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; WESTERBLAD H, 1992, EXP PHYSIOL, V77, P733, DOI 10.1113/expphysiol.1992.sp003639; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Wojtaszek P, 2005, FUNCT PLANT BIOL, V32, P721, DOI 10.1071/FP05004; YAMAMOTO K, 1994, P JPN ACAD B-PHYS, V70, P175, DOI 10.2183/pjab.70.175; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; YAZAKI Y, 1988, PLANT CELL PHYSIOL, V29, P919; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; YOKOTA E, 1994, PROTOPLASMA, V177, P153, DOI 10.1007/BF01378989; Yoshimura M, 2001, J BIOL CHEM, V276, P39600, DOI 10.1074/jbc.M105080200	92	26	28	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12343	12355		10.1074/jbc.M113.521716	http://dx.doi.org/10.1074/jbc.M113.521716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24637024	Green Published, hybrid			2022-12-28	WOS:000335581400013
J	Hartman, KG; Vitolo, MI; Pierce, AD; Fox, JM; Shapiro, P; Martin, SS; Wilder, PT; Weber, DJ				Hartman, Kira G.; Vitolo, Michele I.; Pierce, Adam D.; Fox, Jennifer M.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.			Complex Formation between S100B Protein and the p90 Ribosomal S6 Kinase ( RSK) in Malignant Melanoma Is Calcium-dependent and Inhibits Extracellular Signalregulated Kinase ( ERK)-mediated Phosphorylation of RSK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Binding Proteins; Cancer; ERK; MAP Kinases (MAPKs); Melanoma; RSK; S100 Proteins	MAGNETIC-RESONANCE-SPECTROSCOPY; GLYCATION END-PRODUCTS; BINDING PROTEIN; WILD-TYPE; P53; S100B(BETA-BETA); ACTIVATION; RECEPTOR; CANCER; FAMILY	Background: S100B is overexpressed in malignant melanoma and contributes to cancer progression. Results: The S100B-RSK complex was found to be Ca2+-dependent, block phosphorylation of RSK at Thr-573, and sequester RSK to the cytosol. Conclusion: The Ca2+-dependent S100B-RSK complex provides a new link between the MAPK and Ca2+ signaling pathways. Significance: S100B inhibitors may restore normal MAPK and Ca2+ signaling in malignant melanoma. S100B is a prognostic marker for malignant melanoma. Increasing S100B levels are predictive of advancing disease stage, increased recurrence, and low overall survival in malignant melanoma patients. Using S100B overexpression and shRNA(S100B) knockdown studies in melanoma cell lines, elevated S100B was found to enhance cell viability and modulate MAPK signaling by binding directly to the p90 ribosomal S6 kinase (RSK). S100B-RSK complex formation was shown to be Ca2+-dependent and to block ERK-dependent phosphorylation of RSK, at Thr-573, in its C-terminal kinase domain. Additionally, the overexpression of S100B sequesters RSK into the cytosol and prevents it from acting on nuclear targets. Thus, elevated S100B contributes to abnormal ERK/RSK signaling and increased cell survival in malignant melanoma.	[Pierce, Adam D.; Wilder, Paul T.; Weber, David J.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Hartman, Kira G.; Fox, Jennifer M.; Martin, Stuart S.; Weber, David J.] Univ Maryland, Program Mol Med, Grad Program Life Sci, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Martin, Stuart S.; Wilder, Paul T.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Pierce, Adam D.; Weber, David J.] Univ Maryland, Ctr Biomol Therapeut, Sch Med, Baltimore, MD 21201 USA; [Shapiro, Paul] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.] Univ Maryland, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Shapiro, Paul; Martin, Stuart S.; Wilder, Paul T.; Weber, David J.] Stewart Greenebaum NCI Canc Ctr, Baltimore, MD 21201 USA; [Fox, Jennifer M.] Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Dept Pediat, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Wilder, PT (corresponding author), Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	pwild001@umaryland.edu; dweber@som.umaryland.edu	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Vitolo, Michele/0000-0001-8055-9645	National Institutes of Health [GM58888, CA107331, CA166576]; NATIONAL CANCER INSTITUTE [K01CA166576, R01CA107331, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This works was supported, in whole or in part, by National Institutes of Health grants GM58888 and CA107331 (to D.J.W.) and CA166576 (to M.I.V.).	AMBURGEY JC, 1995, J BIOMOL NMR, V6, P171, DOI 10.1007/BF00211781; Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Boni R, 1997, J CUTAN PATHOL, V24, P76, DOI 10.1111/j.1600-0560.1997.tb01100.x; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; Chaudhuri D, 1997, BIOCHEMISTRY-US, V36, P9674, DOI 10.1021/bi9704358; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; GAYNOR R, 1981, LANCET, V1, P869; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Hauschild A, 1999, ONCOLOGY-BASEL, V56, P338, DOI 10.1159/000011989; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; HEIZMANN CW, 1986, J CARDIOVASC PHARM, V8, pS7, DOI 10.1097/00005344-198600088-00003; Jung DH, 2010, EUR J PHARMACOL, V641, P7, DOI 10.1016/j.ejphar.2010.04.061; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lin J, 2010, J BIOL CHEM, V285, P27487, DOI 10.1074/jbc.M110.155382; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liriano MA, 2012, J MOL BIOL, V423, P365, DOI 10.1016/j.jmb.2012.07.011; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; NAGASAKA A, 1987, METABOLISM, V36, P388, DOI 10.1016/0026-0495(87)90213-7; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Romeo Y, 2013, ONCOGENE, V32, P2917, DOI 10.1038/onc.2012.312; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tsoporis JN, 2012, J MOL CELL CARDIOL, V52, P464, DOI 10.1016/j.yjmcc.2011.08.015; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xu SQ, 2006, AM J PHYSIOL-CELL PH, V291, pC1336, DOI 10.1152/ajpcell.00552.2005; Yang Jian-Fu, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V29, P301; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052; Zimmer Danna B, 2013, Methods Mol Biol, V963, P303, DOI 10.1007/978-1-62703-230-8_18; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	64	23	23	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12886	12895		10.1074/jbc.M114.561613	http://dx.doi.org/10.1074/jbc.M114.561613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627490	hybrid, Green Published			2022-12-28	WOS:000335581400057
J	Sui, XW; Kiser, PD; Che, T; Carey, PR; Golczak, M; Shi, WX; von Lintig, J; Palczewski, K				Sui, Xuewu; Kiser, Philip D.; Che, Tao; Carey, Paul R.; Golczak, Marcin; Shi, Wuxian; von Lintig, Johannes; Palczewski, Krzysztof			Analysis of Carotenoid Isomerase Activity in a Prototypical Carotenoid Cleavage Enzyme, Apocarotenoid Oxygenase ( ACO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotene; Carotenoid; Enzyme Catalysis; Enzyme Inactivation; Enzyme Mechanisms; Enzyme Structure; Vitamin A	IN-VITRO CHARACTERIZATION; BETA-CAROTENE; RETINOID ISOMERASE; KEY RESIDUES; ALL-TRANS; RESONANCE RAMAN; VISUAL CYCLE; VITAMIN-A; RPE65; ISOMEROHYDROLASE	Background: Isomerase activity for Synechocystis apocarotenoid oxygenase (ACO) has not been verified biochemically. Results: ACO exclusively produces all-trans-retinal from all-trans-apo-8-carotenol and is inhibited by linear polyoxyethylene detergents. Conclusion: ACO cleaves but does not isomerize all-trans-8-apocarotenol. Significance: This study clarifies the activity of and influence of detergent on ACO, a classical non-isomerizing member of the carotenoid cleavage enzyme family. Carotenoid cleavage enzymes (CCEs) constitute a group of evolutionarily related proteins that metabolize a variety of carotenoid and non-carotenoid substrates. Typically, these enzymes utilize a non-heme iron center to oxidatively cleave a carbon-carbon double bond of a carotenoid substrate. Some members also isomerize specific double bonds in their substrates to yield cis-apocarotenoid products. The apocarotenoid oxygenase from Synechocystis has been hypothesized to represent one such member of this latter category of CCEs. Here, we developed a novel expression and purification protocol that enabled production of soluble, native ACO in quantities sufficient for high resolution structural and spectroscopic investigation of its catalytic mechanism. High performance liquid chromatography and Raman spectroscopy revealed that ACO exclusively formed all-trans products. We also found that linear polyoxyethylene detergents previously used for ACO crystallization strongly inhibited the apocarotenoid oxygenase activity of the enzyme. We crystallized the native enzyme in the absence of apocarotenoid substrate and found electron density in the active site that was similar in appearance to the density previously attributed to a di-cis-apocarotenoid intermediate. Our results clearly demonstrated that ACO is in fact a non-isomerizing member of the CCE family. These results indicate that careful selection of detergent is critical for the success of structural studies aimed at elucidating structures of CCE-carotenoid/retinoid complexes.	[Sui, Xuewu; Kiser, Philip D.; Golczak, Marcin; von Lintig, Johannes; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Che, Tao; Carey, Paul R.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Shi, Wuxian] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kiser, PD (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	pdk7@case.edu		von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health from the National Center for Research Resources [GM103403]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020551, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, R01GM054072, P41GM103403, R56GM054072, P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Leslie T. Webster, Jr., and members of the Palczewski laboratory (Case Western Reserve University) for valuable comments on the manuscript. We also thank Dr. Zhaoyang (John) Feng (Case Western Reserve University) for providing equipment used for this study. A portion of this work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which is supported by National Institutes of Health Grant GM103403 from the National Center for Research Resources. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract number DE-AC02-06CH11357. Some data for this study were measured at beamline X29 of the National Synchrotron Light Source.	Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; BRAIMAN M, 1980, BIOCHEMISTRY-US, V19, P5421, DOI 10.1021/bi00564a042; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; CALLENDER R, 1977, ANNU REV BIOPHYS BIO, V6, P33, DOI 10.1146/annurev.bb.06.060177.000341; Chander P, 2012, J BIOL CHEM, V287, P30552, DOI 10.1074/jbc.M112.364596; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Frisch M.J., 2016, GAUSSIAN16 REV B01; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Maeda T, 2011, MOL PHARMACOL, V80, P943, DOI 10.1124/mol.111.074732; Matthews BW, 2009, PROTEIN SCI, V18, P494, DOI 10.1002/pro.61; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAGAO A, 1994, FASEB J, V8, P968, DOI 10.1096/fasebj.8.12.8088462; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; Solomon EI, 2003, P NATL ACAD SCI USA, V100, P3589, DOI 10.1073/pnas.0336792100; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2012, BIOCHEMISTRY-US, V51, P4217, DOI 10.1021/bi300144n; Takahashi Y, 2011, FEBS J, V278, P973, DOI 10.1111/j.1742-4658.2011.08019.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TEETER MM, 1991, ANNU REV BIOPHYS BIO, V20, P577, DOI 10.1146/annurev.bb.20.060191.003045; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Voolstra O, 2010, J BIOL CHEM, V285, P2130, DOI 10.1074/jbc.M109.056101; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	63	26	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12286	12299		10.1074/jbc.M114.552836	http://dx.doi.org/10.1074/jbc.M114.552836			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648526	hybrid, Green Published			2022-12-28	WOS:000335581400009
J	Neuhauser, B; Ludewig, U				Neuhaeuser, Benjamin; Ludewig, Uwe			Uncoupling of Ionic Currents from Substrate Transport in the Plant Ammonium Transporter AtAMT1; 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ammonia; Electrophysiology; Membrane Transport; Plant; Proton Transport	ESCHERICHIA-COLI; CHANNEL AMTB; DEPROTONATION MECHANISM; CRYSTAL-STRUCTURE; PROTEINS; NH4+; ARRANGEMENT; SELECTIVITY; AFFINITY; BINDING	Background: The substrate transported by AMT/Rh proteins (NH3/NH<sub arrange="stack">4<sup arrange="stack">+/NH<sub arrange="stack">3<sup arrange="stack">+H+) is strongly disputed. Results: In the net NH<sub arrange="stack">4<sup arrange="stack">+ transporter AtAMT1;2 mutations led to a change in coupling of NH3 and H+ transport. Conclusion: AMT/Rh proteins might share a general mechanism of NH3 transport with different H+ coupling ratios. Significance: Different NH3/H+ coupling ratios in AMT/Rh proteins can explain the contrasting results for their transported substrate (NH3/NH<sub arrange="stack">4<sup arrange="stack">+/NH<sub arrange="stack">3<sup arrange="stack">+H+). The ammonium flux across prokaryotic, plant, and animal membranes is regulated by structurally related ammonium transporters (AMT) and/or related Rhesus (Rh) glycoproteins. Several plant AMT homologs, such as AtAMT1;2 from Arabidopsis, elicit ionic, ammonium-dependent currents when expressed in oocytes. By contrast, functional evidence for the transport of NH3 and the lack of coupled ionic currents has been provided for many Rh proteins. Furthermore, despite high resolution structures the transported substrate in many bacterial homologs, such as AmtB from Escherichia coli, is still unclear. In a heterologous genetic screen in yeast, AtAMT1;2 mutants with reduced transport activity were identified based on the resistance of yeast to the toxic transport analog methylamine. When expressed in oocytes, the reduced transport capacity was confirmed for either of the mutants Q67K, M72I,and W145S. Structural alignments suggest that these mutations were dispersed at subunit contact sites of trimeric AMTs, without direct contact to the pore lumen. Surprisingly, and in contrast to the wild type AtAMT1;2 transporter, ionic currents were not associated with the substrate transport in these mutants. Whether these data suggest that the wild type AtAMT1;2 functions as H+/NH3 co-transporter, as well as how the strict substrate coupling with protons is lost by the mutations, is discussed.	[Neuhaeuser, Benjamin; Ludewig, Uwe] Univ Hohenheim, Inst Crop Sci, D-70593 Stuttgart, Germany	University Hohenheim	Neuhauser, B (corresponding author), Univ Hohenheim, Inst Crop Sci, Fruwirthstr 20, D-70593 Stuttgart, Germany.	benjamin.neuhaeuser@uni-hohenheim.de		Neuhauser, Benjamin/0000-0002-2391-0598	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially supported by grants from the Deutsche Forschungsgemeinschaft.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Besserer A, 2012, PLANT CELL, V24, P3463, DOI 10.1105/tpc.112.101758; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Furuichi T, 2010, PLANT J, V64, P47, DOI 10.1111/j.1365-313X.2010.04309.x; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Hall JA, 2013, J BIOL CHEM, V288, P14080, DOI 10.1074/jbc.M113.457952; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Loque D, 2004, J EXP BOT, V55, P1293, DOI 10.1093/jxb/erh147; Loque D, 2009, J BIOL CHEM, V284, P24988, DOI 10.1074/jbc.M109.020842; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Martinez-Torres A, 2001, P NATL ACAD SCI USA, V98, P1947, DOI 10.1073/pnas.031584898; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Ortiz-Ramirez C, 2011, J BIOL CHEM, V286, P31113, DOI 10.1074/jbc.M111.261693; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	34	22	25	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11650	11655		10.1074/jbc.C114.552802	http://dx.doi.org/10.1074/jbc.C114.552802			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634212	Green Published, hybrid			2022-12-28	WOS:000335010600008
J	Yamashiro, S; Gokhin, DS; Sui, ZH; Bergeron, SE; Rubenstein, PA; Fowler, VM				Yamashiro, Sawako; Gokhin, David S.; Sui, Zhenhua; Bergeron, Sarah E.; Rubenstein, Peter A.; Fowler, Velia M.			Differential Actin-regulatory Activities of Tropomodulin1 and Tropomodulin3 with Diverse Tropomyosin and Actin Isoforms*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Protein Chemistry; Protein-Protein Interactions; Tropomyosin; Actin Capping; Actin-binding Proteins; Tropomodulin	SKELETAL-MUSCLE FIBERS; ALPHA-TROPOMYOSIN; TROPOMODULIN/TROPOMYOSIN INTERACTIONS; BINDING-PROPERTIES; CAPPING PROTEIN; COILED-COIL; YEAST ACTIN; GENE FAMILY; N-TERMINUS; END	Background: Tropomodulins (Tmods) cap pointed ends of actin filaments in a tropomyosin (TM)-dependent manner. Results: Tmod1 and Tmod3 similarly cap actin filaments with diverse TM and actin isoforms, but only Tmod3 sequesters - and (cyto)-actin monomers. Conclusion: Isoform-specific actin monomer sequestration by Tmod3 may provide a mechanism for actin remodeling in TM-deficient regions of cells. Significance: Defining the actin-regulatory activities of Tmods illuminates cytoskeletal dynamics. Tropomodulins (Tmods) are F-actin pointed end capping proteins that interact with tropomyosins (TMs) and cap TM-coated filaments with higher affinity than TM-free filaments. Here, we tested whether differences in recognition of TM or actin isoforms by Tmod1 and Tmod3 contribute to the distinct cellular functions of these Tmods. We found that Tmod3 bound approximate to 5-fold more weakly than Tmod1 to /TM, TM5b, and TM5NM1. However, surprisingly, Tmod3 was as effective as Tmod1 at capping pointed ends of skeletal muscle -actin ((sk)-actin) filaments coated with /TM, TM5b, or TM5NM1. Tmod3 only capped TM-coated (sk)-actin filaments more weakly than Tmod1 in the presence of recombinant TM2, which is unacetylated at its NH2 terminus, binds F-actin weakly, and has a disabled Tmod-binding site. Moreover, both Tmod1 and Tmod3 were similarly effective at capping pointed ends of platelet /cytoplasmic ((cyto))-actin filaments coated with TM5NM1. In the absence of TMs, both Tmod1 and Tmod3 had similarly weak abilities to nucleate /(cyto)-actin filament assembly, but only Tmod3 could sequester cytoplasmic - and (cyto)-actin (but not (sk)-actin) monomers and prevent polymerization under physiological conditions. Thus, differences in TM binding by Tmod1 and Tmod3 do not appear to regulate the abilities of these Tmods to cap TM-(sk)-actin or TM-/(cyto)-actin pointed ends and, thus, are unlikely to determine selective co-assembly of Tmod, TM, and actin isoforms in different cell types and cytoskeletal structures. The ability of Tmod3 to sequester - and (cyto)-actin (but not (sk)-actin) monomers in the absence of TMs suggests a novel function for Tmod3 in regulating actin remodeling or turnover in cells.	[Yamashiro, Sawako; Gokhin, David S.; Sui, Zhenhua; Fowler, Velia M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Yamashiro, Sawako] Tohoku Univ, Lab Single Mol Cell Biol, Sendai, Miyagi 9808578, Japan; [Bergeron, Sarah E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Scripps Research Institute; Tohoku University; University of Iowa	Fowler, VM (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd,CB163, La Jolla, CA 92037 USA.	velia@scripps.edu		Yamashiro, Sawako/0000-0002-5980-0470; Rubenstein, Peter/0000-0003-1225-4414; Fowler, Velia/0000-0002-3161-8802	National Institutes of Health [R01-HL083464, R01-DC008803]; Muscular Dystrophy Association; Japan Society for the Promotion of Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL083464 (to V. M. F.) and R01-DC008803 (to P. A. R.). This work was also supported by a development grant from the Muscular Dystrophy Association (to D. S. G.) and grants-in-aid for young scientists and for scientific research on innovative areas from the Japan Society for the Promotion of Science (to S. Y.).	Almenar-Queralt A, 1999, J CELL SCI, V112, P1111; BABCOCK GG, 1994, J BIOL CHEM, V269, P27510; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Bunnell TM, 2011, CRIT REV EUKAR GENE, V21, P255, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.30; CARLIER MF, 1994, ADV EXP MED BIOL, V358, P71; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; FOWLER VM, 1985, J CELL BIOL, V100, P47, DOI 10.1083/jcb.100.1.47; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Ilkovski B, 2008, J NEUROPATH EXP NEUR, V67, P867, DOI 10.1097/NEN.0b013e318183a44f; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2008, ADV EXP MED BIOL, V644, P283; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON H, 1988, BIOCHIM BIOPHYS ACTA, V953, P95, DOI 10.1016/0167-4838(88)90013-1; Maytum R, 2004, J BIOL CHEM, V279, P18203, DOI 10.1074/jbc.M311636200; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Moroz NA, 2013, J BIOL CHEM, V288, P4899, DOI 10.1074/jbc.M112.434522; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Ochala J, 2014, FASEB J, V28, P408, DOI 10.1096/fj.13-239640; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; PINDER JC, 1983, J CELL BIOL, V96, P768, DOI 10.1083/jcb.96.3.768; PINDER JC, 1978, J SUPRAMOL STR CELL, V8, P439, DOI 10.1002/jss.400080406; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Prins KW, 2011, J CELL SCI, V124, P951, DOI 10.1242/jcs.079848; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sung LA, 2000, BLOOD, V95, P1473, DOI 10.1182/blood.V95.4.1473.004k50_1473_1480; TemmGrove CJ, 1996, CELL MOTIL CYTOSKEL, V33, P223, DOI 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Tzima E, 2000, EUR J BIOCHEM, V267, P4720, DOI 10.1046/j.1432-1327.2000.01525.x; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; URSITTI JA, 1994, J CELL SCI, V107, P1633; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Vera C, 2000, ARCH BIOCHEM BIOPHYS, V378, P16, DOI 10.1006/abbi.2000.1802; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; YANG YZ, 1979, J BIOL CHEM, V254, P7137; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005	77	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11616	11629		10.1074/jbc.M114.555128	http://dx.doi.org/10.1074/jbc.M114.555128			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24644292	hybrid, Green Published			2022-12-28	WOS:000335010600005
J	Azami, Y; Hattori, A; Nishimura, H; Kawaide, H; Yoshimura, T; Hemmi, H				Azami, Yasuhiro; Hattori, Ai; Nishimura, Hiroto; Kawaide, Hiroshi; Yoshimura, Tohru; Hemmi, Hisashi			(R)-Mevalonate 3-Phosphate Is an Intermediate of the Mevalonate Pathway in Thermoplasma acidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL PHOSPHATE KINASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; DIPHOSPHATE DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; IDENTIFICATION; JANNASCHII; SYNTHASE; CLONING	The lack of a few conserved enzymes in the classical mevalonate pathway and the widespread existence of isopentenyl phosphate kinase suggest the presence of a partly modified mevalonate pathway in most archaea and in some bacteria. In the pathway, (R)-mevalonate 5-phosphate is thought to be metabolized to isopentenyl diphosphate via isopentenyl phosphate. The long anticipated enzyme that catalyzes the reaction from (R)-mevalonate 5-phosphate to isopentenyl phosphate was recently identified in a Cloroflexi bacterium, Roseiflexus casten-holzii, and in a halophilic archaeon, Haloferax volcanii. However, our trial to convert the intermediates of the classical and modified mevalonate pathways into isopentenyl diphosphate using cell-free extract from a thermophilic archaeon Thermoplasma acidophilum implied that the branch point intermediate of these known pathways, i.e. (R)-mevalonate 5-phosphate, is unlikely to be the precursor of isoprenoid. Through the process of characterizing the recombinant homologs of mevalonate pathway-related enzymes from the archaeon, a distant homolog of diphosphomevalonate decarboxylase was found to catalyze the phosphorylation of (R)-mevalonate to yield (R)-mevalonate 3-phosphate. The product could be converted into isopentenyl phosphate, probably through (R)-mevalonate 3,5-bisphosphate, by the action of unidentified T. acidophilum enzymes fractionated by anion-exchange chromatography. These findings demonstrate the presence of a third alternative "Thermoplasmatype" mevalonate pathway, which involves (R)-mevalonate 3-phosphotransferase and probably both (R)-mevalonate 3-phosphate 5-phosphotransferase and (R)-mevalonate 3,5-bisphosphate decarboxylase, in addition to isopentenyl phosphate kinase.	[Azami, Yasuhiro; Hattori, Ai; Nishimura, Hiroto; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagricultural Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Nagoya University; Tokyo University of Agriculture & Technology	Hemmi, H (corresponding author), Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagricultural Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Kawaide, Hiroshi/F-9243-2013; Hemmi, Hisashi/I-6868-2014	Kawaide, Hiroshi/0000-0001-6693-1332; Hemmi, Hisashi/0000-0002-9538-809X	Japan Society for the Promotion of Science KAKENHI [23580111, 23108531, 25108712]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23580111, 23108531, and 25108712 (to H. H.).	Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Chen M, 2010, BIOCHEMISTRY-US, V49, P207, DOI 10.1021/bi9017957; Delcourt M., 2013, International Patent Application, Patent No. [PCT/EP2013/057108, 2013057108]; Dellas N, 2013, ELIFE, V2, DOI 10.7554/eLife.00672; Dellas N, 2010, ACS CHEM BIOL, V5, P589, DOI 10.1021/cb1000313; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; Hemmi H, 2004, J BIOL CHEM, V279, P50197, DOI 10.1074/jbc.M409207200; Huang KX, 1999, PROTEIN EXPRES PURIF, V17, P33, DOI 10.1006/prep.1999.1106; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Kuzuyama T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P493; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Mabanglo MF, 2010, ACS CHEM BIOL, V5, P517, DOI 10.1021/cb100032g; Matsumi R, 2011, RES MICROBIOL, V162, P39, DOI 10.1016/j.resmic.2010.10.003; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; OHNUMA S, 1994, J BIOL CHEM, V269, P14792; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Sambrook J., 2002, MOL CLONING LAB MANU; Smit A, 2000, GENOME RES, V10, P1468, DOI 10.1101/gr.145600; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13	23	29	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15957	15967		10.1074/jbc.M114.562686	http://dx.doi.org/10.1074/jbc.M114.562686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755225	Green Published, hybrid			2022-12-28	WOS:000337965700007
J	Chowdhury, S; Mukhopadhyay, R; Saha, S; Mishra, A; Sengupta, S; Roy, S; Majumder, HK				Chowdhury, Sayan; Mukhopadhyay, Rupkatha; Saha, Sourav; Mishra, Amartya; Sengupta, Souvik; Roy, Syamal; Majumder, Hemanta K.			Flavone-resistant Leishmania donovani Overexpresses LdMRP2 Transporter in the Parasite and Activates Host MRP2 on Macrophages to Circumvent the Flavone-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; BINDING CASSETTE TRANSPORTER; NF-KAPPA-B; MULTIDRUG-RESISTANCE; ANTIMONY-RESISTANT; NUCLEAR TRANSLOCATION; DNA TOPOISOMERASE; GENE-EXPRESSION; PROTEIN; LOCALIZATION	In parasites, ATP-binding cassette (ABC) transporters represent an important family of proteins related to drug resistance and other biological activities. Resistance of leishmanial parasites to therapeutic drugs continues to escalate in developing countries, and in many instances, it is due to overexpressed ABC efflux pumps. Progressively adapted baicalein (BLN)-resistant parasites (pB(25)R) show overexpression of a novel ABC transporter, which was classified as ABCC2 or Leishmania donovani multidrug resistance protein 2 (LdMRP2). The protein is primarily localized in the flagellar pocket region and in internal vesicles. Overexpressed LdABCC2 confers substantial BLN resistance to the parasites by rapid drug efflux. The BLN-resistant promastigotes when transformed into amastigotes in macrophage cells cannot be cured by treatment of macrophages with BLN. Amastigote resistance is concomitant with the overexpression of macrophage MRP2 transporter. Reporter analysis and site-directed mutagenesis assays demonstrated that antioxidant response element 1 is activated upon infection. The expression of this phase II detoxifying gene is regulated by NFE2-related factor 2 (Nrf2)-mediated antioxidant response element activation. In view of the fact that the signaling pathway of phosphoinositol 3-kinase controls microfilament rearrangement and translocation of actin-associated proteins, the current study correlates with the intricate pathway of phosphoinositol 3-kinase-mediated nuclear translocation of Nrf2, which activates MRP2 expression in macrophages upon infection by the parasites. In contrast, phalloidin, an agent that prevents depolymerization of actin filaments, inhibits Nrf2 translocation and Mrp(2) gene activation by pB(25)R infection. Taken together, these results provide insight into the mechanisms by which resistant clinical isolates of L. donovani induce intracellular events relevant to drug resistance.	[Chowdhury, Sayan; Saha, Sourav; Mishra, Amartya; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata 700032, India; [Mukhopadhyay, Rupkatha; Roy, Syamal] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India; [Sengupta, Souvik] Indian Assoc Cultivat Sci, Dept Phys Chem, Mol Biol Lab, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Majumder, HK (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	hkmajumder@iicb.res.in	Mukhopadhyay, Rupkatha/AAY-4304-2020; Gupta, Souvik Sen/X-9547-2019; Mishra, Amartya/ABG-7216-2021	Gupta, Souvik Sen/0000-0001-7452-979X; Mukhopadhyay, Rupkatha/0000-0002-4120-2966	Department of Biotechnology, Government of India [BT/PR4456/MED/29/355/2012]; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research work was supported by Department of Biotechnology, Government of India Grant BT/PR4456/MED/29/355/2012.; Supported by a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.	Akao T, 2009, BIOL PHARM BULL, V32, P2079, DOI 10.1248/bpb.32.2079; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Beverley SM, 1996, CELL, V87, P787, DOI 10.1016/S0092-8674(00)81984-4; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; BoseDasgupta S, 2008, MOL BIOCHEM PARASIT, V158, P176, DOI 10.1016/j.molbiopara.2007.12.007; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Chowdhury S, 2011, MOL PHARMACOL, V80, P694, DOI 10.1124/mol.111.072785; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Cuvillier A, 2000, J CELL SCI, V113, P2065; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; Dodge MA, 2004, MOL MICROBIOL, V51, P1563, DOI 10.1111/j.1365-2958.2003.03927.x; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gong PF, 2002, ANTIOXID REDOX SIGN, V4, P249, DOI 10.1089/152308602753666307; Grassme HUC, 1996, INFECT IMMUN, V64, P1621; Gueiros FJ, 1995, EXP PARASITOL, V81, P480, DOI 10.1006/expr.1995.1141; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jedlitschky G, 1996, CANCER RES, V56, P988; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kaur J, 2000, BIOCHEM BIOPH RES CO, V271, P615, DOI 10.1006/bbrc.2000.2680; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2011, HUM VACCINES, V7, P1204, DOI 10.4161/hv.7.11.17752; Kobets T, 2012, CURR MED CHEM, V19, P1443, DOI 10.2174/092986712799828300; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Leprohon P, 2009, ANTIMICROB AGENTS CH, V53, P2646, DOI 10.1128/AAC.01474-08; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Marquis JF, 2005, ANTIMICROB AGENTS CH, V49, P1441, DOI 10.1128/AAC.49.4.1441-1446.2005; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; Mittra B, 2000, MOL MED, V6, P527, DOI 10.1007/BF03401792; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Reguera RM, 2008, CURR DRUG TARGETS, V9, P966, DOI 10.2174/138945008786786118; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Stockel B, 2000, EUR J BIOCHEM, V267, P1347, DOI 10.1046/j.1432-1327.2000.01106.x; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Vince JE, 2008, EUKARYOT CELL, V7, P1256, DOI 10.1128/EC.00090-08; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51	64	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16129	16147		10.1074/jbc.M113.539742	http://dx.doi.org/10.1074/jbc.M113.539742			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24706751	Green Published, hybrid			2022-12-28	WOS:000337965700020
J	Dyle, MC; Ebert, SM; Cook, DP; Kunkel, SD; Fox, DK; Bongers, KS; Bullard, SA; Dierdorff, JM; Adams, CM				Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.			Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOMATINE; EXPRESSION SIGNATURES; DEFICIENT MICE; FAT MASS; SARCOPENIA; HYPERTROPHY; ACTIVATION; MANAGEMENT; PROTECTS; TOMATOES	Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.	[Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Bullard, Steven A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Bongers, Kale/0000-0002-9297-9185; Cook, Daniel/0000-0002-1152-4454	University of Iowa Research Foundation; National Institutes of Health [AR059115-04, 1F31AG04603801, HL07638-27, F30AG04496401, F30AG04330401]; Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service [IBX000976A]; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG046038, F30AG044964] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001477, I01BX000976] Funding Source: NIH RePORTER	University of Iowa Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the University of Iowa Research Foundation, the National Institutes of Health (Grants AR059115-04, 1F31AG04603801, HL07638-27, F30AG04496401, and F30AG04330401), the Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service (Grant IBX000976A), and the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Friedman M, 2003, FOOD CHEM TOXICOL, V41, P61, DOI 10.1016/S0278-6915(02)00205-3; Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e; Fujiwara Y, 2012, J AGR FOOD CHEM, V60, P2472, DOI 10.1021/jf204197r; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Koh E, 2013, J SCI FOOD AGR, V93, P1537, DOI 10.1002/jsfa.5951; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; MENDEZ J, 1960, METABOLISM, V9, P184; Michael K, 2000, Biol Res Nurs, V2, P117, DOI 10.1177/109980040000200205; RICK CM, 1994, P NATL ACAD SCI USA, V91, P12877, DOI 10.1073/pnas.91.26.12877; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1	34	82	88	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14913	14924		10.1074/jbc.M114.556241	http://dx.doi.org/10.1074/jbc.M114.556241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719321	Green Published, hybrid			2022-12-28	WOS:000337248100042
J	Wang, RP; Cleary, RA; Wang, T; Li, J; Tang, DD				Wang, Ruping; Cleary, Rachel A.; Wang, Tao; Li, Jia; Tang, Dale D.			The Association of Cortactin with Profilin-1 Is Critical for Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Excitation-Contraction Coupling; Protein Phosphorylation; Smooth Muscle; Adapter Protein; Contraction	CRK-ASSOCIATED SUBSTRATE; ACTIN POLYMERIZATION; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; P21-ACTIVATED KINASE; TENSION DEVELOPMENT; CELL PROLIFERATION; FORCE DEVELOPMENT; VIMENTIN NETWORK; ABL	Background: Profilin-1 (Pfn-1) regulates actin dynamics and contraction in smooth muscle. Results: Contractile activation increases the association of cortactin with Pfn-1 via c-Abl, which controls actin dynamics and contraction. Conclusion: The coupling of cortactin with Pfn-1 regulated by c-Abl is critical for actin polymerization and contraction. Significance: The c-Abl-mediated cortactin/Pfn-1 interaction is a novel mechanism for the regulation of smooth muscle contraction. Profilin-1 (Pfn-1) is an actin-regulatory protein that has a role in modulating smooth muscle contraction. However, the mechanisms that regulate Pfn-1 in smooth muscle are not fully understood. Here, stimulation with acetylcholine induced an increase in the association of the adapter protein cortactin with Pfn-1 in smooth muscle cells/tissues. Furthermore, disruption of the protein/protein interaction by a cell-permeable peptide (CTTN-I peptide) attenuated actin polymerization and smooth muscle contraction without affecting myosin light chain phosphorylation at Ser-19. Knockdown of cortactin by lentivirus-mediated RNAi also diminished actin polymerization and smooth muscle force development. However, cortactin knockdown did not affect myosin activation. In addition, cortactin phosphorylation has been implicated in nonmuscle cell migration. In this study, acetylcholine stimulation induced cortactin phosphorylation at Tyr-421 in smooth muscle cells. Phenylalanine substitution at this position impaired cortactin/Pfn-1 interaction in response to contractile activation. c-Abl is a tyrosine kinase that is necessary for actin dynamics and contraction in smooth muscle. Here, c-Abl silencing inhibited the agonist-induced cortactin phosphorylation and the association of cortactin with Pfn-1. Finally, treatment with CTTN-I peptide reduced airway resistance and smooth muscle hyperreactivity in a murine model of asthma. These results suggest that the interaction of cortactin with Pfn-1 plays a pivotal role in regulating actin dynamics, smooth muscle contraction, and airway hyperresponsiveness in asthma. The association of cortactin with Pfn-1 is regulated by c-Abl-mediated cortactin phosphorylation.	[Wang, Ruping; Cleary, Rachel A.; Wang, Tao; Li, Jia; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave,MC 8, Albany, NY 12208 USA.	tangd@mail.amc.edu		Tang, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	National Institutes of Health [HL-110951, HL-113208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110951, R01HL113208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-110951 and HL-113208 (to D. D. T.).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Amrani Y, 2004, CURR OPIN PHARMACOL, V4, P230, DOI 10.1016/j.coph.2004.02.004; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; BJORCK T, 1992, AM REV RESPIR DIS, V145, P1087; Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chen S, 2009, AM J PHYSIOL-HEART C, V297, pH533, DOI 10.1152/ajpheart.00237.2009; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Coulson FR, 2003, PHARMACOL THERAPEUT, V98, P59, DOI 10.1016/S0163-7258(03)00004-4; Deshpande DA, 2004, AM J RESP CELL MOL, V31, P36, DOI 10.1165/rcmb.2003-0313OC; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Forsythe SM, 2002, AM J RESP CELL MOL, V26, P298, DOI 10.1165/ajrcmb.26.3.4564; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Guedes AGP, 2006, AM J PHYSIOL-LUNG C, V291, pL1286, DOI 10.1152/ajplung.00187.2006; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Morgan KG, 2008, J CELL MOL MED, V12, P2157, DOI 10.1111/j.1582-4934.2008.00565.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Tang DD, 2003, AM J PHYSIOL-HEART C, V285, pH1528, DOI 10.1152/ajpheart.00188.2003; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wegmann M, 2007, AM J RESP CELL MOL, V36, P61, DOI 10.1165/rcmb.2006-0188OC; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	50	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14157	14169		10.1074/jbc.M114.548099	http://dx.doi.org/10.1074/jbc.M114.548099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700464	hybrid, Green Published			2022-12-28	WOS:000335984600043
J	dela Sena, C; Riedl, KM; Narayanasamy, S; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Riedl, Kenneth M.; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			The Human Enzyme That Converts Dietary Provitamin A Carotenoids to Vitamin A Is a Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Dioxygenase; Enzyme Catalysis; Enzyme Mechanisms; Oxidation-Reduction; Retinoid; Vitamin A; Monooxygenase; Oxygenase	PSEUDOMONAS-PAUCIMOBILIS TMY1009; BETA-CAROTENE; LIGNOSTILBENE-ALPHA,BETA-DIOXYGENASE GENE; INTESTINAL-ABSORPTION; CLEAVAGE; CLONING; BIOSYNTHESIS	Background: The human enzyme -carotene 15-15-oxygenase (BCO1) has been thought to be a monooxygenase. Results: Incubation of BCO1 and -carotene in (H2O)-O-18-O-16(2) or (H2O)-O-16-O-18(2) medium yields two retinals both of which contain oxygen atoms originating solely from O-2 gas. Conclusion: BCO1 is a dioxygenase. Significance: It is important to clearly establish the reaction mechanism of an enzyme, especially when the name reflects the mechanism. -Carotene 15-15-oxygenase (BCO1) catalyzes the oxidative cleavage of dietary provitamin A carotenoids to retinal (vitamin A aldehyde). Aldehydes readily exchange their carbonyl oxygen with water, making oxygen labeling experiments challenging. BCO1 has been thought to be a monooxygenase, incorporating oxygen from O-2 and H2O into its cleavage products. This was based on a study that used conditions that favored oxygen exchange with water. We incubated purified recombinant human BCO1 and -carotene in either O-16(2)-(H2O)-O-18 or O-18(2)-(H2O)-O-16 medium for 15 min at 37 degrees C, and the relative amounts of O-18-retinal and O-16-retinal were measured by liquid chromatography-tandem mass spectrometry. At least 79% of the retinal produced by the reaction has the same oxygen isotope as the O-2 gas used. Together with the data from O-18-retinal-(H2O)-O-16 and O-16-retinal-(H2O)-O-18 incubations to account for nonenzymatic oxygen exchange, our results show that BCO1 incorporates only oxygen from O-2 into retinal. Thus, BCO1 is a dioxygenase.	[dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	NARAYANASAMY, SURESHBABU/AAN-6604-2021; Harrison, Earl H/AAN-5378-2021; riedl, ken/G-8621-2014; Riedl, Ken/K-1881-2019	riedl, ken/0000-0002-9020-3471; Schwartz, Steven/0000-0002-1427-5780; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health (NHLBI) [R01-HL49879]; National Institutes of Health (National Institutes of Health Office of Dietary Supplements); Ohio State University Food Innovation Center; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (National Institutes of Health Office of Dietary Supplements)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Food Innovation Center; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL49879 (NHLBI and the National Institutes of Health Office of Dietary Supplements). This work was also supported by grants from The Ohio State University Food Innovation Center and the Ohio Agricultural Research Development Center. The mass spectrometry experiments were done at the Nutrient and Phytochemical Analytic Shared Resource of the Ohio State University Comprehensive Cancer Center.	BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; CREELMAN RA, 1984, PLANT PHYSIOL, V75, P166, DOI 10.1104/pp.75.1.166; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; dePee S, 1996, EUR J CLIN NUTR, V50, pS38; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; HENEHAN GTM, 1993, BIOCHEMISTRY-US, V32, P736, DOI 10.1021/bi00054a001; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; JUTTNER F, 1985, ARCH MICROBIOL, V141, P337, DOI 10.1007/BF00428846; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; KAMODA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1866, DOI 10.1271/bbb.59.1866; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; KAMODA S, 1991, AGR BIOL CHEM TOKYO, V55, P1411, DOI 10.1080/00021369.1991.10870789; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P931, DOI 10.1271/bbb.57.931; Kawanishi Y, 2011, CHEM ENG J, V167, P531, DOI 10.1016/j.cej.2010.10.052; Kim YS, 2009, J BIOL CHEM, V284, P15781, DOI 10.1074/jbc.M109.002618; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lide D. R., 2013, HDB CHEM PHYS, p[11, 11]; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; Moss G. P., 2014, ENZYME NOMENCLATURE; Mutti FG, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/626909; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872	25	51	52	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13661	13666		10.1074/jbc.M114.557710	http://dx.doi.org/10.1074/jbc.M114.557710			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668807	hybrid, Green Published			2022-12-28	WOS:000335522800059
J	Mogami, H; Keller, PW; Shi, HL; Word, RA				Mogami, Haruta; Keller, Patrick W.; Shi, Haolin; Word, R. Ann			Effect of Thrombin on Human Amnion Mesenchymal Cells, Mouse Fetal Membranes, and Preterm Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Fibronectin; Matrix Metalloproteinase (MMP); Prostaglandins; Thrombin; Amnion; Decidua; Fetal Membrane; Protease-activated Receptor-1	PREMATURE RUPTURE; MECHANISMS; EXPRESSION; MICE; MATRIX-METALLOPROTEINASE-9; TRIMESTER; PREGNANCY; ENDOTOXIN; REMOVAL; LABOR	Background: Bleeding during pregnancy is a risk factor for premature rupture of the fetal membranes. Results: Thrombin causes preterm birth in mice and activates PAR-1 and TLR4 to increase MMPs and COX-2. Conclusion: Thrombin acts through multiple mechanisms to increase MMPs and PGE(2) in amnion. Significance: Thrombin plays a pivotal role in the pathogenesis of preterm labor and rupture of the membranes. Here, we investigated the effects of thrombin on matrix metalloproteinases (MMPs) and prostaglandin (PG) synthesis in fetal membranes. Thrombin activity was increased in human amnion from preterm deliveries. Treatment of mesenchymal, but not epithelial, cells with thrombin resulted in increased MMP-1 and MMP-9 mRNA and enzymatic activity. Thrombin also increased COX2 mRNA and PGE(2) in these cells. Protease-activated receptor-1 (PAR-1) was localized to amnion mesenchymal and decidual cells. PAR-1-specific inhibitors and activating peptides indicated that thrombin-induced up-regulation of MMP-9 was mediated via PAR-1. In contrast, thrombin-induced up-regulation of MMP-1 and COX-2 was mediated through Toll-like receptor-4, possibly through thrombin-induced release of soluble fetal fibronectin. In vivo, thrombin-injected pregnant mice delivered preterm. Mmp8, Mmp9, and Mmp13, and PGE(2) content was increased significantly in fetal membranes from thrombin-injected animals. These results indicate that thrombin acts through multiple mechanisms to activate MMPs and PGE2 synthesis in amnion.	[Mogami, Haruta; Keller, Patrick W.; Shi, Haolin; Word, R. Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Div Reprod Endocrinol & Urogynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu			National Institutes of Health [HD11149]; SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD011149] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25861488, 24119004] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant HD11149. This work was also supported by a fellowship from SUMITOMO Life Social Welfare Service Foundation and the Human Tissue and Biologic Fluid Core Laboratory.	ADAM O, 1995, ANAL BIOCHEM, V225, P321, DOI 10.1006/abio.1995.1161; Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BRAVERMAN MB, 1984, J CLIN ENDOCR METAB, V58, P521, DOI 10.1210/jcem-58-3-521; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P368, DOI 10.1080/713605566; Challis JRG, 2002, REPRODUCTION, V124, P1; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Economopoulos P, 1996, MOL CELL ENDOCRINOL, V117, P141, DOI 10.1016/0303-7207(95)03739-X; Elovitz MA, 2000, AM J OBSTET GYNECOL, V183, P799, DOI 10.1067/mob.2000.108897; Erez O, 2009, J MATERN-FETAL NEO M, V22, P971, DOI 10.3109/14767050902994762; FUNDERBURK SJ, 1980, BRIT J OBSTET GYNAEC, V87, P100, DOI 10.1111/j.1471-0528.1980.tb04500.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1; Kumar D, 2011, PLACENTA, V32, P206, DOI 10.1016/j.placenta.2011.01.006; LOCKWOOD CJ, 1994, ANN NY ACAD SCI, V734, P57, DOI 10.1111/j.1749-6632.1994.tb21736.x; Mackenzie AP, 2004, AM J OBSTET GYNECOL, V191, P1996, DOI 10.1016/j.ajog.2004.08.003; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; Mogami H, 2013, J BIOL CHEM, V288, P1953, DOI 10.1074/jbc.M112.424366; Moore RM, 2010, PLACENTA, V31, P886, DOI 10.1016/j.placenta.2010.07.012; Nagy S, 2003, OBSTET GYNECOL, V102, P94, DOI 10.1016/S0029-7844(03)00403-4; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Puthiyachirakkal M, 2013, PLACENTA, V34, P924, DOI 10.1016/j.placenta.2013.07.064; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Rosen T, 2001, J Matern Fetal Med, V10, P297, DOI 10.1080/714904361; Rosen T, 2002, J Matern Fetal Neonatal Med, V11, P11, DOI 10.1080/713605444; Signore CC, 1998, AM J OBSTET GYNECOL, V178, P336, DOI 10.1016/S0002-9378(98)80022-7; Stephenson CD, 2005, J MATERN-FETAL NEO M, V18, P17, DOI 10.1080/14767050500123632; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x	34	26	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13295	13307		10.1074/jbc.M114.550541	http://dx.doi.org/10.1074/jbc.M114.550541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24652285	Green Published, hybrid			2022-12-28	WOS:000335522800029
J	Sheng, JH; Luo, C; Jiang, YX; Hinds, PW; Xu, ZP; Hu, GF				Sheng, Jinghao; Luo, Chi; Jiang, Yuxiang; Hinds, Philip W.; Xu, Zhengping; Hu, Guo-fu			Transcription of Angiogenin and Ribonuclease 4 Is Regulated by RNA Polymerase III Elements and a CCCTC Binding Factor ( CTCF)-dependent Intragenic Chromatin Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Promoters; Ribonuclease; RNA Polymerase; Transcription; Angiogenin; Rinonuclease 4	AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE-SPECIFIC EXPRESSION; GENOME-WIDE; CELL-PROLIFERATION; PROSTATE-CANCER; POL II; CTCF; STRESS; GENES; SURVIVAL	Background: Angiogenin and ribonuclease 4 share genetic regions with promoter activities, and both have growth and survival activity. Results: RNA polymerase III elements and CTCF-dependent intragenic chromatin loop regulate the transcription. Conclusion: Multiple layers of transcription regulation of this gene locus encode two functionally similar but distinctive proteins. Significance: Elucidating how angiogenin and ribonuclease 4 are differentially transcribed help understand their biological activities. Angiogenin (ANG) and ribonuclease 4 (RNASE4), two members of the secreted and vertebrate-specific ribonuclease superfamily, play important roles in cancers and neurodegenerative diseases. The ANG and RNASE4 genes share genetic regions with promoter activities, but the structure and regulation of these putative promotes are unknown. We have characterized the promoter regions, defined the transcription start site, and identified a mechanism of transcription regulation that involves both RNA polymerase III (Pol III) elements and CCCTC binding factor (CTCF) sites. We found that two Pol III elements within the promoter region influence ANG and RNASE4 expression in a position- and orientation-dependent manner. We also provide evidence for the presence of an intragenic chromatin loop between the two CTCF binding sites located in two introns flanking the ANG coding exon. We found that formation of this intragenic loop preferentially enhances ANG transcription. These results suggest a multilayer transcriptional regulation of ANG and RNASE4 gene locus. These data also add more direct evidence to the notion that Pol III elements are able to directly influence Pol II gene transcription. Furthermore, our data indicate that a CTCF-dependent chromatin loop is able to differentially regulate transcription of genes that share the same promoters.	[Sheng, Jinghao; Luo, Chi; Jiang, Yuxiang; Hinds, Philip W.; Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Sheng, Jinghao; Xu, Zhengping] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310058, Zhejiang, Peoples R China	Tufts Medical Center; Zhejiang University	Xu, ZP (corresponding author), Zhejiang Univ, Sch Med, Inst Environm Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zpxu@zju.edu.cn; ghu@tuftsmedicalcenter.org		LUO, CHI/0000-0001-7669-9506	National Institutes of Health [R01CA105241, R01NS065237]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA105241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA105241 and R01NS065237 (to G.-f. H.). This work was also supported by the China Scholarship Council (to J. S.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; berg U W., 2011, PLOS ONE, V6; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dyer KD, 2005, NUCLEIC ACIDS RES, V33, P1077, DOI 10.1093/nar/gki250; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Ibaragi S, 2009, CLIN CANCER RES, V15, P1981, DOI 10.1158/1078-0432.CCR-08-2593; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YN, 2012, PROG NEURO-PSYCHOPH, V38, P116, DOI 10.1016/j.pnpbp.2012.02.010; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Li SP, 2013, ANGIOGENESIS, V16, P387, DOI 10.1007/s10456-012-9322-9; Li SP, 2011, CURR CANCER THER REV, V7, P83, DOI 10.2174/1573394711107020083; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; McLaughlin RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015402; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Riordan JF, 2001, METHOD ENZYMOL, V341, P263, DOI 10.1016/S0076-6879(01)41157-8; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P7255, DOI 10.1021/bi00371a002; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; van Bortle K, 2012, TRANSCR-AUSTIN, V3, P277, DOI 10.4161/trns.21579; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-456; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zambelli F, 2012, NUCLEIC ACIDS RES, V40, pW510, DOI 10.1093/nar/gks483	52	21	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12520	12534		10.1074/jbc.M114.551762	http://dx.doi.org/10.1074/jbc.M114.551762			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24659782	Green Published, hybrid			2022-12-28	WOS:000335581400027
J	Richards, J; Ko, B; All, S; Cheng, KY; Hoover, RS; Gumz, ML				Richards, Jacob; Ko, Benjamin; All, Sean; Cheng, Kit-Yan; Hoover, Robert S.; Gumz, Michelle L.			A Role for the Circadian Clock Protein Per1 in the Regulation of the NaCl Co-transporter ( NCC) and the with-no-lysine Kinase ( WNK) Cascade in Mouse Distal Convoluted Tubule Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Gene Expression; Kidney; Renal Physiology; Sodium Transport; Transcription	ALPHA-ENAC EXPRESSION; NA+/H+ EXCHANGER NHE3; GENE-EXPRESSION; BLOOD-PRESSURE; PERIOD 1; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATION; RHYTHMICITY; INHIBITION; FEEDBACK	Background: The role of the circadian protein Per1 in the regulation of sodium reabsorption in the distal convoluted tubule (DCT) is unknown. Results: Per1 transcriptionally regulates the sodium transporter NCC and the WNK kinase cascade. Conclusion: Per1 regulates sodium reabsorption in the DCT through NCC and the WNK cascade. Significance: These data demonstrate a role for Per1 in the regulation of renal sodium transporters. It has been well established that blood pressure and renal function undergo circadian fluctuations. We have demonstrated that the circadian protein Per1 regulates multiple genes involved in sodium transport in the collecting duct of the kidney. However, the role of Per1 in other parts of the nephron has not been investigated. The distal convoluted tubule (DCT) plays a critical role in renal sodium reabsorption. Sodium is reabsorbed in this segment through the actions of the NaCl co-transporter (NCC), which is regulated by the with-no-lysine kinases (WNKs). The goal of this study was to test if Per1 regulates sodium transport in the DCT through modulation of NCC and the WNK kinases, WNK1 and WNK4. Pharmacological blockade of nuclear Per1 entry resulted in decreased mRNA expression of NCC and WNK1 but increased expression of WNK4 in the renal cortex of mice. These findings were confirmed by using Per1 siRNA and pharmacological blockade of Per1 nuclear entry in mDCT15 cells, a model of the mouse distal convoluted tubule. Transcriptional regulation was demonstrated by changes in short lived heterogeneous nuclear RNA. Chromatin immunoprecipitation experiments demonstrated interaction of Per1 and CLOCK with the promoters of NCC, WNK1, and WNK4. This interaction was modulated by blockade of Per1 nuclear entry. Importantly, NCC protein expression and NCC activity, as measured by thiazide-sensitive, chloride-dependent Na-22 uptake, were decreased upon pharmacological inhibition of Per1 nuclear entry. Taken together, these data demonstrate a role for Per1 in the transcriptional regulation of NCC, WNK1, and WNK4.	[Richards, Jacob; All, Sean; Cheng, Kit-Yan; Gumz, Michelle L.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Richards, Jacob; Gumz, Michelle L.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ko, Benjamin] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hoover, Robert S.] Emory Univ, Div Nephrol, Dept Med, Atlanta, GA 30322 USA; [Hoover, Robert S.] Atlanta Vet Affairs Med Ctr, Res Serv, Atlanta, GA 30033 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Gumz, ML (corresponding author), Univ Florida, Dept Med, Dept Biochem & Mol Biol, 1600 SW Archer Rd,Box 100224, Gainesville, FL 32610 USA.	Michelle.Gumz@medicine.ufl.edu	Gumz, Michelle/AGX-2097-2022	Gumz, Michelle/0000-0002-1342-0878; All, Sean/0000-0002-9191-083X	National Institutes of Health [DK085193, DK098460, NIHK08 DK081728, NIHR01 DK085097]; American Society of Nephrology Foundation for Kidney Research; American Heart Association Predoctoral Fellowship [13PRE16910096]; Research Service, Atlanta Veterans Affairs Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK098460, R01DK085097, K08DK081728, K01DK085193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Foundation for Kidney Research; American Heart Association Predoctoral Fellowship(American Heart Association); Research Service, Atlanta Veterans Affairs Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK085193 and DK098460 (to M. L. G.), NIHK08 DK081728 (to B. K.), and NIHR01 DK085097 (to R. S. H.). This work was also supported by the American Society of Nephrology Foundation for Kidney Research (to M. L. G.), American Heart Association Predoctoral Fellowship 13PRE16910096 (to J. R.), and the Research Service, Atlanta Veterans Affairs Medical Center (to R. S. H.).	Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balakrishnan A, 2012, DIGEST DIS SCI, V57, P1525, DOI 10.1007/s10620-012-2166-8; Bhutta HY, 2013, DIGEST DIS SCI, V58, P1537, DOI 10.1007/s10620-013-2669-y; Bonny O, 2013, CURR OPIN NEPHROL HY, V22, P439, DOI 10.1097/MNH.0b013e32836213b8; Bose S, 2010, ENDOCRINOLOGY, V151, P2287, DOI 10.1210/en.2009-1252; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Chavez-Canales M, 2013, J HYPERTENS, V31, P303, DOI 10.1097/HJH.0b013e32835bbb83; Chen H, 2006, J NUTR, V136, P2463, DOI 10.1093/jn/136.10.2463; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gamba G, 2012, AM J PHYSIOL-RENAL, V303, pF1573, DOI 10.1152/ajprenal.00508.2012; Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Ko B, 2009, CURR OPIN NEPHROL HY, V18, P421, DOI 10.1097/MNH.0b013e32832f2fcb; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Nishinaga H, 2009, BIOMED RES-TOKYO, V30, P87, DOI 10.2220/biomedres.30.87; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Perreau-Lenz S, 2012, NEUROPSYCHOPHARMACOL, V37, P2121, DOI 10.1038/npp.2012.62; Richards J, 2013, AM J PHYSIOL-RENAL, V305, pF1697, DOI 10.1152/ajprenal.00472.2013; Richards J, 2013, AM J PHYSIOL-REG I, V305, pR735, DOI 10.1152/ajpregu.00195.2013; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Richards J, 2012, AM J PHYSIOL-RENAL, V303, pF918, DOI 10.1152/ajprenal.00678.2011; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Stow LR, 2012, HYPERTENSION, V59, P1151, DOI 10.1161/HYPERTENSIONAHA.112.190892; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Susa K, 2012, BIOCHEM BIOPH RES CO, V427, P743, DOI 10.1016/j.bbrc.2012.09.130; Suzuki J, 2010, HYPERTENS RES, V33, P1060, DOI 10.1038/hr.2010.125; Vukolic A, 2010, AM J PHYSIOL-REG I, V298, pR627, DOI 10.1152/ajpregu.00404.2009; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	52	43	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11791	11806		10.1074/jbc.M113.531095	http://dx.doi.org/10.1074/jbc.M113.531095			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610784	Green Published, hybrid			2022-12-28	WOS:000335010600020
J	Baba, T; Kashiwagi, Y; Arimitsu, N; Kogure, T; Edo, A; Maruyama, T; Nakao, K; Nakanishi, H; Kinoshita, M; Frohman, MA; Yamamoto, A; Tani, K				Baba, Takashi; Kashiwagi, Yuriko; Arimitsu, Nagisa; Kogure, Takeshi; Edo, Ayumi; Maruyama, Tomohiro; Nakao, Kazuki; Nakanishi, Hiroki; Kinoshita, Makoto; Frohman, Michael A.; Yamamoto, Akitsugu; Tani, Katsuko			Phosphatidic Acid ( PA)-preferring Phospholipase A1 Regulates Mitochondrial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane; Mitochondria; Phosphatidic Acid; Phospholipase A; Sperm	HEREDITARY SPASTIC PARAPLEGIA; MAMMALIAN SEC23P-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM; NUAGE FORMATION; A(1) KIAA0725P; FUSION; MEMBRANE; MUTATIONS; FISSION; TESTIS	Background: Phosphatidic acid (PA) is involved in membrane dynamics. Results: PA-preferring phospholipase A(1) (PA-PLA(1)) affects mitochondrial morphology in an activity-dependent manner. Gene disruption of PA-PLA(1) in mice causes sperm malformation due to mitochondrial organization defects. Conclusion: PA-PLA(1) regulates mitochondrial dynamics. Significance: We demonstrate an in vivo function of PA-PLA(1) and suggest a possible mechanism of PA regulation of the mitochondrial membrane. Recent studies have suggested that phosphatidic acid (PA), a cone-shaped phospholipid that can generate negative curvature of lipid membranes, participates in mitochondrial fusion. However, precise mechanisms underling the production and consumption of PA on the mitochondrial surface are not fully understood. Phosphatidic acid-preferring phospholipase A(1) (PA-PLA(1))/DDHD1 is the first identified intracellular phospholipase A(1) and preferentially hydrolyzes PA in vitro. Its cellular and physiological functions have not been elucidated. In this study, we show that PA-PLA(1) regulates mitochondrial dynamics. PA-PLA(1), when ectopically expressed in HeLa cells, induced mitochondrial fragmentation, whereas its depletion caused mitochondrial elongation. The effects of PA-PLA(1) on mitochondrial morphology appear to counteract those of MitoPLD, a mitochondrion-localized phospholipase D that produces PA from cardiolipin. Consistent with high levels of expression of PA-PLA(1) in testis, PA-PLA(1) knock-out mice have a defect in sperm formation. In PA-PLA(1)-deficient sperm, the mitochondrial structure is disorganized, and an abnormal gap structure exists between the middle and principal pieces. A flagellum is bent at that position, leading to a loss of motility. Our results suggest a possible mechanism of PA regulation of the mitochondrial membrane and demonstrate an in vivo function of PA-PLA(1) in the organization of mitochondria during spermiogenesis.	[Baba, Takashi; Kashiwagi, Yuriko; Arimitsu, Nagisa; Kogure, Takeshi; Edo, Ayumi; Maruyama, Tomohiro; Tani, Katsuko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan; [Nakao, Kazuki] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakanishi, Hiroki] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Kinoshita, Makoto] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Tokyo University of Pharmacy & Life Sciences; RIKEN; Akita University; Nagoya University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tani, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tani@toyaku.ac.jp		Nakanishi, Hiroki/0000-0002-5108-1598; zhong wei, he gui/0000-0002-3066-3564	Ministry of Education, Culture, Sports, Science and Technology of Japan [23570239]; Grants-in-Aid for Scientific Research [25116702] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 23570239 (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arimitsu N, 2011, FEBS LETT, V585, P2171, DOI 10.1016/j.febslet.2011.05.050; Baba T, 2013, MOL CELL BIOCHEM, V376, P151, DOI 10.1007/s11010-013-1563-4; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Cowell CF, 2009, J CELL SCI, V122, P919, DOI 10.1242/jcs.041061; Douglas DS, 2009, J NEUROSCI, V29, P12089, DOI 10.1523/JNEUROSCI.2029-09.2009; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Gonzalez M, 2013, EUR J HUM GENET, V21, P1214, DOI 10.1038/ejhg.2013.29; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Honda S, 2003, BIOCHEM BIOPH RES CO, V311, P424, DOI 10.1016/j.bbrc.2003.10.008; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Inoue H, 2012, BBA-MOL CELL RES, V1823, P930, DOI 10.1016/j.bbamcr.2012.02.002; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jin JK, 2006, NEUROSCI LETT, V407, P263, DOI 10.1016/j.neulet.2006.08.062; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Muliyil S, 2011, DEVELOPMENT, V138, P3043, DOI 10.1242/dev.060731; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suzuki J, 2004, ONCOGENE, V23, P8527, DOI 10.1038/sj.onc.1207894; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Tani K., 2013, BIOMOL CONCEPTS, V3, P471, DOI [10.1515/bmc-2012-0014, DOI 10.1515/BMC-2012-0014]; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	46	85	89	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11497	11511		10.1074/jbc.M113.531921	http://dx.doi.org/10.1074/jbc.M113.531921			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599962	hybrid, Green Published			2022-12-28	WOS:000334638500050
J	Fitzpatrick, P; Shattil, SJ; Ablooglu, AJ				Fitzpatrick, Paul; Shattil, Sanford J.; Ablooglu, Ararat J.			C-terminal COOH of Integrin beta 1 Is Necessary for beta 1 Association with the Kindlin-2 Adapter Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Development; Integrins; Protein-Protein Interactions; Zebrafish; FERM; PDZ; cd29; cd51; Kindlin	BINDING-LIKE DOMAIN; PDZ DOMAIN; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; ALPHA-V; TALIN; RECOGNITION; ACTIVATION; EXPRESSION; ZEBRAFISH	Background: Modulation of integrin/kindlin interactions can lead to human disease pathogenesis. Results: Interaction between integrin 1 and the kindlin-2 is mainly governed by the 1 C-terminal carboxylate moiety. Conclusion: The interaction chemistry identified here between integrin 1 and kindlin-2 appears to represent a novel protein-protein interaction mode. Significance: The unusual integrin 1/kindlin-2 association chemistry sheds new light on this aspect of integrin biology. Protein-protein interactions are driving forces in cellular processes. As a prime example, transmembrane integrins link extracellular matrix and intracellular proteins, resulting in bidirectional signaling that regulates cell migration, proliferation, differentiation, and survival. Here we provide the first evidence that interaction between the integrin 1 cytoplasmic tail and kindlin-2, a member of a family of adapters implicated in human disease pathogenesis, is mainly governed by the 1 C-terminal carboxylate moiety and is required for laterality organ development in zebrafish. Affinity measurements indicate that this unusual protein-protein interaction mode is coordinated by a putative carboxylate-binding motif in the kindlin-2 FERM subdomain F3. Contrary to the C terminus of proteins that engage PDZ domains, the C-terminal three residues of 1, per se, do not contribute to kindlin-2 binding or to laterality organ development. Thus, by employing zebrafish as an in situ physiological tool to correlate protein structure and function, we have discovered an unexpected association chemistry between an integrin and a key adapter involved in integrin signaling.	[Fitzpatrick, Paul; Shattil, Sanford J.; Ablooglu, Ararat J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ablooglu, AJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	aablooglu@ucsd.edu			National Institutes of Health [P30 NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Jim Dowling for generously providing kindlin-2 MOs and the UCSD Fish Facility for animal maintenance. Confocal images were gathered at the UCSD Neuroscience Microscopy Shared Facility (supported by National Institutes of Health Grant P30 NS047101)	Ablooglu AJ, 2007, DEV DYNAM, V236, P2268, DOI 10.1002/dvdy.21229; Ablooglu AJ, 2010, DEVELOPMENT, V137, P3449, DOI 10.1242/dev.045310; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lee KK, 2006, GLIA, V53, P836, DOI 10.1002/glia.20343; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tsai WB, 2005, DEV BIOL, V277, P129, DOI 10.1016/j.ydbio.2004.08.052; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yates LA, 2012, J BIOL CHEM, V287, P43246, DOI 10.1074/jbc.M112.422089	39	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11183	11193		10.1074/jbc.M113.535369	http://dx.doi.org/10.1074/jbc.M113.535369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599960	hybrid, Green Published			2022-12-28	WOS:000334638500022
J	Nam, TS; Park, KH; Shawl, AI; Kim, BJ; Han, MK; Kim, Y; Moss, J; Kim, UH				Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Han, Myung-Kwan; Kim, Youngho; Moss, Joel; Kim, Uh-Hyun			Critical Role for NAD Glycohydrolase in Regulation of Erythropoiesis by Hematopoietic Stem Cells through Control of Intracellular NAD Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; MOLECULAR CHARACTERIZATION; NICOTINAMIDE RIBOSIDE; RABBIT ERYTHROCYTES; SKELETAL-MUSCLE; RIBOSYLTRANSFERASE; MEMBRANE; RAT; MOUSE; METABOLISM	NAD glycohydrolases (NADases) catalyze the hydrolysis of NAD to ADP-ribose and nicotinamide. Although many members of the NADase family, including ADP-ribosyltransferases, have been cloned and characterized, the structure and function of NADases with pure hydrolytic activity remain to be elucidated. Here, we report the structural and functional characterization of a novel NADase from rabbit reticulocytes. The novel NADase is a glycosylated, glycosylphosphatidylinositol-anchored cell surface protein exclusively expressed in reticulocytes. shRNA-mediated knockdown of the NADase in bone marrow cells resulted in a reduction of erythroid colony formation and an increase in NAD level. Furthermore, treatment of bone marrow cells with NAD, nicotinamide, or nicotinamide riboside, which induce an increase in NAD content, resulted in a significant decrease in erythroid progenitors. These results indicate that the novel NADase may play a critical role in regulating erythropoiesis of hematopoietic stem cells by modulating intracellular NAD.	[Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Nam, Tae-Sik; Park, Kwang-Hyun; Shawl, Asif Iqbal; Kim, Byung-Ju; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561182, South Korea; [Kim, Youngho] Wonkwang Univ, Sch Med, Dept Biochem, Iksan 570749, South Korea; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Wonkwang University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Keumam Dong 561182, Jeonju, South Korea.	uhkim@chonbuk.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	National Institutes of Health Intramural Research Program, NHLBI; National Research Foundation - Korean government [2012R1A3A2026453]; Chonbuk National University for the International Collaborative Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NHLBI; National Research Foundation - Korean government(Korean Government); Chonbuk National University for the International Collaborative Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NHLBI (to J. M.). This work was also supported by National Research Foundation Grant 2012R1A3A2026453 funded by the Korean government (to U.-H. K.) and the Chonbuk National University for the International Collaborative Research (2009) (to U.-H. K.).	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Aslesen R, 1998, AM J PHYSIOL-ENDOC M, V275, pE448, DOI 10.1152/ajpendo.1998.275.3.E448; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bortell R, 1999, MOL CELL BIOCHEM, V193, P61, DOI 10.1023/A:1006951809531; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cho YS, 1998, COMP BIOCHEM PHYS B, V120, P175, DOI 10.1016/S0305-0491(98)10006-8; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; FERGUSON MAJ, 1992, BIOCHEM SOC T, V20, P243, DOI 10.1042/bst0200243; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hara N, 1996, J BIOL CHEM, V271, P29552, DOI 10.1074/jbc.271.47.29552; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; ISSAAD C, 1993, BLOOD, V81, P2916; KIM UH, 1993, ARCH BIOCHEM BIOPHYS, V305, P147, DOI 10.1006/abbi.1993.1404; KIM UH, 1988, BIOCHIM BIOPHYS ACTA, V965, P76, DOI 10.1016/0304-4165(88)90153-5; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432; Maehama T, 1996, FEBS LETT, V388, P189, DOI 10.1016/0014-5793(96)00568-6; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; Okazaki IJ, 1996, BLOOD, V88, P915; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; TAKADA T, 1994, J BIOL CHEM, V269, P9420; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; UDENFRIEND S, 1992, CELL MOL BIOL, V38, P11; Weng BY, 1999, J BIOL CHEM, V274, P31797, DOI 10.1074/jbc.274.45.31797; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Ziegler M, 1996, BIOCHEMISTRY-US, V35, P5207, DOI 10.1021/bi9527698; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	34	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16362	16373		10.1074/jbc.M114.560359	http://dx.doi.org/10.1074/jbc.M114.560359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24759100	hybrid, Green Published			2022-12-28	WOS:000337965700039
J	Charman, M; Colbourne, TR; Pietrangelo, A; Kreplak, L; Ridgway, ND				Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Kreplak, Laurent; Ridgway, Neale D.			Oxysterol-binding Protein (OSBP)-related Protein 4 (ORP4) Is Essential for Cell Proliferation and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cholesterol; Lipid Transport; Phospholipid; RNA Interference (RNAi); Oxysterol-binding Protein; Phosphatidylinositol 4-Phosphate; Vimentin	STEROL-BINDING; SPHINGOMYELIN SYNTHESIS; ENDOPLASMIC-RETICULUM; DEPENDENT ACTIVATION; CERAMIDE TRANSPORT; PLASMA-MEMBRANE; INTERACTS; APOPTOSIS; OSBP; 25-HYDROXYCHOLESTEROL	Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) comprise a large gene family with sterol/lipid transport and regulatory activities. ORP4 (OSBP2) is a closely related paralogue of OSBP, but its function is unknown. Here we show that ORP4 binds similar sterol and lipid ligands as OSBP and other ORPs but is uniquely required for the proliferation and survival of cultured cells. Recombinant ORP4L and a variant without a pleckstrin homology (PH) domain (ORP4S) bind 25-hydroxycholesterol and extract and transfer cholesterol between liposomes. Two conserved histidine residues in the OSBP homology domain ORP4 are essential for binding phosphatidylinositol 4-phosphate but not sterols. The PH domain of ORP4L also binds phosphatidylinositol 4-phosphate in the Golgi apparatus. However, in the context of ORP4L, the PH domain is required for normal organization of the vimentin network. Unlike OSBP, RNAi silencing of all ORP4 variants (including a partial PH domain truncation termed ORP4M) in HEK293 and HeLa cells resulted in growth arrest but not cell death. ORP4 silencing in non-transformed intestinal epithelial cells (IEC)-18 caused apoptosis characterized by caspase 3 and poly(ADP-ribose) polymerase processing, DNA cleavage, and JNK phosphorylation. IEC-18 transformed with oncogenic H-Ras have increased expression of ORP4L and ORP4S proteins and are resistant to the growth-inhibitory effects of ORP4 silencing. Results suggest that ORP4 promotes the survival of rapidly proliferating cells.	[Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Atlantic Res Ctr, 5849 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228; kreplak, laurent/0000-0001-9370-9809	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research [MOP-15284]; Nova Scotia Health Research Foundation	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation	This work was supported by grants from The Heart and Stroke Foundation of Canada and Canadian Institutes of Health Research Grant MOP-15284 (to N. D. R.).; Recipient of a studentship from the Nova Scotia Health Research Foundation.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Beh CT, 2001, GENETICS, V157, P1117; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dirsch VM, 2003, CANCER RES, V63, P8869; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; Garcia-Prieto C, 2013, J BIOL CHEM, V288, P3240, DOI 10.1074/jbc.M112.384776; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lopez-Anton N, 2006, J BIOL CHEM, V281, P33078, DOI 10.1074/jbc.M607904200; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Muller IM, 2005, MOL PHARMACOL, V67, P1684, DOI 10.1124/mol.104.004234; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Rudy A, 2008, J NAT PROD, V71, P482, DOI 10.1021/np070534e; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Udagawa O, 2014, GENES CELLS, V19, P13, DOI 10.1111/gtc.12105; Vihervaara T, 2011, CHEM PHYS LIPIDS, V164, P443, DOI 10.1016/j.chemphyslip.2011.03.002; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	36	63	64	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15705	15717		10.1074/jbc.M114.571216	http://dx.doi.org/10.1074/jbc.M114.571216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742681	hybrid, Green Published			2022-12-28	WOS:000337465400051
J	Randall, LM; Manta, B; Hugo, M; Gil, M; Batthyany, C; Trujillo, M; Poole, LB; Denicola, A				Randall, Lia M.; Manta, Bruno; Hugo, Martin; Gil, Magdalena; Batthyany, Carlos; Trujillo, Madia; Poole, Leslie B.; Denicola, Ana			Nitration Transforms a Sensitive Peroxiredoxin 2 into a More Active and Robust Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Oxidative Stress; Peroxiredoxin; Post-translational Modification; Redox Signaling; Overoxidation; Peroxynitrite; Tyrosine Nitration	2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; NITRIC-OXIDE; PHOSPHORYLATION; PEROXYNITRITE; INACTIVATION; H2O2; OLIGOMERIZATION; REDUCTION; EVOLUTION	Peroxiredoxins (Prx) are efficient thiol-dependent peroxidases and key players in the mechanism of H2O2-induced redox signaling. Any structural change that could affect their redox state, oligomeric structure, and/or interaction with other proteins could have a significant impact on the cascade of signaling events. Several post-translational modifications have been reported to modulate Prx activity. One of these, overoxidation of the peroxidatic cysteine to the sulfinic derivative, inactivates the enzyme and has been proposed as a mechanism of H2O2 accumulation in redox signaling (the floodgate hypothesis). Nitration of Prx has been reported in vitro as well as in vivo; in particular, nitrated Prx2 was identified in brains of Alzheimer disease patients. In this work we characterize Prx2 tyrosine nitration, a post-translational modification on a noncatalytic residue that increases its peroxidase activity and its resistance to overoxidation. Mass spectrometry analysis revealed that treatment of disulfide-oxidized Prx2 with excess peroxynitrite renders mainly mononitrated and dinitrated species. Tyrosine 193 of the YF motif at the C terminus, associated with the susceptibility toward overoxidation of eukaryotic Prx, was identified as nitrated and is most likely responsible for the protection of the peroxidatic cysteine against oxidative inactivation. Kinetic analyses suggest that tyrosine nitration facilitates the intermolecular disulfide formation, transforming a sensitive Prx into a robust one. Thus, tyrosine nitration appears as another mechanism to modulate these enzymes in the complex network of redox signaling.	[Randall, Lia M.; Manta, Bruno; Denicola, Ana] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Montevideo 11400, Uruguay; [Randall, Lia M.; Hugo, Martin; Batthyany, Carlos; Trujillo, Madia; Denicola, Ana] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo 11100, Uruguay; [Manta, Bruno] Inst Pasteur Montevideo, Lab Biol Redox Tripanosomas, Montevideo 11400, Uruguay; [Hugo, Martin; Batthyany, Carlos; Trujillo, Madia] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11100, Uruguay; [Gil, Magdalena; Batthyany, Carlos] Inst Pasteur Montevideo, Unidad Bioquim & Proteom Analit, Montevideo 11400, Uruguay; [Gil, Magdalena] Minist Educ & Cultura, Inst Invest Biol Clemente Estable, Unidad Bioquim & Proteom Analit, Montevideo 11600, Uruguay; [Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Wake Forest University	Denicola, A (corresponding author), Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Igua 4225, Montevideo 11400, Uruguay.	denicola@fcien.edu.uy	Hugo, Martín/AAW-8351-2020	Hugo, Martín/0000-0003-3430-6457; Manta, Bruno/0000-0001-8366-8935; Gil, Magdalena/0000-0002-9039-014X; Trujillo, Madia/0000-0003-2087-017X; Denicola, Ana/0000-0002-5181-9708; Batthyany, Carlos/0000-0002-0627-1982; Poole, Leslie/0000-0003-0334-7328	National Institutes of Health [GM050389]; Comision Sectorial de Investigacion Cientifica UdelaR [CSIC C007-348]; Agencia Nacional de Investigacion e Innovacion [FCE_2011_1_S706, FCE_2007_217]; Comision Academica de Posgrados; UdelaR; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas); Agencia Nacional de Investigacion e Innovacion; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Sectorial de Investigacion Cientifica UdelaR; Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrados; UdelaR; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas); Agencia Nacional de Investigacion e Innovacion; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM050389 (to L. B. P.). This work was also supported by Comision Sectorial de Investigacion Cientifica UdelaR Grant CSIC C007-348 (to A. D.) and Agencia Nacional de Investigacion e Innovacion Grants FCE_2011_1_S706 (to M. T.) and FCE_2007_217 (to B. M.).; Supported by Comision Academica de Posgrados, UdelaR, and PEDECIBA (Programa de Desarrollo de las Ciencias Basicas).; Supported in part by the Agencia Nacional de Investigacion e Innovacion.	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; Brito C, 1999, J IMMUNOL, V162, P3356; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cho CS, 2010, ANTIOXID REDOX SIGN, V13, P1, DOI 10.1089/ars.2009.2978; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Denicola A., 2008, FREE RADICALS PATHOP, P39; Egwim IOC, 2001, ANAL BIOCHEM, V288, P188, DOI 10.1006/abio.2000.4891; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jornvall H, 2000, EXS, V88, pXI; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Leite PF, 2004, WORLD J SURG, V28, P331, DOI 10.1007/s00268-003-7399-4; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Perry G, 2000, FREE RADICAL BIO MED, V28, P831, DOI 10.1016/S0891-5849(00)00158-1; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Reed TT, 2009, J CELL MOL MED, V13, P2019, DOI 10.1111/j.1582-4934.2008.00478.x; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Salsbury FR, 2012, J PHYS CHEM B, V116, P6832, DOI 10.1021/jp212606k; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Trujillo M., 2010, NITRIC OXIDE BIOL PA, P61, DOI DOI 10.1016/B978-0-12-373866-0.00003-4; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yuan Y, 2010, J BIOMOL STRUCT DYN, V28, P51, DOI 10.1080/07391102.2010.10507343; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	58	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15536	15543		10.1074/jbc.M113.539213	http://dx.doi.org/10.1074/jbc.M113.539213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719319	Green Published, hybrid			2022-12-28	WOS:000337465400036
J	Mills, KV; Johnson, MA; Perler, FB				Mills, Kenneth V.; Johnson, Margaret A.; Perler, Francine B.			Protein Splicing: How Inteins Escape from Precursor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TUBERCULOSIS-RECA INTEIN; BRANCHED INTERMEDIATE FORMATION; SYNECHOCYSTIS SP PCC6803; YEAST VMA1 PROTOZYME; C-TERMINAL CLEAVAGE; SSP DNAE INTEIN; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; VMA1-DERIVED ENDONUCLEASE	Inteins are nature's escape artists; they facilitate their excision from flanking polypeptides (exteins) concomitant with extein ligation to produce a mature host protein. Splicing requires sequential nucleophilic displacement reactions catalyzed by strategies similar to proteases and asparagine lyases. Inteins require precise reaction coordination rather than rapid turnover or tight substrate binding because they are single turnover enzymes with covalently linked substrates. This has allowed inteins to explore alternative mechanisms with different steps or to use different methods for activation and coordination of the steps. Pressing issues include understanding the underlying details of catalysis and how the splicing steps are controlled.	[Mills, Kenneth V.] Coll Holy Cross, Dept Chem, Worcester, MA 01610 USA; [Johnson, Margaret A.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Perler, Francine B.] New England Biolabs Inc, Ipswich, MA 01938 USA	College of the Holy Cross; University of Alabama System; University of Alabama Birmingham; New England Biolabs	Perler, FB (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	perler@neb.com			National Science Foundation [MCB-1244089]; Henry Dreyfus Teacher-Scholar Award; New England Biolabs; University of Alabama at Birmingham; Direct For Biological Sciences [1244089] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Henry Dreyfus Teacher-Scholar Award; New England Biolabs; University of Alabama at Birmingham; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation under Grant MCB-1244089 (to K. V. M.), by a Henry Dreyfus Teacher-Scholar Award (to K. V. M.), by New England Biolabs (to F. B. P.), and by University of Alabama at Birmingham startup funding (to M. A. J.). This is the second article in the Thematic Minireview Series "Inteins."	Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Amitai G, 2003, MOL MICROBIOL, V47, P61, DOI 10.1046/j.1365-2958.2003.03283.x; Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Aranko AS, 2013, FEBS J, V280, P3256, DOI 10.1111/febs.12307; Brace LE, 2010, PROTEIN SCI, V19, P1525, DOI 10.1002/pro.431; BRENNAN TV, 1995, INT J PEPT PROT RES, V45, P547; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Cambon-Bonavita MA, 2000, EXTREMOPHILES, V4, P215, DOI 10.1007/PL00010714; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Caspi J, 2003, MOL MICROBIOL, V50, P1569, DOI 10.1046/j.1365-2958.2003.03825.x; Chen LX, 2000, J BIOL CHEM, V275, P20431, DOI 10.1074/jbc.M000178200; Chen W, 2012, J AM CHEM SOC, V134, P2500, DOI 10.1021/ja211010g; Cheriyan M, 2013, J BIOL CHEM, V288, P6202, DOI 10.1074/jbc.M112.433094; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; COOPER AA, 1993, EMBO J, V12, P2575, DOI 10.1002/j.1460-2075.1993.tb05913.x; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Dassa B, 2004, J BIOL CHEM, V279, P32001, DOI 10.1074/jbc.M404562200; DAVIS EO, 1992, CELL, V71, P201, DOI 10.1016/0092-8674(92)90349-H; Dearden AK, 2013, PROTEIN SCI, V22, P557, DOI 10.1002/pro.2236; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Elleuche S, 2008, BIOCHEM BIOPH RES CO, V366, P239, DOI 10.1016/j.bbrc.2007.11.126; Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.3.CO;2-R; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HODGES RA, 1992, NUCLEIC ACIDS RES, V20, P6153, DOI 10.1093/nar/20.23.6153; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 2005, J BIOL CHEM, V280, P2714, DOI 10.1074/jbc.M412313200; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mills KV, 2001, J BIOL CHEM, V276, P10832, DOI 10.1074/jbc.M011149200; Mizutani R, 2004, J SYNCHROTRON RADIAT, V11, P109, DOI 10.1107/S0909049503023495; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Mujika JI, 2012, ORG BIOMOL CHEM, V10, P1207, DOI 10.1039/c1ob06444d; Mujika JI, 2009, J PHYS CHEM B, V113, P5607, DOI 10.1021/jp808911p; Nicastri MC, 2013, BIOCHEMISTRY-US, V52, P5920, DOI 10.1021/bi400736c; Nichols NM, 2004, BIOCHEMISTRY-US, V43, P10265, DOI 10.1021/bi0494065; Nichols NM, 2003, BIOCHEMISTRY-US, V42, P5301, DOI 10.1021/bi020679e; Nogami S, 1997, GENETICS, V147, P73; Novikova O, 2014, J BIOL CHEM, V289, P14490, DOI 10.1074/jbc.R114.548255; O'Brien KM, 2010, BIOCHEM BIOPH RES CO, V403, P457, DOI 10.1016/j.bbrc.2010.11.055; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Paulus H, 2001, BIOORG CHEM, V29, P119, DOI 10.1006/bioo.2001.1203; Pearl EJ, 2007, BBA-PROTEINS PROTEOM, V1774, P995, DOI 10.1016/j.bbapap.2007.05.015; Pearl EJ, 2007, FEBS LETT, V581, P3000, DOI 10.1016/j.febslet.2007.05.060; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Saleh L, 2011, BIOCHEMISTRY-US, V50, P10576, DOI 10.1021/bi200810j; Schwarzer D, 2012, BIOCHEMISTRY-US, V51, P233, DOI 10.1021/bi2014823; Shah NH, 2013, J AM CHEM SOC, V135, P5839, DOI 10.1021/ja401015p; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shao Y, 1997, J PEPT RES, V50, P193; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; SHAO Y, 1995, BIOCHEMISTRY-US, V34, P10844, DOI 10.1021/bi00034a017; Shemella P, 2007, BIOPHYS J, V92, P847, DOI 10.1529/biophysj.106.092049; Shemella PT, 2011, BIOPHYS J, V100, P2217, DOI 10.1016/j.bpj.2011.02.037; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; Shingledecker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P138, DOI 10.1006/abbi.1999.1645; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Southworth MW, 2004, BIOCHEM SOC T, V32, P250, DOI 10.1042/BST0320250; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Telenti A, 1997, J BACTERIOL, V179, P6378, DOI 10.1128/jb.179.20.6378-6382.1997; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026361; Tori K, 2011, J BACTERIOL, V193, P2035, DOI 10.1128/JB.01407-10; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Volkmann G, 2013, CELL MOL LIFE SCI, V70, P1185, DOI 10.1007/s00018-012-1120-4; Volkmann G, 2011, FEBS J, V278, P3431, DOI 10.1111/j.1742-4658.2011.08266.x; Wang SL, 1997, J BIOL CHEM, V272, P11869, DOI 10.1074/jbc.272.18.11869; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zhang LY, 2010, CHEM-EUR J, V16, P4297, DOI 10.1002/chem.200903584	100	82	87	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14498	14505		10.1074/jbc.R113.540310	http://dx.doi.org/10.1074/jbc.R113.540310			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24695729	Green Published, hybrid			2022-12-28	WOS:000337248100008
J	Komori, T; Tanaka, M; Senba, E; Miyajima, A; Morikawa, Y				Komori, Tadasuke; Tanaka, Minoru; Senba, Emiko; Miyajima, Atsushi; Morikawa, Yoshihiro			Deficiency of OncostatinMReceptor beta (OSMR beta) Exacerbates High-fat Diet-induced Obesity and Related Metabolic Disorders in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Cytokine; Inflammation; Insulin Resistance; Obesity; Hepatic Steatosis; High-fat Diet	ADIPOSE-TISSUE INFLAMMATION; INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; SKELETAL-MUSCLE; T-CELLS; LIVER; ACTIVATION; RECEPTOR; KINASE; EXPRESSION	Background: Obesity is associated with adipose tissue inflammation, insulin resistance, and hepatic steatosis. Results: OSM receptor (OSMR)-deficient mice fed a high-fat diet exhibited severe obesity, adipose tissue inflammation, insulin resistance, and hepatic steatosis. Conclusion: OSM signaling has suppressive effects on the deterioration of obesity-induced metabolic disorders. Significance: These results indicate that OSM signaling may be a promising therapeutic target of obesity-induced metabolic disorders. Oncostatin M (OSM) belongs to the IL-6 family of cytokines and has diverse biological effects, including the modulation of inflammatory responses. In the present study we analyzed the roles of OSM signaling in obesity and related metabolic disorders. Under a high-fat diet condition, OSM receptor subunit-deficient (OSMR-/-) mice exhibited increases in body weight and food intake compared with those observed in WT mice. In addition, adipose tissue inflammation, insulin resistance, and hepatic steatosis were more severe in OSMR-/- mice than in wild-type (WT) mice. These metabolic phenotypes did not improve when OSMR-/- mice were pair-fed with WT mice, suggesting that the effects of OSM signaling on these phenotypes are independent of the increases in the body weight and food intake. In the liver of OSMR-/- mice, the insulin-induced phosphorylation of p70 S6 kinase remained intact, whereas insulin-induced FOXO1 phosphorylation was impaired. In addition, OSMR-/- mice displayed a higher expression of genes related to de novo lipogenesis in the liver than WT mice. Furthermore, treatment of genetically obese ob/ob mice with OSM improved insulin resistance, adipose tissue inflammation, and hepatic steatosis. Intraportal administration of OSM into ob/ob mice activated STAT3 and increased the expression of long-chain acyl-CoA synthetase (ACSL) 3 and ACSL5 with decreased expression of fatty acid synthase in the liver, suggesting that OSM directly induces lipolysis and suppresses lipogenesis in the liver of obese mice. These findings suggest that defects in OSM signaling promote the deterioration of high-fat diet-induced obesity and related metabolic disorders.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Tanaka, Minoru; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo 1130032, Japan	Wakayama Medical University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp			Wakayama Medical University	Wakayama Medical University	This work was supported in part by a Research Grant on Priority Areas from Wakayama Medical University.	Bae EJ, 2012, J BIOL CHEM, V287, P18769, DOI 10.1074/jbc.M112.365544; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Broxmeyer HE, 2002, IMMUNITY, V16, P815, DOI 10.1016/S1074-7613(02)00319-9; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Grzelkowska-Kowalczyk K, 2010, CELL BIOL INT, V34, P117, DOI 10.1042/CBI20090135; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Komori T, 2012, J BIOL CHEM, V287, P19985, DOI 10.1074/jbc.M112.367854; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Repovic P, 2002, J NEUROSCI, V22, P5334; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429	51	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13821	13837		10.1074/jbc.M113.542399	http://dx.doi.org/10.1074/jbc.M113.542399			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695736	hybrid, Green Published			2022-12-28	WOS:000335984600016
J	Pokutta, S; Choi, HJ; Ahlsen, G; Hansen, SD; Weis, WI				Pokutta, Sabine; Choi, Hee-Jung; Ahlsen, Goran; Hansen, Scott D.; Weis, William I.			Structural and Thermodynamic Characterization of Cadherin center dot beta-Catenin center dot alpha-Catenin Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Cadherins; Cell Adhesion; Isothermal Titration Calorimetry; X-ray Crystallography; -Catenin; -Catenin	CRYSTAL-STRUCTURE; VINCULIN ACTIVATION; CELL-ADHESION; F-ACTIN; BINDING; PROTEIN; PHOSPHORYLATION; CONTACTS; TENSION; SITES	Background: Cadherin cell adhesion molecules are linked to the actin cytoskeleton by the proteins - and -catenin. Results: The interactions of -catenins in the cadherin-catenin-catenin complex have been thermodynamically and structurally defined. Conclusion: The architecture of -catenin enables regulation of its interactions in the adhesive complex. Significance: The data provide molecular insights into the regulation of the cadherincatenin complex. The classical cadherin-catenin-catenin complex mediates homophilic cell-cell adhesion and mechanically couples the actin cytoskeletons of adjacent cells. Although -catenin binds to -catenin and to F-actin, -catenin significantly weakens the affinity of -catenin for F-actin. Moreover, -catenin self-associates into homodimers that block -catenin binding. We investigated quantitatively and structurally E- and N-catenin dimer formation, their interaction with -catenin and the cadherin-catenin complex, and the effect of the -catenin actin-binding domain on -catenin association. The two -catenin variants differ in their self-association properties: at physiological temperatures, E-catenin homodimerizes 10x more weakly than does N-catenin but is kinetically trapped in its oligomeric state. Both E- and N-catenin bind to -catenin with a K-d of 20 nm, and this affinity is increased by an order of magnitude when cadherin is bound to -catenin. We describe the crystal structure of a complex representing the full -cateninN-catenin interface. A three-dimensional model of the cadherin-catenin-catenin complex based on these new structural data suggests mechanisms for the enhanced stability of the ternary complex. The C-terminal actin-binding domain of -catenin has no influence on the interactions with -catenin, arguing against models in which -catenin weakens actin binding by stabilizing inhibitory intramolecular interactions between the actin-binding domain and the rest of -catenin.	[Pokutta, Sabine; Choi, Hee-Jung; Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Pokutta, Sabine; Choi, Hee-Jung; Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Choi, Hee-Jung] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Ahlsen, Goran] Columbia Univ, Howard Hughes Med Inst, Dept Syst Biol, New York, NY 10032 USA; [Ahlsen, Goran] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hansen, Scott D.] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Stanford University; Stanford University; Seoul National University (SNU); Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weis, WI (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526	United States Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, U01GM094663] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0918535] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Barry Honig and Larry Shapiro for access to AUC facilities at Columbia University and James Nelson for comments on the manuscript. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, which is supported by the United States Department of Energy and the National Institutes of Health.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	48	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13589	13601		10.1074/jbc.M114.554709	http://dx.doi.org/10.1074/jbc.M114.554709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692547	Green Published, hybrid			2022-12-28	WOS:000335522800053
J	Ray, S; Bender, S; Kang, S; Lin, R; Glicksman, MA; Liu, M				Ray, Soumya; Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min			The Parkinson Disease-linked LRRK2 Protein Mutation I2020T Stabilizes an Active State Conformation Leading to Increased Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Kinetics; LRRK2; Molecular modeling; Parkinson Disease	STRUCTURAL MECHANISM; NEURONAL TOXICITY; GTP-BINDING; MUTANT; INHIBITORS; GENE; PHOSPHORYLATES; G2019S	Background: LRRK2 has emerged as one of the most relevant players in Parkinson disease pathogenesis. Results: Enzyme kinetic and modeling studies elucidate the effect of the LRRK2 I2020T mutant on kinase activity. Conclusion: The I2020T mutant stabilizes the active conformation and leads to increased kinase activity. As a result, it binds to type II inhibitors competitively. Significance: This study may contribute to the development of new classes of inhibitors of LRRK2. The effect of leucine-rich repeat kinase 2 (LRRK2) mutation I2020T on its kinase activity has been controversial, with both increased and decreased effects being reported. We conducted steady-state and pre-steady-state kinetic studies on LRRKtide and its analog LRRKtide(S). Their phosphorylation differs by the rate-limiting steps: product release is rate-limiting for LRRKtide and phosphoryl transfer is rate-limiting for LRRKtide(S). As a result, we observed that the I2020T mutant is more active than wild type (WT) LRRK2 for LRRKtide(S) phosphorylation, whereas it is less active than WT for LRRKtide phosphorylation. Our pre-steady-state kinetic data suggest that (i) the I2020T mutant accelerates the rates of phosphoryl transfer of both reactions by 3-7-fold; (ii) this increase is masked by a rate-limiting product release step for LRRKtide phosphorylation; and (iii) the observed lower activity of the mutant for LRRKtide phosphorylation is a consequence of its instability: the concentration of the active form of the mutant is 3-fold lower than WT. The I2020T mutant has a dramatically low K-ATP and therefore leads to resistance to ATP competitive inhibitors. Two well known DFG-out or type II inhibitors are also weaker toward the mutant because they inhibit the mutant in an unexpected ATP competitive mechanism. The I2020 residue lies next to the DYG motif of the activation loop of the LRRK2 kinase domain. Our modeling and metadynamic simulations suggest that the I2020T mutant stabilizes the DYG-in active conformation and creates an unusual allosteric pocket that can bind type II inhibitors but in an ATP competitive fashion.	[Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min] Harvard Univ, Sch Med, Lab Drug Discovery Neurodegenerat, Harvard NeuroDiscovery Ctr, Cambridge, MA 02139 USA; [Ray, Soumya; Bender, Samantha; Kang, Stephanie; Lin, Regina; Glicksman, Marcie A.; Liu, Min] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cambridge, MA 02139 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Liu, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Cambridge, MA 02139 USA.	mliu@rics.bwh.harvard.edu		liu, min/0000-0003-0500-3246	National Institutes of Health [R21 NS 072519]; Harvard Milton fund foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Milton fund foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS 072519 and the Harvard Milton fund foundation.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barducci A, 2010, BIOPHYS J, V98, pL44, DOI 10.1016/j.bpj.2010.01.033; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Berteotti A, 2011, J AM CHEM SOC, V133, P17200, DOI 10.1021/ja202849a; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013208; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Choi HG, 2012, BIOORG MED CHEM LETT, V22, P5297, DOI 10.1016/j.bmcl.2012.06.036; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Leone V, 2010, CURR OPIN STRUC BIOL, V20, P148, DOI 10.1016/j.sbi.2010.01.011; Limongelli V, 2012, P NATL ACAD SCI USA, V109, P1467, DOI 10.1073/pnas.1112181108; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Liu M, 2013, BIOCHEMISTRY-US, V52, P1725, DOI 10.1021/bi3012077; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Mata IF, 2005, NEUROSCI LETT, V382, P309, DOI 10.1016/j.neulet.2005.03.033; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Ohta E, 2009, BIOCHEM BIOPH RES CO, V390, P710, DOI 10.1016/j.bbrc.2009.10.034; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ray S, 2012, FUTURE MED CHEM, V4, P1701, DOI [10.4155/fmc.12.110, 10.4155/FMC.12.110]; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Sanchez R, 1997, PROTEINS, P50; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Segel I.H., 1975, ENZYME KINETICS; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	54	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13042	13053		10.1074/jbc.M113.537811	http://dx.doi.org/10.1074/jbc.M113.537811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24695735	Green Published, hybrid			2022-12-28	WOS:000335522800008
J	Harada, J; Mizoguchi, T; Tsukatani, Y; Yokono, M; Tanaka, A; Tamiaki, H				Harada, Jiro; Mizoguchi, Tadashi; Tsukatani, Yusuke; Yokono, Makio; Tanaka, Ayumi; Tamiaki, Hitoshi			Chlorophyllide a Oxidoreductase Works as One of the Divinyl Reductases Specifically Involved in Bacteriochlorophyll a Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Evolution; Microbiology; Photosynthesis; Photosynthetic Pigments; Reductase; BciA; BciB; DVR; Photosynthetic Bacteria; Purple Bacteria	HELIOBACTERIUM-MODESTICALDUM; CHROMOSOMAL INSERTION; ARABIDOPSIS-THALIANA; 8-VINYL REDUCTASE; IDENTIFICATION; PROTOCHLOROPHYLLIDE; DERIVATIVES; MUTAGENESIS; EVOLUTION; MONOVINYL	Background: An unknown third divinyl-chlorophyllide a reductase (DVR) was proposed among phototrophs. Results: The double mutant lacking the conventional DVR and chlorophyllide a reductase (COR) of a purple bacterium uniquely accumulated divinyl-chlorophyllide a. Conclusion: An additional activity of COR corresponds to the third DVR, which is conserved among other photosynthetic bacteria. Significance: COR is suggested to be the evolutionarily oldest DVR among three DVRs. Bacteriochlorophyll a is widely distributed among anoxygenic photosynthetic bacteria. In bacteriochlorophyll a biosynthesis, the reduction of the C8 vinyl group in 8-vinyl-chlorophyllide a is catalyzed to produce chlorophyllide a by an 8-vinyl reductase called divinyl reductase (DVR), which has been classified into two types, BciA and BciB. However, previous studies demonstrated that mutants lacking the DVR still synthesize normal bacteriochlorophyll a with the C8 ethyl group and suggested the existence of an unknown third DVR. Meanwhile, we recently observed that chlorophyllide a oxidoreductase (COR) of a purple bacterium happened to show the 8-vinyl reduction of 8-vinyl-chlorophyllide a in vitro. In this study, we made a double mutant lacking BciA and COR of the purple bacterium Rhodobacter sphaeroides in order to investigate whether the mutant still produces pigments with the C8 ethyl group or if COR actually works as the third DVR. The single mutant deleting BciA or COR showed production of the C8 ethyl group pigments, whereas the double mutant accumulated 8-vinyl-chlorophyllide, indicating that there was no enzyme other than BciA and COR functioning as the unknown third DVR in Rhodobacter sphaeroides (note that this bacterium has no bciB gene). Moreover, some COR genes derived from other groups of anoxygenic photosynthetic bacteria were introduced into the double mutant, and all of the complementary strains produced normal bacteriochlorophyll a. This observation indicated that COR of these bacteria performs two functions, reductions of the C8 vinyl group and the C7=C8 double bond, and that such an activity is probably conserved in the widely ranging groups.	[Harada, Jiro] Kurume Univ, Dept Med Biochem, Sch Med, Kurume, Fukuoka 8300011, Japan; [Mizoguchi, Tadashi; Tsukatani, Yusuke; Tamiaki, Hitoshi] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan; [Yokono, Makio; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Tsukatani, Yusuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tanaka, Ayumi] Japan Sci & Technol Agcy, CREST, Sapporo, Hokkaido 0600819, Japan	Kurume University; Ritsumeikan University; Hokkaido University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Harada, J (corresponding author), Kurume Univ, Dept Med Biochem, Sch Med, Asahi Machi 67, Kurume, Fukuoka 8300011, Japan.	jiro_harada@med.kurume-u.ac.jp; tamiaki@fc.ritsumei.ac.jp	Tanaka, Ayumi/D-9003-2012; Yokono, Makio/N-8425-2015; Tsukatani, Yusuke/A-6448-2014	Yokono, Makio/0000-0002-4813-2120; Tsukatani, Yusuke/0000-0003-2831-8996	Japan Society for the Promotion of Science [22245030, 24590366, 24750169, 24107002]; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25650092, 24107002, 24550201] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) 22245030 (to H. T.), Grant-in-Aid for Scientific Research (C) 24590366 (to T. M.), Grant-in-Aid for Scientific Research for Young Scientists (B) 24750169 (to J. H.), and Grant-in-Aid for Scientific Research on Innovative Areas "Artificial Photosynthesis (AnApple)" 24107002 (to H. T.) from the Japan Society for the Promotion of Science.; Supported by a PRESTO (Precursory Research for Embryonic Science and Technology) fellowship from the Japan Science and Technology Agency. Present address: Earth-Life Science Institute (ELSI), Tokyo Institute of Technology, Meguro-ku, Tokyo 152-8550, Japan.	BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Canniffe DP, 2013, BIOCHEM J, V450, P397, DOI 10.1042/BJ20121723; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada J, 2008, PHOTOSYNTH RES, V95, P213, DOI 10.1007/s11120-007-9254-1; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; Islam MR, 2008, PLANT PHYSIOL, V148, P1068, DOI 10.1104/pp.108.123117; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda S, 2002, BIOCHEMISTRY-US, V41, P11211, DOI 10.1021/bi0258492; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Mizoguchi T, 2006, FEBS LETT, V580, P6644, DOI 10.1016/j.febslet.2006.11.020; Mizoguchi T, 2012, BIOORGAN MED CHEM, V20, P6803, DOI 10.1016/j.bmc.2012.09.054; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Nagashima S., 2013, ADV BOT RES GENOME E, P152; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Nakanishi H, 2005, PLANT CELL PHYSIOL, V46, P467, DOI 10.1093/pcp/pci053; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; SAEKI K, 1991, J BIOL CHEM, V266, P12889; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; Saunders AH, 2013, BIOCHEMISTRY-US, V52, P8442, DOI 10.1021/bi401172b; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; SUZUKI JY, 1995, J BIOL CHEM, V270, P3732, DOI 10.1074/jbc.270.8.3732; Swingley Wesley D., 2009, V28, P17; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; Walker JS, 2003, RAPID COMMUN MASS SP, V17, P1125, DOI 10.1002/rcm.1015	40	20	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12716	12726		10.1074/jbc.M113.546739	http://dx.doi.org/10.1074/jbc.M113.546739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24637023	hybrid, Green Published			2022-12-28	WOS:000335581400043
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			Identification of a Novel Protein Binding Motif within the T-synthase for the Molecular Chaperone Cosmc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycobiology; Glycoprotein; Glycoprotein Biosynthesis; Glycosylation; Molecular Chaperone; Protein Folding; Cosmc; T-synthase	COLLAGEN TRIPLE-HELIX; TOLL-LIKE RECEPTORS; O-GLYCOSYLATION; IN-VITRO; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; CAENORHABDITIS-ELEGANS; LEUKOCYTE RECRUITMENT; PSGL-1 BINDING; UDP-GLCNAC; MUCIN	Background: We hypothesize that ER chaperone Cosmc binds specifically to its single client T-synthase. Results: Using molecular and biochemical approaches, we demonstrate that Cosmc recognizes a specific peptide within unfolded T-synthase. Conclusion: Cosmc-T-synthase interaction requires unique peptide recognition in the unfolded T-synthase that becomes inaccessible to Cosmc upon final folding. Significance: This study describes a novel peptide-specific chaperone recognition that regulates protein O-glycosylation. Prior studies suggested that the core 1 3-galactosyltransferase (T-synthase) is a specific client of the endoplasmic reticulum chaperone Cosmc, whose function is required for T-synthase folding, activity, and consequent synthesis of normal O-glycans in all vertebrate cells. To explore whether the T-synthase encodes a specific recognition motif for Cosmc, we used deletion mutagenesis to identify a cryptic linear and relatively hydrophobic peptide in the N-terminal stem region of the T-synthase that is essential for binding to Cosmc (Cosmc binding region within T-synthase, or CBRT). Using this sequence information, we synthesized a peptide containing CBRT and found that it directly interacts with Cosmc and also inhibits Cosmc-assisted in vitro refolding of denatured T-synthase. Moreover, engineered T-synthase carrying mutations within CBRT exhibited diminished binding to Cosmc that resulted in the formation of inactive T-synthase. To confirm the general recognition of CBRT by Cosmc, we performed a domain swap experiment in which we inserted the stem region of the T-synthase into the human 4GalT1 and found that the CBRT element can confer Cosmc binding onto the 4GalT1 chimera. Thus, CBRT is a unique recognition motif for Cosmc to promote its regulation and formation of active T-synthase and represents the first sequence-specific chaperone recognition system in the ER/Golgi required for normal protein O-glycosylation.	[Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Ju, TZ (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Ste 4001, Atlanta, GA 30322 USA.	tju@emory.edu; rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [DK0808760, GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0808760 (to T. J.) and GM068559 (to R. D. C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; BROCKHAUSEN I, 1985, BIOCHEMISTRY-US, V24, P1866, DOI 10.1021/bi00329a010; Cho SK, 1997, J BIOL CHEM, V272, P13622, DOI 10.1074/jbc.272.21.13622; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dafforn TR, 2001, J BIOL CHEM, V276, P49310, DOI 10.1074/jbc.M108896200; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Huang J, 2014, MOL CARCINOGEN, V53, pE62, DOI 10.1002/mc.22011; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johswich A, 2009, J CELL BIOL, V184, P173, DOI 10.1083/jcb.200801071; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitazume-Kawaguchi S, 1999, GLYCOBIOLOGY, V9, P1397; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Kraft B, 2011, CELL MOL LIFE SCI, V68, P4091, DOI 10.1007/s00018-011-0725-3; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Lee JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056211; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; Madsen CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072413; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McEver RP, 1997, J CLIN INVEST, V100, pS97; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yagi-Utsumi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045930; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	67	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11630	11641		10.1074/jbc.M114.555870	http://dx.doi.org/10.1074/jbc.M114.555870			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616093	hybrid, Green Published			2022-12-28	WOS:000335010600006
J	Eram, MS; Bustos, SP; Lima-Fernandes, E; Siarheyeva, A; Senisterra, G; Hajian, T; Chau, I; Duan, SL; Wu, H; Dombrovski, L; Schapira, M; Arrowsmith, CH; Vedadi, M				Eram, Mohammad S.; Bustos, Susan P.; Lima-Fernandes, Evelyne; Siarheyeva, Alena; Senisterra, Guillermo; Hajian, Taraneh; Chau, Irene; Duan, Shili; Wu, Hong; Dombrovski, Ludmila; Schapira, Matthieu; Arrowsmith, Cheryl H.; Vedadi, Masoud			Trimethylation of Histone H3 Lysine 36 by Human Methyltransferase PRDM9 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Enzyme Inhibitors; Enzyme Kinetics; Epigenetics; Histone Methylation; Methyltransferase	SINGLE-NUCLEOTIDE POLYMORPHISMS; RECOMBINATION HOT-SPOTS; ZINC-FINGER PROTEIN; MEIOTIC RECOMBINATION; MEISETZ GENE; PR DOMAIN; METHYLATION; BINDING; FAMILY; REPAIR	Background: Histone methyltransferase PRDM9 marks recombination hot spots and is implicated in sterility and cancers. Results: We identified histone H3K36 as a new methylation mark for PRDM9. Conclusion: PRDM9 is a highly active histone methyltransferase that trimethylates H3K4 and H3K36. Significance: Discovering PRDM9 as a H3K36 methyltransferase could lead to identifying the roles that PRDM9 may play in human fertility and susceptibility to cancer. PRDM9 (PR domain-containing protein 9) is a meiosis-specific protein that trimethylates H3K4 and controls the activation of recombination hot spots. It is an essential enzyme in the progression of early meiotic prophase. Disruption of the PRDM9 gene results in sterility in mice. In human, several PRDM9 SNPs have been implicated in sterility as well. Here we report on kinetic studies of H3K4 methylation by PRDM9 in vitro indicating that PRDM9 is a highly active histone methyltransferase catalyzing mono-, di-, and trimethylation of the H3K4 mark. Screening for other potential histone marks, we identified H3K36 as a second histone residue that could also be mono-, di-, and trimethylated by PRDM9 as efficiently as H3K4. Overexpression of PRDM9 in HEK293 cells also resulted in a significant increase in trimethylated H3K36 and H3K4 further confirming our in vitro observations. Our findings indicate that PRDM9 may play critical roles through H3K36 trimethylation in cells.	[Eram, Mohammad S.; Bustos, Susan P.; Lima-Fernandes, Evelyne; Siarheyeva, Alena; Senisterra, Guillermo; Hajian, Taraneh; Chau, Irene; Wu, Hong; Dombrovski, Ludmila; Schapira, Matthieu; Arrowsmith, Cheryl H.; Vedadi, Masoud] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, MaRS Ctr, South Tower,101 Coll St,7th Floor,Rm 714, Toronto, ON M5G 1L7, Canada.	m.vedadi@utoronto.ca		Lima Fernandes, Evelyne/0000-0002-3628-9745; Hajian, Taraneh/0000-0002-3248-6266; Arrowsmith, Cheryl/0000-0002-4971-3250	AbbVie [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust Grant [092809/Z/10/Z]; National Research Fund, Luxembourg; European Commission	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust Grant(Wellcome Trust); National Research Fund, Luxembourg(Luxembourg National Research Fund); European Commission(European CommissionEuropean Commission Joint Research Centre)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust Grant 092809/Z/10/Z.; Recipient of a Post-doctoral fellowship by the National Research Fund, Luxembourg, and in part by the Marie Curie Actions of the European Commission (FP7-COFUND).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Allali-Hassani A, 2012, J BIOMOL SCREEN, V17, P71, DOI 10.1177/1087057111422256; Anand Mt, 2012, J Hum Reprod Sci, V5, P266, DOI 10.4103/0974-1208.106339; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BORUN TW, 1972, J BIOL CHEM, V247, P4288; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Feichtinger J, 2012, ONCOTARGET, V3, P843; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HEMPEL K, 1968, NATURWISSENSCHAFTEN, V55, P37, DOI 10.1007/BF00593411; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim KC, 2003, CANCER RES, V63, P7619; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Newbold RF, 2010, ANTICANCER RES, V30, P3309; Nimura K, 2010, J MOL MED, V88, P1213, DOI 10.1007/s00109-010-0668-4; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V27, P479, DOI 10.1016/S0006-291X(67)80010-X; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	61	75	76	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12177	12188		10.1074/jbc.M113.523183	http://dx.doi.org/10.1074/jbc.M113.523183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634223	hybrid, Green Published			2022-12-28	WOS:000335010600053
J	Kurimoto, A; Kitazume, S; Kizuka, Y; Nakajima, K; Oka, R; Fujinawa, R; Korekane, H; Yamaguchi, Y; Wada, Y; Taniguchi, N				Kurimoto, Ayako; Kitazume, Shinobu; Kizuka, Yasuhiko; Nakajima, Kazuki; Oka, Ritsuko; Fujinawa, Reiko; Korekane, Hiroaki; Yamaguchi, Yoshiki; Wada, Yoshinao; Taniguchi, Naoyuki			The Absence of Core Fucose Up-regulates GnT-III and Wnt Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Glycosyltransferases; Lectin; Mass Spectrometry (MS); Oxidative Stress; Wnt Pathway; Fut8; GnT-III; Bisecting GlcNAc; Core Fucose	N-ACETYLGLUCOSAMINYLTRANSFERASE-III; TANDEM MASS-SPECTROMETRY; BETA-CATENIN; E-CADHERIN; GLYCOPROTEIN-SYNTHESIS; DEFICIENT MICE; CELL-ADHESION; CDNA CLONING; LUNG-CANCER; PURIFICATION	Background: Little is known about how loss of a given glycan causes adaptive regulation of other glycosylation. Results: Deficiency in core 1,6-fucose specifically up-regulates bisecting GlcNAc by enhanced gene expression of a biosynthetic enzyme GnT-III. Conclusion: Wnt signaling pathway regulates the expression of GnT-III. Significance: Wnt-mediated GnT-III up-regulation may be an adaptive response to the loss of core fucose. Glycans play key roles in a variety of protein functions under normal and pathological conditions, but several glycosyltransferase-deficient mice exhibit no or only mild phenotypes due to redundancy or compensation of glycan functions. However, we have only a limited understanding of the underlying mechanism for these observations. Our previous studies indicated that 70% of Fut8-deficient (Fut8(-/-)) mice that lack core fucose structure die within 3 days after birth, but the remainder survive for up to several weeks although they show growth retardation as well as emphysema. In this study, we show that, in mouse embryonic fibroblasts (MEFs) from Fut8(-/-) mice, another N-glycan branching structure, bisecting GlcNAc, is specifically up-regulated by enhanced gene expression of the responsible enzyme N-acetylglucosaminyltransferase III (GnT-III). As candidate target glycoproteins for bisecting GlcNAc modification, we confirmed that level of bisecting GlcNAc on 1-integrin and N-cadherin was increased in Fut8(-/-) MEFs. Moreover using mass spectrometry, glycan analysis of IgG(1) in Fut8(-/-) mouse serum demonstrated that bisecting GlcNAc contents were also increased by Fut8 deficiency in vivo. As an underlying mechanism, we found that in Fut8(-/-) MEFs Wnt/-catenin signaling is up-regulated, and an inhibitor against Wnt signaling was found to abrogate GnT-III expression, indicating that Wnt/-catenin is involved in GnT-III up-regulation. Furthermore, various oxidative stress-related genes were also increased in Fut8(-/-) MEFs. These data suggest that Fut8(-/-) mice adapted to oxidative stress, both ex vivo and in vivo, by inducing various genes including GnT-III, which may compensate for the loss of core fucose functions.	[Korekane, Hiroaki; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr, RIKEN Global Res Cluster, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yamaguchi, Yoshiki] RIKEN, RIKEN Max Planck Joint Res Ctr, RIKEN Global Res Cluster, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Wada, Yoshinao] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Izumi Ku, Osaka 5941101, Japan	RIKEN; RIKEN	Taniguchi, N (corresponding author), RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Yamaguchi, Yoshiki/N-5246-2015; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Yamaguchi, Yoshiki/0000-0003-0100-5439; Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743	RIKEN (the Systems Glycobiology Research project) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [20249018]; global Certificate of Eligibility (COE) program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN (the Systems Glycobiology Research project) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global Certificate of Eligibility (COE) program from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by RIKEN (the Systems Glycobiology Research project) (to N. T.), Grant-in-Aid for Scientific Research (A) 20249018 (to N. T.), and the global Certificate of Eligibility (COE) program (to N. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ashline DJ, 2007, ANAL CHEM, V79, P3830, DOI 10.1021/ac062383a; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Korekane H, 2010, J BIOCHEM, V148, P359, DOI 10.1093/jb/mvq077; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; MIZUOCHI T, 1987, ARCH BIOCHEM BIOPHYS, V257, P387, DOI 10.1016/0003-9861(87)90581-9; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Nishima W, 2012, J PHYS CHEM B, V116, P8504, DOI 10.1021/jp212550z; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; SANTER UV, 1979, BIOCHEMISTRY-US, V18, P2533, DOI 10.1021/bi00579a016; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Taniguchi N, 1996, GLYCOBIOLOGY, V6, P691, DOI 10.1093/glycob/6.7.691; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wada Y, 2010, J PROTEOME RES, V9, P1367, DOI 10.1021/pr900913k; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2006, METHOD ENZYMOL, V417, P11, DOI 10.1016/S0076-6879(06)17002-0; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	48	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11704	11714		10.1074/jbc.M113.502542	http://dx.doi.org/10.1074/jbc.M113.502542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24619415	hybrid, Green Published			2022-12-28	WOS:000335010600013
J	Tar, K; Dange, T; Yang, CY; Yao, YH; Bulteau, AL; Salcedo, EF; Braigen, S; Bouillaud, F; Finley, D; Schmidt, M				Tar, Krisztina; Dange, Thomas; Yang, Ciyu; Yao, Yanhua; Bulteau, Anne-Laure; Salcedo, Elena Fernandez; Braigen, Stephen; Bouillaud, Frederic; Finley, Daniel; Schmidt, Marion			Proteasomes Associated with the Blm10 Activator Protein Antagonize Mitochondrial Fission through Degradation of the Fission Protein Dnm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Oxidative Stress; Proteasome; Protein Degradation; Respiration	PROGRAMMED CELL-DEATH; REG-GAMMA-PROTEASOME; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; REPEAT PROTEIN; CORE PARTICLE; DNA-REPAIR; YEAST; PA200; MITOFUSIN	Background: Blm10 binds to the proteasome core particle and stimulates its proteolytic activity. Results: Loss of BLM10 results in impaired respiration, elevated oxidative stress sensitivity, increased mitochondrial fission, and stabilization of the fission protein Dnm1. Conclusion: Blm10 proteasome-mediated Dnm1 degradation is a regulatory mechanism to maintain correct mitochondrial function. Significance: Blm10 is involved in mitochondrial quality control under oxidative stress. The conserved Blm10/PA200 activators bind to the proteasome core particle gate and facilitate turnover of peptides and unfolded proteins in vitro. We report here that Blm10 is required for the maintenance of functional mitochondria. BLM10 expression is induced 25-fold upon a switch from fermentation to oxidative metabolism. In the absence of BLM10, Saccharomyces cerevisiae cells exhibit a temperature-sensitive growth defect under oxidative growth conditions and produce colonies with dysfunctional mitochondria at high frequency. Loss of BLM10 leads to reduced respiratory capacity, increased mitochondrial oxidative damage, and reduced viability in the presence of oxidative stress or death stimuli. In the absence of BLM10, increased fragmentation of the mitochondrial network under oxidative stress is observed indicative of elevated activity of the mitochondrial fission machinery. The degradation of Dnm1, the main factor mediating mitochondrial fission, is impaired in the absence of BLM10 in vitro and in vivo. These data suggest that the mitochondrial functional and morphological changes observed are related to elevated Dnm1 levels. This hypothesis is supported by the finding that cells that constitutively overexpress DNM1 display the same mitochondrial defects as blm10 cells. The data are consistent with a model in which Blm10 proteasome-mediated turnover of Dnm1 is required for the maintenance of mitochondrial function and provides cytoprotection under conditions that induce increased mitochondrial damage and programmed cell death.	[Tar, Krisztina; Dange, Thomas; Yang, Ciyu; Yao, Yanhua; Salcedo, Elena Fernandez; Braigen, Stephen; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Bulteau, Anne-Laure; Bouillaud, Frederic] INSERM, Inst Cochin, F-75014 Paris, France; [Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School	Schmidt, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	marion.schmidt@einstein.yu.edu	Bouillaud, Frédéric R/L-3238-2017; bulteau, anne-laure/AAN-4004-2020; YAO, Yanhua/E-6513-2016	Bouillaud, Frédéric R/0000-0002-7518-9237; YAO, Yanhua/0000-0002-7989-8604	National Institutes of Health [R01 GM084228, R37 GM43601, R01 GM65592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592, R01GM084228, R37GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM084228 (to M. S.) and R37 GM43601 and R01 GM65592 (to D. F.).	Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Anton F, 2013, MOL CELL, V49, P487, DOI 10.1016/j.molcel.2012.12.003; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Blickwedehl J, 2012, MOL CANCER RES, V10, P937, DOI 10.1158/1541-7786.MCR-11-0493-T; Brachmann CB, 1998, YEAST, V14, P115; Braun RJ, 2011, BIOCHEM SOC T, V39, P1520, DOI 10.1042/BST0391520; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Joshi KK, 2011, J MOL BIOL, V410, P383, DOI 10.1016/j.jmb.2011.05.005; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sutovsky P, 1996, BIOL REPROD, V55, P1195, DOI 10.1095/biolreprod55.6.1195; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Teng XC, 2009, METHODS MOL BIOL, V559, P335, DOI 10.1007/978-1-60327-017-5_23; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	66	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12145	12156		10.1074/jbc.M114.554105	http://dx.doi.org/10.1074/jbc.M114.554105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24604417	hybrid, Green Published			2022-12-28	WOS:000335010600050
J	Belogurov, A; Kudriaeva, A; Kuzina, E; Smirnov, I; Bobik, T; Ponomarenko, N; Kravtsova-Ivantsiv, Y; Ciechanover, A; Gabibov, A				Belogurov, Alexey, Jr.; Kudriaeva, Anna; Kuzina, Ekaterina; Smirnov, Ivan; Bobik, Tatyana; Ponomarenko, Natalia; Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron; Gabibov, Alexander			Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination during Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; PEPTIDES; ENCEPHALOMYELITIS; PATHWAY; OLIGODENDROCYTES; ELECTROPHORESIS; AUTOANTIBODIES; SUSCEPTIBILITY; PURIFICATION; DESTRUCTION	The vast majority of cellular proteins are degraded by the 26S proteasome after their ubiquitination. Here, we report that the major component of the myelin multilayered membrane sheath, myelin basic protein (MBP), is hydrolyzed by the 26S proteasome in a ubiquitin-independent manner both in vitro and in mammalian cells. As a proteasomal substrate, MBP reveals a distinct and physiologically relevant concentration range for ubiquitin-independent proteolysis. Enzymatic deimination prevents hydrolysis of MBP by the proteasome, suggesting that an abnormally basic charge contributes to its susceptibility toward proteasome-mediated degradation. To our knowledge, our data reveal the first case of a pathophysiologically important autoantigen as a ubiquitin-independent substrate of the 26S proteasome.	[Belogurov, Alexey, Jr.; Kudriaeva, Anna; Kuzina, Ekaterina; Smirnov, Ivan; Bobik, Tatyana; Ponomarenko, Natalia; Gabibov, Alexander] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia; [Belogurov, Alexey, Jr.; Gabibov, Alexander] Russian Acad Sci, Inst Gene Biol, Moscow 117334, Russia; [Kuzina, Ekaterina; Smirnov, Ivan; Gabibov, Alexander] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia; [Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron] Technion Israel Inst Technol, Canc & Vasc Biol Ctr, Rappaport Fac Med, IL-31096 Haifa, Israel; [Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Ciechanover, A (corresponding author), Technion Israel Inst Technol, Canc & Vasc Biol Ctr, Rappaport Fac Med, IL-31096 Haifa, Israel.	c_tzachy@netvision.net.il; gabibov@mx.ibch.ru	Smirnov, Ivan/N-5635-2017; Kudriaeva, Anna/P-5893-2017; Belogurov, Alexey/L-5859-2017; Bobik, Tatyana/E-6742-2014; Ciechanover, Aaron J/C-9166-2017	Smirnov, Ivan/0000-0002-0384-6568; Kudriaeva, Anna/0000-0003-1163-9929; Belogurov, Alexey/0000-0002-2033-9621; Bobik, Tatyana/0000-0002-4113-9442; Kuzina, Ekaterina/0000-0002-5468-0262	Russian Scientific Foundation [14-14-00585]; Russian Foundation for Basic Research [12-04-33258, 12-04-01609-a]; Russian Federation [CPi 2445.2013.4]; Skolkovo program; RFBR [10-04-00673, 13-04-40277-H]; Scientific School Support Program "Chemical Basis of Biocatalysis" [2046.2012.4]; Presidium of the Russian Academy of Sciences [24]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]; European Union Treat PolyQ Network; Deutsch-Israelische Projektkooperation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Skolkovo program; RFBR(Russian Foundation for Basic Research (RFBR)); Scientific School Support Program "Chemical Basis of Biocatalysis"; Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); European Union Treat PolyQ Network; Deutsch-Israelische Projektkooperation	This work was supported by Russian Scientific Foundation Project 14-14-00585 "Molecular mechanism and physiological significance of the ubiquitin-independent proteasomal degradation of the proteins," which was supported in part by Russian Foundation for Basic Research Grant 12-04-33258, 12-04-01609-a, and Fellowship of President of Russian Federation C Pi 2445.2013.4 (to A. B.). This work was also supported in part by the Skolkovo program and RFBR 10-04-00673, 13-04-40277-H, the Scientific School Support Program "Chemical Basis of Biocatalysis" 2046.2012.4, the programs of the Presidium of the Russian Academy of Sciences "Peculiarities of Antigen Degradation in Autoimmune Neurodegeneration," " Nanotechnologies and Nanomaterials" 24 (Federal Special Research Programs "Fundamental Science for Medicine"), and "Molecular and Cellular Biology" (to A. G.). This work was also supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Israel Science Foundation, the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (Grant 1775/12), the European Union Treat PolyQ Network, and the Deutsch-Israelische Projektkooperation (to A. C.).	Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Akaishi T, 1996, BRAIN RES, V722, P139, DOI 10.1016/0006-8993(96)00212-0; BARBARESE E, 1981, P NATL ACAD SCI-BIOL, V78, P1953, DOI 10.1073/pnas.78.3.1953; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov AA, 2013, FASEB J, V27, P222, DOI 10.1096/fj.12-213975; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Happel P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01806; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huber EM, 2012, ANGEW CHEM INT EDIT, V51, P8708, DOI 10.1002/anie.201201616; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jurewicz A, 1998, J IMMUNOL, V160, P3056; KARIN N, 1994, J EXP MED, V180, P2227, DOI 10.1084/jem.180.6.2227; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; KONO DH, 1988, J EXP MED, V168, P213, DOI 10.1084/jem.168.1.213; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; KRISTENSSON K, 1986, NATURE, V322, P544, DOI 10.1038/322544a0; LAATSCH RH, 1962, J EXP MED, V115, P777, DOI 10.1084/jem.115.4.777; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MONFERRAN CG, 1986, MOL CELL BIOCHEM, V70, P131; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171	39	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17758	17766		10.1074/jbc.M113.544247	http://dx.doi.org/10.1074/jbc.M113.544247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24739384	hybrid, Green Published			2022-12-28	WOS:000338018100039
J	Fay, MM; Clegg, JM; Uchida, KA; Powers, MA; Ullman, KS				Fay, Marta M.; Clegg, James M.; Uchida, Kimberly A.; Powers, Matthew A.; Ullman, Katharine S.			Enhanced Arginine Methylation of Programmed Cell Death 4 Protein during Nutrient Deprivation Promotes Tumor Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PDCD4; EUKARYOTIC TRANSLATION; STRUCTURAL BASIS; EXPRESSION; BINDING; CANCER; TRANSFORMATION; INITIATION; INVASION; PHOSPHORYLATION	The role of programmed cell death 4 (PDCD4) in tumor biology is context-dependent. PDCD4 is described as a tumor suppressor, but its coexpression with protein arginine methyltransferase 5 (PRMT5) promotes accelerated tumor growth. Here, we report that PDCD4 is methylated during nutrient deprivation. Methylation occurs because of increased stability of PDCD4 protein as well as increased activity of PRMT5 toward PDCD4. During nutrient deprivation, levels of methylated PDCD4 promote cell viability, which is dependent on an enhanced interaction with eIF4A. Upon recovery from nutrient deprivation, levels of methylated PDCD4 are regulated by phosphorylation, which controls both the localization and stability of methylated PDCD4. This study reveals that, in response to particular environmental cues, the role of PDCD4 is up-regulated and is advantageous for cell viability. These findings suggest that the methylated form of PDCD4 promotes tumor viability during nutrient deprivation, ultimately allowing the tumor to grow more aggressively.	[Fay, Marta M.; Clegg, James M.; Uchida, Kimberly A.; Powers, Matthew A.; Ullman, Katharine S.] Univ Utah, Oncol Sci Dept, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Uchida, Kimberly A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ullman, KS (corresponding author), Univ Utah, Oncol Sci Dept, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	katie.ullman@hci.utah.edu		Ullman, Katharine/0000-0003-3693-2830	NCI, National Institutes of Health [R21 CA173064]; National Institutes of Health through the Huntsman Cancer Institute [P30 CA042014]; Huntsman Cancer Foundation; graduate research fellowship from the graduate school at the University of Utah; National Institutes of Health Multidisciplinary Cancer Research Training Grant [T32 CA093247]; Undergraduate Research Opportunities Program at the University of Utah; NATIONAL CANCER INSTITUTE [P30CA042014, R21CA173064] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the Huntsman Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; graduate research fellowship from the graduate school at the University of Utah; National Institutes of Health Multidisciplinary Cancer Research Training Grant; Undergraduate Research Opportunities Program at the University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R21 CA173064 and by shared resources supported in part by National Institutes of Health Grant P30 CA042014 through the Huntsman Cancer Institute. This work was also supported by the Huntsman Cancer Foundation.; Supported by a graduate research fellowship from the graduate school at the University of Utah and National Institutes of Health Multidisciplinary Cancer Research Training Grant T32 CA093247.; Supported by the Undergraduate Research Opportunities Program at the University of Utah.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fassan M, 2010, ONCOL REP, V24, P135, DOI 10.3892/or_00000838; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao F, 2009, J CELL MOL MED, V13, P4257, DOI 10.1111/j.1582-4934.2008.00497.x; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kakade D, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-2; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kumar N, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2012.37; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nakashima M, 2010, BBA-MOL CELL RES, V1803, P1020, DOI 10.1016/j.bbamcr.2010.05.002; Olson CM, 2013, ELIFE, V2, DOI 10.7554/eLife.00542; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Song XG, 2013, AUTOPHAGY, V9, P743, DOI 10.4161/auto.24069; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Tsai WW, 2013, P NATL ACAD SCI USA, V110, P8870, DOI 10.1073/pnas.1304602110; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang XY, 2008, ANTICANCER RES, V28, P2991; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Waters LC, 2010, BIOMOL NMR ASSIGN, V4, P49, DOI 10.1007/s12104-009-9205-1; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17541	17552		10.1074/jbc.M113.541300	http://dx.doi.org/10.1074/jbc.M113.541300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24764298	Green Published, hybrid			2022-12-28	WOS:000338018100020
J	Yokom, AL; Morishima, Y; Lau, M; Su, M; Glukhova, A; Osawa, Y; Southworth, DR				Yokom, Adam L.; Morishima, Yoshihiro; Lau, Miranda; Su, Min; Glukhova, Alisa; Osawa, Yoichi; Southworth, Daniel R.			Architecture of the Nitric-oxide Synthase Holoenzyme Reveals Large Conformational Changes and a Calmodulin-driven Release of the FMN Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO COMPLEX-FORMATION; CRYO-EM STRUCTURE; ELECTRON-TRANSFER; REDUCTASE DOMAIN; HEME REDUCTION; CATALYSIS; MICROSCOPY; ACTIVATION; OXYGENASE; VISUALIZATION	Nitric-oxide synthase (NOS) is required in mammals to generate NO for regulating blood pressure, synaptic response, and immune defense. NOS is a large homodimer with well characterized reductase and oxygenase domains that coordinate a multistep, interdomain electron transfer mechanism to oxidize L-arginine and generate NO. Ca2+-calmodulin (CaM) binds between the reductase and oxygenase domains to activate NO synthesis. Although NOS has long been proposed to adopt distinct conformations that alternate between interflavin and FMN-heme electron transfer steps, structures of the holoenzyme have remained elusive and the CaM-bound arrangement is unknown. Here we have applied single particle electron microscopy (EM) methods to characterize the full-length of the neuronal isoform (nNOS) complex and determine the structural mechanism of CaM activation. We have identified that nNOS adopts an ensemble of open and closed conformational states and that CaM binding induces a dramatic rearrangement of the reductase domain. Our three-dimensional reconstruction of the intact nNOS-CaM complex reveals a closed conformation and a cross-monomer arrangement with the FMN domain rotated away from the NADPH-FAD center, toward the oxygenase dimer. This work captures, for the first time, the reductase-oxygenase structural arrangement and the CaM-dependent release of the FMN domain that coordinates to drive electron transfer across the domains during catalysis.	[Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Glukhova, Alisa] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Su, Min; Southworth, Daniel R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Southworth, DR (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	dsouth@umich.edu		Glukhova, Alisa/0000-0003-4146-965X	American Heart Association; National Institutes of Health [GM077430]; University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an American Heart Association Scientist Development Grant, National Institutes of Health Grant GM077430 (to Y. O.), and the University of Michigan Protein Folding Diseases Initiative.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bogdan C, 2001, NAT IMMUNOL; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh S, 1999, J BIOL CHEM, V274, P24100, DOI 10.1074/jbc.274.34.24100; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda SP, 2013, ARCH BIOCHEM BIOPHYS, V533, P88, DOI 10.1016/j.abb.2013.03.004; PARADIES HH, 1979, J BIOL CHEM, V254, P7495; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Rozhkova EA, 2002, J BIOL CHEM, V277, P16888, DOI 10.1074/jbc.M200642200; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	48	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16855	16865		10.1074/jbc.M114.564005	http://dx.doi.org/10.1074/jbc.M114.564005			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24737326	Green Published, hybrid			2022-12-28	WOS:000338016200023
J	Lin, W; Wang, Y; Han, XB; Zhang, ZL; Wang, CY; Wang, J; Yang, HY; Lu, YH; Jiang, WH; Zhao, GP; Zhang, P				Lin, Wei; Wang, Ying; Han, Xiaobiao; Zhang, Zilong; Wang, Chengyuan; Wang, Jin; Yang, Huaiyu; Lu, Yinhua; Jiang, Weihong; Zhao, Guo-Ping; Zhang, Peng			Atypical OmpR/PhoB Subfamily Response Regulator GlnR of Actinomycetes Functions as a Homodimer, Stabilized by the Unphosphorylated Conserved Asp-focused Charge Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actinobacteria; Crystal Structure; Gene Regulation; Phosphorylation; Protein Conformation; OmpR; PhoB Subfamily; Homodimer; Receiver Domain; Unphosphorylated Aspartate	2-COMPONENT SIGNAL-TRANSDUCTION; AMYCOLATOPSIS-MEDITERRANEI U32; STREPTOMYCES-COELICOLOR A3(2); MYCOBACTERIUM-TUBERCULOSIS; NITROGEN-METABOLISM; RECEIVER DOMAIN; ACTIVATION; MECHANISM; PHOSPHORYLATION; TRANSCRIPTION	Background: Orphan response transcription factor GlnR regulates nitrogen metabolism in important actinomycetes. Results: GlnR has no typical phosphorylation pocket, where the only conserved Asp is unphosphorylated but is essential for functional homodimerization. Conclusion: Actinomycete GlnR is an atypical response regulator functioning as a homodimer. Significance: Conserved Asp-focused charge interactions of actinomycete GlnR are probably the mechanism that stabilizes the homodimer for physiological function. The OmpR/PhoB subfamily protein GlnR of actinomycetes is an orphan response regulator that globally coordinates the expression of genes related to nitrogen metabolism. Biochemical and genetic analyses reveal that the functional GlnR from Amycolatopsis mediterranei is unphosphorylated at the potential phosphorylation Asp(50) residue in the N-terminal receiver domain. The crystal structure of this receiver domain demonstrates that it forms a homodimer through the 4-5-5 dimer interface highly similar to the phosphorylated typical response regulator, whereas the so-called phosphorylation pocket is not conserved, with its space being occupied by an Arg(52) from the 3-3 loop. Both in vitro and in vivo experiments confirm that GlnR forms a functional homodimer via its receiver domain and suggest that the charge interactions of Asp(50) with the highly conserved Arg(52) and Thr(9) in the receiver domain may be crucial in maintaining the proper conformation for homodimerization, as also supported by molecular dynamics simulations of the wild type GlnR versus the deficient mutant GlnR(D50A). This model is backed by the distinct phenotypes of the total deficient GlnR(R52A/T9A) double mutant versus the single mutants of GlnR (i.e. D50N, D50E, R52A and T9A), which have only minor effects upon both dimerization and physiological function of GlnR in vivo, albeit their DNA binding ability is weakened compared with that of the wild type. By integrating the supportive data of GlnRs from the model Streptomyces coelicolor and the pathogenic Mycobacterium tuberculosis, we conclude that the actinomycete GlnR is atypical with respect to its unphosphorylated conserved Asp residue being involved in the critical Arg/Asp/Thr charge interactions, which is essential for maintaining the biologically active homodimer conformation.	[Lin, Wei; Wang, Ying; Han, Xiaobiao; Zhang, Zilong; Wang, Jin; Lu, Yinhua; Jiang, Weihong; Zhao, Guo-Ping; Zhang, Peng] Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Wang, Chengyuan; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, State Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; [Wang, Ying; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Yang, Huaiyu] Chinese Acad Sci, Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhao, GP (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	gpzhao@sibs.ac.cn; pengzhang01@sibs.ac.cn	Wang, Jin/P-5458-2019; WANG, Jin/K-2085-2016	Wang, Jin/0000-0003-4008-9284; WANG, Jin/0000-0003-4008-9284; zhang, peng/0000-0003-0408-2923; Zhao, Guo-Ping/0000-0002-7621-6620	National Basic Research Program of China [2012CB721102]; National Nature Science Foundation [31322016, 31121001, 30830002]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012OHTP, 2009CSP001, KSCX2-EW-J-12]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by National Basic Research Program of China Grant 2012CB721102; National Nature Science Foundation Grants 31322016, 31121001, and 30830002; and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grants 2012OHTP, 2009CSP001, and KSCX2-EW-J-12.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; Appleby JL, 1999, MOL MICROBIOL, V34, P915, DOI 10.1046/j.1365-2958.1999.01653.x; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Darbon E, 2012, APPL MICROBIOL BIOT, V95, P1553, DOI 10.1007/s00253-012-3995-2; Ding Xiao-Ming, 2002, Sheng Wu Gong Cheng Xue Bao, V18, P431; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2006, J BACTERIOL, V188, P5204, DOI 10.1128/JB.00387-06; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Jenkins VA, 2012, FEMS MICROBIOL LETT, V330, P38, DOI 10.1111/j.1574-6968.2012.02530.x; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; KIESER T, 1991, METHOD ENZYMOL, V204, P430; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lewis Richard A, 2011, BMC Res Notes, V4, P78, DOI 10.1186/1756-0500-4-78; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Mejia A, 1998, J ANTIBIOT, V51, P58, DOI 10.7164/antibiotics.51.58; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; O'Connor TJ, 2005, J MOL BIOL, V351, P1030, DOI 10.1016/j.jmb.2005.06.053; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Sheridan R. C., 2007, INORG SYN, P23; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Tiffert Y, 2011, APPL MICROBIOL BIOT, V89, P1149, DOI 10.1007/s00253-011-3086-9; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Wang J, 2009, BIOCHEM BIOPH RES CO, V386, P77, DOI 10.1016/j.bbrc.2009.05.147; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang Y, 2013, J BACTERIOL, V195, P2595, DOI 10.1128/JB.00182-13; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu H, 2006, ACTA BIOCH BIOPH SIN, V38, P831, DOI 10.1111/j.1745-7270.2006.00238.x; Zhao W, 2010, CELL RES, V20, P1096, DOI 10.1038/cr.2010.87	54	24	25	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15413	15425		10.1074/jbc.M113.543504	http://dx.doi.org/10.1074/jbc.M113.543504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24733389	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000337465400025
J	Shibasaki, K; Ikenaka, K; Tamalu, F; Tominaga, M; Ishizaki, Y				Shibasaki, Koji; Ikenaka, Kazuhiro; Tamalu, Fuminobu; Tominaga, Makoto; Ishizaki, Yasuki			A Novel Subtype of Astrocytes Expressing TRPV4 (Transient Receptor Potential Vanilloid 4) Regulates Neuronal Excitability via Release of Gliotransmitters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; CATION CHANNEL; ATP RELEASE; SYNAPTIC-TRANSMISSION; ASTROGLIAL NETWORKS; CALCIUM TRANSIENTS; NEURAL-ACTIVITY; HIPPOCAMPUS; ENDFEET; STRETCH	Astrocytes play active roles in the regulation of synaptic transmission. Neuronal excitation can evoke Ca2+ transients in astrocytes, and these Ca2+ transients can modulate neuronal excitability. Although only a subset of astrocytes appears to communicate with neurons, the types of astrocytes that can regulate neuronal excitability are poorly characterized. We found that similar to 30% of astrocytes in the brain express transient receptor potential vanilloid 4 (TRPV4), indicating that astrocytic subtypes can be classified on the basis of their expression patterns. When TRPV4(+) astrocytes are activated by ligands such as arachidonic acid, the activation propagates to neighboring astrocytes through gap junctions and by ATP release from the TRPV4(+) astrocytes. After activation, both TRPV4(+) and TRPV4(-) astrocytes release glutamate, which acts as an excitatory gliotransmitter to increase synaptic transmission through type 1 metabotropic glutamate receptor (mGluR). Our results indicate that TRPV4(+) astrocytes constitute a novel subtype of the population and are solely responsible for initiating excitatory gliotransmitter release to enhance synaptic transmission. We propose that TRPV4(+) astrocytes form a core of excitatory glial assembly in the brain and function to efficiently increase neuronal excitation in response to endogenous TRPV4 ligands.	[Shibasaki, Koji; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 3718511, Japan; [Ikenaka, Kazuhiro] Natl Inst Nat Sci, Div Neurobiol Neuroinformat, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Natl Inst Nat Sci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Ikenaka, Kazuhiro; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Tamalu, Fuminobu] Saitama Med Univ, Dept Physiol, Moroyama, Saitama 3500495, Japan	Gunma University; National Institutes of Natural Sciences (NINS) - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Saitama Medical University	Shibasaki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 3718511, Japan.	shibasaki@gunma-u.ac.jp	Tamalu, Fuminobu/AAE-4580-2020; Shibasaki, Koji/U-8674-2018; Ishizaki, Yasuki/AAB-1209-2020	Tamalu, Fuminobu/0000-0002-2756-8822; Shibasaki, Koji/0000-0003-2330-1749; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology [21200012, 20399554, 24111507, 26111702, 26117502, 23650159, 18077012]; Uehara Memorial Foundation; Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation [13C2]; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research (KAKENHI Projects 21200012, 20399554, 24111507, and 26111702 "Brain Environment" and 26117502 "glial assembly" (to K. S.), 23650159 (to Y. I.), and 18077012 (to M. T.)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, by grants from the Uehara Memorial Foundation, Sumitomo Foundation, Brain Science Foundation, Narishige Neuroscience Research Foundation, and Salt Science Research Foundation no. 13C2 (all to K. S.), and by a grant from the Takeda Science Foundation (to K. S. and Y. I.).	Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Guler AD, 2002, J NEUROSCI, V22, P6408; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kettenmann H. R. B., 2005, NEUROGLIA, P135; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lee HU, 2013, GLIA, V61, P210, DOI 10.1002/glia.22427; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Sasaki T, 2011, CEREB CORTEX, V21, P1889, DOI 10.1093/cercor/bhq256; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shi M, 2013, ACTA NEUROPATHOL, V126, P725, DOI 10.1007/s00401-013-1166-x; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shibasaki K, 2013, BIOCHEM BIOPH RES CO, V441, P327, DOI 10.1016/j.bbrc.2013.10.046; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takayama Y., 2014, FASEB J IN PRESS; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2	45	72	72	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14470	14480		10.1074/jbc.M114.557132	http://dx.doi.org/10.1074/jbc.M114.557132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24737318	hybrid, Green Published			2022-12-28	WOS:000337248100004
J	Suzuki, H; Ohto, U; Higaki, K; Mena-Barragan, T; Aguilar-Moncayo, M; Mellet, CO; Nanba, E; Fernandez, JMG; Suzuki, Y; Shimizu, T				Suzuki, Hironori; Ohto, Umeharu; Higaki, Katsumi; Mena-Barragan, Teresa; Aguilar-Moncayo, Matilde; Ortiz Mellet, Carmen; Nanba, Eiji; Garcia Fernandez, Jose M.; Suzuki, Yoshiyuki; Shimizu, Toshiyuki			Structural Basis of Pharmacological Chaperoning for Human beta-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; MUTANT ENZYME; CHEMICAL CHAPERONES; GM1 GANGLIOSIDOSIS; GENE-MUTATIONS; FABRY DISEASE; THERAPY; PURIFICATION; REPLACEMENT; GLUCOSIDASE	G(M1) gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal beta-galactosidase (beta-Gal), frequently related to misfolding and subsequent endoplasmic reticulum-associated degradation. Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome. In this report, we describe the enzymological properties of purified recombinant human beta-Gal(WT) and two representative mutations in GM1 gangliosidosis Japanese patients, beta-Gal(R201C) and beta-Gal(151T). We have also evaluated the PC effect of two competitive inhibitors of beta-Gal. Moreover, we provide a detailed atomic view of the recognition mechanism of these compounds in comparison with two structurally related analogues. All compounds bind to the active site of beta-Gal with the sugar-mimicking moiety making hydrogen bonds to active site residues. Moreover, the binding affinity, the enzyme selectivity, and the PC potential are strongly affected by the mono-or bicyclic structure of the core as well as the orientation, nature, and length of the exocyclic substituent. These results provide understanding on the mechanism of action of beta-Gal selective chaperoning by newly developed PC compounds.	[Suzuki, Hironori; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Higaki, Katsumi; Nanba, Eiji] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Mena-Barragan, Teresa; Aguilar-Moncayo, Matilde; Ortiz Mellet, Carmen] Univ Seville, Fac Chem, Dept Organ Chem, E-41012 Seville, Spain; [Garcia Fernandez, Jose M.] Univ Seville, CSIC, Inst Chem Res IIQ, E-41092 Seville, Spain; [Suzuki, Yoshiyuki] Int Univ Hlth & Welf Grad Sch, Otawara, Tochigi 3248501, Japan; [Shimizu, Toshiyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Tottori University; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); International University of Health & Welfare; Japan Science & Technology Agency (JST)	Shimizu, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	Fernandez, Jose M Garcia/D-8105-2011; Mellet, Carmen Ortiz/C-7993-2011; Aguilar-Moncayo, Matilde/K-8113-2014	Fernandez, Jose M Garcia/0000-0002-6827-0387; Mellet, Carmen Ortiz/0000-0002-7676-7721; Aguilar-Moncayo, Matilde/0000-0003-3652-2639	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [H20-Kokoro-022, H22-Nanji-Ippan-002]; Japan Science and Technology Agency [AS232Z00009G]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Spanish Ministerio de Economia y Competitividad [SAF2010-15670, CTQ2010-15848]; Fundacion Ramon Areces; Junta de Andalucia; European Regional Development Funds (FEDER); Eurpean Social Funds (FSE); Center for Research, Technology and Innovation of the University of Seville (CITIUS);  [13680918];  [14207106]	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Spanish Ministerio de Economia y Competitividad(Spanish Government); Fundacion Ramon Areces; Junta de Andalucia(Junta de Andalucia); European Regional Development Funds (FEDER)(European Commission); Eurpean Social Funds (FSE); Center for Research, Technology and Innovation of the University of Seville (CITIUS); ; 	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to U. O. and T. S.) and Grants 13680918 and 14207106 (to Y. S.), Ministry of Health, Labor and Welfare of Japan H20-Kokoro-022 and H22-Nanji-Ippan-002, and Japan Science and Technology Agency Grant AS232Z00009G (to Y. S.), grants from the Takeda Science Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research (to U. O. and T. S.), and Spanish Ministerio de Economia y Competitividad contracts SAF2010-15670 and CTQ2010-15848, the Fundacion Ramon Areces, the Junta de Andalucia, the European Regional Development Funds (FEDER), the Eurpean Social Funds (FSE), and the Center for Research, Technology and Innovation of the University of Seville (CITIUS).	Aguilar M, 2008, CHEMBIOCHEM, V9, P2612, DOI 10.1002/cbic.200800451; Aguilar-Moncayo M, 2012, CHEM COMMUN, V48, P6514, DOI 10.1039/c2cc32065g; Aguilar-Moncayo M, 2011, ORG BIOMOL CHEM, V9, P3698, DOI 10.1039/c1ob05234a; ALPERS DH, 1969, GASTROENTEROLOGY, V56, P985; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benito JM, 2011, EXPERT OPIN THER PAT, V21, P885, DOI 10.1517/13543776.2011.569162; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; Coelho C. J., 1999, CLIN BIOCHEM, V32, P1801; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Guce AI, 2011, CHEM BIOL, V18, P1521, DOI 10.1016/j.chembiol.2011.10.012; Higaki K, 2011, HUM MUTAT, V32, P843, DOI 10.1002/humu.21516; Hofer D, 2009, HUM MUTAT, V30, P1214, DOI 10.1002/humu.21031; Kuno S, 2013, CARBOHYD RES, V368, P8, DOI 10.1016/j.carres.2012.12.010; Luan Z, 2009, CHEMBIOCHEM, V10, P2780, DOI 10.1002/cbic.200900442; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa S, 2002, BIOORGAN MED CHEM, V10, P1967, DOI 10.1016/S0968-0896(02)00005-6; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Perez VMD, 2000, J ORG CHEM, V65, P136, DOI 10.1021/jo991242o; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Sanchez-Fernandez EM, 2012, CHEM-EUR J, V18, P8527, DOI 10.1002/chem.201200279; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Suzuki Y., 2013, ONLINE METABOLIC MOL; Suzuki Y, 2013, BRAIN DEV-JPN, V35, P515, DOI 10.1016/j.braindev.2012.12.002; Suzuki Y, 2009, PERSPECT MED CHEM, V3, P7; Takai T, 2013, MOL THER, V21, P526, DOI 10.1038/mt.2012.263; Usui K, 2012, ACTA CRYSTALLOGR F, V68, P73, DOI 10.1107/S1744309111047920; YOSHIDA K, 1991, AM J HUM GENET, V49, P435	37	49	52	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14560	14568		10.1074/jbc.M113.529529	http://dx.doi.org/10.1074/jbc.M113.529529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24737316	Green Published, hybrid			2022-12-28	WOS:000337248100014
J	Dixon, EV; Claridge, JK; Harvey, DJ; Baruah, K; Yu, XJ; Vesiljevic, S; Mattick, S; Pritchard, LK; Krishna, B; Scanlan, CN; Schnell, JR; Higgins, MK; Zitzmann, N; Crispin, M				Dixon, Emma V.; Claridge, Jolyon K.; Harvey, David J.; Baruah, Kavitha; Yu, Xiaojie; Vesiljevic, Snezana; Mattick, Susan; Pritchard, Laura K.; Krishna, Benjamin; Scanlan, Christopher N.; Schnell, Jason R.; Higgins, Matthew K.; Zitzmann, Nicole; Crispin, Max			Fragments of Bacterial Endoglycosidase S and Immunoglobulin G Reveal Subdomains of Each That Contribute to Deglycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody engineering; Enzyme Mechanism; Glycoprotein; Glycosylation	LASER-DESORPTION IONIZATION; N-LINKED GLYCANS; STREPTOCOCCUS-PYOGENES; PROTEIN-PRODUCTION; IGG; ENDOS; RECOGNITION; SPEB; SYSTEM; GLYCOSYLATION	Background: Endoglycosidase S (EndoS) is an immune evasion factor from Streptococcus pyogenes that impedes IgG effector functions by deglycosylation. Results: Analysis of fragments of enzyme and substrate identify components of each that contribute to catalysis. Conclusion: Regions outside of the catalytic domain of EndoS contribute to IgG deglycosylation, and catalysis does not require all antibody subunits. Significance: Engineering of EndoS specificity requires consideration of both catalytic and non-catalytic regions. Endoglycosidase S (EndoS) is a glycoside-hydrolase secreted by the bacterium Streptococcus pyogenes. EndoS preferentially hydrolyzes the N-linked glycans from the Fc region of IgG during infection. This hydrolysis impedes Fc functionality and contributes to the immune evasion strategy of S. pyogenes. Here, we investigate the mechanism of human serum IgG deactivation by EndoS. We expressed fragments of IgG1 and demonstrated that EndoS was catalytically active against all of them including the isolated CH2 domain of the Fc domain. Similarly, we sought to investigate which domains within EndoS could contribute to activity. Bioinformatics analysis of the domain organization of EndoS confirmed the previous predictions of a chitinase domain and leucine-rich repeat but also revealed a putative carbohydrate binding module (CBM) followed by a C-terminal region. Using expressed fragments of EndoS, circular dichroism of the isolated CBM, and a CBM-C-terminal region fusion revealed folded domains dominated by sheet and helical structure, respectively. Nuclear magnetic resonance analysis of the CBM with monosaccharides was suggestive of carbohydrate binding functionality. Functional analysis of truncations of EndoS revealed that, whereas the C-terminal of EndoS is dispensable for activity, its deletion impedes the hydrolysis of IgG glycans.	[Dixon, Emma V.; Harvey, David J.; Baruah, Kavitha; Yu, Xiaojie; Vesiljevic, Snezana; Mattick, Susan; Pritchard, Laura K.; Krishna, Benjamin; Scanlan, Christopher N.; Zitzmann, Nicole; Crispin, Max] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Claridge, Jolyon K.; Schnell, Jason R.; Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Harvey, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Oxford; University of Oxford; University of Warwick	Crispin, M (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, South Parks Rd, Oxford OX1 3QU, England.	emma.dixon@msdtc.ox.ac.uk; max.crispin@bioch.ox.ac.uk	yu, xiaojie/GSI-9676-2022; Harvey, David/A-5579-2013; Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Harvey, David/0000-0003-0544-771X; Krishna, Benjamin/0000-0003-0919-2961; Higgins, Matthew/0000-0002-2870-1955	Medical Research Council, UK; Oxford Glycobiology Endowment; Medical Research Council [MC_PC_12020] Funding Source: researchfish; MRC [MC_PC_12020] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Glycobiology Endowment; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Confidence in Concept grant (to M. C. and C.N.S.) from the Medical Research Council, UK, and by a Oxford Glycobiology Endowment.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Anumula KR, 2012, J IMMUNOL METHODS, V382, P167, DOI 10.1016/j.jim.2012.05.022; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; Bowden TA, 2012, J AM CHEM SOC, V134, P17554, DOI 10.1021/ja306068g; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Collin M., 2012, ISBT SCI SERIES, V7, P142; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crispin M, 2013, P NATL ACAD SCI USA, V110, P10059, DOI 10.1073/pnas.1307776110; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2013, ELECTROPHORESIS, V34, P2368, DOI 10.1002/elps.201200669; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lood C, 2012, ARTHRITIS RHEUM-US, V64, P2698, DOI 10.1002/art.34454; Lund J, 2000, EUR J BIOCHEM, V267, P7246, DOI 10.1046/j.1432-1327.2000.01839.x; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Nandakumar KS, 2013, P NATL ACAD SCI USA, V110, P10252, DOI 10.1073/pnas.1301480110; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yang R, 2010, NEPHROL DIAL TRANSPL, V25, P2479, DOI 10.1093/ndt/gfq115; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375	49	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13876	13889		10.1074/jbc.M113.532812	http://dx.doi.org/10.1074/jbc.M113.532812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668806	Green Published, hybrid			2022-12-28	WOS:000335984600020
J	Ke, Y; Hunter, MJ; Ng, CA; Perry, MD; Vandenberg, JI				Ke, Ying; Hunter, Mark J.; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.			Role of the Cytoplasmic N-terminal Cap and Per-Arnt-Sim ( PAS) Domain in Trafficking and Stabilization of Kv11.1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hERG; Potassium Channels; Site-directed Mutagenesis; Trafficking; Western Blotting; PAS Domain; Subunit-Subunit Interaction	GENE POTASSIUM CHANNELS; LONG-QT SYNDROME; ENDOPLASMIC-RETICULUM; EAG DOMAIN; HERG; INACTIVATION; MUTATIONS; MECHANISM; IDENTIFICATION; ARRHYTHMIA	Background: A cytoplasmic PAS domain regulates Kv11.1 function, but its role in channel assembly is unclear. Results: PAS domain deletion does not alter assembly, but removal of the N-Cap that immediately precedes the PAS domain severely disrupts channel trafficking. Conclusion: The N-Cap is vital for PAS domain stability and channel trafficking. Significance: Kv11.1 channel assembly defects underlie the pathogenesis of long QT syndrome. The N-terminal cytoplasmic region of the Kv11.1a potassium channel contains a Per-Arnt-Sim (PAS) domain that is essential for the unique slow deactivation gating kinetics of the channel. The PAS domain has also been implicated in the assembly and stabilization of the assembled tetrameric channel, with many clinical mutants in the PAS domain resulting in reduced stability of the domain and reduced trafficking. Here, we use quantitative Western blotting to show that the PAS domain is not required for normal channel trafficking nor for subunit-subunit interactions, and it is not necessary for stabilizing assembled channels. However, when the PAS domain is present, the N-Cap amphipathic helix must also be present for channels to traffic to the cell membrane. Serine scan mutagenesis of the N-Cap amphipathic helix identified Leu-15, Ile-18, and Ile-19 as residues critical for the stabilization of full-length proteins when the PAS domain is present. Furthermore, mutant cycle analysis experiments support recent crystallography studies, indicating that the hydrophobic face of the N-Cap amphipathic helix interacts with a surface-exposed hydrophobic patch on the core of the PAS domain to stabilize the structure of this critical gating domain. Our data demonstrate that the N-Cap amphipathic helix is critical for channel stability and trafficking.	[Ke, Ying; Hunter, Mark J.; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Darlinghurst, NSW 2010, Australia; [Ke, Ying; Ng, Chai Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450	Health Foundation of Australia [G11S 5829]; National Health and Medical Research Council Senior Research Fellowship [1019693]	Health Foundation of Australia; National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant-in-aid G11S 5829 from the Health Foundation of Australia and National Health and Medical Research Council Senior Research Fellowship 1019693 (to J.V.).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Heide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045624; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kaltman JR, 2011, CIRCULATION, V123, P1911, DOI 10.1161/CIRCULATIONAHA.110.017228; Ke Y, 2013, BIOCHEM J, V454, P69, DOI 10.1042/BJ20130328; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Knollmann BC, 2008, NATURE, V451, P929, DOI 10.1038/nature06799; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Moss AJ, 2005, CIRCULATION, V111, P1199, DOI 10.1161/01.CIR.0000157069.91834.DA; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Perry MD, 2013, J BIOL CHEM, V288, P11482, DOI 10.1074/jbc.M113.461442; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x	35	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13782	13791		10.1074/jbc.M113.531277	http://dx.doi.org/10.1074/jbc.M113.531277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24695734	Green Published, hybrid			2022-12-28	WOS:000335984600012
J	Qadota, H; Luo, YT; Matsunaga, Y; Park, AS; Gernert, KM; Benian, GM				Qadota, Hiroshi; Luo, Yating; Matsunaga, Yohei; Park, Angela S.; Gernert, Kim M.; Benian, Guy M.			Suppressor Mutations Suggest a Surface on PAT-4 ( Integrin-linked Kinase) That Interacts with UNC-112 ( Kindlin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; C; elegans; Muscle; Protein Structure; Protein-Protein Interactions; Integrin-linked Kinase; Kindlin; Suppressor Genetics	CAENORHABDITIS-ELEGANS; ADHESION COMPLEXES; LOCALIZATION; PROTEINS; UNC-97/PINCH; COMPONENTS; GENE; ILK	Background: Interaction between PAT-4 (ILK) and UNC-112 (kindlin) is required for localization of each protein to integrin adhesions. Results: PAT-4 missense mutations were identified that restore binding of a mutant UNC-112 protein and its proper localization. Conclusion: Residues mutated in the suppressor mutants cluster in two regions on the surface of a homology model of PAT-4. Significance: An interaction surface between PAT-4 and UNC-112 is suggested. Caenorhabditis elegans striated muscle cells attach to basement membrane and transmit the force of muscle contraction through integrin adhesion complexes. The cytoplasmic tail of -integrin (PAT-3) is associated with a conserved four-protein complex that includes UNC-112 (kindlin), PAT-4 (integrin-linked kinase), PAT-6 (-parvin/actopaxin), and UNC-97 (PINCH). The proper localization of UNC-112 to muscle integrin adhesion sites requires PAT-4. A recent report (Qadota, H., Moerman, D. G., and Benian, G. M. (2012) A molecular mechanism for the requirement of PAT-4 (integrin-linked kinase (ILK)) for the localization of UNC-112 (kindlin) to integrin adhesion sites. J. Biol. Chem. 287, 28537-28551) suggests a possible molecular mechanism for this requirement: that UNC-112 exists in closed inactive and open active conformations, and conversion to the open active form is promoted by binding to PAT-4 (ILK). Previously, we also reported identification of a single missense mutation in UNC-112, D382V, which abolishes both binding to PAT-4 and normal localization to integrin adhesion sites in vivo. In this report, we describe isolation and characterization of PAT-4 missense mutations that permit binding with UNC-112 D382V and place nine affected residues on a homology model of PAT-4. These nine residues cluster in two regions on the surface of PAT-4, do not overlap the likely binding surface for PAT-6 (-parvin), and therefore may reside along the interaction surface of PAT-4 for UNC-112 (kindlin). We also show that one of these PAT-4 mutations restores the ability of UNC-112 D382V to localize to integrin adhesions and participate in complex formation.	[Qadota, Hiroshi; Luo, Yating; Matsunaga, Yohei; Park, Angela S.; Benian, Guy M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Gernert, Kim M.] Emory Univ, Atlanta, GA 30322 USA	Emory University; Emory University	Benian, GM (corresponding author), Emory Univ, Dept Pathol, Whitehead Bldg 105E,615 Michael St, Atlanta, GA 30322 USA.	pathgb@emory.edu			American Heart Association [11GRNT7820000]	American Heart Association(American Heart Association)	This study was supported by American Heart Association Grant 11GRNT7820000.	BRENNER S, 1974, GENETICS, V77, P71; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; James P, 1996, GENETICS, V144, P1425; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miller RK, 2006, J CELL BIOL, V175, P853, DOI 10.1083/jcb.200608043; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Moerman D., 2006, WORMBOOK, DOI 10.1895/wormbook.1.81.1; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Norman KR, 2007, DEV BIOL, V309, P45, DOI 10.1016/j.ydbio.2007.06.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadota H, 2007, MOL BIOL CELL, V18, P4317, DOI 10.1091/mbc.E07-03-0278; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qadota H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864749; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Warner A, 2013, MOL BIOL CELL, V24, P601, DOI 10.1091/mbc.E12-06-0478; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Waterston R., 1988, NEMATODE C ELEGANS, P281; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wilson KJ, 2012, METHODS MOL BIOL, V798, P171, DOI 10.1007/978-1-61779-343-1_10; Yochem J, 1998, GENETICS, V149, P1323; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577	34	7	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14252	14262		10.1074/jbc.M114.556308	http://dx.doi.org/10.1074/jbc.M114.556308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692564	Green Published, hybrid			2022-12-28	WOS:000335984600050
J	Rabolli, V; Wallemme, L; Lo Re, S; Uwambayinema, F; Palmai-Pallag, M; Thomassen, L; Tyteca, D; Octave, JN; Marbaix, E; Lison, D; Devuyst, O; Huaux, F				Rabolli, Virginie; Wallemme, Laurent; Lo Re, Sandra; Uwambayinema, Francine; Palmai-Pallag, Mihaly; Thomassen, Leen; Tyteca, Donatienne; Octave, Jean-Noel; Marbaix, Etienne; Lison, Dominique; Devuyst, Olivier; Huaux, Francois			Critical Role of Aquaporins in Interleukin 1 beta( IL-1 beta)- induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aquaporin; Caspase; Inflammation; Interleukin; Water Channel; RVD; Cell Swelling; Inflammasome	NALP3 INFLAMMASOME; EXPRESSION; ACTIVATION; MICE; LUNG; SILICA; CELLS; MACROPHAGES; INFECTION; MIGRATION	Background: Aquaporins are channels permeable to water, and they are essential for immune cell migration. Results: We demonstrate that aquaporin-mediated water fluxes are necessary for the NLRP3 inflammasome-dependent release of mature IL-1 in vitro and in vivo. Conclusion: Aquaporins are implicated in the mechanisms of proinflammatory cytokine secretion during inflammation. Significance: The discovery of a new function for AQPs opens new diagnostic and therapeutic opportunities in inflammatory disorders. Rapid changes in cell volume characterize macrophage activation, but the role of water channels in inflammation remains unclear. We show here that, in vitro, aquaporin (AQP) blockade or deficiency results in reduced IL-1 release by macrophages activated with a variety of NLRP3 activators. Inhibition of AQP specifically during the regulatory volume decrease process is sufficient to limit IL-1 release by macrophages through the NLRP3 inflammasome axis. The immune-related activity of AQP was confirmed in vivo in a model of acute lung inflammation induced by crystals. AQP1 deficiency is associated with a marked reduction of both lung IL-1 release and neutrophilic inflammation. We conclude that AQP-mediated water transport in macrophages constitutes a general danger signal required for NLRP3-related inflammation. Our findings reveal a new function of AQP in the inflammatory process and suggest a novel therapeutic target for anti-inflammatory therapy.	[Rabolli, Virginie; Wallemme, Laurent; Lo Re, Sandra; Uwambayinema, Francine; Palmai-Pallag, Mihaly; Lison, Dominique; Huaux, Francois] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, B-1200 Brussels, Belgium; [Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, Inst Rech Expt & Clin IREC, B-1200 Brussels, Belgium; [Tyteca, Donatienne; Marbaix, Etienne] Catholic Univ Louvain, Cell Biol Unit, Duve Inst, B-1200 Brussels, Belgium; [Octave, Jean-Noel; Lison, Dominique] Catholic Univ Louvain, Inst NeuroSci IoNS, B-1200 Brussels, Belgium; [Thomassen, Leen] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; KU Leuven; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huaux, F (corresponding author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Ave Mounier 53 Bte B1 52 12, B-1200 Brussels, Belgium.	francois.huaux@uclouvain.be	Lison, Dominique/A-8985-2010; Thomassen, Leen CJ/A-9186-2015	Thomassen, Leen CJ/0000-0002-4970-7475; Devuyst, Olivier/0000-0003-3744-4767; Lison, Dominique/0000-0001-6557-2518	Programme d'excellence Marshall Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM); Actions de Recherche Concertees; Communaute Francaise de Belgique; Direction de la Recherche Scientifique [ARC 09/14-021]; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS) [PDR T.0119.13 14633768]; European Commission [202047]; Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France); Fondation Saint-Luc at Universite Catholique de Louvain; Baxter extramural grant; NCCR Kidney; CH program (Swiss National Science Foundation); Swiss National Science Foundation [310030-146490]	Programme d'excellence Marshall Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees(University of Liege); Communaute Francaise de Belgique(Australian Research Council); Direction de la Recherche Scientifique; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France); Fondation Saint-Luc at Universite Catholique de Louvain; Baxter extramural grant; NCCR Kidney; CH program (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Programme d'excellence Marshall Diane convention, by the Fonds de la Recherche Scientifique Medicale (FRSM), by Actions de Recherche Concertees, Communaute Francaise de Belgique, Direction de la Recherche Scientifique grant ARC 09/14-021), by the Fondation Contre le Cancer, by Fonds de la Recherche Scientifique (FNRS) Project PDR T.0119.13 14633768, by the European Commission under FP7-HEALTH-F4-2008 contract no. 202047, and by Agence Nationale de Securite Sanitaire de L'Alimentation, de l'Environnement, et du Travail (ANSES, France). This work was also supported in part by the Fondation Saint-Luc at Universite Catholique de Louvain, by a Baxter extramural grant, by the Inter-University Attraction Pole (IUAP, Belgium Federal Government), by the NCCR Kidney. CH program (Swiss National Science Foundation), and by Swiss National Science Foundation grant 310030-146490 (to O.D.).	Adamzik M, 2011, ANESTHESIOLOGY, V114, P912, DOI 10.1097/ALN.0b013e31820ca911; AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hansel NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014226; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; HERZYK DJ, 1992, J IMMUNOL METHODS, V148, P243, DOI 10.1016/0022-1759(92)90178-V; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Huysseune S, 2009, FASEB J, V23, P4158, DOI 10.1096/fj.09-140012; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Ko SBH, 2009, J MED INVESTIG, V56, P318; Li LH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-94; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mobasheri A, 2010, ANN ANAT, V192, P116, DOI 10.1016/j.aanat.2010.01.001; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nishino T, 2008, PFLUG ARCH EUR J PHY, V456, P721, DOI 10.1007/s00424-007-0402-4; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; PANKOW W, 1995, CANCER DETECT PREV, V19, P268; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rabolli V, 2011, TOXICOL LETT, V203, P127, DOI 10.1016/j.toxlet.2011.03.009; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Shen Y, 2011, J CELL MOL MED, V15, P1355, DOI 10.1111/j.1582-4934.2010.01103.x; SOKOL RJ, 1987, J ANAT, V151, P27; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Thomassen LCJ, 2010, LANGMUIR, V26, P328, DOI 10.1021/la902050k; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Xu P, 2013, J IMMUNOL, V190, P5247, DOI 10.4049/jimmunol.1203182; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808	50	43	49	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13937	13947		10.1074/jbc.M113.534594	http://dx.doi.org/10.1074/jbc.M113.534594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700466	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000335984600025
J	Chai, RC; Kouspou, MM; Lang, BJ; Nguyen, CH; van der Kraan, AGJ; Vieusseux, JL; Lim, RC; Gillespie, MT; Benjamin, IJ; Quinn, JMW; Price, JT				Chai, Ryan C.; Kouspou, Michelle M.; Lang, Benjamin J.; Nguyen, Chau H.; van der Kraan, A. Gabrielle J.; Vieusseux, Jessica L.; Lim, Reece C.; Gillespie, Matthew T.; Benjamin, Ivor J.; Quinn, Julian M. W.; Price, John T.			Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Heat Shock Protein; HSP90; Osteoclast; Stress Response; HSF1; Cell Stress; Chemotherapy; HSP90 Inhibitors	MICROPHTHALMIA TRANSCRIPTION FACTOR; KAPPA-B ACTIVATION; BREAST-CANCER; HEAT-SHOCK-PROTEIN-90 HSP90; CARCINOMA-CELLS; CLINICAL-TRIAL; BONE LOSS; IN-VITRO; EXPRESSION; DIFFERENTIATION	Background: HSP90 inhibitors increase osteoclast formation and bone loss. Results: Altered Hsf1 activity impacts the ability of stress-inducing compounds to modulate osteoclast formation. Conclusion: Hsf1 plays an important role in stress-associated osteoclast formation, potentially via MITF. Significance: We identified a novel pathway whereby agents inducing stress can enhance osteoclast formation. Many anticancer therapeutic agents cause bone loss, which increases the risk of fractures that severely reduce quality of life. Thus, in drug development, it is critical to identify and understand such effects. Anticancer therapeutic and HSP90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) causes bone loss by increasing osteoclast formation, but the mechanism underlying this is not understood. 17-AAG activates heat shock factor 1 (Hsf1), the master transcriptional regulator of heat shock/cell stress responses, which may be involved in this negative action of 17-AAG upon bone. Using mouse bone marrow and RAW264.7 osteoclast differentiation models we found that HSP90 inhibitors that induced a heat shock response also enhanced osteoclast formation, whereas HSP90 inhibitors that did not (including coumermycin A1 and novobiocin) did not affect osteoclast formation. Pharmacological inhibition or shRNAmir knockdown of Hsf1 in RAW264.7 cells as well as the use of Hsf1 null mouse bone marrow cells demonstrated that 17-AAG-enhanced osteoclast formation was Hsf1-dependent. Moreover, ectopic overexpression of Hsf1 enhanced 17-AAG effects upon osteoclast formation. Consistent with these findings, protein levels of the essential osteoclast transcription factor microphthalmia-associated transcription factor were increased by 17-AAG in an Hsf1-dependent manner. In addition to HSP90 inhibitors, we also identified that other agents that induced cellular stress, such as ethanol, doxorubicin, and methotrexate, also directly increased osteoclast formation, potentially in an Hsf1-dependent manner. These results, therefore, indicate that cellular stress can enhance osteoclast differentiation via Hsf1-dependent mechanisms and may significantly contribute to pathological and therapeutic related bone loss.	[Chai, Ryan C.; Kouspou, Michelle M.; Lang, Benjamin J.; Nguyen, Chau H.; van der Kraan, A. Gabrielle J.; Vieusseux, Jessica L.; Lim, Reece C.; Gillespie, Matthew T.; Quinn, Julian M. W.; Price, John T.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [van der Kraan, A. Gabrielle J.; Gillespie, Matthew T.; Quinn, Julian M. W.] Prince Henrys Inst, Clayton, Vic 3168, Australia; [Benjamin, Ivor J.] Med Coll Wisconsin, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [Price, John T.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Monash University; Prince Henry's Institute of Medical Research; Medical College of Wisconsin; Victoria University	Price, JT (corresponding author), Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 3801, Australia.	john.price@vu.edu.au	Lang, Benjamin/AAO-9976-2020	Lang, Benjamin/0000-0002-2205-8591; Price, John/0000-0002-8244-1023; Gillespie, Matthew/0000-0001-6543-8909	Australian National Health and Medical Research Council [606549, 1057706]; RD Wright Fellowship [395525]; Victorian Government Operational Infrastructure Support Program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); RD Wright Fellowship; Victorian Government Operational Infrastructure Support Program	This work was supported by Australian National Health and Medical Research Council Project Grants 606549 and 1057706, by RD Wright Fellowship No. 395525 (to J.T.P.), and by the Victorian Government Operational Infrastructure Support Program.	Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Arikoski P, 1999, J BONE MINER RES, V14, P2002, DOI 10.1359/jbmr.1999.14.12.2002; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; CIOCCA DR, 1992, CANCER RES, V52, P3648; Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]; Dai JL, 2000, J CLIN INVEST, V106, P887, DOI 10.1172/JCI10483; Davies JH, 2002, BONE, V31, P319, DOI 10.1016/S8756-3282(02)00822-0; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; FRIEDLAENDER GE, 1984, J BONE JOINT SURG AM, V66A, P602, DOI 10.2106/00004623-198466040-00016; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Hadji P, 2009, EUR J CANCER, V45, P3205, DOI 10.1016/j.ejca.2009.09.026; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Iitsuka N, 2012, INT J MOL MED, V30, P165, DOI [10.3892/ijmnn.2012.974, 10.3892/ijmm.2012.974]; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; King TJ, 2012, AM J PATHOL, V181, P121, DOI 10.1016/j.ajpath.2012.03.037; Lamoureux F, 2011, CLIN CANCER RES, V17, P2301, DOI 10.1158/1078-0432.CCR-10-3077; Lang BJ, 2012, CELL STRESS CHAPERON, V17, P765, DOI 10.1007/s12192-012-0349-z; Langer T, 2002, CELL BIOL INT, V26, P653, DOI 10.1006/cbir.2002.0882; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; LI GC, 1983, J CELL PHYSIOL, V115, P116, DOI 10.1002/jcp.1041150203; Lu SY, 2010, MOL BIOL CELL, V21, P1763, DOI 10.1091/mbc.E09-07-0584; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mandrekar P, 2008, J LEUKOCYTE BIOL, V84, P1335, DOI 10.1189/jlb.0407256; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Nomura S, 2001, J BONE MINER METAB, V19, P183, DOI 10.1007/s007740170040; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pfeilschifter J, 2000, J CLIN ONCOL, V18, P1570, DOI 10.1200/JCO.2000.18.7.1570; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Quinn JMW, 2002, BONE, V30, P164, DOI 10.1016/S8756-3282(01)00654-8; Radanyi C, 2008, BIOORG MED CHEM LETT, V18, P2495, DOI 10.1016/j.bmcl.2008.01.128; Rangan GK, 1999, AM J PHYSIOL-RENAL, V277, pF779, DOI 10.1152/ajprenal.1999.277.5.F779; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roccisana JL, 2004, J BIOL CHEM, V279, P10500, DOI 10.1074/jbc.M303727200; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu BY, 2000, J NEUROSCI RES, V62, P730, DOI 10.1002/1097-4547(20001201)62:5<730::AID-JNR13>3.3.CO;2-B; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yokota S, 2000, CANCER RES, V60, P2942; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	68	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13602	13614		10.1074/jbc.M113.530626	http://dx.doi.org/10.1074/jbc.M113.530626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692538	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000335522800054
J	Yoon, JH; Choudhury, JR; Park, J; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise			A Role for DNA Polymerase theta in Promoting Replication through Oxidative DNA Lesion, Thymine Glycol, in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA Damage; DNA Polymerase; DNA Repair; DNA Replication; DNA Polymerase; Lesion Bypass; Thymine Glycol	EPSTEIN-BARR-VIRUS; LOW-FIDELITY; TRANSLESION SYNTHESIS; STABLE REPLICATION; PLASMID ORIGIN; LATENT ORIGIN; DUPLEX DNA; BYPASS; PROTEIN; DAMAGE	Background: Little is known of biological functions of DNA polymerase (pol) in human cells. Results: pol promotes replication through the common oxidation product, thymine glycol, in human cells. Conclusion: pol active site can accommodate the considerable distortion imposed by thymine glycol at the extension step. Significance: pol may function in translesion synthesis opposite a variety of DNA lesions. The biological functions of human DNA polymerase (pol) , an A family polymerase, have remained poorly defined. Here we identify a role of pol in translesion synthesis (TLS) in human cells. We show that TLS through the thymine glycol (TG) lesion, the most common oxidation product of thymine, occurs via two alternative pathways, in one of which, polymerases and function together and mediate error-free TLS, whereas in the other, pol functions in an error-prone manner. Human pol is comprised of an N-terminal ATPase/helicase domain, a large central domain, and a C-terminal polymerase domain; however, we find that only the C-terminal polymerase domain is required for TLS opposite TG in human cells. In contrast to TLS mediated by pol and pol, in which pol would elongate the chain from the TG:A base pair formed by pol action, the ability of pol alone to carry out the nucleotide insertion step, as well as the subsequent extension step that presents a considerable impediment due to displacement of the 5 template base, suggests that the pol active site can accommodate highly distorting DNA lesions.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	l.prakash@utmb.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	National Institutes of Health NIEHS Center [P30-ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020833, P30ES006676, R01ES012411] Funding Source: NIH RePORTER	National Institutes of Health NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Richard Hodge (University of Texas Medical Branch at Galveston) for providing TG containing DNAs, Dr. Thomas Wood (University of Texas Medical Branch at Galveston) for sequencing the TLS products, and Dr. Narottam Acharya for initial biochemical studies with pol theta. The TG containing DNAs were constructed by Dr. Richard Hodge in the Synthetic Organic Chemistry Core Laboratory at the University of Texas Medical Branch at Galveston, supported by National Institutes of Health NIEHS Center Grant P30-ES06676.	ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BREIMER LH, 1985, BIOCHEMISTRY-US, V24, P4018, DOI 10.1021/bi00336a032; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; FRENKEL K, 1981, BIOCHEMISTRY-US, V20, P7566, DOI 10.1021/bi00529a035; Hogg M, 2011, J MOL BIOL, V405, P642, DOI 10.1016/j.jmb.2010.10.041; Johnson RE, 2003, GENE DEV, V17, P77, DOI 10.1101/gad.1048303; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; KAO JY, 1993, J BIOL CHEM, V268, P17787; Kung HC, 1997, J BIOL CHEM, V272, P9227; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Maga G, 2002, J MOL BIOL, V319, P359, DOI 10.1016/S0022-2836(02)00325-X; McNulty JM, 1998, CHEM RES TOXICOL, V11, P666, DOI 10.1021/tx970225w; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; TEOULE R, 1977, RADIAT RES, V72, P190, DOI 10.2307/3574690; Wang JD, 2006, MOL CELL BIOL, V26, P1124, DOI 10.1128/MCB.26.3.1124-1134.2006; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yoon JH, 2012, MBIO, V3, DOI 10.1128/mBio.00271-12; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004	39	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13177	13185		10.1074/jbc.M114.556977	http://dx.doi.org/10.1074/jbc.M114.556977			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648516	hybrid, Green Published			2022-12-28	WOS:000335522800019
J	Zhou, LC; Yang, H; Okoro, EU; Guo, ZM				Zhou, LiChun; Yang, Hong; Okoro, Emmanuel U.; Guo, Zhongmao			Up-regulation of Cholesterol Absorption Is a Mechanism for Cholecystokinin-induced Hypercholesterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Metabolism; Hormone Receptors; Intestine; Signal Transduction; Transporters	DENSITY-LIPOPROTEIN RECEPTOR; PLASMA CHOLECYSTOKININ; EPITHELIAL-CELLS; MICE; NPC1L1; SECRETION; MULTIPLE; PATHWAYS; SURFACE; TRANSLOCATION	Background: Intravenous injection of cholecystokinin (CCK) elevated mouse plasma cholesterol level. Results: CCK enhances cholesterol absorption in mice and cultured cells. Inhibition of CCK receptors and their downstream signaling proteins diminishes CCK-induced cholesterol absorption. Conclusion: Activation of enterocyte CCK receptors accelerates cholesterol absorption and induces hypercholesterolemia. Significance: Inhibition of CCK receptors could be a therapeutic strategy for treatment of hypercholesterolemia. Excessive absorption of intestinal cholesterol is a risk factor for atherosclerosis. This report examines the effect of cholecystokinin (CCK) on plasma cholesterol level and intestinal cholesterol absorption using the in vivo models of C57BL/6 wild-type and low density lipoprotein receptor knock-out (LDLR-/-) mice. These data were supported by in vitro studies involving mouse primary intestinal epithelial cells and human Caco-2 cells; both express CCK receptor 1 and 2 (CCK1R and CCK2R). We found that intravenous injection of [Thr(28),Nle(31)]CCK increased plasma cholesterol levels and intestinal cholesterol absorption in both wild-type and LDLR-/- mice. Treatment of mouse primary intestinal epithelial cells with [Thr(28),Nle(31)]CCK increased cholesterol absorption, whereas selective inhibition of CCK1R and CCK2R with antagonists attenuated CCK-induced cholesterol absorption. In Caco-2 cells, CCK enhanced CCK1R/CCK2R heterodimerization. Knockdown of both CCK1R and CCK2 or either one of them diminished CCK-induced cholesterol absorption to the same extent. CCK also increased cell surface-associated NPC1L1 (Niemann-Pick C1-like 1) transporters but did not alter their total protein expression. Inhibition or knockdown of NPC1L1 attenuated CCK-induced cholesterol absorption. CCK enhanced phosphatidylinositide 3-kinase (PI3K) and Akt phosphorylation and augmented the interaction between NPC1L1 and Rab11a (Rab-GTPase-11a), whereas knockdown of CCK receptors or inhibition of G protein dimer (G) diminished CCK-induced PI3K and Akt phosphorylation. Inhibition of PI3K and Akt or knockdown of PI3K diminished CCK-induced NPC1L1-Rab11a interaction and cholesterol absorption. Knockdown of Rab11a suppressed CCK-induced NPC1L1 translocation and cholesterol absorption. These data imply that CCK enhances cholesterol absorption by activation of a pathway involving CCK1R/CCK2R, G, PI3K, Akt, Rab11a, and NPC1L.	[Zhou, LiChun; Yang, Hong; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Guo, ZM (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	zguo@mmc.edu			National Institutes of Health [R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089382 (to Z. G.) and SC1HL101431 (to H. Y.).	Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Cawston EE, 2010, BRIT J PHARMACOL, V159, P1009, DOI 10.1111/j.1476-5381.2009.00489.x; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Flint A, 2002, NEUROPSYCHOPHARMACOL, V27, P663; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; GERTLER MM, 1950, CIRCULATION, V2, P517, DOI 10.1161/01.CIR.2.4.517; GOMEZ G, 1990, J CLIN INVEST, V86, P323, DOI 10.1172/JCI114703; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Jin Honglian, 2008, J Med Dent Sci, V55, P145; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; MacIntosh CG, 1999, AM J CLIN NUTR, V69, P999; MASCLEE AAM, 1988, AGE, V11, P136, DOI 10.1007/BF02432293; NIEDERAU C, 1987, GUT, V28, P63, DOI 10.1136/gut.28.Suppl.63; Pasley J N, 1987, Prog Clin Biol Res, V227A, P371; Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200; Piiper A, 1997, AM J PHYSIOL-GASTR L, V272, pG135, DOI 10.1152/ajpgi.1997.272.1.G135; Rackley C E, 2000, Cardiol Rev, V8, P124, DOI 10.1097/00045415-200008020-00010; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; SCEMAMA JL, 1988, FEBS LETT, V242, P61, DOI 10.1016/0014-5793(88)80985-2; SOUDAH HC, 1992, AM J PHYSIOL, V263, pG102, DOI 10.1152/ajpgi.1992.263.1.G102; Wang DQH, 2002, J LIPID RES, V43, P1950, DOI 10.1194/jlr.M200078-JLR200; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhou LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051011	44	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12989	12999		10.1074/jbc.M113.534388	http://dx.doi.org/10.1074/jbc.M113.534388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24692543	Green Published, hybrid			2022-12-28	WOS:000335522800004
J	Chiyomaru, T; Fukuhara, S; Saini, S; Majid, S; Deng, GR; Shahryari, V; Chang, I; Tanaka, Y; Enokida, H; Nakagawa, M; Dahiya, R; Yamamura, S				Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Enokida, Hideki; Nakagawa, Masayuki; Dahiya, Rajvir; Yamamura, Soichiro			Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; Gene Regulation; Invasion; MicroRNA; Genistein; HOTAIR; Long Non-coding RNA; miR-141; Renal Carcinoma	EPITHELIAL-MESENCHYMAL TRANSITION; MAMMALIAN MESSENGER-RNAS; TRANSCRIPTIONAL ACTIVITY; MICRORNA TARGETS; MIR-200 FAMILY; CODING REGIONS; PROSTATE-CANCER; GENE-EXPRESSION; REPRESSORS ZEB1; ALPHA-AMANITIN	Background: Silencing of long non-coding RNA (lncRNA) by microRNA (miRNA) has only been recently observed. Results: miR-141 binds to HOTAIR and suppresses its oncogenic function in Ago2 (Argounaute2). Conclusion: miR-141 targets and silences HOTAIR in an Ago2-dependent manner in cancer cells. Significance: Our results suggest that regulation of lncRNA expression by miRNA plays essential roles in gene expression and cellular functions. HOTAIR is a long non-coding RNA that interacts with the polycomb repressive complex and suppresses its target genes. HOTAIR has also been demonstrated to promote malignancy. MicroRNA-141 (miR-141) has been reported to play a role in the epithelial to mesenchymal transition process, and the expression of miR-141 is inversely correlated with tumorigenicity and invasiveness in several human cancers. We found that HOTAIR expression is inversely correlated to miR-141 expression in renal carcinoma cells. HOTAIR promotes malignancy, including proliferation and invasion, whereas miR-141 suppresses malignancy in human cancer cells. miR-141 binds to HOTAIR in a sequence-specific manner and suppresses HOTAIR expression and functions, including proliferation and invasion. Both HOTAIR and miR-141 were associated with the immunoprecipitated Ago2 (Argonaute2) complex, and the Ago2 complex cleaved HOTAIR in the presence of miR-141. These results demonstrate that HOTAIR is suppressed by miR-141 in an Ago2-dependent manner.	[Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Chang, Inik] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul 120752, South Korea; [Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Yonsei University; Yonsei University Health System; Kagoshima University	Yamamura, S (corresponding author), Vet Affairs Med Ctr, Urol Res Ctr 112F, 4150 Clement St, San Francisco, CA 94121 USA.	yamamuras@urology.ucsf.edu			National Institutes of Health [RO1CA130860]; Veterans Affairs Program Project; Veterans Affairs Merit Review grants; NATIONAL CANCER INSTITUTE [R01CA130860, R01CA160079] Funding Source: NIH RePORTER; Veterans Affairs [IP1BX001604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Program Project; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA130860. This study was also supported by Veterans Affairs Program Project and Veterans Affairs Merit Review grants.	Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bhan A, 2013, J MOL BIOL, V425, P3707, DOI 10.1016/j.jmb.2013.01.022; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058929; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Liu C, 2012, THESIS U TEXAS HOUST; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xiao J, 2012, PROSTATE, V72, P1514, DOI 10.1002/pros.22501; Xu H., 2013, CELL BIOCH IN PRESS; Zhang YK, 2011, EPIGENETICS-US, V6, P888, DOI 10.4161/epi.6.7.16315; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110	61	152	164	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12550	12565		10.1074/jbc.M113.488593	http://dx.doi.org/10.1074/jbc.M113.488593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24616104	Green Published, hybrid			2022-12-28	WOS:000335581400029
J	Hancer, NJ; Qiu, W; Cherella, C; Li, YD; Copps, KD; White, MF				Hancer, Nancy J.; Qiu, Wei; Cherella, Christine; Li, Yedan; Copps, Kyle D.; White, Morris F.			Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Insulin Resistance; Phosphotyrosine Signaling; Protein Phosphorylation; Signal Transduction; CHO Cells; IRS1; Insulin Signaling; Metabolic Stress; Monoclonal Antibodies	PROTEIN-KINASE-C; PLECKSTRIN-HOMOLOGY-DOMAIN; IRS-1 SERINE PHOSPHORYLATION; DIET-INDUCED OBESITY; SKELETAL-MUSCLE; PHOSPHOPROTEOME REVEALS; REGULATORY ROLE; IN-VITRO; RESISTANCE; MTOR	Background: Metabolic stresses, including hyperinsulinemia, promote insulin resistance. Results: Monoclonal antibodies raised against Ser(P)/Thr(P) residues in IRS1 were used to quantify phosphorylation in response to insulin or agents that model metabolic stress. Conclusion: Similar IRS1 Ser(P)/Thr(P) residues are increased by insulin or metabolic stress, and some correlate significantly with reduced IRS1 tyrosine phosphorylation. Significance: Metabolic stress co-opts insulin-dependent IRS1 phosphorylation to aggravate insulin resistance. IRS1 and IRS2 are key substrates of the insulin receptor tyrosine kinase. Mass spectrometry reveals more than 50 phosphorylated IRS1 serine and threonine residues (Ser(P)/Thr(P) residues) in IRS1 from insulin-stimulated cells or human tissues. We investigated a subset of IRS1 Ser(P)/Thr(P) residues using a newly developed panel of 25 phospho-specific monoclonal antibodies (pS/TmAb(Irs1)). CHO cells overexpressing the human insulin receptor and rat IRS1 were stimulated with insulin in the absence or presence of inhibitors of the PI3K Akt mechanistic target of rapamycin (mTOR) S6 kinase or MEK pathways. Nearly all IRS1 Ser(P)/Thr(P) residues were stimulated by insulin and significantly suppressed by PI3K inhibition; fewer were suppressed by Akt or mTOR inhibition, and none were suppressed by MEK inhibition. Insulin-stimulated Irs1 tyrosine phosphorylation (Tyr(P)(Irs1)) was enhanced by inhibition of the PI3K Akt mTOR pathway and correlated with decreased Ser(P)-302(Irs1), Ser(P)-307(Irs1), Ser(P)-318(Irs1), Ser(P)-325(Irs1), and Ser(P)-346(Irs1). Metabolic stress modeled by anisomycin, thapsigargin, or tunicamycin increased many of the same Ser(P)/Thr(P) residues as insulin, some of which (Ser(P)-302(Irs1), Ser(P)-307(Irs1), and four others) correlated significantly with impaired insulin-stimulated Tyr(P)(Irs1). Thus, IRS1 Ser(P)/Thr(P) is an integrated response to insulin stimulation and metabolic stress, which associates with reduced Tyr(P)(Irs1) in CHOIR/IRS1 cells.	[Hancer, Nancy J.; Qiu, Wei; Cherella, Christine; Li, Yedan; Copps, Kyle D.; White, Morris F.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	White, MF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med,Ctr Life Sci, Rm 16020,3 Blackfan Circle, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu			National Institutes of Health [DK38712, DK55326, DK098655, GM021700]; Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055326, R29DK038712, R01DK038712, R01DK098655, R55DK038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Foundation International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK38712, DK55326, DK098655 and GM021700 (to M. F. W.). This work was also supported by an award from the Juvenile Diabetes Foundation International.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Giraud J, 2007, MOL ENDOCRINOL, V21, P2294, DOI 10.1210/me.2007-0159; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Gupta A, 2012, MOL BIOL CELL, V23, P3882, DOI 10.1091/mbc.E12-05-0337; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennige AM, 2006, FASEB J, V20, P1206, DOI 10.1096/fj.05-4635fje; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jiang GQ, 2004, BIOCHEM J, V377, P339, DOI 10.1042/BJ20031207; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Kim SJ, 2012, MOL CELL, V48, P875, DOI 10.1016/j.molcel.2012.09.029; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Langlais P, 2011, DIABETOLOGIA, V54, P2878, DOI 10.1007/s00125-011-2271-9; Levkovitz Y, 2007, MOL CELL NEUROSCI, V36, P305, DOI 10.1016/j.mcn.2007.05.009; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; Mandavia C, 2012, CARDIORENAL MED, V2, P308, DOI 10.1159/000343889; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheufele F, 2014, CELL SIGNAL, V26, P233, DOI 10.1016/j.cellsig.2013.11.005; SEGER R, 1995, J BIOL CHEM, V270, P28325; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Waraich RS, 2008, J BIOL CHEM, V283, P11226, DOI 10.1074/jbc.M708588200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355; Yi ZP, 2006, J AM SOC MASS SPECTR, V17, P562, DOI 10.1016/j.jasms.2005.12.010; Yi ZP, 2005, ANAL CHEM, V77, P5693, DOI 10.1021/ac050760y; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; ZINCK R, 1995, MOL CELL BIOL, V15, P4930; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	91	63	66	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12467	12484		10.1074/jbc.M114.554162	http://dx.doi.org/10.1074/jbc.M114.554162			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24652289	Green Published, hybrid			2022-12-28	WOS:000335581400023
J	Weathington, NM; Snavely, CA; Chen, BB; Zhao, J; Zhao, YT; Mallampalli, RK				Weathington, Nathaniel M.; Snavely, Courtney A.; Chen, Bill B.; Zhao, Jing; Zhao, Yutong; Mallampalli, Rama K.			Glycogen Synthase Kinase-3 beta Stabilizes the Interleukin (IL)-22 Receptor from Proteasomal Degradation in Murine Lung Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE LYMPHOID-CELLS; ACTIN POLYMERIZATION; TH17 CELLS; IL-22; UBIQUITINATION; PHOSPHORYLATES; CORTACTIN; PATHWAY; ERK	Signaling through the interleukin (IL)-22 cytokine axis provides essential immune protection in the setting of extracellular infection as part of type 17 immunity. Molecular regulation of IL-22 receptor (IL-22R) protein levels is unknown. In murine lung epithelia, IL-22R is a relatively short-lived protein (t(1/2) similar to 1.5 h) degraded by the ubiquitin proteasome under normal unstimulated conditions, but its degradation is accelerated by IL-22 treatment. Lys(449) within the intracellular C-terminal domain of the IL-22R serves as a ubiquitin acceptor site as disruption of this site by deletion or site-directed mutagenesis creates an IL-22R variant that, when expressed in cells, is degradation-resistant and not ubiquitinated. Glycogen synthase kinase (GSK)-3 beta phosphorylates the IL-22R within a consensus phosphorylation signature at Ser(410) and Ser(414), and IL-22 treatment of cells triggers GSK-3 beta inactivation. GSK-3 beta overexpression results in accumulation of IL-22R protein, whereas GSK-3 beta depletion in cells reduces levels of the receptor. Mutagenesis of IL-22R at Ser(410) and Ser(414) results in receptor variants that display reduced phosphorylation levels and are more labile as compared with wild-type IL-22R when expressed in cells. Further, the cytoskeletal protein cortactin, which is important for epithelial spreading and barrier formation, is phosphorylated and activated at the epithelial cell leading edge after treatment with IL-22, but this effect is reduced after GSK-3 beta knockdown. These findings reveal the ability of GSK-3 beta to modulate IL-22R protein stability that might have significant implications for cyto-protective functions and therapeutic targeting of the IL-22 signaling axis.	[Weathington, Nathaniel M.; Snavely, Courtney A.; Chen, Bill B.; Zhao, Jing; Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Dept Med, Div Pulm Allergy & Crit Care Med, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; National Institutes of Health R01 [HL096376, HL097376, HL098174, HL081784, UH2 HL123502, P01 HL114453, HL116472, HL01916]; American Heart Association [12SDG9050005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL096376, P01HL114453, R01HL097376, R01HL081784, UH2HL123502, R01HL112791, R01HL116472] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, and a Merit Review Award from the United States Department of Veterans Affairs (to R. K. M. and N.M.W.). This work was also supported, in part, by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, UH2 HL123502, and P01 HL114453 (to R. K. M.), HL116472 (to B. B. C.), and HL01916 (to Y.Z.), and an American Heart Association Award 12SDG9050005 (to J.Z.).	Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jiang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027464; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kumar KGS, 2003, EMBO J, V22, P5480; Kwiek NC, 2007, CELL SIGNAL, V19, P593, DOI 10.1016/j.cellsig.2006.08.009; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	31	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17610	17619		10.1074/jbc.M114.551747	http://dx.doi.org/10.1074/jbc.M114.551747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24742671	hybrid, Green Published			2022-12-28	WOS:000338018100026
J	Kouro, H; Kon, S; Matsumoto, N; Miyashita, T; Kakuchi, A; Ashitomi, D; Saitoh, K; Nakatsuru, T; Togi, S; Muromoto, R; Matsuda, T				Kouro, Hitomi; Kon, Shigeyuki; Matsumoto, Naoki; Miyashita, Tomoe; Kakuchi, Ayaka; Ashitomi, Dai; Saitoh, Kodai; Nakatsuru, Takuya; Togi, Sumihito; Muromoto, Ryuta; Matsuda, Tadashi			The Novel alpha 4B Murine alpha 4 Integrin Protein Splicing Variant Inhibits alpha 4 Protein-dependent Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CYTOPLASMIC DOMAINS; CONFORMATIONAL-CHANGES; TUMOR-METASTASIS; KINASE; LIGAND; OSTEOPONTIN; EXPRESSION; PAXILLIN; ALPHA(4)BETA(1)	Integrins affect the motility of multiple cell types to control cell survival, growth, or differentiation, which are mediated by cell-cell and cell-extracellular matrix interactions. We reported previously that the alpha 9 integrin splicing variant, SF alpha 9, promotes WT alpha 9 integrin-dependent adhesion. In this study, we introduced a new murine alpha 4 integrin splicing variant, alpha 4B, which has a novel short cytoplasmic tail. In inflamed tissues, the expression of alpha 4B, as well as WT alpha 4 integrin, was up-regulated. Cells expressing alpha 4B specifically bound to VCAM-1 but not other alpha 4 integrin ligands, such as fibronectin CS1 or osteopontin. The binding of cells expressing WT alpha 4 integrin to alpha 4 integrin ligands is inhibited by coexpression of alpha 4B. Knockdown of alpha 4B in metastatic melanoma cell lines results in a significant increase in lung metastasis. Expression levels of WT alpha 4 integrin are unaltered by alpha 4B, with alpha 4B acting as a regulatory subunit for WT alpha 4 integrin by a dominant-negative effect or inhibiting alpha 4 integrin activation.	[Kouro, Hitomi; Kon, Shigeyuki; Matsumoto, Naoki; Miyashita, Tomoe; Kakuchi, Ayaka; Ashitomi, Dai; Saitoh, Kodai; Nakatsuru, Takuya; Togi, Sumihito; Muromoto, Ryuta; Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kon, S (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	kon@pharm.hokudai.ac.jp; tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Togi, Sumihito/ABH-6734-2020; Muromoto, Ryuta/E-4203-2012	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Togi, Sumihito/0000-0002-3189-8111	JSPS KAKENHI [24590072]; Akiyama Life Science Foundation; Suzuken Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Akiyama Life Science Foundation; Suzuken Memorial Foundation	This study was supported in part by JSPS KAKENHI Grant 24590072, by the Akiyama Life Science Foundation, and by the Suzuken Memorial Foundation.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; de Melker AA, 1999, BIOESSAYS, V21, P499, DOI 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; ELICES MJ, 1994, J CLIN INVEST, V93, P405, DOI 10.1172/JCI116975; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; HEMLER ME, 1992, COLD SPRING HARB SYM, V57, P213, DOI 10.1101/SQB.1992.057.01.026; Holzmann B, 1998, CURR TOP MICROBIOL, V231, P125; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1994, CURR OPIN GENET DEV, V4, P569, DOI 10.1016/0959-437X(94)90074-D; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Isobe T, 1997, J BIOL CHEM, V272, P8447, DOI 10.1074/jbc.272.13.8447; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kon S, 2000, J CELL BIOCHEM, V77, P487; Kon S, 2011, EXP CELL RES, V317, P1774, DOI 10.1016/j.yexcr.2011.04.005; Liu SC, 2000, J CELL SCI, V113, P3563; Newham P, 1998, J IMMUNOL, V160, P4508; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	37	4	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16389	16398		10.1074/jbc.M114.553610	http://dx.doi.org/10.1074/jbc.M114.553610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24755217	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000337965700041
J	Chi, YC; Armstrong, GS; Jones, DNM; Eisenmesser, EZ; Liu, CW				Chi, Ying-Chih; Armstrong, Geoffrey S.; Jones, David N. M.; Eisenmesser, Elan Z.; Liu, Chang-Wei			Residue Histidine 50 Plays a Key Role in Protecting alpha-Synuclein from Aggregation at Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mutant; Nuclear Magnetic Resonance; Parkinson Disease; Protein Aggregation; Synuclein	FAMILIAL PARKINSONS-DISEASE; IN-VITRO; FIBRIL FORMATION; E46K MUTATION; MICE; IMPACT; NMR; PATHOGENESIS; BINDING; DUPLICATION	alpha-Synuclein (Syn) aggregation is involved in the pathogenesis of Parkinson disease (PD). Recently, substitution of histidine 50 in Syn with a glutamine, H50Q, was identified as a new familial PD mutant. Here, nuclear magnetic resonance (NMR) studies revealed that the H50Q substitution causes an increase of the flexibility of the C-terminal region. This finding provides direct evidence that this PD-causing mutant can mediate long range effects on the sampling of Syn conformations. In vitro aggregation assays showed that substitution of His-50 with Gln, Asp, or Ala promotes Syn aggregation, whereas substitution with the positively charged Arg suppresses Syn aggregation. Histidine carries a partial positive charge at neutral pH, and so our result suggests that positively charged His-50 plays a role in protecting Syn from aggregation under physiological conditions.	[Chi, Ying-Chih; Eisenmesser, Elan Z.; Liu, Chang-Wei] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Armstrong, Geoffrey S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Jones, DNM (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	david.jones@ucdenver.edu; elan.eisenmesser@ucdenver.edu; changwei.liu@ucdenver.edu			National Institutes of Health [5R01NS72397]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS72397 (to C.-W.L.).	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chatterjee A, 2005, J CHEM SCI, V117, P3, DOI 10.1007/BF02704356; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Coelho-Cerqueira E, 2013, FEBS J, V280, P4915, DOI 10.1111/febs.12471; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Ulrih NP, 2008, BBA-MOL BASIS DIS, V1782, P581, DOI 10.1016/j.bbadis.2008.07.004; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P498, DOI 10.1021/cn3002027; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	17	17	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15474	15481		10.1074/jbc.M113.544049	http://dx.doi.org/10.1074/jbc.M113.544049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742669	Green Published, hybrid			2022-12-28	WOS:000337465400030
J	Morimoto, R; Shindou, H; Tarui, M; Shimizu, T				Morimoto, Ryo; Shindou, Hideo; Tarui, Megumi; Shimizu, Takao			Rapid Production of Platelet-activating Factor Is Induced by Protein Kinase C alpha-mediated Phosphorylation of Lysophosphatidylcholine Acyltransferase 2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Inflammation; Macrophages; Membrane Lipids; Phosphorylation; Protein Kinase C (PKC); Platelet-activating Factor; Lysophospholipid Acyltransferase	CYTOSOLIC PHOSPHOLIPASE A(2); POLYUNSATURATED FATTY-ACIDS; LYSO-PAF ACETYLTRANSFERASE; FACTOR-ACETYLHYDROLASE; CELL-DEATH; RECEPTOR; CLONING; BINDING; IDENTIFICATION; BIOSYNTHESIS	Platelet-activating factor (PAF), a potent proinflammatory lipid mediator, is synthesized rapidly in response to extracellular stimuli by the activation of acetyl-CoA:lyso-PAF acetyltransferase (lyso-PAFAT). We have reported previously that lyso-PAFAT activity is enhanced in three distinct ways in mouse macrophages: rapid activation (30 s) after PAF stimulation and minutes to hours after LPS stimulation. Lysophosphatidylcholine acyltransferase 2 (LPCAT2) was later identified as a Ca2+-dependent lyso-PAFAT. However, the mechanism of rapid lyso-PAFAT activation within 30 s has not been elucidated. Here we show a new signaling pathway for rapid biosynthesis of PAF that is mediated by phosphorylation of LPCAT2 at Ser-34. Stimulation by either PAF or ATP resulted in PKC-mediated phosphorylation of LPCAT2 to enhance lyso-PAFAT activity and rapid PAF production. Biochemical analyses showed that the phosphorylation of Ser-34 resulted in augmentation of V-max with minimal K-m change. Our results offer an answer for the previously unknown mechanism of rapid PAF production.	[Morimoto, Ryo; Shindou, Hideo; Tarui, Megumi; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Morimoto, Ryo; Shimizu, Takao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Shindou, Hideo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	hshindou-tky@umin.net	Shimizu, Takao/AAV-7052-2021	Morimoto, Ryo/0000-0002-5497-4666	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Center for Global Health and Medicine [24-001, 25-201]; Takeda Science Foundation; Cell Science Research Foundation; CREST, the Japan Science and Technology Agency; Gushinkai	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); CREST, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Gushinkai	This work was supported by a grant-in-aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; by National Center for Global Health and Medicine grant 24-001, 25-201; and by the Takeda Science Foundation (to T. S.).; Supported by the Takeda Science Foundation and The Cell Science Research Foundation.; Supported by CREST, the Japan Science and Technology Agency, Gushinkai, and The Cell Science Research Foundation.	BALLESTER R, 1985, J BIOL CHEM, V260, P5194; Bitencourt CS, 2013, J CELL MOL MED, V17, P1554, DOI 10.1111/jcmm.12118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; JAMESKRACKE MR, 1994, J PHARMACOL EXP THER, V271, P824; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Karasawa K, 1996, J BIOCHEM-TOKYO, V120, P838; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Kume K, 1997, J BIOL CHEM, V272, P22898, DOI 10.1074/jbc.272.36.22898; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; NIETO ML, 1988, J BIOL CHEM, V263, P2217; NIETO ML, 1988, J BIOL CHEM, V263, P4607; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; OHNO S, 1990, J BIOL CHEM, V265, P6296; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tokuoka SM, 2013, BIOCHEM BIOPH RES CO, V436, P306, DOI 10.1016/j.bbrc.2013.05.099; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1	44	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15566	15576		10.1074/jbc.M114.558874	http://dx.doi.org/10.1074/jbc.M114.558874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742674	hybrid, Green Published			2022-12-28	WOS:000337465400039
J	Hikosaka, K; Ikutani, M; Shito, M; Kazuma, K; Gulshan, M; Nagai, Y; Takatsu, K; Konno, K; Tobe, K; Kanno, H; Nakagawa, T				Hikosaka, Keisuke; Ikutani, Masashi; Shito, Masayuki; Kazuma, Kohei; Gulshan, Maryam; Nagai, Yoshinori; Takatsu, Kiyoshi; Konno, Katsuhiro; Tobe, Kazuyuki; Kanno, Hitoshi; Nakagawa, Takashi			Deficiency of Nicotinamide Mononucleotide Adenylyltransferase 3 (Nmnat3) Causes Hemolytic Anemia by Altering the Glycolytic Flow in Mature Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; PYRUVATE-KINASE DEFICIENCY; SUBCELLULAR COMPARTMENTATION; ADENINE-DINUCLEOTIDE; AXONAL DEGENERATION; ENZYMATIC-SYNTHESIS; NAD SYNTHESIS; METABOLISM; MUTATIONS; MICE	NAD biosynthesis is of substantial interest because of its important roles in regulating various biological processes. Nicotinamide mononucleotide adenylyltransferase 3 (Nmnat3) is considered a mitochondria-localized NAD synthesis enzyme involved in de novo and salvage pathways. Although the biochemical properties of Nmnat3 are well documented, its physiological function in vivo remains unclear. In this study, we demonstrated that Nmnat3 was localized in the cytoplasm of mature erythrocytes and critically regulated their NAD pool. Deficiency of Nmnat3 in mice caused splenomegaly and hemolytic anemia, which was associated with the findings that Nmnat3-deficient erythrocytes had markedly lower ATP levels and shortened lifespans. However, the NAD level in other tissues were not apparently affected by the deficiency of Nmnat3. LC-MS/MS-based metabolomics revealed that the glycolysis pathway in Nmnat3-deficient erythrocytes was blocked at a glyceraldehyde 3-phosphate dehydrogenase (GAPDH) step because of the shortage of the coenzyme NAD. Stable isotope tracer analysis further demonstrated that deficiency of Nmnat3 resulted in glycolysis stall and a shift to the pentose phosphate pathway. Our findings indicate the critical roles of Nmnat3 in maintenance of the NAD pool in mature erythrocytes and the physiological impacts at its absence in mice.	[Hikosaka, Keisuke; Gulshan, Maryam; Nakagawa, Takashi] Toyama Univ, Frontier Res Core Life Sci, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Ikutani, Masashi; Nagai, Yoshinori; Takatsu, Kiyoshi] Toyama Univ, Dept Immunobiol & Pharmacol Genet, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Gulshan, Maryam; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Kazuma, Kohei; Konno, Katsuhiro] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Shito, Masayuki; Kanno, Hitoshi] Tokyo Womens Med Univ, Dept Transfus Med & Cell Proc, Grad Sch Med, Tokyo 1628666, Japan; [Kanno, Hitoshi] Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Grad Sch Med, Tokyo 1628666, Japan; [Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, Kosugi, Toyama 9390363, Japan; [Nagai, Yoshinori] PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	University of Toyama; University of Toyama; University of Toyama; University of Toyama; Tokyo Women's Medical University; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Nakagawa, T (corresponding author), Toyama Univ, 2630 Sugitani, Toyama 9300194, Japan.	nakagawa@med.u-toyama.ac.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Konno, Katsuhiro/0000-0002-1949-1845	Sumitomo Foundation; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation;  [24609019];  [24116511]; Grants-in-Aid for Scientific Research [25461609, 24590577] Funding Source: KAKEN	Sumitomo Foundation; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Young Scientists (A) (24609019) and a Grant-in-Aid for Scientific Research on Innovative Areas (24116511) (to T. N.). This work was also supported by grants from The Sumitomo Foundation, Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders, and the Takeda Science Foundation (to T. N.).	Aizawa S, 2005, EXP HEMATOL, V33, P1292, DOI 10.1016/j.exphem.2005.07.008; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Climent Fernando, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P95; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Darghouth D, 2011, BLOOD, V117, pE57, DOI 10.1182/blood-2010-07-299636; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; KANNO H, 1995, BLOOD, V86, P3205, DOI 10.1182/blood.V86.8.3205.bloodjournal8683205; KIRTLEY ME, 1977, MOL CELL BIOCHEM, V18, P141, DOI 10.1007/BF00280279; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Liu J, 2011, CURR OPIN HEMATOL, V18, P133, DOI 10.1097/MOH.0b013e32834521f3; LIU RH, 1995, NUCLEIC ACIDS RES, V23, P3742, DOI 10.1093/nar/23.18.3742; LOKEN MR, 1987, BLOOD, V69, P255; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Manodori AB, 2002, J LAB CLIN MED, V140, P161, DOI 10.1067/mlc.2002.126504; MICHELI V, 1990, ARCH BIOCHEM BIOPHYS, V283, P40, DOI 10.1016/0003-9861(90)90609-3; MICHELI V, 1991, ADV EXP MED BIOL, V307, P139; Micheli V, 1997, METHOD ENZYMOL, V280, P211; MIWA S, 1993, AM J HEMATOL, V42, P31, DOI 10.1002/ajh.2830420108; MORIMOTO M, 1995, BLOOD, V86, P4323, DOI 10.1182/blood.V86.11.4323.bloodjournal86114323; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; NOBLE NA, 1989, BLOOD, V74, P475; Orsomando G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053271; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; PITTMAN JG, 1966, J CLIN INVEST, V45, P165, DOI 10.1172/JCI105328; PREISS J, 1957, J BIOL CHEM, V225, P759; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; SESTINI S, 1993, ARCH BIOCHEM BIOPHYS, V302, P206, DOI 10.1006/abbi.1993.1200; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tyan YC, 2005, J PROTEOME RES, V4, P748, DOI 10.1021/pr0497780; VANDENBOS C, 1993, EXP HEMATOL, V21, P350; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	63	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14796	14811		10.1074/jbc.M114.554378	http://dx.doi.org/10.1074/jbc.M114.554378			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24739386	Green Published, hybrid			2022-12-28	WOS:000337248100035
J	Wu, XM; Gao, H; Bleday, R; Zhu, ZL				Wu, Xiaoming; Gao, Hong; Bleday, Ronald; Zhu, Zhenglun			Homeobox Transcription Factor VentX Regulates Differentiation and Maturation of Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-6 GENE; ACTIVATION; MACROPHAGES; EXPRESSION; MONOCYTES; PROMOTES; SUSCEPTIBILITY; INHIBITION; PRECURSORS; SWITCHES	Dendritic cells (DCs) are specialized antigen presentation cells that play critical roles in the initiation and regulation of immune responses. The molecular determinants of DC differentiation and maturation are target of extensive investigation. VentX is a human homeobox transcriptional factor that regulates proliferation and differentiation of hematopoietic cells. In the current study, we report that ablation of VentX expression in monocytes significantly impaired their differentiation into DCs. Conversely, overexpression of VentX in monocytic THP1 cells accelerated their differentiation toward DCs. We showed that VentX regulates DC differentiation, in part, through modulating IL6 expression. Clinically, we found that VentX expression was elevated in intestinal lamina propria DCs (LPDCs) of inflamed mucosa from inflammatory bowel disease patients. Knockdown experiments suggested that VentX is essential for the maturation of LPDCs. In addition, corticosteroid treatment markedly decreased VentX expression in LPDCs and enforced expression of VentX counteracted the effects of corticosteroid on DCs maturation. Our data suggest that VentX is a critical transcriptional regulator of DC differentiation and maturation, and a potential target of immune regulation and therapy.	[Wu, Xiaoming; Zhu, Zhenglun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Gastroenterol Div, Boston, MA 02115 USA; [Bleday, Ronald] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gao, Hong] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center	Zhu, ZL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	zzhu@partners.org			National Institutes of Health, American Cancer Society; Brigham and Women's Hospital	National Institutes of Health, American Cancer Society; Brigham and Women's Hospital	This work was supported, in whole or in part, by grants from the National Institutes of Health, American Cancer Society, and a research fund from Brigham and Women's Hospital (to Z. Z.).	Appel S, 2006, BLOOD, V107, P3265, DOI 10.1182/blood-2005-06-2480; Bell SJ, 2001, J IMMUNOL, V166, P4958, DOI 10.4049/jimmunol.166.8.4958; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Chim CS, 2008, J CLIN PATHOL, V61, P1214, DOI 10.1136/jcp.2008.060152; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2012, J BIOL CHEM, V287, P29979, DOI 10.1074/jbc.M112.383018; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kramer JL, 2002, BRIT J HAEMATOL, V117, P727, DOI 10.1046/j.1365-2141.2002.03498.x; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mellman I, 2005, ADV EXP MED BIOL, V560, P63; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Mitani H, 2000, BRIT J HAEMATOL, V109, P288, DOI 10.1046/j.1365-2141.2000.02020.x; Piemonti L, 1999, J IMMUNOL, V162, P6473; PIGNATA C, 1990, GUT, V31, P879, DOI 10.1136/gut.31.8.879; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556; Wu XM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206078; Yang JM, 2012, CANCER RES, V72, P4682, DOI 10.1158/0008-5472.CAN-12-0440; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169	41	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14633	14643		10.1074/jbc.M113.509158	http://dx.doi.org/10.1074/jbc.M113.509158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706756	hybrid, Green Published			2022-12-28	WOS:000337248100020
J	Fei, C; He, XL; Xie, SC; Miao, HF; Zhou, ZL; Li, L				Fei, Cong; He, Xiaoli; Xie, Sichun; Miao, Haofei; Zhou, Zhilei; Li, Lin			Smurf1-mediated Axin Ubiquitination Requires Smurf1 C2 Domain and Is Cell Cycle-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Cell Cycle; Protein-Protein Interactions; Ubiquitination; Wnt Signaling	LIGASE SMURF1; CATENIN; PROMOTE; PATHWAY; CANCER; DEGRADATION; STABILITY; DISEASE; PROTEIN; TARGET	Background: Smurf1 ubiquitinates Axin via K29 poly-ubiquitin chains, and interferes with Wnt/-catenin signaling. Results: The C2 domain of Smurf1 is responsible for interacting with Axin, and Smurf1-mediated Axin ubiquitination attenuates in the G2/M phase of cell cycle. Conclusion: Smurf1-Axin interaction follows a non-canonical pattern and is under the control of cell cycle. Significance: Further clarification of the characteristic of Smurf1-mediated K29-linked poly-ubiquitination of Axin. Previously, Smad ubiquitination regulatory factor 1 (Smurf1)-mediated Lys29 (K29)-linked poly-ubiquitination of Axin has been identified as a novel regulatory process in Wnt/-catenin signaling. In this work, we discovered that the C2 domain of Smurf1 is critical for targeting Axin for ubiquitination. We found that the C2 domain-mediated plasma membrane localization of Smurf1 is required for Axin ubiquitination, and interfering with that disturbs the co-localization of Smurf1 and Axin around the plasma membrane. Moreover, the C2 domain of Smurf1, rather than its WW domains, is involved in Smurf1's interaction with Axin; and the putative PPXY motifs (PY motif) of Axin are not essential for such an interaction, indicating that Smurf1 binds to Axin in a non-canonical way independent of WW-PY interaction. Further, we found that Smurf1-Axin interaction and Axin ubiquitination are attenuated in the G2/M phase of cell cycle, contributing to an increased cell response to Wnt stimulation at that stage. Collectively, we uncovered a dual role of Smurf1 C2 domain, recruiting Smurf1 to membrane for accessing Axin and mediating its interaction with Axin, and that Smurf1-mediated Axin ubiquitination is subjected to the regulation of cell cycle.	[Fei, Cong; He, Xiaoli; Xie, Sichun; Miao, Haofei; Zhou, Zhilei; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; zhou, zhou/HCH-1084-2022; LI, LI/GVS-5344-2022		Ministry of Science and Technology of China [2010CB912100]; National Natural Science Foundation of China [31230044, 30930052, 91213304]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China Grant 2010CB912100, and National Natural Science Foundation of China Grants 31230044, 30930052, and 91213304.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chen YL, 2009, J BIOL CHEM, V284, P23481, DOI 10.1074/jbc.M109.007864; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Sangadala S, 2007, J BIOMOL STRUCT DYN, V25, P11, DOI 10.1080/07391102.2007.10507151; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tian MY, 2011, FEBS LETT, V585, P2199, DOI 10.1016/j.febslet.2011.06.016; Wang JY, 2013, J BIOL CHEM, V288, P33667, DOI 10.1074/jbc.M113.503292; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	23	12	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14170	14177		10.1074/jbc.M113.536714	http://dx.doi.org/10.1074/jbc.M113.536714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24700460	Green Published, hybrid			2022-12-28	WOS:000335984600044
J	Koraishy, FM; Silva, C; Mason, S; Wu, DQ; Cantley, LG				Koraishy, Farrukh M.; Silva, Cynthia; Mason, Sherene; Wu, Dianqing; Cantley, Lloyd G.			Hepatocyte Growth Factor ( Hgf) Stimulates Low Density Lipoprotein Receptor-related Protein ( Lrp) 5/6 Phosphorylation and Promotes Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Glycogen synthase kinase 3; Hepatocyte growth factor; Kidney; Wnt signaling	GLYCOGEN-SYNTHASE KINASE-3; EPITHELIAL-CELLS; MET; KIDNEY; BETA; ACTIVATION; REPAIR; REGENERATION; INHIBITION; EXPRESSION	Background: The crosstalk between Hgf and Wnt signaling pathways is not well defined. Results: Hgf was found to stimulate Gsk3-dependent Lrp5/6 phosphorylation, increase nuclear -catenin and reduce apoptosis in an Lrp5/6-dependent fashion. Conclusion: Hgf transactivates canonical Wnt signaling. Significance: This pathway is involved in the survival of renal epithelial cells and is activated in vivo after renal ischemia. While Wnt and Hgf signaling pathways are known to regulate epithelial cell responses during injury and repair, whether they exhibit functional cross-talk is not well defined. Canonical Wnt signaling is initiated by the phosphorylation of the Lrp5/6 co-receptors. In the current study we demonstrate that Hgf stimulates Met and Gsk3-dependent and Wnt-independent phosphorylation of Lrp5/6 at three separate activation motifs in subconfluent, de-differentiated renal epithelial cells. Hgf treatment stimulates the selective association of active Gsk3 with Lrp5/6. In contrast, Akt-phosphorylated inactive Gsk3 is excluded from this association. Hgf stimulates -catenin stabilization and nuclear accumulation and protects against epithelial cell apoptosis in an Lrp5/6-dependent fashion. In vivo, the increase in Lrp5/6 phosphorylation and -catenin stabilization in the first 6-24 h after renal ischemic injury was significantly reduced in mice lacking Met receptor in the renal proximal tubule. Our results thus identify Hgf as an important transactivator of canonical Wnt signaling that is mediated by Met-stimulated, Gsk3-dependent Lrp5/6 phosphorylation.	[Koraishy, Farrukh M.; Cantley, Lloyd G.] Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT 06510 USA; [Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Silva, Cynthia; Mason, Sherene] Connecticut Childrens Med Ctr, Sect Pediat Nephrol, Hartford, CT 06106 USA	Yale University; Yale University; Connecticut Children's Medical Center	Koraishy, FM (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Box 208029, New Haven, CT 06520 USA.	farrukh.koraishy@yale.edu	Koraishy, Farrukh/GLQ-8827-2022	Koraishy, Farrukh/0000-0001-6974-5674	NIDDK, National Institutes of Health [DK65109]; American Society of Nephrology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD068201] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA139395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065109, P30DK079310, T32DK007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112182] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant DK65109 (to L. G. C.) and an American Society of Nephrology (Ben J. Lipps) Research Fellowship (to F. M. K.).	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; CANTLEY LG, 1994, AM J PHYSIOL, V267, pF271, DOI 10.1152/ajprenal.1994.267.2.F271; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Li QF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-302; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Lyu J, 2004, DEVELOPMENT, V131, P1813, DOI 10.1242/dev.01060; Ma H, 2009, KIDNEY INT, V76, P868, DOI 10.1038/ki.2009.304; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mason S, 2014, J AM SOC NEPHROL, V25, P329, DOI 10.1681/ASN.2013050473; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang T, 2001, CANCER RES, V61, P8664; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173	46	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14341	14350		10.1074/jbc.M114.563213	http://dx.doi.org/10.1074/jbc.M114.563213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692544	Green Published, hybrid			2022-12-28	WOS:000335984600059
J	Yamazaki, Y; Nagata, T; Terakita, A; Kandori, H; Shichida, Y; Imamoto, Y				Yamazaki, Yoichi; Nagata, Tomoko; Terakita, Akihisa; Kandori, Hideki; Shichida, Yoshinori; Imamoto, Yasushi			Intramolecular Interactions That Induce Helical Rearrangement upon Rhodopsin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fourier Transform IR (FTIR); G-protein-coupled Receptor (GPCR); Phototransduction; Protein Conformation; Rhodopsin; Vision	PROTEIN-COUPLED RECEPTOR; S-H BAND; METARHODOPSIN-II; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; TRANSMEMBRANE HELICES; VISUAL PIGMENTS; CONFORMATIONAL-CHANGES; MOLECULAR-PROPERTIES; SIDE-CHAINS	Background: Identification of the intramolecular interactions in metarhodopsin IIa is essential for understanding the activation mechanism of rhodopsin. Results: Environmental changes around the chromophore, Ala-164, His-211, and Phe-261 were observed by probing with cysteine S-H vibrations. Conclusion: The interactions involving these residues are altered before the helical rearrangements. Significance: The intramolecular interactions by which rhodopsin adopts the transducin-activating conformation are shown. Rhodopsin undergoes rearrangements of its transmembrane helices after photon absorption to transfer a light signal to the G-protein transducin. To investigate the mechanism by which rhodopsin adopts the transducin-activating conformation, the local environmental changes in the transmembrane region were probed using the cysteine S-H group, whose stretching frequency is well isolated from the other protein vibrational modes. The S-H stretching modes of cysteine residues introduced into Helix III, which contains several key residues for the helical movements, and of native cysteine residues were measured by Fourier transform infrared spectroscopy. This method was applied to metarhodopsin IIa, a precursor of the transducin-activating state in which the intramolecular interactions are likely to produce a state ready for helical movements. No environmental change was observed near the ionic lock between Arg-135 in Helix III and Glu-247 in Helix VI that maintains the inactive conformation. Rather, the cysteine residues that showed environmental changes were located around the chromophore, Ala-164, His-211, and Phe-261. These findings imply that the hydrogen bond between Helix III and Helix V involving Glu-122 and His-211 and the hydrophobic packing between Helix III and Helix VI involving Gly-121, Leu-125, Phe-261, and Trp-265 are altered before the helical rearrangement leading toward the active conformation.	[Yamazaki, Yoichi; Nagata, Tomoko; Terakita, Akihisa; Kandori, Hideki; Shichida, Yoshinori; Imamoto, Yasushi] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan; [Yamazaki, Yoichi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Terakita, Akihisa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 5588585, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Grad Sch Engn, Nagoya, Aichi 4668555, Japan	Kyoto University; Nara Institute of Science & Technology; Osaka Metropolitan University; Nagoya Institute of Technology	Imamoto, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	imamoto@rh.biophys.kyoto-u.ac.jp		Terakita, Akihisa/0000-0002-8379-8913; Imamoto, Yasushi/0000-0002-0803-4163	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y.Y., A. T., H. K., Y.S., and Y.I.).	ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; IMAI H, 1994, BIOCHEMISTRY-US, V33, P14351, DOI 10.1021/bi00251a049; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Imai H, 2007, J BIOL CHEM, V282, P6677, DOI 10.1074/jbc.M610086200; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Kandori H, 1998, J AM CHEM SOC, V120, P5828, DOI 10.1021/ja980837i; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; LI HM, 1991, J AM CHEM SOC, V113, P456, DOI 10.1021/ja00002a012; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Nagata T, 1998, BIOCHEMISTRY-US, V37, P17216, DOI 10.1021/bi9810149; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1989, VISION RES, V29, P907, DOI 10.1016/0042-6989(89)90105-3; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nishimura S, 1995, BIOCHEMISTRY-US, V34, P16758, DOI 10.1021/bi00051a025; OHKITA YJ, 1995, BIOPHYS CHEM, V56, P71, DOI 10.1016/0301-4622(95)00017-R; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; RATH P, 1994, BIOPHYS J, V66, P2085, DOI 10.1016/S0006-3495(94)81003-3; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sato K, 2010, BIOCHEMISTRY-US, V49, P736, DOI 10.1021/bi9018412; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Vogel R, 2003, BIOPOLYMERS, V72, P133, DOI 10.1002/bip.10407; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; WEITZ CJ, 1992, NEURON, V8, P465, DOI 10.1016/0896-6273(92)90274-H; Yamazaki Yoichi, 2014, Biophysics (Nagoya-shi), V10, P1, DOI 10.2142/biophysics.10.1; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zaitseva E, 2010, J AM CHEM SOC, V132, P4815, DOI 10.1021/ja910317a; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	47	9	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13792	13800		10.1074/jbc.M113.527606	http://dx.doi.org/10.1074/jbc.M113.527606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24692562	hybrid, Green Published			2022-12-28	WOS:000335984600013
J	Machova, I; Snasel, J; Zimmermann, M; Laubitz, D; Plocinski, P; Oehlmann, W; Singh, M; Dostal, J; Sauer, U; Pichova, I				Machova, Iva; Snasel, Jan; Zimmermann, Michael; Laubitz, Daniel; Plocinski, Przemyslaw; Oehlmann, Wulf; Singh, Mahavir; Dostal, Jiri; Sauer, Uwe; Pichova, Iva			Mycobacterium tuberculosis Phosphoenolpyruvate Carboxykinase Is Regulated by Redox Mechanisms and Interaction with Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Hypoxia; Metabolism; Mycobacterium Tuberculosis; Oxidation-Reduction; Thioredoxin; Phosphoenolpyruvate Carboxykinase	MACROPHAGES; EXPRESSION; CATALYSIS; SMEGMATIS; CYCLE	Background: Phosphoenolpyruvate carboxykinase (Pck) catalyzes the interconversion of phosphoenolpyruvate and oxaloacetate but typically prefers gluconeogenic formation of phosphoenolpyruvate. Results: Interactions of Mycobacterium tuberculosis (MTb) Pck with thioredoxin and reducing environments favor the anaplerotic oxaloacetate synthesis. Conclusion: A mechanism explaining the regulation of Pck functions is proposed. Significance: Regulation of Pck is important for the MTb non-replicative state associated with latent tuberculosis infection. Tuberculosis remains a major health concern worldwide. Eradication of its causative agent, the bacterial pathogen Mycobacterium tuberculosis, is particularly challenging due to a vast reservoir of latent carriers of the disease. Despite the misleading terminology of a so-called dormant state associated with latent infections, the bacteria have to maintain basic metabolic activities. Hypoxic conditions have been widely used as an in vitro system to study this dormancy. Such studies identified a rearrangement of central carbon metabolism to exploit fermentative processes caused by the lack of oxygen. Phosphoenolpyruvate carboxykinase (Pck; EC 4.1.1.32) is the enzyme at the center of these metabolic rearrangements. Although Pck is associated with gluconeogenesis under standard growth conditions, the enzyme can catalyze the reverse reaction, supporting anaplerosis of the tricarboxylic acid cycle, under conditions leading to slowed or stopped bacterial replication. To study the mechanisms that regulate the switch between two Pck functions, we systematically investigated factors influencing the gluconeogenic and anaplerotic reaction kinetics. We demonstrate that a reducing environment, as found under hypoxia-triggered non-replicating conditions, accelerates the reaction in the anaplerotic direction. Furthermore, we identified proteins that interact with Pck. The interaction between Pck and the reduced form of mycobacterial thioredoxin, gene expression of which is increased under hypoxic conditions, also increased the Pck anaplerotic activity. We thus propose that a reducing environment and the protein-protein interaction with thioredoxin in particular enable the Pck anaplerotic function under fermentative growth conditions.	[Machova, Iva; Snasel, Jan; Dostal, Jiri; Pichova, Iva] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic; [Zimmermann, Michael; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Laubitz, Daniel; Plocinski, Przemyslaw] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Oehlmann, Wulf; Singh, Mahavir] Lionex, D-38126 Braunschweig, Germany	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Pichova, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Flemingovo Nam 2, CR-16610 Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Płociński, Przemysław A/S-5587-2017; Sauer, Uwe/Y-3556-2019; Snasel, Jan/G-8921-2014; Machova, Iva/AAH-7522-2020; Pichova, Iva/G-7917-2014; Dostal, Jiri/E-9584-2012; Machova, Iva/G-5578-2014	Płociński, Przemysław A/0000-0002-6623-3494; Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Laubitz, Daniel/0000-0002-7482-8500; Zimmermann, Michael/0000-0002-5797-3589	EU [241587]; RVO [61388963]; Operacni program Praha-Konkurenceschopnost (OPPK) Project [CZ.2.16/3.1.00/24016]	EU(European Commission); RVO; Operacni program Praha-Konkurenceschopnost (OPPK) Project	This work was supported by EU-PF7 SysteMtb Collaborative Project 241587, RVO 61388963, and by Operacni program Praha-Konkurenceschopnost (OPPK) Project CZ.2.16/3.1.00/24016.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; BALLARD F J, 1970, Biochemical Journal, V120, P809; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dharmarajan L, 2008, FEBS J, V275, P5810, DOI 10.1111/j.1742-4658.2008.06702.x; DYSON JED, 1969, J BIOL CHEM, V244, P560; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Johnson TA, 2012, BIOCHEMISTRY-US, V51, P9547, DOI 10.1021/bi301278t; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; MAKINEN AL, 1989, J BIOL CHEM, V264, P12148; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Pocinski P., 2014, PLOS ONE, V9; Rios SE, 2002, ARCH BIOCHEM BIOPHYS, V404, P25, DOI 10.1016/S0003-9861(02)00236-9; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Srinivasan V, 2006, BIOL BULL-US, V210, P1, DOI 10.2307/4134531; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zamboni N, 2004, METAB ENG, V6, P277, DOI 10.1016/j.ymben.2004.03.001	35	18	19	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13066	13078		10.1074/jbc.M113.536748	http://dx.doi.org/10.1074/jbc.M113.536748			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24659783	Green Published, hybrid			2022-12-28	WOS:000335522800010
J	Chua, CEL; Tang, BL				Chua, Christelle En Lin; Tang, Bor Luen			Engagement of the Small GTPase Rab31 Protein and Its Effector, Early Endosome Antigen 1, Is Important for Trafficking of the Ligand-bound Epidermal Growth Factor Receptor from the Early to the Late Endosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endosomes; Epidermal Growth Factor Receptor (EGFR); Rab; Trafficking	TRANS-GOLGI NETWORK; NUCLEOTIDE EXCHANGE FACTOR; EARLY ENDOCYTIC PATHWAY; EGF RECEPTOR; INTRACELLULAR TRAFFICKING; MEMBRANE TRAFFICKING; BREAST-CANCER; EEA1; EXPRESSION; BINDING	Background: Rab31 is a member of the Rab5 subfamily of Rab GTPases. Results: Manipulation of Rab31 and interacting partners affects trafficking of the EGF receptor (EGFR) to the late endosome. Conclusion: Rab31, with its regulator and effector, plays an important role in the trafficking of the EGFR from the early to the late endosome. Significance: Evidence is provided for Rab31 being a key regulator of endocytic traffic of the EGFR. Rab31 is a member of the Rab5 subfamily of Rab GTPases. Although localized largely to the trans-Golgi network, it shares common guanine nucleotide exchange factors and effectors with other Rab5 subfamily members that have been implicated in endocytic membrane traffic. We investigated whether Rab31 also has a role in the trafficking of the ligand-bound EGF receptor (EGFR) internalized through receptor-mediated endocytosis. We found that loss of Rab31 inhibits, but overexpression enhances, EGFR trafficking to the late endosomes and that the effect of Rab31 silencing could be specifically rescued by overexpression of a silencing-resistant form of Rab31. Rab31 was found to interact with the EGFR by coimmunoprecipitation and affinity pulldown analyses, and the primarily trans-Golgi network-localized Rab31 has increased colocalization with the EGFR in A431 cells 30 min after pulsing with EGF. A glycerol gradient sedimentation assay suggested that Rab31 is sequestered into a high molecular weight complex after stimulation with EGF, as was early endosome antigen 1 (EEA1), a factor responsible for endosomal tethering and fusion events. We found that loss of EEA1 reduced the interaction between Rab31 and the EGFR and abrogated the effect of Rab31 overexpression on the trafficking of the EGFR. Likewise, loss of GAPex5, a Rab31 guanine nucleotide exchange factor that has a role in ubiquitination and degradation of the EGFR, reduced the interaction of Rab31 with the EGFR and its effect on EGFR trafficking. Taken together, our results suggest that Rab31 is an important regulator of endocytic trafficking of the EGFR and functions in an EGFR trafficking complex that includes EEA1 and GAPex5.	[Chua, Christelle En Lin; Tang, Bor Luen] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore; [Chua, Christelle En Lin; Tang, Bor Luen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Chua, CEL (corresponding author), Natl Univ Singapore, Dept Biochem, Block MD7,8 Med Dr,01-05, Singapore 117597, Singapore.	g0901904@nus.edu.sg; bchtbl@nus.edu.sg	Tang, Bor Luen/E-4548-2012	Tang, Bor Luen/0000-0002-1925-636X	National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS)	National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS)	This work was supported by the National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS).	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Grismayer B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-62; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Kauppi M, 2002, J CELL SCI, V115, P899; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; Kunkle BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064140; Li L, 2001, J BIOL CHEM, V276, P5265, DOI 10.1074/jbc.M003883200; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Mills IG, 2001, J CELL SCI, V114, P1959; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Ng EL, 2009, J CELL PHYSIOL, V221, P716, DOI 10.1002/jcp.21911; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Segev N., 2001, SCI STKE, V2001, pre11; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P33, DOI 10.1016/j.semcdb.2010.11.005; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Tong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064817; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Yang X, 2012, BIOCHEM BIOPH RES CO, V421, P651, DOI 10.1016/j.bbrc.2012.04.049; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	46	31	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12375	12389		10.1074/jbc.M114.548321	http://dx.doi.org/10.1074/jbc.M114.548321			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644286	Green Published, hybrid			2022-12-28	WOS:000335581400016
J	Kronert, WA; Melkani, GC; Melkani, A; Bernstein, SI				Kronert, William A.; Melkani, Girish C.; Melkani, Anju; Bernstein, Sanford I.			Mapping Interactions between Myosin Relay and Converter Domains That Power Muscle Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Drosophila; Electron Microscopy (EM); Myosin; Skeletal Muscle; Myofibril	DROSOPHILA INDIRECT FLIGHT; HEAVY-CHAIN; MOLECULAR MOTOR; RECOVERY STROKE; ATP HYDROLYSIS; CONFORMATIONAL-CHANGES; LEVER ARM; MELANOGASTER; MECHANISM; DICTYOSTELIUM	Background: Dissecting the molecular mechanism of muscle myosin function in vivo has proved difficult. Results: Transgenic fruit flies expressing mutant myosin and potential suppressor mutations suggest interacting amino acids. Conclusion: Communication between a relay domain residue and one in the converter is likely critical to myosin motor function. Significance: The transgenic system allows mapping of putative protein interactions essential for muscle contraction. Intramolecular communication within myosin is essential for its function as motor, but the specific amino acid residue interactions required are unexplored within muscle cells. Using Drosophila melanogaster skeletal muscle myosin, we performed a novel in vivo molecular suppression analysis to define the importance of three relay loop amino acid residues (Ile(508), Asn(509), and Asp(511)) in communicating with converter domain residue Arg(759). We found that the N509K relay mutation suppressed defects in myosin ATPase, in vitro motility, myofibril stability, and muscle function associated with the R759E converter mutation. Through molecular modeling, we define a mechanism for this interaction and suggest why the I508K and D511K relay mutations fail to suppress R759E. Interestingly, I508K disabled motor function and myofibril assembly, suggesting that productive relay-converter interaction is essential for both processes. We conclude that the putative relay-converter interaction mediated by myosin residues 509 and 759 is critical for the biochemical and biophysical function of skeletal muscle myosin and the normal ultrastructural and mechanical properties of muscle.	[Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Bernstein, SI (corresponding author), San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu		Melkani, Girish/0000-0003-0353-4633; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [R01 GM32443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM32443 (to S. I. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Baumketner A, 2012, PROTEINS, V80, P2701, DOI 10.1002/prot.24155; BECKER KD, 1992, J CELL BIOL, V116, P669, DOI 10.1083/jcb.116.3.669; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Bloemink MJ, 2011, J BIOL CHEM, V286, P28435, DOI 10.1074/jbc.M111.258228; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Caldwell JT, 2012, METHODS, V56, P25, DOI 10.1016/j.ymeth.2011.12.002; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEORGE EL, 1989, MOL CELL BIOL, V9, P2957, DOI 10.1128/MCB.9.7.2957; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Highsmith S, 2000, BIOCHEMISTRY-US, V39, P12330, DOI 10.1021/bi001146d; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2010, J MOL BIOL, V398, P625, DOI 10.1016/j.jmb.2010.03.049; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Ramanath S, 2011, BIOPHYS J, V101, P1114, DOI 10.1016/j.bpj.2011.07.045; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Suzuki Y, 2000, METHODS, V22, P355, DOI 10.1006/meth.2000.1087; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Swank DM, 2012, METHODS, V56, P69, DOI 10.1016/j.ymeth.2011.10.015; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wang Y, 2012, MOL BIOL CELL, V23, P2057, DOI 10.1091/mbc.E12-02-0120; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Yang CX, 2008, BIOPHYS J, V95, P5228, DOI 10.1529/biophysj.108.136192; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Zhang SX, 2001, MECH DEVELOP, V101, P35, DOI 10.1016/S0925-4773(00)00549-9	45	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12779	12790		10.1074/jbc.M114.550673	http://dx.doi.org/10.1074/jbc.M114.550673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627474	Green Published, hybrid			2022-12-28	WOS:000335581400047
J	Vangala, JR; Dudem, S; Jain, N; Kalivendi, SV				Vangala, Janakiram Reddy; Dudem, Srikanth; Jain, Nishant; Kalivendi, Shasi V.			Regulation of PSMB5 Protein and beta Subunits of Mammalian Proteasome by Constitutively Activated Signal Transducer and Activator of Transcription 3 ( STAT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Chemoresistance; Epidermal Growth Factor (EGF); Proteasome; STAT3	PROSTATE-CANCER CELLS; NF-KAPPA-B; BORTEZOMIB RESISTANCE; GENE-EXPRESSION; NUCLEAR FACTOR; MULTIPLE-MYELOMA; INHIBITOR; APOPTOSIS; PATHWAY; DEGRADATION	Background: Malignancies are frequently associated with altered abundance of proteasome and elevated proteasome activity. Results: EGF-induced PSMB5 expression requires STAT3 activation. Conclusion: The catalytic subunits and activities of the mammalian proteasome are regulated by STAT3. Significance: Proteasome function is regulated by oncogenic signaling. The ubiquitin-proteasome system facilitates the degradation of ubiquitin-tagged proteins and performs a regulatory role in cells. Elevated proteasome activity and subunit expression are found in several cancers. However, the inherent molecular mechanisms responsible for increased proteasome function in cancers remain unclear despite the well investigated and defined role of the mammalian proteasome. This study was initiated to elucidate the mechanisms involved in the regulation of subunits of the mammalian proteasome. Suppression of STAT3 tyrosine phosphorylation coordinately decreased the mRNA and protein levels of the subunits of the 20 S core complex in DU145 cells. Notably, PSMB5, a molecular target of bortezomib, was shown to be a target of STAT3. Knockdown of STAT3 decreased PSMB5 protein. Inhibition of phospho-STAT3 substantially reduced PSMB5 protein levels in cells expressing constitutively active-STAT3. Accumulation of activated STAT3 resulted in the induction of PSMB5 promoter and protein levels. In addition, a direct correlation was observed between the endogenous levels of PSMB5 and constitutively active STAT3. PSMB5 and STAT3 protein levels remained unaltered following the inhibition of proteasome activity. The EGF-induced concerted increase of subunits was blocked by inhibition of the EGF receptor or STAT3 but not by the PI3K/AKT or MEK/ERK pathways. Decreased proteasome activities were due to reduced protein levels of catalytic subunits of the proteasome in STAT3-inhibited cells. Combined treatments with bortezomib and inhibitor of STAT3 abrogated proteasome activity and enhanced cellular apoptosis. Overall, we demonstrate that aberrant activation of STAT3 regulates the expression of subunits, in particular PSMB5, and the catalytic activity of the proteasome.	[Vangala, Janakiram Reddy; Dudem, Srikanth; Jain, Nishant; Kalivendi, Shasi V.] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad 500607, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Jain, N (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Uppal Rd, Hyderabad 500607, Andhra Pradesh, India.	nishant@iict.res.in; kalivendi@iict.res.in		Dudem, Srikanth/0000-0003-4601-2771; Jain, Nishant/0000-0003-3260-2543	Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR) SMiLE Project, India [CSC-0111]; Indian Council of Medical Research	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR) SMiLE Project, India; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Science and Technology, India (to S. V. K.); by Council of Scientific and Industrial Research (CSIR) SMiLE Project CSC-0111, India (to S. V. K.); and by a senior research fellowship from the Indian Council of Medical Research (to V. J. R.).	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; de Wilt LHAM, 2012, BIOCHEM PHARMACOL, V83, P207, DOI 10.1016/j.bcp.2011.10.009; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jain N, 2005, J BIOL CHEM, V280, P36664, DOI 10.1074/jbc.M413261200; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kraus M, 2007, LEUKEMIA, V21, P84, DOI 10.1038/sj.leu.2404414; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Li CY, 2009, MOL CANCER THER, V8, P2211, DOI 10.1158/1535-7163.MCT-09-0327; Lichter DI, 2012, BLOOD, V120, P4513, DOI 10.1182/blood-2012-05-426924; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mora LB, 2002, CANCER RES, V62, P6659; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Politou M, 2006, LEUKEMIA RES, V30, P240, DOI 10.1016/j.leukres.2005.06.014; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xie YM, 2010, CANCER METAST REV, V29, P687, DOI 10.1007/s10555-010-9255-y; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhou J, 2010, BIOCHEM PHARMACOL, V79, P1242, DOI 10.1016/j.bcp.2009.12.014	51	47	49	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12612	12622		10.1074/jbc.M113.542829	http://dx.doi.org/10.1074/jbc.M113.542829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24627483	hybrid, Green Published			2022-12-28	WOS:000335581400033
J	Yao, Q; Liu, BQ; Li, H; McGarrigle, D; Xing, BW; Zhou, MT; Wang, Z; Zhang, JJ; Huang, XY; Guo, L				Yao, Qi; Liu, Bing-Qian; Li, Hui; McGarrigle, Deirdre; Xing, Bo-Wen; Zhou, Mao-Tian; Wang, Zhe; Zhang, J. Jillian; Huang, Xin-Yun; Guo, Lin			C-terminal Src Kinase ( Csk)-mediated Phosphorylation of Eukaryotic Elongation Factor 2 ( eEF2) Promotes Proteolytic Cleavage and Nuclear Translocation of eEF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Nuclear Translocation; Phosphorylation; Sumoylation; Translation Elongation Factors; Csk; Nuclear Pleomorphism; Proteolytic Cleavage	PROTEIN-TYROSINE KINASE; FACTOR-II; RABBIT RETICULOCYTES; FAMILY KINASES; CELL-CYCLE; CSK GENE; CANCER; SUMO; OVEREXPRESSION; IDENTIFICATION	Background: The C-terminal Src kinase (Csk) is known as a tumor suppressor, but Src-independent function is unclear. Results: eEF2 is a new protein substrate of Csk. Conclusion: eEF2 phosphorylation and SUMOylation promote its proteolytic cleavage and nuclear localization. Significance: Our findings suggest that a tyrosine kinase can be both a tumor suppressor and a promoter through regulation of different substrate proteins. Protein-tyrosine kinase C-terminal Src kinase (Csk) was originally purified as a kinase for phosphorylating Src and other Src family kinases. The phosphorylation of a C-terminal tyrosine residue of Src family kinases suppresses their kinase activity. Therefore, most physiological studies regarding Csk function have been focused on Csk as a negative regulator of Src family tyrosine kinases and as a potential tumor suppressor. Paradoxically, the protein levels of Csk were elevated in some human carcinomas. In this report, we show that eukaryotic elongation factor 2 (eEF2) is a new protein substrate of Csk and could locate in the nucleus. We demonstrate that Csk-mediated phosphorylation of eEF2 has no effect on its cytoplasmic function in regulating protein translation. However, phosphorylation of eEF2 enhances its proteolytic cleavage and the nuclear translocation of the cleaved eEF2 through a SUMOylation-regulated process. Furthermore, we show that cleaved fragments of eEF2 can induce nuclear morphological changes and aneuploidy similar to those in cancer cells, suggesting that there is an additional mechanism for Csk in tumorigenesis through regulation of eEF2 subcellular localization.	[Yao, Qi; Liu, Bing-Qian; Li, Hui; Xing, Bo-Wen; Zhou, Mao-Tian; Wang, Zhe; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [McGarrigle, Deirdre; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu; guol@whu.edu.cn	Wang, Zhe/GZB-1109-2022	Wang, Zhe/0000-0001-7071-3370	National Institutes of Health [HL091525]; National Science Foundation of China [31028015, 31221061]; National Basic Research Program of China [2013CB911102]; 111 Project of China [B06018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 111 Project of China(Ministry of Education, China - 111 Project); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091525 (to X.-Y. H.). This work was also supported by National Science Foundation of China Grants 31028015 and 31221061, National Basic Research Program of China Grant 2013CB911102, and the 111 Project of China Grant B06018 (to L. G.).	Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Benistant C, 2001, CANCER RES, V61, P1415; Bermek E, 1978, Prog Nucleic Acid Res Mol Biol, V21, P63, DOI 10.1016/S0079-6603(08)60267-6; BOLEN JB, 1993, ONCOGENE, V8, P2025; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Chen CY, 2011, CANCER SCI, V102, P1582, DOI 10.1111/j.1349-7006.2011.01975.x; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Duesberg P, 2004, IUBMB LIFE, V56, P65, DOI 10.1080/15216540410001667902; Duprez E, 1999, J CELL SCI, V112, P381; Gevaert K, 2005, PROTEOMICS, V5, P3589, DOI 10.1002/pmic.200401217; GIOVANE A, 1987, BIOCHEM J, V244, P337, DOI 10.1042/bj2440337; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; HINCKE MT, 1992, BIOCHEM J, V282, P877, DOI 10.1042/bj2820877; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kimura M, 2013, J BIOL CHEM, V288, P24540, DOI 10.1074/jbc.M113.489286; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miller MA, 2000, ONCOGENE, V19, P3925, DOI 10.1038/sj.onc.1203714; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Miura Y, 2007, J BIOCHEM, V142, P145, DOI 10.1093/jb/mvm118; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Parrado J, 1999, FREE RADICAL BIO MED, V26, P362, DOI 10.1016/S0891-5849(98)00202-0; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sedek M, 2013, BIOCHEM J, V453, P231, DOI 10.1042/BJ20121375; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; WATANABE N, 1995, JPN J CLIN ONCOL, V25, P5; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	57	15	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12666	12678		10.1074/jbc.M113.546481	http://dx.doi.org/10.1074/jbc.M113.546481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648518	hybrid, Green Published			2022-12-28	WOS:000335581400038
J	Tsvetkov, P; Myers, N; Eliav, R; Adamovich, Y; Hagai, T; Adler, J; Navon, A; Shaul, Y				Tsvetkov, Peter; Myers, Nadav; Eliav, Raz; Adamovich, Yaarit; Hagai, Tzachi; Adler, Julia; Navon, Ami; Shaul, Yosef			NADH Binds and Stabilizes the 26S Proteasomes Independent of ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; ATPases; Magnesium; NADH; Proteasome; Protein Degradation; Psmc1; Rotenone	DNA-BINDING; PROTEIN; COMPLEX; NAD(+); 20S; SPECIFICITY; ACTIVATION; MECHANISMS; ATPASES; TERMINI	Background: 26S proteasome complex is highly dependent on ATP. Results: NADH binds the proteasome via the Psmc1 subunit resulting in ATP-independent stabilization of the 26S proteasome complex, in vitro and in cells. Conclusion: NADH is a novel regulator of the 26S proteasome. Significance: NADH can maintain proteasomal integrity in the absence of ATP, linking cellular redox state to protein degradation. The 26S proteasome is the end point of the ubiquitin- and ATP-dependent degradation pathway. The 26S proteasome complex (26S PC) integrity and function has been shown to be highly dependent on ATP and its homolog nucleotides. We report here that the redox molecule NADH binds the 26S PC and is sufficient in maintaining 26S PC integrity even in the absence of ATP. Five of the 19S proteasome complex subunits contain a putative NADH binding motif (GxGxxG) including the AAA-ATPase subunit, Psmc1 (Rpt2). We demonstrate that recombinant Psmc1 binds NADH via the GxGxxG motif. Introducing the GxGxxG Psmc1 mutant into cells results in reduced NADH-stabilized 26S proteasomes and decreased viability following redox stress induced by the mitochondrial inhibitor rotenone. The newly identified NADH binding of 26S proteasomes advances our understanding of the molecular mechanisms of protein degradation and highlights a new link between protein homeostasis and the cellular metabolic/redox state.	[Tsvetkov, Peter; Myers, Nadav; Eliav, Raz; Adamovich, Yaarit; Adler, Julia; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Hagai, Tzachi] Univ Calif San Francisco, San Francisco Sch Med, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California San Francisco	Tsvetkov, P (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	petert@wi.mit.edu; yosef.shaul@weizmann.ac.il	Tsvetkov, Peter/J-9878-2019; Hagai, Tzachi/AAL-8758-2021	Tsvetkov, Peter/0000-0002-7577-2342; Adamovich, Yaarit/0000-0001-9583-0338; Tzachi, Hagai/0000-0002-4575-6624	Israel Science Foundation [551/11]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 551/11.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Berko D, 2012, MOL CELL, V48, P601, DOI 10.1016/j.molcel.2012.08.029; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Chou AP, 2010, NEUROTOXICOLOGY, V31, P367, DOI 10.1016/j.neuro.2010.04.006; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; McLure KG, 2004, MOL CELL BIOL, V24, P9958, DOI 10.1128/MCB.24.22.9958-9967.2004; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Tai H. C., 2010, FRONT MOL NEUROSCI, DOI [10.3389/fnmol.2010.00012, DOI 10.3389/FNMOL. 2010. 00012]; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Um JW, 2010, J NEUROSCI, V30, P11805, DOI 10.1523/JNEUROSCI.2862-09.2010; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	41	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11272	11281		10.1074/jbc.M113.537175	http://dx.doi.org/10.1074/jbc.M113.537175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596095	Green Published, hybrid			2022-12-28	WOS:000334638500030
J	Landrum, E; Wetzel, R				Landrum, Elizabeth; Wetzel, Ronald			Biophysical Underpinnings of the Repeat Length Dependence of Polyglutamine Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Huntington Disease; Kinetics; Polyglutamine; Protein Aggregation; Protein Stability; Nucleation; Repeat Length	HUNTINGTONS-DISEASE; AGGREGATION NUCLEATION; MUTANT HUNTINGTIN; IN-VITRO; MOLECULAR-MECHANISMS; PROTEIN AGGREGATION; FIBRIL ELONGATION; OLIGOMERS; PEPTIDES; TOXICITY	Background: The molecular basis for the repeat length dependence of disease risk in polyglutamine diseases is not known. Results: We show here a nonlinear dependence of aggregation propensity versus polyglutamine repeat length that qualitatively mirrors how age of onset depends on repeat length. Conclusion: This provides further support for a role for aggregation in these diseases. Significance: This lends support to therapeutic strategies targeting aggregation. There are now 10 expanded CAG repeat diseases in which both disease risk and age of onset are strongly dependent on the repeat length of the polyglutamine (polyQ) sequence in the disease protein. Large, polyQ-rich inclusions in patient brains and in cell and animal models are consistent with the involvement of polyQ aggregation in the disease mechanism. This possibility is reinforced by studies showing strong repeat length dependence to the aggregation process, qualitatively mirroring the repeat length dependence of disease risk. Our understanding of the underlying biophysical principles that mediate the repeat length dependence of aggregation, however, is far from complete. A previous study of simple polyQ peptides showed that N*, the size of the critical nucleus that controls onset of aggregation, decreases from unfavorable tetramer to favorable monomer over the range Q(23) to Q(26). These data, however, do not explain why, for all peptides exhibiting N* approximate to 1, spontaneous aggregation rates continue to increase with increasing repeat length. Here we describe a novel kinetics analyses that maps out the nonlinear dependence with repeat length of a nucleation efficiency term that is likely related to aspects of nucleus structure. This trend accounts for why nucleus size increases to tetrameric at repeat lengths of Q(23) or below. Intriguingly, both aggregation and age of onset trend with repeat length in similar ways, exhibiting large changes per added Gln at low repeat lengths and small changes per added Gln at relatively long repeat lengths. Fibril stability also increases with repeat length in a nonlinear fashion.	[Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	rwetzel@pitt.edu	Wetzel, Ronald/G-7453-2011		National Institutes of Health [R01 AG019322, R01 GM099718]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG019322 and R01 GM099718.	Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; BATES G, 2002, HUNTINGTONS DIS; Bates G. P., 2002, HUNTINGTONS DIS, P429; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hughes A, 2014, HUNTINGTONS DIS, P323; Jayaraman M, 2011, METHODS, V53, P246, DOI 10.1016/j.ymeth.2011.01.001; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Kar K, 2013, J MOL BIOL, V425, P1183, DOI 10.1016/j.jmb.2013.01.016; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kurouski D, 2013, FEBS LETT, V587, P1638, DOI 10.1016/j.febslet.2013.03.038; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nakano M, 2013, J MOL MODEL, V19, P1627, DOI 10.1007/s00894-012-1712-9; Nakano M, 2010, J PHYS CHEM B, V114, P7056, DOI 10.1021/jp9122024; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Snowden J., 2014, HUNTINGTONS DIS, P36; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; van Eyk CL, 2012, ADV EXP MED BIOL, V769, P55; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006; Wetzel R., 2014, HUNTINGTONS DIS, P274; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	54	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10254	10260		10.1074/jbc.C114.552943	http://dx.doi.org/10.1074/jbc.C114.552943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596088	Green Published, hybrid			2022-12-28	WOS:000334226400001
